Citrus Sinensis ID: 017621

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------37
Protein Sequence
MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTSAKAPPPHHKGNDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPASEWWH
Secondary Structure (PSIPRED)
cccccccccccHHccccccccEEEcccccccccccHHHHccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEcccccccHHHHHHHHHccccccEEEEcccccEEEEEcccccEEEEEEEEcccccccccHHHHHHHHHHHHcccccccccccEEEEcccccEEEEcccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccHHHccccccEEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHccccEEcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHccccccccHHHHcccccEEcHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEcccccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEcccHHHHEEcccHccEEEcHHcHHHHccccccEEEEEEcccccccHHHHccc
Coil and Loop (DISEMBL)
mynnkldgpipqelmncSKLRILILGNnllsgsisseigklqelnyldlshnlingkipsqlgeipridtvnlsmnnlsgsipesvkkvpllyvsgnnfeveipstsakappphhkgndkKIATRLVAIILPMSAFLALIFGILFVRrrrdkkveptetgeitkcadefaiwnydgritFQDMIEATEDFHIKYcigtggygsvyrarlpsgkvVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFcvlrtdeeavgldWAKRVNIVKGMAHALSYLhhhctppivhrdissnnvLLNSELEAFVADFGVArllnfdssnrtllagtsgyiapasewwh
Flexible Loop (DISEMBL)
mynnkldgpipqELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIpstsakappphhkGNDKKIATRLVAIILPMSAFLALIFGILFVRRRRdkkveptetgeitkcadefaiWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFdssnrtllagtsgyiapasewwh
Low Complexity Region (SEG)
MYNNKLDGPIPQELMNCSKLRililgnnllsgsisseigKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTSAKAPPPHHKGNDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPASEWWH
Disordered region (IsUnstruct)
*************LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEV********************IATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLH*********LESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPASEW**
Disordered Region (DISOPRED)
MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEI***********************VAIILPMSAFLALIFGILFVRRR********************AIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHR**********SFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPASEWW*
Disordered Region (DISEMBL)
MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPS*************DKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPASEWWH
Disordered Region (DISPRO)
**NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTSAKAPPPHHKGNDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVE***TGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPASEWWH
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTSAKAPPPHHKGNDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPASEWWH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	368	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.961	0.338	0.425	2e-77
Q9LP24	1120	Probable leucine-rich rep	no	no	0.959	0.315	0.407	3e-71
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.970	0.324	0.363	3e-57
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.959	0.292	0.368	3e-57
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.961	0.293	0.361	1e-56
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.970	0.285	0.362	3e-55
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.970	0.285	0.355	6e-54
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.970	0.323	0.360	1e-52
C0LGX3	993	LRR receptor-like serine/	no	no	0.913	0.338	0.384	5e-51
C0LGU5	614	Probable LRR receptor-lik	no	no	0.937	0.561	0.354	6e-51

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  289 bits (740), Expect = 2e-77,   Method: Compositional matrix adjust.
 Identities = 158/371 (42%), Positives = 232/371 (62%), Gaps = 17/371 (4%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
           N LD  IP+ L   S+L++L L  N L G ISS+   LQ L  LDLSHN ++G+IP    
Sbjct: 584 NDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFK 643

Query: 64  EIPRIDTVNLSMNNLSGSIPESV--KKVPLLYVSGN-------NFEVEIPSTSAKAPPPH 114
           ++  +  V++S NNL G IP++   +  P     GN       N    +   S  +    
Sbjct: 644 DMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKS 703

Query: 115 HKGNDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNY 174
           HK  D+ +   ++  I+     L++  GI    R+R K++E  E  +     +  +I+++
Sbjct: 704 HK--DRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIE--EHTDSESGGETLSIFSF 759

Query: 175 DGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELA---SL 231
           DG++ +Q++I+AT +F  KY IGTGG+G VY+A+LP+  ++A+KKL+ +    ++   + 
Sbjct: 760 DGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTK 818

Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK 291
           + F NE R L++I HRN+VKL+GFC HR+  FL+YEYME GSL  VL  D+EA  LDW K
Sbjct: 819 QEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGK 878

Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
           R+N+VKG+AHALSY+HH  +P IVHRDISS N+LL  + EA ++DFG A+LL  DSSN +
Sbjct: 879 RINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWS 938

Query: 352 LLAGTSGYIAP 362
            +AGT GY+AP
Sbjct: 939 AVAGTYGYVAP 949

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  268 bits (686), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 162/398 (40%), Positives = 229/398 (57%), Gaps = 45/398 (11%)

Query: 1    MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
            + +N     IPQ   +  KL  + L  N   GSI   + KL +L  LDLSHN ++G+IPS
Sbjct: 637  LSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPS 695

Query: 61   QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLY---VSGNNFEVEIPSTSA--------- 108
            QL  +  +D ++LS NNLSG IP + + +  L    +S N  E  +P T           
Sbjct: 696  QLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADAL 755

Query: 109  -------------KAPPPHHKGNDKKIATRLVAIILPMSAFLAL--IFGILF---VRRRR 150
                         +  P       KK    +V I++P+   L +  I    F   +R+R+
Sbjct: 756  EENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRK 815

Query: 151  ---DKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRA 207
                +  +P ETGE        +I++ DG+  +QD+IE+T +F   + IGTGGY  VYRA
Sbjct: 816  LQNGRNTDP-ETGE------NMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRA 868

Query: 208  RLPSGKVVALKKLHRSETEELAS---LESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL 264
             L    ++A+K+LH +  EE++     + F NE + L++I HRN+VKL+GFC HR+  FL
Sbjct: 869  NL-QDTIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFL 927

Query: 265  IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV 324
            IYEYME GSL  +L  DEEA  L W KR+N+VKG+AHALSY+HH    PIVHRDISS N+
Sbjct: 928  IYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNI 987

Query: 325  LLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            LL+++  A ++DFG A+LL  DSSN + +AGT GY+AP
Sbjct: 988  LLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAP 1025

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  222 bits (566), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 145/399 (36%), Positives = 208/399 (52%), Gaps = 42/399 (10%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNY-LDLSHNLINGKIP 59
           + +N+L G IP    + ++L  L LG NLLS +I  E+GKL  L   L++SHN ++G IP
Sbjct: 578 LSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIP 637

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYV---SGNNFEVEIPSTS--------- 107
             LG +  ++ + L+ N LSG IP S+  +  L +   S NN    +P T+         
Sbjct: 638 DSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSN 697

Query: 108 ------------AKAPP--PH---------HKGNDKKIATRLVAIILPMSAFLALIFGIL 144
                       +   P  PH         +    +KI T  +  I+  S FL    G+ 
Sbjct: 698 FAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILT--ITCIVIGSVFLITFLGLC 755

Query: 145 FVRRRRDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSV 204
           +  +RR+      E        D +  +      T+Q +++AT +F     +G G  G+V
Sbjct: 756 WTIKRREPAFVALEDQTKPDVMDSY--YFPKKGFTYQGLVDATRNFSEDVVLGRGACGTV 813

Query: 205 YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL 264
           Y+A +  G+V+A+KKL+ S  E  +S  SFR E   L +I HRNIVKLYGFC H+    L
Sbjct: 814 YKAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLL 872

Query: 265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV 324
           +YEYM  GSL   L+  E+   LDW  R  I  G A  L YLHH C P IVHRDI SNN+
Sbjct: 873 LYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNI 932

Query: 325 LLNSELEAFVADFGVARLLNFD-SSNRTLLAGTSGYIAP 362
           LL+   +A V DFG+A+L++   S + + +AG+ GYIAP
Sbjct: 933 LLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAP 971

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  222 bits (566), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 145/394 (36%), Positives = 219/394 (55%), Gaps = 41/394 (10%)

Query: 4    NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
            NKL+G IP+EL     L IL LG+N LSG I  ++G L+ +  LDLS+N  NG IP+ L 
Sbjct: 673  NKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLT 732

Query: 64   EIPRIDTVNLSMNNLSGSIPESV--KKVPLLYVSGNN---FEVEIPSTSA-KAPPPHHKG 117
             +  +  ++LS NNLSG IPES      P    + N+   + + IP +S  K+    H+ 
Sbjct: 733  SLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNSLCGYPLPIPCSSGPKSDANQHQK 792

Query: 118  NDKKIATRLVAIILPMSAFLALIFGILFV-------RRRRDKKVEPTETGEITKCADEFA 170
            + ++ A+   ++ + +   L  IFG++ V       RR+++  +E    G  +  A   +
Sbjct: 793  SHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGH-SHSATANS 851

Query: 171  IWNYDG-----------------RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGK 213
             W +                   ++TF D++EAT  FH    +G+GG+G VY+A+L  G 
Sbjct: 852  AWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGS 911

Query: 214  VVALKKL-HRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMG 272
            VVA+KKL H S   +      F  E   + +I HRN+V L G+C   +   L+YEYM+ G
Sbjct: 912  VVAIKKLIHVSGQGD----REFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYG 967

Query: 273  SLFCVLRTDEEAVG--LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL 330
            SL  VL  D + +G  L+W  R  I  G A  L++LHH+C P I+HRD+ S+NVLL+  L
Sbjct: 968  SLEDVLH-DRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENL 1026

Query: 331  EAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
            EA V+DFG+ARL++   ++ ++  LAGT GY+ P
Sbjct: 1027 EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1060

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  221 bits (562), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 142/393 (36%), Positives = 218/393 (55%), Gaps = 39/393 (9%)

Query: 4    NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
            NKL+G IP+EL     L IL LG+N LSG I  ++G L+ +  LDLS+N  NG IP+ L 
Sbjct: 673  NKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLT 732

Query: 64   EIPRIDTVNLSMNNLSGSIPESV--KKVPLLYVSGNN---FEVEIPSTSA-KAPPPHHKG 117
             +  +  ++LS NNLSG IPES      P    + N+   + + +P +S  K+    H+ 
Sbjct: 733  SLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNSLCGYPLPLPCSSGPKSDANQHQK 792

Query: 118  NDKKIATRLVAIILPMSAFLALIFGILFV-------RRRRDKKVEPTETGEITKCADEFA 170
            + ++ A+   ++ + +   L  IFG++ V       RR+++  +E    G  +  A   +
Sbjct: 793  SHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGH-SHSATANS 851

Query: 171  IWNYDG-----------------RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGK 213
             W +                   ++TF D++EAT  FH    +G+GG+G VY+A+L  G 
Sbjct: 852  AWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGS 911

Query: 214  VVALKKL-HRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMG 272
            VVA+KKL H S   +      F  E   + +I HRN+V L G+C   +   L+YEYM+ G
Sbjct: 912  VVAIKKLIHVSGQGD----REFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYG 967

Query: 273  SLFCVLRTDEE-AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE 331
            SL  VL   ++  + L+W  R  I  G A  L++LHH+C P I+HRD+ S+NVLL+  LE
Sbjct: 968  SLEDVLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLE 1027

Query: 332  AFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
            A V+DFG+ARL++   ++ ++  LAGT GY+ P
Sbjct: 1028 ARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1060

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  215 bits (548), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 147/406 (36%), Positives = 220/406 (54%), Gaps = 49/406 (12%)

Query: 4    NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQEL-NYLDLSHNLINGKIPSQL 62
            N+  G +PQ +   SKL  L L  N L+G I  EIG+LQ+L + LDLS+N   G IPS +
Sbjct: 729  NQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTI 788

Query: 63   GEIPRIDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIPSTSAKAPPPHHKGN- 118
            G + +++T++LS N L+G +P SV   K +  L VS NN   ++    ++ P     GN 
Sbjct: 789  GTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNT 848

Query: 119  ------------------DKKIATRLVAIILPMSAFLALIFGIL----FVRRRRD--KKV 154
                               + ++ R V II  +SA  A+   IL    F ++R D  KKV
Sbjct: 849  GLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKV 908

Query: 155  EPTETGEITKCADEFAIWN-------YDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRA 207
                T   +  +   A              I ++D++EAT +   ++ IG+GG G VY+A
Sbjct: 909  GHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKA 968

Query: 208  RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK--CMFLI 265
             L +G+ VA+KK+   +  +L S +SF  E + L +I HR++VKL G+C  +      LI
Sbjct: 969  ELENGETVAVKKILWKD--DLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLI 1026

Query: 266  YEYMEMGSLFCVLRTDEEAVG-----LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDIS 320
            YEYM+ GS++  L  D+  +      LDW  R+ I  G+A  + YLHH C PPIVHRDI 
Sbjct: 1027 YEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIK 1086

Query: 321  SNNVLLNSELEAFVADFGVARLL----NFDSSNRTLLAGTSGYIAP 362
            S+NVLL+S +EA + DFG+A++L    + ++ + T  A + GYIAP
Sbjct: 1087 SSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAP 1132

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  211 bits (537), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 142/400 (35%), Positives = 221/400 (55%), Gaps = 43/400 (10%)

Query: 4    NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQEL-NYLDLSHNLINGKIPSQL 62
            N+L GP+P  +   SKL  L L  N L+G I  EIG+LQ+L + LDLS+N   G+IPS +
Sbjct: 730  NQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTI 789

Query: 63   GEIPRIDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIPSTSAK---------- 109
              +P++++++LS N L G +P  +   K +  L +S NN E ++    ++          
Sbjct: 790  STLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNA 849

Query: 110  ---APPPHH-----KGNDKKIATRLVAIILPMSAFLAL----IFGILFVRRRRD--KKVE 155
                 P  H       N + ++ + V II  +S+  A+    +  ILF ++  D  KKV 
Sbjct: 850  GLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVR 909

Query: 156  ----PTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPS 211
                   +   +  A  F+       I + D++EAT   + ++ IG+GG G VY+A L +
Sbjct: 910  GGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKN 969

Query: 212  GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK--CMFLIYEYM 269
            G+ +A+KK+   +  +L S +SF  E + L  I HR++VKL G+C  +      LIYEYM
Sbjct: 970  GETIAVKKILWKD--DLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYM 1027

Query: 270  EMGSLFCVLRTDEEAVG---LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL 326
              GS++  L  +E       L W  R+ I  G+A  + YLH+ C PPIVHRDI S+NVLL
Sbjct: 1028 ANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLL 1087

Query: 327  NSELEAFVADFGVARLL--NFDSS--NRTLLAGTSGYIAP 362
            +S +EA + DFG+A++L  N+D++  + T+ AG+ GYIAP
Sbjct: 1088 DSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAP 1127

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  207 bits (526), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 144/399 (36%), Positives = 210/399 (52%), Gaps = 42/399 (10%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNY-LDLSHNLINGKIP 59
           + NN L G IP  L N S+L  L +G NL +GSI  E+G L  L   L+LS+N + G+IP
Sbjct: 584 LSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIP 643

Query: 60  SQL-----------------GEIPR-------IDTVNLSMNNLSGSIPESVKKVPLLYVS 95
            +L                 GEIP        +   N S N+L+G IP  ++ + +    
Sbjct: 644 PELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP-LLRNISMSSFI 702

Query: 96  GNNFEVEIP-----STSAKAPPPHHKGNDKKIATRLVAIILPM--SAFLALIFGILFVRR 148
           GN      P      T   AP           +++++AI   +     L LI  I+++ R
Sbjct: 703 GNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMR 762

Query: 149 RRDKKVEPT-ETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRA 207
           R  + V  + + G+ ++ + +      +G  TFQD++ AT++F   + +G G  G+VY+A
Sbjct: 763 RPVRTVASSAQDGQPSEMSLDIYFPPKEG-FTFQDLVAATDNFDESFVVGRGACGTVYKA 821

Query: 208 RLPSGKVVALKKL---HRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL 264
            LP+G  +A+KKL   H           SFR E   L  I HRNIVKL+GFC H+    L
Sbjct: 822 VLPAGYTLAVKKLASNHEGGNNNNVD-NSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLL 880

Query: 265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV 324
           +YEYM  GSL  +L   + +  LDW+KR  I  G A  L+YLHH C P I HRDI SNN+
Sbjct: 881 LYEYMPKGSLGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNI 938

Query: 325 LLNSELEAFVADFGVARLLNFD-SSNRTLLAGTSGYIAP 362
           LL+ + EA V DFG+A++++   S + + +AG+ GYIAP
Sbjct: 939 LLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAP 977

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  201 bits (512), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 146/380 (38%), Positives = 206/380 (54%), Gaps = 44/380 (11%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           M  N LDG IP  + +C++L  L L NN L G I  E+G L  LNYLDLS+N + G+IP+
Sbjct: 514 MQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPA 573

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTSAKAPPPHHKGNDK 120
           +L  + +++  N+S N L G IP               F+ +I   S    P     N  
Sbjct: 574 ELLRL-KLNQFNVSDNKLYGKIPSG-------------FQQDIFRPSFLGNPNLCAPNLD 619

Query: 121 KI----ATRLVAIILPMS--AFLALIFGI--LFVRRRRDKKVEPTETGEITKCADEFAIW 172
            I    + R    ILP+S    +AL   +  LF++ +   K +P  T +IT       I+
Sbjct: 620 PIRPCRSKRETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKRTNKIT-------IF 672

Query: 173 NYDGRITFQDMI-EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASL 231
              G  T +D+  + TED      IG+GG G VYR +L SG+ +A+KKL     ++  S 
Sbjct: 673 QRVG-FTEEDIYPQLTED----NIIGSGGSGLVYRVKLKSGQTLAVKKLWGETGQKTESE 727

Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE--AVG-LD 288
             FR+E   L ++ H NIVKL   C   +  FL+YE+ME GSL  VL +++E  AV  LD
Sbjct: 728 SVFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLD 787

Query: 289 WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           W  R +I  G A  LSYLHH   PPIVHRD+ SNN+LL+ E++  VADFG+A+ L  + +
Sbjct: 788 WTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDN 847

Query: 349 N------RTLLAGTSGYIAP 362
           +       + +AG+ GYIAP
Sbjct: 848 DGVSDVSMSCVAGSYGYIAP 867

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1

 Score =  201 bits (512), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 133/375 (35%), Positives = 199/375 (53%), Gaps = 30/375 (8%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           NN+L GPIP EL   S+L  L L  N  SG I + +G L  LNYL LS NL++G++P  +
Sbjct: 112 NNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQVPHLV 171

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPST---SAKAPPPHHKGND 119
             +  +  ++LS NNLSG  P    K     + GN F     S    S   P  +  G  
Sbjct: 172 AGLSGLSFLDLSFNNLSGPTPNISAKD--YRIVGNAFLCGPASQELCSDATPVRNATGLS 229

Query: 120 KKIATRLVAIILPMS---------AFLALIFGILFVRRRRDKKVEPTETGEITKCADEFA 170
           +K  ++  +++L  +         + + L F +L+ R R  +     +         EF 
Sbjct: 230 EKDNSKHHSLVLSFAFGIVVAFIISLMFLFFWVLWHRSRLSRSHVQQDY--------EFE 281

Query: 171 IWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRS-ETEELA 229
           I +   R +F+++  AT +F  K  +G GG+G VY+  LP+G VVA+K+L     T E+ 
Sbjct: 282 IGHLK-RFSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKDPIYTGEV- 339

Query: 230 SLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD-EEAVGLD 288
               F+ E  ++    HRN+++L+GFC+  +   L+Y YM  GS+   LR +  E   LD
Sbjct: 340 ---QFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLD 396

Query: 289 WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN-FDS 347
           W +R++I  G A  L YLH  C P I+HRD+ + N+LL+   EA V DFG+A+LL+  DS
Sbjct: 397 WNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDS 456

Query: 348 SNRTLLAGTSGYIAP 362
              T + GT G+IAP
Sbjct: 457 HVTTAVRGTIGHIAP 471

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	368
359488981	757	PREDICTED: probable LRR receptor-like se	0.956	0.464	0.546	1e-103
359488983	758	PREDICTED: probable LRR receptor-like se	0.956	0.464	0.544	1e-102
357501751	799	Receptor kinase [Medicago truncatula] gi	0.972	0.448	0.522	1e-101
225452698	727	PREDICTED: probable LRR receptor-like se	0.972	0.492	0.511	1e-100
147834735	513	hypothetical protein VITISV_033633 [Viti	0.951	0.682	0.528	4e-99
296085303	789	unnamed protein product [Vitis vinifera]	0.967	0.451	0.510	2e-98
359484066	843	PREDICTED: probable LRR receptor-like se	0.967	0.422	0.510	2e-98
225466223	736	PREDICTED: probable leucine-rich repeat	0.934	0.467	0.517	3e-98
225452751	878	PREDICTED: probable leucine-rich repeat	0.970	0.406	0.541	2e-97
296085307	874	unnamed protein product [Vitis vinifera]	0.964	0.406	0.510	3e-97

>gi|359488981|ref|XP_002275364.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  380 bits (977), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 206/377 (54%), Positives = 269/377 (71%), Gaps = 25/377 (6%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
           N++ G IP E+ +   L  L L  N +SG I  E+  L++L++LD+S+NLI+GKIPSQLG
Sbjct: 270 NQISGFIPPEIGHLLNLSYLDLSENQISGFIPEEMVNLKKLSHLDMSNNLISGKIPSQLG 329

Query: 64  EIPRIDTVNLSMNNLSGSIPESVK---KVPLLYVSGNNFEVEIPSTSAKAPPP---HHKG 117
            +  +   NLS NNLSG+IP S+    +  L+ +S N  E +     A+AP     H+KG
Sbjct: 330 NLKEVKYFNLSHNNLSGTIPYSISSNYRWTLIDLSNNRLEGQ-----ARAPVEAFGHNKG 384

Query: 118 ---------NDKKIATRLVAIILPMSAFLAL---IFGILFVRRRRDKKVEPTETGEITKC 165
                      KK     + I++ +S  L L   I G LF  +RR +K +  ET ++ K 
Sbjct: 385 LCGEIKGWARCKKRHQITLIIVVSLSTTLLLSVAILGFLF-HKRRIRKNQLLETTKV-KN 442

Query: 166 ADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSET 225
            D F+IW++DG I +QD+I+ATEDF IKYCIGTGGYGSVYRA+LPSGKVVALKKLH  E 
Sbjct: 443 GDLFSIWDFDGVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWER 502

Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 285
           E+   L+SF NE ++L++I HRNIVKL+GFCLH++CMFL+Y+YME GSL+C+LR + EAV
Sbjct: 503 EDPTYLKSFENEVQMLTRIRHRNIVKLHGFCLHKRCMFLVYKYMEKGSLYCMLRDEVEAV 562

Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            LDW KRVN+VK +A+ALSY+HH C  PI+HRDISSNN+LL+S+LEAFV+DFG ARLL+ 
Sbjct: 563 ELDWIKRVNVVKSIANALSYMHHDCDLPIIHRDISSNNILLDSKLEAFVSDFGTARLLDN 622

Query: 346 DSSNRTLLAGTSGYIAP 362
           DSSNRTLLAGT GYIAP
Sbjct: 623 DSSNRTLLAGTYGYIAP 639

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488983|ref|XP_002277433.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  379 bits (972), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 206/378 (54%), Positives = 266/378 (70%), Gaps = 26/378 (6%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
           N++ G IP E+     L  L L  N +SG I  EI  L++L++LD+S+NLI+GKIPSQLG
Sbjct: 270 NQISGFIPLEIWYLLNLSYLDLSENQISGFIPEEIVNLKKLSHLDMSNNLISGKIPSQLG 329

Query: 64  EIPRIDTVNLSMNNLSGSIPESVK----KVPLLYVSGNNFEVEIPSTSAKAPPP---HHK 116
            +  +   NLS NNLSG+IP S+     K  L+ +S N  E +      +AP     H+K
Sbjct: 330 NLKEVKYFNLSHNNLSGTIPYSISSNYNKWTLIDLSNNRLEGQ-----TRAPVEAFGHNK 384

Query: 117 GNDKKIATR---------LVAIILPMSAFLAL---IFGILFVRRRRDKKVEPTETGEITK 164
           G   +I  R          + I++ +S  L L   I G LF  +RR +K +  ET ++ K
Sbjct: 385 GLCGEIKGRPRCKKRHQITLIIVVSLSTTLLLSIAILGFLF-HKRRIRKNQLLETTKV-K 442

Query: 165 CADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSE 224
             D F+IW+YDG I +QD+I+ATEDF IKYCIGTGGYGSVYRA+LPSGKVVALKKLH  E
Sbjct: 443 NGDLFSIWDYDGVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWE 502

Query: 225 TEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEA 284
             +   L+SF NE ++L++I HRNIVKL+GFCLH++CMFL+Y+YME GSL+C+LR + EA
Sbjct: 503 RGDPTYLKSFENEVQMLTRIRHRNIVKLHGFCLHKRCMFLVYKYMEKGSLYCMLRDEVEA 562

Query: 285 VGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
           V LDW KRVN+VK +A+ALSY+HH C  PI+HRDISSNN+LL+S+LEAFV+DFG ARLL+
Sbjct: 563 VELDWIKRVNVVKSIANALSYMHHDCDLPIIHRDISSNNILLDSKLEAFVSDFGTARLLD 622

Query: 345 FDSSNRTLLAGTSGYIAP 362
            DSSNRTLL GT GYIAP
Sbjct: 623 NDSSNRTLLVGTYGYIAP 640

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357501751|ref|XP_003621164.1| Receptor kinase [Medicago truncatula] gi|355496179|gb|AES77382.1| Receptor kinase [Medicago truncatula]

 Score =  374 bits (961), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 198/379 (52%), Positives = 259/379 (68%), Gaps = 21/379 (5%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
           N   G IP  L NCS L++L L +N ++GSI S IG+L  L+ +DLSHNL++G+IP QLG
Sbjct: 315 NMFYGDIPTSLSNCSNLKVLNLSHNNITGSIPSHIGELVNLDLIDLSHNLLSGEIPYQLG 374

Query: 64  EIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPST-SAKAPPPHHKGND--- 119
            +     ++LS N+L G+IP S+  +  + +S N+ E +IPS+    A P    GN+   
Sbjct: 375 NVKYTRVLDLSHNHLIGTIPSSLVLLRNIDLSYNSLEGKIPSSLQDTAAPNAFIGNEFLC 434

Query: 120 -------------KKIATRL---VAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEIT 163
                         K  TRL   + I +P+ +FLAL+   L+V     K        + T
Sbjct: 435 NQFRYSTTCYSSPTKTNTRLKTHMKIFIPLISFLALLCS-LYVFLCWCKACSFISRTQTT 493

Query: 164 KCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRS 223
           K  D F+IWNYDG+I ++D+IEATE+F IKYCIG GGYGSVY+A LPSG+VVALKKLH  
Sbjct: 494 KNGDFFSIWNYDGKIAYEDIIEATENFDIKYCIGVGGYGSVYKANLPSGRVVALKKLHNL 553

Query: 224 ETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE 283
           E  E    + F+NE R+L++I HRNI+KLYGFCLH +CMFL+ EYME GSL+CVLR D E
Sbjct: 554 EANEPLIRKIFKNEVRMLTKIRHRNILKLYGFCLHNRCMFLVLEYMEKGSLYCVLRNDVE 613

Query: 284 AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           AV LDW KRV IVKG+A++LSYLH+ C P I+HRD+++ NVLLNSE+EA ++DFG+ARL 
Sbjct: 614 AVELDWCKRVEIVKGIANSLSYLHYDCEPAIIHRDVTTKNVLLNSEMEACLSDFGIARLR 673

Query: 344 NFDSSNRTLLAGTSGYIAP 362
           N  SSNRT+LAGT GYIAP
Sbjct: 674 NSSSSNRTVLAGTYGYIAP 692

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452698|ref|XP_002276923.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  370 bits (951), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 194/379 (51%), Positives = 257/379 (67%), Gaps = 21/379 (5%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
           N+L G IP    + S L  L L NN ++G I  +IG L++L  LDLS N I+GKIPSQ+ 
Sbjct: 229 NELSGDIPSSFGHLSNLISLCLNNNQINGPIPEDIGNLEDLVDLDLSSNSISGKIPSQIQ 288

Query: 64  EIPRIDTVNLSMNNLSGSIPESVK---KVPLLYVSGNNFEVEIP-STSAKAPP------- 112
            + R++ +NLS N LSG+IP S+    K   + +S N+ E  IP     ++PP       
Sbjct: 289 NLKRLENLNLSRNKLSGAIPPSLTYDYKWTSIDLSYNDLEGHIPFELQFESPPGVFEHNK 348

Query: 113 ---------PHHKGNDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEIT 163
                    PH K   K     +++++  +    A +  +L  R+ R  +       E T
Sbjct: 349 HLCGEIRHWPHCKKGQKITLILVISLLATLCIAFAFLKFLLLPRKMRKMRHMSASAAE-T 407

Query: 164 KCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRS 223
           +  D F++W+YDG I +QD+I++TE+F IKYC+G GGYGSVYRA+LP GKVVALKKLH  
Sbjct: 408 RRGDLFSVWDYDGTIAYQDIIQSTENFDIKYCVGVGGYGSVYRAQLPCGKVVALKKLHGW 467

Query: 224 ETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE 283
           E EE   L+SF NEA++LS+I HRNIVKL+GFCLHR+ MFL+Y++ME GSLFC+L  + E
Sbjct: 468 EREEPTYLKSFENEAQILSKIRHRNIVKLHGFCLHRRSMFLVYQFMERGSLFCMLSHEVE 527

Query: 284 AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           A+ LDW KR+N+VK +AHALSY+HH C+PPI+HRDISSNNVLLNS+LEAFV+DFG ARLL
Sbjct: 528 ALELDWTKRLNVVKSIAHALSYMHHDCSPPIIHRDISSNNVLLNSQLEAFVSDFGTARLL 587

Query: 344 NFDSSNRTLLAGTSGYIAP 362
           + DSS +TLL GT GYIAP
Sbjct: 588 DPDSSIQTLLVGTYGYIAP 606

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147834735|emb|CAN59749.1| hypothetical protein VITISV_033633 [Vitis vinifera]

 Score =  367 bits (943), Expect = 4e-99,   Method: Compositional matrix adjust.
 Identities = 195/369 (52%), Positives = 250/369 (67%), Gaps = 19/369 (5%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
           N+L   IP  L   +KL  L L  N + GSI  EIG +++L  L+LS NLI+G+IPS+L 
Sbjct: 148 NELTSAIPSSLDRLTKLTSLNLCRNQIKGSIPPEIGNIEDLVSLNLSSNLISGEIPSKLK 207

Query: 64  EIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIP---STSAKAPPPHHKGNDK 120
            + R+  +NLS N LSG++P         +++ N +   I    +   ++  P    N +
Sbjct: 208 NLKRLKNLNLSYNRLSGNVPP--------FITNNCYRTTIDLSYNDDLESYTPFF-CNGR 258

Query: 121 KIATRLVAIILPMS------AFLALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNY 174
           K+ T     I P        + L LI G       + ++V+P E+    K  D F+IW+Y
Sbjct: 259 KVPTGGTTAIDPFQLTIIIFSLLTLILGFALGLWWKKRQVQP-ESMVAKKNGDLFSIWDY 317

Query: 175 DGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESF 234
           DGRI F+D+I ATEDF I+YCIG GGYGSVYRA+LPSGKVVA+KKLHRSE +E A L SF
Sbjct: 318 DGRIAFEDIISATEDFDIRYCIGVGGYGSVYRAQLPSGKVVAVKKLHRSEIDEPAYLRSF 377

Query: 235 RNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 294
           +NE R+L QI HRNIVKL+G+CLH +CMFLIY YM  GSL+C+L    EAV LDW KRVN
Sbjct: 378 KNEVRMLEQIRHRNIVKLHGYCLHNRCMFLIYMYMGRGSLYCMLSDAVEAVELDWVKRVN 437

Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           IVK MAHALSY+HH CTP I+HRDISS+N+LL+S+LE FV+DFG ARLL+ DSSN+TL+A
Sbjct: 438 IVKNMAHALSYMHHDCTPSIIHRDISSSNILLDSKLEGFVSDFGTARLLDPDSSNQTLVA 497

Query: 355 GTSGYIAPA 363
           GT GYIAP 
Sbjct: 498 GTYGYIAPG 506

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera]

 Score =  365 bits (936), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 194/380 (51%), Positives = 257/380 (67%), Gaps = 24/380 (6%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           +N L G IP  L     L    +  N ++G I S IG L  L  LDLS NLI+GKIPSQ+
Sbjct: 296 HNNLTGVIPSSLGYLIHLNEFNISGNRINGHIPSTIGNLNNLTRLDLSANLIHGKIPSQV 355

Query: 63  GEIPRIDTVNLSMNNLSGSIP-----ESVKKVPLLYVSGNNFEVEIP----STSAKAPPP 113
             + R+  +NLS N LSGSIP     + +K  P L +S N+ E  IP    S  ++    
Sbjct: 356 QNLKRLTYLNLSHNKLSGSIPTLLIYDHIK--PSLDLSHNDLEGHIPFELQSKFSQGSFD 413

Query: 114 HHKG-----------NDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEI 162
           ++KG            ++   TR++ I L  + FL  +     +  R+ +K++  E    
Sbjct: 414 NNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFLLLSRKTRKIQTKEIP-- 471

Query: 163 TKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHR 222
           TK  D F++WNYDG+I ++D+I+ATEDF IKYCIGTGGYGSVY+A+LP+G VVALKKLH 
Sbjct: 472 TKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHG 531

Query: 223 SETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE 282
            E +E   L+SF+NE ++LS+I HRNIVKL G+CLH++CMFLIY YM  GSL+CVL  + 
Sbjct: 532 WERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEV 591

Query: 283 EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
           EA+ LDW KRVN+VK + HA+ Y+HH CTPPI+HRDISSNN+LL+S+L+AF++DFG ARL
Sbjct: 592 EALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTARL 651

Query: 343 LNFDSSNRTLLAGTSGYIAP 362
           L+ DSSN+TLLAGT GYIAP
Sbjct: 652 LHPDSSNQTLLAGTYGYIAP 671

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  365 bits (936), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 194/380 (51%), Positives = 257/380 (67%), Gaps = 24/380 (6%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           +N L G IP  L     L    +  N ++G I S IG L  L  LDLS NLI+GKIPSQ+
Sbjct: 350 HNNLTGVIPSSLGYLIHLNEFNISGNRINGHIPSTIGNLNNLTRLDLSANLIHGKIPSQV 409

Query: 63  GEIPRIDTVNLSMNNLSGSIP-----ESVKKVPLLYVSGNNFEVEIP----STSAKAPPP 113
             + R+  +NLS N LSGSIP     + +K  P L +S N+ E  IP    S  ++    
Sbjct: 410 QNLKRLTYLNLSHNKLSGSIPTLLIYDHIK--PSLDLSHNDLEGHIPFELQSKFSQGSFD 467

Query: 114 HHKG-----------NDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEI 162
           ++KG            ++   TR++ I L  + FL  +     +  R+ +K++  E    
Sbjct: 468 NNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFLLLSRKTRKIQTKEIP-- 525

Query: 163 TKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHR 222
           TK  D F++WNYDG+I ++D+I+ATEDF IKYCIGTGGYGSVY+A+LP+G VVALKKLH 
Sbjct: 526 TKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHG 585

Query: 223 SETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE 282
            E +E   L+SF+NE ++LS+I HRNIVKL G+CLH++CMFLIY YM  GSL+CVL  + 
Sbjct: 586 WERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMGRGSLYCVLSNEV 645

Query: 283 EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
           EA+ LDW KRVN+VK + HA+ Y+HH CTPPI+HRDISSNN+LL+S+L+AF++DFG ARL
Sbjct: 646 EALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKLDAFLSDFGTARL 705

Query: 343 LNFDSSNRTLLAGTSGYIAP 362
           L+ DSSN+TLLAGT GYIAP
Sbjct: 706 LHPDSSNQTLLAGTYGYIAP 725

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225466223|ref|XP_002267065.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710 [Vitis vinifera] gi|147859823|emb|CAN79273.1| hypothetical protein VITISV_014885 [Vitis vinifera]

 Score =  364 bits (935), Expect = 3e-98,   Method: Compositional matrix adjust.
 Identities = 193/373 (51%), Positives = 248/373 (66%), Gaps = 29/373 (7%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           NNKL G IP+EL NC  LR L +  N L+GSI SEIG L  L  LDLS N I+G IP Q 
Sbjct: 262 NNKLVGVIPKELGNCHSLRYLSMKFNRLNGSIPSEIGGLVALRKLDLSVNNISGTIPLQF 321

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPS-------------TSAK 109
                ++ ++LS N L G +P               FE+ +PS              +  
Sbjct: 322 QNFNSLEYLDLSYNYLEGYVP---------------FELHLPSLFRAFEHNKGLCGDTKF 366

Query: 110 APPPHHKGNDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEITKCADEF 169
             PP  K N   I   +V  +       ++IFG+L + RR+ +K++P E    T+  D F
Sbjct: 367 GIPPCRKRNRITIIIIVVICLCSALLISSIIFGVLLIWRRKTRKLQPEE-ATTTQNGDIF 425

Query: 170 AIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELA 229
           +IW+YDG+I ++D+IEATEDF IKYCIGTGGYGSVYRA+L +GK VALKKLH  E++   
Sbjct: 426 SIWDYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYRAKLTNGKEVALKKLHTLESQNPT 485

Query: 230 SLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDW 289
            ++SF NE R+LS+I HRNIVKLYGFCLH++CMFL+YEYME GSL CVL  + EA+  DW
Sbjct: 486 YMKSFTNEVRVLSKIRHRNIVKLYGFCLHKRCMFLVYEYMERGSLHCVLSDEIEALEFDW 545

Query: 290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 349
            KRVN+VK +A+ALSY+H+ C PP++HRDISS N+LL+SE  A V+DFG ARLL+ DSSN
Sbjct: 546 IKRVNVVKSIANALSYMHNDCIPPLLHRDISSGNILLDSEFRAVVSDFGTARLLDPDSSN 605

Query: 350 RTLLAGTSGYIAP 362
           +TLLAGT GY+AP
Sbjct: 606 QTLLAGTYGYVAP 618

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452751|ref|XP_002277606.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera]

 Score =  362 bits (929), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 201/371 (54%), Positives = 260/371 (70%), Gaps = 14/371 (3%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
           N+++G IP E+     L  L L  N +SG I  EI  L++L +LD+S+NLI+GKIPS+LG
Sbjct: 392 NQINGSIPPEIGYLLDLLYLDLNTNQISGFIPEEILNLKKLGHLDISNNLISGKIPSELG 451

Query: 64  EIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTSAKAPPPHHKG------ 117
            +      NLS NN+SG+IP S+          ++ ++E  ST+      H+KG      
Sbjct: 452 NLKEAIYFNLSRNNISGTIPLSISNNMWTLFDLSHNQLEGQSTAPLEAFDHNKGLCDGIK 511

Query: 118 ---NDKKIATRLVAIILPMSAFLAL---IFGILFVRRRRDKKVEPTETGEITKCADEFAI 171
              + KK    ++ I + +SA L L   + G LF +++  K   P  T    K  D F+I
Sbjct: 512 GLSHCKKRHQIILIIAISLSATLLLSVAVLGFLFRKQKIRKNQLPKTTK--VKNGDLFSI 569

Query: 172 WNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASL 231
           W+YDG I +QD+I+ATEDF IKYCIGTGGYGSVYRA+LPSGKVVALKKLH  E ++   L
Sbjct: 570 WDYDGVIAYQDIIQATEDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWERDDPTYL 629

Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK 291
           +SF NE ++LS+I HRNIVKL+GFCLH KCMFL+Y+YME GSL+C+LR + E V LDW K
Sbjct: 630 KSFENEVQMLSRIQHRNIVKLHGFCLHNKCMFLVYKYMEKGSLYCMLRDEVEVVQLDWIK 689

Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
           RVN+VKG+A+ALSY+HH  T PI+HRDISSNN+LL+S+LEAFVADFG ARLL+ DSSN+T
Sbjct: 690 RVNVVKGIANALSYMHHDSTLPIIHRDISSNNILLDSKLEAFVADFGTARLLDPDSSNQT 749

Query: 352 LLAGTSGYIAP 362
           LLAGT GYIAP
Sbjct: 750 LLAGTYGYIAP 760

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera]

 Score =  361 bits (926), Expect = 3e-97,   Method: Compositional matrix adjust.
 Identities = 193/378 (51%), Positives = 255/378 (67%), Gaps = 23/378 (6%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           +N L G IP  L     L +  +  N + G I S+IG L  L  LDLS NLI+GKIPSQL
Sbjct: 384 HNNLTGVIP-SLGYLIHLNVFNIRRNRIRGHIPSKIGNLNNLTSLDLSDNLIDGKIPSQL 442

Query: 63  GEIPRIDTVNLSMNNLSGSIPE---SVKKVPLLYVSGNNFEVEIPSTSAKAPPPHHKGND 119
             +  ++++NLS N LSG IP     + K   +  S N+FE  IP       PP   G++
Sbjct: 443 QNLKSLESLNLSHNKLSGHIPPLSIYIHKGSSIDFSHNDFEGHIPHELQFVYPPRVFGHN 502

Query: 120 KKIATRL-----------VAIILPMSAFLALIF---GILFVRRR-RDKKVEPTETGEITK 164
           K +                 +I+ +S  L L F   GIL + R+ R  + + T T    K
Sbjct: 503 KGLCGEREGLPHCKRGHKTILIISLSTILFLSFVALGILLLSRKTRRNQTKATST----K 558

Query: 165 CADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSE 224
             D F++WNYDG+I ++D+IEATEDF IKYCIGTGGYGSVY+A+LP+G VVALKKLH  E
Sbjct: 559 NGDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYKAQLPTGNVVALKKLHGWE 618

Query: 225 TEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEA 284
            +E   L+SF+NE ++LS+I HRNI+KL+G+CLH++CMFLIY+YME GSL+CVL  + EA
Sbjct: 619 RDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCMFLIYKYMERGSLYCVLSNEVEA 678

Query: 285 VGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
           + LDW KRVN++K + HAL Y+HH  TPPI+HRD+SSNN+LL+ +L+AF++DFG ARLL+
Sbjct: 679 LELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDVSSNNILLDFKLDAFLSDFGTARLLH 738

Query: 345 FDSSNRTLLAGTSGYIAP 362
            DSSN+TLLAGT GYIAP
Sbjct: 739 PDSSNQTLLAGTYGYIAP 756

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	368
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.967	0.340	0.406	3.1e-67
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.961	0.316	0.397	2.9e-61
TAIR|locus:2168907	966	XIP1 "XYLEM INTERMIXED WITH PH	0.945	0.360	0.367	1.6e-48
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.964	0.322	0.342	1.7e-47
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.956	0.567	0.336	1.4e-46
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.497	0.153	0.430	5.6e-46
UNIPROTKB|Q942F3	1121	P0480C01.18-1 "cDNA clone:J033	0.489	0.160	0.447	6.6e-46
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.970	0.323	0.341	4e-45
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.967	0.284	0.342	4.1e-45
TAIR|locus:2206179	592	FEI1 "FEI 1" [Arabidopsis thal	0.970	0.603	0.343	9.1e-45

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 688 (247.2 bits), Expect = 3.1e-67, P = 3.1e-67
 Identities = 150/369 (40%), Positives = 222/369 (60%)

Query:     4 NKLDGPIPQELMNCSKLRXXXXXXXXXXXXXXXXXXKLQELNYLDLSHNLINGKIPSQLG 63
             N LD  IP+ L   S+L+                   LQ L  LDLSHN ++G+IP    
Sbjct:   584 NDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFK 643

Query:    64 EIPRIDTVNLSMNNLSGSIPESV--KKVPLLYVSGNNFEVEIPSTSAKAPPPHHKGNDKK 121
             ++  +  V++S NNL G IP++   +  P     GN       +T+    P     + K 
Sbjct:   644 DMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKS 703

Query:   122 IATR--LVAIILPMSA---FLALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNYDG 176
                R  ++ I++P+      L++  GI    R+R K++E     E     +  +I+++DG
Sbjct:   704 HKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSE--SGGETLSIFSFDG 761

Query:   177 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELAS---LES 233
             ++ +Q++I+AT +F  KY IGTGG+G VY+A+LP+  ++A+KKL+ +    +++    + 
Sbjct:   762 KVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQE 820

Query:   234 FRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV 293
             F NE R L++I HRN+VKL+GFC HR+  FL+YEYME GSL  VL  D+EA  LDW KR+
Sbjct:   821 FLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRI 880

Query:   294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 353
             N+VKG+AHALSY+HH  +P IVHRDISS N+LL  + EA ++DFG A+LL  DSSN + +
Sbjct:   881 NVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAV 940

Query:   354 AGTSGYIAP 362
             AGT GY+AP
Sbjct:   941 AGTYGYVAP 949

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 635 (228.6 bits), Expect = 2.9e-61, P = 2.9e-61
 Identities = 146/367 (39%), Positives = 211/367 (57%)

Query:     4 NKLDGPIPQELMNCSKLRXXXXXXXXXXXXXXXXXXKLQELNYLDLSHNLINGKIPSQLG 63
             NK DG IP+ L   ++L                    LQ L+ LDLSHN ++G IP+   
Sbjct:   664 NKFDGSIPR-LSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFE 722

Query:    64 EIPRIDTVNLSMNNLSGSIPES--VKKVPLLYVSGN-NFEVEIPSTSAKAPPPHHKGNDK 120
              +  +  V++S N L G +P++   +K     +  N      IP    K  P       K
Sbjct:   723 GMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLK--PCRELKKPK 780

Query:   121 KIATRLVAIILPMSAFLAL--IFGILFVRRRRDKKVEPTETGEITKCADEFAIWNYDGRI 178
             K    +V I++P+   L +  I    F    R +K++     +  +  +  +I++ DG+ 
Sbjct:   781 KNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTD-PETGENMSIFSVDGKF 839

Query:   179 TFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELAS---LESFR 235
              +QD+IE+T +F   + IGTGGY  VYRA L    ++A+K+LH +  EE++     + F 
Sbjct:   840 KYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFL 898

Query:   236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI 295
             NE + L++I HRN+VKL+GFC HR+  FLIYEYME GSL  +L  DEEA  L W KR+N+
Sbjct:   899 NEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINV 958

Query:   296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG 355
             VKG+AHALSY+HH    PIVHRDISS N+LL+++  A ++DFG A+LL  DSSN + +AG
Sbjct:   959 VKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAG 1018

Query:   356 TSGYIAP 362
             T GY+AP
Sbjct:  1019 TYGYVAP 1025

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 515 (186.3 bits), Expect = 1.6e-48, P = 1.6e-48
 Identities = 139/378 (36%), Positives = 199/378 (52%)

Query:     3 NNKLDGPIPQELMNCSKLRXXXXXXXXXXXXXXXXXXKLQELNYLDLSHNLINGKIPSQL 62
             NN+L GPIP E+    KL                    L+ LN LDLS NL+ G+IP  L
Sbjct:   469 NNQLSGPIPSEVGRLRKLNLLVLQGNHLDSSIPDSLSNLKSLNVLDLSSNLLTGRIPENL 528

Query:    63 GEI-PRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTSAKAP---PPHHKGN 118
              E+ P   ++N S N LSG IP S+ +  L+    +N  + IP T+  +    P   + +
Sbjct:   529 SELLPT--SINFSSNRLSGPIPVSLIRGGLVESFSDNPNLCIPPTAGSSDLKFPMCQEPH 586

Query:   119 DKKIATRLVAIILPMSAFLALIFGIL--FVRRRRDKKVEPTETGEITKCADEFAIWNYD- 175
              KK  + + AI++  S F+ L+ G++  ++R+R  K     E  E    A  F  ++YD 
Sbjct:   587 GKKKLSSIWAILV--SVFI-LVLGVIMFYLRQRMSKNRAVIEQDETL--ASSF--FSYDV 639

Query:   176 ---GRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLE 232
                 RI+F D  E  E    K  +G GG G+VYR  L SG+VVA+KKL     ++ AS +
Sbjct:   640 KSFHRISF-DQREILESLVDKNIVGHGGSGTVYRVELKSGEVVAVKKLWSQSNKDSASED 698

Query:   233 SF------RNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG 286
                     + E   L  I H+NIVKL+ +     C  L+YEYM  G+L+  L   +  V 
Sbjct:   699 KMHLNKELKTEVETLGSIRHKNIVKLFSYFSSLDCSLLVYEYMPNGNLWDALH--KGFVH 756

Query:   287 LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF- 345
             L+W  R  I  G+A  L+YLHH  +PPI+HRDI S N+LL+   +  VADFG+A++L   
Sbjct:   757 LEWRTRHQIAVGVAQGLAYLHHDLSPPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQAR 816

Query:   346 -DSSNRTLLAGTSGYIAP 362
                S  T++AGT GY+AP
Sbjct:   817 GKDSTTTVMAGTYGYLAP 834

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 507 (183.5 bits), Expect = 1.7e-47, P = 1.7e-47
 Identities = 127/371 (34%), Positives = 191/371 (51%)

Query:     4 NKLDGPIPQELMNCSKLRXXXXXXXXXXXXXX-XXXXKLQELNYLDLSHNLINGKIPSQL 62
             N L   IP EL   + L+                    LQ L  L L+ N ++G+IP+ +
Sbjct:   605 NLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASI 664

Query:    63 GEIPRIDTVNLSMNNLSGSIPESV--KKVPLLYVSGNNFEVEIPSTSAKAPPPHH----- 115
             G +  +   N+S NNL G++P++   +++     +GN+       +  +   PH      
Sbjct:   665 GNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLN 724

Query:   116 ---KGNDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEITKCADEFAIW 172
                 G+ ++    +  I++  S FL    G+ +  +RR+      E        D +  +
Sbjct:   725 WLINGSQRQKILTITCIVIG-SVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSY-YF 782

Query:   173 NYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLE 232
                G  T+Q +++AT +F     +G G  G+VY+A +  G+V+A+KKL+ S  E  +S  
Sbjct:   783 PKKG-FTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGASSDN 840

Query:   233 SFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR 292
             SFR E   L +I HRNIVKLYGFC H+    L+YEYM  GSL   L+  E+   LDW  R
Sbjct:   841 SFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNAR 900

Query:   293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD-SSNRT 351
               I  G A  L YLHH C P IVHRDI SNN+LL+   +A V DFG+A+L++   S + +
Sbjct:   901 YRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMS 960

Query:   352 LLAGTSGYIAP 362
              +AG+ GYIAP
Sbjct:   961 AVAGSYGYIAP 971

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 488 (176.8 bits), Expect = 1.4e-46, P = 1.4e-46
 Identities = 125/371 (33%), Positives = 193/371 (52%)

Query:     1 MYNNKLDGPIPQELMNCSKLRXXXXXXXXXXXXXXXXXXKLQELNYLDLSHNLINGKIPS 60
             +Y+N + G IP+EL +  +L                   KL +L +L L++N ++G+IP 
Sbjct:   106 LYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKLRFLRLNNNSLSGEIPM 165

Query:    61 QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVS-GNNFEVEIP-----STSAKAPPPH 114
              L  + ++  +++S N LSG IP +        +S  NN   ++P     STS   PPP 
Sbjct:   166 TLTSV-QLQVLDISNNRLSGDIPVNGSFSLFTPISFANNSLTDLPEPPPTSTSPTPPPPS 224

Query:   115 HKGNDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVE-PTETGEITKCADEFAIWN 173
                    IA  + A    + A  A+ F     R+ +D   + P E         E  +  
Sbjct:   225 GGQMTAAIAGGVAAGAALLFAVPAIAFAWWLRRKPQDHFFDVPAEEDP------EVHLGQ 278

Query:   174 YDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLES 233
                R T ++++ AT++F  K  +G GG+G VY+ RL  G +VA+K+L    T+    L+ 
Sbjct:   279 LK-RFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKG-GELQ- 335

Query:   234 FRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEA-VGLDWAKR 292
             F+ E  ++S   HRN+++L GFC+      L+Y YM  GS+   LR   E    LDW KR
Sbjct:   336 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKR 395

Query:   293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RT 351
              +I  G A  L+YLH HC   I+HRD+ + N+LL+ E EA V DFG+A+L+N++ S+  T
Sbjct:   396 KHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTT 455

Query:   352 LLAGTSGYIAP 362
              + GT G+IAP
Sbjct:   456 AVRGTIGHIAP 466

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 376 (137.4 bits), Expect = 5.6e-46, Sum P(2) = 5.6e-46
 Identities = 81/188 (43%), Positives = 116/188 (61%)

Query:   177 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN 236
             ++   D++EAT+ F  K  IG GG+G+VY+A LP  K VA+KKL  ++T+       F  
Sbjct:   904 KVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQ---GNREFMA 960

Query:   237 EARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNI 295
             E   L ++ H N+V L G+C   +   L+YEYM  GSL   LR     +  LDW+KR+ I
Sbjct:   961 EMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKI 1020

Query:   296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RTLLA 354
               G A  L++LHH   P I+HRDI ++N+LL+ + E  VADFG+ARL++   S+  T++A
Sbjct:  1021 AVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIA 1080

Query:   355 GTSGYIAP 362
             GT GYI P
Sbjct:  1081 GTFGYIPP 1088

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 398 (145.2 bits), Expect = 6.6e-46, Sum P(2) = 6.6e-46
 Identities = 85/190 (44%), Positives = 123/190 (64%)

Query:   178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKL-HRSETEELASLESFRN 236
             +T  D++EAT  FHI   IG+GG+G VY+A+L  GKVVA+KKL H S   +      F  
Sbjct:   795 LTLADLVEATNGFHIACQIGSGGFGDVYKAQLKDGKVVAIKKLIHVSGQGD----REFTA 850

Query:   237 EARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG--LDWAKRVN 294
             E   + +I HRN+V L G+C   +   L+Y+YM+ GSL  VL  D + +G  L+W  R  
Sbjct:   851 EMETIGKIKHRNLVPLLGYCKAGEERLLVYDYMKFGSLEDVLH-DRKKIGKKLNWEARRK 909

Query:   295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-- 352
             I  G A  L++LHH+C P I+HRD+ S+NVL++ +LEA V+DFG+ARL++   ++ ++  
Sbjct:   910 IAVGAARGLAFLHHNCIPHIIHRDMKSSNVLIDEQLEARVSDFGMARLMSVVDTHLSVST 969

Query:   353 LAGTSGYIAP 362
             LAGT GY+ P
Sbjct:   970 LAGTPGYVPP 979

GO:0001578 "microtubule bundle formation" evidence=IMP

GO:0009647 "skotomorphogenesis" evidence=IMP

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 485 (175.8 bits), Expect = 4.0e-45, P = 4.0e-45
 Identities = 128/375 (34%), Positives = 197/375 (52%)

Query:     1 MYNNKLDGPIPQELMNCSKLRXXXXXXXXXXXXXXX-XXXKLQELNYLDLSHNLINGKIP 59
             M  N  +G IP+EL + + L+                    L  L +L L++N ++G+IP
Sbjct:   608 MGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIP 667

Query:    60 SQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTSA--KAP--PPHH 115
             S    +  +   N S N+L+G IP  ++ + +    GN      P        P  P   
Sbjct:   668 SSFANLSSLLGYNFSYNSLTGPIP-LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQS 726

Query:   116 KGNDKKI-ATRLVAIILPM--SAFLALIFGILFVRRRRDKKVEPT-ETGEITKCADEFAI 171
              G    + +++++AI   +     L LI  I+++ RR  + V  + + G+ ++ + +   
Sbjct:   727 TGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYF 786

Query:   172 WNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKL---HRSETEEL 228
                +G  TFQD++ AT++F   + +G G  G+VY+A LP+G  +A+KKL   H       
Sbjct:   787 PPKEG-FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNN 845

Query:   229 ASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLD 288
                 SFR E   L  I HRNIVKL+GFC H+    L+YEYM  GSL  +L   + +  LD
Sbjct:   846 VD-NSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH--DPSCNLD 902

Query:   289 WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD-S 347
             W+KR  I  G A  L+YLHH C P I HRDI SNN+LL+ + EA V DFG+A++++   S
Sbjct:   903 WSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHS 962

Query:   348 SNRTLLAGTSGYIAP 362
              + + +AG+ GYIAP
Sbjct:   963 KSMSAIAGSYGYIAP 977

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 486 (176.1 bits), Expect = 4.1e-45, P = 4.1e-45
 Identities = 129/377 (34%), Positives = 198/377 (52%)

Query:     4 NKLDGPIPQELMNCSKLRXXXXXXXXXXXXXX-XXXXKLQELNYLDLSHNLINGKIPSQL 62
             N L G IP E+     L+                    L +L  LDLSHN + G++P Q+
Sbjct:   754 NALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQI 813

Query:    63 GEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIP-STSAKAPPPHHKGNDKK 121
             G++  +  +NLS NNL G + +   +       GN      P S   +A   + +    K
Sbjct:   814 GDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPK 873

Query:   122 IATRLVAII-LPMSAFLALIFGILFVRRRRD--KKVEPTETGEITKCADEFA-IWNYDGR 177
                 + AI  L   A + L+  ILF ++  D  KKV    +   +  +   A +++  G 
Sbjct:   874 TVVIISAISSLAAIALMVLVI-ILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGA 932

Query:   178 ---ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESF 234
                I + D++EAT   + ++ IG+GG G VY+A L +G+ +A+KK+   +  +L S +SF
Sbjct:   933 KSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKD--DLMSNKSF 990

Query:   235 RNEARLLSQIWHRNIVKLYGFCLHRK--CMFLIYEYMEMGSLFCVLRTDEEAVG---LDW 289
               E + L  I HR++VKL G+C  +      LIYEYM  GS++  L  +E       L W
Sbjct:   991 NREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGW 1050

Query:   290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL--NFDS 347
               R+ I  G+A  + YLH+ C PPIVHRDI S+NVLL+S +EA + DFG+A++L  N+D+
Sbjct:  1051 ETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDT 1110

Query:   348 S--NRTLLAGTSGYIAP 362
             +  + T+ AG+ GYIAP
Sbjct:  1111 NTESNTMFAGSYGYIAP 1127

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 471 (170.9 bits), Expect = 9.1e-45, P = 9.1e-45
 Identities = 129/376 (34%), Positives = 189/376 (50%)

Query:     1 MYNNKLDGPIPQELMNCSKLRXXXXXXXXXXXXXXXXXXKLQELNYLDLSHNLINGKIPS 60
             ++NN L G IP  L NC+ L                    L  L  LD+S N ++G IP+
Sbjct:   105 LHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGDLPGLQKLDMSSNTLSGPIPA 164

Query:    61 QLGEIPRIDTVNLSMNNLSGSIPES-----VKK---VPLLYVSGNNFEVEIPSTSAKAPP 112
              LG++ ++   N+S N L G IP         K   +  L + G + +V     S   P 
Sbjct:   165 SLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNLNLCGKHVDVVCQDDSGN-PS 223

Query:   113 PHHKG--NDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEITKCADEFA 170
              H +   N KK + +L+         L L+  + F      KK+   E   + K     A
Sbjct:   224 SHSQSGQNQKKNSGKLLISASATVGALLLVALMCFWGCFLYKKLGKVEIKSLAKDVGGGA 283

Query:   171 -IWNYDGRITF--QDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEE 227
              I  + G + +  +D+I+  E  + ++ IG GG+G+VY+  +  GKV ALK++ +   E 
Sbjct:   284 SIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALKRILKLN-EG 342

Query:   228 LASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGL 287
                   F  E  +L  I HR +V L G+C       L+Y+Y+  GSL   L   E    L
Sbjct:   343 FDRF--FERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHV-ERGEQL 399

Query:   288 DWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
             DW  RVNI+ G A  LSYLHH C+P I+HRDI S+N+LL+  LEA V+DFG+A+LL  + 
Sbjct:   400 DWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 459

Query:   348 SN-RTLLAGTSGYIAP 362
             S+  T++AGT GY+AP
Sbjct:   460 SHITTIVAGTFGYLAP 475

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0030243 "cellulose metabolic process" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	368
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-40
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-38
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-38
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-33
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-28
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-24
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-24
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-24
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-22
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-19
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-18
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-15
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-13
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-10
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	9e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-07
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-04
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.002
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.003
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	0.004
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  142 bits (360), Expect = 1e-40
 Identities = 62/169 (36%), Positives = 95/169 (56%), Gaps = 9/169 (5%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G GG+G+VY AR   +GK VA+K + + ++  L  LE    E  +L ++ H NIVKLYG
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                  ++L+ EY E GSL  +L+  E    L   + + I+  +   L YLH +    I
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHSN---GI 113

Query: 315 VHRDISSNNVLLNS-ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRD+   N+LL+S   +  +ADFG+++LL  D S    + GT  Y+AP
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  138 bits (349), Expect = 1e-38
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 10/174 (5%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           + I   +G G +G VY AR   +GK+VA+K + + + ++    E    E ++L ++ H N
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           IV+LY        ++L+ EY E G LF +L+     +  D A+    ++ +  AL YLH 
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARF--YLRQILSALEYLHS 115

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                IVHRD+   N+LL+ +    +ADFG+AR L+      T   GT  Y+AP
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  137 bits (347), Expect = 3e-38
 Identities = 56/174 (32%), Positives = 90/174 (51%), Gaps = 8/174 (4%)

Query: 190 FHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           + +   +G+G +G+VY+A+    GK+VA+K L +   +     ++ R E R+L ++ H N
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPN 59

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           IV+L      +  ++L+ EY E G LF  L        L   +   I   +   L YLH 
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHS 116

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +    I+HRD+   N+LL+      +ADFG+A+ L   SS+ T   GT  Y+AP
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167

Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  141 bits (357), Expect = 6e-37
 Identities = 106/360 (29%), Positives = 174/360 (48%), Gaps = 55/360 (15%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
           N+  G +P++L + S+L  L L  N LSG I  E+   ++L  LDLSHN ++G+IP+   
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS 544

Query: 64  EIPRIDTVNLSMNNLSGSIPESVKKVPLLY---VSGNNFEVEIPST--------SAKAPP 112
           E+P +  ++LS N LSG IP+++  V  L    +S N+    +PST        SA A  
Sbjct: 545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGN 604

Query: 113 PHHKGNDK-----------KIATRLVAIILPMSAFLALI---FGILFVRRRRDKKVEPTE 158
               G D            K  +    I   + AFL L    FG +F+R R +       
Sbjct: 605 IDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNL------ 658

Query: 159 TGEITKCADEFAIWN---YDGR----ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPS 211
             E+ +  +E   W    +D +    IT  D++ + ++ ++   I  G  G+ Y+ +   
Sbjct: 659 --ELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENV---ISRGKKGASYKGKSIK 713

Query: 212 GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM 271
             +  + K    E  ++ S+ S  +E   + ++ H NIVKL G C   K  +LI+EY+E 
Sbjct: 714 NGMQFVVK----EINDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767

Query: 272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE 331
            +L  VLR       L W +R  I  G+A AL +LH  C+P +V  ++S   ++++ + E
Sbjct: 768 KNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE 821

Length = 968

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  123 bits (312), Expect = 3e-33
 Identities = 48/153 (31%), Positives = 81/153 (52%), Gaps = 12/153 (7%)

Query: 196 IGTGGYGSVYRARL--PSGKV---VALKKLHRSETEELASLESFRNEARLLSQIWHRNIV 250
           +G G +G VY+ +L    GK    VA+K L    +E+   +E F  EAR++ ++ H N+V
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
           KL G C   + ++++ EYME G L   LR +     L  +  ++    +A  + YL    
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLESK- 121

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
               +HRD+++ N L+   L   ++DFG++R L
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDL 152

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  123 bits (311), Expect = 4e-33
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)

Query: 196 IGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIV 250
           +G G +G VY+  L      +   VA+K L    +EE    E F  EA ++ ++ H NIV
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKLSHPNIV 64

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
           +L G C   + ++++ EYM  G L   LR   E + L     + +   +A  + YL    
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLESK- 121

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
               VHRD+++ N L+   L   ++DFG++R +  D   R 
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK 160

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  122 bits (309), Expect = 8e-33
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 11/153 (7%)

Query: 196 IGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIV 250
           +G G +G VY+  L          VA+K L    +E+   +E F  EAR++ ++ H NIV
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNIV 64

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
           KL G C   + + ++ EYM  G L   LR +     L  +  ++    +A  + YL    
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESK- 122

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
               +HRD+++ N L+   L   ++DFG++R L
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  121 bits (305), Expect = 3e-32
 Identities = 59/180 (32%), Positives = 89/180 (49%), Gaps = 20/180 (11%)

Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
            F I   IG GG+G VY+AR   +GK VA+K +     E     E   NE ++L +  H 
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSL-----FCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           NIVK YG  L +  ++++ E+   GSL            E  +         + K +   
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-------VCKELLKG 110

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           L YLH +    I+HRDI + N+LL S+ E  + DFG++  L+ D+  R  + GT  ++AP
Sbjct: 111 LEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  111 bits (281), Expect = 1e-28
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 15/159 (9%)

Query: 196 IGTGGYGSVYRARL---PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G G +G VY+ +L         VA+K L    +EE    + F  EAR++ ++ H N+V+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVR 60

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRT------DEEAVGLDWAKRVNIVKGMAHALSY 305
           L G C   + ++L+ EYME G L   LR         E   L     ++    +A  + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
           L        VHRD+++ N L+  +L   ++DFG++R + 
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  109 bits (276), Expect = 6e-28
 Identities = 61/178 (34%), Positives = 92/178 (51%), Gaps = 22/178 (12%)

Query: 195 CIGTGGYGSVYRARLP-SGKVVALKK--LHRSETEELASLESFRNEARLLSQIWHRNIVK 251
            +G G +GSVY A    +G+++A+K   L     EEL +LE    E R+LS + H NIV+
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE---REIRILSSLQHPNIVR 63

Query: 252 LYGFCLHR-KCMFLIY-EYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYL 306
            YG      K    I+ EY+  GSL  +L+      E V   + ++  I++G    L+YL
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--ILEG----LAYL 117

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL--NFDSSNRTLLAGTSGYIAP 362
           H +    IVHRDI   N+L++S+    +ADFG A+ L           + GT  ++AP
Sbjct: 118 HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (265), Expect = 2e-26
 Identities = 56/182 (30%), Positives = 84/182 (46%), Gaps = 20/182 (10%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
            D      +G G  G VY+ R  P+GK+ ALKK+H    EE         E + L     
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ--LLRELKTLRSCES 58

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAHA 302
             +VK YG       + ++ EYM+ GSL  +L+      E  +         I + +   
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-------IARQILKG 111

Query: 303 LSYLH--HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
           L YLH   H    I+HRDI  +N+L+NS+ E  +ADFG++++L           GT  Y+
Sbjct: 112 LDYLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYM 167

Query: 361 AP 362
           +P
Sbjct: 168 SP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  107 bits (268), Expect = 3e-26
 Identities = 61/182 (33%), Positives = 93/182 (51%), Gaps = 13/182 (7%)

Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHR 247
            + I   +G G +G VY AR    K+VALK L +    +   +E F  E ++L+ +    
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NIVKLY F      ++L+ EY++ GSL  +L+       L  ++ + I+  +  AL YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFV-ADFGVARLLNFDSSNRTLLA------GTSGYI 360
                 I+HRDI   N+LL+ +       DFG+A+LL    S  ++ A      GT GY+
Sbjct: 119 SKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 361 AP 362
           AP
Sbjct: 176 AP 177

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 1e-25
 Identities = 56/179 (31%), Positives = 88/179 (49%), Gaps = 16/179 (8%)

Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ +   IG G +G VY+   L +G  VA+K++   + +E  +L+S   E  LL  + H 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHP 59

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHAL 303
           NIVK  G       +++I EY E GSL  +++      E  V          V  +   L
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-------VYVYQVLQGL 112

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +YLH      ++HRDI + N+L   +    +ADFGVA  LN  S +   + GT  ++AP
Sbjct: 113 AYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 2e-24
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 8/157 (5%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           +     +G G YG VY+AR   +G++VALKK+     EE     + R E  LL ++ H N
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPN 59

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           IVKL       + ++L++EY +M  L   L      +  +  K   I+  +   L+Y H 
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCHS 116

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
           H    I+HRD+   N+L+N +    +ADFG+AR    
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.7 bits (249), Expect = 4e-24
 Identities = 53/152 (34%), Positives = 81/152 (53%), Gaps = 11/152 (7%)

Query: 196 IGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           IG G +G V R RL  P  K   VA+K L    +++      F  EA ++ Q  H NI++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNIIR 69

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L G     + + +I EYME GSL   LR ++        + V +++G+A  + YL     
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 312 PPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
              VHRD+++ N+L+NS L   V+DFG++R L
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 99.8 bits (249), Expect = 4e-24
 Identities = 59/175 (33%), Positives = 99/175 (56%), Gaps = 21/175 (12%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLH-RSETEELASLESFRNEARLLSQIWH---RNIV 250
           IG G YG+VYR + +P+G+VVALK ++  +  ++++ ++    E  LLSQ+      NI 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ---REVALLSQLRQSQPPNIT 65

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHALSYLH 307
           K YG  L    +++I EY E GS+  +++     E+ + +       I++ +  AL Y+H
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIH 118

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                 ++HRDI + N+L+ +     + DFGVA LLN +SS R+   GT  ++AP
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 99.5 bits (249), Expect = 5e-24
 Identities = 56/166 (33%), Positives = 87/166 (52%), Gaps = 26/166 (15%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESF-----RNEARLLSQIWHRNI 249
           IG G YG VY+AR   +G++VALKK+ R E E+    E F     R E +LL ++ H NI
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI-RMENEK----EGFPITAIR-EIKLLQKLRHPNI 60

Query: 250 VKLYGFCLHRKC--MFLIYEYME---MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
           V+L      +    +++++EYM+    G    +L + E        K    +K +   L 
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTG----LLDSPEVKFTESQIKC--YMKQLLEGLQ 114

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
           YLH +    I+HRDI  +N+L+N++    +ADFG+AR     +S  
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 60/179 (33%), Positives = 95/179 (53%), Gaps = 22/179 (12%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW---HRNIVK 251
           IG G YG+VY+AR L +G+ VALKK+    +EE   L + R E  LL Q+    H NIV+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVR 65

Query: 252 LYGFC----LHRKC-MFLIYEYMEMGSLFCVLRTDEEAV---GLDWAKRVNIVKGMAHAL 303
           L   C      R+  + L++E+++       L T        GL      ++++ +   +
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            +LH H    IVHRD+   N+L+ S+ +  +ADFG+AR+ +F+ +  T +  T  Y AP
Sbjct: 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAP 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 96.7 bits (241), Expect = 5e-23
 Identities = 55/180 (30%), Positives = 92/180 (51%), Gaps = 10/180 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +D+ +   IG G    VY A  LP+ + VA+K++   + +   S++  R E + +SQ  H
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNH 58

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            N+VK Y   +    ++L+  Y+  GSL  ++++     GLD A    ++K +   L YL
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL--NFDSSN--RTLLAGTSGYIAP 362
           H +     +HRDI + N+LL  +    +ADFGV+  L    D +   R    GT  ++AP
Sbjct: 119 HSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.1 bits (240), Expect = 7e-23
 Identities = 59/179 (32%), Positives = 88/179 (49%), Gaps = 16/179 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E F +  CIG G +G VY+A    + +VVA+K +   E E+   +E  + E + LSQ   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED--EIEDIQQEIQFLSQCRS 58

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHAL 303
             I K YG  L    +++I EY   GS   +L+    DE  +         I++ +   L
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGL 111

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            YLH       +HRDI + N+LL+ E +  +ADFGV+  L    S R    GT  ++AP
Sbjct: 112 EYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP 167

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 59/181 (32%), Positives = 88/181 (48%), Gaps = 21/181 (11%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E F I   +G G YGSVY+A    +G+VVA+K +     EE   L+    E  +L Q   
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEE--DLQEIIKEISILKQCDS 57

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNIVKGMAH 301
             IVK YG       ++++ EY   GS+  +++       EE +         I+     
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLK 110

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
            L YLH +     +HRDI + N+LLN E +A +ADFGV+  L    + R  + GT  ++A
Sbjct: 111 GLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMA 167

Query: 362 P 362
           P
Sbjct: 168 P 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 94.5 bits (236), Expect = 2e-22
 Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 19/184 (10%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL-Y 253
           +G G +G V   R   +GK+ A+K L + +  +   +E    E  +LS+I H  IVKL Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
            F    K ++L+ EY   G LF  L   E     + A+       +  AL YLH      
Sbjct: 61  AFQTEEK-LYLVLEYAPGGELFSHLS-KEGRFSEERARF--YAAEIVLALEYLHSL---G 113

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----------A 363
           I++RD+   N+LL+++    + DFG+A+ L+ + S      GT  Y+AP          A
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 364 SEWW 367
            +WW
Sbjct: 174 VDWW 177

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 93.9 bits (234), Expect = 4e-22
 Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 26/179 (14%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G VY A  L +G+++A+K++ R +  +  +++   +E ++L  + H N+VK YG
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
             +HR+ +++  EY   G+L  +L      DE  + +           +   L+YLH H 
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-------YTLQLLEGLAYLHSH- 118

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-------LAGTSGYIAP 362
              IVHRDI   N+ L+      + DFG A  L    +N T        LAGT  Y+AP
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 93.8 bits (234), Expect = 7e-22
 Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 22/174 (12%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLH-RSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           IG G  G VY+A    +GK VA+KK+  R + +EL       NE  ++    H NIV  Y
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI-----INEILIMKDCKHPNIVDYY 81

Query: 254 GFCLHRKCMFLIYEYMEMGSL-----FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
              L    ++++ EYM+ GSL        +R +E  +         + + +   L YLH 
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYLHS 134

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                ++HRDI S+N+LL+ +    +ADFG A  L  + S R  + GT  ++AP
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 92.9 bits (232), Expect = 9e-22
 Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 22/184 (11%)

Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
            + I   IG G +G VY  R    GK+  LK++  S   E    E   NE ++L ++ H 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHP 59

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD--------EEAVGLDWAKRVNIVKGM 299
           NI+K Y     +  + ++ EY + G L   ++          EE + LDW   V +    
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-LDWF--VQLCL-- 114

Query: 300 AHALSYLH-HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
             AL YLH       I+HRDI   N+ L S     + DFG++++L+        + GT  
Sbjct: 115 --ALKYLHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY 168

Query: 359 YIAP 362
           Y++P
Sbjct: 169 YLSP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 9e-22
 Identities = 56/179 (31%), Positives = 92/179 (51%), Gaps = 15/179 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ED+ +   IG+G YG VY+AR + +G++VA+K +     ++   +   + E  +L +  H
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEII---QQEISMLKECRH 59

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSL---FCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
            NIV  +G  L R  ++++ EY   GSL   + V R     + + +  R   +KG    L
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-ETLKG----L 114

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +YLH       +HRDI   N+LL  + +  +ADFGV+  L    + R    GT  ++AP
Sbjct: 115 AYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAP 170

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 4e-21
 Identities = 46/154 (29%), Positives = 82/154 (53%), Gaps = 9/154 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++  +   IG G +G V       G+ VA+K L      +  + ++F  EA +++ + H 
Sbjct: 6   KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKD----DSTAAQAFLAEASVMTTLRHP 60

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           N+V+L G  L    ++++ EYM  GSL   LR+   AV +  A+++     +   + YL 
Sbjct: 61  NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE 119

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                  VHRD+++ NVL++ +L A V+DFG+A+
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 90.2 bits (224), Expect = 9e-21
 Identities = 43/148 (29%), Positives = 79/148 (53%), Gaps = 13/148 (8%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G+G +G V+  +      VA+K +     E   S + F  EA+++ ++ H N+V+LYG 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR----EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV--NIVKGMAHALSYLHHHCTPP 313
           C  ++ +F++ EYM  G L   LR  +  +G +W   +  ++ + M     YL  +    
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME----YLESNG--- 120

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVAR 341
            +HRD+++ N L+  +    V+DFG+AR
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 67/195 (34%), Positives = 94/195 (48%), Gaps = 28/195 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +GTG +G V   R   SGK  ALK L +++  +L  +E   NE R+L  I H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHAL 303
             +V LYG       ++L+ EY+  G LF  LR      E V   +A +V +      AL
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL------AL 114

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP 362
            YLH      IV+RD+   N+LL+S+    + DFG A+ +      RT  L GT  Y+AP
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYTLCGTPEYLAP 167

Query: 363 ----------ASEWW 367
                     A +WW
Sbjct: 168 EIILSKGYGKAVDWW 182

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.2 bits (221), Expect = 2e-20
 Identities = 59/173 (34%), Positives = 92/173 (53%), Gaps = 11/173 (6%)

Query: 192 IKYCIGTGGYGSVYRARL-PSGK---VVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           I+  IG G +G V R RL   GK    VA+K L    TE+      F +EA ++ Q  H 
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEASIMGQFDHP 65

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NI+ L G     + + +I E+ME G+L   LR ++    +   + V +++G+A  + YL 
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLS 123

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
                  VHRD+++ N+L+NS L   V+DFG++R L  D+S+ T  +   G I
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.1 bits (219), Expect = 6e-20
 Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 21/174 (12%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLS--QIWHR----N 248
           +G G  G V +    P+GK++A+K +     E +        + ++L    I H+     
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI--------QKQILRELDILHKCNSPY 60

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           IV  YG   +   + +  EYM+ GSL  +L+  +  +      ++ +   +   L+YLH 
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHE 118

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                I+HRD+  +N+L+NS  +  + DFGV+  L  +S  +T   GTS Y+AP
Sbjct: 119 --KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKT-FVGTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 58/186 (31%), Positives = 93/186 (50%), Gaps = 24/186 (12%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG VY+AR   +G++VA+KK+      E     + R E +LL ++ H NI+KL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
              H+  ++L++E+M+   L+ +++      GL  +   + +  +   L++ H H    I
Sbjct: 66  VFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT--------------LLAGTSGYI 360
           +HRD+   N+L+N+E    +ADFG+AR   F S  R               LL G  GY 
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177

Query: 361 APASEW 366
            P   W
Sbjct: 178 TPVDIW 183

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 28/194 (14%)

Query: 190 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           F +   IG G +G V   +   + K+ A+K +++ +  E  S+ +  NE R+L ++ H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 249 IVKL-YGFCLHRKCMFLIYEYMEMGSL-FCVLRT---DEEAVGLDWAKRVNIVKGMAHAL 303
           +V L Y F    + M+L+ + +  G L + + +     EE V          +  +  AL
Sbjct: 62  LVNLWYSFQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLAL 113

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP- 362
            YLH      I+HRDI  +N+LL+ +    + DF +A  +    +  T  +GT GY+AP 
Sbjct: 114 EYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMAPE 169

Query: 363 ---------ASEWW 367
                    A +WW
Sbjct: 170 VLCRQGYSVAVDWW 183

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 31/192 (16%)

Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLH-----RSETEELASLESFRNEARLLS 242
           D+ +   IG G +G+V +  R   GK++  K++        E ++L       +E  +L 
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV------SEVNILR 54

Query: 243 QIWHRNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVL--------RTDEEAVGLDWAKR 292
           ++ H NIV+ Y   + R  + ++++ EY E G L  ++          +EE +   W   
Sbjct: 55  ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI---W--- 108

Query: 293 VNIVKGMAHALSYLHH--HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
             I+  +  AL   H+       ++HRD+   N+ L++     + DFG+A++L  DSS  
Sbjct: 109 -RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167

Query: 351 TLLAGTSGYIAP 362
               GT  Y++P
Sbjct: 168 KTYVGTPYYMSP 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 51/162 (31%), Positives = 87/162 (53%), Gaps = 21/162 (12%)

Query: 196 IGTGGYGSVYRAR-LPSGK----VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIV 250
           +G+G +G+VY+   +P G+     VA+K L   E     + +   +EA +++ + H ++V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASVDHPHVV 72

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYL 306
           +L G CL  +   LI + M +G L   +R  ++ +G    L+W   V I KGM    SYL
Sbjct: 73  RLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGM----SYL 125

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
                  +VHRD+++ NVL+ +     + DFG+A+LL+ D  
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.4 bits (214), Expect = 2e-19
 Identities = 53/181 (29%), Positives = 93/181 (51%), Gaps = 18/181 (9%)

Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF I   IG G +G V++  R    +V A+K++  S+       E+  +EAR+L+++   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL------RTDEEAVGLDWAKRVNIVKGMAH 301
            I++ Y   L +  + ++ EY E G L  +L         E+ V   W   + I+ G   
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV---WRFFIQILLG--- 113

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
            L++LH   +  I+HRDI S N+ L++     + D GVA+LL+ +++    + GT  Y++
Sbjct: 114 -LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLS 169

Query: 362 P 362
           P
Sbjct: 170 P 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 85.8 bits (212), Expect = 3e-19
 Identities = 57/156 (36%), Positives = 86/156 (55%), Gaps = 13/156 (8%)

Query: 196 IGTGGYGSVYRA--RLPSGK--VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           IG G +G V+R   ++P  K   VA+K L    TE+    + F +EA ++ Q  H NI++
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNIIR 70

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
           L G     K   +I EYME G+L   LR  D E       + V +++G+A  + YL    
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYLSDM- 126

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
               VHRD+++ N+L+NS LE  V+DFG++R+L  D
Sbjct: 127 --NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 55/174 (31%), Positives = 83/174 (47%), Gaps = 26/174 (14%)

Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E  H+K+   +G G +G V   R       +G+ VA+K L+ S  E       F  E  +
Sbjct: 2   EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEI 59

Query: 241 LSQIWHRNIVKLYGFC--LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-----V 293
           L  + H NIVK  G C     + + LI EY+  GSL   L+   + + L   KR      
Sbjct: 60  LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL---KRLLLFSS 116

Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            I KGM     YL    +   +HRD+++ N+L+ SE    ++DFG+A++L  D 
Sbjct: 117 QICKGMD----YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 28/195 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +D      +GTG +G V+  R   S    ALK +   E   L   +   NE R+L ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHAL 303
             I++L+     ++ ++++ EY+  G LF  LR       + GL +A  +        AL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI------VCAL 114

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP 362
            YLH      IV+RD+   N+LL+ E    + DFG A+ L     +RT  L GT  Y+AP
Sbjct: 115 EYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAP 167

Query: 363 ----------ASEWW 367
                     A +WW
Sbjct: 168 EVIQSKGHNKAVDWW 182

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 58/172 (33%), Positives = 83/172 (48%), Gaps = 14/172 (8%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG VYRAR   SG++VALKK+      +   + S R E  LL  + H NIV+L  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKE 73

Query: 255 FCL--HRKCMFLIYEYME--MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
             +  H   +FL+ EY E  + SL      D        ++   ++  +   L YLH + 
Sbjct: 74  VVVGKHLDSIFLVMEYCEQDLASLL-----DNMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
              I+HRD+  +N+LL  +    +ADFG+AR     +   T    T  Y AP
Sbjct: 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 57/196 (29%), Positives = 85/196 (43%), Gaps = 34/196 (17%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLL-- 241
           + T  F +   IG G YG VY+AR   +G++VA+K +   E EE    E  + E  +L  
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRK 58

Query: 242 -SQIWHRNIVKLYGFCL------HRKCMFLIYEYMEMGS--------LFCVLRTDEEAVG 286
            S   H NI   YG  +      +   ++L+ E    GS             R  EE + 
Sbjct: 59  YSN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116

Query: 287 LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                   I++     L+YLH +    ++HRDI   N+LL    E  + DFGV+  L+  
Sbjct: 117 Y-------ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166

Query: 347 SSNRTLLAGTSGYIAP 362
              R    GT  ++AP
Sbjct: 167 LGRRNTFIGTPYWMAP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 8/149 (5%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G YG V + R   +G++VA+KK   SE +E     + R E ++L Q+ H NIV L  
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKE 67

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
               +  ++L++EY+E  +L  +L  +    GL      + +  +  A++Y H H    I
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELL--EASPGGLPPDAVRSYIWQLLQAIAYCHSH---NI 121

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLL 343
           +HRDI   N+L++      + DFG AR L
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARAL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 8/150 (5%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++A+   +G+ VALKK+     E     ++ R E + L    H  +VKL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
              H     L+ EYM    L  VLR +E  +     K    ++ +   ++Y+H +    I
Sbjct: 67  VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMHAN---GI 120

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLN 344
           +HRD+   N+L++++    +ADFG+ARL +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFS 150

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 26/173 (15%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK------VVALKKLHRSETEELASLESFRNEARLL 241
           +   +K  +G G +G V+       +      +VA+K L  + + +    + F  EA LL
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELL 62

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKR-------- 292
           +   H NIVK YG C       +++EYME G L   LR+   +A  L             
Sbjct: 63  TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 293 --VNIVKGMAHALSYL--HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             + I   +A  + YL   H      VHRD+++ N L+  +L   + DFG++R
Sbjct: 123 QLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 33/195 (16%)

Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           I  G YG V+ A+  S G + A+K + +++      ++    E  +LSQ     +VKLY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
               +K ++L+ EY+  G L  +L      DE     D A+    +  +  AL YLH + 
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDE-----DVAR--IYIAEIVLALEYLHSN- 112

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARL--------LNFDSSNRTLLAGTSGYIAP 362
              I+HRD+  +N+L++S     + DFG++++        LN D      + GT  YIAP
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Query: 363 ----------ASEWW 367
                       +WW
Sbjct: 171 EVILGQGHSKTVDWW 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 33/169 (19%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKL---HRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G G Y  VY+AR   +G++VA+KK+    R E ++  +  + R E +LL ++ H NI+ 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH---------- 301
           L     H+  + L++E+ME         TD E V     K  +IV   A           
Sbjct: 67  LLDVFGHKSNINLVFEFME---------TDLEKV----IKDKSIVLTPADIKSYMLMTLR 113

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
            L YLH +    I+HRD+  NN+L+ S+    +ADFG+AR  +F S NR
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNR 157

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 81.7 bits (202), Expect = 8e-18
 Identities = 44/146 (30%), Positives = 71/146 (48%), Gaps = 7/146 (4%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG G +G VY+  L     VA+K    +   +L     F  EA +L Q  H NIVKL G 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIGV 60

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C+ ++ ++++ E +  GSL   LR   +   L   K + +    A  + YL        +
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKNC---I 115

Query: 316 HRDISSNNVLLNSELEAFVADFGVAR 341
           HRD+++ N L+       ++DFG++R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 81.7 bits (202), Expect = 8e-18
 Identities = 47/156 (30%), Positives = 88/156 (56%), Gaps = 7/156 (4%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E+F ++  +G+G +G V+     +   VA+K L     ++L   + F+ E + L ++ H+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQDFQKEVQALKRLRHK 62

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           +++ L+  C   + +++I E ME GSL   LR+ E  V L  A  +++   +A  ++YL 
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLE 121

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
                  +HRD+++ N+L+  +L   VADFG+ARL+
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI 154

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 49/167 (29%), Positives = 83/167 (49%), Gaps = 7/167 (4%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G VY+A+     + A  K    + E    LE F  E  +LS+  H NIV LY  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAK--IIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
             +   ++++ E+ + G+L  ++   E   GL   +   + + M  AL++LH H    ++
Sbjct: 71  YFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125

Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           HRD+ + N+LL  + +  +ADFGV+         R    GT  ++AP
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 55/159 (34%), Positives = 85/159 (53%), Gaps = 11/159 (6%)

Query: 192 IKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           I+  IG G +G V   R +LP  +   VA+K L    TE+      F +EA ++ Q  H 
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHP 65

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NI+ L G     K + ++ EYME GSL   LR  +    +   + V +++G+A  + YL 
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYLS 123

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                  VHRD+++ N+L+NS L   V+DFG++R+L  D
Sbjct: 124 DM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 2e-17
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 19/160 (11%)

Query: 196 IGTGGYGSVYRA--RLPSGKV--VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G G +GSV +    + SGK   VA+K L   +    A  + F  EA +++Q+ H  IV+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK--QEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLD---WAKRVNIVKGMAHALSYLHH 308
           L G C     M L+ E   +G L   L+   E    D    A +V +  GMA    YL  
Sbjct: 61  LIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAM--GMA----YLE- 112

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
             +   VHRD+++ NVLL +  +A ++DFG++R L   S 
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 60/172 (34%), Positives = 86/172 (50%), Gaps = 25/172 (14%)

Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S  E L     F  E  +
Sbjct: 2   EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL---RDFEREIEI 58

Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV----N 294
           L  + H NIVK  G C    R+ + L+ EY+  GSL   L+   E   LD  K +     
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQ 116

Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           I KGM     YL    +   VHRD+++ N+L+ SE    + DFG+ ++L  D
Sbjct: 117 ICKGM----EYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 79.8 bits (197), Expect = 6e-17
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 26/167 (15%)

Query: 196 IGTGGYGSVYRARL--PSGK----VVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY+  L  P+ +     VA+K L   E  E    + FR EA L+S + H NI
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTL--KENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSL--FCVLRTDEEAVG-----------LDWAKRVNIV 296
           V L G C   +   +++EY+  G L  F V  +    VG           LD +  ++I 
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 297 KGMAHALSYLH-HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
             +A  + YL  HH     VHRD+++ N L+   L   ++DFG++R 
Sbjct: 131 IQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFGLSRD 173

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.1 bits (195), Expect = 8e-17
 Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 11/161 (6%)

Query: 189 DFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY          VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 62

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNIVKGMAHALSYL 306
           N+V+L G C      ++I E+M  G+L   LR  + +   ++    + +   ++ A+ YL
Sbjct: 63  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYL 120

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
                   +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 121 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 59/184 (32%), Positives = 90/184 (48%), Gaps = 22/184 (11%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHR 247
           F +   +G G YG VY+ R + +G++ A+K +  +E EE    E  + E  +L +   HR
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSHHR 73

Query: 248 NIVKLYGFCL------HRKCMFLIYEYMEMGSLF-CVLRTDEEAVGLDWAKRV--NIVKG 298
           NI   YG  +      H   ++L+ E+   GS+   V  T   A+  DW   +   I++G
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           +AH    LH H    ++HRDI   NVLL    E  + DFGV+  L+     R    GT  
Sbjct: 134 LAH----LHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186

Query: 359 YIAP 362
           ++AP
Sbjct: 187 WMAP 190

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.9 bits (197), Expect = 4e-16
 Identities = 46/105 (43%), Positives = 62/105 (59%), Gaps = 3/105 (2%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           +N+L G IP+EL     L+ + LG N LSG I  EIG L  LN+LDL +N + G IPS L
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256

Query: 63  GEIPRIDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIP 104
           G +  +  + L  N LSG IP S+   +K+  L +S N+   EIP
Sbjct: 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.5 bits (196), Expect = 5e-16
 Identities = 36/113 (31%), Positives = 63/113 (55%), Gaps = 2/113 (1%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +++N L+G IP+ L  C  LR + L +N  SG + SE  KL  + +LD+S+N + G+I S
Sbjct: 387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESV--KKVPLLYVSGNNFEVEIPSTSAKAP 111
           +  ++P +  ++L+ N   G +P+S   K++  L +S N F   +P       
Sbjct: 447 RKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS 499

Length = 968

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 47/151 (31%), Positives = 81/151 (53%), Gaps = 15/151 (9%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG VY+AR   +G++VALKK+ R ETE+     +   E  LL ++ H NIV+L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG----MAHALSYLHHHC 310
                  ++L++E++++      L+   ++  L       ++K     +   ++Y H H 
Sbjct: 66  VVHSENKLYLVFEFLDLD-----LKKYMDSSPLT-GLDPPLIKSYLYQLLQGIAYCHSH- 118

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
              ++HRD+   N+L++ E    +ADFG+AR
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 76.3 bits (188), Expect = 7e-16
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 17/155 (10%)

Query: 196 IGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G G +G V R       GKV  VA+K L   +  ++  ++ F  EA ++  + H N+++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEA---VGLDWAKRVNIVKGMAHALSYLHH 308
           LYG  L    M ++ E   +GSL   LR D      +       V I  GM     YL  
Sbjct: 61  LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR----YLE- 114

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
             +   +HRD+++ N+LL S+ +  + DFG+ R L
Sbjct: 115 --SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 8e-16
 Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 25/157 (15%)

Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHR--SETEELASLESFRNEARLLSQI-WHRNIV 250
            +G G +GSVY AR   +G++VA+KK+ +     EE  +L     E + L ++  H NIV
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL----REVKSLRKLNEHPNIV 61

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRT------DEEAVGLDWAKRVNIVKGMAHALS 304
           KL         ++ ++EYME G+L+ +++        E  +        +I+  +   L+
Sbjct: 62  KLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIR-------SIIYQILQGLA 113

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           ++H H      HRD+   N+L++      +ADFG+AR
Sbjct: 114 HIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 20/184 (10%)

Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G GG+G V   ++    +  ALK + +    E    E   +E  +L +  H  IVKLY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
               +K ++++ EY   G L+ +LR   +    D       +  +  A  YLH+     I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNR---GI 114

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGYIAP----------A 363
           ++RD+   N+LL+S     + DFG A+ L   S  +T    GT  Y+AP          +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAPEIILNKGYDFS 172

Query: 364 SEWW 367
            ++W
Sbjct: 173 VDYW 176

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 54/158 (34%), Positives = 81/158 (51%), Gaps = 19/158 (12%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARL--LSQIWHRNIVKL 252
           IG G YG+VY+AR P SG  VALK +     E+   L + R  A L  L    H NIV+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 253 YGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAV---GLDWAKRVNIVKGMAHALS 304
              C   +      + L++E+++       LRT  + V   GL      ++++     L 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQD-----LRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
           +LH +C   IVHRD+   N+L+ S  +  +ADFG+AR+
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 56/170 (32%), Positives = 91/170 (53%), Gaps = 17/170 (10%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG+G  G+VY+    P+G++ ALK ++ +  +          E  +L  + H N+VK + 
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHD 139

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
              H   + ++ E+M+ GSL      DE+ +  D A++  I+ G+A    YLH      I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-DVARQ--ILSGIA----YLHRR---HI 189

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLN--FDSSNRTLLAGTSGYIAP 362
           VHRDI  +N+L+NS     +ADFGV+R+L    D  N ++  GT  Y++P
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSP 237

Length = 353

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 44/109 (40%), Positives = 59/109 (54%), Gaps = 3/109 (2%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +Y NKL GPIP  + +  KL  L L +N LSG I   + +LQ L  L L  N   GKIP 
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKK---VPLLYVSGNNFEVEIPST 106
            L  +PR+  + L  N  SG IP+++ K   + +L +S NN   EIP  
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375

Length = 968

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 56/172 (32%), Positives = 87/172 (50%), Gaps = 34/172 (19%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY- 253
           IG G YG VY+AR   +G++VALKK+     +E   + + R E ++L Q+ HRNIV L  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNLKE 73

Query: 254 ---------GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN--------IV 296
                     F   +   +L++EYM           D + +GL  +  V+         +
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYM-----------DHDLMGLLESGLVHFSEDHIKSFM 122

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           K +   L+Y H       +HRDI  +N+LLN++ +  +ADFG+ARL N + S
Sbjct: 123 KQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 8/164 (4%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-W 245
           +DF     IG G + +V  A+   + K  A+K L + +  +   ++  + E  +L+++  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H  I+KLY      + ++ + EY   G L   +R       LD          +  AL Y
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEY 117

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 349
           LH      I+HRD+   N+LL+ ++   + DFG A++L+ +SS 
Sbjct: 118 LHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 19/153 (12%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G V+       + VA+K +     E   S E F  EA+++ ++ H  +V+LYG 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR----EGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-----VNIVKGMAHALSYLHHHC 310
           C  R  + L++E+ME G L   LR      G    +      +++ +GMA    YL    
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMA----YLESSN 120

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
              ++HRD+++ N L+       V+DFG+ R +
Sbjct: 121 ---VIHRDLAARNCLVGENQVVKVSDFGMTRFV 150

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 21/173 (12%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKK--LHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG G  G V  A    +G+ VA+KK  L + +  EL       NE  ++    H NIV++
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL-----LFNEVVIMRDYQHPNIVEM 81

Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           Y   L    ++++ E++E G+L  ++   R +EE +         +   +  ALS+LH  
Sbjct: 82  YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLAVLKALSFLHAQ 134

Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRDI S+++LL S+    ++DFG    ++ +   R  L GT  ++AP
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 8/159 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHD 61

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY  C   + ++++ EYM  GSL   L++  E   L   + V++   +A  ++YL 
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLE 120

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                  +HRD+++ N+L+   L   +ADFG+ARL+  D
Sbjct: 121 SR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.9 bits (185), Expect = 4e-15
 Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 54/196 (27%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRN---------EAR 239
           + I   +G G YG V++A    + +VVALKK+           ++FRN         E  
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI----------FDAFRNATDAQRTFREIM 58

Query: 240 LLSQIW-HRNIVKLYGFCLHR----KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 294
            L ++  H NIVKL    + +    K ++L++EYME         TD  AV      R N
Sbjct: 59  FLQELGDHPNIVKLLN--VIKAENDKDIYLVFEYME---------TDLHAV-----IRAN 102

Query: 295 IVKGMAH---------ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
           I++ +           AL Y+H   +  ++HRD+  +N+LLNS+    +ADFG+AR L+ 
Sbjct: 103 ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159

Query: 346 DSSNRTLLAGTSGYIA 361
              N      T  Y+A
Sbjct: 160 LEENPENPVLTD-YVA 174

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 12/170 (7%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V++ R   +G++VA+KK   SE + +    + R E R+L Q+ H N+V L  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRMLKQLKHPNLVNLIE 67

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLH-HHCTP 312
               ++ + L++EY +      VL   ++   G+       I+     A+++ H H+C  
Sbjct: 68  VFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC-- 121

Query: 313 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             +HRD+   N+L+  + +  + DFG AR+L     + T    T  Y AP
Sbjct: 122 --IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 73.7 bits (181), Expect = 5e-15
 Identities = 40/146 (27%), Positives = 79/146 (54%), Gaps = 9/146 (6%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G+G +G V+  +  +   VA+K ++     E    E F  EA+++ ++ H  +V+LYG 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C  +K ++++ E+ME G L   LR  +  +  D    +++ + +   + YL  +     +
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFI 122

Query: 316 HRDISSNNVLLNSELEAFVADFGVAR 341
           HRD+++ N L++S     V+DFG+ R
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 73.8 bits (181), Expect = 5e-15
 Identities = 39/146 (26%), Positives = 75/146 (51%), Gaps = 9/146 (6%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +GTG +G V   +      VA+K +      E    + F  EA+++ ++ H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C  ++ ++++ EYM  G L   LR  E       ++ + + K +   ++YL        +
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLR--EHGKRFQPSQLLEMCKDVCEGMAYLESK---QFI 122

Query: 316 HRDISSNNVLLNSELEAFVADFGVAR 341
           HRD+++ N L++ +    V+DFG++R
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.1 bits (182), Expect = 6e-15
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 7/147 (4%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H NIVKL  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                  ++L++E++       +  +    + L   K  + +  +   L++ H H    +
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSH---RV 121

Query: 315 VHRDISSNNVLLNSELEAFVADFGVAR 341
           +HRD+   N+L+N+E    +ADFG+AR
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 38/197 (19%)

Query: 190 FHIKYCIGTGGYGSVYRARL---PSGKVVALKKLHRSETEELA--SLESFRNEARLLSQI 244
           + I+ CIG G YG VY+A+      GK  A+KK  + + E+    S  + R E  LL ++
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACR-EIALLREL 59

Query: 245 WHRNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA-- 300
            H N+V L    L    K ++L+++Y E   L+ +++   +      AKRV+I   M   
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQ------AKRVSIPPSMVKS 112

Query: 301 ------HALSYLHHHCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNR 350
                 + + YLH +    ++HRD+   N+L+  E        + D G+ARL  F++  +
Sbjct: 113 LLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL--FNAPLK 167

Query: 351 TLLAG-----TSGYIAP 362
            L        T  Y AP
Sbjct: 168 PLADLDPVVVTIWYRAP 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 75.7 bits (186), Expect = 7e-15
 Identities = 45/112 (40%), Positives = 62/112 (55%), Gaps = 4/112 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +YNN L GPIP  L N   L+ L L  N LSG I   I  LQ+L  LDLS N ++G+IP 
Sbjct: 244 VYNN-LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVS---GNNFEVEIPSTSAK 109
            + ++  ++ ++L  NN +G IP ++  +P L V     N F  EIP    K
Sbjct: 303 LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354

Length = 968

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.7 bits (181), Expect = 8e-15
 Identities = 54/174 (31%), Positives = 82/174 (47%), Gaps = 36/174 (20%)

Query: 196 IGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASLE---SFRNEARLLSQIWH 246
           IG G +G V++AR P         +VA+K L     +E AS +    F+ EA L+++  H
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-----KEEASADMQADFQREAALMAEFDH 67

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------------------DEEAVGL 287
            NIVKL G C   K M L++EYM  G L   LR                        + L
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 288 DWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
              +++ I K +A  ++YL        VHRD+++ N L+   +   +ADFG++R
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 73.6 bits (181), Expect = 9e-15
 Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 27/179 (15%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G  GSV + RL  +G + ALK +      +L   +  R E  +        IVK YG
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK-QILR-ELEINKSCKSPYIVKYYG 66

Query: 255 FCL--HRKCMFLIYEYMEMGSLFCVL--------RTDEEAVGLDWAKRVNIVKGMAHALS 304
             L      + +  EY E GSL  +         R  E+ +G        I + +   LS
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-------KIAESVLKGLS 119

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA-RLLNFDSSNRTLLAGTSGYIAP 362
           YLH   +  I+HRDI  +N+LL  + +  + DFGV+  L+N  +   T   GTS Y+AP
Sbjct: 120 YLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAP 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 73.7 bits (181), Expect = 9e-15
 Identities = 47/152 (30%), Positives = 82/152 (53%), Gaps = 16/152 (10%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG VY+AR   + + +ALKK+   + +E     + R E  LL ++ H NIV+L  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG----MAHALSYLHHHC 310
                K ++L++EY+++      L+   ++   D+AK   ++K     +   ++Y H H 
Sbjct: 69  VVHSEKRLYLVFEYLDLD-----LKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH- 121

Query: 311 TPPIVHRDISSNNVLLNSELEAF-VADFGVAR 341
              ++HRD+   N+L++    A  +ADFG+AR
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 41/110 (37%), Positives = 62/110 (56%), Gaps = 9/110 (8%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           NN L G IP ++ + S L++L LG N+L G I + +  L  L +L L+ N + G+IP +L
Sbjct: 149 NNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPREL 208

Query: 63  GEIPRIDTVNLSMNNLSGSIP------ESVKKVPLLYVSGNNFEVEIPST 106
           G++  +  + L  NNLSG IP       S+  + L+Y   NN    IPS+
Sbjct: 209 GQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY---NNLTGPIPSS 255

Length = 968

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 56/168 (33%), Positives = 83/168 (49%), Gaps = 10/168 (5%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++     + KVVA+K +   E E+   +E  + E  +LSQ     + K YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    +++I EY+  GS   +L    E   LD  +   I++ +   L YLH   +   
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKK 122

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI + NVLL+   E  +ADFGVA  L      R    GT  ++AP
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 18/182 (9%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHR 247
           F +   +G G YG VY+ R + +G++ A+K +  +  EE    E  + E  +L +   HR
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 63

Query: 248 NIVKLYGFCLHRKC------MFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNIVKGMA 300
           NI   YG  + +        ++L+ E+   GS+  +++ T    +  +W     I + + 
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 121

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
             LS+LH H    ++HRDI   NVLL    E  + DFGV+  L+     R    GT  ++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178

Query: 361 AP 362
           AP
Sbjct: 179 AP 180

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 52/179 (29%), Positives = 98/179 (54%), Gaps = 21/179 (11%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKL---HRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +GTG + S Y+AR + +G ++A+K++     + +E+   +E+ R E RL++++ H +I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHH 308
           + G         L  E+M  GS+  +L      +EAV +++ ++  +++G    LSYLH 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ--LLRG----LSYLHE 121

Query: 309 HCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTL----LAGTSGYIAP 362
           +    I+HRD+   N+L++S  +   +ADFG A  L    +        L GT  ++AP
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 34/197 (17%)

Query: 189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF +   +GTG +G V  A+   +G+  A+K L + E  ++  ++    E  +L ++ H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 248 NIVKLY-GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH----- 301
            IV +   F    +  FL+ E++  G LF  LR           +  N V    H     
Sbjct: 79  FIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKA--------GRFPNDVAKFYHAELVL 129

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGYI 360
           A  YL H     I++RD+   N+LL+++    V DFG A+ +     +RT  L GT  Y+
Sbjct: 130 AFEYL-HSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYL 182

Query: 361 AP----------ASEWW 367
           AP          A +WW
Sbjct: 183 APEVIQSKGHGKAVDWW 199

Length = 329

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 5/105 (4%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           NN   G IP+  +    L  L L NN+LSG I ++IG    L  LDL  N++ GKIP+ L
Sbjct: 127 NNNFTGSIPRGSIPN--LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184

Query: 63  GEIPRIDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIP 104
             +  ++ + L+ N L G IP  +   K +  +Y+  NN   EIP
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229

Length = 968

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 30/176 (17%)

Query: 188 EDFHIKYCIGTGGYGSVYR---ARLPSGKV---VALKKLHRSETEELASLESFRNEARLL 241
           E   +   +G G +G VY      +  G+    VA+K ++  E   +     F NEA ++
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN--ENASMRERIEFLNEASVM 63

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLD--------- 288
            +    ++V+L G     +   ++ E M  G L   LR+     E   GL          
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 289 WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            A    I  GMA+ L+          VHRD+++ N ++  +L   + DFG+ R + 
Sbjct: 124 MA--AEIADGMAY-LAAKK------FVHRDLAARNCMVAEDLTVKIGDFGMTRDIY 170

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 57/184 (30%), Positives = 87/184 (47%), Gaps = 21/184 (11%)

Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEA 238
           F D+ E          IG G +G+VY AR + + +VVA+KK+  S  +     +    E 
Sbjct: 17  FTDLRE----------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 66

Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           R L Q+ H N ++  G  L     +L+ EY  +GS   +L   ++   L   +   I  G
Sbjct: 67  RFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKK--PLQEVEIAAICHG 123

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
               L+YLH H     +HRDI + N+LL       +ADFG A L++  +S      GT  
Sbjct: 124 ALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPY 176

Query: 359 YIAP 362
           ++AP
Sbjct: 177 WMAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 71.8 bits (176), Expect = 2e-14
 Identities = 46/148 (31%), Positives = 81/148 (54%), Gaps = 9/148 (6%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L     +   S E+F  EA L+ Q+ H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA- 68

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T E  + L   K +++   +A  ++++        +
Sbjct: 69  VVTQEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYI 124

Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 10/168 (5%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++     + +VVA+K +   E E+   +E  + E  +LSQ     + K YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    +++I EY+  GS   +LR    A   D  +   ++K +   L YLH   +   
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLH---SEKK 122

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI + NVLL+ + +  +ADFGVA  L      R    GT  ++AP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 71.6 bits (175), Expect = 3e-14
 Identities = 44/147 (29%), Positives = 76/147 (51%), Gaps = 8/147 (5%)

Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V+  RL +    VA+K    +   +L +   F  EAR+L Q  H NIV+L G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNIVRLIG 60

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
            C  ++ ++++ E ++ G     LRT  E   L   + + +V+  A  + YL        
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHC--- 115

Query: 315 VHRDISSNNVLLNSELEAFVADFGVAR 341
           +HRD+++ N L+  +    ++DFG++R
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 46/165 (27%), Positives = 88/165 (53%), Gaps = 16/165 (9%)

Query: 186 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
              D+ I   +G G +G VY+AR + +G+VVALKK+     ++   + + R E ++L ++
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64

Query: 245 WHRNIVKLYGFCLHR--------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIV 296
            H N+V L    + R          ++++  YM+   L  +L  +  +V L  ++    +
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLL--ENPSVKLTESQIKCYM 121

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +   ++YLH +    I+HRDI + N+L++++    +ADFG+AR
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 73.7 bits (181), Expect = 4e-14
 Identities = 36/106 (33%), Positives = 61/106 (57%), Gaps = 3/106 (2%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
           N L G IP  L N + L  L L +N L G I  E+G+++ L ++ L +N ++G+IP ++G
Sbjct: 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG 233

Query: 64  EIPRIDTVNLSMNNLSGSIPES---VKKVPLLYVSGNNFEVEIPST 106
            +  ++ ++L  NNL+G IP S   +K +  L++  N     IP +
Sbjct: 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279

Length = 968

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 10/169 (5%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G YG V + +   +G++VA+KK   SE +++    + R E R+L Q+ H N+V L  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLIE 67

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV-GLDWAKRVNIVKGMAHALSYLHHHCTPP 313
               +K ++L++E+++      VL   E+   GLD ++    +  +   + + H H    
Sbjct: 68  VFRRKKRLYLVFEFVD----HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---N 120

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           I+HRDI   N+L++      + DFG AR L       T    T  Y AP
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 52/176 (29%), Positives = 89/176 (50%), Gaps = 15/176 (8%)

Query: 196 IGTGGYGSVYRAR--LPSGKVVALKKLHRSETEELASLESFRNEA--RLLSQIWHRNIVK 251
           IG G YG V++AR     G+ VALK++     EE   L + R  A  R L    H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 252 LYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
           L+  C   +      + L++E+++      + +  E  V  +  K  +++  +   L +L
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLDFL 126

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    +VHRD+   N+L+ S  +  +ADFG+AR+ +F  +  +++  T  Y AP
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAP 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 21/139 (15%)

Query: 215 VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSL 274
           VA+K L    ++     E F  E ++LS++   NI +L G C     + +I EYME G L
Sbjct: 49  VAVKVLRPDASDNA--REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 275 FCVLRTDE-EAVGLDWAKR-----------VNIVKGMAHALSYLHHHCTPPIVHRDISSN 322
              L+    E  GL    +             I  GM + L  L+       VHRD+++ 
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRY-LESLN------FVHRDLATR 159

Query: 323 NVLLNSELEAFVADFGVAR 341
           N L+       +ADFG++R
Sbjct: 160 NCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 38/158 (24%), Positives = 76/158 (48%), Gaps = 17/158 (10%)

Query: 196 IGTGGYGSVYRARLPSG------KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G V+ A+           +V +K L   +T++      FR E  +  ++ H+N+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG------LDWAKRVNIVKGMAHAL 303
           V+L G C   +  ++I EY ++G L   LR  +          L   ++V +   +A  +
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +L +      VHRD+++ N L++S+ E  V+   +++
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+     +   VA+K L         S+++F  EA L+  + H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
               + +++I EYM  GSL   L++DE    +   K ++    +A  ++Y+        +
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERK---NYI 125

Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + NVL++  L   +ADFG+AR++
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVI 153

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 11/168 (6%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G+VY A    + +VVA+KK+  S  +     +    E + L Q+ H N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L     +L+ EY  +GS   +L   ++   L   +   I  G    L+YLH H    +
Sbjct: 89  CYLKEHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHN---M 142

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI + N+LL    +  +ADFG A      SS      GT  ++AP
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASK----SSPANSFVGTPYWMAP 186

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 10/168 (5%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G VY+     + +VVA+K +   E E+   +E  + E  +LSQ     I + YG
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYITRYYG 69

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    +++I EY+  GS   +L+       L+      I++ +   L YLH   +   
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLH---SERK 122

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI + NVLL+ + +  +ADFGVA  L      R    GT  ++AP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 32/176 (18%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR----LPSGK--VVALKKLHRSETEELASLESFRNEARLL 241
            D  +K+ +G G +G V+ A     LP     +VA+K L   E  E A  + F+ EA LL
Sbjct: 5   RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESARQD-FQREAELL 61

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRV------- 293
           + + H++IV+ YG C   + + +++EYM  G L   LR+   +A  L   + V       
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 294 --------NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                    I  GM + L+ LH       VHRD+++ N L+   L   + DFG++R
Sbjct: 122 GQMLAIASQIASGMVY-LASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 52/182 (28%), Positives = 91/182 (50%), Gaps = 18/182 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +++     I  G YG VYRAR   +G++VALKKL   + +E   + S R E  +L ++ H
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63

Query: 247 RNIVKL----YGFCLHRKCMFLIYEYMEMGSLFCVLRT--DEEAVGLDWAKRVNIVKGMA 300
            NIV +     G  L +  ++++ EY+E       L++  +        ++   ++  + 
Sbjct: 64  PNIVTVKEVVVGSNLDK--IYMVMEYVEHD-----LKSLMETMKQPFLQSEVKCLMLQLL 116

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
             +++LH +    I+HRD+ ++N+LLN+     + DFG+AR         T L  T  Y 
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173

Query: 361 AP 362
           AP
Sbjct: 174 AP 175

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 8/148 (5%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+     +   VA+K L +  T      + F  EA+++ ++ H  +++LY  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTL-KPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C   + ++++ E M+ GSL   L+       L   + +++   +A  ++YL        +
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQ---NYI 125

Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+++ NVL+       VADFG+AR++
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVI 153

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 20/153 (13%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG+V++A+   + ++VALK++   + +E     + R E  LL ++ H+NIV+LY 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66

Query: 255 FCLHRKCMFLIYEYME--MGSLFCVLRTDEEAVGLDWAKRVNIVKG----MAHALSYLHH 308
                K + L++EY +  +   F     D +           IVK     +   L++ H 
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP---------EIVKSFMFQLLKGLAFCHS 117

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           H    ++HRD+   N+L+N   E  +ADFG+AR
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 9/148 (6%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L         S ESF  EA+++ ++ H  +V+LY  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYA- 68

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            +  + ++++ EYM  GSL   L+ D E   L     V++   +A  ++Y+        +
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIERM---NYI 124

Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ S N+L+   L   +ADFG+ARL+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 52/168 (30%), Positives = 84/168 (50%), Gaps = 11/168 (6%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G+VY AR + + +VVA+KK+  S  +     +    E + L +I H N ++  G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L     +L+ EY  +GS   +L   ++   L   +   I  G    L+YLH H    +
Sbjct: 93  CYLREHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSH---NM 146

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI + N+LL    +  +ADFG A + +  +S      GT  ++AP
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAP 190

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 39/107 (36%), Positives = 59/107 (55%), Gaps = 6/107 (5%)

Query: 3   NNKLDGPIPQELMN-CSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
           NN+L GPIP ++    S LR L L NN  +GSI    G +  L  LDLS+N+++G+IP+ 
Sbjct: 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPND 159

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPS 105
           +G    +  ++L  N L G IP S+  +     L ++ N    +IP 
Sbjct: 160 IGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206

Length = 968

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 21/179 (11%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN---EARLLSQIWHRNIVKL 252
           +G G YG+VY      G+++A+K++    +  LA+ + +     E  LL  + H NIV+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
            G CL    + +  E++  GS+  +L       E V   + K+  I+ G+A    YLH++
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ--ILDGVA----YLHNN 121

Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT------LLAGTSGYIAP 362
           C   +VHRDI  NNV+L       + DFG AR L +   + T       + GT  ++AP
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 51/177 (28%), Positives = 87/177 (49%), Gaps = 24/177 (13%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKL-----HRSETEELASLESFRNEARLLSQIWHRNI 249
           +G+G +GSVY    L  G   A+K++      ++  E +  LE    E  LLS++ H NI
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE---QEIALLSKLQHPNI 64

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSY 305
           V+  G       +++  E +  GSL  +L+      E  + L + ++  I+ G    L Y
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL-YTRQ--ILLG----LEY 117

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH       VHRDI   N+L+++     +ADFG+A+ +   S  ++   G+  ++AP
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 58/176 (32%), Positives = 87/176 (49%), Gaps = 22/176 (12%)

Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G YG VY AR  S +V +A+K++   ++  +  L     E  L S + HRNIV+  G
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQYLG 72

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRT------DEEAVGLDWAKRVNIVKGMAHALSYLHH 308
                    +  E +  GSL  +LR+      D E   + + K+  I++G    L YLH 
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ--ILEG----LKYLHD 126

Query: 309 HCTPPIVHRDISSNNVLLNSELEAF-VADFGVA-RLLNFDSSNRTLLAGTSGYIAP 362
           +    IVHRDI  +NVL+N+      ++DFG + RL   +    T   GT  Y+AP
Sbjct: 127 N---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAP 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 67.7 bits (165), Expect = 5e-13
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 9/147 (6%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V++  L     VA+K       +EL     F +EAR+L Q  H NIVKL G 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGV 60

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HHCTPPI 314
           C  R+ ++++ E +  G     LR  ++   L   + V      A  ++YL   +C    
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAGMAYLESKNC---- 114

Query: 315 VHRDISSNNVLLNSELEAFVADFGVAR 341
           +HRD+++ N L+       ++DFG++R
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 10/176 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
            D+ +   +G+G YG VY+AR L +G++ A+K +     ++ + ++    E  ++ +  H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKH 65

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIV  +G  L R+ +++  EY   GSL  +         L  A    + +     L+YL
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---VCRETLQGLAYL 122

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +   +HRDI   N+LL    +  +ADFGVA  +    + R    GT  ++AP
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 67.7 bits (165), Expect = 6e-13
 Identities = 47/159 (29%), Positives = 82/159 (51%), Gaps = 19/159 (11%)

Query: 188 EDFHIKYCIGTGGYGSV----YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           ++  +   IG G +G V    YR     G  VA+K +        A+ ++F  EA +++Q
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND-----ATAQAFLAEASVMTQ 55

Query: 244 IWHRNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           + H N+V+L G  +  K  ++++ EYM  GSL   LR+   +V L     +     +  A
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEA 114

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + YL  +     VHRD+++ NVL++ +  A V+DFG+ +
Sbjct: 115 MEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 67.5 bits (165), Expect = 6e-13
 Identities = 52/191 (27%), Positives = 88/191 (46%), Gaps = 30/191 (15%)

Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLH---RSETEELASLESFRNEARLLSQI 244
           DF +   +G G YGSVY+  RL   +  ALK++     S+ E   ++    NE R+L+ +
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV----NEIRILASV 56

Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD--------EEAVGLDWAKRVNIV 296
            H NI+      L    + ++ EY   G L   +           E+ +   W   + ++
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI---WRIFIQLL 113

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT 356
           +G    L  LH      I+HRD+ S N+LL +     + D G++++L  + +   +  GT
Sbjct: 114 RG----LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--GT 164

Query: 357 SGYIAPASEWW 367
             Y+AP  E W
Sbjct: 165 PHYMAP--EVW 173

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 7/167 (4%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G VY+A+      +A  K+  +++EE   LE +  E  +L+   H  IVKL G 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
                 ++++ E+   G++  ++   E   GL   +   I + M  AL YLH   +  I+
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVICRQMLEALQYLH---SMKII 132

Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           HRD+ + NVLL  + +  +ADFGV+         R    GT  ++AP
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 27/195 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKV--VALKKLHRSETEELASLESFRNEARLLSQIW 245
           EDF+    +GTG +G V  A   +     VA+K+  +S+  +   ++   +E ++L+ I 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE---AVGLDWAKRVNIVKGMAHA 302
           H   V LYG       ++L+ E++  G  F  LR ++     VG  +A ++ ++     +
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           L+         IV+RD+   N+LL+ +    + DFG A+++  D+   T L GT  YIAP
Sbjct: 150 LN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT-LCGTPEYIAP 197

Query: 363 ----------ASEWW 367
                     A++WW
Sbjct: 198 EILLNVGHGKAADWW 212

Length = 340

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 25/172 (14%)

Query: 189 DFHIKYCIGTGGYGSVYRARL----PSGK--VVALKKLHRSETEELASLESFRNEARLLS 242
           D  +K  +G G +G V+ A      P+    +VA+K L   +   LA+ + F+ EA LL+
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLT 62

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD------------EEAVG-LDW 289
            + H +IVK YG C     + +++EYM+ G L   LR               +A G L  
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           ++ ++I   +A  + YL    +   VHRD+++ N L+ + L   + DFG++R
Sbjct: 123 SQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.4 bits (164), Expect = 8e-13
 Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 10/176 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF +   IG+G YG VY+AR + +G++ A+K +     E+ A ++    E  ++    H
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKH 65

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIV  +G  L R  +++  E+   GSL  +         L  ++   + +     L YL
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYL 122

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H       +HRDI   N+LL       +ADFGV+  +    + R    GT  ++AP
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 43/113 (38%), Positives = 64/113 (56%), Gaps = 4/113 (3%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
           YNN L G IP E+   + L  L L  N L+G I S +G L+ L YL L  N ++G IP  
Sbjct: 221 YNN-LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS 279

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIPSTSAKAP 111
           +  + ++ +++LS N+LSG IPE V   + + +L++  NNF  +IP      P
Sbjct: 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLP 332

Length = 968

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 7/168 (4%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G YGSVY+    P+G  +A+K++ R E +E +       E  +L +     IV  YG
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDE-SKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                  +++  EYM+ GSL  +        G+       I   +   L +L       I
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRD+   NVL+N   +  + DFGV+   N  +S      G   Y+AP
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 55/173 (31%), Positives = 93/173 (53%), Gaps = 22/173 (12%)

Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGK----VVALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+     VA+K+L R  T   A+ E   +E
Sbjct: 3   ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 59

Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 60  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 116

Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL  D
Sbjct: 117 QIAKGM----NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 44/147 (29%), Positives = 77/147 (52%), Gaps = 7/147 (4%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G Y +VY+ R   +G++VALK++H  + EE     + R E  L+ ++ H NIV+L+ 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHL-DAEEGTPSTAIR-EISLMKELKHENIVRLHD 65

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                  + L++EYM+   L   + T      LD     +    +   +++ H +    +
Sbjct: 66  VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121

Query: 315 VHRDISSNNVLLNSELEAFVADFGVAR 341
           +HRD+   N+L+N   E  +ADFG+AR
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 9/156 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 61

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 119

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
                  VHRD+ + N+L+   L   VADFG+ARL+
Sbjct: 120 RM---NYVHRDLRAANILVGENLVCKVADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 11/168 (6%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G+VY AR + + +VVA+KK+  S  +     +    E R L ++ H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L     +L+ EY  +GS   +L   ++   L   +   +  G    L+YLH H    +
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSH---NM 136

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRD+ + N+LL+      + DFG A ++   +       GT  ++AP
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 44/138 (31%), Positives = 63/138 (45%), Gaps = 27/138 (19%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +++N   G IP  L +  +L++L L +N  SG I   +GK   L  LDLS N + G+IP 
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374

Query: 61  QL-----------------GEIPR-------IDTVNLSMNNLSGSIPESVKKVPLLY--- 93
            L                 GEIP+       +  V L  N+ SG +P    K+PL+Y   
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434

Query: 94  VSGNNFEVEIPSTSAKAP 111
           +S NN +  I S     P
Sbjct: 435 ISNNNLQGRINSRKWDMP 452

Length = 968

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 31/89 (34%), Positives = 49/89 (55%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           N  L G IP ++     L+ + L  N + G+I   +G +  L  LDLS+N  NG IP  L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVPL 91
           G++  +  +NL+ N+LSG +P ++    L
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGRLL 515

Length = 623

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 18/166 (10%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG+G YG V  A    +G+ VA+KK+     + + +    R E +LL  + H NI+ L  
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLD 66

Query: 255 FCLHRKCM-----FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV--NIVKGMAHALSYLH 307
                        +++ E ME   L  V+++  + +  D  +     I++G    L YLH
Sbjct: 67  ILRPPSPEDFNDVYIVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRG----LKYLH 120

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 353
              +  ++HRD+  +N+L+NS  +  + DFG+AR ++ D   +  L
Sbjct: 121 ---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 6/147 (4%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG VY+ R   +G++VA+KK+ R E+EE     +   E  LL ++ H NIV L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             +    ++LI+E++ M  L   L +  +   +D     + +  +   + + H      +
Sbjct: 67  VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122

Query: 315 VHRDISSNNVLLNSELEAFVADFGVAR 341
           +HRD+   N+L++++    +ADFG+AR
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 40/148 (27%), Positives = 79/148 (53%), Gaps = 9/148 (6%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+ A       VA+K +         S+E+F  EA ++  + H  +VKL+  
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHA- 68

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I E+M  GSL   L++DE        K ++    +A  ++++        +
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 124

Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L+++ L   +ADFG+AR++
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVI 152

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 18/177 (10%)

Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLH--RSETEELASLESFRNEARLLSQIWHRNIVK 251
            +G G +G VY    + +G+ +A+K++       E    + +   E +LL  + H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHH 308
            YG     + + +  EYM  GS+   L+      E V   + +++         + YLH 
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLHS 122

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
           +    IVHRDI   N+L +S     + DFG ++ L    S+ T +    GT  +++P
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 54/172 (31%), Positives = 92/172 (53%), Gaps = 20/172 (11%)

Query: 183 MIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALK---KLHRSETEELASLESFRNEA 238
           +++ TE   +K  +G+G +G+VY+   +P G+ V +    K+    T   A++E F +EA
Sbjct: 3   ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEA 60

Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVN 294
            +++ + H ++V+L G CL    + L+ + M  G L   +   ++ +G    L+W   V 
Sbjct: 61  LIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQ 117

Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           I KGM     YL       +VHRD+++ NVL+ S     + DFG+ARLL  D
Sbjct: 118 IAKGMM----YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 56/187 (29%), Positives = 86/187 (45%), Gaps = 32/187 (17%)

Query: 188 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ED      +G G  GSV +   +P+G V+A K +H      + +  S R +     QI H
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH------IGAKSSVRKQILRELQIMH 58

Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKG 298
                 IV  YG  L+   + +  E+M+ GSL  + +       E +G        I   
Sbjct: 59  ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-------KIAVA 111

Query: 299 MAHALSYLH--HHCTPPIVHRDISSNNVLLNSELEAFVADFGVA-RLLNFDSSNRTLLAG 355
           +   L+YL+  H     I+HRDI  +N+L+NS  +  + DFGV+  L+N   S      G
Sbjct: 112 VVEGLTYLYNVHR----IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---SIADTFVG 164

Query: 356 TSGYIAP 362
           TS Y++P
Sbjct: 165 TSTYMSP 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 50/173 (28%), Positives = 89/173 (51%), Gaps = 21/173 (12%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALK--KLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG G  G V  AR   SG+ VA+K   L + +  EL       NE  ++    H+N+V++
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL-----LFNEVVIMRDYQHQNVVEM 83

Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           Y   L  + ++++ E+++ G+L  ++   R +EE +         + + +  AL YLH  
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-------TVCESVLQALCYLH-- 134

Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            +  ++HRDI S+++LL  +    ++DFG    ++ D   R  L GT  ++AP
Sbjct: 135 -SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 14/178 (7%)

Query: 196 IGTGGYGSVYRARL--PSGKVVALKKLH-------RSETEELASLESFRNEARLL-SQIW 245
           +G+G +G VY+ R       ++ALK+++       + + E   S+    +E  ++  Q+ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV-NIVKGMAHALS 304
           H NIV+ Y   L    ++++ + +E   L     + +E       +R+ NI   M  AL 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           YLH      IVHRD++ NN++L  + +  + DFG+A+      S  T + GT  Y  P
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVVGTILYSCP 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 19/185 (10%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
             +F I+  IG G +  VY+A  L  G+VVALKK+   E  +  + +    E  LL Q+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR--------TDEEAVGLDWAKRVNIVK 297
           H N++K     +    + ++ E  + G L  +++          E  +   W   V +  
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI---WKYFVQL-- 115

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTS 357
               AL ++H      I+HRDI   NV + +     + D G+ R  +  ++    L GT 
Sbjct: 116 --CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170

Query: 358 GYIAP 362
            Y++P
Sbjct: 171 YYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 26/178 (14%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKL---HRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G G +G V+   R    K+V +K++     ++ E LA+     NE ++L  + H NI++
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ----NECQVLKLLSHPNIIE 63

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLF------CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
            Y   L  K + ++ EY   G+L       C    DE+           I+      L  
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED----------TILHFFVQILLA 113

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LHH  T  I+HRD+ + N+LL+       + DFG++++L+  S   T++ GT  YI+P
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPCYISP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 21/173 (12%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKK--LHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG G  G V  A    +GK VA+KK  L + +  EL       NE  ++    H N+V +
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL-----LFNEVVIMRDYHHENVVDM 84

Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           Y   L    ++++ E++E G+L  ++   R +EE +         +   +  ALSYLH  
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYLH-- 135

Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRDI S+++LL S+    ++DFG    ++ +   R  L GT  ++AP
Sbjct: 136 -NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 7/170 (4%)

Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL-Y 253
           +G GG+G V   ++  +GK+ A KKL++   ++    E    E R+L+++  R IV L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 254 GFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTP 312
            F   +  + L+   M  G L + +   DEE  G    +       +   L +LH     
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 313 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            I++RD+   NVLL+++    ++D G+A  L    S     AGT G++AP
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAP 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 23/163 (14%)

Query: 196 IGTGGYGSVYRARLP------SGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           +G+G +G VY           SG + VA+K L +  T++      F  EA L+S   H N
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNIVKGMAHALS 304
           IVKL G CL  +  ++I E ME G L   LR           L   + ++I   +A    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 305 YLHH-HCTPPIVHRDISSNNVLLNSELEAF-----VADFGVAR 341
           YL   H     +HRD+++ N L++ +         + DFG+AR
Sbjct: 121 YLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 7/167 (4%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G VY+A+     V+A  K+  +++EE   LE +  E  +L+   H NIVKL   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
             +   ++++ E+   G++  V+   E  +     + V   K    AL+YLH +    I+
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVV--CKQTLEALNYLHEN---KII 125

Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           HRD+ + N+L   + +  +ADFGV+         R    GT  ++AP
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.1 bits (158), Expect = 7e-12
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 24/165 (14%)

Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G   +G VY+  L         + VA+K L   +  E    E F++EA + S++ H NI
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSL--FCVLRTDEEAVG-----------LDWAKRVNIV 296
           V L G     + + +I+ Y     L  F V+R+    VG           L+ A  V+IV
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +A  + +L  H    +VH+D+++ NVL+  +L   ++D G+ R
Sbjct: 131 TQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 26/186 (13%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEAR-LLSQIWHRNIVKLY 253
           I  G +GSVY A+   +G   A+K L +S+      + + + E   ++ Q     + KLY
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
                +  ++L+ EY+  G    +++T    +  DWAK    +  +   +  LH      
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAK--QYIAEVVLGVEDLHQR---G 117

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVAR--LLNFDSSNRTLLAGTSGYIAP--------- 362
           I+HRDI   N+L++      + DFG++R  L N          GT  Y+AP         
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDD 171

Query: 363 -ASEWW 367
             S+WW
Sbjct: 172 KMSDWW 177

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 8e-12
 Identities = 56/180 (31%), Positives = 87/180 (48%), Gaps = 13/180 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF I   IG G +G V   ++  +G+V A+K L++ E  + A    FR E  +L     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 247 RNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           R I  L Y F      ++L+ +Y   G L  +L   E+ +  D A+    +  M  A+  
Sbjct: 61  RWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--LAEMVLAIDS 117

Query: 306 LH--HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTSGYIAP 362
           +H   +     VHRDI  +NVLL+      +ADFG    L  D + ++ +A GT  YI+P
Sbjct: 118 VHQLGY-----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 29/157 (18%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G Y +V++ R   +  +VALK++ R E EE A   + R E  LL  + H NIV L+ 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70

Query: 255 FCLHRKCMFLIYEYME---------MGSLFCVLRTDEEAVGLDWAKRVNIVK-GMAHALS 304
                +C+ L++EY++          G+L  +               V I    +   LS
Sbjct: 71  IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSM-------------HNVKIFMFQLLRGLS 117

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           Y H      I+HRD+   N+L+N + E  +ADFG+AR
Sbjct: 118 YCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 64.5 bits (157), Expect = 9e-12
 Identities = 53/183 (28%), Positives = 97/183 (53%), Gaps = 25/183 (13%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLH------RSETEELASLESFRNEARLLSQIWHRN 248
           IG+G +GSVY      SG+++A+K++        S+  + + L++   E  LL ++ H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSY 305
           IV+  G  L    + +  EY+  GS+  +L      EE +  ++ ++  I+KG    L+Y
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ--ILKG----LNY 121

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS------SNRTLLAGTSGY 359
           LH+     I+HRDI   N+L++++    ++DFG+++ L  +S        R  L G+  +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 360 IAP 362
           +AP
Sbjct: 179 MAP 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 54/180 (30%), Positives = 90/180 (50%), Gaps = 23/180 (12%)

Query: 189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKK--LHRSETEELASLESFRNEARLLSQIW 245
           D  IK  IG G  G V  A +  SGK+VA+KK  L + +  EL       NE  ++    
Sbjct: 23  DNFIK--IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL-----LFNEVVIMRDYQ 75

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHA 302
           H N+V++Y   L    ++++ E++E G+L  ++   R +EE +         +   +  A
Sbjct: 76  HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKA 128

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LS LH      ++HRDI S+++LL  +    ++DFG    ++ +   R  L GT  ++AP
Sbjct: 129 LSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 19/161 (11%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALK---KLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G+G +G+VY+   +P G+ V +    K+ R  T   A+ E   +EA +++ +    + +
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEIL-DEAYVMAGVGSPYVCR 73

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLH 307
           L G CL      L+ + M  G L   +R +++ +G    L+W   V I KGM    SYL 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKGM----SYLE 126

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
                 +VHRD+++ NVL+ S     + DFG+ARLL+ D +
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.4 bits (156), Expect = 1e-11
 Identities = 48/168 (28%), Positives = 86/168 (51%), Gaps = 11/168 (6%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G  G+V+ A  + +G+ VA+K+++    ++    E   NE  ++ ++ + NIV    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    +F++ EY+  GSL  V+        +D A+   + +    AL +LH +    +
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---QV 136

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI S+NVLL  +    + DFG    +  + S R+ + GT  ++AP
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 12/164 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRA--RLPSGKV--VALKKLHRSETEELASLESFRNEARLLSQ 243
           ED  +  CIG G +G VY+     P  +   VA+K      +  +   E F  EA ++ Q
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQ 63

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H +IVKL G       ++++ E   +G L   L+ ++ +  LD A  +     ++ AL
Sbjct: 64  FDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYS--LDLASLILYSYQLSTAL 120

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
           +YL    +   VHRDI++ NVL++S     + DFG++R L  +S
Sbjct: 121 AYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 43/146 (29%), Positives = 82/146 (56%), Gaps = 11/146 (7%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG G +G+V +    +G+ VA+K +    T +     +F  E  +++++ H+N+V+L G 
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQ-----AFLEETAVMTKLHHKNLVRLLGV 67

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            LH   ++++ E M  G+L   LRT   A+ +   + +     +A  + YL    +  +V
Sbjct: 68  ILHNG-LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLE---SKKLV 122

Query: 316 HRDISSNNVLLNSELEAFVADFGVAR 341
           HRD+++ N+L++ +  A V+DFG+AR
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 22/166 (13%)

Query: 192 IKYCIGTGGYGSVYRARL----PSGK--VVALKKLHRSETEELASLESFRNEARLLSQIW 245
           +K  +G G +G V+ A      P     +VA+K L  +      + + F  EA LL+ + 
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQ 65

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD-EEAV---------GLDWAKRVNI 295
           H +IVK YG C+    + +++EYM+ G L   LR    +AV          L  ++ ++I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +A  + YL    +   VHRD+++ N L+   L   + DFG++R
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 49/159 (30%), Positives = 70/159 (44%), Gaps = 18/159 (11%)

Query: 196 IGTGGYGSVY------RARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY      R        VA+K L  S +E+      F  EA ++S+  H+NI
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ--DESDFLMEALIMSKFNHQNI 71

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNIVKGMAHALSY 305
           V+L G    R   F++ E M  G L   LR      E    L     +   + +A    Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELE---AFVADFGVAR 341
           L        +HRDI++ N LL  +     A +ADFG+AR
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 17/153 (11%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G+ VA+KKL R    E+ +  ++R E  LL  + H N++ L  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGL-- 79

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAV-GLDWA--KRVNIVKGMAHALSYLHH 308
             L      +  +  E    + V+   +TD + + G   +  K   +V  M   L Y+H 
Sbjct: 80  --LDVFTSAVSGD--EFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH- 134

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +  I+HRD+   N+ +N + E  + DFG+AR
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 54/166 (32%), Positives = 89/166 (53%), Gaps = 25/166 (15%)

Query: 190 FHIKYC-----IGTGGYGSV--YR---ARLPSGKVVALKKLHRSETEELASLESFRNEAR 239
           FH +Y      +G G +G V  Y    A   +G++VA+K L R   ++  S   ++ E  
Sbjct: 1   FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTS--GWKKEIN 58

Query: 240 LLSQIWHRNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVG--LDWAKRVNI 295
           +L  ++H NIVK  G C  +  K + LI EY+ +GSL   L   +  +   L +A++  I
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ--I 116

Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +GMA    YLH   +   +HRD+++ NVLL+++    + DFG+A+
Sbjct: 117 CEGMA----YLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 54/169 (31%), Positives = 78/169 (46%), Gaps = 31/169 (18%)

Query: 196 IGTGGYGSVYRA------RLPSGKVVALKKL----HRSETEELASLESFRNEARLLSQIW 245
           +G G +G V  A      +  +   VA+K L    H SE E L S      E +++S + 
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS------ELKIMSHLG 96

Query: 246 -HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-----LDWAKRVNIVKGM 299
            H NIV L G C     + +I EY   G L   LR   E+       L ++ +V   KGM
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV--AKGM 154

Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           A   S    +C    +HRD+++ NVLL       + DFG+AR +  DS+
Sbjct: 155 AFLAS---KNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN 196

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 50/179 (27%), Positives = 77/179 (43%), Gaps = 15/179 (8%)

Query: 190 FHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           + I   IG G +G +Y A+  S     + K        +   E+ + E  LL+++ H NI
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNIVKGMAHALS 304
           V  +        +F++ EY + G L   +         E   L W   V I  G+ H   
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLGLKH--- 116

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            +H      I+HRDI S N+ L+   + A + DFG+AR LN          GT  Y++P
Sbjct: 117 -IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 21/157 (13%)

Query: 196 IGTGGYGSVYRA-RLPSGKV----VALKKLHRSETEELASLESFRNEARLLSQIWHRNIV 250
           +G+G +G+V++   +P G      VA+K +      +  + +   +    +  + H  IV
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQ--TFQEITDHMLAMGSLDHAYIV 72

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYL 306
           +L G C     + L+ +   +GSL   +R   +++     L+W   V I KGM     YL
Sbjct: 73  RLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGM----YYL 125

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
             H    +VHR++++ N+LL S+    +ADFGVA LL
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 33/86 (38%), Positives = 52/86 (60%), Gaps = 3/86 (3%)

Query: 23  LILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSI 82
           L L N  L G I ++I KL+ L  ++LS N I G IP  LG I  ++ ++LS N+ +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 83  PESVKKVPLLYV---SGNNFEVEIPS 105
           PES+ ++  L +   +GN+    +P+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 11/168 (6%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G  G+VY A  + +G+ VA+K+++  +  +    E   NE  ++ +  H NIV    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    ++++ EY+  GSL  V+        +D  +   + +    AL +LH +    +
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QV 136

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI S+N+LL  +    + DFG    +  + S R+ + GT  ++AP
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 17/159 (10%)

Query: 196 IGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G G +GSV  A+L     S + VA+K L +++    + +E F  EA  + +  H N++K
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 252 LYGFCLHRKCM------FLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHA 302
           L G  L  +         +I  +M+ G L   L   R  EE   L     V  +  +A  
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + YL    +   +HRD+++ N +LN  +   VADFG+++
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 20/155 (12%)

Query: 196 IGTGGYGSV-YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YG+V       +G  VA+KKL+R    EL +  ++R E RLL  + H N++ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81

Query: 255 FCLHRKCM------FLIYEYM--EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                  +      +L+  +M  ++G L    +  E+ +         +V  M   L Y+
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-------LVYQMLKGLKYI 134

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           H      I+HRD+   N+ +N + E  + DFG+AR
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 17/177 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +D   +  +G G  G+VY+A  L + +++A+K +    T EL   +   +E  +L +   
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDS 58

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
             I+  YG       + +  E+M+ GSL    +  E  +G      V +VKG+ +  S  
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG---RIAVAVVKGLTYLWSL- 114

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR-LLNFDSSNRTLLAGTSGYIAP 362
                  I+HRD+  +N+L+N+  +  + DFGV+  L+N   S      GT+ Y+AP
Sbjct: 115 ------KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---SIAKTYVGTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 62.1 bits (151), Expect = 4e-11
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 20/175 (11%)

Query: 196 IGTGGYGS--VYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G G +G   +YR R     +V  K+++ +   E    ++  NE  +LS + H NI+  Y
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILSLLQHPNIIAYY 65

Query: 254 GFCLHRKCMFLIYEYMEMGSLF-CVLRT-----DEEAVGLDWAKRVNIVKGMAHALSYLH 307
              +    + +  EY   G+L+  ++R      +EE V   W      +  +  A+SY+H
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVL--W-----YLFQIVSAVSYIH 118

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                 I+HRDI + N+ L       + DFG++++L  + S    + GT  Y++P
Sbjct: 119 KA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 49/149 (32%), Positives = 79/149 (53%), Gaps = 13/149 (8%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G Y +VY+ R   +G++VALK++ R E EE A   + R EA LL  + H NIV L+ 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRT--DEEAVGLDWAKRVNIVKGMAHALSYLHHHCTP 312
               +K + L++EY++       L+   D+   GL        +  +   L+Y H     
Sbjct: 71  IIHTKKTLTLVFEYLDTD-----LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR--- 122

Query: 313 PIVHRDISSNNVLLNSELEAFVADFGVAR 341
            ++HRD+   N+L++   E  +ADFG+AR
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 29/200 (14%)

Query: 178 ITFQDMIEATEDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHR-SETEELASLESFR 235
           +  + + + T+ + I   IG G YG VY+      G + A+K L   S+ +E   +E+  
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE--EIEAEY 69

Query: 236 NEARLLSQIWHRNIVKLYG-FCLHRKC----MFLIYEYMEMGS--------LFCVLRTDE 282
           N  + L    H N+VK YG F    K     ++L+ E    GS        L C  R DE
Sbjct: 70  NILQSLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127

Query: 283 EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
             +         I+ G    L +LH++    I+HRD+  NN+LL +E    + DFGV+  
Sbjct: 128 AMISY-------ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177

Query: 343 LNFDSSNRTLLAGTSGYIAP 362
           L      R    GT  ++AP
Sbjct: 178 LTSTRLRRNTSVGTPFWMAP 197

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 54/177 (30%), Positives = 81/177 (45%), Gaps = 23/177 (12%)

Query: 196 IGTGGYGSVYRARLPS-GKVVALKKL---HRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G G YG V   R  + GK   +KKL   + S  E  A+      EA+LLSQ+ H NIV 
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA----EQEAQLLSQLKHPNIVA 63

Query: 252 LYGFCLHRKCM-FLIYEYMEMGSLFCVLRTDE-----EAVGLDWAKRVNIVKGMAHALSY 305
                     + +++  + E G L+  L+  +     E   ++W  ++      A AL Y
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQY 117

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH      I+HRD+ + NV L       V D G+AR+L       + L GT  Y++P
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 33/113 (29%), Positives = 60/113 (53%), Gaps = 11/113 (9%)

Query: 217 LKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFC 276
           L K HR+ +E      SF   A ++SQ+ H+++V  YG C+      ++ EY++ GSL  
Sbjct: 35  LDKSHRNYSE------SFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT 88

Query: 277 VLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE 329
            L+ ++  + + W  ++ + K +A AL +L       + H ++ + NVLL  E
Sbjct: 89  YLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIRE 136

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 22/170 (12%)

Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIW 245
           D   +  IG G +G V +AR+    +    A+K++    +++      F  E  +L ++ 
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLG 65

Query: 246 -HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR------TD-------EEAVGLDWAK 291
            H NI+ L G C HR  ++L  EY   G+L   LR      TD         A  L   +
Sbjct: 66  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            ++    +A  + YL        +HRD+++ N+L+     A +ADFG++R
Sbjct: 126 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 54/181 (29%), Positives = 84/181 (46%), Gaps = 15/181 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF I   IG G +G V   +L +  KV A+K L++ E  + A    FR E  +L    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK----RVNIVKGMAHA 302
           + I  L+        ++L+ +Y   G L  +L   E+ +  D A+     + I     H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTSGYIA 361
           L Y         VHRDI  +N+L++      +ADFG    L  D + ++ +A GT  YI+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 362 P 362
           P
Sbjct: 172 P 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 49/180 (27%), Positives = 100/180 (55%), Gaps = 22/180 (12%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLH-------RSETEELASLESFRNEARLLSQIWHR 247
           IG G YG VY A  + +G+++A+K++        R ++ +   +++ R+E   L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALS 304
           NIV+  GF    + + +  EY+  GS+   LRT    EE +   + ++V  ++G    L+
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV--LEG----LA 122

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN--FDSSNRTLLAGTSGYIAP 362
           YLH   +  I+HRD+ ++N+L++++    ++DFG+++  +  +D+     + G+  ++AP
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 7/177 (3%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF I   IG G +G V   ++    ++ A+K L++ E  + A    FR E  +L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
           + I  L+        ++L+ +Y   G L  +L   E+ +  D A+    +  M  A+  +
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--IAEMVLAIHSI 118

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTSGYIAP 362
           H       VHRDI  +NVLL+      +ADFG    +N D + ++ +A GT  YI+P
Sbjct: 119 HQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 48/147 (32%), Positives = 76/147 (51%), Gaps = 9/147 (6%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G Y +VY+ +   +GK+VALK + R + EE     + R EA LL  + H NIV L+ 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
               ++ + L++EY+      C    D+   GL        +  +   LSY+H      I
Sbjct: 71  IIHTKETLTLVFEYVHTD--LCQY-MDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124

Query: 315 VHRDISSNNVLLNSELEAFVADFGVAR 341
           +HRD+   N+L++   E  +ADFG+AR
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 26/160 (16%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++AR   + ++VALKK+     +E   + + R E ++L  + H N+V L  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 78

Query: 255 FCLHRKCMF-----LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-----IVKGMAHALS 304
            C  +   +       Y   E    FC    + +  GL   K V      I K M   L+
Sbjct: 79  ICRTKATPYNRYKGSFYLVFE----FC----EHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130

Query: 305 ---YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
              Y+H      I+HRD+ + N+L+  +    +ADFG+AR
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 58/205 (28%), Positives = 86/205 (41%), Gaps = 40/205 (19%)

Query: 176 GRITFQDMIEAT--EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLE 232
           G +T           D      IG+G  G VY+ R   +G V+A+K++ R+  +E     
Sbjct: 1   GYLTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE----- 55

Query: 233 SFRNEARLLS-----QIWHR--NIVKLYGFCLHRKCMFLIYEYME-MGSLFCVLRT---- 280
                 R+L         H    IVK YG          I   ME M +    L      
Sbjct: 56  ---ENKRILMDLDVVLKSHDCPYIVKCYG-YFITDSDVFI--CMELMSTCLDKLLKRIQG 109

Query: 281 --DEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG 338
              E+ +G      V IVK    AL YL       ++HRD+  +N+LL++     + DFG
Sbjct: 110 PIPEDILG---KMTVAIVK----ALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFG 160

Query: 339 VA-RLLNFDSSNRTLLAGTSGYIAP 362
           ++ RL+  DS  +T  AG + Y+AP
Sbjct: 161 ISGRLV--DSKAKTRSAGCAAYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 24/165 (14%)

Query: 196 IGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIV 250
           +G   +G +Y+  L        ++VA+K L      +      F+ EA L++++ H NIV
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQ--QWGEFQQEASLMAELHHPNIV 70

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSL--FCVLRTDEEAVG------------LDWAKRVNIV 296
            L G     + + +++EY+  G L  F ++R+    VG            LD    ++I 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +A  + YL  H     VH+D+++ N+L+  +L   ++D G++R
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 46/168 (27%), Positives = 84/168 (50%), Gaps = 11/168 (6%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G  G+VY A  + +G+ VA+K+++    ++    E   NE  ++ +  + NIV    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    ++++ EY+  GSL  V+        +D  +   + +    AL +LH +    +
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---QV 136

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI S+N+LL  +    + DFG    +  + S R+ + GT  ++AP
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 29/200 (14%)

Query: 189 DFHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSETEELA-SLESFRNEARLLSQ 243
           +F +   +GTG YG V+  R  SG    K+ A+K L ++   + A + E  R E ++L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 244 IWHRN-IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG-MA 300
           I     +V L Y F    K + LI +Y+  G LF  L   E        + V I  G + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIV 115

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGY 359
            AL +LH      I++RDI   N+LL+S     + DFG+++  + D   R     GT  Y
Sbjct: 116 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 360 IAP------------ASEWW 367
           +AP            A +WW
Sbjct: 173 MAPDIVRGGDGGHDKAVDWW 192

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 54/183 (29%), Positives = 81/183 (44%), Gaps = 19/183 (10%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF +K  +G G +G V   R   +G + A+K + +S      ++  F  E  +LS    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 247 RNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNIVKGMA 300
             I +L Y F   +  ++L+ EY   G L  +L       DE+      A+ V  +  + 
Sbjct: 61  PWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV- 118

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS-NRTLLAGTSGY 359
           H + Y         VHRDI   NVL++      +ADFG A  L  +   N  L  GT  Y
Sbjct: 119 HQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169

Query: 360 IAP 362
           IAP
Sbjct: 170 IAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 50/182 (27%)

Query: 196 IGTGGYGSVYRAR------LPSGKVVALKKLHR-SETEELASLESFRNEARLLSQIWHRN 248
           +G G +G V +A             VA+K L   + + EL  L S   E  LL Q+ H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLS---EFNLLKQVNHPH 64

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----------------------DEEAV 285
           ++KLYG C     + LI EY + GSL   LR                        DE A+
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 286 GLD------WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV 339
            +       W     I +GM + L+ +       +VHRD+++ NVL+    +  ++DFG+
Sbjct: 125 TMGDLISFAW----QISRGMQY-LAEMK------LVHRDLAARNVLVAEGRKMKISDFGL 173

Query: 340 AR 341
           +R
Sbjct: 174 SR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 3/175 (1%)

Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           +F I+  IG G +  VYRA  L  G  VALKK+   +  +  +      E  LL Q+ H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           N++K Y   +    + ++ E  + G L  +++  ++   L   K V   K      S L 
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV--WKYFVQLCSALE 120

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H  +  ++HRDI   NV + +     + D G+ R  +  ++    L GT  Y++P
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 9/175 (5%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           F +   +G G YG V + R   + ++VA+KK   SE  E     + R E ++L  +   N
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQEN 61

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           IV+L      R  ++L++EY+E   L  +   +E   G+   K  + +  +  A+ + H 
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQLIKAIHWCHK 118

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS-SNRTLLAGTSGYIAP 362
           +    IVHRDI   N+L++      + DFG AR L+  S +N T    T  Y +P
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 24/164 (14%)

Query: 186 ATEDFHIKYCIGTGGYGSVYR--ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           AT   +++  +G G Y +VY+  +R+ +G++VALK +   +TEE     + R EA LL  
Sbjct: 4   ATSYLNLEK-LGEGSYATVYKGISRI-NGQLVALKVISM-KTEEGVPFTAIR-EASLLKG 59

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD------EEAVGLDWAKRVNIVK 297
           + H NIV L+     ++ +  ++EYM          TD      +   GL        + 
Sbjct: 60  LKHANIVLLHDIIHTKETLTFVFEYMH---------TDLAQYMIQHPGGLHPYNVRLFMF 110

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +   L+Y+H      I+HRD+   N+L++   E  +ADFG+AR
Sbjct: 111 QLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 9/156 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   +   +G G +G V+         VA+K L           E+F  EA+++ ++ H 
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHD 61

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V LY   +  + ++++ E+M  GSL   L+ + +   L   + V++   +A  ++Y+ 
Sbjct: 62  KLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGMAYIE 119

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
                  +HRD+ + N+L+   L   +ADFG+ARL+
Sbjct: 120 RM---NYIHRDLRAANILVGDNLVCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 58.8 bits (142), Expect = 7e-10
 Identities = 54/172 (31%), Positives = 81/172 (47%), Gaps = 10/172 (5%)

Query: 196 IGTGGYGSVYRARLPSGKVVA---LKKLHRSETEELASLESFRN--EARLLSQIWHRNIV 250
           +G G +G+VY  +    K VA   LK L      EL   E+ +   EA+LLS++ H  IV
Sbjct: 8   LGKGSFGTVYLVK--DKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
           K +   L R    +I EY E   L C L   +   G   ++   + +     L  +H+  
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHT-GKTLSEN-QVCEWFIQLLLGVHYMH 123

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
              I+HRD+ + N+ L + L   + DFGV+RLL       T   GT  Y++P
Sbjct: 124 QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.3 bits (144), Expect = 8e-10
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 21/166 (12%)

Query: 189 DFHIKY----CIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           D   +Y     IG+G YG V  A    SGK VA+KK+  +      +  + R E ++L  
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRH 60

Query: 244 IWHRNIVKLYGFCL----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV--NIVK 297
             H NI+ +           K ++++ + ME   L  ++ +D+  +  +  +     +++
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQP-LTEEHIRYFLYQLLR 118

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           G    L Y+H      ++HRD+  +N+L+N + E  + DFG+AR L
Sbjct: 119 G----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 58.4 bits (141), Expect = 8e-10
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 11/151 (7%)

Query: 192 IKYCIGTGGYGSVYRA--RLPSGK--VVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           I+  +GTG +G + R   +LPS +   VA+  L    +++      F  EA  L Q  H 
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK--QRRGFLAEALTLGQFDHS 66

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NIV+L G       M ++ EYM  G+L   LR  E    L   + + ++ G+A  + YL 
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYLS 124

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFG 338
                  VH+ ++++ VL+NS+L   ++ F 
Sbjct: 125 EM---GYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 58.2 bits (140), Expect = 1e-09
 Identities = 45/168 (26%), Positives = 84/168 (50%), Gaps = 11/168 (6%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G  G+VY A  + +G+ VA+++++    ++    E   NE  ++ +  + NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    ++++ EY+  GSL  V+        +D  +   + +    AL +LH +    +
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QV 137

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI S+N+LL  +    + DFG    +  + S R+ + GT  ++AP
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 21/153 (13%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G Y +VY+ R   +  +VALK++ R E EE A   + R E  LL  + H NIV L+ 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI--VK----GMAHALSYLHH 308
                K + L++EY++          D +    D    +N+  VK     +   L+Y H 
Sbjct: 72  IIHTEKSLTLVFEYLD---------KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                ++HRD+   N+L+N   E  +ADFG+AR
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 37/204 (18%)

Query: 189 DFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELA-SLESFRNEARLLSQ 243
           +F +   +GTG YG V+  R       GK+ A+K L ++   + A + E  R E ++L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 244 IWHRN--IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIV 296
           +  R   +V L Y F    K + LI +Y+  G LF  L       E  V      RV I 
Sbjct: 61  V-RRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESEV------RVYIA 112

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAG 355
           + +  AL +LH      I++RDI   N+LL+SE    + DFG+++    +   R     G
Sbjct: 113 E-IVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168

Query: 356 TSGYIAP------------ASEWW 367
           T  Y+AP            A +WW
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWW 192

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 28/189 (14%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLY 253
           +G G +G V  A L  + ++ A+K L +    +   +E    E R+L+    H  + +L+
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                +  +F + EY+  G L   ++     +E     +A  + +       L +LH   
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL------GLQFLHER- 115

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVAR--LLNFDSSNRTLLAGTSGYIAP------ 362
              I++RD+  +NVLL+SE    +ADFG+ +  +L   +++     GT  YIAP      
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--FCGTPDYIAPEILSYQ 171

Query: 363 ----ASEWW 367
               A +WW
Sbjct: 172 PYGPAVDWW 180

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 47/157 (29%), Positives = 72/157 (45%), Gaps = 24/157 (15%)

Query: 196 IGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           IG G +G VY   L          A+K L+R    +L  +E F  E  ++    H N++ 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 252 LYGFCLHRKCMFLI-YEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGMAHALS 304
           L G CL  +   L+   YM+ G L   +R      T ++ +G      + + KGM     
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG----LQVAKGM----E 112

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           YL    +   VHRD+++ N +L+      VADFG+AR
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 3/175 (1%)

Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           +F I+  IG G +  VYRA  L   K VALKK+   E  +  + +    E  LL Q+ H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           N++K     +    + ++ E  + G L  +++  ++   L       + K      S + 
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL--IPERTVWKYFVQLCSAVE 120

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H  +  ++HRDI   NV + +     + D G+ R  +  ++    L GT  Y++P
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 48/174 (27%), Positives = 80/174 (45%), Gaps = 18/174 (10%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G     +    GK   +K+++ S+       ES R E  +LS + H NIV+   
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQYQE 66

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTD------EEAVGLDWAKRVNIVKGMAHALSYLHH 308
                  ++++ +Y E G L+  +         E+ + LDW  ++ +      AL ++H 
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDWFVQICL------ALKHVHD 119

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                I+HRDI S N+ L  +    + DFG+AR+LN          GT  Y++P
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 18/166 (10%)

Query: 196 IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIV 250
           +G G +G V   R       +G+ VA+K L          +   + E  +L  ++H NIV
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIV 69

Query: 251 KLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR--VNIVKGMAHALSYL 306
           K  G C       + LI E++  GSL   L  ++  + L    +  V I KGM +  S  
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
           +       VHRD+++ NVL+ SE +  + DFG+ + +  D    T+
Sbjct: 130 Y-------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 18/162 (11%)

Query: 188 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
             +     IG G YG V  A   P+G  VA+KK+   E  +     + R E ++L +  H
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLR-EIKILRRFKH 62

Query: 247 RNIVKLY------GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
            NI+ +        F      ++++ E ME   L+ +++T    +  D  +    +  + 
Sbjct: 63  ENIIGILDIIRPPSFESFND-VYIVQELMET-DLYKLIKTQH--LSNDHIQY--FLYQIL 116

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
             L Y+H   +  ++HRD+  +N+LLN+  +  + DFG+AR+
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 21/153 (13%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G Y +V++ R   +  +VALK++ R E EE A   + R E  LL  + H NIV L+ 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 255 FCLHRKCMFLIYEYME------MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
                K + L++EY++      M     ++      + L       I++G+A    Y H 
Sbjct: 72  IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL-----YQILRGLA----YCHR 122

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                ++HRD+   N+L+N   E  +ADFG+AR
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 18/184 (9%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLY 253
           +G G +G V+ A L  + +  A+K L +        +E    E R+LS  W H  +  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
                ++ +F + EY+  G L   +++  +    D  +       +   L +LH   +  
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLH---SKG 116

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----------A 363
           IV+RD+  +N+LL+++    +ADFG+ +      +      GT  YIAP          +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176

Query: 364 SEWW 367
            +WW
Sbjct: 177 VDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 47/181 (25%), Positives = 87/181 (48%), Gaps = 22/181 (12%)

Query: 189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF I   +G GGYG V+ A+   +G++VALK++ +S   +L  +     E  +L+     
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMG---SLFCVLRT--DEEAVGLDWAKRVNIVKGMAHA 302
            +VKL       + ++L  EY+  G   +L   L    ++ A       R  + + M  A
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA-------RFYMAE-MFEA 113

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR-LLNFDSSNRTLLAGTSGYIA 361
           +  LH       +HRD+   N L+++     + DFG+++ ++ + +S    + G+  Y+A
Sbjct: 114 VDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS----VVGSPDYMA 166

Query: 362 P 362
           P
Sbjct: 167 P 167

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 55/192 (28%), Positives = 93/192 (48%), Gaps = 31/192 (16%)

Query: 196 IGTGGYGSVYRARL----PSGKVVALKKLHRS----ETEELASLESFRNEARLLSQIWHR 247
           +G GGYG V++ R      +GK+ A+K L ++      ++ A  ++ RN   +L  + H 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERN---ILEAVKHP 60

Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGL-DWAKRVNIVKGMAHALSY 305
            IV L Y F    K ++LI EY+  G LF  L  + E + + D A     +  ++ AL +
Sbjct: 61  FIVDLIYAFQTGGK-LYLILEYLSGGELFMHL--EREGIFMEDTACFY--LSEISLALEH 115

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP--- 362
           LH      I++RD+   N+LL+++    + DFG+ +    + +      GT  Y+AP   
Sbjct: 116 LHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172

Query: 363 -------ASEWW 367
                  A +WW
Sbjct: 173 MRSGHGKAVDWW 184

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 18/169 (10%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFRNEARLLSQI 244
           ED   +  IG G +G V RA +    +    A+K L    +E       F  E  +L ++
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN--DHRDFAGELEVLCKL 59

Query: 245 -WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR------TD-----EEAVGLDWAKR 292
             H NI+ L G C +R  +++  EY   G+L   LR      TD     E         +
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +++  +   + + +      +HRD+++ NVL+   L + +ADFG++R
Sbjct: 120 -QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 27/167 (16%)

Query: 196 IGTGGYGSVYRARL-----PSGKV-VALKKLHRSETE-ELASLESFRNEARLLSQIWHRN 248
           +G G +G V +A       P+    VA+K L    TE +L+ L S     +++ +  H+N
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG---------- 298
           I+ L G C     ++++ EY   G+L   LR      G   +                  
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLR-ARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 299 ----MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
               +A  + +L    +   +HRD+++ NVL+  +    +ADFG+AR
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 38/136 (27%), Positives = 68/136 (50%), Gaps = 8/136 (5%)

Query: 214 VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGS 273
           +VA+K L R++  + A    F  E +++S++ + NI++L G C+    + +I EYME G 
Sbjct: 46  LVAVKML-RADVTKTAR-NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103

Query: 274 LFCVLRTDE------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN 327
           L   L   E       A  +      N++       S + +  +   VHRD+++ N L+ 
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163

Query: 328 SELEAFVADFGVARLL 343
           +     +ADFG++R L
Sbjct: 164 NHYTIKIADFGMSRNL 179

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 23/197 (11%)

Query: 178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKL---HRSETEELASLES 233
           I F    + ++ + I   IG G YG V++     +G   A+K L   H  + E    +E+
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEA 63

Query: 234 FRNEARLLSQIWHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLD 288
             N  + LS   H N+VK YG    +       ++L+ E    GS+     TD     L 
Sbjct: 64  EYNILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKGFLK 116

Query: 289 WAKRVN--IVKGMAH-ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
             +R+   I+  + H AL  L H      +HRD+  NN+LL +E    + DFGV+  L  
Sbjct: 117 RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176

Query: 346 DSSNRTLLAGTSGYIAP 362
               R    GT  ++AP
Sbjct: 177 TRLRRNTSVGTPFWMAP 193

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 28/199 (14%)

Query: 189 DFHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSE-TEELASLESFRNEARLLSQ 243
           +F +   +GTG YG V+  R  +G    K+ A+K L ++   ++  ++E  R E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 244 IWHRN-IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG-MA 300
           +     +V L Y F    K + LI +Y+  G +F  L   +          V    G + 
Sbjct: 61  VRQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEII 115

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGY 359
            AL +LH      IV+RDI   N+LL+SE    + DFG+++    +   RT    GT  Y
Sbjct: 116 LALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 360 IAP-----------ASEWW 367
           +AP           A +WW
Sbjct: 173 MAPEIIRGKGGHGKAVDWW 191

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.5 bits (133), Expect = 9e-09
 Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 22/163 (13%)

Query: 196 IGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIWHR-NIVK 251
           IG G +G V +AR+    +    A+K++    +++      F  E  +L ++ H  NI+ 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIIN 60

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLR------TDE-------EAVGLDWAKRVNIVKG 298
           L G C HR  ++L  EY   G+L   LR      TD         A  L   + ++    
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +A  + YL        +HRD+++ N+L+     A +ADFG++R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 9e-09
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 15/160 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F I   I  G +G VY  R   + K+ A+K + +++      +   + E   L+    
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
             IV LY        ++L+ EY+  G +  +L      DEE         V  +  +A A
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-------VKYISEVALA 116

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
           L YLH H    I+HRD+  +N+L+++E    + DFG++++
Sbjct: 117 LDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 3/107 (2%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
           N L G IP+ L +   L  LIL +N L G I   +G  + L  + L  N  +G++PS+  
Sbjct: 366 NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFT 425

Query: 64  EIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPSTS 107
           ++P +  +++S NNL G I      +P   +L ++ N F   +P + 
Sbjct: 426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF 472

Length = 968

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 58/188 (30%), Positives = 87/188 (46%), Gaps = 44/188 (23%)

Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-------WHR 247
           IG G +G+V +    PSG ++A+K++ RS  +E       + + RLL  +          
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDE-------KEQKRLLMDLDVVMRSSDCP 63

Query: 248 NIVKLYGFCLHRK----CMFLIYEYMEMGSL-------FCVLRT--DEEAVGLDWAKRVN 294
            IVK YG          CM    E M++ SL       + VL++   EE +G      V 
Sbjct: 64  YIVKFYGALFREGDCWICM----ELMDI-SLDKFYKYVYEVLKSVIPEEILG---KIAVA 115

Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
            VK    AL+YL       I+HRD+  +N+LL+      + DFG++  L  DS  +T  A
Sbjct: 116 TVK----ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRDA 168

Query: 355 GTSGYIAP 362
           G   Y+AP
Sbjct: 169 GCRPYMAP 176

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 33/192 (17%)

Query: 196 IGTGGYGSVYRAR----LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G G +G V+  R      +G++ A+K L ++ T ++      + E  +L+++ H  IVK
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKA-TLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 252 L-YGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAHALSYL 306
           L Y F    K ++LI +++  G LF  L  +    EE V    A+       +A AL +L
Sbjct: 63  LHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHL 114

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGYIAP--- 362
           H   +  I++RD+   N+LL+ E    + DFG+++  + D   +     GT  Y+AP   
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 363 -------ASEWW 367
                  +++WW
Sbjct: 171 NRRGHTQSADWW 182

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 39/158 (24%), Positives = 68/158 (43%), Gaps = 15/158 (9%)

Query: 196 IGTGGYGSVYRARLPSGKVVALK---KLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G G +GSV   +L       LK   K  + +    + +E F +EA  +    H N++KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHAL 303
            G C     +       +I  +M+ G L   L   R       L     +  +  +A  +
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            YL        +HRD+++ N +L  ++   VADFG+++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 43/154 (27%), Positives = 80/154 (51%), Gaps = 11/154 (7%)

Query: 196 IGTGGYGSVYRA---RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G+G +G+V +       S K VA+K L +++  + A  +    EA ++ Q+ +  IV++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTP 312
            G C     M L+ E  E+G L   L+ ++     +  + V+ V   +  + YL      
Sbjct: 62  IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEET--- 114

Query: 313 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
             VHRD+++ NVLL ++  A ++DFG+++ L  D
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 26/184 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V + +  PSG ++A K +H      L    + RN+     Q+ H
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH------LEIKPAIRNQIIRELQVLH 58

Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  EE +G      + +++G
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSIAVLRG 115

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           +A+ L   H      I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT  
Sbjct: 116 LAY-LREKHQ-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRS 167

Query: 359 YIAP 362
           Y++P
Sbjct: 168 YMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 26/163 (15%)

Query: 196 IGTGGYGSVYRARLPSGKV---VALKKLH-----RSETEELASLESFRNEARLLSQIWHR 247
           +G G +GSV   +L        VA+K +      RSE      +E F +EA  + +  H 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE------MEDFLSEAVCMKEFDHP 60

Query: 248 NIVKLYGFCLHRK------CMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKG 298
           N+++L G CL            +I  +M+ G L   L   R  +    L     V  +  
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +A  + YL    +   +HRD+++ N +LN  +   VADFG+++
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.5 bits (132), Expect = 2e-08
 Identities = 34/118 (28%), Positives = 60/118 (50%), Gaps = 11/118 (9%)

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           + N +KLY      K   LI +Y++ G LF +L+ + +   L  A+   I++ +  AL+ 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALND 124

Query: 306 LHHHCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH H    I+H DI   NVL + ++   ++ D+G+ +++   S       GT  Y +P
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSP 175

Length = 267

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 31/170 (18%)

Query: 196 IGTGGYGSVYRA--------RLPSGKVVALKKLHRSETE-ELASLESFRNEARLLSQIWH 246
           +G G +G V RA        R      VA+K L  + T+ +LA L S     +L+ +  H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSL---------------FCVLRTDEEAVGLDWAK 291
           +NI+ L G C     +++I EY   G+L               F + +  EE   L +  
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ--LSFKD 135

Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            V+    +A  + YL    +   +HRD+++ NVL+  +    +ADFG+AR
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 33/198 (16%)

Query: 181 QDMIEATEDFHIKY----CIGTGGYGSVYRARLPSGKV-VALKKLHRS-ETEELASLESF 234
           Q++ +   +   +Y     +G+G YG V  A        VA+KKL R  ++   A   ++
Sbjct: 4   QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK-RTY 62

Query: 235 RNEARLLSQIWHRNIVKLYG-FCLHRKCM-----FLIYEYMEMGSLFCVLR----TDEEA 284
           R E RLL  + H N++ L   F            +L+   M    L  +++    +D+  
Sbjct: 63  R-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDDHI 120

Query: 285 VGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
             L        V  +   L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR  +
Sbjct: 121 QFL--------VYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169

Query: 345 FDSSNRTLLAGTSGYIAP 362
            +    T    T  Y AP
Sbjct: 170 DE---MTGYVATRWYRAP 184

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 30/186 (16%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRN----EARLLS 242
           +DF     +G G  G V +    PSG ++A K +H      L    + RN    E ++L 
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH------LEIKPAIRNQIIRELKVLH 54

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNI--V 296
           +     IV  YG       + +  E+M+ GSL  VL    R  E  +G     +++I  +
Sbjct: 55  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVL 109

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT 356
           +G    L+YL       I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT
Sbjct: 110 RG----LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GT 161

Query: 357 SGYIAP 362
             Y++P
Sbjct: 162 RSYMSP 167

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 27/162 (16%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN-IVKLY 253
           IG G YG VY+AR   +GK+VALKK  R E +E     +   E  LL  +     IV+L 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66

Query: 254 GFCLH-------RKCMFLIYEYMEMG-SLFCVLRTDEEAVGLDWAKRV-----NIVKGMA 300
              +        +  ++L++EY++     F           L  AK +      ++KG+A
Sbjct: 67  -LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLP-AKTIKSFMYQLLKGVA 124

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVAR 341
           H     H H    ++HRD+   N+L++ +     +AD G+ R
Sbjct: 125 H----CHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 19/169 (11%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFR-----------NEARLLSQ 243
           +G G YG V +A    +GK+VA+KK+   E     + +               E +++++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           I H NI+ L    +    + L+ + M    L  V+   +  + L  ++   I+  + + L
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV---DRKIRLTESQVKCILLQILNGL 132

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
           + LH       +HRD+S  N+ +NS+    +ADFG+AR   +   + TL
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Length = 335

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 40/142 (28%), Positives = 72/142 (50%), Gaps = 21/142 (14%)

Query: 196 IGTGGYGSVYRARL---PSGKV--------VALKKLHRSETEELASLESFRNEARLLSQI 244
           +G G + ++Y+  L       +        V LK L     + LA  E+    A L+SQ+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET----ASLMSQL 58

Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H+++VKLYG C+  + + ++ EY++ G L   L  ++  V L W  ++++ K +A AL 
Sbjct: 59  SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALH 115

Query: 305 YLHHHCTPPIVHRDISSNNVLL 326
           YL       +VH ++   N+L+
Sbjct: 116 YLEDK---KLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 56/188 (29%), Positives = 87/188 (46%), Gaps = 45/188 (23%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ--IWHR----- 247
           +G G YG V + R +P+G ++A+K++        A++ S + + RLL    I  R     
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIR-------ATVNS-QEQKRLLMDLDISMRSVDCP 60

Query: 248 NIVKLYGFCLHRK-----CMFLIYEYMEMGSLFCV--------LRTDEEAVGLDWAKRVN 294
             V  YG  L R+     CM    E M+  SL           L   E+ +G        
Sbjct: 61  YTVTFYG-ALFREGDVWICM----EVMDT-SLDKFYKKVYDKGLTIPEDILG-------K 107

Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I   +  AL YLH   +  ++HRD+  +NVL+N   +  + DFG++  L  DS  +T+ A
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDA 164

Query: 355 GTSGYIAP 362
           G   Y+AP
Sbjct: 165 GCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 28/182 (15%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLH-----RSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY    + +G+ +A K++         ++E+++LE    E +LL  + H  I
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC---EIQLLKNLQHERI 66

Query: 250 VKLYGFCLH---RKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHAL 303
           V+ YG CL     K + +  EYM  GS+   L+      E+V   + ++  I++GM    
Sbjct: 67  VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ--ILEGM---- 119

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN---FDSSNRTLLAGTSGYI 360
           SYLH +    IVHRDI   N+L +S     + DFG ++ L       +    + GT  ++
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 361 AP 362
           +P
Sbjct: 177 SP 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 51/179 (28%), Positives = 79/179 (44%), Gaps = 25/179 (13%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK--- 251
           IG G +G V+    P  GK VALKK+       ++    FR E ++L    H N++    
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66

Query: 252 -----LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHALS 304
                          ++++ E M+   L  ++    + +  D  K     I++G    L 
Sbjct: 67  ILQPPHIDPFEE---IYVVTELMQ-SDLHKII-VSPQPLSSDHVKVFLYQILRG----LK 117

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS-NRTLLAGTSGYIAP 362
           YLH   +  I+HRDI   N+L+NS     + DFG+AR+   D S + T    T  Y AP
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 21/227 (9%)

Query: 138 ALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIG 197
           AL++ + F   R++K +            D F     D     +D+    ED+ +   IG
Sbjct: 5   ALVYDLDFPALRKNKNI------------DNFLNRYKDTINKIRDLRMKAEDYEVVKVIG 52

Query: 198 TGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFC 256
            G +G V   R  S  KV A+K L + E  + +    F  E  +++      +V+L+   
Sbjct: 53  RGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112

Query: 257 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVH 316
              + ++++ EYM  G L  ++   +  V   WA+       +  AL  +H   +   +H
Sbjct: 113 QDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYT--AEVVLALDAIH---SMGFIH 165

Query: 317 RDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTSGYIAP 362
           RD+  +N+LL+      +ADFG    +N +   R   A GT  YI+P
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 41/146 (28%), Positives = 71/146 (48%), Gaps = 21/146 (14%)

Query: 214 VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGS 273
           +VA+K L     +   +   F  E ++LS++   NI++L G C+    + +I EYME G 
Sbjct: 48  LVAVKILRPDANKNARN--DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105

Query: 274 LFCVLRT----DEEAVGLD------------WAKRVNIVKGMAHALSYLHHHCTPPIVHR 317
           L   L +    D+E  G D            ++  +++   +A  + YL    +   VHR
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHR 162

Query: 318 DISSNNVLLNSELEAFVADFGVARLL 343
           D+++ N L+   L   +ADFG++R L
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNL 188

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 47/159 (29%), Positives = 77/159 (48%), Gaps = 21/159 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           +DF     IG G +G V   RL     +G + A+KKL +SE  E   +   R E  +L++
Sbjct: 1   DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE 57

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL-RTD---EEAVGLDWAKRVNIVKGM 299
             +  +VKLY        ++LI EY+  G +  +L + D   EE      A+ +  +  +
Sbjct: 58  ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI 117

Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG 338
            H L Y         +HRDI  +N+LL+++    ++DFG
Sbjct: 118 -HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFG 146

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 54/188 (28%), Positives = 86/188 (45%), Gaps = 26/188 (13%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLY 253
           +G G +G V  ARL  SG++ A+K L +    +   +E    E R+LS    H  + +LY
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 254 GFCLHR-KCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
             C      +F + E++  G L   +   R  +EA    +A  +        AL +LH  
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI------TSALMFLH-- 113

Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP------- 362
               I++RD+  +NVLL+ E    +ADFG+ +   F+    +   GT  YIAP       
Sbjct: 114 -DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML 172

Query: 363 ---ASEWW 367
              + +WW
Sbjct: 173 YGPSVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 56/190 (29%), Positives = 84/190 (44%), Gaps = 30/190 (15%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRS---ETEELASLESFRNEARLLSQIWHRNIVK 251
           IG G +G V  A R   GK  A+K L +      +E   + + RN   LL  + H  +V 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV--LLKNVKHPFLVG 60

Query: 252 L-YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           L Y F    K ++ + +++  G LF  L   R+  E     +A        +A AL YLH
Sbjct: 61  LHYSFQTTEK-LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE------IASALGYLH 113

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----- 362
              +  IV+RD+   N+LL+S+    + DFG+ +     S   T   GT  Y+AP     
Sbjct: 114 ---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170

Query: 363 -----ASEWW 367
                  +WW
Sbjct: 171 QPYDNTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.3 bits (125), Expect = 9e-08
 Identities = 35/116 (30%), Positives = 58/116 (50%), Gaps = 10/116 (8%)

Query: 215 VALKKLHRSETE-ELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGS 273
           V LK L  S  +  LA  E+    A ++ Q+ H++IV LYG C+      ++ E++E G 
Sbjct: 35  VILKVLDPSHRDISLAFFET----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90

Query: 274 LFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE 329
           L   +    + +   W  +  + K +A ALSYL       +VH ++ + N+LL  E
Sbjct: 91  LDLFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILLARE 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 52/175 (29%), Positives = 81/175 (46%), Gaps = 20/175 (11%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL-Y 253
           +G GG+G V   ++  +GK+ A KKL +   ++    +   NE ++L ++  R IV L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 254 GFCLHRKC-MFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRV----NIVKGMAHALSYLH 307
            F    K  + L+   M  G L + +    E   G   A+ +     I+ G+ H    LH
Sbjct: 61  AF--ETKDDLCLVMTLMNGGDLKYHIYNVGEP--GFPEARAIFYAAQIICGLEH----LH 112

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                 IV+RD+   NVLL+      ++D G+A  L          AGT GY+AP
Sbjct: 113 QR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK-GGKKIKGRAGTPGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 29/172 (16%)

Query: 196 IGTGGYGSVYRA--------RLPSGKVVALKKLHRSETE-ELASLESFRNEARLLSQIWH 246
           +G G +G V  A        +      VA+K L    TE +L+ L S     +++ +  H
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG-------- 298
           +NI+ L G C     +++I EY   G+L   LR      G++++  +  V          
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 299 ------MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    +   +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 14/152 (9%)

Query: 196 IGTGGYGSVYRARLPSGKVVA---LKKLHRSET--EELASLESFRNEARLLSQIWHRNIV 250
           IG G +G V       G   A   +K+L  S T  E+L  L+    E +   ++ H N++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ----EVQPYRELNHPNVL 58

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH--ALSYLHH 308
           +  G C+      L+ E+  +G L   LR++   V     K V  ++ MA   A   L  
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQRMACEVASGLLWL 116

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
           H     +H D++  N  L ++L   + D+G+A
Sbjct: 117 H-QADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 42/152 (27%), Positives = 77/152 (50%), Gaps = 17/152 (11%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKL--HRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG G +  V +A+   +GK  A+K +  H    E++ +L   +   RL     H NI++L
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP---HPNILRL 63

Query: 253 YGFCLHRK--CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV-NIVKGMAHALSYLHHH 309
                 RK   + L++E M+M +L+ +++  +  +     KRV + +  +  +L ++H +
Sbjct: 64  IEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMHRN 119

Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
               I HRDI   N+L+  ++   +ADFG  R
Sbjct: 120 ---GIFHRDIKPENILIKDDILK-LADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 36/138 (26%), Positives = 66/138 (47%), Gaps = 13/138 (9%)

Query: 214 VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGS 273
           +VA+K L R +  + A    F  E +++S++   NI++L   C+    + +I EYME G 
Sbjct: 48  LVAVKML-REDANKNAR-NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105

Query: 274 L---FCVLR-----TDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVL 325
           L                + V + ++  + +   +A  + YL    +   VHRD+++ N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCL 162

Query: 326 LNSELEAFVADFGVARLL 343
           +       +ADFG++R L
Sbjct: 163 VGKNYTIKIADFGMSRNL 180

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 29/165 (17%)

Query: 196 IGTGGYGSVYRA--RLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G+G +G V +   ++   ++ VA+K L ++E E+    E  R EA ++ Q+ +  IV++
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMR-EAEIMHQLDNPYIVRM 60

Query: 253 YGFCLHRKCMFLIYEYMEMGS-----LFCVLRTDEEAVGLDWAKRVNIVKGMAHALS--- 304
            G C     M +    MEM S      F   + DE  V        N+V+ M H +S   
Sbjct: 61  IGVCEAEALMLV----MEMASGGPLNKFLSGKKDEITVS-------NVVELM-HQVSMGM 108

Query: 305 -YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            YL        VHRD+++ NVLL ++  A ++DFG+++ L  D S
Sbjct: 109 KYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 30/190 (15%)

Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRS---ETEELASLESFRNEARLLSQIWHRNIVK 251
           IG G +G V  A+  S G   A+K L +    + +E   + + RN   LL  + H  +V 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV--LLKNLKHPFLVG 60

Query: 252 L-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDE---EAVGLDWAKRVNIVKGMAHALSYLH 307
           L Y F    K ++ + +Y+  G LF  L+ +    E     +A  V      A A+ YLH
Sbjct: 61  LHYSFQTAEK-LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV------ASAIGYLH 113

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----- 362
              +  I++RD+   N+LL+S+    + DFG+ +         +   GT  Y+AP     
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK 170

Query: 363 -----ASEWW 367
                  +WW
Sbjct: 171 EPYDRTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 49/184 (26%), Positives = 85/184 (46%), Gaps = 23/184 (12%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF +   IG G +G V   R   S +V A+K L + E  + +    F  E  +++   H
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA---H 99

Query: 247 RN---IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMA- 300
            N   IV+L+      K ++++ EYM  G L  ++   +  +   WA+     +V  +  
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDA 157

Query: 301 -HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTSG 358
            H++ +         +HRD+  +N+LL+      +ADFG    ++ +   R   A GT  
Sbjct: 158 IHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD 208

Query: 359 YIAP 362
           YI+P
Sbjct: 209 YISP 212

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 50/222 (22%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF +   IG G +G V+  R   +G+V A+K L +S+  +   +   R E  +L+    
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
             IVKLY      + ++L+ EYM  G L  +L   ++    + A R  I + +  AL  +
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPEETA-RFYIAE-LVLALDSV 117

Query: 307 H--HHCTPPIVHRDISSNNVLLNSELEAFVADFGVA------------------------ 340
           H         +HRDI  +N+L++++    +ADFG+                         
Sbjct: 118 HKLGF-----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 341 -----RLLNFDSSNRTLLAGTSGYIAP----------ASEWW 367
                R             GT  YIAP            +WW
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWW 214

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 50/184 (27%), Positives = 79/184 (42%), Gaps = 19/184 (10%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL-Y 253
           +G G +G V   R   SGK  A+K L +        +     E+R+L    H  +  L Y
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
            F    +  F++ EY+  G LF  L + E     D  +       +  AL YLH   +  
Sbjct: 63  SFQTKDRLCFVM-EYVNGGELFFHL-SRERVFSEDRTRFYG--AEIVSALDYLH---SGK 115

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----------A 363
           IV+RD+   N++L+ +    + DFG+ +    D++      GT  Y+AP          A
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 364 SEWW 367
            +WW
Sbjct: 176 VDWW 179

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 56/184 (30%), Positives = 88/184 (47%), Gaps = 26/184 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V++ +  PSG ++A K +H      L    + RN+     Q+ H
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH------LEIKPAIRNQIIRELQVLH 58

Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  E+ +G      + ++KG
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG 115

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
               L+YL       I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT  
Sbjct: 116 ----LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRS 167

Query: 359 YIAP 362
           Y++P
Sbjct: 168 YMSP 171

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 38/200 (19%)

Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRN----EARLLSQIWHRNIV 250
           IG GG G VY A  P   + VALKK+     E+L+     +     EA++ + + H  IV
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIR----EDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRT--DEEAVGLDWAKR------VNIVKGMAHA 302
            +Y  C     ++    Y+E  +L  +L++   +E++  + A++      ++I   +   
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD---------------S 347
           + Y+H   +  ++HRD+  +N+LL    E  + D+G A     +                
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 348 SNRTL---LAGTSGYIAPAS 364
           S+ T+   + GT  Y+AP  
Sbjct: 183 SSMTIPGKIVGTPDYMAPER 202

Length = 932

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 16/154 (10%)

Query: 174 YDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE-ELASLE 232
           YDGR+  +   E  ED          G  +    R      V LK L  S  +  LA  E
Sbjct: 12  YDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELR------VVLKVLDPSHRDIALAFFE 65

Query: 233 SFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR 292
           +    A L+SQ+ H ++  ++G C+      ++ E++E G L   LR ++  V + W  +
Sbjct: 66  T----ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--K 119

Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL 326
           + + + +A ALSYL       +VH ++ + N+LL
Sbjct: 120 ITVAQQLASALSYLEDK---NLVHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 30/184 (16%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLH----RSET-EELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY      +G+ +A+K++       ET +E+ +LE    E +LL  + H  I
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC---EIQLLKNLLHERI 66

Query: 250 VKLYGFCLH---RKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHAL 303
           V+ YG CL     + + +  E+M  GS+   L++     E V   + ++  I++G    +
Sbjct: 67  VQYYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ--ILEG----V 119

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA 363
           SYLH   +  IVHRDI   N+L +S     + DFG ++ L         L+GT       
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-----QTICLSGTGMKSVTG 171

Query: 364 SEWW 367
           + +W
Sbjct: 172 TPYW 175

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 24/187 (12%)

Query: 196 IGTGGYGSVYRARLPSG-KVVALKKLHRS---ETEELASLESFRNEARLLSQIWHRNIVK 251
           IG G +G V  AR  +  K  A+K L +    + +E   + S RN   LL  + H  +V 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV--LLKNVKHPFLVG 60

Query: 252 L-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
           L + F    K ++ + +Y+  G LF  L+   E   L+   R    + +A AL YLH   
Sbjct: 61  LHFSFQTADK-LYFVLDYINGGELFYHLQ--RERCFLEPRARFYAAE-IASALGYLH--- 113

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP-------- 362
           +  IV+RD+   N+LL+S+    + DFG+ +     +   +   GT  Y+AP        
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 363 --ASEWW 367
               +WW
Sbjct: 174 DRTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 54/190 (28%), Positives = 86/190 (45%), Gaps = 30/190 (15%)

Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRS---ETEELASLESFRNEARLLSQIWHRNIVK 251
           IG G +G V  A+  + GK  A+K L +    + +E   + + RN   LL  + H  +V 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV--LLKNVKHPFLVG 60

Query: 252 L-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDE---EAVGLDWAKRVNIVKGMAHALSYLH 307
           L Y F    K  F++ +Y+  G LF  L+ +    E     +A  +      A AL YLH
Sbjct: 61  LHYSFQTADKLYFVL-DYVNGGELFFHLQRERSFPEPRARFYAAEI------ASALGYLH 113

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----- 362
              +  I++RD+   N+LL+S+    + DFG+ +     S   +   GT  Y+AP     
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 363 -----ASEWW 367
                  +WW
Sbjct: 171 QPYDRTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 25/188 (13%)

Query: 189 DFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
            +++   +G G +G   RA L     S +  A+K++   ++   +++E  R EA LL+++
Sbjct: 1   QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKM 55

Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE-----EAVGLDWAKRVNIVKGM 299
            H NIV           ++++ EY + G L   ++        E   L W  +      M
Sbjct: 56  KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------M 109

Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGY 359
              + ++H      ++HRDI S N+ L    +  + DFG ARLL    +      GT  Y
Sbjct: 110 CLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYY 166

Query: 360 IAPASEWW 367
           + P  E W
Sbjct: 167 VPP--EIW 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 9/177 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ED+ +   IG G +G V   R   S KV A+K L + E  + +    F  E  +++    
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
             +V+L+      K ++++ EYM  G L  ++   +  V   WAK       +  AL  +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYT--AEVVLALDAI 158

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTSGYIAP 362
           H   +  ++HRD+  +N+LL+      +ADFG    ++     R   A GT  YI+P
Sbjct: 159 H---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 24/187 (12%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLS-QIWHRNIVKLY 253
           +G G +G V  A L  + +V A+K L +    +   ++    E R+L+    H  +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                +  +F + EY+  G L   +   R  +E     +A  V +      AL +LH H 
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTL------ALMFLHRH- 115

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP-------- 362
              +++RD+  +N+LL++E    +ADFG+ +    +    T   GT  YIAP        
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 363 --ASEWW 367
             + +WW
Sbjct: 174 GPSVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 15/155 (9%)

Query: 189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
            F     +G G  G V+  RL  +GK+ ALK L + E  +   ++    E  +L+ + H 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNIVKGMAHA 302
            +  LY        + L+ +Y   G LF +L+        E V   +A  V +      A
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL------A 115

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF 337
           L YLH      IV+RD+   N+LL+      ++DF
Sbjct: 116 LEYLH---LLGIVYRDLKPENILLHESGHIMLSDF 147

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 8e-07
 Identities = 31/136 (22%), Positives = 50/136 (36%), Gaps = 27/136 (19%)

Query: 237 EARLLSQIWHRNIVKL-----YG--FCL---HRKCMFLIYEYMEMGSLFCVLRTDEEAVG 286
           EA LL  + H +++++      G   C+   H       Y       L            
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPL------------ 154

Query: 287 LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
               + + I K +   L YLH      I+HRD+ + N+ +N   +  + D G A+     
Sbjct: 155 -PIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVV 209

Query: 347 SSNRTLLAGTSGYIAP 362
           +     LAGT    AP
Sbjct: 210 APAFLGLAGTVETNAP 225

Length = 357

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 49.6 bits (118), Expect = 9e-07
 Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 19/184 (10%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL-Y 253
           +G G +G V   R   +G+  A+K L +        +     E+R+L    H  +  L Y
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
            F  H +  F++ EY   G LF  L + E     + A+       +  AL YLH   +  
Sbjct: 63  AFQTHDRLCFVM-EYANGGELFFHL-SRERVFTEERARFYG--AEIVSALEYLH---SRD 115

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----------A 363
           +V+RDI   N++L+ +    + DFG+ +    D +      GT  Y+AP          A
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 364 SEWW 367
            +WW
Sbjct: 176 VDWW 179

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 18/184 (9%)

Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G GG+G V   ++  +GK+ A KKL +   ++        NE ++L ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 255 FCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
               +  + L+   M  G L F +    E   G +  + V     +   L  LH      
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---R 122

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----------A 363
           IV+RD+   N+LL+      ++D G+A  +    + +  + GT GY+AP          +
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFS 181

Query: 364 SEWW 367
            +WW
Sbjct: 182 PDWW 185

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 22/156 (14%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83

Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 135

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 136 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 28/66 (42%), Positives = 37/66 (56%), Gaps = 4/66 (6%)

Query: 47  LDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVE 102
           +DLS   I+GKI S +  +P I T+NLS N LSG IP+ +      +  L +S NNF   
Sbjct: 74  IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133

Query: 103 IPSTSA 108
           IP  S 
Sbjct: 134 IPRGSI 139

Length = 968

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 26/179 (14%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSE---TEELASLESFRNEARLLSQIWHRNIVK 251
           IG G +G VY+ R   + ++ A+K L + E    +E+A     RN       I  R ++ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERN-------ILVRTLLD 53

Query: 252 LYGFCLHRKCMF-------LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHAL 303
              F +  K  F       L+ +YM  G LF  L+ +    G     R    +  +  AL
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE----GRFSEDRAKFYIAELVLAL 109

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            +LH +    IV+RD+   N+LL++     + DFG+++    D+       GT+ Y+AP
Sbjct: 110 EHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 26/188 (13%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLY 253
           +G G +G V  A L  + +  A+K L +    E   +E    E R+L+  W H  +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 254 GFCLHRKCMFLIYEYMEMGSLF----CVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                ++ +F + EY+  G L        R DE       A+   I+ G    L +LH  
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE---IICG----LQFLH-- 113

Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP------- 362
               I++RD+  +NVLL+ +    +ADFG+ +         +   GT  YIAP       
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK 172

Query: 363 ---ASEWW 367
              + +WW
Sbjct: 173 YNESVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 25/158 (15%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKL-----HRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY      +G+ +A+K++      +  ++E+ +LE    E +LL  + H  I
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC---EIQLLKNLRHDRI 66

Query: 250 VKLYGFCLH---RKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHAL 303
           V+ YG CL     K + +  EYM  GS+   L+      E V   + ++  I++G    +
Sbjct: 67  VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ--ILQG----V 119

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           SYLH +    IVHRDI   N+L +S     + DFG ++
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 30/180 (16%)

Query: 196 IGTGGYGSVYRA--------RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A        +      VA+K L    T++   L    +E  ++  I  H
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK--DLSDLVSEMEMMKMIGKH 77

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWA--------------KR 292
           +NI+ L G C     ++++ EY   G+L   LR      G+D++                
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRA-RRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR-LLNFDSSNRT 351
           V+    +A  + YL    +   +HRD+++ NVL+  +    +ADFG+AR + N D   +T
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 45/174 (25%), Positives = 84/174 (48%), Gaps = 14/174 (8%)

Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            IG G YG V  A+   + + VA+KK+  +    + +  + R E +LL  + H N++ + 
Sbjct: 12  PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIK 70

Query: 254 GFCL--HR---KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
                 HR     ++++YE M+   L  ++R+ +  +  D  +    +  +   L Y+H 
Sbjct: 71  DIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQ-TLSDDHCQY--FLYQLLRGLKYIH- 125

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             +  ++HRD+  +N+LLN+  +  + DFG+AR  +      T    T  Y AP
Sbjct: 126 --SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 14/158 (8%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           + I+  IG G YG V  A    +G+ VA+KK++    E ++       E +LL  + H +
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 60

Query: 249 IVKLYGFCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           IV++    L       K +++++E ME   L  V++ +++   L        +  +  AL
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD---LTPEHHQFFLYQLLRAL 116

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            Y+H   T  + HRD+   N+L N++ +  + DFG+AR
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.1 bits (117), Expect = 3e-06
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 6/93 (6%)

Query: 16  NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIP-RIDTVNLS 74
           N S++  + L    +SG ISS I +L  +  ++LS+N ++G IP  +      +  +NLS
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 75  MNNLSGSIPESVKKVPLLY---VSGNNFEVEIP 104
            NN +GSIP     +P L    +S N    EIP
Sbjct: 127 NNNFTGSIPRG--SIPNLETLDLSNNMLSGEIP 157

Length = 968

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 24/157 (15%)

Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G+G YGSV   Y  RL   + VA+KKL R     + +  ++R E RLL  + H N++ L
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGL 79

Query: 253 YGFCLHRKCM------FLIYEYM--EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
                    +      +L+   M  ++ ++    +  +E V         ++  +   L 
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLK 132

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           Y+H   +  I+HRD+  +NV +N + E  + DFG+AR
Sbjct: 133 YIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 23/155 (14%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ------IWHRNI 249
           IG G +G V  + + +   VA     R   +EL +  S + +   L Q      + H NI
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVA-----RVVVKELKANASSKEQNEFLQQGDPYRILQHPNI 57

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG---LDWAKRV--NIVKGMAHALS 304
           ++  G C+      L++EY E+G L   L  ++       L   +R+   I  G+ H   
Sbjct: 58  LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH--- 114

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV 339
            +H H     +H D++  N  L S+L   V D+G+
Sbjct: 115 -MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 45/187 (24%), Positives = 80/187 (42%), Gaps = 24/187 (12%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLY 253
           IG G Y  V   RL  + ++ A+K + +    +   ++  + E  +  Q   H  +V L+
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   +F + EY+  G L   +   R   E     ++  +++      AL+YLH   
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNYLHER- 115

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP-------- 362
              I++RD+  +NVLL+SE    + D+G+ +         +   GT  YIAP        
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 363 --ASEWW 367
             + +WW
Sbjct: 174 GFSVDWW 180

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 39/151 (25%), Positives = 79/151 (52%), Gaps = 15/151 (9%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G +G V  AR   +G+ VA+KK+ +  +  + +  ++R E +LL  + H NI+ L  
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76

Query: 255 -FCLHRKCMFLIYEYM--EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
            F    + ++ + E +  ++  L      +++ +     +   I++G    L Y+H   +
Sbjct: 77  IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ---ILRG----LKYVH---S 126

Query: 312 PPIVHRDISSNNVLLNSELEAFVADFGVARL 342
             +VHRD+  +N+L+N   +  + DFG+AR+
Sbjct: 127 AGVVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 18/184 (9%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN-IVKLY 253
           +G G +G V  A L   G+  A+K L +        +E    E R+L+  W    +  LY
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
                ++ +F + E++  G L   +   ++    D  +       +   L +LH   +  
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHI---QDKGRFDLYRATFYAAEIVCGLQFLH---SKG 116

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----------A 363
           I++RD+  +NV+L+ +    +ADFG+ +   F  +  +   GT  YIAP          +
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176

Query: 364 SEWW 367
            +WW
Sbjct: 177 VDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 48/169 (28%), Positives = 67/169 (39%), Gaps = 29/169 (17%)

Query: 211 SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY--GFCLHRKCMFLIYEY 268
           +G  VA+K L     EE      FR E  L ++++H NIV L   G       +F ++EY
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60

Query: 269 MEMGSLFCVLRTD-----EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNN 323
           +   +L  VL  D      E   L           M   L  L       IVHRD+   N
Sbjct: 61  VPGRTLREVLAADGALPAGETGRL-----------MLQVLDALACAHNQGIVHRDLKPQN 109

Query: 324 VLLNS---ELEAFVADFGVARLL-NFDSSNRTLLA------GTSGYIAP 362
           ++++       A V DFG+  LL     ++   L       GT  Y AP
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 15/157 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     IG G +G V    +  +G V A+K L +++  E   +   R E  +L +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAHA 302
             +VK++     +  ++LI E++  G +  +L       EE      A+ V  +  + H 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQ 119

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV 339
           L +         +HRDI  +N+LL+S+    ++DFG+
Sbjct: 120 LGF---------IHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 19/141 (13%)

Query: 215 VALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMFLIYEYMEMGS 273
           VA+K L    TE+   L    +E  ++  I  H+NI+ L G C     +++I EY   G+
Sbjct: 53  VAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110

Query: 274 L-------------FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDIS 320
           L             +C   T      L +   V+    +A  + YL    +   +HRD++
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLA 167

Query: 321 SNNVLLNSELEAFVADFGVAR 341
           + NVL+  +    +ADFG+AR
Sbjct: 168 ARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 29/190 (15%)

Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLL---SQIWHRNIVK 251
           +G G +G V  A    +G++ A+K L + +      +ES   E R+    +   H  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 252 LYGFCLHRKC-MFLIYEYMEMGSLFCVLRTD--EEAVGLDWAKRVNIVKGMAHALSYLHH 308
           L+  C   +  +  + EY   G L   + TD   E   + +A  V +       L YLH 
Sbjct: 67  LFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL------GLQYLHE 119

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAGTSGYIAP----- 362
           +    IV+RD+  +N+LL++E    +ADFG+ +  + F     T   GT  ++AP     
Sbjct: 120 N---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEVLTE 175

Query: 363 -----ASEWW 367
                A +WW
Sbjct: 176 TSYTRAVDWW 185

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 13/157 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDFH    IG G +G V    +  +GK+ A+K L +SE  +   L   + E  +L++   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHAL 303
             +V LY      + ++LI E++  G L  +L    T  E V   +     +     H L
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
            +         +HRDI  +N+L++      ++DFG++
Sbjct: 121 GF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 33/180 (18%)

Query: 194 YCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
             +G G  G V+ A      K VA+KK+  ++ +   S++    E +++ ++ H NIVK+
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKV 67

Query: 253 Y--------------GFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNI 295
           Y              G       ++++ EYME   L  VL      EE   L        
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL-------F 119

Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLA 354
           +  +   L Y+H   +  ++HRD+   NV +N+E L   + DFG+AR+++   S++  L+
Sbjct: 120 MYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 46/194 (23%), Positives = 85/194 (43%), Gaps = 24/194 (12%)

Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLS-QIWH 246
           DF+    +G G +G V  A R  + ++ A+K L +    +   +E    E R+L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHAL 303
             + +L+        ++ + EY+  G L   ++     +E   + +A  + I       L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAI------GL 114

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP- 362
            +LH   +  I++RD+  +NV+L++E    +ADFG+ +   F         GT  YIAP 
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPE 171

Query: 363 ---------ASEWW 367
                    + +WW
Sbjct: 172 IIAYQPYGKSVDWW 185

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 46/194 (23%), Positives = 83/194 (42%), Gaps = 24/194 (12%)

Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF+    +G G +G V  A R  + ++ A+K L +    +   +E    E R+L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 248 NIVKLYGFCLHR-KCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHAL 303
             +     C      ++ + EY+  G L   ++     +E   + +A  +++       L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GL 114

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP- 362
            +LH      I++RD+  +NV+L+SE    +ADFG+ +    D        GT  YIAP 
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPE 171

Query: 363 ---------ASEWW 367
                    + +WW
Sbjct: 172 IIAYQPYGKSVDWW 185

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 39/157 (24%), Positives = 75/157 (47%), Gaps = 15/157 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     IG G +G V    +  +G + A+K L +++  E   +   R E  +L +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
             +VK++     ++ ++LI E++  G +  +L       EEA     A+ V  +  + H 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQ 119

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV 339
           L +         +HRDI  +N+LL+++    ++DFG+
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 10/170 (5%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL-Y 253
           +G GG+G V   ++  +GK+ A KKL +   ++ +  +    E  +L ++    IV L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 254 GFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTP 312
            F   +  + L+   M  G L + +    E   GL+  + ++    +   + +LH   + 
Sbjct: 61  AF-ESKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLH---SM 114

Query: 313 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            IV+RD+   NVLL+ +    ++D G+A  L  D    T  AGT+GY+AP
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKTITQRAGTNGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 46/184 (25%), Positives = 79/184 (42%), Gaps = 18/184 (9%)

Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G GG+G V   ++  +GK+ A KKL +   ++        NE R+L ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 255 FCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
               +  + L+   M  G L F +        G D  + +     +   L  L       
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFDEQRAIFYAAELCCGLEDLQRE---R 122

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----------A 363
           IV+RD+   N+LL+      ++D G+A  +    + R  + GT GY+AP          +
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINNEKYTFS 181

Query: 364 SEWW 367
            +WW
Sbjct: 182 PDWW 185

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)

Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81

Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 135

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 177

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 48/188 (25%), Positives = 78/188 (41%), Gaps = 26/188 (13%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL-Y 253
           +G G +G V   +   +G+  A+K L +        +     E R+L    H  +  L Y
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAHALSYLHHH 309
            F  H +  F++ EY   G LF  L  +    E+      A+ V+       AL YLH  
Sbjct: 63  SFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVS-------ALDYLHSE 114

Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP------- 362
               +V+RD+   N++L+ +    + DFG+ +    D +      GT  Y+AP       
Sbjct: 115 --KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172

Query: 363 ---ASEWW 367
              A +WW
Sbjct: 173 YGRAVDWW 180

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 17/153 (11%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG+G  G V  A     G  VA+KKL R    +  +  ++R E  LL  + H+NI+ L  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87

Query: 255 FCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
               +K +      +L+ E M+  +L  V+  +     LD  +   ++  M   + +LH 
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMD-ANLCQVIHME-----LDHERMSYLLYQMLCGIKHLH- 140

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +  I+HRD+  +N+++ S+    + DFG+AR
Sbjct: 141 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 29/189 (15%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRS---ETEELASLESFRNEARLLSQIWHRNIVK 251
           +G G +G V   R   +GK  A+K L +      +E+A   +   E+R+L    H  +  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT---ESRVLQNTRHPFLTA 59

Query: 252 L-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHALSYLHH 308
           L Y F  H +  F++ EY   G LF  L   E     D A+     IV     AL YLH 
Sbjct: 60  LKYSFQTHDRLCFVM-EYANGGELFFHLSR-ERVFSEDRARFYGAEIVS----ALGYLH- 112

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP------ 362
             +  +V+RD+   N++L+ +    + DFG+ +    D +      GT  Y+AP      
Sbjct: 113 --SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 363 ----ASEWW 367
               A +WW
Sbjct: 171 DYGRAVDWW 179

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 40/210 (19%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     I  G YG+VY  R    +   A+KK+++        ++    E  +L+   +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
             +V ++     ++ + ++ EY+E G    +L+       +   + +A+ V        A
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETV-------LA 113

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR--LLNF---------DSSNRT 351
           L YLH++    IVHRD+  +N+L+ S     + DFG+++  L++          +   R 
Sbjct: 114 LEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 352 LL----AGTSGYIAP----------ASEWW 367
            L     GT  YIAP            +WW
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWW 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.5 bits (107), Expect = 3e-05
 Identities = 30/113 (26%), Positives = 51/113 (45%), Gaps = 18/113 (15%)

Query: 236 NEARLLSQIWHRNIVKL--------YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGL 287
           NE   L ++ H NI+K+          + + +K  F +Y +M   +       D +   L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPL 265

Query: 288 DWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
               R  I+K +  A+ Y+H      ++HRDI   N+ LN + +  + DFG A
Sbjct: 266 LKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314

Length = 501

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 20/160 (12%)

Query: 196 IGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           +G G +G VY   +  G V       VA+K +  +E   +     F NEA ++ +    +
Sbjct: 14  LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCHH 70

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGL----DWAKRVNIVKGMAH 301
           +V+L G     +   +I E M  G L   LR+   + E   +       K + +   +A 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 33/112 (29%), Positives = 48/112 (42%), Gaps = 23/112 (20%)

Query: 237 EARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY-------MEMGSLFCVLRTDEEAVG-LD 288
           E  +L  I HR I+ L            I+ Y       M M    C L T  +  G L 
Sbjct: 136 EIDILKTISHRAIINL------------IHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLP 183

Query: 289 WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
             + + I + +  AL+YLH      I+HRD+ + N+ L+    A + DFG A
Sbjct: 184 LEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 22/163 (13%)

Query: 196 IGTGGYGSVYRARLPSG---KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G G YG VY+A+   G   +  ALK++  +      S+ + R E  LL ++ H N++ L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACR-EIALLRELKHPNVISL 63

Query: 253 YGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY----- 305
               L    + ++L+++Y E   L+ +++    +      K V + +GM  +L Y     
Sbjct: 64  QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANK--KPVQLPRGMVKSLLYQILDG 120

Query: 306 LHHHCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLLN 344
           +H+     ++HRD+   N+L+  E        +AD G ARL N
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 46/185 (24%), Positives = 84/185 (45%), Gaps = 21/185 (11%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL-Y 253
           IG G +G V + R   + ++ ALK + ++     + +     E  +L+Q+    IV L +
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
            F    K ++L+  ++  G LF  L+ +      D ++       +  AL  LH      
Sbjct: 61  SFQSPEK-LYLVLAFINGGELFHHLQREGR---FDLSRARFYTAELLCALENLHKF---N 113

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP---------- 362
           +++RD+   N+LL+ +    + DFG+ + LN    ++T    GT  Y+AP          
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172

Query: 363 ASEWW 367
           A +WW
Sbjct: 173 AVDWW 177

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 47/194 (24%), Positives = 84/194 (43%), Gaps = 24/194 (12%)

Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF+    +G G +G V  A R  + ++ A+K L +    +   +E    E R+L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 248 NIVKLYGFCLHR-KCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHAL 303
             +     C      ++ + EY+  G L   ++     +E   + +A  + I       L
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GL 114

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP- 362
            +LH   +  I++RD+  +NV+L+SE    +ADFG+ +   +D        GT  YIAP 
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE 171

Query: 363 ---------ASEWW 367
                    + +WW
Sbjct: 172 IIAYQPYGKSVDWW 185

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.2 bits (95), Expect = 6e-05
 Identities = 21/61 (34%), Positives = 29/61 (47%), Gaps = 2/61 (3%)

Query: 19 KLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNN 77
           L+ L L NN L+  I       L  L  LDLS N +    P     +P + +++LS NN
Sbjct: 1  NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 78 L 78
          L
Sbjct: 60 L 60

Length = 60

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 44.3 bits (104), Expect = 6e-05
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 32/176 (18%)

Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88

Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 184

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 42/184 (22%), Positives = 79/184 (42%), Gaps = 18/184 (9%)

Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G GG+G V   ++  +GK+ A K+L +   ++        NE ++L ++  + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 255 FCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
               +  + L+   M  G L F +        G +  + +     +   L  LH      
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNP--GFEEERALFYAAEILCGLEDLHRE---N 122

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----------A 363
            V+RD+   N+LL+      ++D G+A  +    S R  + GT GY+AP          +
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQRYTLS 181

Query: 364 SEWW 367
            ++W
Sbjct: 182 PDYW 185

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 32/137 (23%), Positives = 60/137 (43%), Gaps = 12/137 (8%)

Query: 195 CIGTGGYGSVYRARLPSGKVVALKK--LHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           C        + + + P+  +VA+KK  L     E+L  L+    E     Q+ H NI+  
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQ---QEIITSRQLQHPNILPY 64

Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCT 311
               +    ++++   M  GS   +L+T     GL       I+K + +AL Y+H     
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKT-HFPEGLPELAIAFILKDVLNALDYIHSKGF- 122

Query: 312 PPIVHRDISSNNVLLNS 328
              +HR + ++++LL+ 
Sbjct: 123 ---IHRSVKASHILLSG 136

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 31/104 (29%), Positives = 49/104 (47%), Gaps = 7/104 (6%)

Query: 237 EARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIV 296
           EA +L  I H +I++L G   + K   LI    +   L+C L         D    + I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDI---LAIE 188

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
           + +  A+ YLH +    I+HRDI + N+ +N   +  + DFG A
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 14/154 (9%)

Query: 196 IGTGGYGSVYRARLPSG---KVVALKKLHRSET--EELASLESFRNEARLLSQIWHRNIV 250
           IG G +G V    + SG     V +K+L  S +  E++  LE    EA+    + H N++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE----EAQPYRSLQHSNLL 58

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH--ALSYLHH 308
           +  G C       L+ E+  +G L   LR+  +A  +        ++ MA   AL  LH 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELM--TPDPTTLQRMACEIALGLLHL 116

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
           H     +H D++  N LL ++L   + D+G++  
Sbjct: 117 H-KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 31/89 (34%), Positives = 42/89 (47%), Gaps = 3/89 (3%)

Query: 10  IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRID 69
           +   L N   L  L L NN L     S IG L  L  LDLS+N I     S LG +  + 
Sbjct: 224 LLSSLSNLKNLSGLELSNNKLEDLPES-IGNLSNLETLDLSNNQI--SSISSLGSLTNLR 280

Query: 70  TVNLSMNNLSGSIPESVKKVPLLYVSGNN 98
            ++LS N+LS ++P     + LL +  N 
Sbjct: 281 ELDLSGNSLSNALPLIALLLLLLELLLNL 309

Length = 394

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 16/160 (10%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G YG VY+A+   GK      L + E   + S+ + R E  LL ++ H N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACR-EIALLRELKHPNVIALQKV 66

Query: 256 CLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY-----LHH 308
            L    + ++L+++Y E   L+ +++    +      K + + + M  +L Y     +H+
Sbjct: 67  FLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANK--KPMQLPRSMVKSLLYQILDGIHY 123

Query: 309 HCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLLN 344
                ++HRD+   N+L+  E        +AD G ARL N
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 14/159 (8%)

Query: 190 FHIKYCIGTGGYGSVYRARLPS---GKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           + +   +G G YG V  AR       + VA+KK+    ++++ +  + R E +LL     
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRG 60

Query: 246 HRNIVKLYGFCLHRKCMF-LIYEYMEM--GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           H+NI  LY   +     F  +Y Y E+    L  ++R+ +    L  A   + +  +   
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP---LTDAHFQSFIYQILCG 117

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           L Y+H   +  ++HRD+   N+L+N++ E  + DFG+AR
Sbjct: 118 LKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR 153

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 24/187 (12%)

Query: 196 IGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G Y  V   RL    ++ A+K + +    +   ++  + E  +  Q      +    
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 255 FCLHRKC-MFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
            C      +FL+ EY+  G L   +   R   E     +A  + I      AL++LH   
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI------ALNFLHER- 115

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP-------- 362
              I++RD+  +NVLL+++    + D+G+ +         +   GT  YIAP        
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 363 --ASEWW 367
             + +WW
Sbjct: 174 GFSVDWW 180

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 49/196 (25%), Positives = 81/196 (41%), Gaps = 42/196 (21%)

Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL-Y 253
           +G GG+G V   ++  +GK+ A KKL +   ++        NE ++L ++  R +V L Y
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 254 GF------CLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
            +      CL    M      F IY     G         +E   + +A  +        
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGF--------DEERAVFYAAEITC------ 113

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
            L  LH      IV+RD+   N+LL+      ++D G+A  +    + R  + GT GY+A
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMA 169

Query: 362 P----------ASEWW 367
           P          + +WW
Sbjct: 170 PEVVKNERYTFSPDWW 185

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 17/153 (11%)

Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG+G  G V  A    +G+ VA+KKL R       +  ++R E  L+  + H+NI+ L  
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN 82

Query: 255 -FCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
            F   +       ++L+ E M+  +L  V++ D     LD  +   ++  M   + +LH 
Sbjct: 83  VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLH- 135

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +  I+HRD+  +N+++ S+    + DFG+AR
Sbjct: 136 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 22/159 (13%)

Query: 199 GGYGSVYRARLPSGKV-----VALKKL--HRSETEELASLESFRNEARLLSQIWHRNIVK 251
           G +G ++   L   K      V +K +  H SE +    +     E+ LL  + H+NI+ 
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ----VTLLLQESCLLYGLSHQNILP 72

Query: 252 LYGFC--LHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-----LDWAKRVNIVKGMAHALS 304
           +   C        F++Y YM  G+L   L+            L   + V++   +A  +S
Sbjct: 73  ILHVCIEDGEP-PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           YLH      ++H+DI++ N +++ EL+  + D  ++R L
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.5 bits (95), Expect = 3e-04
 Identities = 25/149 (16%), Positives = 49/149 (32%), Gaps = 18/149 (12%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIV--KLY 253
           +  G    VY         V LK     E            E  +L  +  + +   K+ 
Sbjct: 6   LKGGLTNRVYLLGTKDEDYV-LKINPSREKGAD-----REREVAILQLLARKGLPVPKVL 59

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
                    +L+ E++E           E    +   ++ +I + +A  L+ LH      
Sbjct: 60  ASGESDGWSYLLMEWIE----------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV 109

Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARL 342
           + H D+   N+L++      + D+  A  
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 20/175 (11%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN----IV 250
           IG GG+G VY  R   +GK+ A+K L +   +         NE  +LS +   +    + 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR---VNIVKGMAHALSYLH 307
             Y F    K  F I + M  G L   L   +  V  +   R     I+ G+ H    +H
Sbjct: 62  MTYAFHTPDKLCF-ILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEH----MH 114

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +     +V+RD+   N+LL+      ++D G+A   +F         GT GY+AP
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 6/94 (6%)

Query: 10  IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRID 69
           +P  L N   L+ L L  N LS  +   +  L  LN LDLS N I+  +P ++  +  ++
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212

Query: 70  TVNLSMNNLSGSIPESVKKVP---LLYVSGNNFE 100
            ++LS NN    +  S+  +     L +S N  E
Sbjct: 213 ELDLS-NNSIIELLSSLSNLKNLSGLELSNNKLE 245

Length = 394

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 33/100 (33%), Positives = 44/100 (44%), Gaps = 17/100 (17%)

Query: 196 IGTGGYGSVYRA------RLPSGKVVALKKL----HRSETEELASLESFRNEARLLSQI- 244
           +G G +G V  A      +  +   VA+K L    H  E E L S      E ++LS + 
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMS------ELKILSHLG 99

Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEA 284
            H+NIV L G C H   + +I EY   G L   LR   E 
Sbjct: 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAET 139

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 28/128 (21%), Positives = 58/128 (45%), Gaps = 10/128 (7%)

Query: 203 SVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF----CLH 258
           S+Y+    + K V ++   +        ++   NE + L +I   NI+K+YGF       
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 259 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRD 318
              + LI EY   G L  VL  +++   L +  ++++       L  L+ +   P  +++
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148

Query: 319 ISSNNVLL 326
           ++S + L+
Sbjct: 149 LTSVSFLV 156

Length = 283

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 41/197 (20%), Positives = 89/197 (45%), Gaps = 37/197 (18%)

Query: 196 IGTGGYGSVYRARLPSG------KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           IG G +G V+  +          K ++ + L   E  +L        E  ++ ++ H+NI
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI------EVNVMRELKHKNI 74

Query: 250 VKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYL 306
           V+     L++  + ++++ E+ + G L   ++   +  G ++    V+I + + HAL+Y 
Sbjct: 75  VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134

Query: 307 HHHCTPP----IVHRDISSNNVLLNSELE-----------------AFVADFGVARLLNF 345
           H+    P    ++HRD+   N+ L++ +                  A + DFG+++ +  
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194

Query: 346 DSSNRTLLAGTSGYIAP 362
           +S   + + GT  Y +P
Sbjct: 195 ESMAHSCV-GTPYYWSP 210

Length = 1021

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 34/182 (18%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALK-------KLHRSETEELASLESFRNEARLLSQIWHR 247
           IG GG+G VY  R   +GK+ A+K       K+ + ET  L       NE  +LS +   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL-------NERIMLSLVSTG 54

Query: 248 N---IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR---VNIVKGMA 300
           +   IV + Y F    K  F I + M  G L   L   +  V  +   R     I+ G+ 
Sbjct: 55  DCPFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLE 111

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
           H    +H+     +V+RD+   N+LL+      ++D G+A   +F         GT GY+
Sbjct: 112 H----MHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYM 162

Query: 361 AP 362
           AP
Sbjct: 163 AP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 41/189 (21%), Positives = 80/189 (42%), Gaps = 28/189 (14%)

Query: 196 IGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLY 253
           IG G Y  V    L    ++ A+K + +    +   ++  + E  +      H  +V L+
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 254 GFCLHRKC-MFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
             C   +  +F + E++  G L   +    +  EE     ++  +++      AL++LH 
Sbjct: 63  S-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-YSAEISL------ALNFLHE 114

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP------ 362
                I++RD+  +NVLL++E    + D+G+ +         +   GT  YIAP      
Sbjct: 115 R---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 363 ----ASEWW 367
               + +WW
Sbjct: 172 DYGFSVDWW 180

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	368
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.98
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.98
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.98
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.98
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.98
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.98
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.98
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.98
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.98
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.98
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.98
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.98
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.98
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
PTZ00267	478	NIMA-related protein kinase; Provisional	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.96
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
PHA02988	283	hypothetical protein; Provisional	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.96
KOG0584	632	consensus Serine/threonine protein kinase [General	99.96
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.96
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.96
PTZ00283	496	serine/threonine protein kinase; Provisional	99.96
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.96
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.96
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.96
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
PTZ00036	440	glycogen synthase kinase; Provisional	99.96
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.96
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.96
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.96
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.96
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.96
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.96
PHA03209	357	serine/threonine kinase US3; Provisional	99.96
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.95
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.95
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.95
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.95
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.95
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.95
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.95
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.95
PHA03207	392	serine/threonine kinase US3; Provisional	99.95
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.95
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.95
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.95
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.95
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.95
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.95
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.95
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.95
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.95
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.95
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.95
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.95
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.95
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.95
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.95
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.95
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.95
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.95
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.95
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.95
PTZ00284	467	protein kinase; Provisional	99.95
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.95
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.95
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.95
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.95
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.95
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.95
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.95
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.95
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.95
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.95
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.95
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.95
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.95
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.95
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.95
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.95
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.95
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.95
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.95
PHA03210	501	serine/threonine kinase US3; Provisional	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.95
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.95
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.95
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.95
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.95
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.95
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.95
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.95
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.95
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.95
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.95
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.95
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.95
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.95
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.95
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.95
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.95
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.95
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.95
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.95
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.94
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.94
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.94
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.94
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.94
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.94
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.94
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.94
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.94
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.94
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.94
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.94
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.94
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.94
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.94
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.94
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.94
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.94
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.94
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.94
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.94
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.94
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.94
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.94
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.94
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.94
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.94
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.94
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.93
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.93
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.93
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.93
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.93
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.93
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.93
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.93
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.93
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.93
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.93
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.93
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.93
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.93
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.93
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.93
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.93
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.93
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.93
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.93
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.93
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.93
PHA02882	294	putative serine/threonine kinase; Provisional	99.93
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.93
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.93
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.93
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.93
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.93
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.93
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.92
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.92
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.92
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.92
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.92
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.92
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.92
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.92
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.92
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.91
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.91
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.9
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.9
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.9
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.89
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.89
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.89
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.88
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.88
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.87
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
smart00090	237	RIO RIO-like kinase.	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.81
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.79
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
PLN03150	623	hypothetical protein; Provisional	99.76
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.71
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
PLN00181	793	protein SPA1-RELATED; Provisional	99.69
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.65
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.55
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.48
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.47
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.46
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.45
PLN03150	623	hypothetical protein; Provisional	99.45
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.44
KOG3087	229	consensus Serine/threonine protein kinase [General	99.39
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.39
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.35
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.32
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.31
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.31
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.22
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.21
KOG1243	690	consensus Protein kinase [General function predict	99.16
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.14
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.13
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.1
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.04
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.04
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.98
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.95
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.89
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.86
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.85
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.84
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.84
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.81
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.8
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.79
PRK09902	216	hypothetical protein; Provisional	98.79
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.75
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.72
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.7
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.7
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.7
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.68
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.66
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.64
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.62
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.6
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.58
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.57
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.56
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.53
PF01636	239	APH: Phosphotransferase enzyme family This family	98.5
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.49
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.49
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.45
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.44
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.4
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.4
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.39
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.36
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.36
PLN02876	822	acyl-CoA dehydrogenase	98.35
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.34
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.31
PRK10593	297	hypothetical protein; Provisional	98.29
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.27
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.25
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.24
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.23
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.22
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.22
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.17
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.15
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.14
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.14

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.9e-47  Score=399.45  Aligned_cols=339  Identities=30%  Similarity=0.476  Sum_probs=244.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+++|.+|..+.++++|+.|+|++|+++|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|
T Consensus       482 ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  561 (968)
T PLN00113        482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG  561 (968)
T ss_pred             CcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence            57899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC---cccccccCCCcccccccCCC----------CCCCCCC------CCCcc---cccceeeeeehhhhh--H
Q 017621           81 SIPESVKK---VPLLYVSGNNFEVEIPSTSA----------KAPPPHH------KGNDK---KIATRLVAIILPMSA--F  136 (368)
Q Consensus        81 ~~p~~~~~---~~~~~~~~N~~~~~~P~~~~----------~~p~~~~------~~~~~---~~~~~~~~i~~~~~~--~  136 (368)
                      .+|..+..   +..+++++|++++.+|+...          ..+..|.      .+.+.   +.....+.+++++++  +
T Consensus       562 ~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~  641 (968)
T PLN00113        562 EIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLV  641 (968)
T ss_pred             cCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHH
Confidence            99987764   55689999999998886421          0000010      01111   111111222222211  1


Q ss_pred             HHHHHHHhhhhhhccC-CCCCCCccccccccccceee--cCCCcccHHHHHHHhhccccceeeeecCCccEEEEEc-CCC
Q 017621          137 LALIFGILFVRRRRDK-KVEPTETGEITKCADEFAIW--NYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSG  212 (368)
Q Consensus       137 l~~i~~~~~~~rrr~~-~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~  212 (368)
                      +++++.+++++|+|++ +.+..+.....   .+....  .....++++++   ...|+..+.||+|+||.||+|+. .++
T Consensus       642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~  715 (968)
T PLN00113        642 LALVAFGFVFIRGRNNLELKRVENEDGT---WELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNG  715 (968)
T ss_pred             HHHHHHHHHHHHhhhccccccccccccc---ccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCC
Confidence            1222222222222221 11111100000   000000  01112344443   34677788999999999999986 578


Q ss_pred             CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHH
Q 017621          213 KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR  292 (368)
Q Consensus       213 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~  292 (368)
                      ..||+|++......       ...|++.+++++|||||+++++|.+.+..|+||||+++|+|.++++.      ++|.++
T Consensus       716 ~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~  782 (968)
T PLN00113        716 MQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERR  782 (968)
T ss_pred             cEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHH
Confidence            99999998653321       13468889999999999999999999999999999999999999963      789999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       293 ~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .+++.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||........    ....||+.|||||
T Consensus       783 ~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE  848 (968)
T PLN00113        783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPE  848 (968)
T ss_pred             HHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcc
Confidence            9999999999999997666799999999999999999888875 6665443221    1236899999999

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=314.91  Aligned_cols=188  Identities=41%  Similarity=0.717  Sum_probs=165.8

Q ss_pred             CCCcccHHHHHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEE
Q 017621          174 YDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY  253 (368)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  253 (368)
                      ....|++.++..+|++|...+.||+|+||.||+|...+++.||||++.......   ..+|.+|++++.+++|||+|+++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence            345689999999999999999999999999999999999999999887655431   35699999999999999999999


Q ss_pred             EEEeeCC-eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCe
Q 017621          254 GFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEA  332 (368)
Q Consensus       254 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  332 (368)
                      |||.+.+ ..+||||||++|+|.+++...... .++|..+++|+.++|+||+|||+.+.++||||||||+|||+|+++++
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9999998 599999999999999999876543 68999999999999999999999998899999999999999999999


Q ss_pred             EEeeeccceecCC-CCCCccccccccccccCCCC
Q 017621          333 FVADFGVARLLNF-DSSNRTLLAGTSGYIAPASE  365 (368)
Q Consensus       333 kl~DFg~a~~~~~-~~~~~~~~~gt~~y~aPE~d  365 (368)
                      ||+|||+|+.... .....+...||.+|+|||+.
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~  250 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYA  250 (361)
T ss_pred             EccCccCcccCCccccceeeecCCCCccCChhhh
Confidence            9999999976654 22221111799999999974

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=300.29  Aligned_cols=176  Identities=30%  Similarity=0.532  Sum_probs=161.5

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||+||.++. .+++.+|+|++++....+....+...+|..++.+++||+||+++-.|++.+.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            356899999999999999999985 4689999999998877766667888999999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |+||+.||.|..+|++...   +++..+..++.+|+.||.|||++   +||||||||+|||+|.+|+++|+|||+|+...
T Consensus       103 Vld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999999999986554   89999999999999999999999   99999999999999999999999999999776


Q ss_pred             CCCCCccccccccccccCC----------CCcC
Q 017621          345 FDSSNRTLLAGTSGYIAPA----------SEWW  367 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE----------~d~w  367 (368)
                      ..+.....+|||+.|||||          ||||
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWW  209 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWW  209 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCcccchH
Confidence            6666666789999999997          9999

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-41  Score=299.78  Aligned_cols=171  Identities=31%  Similarity=0.506  Sum_probs=151.0

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ...+|...+.||+|+|++||+|+++ ++..||||.+.+.... ....+.+..|+++|+.++|||||.++++++.++.+|+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            4567888889999999999999864 6889999999876532 2345778899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC------CCeEEeeec
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE------LEAFVADFG  338 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DFg  338 (368)
                      |||||.||||.++++....   +++..+..++.|+|.||++||++   +||||||||.|||++..      -.+||+|||
T Consensus        87 VMEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            9999999999999998653   89999999999999999999999   99999999999999864      458999999


Q ss_pred             cceecCCCCCCccccccccccccCCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +|+.+.. .......||+|.|||||+
T Consensus       161 fAR~L~~-~~~a~tlcGSplYMAPEV  185 (429)
T KOG0595|consen  161 FARFLQP-GSMAETLCGSPLYMAPEV  185 (429)
T ss_pred             hhhhCCc-hhHHHHhhCCccccCHHH
Confidence            9999874 344456799999999993

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-39  Score=303.91  Aligned_cols=174  Identities=29%  Similarity=0.548  Sum_probs=162.8

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .+|+..+.||+|+|++||++++ .+|+.||+|++.+....+....+...+|+++.+.|+|||||+++++|++.+++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999997 789999999998877766677789999999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |+|+.++|..+++++..   +++.++..++.||+.||.|||++   +|+|||||..|+|++++.++||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~Krrk~---ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKP---LTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHhcCC---CCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence            99999999999985443   99999999999999999999999   9999999999999999999999999999999988


Q ss_pred             CCCccccccccccccCC----------CCcC
Q 017621          347 SSNRTLLAGTSGYIAPA----------SEWW  367 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE----------~d~w  367 (368)
                      .....+.||||.|+|||          +|.|
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiW  202 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIW  202 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhh
Confidence            77778899999999995          8888

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-39  Score=289.27  Aligned_cols=171  Identities=30%  Similarity=0.498  Sum_probs=147.5

Q ss_pred             HhhccccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhh----HHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEE----LASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      ..+.|.+.+.||+|+||.|-+|. .++|+.||||++++.....    ........+|+++|++++|||||+++++++..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            44568888999999999999997 4679999999998764433    112334579999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CCeEEeee
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE---LEAFVADF  337 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DF  337 (368)
                      +.||||||++||+|.+.+-.+..   +.+.....++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999998876543   66667788999999999999999   99999999999999766   78999999


Q ss_pred             ccceecCCCCCCccccccccccccCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      |+|+... ......+.||||.|.|||
T Consensus       324 GlAK~~g-~~sfm~TlCGTpsYvAPE  348 (475)
T KOG0615|consen  324 GLAKVSG-EGSFMKTLCGTPSYVAPE  348 (475)
T ss_pred             chhhccc-cceehhhhcCCccccChh
Confidence            9999987 444556679999999999

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=273.53  Aligned_cols=172  Identities=32%  Similarity=0.538  Sum_probs=158.4

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|+..+.||.|+||+|..++.+ +|..+|+|++.+...-+....+...+|.++|+.+.||+++++++.+.+.+.+|||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            357888999999999999999864 5889999999988777777788899999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||.+||.|.+++++.+.   +++..+..++.||+.||+|||+.   +|++|||||+|||+|.+|.+||+|||+|+.+..
T Consensus       123 meyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            999999999999987654   89999999999999999999999   999999999999999999999999999998753


Q ss_pred             CCCCccccccccccccCC----------CCcC
Q 017621          346 DSSNRTLLAGTSGYIAPA----------SEWW  367 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE----------~d~w  367 (368)
                      .   ..+.||||.|+|||          +|||
T Consensus       197 r---T~TlCGTPeYLAPEii~sk~ynkavDWW  225 (355)
T KOG0616|consen  197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWW  225 (355)
T ss_pred             c---EEEecCCccccChHHhhcCCCCcchhHH
Confidence            2   45679999999998          8999

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=275.92  Aligned_cols=164  Identities=31%  Similarity=0.442  Sum_probs=144.5

Q ss_pred             cccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-eEEEEEe
Q 017621          190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-CMFLIYE  267 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  267 (368)
                      .+....||+|..|+||+++++ +++.+|+|.+.....  ....+++.+|+++++..+||+||.+||.|..++ .++++||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~--~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID--PALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC--HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            345678999999999999875 688999999954332  234578999999999999999999999999998 5999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||++|+|.++++..+.   +++....+|+.+|++||.|||+ +   +||||||||+|||++..|++||||||.++.+...
T Consensus       159 YMDgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hcCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            9999999999986533   8999999999999999999996 5   9999999999999999999999999999988654


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                        ...+++||..|||||
T Consensus       233 --~a~tfvGT~~YMsPE  247 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPE  247 (364)
T ss_pred             --hcccccccccccChh
Confidence              445678999999999

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.6e-38  Score=270.98  Aligned_cols=169  Identities=28%  Similarity=0.434  Sum_probs=148.9

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      +.|+....+|+|+||+||+|+.+ +|+.||||++..++.+. ...+-..+|++++++++|||+|.++++|.....+++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~-~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP-VVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH-HHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            46788889999999999999975 59999999998765533 23355678999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||+. ++.+-+++...  +++...+.+++.|+++|+.|+|++   ++|||||||+|||++.++.+||||||+|+.+..+
T Consensus        81 E~~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             eecch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            99987 55555554433  388999999999999999999999   9999999999999999999999999999999877


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      +...+..+.|.+|.|||
T Consensus       155 gd~YTDYVATRWYRaPE  171 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPE  171 (396)
T ss_pred             cchhhhhhhhhhccChh
Confidence            77888889999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-39  Score=273.96  Aligned_cols=175  Identities=27%  Similarity=0.416  Sum_probs=150.9

Q ss_pred             hhccccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEE-EEeeCCe-EE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG-FCLHRKC-MF  263 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~  263 (368)
                      ..+|++.++||+|.||+||++. ..+|..+|.|.+.-... +....+....|+.+|++++|||||++++ .+.+++. ++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            3568889999999999999997 56899999999985443 3445678899999999999999999998 4444444 89


Q ss_pred             EEEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          264 LIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPP--IVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      +|||||..|+|..+++... +...+++..+++++.|++.||.++|+... +  |+||||||.||+++.+|.+||+|||++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhH
Confidence            9999999999999887532 23448999999999999999999999422 4  899999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +.+........+.+|||.||+||
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE  198 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPE  198 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHH
Confidence            99987777777889999999998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-37  Score=281.36  Aligned_cols=170  Identities=33%  Similarity=0.578  Sum_probs=147.5

Q ss_pred             cccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-eEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-CMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  268 (368)
                      +.+.+.+|+|+||+||+|.+.....||||++......... .++|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3445559999999999999855555999999876654433 679999999999999999999999999987 79999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCCCCeeecCCC-CeEEeeeccceecCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP-IVHRDISSNNVLLNSEL-EAFVADFGVARLLNFD  346 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DFg~a~~~~~~  346 (368)
                      +++|+|.+++... ....+++..++.++.|||+||+|||++   + ||||||||+|||++.++ ++||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999874 234499999999999999999999999   7 99999999999999998 9999999999987654


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ....+...||+.|||||+
T Consensus       198 ~~~~~~~~GT~~wMAPEv  215 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEV  215 (362)
T ss_pred             cccccCCCCCccccChhh
Confidence            333444689999999995

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-36  Score=277.93  Aligned_cols=170  Identities=31%  Similarity=0.462  Sum_probs=147.9

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMF  263 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  263 (368)
                      .+.|+.++.||+|+||.||+|++ .+|+.||+|+++...... ....-..+||.+|++|+||||+++.+...+.  ..+|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            45677889999999999999984 679999999998755332 3445677899999999999999999988876  6899


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      ||+|||+. ||.-++....  ..+++.++..++.|++.||+|+|++   +|+|||||.+|||||.+|.+||+|||+|+++
T Consensus       195 lVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            99999986 8888887643  3499999999999999999999999   9999999999999999999999999999988


Q ss_pred             CCCCCC-ccccccccccccCC
Q 017621          344 NFDSSN-RTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~-~~~~~gt~~y~aPE  363 (368)
                      ...... .+..+-|.+|.|||
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPE  289 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPE  289 (560)
T ss_pred             cCCCCcccccceEEeeccChH
Confidence            765543 56667899999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1e-35  Score=273.77  Aligned_cols=151  Identities=27%  Similarity=0.442  Sum_probs=141.9

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++...||+|+||.||.|+. .+|..+|+|++++........++..+.|-.+|...++|+||+++-.|++.+++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            467999999999999999999984 5699999999999998888888999999999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ||||++||++..+|.+...   +++..+..++.+++.|++.||+.   |+|||||||+|+|||..|++||+|||+|.-
T Consensus       219 iMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999986543   89999999999999999999999   999999999999999999999999999853

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.8e-36  Score=253.63  Aligned_cols=169  Identities=30%  Similarity=0.452  Sum_probs=150.1

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .+|...+.+|+|.||.||+|++ .+|+.||||+++.....+... ....+|++.|+.++|+||+.++++|...+.+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            4678889999999999999985 579999999998765543222 35678999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||++. +|+..++...  ..++..++..++.++++|++|||++   .|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus        81 Efm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             Eeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            99984 9999998654  3489999999999999999999999   9999999999999999999999999999999877


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      ....+..+-|.+|.|||
T Consensus       155 ~~~~~~~V~TRWYRAPE  171 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPE  171 (318)
T ss_pred             CcccccceeeeeccChH
Confidence            76666667899999999

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=282.38  Aligned_cols=175  Identities=26%  Similarity=0.488  Sum_probs=157.6

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  263 (368)
                      ..++|.+.++||+|.||+|+++..+ +++.+|||.+++...-....++..+.|.+++... +||++++++..|+..+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4578999999999999999999864 6889999999998777767788889999998887 6999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      .||||+.||++..+.+..    .+++..+..++.+|+.||+|||++   +|||||||.+|||+|.+|.+||+|||+|+..
T Consensus       446 fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999955444432    399999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCCccccccccccccCC----------CCcC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA----------SEWW  367 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE----------~d~w  367 (368)
                      ...+...+++||||.|||||          ||||
T Consensus       519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW  552 (694)
T KOG0694|consen  519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWW  552 (694)
T ss_pred             CCCCCccccccCChhhcChhhhccCcccchhhHH
Confidence            65666777899999999998          9999

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-36  Score=275.55  Aligned_cols=174  Identities=28%  Similarity=0.467  Sum_probs=155.2

Q ss_pred             HHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCe
Q 017621          184 IEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       184 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  261 (368)
                      .....||.+.+.||+|+|++||+|+. .+++.||||++.+....+....+...+|-+.|.+| .||.|++|+-.|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34467899999999999999999984 57899999999887776666667788899999999 99999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      +|+|+||+++|+|.+++++.+.   +++..+..++.||+.||+|||++   |||||||||+|||+|+||++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999997654   89999999999999999999999   99999999999999999999999999999


Q ss_pred             ecCCCCC-------------CccccccccccccCC
Q 017621          342 LLNFDSS-------------NRTLLAGTSGYIAPA  363 (368)
Q Consensus       342 ~~~~~~~-------------~~~~~~gt~~y~aPE  363 (368)
                      .+.....             ....++||..|.+||
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPE  257 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPE  257 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHH
Confidence            8754211             124589999999998

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-36  Score=267.19  Aligned_cols=170  Identities=25%  Similarity=0.457  Sum_probs=155.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .-+|++.+.||+|.||+|-+|.. ..|+.||||.+++....+.+..-.+++|+++|+.++||||+++|.+|+..+.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            34688889999999999999974 68999999999998888888888999999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||..+|.|++++.+.+.   +++.++..+++||..|+.|+|.+   +++|||||.+|||+|.++++||+|||++..+..
T Consensus       132 MEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999987654   99999999999999999999999   999999999999999999999999999988764


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      . ...+.+||+|-|.+||
T Consensus       206 ~-kfLqTFCGSPLYASPE  222 (668)
T KOG0611|consen  206 K-KFLQTFCGSPLYASPE  222 (668)
T ss_pred             c-cHHHHhcCCcccCCcc
Confidence            3 3345678888888874

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=272.32  Aligned_cols=169  Identities=25%  Similarity=0.411  Sum_probs=147.1

Q ss_pred             HhhccccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCC-eE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRK-CM  262 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~  262 (368)
                      ..++|.+++.||.|+||.||+|+ ..++..||||++++....-. .. .-.+|+.-|++++ ||||+++.+++.+.+ .+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~-~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-EC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            45689999999999999999998 45789999999987654321 11 2257999999998 999999999999888 99


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+|||||+ .+|+++++.+  ...+++..+..|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+||.
T Consensus        86 ~fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence            99999997 4999999877  34599999999999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCCCccccccccccccCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +.... ..+..+.|.+|.|||
T Consensus       160 v~Skp-PYTeYVSTRWYRAPE  179 (538)
T KOG0661|consen  160 VRSKP-PYTEYVSTRWYRAPE  179 (538)
T ss_pred             cccCC-CcchhhhcccccchH
Confidence            87443 345568999999999

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-35  Score=273.91  Aligned_cols=168  Identities=33%  Similarity=0.539  Sum_probs=152.9

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+....+ ...+.+++|+++++.++||||+.++++|+...++|+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            57888999999999999999854 68899999997754432 34567899999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+.| +|..++..+..   ++++.+..++.++..||.|||+.   +|+|||+||.|||++..+.+|+||||+|+.+...
T Consensus        81 e~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            99986 99999987654   99999999999999999999999   9999999999999999999999999999998877


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      ....+...|||.|||||
T Consensus       154 t~vltsikGtPlYmAPE  170 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPE  170 (808)
T ss_pred             ceeeeeccCcccccCHH
Confidence            66677788999999998

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.2e-35  Score=255.92  Aligned_cols=172  Identities=28%  Similarity=0.368  Sum_probs=149.9

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--Ce
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KC  261 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  261 (368)
                      +..++|+..+.|++|+||.||+|+++ +++.||+|+++...... ...-.-.+|+.++.+++|||||.+..+....  +.
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            34567889999999999999999974 68899999998765332 2223456899999999999999999987754  57


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      +|||||||+. +|..+++...  ..+...++..++.|+++|++|||.+   .|+||||||+|+|++..|.+||+|||+|+
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhh
Confidence            9999999986 9999998755  3488899999999999999999999   99999999999999999999999999999


Q ss_pred             ecCCCCCCccccccccccccCC
Q 017621          342 LLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       342 ~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .+..+....+..+-|.+|.|||
T Consensus       226 ~ygsp~k~~T~lVVTLWYRaPE  247 (419)
T KOG0663|consen  226 EYGSPLKPYTPLVVTLWYRAPE  247 (419)
T ss_pred             hhcCCcccCcceEEEeeecCHH
Confidence            9988877777788899999997

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=257.69  Aligned_cols=172  Identities=31%  Similarity=0.511  Sum_probs=153.5

Q ss_pred             hhccccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||.|..++||+|+ .+.+..||||++.-.....  ..+.+++|+..|+.++||||++++..|..+..+|+|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            4689999999999999999998 4678999999998776654  368999999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |.||.+|++.++++..-. .++++..+..|.+++++||.|||++   |.||||||+.||||+.+|.+||+|||.+..+..
T Consensus       103 mpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             ehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999999987543 3499999999999999999999999   999999999999999999999999998877655


Q ss_pred             CCCC---c-cccccccccccCCC
Q 017621          346 DSSN---R-TLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~---~-~~~~gt~~y~aPE~  364 (368)
                      .+..   + ..++||+.|||||+
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEv  201 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEV  201 (516)
T ss_pred             cCceeeEeeccccCcccccChHH
Confidence            4432   1 45689999999997

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=259.81  Aligned_cols=165  Identities=33%  Similarity=0.566  Sum_probs=141.1

Q ss_pred             ccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhc--cCCCceeeEEEEEeeCC----eE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ--IWHRNIVKLYGFCLHRK----CM  262 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~  262 (368)
                      ...+.+.+|+|.||.||+|.+ +++.||||++....      .+.|+.|-++.+.  ++|+||++++++-....    .+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             chhhHHHhhcCccceeehhhc-cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            345567799999999999998 45999999997543      3577888887765  48999999999877655    79


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH------CTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                      +||+||.+.|+|.++|..+-    .+|.+..+++..+++||+|||+.      .+|+|+|||||..|||+.+|+++.|+|
T Consensus       284 wLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            99999999999999998764    89999999999999999999974      357899999999999999999999999


Q ss_pred             eccceecCCCCCC--ccccccccccccCCC
Q 017621          337 FGVARLLNFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       337 Fg~a~~~~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      ||+|..+......  ....+||..|||||+
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEv  389 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEV  389 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHH
Confidence            9999988754332  233589999999995

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-34  Score=265.12  Aligned_cols=174  Identities=24%  Similarity=0.422  Sum_probs=149.4

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchh-h-HHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCC
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE-E-LASLESFRNEARLLSQIW-HRNIVKLYGFCLHRK  260 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  260 (368)
                      .....|.+.+.||+|+||+|+.|.. .++..||+|++.+.... . ....+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999975 46899999977664221 1 123356668999999998 999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CCeEEeeecc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGV  339 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFg~  339 (368)
                      .+|+||||+.+|+|.+++.....   +.+.++..++.|++.|++|+|++   +|+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999987333   88899999999999999999999   99999999999999999 9999999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +.............|||+.|+|||+
T Consensus       168 s~~~~~~~~~l~t~cGsp~Y~aPEv  192 (370)
T KOG0583|consen  168 SAISPGEDGLLKTFCGSPAYAAPEV  192 (370)
T ss_pred             ccccCCCCCcccCCCCCcccCCHHH
Confidence            9988433344556799999999983

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=267.57  Aligned_cols=171  Identities=29%  Similarity=0.491  Sum_probs=155.3

Q ss_pred             hhccccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ...|.....||+|+.|.||.|+ ..+++.||||++.......   .+-+.+|+.+|+..+|+|||.+++.|...+.+|+|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            4567778889999999999997 4578899999997765442   35678999999999999999999999988999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||||++|+|.+.+....    +++.++..|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||+|..+..
T Consensus       349 MEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            99999999999987644    89999999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCCccccccccccccCC----------CCcC
Q 017621          346 DSSNRTLLAGTSGYIAPA----------SEWW  367 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE----------~d~w  367 (368)
                      ....+...+|||+|||||          +|+|
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIW  453 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIW  453 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcccCccccch
Confidence            888888899999999997          7888

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-35  Score=243.46  Aligned_cols=171  Identities=36%  Similarity=0.541  Sum_probs=154.2

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|.||.||.|+. +++-.||+|++.++.........++.+|+++-+.++||||+++|++|-+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46799999999999999999984 56889999999888777666677899999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      +||...|++...++.... ..+++.....++.|+|.||.|+|..   +|+||||||+|+|++.++..||+|||-+.... 
T Consensus       101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999985443 2378888999999999999999999   99999999999999999999999999987654 


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                       ...+...|||..|.|||
T Consensus       176 -~~kR~tlcgt~dyl~pE  192 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPE  192 (281)
T ss_pred             -CCCceeeecccccCCHh
Confidence             45567789999999998

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-34  Score=257.86  Aligned_cols=173  Identities=29%  Similarity=0.441  Sum_probs=143.5

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHH-----------hHHHHHHHHHHHhccCCCceeeEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELA-----------SLESFRNEARLLSQIWHRNIVKLY  253 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~  253 (368)
                      ..++|++.+.||+|.||+|-+|+. .+++.||||++.+.......           ..+...+|+.+|+++.|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            457899999999999999999986 46899999999765433211           245788999999999999999999


Q ss_pred             EEEeeC--CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC
Q 017621          254 GFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE  331 (368)
Q Consensus       254 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  331 (368)
                      ++..+.  +.+|||+|||..|.+...-   .....+++.++.++++++..||+|||.+   +||||||||+|+|++++|+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence            998875  5799999999988765322   2222289999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccceecCCCC-----CCccccccccccccCCC
Q 017621          332 AFVADFGVARLLNFDS-----SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       332 ~kl~DFg~a~~~~~~~-----~~~~~~~gt~~y~aPE~  364 (368)
                      +||+|||.+.......     ......+|||.|||||.
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~  286 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL  286 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence            9999999998773321     12233689999999994

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.4e-34  Score=251.04  Aligned_cols=173  Identities=31%  Similarity=0.428  Sum_probs=148.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCc-eeeEEEEEeeCC----
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN-IVKLYGFCLHRK----  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----  260 (368)
                      ...|...+.||+|+||+||+|+. .+|+.||+|+++.....+ .......+|+.+++.++|+| |+.+++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            44577778899999999999985 578999999997654421 22345678999999999999 999999998877    


Q ss_pred             --eEEEEEeecCCCChhHHhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          261 --CMFLIYEYMEMGSLFCVLRTDEEA-VGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       261 --~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                        .+++|+||++. +|..++...... ..++...+..++.||+.||+|||++   +|+||||||.|||++++|.+||+||
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence              79999999975 999999875532 3477788999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccCCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+|+.+..+....+..++|.+|.|||+
T Consensus       165 GlAra~~ip~~~yt~evvTlWYRaPEv  191 (323)
T KOG0594|consen  165 GLARAFSIPMRTYTPEVVTLWYRAPEV  191 (323)
T ss_pred             chHHHhcCCcccccccEEEeeccCHHH
Confidence            999988766666677789999999983

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-33  Score=251.18  Aligned_cols=169  Identities=31%  Similarity=0.480  Sum_probs=145.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC--eEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK--CMFL  264 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  264 (368)
                      .++...+.||+|+||.||++... +|...|||.+.......   .+.+.+|+.+|++++|||||+++|......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            45777889999999999999864 48999999987653322   567899999999999999999999855444  6899


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCCeEEeeeccceec
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-ELEAFVADFGVARLL  343 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFg~a~~~  343 (368)
                      .|||+++|+|.+++...+.  .+++..+..+..||++||+|||++   +||||||||+|||++. ++.+||+|||+++..
T Consensus        94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            9999999999999997654  499999999999999999999999   9999999999999999 799999999999887


Q ss_pred             CC---CCCCccccccccccccCCC
Q 017621          344 NF---DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~---~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..   .........||+.|||||+
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEv  192 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEV  192 (313)
T ss_pred             ccccccccccccccCCccccCchh
Confidence            63   1122334689999999985

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-33  Score=250.94  Aligned_cols=151  Identities=23%  Similarity=0.334  Sum_probs=138.5

Q ss_pred             hhccccceeeeecCCccEEEEEcCC-CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|.-|+||++++.+ +..+|+|++.+..........+.+.|.+||+.++||.++.+|+.++.++..|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3467788999999999999999754 589999999988877777778888999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      ||||+||+|..+++++... .+++..+..++.+|+-||+|||-.   |||+|||||+||||.++|++.|+||.++.
T Consensus       156 meyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             EecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence            9999999999999876544 489999999999999999999999   99999999999999999999999999874

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.4e-33  Score=262.09  Aligned_cols=151  Identities=26%  Similarity=0.407  Sum_probs=134.8

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.............+.+|+.++.+++||||+++++.+.+.+..|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999754 68899999997654433344567888999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            9999999999997643   389999999999999999999999   99999999999999999999999999997653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.3e-33  Score=260.49  Aligned_cols=172  Identities=25%  Similarity=0.360  Sum_probs=147.8

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ...++|++.+.||+|+||.||+|+.. +++.+|+|.+.+.........+.+.+|+.+++.++||||+++++++.+++..|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999864 58899999986543333333456788999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +||||+++|+|.+++...    .+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++..
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            999999999999998653    278888999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCC-CccccccccccccCC
Q 017621          344 NFDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~-~~~~~~gt~~y~aPE  363 (368)
                      ..... .....+||+.|+|||
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE  213 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPE  213 (370)
T ss_pred             ccCCceecccCCCCcccCCHH
Confidence            54322 223457999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=258.11  Aligned_cols=169  Identities=28%  Similarity=0.535  Sum_probs=144.1

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .+.+++.+.||+|.||.||.|.+.....||+|.++.....    .+.|.+|+.+|++|+|+|||+++++|..++.+||||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            3456677889999999999999977779999999876443    368889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||+.|+|.++|+... ...+...+.+.++.|||+||+||+++   ++|||||.++|||++++..+||+|||+|+...++
T Consensus       281 E~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            9999999999999733 33488899999999999999999999   9999999999999999999999999999955433


Q ss_pred             CCCcc-ccccccccccCC
Q 017621          347 SSNRT-LLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~-~~~gt~~y~aPE  363 (368)
                      ..... ..--...|.|||
T Consensus       357 ~Y~~~~~~kfPIkWtAPE  374 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPE  374 (468)
T ss_pred             ceeecCCCCCCceecCHH
Confidence            32111 111245699999

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-32  Score=247.61  Aligned_cols=168  Identities=27%  Similarity=0.454  Sum_probs=144.1

Q ss_pred             HhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc--CCCceeeEEEEEeeCC---
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI--WHRNIVKLYGFCLHRK---  260 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~---  260 (368)
                      ..++..+.+.||+|.||+||+|++ .|+.||||++...+.      +.+.+|.++.+.+  +|+||+.+++.-..++   
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc-cCCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            457788999999999999999998 688999999976553      4677888888765  9999999998765443   


Q ss_pred             -eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeeecCCCCCCeeecCCCCeEE
Q 017621          261 -CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-----HCTPPIVHRDISSNNVLLNSELEAFV  334 (368)
Q Consensus       261 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl  334 (368)
                       ++|||++|.+.|||+|+|.+..    ++....++++..+|.||+|||.     +..|.|.|||||+.|||+.+++.+.|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence             5899999999999999998743    8899999999999999999995     35689999999999999999999999


Q ss_pred             eeeccceecCCCCC----CccccccccccccCCC
Q 017621          335 ADFGVARLLNFDSS----NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       335 ~DFg~a~~~~~~~~----~~~~~~gt~~y~aPE~  364 (368)
                      +|+|+|.....+..    .....+||..|||||+
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEv  391 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEV  391 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHH
Confidence            99999987765432    2345689999999995

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=259.45  Aligned_cols=151  Identities=27%  Similarity=0.432  Sum_probs=134.9

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|+.. +++.||||++.............+.+|++++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999864 68999999997654333344567889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            9999999999987643   389999999999999999999999   99999999999999999999999999997653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2e-32  Score=253.49  Aligned_cols=164  Identities=24%  Similarity=0.349  Sum_probs=142.1

Q ss_pred             eeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCC
Q 017621          194 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMG  272 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  272 (368)
                      +.||+|+||.||+|+. .+++.||+|++.............+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999985 468999999987654333334567788999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccc
Q 017621          273 SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL  352 (368)
Q Consensus       273 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~  352 (368)
                      +|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            9999887543   388999999999999999999999   9999999999999999999999999999865433333445


Q ss_pred             cccccccccCC
Q 017621          353 LAGTSGYIAPA  363 (368)
Q Consensus       353 ~~gt~~y~aPE  363 (368)
                      .+||+.|+|||
T Consensus       155 ~~gt~~y~aPE  165 (323)
T cd05571         155 FCGTPEYLAPE  165 (323)
T ss_pred             eecCccccChh
Confidence            67999999999

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=259.13  Aligned_cols=149  Identities=26%  Similarity=0.390  Sum_probs=133.2

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|+. .+++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4789999999999999999975 478999999987654333344567889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999987543   378889999999999999999999   999999999999999999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-32  Score=254.58  Aligned_cols=168  Identities=27%  Similarity=0.425  Sum_probs=147.6

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+.. +++.||+|.+...........+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            357999999999999999999864 6889999998765443334456788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999987643   378888999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      ..   ...+||+.|+|||
T Consensus       171 ~~---~~~~gt~~y~aPE  185 (329)
T PTZ00263        171 RT---FTLCGTPEYLAPE  185 (329)
T ss_pred             Cc---ceecCChhhcCHH
Confidence            22   2357999999998

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.3e-32  Score=258.78  Aligned_cols=149  Identities=20%  Similarity=0.333  Sum_probs=133.2

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      .|++++.||+|+||+||+|+. .+++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999975 4688999999976544444455678999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      |+++|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            999999999987643   378888999999999999999999   9999999999999999999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-32  Score=258.46  Aligned_cols=149  Identities=20%  Similarity=0.333  Sum_probs=132.5

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++.............+.+|++++.+++||||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3789999999999999999985 468899999987644333334567889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|..
T Consensus        81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            9999999999997643   378888889999999999999999   999999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-32  Score=254.85  Aligned_cols=169  Identities=28%  Similarity=0.434  Sum_probs=146.1

Q ss_pred             hhccccceeeeecCCccEEEEEcCC--CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS--GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      .++|++.+.||+|+||.||+|....  +..||+|.+...........+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3579999999999999999997533  46899999865443333345678899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999997654   388999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..   ....+||+.|||||+
T Consensus       183 ~~---~~~~~gt~~y~aPE~  199 (340)
T PTZ00426        183 TR---TYTLCGTPEYIAPEI  199 (340)
T ss_pred             CC---cceecCChhhcCHHH
Confidence            32   234579999999983

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.4e-32  Score=257.84  Aligned_cols=148  Identities=20%  Similarity=0.328  Sum_probs=132.4

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      .|++.+.||+|+||+||+|+. .+++.||+|++...........+.+.+|++++++++||||+++++.+.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999985 4688999999976544334455678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999987643   378888899999999999999999   999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.4e-32  Score=250.97  Aligned_cols=167  Identities=31%  Similarity=0.457  Sum_probs=146.1

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47889999999999999999864 68899999987544333334567889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999997643   388899999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                         ....+||+.|+|||
T Consensus       155 ---~~~~~gt~~y~aPE  168 (291)
T cd05612         155 ---TWTLCGTPEYLAPE  168 (291)
T ss_pred             ---cccccCChhhcCHH
Confidence               22357999999999

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.98  E-value=5.1e-32  Score=255.32  Aligned_cols=176  Identities=24%  Similarity=0.363  Sum_probs=150.2

Q ss_pred             HHHHHHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC
Q 017621          181 QDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR  259 (368)
Q Consensus       181 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  259 (368)
                      .++....++|++.+.||+|+||.||+|+.. +++.+|+|++...........+.+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344445689999999999999999999864 6889999998654433333445678899999999999999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      +..|+||||+++|+|.+++...    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            9999999999999999998753    278888899999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCC-CccccccccccccCC
Q 017621          340 ARLLNFDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~-~~~~~~gt~~y~aPE  363 (368)
                      ++....... .....+||+.|||||
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE  213 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPE  213 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHH
Confidence            987754332 223457999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.98  E-value=6.8e-32  Score=250.46  Aligned_cols=164  Identities=26%  Similarity=0.366  Sum_probs=141.7

Q ss_pred             eeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCC
Q 017621          194 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMG  272 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  272 (368)
                      +.||+|+||.||+++. .+++.||+|++.............+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3599999999999985 468999999997654333334567888999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccc
Q 017621          273 SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL  352 (368)
Q Consensus       273 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~  352 (368)
                      +|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            9998887543   388999999999999999999999   9999999999999999999999999999865433333344


Q ss_pred             cccccccccCC
Q 017621          353 LAGTSGYIAPA  363 (368)
Q Consensus       353 ~~gt~~y~aPE  363 (368)
                      .+||+.|+|||
T Consensus       155 ~~gt~~y~aPE  165 (328)
T cd05593         155 FCGTPEYLAPE  165 (328)
T ss_pred             ccCCcCccChh
Confidence            67999999999

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.5e-32  Score=251.69  Aligned_cols=168  Identities=26%  Similarity=0.409  Sum_probs=147.3

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++..++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999865 58899999997654433344567889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+++....   .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999997543   378999999999999999999999   999999999999999999999999999987643 


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                        ......||+.|+|||+
T Consensus       154 --~~~~~~gt~~y~aPE~  169 (333)
T cd05600         154 --YANSVVGSPDYMAPEV  169 (333)
T ss_pred             --ccCCcccCccccChhH
Confidence              2234579999999993

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.3e-33  Score=243.49  Aligned_cols=175  Identities=26%  Similarity=0.417  Sum_probs=156.2

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|...++||+|.||+|..++- .+++.+|+|++++...-....+..-..|-++|+..+||.+..+.-.|+..+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46788899999999999999984 47999999999887655444455667799999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||..||.|.-++.+.+   .+++..+..+..+|..||.|||++   +||.||||.+|.|+|.+|++||+|||+|+.--.
T Consensus       247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999998887643   388888899999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCccccccccccccCC----------CCcC
Q 017621          346 DSSNRTLLAGTSGYIAPA----------SEWW  367 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE----------~d~w  367 (368)
                      .+.....+||||.|.|||          ||||
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWW  352 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWW  352 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehh
Confidence            666777889999999998          8999

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.98  E-value=5.3e-32  Score=254.45  Aligned_cols=150  Identities=24%  Similarity=0.413  Sum_probs=133.8

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.............+.+|+.++..++||||+++++.+.+.+..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999864 68899999997544333344567888999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            9999999999987643   388999999999999999999999   9999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.98  E-value=6.3e-32  Score=250.20  Aligned_cols=165  Identities=24%  Similarity=0.351  Sum_probs=141.7

Q ss_pred             eeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCC
Q 017621          194 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMG  272 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  272 (368)
                      +.||+|+||.||+++. .+++.||+|++.............+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999985 468999999987654333334567788999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccc
Q 017621          273 SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL  352 (368)
Q Consensus       273 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~  352 (368)
                      +|..++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            9998887543   388999999999999999999999   9999999999999999999999999998865433333344


Q ss_pred             cccccccccCCC
Q 017621          353 LAGTSGYIAPAS  364 (368)
Q Consensus       353 ~~gt~~y~aPE~  364 (368)
                      ..||+.|+|||+
T Consensus       155 ~~gt~~y~aPE~  166 (323)
T cd05595         155 FCGTPEYLAPEV  166 (323)
T ss_pred             ccCCcCcCCccc
Confidence            679999999994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=6.2e-32  Score=249.05  Aligned_cols=162  Identities=25%  Similarity=0.409  Sum_probs=140.7

Q ss_pred             eeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCCh
Q 017621          196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSL  274 (368)
Q Consensus       196 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  274 (368)
                      ||+|+||+||+|+.. +++.||+|.+.............+.+|++++++++||||+++++++...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999864 5889999998754433334456788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccccc
Q 017621          275 FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA  354 (368)
Q Consensus       275 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~  354 (368)
                      .+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++............+
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            99997643   388999999999999999999999   999999999999999999999999999986544333344567


Q ss_pred             cccccccCC
Q 017621          355 GTSGYIAPA  363 (368)
Q Consensus       355 gt~~y~aPE  363 (368)
                      ||+.|+|||
T Consensus       155 gt~~y~aPE  163 (312)
T cd05585         155 GTPEYLAPE  163 (312)
T ss_pred             CCcccCCHH
Confidence            999999998

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.98  E-value=6.4e-32  Score=254.61  Aligned_cols=171  Identities=26%  Similarity=0.364  Sum_probs=146.9

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||+||+|+.. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3568999999999999999999864 688999999875433333344567889999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++|+|.+++...    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999998653    278888889999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC-CccccccccccccCC
Q 017621          345 FDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~-~~~~~~gt~~y~aPE  363 (368)
                      .... .....+||+.|+|||
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE  213 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPE  213 (370)
T ss_pred             CCCcccCCCCCCCcCeECHH
Confidence            4322 223457999999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9e-32  Score=250.01  Aligned_cols=171  Identities=30%  Similarity=0.413  Sum_probs=147.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+++.. +++.||+|++.+.........+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999854 68899999997644433344567889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999975332  388899999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC-ccccccccccccCC
Q 017621          347 SSN-RTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~-~~~~~gt~~y~aPE  363 (368)
                      ... .....||+.|+|||
T Consensus       156 ~~~~~~~~~gt~~y~aPE  173 (331)
T cd05597         156 GTVQSNVAVGTPDYISPE  173 (331)
T ss_pred             CCccccceeccccccCHH
Confidence            322 22346999999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.98  E-value=1.7e-31  Score=242.93  Aligned_cols=170  Identities=25%  Similarity=0.361  Sum_probs=144.8

Q ss_pred             cccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |+..+.||+|+||+||+|.. .+++.||+|.+.............+.+|++++++++|+||+++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67789999999999999985 57899999998765443333345678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +++|+|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++....... 
T Consensus        82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999988876432 22488999999999999999999999   99999999999999999999999999998764332 


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                      ......||+.|+|||+
T Consensus       157 ~~~~~~g~~~y~aPE~  172 (285)
T cd05631         157 TVRGRVGTVGYMAPEV  172 (285)
T ss_pred             eecCCCCCCCccCHhh
Confidence            2234579999999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=6.7e-32  Score=251.35  Aligned_cols=171  Identities=29%  Similarity=0.465  Sum_probs=151.8

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  263 (368)
                      ....|++.+.||+|.||.||+|+.+ +|+.+|+|.+.+.........+.+.+|+.+|+++. |||||.+++++++.+.++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3457888899999999999999865 49999999998766554445578899999999997 999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC----CCeEEeeecc
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE----LEAFVADFGV  339 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFg~  339 (368)
                      +|||++.||.|.+.+...    .+++..+..++.|++.++.|||+.   +|+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999776    289999999999999999999998   99999999999999633    5799999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +..... .......+||+.|+|||+
T Consensus       186 a~~~~~-~~~~~~~~Gtp~y~APEv  209 (382)
T KOG0032|consen  186 AKFIKP-GERLHTIVGTPEYVAPEV  209 (382)
T ss_pred             ceEccC-CceEeeecCCccccCchh
Confidence            999886 455666799999999984

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3e-33  Score=275.73  Aligned_cols=181  Identities=30%  Similarity=0.444  Sum_probs=163.0

Q ss_pred             HHHHHHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC
Q 017621          181 QDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR  259 (368)
Q Consensus       181 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  259 (368)
                      .++.-..+||++.++||+|+||.|..++.+ +++.||+|++++....++.....|+.|-.+|..-+.+.|+.++-.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344455789999999999999999999864 6889999999987777666677899999999999999999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      +++|+|||||+||+|..++.+..   .+++.-+..++.+|.-||.-||+.   |+|||||||+|||+|..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999998766   288888999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCC-ccccccccccccC---------------CCCcC
Q 017621          340 ARLLNFDSSN-RTLLAGTSGYIAP---------------ASEWW  367 (368)
Q Consensus       340 a~~~~~~~~~-~~~~~gt~~y~aP---------------E~d~w  367 (368)
                      |-.+..++.- ....+|||-|++|               |||||
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwW  265 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWW  265 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchh
Confidence            9988866653 3456899999999               59999

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.98  E-value=1.6e-31  Score=247.79  Aligned_cols=164  Identities=23%  Similarity=0.343  Sum_probs=140.7

Q ss_pred             eeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCC
Q 017621          194 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMG  272 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  272 (368)
                      +.||+|+||+||+++. .+++.||+|.+.............+.+|++++..++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999985 468999999997654333334467788999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          273 SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       273 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      +|.+++....   .+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence            9998887543   38999999999999999999997 6   999999999999999999999999999986543333334


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ...||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (325)
T cd05594         155 TFCGTPEYLAPE  166 (325)
T ss_pred             cccCCcccCCHH
Confidence            457999999998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.98  E-value=1.3e-31  Score=248.95  Aligned_cols=171  Identities=29%  Similarity=0.406  Sum_probs=147.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+++.. +++.||+|.+...........+.+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999864 67889999987644333344566888999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999976332  378889999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC-ccccccccccccCC
Q 017621          347 SSN-RTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~-~~~~~gt~~y~aPE  363 (368)
                      ... .....||+.|+|||
T Consensus       156 ~~~~~~~~~gt~~y~aPE  173 (331)
T cd05624         156 GTVQSSVAVGTPDYISPE  173 (331)
T ss_pred             CceeeccccCCcccCCHH
Confidence            332 23357999999999

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.5e-32  Score=256.51  Aligned_cols=169  Identities=25%  Similarity=0.411  Sum_probs=149.9

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .-|++.+.||+|+.|.|-.|++ .+|+.+|||++.+...........+.+|+.+|+-+.|||++++++++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4578889999999999999985 589999999998764333334467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|.|++++-+.+.   +++.++.++++||+.|+.|+|..   +|+|||+||+|+|+|..+.+||+|||+|..-..+
T Consensus        92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            99999999999987654   89999999999999999999999   9999999999999999999999999999875533


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                       ......||+|.|.|||
T Consensus       166 -klLeTSCGSPHYA~PE  181 (786)
T KOG0588|consen  166 -KLLETSCGSPHYAAPE  181 (786)
T ss_pred             -ccccccCCCcccCCch
Confidence             3344569999999999

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=1.5e-31  Score=247.83  Aligned_cols=170  Identities=25%  Similarity=0.374  Sum_probs=144.1

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC-CceeeEEEEEeeCCeEEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH-RNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  266 (368)
                      +|++.+.||+|+||.||+|+.. +++.||+|++...........+.+..|.+++..++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5888999999999999999864 578999999876543333345678889999999966 56888999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999887543   278999999999999999999999   9999999999999999999999999999764433


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      .......+||+.|+|||+
T Consensus       155 ~~~~~~~~gt~~y~aPE~  172 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEI  172 (324)
T ss_pred             CCceeeecCCccccChhh
Confidence            333445679999999993

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=1.6e-31  Score=247.70  Aligned_cols=167  Identities=26%  Similarity=0.407  Sum_probs=141.0

Q ss_pred             cccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHH---hccCCCceeeEEEEEeeCCeEEEE
Q 017621          190 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLL---SQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      |++.+.||+|+||.||+|.. .+++.||||++...........+.+.+|++++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67789999999999999985 46899999999765433333345666676654   567899999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|...+...    .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999998887642    389999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      ........+||+.|+|||
T Consensus       154 ~~~~~~~~~g~~~y~aPE  171 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPE  171 (324)
T ss_pred             CCCcccccccCccccCHh
Confidence            333344567999999999

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=260.09  Aligned_cols=168  Identities=33%  Similarity=0.510  Sum_probs=146.7

Q ss_pred             cccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC------eE
Q 017621          190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK------CM  262 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  262 (368)
                      +...+.||+|+||.||+++ ..+|+.||||.++.....  ...+...+|++++++++|||||++++.-++..      ..
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3456779999999999999 467999999999875432  34578889999999999999999999876544      46


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec--CCC--CeEEeeec
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN--SEL--EAFVADFG  338 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DFg  338 (368)
                      .+|||||.+|||+..+++.++..++++.+.+.++.+++.||.|||++   +|+||||||.||++-  .+|  .-||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            89999999999999999999889999999999999999999999999   999999999999984  334  46899999


Q ss_pred             cceecCCCCCCccccccccccccCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .|+.++++. ....++||+.|.+||
T Consensus       170 ~Arel~d~s-~~~S~vGT~~YLhPe  193 (732)
T KOG4250|consen  170 AARELDDNS-LFTSLVGTEEYLHPE  193 (732)
T ss_pred             ccccCCCCC-eeeeecCchhhcChH
Confidence            999998655 566789999999996

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=2e-31  Score=246.80  Aligned_cols=169  Identities=25%  Similarity=0.388  Sum_probs=144.1

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      +|++.+.||+|+||+||+|+.. +++.||+|.+...........+.+..|.+++..+ +|++|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5888999999999999999864 5789999998765433333445667788888877 6899999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+.+.....   +++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999988875432   88999999999999999999999   9999999999999999999999999999865443


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      .......+||+.|+|||
T Consensus       155 ~~~~~~~~gt~~y~aPE  171 (323)
T cd05616         155 GVTTKTFCGTPDYIAPE  171 (323)
T ss_pred             CCccccCCCChhhcCHH
Confidence            33444567999999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=3.4e-31  Score=246.26  Aligned_cols=171  Identities=30%  Similarity=0.404  Sum_probs=146.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+++.. +++.+|+|.+.+...........+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999864 57889999987544333334456888999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999976332  378889999999999999999999   9999999999999999999999999999765433


Q ss_pred             CC-CccccccccccccCC
Q 017621          347 SS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE  363 (368)
                      .. .....+||+.|+|||
T Consensus       156 ~~~~~~~~~gt~~y~aPE  173 (332)
T cd05623         156 GTVQSSVAVGTPDYISPE  173 (332)
T ss_pred             CcceecccccCccccCHH
Confidence            32 223357999999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=2.5e-31  Score=246.87  Aligned_cols=164  Identities=23%  Similarity=0.373  Sum_probs=141.2

Q ss_pred             eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||.||+|+.. +++.||+|+++..........+.+.+|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999854 6889999999765444334456788899999998 799999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            99998886543   389999999999999999999999   999999999999999999999999999975433333334


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ..+||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (329)
T cd05588         155 TFCGTPNYIAPE  166 (329)
T ss_pred             cccCCccccCHH
Confidence            567999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=2.7e-31  Score=246.75  Aligned_cols=172  Identities=28%  Similarity=0.396  Sum_probs=148.3

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++..........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47899999999999999999854 68899999997654433334567889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999976522  388999999999999999999999   9999999999999999999999999999877543


Q ss_pred             CCC-ccccccccccccCCC
Q 017621          347 SSN-RTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~-~~~~~gt~~y~aPE~  364 (368)
                      ... .....||+.|+|||+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~  174 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEV  174 (330)
T ss_pred             CceeeecccCCccccCHHH
Confidence            322 223479999999993

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-31  Score=251.24  Aligned_cols=170  Identities=29%  Similarity=0.461  Sum_probs=148.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.............+.+|++++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999864 68999999997654433344567889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            9999999999997652   388999999999999999999998   9999999999999999999999999999876543


Q ss_pred             C-----------------------------CCccccccccccccCC
Q 017621          347 S-----------------------------SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~-----------------------------~~~~~~~gt~~y~aPE  363 (368)
                      .                             .......||+.|+|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  200 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE  200 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            3                             1223457999999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.9e-32  Score=250.91  Aligned_cols=171  Identities=26%  Similarity=0.437  Sum_probs=152.4

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe-EEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC-MFLI  265 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv  265 (368)
                      ++|...+.+|+|+||.++.++++ +++.+++|.+......... .+...+|+.++++++|||||.+.+.|+.++. .+||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            57888999999999999999864 5778999999876554433 3467889999999999999999999998887 9999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |+||+||++.+.+.+.. ...++++.+..++.|++.|+.|||++   .|+|||||+.|||++.++.+||+|||+|+.+..
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999998765 34589999999999999999999988   999999999999999999999999999999987


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      +.......+||+.||+||
T Consensus       159 ~~~~a~tvvGTp~YmcPE  176 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPE  176 (426)
T ss_pred             chhhhheecCCCcccCHH
Confidence            775666789999999997

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=2.7e-32  Score=231.78  Aligned_cols=173  Identities=29%  Similarity=0.443  Sum_probs=148.3

Q ss_pred             HHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchh-----hHHhHHHHHHHHHHHhcc-CCCceeeEEEEE
Q 017621          184 IEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE-----ELASLESFRNEARLLSQI-WHRNIVKLYGFC  256 (368)
Q Consensus       184 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  256 (368)
                      ....+.|.-.+.||+|..+.|.++.. ++|+.+|+|++......     ...-.++-.+|+.+++++ .||+|+++.++|
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            34556788889999999999998864 57889999988542211     222345667899999999 899999999999


Q ss_pred             eeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          257 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       257 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                      +.+..+++|+|.|+.|.|.+++...   ..+++.+..+|++|+.+|++|||.+   .||||||||+|||+|++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence            9999999999999999999999764   3489999999999999999999999   999999999999999999999999


Q ss_pred             eccceecCCCCCCccccccccccccCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ||++..+... ......||||+|.|||
T Consensus       167 FGFa~~l~~G-ekLrelCGTPgYLAPE  192 (411)
T KOG0599|consen  167 FGFACQLEPG-EKLRELCGTPGYLAPE  192 (411)
T ss_pred             cceeeccCCc-hhHHHhcCCCcccChh
Confidence            9999988744 4445679999999995

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=2.9e-31  Score=245.74  Aligned_cols=169  Identities=25%  Similarity=0.379  Sum_probs=143.4

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeEEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  266 (368)
                      +|+..+.||+|+||+||+|+. .+++.||+|++...........+.+..|.+++..+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477789999999999999985 468899999987644333334466778999988885 578888999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+++.....   +++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999998876433   89999999999999999999999   9999999999999999999999999999865433


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      ........||+.|+|||
T Consensus       155 ~~~~~~~~gt~~y~aPE  171 (323)
T cd05615         155 GVTTRTFCGTPDYIAPE  171 (323)
T ss_pred             CccccCccCCccccCHH
Confidence            33334457999999998

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=3.9e-31  Score=244.92  Aligned_cols=164  Identities=27%  Similarity=0.431  Sum_probs=139.6

Q ss_pred             eeeeecCCccEEEEEc----CCCCEEEEEEccccchh-hHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          194 YCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      +.||+|+||.||+++.    .+++.||+|.+...... .......+.+|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999974    35789999998754321 122335677899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +++++|.+++....   .+.+..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999987643   278888889999999999999999   999999999999999999999999999986544433


Q ss_pred             CccccccccccccCC
Q 017621          349 NRTLLAGTSGYIAPA  363 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE  363 (368)
                      .....+||+.|+|||
T Consensus       156 ~~~~~~gt~~y~aPE  170 (323)
T cd05584         156 VTHTFCGTIEYMAPE  170 (323)
T ss_pred             cccccCCCccccChh
Confidence            344467999999999

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=2.9e-31  Score=245.48  Aligned_cols=164  Identities=30%  Similarity=0.470  Sum_probs=140.2

Q ss_pred             eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||+||+|+.. +++.||+|++...........+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999864 5889999998764433333456677888888876 799999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            99999887643   388999999999999999999999   999999999999999999999999999986543333344


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ...||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (320)
T cd05590         155 TFCGTPDYIAPE  166 (320)
T ss_pred             ccccCccccCHH
Confidence            567999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=4.5e-31  Score=245.05  Aligned_cols=164  Identities=26%  Similarity=0.400  Sum_probs=140.3

Q ss_pred             eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||+||+|+.. +++.||+|++.+.........+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999854 6789999999765433333456678899888877 899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|..++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            99998886543   389999999999999999999999   999999999999999999999999999986543333344


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ...||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (329)
T cd05618         155 TFCGTPNYIAPE  166 (329)
T ss_pred             cccCCccccCHH
Confidence            567999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=4.6e-31  Score=243.67  Aligned_cols=164  Identities=26%  Similarity=0.421  Sum_probs=138.0

Q ss_pred             eeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||+||+|+. .+++.||+|.++..........+.+..|.+++... +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999985 45789999998764433223345566677777654 899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            99999887543   388999999999999999999999   999999999999999999999999999987544334444


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ..+||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (316)
T cd05592         155 TFCGTPDYIAPE  166 (316)
T ss_pred             cccCCccccCHH
Confidence            567999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-33  Score=234.47  Aligned_cols=170  Identities=28%  Similarity=0.444  Sum_probs=146.1

Q ss_pred             HhhccccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..+.|++.+.||+|.|+.||++. .++|+.+|+|+++....... ..+++.+|+++...++||||+++.+.+.+.+..||
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            34578888999999999999996 46799999998876554432 56889999999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCCeEEeeeccce
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS---ELEAFVADFGVAR  341 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFg~a~  341 (368)
                      |+|+|.|++|..-+-.+   .-.++..+-.++.||++||.|+|.+   +|||||+||+|+++..   .-.+||+|||+|.
T Consensus        88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999996544332   2267888889999999999999999   9999999999999953   3468999999999


Q ss_pred             ecCCCCCCccccccccccccCC
Q 017621          342 LLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       342 ~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .+. ++..+...+|||+|||||
T Consensus       162 ~l~-~g~~~~G~~GtP~fmaPE  182 (355)
T KOG0033|consen  162 EVN-DGEAWHGFAGTPGYLSPE  182 (355)
T ss_pred             EeC-CccccccccCCCcccCHH
Confidence            998 666677789999999998

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=5.2e-32  Score=239.28  Aligned_cols=163  Identities=29%  Similarity=0.439  Sum_probs=134.0

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-----eE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-----CM  262 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  262 (368)
                      .|...+++|+|+||.||+|.. .+++.||||++-.....       --+|+.+|+.++|||||++.-+|....     +.
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            466679999999999999985 45789999998665432       135999999999999999988876432     35


Q ss_pred             EEEEeecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CCeEEeeeccc
Q 017621          263 FLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGVA  340 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFg~a  340 (368)
                      .+||||++. +|.+.++.. .....++...+.-+..||.+||.|||+.   +|+||||||.|+|+|.+ |.+||||||.|
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            689999985 898888742 1123377778888999999999999998   99999999999999966 99999999999


Q ss_pred             eecCCCCCCccccccccccccCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +.+..+.... ...-|..|.|||
T Consensus       174 K~L~~~epni-SYicSRyYRaPE  195 (364)
T KOG0658|consen  174 KVLVKGEPNI-SYICSRYYRAPE  195 (364)
T ss_pred             eeeccCCCce-eEEEeccccCHH
Confidence            9987666553 345689999998

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=6e-31  Score=243.68  Aligned_cols=164  Identities=27%  Similarity=0.416  Sum_probs=137.1

Q ss_pred             eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHH-HHhccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEAR-LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||+||+|+.. +++.||+|++............++..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999864 68999999987644332233345555555 56788999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|.+++....   .+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            99999887643   388899999999999999999999   999999999999999999999999999976543333344


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ..+||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (323)
T cd05575         155 TFCGTPEYLAPE  166 (323)
T ss_pred             cccCChhhcChh
Confidence            567999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=3.9e-31  Score=246.44  Aligned_cols=172  Identities=26%  Similarity=0.420  Sum_probs=140.3

Q ss_pred             hhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  259 (368)
                      .++|++.+.||+|+||.||+|..      .+++.||+|++......  ...+.+.+|++++..+ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--SEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--HHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            46799999999999999999963      23568999998754322  2346788999999999 899999999988764


Q ss_pred             -CeEEEEEeecCCCChhHHhhcCCC-------------------------------------------------------
Q 017621          260 -KCMFLIYEYMEMGSLFCVLRTDEE-------------------------------------------------------  283 (368)
Q Consensus       260 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  283 (368)
                       +..++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             458999999999999998875321                                                       


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC--Ccccccccc
Q 017621          284 ----AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTS  357 (368)
Q Consensus       284 ----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~  357 (368)
                          ...+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++.......  ......+++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                12377888899999999999999999   999999999999999999999999999987643322  122234678


Q ss_pred             ccccCC
Q 017621          358 GYIAPA  363 (368)
Q Consensus       358 ~y~aPE  363 (368)
                      .|+|||
T Consensus       241 ~y~aPE  246 (338)
T cd05102         241 KWMAPE  246 (338)
T ss_pred             cccCcH
Confidence            899999

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=4.6e-31  Score=244.23  Aligned_cols=164  Identities=26%  Similarity=0.426  Sum_probs=140.0

Q ss_pred             eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||+||+|+.. +++.||+|++...........+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            35899999999999864 5789999998764433333446677899988866 899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|...+....   .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence            99998887543   388999999999999999999999   999999999999999999999999999986544444444


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ...||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (321)
T cd05591         155 TFCGTPDYIAPE  166 (321)
T ss_pred             ccccCccccCHH
Confidence            567999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=6.6e-31  Score=241.28  Aligned_cols=173  Identities=25%  Similarity=0.400  Sum_probs=142.4

Q ss_pred             hhccccceeeeecCCccEEEEEcCC-----------------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCce
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS-----------------GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI  249 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  249 (368)
                      .++|++.+.||+|+||.||+|.+.+                 +..||+|.+......  ....++.+|++++.+++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK--NARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH--HHHHHHHHHHHHHhhcCCCCe
Confidence            3578899999999999999997432                 346999998764332  234678999999999999999


Q ss_pred             eeEEEEEeeCCeEEEEEeecCCCChhHHhhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 017621          250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----------------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPP  313 (368)
Q Consensus       250 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  313 (368)
                      +++++++.+.+..++||||+++|+|.+++....                ....+++..+..++.||+.||.|||+.   +
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~  158 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N  158 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence            999999999999999999999999999886432                112367888999999999999999999   9


Q ss_pred             eeecCCCCCCeeecCCCCeEEeeeccceecCCCCC--CccccccccccccCCC
Q 017621          314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       314 ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      |+||||||+|||+++++.+||+|||+++.......  ......++..|+|||+
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWEC  211 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHH
Confidence            99999999999999999999999999987643321  1122346788999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-32  Score=253.47  Aligned_cols=165  Identities=32%  Similarity=0.473  Sum_probs=144.2

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      -|...+.||.|+||.||.|++ .+.+.||||++............++.+|++.|.+++|||++.+.|+|..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            355567899999999999986 4678999999987665555556789999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      ||- |+-.+++.-..+  ++.+.++..|+.+.++||+|||+.   +.||||||+.|||+++.|.+||+|||.|....+. 
T Consensus       107 YCl-GSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             HHh-ccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            996 577777765432  388889999999999999999999   9999999999999999999999999999877543 


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                         ..++|||+|||||
T Consensus       180 ---nsFvGTPywMAPE  192 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPE  192 (948)
T ss_pred             ---hcccCCccccchh
Confidence               3578999999998

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=7.1e-31  Score=243.39  Aligned_cols=164  Identities=27%  Similarity=0.410  Sum_probs=137.4

Q ss_pred             eeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHH-HHhccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEAR-LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||+||+|+. .+++.||+|++.............+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3599999999999985 468999999987643333233345556655 46778999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|..++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            99998887543   388999999999999999999999   999999999999999999999999999986543333344


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ..+||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (325)
T cd05604         155 TFCGTPEYLAPE  166 (325)
T ss_pred             cccCChhhCCHH
Confidence            567999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-32  Score=242.90  Aligned_cols=176  Identities=26%  Similarity=0.408  Sum_probs=156.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .+.|+.-++||+|+||.||-++. .+|+.||+|++.+.............+|-.++.+++.++||.+--.|+..+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            35678889999999999999974 57999999999887776666666778899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      +..|.||+|.-++..... ..+++..++.++.+|+.||++||+.   +||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999988876554 4599999999999999999999999   999999999999999999999999999999875


Q ss_pred             CCCCccccccccccccCC----------CCcC
Q 017621          346 DSSNRTLLAGTSGYIAPA----------SEWW  367 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE----------~d~w  367 (368)
                      ...... .+||.+|||||          +|||
T Consensus       340 g~~~~~-rvGT~GYMAPEvl~ne~Y~~s~Dwf  370 (591)
T KOG0986|consen  340 GKPIRG-RVGTVGYMAPEVLQNEVYDFSPDWF  370 (591)
T ss_pred             CCcccc-ccCcccccCHHHHcCCcccCCccHH
Confidence            544433 48999999998          7898

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=8.6e-31  Score=243.01  Aligned_cols=164  Identities=24%  Similarity=0.377  Sum_probs=141.7

Q ss_pred             eeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||+||+|+. .+++.||+|++...........+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999985 46789999999875544444556788999999888 799999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|..++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence            99998886543   389999999999999999999999   999999999999999999999999999986443333344


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ..+||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (327)
T cd05617         155 TFCGTPNYIAPE  166 (327)
T ss_pred             cccCCcccCCHH
Confidence            567999999998

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-33  Score=239.07  Aligned_cols=165  Identities=32%  Similarity=0.499  Sum_probs=150.0

Q ss_pred             cccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |.+.+.||+|+||.||+|.+ .+|+.+|||.+....     ..+++.+|+.+|.+++.|++|++||.|.....+|+||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            66778899999999999975 479999999986543     347889999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      |..|+..+.++.+.+  .+++.++..++...++||+|||..   .-+|||||+.|||++.+|.+||+|||.|..+.+...
T Consensus       110 CGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  110 CGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             cCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            999999999987543  489999999999999999999998   889999999999999999999999999998887777


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                      .+....|||.||||||
T Consensus       185 KRNTVIGTPFWMAPEV  200 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEV  200 (502)
T ss_pred             hhCccccCcccccHHH
Confidence            7788899999999983

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=8.4e-31  Score=242.48  Aligned_cols=164  Identities=25%  Similarity=0.388  Sum_probs=136.6

Q ss_pred             eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHH-HHhccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEAR-LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||+||+|+.. +++.||+|++.............+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999864 68899999987654333233345555654 57888999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      ++|...+....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            99988886533   378888999999999999999998   999999999999999999999999999986433333344


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ..+||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (321)
T cd05603         155 TFCGTPEYLAPE  166 (321)
T ss_pred             cccCCcccCCHH
Confidence            567999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=8.5e-31  Score=243.58  Aligned_cols=169  Identities=28%  Similarity=0.415  Sum_probs=143.5

Q ss_pred             ccccceeeeecCCccEEEEEc----CCCCEEEEEEccccchh-hHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  262 (368)
                      +|++.+.||+|+||+||+++.    .+++.||+|++.+.... .....+.+.+|+.++..+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            588899999999999999874    35789999998654322 222345678899999999 599999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++|+|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999987543   388999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccCC
Q 017621          343 LNFDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~-~~~~~~gt~~y~aPE  363 (368)
                      ...... .....+||+.|+|||
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE  176 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPE  176 (332)
T ss_pred             ccccCCCccccccCCccccCHH
Confidence            543322 233457999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=247.70  Aligned_cols=174  Identities=27%  Similarity=0.451  Sum_probs=143.7

Q ss_pred             HhhccccceeeeecCCccEEEEEcCC--C--CE-EEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLPS--G--KV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      .-++..+.+.||+|+||.||+|++..  +  .. ||+|..+...........+|.+|+++|.+++|||||+++|++....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            34455566899999999999998542  2  23 8999988644334456789999999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      .+|+|||+|+||+|.++|++...  .++..+...++.+.|.||+|||++   +++||||.++|+|++.++.+||+|||++
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccc
Confidence            99999999999999999998764  489999999999999999999999   9999999999999999999999999998


Q ss_pred             eecCCCCCCccccccccccccCCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +.-..........--...|+|||.
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEt  333 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPET  333 (474)
T ss_pred             cCCcceeeccccccCcceecChhh
Confidence            765311111111112467999994

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=1.1e-30  Score=242.08  Aligned_cols=164  Identities=27%  Similarity=0.392  Sum_probs=135.5

Q ss_pred             eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHH-HHhccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEAR-LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||+||+|++. +++.||+|++.............+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999864 57889999987543322222234444444 56788999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|.+++....   .+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            99999887643   277888888999999999999999   999999999999999999999999999986543333344


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ..+||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (325)
T cd05602         155 TFCGTPEYLAPE  166 (325)
T ss_pred             cccCCccccCHH
Confidence            567999999998

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=248.90  Aligned_cols=178  Identities=29%  Similarity=0.509  Sum_probs=152.9

Q ss_pred             ccHHHHHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEe
Q 017621          178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCL  257 (368)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  257 (368)
                      .+.+++....+++.+.+.||+|.||+||+|++-  ..||||+++.....+. ..+.|++|+..+++-+|.||+-+.|+|.
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            444677777788888999999999999999973  3599999987665543 6789999999999999999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                      .... .||+.+|+|.+|+.+++..+.  .+...+.+.|+.|||+|+.|||.+   +|||||||..||++.+++++||+||
T Consensus       459 ~p~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  459 NPPL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             CCce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence            9887 999999999999999987653  388899999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCC--CCCCccccccccccccCCC
Q 017621          338 GVARLLNF--DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~--~~~~~~~~~gt~~y~aPE~  364 (368)
                      |++.....  ........-|...|||||+
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEv  561 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEV  561 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHH
Confidence            99865432  2222333458889999995

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=1.1e-30  Score=237.90  Aligned_cols=169  Identities=27%  Similarity=0.395  Sum_probs=143.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+......  .....+.+|++++++++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            57999999999999999999854 6889999998654322  12346778999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++ +|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        83 e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          83 EYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             eCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            99985 89888865432  378889999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........||+.|+|||+
T Consensus       157 ~~~~~~~~~~~~y~aPE~  174 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDV  174 (288)
T ss_pred             CccccCceecccccChHH
Confidence            333344578999999983

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=1.2e-30  Score=239.48  Aligned_cols=169  Identities=29%  Similarity=0.407  Sum_probs=143.3

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++.......  ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            468999999999999999999865 68899999987543221  224567899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||++ ++|.+++....  ..+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus        82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          82 FEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             EECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            99996 58887776543  2378889999999999999999999   999999999999999999999999999986544


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      .........||+.|+|||
T Consensus       156 ~~~~~~~~~~~~~y~aPE  173 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPD  173 (303)
T ss_pred             CCccCCCCcccCCCCChH
Confidence            333334457899999998

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=1.3e-30  Score=236.61  Aligned_cols=166  Identities=28%  Similarity=0.407  Sum_probs=141.8

Q ss_pred             eeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCCh
Q 017621          196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSL  274 (368)
Q Consensus       196 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  274 (368)
                      ||+|+||+||++.+. +++.||+|++...........+.+..|+++++.++||||+++.+++...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            689999999999854 6889999998765444434456778899999999999999999999999999999999999999


Q ss_pred             hHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcccc
Q 017621          275 FCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL  353 (368)
Q Consensus       275 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~  353 (368)
                      .+.+... .....+++..+..++.||+.||+|||++   +|+||||||+||++++++.+||+|||++.............
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            8877532 2233489999999999999999999999   99999999999999999999999999998775544434445


Q ss_pred             ccccccccCCC
Q 017621          354 AGTSGYIAPAS  364 (368)
Q Consensus       354 ~gt~~y~aPE~  364 (368)
                      .||+.|+|||+
T Consensus       158 ~g~~~y~aPE~  168 (280)
T cd05608         158 AGTPGFMAPEL  168 (280)
T ss_pred             CCCcCccCHHH
Confidence            79999999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=1.2e-30  Score=240.90  Aligned_cols=164  Identities=25%  Similarity=0.424  Sum_probs=137.9

Q ss_pred             eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||.||+|+.. +++.||+|.++..........+.+..|.+++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999864 6889999998764322222345667788888765 899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|.+++....   .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            99999887543   378899999999999999999999   999999999999999999999999999976433333344


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ..+||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (316)
T cd05620         155 TFCGTPDYIAPE  166 (316)
T ss_pred             ccCCCcCccCHH
Confidence            567999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=8.1e-31  Score=245.76  Aligned_cols=165  Identities=28%  Similarity=0.432  Sum_probs=140.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|+..+.||+|+||+||+|++. +++.||+|++......  ...+.+.+|+++++.++|+||+++++++...+..|+||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH--HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            45667788999999999999854 6899999998654322  23467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+..       ...+..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999999986432       246677888999999999999999   9999999999999999999999999999877544


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........||..|+|||+
T Consensus       222 ~~~~~~~~gt~~y~aPE~  239 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPER  239 (353)
T ss_pred             cccccccccCccccCccc
Confidence            333344579999999994

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=1.3e-30  Score=240.81  Aligned_cols=163  Identities=26%  Similarity=0.383  Sum_probs=140.2

Q ss_pred             eeeeecCCccEEEEEc----CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeec
Q 017621          194 YCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  269 (368)
                      +.||+|+||.||+++.    .+++.||+|++...... ......+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5699999999999874    36789999998754322 123356778999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCC
Q 017621          270 EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN  349 (368)
Q Consensus       270 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~  349 (368)
                      ++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+||++++++.+||+|||+++........
T Consensus        81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence            9999999987543   389999999999999999999999   9999999999999999999999999999876544333


Q ss_pred             ccccccccccccCC
Q 017621          350 RTLLAGTSGYIAPA  363 (368)
Q Consensus       350 ~~~~~gt~~y~aPE  363 (368)
                      .....||+.|+|||
T Consensus       155 ~~~~~g~~~y~aPE  168 (318)
T cd05582         155 AYSFCGTVEYMAPE  168 (318)
T ss_pred             eecccCChhhcCHH
Confidence            44567999999998

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-32  Score=244.98  Aligned_cols=169  Identities=33%  Similarity=0.485  Sum_probs=150.9

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ..|+..+.||+|.||.||+|.+ .+++.||+|++......+  ..+.+++|+.++.+++++||.++|+.+..+..++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            4577778999999999999985 568999999998765543  4578899999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||.||++.+.++...-   +.+.....++++++.|+.|||++   +.+|||||+.|||+..+|.+|++|||.+..+...
T Consensus        91 ey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence            99999999999986542   47777788999999999999999   9999999999999999999999999999988877


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ...+..++|||.||||||
T Consensus       165 ~~rr~tfvGTPfwMAPEV  182 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEV  182 (467)
T ss_pred             hhccccccccccccchhh
Confidence            776678899999999983

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=252.59  Aligned_cols=183  Identities=34%  Similarity=0.535  Sum_probs=154.7

Q ss_pred             CCcccHHHHHHHhhc---------cccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHH
Q 017621          175 DGRITFQDMIEATED---------FHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLL  241 (368)
Q Consensus       175 ~~~~~~~~~~~~~~~---------~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l  241 (368)
                      ...++|+|--++..+         .++.++||.|.||.||+|+++    ....||||.++.....+  ...+|+.|+.||
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek--qrrdFL~EAsIM  684 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK--QRRDFLSEASIM  684 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH--HHhhhhhhhhhc
Confidence            345666665554433         356789999999999999864    24579999998765543  457899999999


Q ss_pred             hccCCCceeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 017621          242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISS  321 (368)
Q Consensus       242 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  321 (368)
                      .++.||||++|.|+......++||+|||++|+|..+|+.+...  +++.+...++++||.|+.||-+.   ++|||||.+
T Consensus       685 GQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAA  759 (996)
T KOG0196|consen  685 GQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAA  759 (996)
T ss_pred             ccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhh
Confidence            9999999999999999999999999999999999999987643  89999999999999999999999   999999999


Q ss_pred             CCeeecCCCCeEEeeeccceecCCCCCC-cccccc--ccccccCCC
Q 017621          322 NNVLLNSELEAFVADFGVARLLNFDSSN-RTLLAG--TSGYIAPAS  364 (368)
Q Consensus       322 ~NIll~~~~~~kl~DFg~a~~~~~~~~~-~~~~~g--t~~y~aPE~  364 (368)
                      +|||++.+..+|++|||+++.+.++... .+...|  ...|.|||.
T Consensus       760 RNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEA  805 (996)
T KOG0196|consen  760 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEA  805 (996)
T ss_pred             hheeeccceEEEeccccceeecccCCCccccccCCccceeecChhH
Confidence            9999999999999999999998766533 333334  357999993

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-31  Score=244.01  Aligned_cols=171  Identities=30%  Similarity=0.434  Sum_probs=146.7

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .+...+.+.||+|.||.|..|....+..||||.++......  ...+|.+|+++|.+++||||++++|+|..++.+++++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            44567789999999999999998778999999998866543  4578999999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||++|+|.+++..+.... ..-....+|+.||+.||+||.+.   ++|||||.+.|+|+|.++++||+|||+++.+-..
T Consensus       615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999998875432 44566678999999999999998   9999999999999999999999999999976443


Q ss_pred             CCC--ccccccccccccCC
Q 017621          347 SSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~--~~~~~gt~~y~aPE  363 (368)
                      ...  ....+-...|||||
T Consensus       691 ~yy~vqgr~vlpiRwmawE  709 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWE  709 (807)
T ss_pred             CceeeecceeeeeeehhHH
Confidence            322  12233467899998

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-30  Score=234.45  Aligned_cols=170  Identities=26%  Similarity=0.361  Sum_probs=144.8

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      .|++.+.||+|+||+||++.. .+++.||+|++.............+.+|+++++.++||||+++++.+.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            377889999999999999985 4688999999876544333334567789999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++|+|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999998886532 23489999999999999999999999   99999999999999999999999999998764332


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                      . .....||+.|+|||
T Consensus       157 ~-~~~~~~~~~y~aPE  171 (285)
T cd05605         157 T-IRGRVGTVGYMAPE  171 (285)
T ss_pred             c-cccccCCCCccCcH
Confidence            2 23347899999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=2.6e-30  Score=238.63  Aligned_cols=164  Identities=26%  Similarity=0.440  Sum_probs=137.5

Q ss_pred             eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||+||+|+.. +++.||+|.++..........+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999864 5789999998764322222335566788888764 999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|.+++....   .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence            99999987543   378899999999999999999999   999999999999999999999999999986543333334


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ...||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (316)
T cd05619         155 TFCGTPDYIAPE  166 (316)
T ss_pred             eecCCccccCHH
Confidence            457999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.5e-30  Score=243.45  Aligned_cols=170  Identities=26%  Similarity=0.458  Sum_probs=150.8

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ....|.+...||+|.|++|..|++ .++..||||.+.+....... .+.+.+|+++|+.++|||||+++.+.+....+|+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            456788999999999999999985 46899999999887665443 3448889999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+.+|.+++++..+..   ..+..+..++.|+..|++|+|++   .|+|||||++|||++.+..+||+|||++..+.
T Consensus       133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence            9999999999999988765   45578888999999999999999   99999999999999999999999999999987


Q ss_pred             CCCCCccccccccccccCC
Q 017621          345 FDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE  363 (368)
                      . .......||++.|.|||
T Consensus       207 ~-~~~lqt~cgsppyAaPE  224 (596)
T KOG0586|consen  207 Y-GLMLQTFCGSPPYAAPE  224 (596)
T ss_pred             c-cccccccCCCCCccChH
Confidence            4 34445679999999995

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-31  Score=232.23  Aligned_cols=171  Identities=27%  Similarity=0.430  Sum_probs=144.5

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee-----
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH-----  258 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  258 (368)
                      +....|...+.||+|+||.|+.|.+ .+|+.||||++...... ....++..+|+++++.++|+||+.+.+.+..     
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~-~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFEN-QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhc-hHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            3445666678999999999999985 47899999999754332 2345677889999999999999999998865     


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                      -+.+|+|+|+|+ .+|...++.+..   ++...+..++.|++.||.|+|+.   +|+||||||+|++++.+..+||+|||
T Consensus        98 f~DvYiV~elMe-tDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   98 FNDVYLVFELME-TDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             cceeEEehhHHh-hHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence            356999999995 599999987543   88899999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCC--CCCccccccccccccCC
Q 017621          339 VARLLNFD--SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~--~~~~~~~~gt~~y~aPE  363 (368)
                      +|+.....  ....+..+-|.+|.|||
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPE  197 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPE  197 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHH
Confidence            99988642  22345567899999998

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=8.9e-31  Score=253.47  Aligned_cols=172  Identities=28%  Similarity=0.498  Sum_probs=143.3

Q ss_pred             hhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      ..+.+..+.||+|+||+||+|+..      +...||||.++.....  +...+|++|++++..++|||||+++|+|.+++
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            455667888999999999999742      4567999999876554  24589999999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEE-----------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                      .+|||+|||..|||.++|+....           ..+++..+.+.|+.|||.||+||-++   .+|||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence            99999999999999999975321           12378899999999999999999999   99999999999999999


Q ss_pred             CCeEEeeeccceecCCCCCCcc--ccccccccccCC
Q 017621          330 LEAFVADFGVARLLNFDSSNRT--LLAGTSGYIAPA  363 (368)
Q Consensus       330 ~~~kl~DFg~a~~~~~~~~~~~--~~~gt~~y~aPE  363 (368)
                      ..+||+|||+++.+-.....+.  ...=...|||||
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppE  675 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPE  675 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHH
Confidence            9999999999987643221110  111256899997

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.5e-30  Score=239.27  Aligned_cols=162  Identities=27%  Similarity=0.399  Sum_probs=135.8

Q ss_pred             eeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc---CCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI---WHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       196 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      ||+|+||+||+|+.. +++.||+|++.............+..|..++...   +||||+++++++.+.+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999854 6899999998754433323334555677777655   699999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|.+++....   .+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            99998887543   388999999999999999999999   999999999999999999999999999976543333344


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ..+||+.|+|||
T Consensus       155 ~~~gt~~y~aPE  166 (330)
T cd05586         155 TFCGTTEYLAPE  166 (330)
T ss_pred             CccCCccccCHH
Confidence            567999999998

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=3.6e-30  Score=259.02  Aligned_cols=174  Identities=27%  Similarity=0.456  Sum_probs=145.3

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++...........+++.+|++++++++||||+++++++.+++..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999864 58899999987644333334568899999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          267 EYMEMGSLFCVLRTDEE--------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                      ||+++|+|.+++.....        ....++..++.++.||++||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998864211        12356778889999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCC------------------CCccccccccccccCCC
Q 017621          339 VARLLNFDS------------------SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       339 ~a~~~~~~~------------------~~~~~~~gt~~y~aPE~  364 (368)
                      +++......                  ......+||+.|||||+
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~  202 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER  202 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHH
Confidence            998762111                  01122469999999994

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=245.73  Aligned_cols=162  Identities=31%  Similarity=0.589  Sum_probs=142.5

Q ss_pred             cccHHHHHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEE
Q 017621          177 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFC  256 (368)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  256 (368)
                      .++|+++.+       .+-||+|+.|.||+|++ .++.||||+++.-.          ..+++-|++|+||||+.+.|+|
T Consensus       120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  120 EIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             cCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeee
Confidence            456776643       45699999999999998 56789999886422          2478889999999999999999


Q ss_pred             eeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          257 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       257 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                      ...-.+|||||||..|-|..+|+....   +.......+..+||.|+.|||.+   .|||||||.-||||..+..+||+|
T Consensus       182 tqsPcyCIiMEfCa~GqL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsD  255 (904)
T KOG4721|consen  182 TQSPCYCIIMEFCAQGQLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISD  255 (904)
T ss_pred             cCCceeEEeeeccccccHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecc
Confidence            999999999999999999999987554   78888899999999999999999   999999999999999999999999


Q ss_pred             eccceecCCCCCCccccccccccccCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ||.++...+. .....++||..|||||
T Consensus       256 FGTS~e~~~~-STkMSFaGTVaWMAPE  281 (904)
T KOG4721|consen  256 FGTSKELSDK-STKMSFAGTVAWMAPE  281 (904)
T ss_pred             ccchHhhhhh-hhhhhhhhhHhhhCHH
Confidence            9999988755 4456689999999998

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=3.5e-30  Score=238.02  Aligned_cols=165  Identities=26%  Similarity=0.407  Sum_probs=140.7

Q ss_pred             eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||+||+|+.. +++.||+|++...........+.+.+|.+++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999864 5789999999765433333456677899998888 799999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|..++....   .+++..+..++.|++.||.|||++   +|+||||||+||++++++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence            99998887643   389999999999999999999999   999999999999999999999999999976433333334


Q ss_pred             ccccccccccCCC
Q 017621          352 LLAGTSGYIAPAS  364 (368)
Q Consensus       352 ~~~gt~~y~aPE~  364 (368)
                      ..+||+.|+|||+
T Consensus       155 ~~~g~~~y~aPE~  167 (318)
T cd05570         155 TFCGTPDYIAPEI  167 (318)
T ss_pred             ceecCccccCHHH
Confidence            4579999999984

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=4.8e-30  Score=233.45  Aligned_cols=169  Identities=30%  Similarity=0.436  Sum_probs=142.4

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            46899999999999999999865 57899999987543322 23467788999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||++++.+..+....   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          80 EYVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            999987766554332   2388999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CC-CccccccccccccCC
Q 017621          347 SS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE  363 (368)
                      .. ......||+.|+|||
T Consensus       154 ~~~~~~~~~~~~~y~aPE  171 (287)
T cd07848         154 SNANYTEYVATRWYRSPE  171 (287)
T ss_pred             ccccccccccccccCCcH
Confidence            22 223357899999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=6.6e-30  Score=242.22  Aligned_cols=162  Identities=26%  Similarity=0.351  Sum_probs=139.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ..+|++.+.||+|+||.||+|.+ .+++.||+|....         +.+.+|++++++++||||+++++++...+..++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            35799999999999999999985 4688999996432         3467899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      +|++. ++|.+++....   .+++.+++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       162 ~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        162 LPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            99996 68888886543   388999999999999999999999   999999999999999999999999999975432


Q ss_pred             CC-CCccccccccccccCCC
Q 017621          346 DS-SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~-~~~~~~~gt~~y~aPE~  364 (368)
                      .. ......+||+.|+|||+
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~  254 (391)
T PHA03212        235 INANKYYGWAGTIATNAPEL  254 (391)
T ss_pred             ccccccccccCccCCCChhh
Confidence            22 22334579999999994

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-30  Score=251.28  Aligned_cols=171  Identities=26%  Similarity=0.399  Sum_probs=141.9

Q ss_pred             hccccceeeeecCCccEEEEEcCCC-CEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEE-EEee---C--
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYG-FCLH---R--  259 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~---~--  259 (368)
                      -++++.+.|.+|||+.||.|++..+ ..||+|++-..+   ....+..++|+++|+.|+ |+|||.+++ ....   .  
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d---e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND---EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC---HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            4677889999999999999997665 999999986553   346688999999999995 999999999 3322   1  


Q ss_pred             -CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          260 -KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       260 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                       -+++|.||||++|.|-+++..+.... +++.++++|+.|+++|+++||.. .++|||||||-+||||+.++..||||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence             25789999999999999998665444 99999999999999999999986 6789999999999999999999999999


Q ss_pred             cceecCCCCCCc---------cccccccccccCC
Q 017621          339 VARLLNFDSSNR---------TLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~~~~~---------~~~~gt~~y~aPE  363 (368)
                      .|..........         -...-|+.|+|||
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPE  225 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPE  225 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChH
Confidence            987543332111         0124699999999

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1.2e-29  Score=246.76  Aligned_cols=169  Identities=21%  Similarity=0.239  Sum_probs=142.8

Q ss_pred             ccccceeeeecCCccEEEEEcC-C-CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-S-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .|.+.+.||+|++|.||+|... + ++.||+|.+......   ....+.+|+++++.++||||+++++++...+..|+||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER---QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHH---HHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            4899999999999999999753 3 677888877544322   3356788999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          267 EYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       267 e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||+++|+|.++++.. .....+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            999999999887642 2233478899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC--CccccccccccccCC
Q 017621          346 DSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~--~~~~~~gt~~y~aPE  363 (368)
                      ...  .....+||+.|+|||
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE  241 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPE  241 (478)
T ss_pred             ccccccccccCCCccccCHh
Confidence            322  233457999999998

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=6.6e-30  Score=241.18  Aligned_cols=173  Identities=29%  Similarity=0.462  Sum_probs=142.1

Q ss_pred             HhhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEee
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLH  258 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  258 (368)
                      ..++|++.+.||+|+||.||+|..      .++..||+|++......+  ..+.+.+|+++++.+ +||||+++++++..
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD--EREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH--HHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            345799999999999999999873      234579999997654332  346788999999999 89999999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCC-------------------------------------------------------
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEE-------------------------------------------------------  283 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  283 (368)
                      .+..++||||+++|+|.+++.....                                                       
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            9999999999999999998854211                                                       


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCC--
Q 017621          284 ------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN--  349 (368)
Q Consensus       284 ------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~--  349 (368)
                                  ...+++.++.+++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++........  
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                        12378888999999999999999998   9999999999999999999999999999876433221  


Q ss_pred             ccccccccccccCC
Q 017621          350 RTLLAGTSGYIAPA  363 (368)
Q Consensus       350 ~~~~~gt~~y~aPE  363 (368)
                      .....++..|||||
T Consensus       271 ~~~~~~~~~y~aPE  284 (374)
T cd05106         271 KGNARLPVKWMAPE  284 (374)
T ss_pred             ccCCCCccceeCHH
Confidence            11223567899998

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=7.6e-30  Score=240.93  Aligned_cols=172  Identities=28%  Similarity=0.418  Sum_probs=142.1

Q ss_pred             hhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  259 (368)
                      .++|++.+.||+|+||+||+|..      .++..||+|+++.....  ...+.+.+|++++..+ +||||+++++++...
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            45799999999999999999963      24668999998754332  2346788999999999 899999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCC--------------------------------------------------------
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEE--------------------------------------------------------  283 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  283 (368)
                      +..++||||+++|+|.++++....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            999999999999999998864321                                                        


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          284 ----------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       284 ----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                                      ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                            12478888999999999999999998   99999999999999999999999999998765432


Q ss_pred             CC--ccccccccccccCC
Q 017621          348 SN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~--~~~~~gt~~y~aPE  363 (368)
                      ..  .....++..|+|||
T Consensus       269 ~~~~~~~~~~~~~y~aPE  286 (375)
T cd05104         269 NYVVKGNARLPVKWMAPE  286 (375)
T ss_pred             cccccCCCCCCcceeChh
Confidence            21  11223567899999

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-30  Score=235.90  Aligned_cols=165  Identities=29%  Similarity=0.457  Sum_probs=140.2

Q ss_pred             ceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          193 KYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      .+.||+|.||+||-|++ ++|+.||||++.+......+ .+.+++|+.+|+++.||.||.+...|+..+.+++|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            47899999999999975 57999999999876555433 37889999999999999999999999999999999999975


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CCeEEeeeccceecCCCCC
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE---LEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFg~a~~~~~~~~  348 (368)
                       +..+++-..+.. .+++.....++.||+.||.|||.+   +|+|+||||+|||+.+.   -.+||||||+|+++.... 
T Consensus       648 -DMLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-  721 (888)
T KOG4236|consen  648 -DMLEMILSSEKG-RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-  721 (888)
T ss_pred             -hHHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence             555555444333 389988999999999999999999   99999999999999644   378999999999987543 


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                      .+...+|||.|.|||+
T Consensus       722 FRrsVVGTPAYLaPEV  737 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEV  737 (888)
T ss_pred             hhhhhcCCccccCHHH
Confidence            4456789999999993

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-30  Score=224.30  Aligned_cols=172  Identities=26%  Similarity=0.443  Sum_probs=145.8

Q ss_pred             cHHHHHHHhhccccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEE
Q 017621          179 TFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFC  256 (368)
Q Consensus       179 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  256 (368)
                      +|+|+...++     +.||+|+|+.|--+. ..+|..||||++.+....   ...+..+|++++.+. .|+||+++++||
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            5788877775     459999999999886 678999999999876443   446788999999999 699999999999


Q ss_pred             eeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---CeE
Q 017621          257 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL---EAF  333 (368)
Q Consensus       257 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k  333 (368)
                      +++..+|||||-|.||+|...++++..   +++.++.++..+|+.||.|||.+   ||.|||+||+|||..+..   .+|
T Consensus       146 Edd~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  146 EDDTRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             cccceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCcee
Confidence            999999999999999999999987544   89999999999999999999999   999999999999996543   579


Q ss_pred             EeeeccceecCCCC-------CCccccccccccccCCC
Q 017621          334 VADFGVARLLNFDS-------SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       334 l~DFg~a~~~~~~~-------~~~~~~~gt~~y~aPE~  364 (368)
                      ||||.++.-+....       ....+.+|+..|||||+
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEV  257 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEV  257 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhH
Confidence            99999876543211       12334689999999993

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=1e-29  Score=236.72  Aligned_cols=168  Identities=29%  Similarity=0.452  Sum_probs=139.0

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-----CeE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-----KCM  262 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  262 (368)
                      +|++.+.||+|+||.||+|.. .+++.||+|++...... .....++.+|++++++++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            588899999999999999985 46899999998643221 12335688999999999999999999987643     258


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+||||++ ++|.+++....   .+++..+..++.|+++||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            99999996 68988887543   389999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCC---CccccccccccccCCC
Q 017621          343 LNFDSS---NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~---~~~~~~gt~~y~aPE~  364 (368)
                      ......   ......||+.|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~  177 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPEL  177 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHH
Confidence            533221   1234579999999993

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.96  E-value=2.9e-29  Score=233.23  Aligned_cols=169  Identities=27%  Similarity=0.354  Sum_probs=145.5

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+......  ...+++.+|++++++++||||+++++++..++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            367999999999999999999864 6888999998754322  2346789999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          82 MEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             eecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            99999999999997643   3788999999999999999999852  699999999999999999999999999986643


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..  .....||+.|+|||+
T Consensus       157 ~~--~~~~~g~~~y~aPE~  173 (331)
T cd06649         157 SM--ANSFVGTRSYMSPER  173 (331)
T ss_pred             cc--cccCCCCcCcCCHhH
Confidence            22  233579999999994

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=3.4e-29  Score=227.84  Aligned_cols=170  Identities=24%  Similarity=0.336  Sum_probs=144.3

Q ss_pred             cccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |+..+.||+|+||+||+|.. .+++.+|+|.+.............+.+|++++++++|+||+.+.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778899999999999985 46889999998765443333345678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99999998886432 23489999999999999999999998   999999999999999999999999999977543222


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                       .....|+..|+|||+
T Consensus       158 -~~~~~g~~~~~aPE~  172 (285)
T cd05632         158 -IRGRVGTVGYMAPEV  172 (285)
T ss_pred             -ccCCCCCcCccChHH
Confidence             233478999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=1.9e-29  Score=227.15  Aligned_cols=170  Identities=26%  Similarity=0.382  Sum_probs=142.0

Q ss_pred             hhccccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++......  ..+.+.+|+.++.+++||||+++++++..++..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK--QRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            357889999999999999999742    35689999987654322  336788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++|+|.+++.....  .+++.+++.++.|++.||+|||++   +++||||||+||+++.++.+|++|||.+..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999999876432  388999999999999999999999   999999999999999999999999998765


Q ss_pred             cCCCCCC-ccccccccccccCC
Q 017621          343 LNFDSSN-RTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~-~~~~~gt~~y~aPE  363 (368)
                      ....... .....++..|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE  178 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPE  178 (266)
T ss_pred             ccccchhcccCCCCceeecCHH
Confidence            4322111 11223567899999

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=2.6e-29  Score=252.87  Aligned_cols=176  Identities=26%  Similarity=0.371  Sum_probs=153.9

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++.............+.+|+.+++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367999999999999999999865 6889999999765443334456788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+.+++|.+++....   .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~  156 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN  156 (669)
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence            99999999999997543   278888999999999999999998   999999999999999999999999999998765


Q ss_pred             CCCCccccccccccccCCCCcCC
Q 017621          346 DSSNRTLLAGTSGYIAPASEWWH  368 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~d~w~  368 (368)
                      .........+|+.|+|||.++++
T Consensus       157 ~~~~~~~~~~t~~~~~pe~~~~~  179 (669)
T cd05610         157 RELNMMDILTTPSMAKPKNDYSR  179 (669)
T ss_pred             CcccccccccCccccCccccccC
Confidence            54444556899999999988764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=2.8e-29  Score=238.28  Aligned_cols=173  Identities=25%  Similarity=0.412  Sum_probs=142.5

Q ss_pred             HhhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEee
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLH  258 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  258 (368)
                      ..++|++.+.||+|+||.||+|...      .+..||+|++......  ...+.+.+|+++++++. ||||+++++++.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            3568899999999999999999742      2347999999754332  23467899999999995 9999999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCC-------------------------------------------------------
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEE-------------------------------------------------------  283 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  283 (368)
                      .+..|+|||||++|+|.+++.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999988864210                                                       


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 017621          284 --------------------------------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVL  325 (368)
Q Consensus       284 --------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  325 (368)
                                                            ...+++.++..++.|+++||+|||+.   +|+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                  12377888899999999999999998   9999999999999


Q ss_pred             ecCCCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          326 LNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       326 l~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      +++++.+||+|||+++.......  ......+++.|+|||
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  309 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE  309 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence            99999999999999987643322  122335678899999

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=3.1e-29  Score=233.12  Aligned_cols=169  Identities=27%  Similarity=0.362  Sum_probs=144.4

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|.+......  ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            368999999999999999999865 6888999988754322  2346788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.++++...   .+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999997643   2788888999999999999999742  799999999999999999999999999976543


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..  .....||..|+|||+
T Consensus       157 ~~--~~~~~~~~~y~aPE~  173 (333)
T cd06650         157 SM--ANSFVGTRSYMSPER  173 (333)
T ss_pred             hc--cccCCCCccccCHHH
Confidence            22  223468999999994

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=2.3e-29  Score=226.42  Aligned_cols=174  Identities=24%  Similarity=0.363  Sum_probs=147.6

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|+. .+++.||+|.+......+......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5789999999999999999985 468999999876543333344567889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          267 EYMEMGSLFCVLRTDEE-AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||+++++|.+++..... ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988864221 23478889999999999999999999   999999999999999999999999999987754


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........|++.|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~aPE~  177 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             hhHHHhcCCCCccccChhh
Confidence            4333334568999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=3.4e-29  Score=224.06  Aligned_cols=168  Identities=24%  Similarity=0.448  Sum_probs=143.1

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      ++|++.+.||+|+||.||+++..++..+|+|.+......    .+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            568889999999999999999888889999988654332    2578889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++|+|.+++.....  .+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          80 FMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            9999999999875432  378999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CC-ccccccccccccCCC
Q 017621          348 SN-RTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~-~~~~~gt~~y~aPE~  364 (368)
                      .. .....++..|+|||+
T Consensus       155 ~~~~~~~~~~~~y~aPE~  172 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEV  172 (256)
T ss_pred             eeccCCCCCchhhCChhh
Confidence            21 122235668999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.96  E-value=2.4e-29  Score=229.19  Aligned_cols=169  Identities=31%  Similarity=0.486  Sum_probs=135.9

Q ss_pred             hccccceeeeecCCccEEEEEc-C-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc---CCCceeeEEEEEee----
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-P-SGKVVALKKLHRSETEELASLESFRNEARLLSQI---WHRNIVKLYGFCLH----  258 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  258 (368)
                      ++|++.+.||+|+||+||+|+. . +++.||+|.+....... .....+.+|+.+++.+   +||||+++++++..    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            4688999999999999999985 2 46789999886543221 1123455677666655   69999999998853    


Q ss_pred             -CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          259 -RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       259 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                       ....++||||++ ++|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence             356899999997 589888875432 3488999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      |+++..... .......||+.|+|||
T Consensus       155 g~~~~~~~~-~~~~~~~~~~~y~aPE  179 (290)
T cd07862         155 GLARIYSFQ-MALTSVVVTLWYRAPE  179 (290)
T ss_pred             cceEeccCC-cccccccccccccChH
Confidence            999876543 2233457899999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=3.8e-29  Score=225.10  Aligned_cols=168  Identities=29%  Similarity=0.476  Sum_probs=145.6

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++......   ....+.+|+.++++++||||+++++++...+..|+|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            45799999999999999999985 56889999998654322   235678899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          85 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999999887543   378999999999999999999998   999999999999999999999999999987754


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      .........|++.|+|||
T Consensus       159 ~~~~~~~~~~~~~y~~PE  176 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPE  176 (267)
T ss_pred             cccccCccccCccccCHh
Confidence            433334457899999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=4.7e-29  Score=225.94  Aligned_cols=164  Identities=27%  Similarity=0.371  Sum_probs=137.6

Q ss_pred             eeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCCh
Q 017621          196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSL  274 (368)
Q Consensus       196 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  274 (368)
                      ||+|+||+||+++. .+|+.||+|.+.............+..|++++++++||||+++++++..+...|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            68999999999985 46899999998754333222234556799999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccccc
Q 017621          275 FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA  354 (368)
Q Consensus       275 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~  354 (368)
                      .+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++....... ......
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~  155 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA  155 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence            98886543 23488899999999999999999999   99999999999999999999999999998765432 223346


Q ss_pred             cccccccCCC
Q 017621          355 GTSGYIAPAS  364 (368)
Q Consensus       355 gt~~y~aPE~  364 (368)
                      ||+.|+|||+
T Consensus       156 ~~~~y~aPE~  165 (277)
T cd05607         156 GTNGYMAPEI  165 (277)
T ss_pred             CCCCccCHHH
Confidence            8999999983

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=5.8e-29  Score=226.31  Aligned_cols=169  Identities=26%  Similarity=0.378  Sum_probs=143.2

Q ss_pred             cccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |+..+.||+|+||.||++.. .+++.||+|.+...........+.+.+|+.++++++|++|+.+++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            67788999999999999985 46889999998764433333345677899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +++++|.+++..... ..+++.++..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            999999988864332 3488999999999999999999998   999999999999999999999999999976543322


Q ss_pred             CccccccccccccCC
Q 017621          349 NRTLLAGTSGYIAPA  363 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE  363 (368)
                       .....||..|+|||
T Consensus       158 -~~~~~g~~~y~aPE  171 (285)
T cd05630         158 -IKGRVGTVGYMAPE  171 (285)
T ss_pred             -ccCCCCCccccChH
Confidence             22347999999998

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=4.4e-29  Score=223.89  Aligned_cols=169  Identities=28%  Similarity=0.482  Sum_probs=144.9

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|++|.||+|...+++.||+|.+.....    ..+.+.+|+.++++++|+||+++++++...+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            467999999999999999999988888999999875433    2367889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.++++.... ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          81 EYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             ecCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            99999999999876432 3478889999999999999999998   9999999999999999999999999999876543


Q ss_pred             CC-CccccccccccccCC
Q 017621          347 SS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE  363 (368)
                      .. ......++..|+|||
T Consensus       157 ~~~~~~~~~~~~~y~aPE  174 (261)
T cd05072         157 EYTAREGAKFPIKWTAPE  174 (261)
T ss_pred             ceeccCCCccceecCCHH
Confidence            22 112234567899998

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.96  E-value=5.4e-29  Score=227.05  Aligned_cols=167  Identities=35%  Similarity=0.511  Sum_probs=146.9

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|++|.||++... +++.+|+|.+...........+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999864 68999999987654433344577889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++....   .+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999987653   388999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                         .....|++.|+|||
T Consensus       155 ---~~~~~~~~~y~aPE  168 (290)
T cd05580         155 ---TYTLCGTPEYLAPE  168 (290)
T ss_pred             ---CCCCCCCccccChh
Confidence               23346899999999

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.96  E-value=5.1e-29  Score=224.00  Aligned_cols=174  Identities=25%  Similarity=0.382  Sum_probs=149.4

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|++|.||+|... +++.||+|.++.....+....+.+.+|++++++++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999865 78999999887544333334578889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          267 EYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||+++++|.+++.... ....+++.++..++.|+++||.|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886432 234478999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........|++.|+|||+
T Consensus       159 ~~~~~~~~~~~~~y~apE~  177 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             CCcccceecCCccccCHHH
Confidence            4333344568999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=4.1e-29  Score=229.95  Aligned_cols=169  Identities=25%  Similarity=0.365  Sum_probs=142.6

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.+.......  ....+.+|++++++++||||+++++++..++..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            57899999999999999999864 67889999987543221  2245778999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++ +|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          84 EYLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             eCCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            99985 88887765432  378889999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........+|+.|+|||+
T Consensus       158 ~~~~~~~~~~~~y~aPE~  175 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDV  175 (309)
T ss_pred             ccccccccccccccCCHH
Confidence            333334568999999993

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=5.1e-29  Score=224.27  Aligned_cols=169  Identities=30%  Similarity=0.479  Sum_probs=146.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.++.....   ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            35788889999999999999985 46889999998654332   235678899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....   .+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          85 MEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            99999999999987544   388999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........|++.|+|||+
T Consensus       159 ~~~~~~~~~~~~~y~aPE~  177 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEV  177 (267)
T ss_pred             cccccccccCcccccChhh
Confidence            4333344579999999994

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.1e-29  Score=237.26  Aligned_cols=150  Identities=19%  Similarity=0.345  Sum_probs=135.1

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .-|..++.||-|+||+|.+++. ++...||+|.+++.+...+......+.|-.||..-+.+.||+||-.|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            3477889999999999999974 456789999998887777777778889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      ||++||++..+|-+.+-   +++..+..++.++..|+++.|..   |+|||||||+|||||.+|++||.|||+|.-+
T Consensus       709 dYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             eccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccc
Confidence            99999999998876543   78888889999999999999999   9999999999999999999999999999643

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.96  E-value=5.2e-29  Score=229.98  Aligned_cols=169  Identities=25%  Similarity=0.458  Sum_probs=139.4

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCC----EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .+|++.+.||+|+||+||+|.+. +++    .||+|.+......  ...+++.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            47999999999999999999753 333    4899998754322  2346788999999999999999999998865 47


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++++||+++|+|.+++.....  .+++..++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            799999999999999986432  378889999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCc--cccccccccccCCC
Q 017621          343 LNFDSSNR--TLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~~--~~~~gt~~y~aPE~  364 (368)
                      ........  ....++..|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~  182 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALES  182 (316)
T ss_pred             ccCCCcceeccCCccceeecChHH
Confidence            75433321  11234678999984

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=2.4e-29  Score=225.48  Aligned_cols=172  Identities=28%  Similarity=0.484  Sum_probs=148.4

Q ss_pred             HhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ...+|++.+.||+|+||.||+|...+++.+|+|.+......   ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            45679999999999999999999878999999998765432   235788899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++..... ..+++.++..++.|++.||+|||++   +++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          81 TELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EeecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            999999999999986432 3489999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~PE~  175 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEA  175 (261)
T ss_pred             ccccccCCCCceEecCHHH
Confidence            3333333346778999983

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=6.7e-29  Score=222.21  Aligned_cols=168  Identities=33%  Similarity=0.534  Sum_probs=144.9

Q ss_pred             cccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |++.+.||+|+||+||+++.. +++.+|+|.+......... .....+|+.++++++||||+++++++...+..++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            678899999999999999865 4668999999887655432 23445699999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +++++|.+++....   .+++..+..++.|+++||++||+.   +++|+||||+||++++++.++|+|||.+........
T Consensus        80 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   80 CPGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             ETTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred             cccccccccccccc---cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999998322   389999999999999999999999   999999999999999999999999999987533334


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                      ......+|..|+|||+
T Consensus       154 ~~~~~~~~~~y~aPE~  169 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEV  169 (260)
T ss_dssp             EBSSSSSSGGGSCHHH
T ss_pred             cccccccccccccccc
Confidence            4445678999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=231.65  Aligned_cols=176  Identities=27%  Similarity=0.436  Sum_probs=153.6

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  263 (368)
                      ...+|.+..+||+|+||+|-+|..+ +.+.+|||++++....+...++.-..|-++|+-. +-|.+++++.+++..+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3457999999999999999999754 5678999999887554444455556788888777 6799999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      .||||+.||+|...++.-..   +.+..+..++.+||-||-|||++   +|+.||||.+|||+|.+|++||+|||+++.-
T Consensus       427 FVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999999988876544   77888899999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCCCccccccccccccCC----------CCcC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA----------SEWW  367 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE----------~d~w  367 (368)
                      -.+......+||||.|+|||          +|||
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWW  534 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW  534 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHH
Confidence            66666667789999999998          8999

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.96  E-value=5.8e-29  Score=223.79  Aligned_cols=174  Identities=25%  Similarity=0.385  Sum_probs=148.8

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|++|.||+|.. .+++.+|||.+......+....+++.+|+++++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999985 578999999887644444444568889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          267 EYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||+++++|.+++.... ....+++..+..++.|+++||.|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 223479999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........|+..|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~ape~  177 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPER  177 (267)
T ss_pred             CCcccccccCCcCccCHHH
Confidence            4433334578999999983

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.4e-28  Score=220.72  Aligned_cols=170  Identities=25%  Similarity=0.458  Sum_probs=144.4

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|++|.||+|...+++.||+|.++.....    .+.+.+|++++++++||||+++++++...+..|+||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            4568999999999999999999877888999998764432    356889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++.... ...+++..+..++.|++.|+.|||+.   +++||||||+||++++++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            9999999999997644 23489999999999999999999998   9999999999999999999999999999887533


Q ss_pred             CCC-ccccccccccccCCC
Q 017621          347 SSN-RTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~-~~~~~gt~~y~aPE~  364 (368)
                      ... .....++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~  175 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEA  175 (261)
T ss_pred             cccccCCCcCceeccCccc
Confidence            221 111123457999994

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PHA02988 hypothetical protein; Provisional

Probab=99.96  E-value=1.2e-28  Score=224.00  Aligned_cols=163  Identities=19%  Similarity=0.270  Sum_probs=138.7

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee----CCeEEEEEee
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH----RKCMFLIYEY  268 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  268 (368)
                      ...||+|+++.||+|.. +|+.||||.+...........+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 788999999976544433345788899999999999999999999877    3468999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +++|+|.+++....   .+++.....++.|++.||.|||+..  +++||||||+||++++++.+||+|||+++...... 
T Consensus       104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999997643   3889999999999999999999732  78899999999999999999999999998764322 


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                        ....||..|+|||+
T Consensus       178 --~~~~~~~~y~aPE~  191 (283)
T PHA02988        178 --FKNVNFMVYFSYKM  191 (283)
T ss_pred             --ccccCcccccCHHH
Confidence              23468899999983

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=1.7e-28  Score=220.77  Aligned_cols=171  Identities=32%  Similarity=0.472  Sum_probs=143.6

Q ss_pred             hhccccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||+||+|.+.    +...||+|.+......  ....+|.+|+.++++++||||+++++++...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD--KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            357899999999999999999863    2457999998754432  2346788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      +++|||+++++|.+++.....  .+++..+..++.|++.||+|||++   +|+|+||||+||++++++.++|+|||+++.
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            999999999999999976433  489999999999999999999998   999999999999999999999999999988


Q ss_pred             cCCCCCCc--cccccccccccCCC
Q 017621          343 LNFDSSNR--TLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~~--~~~~gt~~y~aPE~  364 (368)
                      ........  ....++..|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~  179 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEA  179 (266)
T ss_pred             ccccccceeccCCCCCccccChhh
Confidence            75222211  12234678999983

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=7.9e-29  Score=225.28  Aligned_cols=180  Identities=27%  Similarity=0.398  Sum_probs=148.5

Q ss_pred             ccHHHHHHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEE
Q 017621          178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGF  255 (368)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  255 (368)
                      +.++++.+..++|++.+.||+|+||.||+|.. .+++.+|+|++......    .+.+.+|+.+++.+ +||||++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~   83 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGM   83 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeee
Confidence            44556667888999999999999999999986 45789999987653322    25677899999999 79999999998


Q ss_pred             Ee-----eCCeEEEEEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          256 CL-----HRKCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       256 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                      +.     .++..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.   +++||||||+||+++++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~  160 (286)
T cd06638          84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE  160 (286)
T ss_pred             eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence            74     3456899999999999998876321 223478889999999999999999998   99999999999999999


Q ss_pred             CCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          330 LEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       330 ~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +.+||+|||+++.............|++.|+|||+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV  195 (286)
T ss_pred             CCEEEccCCceeecccCCCccccccCCCcccChhh
Confidence            99999999999876544333344579999999983

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=230.48  Aligned_cols=169  Identities=28%  Similarity=0.406  Sum_probs=148.0

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .-|.+.+.||+|.|+.|-.|++ -+|..||||++.+...... ....+.+|++.|+-++|||||++|++......+|||+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            3467778899999999999985 3799999999988776543 3457778999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCCeEEeeeccceecCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLLNF  345 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFg~a~~~~~  345 (368)
                      |+-++|+|++++-+++..  +.+..+.+++.||+.|+.|+|+.   .+|||||||+|+.+- .-|-+||.|||++..+.+
T Consensus        97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999999876654  89999999999999999999999   899999999998765 568999999999988874


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      . ...+..||+..|-|||
T Consensus       172 G-~kL~TsCGSLAYSAPE  188 (864)
T KOG4717|consen  172 G-KKLTTSCGSLAYSAPE  188 (864)
T ss_pred             c-chhhcccchhhccCch
Confidence            4 4455679999999987

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=1.7e-28  Score=222.91  Aligned_cols=172  Identities=23%  Similarity=0.437  Sum_probs=142.5

Q ss_pred             hccccceeeeecCCccEEEEEc-----CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      ++|++.+.||+|+||+||+|..     .++..+|+|.+......  .....+.+|++++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP--QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            4688899999999999999973     35678999999754332  2346788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 017621          263 FLIYEYMEMGSLFCVLRTDEE--------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS  328 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  328 (368)
                      |+||||+++++|.+++.....              ...+++.+...++.|++.||+|||++   +++||||||+||++++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence            999999999999998853211              12378889999999999999999999   9999999999999999


Q ss_pred             CCCeEEeeeccceecCCCCC--CccccccccccccCCC
Q 017621          329 ELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ++.+||+|||+++.......  ......++..|+|||+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEA  197 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHH
Confidence            99999999999987643321  1223346778999983

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.96  E-value=9.9e-29  Score=221.11  Aligned_cols=167  Identities=25%  Similarity=0.446  Sum_probs=141.4

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      .+|++.+.||+|+||.||+|.++++..+|+|.+......    .+.+.+|++++++++||||+++++++...+..|+|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            468888999999999999999877778999998654332    2567889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++.....  .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||+++......
T Consensus        80 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          80 YMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             cCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            9999999999875433  489999999999999999999999   99999999999999999999999999998764322


Q ss_pred             CCc-cccccccccccCC
Q 017621          348 SNR-TLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~-~~~~gt~~y~aPE  363 (368)
                      ... ....++..|+|||
T Consensus       155 ~~~~~~~~~~~~y~~Pe  171 (256)
T cd05059         155 YTSSQGTKFPVKWAPPE  171 (256)
T ss_pred             ccccCCCCCCccccCHH
Confidence            211 1112345799998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.1e-29  Score=238.06  Aligned_cols=166  Identities=27%  Similarity=0.462  Sum_probs=137.5

Q ss_pred             cceeeeecCCccEEEEEcC-CCCEEEEEEccccc-hhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe--EEEEEe
Q 017621          192 IKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSE-TEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC--MFLIYE  267 (368)
Q Consensus       192 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  267 (368)
                      ....||+|+|-+||+|.+. +|..||--.++... .......++|..|+++|+.|+||||+++++++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3566999999999999864 46666633222211 1222345789999999999999999999999987654  889999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCCeEEeeeccceecCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-ELEAFVADFGVARLLNFD  346 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFg~a~~~~~~  346 (368)
                      .+..|+|..|+++.+.   ........+++||++||.|||++ .|+|+|||||.+||||+. .|.+||+|+|+|......
T Consensus       124 L~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999998765   78888999999999999999998 789999999999999985 589999999999987643


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      ..  ...+|||.|||||
T Consensus       200 ~a--ksvIGTPEFMAPE  214 (632)
T KOG0584|consen  200 HA--KSVIGTPEFMAPE  214 (632)
T ss_pred             cc--ceeccCccccChH
Confidence            33  3368999999998

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.96  E-value=2.4e-28  Score=222.92  Aligned_cols=169  Identities=30%  Similarity=0.449  Sum_probs=145.3

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .+.|++.+.||+|+||.||+|+.. +++.+|+|.+......   ..+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            356889999999999999999864 5889999998754332   346788899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|..++....  ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          88 IEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999988876433  2389999999999999999999998   999999999999999999999999999876544


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      .........|++.|+|||
T Consensus       163 ~~~~~~~~~~~~~y~aPE  180 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPE  180 (292)
T ss_pred             cccccceecCCccccCce
Confidence            333334456899999998

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-30  Score=241.65  Aligned_cols=172  Identities=25%  Similarity=0.372  Sum_probs=147.0

Q ss_pred             HhhccccceeeeecCCccEEEEEcCCCC-EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..+.|.++..||.|+||+||+|..++.. ..|.|++.....   ...+.|.-|+++|+.++||+||++++.|...+.+||
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse---EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE---EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch---hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            3445778889999999999999876543 456677754433   346788999999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      +.|||.||-...++-.-+  ..+++.++.-++.|++.||.|||++   .|||||||+.|||++-+|.++|+|||.+....
T Consensus       107 liEFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             EEeecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch
Confidence            999999999888776543  3489999999999999999999999   99999999999999999999999999987766


Q ss_pred             CCCCCccccccccccccCCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPASE  365 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~d  365 (368)
                      .....+..+.|||+||||||.
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVv  202 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVV  202 (1187)
T ss_pred             hHHhhhccccCCcccccchhe
Confidence            555566778999999999953

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.96  E-value=1.8e-28  Score=219.08  Aligned_cols=170  Identities=28%  Similarity=0.428  Sum_probs=147.0

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|++|.||+|... +++.|++|.+...... ....+++.+|++++++++||||+++++++.+.+..|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            5788899999999999999864 6889999988654322 2344678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||+++......
T Consensus        80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999997642 23488999999999999999999998   99999999999999999999999999998876544


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                      .......|++.|+|||
T Consensus       156 ~~~~~~~~~~~y~aPE  171 (256)
T cd08529         156 NFANTIVGTPYYLSPE  171 (256)
T ss_pred             chhhccccCccccCHH
Confidence            4444457899999999

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.96  E-value=7.8e-29  Score=223.57  Aligned_cols=171  Identities=29%  Similarity=0.521  Sum_probs=144.3

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC---
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR---  259 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---  259 (368)
                      .+.+.|++.+.||+|+||.||+|.. .+++.||+|.+.....    ....+.+|+.++.++ +||||+++++++...   
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   78 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   78 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence            3567788899999999999999985 4688999999865432    225678899999998 799999999998753   


Q ss_pred             ---CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          260 ---KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       260 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                         ...|+||||+++++|.+++..... ..+++..+..++.|++.||+|||++   +|+|+||||+||++++++.++|+|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          79 GMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence               468999999999999999876432 3478999999999999999999999   999999999999999999999999


Q ss_pred             eccceecCCCCCCccccccccccccCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ||++..............|++.|+|||
T Consensus       155 fg~~~~~~~~~~~~~~~~g~~~y~aPE  181 (272)
T cd06637         155 FGVSAQLDRTVGRRNTFIGTPYWMAPE  181 (272)
T ss_pred             CCCceecccccccCCcccccccccCHh
Confidence            999987654433444567999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=8e-29  Score=241.35  Aligned_cols=176  Identities=23%  Similarity=0.295  Sum_probs=145.1

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC---
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK---  260 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  260 (368)
                      ...++|++.+.||+|+||+||+|+. .+++.||||.+....... .....+.+|+.++..++|+||+++++.+...+   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            3456899999999999999999975 578999999987643322 23467888999999999999999988765432   


Q ss_pred             -----eEEEEEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEE
Q 017621          261 -----CMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFV  334 (368)
Q Consensus       261 -----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  334 (368)
                           .+++||||+++|+|.++++... ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence                 3689999999999999886532 234588999999999999999999999   9999999999999999999999


Q ss_pred             eeeccceecCCCC--CCccccccccccccCCC
Q 017621          335 ADFGVARLLNFDS--SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       335 ~DFg~a~~~~~~~--~~~~~~~gt~~y~aPE~  364 (368)
                      +|||+++.+....  ......+||+.|+|||+
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~  216 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI  216 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHH
Confidence            9999998765322  12234579999999983

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.96  E-value=1.6e-28  Score=222.88  Aligned_cols=171  Identities=27%  Similarity=0.485  Sum_probs=142.7

Q ss_pred             hccccceeeeecCCccEEEEEcCC------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      ++|++.+.||+|+||.||+|....      ...||+|.+......  ....++.+|++++.+++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH--HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            478889999999999999997532      257999998754432  234678999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS  328 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  328 (368)
                      .+++|||+++++|.+++.....             ...+++..+..++.|++.||.|||+.   +++||||||+||++++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence            9999999999999999875421             13478889999999999999999999   9999999999999999


Q ss_pred             CCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          329 ELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      ++.+||+|||+++.......  ......+++.|+|||
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  196 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPE  196 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHH
Confidence            99999999999986543221  122345688999999

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.96  E-value=1.4e-28  Score=222.67  Aligned_cols=174  Identities=22%  Similarity=0.363  Sum_probs=142.6

Q ss_pred             HhhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR  259 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  259 (368)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|++......  ....++.+|+.+++.++||||+++++++.++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4578999999999999999998742      3567999998654322  2335788999999999999999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCe
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEA  332 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  332 (368)
                      +..++||||+++++|.+++.....       ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence            999999999999999999865321       12357888999999999999999998   99999999999999999999


Q ss_pred             EEeeeccceecCCCCCC--ccccccccccccCCC
Q 017621          333 FVADFGVARLLNFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       333 kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      +|+|||+++........  .....+++.|+|||+
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  192 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhH
Confidence            99999999765432221  112345788999994

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=1e-28  Score=233.19  Aligned_cols=167  Identities=29%  Similarity=0.379  Sum_probs=140.2

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-----eE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-----CM  262 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  262 (368)
                      +|++.+.||+|+||.||+|.. .+++.||+|++...... ....+++.+|+++++.++||||+++++++...+     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            578889999999999999985 47899999998653222 223467889999999999999999999998776     78


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+||||+. ++|.+.+....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            99999997 57887776533   389999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccCC
Q 017621          343 LNFDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~-~~~~~~gt~~y~aPE  363 (368)
                      ...... ......+|+.|+|||
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE  174 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPE  174 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHH
Confidence            643322 223346899999998

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=1.9e-28  Score=222.61  Aligned_cols=171  Identities=27%  Similarity=0.395  Sum_probs=144.5

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|++|.||+|... +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            5888999999999999999864 68899999986543221 233567889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |++ ++|.+++........+++..+..++.|+++||+|||++   +++||||||+||++++++.+||+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            998 68888887544434589999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                      .......+++.|+|||+
T Consensus       156 ~~~~~~~~~~~y~aPE~  172 (285)
T cd07861         156 RVYTHEVVTLWYRAPEV  172 (285)
T ss_pred             ccccCCcccccccChHH
Confidence            33334467899999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.96  E-value=3.4e-28  Score=220.75  Aligned_cols=167  Identities=29%  Similarity=0.421  Sum_probs=142.9

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      .|++.+.||+|+||.||+|... ++..+++|.+......   ..+.+.+|+++++.++||||+++++++...+..|+|||
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHH---HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            3678889999999999999865 5778899988654432   34678889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|..++....  ..+++..+..++.|+++||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          83 FCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             ecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            999999988876432  2489999999999999999999999   99999999999999999999999999997664433


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                      .......||+.|+|||
T Consensus       158 ~~~~~~~~~~~y~aPE  173 (282)
T cd06643         158 QRRDSFIGTPYWMAPE  173 (282)
T ss_pred             cccccccccccccCHh
Confidence            3334457899999998

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.96  E-value=1.5e-28  Score=222.73  Aligned_cols=172  Identities=27%  Similarity=0.470  Sum_probs=143.6

Q ss_pred             hhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      .++|.+.+.||+|+||.||+|...      +++.||+|.+......  ...+.+.+|++++++++||||+++++++...+
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            356888999999999999999753      3478999998764432  23468899999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDE-----------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                      ..++||||+++++|.++++...           ....+++..+..++.|++.|+.|||++   +++||||||+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence            9999999999999999997542           123478889999999999999999999   99999999999999999


Q ss_pred             CCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          330 LEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       330 ~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      +.+||+|||+++.......  ......+++.|+|||
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE  194 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPE  194 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChh
Confidence            9999999999986533221  122334678899999

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=4e-28  Score=216.90  Aligned_cols=169  Identities=24%  Similarity=0.394  Sum_probs=145.1

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|+||.||++... +++.+|+|.+......  ...+.+.+|+.+++.++||||+++++.+.+++..|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            5788999999999999999864 6889999988643322  234678889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||++   +|+|+||||+||++++++.++++|||.+.......
T Consensus        79 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          79 YCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            9999999998865322 3378889999999999999999999   99999999999999999999999999998775544


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                      .......|++.|+|||
T Consensus       155 ~~~~~~~~~~~~~aPE  170 (255)
T cd08219         155 AYACTYVGTPYYVPPE  170 (255)
T ss_pred             cccccccCCccccCHH
Confidence            3334457899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.96  E-value=2.2e-28  Score=218.92  Aligned_cols=168  Identities=24%  Similarity=0.446  Sum_probs=143.2

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      ++|++.+.||+|+||+||+|+..++..+|+|.+......    .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            578899999999999999998877778999998754332    3578899999999999999999999999889999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++|+|.+++.....  .+++..++.++.||+.||+|||+.   +++|+||||+||++++++.+||+|||.++......
T Consensus        80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            9999999999876432  489999999999999999999999   99999999999999999999999999998764432


Q ss_pred             CC-ccccccccccccCCC
Q 017621          348 SN-RTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~-~~~~~gt~~y~aPE~  364 (368)
                      .. .....++..|+|||+
T Consensus       155 ~~~~~~~~~~~~y~~pe~  172 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEV  172 (256)
T ss_pred             eeecCCCccChhhCCHHH
Confidence            21 112235677999983

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.5e-28  Score=222.91  Aligned_cols=170  Identities=30%  Similarity=0.483  Sum_probs=147.5

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+......   ..+.+.+|++++++++||||+++++++..++..|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE---ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH---HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            467999999999999999999864 6889999998654332   346788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++.....  .+++..+..++.|++.||.|||++   +|+|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          81 IEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             eeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999999876432  389999999999999999999999   999999999999999999999999999876654


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........||+.|+|||+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~  174 (280)
T cd06611         156 TLQKRDTFIGTPYWMAPEV  174 (280)
T ss_pred             cccccceeecchhhcCHHH
Confidence            4333444578999999983

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.96  E-value=2.7e-28  Score=218.73  Aligned_cols=168  Identities=29%  Similarity=0.500  Sum_probs=142.6

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||.||+|..++++.||+|.+......    .+++.+|+.++++++||||+++++++. .+..+++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            4678999999999999999999888999999998754432    357889999999999999999999874 45689999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++.... ...+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          80 EYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999999887543 23488999999999999999999998   9999999999999999999999999999876532


Q ss_pred             CC-CccccccccccccCC
Q 017621          347 SS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE  363 (368)
                      .. ......++..|+|||
T Consensus       156 ~~~~~~~~~~~~~y~~pe  173 (260)
T cd05067         156 EYTAREGAKFPIKWTAPE  173 (260)
T ss_pred             CcccccCCcccccccCHH
Confidence            22 122234567899998

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=2.3e-28  Score=219.61  Aligned_cols=169  Identities=28%  Similarity=0.478  Sum_probs=141.6

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||.||+|++.+...||+|++.....    ..+.+.+|++++++++||||+++++++.+ +..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   79 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence            357999999999999999999877777899999875433    22578899999999999999999998754 5589999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+++.... ...+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          80 EYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999999997542 23478999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC-ccccccccccccCCC
Q 017621          347 SSN-RTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~-~~~~~gt~~y~aPE~  364 (368)
                      ... .....++..|+|||+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~  174 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEA  174 (262)
T ss_pred             ccccccCCcccceecCHhH
Confidence            321 122346778999994

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=7.3e-30  Score=220.55  Aligned_cols=174  Identities=28%  Similarity=0.386  Sum_probs=142.8

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC---C--CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee-
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP---S--GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH-  258 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  258 (368)
                      +....|+.+..||+|+||.||+|..+   +  .+.+|+|+++......... ....+|+.+++.++|||++.+..++.. 
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            45568999999999999999999532   2  3379999998764332222 345679999999999999999998877 


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC----CCe
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDE--EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE----LEA  332 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~  332 (368)
                      +..+++++||.+. +|.++++-+.  ....++...+..|+.||+.|+.|||++   =|+||||||.|||+..+    |.+
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence            7789999999986 8988886432  334588899999999999999999999   79999999999999877    899


Q ss_pred             EEeeeccceecCCCCCC---ccccccccccccCC
Q 017621          333 FVADFGVARLLNFDSSN---RTLLAGTSGYIAPA  363 (368)
Q Consensus       333 kl~DFg~a~~~~~~~~~---~~~~~gt~~y~aPE  363 (368)
                      ||+|||+++.+...-..   ...++-|.+|.|||
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE  209 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE  209 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChH
Confidence            99999999998754332   23356799999998

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-29  Score=220.49  Aligned_cols=175  Identities=25%  Similarity=0.440  Sum_probs=158.1

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  264 (368)
                      .++|.+..+||+|+|++|..+++ ++.+.||+|++++.-..+...++..+.|-.+..+- +||.+|-++.+|+.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            47899999999999999999986 46789999999887666666677778888888777 89999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |.||.+||+|.-+++++++   ++++.+..+..+|+-||.|||++   ||+.||||..|+|+|..|++|+.|+|+++.--
T Consensus       329 vieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence            9999999999877776544   99999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCCccccccccccccCC----------CCcC
Q 017621          345 FDSSNRTLLAGTSGYIAPA----------SEWW  367 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE----------~d~w  367 (368)
                      .++.....+||||.|+|||          +|||
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdww  435 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWW  435 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHH
Confidence            6777778899999999998          8999

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.7e-28  Score=229.18  Aligned_cols=168  Identities=29%  Similarity=0.382  Sum_probs=140.7

Q ss_pred             HHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC---
Q 017621          184 IEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR---  259 (368)
Q Consensus       184 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  259 (368)
                      .+..++|++.+.||+|+||+||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++...   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            34567899999999999999999985 46889999998754322 22345677899999999999999999987543   


Q ss_pred             ---CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          260 ---KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       260 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                         ...|+++|++ +++|.++++..    .+++..+..++.||+.||+|||++   +|+||||||+||++++++.+||+|
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence               3478999988 67898877642    389999999999999999999999   999999999999999999999999


Q ss_pred             eccceecCCCCCCccccccccccccCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ||+++.....   .....||+.|+|||
T Consensus       162 fg~~~~~~~~---~~~~~~t~~y~aPE  185 (343)
T cd07878         162 FGLARQADDE---MTGYVATRWYRAPE  185 (343)
T ss_pred             CccceecCCC---cCCccccccccCch
Confidence            9999876532   23347899999999

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=1.7e-28  Score=228.42  Aligned_cols=172  Identities=26%  Similarity=0.426  Sum_probs=140.0

Q ss_pred             hhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  259 (368)
                      .++|++.+.||+|+||.||+|...      +++.||+|++......  ...+.+.+|+.++.++ +||||+++++++...
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            357999999999999999999632      3578999998754332  2335678899999999 899999999987654


Q ss_pred             -CeEEEEEeecCCCChhHHhhcCCC-------------------------------------------------------
Q 017621          260 -KCMFLIYEYMEMGSLFCVLRTDEE-------------------------------------------------------  283 (368)
Q Consensus       260 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  283 (368)
                       ..++++|||+++++|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             568899999999999998864221                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCC--ccccccccc
Q 017621          284 ---AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTSG  358 (368)
Q Consensus       284 ---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~  358 (368)
                         ...+++..+..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.+......  .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               12478999999999999999999999   9999999999999999999999999999876433221  223356778


Q ss_pred             cccCC
Q 017621          359 YIAPA  363 (368)
Q Consensus       359 y~aPE  363 (368)
                      |+|||
T Consensus       241 y~aPE  245 (337)
T cd05054         241 WMAPE  245 (337)
T ss_pred             ccCcH
Confidence            99999

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.96  E-value=2.3e-28  Score=231.89  Aligned_cols=174  Identities=26%  Similarity=0.420  Sum_probs=142.8

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEe
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCL  257 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  257 (368)
                      ...++|.+.+.||+|+||.||+|++.      .++.||+|+++......  ..+.+.+|++++.++. ||||+++++++.
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS--EKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh--HHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            34457888899999999999999842      34689999997643322  2357889999999997 999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCC------------------------------------------------------
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEE------------------------------------------------------  283 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  283 (368)
                      ..+..++||||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999865321                                                      


Q ss_pred             -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 017621          284 -----------------------------------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSN  322 (368)
Q Consensus       284 -----------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  322 (368)
                                                               ...+++...+.++.|++.||+|||+.   +++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                     12367788899999999999999998   9999999999


Q ss_pred             CeeecCCCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          323 NVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       323 NIll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      |||+++++.+||+|||+++.......  ......+++.|+|||
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE  311 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE  311 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChH
Confidence            99999999999999999987543221  122335788999998

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.96  E-value=3e-28  Score=217.32  Aligned_cols=164  Identities=27%  Similarity=0.454  Sum_probs=136.0

Q ss_pred             eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCC
Q 017621          194 YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMG  272 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  272 (368)
                      +.||+|+||.||+|... +++.+|+|.+......  .....+.+|++++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            35899999999999864 6889999988654322  23467889999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCc--
Q 017621          273 SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR--  350 (368)
Q Consensus       273 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~--  350 (368)
                      +|.+++....  ..+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++..........  
T Consensus        79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            9999987543  2378999999999999999999999   99999999999999999999999999998654321111  


Q ss_pred             cccccccccccCCC
Q 017621          351 TLLAGTSGYIAPAS  364 (368)
Q Consensus       351 ~~~~gt~~y~aPE~  364 (368)
                      ....++..|+|||.
T Consensus       154 ~~~~~~~~y~aPE~  167 (252)
T cd05084         154 GMKQIPVKWTAPEA  167 (252)
T ss_pred             CCCCCceeecCchh
Confidence            11123457999994

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.5e-28  Score=236.29  Aligned_cols=162  Identities=27%  Similarity=0.356  Sum_probs=138.3

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ..|.+.+.||+|+||.||+|.+. .++.||+|....         ..+.+|++++++++||||+++++++...+..++||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            36899999999999999999864 578899996422         34567999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |++. ++|.+++.....  .+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       240 e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        240 PKYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            9996 688888765332  489999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCC--ccccccccccccCCC
Q 017621          347 SSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~--~~~~~gt~~y~aPE~  364 (368)
                      ...  .....||+.|+|||+
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~  333 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEV  333 (461)
T ss_pred             cccccccccCCCcCCcCHHH
Confidence            221  223579999999994

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=2.5e-28  Score=229.47  Aligned_cols=168  Identities=28%  Similarity=0.341  Sum_probs=138.5

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC----
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK----  260 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  260 (368)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++...... ......+.+|+.+++.++||||+++++++...+    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            457899999999999999999986 46889999998754322 223467788999999999999999999986543    


Q ss_pred             --eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          261 --CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       261 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                        ..|+||||+++ ++.+.+..     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence              47999999975 56665542     278888899999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccCCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +++...... ......||+.|+|||+
T Consensus       169 ~a~~~~~~~-~~~~~~~t~~y~aPE~  193 (359)
T cd07876         169 LARTACTNF-MMTPYVVTRYYRAPEV  193 (359)
T ss_pred             CccccccCc-cCCCCcccCCCCCchh
Confidence            998654322 2233478999999993

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.96  E-value=4e-28  Score=223.25  Aligned_cols=168  Identities=28%  Similarity=0.345  Sum_probs=143.4

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||++... ++..+|+|.+......  ....++.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP--AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            46899999999999999999854 6788999988654322  23457888999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.++++...   .+++..+..++.|+++||.|||+.+  +++||||||+||++++++.+||+|||++......
T Consensus        79 ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          79 EHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            9999999999997653   3788999999999999999999732  8999999999999999999999999998765432


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      .  .....|++.|+|||+
T Consensus       154 ~--~~~~~~~~~~~aPE~  169 (308)
T cd06615         154 M--ANSFVGTRSYMSPER  169 (308)
T ss_pred             c--cccCCCCcCccChhH
Confidence            2  233578999999993

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=4.9e-28  Score=219.48  Aligned_cols=163  Identities=25%  Similarity=0.361  Sum_probs=139.8

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|.+......  ...+++.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV--ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh--HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            3678889999999999999985 56889999998654322  23367889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|..+.       .+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++......
T Consensus        79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999986542       267888889999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      .  .....||..|+|||+
T Consensus       149 ~--~~~~~~~~~y~aPE~  164 (279)
T cd06619         149 I--AKTYVGTNAYMAPER  164 (279)
T ss_pred             c--ccCCCCChhhcCcee
Confidence            2  233579999999993

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.96  E-value=2.1e-28  Score=235.45  Aligned_cols=166  Identities=22%  Similarity=0.334  Sum_probs=133.9

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC------
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR------  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  259 (368)
                      .++|++.+.||+|+||+||+|.. .+++.||||++....       ....+|+.+++.++||||+++++++...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            45799999999999999999986 468899999885432       2234699999999999999999886432      


Q ss_pred             --CeEEEEEeecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-CeEEe
Q 017621          260 --KCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-EAFVA  335 (368)
Q Consensus       260 --~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~  335 (368)
                        ..+++||||+++ ++.+++... .....+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence              246799999985 676666432 1233488999999999999999999999   999999999999999664 79999


Q ss_pred             eeccceecCCCCCCccccccccccccCCC
Q 017621          336 DFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       336 DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |||+|+.+..... .....||+.|+|||+
T Consensus       214 DFGla~~~~~~~~-~~~~~~t~~y~aPE~  241 (440)
T PTZ00036        214 DFGSAKNLLAGQR-SVSYICSRFYRAPEL  241 (440)
T ss_pred             ccccchhccCCCC-cccCCCCcCccCHHH
Confidence            9999987653322 233578999999994

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.9e-28  Score=222.77  Aligned_cols=172  Identities=26%  Similarity=0.393  Sum_probs=141.3

Q ss_pred             hhccccceeeeecCCccEEEEEcCC---------------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceee
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS---------------GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK  251 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  251 (368)
                      .++|++.+.||+|+||.||+|+...               ...||+|.++.....  ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK--TARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCcCe
Confidence            3579999999999999999987532               235899998764332  23467899999999999999999


Q ss_pred             EEEEEeeCCeEEEEEeecCCCChhHHhhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 017621          252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE---------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSN  322 (368)
Q Consensus       252 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  322 (368)
                      +++++...+..++||||+++++|.+++.....         ...+++..++.++.|++.||+|||++   +++||||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence            99999999999999999999999998864321         12368889999999999999999999   9999999999


Q ss_pred             CeeecCCCCeEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          323 NVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       323 NIll~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      ||++++++.+||+|||++.........  .....++..|+|||
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  201 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE  201 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence            999999999999999999865432211  12234577899998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.96  E-value=3.9e-28  Score=217.70  Aligned_cols=168  Identities=28%  Similarity=0.486  Sum_probs=141.6

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||.||+|...++..+|+|.+......    .+.+.+|+.++++++|||++++++++.. +..|++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT   79 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence            3578899999999999999999888888999998764432    2568899999999999999999998754 5689999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          80 EYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            99999999999875432 3478999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC-ccccccccccccCC
Q 017621          347 SSN-RTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~-~~~~~gt~~y~aPE  363 (368)
                      ... .....++..|+|||
T Consensus       156 ~~~~~~~~~~~~~y~aPE  173 (260)
T cd05070         156 EYTARQGAKFPIKWTAPE  173 (260)
T ss_pred             ccccccCCCCCccccChH
Confidence            221 11223566899998

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.96  E-value=4.6e-28  Score=218.16  Aligned_cols=170  Identities=33%  Similarity=0.490  Sum_probs=141.9

Q ss_pred             hccccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|++.+.||+|+||.||+|...    .+..+|+|.+.......  ..+.+.+|+.++++++||||+++++++..++..|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH--HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            57889999999999999999753    23479999987543322  3467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +||||+++++|.+++.....  .+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++|||+++..
T Consensus        82 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999999976432  378999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCc---cccccccccccCCC
Q 017621          344 NFDSSNR---TLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~~~~~~---~~~~gt~~y~aPE~  364 (368)
                      .......   ....++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~  180 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEA  180 (267)
T ss_pred             ccccceeeecCCCccceeecCHhH
Confidence            5433211   11223567999983

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.96  E-value=6.5e-28  Score=215.63  Aligned_cols=171  Identities=23%  Similarity=0.366  Sum_probs=147.0

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|+..+.||+|+||.||.++. .+++.+++|.+....... ...+++.+|++++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            488899999999999999974 468899999886543322 234678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++.... ...+++.++..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999999997653 23478999999999999999999998   99999999999999999999999999998775544


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                      .......|++.|+|||+
T Consensus       156 ~~~~~~~~~~~y~ape~  172 (256)
T cd08221         156 SMAETVVGTPYYMSPEL  172 (256)
T ss_pred             ccccccCCCccccCHhh
Confidence            33344578999999993

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.96  E-value=2.9e-28  Score=225.04  Aligned_cols=162  Identities=27%  Similarity=0.434  Sum_probs=131.1

Q ss_pred             ceeeeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee--CCeEEEEEe
Q 017621          193 KYCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH--RKCMFLIYE  267 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  267 (368)
                      ...||+|+||+||+|+..   +++.||+|.+......     ..+.+|++++++++||||+++++++..  +...|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            357999999999999854   4678999998654322     456789999999999999999998864  456899999


Q ss_pred             ecCCCChhHHhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----cCCCCeEEeee
Q 017621          268 YMEMGSLFCVLRTDE------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL----NSELEAFVADF  337 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DF  337 (368)
                      |+. ++|.+++....      ....+++..+..++.||+.||+|||++   +|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            996 48887775321      123488899999999999999999999   99999999999999    45678999999


Q ss_pred             ccceecCCCCC---CccccccccccccCC
Q 017621          338 GVARLLNFDSS---NRTLLAGTSGYIAPA  363 (368)
Q Consensus       338 g~a~~~~~~~~---~~~~~~gt~~y~aPE  363 (368)
                      |+++.......   ......||+.|+|||
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE  185 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPE  185 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCH
Confidence            99987654322   223457899999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=7e-28  Score=219.00  Aligned_cols=169  Identities=26%  Similarity=0.461  Sum_probs=141.5

Q ss_pred             hccccceeeeecCCccEEEEEc-----CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--C
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--K  260 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  260 (368)
                      +-|++.+.||+|+||.||+|+.     .++..||+|.+......  ...+.+.+|++++++++||||+++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH--HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            3478889999999999999973     35788999998755332  2346789999999999999999999998875  5


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..++||||+++++|.+++.+...  .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence            68999999999999999865432  379999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCC---ccccccccccccCC
Q 017621          341 RLLNFDSSN---RTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~---~~~~~gt~~y~aPE  363 (368)
                      +........   .....|+..|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE  182 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPE  182 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHH
Confidence            876543221   12345677899998

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=4.2e-28  Score=221.35  Aligned_cols=174  Identities=26%  Similarity=0.419  Sum_probs=143.4

Q ss_pred             HhhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEee
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLH  258 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  258 (368)
                      ..++|++.+.||+|+||.||++...      ....+|+|.+......  ....++.+|++++.++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3467899999999999999999753      2367999998764332  2345688999999999 89999999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTD-------------EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVL  325 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  325 (368)
                      ++..+++|||+++|+|.++++..             .....+++..++.++.|++.||+|||+.   +|+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence            99999999999999999998643             1234588999999999999999999998   9999999999999


Q ss_pred             ecCCCCeEEeeeccceecCCCCCC--ccccccccccccCCC
Q 017621          326 LNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       326 l~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      +++++.+||+|||+++........  .....++..|+|||+
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  205 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEA  205 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHH
Confidence            999999999999999876543221  111234678999994

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.96  E-value=4e-28  Score=222.01  Aligned_cols=167  Identities=27%  Similarity=0.432  Sum_probs=145.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ..+|++.+.||+|++|.||+|.. .+++.||+|.+......   ..+.+.+|+.+++.+.||||+++++.+...+..|+|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            35789999999999999999985 46889999988754432   236788899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++...    .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999998643    278899999999999999999999   999999999999999999999999999887654


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      .........|++.|+|||
T Consensus       169 ~~~~~~~~~~~~~y~aPE  186 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPE  186 (296)
T ss_pred             cccccCcccCCccccCHH
Confidence            433334457899999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=2.9e-28  Score=219.62  Aligned_cols=165  Identities=23%  Similarity=0.327  Sum_probs=133.6

Q ss_pred             eeeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          195 CIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      .||+|+||+||+|...   ....+|+|.+......  .....+.+|+++++.++||||+++++.+...+..|+||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP--DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh--HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            5899999999999643   3457888887644322  2345788899999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC-
Q 017621          272 GSLFCVLRTDEEA--VGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS-  348 (368)
Q Consensus       272 g~L~~~l~~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~-  348 (368)
                      |+|.+++......  ...++.....++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++....... 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            9999999764321  2246778889999999999999999   999999999999999999999999999876433221 


Q ss_pred             -CccccccccccccCCC
Q 017621          349 -NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 -~~~~~~gt~~y~aPE~  364 (368)
                       ......++..|+|||+
T Consensus       157 ~~~~~~~~~~~y~aPE~  173 (269)
T cd05042         157 ITKDCHAVPLRWLAPEL  173 (269)
T ss_pred             eccCCCCCcccccCHHH
Confidence             1122346778999994

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.9e-28  Score=215.84  Aligned_cols=171  Identities=25%  Similarity=0.403  Sum_probs=144.6

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchh--hHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE--ELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ++|++.+.||+|++|.||+|.. .+++.+|+|.+......  .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688999999999999999985 46889999988654322  12234678899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |+||+++++|.+++.....   +++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999998876432   78888999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCCCc---cccccccccccCCC
Q 017621          345 FDSSNR---TLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~---~~~~gt~~y~aPE~  364 (368)
                      ......   ....|+..|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~  178 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEV  178 (263)
T ss_pred             ccccccccccCCCcCccccCcce
Confidence            322111   23468899999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=2.3e-28  Score=229.48  Aligned_cols=163  Identities=23%  Similarity=0.330  Sum_probs=138.0

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|.....         ....|+.++++++||||+++++++...+..++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3457999999999999999999864 5778999975432         22458999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+. ++|.+++....  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       135 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            999996 58888886533  2389999999999999999999999   99999999999999999999999999997543


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ... ......||+.|+|||+
T Consensus       209 ~~~-~~~~~~gt~~y~aPE~  227 (357)
T PHA03209        209 VAP-AFLGLAGTVETNAPEV  227 (357)
T ss_pred             cCc-ccccccccccccCCee
Confidence            222 2234579999999994

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=3.1e-28  Score=221.42  Aligned_cols=171  Identities=26%  Similarity=0.417  Sum_probs=144.7

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|... +++.||+|.+......  ...+.+.+|+.++++++||||+++++++...+..|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE--SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            36888999999999999999865 7899999988654222  23467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++........+++..+..++.|+++||.|||+.+  +|+|+||||+||+++.++.+||+|||++..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999998876433335899999999999999999999632  8999999999999999999999999999776432


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      .  .....|++.|+|||+
T Consensus       157 ~--~~~~~~~~~y~aPE~  172 (286)
T cd06622         157 L--AKTNIGCQSYMAPER  172 (286)
T ss_pred             c--cccCCCccCccCcch
Confidence            2  223468889999994

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=3.5e-29  Score=200.66  Aligned_cols=169  Identities=28%  Similarity=0.405  Sum_probs=144.6

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|...+.||+|.||+||+|+. .+++.||+|+++..+..+ .......+|+-+++.++|.|||+++++.-.++.+-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            466678899999999999985 468899999998765443 233566789999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      ||.. +|..+...-..  .++.+.+..++.|+++||.|+|++   ++.|||+||.|.||+.+|++|++|||+++.++.+-
T Consensus        82 ~cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HhhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            9974 88887765433  278888899999999999999999   99999999999999999999999999999887665


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                      ......+-|.+|.+|.+
T Consensus       156 rcysaevvtlwyrppdv  172 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDV  172 (292)
T ss_pred             EeeeceeeeeeccCcce
Confidence            55555567999999964

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.95  E-value=2.7e-28  Score=230.38  Aligned_cols=163  Identities=25%  Similarity=0.424  Sum_probs=141.3

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-C-----CceeeEEEEEeeCCe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-H-----RNIVKLYGFCLHRKC  261 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~  261 (368)
                      +|++.+.||+|+||+|.+|.+ ++++.||||+++....    ...+-..|+.+|..++ |     -|+|+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            899999999999999999975 5799999999986543    3456677999999996 4     599999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC--CCeEEeeecc
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE--LEAFVADFGV  339 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFg~  339 (368)
                      +|||+|.++ -+|.++++.+.- .+++...+..++.||+.||.+||+.   +|||+||||+||||.+-  ..+||+|||.
T Consensus       263 lciVfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence            999999996 499999997653 4599999999999999999999998   99999999999999643  4799999999


Q ss_pred             ceecCCCCCCccccccccccccCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      |........   ..+-+..|.|||
T Consensus       338 Sc~~~q~vy---tYiQSRfYRAPE  358 (586)
T KOG0667|consen  338 SCFESQRVY---TYIQSRFYRAPE  358 (586)
T ss_pred             ccccCCcce---eeeeccccccch
Confidence            987653322   457899999998

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=6.3e-28  Score=217.48  Aligned_cols=165  Identities=24%  Similarity=0.336  Sum_probs=135.2

Q ss_pred             eeeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          195 CIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      .||+|+||.||+|...   ++..+|+|.+.......  ....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ--EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            5899999999999753   34679999887654322  235788899999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC-
Q 017621          272 GSLFCVLRTDEE--AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS-  348 (368)
Q Consensus       272 g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~-  348 (368)
                      |+|.+++.....  ....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++....... 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            999999875332  22356777888999999999999999   999999999999999999999999999976543221 


Q ss_pred             -CccccccccccccCCC
Q 017621          349 -NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 -~~~~~~gt~~y~aPE~  364 (368)
                       ......|+..|+|||+
T Consensus       157 ~~~~~~~~~~~y~aPE~  173 (269)
T cd05087         157 VTPDQLWVPLRWIAPEL  173 (269)
T ss_pred             ecCCCcCCcccccCHhH
Confidence             1223457888999993

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=4.4e-28  Score=221.88  Aligned_cols=167  Identities=28%  Similarity=0.432  Sum_probs=146.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ..+|++.+.||+|++|.||+|.. .+++.||+|.+......   ..+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            46899999999999999999985 57899999998654332   235678899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++...    .+++.++..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             ecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999998653    278889999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      .........|++.|+|||
T Consensus       168 ~~~~~~~~~~~~~y~aPE  185 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPE  185 (297)
T ss_pred             CccCcCcccCCccccCHH
Confidence            443334457899999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=6.2e-28  Score=220.47  Aligned_cols=172  Identities=25%  Similarity=0.392  Sum_probs=143.7

Q ss_pred             hhccccceeeeecCCccEEEEEcCC-----------------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCce
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS-----------------GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI  249 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  249 (368)
                      .++|++.+.||+|+||.||+|....                 +..||+|.+......  ...+.+.+|++++++++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence            3578999999999999999987532                 245899998765433  244688999999999999999


Q ss_pred             eeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 017621          250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE--------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISS  321 (368)
Q Consensus       250 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  321 (368)
                      +++++++..++..+++|||+++++|.+++.....        ...+++..++.++.|++.||+|||+.   +++||||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence            9999999999999999999999999999875431        12488999999999999999999998   999999999


Q ss_pred             CCeeecCCCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          322 NNVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       322 ~NIll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      +||+++.++.++|+|||+++.......  ......+++.|+|||
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  202 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE  202 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHH
Confidence            999999999999999999987543321  122335678899998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.95  E-value=4.9e-28  Score=221.87  Aligned_cols=170  Identities=26%  Similarity=0.380  Sum_probs=143.0

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.+.......  ....+.+|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            357999999999999999999864 67899999986543221  224567899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||++ ++|.+++.....  .+++..+..++.|+++||+|||+.   +|+|+||||+||++++++.+||+|||++.....
T Consensus        83 ~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          83 FEYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             Eeccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            99997 588888865432  378899999999999999999999   999999999999999999999999999987554


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........+++.|+|||+
T Consensus       157 ~~~~~~~~~~~~~y~~PE~  175 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDI  175 (301)
T ss_pred             CCCcccccceeecccCcHH
Confidence            3333333467899999983

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=7e-28  Score=216.66  Aligned_cols=171  Identities=25%  Similarity=0.409  Sum_probs=141.7

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccc--hhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSE--TEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  262 (368)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+....  .......+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4788999999999999999986 458899999875422  11223456788999999999999999999988763  468


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      +++|||+++++|.+++.....   +++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            899999999999999875432   78888899999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC---CCccccccccccccCCC
Q 017621          343 LNFDS---SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~---~~~~~~~gt~~y~aPE~  364 (368)
                      .....   .......|+..|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~  180 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEV  180 (265)
T ss_pred             cccccccccccccCCCCccccChhh
Confidence            54321   12223468999999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.95  E-value=4.4e-28  Score=221.01  Aligned_cols=180  Identities=29%  Similarity=0.429  Sum_probs=148.8

Q ss_pred             ccHHHHHHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEE
Q 017621          178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGF  255 (368)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  255 (368)
                      ++.+++..+.++|++.+.||+|+||.||+|.. .+++.+|+|.+......    .+.+.+|+.++.++ +|||+++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            44556666788999999999999999999986 46889999998654322    25677899999998 89999999999


Q ss_pred             EeeC-----CeEEEEEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          256 CLHR-----KCMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       256 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                      +...     +..|+||||+++++|.++++... ....+++..+..++.|++.||+|||+.   +++||||||+||+++++
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~  164 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence            8754     35899999999999999886421 223488999999999999999999998   99999999999999999


Q ss_pred             CCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          330 LEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       330 ~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +.+||+|||++..............|+..|+|||+
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  199 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV  199 (291)
T ss_pred             CCEEEeecccchhcccccccccCccCCccccChhh
Confidence            99999999999876543333334568999999993

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.95  E-value=7.2e-28  Score=216.52  Aligned_cols=170  Identities=28%  Similarity=0.454  Sum_probs=144.0

Q ss_pred             ccccceeeeecCCccEEEEEcCCCCEEEEEEccccch---hhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSET---EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      +|++.+.||+|+||+||+|...+++.+|+|.+.....   ........+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999988899999998865322   1222345788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++.+..   .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999997643   278899999999999999999998   999999999999999999999999999876532


Q ss_pred             CC------CCccccccccccccCCC
Q 017621          346 DS------SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~------~~~~~~~gt~~y~aPE~  364 (368)
                      ..      .......|+..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~  179 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEV  179 (265)
T ss_pred             ccccccccccccccCCCccccChhh
Confidence            11      11223468999999993

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.95  E-value=6.1e-28  Score=216.87  Aligned_cols=168  Identities=29%  Similarity=0.475  Sum_probs=142.1

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .+|++.+.||+|+||.||+|... .++.||+|.+.....    ..+++.+|++++++++||||+++++++..++..+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            46888899999999999999854 588999999875432    2367889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++..... ..+++..++.++.|+++||+|||++   +++||||||+||++++++.+||+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          82 EFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EeCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            99999999999875432 3488999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCC-ccccccccccccCC
Q 017621          347 SSN-RTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~-~~~~~gt~~y~aPE  363 (368)
                      ... .....++..|+|||
T Consensus       158 ~~~~~~~~~~~~~y~aPE  175 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPE  175 (263)
T ss_pred             eeeccCCCCCccccCCHH
Confidence            221 11123466899998

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=1.9e-28  Score=222.65  Aligned_cols=170  Identities=28%  Similarity=0.444  Sum_probs=145.4

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+....... ...+.+.+|+++++.++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            46889999999999999999875 58899999886544332 23456888999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|..+.....   .+++.+++.++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          80 EFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             ecCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999988887765432   289999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........|+..|+|||+
T Consensus       154 ~~~~~~~~~~~~y~aPE~  171 (286)
T cd07846         154 GEVYTDYVATRWYRAPEL  171 (286)
T ss_pred             ccccCcccceeeccCcHH
Confidence            443344568899999993

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.3e-28  Score=223.17  Aligned_cols=153  Identities=26%  Similarity=0.391  Sum_probs=135.7

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|++|.||+|... +++.||+|.+...........+.+.+|+++++.++||||+++++.+...+..|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999865 58999999998765544345577889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||+.+++|.+++.... ...+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            9999999999987543 23489999999999999999999999   99999999999999999999999999987653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.95  E-value=3.7e-28  Score=227.97  Aligned_cols=169  Identities=26%  Similarity=0.347  Sum_probs=139.3

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC----
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR----  259 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  259 (368)
                      ...++|++.+.||+|+||.||+|.+. .++.||+|++....... .....+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-HHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            35578999999999999999999864 68899999987543222 2345677899999999999999999988643    


Q ss_pred             --CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          260 --KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       260 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                        ...|+||||+++ ++.+.+..     .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence              357999999975 66666643     278888999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccCCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+++...... ......||+.|+|||+
T Consensus       164 g~~~~~~~~~-~~~~~~~t~~y~aPE~  189 (355)
T cd07874         164 GLARTAGTSF-MMTPYVVTRYYRAPEV  189 (355)
T ss_pred             cccccCCCcc-ccCCccccCCccCHHH
Confidence            9998764332 2233578999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=7.2e-28  Score=219.41  Aligned_cols=170  Identities=27%  Similarity=0.492  Sum_probs=141.8

Q ss_pred             hccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      .+|.+.+.||+|+||+||++..      .++..+|+|.+.....   ...+.+.+|++++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            5788999999999999999974      2345689998875432   234678899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC
Q 017621          262 MFLIYEYMEMGSLFCVLRTDE----------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE  331 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  331 (368)
                      .++||||+++++|.+++....          ....+++..++.++.|++.||+|||++   +++||||||+||++++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999999999986432          123489999999999999999999998   9999999999999999999


Q ss_pred             eEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          332 AFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       332 ~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      +||+|||+++.......  ......++..|+|||
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  192 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE  192 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHH
Confidence            99999999986643221  112234577899998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=4e-28  Score=226.64  Aligned_cols=173  Identities=24%  Similarity=0.408  Sum_probs=139.2

Q ss_pred             hhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  259 (368)
                      .++|++.+.||+|+||+||+|.+      .+++.||||.++.....  .....+.+|+.++.++ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            35799999999999999999963      35778999998754322  2345788899999999 789999999987654


Q ss_pred             -CeEEEEEeecCCCChhHHhhcCCC-------------------------------------------------------
Q 017621          260 -KCMFLIYEYMEMGSLFCVLRTDEE-------------------------------------------------------  283 (368)
Q Consensus       260 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  283 (368)
                       ...++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             568999999999999998864210                                                       


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC--Cccc
Q 017621          284 ---------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS--NRTL  352 (368)
Q Consensus       284 ---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~--~~~~  352 (368)
                               ...+++.++..++.|+++||+|||++   +|+||||||+||++++++.+||+|||++........  ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     11367888899999999999999999   999999999999999999999999999987543222  1122


Q ss_pred             cccccccccCCC
Q 017621          353 LAGTSGYIAPAS  364 (368)
Q Consensus       353 ~~gt~~y~aPE~  364 (368)
                      ..+++.|+|||+
T Consensus       241 ~~~~~~y~aPE~  252 (343)
T cd05103         241 ARLPLKWMAPET  252 (343)
T ss_pred             CCCCcceECcHH
Confidence            345678999984

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=8e-28  Score=220.79  Aligned_cols=172  Identities=27%  Similarity=0.410  Sum_probs=142.3

Q ss_pred             hhccccceeeeecCCccEEEEEc--------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCL  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  257 (368)
                      .++|++.+.||+|+||.||+|+.        .++..||+|.+......  ...+.+.+|+.+++.+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch--HHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            46788999999999999999963        13457999988754322  2346788999999999 8999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV  324 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  324 (368)
                      ..+..|+||||+++|+|.+++.....             ...+++..+..++.||++||+|||++   +++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            99999999999999999999875421             23478888999999999999999999   999999999999


Q ss_pred             eecCCCCeEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          325 LLNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       325 ll~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      ++++++.+||+|||+++........  .....+++.|+|||
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE  209 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE  209 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCch
Confidence            9999999999999999876543221  12234567899999

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.95  E-value=7e-28  Score=221.03  Aligned_cols=172  Identities=27%  Similarity=0.411  Sum_probs=143.4

Q ss_pred             hhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  259 (368)
                      .++|.+.+.||+|+||.||+|..      .++..+|+|.++.....  ...+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            45799999999999999999963      23557999998754332  2346789999999999 899999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      +..|+||||+++|+|.++++.... ..+++.++..++.|++.||+|||++   +|+|+||||+||+++.++.++++|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999875432 2379999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCC--CccccccccccccCCC
Q 017621          340 ARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ++.......  ......++..|+|||+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~  214 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPES  214 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhh
Confidence            986643322  1122346788999994

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.95  E-value=7.4e-28  Score=219.10  Aligned_cols=168  Identities=33%  Similarity=0.476  Sum_probs=134.7

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc---CCCceeeEEEEEee-----C
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI---WHRNIVKLYGFCLH-----R  259 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~  259 (368)
                      +|++.+.||+|+||+||+|+.. +++.||+|.+....... .....+.+|+++++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            4788999999999999999864 68899999887543221 1123445677766655   79999999998864     2


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      ...+++|||+++ +|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            458999999984 88888875432 3489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ++....... .....||+.|+|||
T Consensus       155 ~~~~~~~~~-~~~~~~~~~y~aPE  177 (288)
T cd07863         155 ARIYSCQMA-LTPVVVTLWYRAPE  177 (288)
T ss_pred             cccccCccc-CCCccccccccCch
Confidence            987653322 23346899999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=7.7e-28  Score=220.14  Aligned_cols=166  Identities=29%  Similarity=0.455  Sum_probs=145.1

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .+|++.+.||.|++|.||+|.. .+++.||+|.+......   ..+.+.+|+++++.++||||+++++++...+..|+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            4689999999999999999975 57899999988654332   2367889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++...    .+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            999999999988643    278999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      ........|++.|+|||
T Consensus       169 ~~~~~~~~~~~~y~aPE  185 (296)
T cd06655         169 QSKRSTMVGTPYWMAPE  185 (296)
T ss_pred             cccCCCcCCCccccCcc
Confidence            43334457899999999

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=9.1e-28  Score=218.14  Aligned_cols=169  Identities=33%  Similarity=0.520  Sum_probs=139.2

Q ss_pred             hccccceeeeecCCccEEEEEc-----CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee--CC
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH--RK  260 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  260 (368)
                      ++|++.+.||+|+||.||+|..     .+++.||+|.+......   ..+.+.+|++++++++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            4788899999999999999973     35789999998755432   34678899999999999999999998754  34


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..++||||+++++|.+++....  ..+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence            6899999999999999987543  2378999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCC---ccccccccccccCCC
Q 017621          341 RLLNFDSSN---RTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~---~~~~~gt~~y~aPE~  364 (368)
                      +........   .....++..|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~  182 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPES  182 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHH
Confidence            876543221   111223456999983

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=5.5e-28  Score=233.66  Aligned_cols=178  Identities=29%  Similarity=0.504  Sum_probs=156.0

Q ss_pred             cHHHHHHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEE
Q 017621          179 TFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFC  256 (368)
Q Consensus       179 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  256 (368)
                      .++.+.+.++-|++.+.||.|.+|+||+++. ++++..|+|+.......+    ++...|.++++.. .|||++.+++++
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEE
Confidence            3444455677899999999999999999984 578899999988766544    6777889999888 899999999998


Q ss_pred             ee-----CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC
Q 017621          257 LH-----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE  331 (368)
Q Consensus       257 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  331 (368)
                      ..     ++.+|||||||.+|+..++++.-. ...+.|..+..|+++++.|+.+||..   .++|||||=.|||++.++.
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCc
Confidence            64     468999999999999999998655 45589999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          332 AFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       332 ~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +|++|||.+..++.....+.+.+|||.||||||
T Consensus       162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEV  194 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEV  194 (953)
T ss_pred             EEEeeeeeeeeeecccccccCcCCCccccccee
Confidence            999999999998877777778899999999983

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.95  E-value=6.6e-28  Score=221.70  Aligned_cols=172  Identities=27%  Similarity=0.402  Sum_probs=141.3

Q ss_pred             hhccccceeeeecCCccEEEEEcC--------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCL  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  257 (368)
                      .++|.+.+.||+|+||.||+|+..        +...+|+|.+......  ...+++.+|+++++++ +||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            467999999999999999999742        2357999999764322  2346788899999999 8999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV  324 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  324 (368)
                      ..+..|+||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||++   +++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence            99999999999999999999975421             12478999999999999999999998   999999999999


Q ss_pred             eecCCCCeEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          325 LLNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       325 ll~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      +++.++.+||+|||.++........  .....+++.|+|||
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  212 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE  212 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChH
Confidence            9999999999999999766432211  11122456899998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.95  E-value=8.5e-28  Score=217.95  Aligned_cols=169  Identities=26%  Similarity=0.413  Sum_probs=137.8

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCC----EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      ++|++.+.||+|+||+||+|.+. +++    .+++|.+.....  .....++..|+..+++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc--hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            47888999999999999999853 344    478888754322  1234677888889999999999999998764 457


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++++||+++|+|.+++.....  .+++..+..++.||+.||+|||++   +++||||||+||++++++.+||+|||+++.
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            899999999999999975432  389999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCC--CccccccccccccCCC
Q 017621          343 LNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ......  ......|+..|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~  182 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALES  182 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHH
Confidence            643322  1223457788999994

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.95  E-value=1.3e-27  Score=213.74  Aligned_cols=171  Identities=30%  Similarity=0.432  Sum_probs=143.7

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee-CCeEEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH-RKCMFLIY  266 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  266 (368)
                      +|++.+.||+|++|.||++... +++.||+|++....... ...+.+.+|++++++++|||++++++.+.. +...|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            4888999999999999999854 57889999986543221 234678889999999999999999998764 44689999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          80 GFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             cccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999999987532 23489999999999999999999999   9999999999999999999999999999877544


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........|++.|+|||+
T Consensus       156 ~~~~~~~~~~~~y~aPE~  173 (257)
T cd08223         156 CDMASTLIGTPYYMSPEL  173 (257)
T ss_pred             CCccccccCCcCccChhH
Confidence            444444578999999993

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.95  E-value=7.6e-28  Score=218.43  Aligned_cols=179  Identities=28%  Similarity=0.501  Sum_probs=149.1

Q ss_pred             ccHHHHHHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEE
Q 017621          178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGF  255 (368)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  255 (368)
                      .+..++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|.+.....    ...++..|+.+++++ +||||++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~   81 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGA   81 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence            45666667788999999999999999999986 4688999998865432    235678899999998 79999999999


Q ss_pred             Eee------CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          256 CLH------RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       256 ~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                      +..      .+..|++|||+++|+|.+++..... ..+++..+..++.|++.||.|||+.   +++|+||||+||+++++
T Consensus        82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~  157 (282)
T cd06636          82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             hhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            853      4578999999999999998875432 3378888899999999999999999   99999999999999999


Q ss_pred             CCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          330 LEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       330 ~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +.++|+|||++..............|++.|+|||+
T Consensus       158 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV  192 (282)
T ss_pred             CCEEEeeCcchhhhhccccCCCcccccccccCHhh
Confidence            99999999998866533333344578999999983

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=4e-28  Score=230.64  Aligned_cols=163  Identities=23%  Similarity=0.348  Sum_probs=138.5

Q ss_pred             hhccccceeeeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ..+|++.+.||+|+||.||+|...   .+..||+|.+....        ...+|++++++++||||+++++++...+..|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            457999999999999999999742   45789999886432        3457999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +|||++. ++|.+++...   ..+++.+++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       163 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9999996 5888888543   2389999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCC--ccccccccccccCCC
Q 017621          344 NFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      ......  .....||+.|+|||+
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~  258 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPEL  258 (392)
T ss_pred             CcccccccccccccccCccCHhH
Confidence            543221  234579999999993

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=7.7e-28  Score=218.12  Aligned_cols=170  Identities=26%  Similarity=0.465  Sum_probs=139.6

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCC----EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGK----VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      .++|++.+.||+|+||+||+|++ .+++    .||+|.+......  ...+.+.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP--KANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH--HHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            45788999999999999999974 3444    4899998754332  2346788999999999999999999998754 4


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .++++||+++|+|.+++.....  .+++..++.++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            7899999999999999876432  388999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCCCc--cccccccccccCCC
Q 017621          342 LLNFDSSNR--TLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~~--~~~~gt~~y~aPE~  364 (368)
                      .........  ....+++.|+|||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~  182 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALES  182 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHH
Confidence            775433221  11234678999994

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.95  E-value=1.3e-27  Score=219.53  Aligned_cols=170  Identities=26%  Similarity=0.380  Sum_probs=143.4

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||++... +++.||+|.+...........+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36889999999999999999864 57899999987654433344567889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999997643   378999999999999999999998   9999999999999999999999999998742111


Q ss_pred             CC---------------CccccccccccccCC
Q 017621          347 SS---------------NRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~---------------~~~~~~gt~~y~aPE  363 (368)
                      ..               ......|+..|+|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  186 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE  186 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCch
Confidence            00               011235788999999

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.95  E-value=1.2e-27  Score=213.22  Aligned_cols=163  Identities=28%  Similarity=0.454  Sum_probs=137.6

Q ss_pred             eeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCCh
Q 017621          195 CIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSL  274 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  274 (368)
                      .||+|+||.||+|...+++.+|+|.+.......  ....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE--LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHH--HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            589999999999998888999999987654322  235688999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCc-ccc
Q 017621          275 FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-TLL  353 (368)
Q Consensus       275 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~-~~~  353 (368)
                      .+++.....  .+++..+..++.|++.||.|+|++   +++||||||+||++++++.+||+|||++.......... ...
T Consensus        80 ~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          80 LSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            998875432  378999999999999999999998   99999999999999999999999999997654322211 122


Q ss_pred             ccccccccCCC
Q 017621          354 AGTSGYIAPAS  364 (368)
Q Consensus       354 ~gt~~y~aPE~  364 (368)
                      .++..|+|||+
T Consensus       155 ~~~~~y~aPE~  165 (250)
T cd05085         155 QIPIKWTAPEA  165 (250)
T ss_pred             CCcccccCHHH
Confidence            34677999983

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=6.8e-28  Score=216.10  Aligned_cols=169  Identities=28%  Similarity=0.523  Sum_probs=144.3

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||.||+|...+++.+|+|.+......    .+++.+|+.++++++||||+++++++......++||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            4679999999999999999999877889999998764432    357889999999999999999999999988999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++..... ..+++..+..++.|++.|+.|||++   +++|+||||+||++++++.+||+|||.++.....
T Consensus        81 e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          81 EYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             eccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            99999999999976432 3489999999999999999999999   9999999999999999999999999999876532


Q ss_pred             CC-CccccccccccccCC
Q 017621          347 SS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE  363 (368)
                      .. ......++..|+|||
T Consensus       157 ~~~~~~~~~~~~~y~~PE  174 (261)
T cd05034         157 EYTAREGAKFPIKWTAPE  174 (261)
T ss_pred             hhhhhhccCCCccccCHH
Confidence            11 111223456899998

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.95  E-value=1.1e-27  Score=219.17  Aligned_cols=171  Identities=24%  Similarity=0.397  Sum_probs=140.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-----------------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCcee
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-----------------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIV  250 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  250 (368)
                      ++|++.+.||+|+||.||+++..                 ++..+|+|.+......  ...+++.+|+++++.++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK--NARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcc
Confidence            57999999999999999998532                 2346899998754322  2346788999999999999999


Q ss_pred             eEEEEEeeCCeEEEEEeecCCCChhHHhhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 017621          251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE--------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSN  322 (368)
Q Consensus       251 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  322 (368)
                      ++++++...+..++||||+++++|.+++.....        ...+++..+..++.|++.||+|||+.   +++||||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~  159 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR  159 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence            999999999999999999999999999875321        12367888999999999999999999   9999999999


Q ss_pred             CeeecCCCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          323 NVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       323 NIll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      ||++++++.++|+|||+++.+.....  ......++..|+|||
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  202 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE  202 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence            99999999999999999986643221  112223467899997

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.95  E-value=1.1e-27  Score=214.90  Aligned_cols=168  Identities=26%  Similarity=0.468  Sum_probs=140.6

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      ++|++.+.||+|++|.||+|....+..+|+|.+.....    ..+.+.+|++++++++|||++++++++.. +..+++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence            56888999999999999999987777899998865432    23578889999999999999999998754 56899999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          81 FMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999999976432 3478999999999999999999998   99999999999999999999999999998764332


Q ss_pred             C-CccccccccccccCCC
Q 017621          348 S-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~-~~~~~~gt~~y~aPE~  364 (368)
                      . ......++..|+|||+
T Consensus       157 ~~~~~~~~~~~~y~~Pe~  174 (260)
T cd05069         157 YTARQGAKFPIKWTAPEA  174 (260)
T ss_pred             ccccCCCccchhhCCHHH
Confidence            2 1122346778999993

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=9.3e-28  Score=218.83  Aligned_cols=169  Identities=28%  Similarity=0.416  Sum_probs=141.8

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|++|.||+|..+ +++.||+|.+.......  ....+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            57899999999999999999865 68899999986543221  1235678999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++ +|.+++.....  .+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          83 EYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             ecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            99985 89988875432  478999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~aPE~  174 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDV  174 (291)
T ss_pred             CccccccccccccCCcHH
Confidence            222233357889999983

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-28  Score=244.34  Aligned_cols=172  Identities=30%  Similarity=0.483  Sum_probs=142.2

Q ss_pred             hhccccceeeeecCCccEEEEEcC--CC----CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP--SG----KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      ....+..+.||+|+||.||+|...  ++    ..||+|.+.+....  +...+|.+|..+|++++|||||+++|+|.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~--~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE--QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            345667889999999999999753  23    35899998765443  45689999999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEE----AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                      ..++++|||++|+|..+|++.+.    ...++..+.+.++.|||+|+.||+++   ++|||||.++|+|++....+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            99999999999999999987521    34488999999999999999999999   999999999999999999999999


Q ss_pred             eccceecCCCCCC-cccc-ccccccccCC
Q 017621          337 FGVARLLNFDSSN-RTLL-AGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~~~~~~-~~~~-~gt~~y~aPE  363 (368)
                      ||+|+.+-..... .... .-...|||||
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PE  874 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPE  874 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHH
Confidence            9999944322211 1111 1135799999

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=1.3e-27  Score=217.67  Aligned_cols=174  Identities=22%  Similarity=0.349  Sum_probs=141.6

Q ss_pred             HhhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR  259 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  259 (368)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+.......  ....+.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR--ERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4578999999999999999998642      24579999887544322  234678899999999999999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCe
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEA  332 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  332 (368)
                      +..|+||||+++|+|.++++....       ....++..+..++.|++.||.|||++   +|+||||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence            999999999999999999975321       12356778889999999999999999   99999999999999999999


Q ss_pred             EEeeeccceecCCCCCC--ccccccccccccCCC
Q 017621          333 FVADFGVARLLNFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       333 kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      +|+|||+++........  .....++..|+|||+
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~  192 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES  192 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHH
Confidence            99999999865432221  112245678999994

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=1.6e-27  Score=214.66  Aligned_cols=174  Identities=28%  Similarity=0.389  Sum_probs=143.6

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      .+++.+.....||+|+||.||+|.+. ++..||+|.+......   ..+.+.+|+.++++++|+||+++++++..++..+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            34555666678999999999999854 5778999988765433   3367889999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCCeEEeeecccee
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-ELEAFVADFGVARL  342 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFg~a~~  342 (368)
                      +|+||+++++|.+++.........++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.++|+|||.+..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999999987643221237788889999999999999998   9999999999999986 67999999999987


Q ss_pred             cCCCCCCccccccccccccCCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ............|++.|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~aPE~  180 (268)
T cd06624         159 LAGINPCTETFTGTLQYMAPEV  180 (268)
T ss_pred             cccCCCccccCCCCccccChhh
Confidence            6433333333468999999994

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=9.5e-28  Score=218.01  Aligned_cols=170  Identities=28%  Similarity=0.438  Sum_probs=144.0

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|++|.||+|+.. +++.||+|++....... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            46888999999999999999865 58899999886443211 22356788999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|..++....   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          80 EYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             eccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999988887765433   389999999999999999999998   9999999999999999999999999999887654


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~~aPE~  171 (286)
T cd07847         154 GDDYTDYVATRWYRAPEL  171 (286)
T ss_pred             cccccCcccccccCCHHH
Confidence            433334467889999983

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.95  E-value=1.5e-27  Score=217.60  Aligned_cols=170  Identities=28%  Similarity=0.477  Sum_probs=142.2

Q ss_pred             hccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      ++|.+.+.||+|+||.||+|+.      .++..+++|.+......   ..+.+.+|++++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH---HHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            4688899999999999999973      23557899988654432   23578899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS  328 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  328 (368)
                      .++||||+++++|.+++.....             ...+++..++.++.|++.||+|||++   +|+||||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence            9999999999999999865321             23478999999999999999999999   9999999999999999


Q ss_pred             CCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          329 ELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      ++.++|+|||++........  ......|+..|+|||
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  195 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE  195 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChH
Confidence            99999999999976543221  122345688899999

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.95  E-value=6e-28  Score=219.19  Aligned_cols=171  Identities=25%  Similarity=0.369  Sum_probs=140.8

Q ss_pred             hccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      .+|++.+.||+|+||.||+|...      +++.||+|++......  ...+.+.+|+.+++.++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG--PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            45778889999999999999753      3578999999754432  234678899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 017621          262 MFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS  328 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  328 (368)
                      .++++||+++++|.+++....             ....+++..+..++.|++.||+|||++   +|+||||||+||++++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence            999999999999999885321             122378888999999999999999999   9999999999999999


Q ss_pred             CCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          329 ELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      ++.+||+|||+++.......  ......+++.|+|||
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  196 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPE  196 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHH
Confidence            99999999999887643221  112234678999998

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.1e-27  Score=216.62  Aligned_cols=172  Identities=22%  Similarity=0.352  Sum_probs=143.0

Q ss_pred             hhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      .++|++.+.||+|+||.||+|...      .+..||+|.+......  .....+.+|+.+++.++||||+++++++...+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            457899999999999999999753      2468999998654322  23357889999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeE
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF  333 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  333 (368)
                      ..++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence            99999999999999999865321       12368889999999999999999998   999999999999999999999


Q ss_pred             EeeeccceecCCCCC--CccccccccccccCC
Q 017621          334 VADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       334 l~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      |+|||+++.......  ......++..|+|||
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE  191 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHH
Confidence            999999986643321  122335678999998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.95  E-value=8.5e-28  Score=220.58  Aligned_cols=171  Identities=27%  Similarity=0.495  Sum_probs=138.5

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCC--EEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGK--VVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||+||+|.+. ++.  .+|+|.+......  ...+.+.+|++++.++ +||||+++++++..++..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH--HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            357889999999999999999854 444  4677776543222  2346788999999999 899999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          263 FLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                      |+||||+++++|.++++....             ...+++.+++.++.|++.|++|||++   +++||||||+|||++++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence            999999999999999875321             12478999999999999999999999   99999999999999999


Q ss_pred             CCeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          330 LEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       330 ~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +.+||+|||+++...... ......++..|+|||
T Consensus       161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE  193 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIE  193 (303)
T ss_pred             CcEEeCccccCcccchhh-hcccCCCcccccCHH
Confidence            999999999986432111 111223466799998

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.95  E-value=1.2e-27  Score=220.78  Aligned_cols=172  Identities=27%  Similarity=0.420  Sum_probs=141.1

Q ss_pred             hhccccceeeeecCCccEEEEEcC--------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCL  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  257 (368)
                      .++|.+.+.||+|+||.||+|+..        ....+|+|.+......  .....+.+|+++++++ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD--KDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh--HHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            467889999999999999999641        2457999998754332  2346788999999999 6999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV  324 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  324 (368)
                      ..+..|++|||+++|+|.+++.....             ...+++.++..++.|++.||.|||++   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence            99999999999999999999965321             13478899999999999999999998   999999999999


Q ss_pred             eecCCCCeEEeeeccceecCCCCCCc--cccccccccccCC
Q 017621          325 LLNSELEAFVADFGVARLLNFDSSNR--TLLAGTSGYIAPA  363 (368)
Q Consensus       325 ll~~~~~~kl~DFg~a~~~~~~~~~~--~~~~gt~~y~aPE  363 (368)
                      ++++++.+||+|||+++.........  ....++..|+|||
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  206 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPE  206 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHH
Confidence            99999999999999998764322211  1123456799998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=1.7e-27  Score=217.10  Aligned_cols=171  Identities=27%  Similarity=0.345  Sum_probs=141.7

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ++++|++.+.||+|+||.||+|.. .+++.||+|.+.......  ....+.+|+.+++.++|+||+++++++..++..|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            356899999999999999999975 468899999986543221  22356789999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+. +++.+.+....  ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||+++...
T Consensus        81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             EEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            999996 67776665432  2377888889999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..........+++.|+|||+
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~  174 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDV  174 (291)
T ss_pred             CCCCCCCCccccccccCCce
Confidence            43333334467999999994

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.95  E-value=8e-28  Score=226.46  Aligned_cols=167  Identities=26%  Similarity=0.340  Sum_probs=138.3

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-----
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-----  259 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  259 (368)
                      ..++|++.+.||+|+||.||+|.. ..++.||||++....... .....+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            457899999999999999999985 468899999987543221 2335677899999999999999999987643     


Q ss_pred             -CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          260 -KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       260 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                       ...|+||||+++ +|.+.+..     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence             357999999975 67776643     278888999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +++...... ......||+.|+|||
T Consensus       172 ~a~~~~~~~-~~~~~~~t~~y~aPE  195 (364)
T cd07875         172 LARTAGTSF-MMTPYVVTRYYRAPE  195 (364)
T ss_pred             CccccCCCC-cccCCcccCCcCCHH
Confidence            998764332 223357899999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.95  E-value=1.7e-27  Score=213.01  Aligned_cols=163  Identities=28%  Similarity=0.451  Sum_probs=138.1

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEe-eCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCL-HRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||++.. .+..+|+|.+.....     .+.+.+|+.++++++|+|++++++++. .++..+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            5788999999999999999986 477899998865332     357889999999999999999999764 456789999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++..... ..+++..++.++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999876433 2378999999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      .   ....++..|+|||
T Consensus       156 ~---~~~~~~~~y~aPE  169 (256)
T cd05082         156 Q---DTGKLPVKWTAPE  169 (256)
T ss_pred             C---CCCccceeecCHH
Confidence            2   2234567899998

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=220.46  Aligned_cols=172  Identities=27%  Similarity=0.413  Sum_probs=143.3

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchh----hHHhHHHHHHHHHHHhccCCCceeeEEEEEee-CCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE----ELASLESFRNEARLLSQIWHRNIVKLYGFCLH-RKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  261 (368)
                      ++|-+..+||+|+|+.||+|.+ ...+.||||+-......    +....+...+|.++-+.++||.||++|+++.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            5677778899999999999974 45778999976433222    22344567789999999999999999999874 567


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec---CCCCeEEeeec
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN---SELEAFVADFG  338 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFg  338 (368)
                      +|-|+|||+|.+|.-+++.+.-   +++.++..|+.||+.||.||... .++|||-||||.|||+-   ..|.+||.|||
T Consensus       543 FCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            9999999999999999987653   89999999999999999999986 67999999999999995   45789999999


Q ss_pred             cceecCCCCCC-------ccccccccccccCC
Q 017621          339 VARLLNFDSSN-------RTLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~~~~-------~~~~~gt~~y~aPE  363 (368)
                      ++++++.+...       ....+||.+|.+||
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPE  650 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPE  650 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcc
Confidence            99998765443       23468999999998

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=1.4e-27  Score=218.36  Aligned_cols=169  Identities=30%  Similarity=0.405  Sum_probs=144.0

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchh--hHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETE--ELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      +|++.+.||+|++|.||+|... +++.||+|.+......  .......+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999854 6899999998765432  111234567899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+ +++|.+++....  ..+++..+..++.||++||.|||++   +++|+||||+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999997644  2489999999999999999999999   999999999999999999999999999988765


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      .........+++.|+|||
T Consensus       155 ~~~~~~~~~~~~~y~aPE  172 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPE  172 (298)
T ss_pred             CCccccccccceeeeCHH
Confidence            433333345788899998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.95  E-value=1.1e-27  Score=213.99  Aligned_cols=166  Identities=34%  Similarity=0.502  Sum_probs=146.1

Q ss_pred             hccccceeeeecCCccEEEEEcCC-CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|...+ ++.+++|.+.....     .+++.+|++++++++||||+++++++......|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            578889999999999999998654 78999999865432     478899999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999986533  3489999999999999999999999   9999999999999999999999999999877654


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      ........|+..|+|||
T Consensus       153 ~~~~~~~~~~~~y~~PE  169 (256)
T cd06612         153 MAKRNTVIGTPFWMAPE  169 (256)
T ss_pred             ccccccccCCccccCHH
Confidence            43334456899999999

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.95  E-value=1.2e-27  Score=218.10  Aligned_cols=171  Identities=27%  Similarity=0.446  Sum_probs=140.2

Q ss_pred             ccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      +|++.+.||+|+||.||+|...      ....+|+|.+......  ...+++.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            4778899999999999999742      2357889988754432  2346788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 017621          263 FLIYEYMEMGSLFCVLRTDE---------------------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISS  321 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  321 (368)
                      ++++||+.+++|.+++....                     ....+++..++.++.|++.||+|||+.   +++||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence            99999999999999886421                     112478899999999999999999998   999999999


Q ss_pred             CCeeecCCCCeEEeeeccceecCCCCC--CccccccccccccCCC
Q 017621          322 NNVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       322 ~NIll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      +||++++++.+||+|||+++.......  ......++..|+|||+
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~  200 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIES  200 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHH
Confidence            999999999999999999986543322  1222345778999994

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.95  E-value=1.4e-27  Score=215.81  Aligned_cols=172  Identities=23%  Similarity=0.413  Sum_probs=143.2

Q ss_pred             hccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      ++|++.+.||+|+||+||+|+.+      +.+.+++|.+......  ...+.+.+|++++++++||||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch--HHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            57888999999999999999853      3467999988654322  234678999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEe
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAV------GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVA  335 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  335 (368)
                      .++||||+++|+|.+++.......      .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence            999999999999999997654221      489999999999999999999999   99999999999999999999999


Q ss_pred             eeccceecCCCC-CCccccccccccccCCC
Q 017621          336 DFGVARLLNFDS-SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       336 DFg~a~~~~~~~-~~~~~~~gt~~y~aPE~  364 (368)
                      |||+++...... .......++..|+|||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~  189 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEA  189 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhh
Confidence            999987543221 12223356788999993

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=2e-27  Score=213.80  Aligned_cols=169  Identities=29%  Similarity=0.492  Sum_probs=142.3

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchh------hHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE------ELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      +|.+...||+|++|.||+|.. .+++.+|+|.+......      .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            366788999999999999985 45789999988654322      11234678899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .++||||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999997643   378889999999999999999998   99999999999999999999999999998


Q ss_pred             ecCCCCC------CccccccccccccCC
Q 017621          342 LLNFDSS------NRTLLAGTSGYIAPA  363 (368)
Q Consensus       342 ~~~~~~~------~~~~~~gt~~y~aPE  363 (368)
                      .......      ......|+..|+|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe  182 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPE  182 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChh
Confidence            7753211      112346889999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.95  E-value=6.3e-28  Score=216.02  Aligned_cols=168  Identities=29%  Similarity=0.453  Sum_probs=146.5

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999865 588999999976544333455788999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++...   ..+++..+..++.|+++||.|||++   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999999765   2388999999999999999999999   99999999999999999999999999998765432


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                       ......|+..|+|||
T Consensus       155 -~~~~~~~~~~y~~PE  169 (258)
T cd05578         155 -LTTSTSGTPGYMAPE  169 (258)
T ss_pred             -cccccCCChhhcCHH
Confidence             223346888999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.95  E-value=1.9e-27  Score=212.73  Aligned_cols=165  Identities=30%  Similarity=0.534  Sum_probs=142.1

Q ss_pred             eeeeecCCccEEEEEcCC----CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeec
Q 017621          194 YCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  269 (368)
                      +.||+|+||.||+|....    +..||+|.+.......  ..+.+.+|++.+..++|+||+++++++...+..++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            358999999999998643    7889999998765433  4578899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          270 EMGSLFCVLRTDEE------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       270 ~~g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      ++++|.+++.....      ...+++.++..++.|+++||+|||++   +++|+||||+||++++++.+||+|||.+...
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999986521      24489999999999999999999998   9999999999999999999999999999887


Q ss_pred             CCCC--CCccccccccccccCC
Q 017621          344 NFDS--SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~--~~~~~~~gt~~y~aPE  363 (368)
                      ....  .......+++.|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE  177 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPE  177 (262)
T ss_pred             ccccccccccCCCcCccccCHH
Confidence            6433  1223345788999999

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.95  E-value=2.6e-27  Score=212.38  Aligned_cols=168  Identities=26%  Similarity=0.469  Sum_probs=142.1

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||.||++...++..+|+|.+.....    ..+.+.+|++++++++|+||+++++++.+ ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            467899999999999999999977778899998875432    23678899999999999999999999887 7789999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++.... ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          80 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999997643 23478889999999999999999998   9999999999999999999999999999876532


Q ss_pred             CC-CccccccccccccCC
Q 017621          347 SS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE  363 (368)
                      .. ......++..|+|||
T Consensus       156 ~~~~~~~~~~~~~y~~PE  173 (260)
T cd05073         156 EYTAREGAKFPIKWTAPE  173 (260)
T ss_pred             CcccccCCcccccccCHh
Confidence            22 112234567799998

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=3.1e-27  Score=211.27  Aligned_cols=166  Identities=28%  Similarity=0.494  Sum_probs=143.6

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||.||+|.. .++.||+|.+.....    ..+++.+|+.++++++|+||+++++++.+.+..++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            45788999999999999999987 478899999976543    3467889999999999999999999999989999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.++++.... ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999976542 2489999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ..   ...++..|+|||+
T Consensus       156 ~~---~~~~~~~~~ape~  170 (256)
T cd05039         156 QD---SGKLPVKWTAPEA  170 (256)
T ss_pred             cc---cCCCcccccCchh
Confidence            22   2234667999994

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=2.6e-27  Score=215.08  Aligned_cols=165  Identities=28%  Similarity=0.453  Sum_probs=136.7

Q ss_pred             cccceeeeecCCccEEEEEc-----CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeE
Q 017621          190 FHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCM  262 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  262 (368)
                      |++.+.||+|+||+||++..     .+++.||+|.+......  .....+.+|++++++++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            38889999999999988642     35788999998764332  2336788899999999999999999988753  468


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      +++|||+++++|.+++...    .+++.++..++.|+++||+|||++   +|+||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence            9999999999999998753    289999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccCC
Q 017621          343 LNFDSSN---RTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~---~~~~~gt~~y~aPE  363 (368)
                      .......   .....++..|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE  180 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVE  180 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHh
Confidence            6543221   11224567799998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=9.1e-28  Score=216.43  Aligned_cols=165  Identities=21%  Similarity=0.349  Sum_probs=132.7

Q ss_pred             eeeecCCccEEEEEcCCC---CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          195 CIGTGGYGSVYRARLPSG---KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      .||+|+||+||+|+..++   ..+++|.+......  ...+.+.+|+.+++.++||||+++++.+.+....|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS--KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh--HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            589999999999975333   35667766544322  2346889999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC--C
Q 017621          272 GSLFCVLRTDEE-AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--S  348 (368)
Q Consensus       272 g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~--~  348 (368)
                      |+|.+++..... ....++..+..++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++.......  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            999999975432 22356677788999999999999998   99999999999999999999999999986432211  1


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                      ......|+..|+|||+
T Consensus       157 ~~~~~~~~~~y~aPE~  172 (268)
T cd05086         157 TEDDKCVPLRWLAPEL  172 (268)
T ss_pred             cccCCcCcccccCchh
Confidence            2233468899999994

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.8e-27  Score=215.08  Aligned_cols=167  Identities=35%  Similarity=0.536  Sum_probs=146.4

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||.|++|.||+|... +++.||+|.+......  .....+.+|+++++.++||||+++++++.++...|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            36888899999999999999854 6889999998754322  23467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++...    .+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++|+|||+++.....
T Consensus        79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999998764    389999999999999999999999   9999999999999999999999999999887655


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      ........|++.|+|||
T Consensus       152 ~~~~~~~~~~~~y~~PE  168 (274)
T cd06609         152 MSKRNTFVGTPFWMAPE  168 (274)
T ss_pred             ccccccccCCccccChh
Confidence            44444557899999999

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.95  E-value=2.9e-27  Score=212.51  Aligned_cols=172  Identities=31%  Similarity=0.512  Sum_probs=147.6

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|.. .++..+|+|++.......  ..+.+.+|+++++.++|+||+++++.+...+..|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            4789999999999999999985 467899999986544332  4467899999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.++++.......+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            9999999999997643334489999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC----ccccccccccccCCC
Q 017621          347 SSN----RTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~----~~~~~gt~~y~aPE~  364 (368)
                      ...    .....|+..|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~  177 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEV  177 (267)
T ss_pred             ccccccccccccCChhhcChHH
Confidence            322    233468999999983

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.95  E-value=1e-27  Score=215.08  Aligned_cols=168  Identities=37%  Similarity=0.579  Sum_probs=136.3

Q ss_pred             ccceeeeecCCccEEEEEcC-----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          191 HIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       191 ~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ++.+.||.|.||.||+|.+.     .+..|+||.++.....  ...+.+.+|++.+++++||||++++|++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE--EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH--HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc--ccceeeeeccccccccccccccccccccccccccccc
Confidence            35688999999999999865     3568999999654332  2357899999999999999999999999988889999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++.... ...+++..+..++.||++||.|||++   +++|+||+++||++++++.+||+|||++.....
T Consensus        80 ~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             ccccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            99999999999998762 23389999999999999999999999   999999999999999999999999999988732


Q ss_pred             CCCC--ccccccccccccCCC
Q 017621          346 DSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~--~~~~~gt~~y~aPE~  364 (368)
                      ....  .....+...|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~  176 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEV  176 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHH
T ss_pred             ccccccccccccccccccccc
Confidence            2221  122346778999984

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.5e-27  Score=213.65  Aligned_cols=170  Identities=24%  Similarity=0.421  Sum_probs=138.0

Q ss_pred             cccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe----
Q 017621          190 FHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC----  261 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  261 (368)
                      |++.+.||+|+||.||+|...    .+..||+|.+...... ....+.+.+|++.++.++||||+++++++...+.    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            567788999999999999753    2467999998754332 2235678999999999999999999998876554    


Q ss_pred             --EEEEEeecCCCChhHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          262 --MFLIYEYMEMGSLFCVLRTDE---EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       262 --~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                        .+++|||+++|+|.+++....   ....+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence              799999999999998885431   223489999999999999999999998   999999999999999999999999


Q ss_pred             eccceecCCCCCC--ccccccccccccCC
Q 017621          337 FGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      ||+++........  .....++..|+|||
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe  185 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIE  185 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHh
Confidence            9999876543321  11223567899998

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.95  E-value=2.4e-27  Score=211.96  Aligned_cols=167  Identities=25%  Similarity=0.457  Sum_probs=142.2

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+......    .+.+.+|++++++++|||++++++++......++|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            478889999999999999998877889999998754432    2568889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++.....  .+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          80 FMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            9999999999875432  378899999999999999999998   99999999999999999999999999998664322


Q ss_pred             CC-ccccccccccccCC
Q 017621          348 SN-RTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~-~~~~~gt~~y~aPE  363 (368)
                      .. .....++..|+|||
T Consensus       155 ~~~~~~~~~~~~~~aPe  171 (256)
T cd05112         155 YTSSTGTKFPVKWSSPE  171 (256)
T ss_pred             ccccCCCccchhhcCHh
Confidence            21 11223567899998

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PTZ00284 protein kinase; Provisional

Probab=99.95  E-value=8.5e-28  Score=233.45  Aligned_cols=167  Identities=18%  Similarity=0.259  Sum_probs=131.8

Q ss_pred             HHHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC------CCceeeEEEEE
Q 017621          184 IEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW------HRNIVKLYGFC  256 (368)
Q Consensus       184 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~  256 (368)
                      ....++|++.+.||+|+||+||+|.+. +++.||||+++....    ....+..|+.+++.++      |++++++++++
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            345678999999999999999999864 578899999864322    1234455666666654      45688999988


Q ss_pred             eeC-CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCC----
Q 017621          257 LHR-KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSEL----  330 (368)
Q Consensus       257 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~----  330 (368)
                      ... +..|+|||++ +++|.+++....   .+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence            764 5789999988 578888886543   38999999999999999999997 5   899999999999998765    


Q ss_pred             ------------CeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          331 ------------EAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       331 ------------~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                                  .+||+|||.+....   ......+||+.|+|||+
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~  316 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEV  316 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHH
Confidence                        49999999886432   22344689999999994

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.5e-27  Score=211.39  Aligned_cols=169  Identities=31%  Similarity=0.519  Sum_probs=146.7

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|... +++.+|+|.+......   ..+.+.+|++++++++||||+++++++.+.+..|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            57899999999999999999864 5788999998754432   3467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++....  ..+++.++..++.|++.||.|||++   +++|+||+|+||++++++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            9999999999887642  2388999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........|+..|+|||.
T Consensus       155 ~~~~~~~~~~~~y~~Pe~  172 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEV  172 (262)
T ss_pred             hhccccccCCccccCchh
Confidence            333344578999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.95  E-value=2.8e-27  Score=213.03  Aligned_cols=171  Identities=34%  Similarity=0.512  Sum_probs=141.4

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CC---CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SG---KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|+..+.||+|+||.||+|... ++   ..+|+|.+.......  ..+.+.+|++++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH--HHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            357888999999999999999864 23   379999987643322  346788999999999999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+||||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||++++++.+||+|||++..
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          82 MIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcccee
Confidence            99999999999999987543  2389999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCc-c--ccccccccccCCC
Q 017621          343 LNFDSSNR-T--LLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~~-~--~~~gt~~y~aPE~  364 (368)
                      ........ .  ....+..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~  181 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEA  181 (268)
T ss_pred             cccccccceeccCCCcCceecCHHH
Confidence            65332211 1  1123457999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=3.2e-27  Score=214.06  Aligned_cols=168  Identities=26%  Similarity=0.459  Sum_probs=139.9

Q ss_pred             hccccceeeeecCCccEEEEEcC-CC----CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SG----KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .+|++.+.||+|+||+||+|... ++    ..+|+|........  ....++.+|+.++++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP--KANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            57888999999999999999853 23    26899988765432  244678899999999999999999999987 778


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999999976433  389999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCCcc--ccccccccccCC
Q 017621          343 LNFDSSNRT--LLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~~~--~~~gt~~y~aPE  363 (368)
                      .........  ...++..|+|||
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE  181 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALE  181 (279)
T ss_pred             ccCcccceecCCCcccccccCHH
Confidence            654332211  122356799998

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.95  E-value=3.4e-27  Score=211.64  Aligned_cols=169  Identities=31%  Similarity=0.479  Sum_probs=148.3

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|++|.||+|... +++.||+|++......  ...+.+.+|++.+.+++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            36888999999999999999865 5899999998765432  23478899999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||+++++|.+++....   .+++..+..++.|+++|++|||+ .   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          79 EYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999997642   38999999999999999999999 8   999999999999999999999999999988765


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........++..|+|||.
T Consensus       153 ~~~~~~~~~~~~~y~~pE~  171 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPER  171 (264)
T ss_pred             CCCcccceeecccccCHhh
Confidence            4444334568999999993

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.95  E-value=2.9e-27  Score=214.54  Aligned_cols=170  Identities=27%  Similarity=0.496  Sum_probs=141.1

Q ss_pred             hccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      ++|+..+.||+|+||.||++..      .++..+|+|.+......   ..+.+.+|+++++.++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH---HHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            4678889999999999999963      24568999988754432   34678999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEE------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                      .+++|||+++++|.+++.....            ...+++..++.++.|++.|++|||+.   +++||||||+|||++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence            9999999999999999875431            12478899999999999999999998   99999999999999999


Q ss_pred             CCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          330 LEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       330 ~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      +.+||+|||++........  ......+++.|+|||
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  194 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE  194 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHH
Confidence            9999999999986543221  112234578899998

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.95  E-value=3.6e-27  Score=212.52  Aligned_cols=170  Identities=35%  Similarity=0.564  Sum_probs=140.6

Q ss_pred             hccccceeeeecCCccEEEEEcCC-C---CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPS-G---KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|++.+.||+|+||.||+|.... +   ..||+|.+......  ....+|..|+.++++++||||+++++++..++..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            468889999999999999998642 3   36999998754322  23468999999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +||||+++++|.+++.....  .+++.+++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||+++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          82 IITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence            99999999999999876432  378999999999999999999998   9999999999999999999999999999866


Q ss_pred             CCCCCCc---ccccc--ccccccCCC
Q 017621          344 NFDSSNR---TLLAG--TSGYIAPAS  364 (368)
Q Consensus       344 ~~~~~~~---~~~~g--t~~y~aPE~  364 (368)
                      .......   ....|  +..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEA  182 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhH
Confidence            4332211   11112  457999983

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.95  E-value=2.5e-27  Score=216.83  Aligned_cols=171  Identities=29%  Similarity=0.491  Sum_probs=137.7

Q ss_pred             hccccceeeeecCCccEEEEEcCC-C--CEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPS-G--KVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|++.+.||+|+||+||+|..++ +  ..+++|.++.....  ...+.+.+|++++.++ +||||+++++++...+..|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE--NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH--HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            578899999999999999998643 3  34788887643222  2346788999999999 7999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 017621          264 LIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL  330 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  330 (368)
                      +||||+++++|.+++.....             ...+++..+..++.|++.||+|||++   +|+||||||+|||+++++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence            99999999999999965321             12478899999999999999999998   999999999999999999


Q ss_pred             CeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          331 EAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       331 ~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      .+||+|||++........ ......+..|+|||+
T Consensus       157 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~  189 (297)
T cd05089         157 ASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIES  189 (297)
T ss_pred             eEEECCcCCCccccceec-cCCCCcCccccCchh
Confidence            999999999875332111 111223557999983

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.95  E-value=2.8e-28  Score=204.63  Aligned_cols=173  Identities=25%  Similarity=0.350  Sum_probs=143.9

Q ss_pred             hhccccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-----C
Q 017621          187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-----K  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  260 (368)
                      .++|++.+.||+|+|+.||.++ ..++..||+|++.....   ...+..++|++..++++|||+++++++...+     .
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            4589999999999999999998 56789999999876553   2457788999999999999999999886543     3


Q ss_pred             eEEEEEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      ..|++++|+..|+|.+.+.... ++..+++.+.+.|+.+|++||++||+. .++++||||||.|||+.+++.+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            5999999999999999887543 333589999999999999999999998 44699999999999999999999999999


Q ss_pred             ceecCCCCCC---------ccccccccccccCC
Q 017621          340 ARLLNFDSSN---------RTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~~---------~~~~~gt~~y~aPE  363 (368)
                      +......-..         +.....|..|.|||
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPE  208 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPE  208 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCch
Confidence            9765432111         12234688999998

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.95  E-value=2.9e-27  Score=214.65  Aligned_cols=170  Identities=28%  Similarity=0.426  Sum_probs=144.1

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|++|.||+|+.. +++.||+|.+......  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            5888999999999999999864 6889999998754322  123567789999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++ +|.+++........+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            9985 8888887654344589999999999999999999998   99999999999999999999999999998665433


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                      .......+|+.|+|||+
T Consensus       155 ~~~~~~~~~~~y~~PE~  171 (284)
T cd07836         155 NTFSNEVVTLWYRAPDV  171 (284)
T ss_pred             cccccccccccccChHH
Confidence            33333467899999994

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.95  E-value=3.7e-27  Score=211.15  Aligned_cols=160  Identities=26%  Similarity=0.419  Sum_probs=131.9

Q ss_pred             eeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCC
Q 017621          196 IGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMG  272 (368)
Q Consensus       196 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  272 (368)
                      ||+|+||.||+|.+.   .+..||+|.+......  ...+.+.+|+.++++++||||+++++++.. +..++||||++++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK--SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccCh--HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            899999999999753   3557999998765332  234678999999999999999999998864 4689999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCC---
Q 017621          273 SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN---  349 (368)
Q Consensus       273 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~---  349 (368)
                      +|.+++....  ..+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++........   
T Consensus        80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9999987533  2389999999999999999999998   9999999999999999999999999999866443221   


Q ss_pred             ccccccccccccCC
Q 017621          350 RTLLAGTSGYIAPA  363 (368)
Q Consensus       350 ~~~~~gt~~y~aPE  363 (368)
                      .....++..|+|||
T Consensus       155 ~~~~~~~~~y~aPE  168 (257)
T cd05115         155 RSAGKWPLKWYAPE  168 (257)
T ss_pred             cCCCCCCcccCCHH
Confidence            11122357899998

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.95  E-value=2e-27  Score=216.36  Aligned_cols=173  Identities=31%  Similarity=0.500  Sum_probs=142.6

Q ss_pred             hhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+......  ...+++.+|+.++++++||||+++++++..++
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            467899999999999999999853      4678999998754332  23467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCC
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDE-------------------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISS  321 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  321 (368)
                      ..++||||+++|+|.+++....                   ....+++..++.++.|++.||+|||++   +++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence            9999999999999999986421                   112478888999999999999999998   999999999


Q ss_pred             CCeeecCCCCeEEeeeccceecCCCCC--CccccccccccccCCC
Q 017621          322 NNVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       322 ~NIll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      +||++++++.++|+|||+++.......  ......++..|+|||+
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  203 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPES  203 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHH
Confidence            999999999999999999986543221  1112234667999993

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.95  E-value=3.2e-27  Score=211.13  Aligned_cols=171  Identities=26%  Similarity=0.387  Sum_probs=145.2

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|+||.||++.. .+++.||+|.+....... ...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            588899999999999999985 468899999986532221 234678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++..... ..+++.++..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          80 YCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999998875332 2378899999999999999999998   99999999999999999999999999998775443


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                      .......|++.|+|||+
T Consensus       156 ~~~~~~~~~~~~~~pe~  172 (256)
T cd08218         156 ELARTCIGTPYYLSPEI  172 (256)
T ss_pred             hhhhhccCCccccCHHH
Confidence            33334468899999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2e-27  Score=214.40  Aligned_cols=171  Identities=30%  Similarity=0.497  Sum_probs=145.5

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCC---
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRK---  260 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---  260 (368)
                      .+++|++.+.||+|++|.||+|... +++.+++|.+.....    ..+.+.+|+++++++ +||||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            5678999999999999999999864 578899999876543    236788999999999 7999999999997644   


Q ss_pred             ---eEEEEEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          261 ---CMFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       261 ---~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                         ..|+||||+++++|.+++.... ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence               4899999999999999886532 123488999999999999999999999   999999999999999999999999


Q ss_pred             eccceecCCCCCCccccccccccccCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ||++..............|+..|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE  183 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPE  183 (275)
T ss_pred             CccceecccchhhhcCccccccccCHh
Confidence            999987654444344457899999998

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=1.1e-27  Score=242.25  Aligned_cols=177  Identities=21%  Similarity=0.382  Sum_probs=142.9

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee--CCe
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH--RKC  261 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~  261 (368)
                      ...++|++.+.||+|+||+||+|++. ++..+|+|.+....... .....+..|+.++++++||||+++++++..  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            45578999999999999999999864 57789999887543322 234678899999999999999999998854  356


Q ss_pred             EEEEEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCeeecCCCCCCeeecCC-------
Q 017621          262 MFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCT----PPIVHRDISSNNVLLNSE-------  329 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlkp~NIll~~~-------  329 (368)
                      +|+||||+++|+|.+++.... ....+++..++.|+.||+.||.|||+...    .+||||||||+|||++.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999987532 12348999999999999999999998521    259999999999999642       


Q ss_pred             ----------CCeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          330 ----------LEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       330 ----------~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                                ..+||+|||++..+..... .....||+.|+|||
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAPE  211 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSPE  211 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccccc-ccccCCCccccCHH
Confidence                      3489999999987653322 23457999999998

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.9e-28  Score=227.80  Aligned_cols=164  Identities=29%  Similarity=0.425  Sum_probs=141.4

Q ss_pred             eeeeecCCccEEEEEcCC-CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCC
Q 017621          194 YCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMG  272 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  272 (368)
                      -+||+|.||+||-|++.+ ...+|||.+......   ..+-+..|+.+.++++|.|||+++|.+.+++.+-+.||-.+||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr---~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR---EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccch---hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            369999999999999765 557999998765543   3356788999999999999999999999999999999999999


Q ss_pred             ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCCeEEeeeccceecCCCCCCcc
Q 017621          273 SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       273 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      +|.++++..-....-.+...-.+.+||++||.|||.+   .|||||||-+|+|++ -.|.+||+|||.++.+..-.....
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            9999998754433336777778999999999999999   999999999999996 578999999999998865555566


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      .+.||..|||||
T Consensus       735 TFTGTLQYMAPE  746 (1226)
T KOG4279|consen  735 TFTGTLQYMAPE  746 (1226)
T ss_pred             ccccchhhhChH
Confidence            678999999998

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.95  E-value=3.1e-27  Score=211.31  Aligned_cols=163  Identities=27%  Similarity=0.463  Sum_probs=138.3

Q ss_pred             eeeeecCCccEEEEEcCC--C--CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeec
Q 017621          194 YCIGTGGYGSVYRARLPS--G--KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  269 (368)
                      +.||+|++|.||+|.+.+  +  ..||+|.+......  ...+.+.+|++++++++||||+++++++.. ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            358999999999998633  3  36999999876553  345788999999999999999999999988 8899999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCC
Q 017621          270 EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN  349 (368)
Q Consensus       270 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~  349 (368)
                      ++++|.+++..... ..+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||+++........
T Consensus        78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99999999976543 3489999999999999999999999   9999999999999999999999999999877543221


Q ss_pred             ---ccccccccccccCC
Q 017621          350 ---RTLLAGTSGYIAPA  363 (368)
Q Consensus       350 ---~~~~~gt~~y~aPE  363 (368)
                         .....++..|+|||
T Consensus       154 ~~~~~~~~~~~~y~~pE  170 (257)
T cd05040         154 YVMEEHLKVPFAWCAPE  170 (257)
T ss_pred             eecccCCCCCceecCHH
Confidence               11235778999999

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.95  E-value=1.1e-27  Score=217.45  Aligned_cols=169  Identities=28%  Similarity=0.419  Sum_probs=141.8

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|+||.||+|+.. +|+.+|+|.+....... .....+.+|++++++++||||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            4788899999999999999864 68899999986543221 223467789999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |++ ++|.+++....  ..+++..+..++.||++||.|||++   +++||||||+||+++.++.+||+|||+++......
T Consensus        80 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          80 YCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            997 57887776432  2389999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                      .......+++.|+|||+
T Consensus       154 ~~~~~~~~~~~y~aPE~  170 (284)
T cd07839         154 RCYSAEVVTLWYRPPDV  170 (284)
T ss_pred             CCcCCCccccCCcChHH
Confidence            33334467899999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.95  E-value=3.2e-27  Score=213.09  Aligned_cols=171  Identities=25%  Similarity=0.418  Sum_probs=135.3

Q ss_pred             cccceeeeecCCccEEEEEcCC-CC--EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC------C
Q 017621          190 FHIKYCIGTGGYGSVYRARLPS-GK--VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR------K  260 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  260 (368)
                      |.+.+.||+|+||.||+|...+ +.  .+|+|.+...... ....+.+.+|+++++.++||||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT-RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3467889999999999998644 32  6899988764322 23356788999999999999999999987532      2


Q ss_pred             eEEEEEeecCCCChhHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDE---EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                      ..+++|||+++|+|.+++....   ....+++.....++.|++.||+|||++   +|+||||||+|||+++++.+||+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence            4689999999999988874321   223478999999999999999999998   9999999999999999999999999


Q ss_pred             ccceecCCCCCC--ccccccccccccCCC
Q 017621          338 GVARLLNFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      |+++........  .....+++.|+|||+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~  185 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIES  185 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHH
Confidence            999876543221  122346778999974

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=4.2e-27  Score=218.99  Aligned_cols=171  Identities=26%  Similarity=0.395  Sum_probs=140.2

Q ss_pred             hccccceeeeecCCccEEEEEcC--------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEee
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLH  258 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  258 (368)
                      .+|++.+.||+|+||.||+|+..        .+..||+|.+......  ...+++.+|+++++++ +||||+++++++..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--HHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            46899999999999999999632        1236899988754322  2346788999999999 89999999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVL  325 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  325 (368)
                      .+..+++|||+++|+|.+++....             ....+++..++.++.|++.||+|||++   +++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence            999999999999999999987532             123478889999999999999999998   9999999999999


Q ss_pred             ecCCCCeEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          326 LNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       326 l~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      ++.++.+||+|||+++........  .....++..|+|||
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  206 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPE  206 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHH
Confidence            999999999999999876532221  11123456799998

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.6e-27  Score=211.26  Aligned_cols=171  Identities=26%  Similarity=0.411  Sum_probs=141.8

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccc--hhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSE--TEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  262 (368)
                      .+|++.+.||+|+||.||+|.+ .+++.||+|.+....  .........+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788999999999999999985 468899999875321  11223456888999999999999999999998764  468


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++++||+++++|.+++.....   +++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998875432   78888999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC---CCccccccccccccCCC
Q 017621          343 LNFDS---SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~---~~~~~~~gt~~y~aPE~  364 (368)
                      .....   .......|+..|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~  180 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEV  180 (264)
T ss_pred             cccccccCccccccCCcccccCHhh
Confidence            54311   11223468999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.95  E-value=4.8e-27  Score=216.78  Aligned_cols=162  Identities=27%  Similarity=0.433  Sum_probs=130.6

Q ss_pred             ceeeeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee--CCeEEEEEe
Q 017621          193 KYCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH--RKCMFLIYE  267 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  267 (368)
                      ...||+|+||+||+|+..   ++..||+|.+......     ..+.+|++++++++||||+++++++..  +...++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            357999999999999854   4578999988754322     456789999999999999999998854  467899999


Q ss_pred             ecCCCChhHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----cCCCCeEEeee
Q 017621          268 YMEMGSLFCVLRTD------EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL----NSELEAFVADF  337 (368)
Q Consensus       268 ~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DF  337 (368)
                      |+++ +|.+++...      .....+++..+..++.|++.||.|||++   +|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9975 777776432      1123478899999999999999999999   99999999999999    56679999999


Q ss_pred             ccceecCCCCC---CccccccccccccCC
Q 017621          338 GVARLLNFDSS---NRTLLAGTSGYIAPA  363 (368)
Q Consensus       338 g~a~~~~~~~~---~~~~~~gt~~y~aPE  363 (368)
                      |+++.......   ......||+.|+|||
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE  185 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPE  185 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcH
Confidence            99987654322   223457899999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.95  E-value=3.6e-27  Score=215.42  Aligned_cols=168  Identities=28%  Similarity=0.437  Sum_probs=145.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||++.. .+++.||+|.+......   ..+.+.+|+.++++++||||+++++++...+..|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            36889999999999999999975 46789999998643322   236788899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      +||+++++|.+++...    .+++.++..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            9999999999998753    278889999999999999999999   999999999999999999999999999887655


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........|++.|+|||+
T Consensus       168 ~~~~~~~~~~~~~y~~PE~  186 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEV  186 (293)
T ss_pred             cccccccccCChhhcCchh
Confidence            4444444578999999993

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=9.9e-28  Score=234.26  Aligned_cols=176  Identities=19%  Similarity=0.285  Sum_probs=133.5

Q ss_pred             HHhhccccceeeeecCCccEEEEEcCC--CCEEEEEE--------------ccccchhhHHhHHHHHHHHHHHhccCCCc
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLPS--GKVVALKK--------------LHRSETEELASLESFRNEARLLSQIWHRN  248 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  248 (368)
                      ...++|++.+.||+|+||+||+|..+.  +...+.|.              +.+...........+.+|+.++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999986432  22222221              11111111123456889999999999999


Q ss_pred             eeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee
Q 017621          249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE--AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL  326 (368)
Q Consensus       249 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll  326 (368)
                      |+++++++...+..|+|+|++. +++.+++.....  .......++..++.|++.||+|||++   +|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            9999999999999999999996 477776643221  11234566778999999999999999   99999999999999


Q ss_pred             cCCCCeEEeeeccceecCCCCC-CccccccccccccCCC
Q 017621          327 NSELEAFVADFGVARLLNFDSS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       327 ~~~~~~kl~DFg~a~~~~~~~~-~~~~~~gt~~y~aPE~  364 (368)
                      +.++.+||+|||+++.+..... ......||+.|+|||+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~  339 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEI  339 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchh
Confidence            9999999999999987754332 2234579999999994

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-29  Score=230.55  Aligned_cols=169  Identities=27%  Similarity=0.399  Sum_probs=149.3

Q ss_pred             hccccceeeeecCCccEEEEEcCCCC-EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .+++.+..||-|+||.|=.++..... .+|+|++++...-+....+....|-++|...+.|.||++|..|.+..++||+|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45566778999999999998864433 48999998776655556678888999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |-|-||.++..++.++.   ++...+..++..+.+|++|||++   +||+|||||+|.++|.+|-+||.|||+|+.+...
T Consensus       500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999999987654   78888889999999999999999   9999999999999999999999999999999866


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      ...+ ++||||.|.|||
T Consensus       574 ~KTw-TFcGTpEYVAPE  589 (732)
T KOG0614|consen  574 RKTW-TFCGTPEYVAPE  589 (732)
T ss_pred             Ccee-eecCCcccccch
Confidence            5544 479999999998

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.95  E-value=4.3e-27  Score=210.26  Aligned_cols=168  Identities=26%  Similarity=0.383  Sum_probs=143.7

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchh--hHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETE--ELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      +|+..+.||+|++|+||+|... +++.|++|.+......  .....+.+.+|+++++.++||||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999865 7899999988653321  122346788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      +||+++++|.+++....   .+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999997643   378999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      .. ......|+..|+|||
T Consensus       155 ~~-~~~~~~~~~~y~~pe  171 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPE  171 (258)
T ss_pred             cc-cccccCCCcceeCHH
Confidence            33 223456899999998

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=7e-27  Score=210.33  Aligned_cols=170  Identities=26%  Similarity=0.414  Sum_probs=141.1

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccch--hhHHhHHHHHHHHHHHhccCCCceeeEEEEEee--CCeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSET--EELASLESFRNEARLLSQIWHRNIVKLYGFCLH--RKCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  262 (368)
                      .+|+..+.||+|+||.||+|.. .+++.||+|++.....  ......+.+.+|+.++++++||||+++++++.+  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688899999999999999986 4688999998864321  122344678899999999999999999998875  3578


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++++||+++++|.+++.....   +++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            999999999999999875432   78889999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCC---CCccccccccccccCC
Q 017621          343 LNFDS---SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~---~~~~~~~gt~~y~aPE  363 (368)
                      .....   .......|+..|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE  179 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPE  179 (266)
T ss_pred             cccccccCCccccCCccccccCHH
Confidence            54321   1122345889999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.95  E-value=3.7e-27  Score=211.02  Aligned_cols=161  Identities=27%  Similarity=0.445  Sum_probs=133.6

Q ss_pred             eeeecCCccEEEEEc---CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          195 CIGTGGYGSVYRARL---PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      .||+|+||.||+|.+   .+++.+|+|++...... ....+++.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-PALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            589999999999964   35788999998654332 2345788999999999999999999998864 467899999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCC--
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN--  349 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~--  349 (368)
                      ++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||.||++++++.+||+|||+++........  
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999987543   388999999999999999999998   9999999999999999999999999999876543321  


Q ss_pred             -ccccccccccccCC
Q 017621          350 -RTLLAGTSGYIAPA  363 (368)
Q Consensus       350 -~~~~~gt~~y~aPE  363 (368)
                       .....++..|+|||
T Consensus       154 ~~~~~~~~~~y~aPE  168 (257)
T cd05116         154 AKTHGKWPVKWYAPE  168 (257)
T ss_pred             ecCCCCCCccccCHh
Confidence             12223467899998

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.95  E-value=3.5e-27  Score=212.27  Aligned_cols=170  Identities=29%  Similarity=0.484  Sum_probs=143.1

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccch---hhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSET---EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      +|+..+.||+|++|.||+|.. .+++.+|+|.+.....   ......+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477788999999999999985 5788999999865432   112235688999999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-CeEEeeeccceec
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARLL  343 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFg~a~~~  343 (368)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||++   +++|+||+|+||+++.++ .+||+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999987543   378899999999999999999999   999999999999998776 5999999999876


Q ss_pred             CCCCCC----ccccccccccccCCC
Q 017621          344 NFDSSN----RTLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~~~~~----~~~~~gt~~y~aPE~  364 (368)
                      ......    .....||..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~  179 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEV  179 (268)
T ss_pred             ccccccCCccccccccccceeCHhH
Confidence            543211    223468899999993

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=3.2e-27  Score=215.61  Aligned_cols=170  Identities=29%  Similarity=0.387  Sum_probs=143.6

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMFL  264 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  264 (368)
                      ++|++.+.||+|+||.||+|... +++.+|+|.++.....+ .....+.+|+.++.+++||||+++++++...  +..|+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            57888999999999999999865 58899999987543321 2234567899999999999999999998877  88999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++ +|.+++.....  .+++..+..++.|+++||+|||+.   +++|+||||+||++++++.+||+|||+++...
T Consensus        84 v~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             EehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            9999984 89888875432  489999999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..........+++.|+|||+
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~  177 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPEL  177 (293)
T ss_pred             CCccccccccccccccCchh
Confidence            54333334567899999983

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.95  E-value=1e-26  Score=210.57  Aligned_cols=167  Identities=34%  Similarity=0.484  Sum_probs=144.0

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      -|++.+.||+|+||.||+|.. .+++.+|+|.+......  ...+.+.+|+.++++++||||+++++++..++..|+|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            477788999999999999975 46889999988654332  234678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          83 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999999988643    378999999999999999999998   99999999999999999999999999998765443


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                      .......|+..|+|||+
T Consensus       156 ~~~~~~~~~~~y~~PE~  172 (277)
T cd06641         156 IKRNTFVGTPFWMAPEV  172 (277)
T ss_pred             hhhccccCCccccChhh
Confidence            33344568999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.95  E-value=1.3e-27  Score=218.29  Aligned_cols=164  Identities=29%  Similarity=0.454  Sum_probs=140.1

Q ss_pred             cccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |.....||+|+||.||++.. .++..||+|.+.....   ...+.+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            33446699999999999985 4688999998865332   2346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +++++|.+++...    .+++.++..++.||+.||+|||++   +|+||||||+||++++++.++|+|||++........
T Consensus       101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            9999999988543    278899999999999999999999   999999999999999999999999999976644333


Q ss_pred             CccccccccccccCC
Q 017621          349 NRTLLAGTSGYIAPA  363 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE  363 (368)
                      ......|+..|+|||
T Consensus       174 ~~~~~~~~~~y~aPE  188 (292)
T cd06658         174 KRKSLVGTPYWMAPE  188 (292)
T ss_pred             cCceeecCccccCHH
Confidence            334457899999999

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.95  E-value=5.9e-27  Score=212.56  Aligned_cols=170  Identities=24%  Similarity=0.410  Sum_probs=137.6

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHH-HhccCCCceeeEEEEEeeCCeEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARL-LSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.......  ...++..|+.. ++..+||||+++++++..++..|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            47889999999999999999864 68999999987643322  12345556665 5666999999999999999999999


Q ss_pred             EeecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          266 YEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |||++ |+|.+++... .....+++..+..++.|++.||+|||+++  +++||||||+||+++.++.+||+|||++....
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99997 6887777542 22345899999999999999999999853  79999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccCC
Q 017621          345 FDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE  363 (368)
                      ... ......|+..|+|||
T Consensus       156 ~~~-~~~~~~~~~~y~aPE  173 (283)
T cd06617         156 DSV-AKTIDAGCKPYMAPE  173 (283)
T ss_pred             ccc-ccccccCCccccChh
Confidence            322 223346889999999

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.95  E-value=3.5e-27  Score=213.65  Aligned_cols=164  Identities=29%  Similarity=0.388  Sum_probs=138.6

Q ss_pred             eeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCCh
Q 017621          196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSL  274 (368)
Q Consensus       196 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  274 (368)
                      ||+|+||+||+|.. .+++.||+|.+.............+.+|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999975 46889999998754433333345667899999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccccc
Q 017621          275 FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA  354 (368)
Q Consensus       275 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~  354 (368)
                      .+++..... ..+++.++..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||.+...... .......
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA  155 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence            999876442 3489999999999999999999999   9999999999999999999999999999866432 2223346


Q ss_pred             cccccccCCC
Q 017621          355 GTSGYIAPAS  364 (368)
Q Consensus       355 gt~~y~aPE~  364 (368)
                      |+..|+|||+
T Consensus       156 ~~~~y~~PE~  165 (277)
T cd05577         156 GTPGYMAPEV  165 (277)
T ss_pred             CCCCcCCHHH
Confidence            7889999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.95  E-value=4.5e-27  Score=212.90  Aligned_cols=173  Identities=28%  Similarity=0.405  Sum_probs=140.5

Q ss_pred             hhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      .++|++.+.||+|++|.||+|.+.      .+..||+|.+......  .....+.+|+.++++++|+||+++++++.+.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            467999999999999999999864      3567999988654322  22356888999999999999999999999988


Q ss_pred             eEEEEEeecCCCChhHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---CeE
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEE----AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL---EAF  333 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k  333 (368)
                      ..++||||+++++|.+++.....    ...+++..++.++.||+.||+|||++   +++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence            99999999999999999875432    12489999999999999999999999   999999999999998654   589


Q ss_pred             EeeeccceecCCCCCC--ccccccccccccCCC
Q 017621          334 VADFGVARLLNFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       334 l~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      |+|||+++........  .....++..|+|||+
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEA  192 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHH
Confidence            9999999876332211  111233567999993

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.95  E-value=1.9e-27  Score=215.30  Aligned_cols=168  Identities=33%  Similarity=0.489  Sum_probs=143.7

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      +.|+..+.||+|+||.||+|.+ .+++.||+|.+.......  ..+.+.+|++++++++||||+++++++..++..|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH--HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            3466778899999999999975 457889999887543322  3467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++...    .+++..+..++.|+++|+.|||++   +++|+||+|+||++++++.++++|||++......
T Consensus        82 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          82 EYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            999999999988643    378899999999999999999998   9999999999999999999999999999876544


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........|+..|+|||+
T Consensus       155 ~~~~~~~~~~~~y~aPE~  172 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEV  172 (277)
T ss_pred             chhhhcccCcccccCHHH
Confidence            333334568999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=5.4e-28  Score=240.55  Aligned_cols=173  Identities=27%  Similarity=0.442  Sum_probs=140.2

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee-----
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH-----  258 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  258 (368)
                      +-..+|+..+.||+||||.||+++.+ ||+.||||++.... . ......+.+|+.++++|+|||||+++..+.+     
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s-~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-S-DKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-H-HHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence            45678899999999999999999965 89999999998765 2 2344678899999999999999999844310     


Q ss_pred             -------------------------------------------------------------------------C------
Q 017621          259 -------------------------------------------------------------------------R------  259 (368)
Q Consensus       259 -------------------------------------------------------------------------~------  259 (368)
                                                                                               .      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                     0      


Q ss_pred             -----------------------------------CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 017621          260 -----------------------------------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS  304 (368)
Q Consensus       260 -----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~  304 (368)
                                                         ..+||-||||+...+.++++++.-.  -.....++++++|++||.
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHH
Confidence                                               1368889999988888888765421  145678899999999999


Q ss_pred             HHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC------------------CCCCCccccccccccccCCC
Q 017621          305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN------------------FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       305 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~------------------~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+|++   +||||||||.||++|+++.+||+|||+|....                  ......+..+||.-|+|||.
T Consensus       712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            99999   99999999999999999999999999998721                  01113456789999999994

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.95  E-value=5.1e-27  Score=212.78  Aligned_cols=172  Identities=22%  Similarity=0.354  Sum_probs=142.3

Q ss_pred             hhccccceeeeecCCccEEEEEcCC-----CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee-CC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS-----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH-RK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  260 (368)
                      .++|++.+.||+|+||.||+|...+     +..|++|.+......  ...+.+.+|+.++++++||||+++++++.. +.
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE--IQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4678999999999999999998654     678999988654322  234678899999999999999999998776 46


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEe
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEA-----VGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVA  335 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  335 (368)
                      ..++++||+++++|.+++......     ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998754322     3589999999999999999999998   99999999999999999999999


Q ss_pred             eeccceecCCCCCC--ccccccccccccCC
Q 017621          336 DFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       336 DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      |||+++.+......  .....++..|+|||
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE  189 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALE  189 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHH
Confidence            99999866432211  11234577899998

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.95  E-value=7e-27  Score=211.63  Aligned_cols=168  Identities=33%  Similarity=0.483  Sum_probs=144.8

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ..|+..+.||+|+||.||+|.+. +++.||+|.+......  ...+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35777888999999999999864 5889999988754332  23467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++...    .+++.++..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          82 EYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            999999999988753    278889999999999999999998   9999999999999999999999999999877544


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........++..|+|||+
T Consensus       155 ~~~~~~~~~~~~y~apE~  172 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEV  172 (277)
T ss_pred             ccccccccCcccccCHhH
Confidence            433344568899999994

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.95  E-value=6.1e-27  Score=208.69  Aligned_cols=164  Identities=28%  Similarity=0.433  Sum_probs=137.9

Q ss_pred             eeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCC
Q 017621          194 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGS  273 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  273 (368)
                      +.||+|+||.||+|.+.+++.||+|.+......  .....+.+|++++++++||||+++++++...+..++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            358999999999999766999999998765443  234678999999999999999999999999999999999999999


Q ss_pred             hhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCC--cc
Q 017621          274 LFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN--RT  351 (368)
Q Consensus       274 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~--~~  351 (368)
                      |.+++.....  .+++..+..++.+++.||+|||++   +++||||||+||+++.++.+||+|||+++........  ..
T Consensus        79 l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          79 LLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            9999875432  378899999999999999999999   9999999999999999999999999999865422211  11


Q ss_pred             ccccccccccCCC
Q 017621          352 LLAGTSGYIAPAS  364 (368)
Q Consensus       352 ~~~gt~~y~aPE~  364 (368)
                      ...++..|+|||.
T Consensus       154 ~~~~~~~y~~PE~  166 (251)
T cd05041         154 LKQIPIKWTAPEA  166 (251)
T ss_pred             cCcceeccCChHh
Confidence            1234567999983

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.95  E-value=5.4e-27  Score=210.44  Aligned_cols=162  Identities=29%  Similarity=0.453  Sum_probs=140.6

Q ss_pred             eeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCCh
Q 017621          196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSL  274 (368)
Q Consensus       196 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  274 (368)
                      ||+|++|.||+|+.. +++.+|+|.+...........+.+.+|+.+++.++||||+++++++.+++..|++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999864 4889999998765544333457889999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccccc
Q 017621          275 FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA  354 (368)
Q Consensus       275 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~  354 (368)
                      .+++.....   +++..+..++.|+++||+|||++   +++|+||+|+||+++.++.++|+|||+++...... ......
T Consensus        81 ~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~  153 (262)
T cd05572          81 WTILRDRGL---FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC  153 (262)
T ss_pred             HHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence            999976432   78899999999999999999998   99999999999999999999999999998775432 223346


Q ss_pred             cccccccCCC
Q 017621          355 GTSGYIAPAS  364 (368)
Q Consensus       355 gt~~y~aPE~  364 (368)
                      |++.|+|||+
T Consensus       154 ~~~~~~~PE~  163 (262)
T cd05572         154 GTPEYVAPEI  163 (262)
T ss_pred             CCcCccChhH
Confidence            8999999984

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=7.6e-27  Score=209.76  Aligned_cols=159  Identities=26%  Similarity=0.374  Sum_probs=131.1

Q ss_pred             eeeeecCCccEEEEEcCC-------------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          194 YCIGTGGYGSVYRARLPS-------------GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      +.||+|+||+||+|...+             ...+|+|.+.....   .....+.+|+.++..++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR---DISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh---hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            358999999999997432             23588898765432   23457888999999999999999999999998


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC-------eE
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE-------AF  333 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~k  333 (368)
                      ..++||||+++|+|..++.....  .+++..+..++.||++||+|||++   +|+||||||+|||++.++.       ++
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            99999999999999888865432  378999999999999999999999   9999999999999987664       89


Q ss_pred             EeeeccceecCCCCCCccccccccccccCCC
Q 017621          334 VADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       334 l~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++|||++......    ....|+..|+|||+
T Consensus       153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~  179 (262)
T cd05077         153 LSDPGIPITVLSR----QECVERIPWIAPEC  179 (262)
T ss_pred             eCCCCCCccccCc----ccccccccccChhh
Confidence            9999998765322    22357889999993

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.95  E-value=6.5e-27  Score=213.22  Aligned_cols=170  Identities=29%  Similarity=0.421  Sum_probs=142.9

Q ss_pred             ccccceeeeecCCccEEEEEc----CCCCEEEEEEccccchhh-HHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEE-LASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  262 (368)
                      +|++.+.||+|+||.||+|+.    .+|+.||+|.+....... ....+.+.+|++++.++ +|+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999975    368899999987543221 12346778899999999 699999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+||||+++++|.+++....   .+++..+..++.|++.||.|||+.   +++||||+|+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999987643   378888899999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccCCC
Q 017621          343 LNFDSS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~-~~~~~~gt~~y~aPE~  364 (368)
                      ...... ......|+..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~  177 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDI  177 (290)
T ss_pred             cccccccccccccCCcccCChhh
Confidence            654322 2223568999999983

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=8.1e-27  Score=211.59  Aligned_cols=169  Identities=28%  Similarity=0.452  Sum_probs=141.7

Q ss_pred             hccccceeeeecCCccEEEEEcC-----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee--CC
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH--RK  260 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  260 (368)
                      ++|++.+.||+|+||.||+|...     ++..+|+|.+......  ...+.+.+|+++++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            46788899999999999999743     4678999998765443  234789999999999999999999999887  55


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..+++|||+++++|.+++.....  .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            78999999999999999976543  389999999999999999999998   9999999999999999999999999999


Q ss_pred             eecCCCCCC---ccccccccccccCC
Q 017621          341 RLLNFDSSN---RTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~---~~~~~gt~~y~aPE  363 (368)
                      .........   .....++..|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe  182 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPE  182 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcH
Confidence            877533221   11123456799998

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=246.32  Aligned_cols=170  Identities=31%  Similarity=0.483  Sum_probs=145.3

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      +-++.-...||.|.||+||-|.. .+|...|+|.++..... ....+.+.+|..++..++|||+|+++|+-..++..+|.
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            34556677899999999999974 57899999988765544 34556788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||||++|+|.+.++....   .++.-...+..|++.|+.|||++   |||||||||+||+++.+|.+|++|||.|..+..
T Consensus      1313 MEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999999999999986432   56666667889999999999999   999999999999999999999999999998765


Q ss_pred             CCC----CccccccccccccCC
Q 017621          346 DSS----NRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~----~~~~~~gt~~y~aPE  363 (368)
                      ...    ......||+.|||||
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPE 1408 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPE 1408 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCch
Confidence            432    223468999999999

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.95  E-value=5.6e-27  Score=213.18  Aligned_cols=170  Identities=29%  Similarity=0.443  Sum_probs=143.8

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|++|.||+|... +++.||+|.++..... ....+.+.+|++++++++|+||+++++++..++..++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            36889999999999999999865 5889999988754332 223467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||++++.+..+.....   .+++.++..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          80 EYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             ecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9999877766554432   378999999999999999999999   9999999999999999999999999999877654


Q ss_pred             CC-CccccccccccccCCC
Q 017621          347 SS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE~  364 (368)
                      .. ......++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~~PE~  172 (288)
T cd07833         154 PASPLTDYVATRWYRAPEL  172 (288)
T ss_pred             ccccccCcccccCCcCCch
Confidence            32 2334568899999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.7e-27  Score=211.19  Aligned_cols=167  Identities=35%  Similarity=0.568  Sum_probs=144.4

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC---CCceeeEEEEEeeCCeEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW---HRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  264 (368)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.+......  ...+++.+|+.++++++   |||++++++++..+...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            477788999999999999985 57899999998654322  23457788999999986   9999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++++|.++++..    .+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            99999999999988653    388999999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..........|+..|+|||+
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~  172 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEV  172 (277)
T ss_pred             CCccccccccCCcceeCHHH
Confidence            55444444578999999993

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=5.2e-27  Score=209.93  Aligned_cols=157  Identities=26%  Similarity=0.443  Sum_probs=131.7

Q ss_pred             eeeeecCCccEEEEEcCCCC-----------EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          194 YCIGTGGYGSVYRARLPSGK-----------VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      +.||+|+||.||+|.+.+..           .+++|.+......    ...+.+|+.++++++||||+++++++.. +..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            35899999999999875432           5778876544321    4678899999999999999999999988 778


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-------CeEEe
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-------EAFVA  335 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~  335 (368)
                      ++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++       .+||+
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            999999999999999976542  488999999999999999999998   999999999999999887       79999


Q ss_pred             eeccceecCCCCCCccccccccccccCCC
Q 017621          336 DFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       336 DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |||++.....    .....++..|+|||+
T Consensus       151 Dfg~a~~~~~----~~~~~~~~~y~aPE~  175 (259)
T cd05037         151 DPGIPITVLS----REERVERIPWIAPEC  175 (259)
T ss_pred             CCCccccccc----ccccccCCCccChhh
Confidence            9999987643    122356778999984

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.95  E-value=8.1e-27  Score=211.88  Aligned_cols=169  Identities=30%  Similarity=0.408  Sum_probs=144.9

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|++|.||+|.+ .+++.||+|++....... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            588899999999999999986 468899999987654322 234678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+ +++|.+++....  ..+++.++..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            99 999999987543  3489999999999999999999999   99999999999999999999999999998775433


Q ss_pred             C-CccccccccccccCCC
Q 017621          348 S-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~-~~~~~~gt~~y~aPE~  364 (368)
                      . ......|+..|+|||+
T Consensus       154 ~~~~~~~~~~~~y~aPE~  171 (286)
T cd07832         154 PRLYSHQVATRWYRAPEL  171 (286)
T ss_pred             CCccccccCcccccCcee
Confidence            2 1233468999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.95  E-value=2.1e-27  Score=217.42  Aligned_cols=165  Identities=28%  Similarity=0.452  Sum_probs=140.7

Q ss_pred             cccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |+....||+|+||.||+|... +++.||+|.+......   ..+.+.+|+.++..++||||+++++++..++..|+||||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            334456999999999999854 6889999998654322   235678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +++++|.+++...    .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus       100 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         100 LQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            9999999877542    278999999999999999999999   999999999999999999999999999976654443


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                      ......|+..|+|||+
T Consensus       173 ~~~~~~~~~~y~aPE~  188 (297)
T cd06659         173 KRKSLVGTPYWMAPEV  188 (297)
T ss_pred             cccceecCccccCHHH
Confidence            3445679999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.95  E-value=6.4e-27  Score=209.78  Aligned_cols=172  Identities=26%  Similarity=0.463  Sum_probs=143.8

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee--CCeEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH--RKCMFLI  265 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  265 (368)
                      +|++.+.||+|+||.||+|.. .+++.+|+|.+...... ....+++.+|++++++++||||+++++++..  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            578889999999999999975 46789999988654332 2234678899999999999999999998764  4568999


Q ss_pred             EeecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          266 YEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLH-----HHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      |||+++++|.+++... .....+++..++.++.|++.||.|||     +.   +++|+||||+||++++++.+||+|||+
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence            9999999999998653 12334899999999999999999999     66   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +..............|++.|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~pE~  181 (265)
T cd08217         157 AKILGHDSSFAKTYVGTPYYMSPEQ  181 (265)
T ss_pred             cccccCCcccccccccCCCccChhh
Confidence            9887654432334578999999994

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-26  Score=206.71  Aligned_cols=168  Identities=31%  Similarity=0.469  Sum_probs=147.1

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|++|.||++... +++.|++|.+...... ....+.+.+|++++++++|||++++++++.+.+..+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            4788899999999999999754 6789999999765442 2345788999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          80 YAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             cCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            999999999987653   389999999999999999999999   99999999999999999999999999998876544


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                      .......|+..|+|||
T Consensus       154 ~~~~~~~~~~~y~~pe  169 (254)
T cd06627         154 KDDASVVGTPYWMAPE  169 (254)
T ss_pred             ccccccccchhhcCHh
Confidence            4334457899999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.95  E-value=1e-26  Score=208.58  Aligned_cols=169  Identities=31%  Similarity=0.497  Sum_probs=145.5

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|+.++++++|+||+++++++...+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            478889999999999999985 46889999998765443 2355788999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++....   .+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999987643   278888999999999999999999   99999999999999999999999999998775433


Q ss_pred             CCc----cccccccccccCCC
Q 017621          348 SNR----TLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~----~~~~gt~~y~aPE~  364 (368)
                      ...    ....+++.|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~  174 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEV  174 (264)
T ss_pred             CcccccccCCcCCcCccChhh
Confidence            321    12467889999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=6.5e-27  Score=216.19  Aligned_cols=163  Identities=20%  Similarity=0.184  Sum_probs=127.2

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC--CCCEEEEEEccccch--hhHHhHHHHHHHHHHHhccCCCceee-EEEEEeeC
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP--SGKVVALKKLHRSET--EELASLESFRNEARLLSQIWHRNIVK-LYGFCLHR  259 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~  259 (368)
                      ....+|++.+.||+|+||+||+|.+.  +++.+|||++.....  ......+.+.+|++++++++|+|++. ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34567999999999999999999754  577789998653311  11123467899999999999999985 4432    


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeecCCCCeEEeeec
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDI-SSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFg  338 (368)
                      +..|+||||+++++|... ..      ..   ...++.|+++||.|||++   +|+|||| ||+|||++.++.+||+|||
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence            457999999999999632 11      11   145788999999999999   9999999 9999999999999999999


Q ss_pred             cceecCCCCCC--------ccccccccccccCCC
Q 017621          339 VARLLNFDSSN--------RTLLAGTSGYIAPAS  364 (368)
Q Consensus       339 ~a~~~~~~~~~--------~~~~~gt~~y~aPE~  364 (368)
                      +|+.+......        .+...+++.|+|||+
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~  191 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDA  191 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCccc
Confidence            99987654321        134568899999985

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=7.8e-27  Score=211.11  Aligned_cols=157  Identities=27%  Similarity=0.360  Sum_probs=128.7

Q ss_pred             eeeecCCccEEEEEcC-------------------------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCce
Q 017621          195 CIGTGGYGSVYRARLP-------------------------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI  249 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  249 (368)
                      .||+|+||.||+|...                         ....||+|.+.....   ....++.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence            5899999999998631                         123588998865432   233578889999999999999


Q ss_pred             eeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       250 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                      +++++++.+.+..++||||+++|+|..++.....  .+++..+..++.|+++||+|||++   +|+||||||+||++++.
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            9999999999999999999999999998865332  378899999999999999999998   99999999999999764


Q ss_pred             C-------CeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          330 L-------EAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       330 ~-------~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +       .+|++|||++......    ....++..|+|||
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe  190 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPE  190 (274)
T ss_pred             CcccCccceeeecCCccccccccc----cccccCCcccCch
Confidence            3       3799999988654322    1235788899998

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.95  E-value=4.4e-27  Score=213.56  Aligned_cols=169  Identities=31%  Similarity=0.457  Sum_probs=142.6

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|+..+.||+|++|.||+|+.. +++.||+|.+....... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            4788999999999999999864 68899999886543221 223578889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+. ++|.+++..... ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          80 FLH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             ccc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            996 588888865432 3489999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                      .......+++.|+|||
T Consensus       155 ~~~~~~~~~~~y~aPE  170 (284)
T cd07860         155 RTYTHEVVTLWYRAPE  170 (284)
T ss_pred             cccccccccccccCCe
Confidence            3333445788999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.94  E-value=9.7e-27  Score=215.89  Aligned_cols=168  Identities=18%  Similarity=0.307  Sum_probs=137.0

Q ss_pred             cceeeeec--CCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          192 IKYCIGTG--GYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       192 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      +.++||+|  +|++||++.. .+++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            45779999  6789999975 578999999987643322 2345677899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +++|+|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||+.+........
T Consensus        81 ~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999999865432 2388999999999999999999998   999999999999999999999999987544322111


Q ss_pred             -------CccccccccccccCCC
Q 017621          349 -------NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 -------~~~~~~gt~~y~aPE~  364 (368)
                             ......++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~  179 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEV  179 (327)
T ss_pred             cccccccccccccceecccChHH
Confidence                   0112356788999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-27  Score=221.68  Aligned_cols=169  Identities=27%  Similarity=0.346  Sum_probs=142.8

Q ss_pred             hhccccceeeeecCCccEEEEEcCC-CCEEEEEEccccchhhHHhHH-----HHHHHHHHHhccC---CCceeeEEEEEe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLE-----SFRNEARLLSQIW---HRNIVKLYGFCL  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~---h~niv~l~~~~~  257 (368)
                      ..+|...+.+|+|+||+|+.|.++. ...|+||.+.+...-....++     ..-.|+.+|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            4578999999999999999998754 567999998776543222211     2335999999997   999999999999


Q ss_pred             eCCeEEEEEeec-CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          258 HRKCMFLIYEYM-EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       258 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                      +++++||+||-. ++-+|++++.....   +++.++..|++||+.|+++||++   +|||||||-+|++++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            999999999987 45599999987554   89999999999999999999999   999999999999999999999999


Q ss_pred             eccceecCCCCCCccccccccccccCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ||.|.......  ...++||..|.|||
T Consensus       714 fgsaa~~ksgp--fd~f~gtv~~aape  738 (772)
T KOG1152|consen  714 FGSAAYTKSGP--FDVFVGTVDYAAPE  738 (772)
T ss_pred             ccchhhhcCCC--cceeeeeccccchh
Confidence            99997765333  34568999999997

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=1.2e-26  Score=209.40  Aligned_cols=169  Identities=26%  Similarity=0.409  Sum_probs=141.7

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchh-------hHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE-------ELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      +|...+.||+|+||.||+|.. .+++.+|+|.+......       .....+.+.+|+.++++++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999975 46889999987542211       1112457888999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..++||||+++++|.++++...   .+++..+..++.|++.||.|||++   +++||||+|+||+++.++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999987653   388899999999999999999998   9999999999999999999999999999


Q ss_pred             eecCCCCC--CccccccccccccCC
Q 017621          341 RLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      +.......  ......|+..|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE  180 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPE  180 (272)
T ss_pred             ccccccccccccccccCCccccCHH
Confidence            86543221  123346889999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=222.32  Aligned_cols=167  Identities=29%  Similarity=0.480  Sum_probs=140.5

Q ss_pred             ccccceeeeecCCccEEEEEcCC---CC--EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLPS---GK--VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      .....++||.|-||.||+|...+   |+  .||||..+.....+  ..+.|..|+.+|+.++||||++++|+|.+. ..|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d--~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD--DTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh--hHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            34456789999999999997432   32  58999988765543  358899999999999999999999999875 589


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +|||.++.|.|..+++.+...  ++......++.||+.||.|||+.   ++|||||..+|||+.....+||+|||+++.+
T Consensus       467 ivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             EEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence            999999999999999876543  88888899999999999999999   9999999999999999999999999999998


Q ss_pred             CCCCCCcccc-ccccccccCC
Q 017621          344 NFDSSNRTLL-AGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~-~gt~~y~aPE  363 (368)
                      .++..-.... .-...|||||
T Consensus       542 ed~~yYkaS~~kLPIKWmaPE  562 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPE  562 (974)
T ss_pred             cccchhhccccccceeecCcc
Confidence            7654432221 1245799999

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=5.9e-27  Score=215.94  Aligned_cols=172  Identities=28%  Similarity=0.469  Sum_probs=140.1

Q ss_pred             ccccceeeeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMF  263 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  263 (368)
                      +|++.+.||+|++|.||+|...   +++.||+|.+...........+.+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999864   4789999998764322222335677899999999999999999999988  7899


Q ss_pred             EEEeecCCCChhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC----CCCeEEeee
Q 017621          264 LIYEYMEMGSLFCVLRTDEE--AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS----ELEAFVADF  337 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DF  337 (368)
                      +||||+++ ++.+.+.....  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 67666643221  22478899999999999999999999   9999999999999999    899999999


Q ss_pred             ccceecCCCCC---CccccccccccccCCC
Q 017621          338 GVARLLNFDSS---NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~---~~~~~~gt~~y~aPE~  364 (368)
                      |+++.......   ......+|+.|+|||+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  186 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPEL  186 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHH
Confidence            99987654322   1223468899999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.94  E-value=9.7e-27  Score=207.89  Aligned_cols=162  Identities=27%  Similarity=0.500  Sum_probs=137.2

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      ++|++.+.||+|+||.||++.. +++.||+|.+.....     .+.+.+|+.++++++||||+++++++..++ .++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e   78 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVME   78 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEE
Confidence            5689999999999999999975 678899999865332     257889999999999999999999987654 799999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        79 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          79 LMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             CCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            9999999999976432 3478999999999999999999998   99999999999999999999999999998654321


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                         .....+..|+|||
T Consensus       155 ---~~~~~~~~y~~pe  167 (254)
T cd05083         155 ---DNSKLPVKWTAPE  167 (254)
T ss_pred             ---CCCCCCceecCHH
Confidence               1223456799998

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.94  E-value=1.7e-26  Score=212.33  Aligned_cols=168  Identities=32%  Similarity=0.475  Sum_probs=141.4

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .+.|+..+.||+|+||+||+|... +++.||+|.+...........+++.+|+++++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            345888899999999999999864 6889999988654333333446788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||++ |++.+.+.....  .+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 577776654322  389999999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .    ....|++.|+|||+
T Consensus       168 ~----~~~~~~~~y~aPE~  182 (307)
T cd06607         168 A----NSFVGTPYWMAPEV  182 (307)
T ss_pred             C----CCccCCccccCcee
Confidence            2    23468889999994

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.94  E-value=2.8e-27  Score=212.48  Aligned_cols=168  Identities=29%  Similarity=0.415  Sum_probs=144.4

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|+..+.||+|++|.||+|... +++.+|+|.+......  ...+++.+|++++++++||||+++++.+...+..++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            36788899999999999999865 6889999988765432  23467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||+++++|.+++....  ..+++..+..++.|++.||+|||+ .   +++|+||||+||++++++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            9999999999997643  348889999999999999999999 7   999999999999999999999999999876643


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      ....  ...|+..|+|||+
T Consensus       154 ~~~~--~~~~~~~y~~PE~  170 (265)
T cd06605         154 SLAK--TFVGTSSYMAPER  170 (265)
T ss_pred             HHhh--cccCChhccCHHH
Confidence            2221  1568999999994

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.3e-26  Score=207.39  Aligned_cols=162  Identities=28%  Similarity=0.431  Sum_probs=133.8

Q ss_pred             eeeeecCCccEEEEEcC--C--CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeec
Q 017621          194 YCIGTGGYGSVYRARLP--S--GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  269 (368)
                      +.||+|+||.||+|...  +  +..+|+|.+......  ...+++.+|+.+++.+.||||+++++++.. +..++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence            36999999999999742  2  368999998765543  234678899999999999999999998764 4689999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCC
Q 017621          270 EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN  349 (368)
Q Consensus       270 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~  349 (368)
                      ++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++........
T Consensus        78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999997654   389999999999999999999998   9999999999999999999999999999876543322


Q ss_pred             cc---ccccccccccCCC
Q 017621          350 RT---LLAGTSGYIAPAS  364 (368)
Q Consensus       350 ~~---~~~gt~~y~aPE~  364 (368)
                      ..   ...++..|+|||+
T Consensus       152 ~~~~~~~~~~~~y~aPE~  169 (257)
T cd05060         152 YRATTAGRWPLKWYAPEC  169 (257)
T ss_pred             cccccCccccccccCHHH
Confidence            11   1123567999993

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.94  E-value=1e-26  Score=210.91  Aligned_cols=162  Identities=25%  Similarity=0.298  Sum_probs=130.8

Q ss_pred             eeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHH---HHhccCCCceeeEEEEEeeCCeEEEEEeecC
Q 017621          195 CIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEAR---LLSQIWHRNIVKLYGFCLHRKCMFLIYEYME  270 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  270 (368)
                      .||+|+||.||++.. .+++.+|+|.+.............+.+|..   ++...+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999986 468899999886543322111223334443   3344579999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCc
Q 017621          271 MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR  350 (368)
Q Consensus       271 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~  350 (368)
                      +++|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.++|+|||++.......  .
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~  152 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence            999999887543   389999999999999999999999   99999999999999999999999999997654322  2


Q ss_pred             cccccccccccCCC
Q 017621          351 TLLAGTSGYIAPAS  364 (368)
Q Consensus       351 ~~~~gt~~y~aPE~  364 (368)
                      ....||..|+|||+
T Consensus       153 ~~~~~~~~y~aPE~  166 (279)
T cd05633         153 HASVGTHGYMAPEV  166 (279)
T ss_pred             cCcCCCcCccCHHH
Confidence            23468999999983

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.94  E-value=7.5e-28  Score=207.16  Aligned_cols=165  Identities=29%  Similarity=0.411  Sum_probs=136.8

Q ss_pred             Hhhccccc-eeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEee----
Q 017621          186 ATEDFHIK-YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLH----  258 (368)
Q Consensus       186 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----  258 (368)
                      .+++|++. ++||-|-.|+|-.+.. .+++.+|+|++...        ...++|+++--.. .|||||.++++|+.    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            45677664 6799999999999975 46889999988643        3446788875555 79999999998864    


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCCeEEe
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS---ELEAFVA  335 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~  335 (368)
                      ...+.+|||.|+||.|++.++.++. ..+++.++..|+.||+.|+.|||+.   +|.||||||+|+|...   +..+||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence            4578999999999999999987653 4599999999999999999999999   9999999999999964   4579999


Q ss_pred             eeccceecCCCCCCccccccccccccCC
Q 017621          336 DFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       336 DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      |||+|+.-.... ...+.|-||+|.|||
T Consensus       207 DfGFAK~t~~~~-~L~TPc~TPyYvaPe  233 (400)
T KOG0604|consen  207 DFGFAKETQEPG-DLMTPCFTPYYVAPE  233 (400)
T ss_pred             ccccccccCCCc-cccCCcccccccCHH
Confidence            999999865433 334468899999998

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=9.4e-27  Score=208.81  Aligned_cols=163  Identities=27%  Similarity=0.435  Sum_probs=131.6

Q ss_pred             eeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEe-eCCeEEEEEee
Q 017621          194 YCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCL-HRKCMFLIYEY  268 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~  268 (368)
                      +.||+|+||+||+|...    +...+|+|.+......  ...+.+.+|+.+++.++||||+++++++. .++..+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH--HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            35899999999999743    2457999988643221  23467889999999999999999999776 45568999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +.+++|.+++.....  ..++..+..++.|+++||+|||+.   +++||||||+|||+++++.+||+|||+++.......
T Consensus        79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          79 MKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            999999999975432  267788889999999999999998   999999999999999999999999999986543221


Q ss_pred             ----CccccccccccccCC
Q 017621          349 ----NRTLLAGTSGYIAPA  363 (368)
Q Consensus       349 ----~~~~~~gt~~y~aPE  363 (368)
                          ......++..|+|||
T Consensus       154 ~~~~~~~~~~~~~~y~aPE  172 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALE  172 (262)
T ss_pred             eeecccccCcCCccccChh
Confidence                112234677899998

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=1.2e-26  Score=209.15  Aligned_cols=169  Identities=31%  Similarity=0.452  Sum_probs=139.1

Q ss_pred             hccccceeeeecCCccEEEEEcCC----CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|.+.+.||+|+||.||+|...+    ...||+|........  ...+.+.+|+.++++++||||+++++++.+ +..|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP--SVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            468889999999999999997533    346899988755432  234678999999999999999999999875 4578


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +||||+++++|.+++.....  .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++..
T Consensus        83 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999999976432  389999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCC-ccccccccccccCCC
Q 017621          344 NFDSSN-RTLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~~~~~-~~~~~gt~~y~aPE~  364 (368)
                      ...... .....++..|+|||+
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~  179 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPES  179 (270)
T ss_pred             ccccceecCCCCccccccChhh
Confidence            543221 122234568999993

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=1.3e-26  Score=209.09  Aligned_cols=165  Identities=28%  Similarity=0.507  Sum_probs=132.4

Q ss_pred             eeeeecCCccEEEEEcCC-CC--EEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeec
Q 017621          194 YCIGTGGYGSVYRARLPS-GK--VVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  269 (368)
                      +.||+|+||.||+|.+.+ +.  .+|+|.+......  ...+.+.+|++++.++ +||||+++++++...+..|+||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH--HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            358999999999998643 43  4688888643222  2346788999999999 8999999999999999999999999


Q ss_pred             CCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          270 EMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       270 ~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                      ++|+|.+++....             ....+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence            9999999987532             112478899999999999999999998   999999999999999999999999


Q ss_pred             eccceecCCCCCCccccccccccccCCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ||++....... .......+..|+|||+
T Consensus       156 fgl~~~~~~~~-~~~~~~~~~~y~apE~  182 (270)
T cd05047         156 FGLSRGQEVYV-KKTMGRLPVRWMAIES  182 (270)
T ss_pred             CCCccccchhh-hccCCCCccccCChHH
Confidence            99986432111 1111234567999983

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.94  E-value=5e-27  Score=210.45  Aligned_cols=162  Identities=29%  Similarity=0.484  Sum_probs=140.1

Q ss_pred             eeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCCh
Q 017621          196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSL  274 (368)
Q Consensus       196 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  274 (368)
                      ||+|+||.||++... +++.+|+|.+...........+.+.+|++++++++||||+++++.+..++..|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999875 4899999998765544344567889999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC------
Q 017621          275 FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS------  348 (368)
Q Consensus       275 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~------  348 (368)
                      .+++....   .+++..+..++.|+++||+|||+.   +++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99997644   389999999999999999999998   999999999999999999999999999876543321      


Q ss_pred             --CccccccccccccCC
Q 017621          349 --NRTLLAGTSGYIAPA  363 (368)
Q Consensus       349 --~~~~~~gt~~y~aPE  363 (368)
                        ......++..|+|||
T Consensus       155 ~~~~~~~~~~~~~~~Pe  171 (265)
T cd05579         155 EKEDKRIVGTPDYIAPE  171 (265)
T ss_pred             cccccCcccCccccCHH
Confidence              223346889999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=7.1e-27  Score=212.37  Aligned_cols=168  Identities=27%  Similarity=0.402  Sum_probs=143.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||++... +++.||+|++......  ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS--SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc--hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            57888999999999999999854 6889999987654322  23467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++....   .+++..+..++.+++.||.|||+..  +++||||||+||++++++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          83 EFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             ecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999999887643   3889999999999999999999732  8999999999999999999999999998765322


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      .  .....|+..|+|||+
T Consensus       158 ~--~~~~~~~~~~~aPE~  173 (284)
T cd06620         158 I--ADTFVGTSTYMSPER  173 (284)
T ss_pred             c--cCccccCcccCCHHH
Confidence            2  223478999999994

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.94  E-value=1.8e-26  Score=206.19  Aligned_cols=168  Identities=30%  Similarity=0.520  Sum_probs=141.4

Q ss_pred             cccceeeeecCCccEEEEEcCC-----CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          190 FHIKYCIGTGGYGSVYRARLPS-----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      +++.+.||+|+||.||++...+     +..||+|.+.......  ..+.+.+|++++..++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            3567889999999999998643     4789999997654321  34688899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      +|||+++++|.+++...... .+++.++..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||+++...
T Consensus        79 i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence            99999999999998764321 279999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCCCcc-ccccccccccCC
Q 017621          345 FDSSNRT-LLAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~~~~-~~~gt~~y~aPE  363 (368)
                      ....... ...+++.|+|||
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe  174 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPE  174 (258)
T ss_pred             cccccccccCCCcccccChH
Confidence            4422111 123678999998

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.94  E-value=1.5e-26  Score=211.19  Aligned_cols=171  Identities=27%  Similarity=0.415  Sum_probs=140.5

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|++|+||+|... +++.||+|.+....... ...+.+.+|++++++++||||+++++++...+..|+||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            57899999999999999999864 68899999986543221 23356788999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCCeEEeeeccceecCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-ELEAFVADFGVARLLNF  345 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFg~a~~~~~  345 (368)
                      ||++ +++.+.+..... ..+++..+..++.||+.||+|||++   +++||||+|+||+++. ++.+||+|||++.....
T Consensus        81 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             eccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            9996 578777764432 2357888889999999999999999   9999999999999985 55789999999987654


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........|++.|+|||+
T Consensus       156 ~~~~~~~~~~~~~y~~PE~  174 (294)
T PLN00009        156 PVRTFTHEVVTLWYRAPEI  174 (294)
T ss_pred             CccccccCceeecccCHHH
Confidence            3333333467899999983

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.94  E-value=7.4e-27  Score=214.35  Aligned_cols=170  Identities=26%  Similarity=0.434  Sum_probs=138.4

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCC----EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      .++|+..+.||+|+||.||+|.+. ++.    .+|+|.+......  ....++.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            356888899999999999999753 343    5789988754332  2235688999999999999999999998764 4


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .++++||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence            6799999999999999875432  378899999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCCC--ccccccccccccCCC
Q 017621          342 LLNFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      ........  .....++..|+|||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~  182 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALEC  182 (303)
T ss_pred             cccCcccccccCCCccccccCCHHH
Confidence            76533221  122345778999983

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.94  E-value=3.8e-27  Score=213.18  Aligned_cols=170  Identities=28%  Similarity=0.472  Sum_probs=146.1

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  265 (368)
                      ++|.+.+.||+|++|.||+|... +++.||+|++...........+.+.+|.+++.+++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999864 78999999987644333334467888999999998 99999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999998654   389999999999999999999998   999999999999999999999999999987654


Q ss_pred             CC--------------------CCccccccccccccCC
Q 017621          346 DS--------------------SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~--------------------~~~~~~~gt~~y~aPE  363 (368)
                      ..                    .......|+..|+|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe  192 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE  192 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHH
Confidence            32                    1122346789999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.94  E-value=1.4e-26  Score=211.41  Aligned_cols=171  Identities=26%  Similarity=0.349  Sum_probs=140.1

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCe----
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKC----  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~----  261 (368)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+...... ......+.+|+.+++++ +||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            46889999999999999999864 6889999987654322 12235678899999999 56999999999887665    


Q ss_pred             -EEEEEeecCCCChhHHhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCCeEEeee
Q 017621          262 -MFLIYEYMEMGSLFCVLRTDEE--AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-ELEAFVADF  337 (368)
Q Consensus       262 -~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DF  337 (368)
                       .|+||||+++ +|.+++.....  ...+++..++.++.||++||+|||++   +|+||||||+||+++. ++.+||+||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence             8999999985 78887764322  23479999999999999999999999   9999999999999998 889999999


Q ss_pred             ccceecCCCCCCccccccccccccCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      |+++.+...........+++.|+|||
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE  181 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPE  181 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChH
Confidence            99987654333333346788999998

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.94  E-value=2e-26  Score=205.74  Aligned_cols=169  Identities=25%  Similarity=0.429  Sum_probs=143.1

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|+..+.||+|++|.||+|.. .+++.+|+|.+....... ...+.+.+|++++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            478899999999999999975 468899999987543322 234678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CCeEEeeeccceecCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFD  346 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFg~a~~~~~~  346 (368)
                      |+++++|.+++.... ...+++..+..++.|+++||+|||++   +++|+||+|+||+++++ +.+||+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999997643 23378999999999999999999999   99999999999999865 46899999999877543


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      ... ....|+..|+|||
T Consensus       156 ~~~-~~~~~~~~y~aPE  171 (256)
T cd08220         156 SKA-YTVVGTPCYISPE  171 (256)
T ss_pred             ccc-cccccCCcccCch
Confidence            322 2346899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-27  Score=194.04  Aligned_cols=174  Identities=24%  Similarity=0.369  Sum_probs=140.1

Q ss_pred             HHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCe
Q 017621          184 IEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       184 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  261 (368)
                      ....++...+..||+|++|.|-+-++ .+|+..|+|.+......+  ...+..+|+.+..+. .+|++|.++|.+.....
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q--~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ--EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH--HHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            34455666678899999999988875 579999999998765543  346777888876655 89999999999998899


Q ss_pred             EEEEEeecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          262 MFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      .|+.||.|+. +|..+.++- ......++.-.-+|+..+.+||.|||++.  .++|||+||+|||++.+|++|+||||++
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence            9999999974 776544321 12234788888899999999999999986  8999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      -.+.+.- ..+...|...|||||
T Consensus       197 G~L~dSi-Akt~daGCkpYmaPE  218 (282)
T KOG0984|consen  197 GYLVDSI-AKTMDAGCKPYMAPE  218 (282)
T ss_pred             eeehhhh-HHHHhcCCCccCChh
Confidence            8876432 334457889999998

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.94  E-value=1.7e-26  Score=210.12  Aligned_cols=170  Identities=32%  Similarity=0.490  Sum_probs=147.4

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      +..+.|+..+.||+|++|.||+|.+. +++.+++|.+.....    ..+.+.+|+++++.++|+|++++++++...+..|
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            34566888899999999999999875 688999999875443    3467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +++||+++++|.+++....  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            9999999999999998754  2489999999999999999999998   9999999999999999999999999998766


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ...........|+..|+|||
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE  186 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPE  186 (286)
T ss_pred             ccchhhhccccCCcccCCHh
Confidence            54433333446889999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.94  E-value=2.3e-26  Score=208.45  Aligned_cols=162  Identities=26%  Similarity=0.303  Sum_probs=131.2

Q ss_pred             eeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHH---HHHhccCCCceeeEEEEEeeCCeEEEEEeecC
Q 017621          195 CIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEA---RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYME  270 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  270 (368)
                      .||+|+||.||+|.. .+++.||+|.+.............+..|.   ..++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999986 45889999998764332111112233333   34555689999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCc
Q 017621          271 MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR  350 (368)
Q Consensus       271 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~  350 (368)
                      +++|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.......  .
T Consensus        81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~  152 (278)
T cd05606          81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (278)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence            999999887543   389999999999999999999998   99999999999999999999999999997654322  2


Q ss_pred             cccccccccccCCC
Q 017621          351 TLLAGTSGYIAPAS  364 (368)
Q Consensus       351 ~~~~gt~~y~aPE~  364 (368)
                      ....|+..|+|||+
T Consensus       153 ~~~~~~~~y~aPE~  166 (278)
T cd05606         153 HASVGTHGYMAPEV  166 (278)
T ss_pred             cCcCCCcCCcCcHH
Confidence            23478999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3e-26  Score=205.34  Aligned_cols=160  Identities=26%  Similarity=0.402  Sum_probs=132.6

Q ss_pred             eeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHH-hccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLL-SQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.||+|+||.||+|.. .+++.||+|.+.............+..|..++ ...+|||++++++++..++..|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4589999999999986 46889999998765433222333445555544 455899999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      ++|.++++...   .+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.+||+|||+++....    ..
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  151 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK  151 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence            99999997643   378899999999999999999998   999999999999999999999999999876543    22


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ...|+..|+|||
T Consensus       152 ~~~~~~~y~~pe  163 (260)
T cd05611         152 KFVGTPDYLAPE  163 (260)
T ss_pred             cCCCCcCccChh
Confidence            346889999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.94  E-value=3.9e-26  Score=210.92  Aligned_cols=166  Identities=31%  Similarity=0.466  Sum_probs=139.9

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      .|+..+.||+|+||.||+++. .++..+|+|.+.............+.+|++++++++|||++++++++.+++..|+|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            367788899999999999985 4688999999865433333344678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+. |++.+.+....  ..+++.++..++.|++.||.|||+.   +|+||||+|+||+++.++.+||+|||++...... 
T Consensus       106 ~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         106 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            997 47777765432  2389999999999999999999999   9999999999999999999999999998765432 


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                         ....|++.|+|||+
T Consensus       179 ---~~~~~~~~y~aPE~  192 (317)
T cd06635         179 ---NSFVGTPYWMAPEV  192 (317)
T ss_pred             ---ccccCCccccChhh
Confidence               23468899999995

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.94  E-value=2.5e-26  Score=211.36  Aligned_cols=172  Identities=33%  Similarity=0.440  Sum_probs=141.7

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCM  262 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  262 (368)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|.+....... .....+.+|++++++++|+||+++++++...  +..
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            356899999999999999999986 468999999986543221 1123456799999999999999999998765  568


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++ +|.+++....  ..+++.++..++.|+++||+|||+.   +++||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence            999999974 8888876533  3489999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCCCccccccccccccCCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ............+++.|+|||+
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~  179 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPEL  179 (309)
T ss_pred             cCCccCCCCcccccccccChhh
Confidence            7654333333456888999994

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.94  E-value=1.1e-26  Score=208.23  Aligned_cols=159  Identities=25%  Similarity=0.422  Sum_probs=131.9

Q ss_pred             eeeeecCCccEEEEEcCC--------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          194 YCIGTGGYGSVYRARLPS--------GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      +.||+|+||.||+|....        ...+|+|.+....   ....+++.+|+.+++.++||||+++++++..++..++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            358999999999997532        2348888775432   22346788899999999999999999999998899999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC--------eEEeee
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE--------AFVADF  337 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DF  337 (368)
                      |||+++|+|.++++....  .+++..++.++.||+.||+|||++   +|+||||||+||+++.++.        ++++||
T Consensus        78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999999976543  478999999999999999999999   9999999999999987765        589999


Q ss_pred             ccceecCCCCCCccccccccccccCCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |++......    ....++..|+|||+
T Consensus       153 g~~~~~~~~----~~~~~~~~y~aPE~  175 (258)
T cd05078         153 GISITVLPK----EILLERIPWVPPEC  175 (258)
T ss_pred             ccccccCCc----hhccccCCccCchh
Confidence            988765422    23468889999983

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=3.8e-26  Score=207.92  Aligned_cols=169  Identities=30%  Similarity=0.387  Sum_probs=140.7

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMFL  264 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  264 (368)
                      ++|+..+.||.|++|.||+|.+. +++.+|+|.+......  ....++.+|++++++++||||+++++++.+.  +..|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            36888999999999999999864 5889999998754332  2346788999999999999999999988653  46899


Q ss_pred             EEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          265 IYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      ||||+++++|.+++.... ....+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            999999999988875321 223478889999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .....  ....++..|+|||
T Consensus       156 ~~~~~--~~~~~~~~y~~pE  173 (287)
T cd06621         156 VNSLA--GTFTGTSFYMAPE  173 (287)
T ss_pred             ccccc--ccccCCccccCHH
Confidence            43222  2346788999998

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.94  E-value=5.3e-26  Score=206.85  Aligned_cols=166  Identities=28%  Similarity=0.430  Sum_probs=141.6

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|...+.||+|++|.||++.. .+++.+++|++......   ..+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            355567899999999999985 46889999988643322   23567889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++...    .+++.++..++.|++.||+|||++   +++||||+|+||+++.++.++|+|||.+.......
T Consensus        97 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          97 FLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             ccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            99999999998762    278899999999999999999999   99999999999999999999999999987665443


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                      .......|++.|+|||+
T Consensus       170 ~~~~~~~~~~~y~aPE~  186 (285)
T cd06648         170 PRRKSLVGTPYWMAPEV  186 (285)
T ss_pred             cccccccCCccccCHHH
Confidence            33344568999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.94  E-value=8.1e-26  Score=200.80  Aligned_cols=166  Identities=35%  Similarity=0.556  Sum_probs=145.6

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|+..+.||+|++|.||++... +++.+++|++.....   ...+.+.+|++++++++|||++++++++...+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            5778899999999999999865 688999999976544   234678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++++|.+++....  ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            999999999987643  3489999999999999999999998   99999999999999999999999999998776543


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                      . .....|+..|+|||
T Consensus       153 ~-~~~~~~~~~~~~PE  167 (253)
T cd05122         153 A-RNTMVGTPYWMAPE  167 (253)
T ss_pred             c-ccceecCCcccCHH
Confidence            2 33456899999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.1e-26  Score=214.57  Aligned_cols=169  Identities=27%  Similarity=0.411  Sum_probs=144.6

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ...|++.+.||+||.++||++...+.+.||+|++..... +....+.|.+|+..|.++ .|.+||++++|-..++.+|||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            356899999999999999999998889999998865443 345678999999999999 699999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||=+ .+|..+|+.....  .+...+..+..||+.|+.++|.+   ||||.||||.|+|+-+ |.+||+|||+|..+..
T Consensus       439 mE~Gd-~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECGD-IDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP  511 (677)
T ss_pred             eeccc-ccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence            99875 5999999875432  33236788999999999999999   9999999999999854 7999999999998876


Q ss_pred             CCCC--ccccccccccccCC
Q 017621          346 DSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~--~~~~~gt~~y~aPE  363 (368)
                      +...  +...+||+.|||||
T Consensus       512 DTTsI~kdsQvGT~NYMsPE  531 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPE  531 (677)
T ss_pred             cccceeeccccCcccccCHH
Confidence            6543  44568999999998

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.94  E-value=4.2e-26  Score=213.84  Aligned_cols=167  Identities=28%  Similarity=0.381  Sum_probs=138.8

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-----
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-----  259 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  259 (368)
                      ..++|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|+.++++++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            457899999999999999999985 46899999998653222 12335677899999999999999999988643     


Q ss_pred             -CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          260 -KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       260 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                       ...|+||||+. ++|.+.+...     +++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence             35799999997 4888777542     78888999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +++....... .....||+.|+|||
T Consensus       164 ~~~~~~~~~~-~~~~~~~~~y~aPE  187 (353)
T cd07850         164 LARTAGTSFM-MTPYVVTRYYRAPE  187 (353)
T ss_pred             cceeCCCCCC-CCCCcccccccCHH
Confidence            9987654322 23346899999998

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.94  E-value=7.5e-26  Score=203.87  Aligned_cols=168  Identities=25%  Similarity=0.433  Sum_probs=137.4

Q ss_pred             cHHHHHHHhhccccceee--eecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEE
Q 017621          179 TFQDMIEATEDFHIKYCI--GTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYG  254 (368)
Q Consensus       179 ~~~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  254 (368)
                      +..+.....++|++.+.+  |+|+||.||++.. .++..+|+|.+.......      .  |+.....+ +||||+++++
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~--e~~~~~~~~~h~~iv~~~~   76 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------I--EPMVHQLMKDNPNFIKLYY   76 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------h--hHHHHHHhhcCCCEEEEEE
Confidence            445666667788887776  9999999999985 468889999986543211      1  22222222 7999999999


Q ss_pred             EEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-CeE
Q 017621          255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-EAF  333 (368)
Q Consensus       255 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~k  333 (368)
                      .+...+..|+||||+++++|.+++....   .+++.++..++.|+++||.|||+.   +++||||||+||+++.++ .++
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~  150 (267)
T PHA03390         77 SVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIY  150 (267)
T ss_pred             EEecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEE
Confidence            9999999999999999999999997653   489999999999999999999999   999999999999999998 999


Q ss_pred             EeeeccceecCCCCCCccccccccccccCCC
Q 017621          334 VADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       334 l~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+|||+++......    ...|+..|+|||+
T Consensus       151 l~dfg~~~~~~~~~----~~~~~~~y~aPE~  177 (267)
T PHA03390        151 LCDYGLCKIIGTPS----CYDGTLDYFSPEK  177 (267)
T ss_pred             EecCccceecCCCc----cCCCCCcccChhh
Confidence            99999998764332    2368999999984

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.94  E-value=3.6e-26  Score=207.44  Aligned_cols=169  Identities=30%  Similarity=0.448  Sum_probs=142.1

Q ss_pred             cccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |++.+.||+|++|.||+|.. .+|+.||+|++....... ...+.+.+|+++++.++|||++++++++.+.+..|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            56788999999999999985 478999999987543221 2235678899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      ++ ++|.+++..... ..+++..+..++.|+++||+|||++   +++||||+|+||++++++.++|+|||+++.......
T Consensus        80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            96 689988876442 3489999999999999999999998   999999999999999999999999999987654333


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                      ......+++.|+|||+
T Consensus       155 ~~~~~~~~~~~~aPE~  170 (283)
T cd07835         155 TYTHEVVTLWYRAPEI  170 (283)
T ss_pred             ccCccccccCCCCCce
Confidence            3333457889999994

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.94  E-value=5.9e-26  Score=202.57  Aligned_cols=171  Identities=28%  Similarity=0.459  Sum_probs=147.2

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|++|.||++... +++.+|+|++...... ....+.+.+|+++++.++|||++++.+.+...+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            5788899999999999999864 6889999998765432 2234678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          268 YMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |+++++|.+++.... ....+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||.+......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999987642 124489999999999999999999999   9999999999999999999999999999877654


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      ........|++.|+|||
T Consensus       157 ~~~~~~~~~~~~y~~pe  173 (258)
T cd08215         157 VDLAKTVVGTPYYLSPE  173 (258)
T ss_pred             cceecceeeeecccChh
Confidence            43333457899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.94  E-value=6.3e-26  Score=204.34  Aligned_cols=172  Identities=27%  Similarity=0.464  Sum_probs=141.4

Q ss_pred             ccccceeeeecCCccEEEEEcCC--CCEEEEEEccccch-------hhHHhHHHHHHHHHHHhc-cCCCceeeEEEEEee
Q 017621          189 DFHIKYCIGTGGYGSVYRARLPS--GKVVALKKLHRSET-------EELASLESFRNEARLLSQ-IWHRNIVKLYGFCLH  258 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  258 (368)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+.....       .......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999998654  67899998754321       112234567788888875 699999999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                      ++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999887532 122348899999999999999999996 5   899999999999999999999999


Q ss_pred             eccceecCCCCCCccccccccccccCCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ||.+....... ......|+..|+|||+
T Consensus       158 fg~~~~~~~~~-~~~~~~~~~~~~~Pe~  184 (269)
T cd08528         158 FGLAKQKQPES-KLTSVVGTILYSCPEI  184 (269)
T ss_pred             ccceeeccccc-ccccccCcccCcChhh
Confidence            99998765443 3344568999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.94  E-value=4.2e-26  Score=212.42  Aligned_cols=168  Identities=27%  Similarity=0.437  Sum_probs=139.1

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-----C
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-----K  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  260 (368)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.+......  .....+.+|+.++++++||||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ--TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            46899999999999999999975 46899999998643221  2345678899999999999999999987654     3


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+|+||+++ ++.+.+...    .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             eEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence            58999999974 888777543    389999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCC---ccccccccccccCCC
Q 017621          341 RLLNFDSSN---RTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~---~~~~~gt~~y~aPE~  364 (368)
                      .........   .....||+.|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~  180 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEI  180 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHH
Confidence            876433221   123468999999994

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.94  E-value=6.6e-26  Score=211.85  Aligned_cols=173  Identities=27%  Similarity=0.375  Sum_probs=143.4

Q ss_pred             cHHHHHHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEe
Q 017621          179 TFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCL  257 (368)
Q Consensus       179 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  257 (368)
                      ...++...+++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            4456677889999999999999999999975 57889999998754322 223456788999999999999999999886


Q ss_pred             eC------CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC
Q 017621          258 HR------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE  331 (368)
Q Consensus       258 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  331 (368)
                      ..      ...|++++++ +++|.++++..    .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence            43      3478888887 67998887643    288999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccceecCCCCCCccccccccccccCC
Q 017621          332 AFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       332 ~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +||+|||+++.....   .....||..|+|||
T Consensus       159 ~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE  187 (345)
T cd07877         159 LKILDFGLARHTDDE---MTGYVATRWYRAPE  187 (345)
T ss_pred             EEEeccccccccccc---ccccccCCCccCHH
Confidence            999999999865432   22346889999998

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.94  E-value=3.5e-26  Score=204.38  Aligned_cols=171  Identities=26%  Similarity=0.407  Sum_probs=143.7

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|+||.||++... ++..+|+|.+....... ...+.+.+|+.+++.++|+||+++++.+...+..++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            4788899999999999999864 58889999986542211 234577899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-CeEEeeeccceecCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARLLNFD  346 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFg~a~~~~~~  346 (368)
                      |+++++|.+++..... ..+++..+..++.|+++||.|||+.   +++|+||||+||++++++ .+||+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          80 YCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999999875432 3478999999999999999999998   999999999999999886 4699999999877544


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........|++.|+|||+
T Consensus       156 ~~~~~~~~~~~~~~ape~  173 (257)
T cd08225         156 MELAYTCVGTPYYLSPEI  173 (257)
T ss_pred             cccccccCCCccccCHHH
Confidence            333333468999999993

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.94  E-value=8.5e-26  Score=203.84  Aligned_cols=170  Identities=28%  Similarity=0.437  Sum_probs=135.3

Q ss_pred             cccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-----
Q 017621          190 FHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-----  260 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  260 (368)
                      |++.+.||+|+||.||+|.+.    +++.||+|.+....... ...+++.+|++++++++||||+++++++...+     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            566788999999999999743    46889999987643322 23467889999999999999999999886532     


Q ss_pred             -eEEEEEeecCCCChhHHhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          261 -CMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       261 -~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                       ..++++||+++|+|.+++...   .....+++...+.++.|++.||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence             247899999999998876432   1223478889999999999999999998   999999999999999999999999


Q ss_pred             eccceecCCCCC--CccccccccccccCC
Q 017621          337 FGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      ||+++.......  ......+++.|++||
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe  185 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALE  185 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHh
Confidence            999987643221  112234567899998

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.94  E-value=3.3e-26  Score=212.95  Aligned_cols=169  Identities=27%  Similarity=0.397  Sum_probs=140.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee----CCe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH----RKC  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  261 (368)
                      .++|++.+.||+|++|.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++..    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            36899999999999999999985 46899999998754322 1234567789999999999999999998763    346


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .|+||||+. ++|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+||++++++.+||+|||+++
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            899999996 58988886543   289999999999999999999998   99999999999999999999999999998


Q ss_pred             ecCCCCCC----ccccccccccccCC
Q 017621          342 LLNFDSSN----RTLLAGTSGYIAPA  363 (368)
Q Consensus       342 ~~~~~~~~----~~~~~gt~~y~aPE  363 (368)
                      ........    .....|+..|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE  181 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPE  181 (334)
T ss_pred             eecccCcCCCcccccccccccccChH
Confidence            76433221    12346899999998

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.93  E-value=9.9e-27  Score=197.99  Aligned_cols=168  Identities=23%  Similarity=0.383  Sum_probs=138.0

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ++.+.+..||.|+.|+|++++.. +|...|||.+.+.....  ..+++...++++.+. ..|+||+.+|||..+..+++.
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke--e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH--HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            44556777999999999999864 58999999998765543  346777788887776 589999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||.|.. .+..++++...  ++++.-+-++...+.+||.||..++  +|+|||+||+|||+|+.|.+|+||||++..+.+
T Consensus       170 MelMs~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  170 MELMST-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHH-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence            999853 55556654332  3777777788899999999999886  999999999999999999999999999988764


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      ... .+..+|.+.|||||
T Consensus       245 SkA-htrsAGC~~YMaPE  261 (391)
T KOG0983|consen  245 SKA-HTRSAGCAAYMAPE  261 (391)
T ss_pred             ccc-cccccCCccccCcc
Confidence            433 34457999999998

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=4.4e-26  Score=212.38  Aligned_cols=169  Identities=25%  Similarity=0.388  Sum_probs=140.6

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-----C
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-----K  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  260 (368)
                      .++|.+.+.||+|+||+||+|+. .+++.||+|.+....... .....+.+|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            45799999999999999999985 468999999987542221 2235667899999999999999999987654     3


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+||||+. ++|.+++....   .+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            4899999996 68888887543   389999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +.............|+..|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE  178 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPE  178 (337)
T ss_pred             cccCCCcccccccccccCccChH
Confidence            87654433333446889999998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.93  E-value=4.8e-26  Score=212.09  Aligned_cols=169  Identities=33%  Similarity=0.474  Sum_probs=139.8

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC--Ce
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR--KC  261 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~  261 (368)
                      ..++|++.+.||+|+||.||+|.+. +++.+|+|++....... .....+.+|+.+++++ +||||+++++++...  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            4567899999999999999999865 58899999886432211 2235677899999999 999999999988654  36


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .|+||||++ ++|..++...    .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            899999997 5998888654    378889999999999999999998   99999999999999999999999999998


Q ss_pred             ecCCCCC-----CccccccccccccCC
Q 017621          342 LLNFDSS-----NRTLLAGTSGYIAPA  363 (368)
Q Consensus       342 ~~~~~~~-----~~~~~~gt~~y~aPE  363 (368)
                      .......     ......||+.|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE  182 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPE  182 (337)
T ss_pred             ccccccccccCcchhcccccccccCce
Confidence            7654321     222346899999999

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=1e-27  Score=225.45  Aligned_cols=170  Identities=29%  Similarity=0.505  Sum_probs=151.1

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      +..++|+....+|+|+||.||||++. +++..|+|.++.....+   ..-.++|+-+++..+|||||.+++.+...+..|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            34568999999999999999999864 68899999998765543   345678999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +.||||.+|+|++..+--.   .+++.++..++++.++|++|||++   +-+|||||=.||++++.|.+|++|||.+..+
T Consensus        89 icMEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi  162 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI  162 (829)
T ss_pred             EEEEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh
Confidence            9999999999998776543   388899999999999999999999   8899999999999999999999999999888


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +..-..+..+.||++|||||
T Consensus       163 tati~KrksfiGtpywmapE  182 (829)
T KOG0576|consen  163 TATIAKRKSFIGTPYWMAPE  182 (829)
T ss_pred             hhhhhhhhcccCCccccchh
Confidence            76666677789999999998

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.93  E-value=6.1e-26  Score=201.93  Aligned_cols=162  Identities=30%  Similarity=0.466  Sum_probs=141.6

Q ss_pred             eeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCCh
Q 017621          196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSL  274 (368)
Q Consensus       196 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  274 (368)
                      ||+|+||.||++... +++.+|+|.+...........+.+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999864 5889999998776544444567889999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccccc
Q 017621          275 FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA  354 (368)
Q Consensus       275 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~  354 (368)
                      .+++....   .+++..+..++.|+++|+.|||+.   +++|+||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            99997653   389999999999999999999998   999999999999999999999999999987754433334457


Q ss_pred             cccccccCC
Q 017621          355 GTSGYIAPA  363 (368)
Q Consensus       355 gt~~y~aPE  363 (368)
                      |+..|+|||
T Consensus       155 ~~~~~~~Pe  163 (250)
T cd05123         155 GTPEYLAPE  163 (250)
T ss_pred             CCccccChH
Confidence            899999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.93  E-value=8e-26  Score=206.40  Aligned_cols=161  Identities=29%  Similarity=0.451  Sum_probs=138.6

Q ss_pred             ceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          193 KYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      ...||+|+||.||++.. .+++.||+|++.....   ...+.+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            35699999999999976 4788999998854332   2346788999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      ++|.+++...    .+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++...........
T Consensus       102 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~  174 (292)
T cd06657         102 GALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  174 (292)
T ss_pred             CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence            9999887543    278899999999999999999999   999999999999999999999999999887654433334


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                      ...|++.|+|||
T Consensus       175 ~~~~~~~y~~pE  186 (292)
T cd06657         175 SLVGTPYWMAPE  186 (292)
T ss_pred             ccccCccccCHH
Confidence            457899999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.93  E-value=8.2e-26  Score=207.69  Aligned_cols=172  Identities=27%  Similarity=0.452  Sum_probs=139.1

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC----
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK----  260 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  260 (368)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+....... .....+.+|++++++++||||+++++++...+    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            3457999999999999999999864 68899999886433221 12235567999999999999999999987653    


Q ss_pred             ----eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          261 ----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       261 ----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                          ..++||||+.+ +|.+.+....  ..+++.++..++.|++.||+|||++   +++|+||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence                45999999974 7887776533  2389999999999999999999999   999999999999999999999999


Q ss_pred             eccceecCCCCCC----ccccccccccccCCC
Q 017621          337 FGVARLLNFDSSN----RTLLAGTSGYIAPAS  364 (368)
Q Consensus       337 Fg~a~~~~~~~~~----~~~~~gt~~y~aPE~  364 (368)
                      ||++.........    .....++..|+|||+
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  194 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL  194 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHH
Confidence            9999876432221    123457889999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.93  E-value=8.9e-26  Score=205.51  Aligned_cols=170  Identities=28%  Similarity=0.423  Sum_probs=142.2

Q ss_pred             ccccceeeeecCCccEEEEEc----CCCCEEEEEEccccchh-hHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  262 (368)
                      +|++.+.||+|++|.||+++.    .+++.||+|.+...... .....+.+.+|+.++.++ +||||+++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478889999999999999874    35788999998754322 222345788899999999 699999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++++|.+++....   .+++..+..++.|+++||.|||+.   +++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999887543   378899999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCC-ccccccccccccCCC
Q 017621          343 LNFDSSN-RTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~-~~~~~gt~~y~aPE~  364 (368)
                      ....... .....|+..|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~  177 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEV  177 (288)
T ss_pred             cccccccccccccCCccccCHHH
Confidence            6543322 223468999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.93  E-value=5e-26  Score=204.93  Aligned_cols=164  Identities=30%  Similarity=0.462  Sum_probs=133.8

Q ss_pred             eeeecCCccEEEEEcCC-------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          195 CIGTGGYGSVYRARLPS-------GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      .||+|+||.||+|+..+       ++.+|+|.+......  .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            58999999999998532       257999988654322  234678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-----CeEEeeec
Q 017621          268 YMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-----EAFVADFG  338 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DFg  338 (368)
                      |+++++|.+++....    ....+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++     .++++|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999987532    123378899999999999999999998   999999999999999877     89999999


Q ss_pred             cceecCCCCC--CccccccccccccCC
Q 017621          339 VARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      +++.......  ......++..|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE  183 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPE  183 (269)
T ss_pred             cccccccccccccCcccCCCccccCHH
Confidence            9976543221  111224577899999

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.93  E-value=2.3e-25  Score=198.71  Aligned_cols=169  Identities=31%  Similarity=0.458  Sum_probs=146.9

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMFLI  265 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  265 (368)
                      +|+..+.||+|++|.||+|... +++.|++|.+...... ....+.+.+|++++++++||||+++++.+...  +..+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            4778899999999999999865 6889999998765432 23457889999999999999999999999988  889999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      +||+++++|.+++....   .+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            99999999999987654   489999999999999999999998   999999999999999999999999999988765


Q ss_pred             CCC--CccccccccccccCCC
Q 017621          346 DSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ...  ......++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~  174 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEV  174 (260)
T ss_pred             ccccccccCCCCCccccCHhh
Confidence            443  1334568999999993

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.93  E-value=1.1e-25  Score=210.29  Aligned_cols=167  Identities=28%  Similarity=0.369  Sum_probs=139.5

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC----
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK----  260 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  260 (368)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++....    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            467899999999999999999974 57899999998653322 223456788999999999999999999987653    


Q ss_pred             --eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          261 --CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       261 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                        ..++||||+ +++|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence              468999999 67888887642    388999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccCCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++.......   ....+++.|+|||+
T Consensus       164 ~~~~~~~~~---~~~~~~~~y~aPE~  186 (343)
T cd07880         164 LARQTDSEM---TGYVVTRWYRAPEV  186 (343)
T ss_pred             cccccccCc---cccccCCcccCHHH
Confidence            998654322   23467899999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.93  E-value=1.2e-25  Score=204.03  Aligned_cols=168  Identities=33%  Similarity=0.479  Sum_probs=141.1

Q ss_pred             cccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeEEEEE
Q 017621          190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMFLIY  266 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  266 (368)
                      |++.+.||+|++|.||+|... +++.+|+|.+.... ........+.+|++++++++|||++++++++...  +..++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            567889999999999999865 58899999998654 1122335678899999999999999999999988  8899999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++ +|.+++....  ..+++..++.++.|+++||+|||+.   +++|+||||+||++++++.+||+|||++......
T Consensus        80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            99985 8888886542  2489999999999999999999998   9999999999999999999999999999877544


Q ss_pred             CC-CccccccccccccCCC
Q 017621          347 SS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE~  364 (368)
                      .. ......++..|+|||+
T Consensus       154 ~~~~~~~~~~~~~y~~PE~  172 (287)
T cd07840         154 NSADYTNRVITLWYRPPEL  172 (287)
T ss_pred             CcccccccccccccCCcee
Confidence            32 1233457889999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.93  E-value=1.1e-25  Score=206.17  Aligned_cols=172  Identities=34%  Similarity=0.516  Sum_probs=140.9

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC---
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK---  260 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  260 (368)
                      ...++|++.+.||+|+||.||+|... +++.||+|.++.....+ .....+.+|++++++++||||+++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            35678999999999999999999864 58899999986543221 12346778999999999999999999987654   


Q ss_pred             -------eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeE
Q 017621          261 -------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF  333 (368)
Q Consensus       261 -------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  333 (368)
                             ..++|+||+++ ++...+....  ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                   78999999986 7777766532  2489999999999999999999999   999999999999999999999


Q ss_pred             EeeeccceecCCCCC-CccccccccccccCC
Q 017621          334 VADFGVARLLNFDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       334 l~DFg~a~~~~~~~~-~~~~~~gt~~y~aPE  363 (368)
                      |+|||++........ ......++..|+|||
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE  187 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPE  187 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChH
Confidence            999999987654332 112234678899998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.93  E-value=2.4e-25  Score=205.28  Aligned_cols=165  Identities=31%  Similarity=0.450  Sum_probs=138.8

Q ss_pred             cccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |...+.||+|+||+||+|+. .+++.||+|++...........+.+.+|+++++.++|||++++++++.+.+..|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66678899999999999985 46889999998654333333446788899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +. |++.+.+....  ..+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 57777776432  2388999999999999999999999   999999999999999999999999999865332   


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                       .....|+..|+|||+
T Consensus       174 -~~~~~~~~~y~aPE~  188 (313)
T cd06633         174 -ANSFVGTPYWMAPEV  188 (313)
T ss_pred             -CCCccccccccChhh
Confidence             223468999999995

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.93  E-value=1.5e-25  Score=206.07  Aligned_cols=167  Identities=29%  Similarity=0.465  Sum_probs=139.3

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      +.|+..+.||+|+||.||+|+.. +++.+|+|.+...........+++.+|+++++.++|+|++++++++...+..++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777788999999999999864 57889999886432222233467888999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+. |++.+.+....  ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 58877765433  2378899999999999999999998   9999999999999999999999999999876432


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                          ....|++.|+|||+
T Consensus       169 ----~~~~~~~~y~aPE~  182 (308)
T cd06634         169 ----NXFVGTPYWMAPEV  182 (308)
T ss_pred             ----ccccCCccccCHHH
Confidence                23468899999983

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.93  E-value=1.6e-25  Score=208.40  Aligned_cols=170  Identities=28%  Similarity=0.346  Sum_probs=138.0

Q ss_pred             hccc-cceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHH-----------hHHHHHHHHHHHhccCCCceeeEEE
Q 017621          188 EDFH-IKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELA-----------SLESFRNEARLLSQIWHRNIVKLYG  254 (368)
Q Consensus       188 ~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  254 (368)
                      ++|. +.+.||+|+||+||+|.+. +++.||+|++.........           ....+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 3567999999999999854 6899999998654322100           0124678999999999999999999


Q ss_pred             EEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEE
Q 017621          255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFV  334 (368)
Q Consensus       255 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  334 (368)
                      ++...+..++||||++ |+|.+++....   .+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence            9999999999999997 58988886533   388899999999999999999998   9999999999999999999999


Q ss_pred             eeeccceecCCC--------------CCCccccccccccccCCC
Q 017621          335 ADFGVARLLNFD--------------SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       335 ~DFg~a~~~~~~--------------~~~~~~~~gt~~y~aPE~  364 (368)
                      +|||.++.....              ........+++.|+|||+
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  204 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPEL  204 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChh
Confidence            999999876511              111223357889999994

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.93  E-value=1.2e-25  Score=208.70  Aligned_cols=166  Identities=24%  Similarity=0.356  Sum_probs=134.2

Q ss_pred             eeeeec--CCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecC
Q 017621          194 YCIGTG--GYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYME  270 (368)
Q Consensus       194 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  270 (368)
                      ..||+|  +||+||+|++ .+++.||+|.+....... ...+.+.+|+.+++.++||||+++++++..++..++||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            346666  8899999986 478999999987543322 234788899999999999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCC-
Q 017621          271 MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-  349 (368)
Q Consensus       271 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~-  349 (368)
                      ++++.+++..... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+......... 
T Consensus        83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999998876432 2488999999999999999999998   9999999999999999999999999865433221111 


Q ss_pred             ------ccccccccccccCCC
Q 017621          350 ------RTLLAGTSGYIAPAS  364 (368)
Q Consensus       350 ------~~~~~gt~~y~aPE~  364 (368)
                            .....++..|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~  179 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPEL  179 (328)
T ss_pred             cccccccccccCccCccChhh
Confidence                  111235667999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=216.75  Aligned_cols=173  Identities=30%  Similarity=0.492  Sum_probs=147.5

Q ss_pred             HHHHHHhhccccceeeeecCCccEEEEEcCC-CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC
Q 017621          181 QDMIEATEDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR  259 (368)
Q Consensus       181 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  259 (368)
                      ++++-...+......||-|.||.||.|.++. .-.||||.++....    .+++|.+|+.+|+.++|||+|+++|+|..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            3444445567778899999999999998764 56799999976554    358999999999999999999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      -.+|||+|||..|+|.++|++... ..++..-.+.++.||+.|++||..+   ++|||||.++|+|+.++..+|++|||+
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence            999999999999999999987543 3367777889999999999999998   999999999999999999999999999


Q ss_pred             ceecCCCCCCcccccc---ccccccCC
Q 017621          340 ARLLNFDSSNRTLLAG---TSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~~~~~~~g---t~~y~aPE  363 (368)
                      ++.+..+..  +...|   ...|.|||
T Consensus       412 sRlMtgDTY--TAHAGAKFPIKWTAPE  436 (1157)
T KOG4278|consen  412 SRLMTGDTY--TAHAGAKFPIKWTAPE  436 (1157)
T ss_pred             hhhhcCCce--ecccCccCcccccCcc
Confidence            999865432  23334   45699998

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.93  E-value=2.8e-25  Score=201.38  Aligned_cols=165  Identities=25%  Similarity=0.346  Sum_probs=135.4

Q ss_pred             cccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC--CeEEEE
Q 017621          190 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR--KCMFLI  265 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~lv  265 (368)
                      |++.+.||+|+||.||+|.. .+++.||+|+++...... .. ....+|+.++.++ +||||+++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            56788999999999999985 468899999987543221 11 2345688889988 499999999999987  889999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||++ +++.+.+....  ..+++.++..++.|++.||+|||+.   +++||||||+||+++. +.+||+|||+++....
T Consensus        79 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          79 FELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             EecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            99997 58887776533  2489999999999999999999999   9999999999999999 9999999999987654


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .... ....++..|+|||+
T Consensus       152 ~~~~-~~~~~~~~y~aPE~  169 (282)
T cd07831         152 KPPY-TEYISTRWYRAPEC  169 (282)
T ss_pred             CCCc-CCCCCCcccCChhH
Confidence            3322 23458899999983

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.93  E-value=1.1e-25  Score=201.04  Aligned_cols=169  Identities=27%  Similarity=0.425  Sum_probs=143.7

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|++.+.||+|++|.||++.. .+++.+|+|.+....... ....++.+|++++++++||||+++++++.+....|+|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            478899999999999999974 468899999987644322 234677889999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          268 YMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |+++++|.+++.... ....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+|++|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999999999886522 123488999999999999999999999   9999999999999999999999999999877654


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      .  .....|++.|+|||
T Consensus       157 ~--~~~~~~~~~~~~Pe  171 (256)
T cd08530         157 M--AKTQIGTPHYMAPE  171 (256)
T ss_pred             C--cccccCCccccCHH
Confidence            2  22245889999998

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.93  E-value=3.9e-25  Score=200.84  Aligned_cols=167  Identities=34%  Similarity=0.516  Sum_probs=136.6

Q ss_pred             cccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc---CCCceeeEEEEEeeCCe----
Q 017621          190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI---WHRNIVKLYGFCLHRKC----  261 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----  261 (368)
                      |++.+.||+|+||.||+|+.. +++.||+|.+......+ .....+.+|+.+++++   +||||+++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            567889999999999999975 48999999997543322 1224566677776655   69999999999988776    


Q ss_pred             -EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          262 -MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       262 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                       .+++|||+.+ +|.+++..... ..+++..+..++.|+++||.|||+.   +++|+||+|+||++++++.+||+|||.+
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence             9999999974 88888865432 2489999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ......... ....++..|+|||
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~~PE  176 (287)
T cd07838         155 RIYSFEMAL-TSVVVTLWYRAPE  176 (287)
T ss_pred             eeccCCccc-ccccccccccChH
Confidence            887544322 2335788999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.93  E-value=1.5e-25  Score=203.95  Aligned_cols=168  Identities=26%  Similarity=0.357  Sum_probs=135.1

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeEEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  266 (368)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+......  .....+.+|+.++.++. ||||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            556678899999999999985 46899999998754332  23467889999999995 999999999999988999999


Q ss_pred             eecCCCChhHHhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          267 EYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       267 e~~~~g~L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      ||+.. ++.++..   .. ....+++..+..++.|++.||+|||+..  +++||||||+||+++.++.+||+|||+++..
T Consensus        83 e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            99874 5544332   11 1234899999999999999999999732  8999999999999999999999999999766


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ...... ....|++.|+|||
T Consensus       159 ~~~~~~-~~~~~~~~y~aPE  177 (288)
T cd06616         159 VDSIAK-TRDAGCRPYMAPE  177 (288)
T ss_pred             ccCCcc-ccccCccCccCHH
Confidence            433222 2336889999998

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.6e-26  Score=216.90  Aligned_cols=168  Identities=27%  Similarity=0.454  Sum_probs=141.9

Q ss_pred             ccccceeeeecCCccEEEEEcC--CCC--EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP--SGK--VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      +..+.++||+|.||.|++|.+.  +|+  .||||+++......  ..+.|++|+.+|.+|+|||++++||+..+ ....|
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            3455678999999999999864  344  58999998765543  56899999999999999999999999987 56889


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |||+++.|+|.+.|++ .....+.......++.|||.||.||.++   ++|||||..+|+|+.....+||+|||+.+.+.
T Consensus       188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence            9999999999999988 3444578888899999999999999999   99999999999999999999999999999987


Q ss_pred             CCCCCccc---cccccccccCC
Q 017621          345 FDSSNRTL---LAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~~~~~---~~gt~~y~aPE  363 (368)
                      ........   .--...|+|||
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPE  285 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPE  285 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHh
Confidence            65543321   11245799998

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.93  E-value=2.6e-25  Score=206.40  Aligned_cols=170  Identities=26%  Similarity=0.398  Sum_probs=140.3

Q ss_pred             HHHHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee-CC
Q 017621          183 MIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH-RK  260 (368)
Q Consensus       183 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  260 (368)
                      +...+++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|++++++++||||+++++++.. .+
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            3456788999999999999999999854 78999999886532221 223567789999999999999999998875 56


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+++||+. ++|.++++..    .+++..+..++.|+++||.|||+.   +|+||||+|+||++++++.++|+|||.+
T Consensus        84 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          84 DIYFVTELLG-TDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             cEEEEeehhc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            7899999994 6888887643    277888889999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccCCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      .......   ....++..|+|||+
T Consensus       156 ~~~~~~~---~~~~~~~~y~aPE~  176 (328)
T cd07856         156 RIQDPQM---TGYVSTRYYRAPEI  176 (328)
T ss_pred             cccCCCc---CCCcccccccCcee
Confidence            8654321   23457889999984

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.93  E-value=2.9e-25  Score=202.94  Aligned_cols=169  Identities=22%  Similarity=0.342  Sum_probs=123.9

Q ss_pred             hccccceeeeecCCccEEEEEcCC----CCEEEEEEccccchhhHHh--------HHHHHHHHHHHhccCCCceeeEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELAS--------LESFRNEARLLSQIWHRNIVKLYGF  255 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~  255 (368)
                      ++|++.+.||+|+||+||+|...+    +..+|+|............        ......+...+..+.|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            579999999999999999998643    4456666543222110000        0122234455677899999999997


Q ss_pred             EeeCC----eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC
Q 017621          256 CLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE  331 (368)
Q Consensus       256 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  331 (368)
                      +....    ..++++|++.. ++.+.+....   ..++..+..++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence            66543    35788887753 6666665432   256788889999999999999999   9999999999999999999


Q ss_pred             eEEeeeccceecCCCCC-------CccccccccccccCC
Q 017621          332 AFVADFGVARLLNFDSS-------NRTLLAGTSGYIAPA  363 (368)
Q Consensus       332 ~kl~DFg~a~~~~~~~~-------~~~~~~gt~~y~aPE  363 (368)
                      ++|+|||+|+.+.....       ......||+.|+|||
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape  203 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLD  203 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHH
Confidence            99999999987643221       122346999999998

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.5e-25  Score=214.20  Aligned_cols=176  Identities=20%  Similarity=0.277  Sum_probs=130.9

Q ss_pred             HhhccccceeeeecCCccEEEEEc-----------------CCCCEEEEEEccccchhhHH-----------hHHHHHHH
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-----------------PSGKVVALKKLHRSETEELA-----------SLESFRNE  237 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E  237 (368)
                      ..++|++.+.||+|+||+||+|..                 ..++.||||++.........           ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            356899999999999999999953                 23567999998653321100           11233457


Q ss_pred             HHHHhccCCCce-----eeEEEEEee--------CCeEEEEEeecCCCChhHHhhcCCC---------------------
Q 017621          238 ARLLSQIWHRNI-----VKLYGFCLH--------RKCMFLIYEYMEMGSLFCVLRTDEE---------------------  283 (368)
Q Consensus       238 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  283 (368)
                      +.++.+++|.++     ++++++|..        .+..|+||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     667777653        3568999999999999998864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCC-ccccccccccccC
Q 017621          284 AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RTLLAGTSGYIAP  362 (368)
Q Consensus       284 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~-~~~~~gt~~y~aP  362 (368)
                      ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........ .....+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            11246778889999999999999998   9999999999999999999999999999765432221 1122358999999


Q ss_pred             CC
Q 017621          363 AS  364 (368)
Q Consensus       363 E~  364 (368)
                      |.
T Consensus       380 E~  381 (507)
T PLN03224        380 EE  381 (507)
T ss_pred             hh
Confidence            94

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.93  E-value=1.6e-25  Score=207.83  Aligned_cols=168  Identities=29%  Similarity=0.423  Sum_probs=142.3

Q ss_pred             ccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-----eE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-----CM  262 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  262 (368)
                      +|++.+.||+|++|.||+|+.. +++.||+|++...... ....+.+.+|+++++.++||||+++++++...+     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            5788999999999999999864 5889999998764321 223467889999999999999999999988775     78


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |++|||++ ++|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++..
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999998 48888887543   489999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCC---CccccccccccccCCC
Q 017621          343 LNFDSS---NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~---~~~~~~gt~~y~aPE~  364 (368)
                      ......   ......+|+.|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~  177 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPEL  177 (330)
T ss_pred             ecccccccccccccccccCcCCcee
Confidence            765431   2233468999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.93  E-value=2.6e-25  Score=201.75  Aligned_cols=166  Identities=28%  Similarity=0.432  Sum_probs=139.0

Q ss_pred             cccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeEEEEEe
Q 017621          190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      |++.+.||+|++|+||+|... +++.||+|++.......  ......+|+..+++++ ||||+++++++.+++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            567889999999999999875 57889999986543221  1123456899999998 9999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+ +|+|.+.+.... ...+++.++..++.|++.+|.|||++   +++|+||+|+||++++++.++|+|||.+.......
T Consensus        79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            99 789988887654 23489999999999999999999998   99999999999999999999999999998765432


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                      . .....|+..|+|||
T Consensus       154 ~-~~~~~~~~~~~aPE  168 (283)
T cd07830         154 P-YTDYVSTRWYRAPE  168 (283)
T ss_pred             C-cCCCCCcccccCce
Confidence            2 22346889999999

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.93  E-value=2.8e-25  Score=204.76  Aligned_cols=167  Identities=18%  Similarity=0.238  Sum_probs=134.0

Q ss_pred             cceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          192 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       192 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      +.+.+|.|+++.||++.. +++.||+|++...... ....+.+.+|+++++.++||||+++++++.+.+..+++|||+++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            344455555555555554 6899999998764222 23457899999999999999999999999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC---
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS---  348 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~---  348 (368)
                      ++|.+++..... ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||.+........   
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            999999976432 2378889999999999999999999   999999999999999999999999999876543221   


Q ss_pred             ----CccccccccccccCCC
Q 017621          349 ----NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ----~~~~~~gt~~y~aPE~  364 (368)
                          ......++..|+|||+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~  179 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEV  179 (314)
T ss_pred             ccccccccccccccccCHHH
Confidence                1122357788999983

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=222.35  Aligned_cols=171  Identities=27%  Similarity=0.500  Sum_probs=141.6

Q ss_pred             cccceeeeecCCccEEEEEc-CCC----CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          190 FHIKYCIGTGGYGSVYRARL-PSG----KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      .+..++||+|+||+||+|.+ +.|    -+||+|++......+  ..+++..|+-+|.+++|||+++++++|.... +.|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~--~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK--ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch--hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            44567899999999999974 444    368999987654432  3478999999999999999999999998876 889


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |++|++.|+|.++++.++..  +-....+.+..|||+||.|||.+   ++|||||.++|||+.+-..+||.|||+++...
T Consensus       775 vtq~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHhcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            99999999999999876543  77788899999999999999999   99999999999999999999999999999987


Q ss_pred             CCCCCcccccc--cccccc----------CCCCcCC
Q 017621          345 FDSSNRTLLAG--TSGYIA----------PASEWWH  368 (368)
Q Consensus       345 ~~~~~~~~~~g--t~~y~a----------PE~d~w~  368 (368)
                      .+........|  .+.|||          |+.|.|+
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWs  885 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWS  885 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhh
Confidence            76655443332  334555          3577775

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.93  E-value=5.7e-25  Score=204.47  Aligned_cols=168  Identities=28%  Similarity=0.408  Sum_probs=135.8

Q ss_pred             ccccceeeeecCCccEEEEEcC-C--CCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC----C
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-S--GKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR----K  260 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~  260 (368)
                      +|++.+.||+|+||.||+++.. +  ++.||+|++...... ....+.+.+|+++++++ +||||+++++++...    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            4788899999999999999864 3  778999998643222 12235678899999999 699999999875432    4


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+++||+. ++|.+++....   .+++..+..++.||+.||+|||+.   +++||||||+|||+++++.+||+|||++
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            5789999986 58988886543   388999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCC----CccccccccccccCCC
Q 017621          341 RLLNFDSS----NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~----~~~~~~gt~~y~aPE~  364 (368)
                      +.......    ......||+.|+|||+
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~  180 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEI  180 (332)
T ss_pred             eecccccccccccccCcccCccccCcHH
Confidence            87653221    1223468999999993

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=2.4e-25  Score=201.74  Aligned_cols=168  Identities=32%  Similarity=0.425  Sum_probs=142.2

Q ss_pred             cccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |+..+.||+|++|.||+|... +++.+|+|.+...... ....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            556788999999999999865 5899999998765422 22346778899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      ++ ++|.+++....  ..+++..+..++.|++.||+|||++   +|+||||+|+||++++++.++|+|||.++.......
T Consensus        80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            98 58999997653  2389999999999999999999999   999999999999999999999999999987755433


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                      ......++..|+|||+
T Consensus       154 ~~~~~~~~~~~~aPE~  169 (282)
T cd07829         154 TYTHEVVTLWYRAPEI  169 (282)
T ss_pred             ccCccccCcCcCChHH
Confidence            3333456788999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.1e-27  Score=201.66  Aligned_cols=169  Identities=29%  Similarity=0.474  Sum_probs=135.1

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee--------
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH--------  258 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  258 (368)
                      ..|+....||+|.||.||+|+.+ +++.||+|++-..... ...-....+|++++..++|+|++.+++.|..        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            45666788999999999999854 5778899876542221 1223455789999999999999999988753        


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                      ...+|+|+++|+. +|..++....  ..++..++.+++.++..||.|+|+.   .|+|||+||+|+||+.++.+||+|||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            2358999999985 8888887543  3388899999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCC----CccccccccccccCC
Q 017621          339 VARLLNFDSS----NRTLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~~~----~~~~~~gt~~y~aPE  363 (368)
                      +++.+.....    ..+..+-|.+|.+||
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppE  198 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPE  198 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHH
Confidence            9977643221    233345699999998

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.92  E-value=5.8e-25  Score=201.04  Aligned_cols=170  Identities=26%  Similarity=0.405  Sum_probs=137.3

Q ss_pred             hhccccceeeeecCCccEEEEEcCC-CCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  264 (368)
                      .++|++.+.||+|++|.||+|...+ ++.||||.+.......  ...++.+|+.++.+. .||||+++++++.+....|+
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            3568889999999999999998754 8899999987543322  234566677777666 59999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      +|||+. +++.+++.....  .+++..+..++.|+++||+|||+..  +|+||||+|+||++++++.+||+|||++..+.
T Consensus        92 v~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          92 CMELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             EeeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            999986 477776655332  4889999999999999999999732  89999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..... ....|+..|+|||+
T Consensus       167 ~~~~~-~~~~~~~~y~aPE~  185 (296)
T cd06618         167 DSKAK-TRSAGCAAYMAPER  185 (296)
T ss_pred             CCCcc-cCCCCCccccCHhh
Confidence            33222 23357889999983

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.92  E-value=5.1e-25  Score=199.63  Aligned_cols=168  Identities=31%  Similarity=0.483  Sum_probs=142.3

Q ss_pred             cccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |++.+.||+|++|.||+|... +++.+++|.+....... .....+.+|++++++++||||+++++++..++..++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            567788999999999999864 68899999987654332 2346778899999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +++ ++.+++....  ..+++..+..++.|+++||.|||+.   +|+|+||||+||++++++.++|+|||.+........
T Consensus        80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            975 8888876543  2489999999999999999999999   999999999999999999999999999988765442


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                      ......++..|+|||.
T Consensus       154 ~~~~~~~~~~~~~PE~  169 (283)
T cd05118         154 PYTHYVVTRWYRAPEL  169 (283)
T ss_pred             cccCccCcccccCcHH
Confidence            2333468889999994

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=5.8e-25  Score=205.26  Aligned_cols=165  Identities=30%  Similarity=0.409  Sum_probs=136.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC------
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR------  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  259 (368)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++....... .....+.+|+++++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            47899999999999999999985 468999999987543221 2235678899999999999999999998754      


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      ...|+|+||+.. ++..+..     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            246999999974 6766543     1378899999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++.....   .....||+.|+|||+
T Consensus       164 ~~~~~~~---~~~~~~~~~y~aPE~  185 (342)
T cd07879         164 ARHADAE---MTGYVVTRWYRAPEV  185 (342)
T ss_pred             CcCCCCC---CCCceeeecccChhh
Confidence            9865332   223467899999994

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.92  E-value=2.5e-25  Score=204.52  Aligned_cols=170  Identities=30%  Similarity=0.464  Sum_probs=137.0

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC------
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR------  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  259 (368)
                      .++|++.+.||+|+||.||+|... +++.+|+|++......+ .....+.+|+++++.++||||+++++++.+.      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            578999999999999999999854 68899999886543221 1124567899999999999999999987543      


Q ss_pred             --CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          260 --KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       260 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                        ...++||||+.+ ++...+....  ..+++..+..++.|+++||+|||++   +++|+||||+||++++++.+||+||
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              347999999975 6766665432  2489999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCC-----------ccccccccccccCC
Q 017621          338 GVARLLNFDSSN-----------RTLLAGTSGYIAPA  363 (368)
Q Consensus       338 g~a~~~~~~~~~-----------~~~~~gt~~y~aPE  363 (368)
                      |+++........           .+...|++.|+|||
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  196 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE  196 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChH
Confidence            999865432211           12235788999999

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.92  E-value=2.3e-25  Score=199.67  Aligned_cols=171  Identities=27%  Similarity=0.388  Sum_probs=136.6

Q ss_pred             ccccceeeeecCCccEEEEEcCC-CCEEEEEEccccchh--hHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETE--ELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      +|.+.+.||+|+||.||+++... +..+++|.++.....  ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998643 444555554432211  111224566799999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          266 YEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |||+++++|.+++... .....+++..++.++.|+++||.|||+.   +++|+||||+||++++ +.++|+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888642 1223489999999999999999999998   9999999999999975 569999999998775


Q ss_pred             CCCCCccccccccccccCC
Q 017621          345 FDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE  363 (368)
                      ..........|++.|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~pe  175 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPE  175 (260)
T ss_pred             CCcccccCCCCCcCccCHH
Confidence            4444344456899999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.92  E-value=8.5e-25  Score=215.24  Aligned_cols=168  Identities=22%  Similarity=0.289  Sum_probs=118.7

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-C----CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEE-----
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-S----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF-----  255 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-----  255 (368)
                      ..++|++.+.||+|+||.||+|.+. +    +..||+|++......     +.+..|  .+....+.++..+...     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            4578999999999999999999864 4    689999987643221     111111  1111122222222111     


Q ss_pred             -EeeCCeEEEEEeecCCCChhHHhhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeec
Q 017621          256 -CLHRKCMFLIYEYMEMGSLFCVLRTDEEA-----------------VGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHR  317 (368)
Q Consensus       256 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  317 (368)
                       ...+...++||||+++++|.+++......                 .......+..++.|++.||+|||++   +|+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence             24556799999999999999988753211                 0012234567999999999999999   99999


Q ss_pred             CCCCCCeeecC-CCCeEEeeeccceecCCCCC-CccccccccccccCC
Q 017621          318 DISSNNVLLNS-ELEAFVADFGVARLLNFDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       318 Dlkp~NIll~~-~~~~kl~DFg~a~~~~~~~~-~~~~~~gt~~y~aPE  363 (368)
                      ||||+|||++. ++.+||+|||+|+.+..... ......||+.|||||
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE  327 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE  327 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChH
Confidence            99999999986 57999999999986643322 233457899999999

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.92  E-value=9.1e-25  Score=203.93  Aligned_cols=165  Identities=27%  Similarity=0.397  Sum_probs=135.3

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-------
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-------  259 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  259 (368)
                      .+|++.+.||+|+||.||+|.. .+++.||+|++.....   ...+.+.+|++++++++||||+++++++...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            6799999999999999999985 4688999998865443   2346788899999999999999999876543       


Q ss_pred             -------CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCC
Q 017621          260 -------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-ELE  331 (368)
Q Consensus       260 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~  331 (368)
                             ...|+||||++ ++|.+++...    .+++..+..++.||++||.|||+.   +|+||||||+||+++. ++.
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~  153 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence                   35799999997 5888887643    278999999999999999999999   9999999999999974 567


Q ss_pred             eEEeeeccceecCCCCCC---ccccccccccccCC
Q 017621          332 AFVADFGVARLLNFDSSN---RTLLAGTSGYIAPA  363 (368)
Q Consensus       332 ~kl~DFg~a~~~~~~~~~---~~~~~gt~~y~aPE  363 (368)
                      +|++|||.++........   .....|+..|+|||
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  188 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR  188 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHH
Confidence            899999999876432111   12235788999998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=1e-24  Score=185.59  Aligned_cols=144  Identities=20%  Similarity=0.201  Sum_probs=110.2

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHH-----------------------hHHHHHHHHHHHhccCCCce
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELA-----------------------SLESFRNEARLLSQIWHRNI  249 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~ni  249 (368)
                      ...||+|++|+||+|...+|+.||+|+++........                       ......+|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999999764321100                       01123459999999988877


Q ss_pred             eeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCCCCCCeeecC
Q 017621          250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHHCTPPIVHRDISSNNVLLNS  328 (368)
Q Consensus       250 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~NIll~~  328 (368)
                      .....+...  ..++||||++++++.......   ..++..+...++.|++.+|.|+ |+.   +|+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            544433222  238999999987775443222   2378899999999999999999 677   999999999999998 


Q ss_pred             CCCeEEeeeccceecCC
Q 017621          329 ELEAFVADFGVARLLNF  345 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~~  345 (368)
                      ++.++|+|||+|.....
T Consensus       153 ~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         153 DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CCcEEEEEccccccCCC
Confidence            47899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-26  Score=196.69  Aligned_cols=163  Identities=32%  Similarity=0.429  Sum_probs=135.2

Q ss_pred             ceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-----eEEEEE
Q 017621          193 KYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-----CMFLIY  266 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~  266 (368)
                      .+.||-|+||.||.+.++ +|+.||.|++..-. ......+++.+|++++..++|.|++..++...-..     ++|+++
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            466999999999999864 79999999986533 33445578889999999999999999988766442     478899


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |.|.. +|..++-....   ++...+.-++.||++||.|||+.   +|.||||||.|.|++.+..+||||||+++..+.+
T Consensus       137 ELmQS-DLHKIIVSPQ~---Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  137 ELMQS-DLHKIIVSPQA---LTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHh-hhhheeccCCC---CCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence            99974 88887765443   77778888999999999999999   9999999999999999999999999999987654


Q ss_pred             CC-CccccccccccccCC
Q 017621          347 SS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE  363 (368)
                      .. ..+..+-|-+|.|||
T Consensus       210 ~~~hMTqEVVTQYYRAPE  227 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPE  227 (449)
T ss_pred             hhhhhHHHHHHHHhccHH
Confidence            43 344456789999998

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.91  E-value=1.2e-24  Score=203.27  Aligned_cols=166  Identities=27%  Similarity=0.394  Sum_probs=139.7

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe---
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC---  261 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  261 (368)
                      ..++|++.+.||+|++|.||+|+.. +++.||+|++....... ...+.+.+|+.++++++||||+++++++...+.   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            4568999999999999999999864 57899999986543222 233567789999999999999999988776554   


Q ss_pred             ---EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          262 ---MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       262 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                         .++|+||+ +++|.+++...    .+++..+..++.|+++||+|||+.   +|+||||||+||++++++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence               89999999 56999888752    389999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCCccccccccccccCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ++......   .....++..|+|||
T Consensus       164 ~~~~~~~~---~~~~~~~~~y~aPE  185 (343)
T cd07851         164 LARHTDDE---MTGYVATRWYRAPE  185 (343)
T ss_pred             cccccccc---ccCCcccccccCHH
Confidence            99876433   22346788999998

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.91  E-value=2.4e-24  Score=190.65  Aligned_cols=149  Identities=22%  Similarity=0.208  Sum_probs=125.0

Q ss_pred             cCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCChhHH
Q 017621          199 GGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCV  277 (368)
Q Consensus       199 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  277 (368)
                      |.+|+||++++ .+++.||+|.+.....        +.+|...+....||||+++++++.+.+..++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            88999999986 4688999999875431        23345555566799999999999999999999999999999998


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcccccccc
Q 017621          278 LRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTS  357 (368)
Q Consensus       278 l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~  357 (368)
                      +....   .+++..+..++.|+++||+|||++   +++||||||+||+++.++.++++|||.+.......   ....++.
T Consensus        76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~  146 (237)
T cd05576          76 ISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVEN  146 (237)
T ss_pred             HHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCc
Confidence            87543   289999999999999999999998   99999999999999999999999999887654322   2234677


Q ss_pred             ccccCCC
Q 017621          358 GYIAPAS  364 (368)
Q Consensus       358 ~y~aPE~  364 (368)
                      .|+|||+
T Consensus       147 ~y~aPE~  153 (237)
T cd05576         147 MYCAPEV  153 (237)
T ss_pred             cccCCcc
Confidence            8999983

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.91  E-value=3.2e-26  Score=194.12  Aligned_cols=165  Identities=27%  Similarity=0.382  Sum_probs=131.2

Q ss_pred             ceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeecC
Q 017621          193 KYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYME  270 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  270 (368)
                      ...||.|+||+|++-.+ +.|+..|||+++......  ...+++.|.+...+- +.||||+++|.+..++..|+-||+|+
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k--eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK--EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH--HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            45699999999999875 579999999998766533  346788888765554 89999999999998889999999996


Q ss_pred             CCChhHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          271 MGSLFCVLRTD--EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       271 ~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                       .++..+.+.-  -....+++.-.-.|......||.||-...  .|||||+||+|||++..|.+||||||++..+... -
T Consensus       147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-i  222 (361)
T KOG1006|consen  147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-I  222 (361)
T ss_pred             -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-H
Confidence             3665443321  11223777777778888899999998765  8999999999999999999999999999776532 2


Q ss_pred             CccccccccccccCC
Q 017621          349 NRTLLAGTSGYIAPA  363 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE  363 (368)
                      ..+.-+|...|||||
T Consensus       223 AkT~daGCrpYmAPE  237 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPE  237 (361)
T ss_pred             HhhhccCCccccChh
Confidence            334457999999998

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=1.5e-23  Score=178.91  Aligned_cols=144  Identities=22%  Similarity=0.284  Sum_probs=113.0

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhh-----------------------HHhHHHHHHHHHHHhccCCCce
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEE-----------------------LASLESFRNEARLLSQIWHRNI  249 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~h~ni  249 (368)
                      ...||+|++|+||+|.+.+|+.||||+++......                       ......+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999998789999999987652110                       0012234679999999999988


Q ss_pred             eeEEEEEeeCCeEEEEEeecCCCChhHH-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeec
Q 017621          250 VKLYGFCLHRKCMFLIYEYMEMGSLFCV-LRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLN  327 (368)
Q Consensus       250 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~  327 (368)
                      .....+....  .|+||||++++++... +..    ..++..+...++.|++.++.++|+ .   +|+||||||+||+++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            6555443332  4899999998755433 332    226778889999999999999999 8   999999999999999


Q ss_pred             CCCCeEEeeeccceecCCC
Q 017621          328 SELEAFVADFGVARLLNFD  346 (368)
Q Consensus       328 ~~~~~kl~DFg~a~~~~~~  346 (368)
                       ++.++|+|||+++....+
T Consensus       153 -~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         153 -DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             -CCCEEEEEcccceecCCC
Confidence             889999999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.3e-24  Score=204.73  Aligned_cols=165  Identities=26%  Similarity=0.419  Sum_probs=138.9

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  263 (368)
                      .+++|.+...+|.|+|+.|-++.. .+++..++|++.+...       .-.+|+.++... +||||+++.+.+.++.+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence            367899999999999999999875 5688899999977622       234577666666 8999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee-cCCCCeEEeeecccee
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL-NSELEAFVADFGVARL  342 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DFg~a~~  342 (368)
                      +|||++.++-+.+.+.....   .. .++..|+.+|+.|+.|||++   +||||||||+|||+ ++.++++|+|||.++.
T Consensus       393 ~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             eeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            99999999988877765442   23 67778999999999999998   99999999999999 5899999999999998


Q ss_pred             cCCCCCCccccccccccccCC----------CCcC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPA----------SEWW  367 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE----------~d~w  367 (368)
                      ....   ....+-|..|.|||          ||||
T Consensus       466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~W  497 (612)
T KOG0603|consen  466 LERS---CDTPALTLQYVAPEVLAIQEYTEACDWW  497 (612)
T ss_pred             Cchh---hcccchhhcccChhhhccCCCCcchhhH
Confidence            7654   22346688999997          8999

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=2.7e-23  Score=206.56  Aligned_cols=173  Identities=30%  Similarity=0.475  Sum_probs=142.0

Q ss_pred             HhhccccceeeeecCCccEEEEEcC----C----CCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP----S----GKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFC  256 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  256 (368)
                      ..++..+.+.||+|.||+|++|...    .    ...||||.++.....  ...+.+..|+++|+.+ +||||+.++|+|
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            3444566679999999999999632    1    457999998865544  3557899999999999 799999999999


Q ss_pred             eeCCeEEEEEeecCCCChhHHhhcCC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 017621          257 LHRKCMFLIYEYMEMGSLFCVLRTDE-----EA--------VGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNN  323 (368)
Q Consensus       257 ~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  323 (368)
                      ..++..++|+||++.|+|.++++..+     ..        ..++..+.+.++.|||.|++||++.   ++|||||.++|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence            99999999999999999999998765     00        1388899999999999999999999   99999999999


Q ss_pred             eeecCCCCeEEeeeccceecCCCCCCc-cccccc--cccccCC
Q 017621          324 VLLNSELEAFVADFGVARLLNFDSSNR-TLLAGT--SGYIAPA  363 (368)
Q Consensus       324 Ill~~~~~~kl~DFg~a~~~~~~~~~~-~~~~gt--~~y~aPE  363 (368)
                      ||+.++..+||+|||+|+......... ....|+  ..|||||
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApE  491 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPE  491 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHH
Confidence            999999999999999999765433322 112222  3499998

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.90  E-value=7.7e-23  Score=178.58  Aligned_cols=168  Identities=37%  Similarity=0.570  Sum_probs=143.6

Q ss_pred             cccceeeeecCCccEEEEEcCC-CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |++.+.||+|++|.||++...+ ++.+|+|.+......  ...+.+.+|++.+.+++|+|++++++++...+..++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            5667889999999999998754 889999999865443  2346888999999999999999999999998999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC-
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS-  347 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~-  347 (368)
                      +++++|.+++......  +++.....++.+++.++.+||+.   +++|+|++|.||+++.++.++|+|||.+....... 
T Consensus        79 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       79 CEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             cCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            9999999998764322  78889999999999999999999   99999999999999999999999999998876543 


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                      .......++..|++||+
T Consensus       154 ~~~~~~~~~~~~~~pe~  170 (225)
T smart00221      154 ALLKTVKGTPFYLAPEV  170 (225)
T ss_pred             ccccceeccCCcCCHhH
Confidence            12233467888999984

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.90  E-value=5.9e-24  Score=204.99  Aligned_cols=163  Identities=28%  Similarity=0.401  Sum_probs=131.8

Q ss_pred             ccceeeeecCCc-cEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEee
Q 017621          191 HIKYCIGTGGYG-SVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       191 ~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      .-.+.+|.|+.| .||+|.. +|+.||||++.....      +-..+|+..+..- +|||||++++.-.++...|+..|.
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             ccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            334668999887 5799998 688999999865433      4567899999888 799999999999999999999999


Q ss_pred             cCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---C--CCeEEeeecccee
Q 017621          269 MEMGSLFCVLRTDEE-AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS---E--LEAFVADFGVARL  342 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DFg~a~~  342 (368)
                      |. .+|.++++.... .........+.+..|+++||++||+.   +||||||||.||||+.   +  .+++|+|||+|+.
T Consensus       585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            97 599999987411 11112144577899999999999997   9999999999999975   3  4788999999999


Q ss_pred             cCCCCCC---ccccccccccccCCC
Q 017621          343 LNFDSSN---RTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~---~~~~~gt~~y~aPE~  364 (368)
                      +..+...   .....||.+|+|||.
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~  685 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQ  685 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHH
Confidence            8766543   334579999999994

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.89  E-value=3e-24  Score=178.61  Aligned_cols=162  Identities=22%  Similarity=0.374  Sum_probs=136.8

Q ss_pred             HhhccccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCC--e
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRK--C  261 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  261 (368)
                      ..++|++.+.+|+|.|++||.|. ..+.+.++||++++-..      +.+.+|+.++..+. ||||+++++...+..  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk------kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK------KKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH------HHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            35689999999999999999997 45788899999976443      56889999999995 999999999988754  4


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CCeEEeeeccc
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGVA  340 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFg~a  340 (368)
                      ..+++||..+.+...+...      ++..++..++.++++||.|+|++   ||+|||+||.|++||.. ..++|+|+|+|
T Consensus       110 paLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             chhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence            7899999999887666543      67778889999999999999999   99999999999999954 57999999999


Q ss_pred             eecCCCCCCccccccccccccCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .++.+... ....+.+..|.-||
T Consensus       181 EFYHp~~e-YnVRVASRyfKGPE  202 (338)
T KOG0668|consen  181 EFYHPGKE-YNVRVASRYFKGPE  202 (338)
T ss_pred             hhcCCCce-eeeeeehhhcCCch
Confidence            98875433 34446788889998

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.89  E-value=4.7e-23  Score=183.16  Aligned_cols=166  Identities=22%  Similarity=0.308  Sum_probs=137.6

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC--C----ceeeEEEEEee
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH--R----NIVKLYGFCLH  258 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~  258 (368)
                      .+++|.+...+|+|.||+|-++.+ ..+..||+|+++.-..    ..++.+-|++++.++.+  |    -+|.+.++|..
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            378899999999999999999975 3578999999975443    33566779999999932  2    46788899999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC----------
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS----------  328 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----------  328 (368)
                      .++.++|+|.+ |-++.+++..+.. .+++...+..++.|++++++|||+.   +++|-||||+|||+.+          
T Consensus       163 rghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccC
Confidence            99999999998 4599999987653 4588999999999999999999999   9999999999999832          


Q ss_pred             ----------CCCeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          329 ----------ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       329 ----------~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                                +..+|++|||.|..-...   ....+.|..|.|||
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPE  279 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPE  279 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCch
Confidence                      234789999999875432   35568899999999

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.89  E-value=5.5e-22  Score=170.61  Aligned_cols=162  Identities=38%  Similarity=0.624  Sum_probs=138.8

Q ss_pred             eeecCCccEEEEEcCC-CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCCh
Q 017621          196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSL  274 (368)
Q Consensus       196 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  274 (368)
                      ||+|.+|.||++.... ++.+++|++.......  ..+.+.+|++.++.++|++|+++++++......++++||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            6899999999998754 8999999998665432  346788999999999999999999999999999999999999999


Q ss_pred             hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCCeEEeeeccceecCCCCCCcccc
Q 017621          275 FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-ELEAFVADFGVARLLNFDSSNRTLL  353 (368)
Q Consensus       275 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~  353 (368)
                      .+++....  ..+++..+..++.++++++.+||+.   +++|+||+|.||+++. ++.++|+|||.+.............
T Consensus        79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            99987642  2378999999999999999999999   9999999999999999 8999999999998776543223334


Q ss_pred             ccccccccCCC
Q 017621          354 AGTSGYIAPAS  364 (368)
Q Consensus       354 ~gt~~y~aPE~  364 (368)
                      .++..|++||.
T Consensus       154 ~~~~~~~~pe~  164 (215)
T cd00180         154 VGTPAYMAPEV  164 (215)
T ss_pred             cCCCCccChhH
Confidence            57888999974

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.88  E-value=3.1e-22  Score=176.49  Aligned_cols=156  Identities=33%  Similarity=0.551  Sum_probs=135.2

Q ss_pred             CCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCChhHHh
Q 017621          200 GYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL  278 (368)
Q Consensus       200 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l  278 (368)
                      +||.||+|... +++.+|+|++........  .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999875 589999999876544321  478899999999999999999999999999999999999999999998


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccccccccc
Q 017621          279 RTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG  358 (368)
Q Consensus       279 ~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~  358 (368)
                      .....   +++..+..++.+++.++.|||+.   +++|+||+|+||++++++.++|+|||.+....... ......|+..
T Consensus        79 ~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~  151 (244)
T smart00220       79 KKRGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE  151 (244)
T ss_pred             HhccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence            76443   78899999999999999999999   99999999999999999999999999998876442 2234468899


Q ss_pred             cccCCC
Q 017621          359 YIAPAS  364 (368)
Q Consensus       359 y~aPE~  364 (368)
                      |+|||.
T Consensus       152 ~~~pE~  157 (244)
T smart00220      152 YMAPEV  157 (244)
T ss_pred             CCCHHH
Confidence            999983

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.88  E-value=6e-23  Score=174.81  Aligned_cols=164  Identities=22%  Similarity=0.380  Sum_probs=131.3

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEE-EeeCCeE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGF-CLHRKCM  262 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~  262 (368)
                      ..+.|.+.+.+|+|.||.+-+|+++ +.+.+++|.+.....    ...+|.+|...--.| .|.||+.-|++ |+..+.+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            3456889999999999999999875 577899999876544    347888888876666 69999988774 6777888


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec--CCCCeEEeeeccc
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN--SELEAFVADFGVA  340 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFg~a  340 (368)
                      ++++||++.|+|.+-+...    ++-+....+++.|+++|++|+|++   ++||||||.+||||-  +..++|+||||..
T Consensus        98 vF~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             EEeeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence            8999999999998877543    378888899999999999999999   999999999999993  3358999999998


Q ss_pred             eecCCCCCCccccccccccccCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +..+..-..   .--+..|.|||
T Consensus       171 ~k~g~tV~~---~~~~~~y~~pe  190 (378)
T KOG1345|consen  171 RKVGTTVKY---LEYVNNYHAPE  190 (378)
T ss_pred             cccCceehh---hhhhcccCCcH
Confidence            765432211   12345577775

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-22  Score=176.86  Aligned_cols=164  Identities=29%  Similarity=0.360  Sum_probs=133.0

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC------
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK------  260 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  260 (368)
                      .+|.-...+|.|.- .|..|-+ -.++.||+|++...... ....++..+|..++..++|+||++++.++.-..      
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            35666677888877 5655543 25889999998765333 233456678999999999999999999987543      


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+|||||. .+|...+..     .++......+..|++.|+.|||+.   +|+||||||+||++..++.+||.|||+|
T Consensus        95 e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence            5899999997 588887762     167788889999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +..+.+ -..+..+.|..|.|||
T Consensus       166 r~e~~~-~~mtpyVvtRyyrape  187 (369)
T KOG0665|consen  166 RTEDTD-FMMTPYVVTRYYRAPE  187 (369)
T ss_pred             cccCcc-cccCchhheeeccCch
Confidence            876544 2345567899999998

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.86  E-value=2.7e-22  Score=180.47  Aligned_cols=145  Identities=29%  Similarity=0.441  Sum_probs=127.5

Q ss_pred             HHHHhhccccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEe
Q 017621          183 MIEATEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCL  257 (368)
Q Consensus       183 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  257 (368)
                      +....+.|..++.||+|.|+.||++.+.    ..+.||+|.+......     .++.+|+++|..+ .+.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhc
Confidence            3344567899999999999999999753    4678999999876554     5678899999999 7999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCCeEEee
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-ELEAFVAD  336 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~D  336 (368)
                      .++...+|+||++.....++...      ++..++..+++.+..||.++|.+   |||||||||+|+|.+. .+.-.|+|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence            99999999999999888888764      67788899999999999999999   9999999999999984 46788999


Q ss_pred             eccce
Q 017621          337 FGVAR  341 (368)
Q Consensus       337 Fg~a~  341 (368)
                      ||+|.
T Consensus       177 FgLA~  181 (418)
T KOG1167|consen  177 FGLAQ  181 (418)
T ss_pred             chhHH
Confidence            99997

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=3.7e-21  Score=165.30  Aligned_cols=138  Identities=18%  Similarity=0.260  Sum_probs=106.0

Q ss_pred             ccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-----CCCceeeEEEEEeeCC---eE
Q 017621          191 HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-----WHRNIVKLYGFCLHRK---CM  262 (368)
Q Consensus       191 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~  262 (368)
                      .-.+.||+|+||.||.  +++....+||++......   ..+.+.+|+.+++.+     .||||++++|+++++.   ..
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            3457799999999996  443333479988654322   236789999999999     5799999999999873   43


Q ss_pred             E-EEEee--cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeeecCCCCCCeeecC----CCCeEE
Q 017621          263 F-LIYEY--MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL-SYLHHHCTPPIVHRDISSNNVLLNS----ELEAFV  334 (368)
Q Consensus       263 ~-lv~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl  334 (368)
                      + +|+||  +.+++|.++++...    +++.  ..++.|++.++ +|||++   +|+||||||+|||++.    +..++|
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence            4 78999  55799999997532    4444  35678888777 999999   9999999999999974    347999


Q ss_pred             ee-ecccee
Q 017621          335 AD-FGVARL  342 (368)
Q Consensus       335 ~D-Fg~a~~  342 (368)
                      +| ||....
T Consensus       151 iDg~G~~~~  159 (210)
T PRK10345        151 CDNIGESTF  159 (210)
T ss_pred             EECCCCcce
Confidence            99 555444

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=3.9e-21  Score=165.76  Aligned_cols=161  Identities=14%  Similarity=0.159  Sum_probs=126.8

Q ss_pred             ceeecCCCcccHHHHHH--HhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHH------HHHHHHH
Q 017621          169 FAIWNYDGRITFQDMIE--ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLES------FRNEARL  240 (368)
Q Consensus       169 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~  240 (368)
                      +..+..+....|.++.+  ..++|+..+.+|.|+||.||.+.. ++..+|+|.+++...........      +.+|++.
T Consensus        10 ~~~~~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~   88 (232)
T PRK10359         10 YTVFYKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQ   88 (232)
T ss_pred             eEEEecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHH
Confidence            34444444545555554  367899999999999999999766 57789999998665444333333      6789999


Q ss_pred             HhccCCCceeeEEEEEeeC--------CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 017621          241 LSQIWHRNIVKLYGFCLHR--------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTP  312 (368)
Q Consensus       241 l~~l~h~niv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  312 (368)
                      +.++.||+|..+.+++...        +..++||||++|.+|.++..       ++.    ....+++.++..+|+.   
T Consensus        89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---  154 (232)
T PRK10359         89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---  154 (232)
T ss_pred             HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---
Confidence            9999999999999886643        35899999999999977632       222    2456999999999999   


Q ss_pred             CeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          313 PIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       313 ~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      +++|||+||+||++++++ ++++|||..+....
T Consensus       155 gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e  186 (232)
T PRK10359        155 GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQ  186 (232)
T ss_pred             CCccCCCChHHEEEeCCC-EEEEECCCcccccc
Confidence            999999999999999988 99999999876643

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=4.3e-21  Score=161.01  Aligned_cols=166  Identities=19%  Similarity=0.320  Sum_probs=135.5

Q ss_pred             HhhccccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC-CceeeEEEEEeeCCeEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH-RNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~  263 (368)
                      ....|.+++.||+|+||.+|.|. ..+|..||||.-+.....     .++..|.++...+++ ..|..+..|..+.++-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            35689999999999999999997 568999999987654432     467779999998864 77888888888888999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CCeEEeeeccc
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE---LEAFVADFGVA  340 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFg~a  340 (368)
                      +|||.. |.+|++++.-...  .++...++-++.|++.-++|+|.+   +++||||||+|+|..-+   ..+.++|||+|
T Consensus        88 lVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence            999998 5799888865432  278889999999999999999999   99999999999998633   46789999999


Q ss_pred             eecCCCCCC-------ccccccccccccC
Q 017621          341 RLLNFDSSN-------RTLLAGTSGYIAP  362 (368)
Q Consensus       341 ~~~~~~~~~-------~~~~~gt~~y~aP  362 (368)
                      +.+.+..+.       .....||..|.+-
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASi  190 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASI  190 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhh
Confidence            987654332       2345789998764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.85  E-value=1.2e-21  Score=180.13  Aligned_cols=177  Identities=22%  Similarity=0.285  Sum_probs=147.2

Q ss_pred             cccHHHHHHHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC------Cce
Q 017621          177 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH------RNI  249 (368)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~ni  249 (368)
                      .+.+.=.+....+|.+....|+|-|++|.+|.+. .|+.||||++.......    +.=++|+++|++|+.      -|+
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHH
Confidence            3444433445678999999999999999999864 48899999998765443    344679999999963      588


Q ss_pred             eeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       250 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                      ++++..|...+++|||+|-+. -+|.++++..+...++....+..++.|+.-||..|-..   +|+|.||||.|||+++.
T Consensus       497 lrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  497 LRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence            999999999999999999886 59999999988888899999999999999999999887   99999999999999865


Q ss_pred             -CCeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          330 -LEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       330 -~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                       ..+||||||.|..........  ..-+..|.|||
T Consensus       573 k~iLKLCDfGSA~~~~eneitP--YLVSRFYRaPE  605 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEITP--YLVSRFYRAPE  605 (752)
T ss_pred             cceeeeccCccccccccccccH--HHHHHhccCcc
Confidence             578999999998876544332  23467899999

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.5e-20  Score=158.91  Aligned_cols=154  Identities=16%  Similarity=0.131  Sum_probs=116.3

Q ss_pred             cceeeeecCCccEEEEEcCCCCEEEEEEccccchhhH-HhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeec
Q 017621          192 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL-ASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       192 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  269 (368)
                      +...|++|+||+||.+.. .+..++.+.+........ .....+.+|+++|+++ +|+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            467899999999998876 677788777765443211 1123578999999999 45889999886    3469999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC-CCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          270 EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDI-SSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       270 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      .|.+|.+....          ....++.|++++|+++|++   ||+|||| ||+|||++.++.++|+|||+|........
T Consensus        81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            99888653321          1134778999999999999   9999999 79999999999999999999986654332


Q ss_pred             C-------------ccccccccccccCC
Q 017621          349 N-------------RTLLAGTSGYIAPA  363 (368)
Q Consensus       349 ~-------------~~~~~gt~~y~aPE  363 (368)
                      .             ......++.|++|+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~  175 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPV  175 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHH
Confidence            1             01123577888884

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=1.1e-20  Score=166.24  Aligned_cols=149  Identities=21%  Similarity=0.206  Sum_probs=113.8

Q ss_pred             hccccceeeeecCCccEEEEE--cCCCCEEEEEEccccchhh---------------------HHhHHHHHHHHHHHhcc
Q 017621          188 EDFHIKYCIGTGGYGSVYRAR--LPSGKVVALKKLHRSETEE---------------------LASLESFRNEARLLSQI  244 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l  244 (368)
                      ..|++.+.||+|++|.||+|.  ..+|+.||+|+++......                     ......+.+|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358889999999999999998  5689999999987543110                     00112457899999999


Q ss_pred             CCCc--eeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eeecCCCC
Q 017621          245 WHRN--IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP-IVHRDISS  321 (368)
Q Consensus       245 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp  321 (368)
                      .+..  +.+++++    ...++||||++++++........   .....+...++.|++.++++||+.   + ++||||||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            7533  3444443    23589999999988866542221   245566778999999999999999   8 99999999


Q ss_pred             CCeeecCCCCeEEeeeccceecCCCC
Q 017621          322 NNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       322 ~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      +||+++ ++.++|+|||.+.....+.
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~~~~  202 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELDHPM  202 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccCCcc
Confidence            999999 8899999999998765443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.5e-20  Score=164.59  Aligned_cols=164  Identities=23%  Similarity=0.346  Sum_probs=137.0

Q ss_pred             hccccceeeeecCCccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  265 (368)
                      -.|++.+.||+|.||+++.|+ +-+++.||||.-......     .++..|.+..+.| ..++|...+-|..++.+-.||
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            368999999999999999997 457999999986544322     5677888888888 679999999998888888999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-----CCeEEeeeccc
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-----LEAFVADFGVA  340 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DFg~a  340 (368)
                      +|++ |.+|+++..-...  .++...+..++.|++.-++|+|++   .+|.|||||+|+||...     ..+.++|||+|
T Consensus       103 idLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            9998 5688888875433  389999999999999999999999   99999999999999643     35779999999


Q ss_pred             eecCCCCCC-------ccccccccccccC
Q 017621          341 RLLNFDSSN-------RTLLAGTSGYIAP  362 (368)
Q Consensus       341 ~~~~~~~~~-------~~~~~gt~~y~aP  362 (368)
                      +.+.+..+.       .....||..||+=
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSI  205 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSI  205 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEe
Confidence            998765543       3346799999984

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.7e-20  Score=159.61  Aligned_cols=139  Identities=19%  Similarity=0.335  Sum_probs=115.7

Q ss_pred             eeeeecCCccEEEEEcCCCCEEEEEEccccch-----hhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          194 YCIGTGGYGSVYRARLPSGKVVALKKLHRSET-----EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      +.||+|++|.||+|.. ++..+++|+......     ........+.+|++++..+.|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5689999999999987 677889997654321     1112235678899999999999998888777777788999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ++|++|.+++....      + .+..++.+++.+|.++|+.   +++|+|++|+|||++ ++.++++|||.+....
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~  145 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK  145 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence            99999999886421      2 7788999999999999999   999999999999999 7899999999987643

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=5.8e-20  Score=157.97  Aligned_cols=149  Identities=19%  Similarity=0.248  Sum_probs=113.7

Q ss_pred             HHHHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhH-------------------HhHHHHHHHHHHH
Q 017621          181 QDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL-------------------ASLESFRNEARLL  241 (368)
Q Consensus       181 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l  241 (368)
                      +++.....-|.+.+.||+|+||.||++..++|+.||||++........                   .....+.+|..++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            344444444888899999999999999988899999998764321000                   0112367789999


Q ss_pred             hccCCCc--eeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 017621          242 SQIWHRN--IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDI  319 (368)
Q Consensus       242 ~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  319 (368)
                      ..+.|++  ++..++.    ...++||||+++++|......         .....++.+++.++.++|+.   +++||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl  151 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDL  151 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence            9998774  4444442    346899999999988764321         23456889999999999998   9999999


Q ss_pred             CCCCeeecCCCCeEEeeeccceecCC
Q 017621          320 SSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       320 kp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||+||++++++.++|+|||.+.....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999976654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=5.9e-20  Score=169.77  Aligned_cols=167  Identities=23%  Similarity=0.322  Sum_probs=132.7

Q ss_pred             ccccceeeeecCCccEEEEEcCCC--CEEEEEEccccchhhHHhHHHHHHHHHHHhccCC----CceeeEEEEE-eeCCe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLPSG--KVVALKKLHRSETEELASLESFRNEARLLSQIWH----RNIVKLYGFC-LHRKC  261 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~  261 (368)
                      +|++.+.||+|+||.||.+.....  ..+|+|..........   ..+..|..++..+..    +++..+++.. .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            799999999999999999986553  4788888765432211   256778888888863    6899999998 57778


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-----CCeEEee
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-----LEAFVAD  336 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~D  336 (368)
                      .|+||+.+ |.+|.++..... ...++...+..|+.|++.+|++||+.   |++||||||+|+.+...     ..+.|.|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            99999988 579999886655 44599999999999999999999999   99999999999999754     4689999


Q ss_pred             eccceecC--CCC--------CCccccccccccccCC
Q 017621          337 FGVARLLN--FDS--------SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~--~~~--------~~~~~~~gt~~y~aPE  363 (368)
                      ||+++.+.  ...        .......||..|++++
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~  207 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASIN  207 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHH
Confidence            99998322  111        1123356999999985

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2e-19  Score=154.77  Aligned_cols=135  Identities=22%  Similarity=0.358  Sum_probs=109.3

Q ss_pred             eeeecCCccEEEEEcCCCCEEEEEEccccc-----hhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeec
Q 017621          195 CIGTGGYGSVYRARLPSGKVVALKKLHRSE-----TEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  269 (368)
                      .||+|++|.||+|.. ++..+++|......     .......+++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999995 67789999854322     111223467788999999999887766665666666789999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          270 EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       270 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      +|++|.+.+....    .      .++.+++.+|.++|+.   +++|+|++|+||+++ ++.++++|||++....
T Consensus        80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            9999988775421    0      6899999999999999   999999999999999 8899999999987754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=2.3e-19  Score=176.78  Aligned_cols=143  Identities=21%  Similarity=0.323  Sum_probs=114.1

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEE-cccc----chhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKK-LHRS----ETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~----~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      ...|...+.||+|+||+||++.+.... +++|+ ..+.    ........+++.+|+++++.++|++++....++...+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            344566789999999999999875443 33333 2211    11122234678899999999999999988888777777


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .++||||+++++|.+++.           ....++.+++++|.|||+.   +++||||||+|||+ +++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999988775           2456899999999999999   99999999999999 67799999999998


Q ss_pred             ecCC
Q 017621          342 LLNF  345 (368)
Q Consensus       342 ~~~~  345 (368)
                      ....
T Consensus       476 ~~~~  479 (535)
T PRK09605        476 YSDL  479 (535)
T ss_pred             cCCc
Confidence            7543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.81  E-value=7.1e-19  Score=161.43  Aligned_cols=170  Identities=36%  Similarity=0.546  Sum_probs=142.9

Q ss_pred             cccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCC-ceeeEEEEEeeCCeEEEEEee
Q 017621          190 FHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR-NIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  268 (368)
                      |.+.+.||.|+|+.||++...  ..+++|.+.............+.+|+.++..+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667888999999999999876  78899998776554333457889999999999888 799999999887778999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-CeEEeeeccceecCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARLLNFDS  347 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFg~a~~~~~~~  347 (368)
                      +.++++.+++........+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997776543112378889999999999999999999   999999999999999988 79999999998665443


Q ss_pred             C------CccccccccccccCCC
Q 017621          348 S------NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~------~~~~~~gt~~y~aPE~  364 (368)
                      .      ......||..|+|||.
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~  179 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEV  179 (384)
T ss_pred             ccccccccccccccccccCCHHH
Confidence            2      2345689999999984

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=7e-19  Score=161.03  Aligned_cols=134  Identities=26%  Similarity=0.453  Sum_probs=113.8

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-----C---CceeeEEEEEee
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-----H---RNIVKLYGFCLH  258 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~  258 (368)
                      .+|.+.+.||-|.|++||+|.+. +.+.||+|+.+....    ..+....|+++|++++     |   .+||++++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            68999999999999999999864 567899999876543    3466778999999883     2   479999999975


Q ss_pred             ----CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          259 ----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       259 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                          +.+++||+|++ |.+|..++..... ++++...+.+|+.||+.||.|||..|  +|||-||||+|||+..+
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence                45799999999 5688888876543 45999999999999999999999998  99999999999999654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.78  E-value=3.9e-19  Score=158.66  Aligned_cols=178  Identities=19%  Similarity=0.304  Sum_probs=140.5

Q ss_pred             HHHHHHhhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEE
Q 017621          181 QDMIEATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG  254 (368)
Q Consensus       181 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  254 (368)
                      +++.....+++....+-+|.||.||+|.+.      +.+.|-+|.++....+  .....+..|.-++..+.|||+..+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~--iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ--IQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH--HHHHHHHHHHHHHhcCcCCCccceeE
Confidence            455556677888888999999999999543      3455777777654432  35578889999999999999999999


Q ss_pred             EEeeC-CeEEEEEeecCCCChhHHhh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 017621          255 FCLHR-KCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS  328 (368)
Q Consensus       255 ~~~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  328 (368)
                      ++.++ +..++++.++.-|+|..++.     +....+.++-.+...++.|++.|++|||++   +|||.||.++|++||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence            88764 56789999999999999997     333445577788889999999999999999   9999999999999999


Q ss_pred             CCCeEEeeeccceecCCCCCCcc--ccccccccccCC
Q 017621          329 ELEAFVADFGVARLLNFDSSNRT--LLAGTSGYIAPA  363 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~~~~~~~~--~~~gt~~y~aPE  363 (368)
                      ...+||+|=.+++.+-+.....-  ..--...||+||
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslE  468 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLE  468 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHH
Confidence            99999999999987654322110  011245799997

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=1.9e-18  Score=147.08  Aligned_cols=140  Identities=21%  Similarity=0.235  Sum_probs=100.4

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHH---------------------HHHHHHHHHhccCCCc--e
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLE---------------------SFRNEARLLSQIWHRN--I  249 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~h~n--i  249 (368)
                      .+.||+|+||+||+|...+++.||||++............                     ....|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999988754322111111                     1135666666664433  4


Q ss_pred             eeEEEEEeeCCeEEEEEeecCCCChhH-HhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeec
Q 017621          250 VKLYGFCLHRKCMFLIYEYMEMGSLFC-VLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLN  327 (368)
Q Consensus       250 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~  327 (368)
                      .+.+++    ...++||||++++.+.. .+....    .. .+...++.+++.++.++|. .   +|+|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            444443    23589999999865432 121111    11 5567899999999999999 7   999999999999999


Q ss_pred             CCCCeEEeeeccceecCC
Q 017621          328 SELEAFVADFGVARLLNF  345 (368)
Q Consensus       328 ~~~~~kl~DFg~a~~~~~  345 (368)
                       ++.++++|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             89999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PLN03150 hypothetical protein; Provisional

Probab=99.76  E-value=1.4e-18  Score=173.25  Aligned_cols=104  Identities=32%  Similarity=0.523  Sum_probs=96.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.|+|.+|.++++|++|+.|+|++|+|+|.+|..++.|++|+.|||++|+|+|.+|+.++.+++|+.|+|++|+|+|
T Consensus       425 L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g  504 (623)
T PLN03150        425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG  504 (623)
T ss_pred             CCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc
Confidence            67899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc----ccccccCCCcccccc
Q 017621           81 SIPESVKKV----PLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~~~----~~~~~~~N~~~~~~P  104 (368)
                      .+|..+..+    ..+++.+|...|..|
T Consensus       505 ~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        505 RVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             cCChHHhhccccCceEEecCCccccCCC
Confidence            999987643    357888998776554

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.75  E-value=1.9e-17  Score=135.26  Aligned_cols=136  Identities=18%  Similarity=0.137  Sum_probs=114.0

Q ss_pred             cceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC--CceeeEEEEEeeCCeEEEEEeec
Q 017621          192 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH--RNIVKLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       192 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~  269 (368)
                      +.+.||+|.++.||++...+ ..+++|.......     ...+.+|+..+..++|  .++++++++....+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            35779999999999999744 7899999866443     2568889999999976  58999999888888899999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          270 EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       270 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +++.+..+          +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+...
T Consensus        76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            98776543          44566778999999999999864457999999999999999899999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=5e-17  Score=143.33  Aligned_cols=140  Identities=19%  Similarity=0.288  Sum_probs=107.1

Q ss_pred             ceeee-ecCCccEEEEEcCCCCEEEEEEccccch----------hhHHhHHHHHHHHHHHhccCCCce--eeEEEEEeeC
Q 017621          193 KYCIG-TGGYGSVYRARLPSGKVVALKKLHRSET----------EELASLESFRNEARLLSQIWHRNI--VKLYGFCLHR  259 (368)
Q Consensus       193 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  259 (368)
                      ...|| .|+.|+||++... +..+++|.+.....          ........+.+|++++..++|++|  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8899999999874 67889998854221          011223567889999999998875  6777765433


Q ss_pred             C----eEEEEEeecCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEE
Q 017621          260 K----CMFLIYEYMEM-GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFV  334 (368)
Q Consensus       260 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  334 (368)
                      .    ..++||||+++ .+|.+++....    ++..    .+.+++.++.+||+.   ||+||||||+|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAP----LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCC----CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 68888876421    4433    367899999999999   9999999999999999999999


Q ss_pred             eeeccceecC
Q 017621          335 ADFGVARLLN  344 (368)
Q Consensus       335 ~DFg~a~~~~  344 (368)
                      +|||.+....
T Consensus       184 IDfg~~~~~~  193 (239)
T PRK01723        184 IDFDRGELRT  193 (239)
T ss_pred             EECCCcccCC
Confidence            9999998754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.71  E-value=8.8e-19  Score=165.64  Aligned_cols=161  Identities=28%  Similarity=0.418  Sum_probs=135.3

Q ss_pred             eeecCCccEEEEE----cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeEEEEEeecC
Q 017621          196 IGTGGYGSVYRAR----LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMFLIYEYME  270 (368)
Q Consensus       196 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  270 (368)
                      +|+|+||.|+.++    ...+..+|+|..++......... ....|..++..++ ||.+++++-.++.+...+++++|..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            7899999999875    23577899998876544332222 5566888899996 9999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCc
Q 017621          271 MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR  350 (368)
Q Consensus       271 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~  350 (368)
                      +|++...+.....   +.+.....+...++-+++++|..   +|+|||+|++||+++.+|.+++.|||+++..-..... 
T Consensus        81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            9999888876543   66777777888999999999999   9999999999999999999999999999886543332 


Q ss_pred             cccccccccccCC--------CCcC
Q 017621          351 TLLAGTSGYIAPA--------SEWW  367 (368)
Q Consensus       351 ~~~~gt~~y~aPE--------~d~w  367 (368)
                         |||..|||||        +|||
T Consensus       154 ---cgt~eymApEI~~gh~~a~D~w  175 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIINGHLSAADWW  175 (612)
T ss_pred             ---ccchhhhhhHhhhccCCcccch
Confidence               8999999998        7898

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=3.3e-17  Score=165.09  Aligned_cols=167  Identities=25%  Similarity=0.315  Sum_probs=126.4

Q ss_pred             HHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC---CCceeeEEEEEeeCCe
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW---HRNIVKLYGFCLHRKC  261 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~  261 (368)
                      ...+.|.+.+.+|+|+||+||+|...+|+.||+|+-++....+.--..++      +.+|+   -+-|..+...+...+.
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~------~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQV------MERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHH------HHhhchhhhcchHHHHHHHccCCc
Confidence            34567889999999999999999988899999999887765543222222      23333   2345555555566677


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-------CCCeEE
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-------ELEAFV  334 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl  334 (368)
                      -++|+||.+.|+|.+++...   ..++|..++.++.|++..+++||..   +|||+||||+|+||..       ...++|
T Consensus       769 S~lv~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             ceeeeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence            78999999999999999843   3389999999999999999999999   9999999999999942       346899


Q ss_pred             eeeccceecCC--CCCCccccccccccccCC
Q 017621          335 ADFGVARLLNF--DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       335 ~DFg~a~~~~~--~~~~~~~~~gt~~y~aPE  363 (368)
                      +|||.+-.+.-  +.......++|-.+-.+|
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~E  873 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIE  873 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHH
Confidence            99999865432  333334445666666665

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=1.8e-17  Score=163.31  Aligned_cols=166  Identities=23%  Similarity=0.339  Sum_probs=127.5

Q ss_pred             ccceeeeecCCccEEEEEcC-CCCEEEEEEcc----ccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          191 HIKYCIGTGGYGSVYRARLP-SGKVVALKKLH----RSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       191 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ...+.+|.|++|.|+.+... ..+..+.|..+    ..... ......+..|.-+-..+.|||++.....+.+....+-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~-~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESE-RKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccH-HHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence            34678999999988877532 33334444333    22221 12222366788888889999998888777776666666


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||||++ +|..++.....   +...++..++.|++.|+.|+|+.   ||.|||+|++|++++.+|.+||+|||.+..+..
T Consensus       400 mE~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hhcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            999999 99999876522   77888899999999999999999   999999999999999999999999999987755


Q ss_pred             CCC----CccccccccccccCCC
Q 017621          346 DSS----NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~----~~~~~~gt~~y~aPE~  364 (368)
                      +..    .....+|+..|+|||+
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~  495 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEV  495 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCccc
Confidence            433    2345689999999993

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.69  E-value=1.2e-17  Score=172.18  Aligned_cols=116  Identities=17%  Similarity=0.195  Sum_probs=85.0

Q ss_pred             ccCC-CceeeEEEEE-------eeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 017621          243 QIWH-RNIVKLYGFC-------LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI  314 (368)
Q Consensus       243 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  314 (368)
                      .+.| +||+++++++       ...+.++.++||+ +++|.++++...  ..+++.+++.++.||++||+|||++   +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            3445 5777888877       2334577888988 469999997532  3489999999999999999999999   99


Q ss_pred             eecCCCCCCeeecC-------------------CCCeEEeeeccceecCCCC----------------CCcccccccccc
Q 017621          315 VHRDISSNNVLLNS-------------------ELEAFVADFGVARLLNFDS----------------SNRTLLAGTSGY  359 (368)
Q Consensus       315 vH~Dlkp~NIll~~-------------------~~~~kl~DFg~a~~~~~~~----------------~~~~~~~gt~~y  359 (368)
                      +||||||+|||++.                   ++.+|++|||+++......                .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   4456667777665422100                001123689999


Q ss_pred             ccCCC
Q 017621          360 IAPAS  364 (368)
Q Consensus       360 ~aPE~  364 (368)
                      ||||+
T Consensus       182 ~APE~  186 (793)
T PLN00181        182 TSPEE  186 (793)
T ss_pred             EChhh
Confidence            99994

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.65  E-value=1.4e-15  Score=145.32  Aligned_cols=145  Identities=23%  Similarity=0.268  Sum_probs=101.9

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHH---------------------------hH----------HHHH
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELA---------------------------SL----------ESFR  235 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------------------~~----------~~~~  235 (368)
                      .+.||+|++|+||+|+..+|+.||||+.++.......                           ..          -.|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3679999999999999999999999998765321110                           00          0245


Q ss_pred             HHHHHHhccC-----CCceeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHhcC
Q 017621          236 NEARLLSQIW-----HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH-ALSYLHHH  309 (368)
Q Consensus       236 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~  309 (368)
                      +|++.+.+++     ++++.-..-+....+..++||||++|++|.+........  .+   ...++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhC
Confidence            5666655552     344322222222334579999999999998876532211  22   3446666665 46788988


Q ss_pred             CCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       310 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                         |++|+|++|.||++++++.++++|||++..+..
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence               999999999999999999999999999987753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.55  E-value=6.4e-15  Score=142.61  Aligned_cols=148  Identities=19%  Similarity=0.174  Sum_probs=95.1

Q ss_pred             hhccccceeeeecCCccEEEEEcCC-CCEEEEEEccccchhhH-------------------------------HhHH--
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL-------------------------------ASLE--  232 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~-------------------------------~~~~--  232 (368)
                      ..+|+. +.||+|++|+||+|++++ |+.||||+.++......                               ...+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            445665 789999999999999877 99999999986531110                               0011  


Q ss_pred             ----HHHHHHHHHhccC----CCceeeEEEEEee-CCeEEEEEeecCCCChhHHh--hcCCC-CCCCCHHHHHHHHHHHH
Q 017621          233 ----SFRNEARLLSQIW----HRNIVKLYGFCLH-RKCMFLIYEYMEMGSLFCVL--RTDEE-AVGLDWAKRVNIVKGMA  300 (368)
Q Consensus       233 ----~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~-~~~l~~~~~~~i~~~i~  300 (368)
                          ++.+|+..+.+++    +...+.+-.++.+ ....+|||||++|+.+.++-  ..... ...+....+..++.|  
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence                2344555444442    3333333333322 34578999999999997643  22110 001222222233333  


Q ss_pred             HHHHHHhcCCCCCeeecCCCCCCeeecCCC----CeEEeeeccceecCC
Q 017621          301 HALSYLHHHCTPPIVHRDISSNNVLLNSEL----EAFVADFGVARLLNF  345 (368)
Q Consensus       301 ~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFg~a~~~~~  345 (368)
                           ++..   |++|+|+||.||+++.++    .++++|||++..++.
T Consensus       276 -----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 -----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 3345   999999999999999888    999999999987753

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.52  E-value=1.7e-14  Score=152.59  Aligned_cols=101  Identities=40%  Similarity=0.604  Sum_probs=92.2

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+++|.+|.++++|++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+++|+.|++++|+++|
T Consensus       506 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  585 (968)
T PLN00113        506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG  585 (968)
T ss_pred             CcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence            68999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccc--ccCcccccccCCCccc
Q 017621           81 SIPES--VKKVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p~~--~~~~~~~~~~~N~~~~  101 (368)
                      .+|..  +..+....+.+|...+
T Consensus       586 ~~p~~~~~~~~~~~~~~~n~~lc  608 (968)
T PLN00113        586 SLPSTGAFLAINASAVAGNIDLC  608 (968)
T ss_pred             eCCCcchhcccChhhhcCCcccc
Confidence            99964  3345556678887544

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=1.1e-13  Score=115.60  Aligned_cols=132  Identities=22%  Similarity=0.212  Sum_probs=96.3

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCce-eeEEEEEeeCCeEEEEEeecCC
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI-VKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      ++.++.|.++.||+++.. ++.+++|........    ...+.+|+++++.+.+.++ .+++.+..  +..++||||+++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence            456889999999999874 778999987654321    1245678888888865444 45555433  335799999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC--TPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      .++.+.    .    ..   ...++.+++++|+.||+..  ...++|+|++|.||+++ ++.++++|||.+..-
T Consensus        76 ~~l~~~----~----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          76 SELLTE----D----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             Cccccc----c----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            877542    0    11   1235678999999999982  12359999999999999 668999999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=3.7e-14  Score=127.54  Aligned_cols=112  Identities=28%  Similarity=0.417  Sum_probs=84.8

Q ss_pred             CCCceeeEEEEEee---------------------------CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHH
Q 017621          245 WHRNIVKLYGFCLH---------------------------RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK  297 (368)
Q Consensus       245 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  297 (368)
                      +|||||++.++|.+                           ...+|+||.-++. +|.+++..+.    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            59999999987642                           2358999998864 9999998654    45556667899


Q ss_pred             HHHHHHHHHhcCCCCCeeecCCCCCCeee--cCCC--CeEEeeeccceecCCC------CCCccccccccccccCCC
Q 017621          298 GMAHALSYLHHHCTPPIVHRDISSNNVLL--NSEL--EAFVADFGVARLLNFD------SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       298 ~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DFg~a~~~~~~------~~~~~~~~gt~~y~aPE~  364 (368)
                      |+++|+.|||.+   +|.|||+|.+|||+  |+|+  .+.|+|||+|---+..      .+..-...|...-||||+
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            999999999999   99999999999998  4554  3568999988532211      111223467888999983

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.47  E-value=1.3e-13  Score=122.73  Aligned_cols=170  Identities=19%  Similarity=0.260  Sum_probs=108.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC----------CCceeeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW----------HRNIVKLYGFC  256 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~  256 (368)
                      ..+...+.||.|+++.||.+.+. +++.+|+|++...........+++++|.-....+.          |-.++..++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            34566788999999999999875 58999999987655555556778887775555432          22333333332


Q ss_pred             e---------eC---C-----eEEEEEeecCCCChhHHhhc---CCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCee
Q 017621          257 L---------HR---K-----CMFLIYEYMEMGSLFCVLRT---DEE-AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV  315 (368)
Q Consensus       257 ~---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  315 (368)
                      .         ..   .     ..+++|+-+. +||.+++..   ... ...+....++.+..|+++.+++||+.   |++
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence            2         11   1     1366777775 588776542   111 11233445566778999999999999   999


Q ss_pred             ecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       316 H~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+||||+|++++.+|.++|+||+.....+.....   ...+..|.+||.
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~  213 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPEL  213 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhh
Confidence            9999999999999999999999988765432211   234567888873

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.46  E-value=8.1e-15  Score=146.18  Aligned_cols=145  Identities=23%  Similarity=0.286  Sum_probs=117.4

Q ss_pred             ccccceeeeecCCccEEEEEcCCCCEEEEEEccccc-hhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSE-TEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|...+.||++.|=+|.+|+++.|. |+||++-+.. ........+...|++ ...++|||.+.+.-+...+...|||=+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777889999999999999998887 8899886544 222222333344555 556699999999888777778899999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |... +|+|.+..+.-   +...+.+.|+.|++.||.-+|..   +|+|||||.+|||++.=.-+.|+||..-+.
T Consensus       102 yvkh-nLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHhh-hhhhhhccchH---HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCC
Confidence            9875 99998886542   67778888999999999999999   999999999999999988999999976553

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.46  E-value=4.6e-14  Score=140.58  Aligned_cols=135  Identities=31%  Similarity=0.528  Sum_probs=95.1

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ..+|..++.|..|+||.||.++++ +.+.+|+ ++++...-       +++   ++.....|.+|               
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-------lRn---ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-------LRN---ILTFAGNPFVV---------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh-------hhc---cccccCCccee---------------
Confidence            357889999999999999999876 4678888 44433221       111   33333444444               


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                            |+-...++....   ++..        ++.+++|+|+.   +|+|||+||+|.+|+.-|++|+.|||+++..-.
T Consensus       136 ------gDc~tllk~~g~---lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 ------GDCATLLKNIGP---LPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             ------chhhhhcccCCC---Ccch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                  444445543222   3322        27789999999   999999999999999999999999999875321


Q ss_pred             CCC---------------CccccccccccccCC----------CCcC
Q 017621          346 DSS---------------NRTLLAGTSGYIAPA----------SEWW  367 (368)
Q Consensus       346 ~~~---------------~~~~~~gt~~y~aPE----------~d~w  367 (368)
                      ...               .....||||.|+|||          ||||
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdww  242 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWW  242 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHH
Confidence            100               123468999999998          8999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.45  E-value=8.2e-13  Score=111.73  Aligned_cols=140  Identities=19%  Similarity=0.191  Sum_probs=99.9

Q ss_pred             eeeeecCCccEEEEEcCC-------CCEEEEEEccccchh----------h---------HHhHHHH----HHHHHHHhc
Q 017621          194 YCIGTGGYGSVYRARLPS-------GKVVALKKLHRSETE----------E---------LASLESF----RNEARLLSQ  243 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~----------~---------~~~~~~~----~~E~~~l~~  243 (368)
                      ..||.|.-+.||.|...+       +..+|||+.+.....          +         ......+    .+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543       478999977542100          0         0112223    379999999


Q ss_pred             cCC--CceeeEEEEEeeCCeEEEEEeecCCCChhH-HhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeeecCC
Q 017621          244 IWH--RNIVKLYGFCLHRKCMFLIYEYMEMGSLFC-VLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHHCTPPIVHRDI  319 (368)
Q Consensus       244 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dl  319 (368)
                      +..  -++.+++++    ...++||||+.++.+.. .++..    .++..+...+..+++.+|..+ |..   ++||+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            853  466667765    34689999998654422 22211    144556677889999999999 777   9999999


Q ss_pred             CCCCeeecCCCCeEEeeeccceecCC
Q 017621          320 SSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       320 kp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ++.|||++ ++.+.|+|||.+.....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCCC
Confidence            99999997 46899999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PLN03150 hypothetical protein; Provisional

Probab=99.45  E-value=1.5e-13  Score=137.39  Aligned_cols=89  Identities=37%  Similarity=0.606  Sum_probs=82.7

Q ss_pred             CCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccccccccC---ccccccc
Q 017621           19 KLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKK---VPLLYVS   95 (368)
Q Consensus        19 ~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~~~~~---~~~~~~~   95 (368)
                      .++.|+|++|.++|.+|.+++.|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..++.   +..++++
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            4889999999999999999999999999999999999999999999999999999999999999997764   5568999


Q ss_pred             CCCcccccccCC
Q 017621           96 GNNFEVEIPSTS  107 (368)
Q Consensus        96 ~N~~~~~~P~~~  107 (368)
                      +|+++|.+|...
T Consensus       499 ~N~l~g~iP~~l  510 (623)
T PLN03150        499 GNSLSGRVPAAL  510 (623)
T ss_pred             CCcccccCChHH
Confidence            999999998653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.44  E-value=2.3e-14  Score=122.78  Aligned_cols=162  Identities=23%  Similarity=0.364  Sum_probs=123.9

Q ss_pred             ccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecC
Q 017621          191 HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYME  270 (368)
Q Consensus       191 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  270 (368)
                      .+...|.+...|+.|+|+++ |..+++|++.-.+...+. .+.|..|.-.++-+.||||..+++.|.....+.++..||+
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~ri-srdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARI-SRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhccCCCccccccccc-Ccchhhhhhhhhhcchhh-cchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            34556888899999999994 555667877654443322 2578889888998999999999999999999999999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEe--eeccceecCCCCC
Q 017621          271 MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVA--DFGVARLLNFDSS  348 (368)
Q Consensus       271 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DFg~a~~~~~~~~  348 (368)
                      .|+|+..++..... -.+..++.+++.+||+|++|||+. .+-|.---|....+++|++.+++|+  |--++.  ..   
T Consensus       271 ~gslynvlhe~t~v-vvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--qe---  343 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSV-VVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE---  343 (448)
T ss_pred             chHHHHHHhcCccE-EEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--ec---
Confidence            99999999976543 367788999999999999999997 3334444688899999999988874  322211  11   


Q ss_pred             CccccccccccccCC
Q 017621          349 NRTLLAGTSGYIAPA  363 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE  363 (368)
                        ....-.|.||+||
T Consensus       344 --~gr~y~pawmspe  356 (448)
T KOG0195|consen  344 --VGRAYSPAWMSPE  356 (448)
T ss_pred             --cccccCcccCCHH
Confidence              1123468899998

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.39  E-value=8.9e-12  Score=101.66  Aligned_cols=148  Identities=19%  Similarity=0.269  Sum_probs=109.3

Q ss_pred             cceeeeecCCccEEEEEcCCCCEEEEEEc-----cccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          192 IKYCIGTGGYGSVYRARLPSGKVVALKKL-----HRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       192 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-----~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ....+-+|+-+.|+++.+ .|+...||.-     +....+..-...+..+|++.+.++.--.|....=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            467788999999999998 5777666643     2223333334567788999999987667766666666666678999


Q ss_pred             eecCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---CeEEeeecccee
Q 017621          267 EYMEM-GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL---EAFVADFGVARL  342 (368)
Q Consensus       267 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFg~a~~  342 (368)
                      ||+++ .++.+++.........+ .....++.+|-+.+.-||..   +|+|+||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99986 36777776544332222 22357888899999999999   999999999999997665   357999999876


Q ss_pred             cC
Q 017621          343 LN  344 (368)
Q Consensus       343 ~~  344 (368)
                      ..
T Consensus       166 s~  167 (229)
T KOG3087|consen  166 SR  167 (229)
T ss_pred             cc
Confidence            43

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=4.7e-12  Score=103.68  Aligned_cols=135  Identities=21%  Similarity=0.333  Sum_probs=102.8

Q ss_pred             eeeecCCccEEEEEcCCCCEEEEEEccc-----cchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeec
Q 017621          195 CIGTGGYGSVYRARLPSGKVVALKKLHR-----SETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~-----~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  269 (368)
                      .+++|+-+.+|.+.+.+ ..+++|.-.+     ......-..++-.+|++++.+++--.|....=+..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            47889999999997643 3355553222     23333334567788999999997767666666666777788999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          270 EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       270 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      +|..|.+.+...          ...++..+-.-+.-||..   +|+|+||.++||++..+. +.++|||++..-.
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            998888888754          144677777788889999   999999999999998775 8899999998643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.35  E-value=8.1e-12  Score=108.96  Aligned_cols=143  Identities=22%  Similarity=0.253  Sum_probs=108.8

Q ss_pred             eeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC--CceeeEEEEEeeCC---eEEEEEee
Q 017621          194 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH--RNIVKLYGFCLHRK---CMFLIYEY  268 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~  268 (368)
                      +.|+.|..+.||++...+|+.+++|........  .....+.+|.++++.+.+  ..+.+++.+.....   ..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            568999999999998866788999998654321  123567889999999965  44677777776542   56899999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC--------------------------------------  310 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------  310 (368)
                      ++|.++.+.+..    ..++..+...++.+++++|..||+..                                      
T Consensus        82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999888765431    12667777788888888888888521                                      


Q ss_pred             ---------------CCCeeecCCCCCCeeecC--CCCeEEeeecccee
Q 017621          311 ---------------TPPIVHRDISSNNVLLNS--ELEAFVADFGVARL  342 (368)
Q Consensus       311 ---------------~~~ivH~Dlkp~NIll~~--~~~~kl~DFg~a~~  342 (368)
                                     ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           235799999999999998  56688999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.32  E-value=2.8e-12  Score=107.80  Aligned_cols=74  Identities=20%  Similarity=0.127  Sum_probs=63.5

Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCcc
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT  351 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~  351 (368)
                      |+|.++++.+.  ..+++.++..++.|++.||+|||++   +      ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            68899997543  2389999999999999999999998   5      999999999999999  99998765432    


Q ss_pred             ccccccccccCC
Q 017621          352 LLAGTSGYIAPA  363 (368)
Q Consensus       352 ~~~gt~~y~aPE  363 (368)
                       ..||+.|||||
T Consensus        64 -~~g~~~y~aPE   74 (176)
T smart00750       64 -SRVDPYFMAPE   74 (176)
T ss_pred             -CCCcccccChH
Confidence             25899999999

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=3.3e-13  Score=133.28  Aligned_cols=171  Identities=25%  Similarity=0.357  Sum_probs=134.9

Q ss_pred             hccccceeeeecCCccEEEEEcC--CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP--SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  264 (368)
                      ..|.+.+.||+|+|+.|-.+...  ....+|+|.+.... ......+....|..+-+.+. |+|++.+++...+.+..++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            45777788999999999888653  34567777776543 11223345556777777775 9999999999999999999


Q ss_pred             EEeecCCCChhHHh-hcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeeecCCCCCCeeecCCC-CeEEeeeccce
Q 017621          265 IYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKGMAHALSYLH-HHCTPPIVHRDISSNNVLLNSEL-EAFVADFGVAR  341 (368)
Q Consensus       265 v~e~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFg~a~  341 (368)
                      +++|..++++.+.+ ....  ...+...+..++.|+..++.|+| ..   ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            99999999998887 3322  13566667789999999999999 77   999999999999999999 99999999998


Q ss_pred             ecCC-CCCC--cccccc-ccccccCCC
Q 017621          342 LLNF-DSSN--RTLLAG-TSGYIAPAS  364 (368)
Q Consensus       342 ~~~~-~~~~--~~~~~g-t~~y~aPE~  364 (368)
                      .+.. .+..  ....+| ++.|+|||.
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~  200 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEH  200 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCccc
Confidence            8766 3332  334578 999999984

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.31  E-value=3.2e-13  Score=108.41  Aligned_cols=98  Identities=30%  Similarity=0.585  Sum_probs=75.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      ||+|+++ .+|+.|..|.+|++|++++|+++ .+|.++++|+.|+.|+++-|+|. .+|..||.++-|..|||++|+++.
T Consensus        40 LSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e  116 (264)
T KOG0617|consen   40 LSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNE  116 (264)
T ss_pred             cccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccccc
Confidence            5788888 47777888888888888888886 78888888888888888888888 888888888888888888888864


Q ss_pred             -cccccccCc---ccccccCCCccc
Q 017621           81 -SIPESVKKV---PLLYVSGNNFEV  101 (368)
Q Consensus        81 -~~p~~~~~~---~~~~~~~N~~~~  101 (368)
                       .+|..+-.+   ..++++.|-|..
T Consensus       117 ~~lpgnff~m~tlralyl~dndfe~  141 (264)
T KOG0617|consen  117 NSLPGNFFYMTTLRALYLGDNDFEI  141 (264)
T ss_pred             ccCCcchhHHHHHHHHHhcCCCccc
Confidence             456665433   346777777764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.22  E-value=1.7e-11  Score=116.34  Aligned_cols=120  Identities=28%  Similarity=0.478  Sum_probs=99.5

Q ss_pred             HhccCCCceeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-eecCC
Q 017621          241 LSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI-VHRDI  319 (368)
Q Consensus       241 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~Dl  319 (368)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+...  ...+++.....++++|+.||+|+|+.   +| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            45789999999999999999999999999999999999873  34489999999999999999999987   55 99999


Q ss_pred             CCCCeeecCCCCeEEeeeccceecCC--CCCCccccccccccccCCCC
Q 017621          320 SSNNVLLNSELEAFVADFGVARLLNF--DSSNRTLLAGTSGYIAPASE  365 (368)
Q Consensus       320 kp~NIll~~~~~~kl~DFg~a~~~~~--~~~~~~~~~gt~~y~aPE~d  365 (368)
                      ++.|+++|....+||+|||+......  .........-..-|.|||..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPell  123 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELL  123 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHh
Confidence            99999999999999999999887742  11111111234568888854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.21  E-value=1.2e-10  Score=98.13  Aligned_cols=130  Identities=25%  Similarity=0.345  Sum_probs=85.0

Q ss_pred             cEEEEEcCCCCEEEEEEccccch-----------------------hhHHhHHHHHHHHHHHhccCCC--ceeeEEEEEe
Q 017621          203 SVYRARLPSGKVVALKKLHRSET-----------------------EELASLESFRNEARLLSQIWHR--NIVKLYGFCL  257 (368)
Q Consensus       203 ~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  257 (368)
                      .||.|...+|..+|+|+.+....                       ..........+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999988899999998754210                       0111234567899999999765  566776553 


Q ss_pred             eCCeEEEEEeecC--CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeeecCCCCCCeeecCCCCeEE
Q 017621          258 HRKCMFLIYEYME--MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY-LHHHCTPPIVHRDISSNNVLLNSELEAFV  334 (368)
Q Consensus       258 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  334 (368)
                         ..++||||++  |..+..+....     ++......++.+++..+.. +|..   +|+|+|+.+.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence               2469999998  54554433322     1123345677788886665 4677   99999999999999988 9999


Q ss_pred             eeeccceecCC
Q 017621          335 ADFGVARLLNF  345 (368)
Q Consensus       335 ~DFg~a~~~~~  345 (368)
                      +|||.+.....
T Consensus       148 IDf~qav~~~~  158 (188)
T PF01163_consen  148 IDFGQAVDSSH  158 (188)
T ss_dssp             --GTTEEETTS
T ss_pred             EecCcceecCC
Confidence            99999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.16  E-value=1.4e-10  Score=111.43  Aligned_cols=123  Identities=20%  Similarity=0.271  Sum_probs=101.6

Q ss_pred             cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCC
Q 017621          209 LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLD  288 (368)
Q Consensus       209 ~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~  288 (368)
                      ..++.+|.|...+....   ...+...+-++.++.++||||+++++.++..+..|+|+|-+.  .|..++++      +.
T Consensus        34 k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~  102 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LG  102 (690)
T ss_pred             eccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hH
Confidence            44678888887765544   123456677889999999999999999999999999999985  67777765      33


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          289 WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       289 ~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      .......+.||+.||.|||+.|  +++|+++.-..|+++..|.-||++|.++....
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence            4566678899999999999776  89999999999999999999999999887654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.14  E-value=7.4e-12  Score=116.92  Aligned_cols=97  Identities=23%  Similarity=0.389  Sum_probs=85.4

Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ++|+.|++|...+|.+++.++......++...+.++.|++.|++|   +   +.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            589999999999999999877766778889999999999999999   5   8999999999999999999999999999


Q ss_pred             eecCCCC------CCccccccccccccCC
Q 017621          341 RLLNFDS------SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~------~~~~~~~gt~~y~aPE  363 (368)
                      .......      ...+...||..||+||
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPE  432 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPE  432 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHH
Confidence            8776544      1345568999999998

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.13  E-value=1.3e-09  Score=97.39  Aligned_cols=143  Identities=20%  Similarity=0.138  Sum_probs=99.7

Q ss_pred             eeeecCCccEEEEEcCCCCEEEEEEccccchhhH--------HhHHHHHHHHHHHhccCCCce--eeEEEEEee-----C
Q 017621          195 CIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL--------ASLESFRNEARLLSQIWHRNI--VKLYGFCLH-----R  259 (368)
Q Consensus       195 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~  259 (368)
                      .+-+-....|++... +|+.|.||..........        .....+.+|.+.+.++...+|  +.++++.+.     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            344444445677765 677899997754332110        011246788888888854444  344555543     2


Q ss_pred             CeEEEEEeecCCC-ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-------CCC
Q 017621          260 KCMFLIYEYMEMG-SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-------ELE  331 (368)
Q Consensus       260 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~  331 (368)
                      ..-++|||++++. +|.+++..... ...+......++.+++..+.-||..   ||+|+|++++|||++.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence            3478999999976 78888753221 2245566778999999999999999   9999999999999985       467


Q ss_pred             eEEeeecccee
Q 017621          332 AFVADFGVARL  342 (368)
Q Consensus       332 ~kl~DFg~a~~  342 (368)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            89999998864

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.10  E-value=1.2e-11  Score=99.40  Aligned_cols=85  Identities=31%  Similarity=0.574  Sum_probs=78.6

Q ss_pred             cccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccccccccCccc-
Q 017621           13 ELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPL-   91 (368)
Q Consensus        13 ~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~~~~~~~~-   91 (368)
                      .+.++++.+.|.||+|+++ .+|++|..+.+|+.|++++|+++ .+|.++..++.|+.|+++-|++. .+|+.++++|. 
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence            3668899999999999998 88999999999999999999999 99999999999999999999998 88998888774 


Q ss_pred             --ccccCCCcc
Q 017621           92 --LYVSGNNFE  100 (368)
Q Consensus        92 --~~~~~N~~~  100 (368)
                        +++..|++.
T Consensus       105 evldltynnl~  115 (264)
T KOG0617|consen  105 EVLDLTYNNLN  115 (264)
T ss_pred             hhhhccccccc
Confidence              789999875

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.04  E-value=1.8e-10  Score=78.79  Aligned_cols=60  Identities=35%  Similarity=0.515  Sum_probs=54.5

Q ss_pred             CCCcEEEecCccccccCC-ccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcc
Q 017621           18 SKLRILILGNNLLSGSIS-SEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNL   78 (368)
Q Consensus        18 ~~l~~l~l~~N~~~g~~p-~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l   78 (368)
                      ++|+.|+|++|+++ .|| ..|..+++|+.|++++|+++...|..|..+++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            57899999999998 555 5789999999999999999977778999999999999999986

...

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.04  E-value=1.8e-10  Score=109.58  Aligned_cols=169  Identities=25%  Similarity=0.228  Sum_probs=129.7

Q ss_pred             ccccceeeee--cCCccEEEEEc---CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeE
Q 017621          189 DFHIKYCIGT--GGYGSVYRARL---PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       189 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  262 (368)
                      .|.+...+|.  |.+|.||.++.   .++..+|+|+-+......... .+=.+|+...+++ .|+|.++.+..++..+..
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~-~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS-KRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc-ccccchhhcccccCccccccccCcccccCCcc
Confidence            4666788999  99999999975   467889999743322211111 2223566666777 699999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeeecCCCCCCeeecCC-CCeEEeee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH----ALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADF  337 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DF  337 (368)
                      |+-+|++. .+|.++......  .++....+.+..+..+    |+.++|+.   .++|-|+||.||+...+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            99999996 688877765433  2667777888888888    99999999   99999999999999999 88999999


Q ss_pred             ccceecCCCCCCccc-----cccccccccCCC
Q 017621          338 GVARLLNFDSSNRTL-----LAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~~~~~-----~~gt~~y~aPE~  364 (368)
                      |+...+....-....     ..|...|++||+
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~  299 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL  299 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhh
Confidence            999888655422211     257788999984

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.98  E-value=5e-09  Score=91.15  Aligned_cols=140  Identities=24%  Similarity=0.272  Sum_probs=99.4

Q ss_pred             cccceeeeecCCccEEEEEcCCCCEEEEEEccccchhh-------------------HHhHHHHHHHHHHHhccCCC--c
Q 017621          190 FHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEE-------------------LASLESFRNEARLLSQIWHR--N  248 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~~~~E~~~l~~l~h~--n  248 (368)
                      ..+...||-|.-+.||.|..+.|.++|||.-+.....-                   .......++|.+.|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            44567899999999999999999999999653321110                   11233557899999999654  6


Q ss_pred             eeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 017621          249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS  328 (368)
Q Consensus       249 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  328 (368)
                      +.+.+++    +...+||||++|-.|...-        ++....-.++..|++-+.-+-..   |+||+|+.+-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            7777665    4567999999986654322        11222333455555555544455   9999999999999999


Q ss_pred             CCCeEEeeeccceecC
Q 017621          329 ELEAFVADFGVARLLN  344 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~  344 (368)
                      +|.+.++||--+....
T Consensus       238 dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         238 DGDIVVIDWPQAVPIS  253 (304)
T ss_pred             CCCEEEEeCcccccCC
Confidence            9999999998776544

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.95  E-value=2.3e-10  Score=103.51  Aligned_cols=95  Identities=36%  Similarity=0.555  Sum_probs=80.3

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCC----------------------
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP----------------------   59 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p----------------------   59 (368)
                      ++|.++ .+|..++.+++|+.|+|+||.+. .+|.+++.+-+||+||+|+|+|- .+|                      
T Consensus       420 snn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~v  496 (565)
T KOG0472|consen  420 SNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSV  496 (565)
T ss_pred             hcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccccc
Confidence            455554 79999999999999999999996 99999999999999999999886 555                      


Q ss_pred             -cc-cCCCCCCceecccCCcccccccccccCcc---cccccCCCcc
Q 017621           60 -SQ-LGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFE  100 (368)
Q Consensus        60 -~~-~~~~~~l~~l~l~~n~l~g~~p~~~~~~~---~~~~~~N~~~  100 (368)
                       ++ +++|.+|+.|||.+|.+. .||+.++++.   .+.++||+|.
T Consensus       497 d~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  497 DPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence             33 667888999999999998 8888877654   5789999885

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.89  E-value=1.6e-08  Score=97.81  Aligned_cols=144  Identities=21%  Similarity=0.252  Sum_probs=95.4

Q ss_pred             eeeeecCCccEEEEEcCCCCEEEEEEccccchhhHH---------------------------hHH----------HHHH
Q 017621          194 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELA---------------------------SLE----------SFRN  236 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------------------~~~----------~~~~  236 (368)
                      +.|+.++-|+||+|++++|+.||||+.++.-.....                           ..+          .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            668999999999999999999999998775322111                           011          2334


Q ss_pred             HHHHHhccC-----CCceeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHH-HHHHhcCC
Q 017621          237 EARLLSQIW-----HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA-LSYLHHHC  310 (368)
Q Consensus       237 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~~  310 (368)
                      |..-+.+++     .|++.-..=|++..+...|+|||++|-.+.+.......  +.+...   ++..++++ +..+-.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHHHHhc-
Confidence            555554442     34443333344445667899999999888777432222  244333   33333322 2222234 


Q ss_pred             CCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       311 ~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                        +++|.|..|.||+++.++++.+.|||+...+..
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              899999999999999999999999999987653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.86  E-value=2.1e-08  Score=86.54  Aligned_cols=107  Identities=22%  Similarity=0.324  Sum_probs=83.7

Q ss_pred             HHHHHHHHHHhccCCCc--eeeEEEEEeeCC----eEEEEEeecCCC-ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 017621          232 ESFRNEARLLSQIWHRN--IVKLYGFCLHRK----CMFLIYEYMEMG-SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS  304 (368)
Q Consensus       232 ~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~  304 (368)
                      ....+|.+.+..+..-.  +++.+++.+...    .-++|+|++++. +|.+++.....   .+......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            45677888877775433  455666665532    458999999874 78888876332   455667789999999999


Q ss_pred             HHhcCCCCCeeecCCCCCCeeecCCC---CeEEeeeccceecC
Q 017621          305 YLHHHCTPPIVHRDISSNNVLLNSEL---EAFVADFGVARLLN  344 (368)
Q Consensus       305 ~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFg~a~~~~  344 (368)
                      -||..   ||+|+|+++.|||++.+.   .+.++||+-++...
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            99999   999999999999999887   78899999888654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.85  E-value=3.8e-10  Score=102.11  Aligned_cols=91  Identities=22%  Similarity=0.318  Sum_probs=62.2

Q ss_pred             cccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccC-CCCCCceecccCCccccccccc
Q 017621            7 DGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG-EIPRIDTVNLSMNNLSGSIPES   85 (368)
Q Consensus         7 ~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~-~~~~l~~l~l~~n~l~g~~p~~   85 (368)
                      -+++|++++.|.+|+-|||..|+++ .+| +|..|..|..|.++.|+++ .+|+..+ .+++|..|||..|+++ .+|..
T Consensus       195 L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde  270 (565)
T KOG0472|consen  195 LETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDE  270 (565)
T ss_pred             hhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchH
Confidence            3478888888888888888888887 667 7777777766666666666 6665544 5666666666666666 56665


Q ss_pred             cc---CcccccccCCCccc
Q 017621           86 VK---KVPLLYVSGNNFEV  101 (368)
Q Consensus        86 ~~---~~~~~~~~~N~~~~  101 (368)
                      ++   ++..+|+|+|.+++
T Consensus       271 ~clLrsL~rLDlSNN~is~  289 (565)
T KOG0472|consen  271 ICLLRSLERLDLSNNDISS  289 (565)
T ss_pred             HHHhhhhhhhcccCCcccc
Confidence            44   34456666666653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.84  E-value=1.9e-09  Score=102.67  Aligned_cols=153  Identities=22%  Similarity=0.219  Sum_probs=119.1

Q ss_pred             HHHHhhccccceeeeecCCccEEEEEc--CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC
Q 017621          183 MIEATEDFHIKYCIGTGGYGSVYRARL--PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR  259 (368)
Q Consensus       183 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  259 (368)
                      ......+|..+..||.|.|+.|+....  .++..|++|............+.. ..|+-+...+ .|.+++.++..+...
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccc
Confidence            344567888999999999999999863  467889999876654433222222 2355555555 688999988888887


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CCeEEeeec
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFG  338 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFg  338 (368)
                      ...|+-.|||+++++.......   ..+++..++++..|++.++.++|+.   .++|+|+||+||++..+ +..++.|||
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence            7888999999999876555322   2267778889999999999999998   99999999999999886 788899999


Q ss_pred             ccee
Q 017621          339 VARL  342 (368)
Q Consensus       339 ~a~~  342 (368)
                      .+..
T Consensus       413 ~~t~  416 (524)
T KOG0601|consen  413 CWTR  416 (524)
T ss_pred             cccc
Confidence            8864

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.84  E-value=5.4e-10  Score=106.39  Aligned_cols=87  Identities=26%  Similarity=0.398  Sum_probs=52.8

Q ss_pred             CCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcc-cCCCCCCceecccCCcccccccccc--
Q 017621           10 IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ-LGEIPRIDTVNLSMNNLSGSIPESV--   86 (368)
Q Consensus        10 ~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~-~~~~~~l~~l~l~~n~l~g~~p~~~--   86 (368)
                      ||++|..|..|+.||||+|+++ ..|.++..-.++-.|+||+|++. .||.+ +.++.-|-.||||+|+|. .+|++.  
T Consensus        95 iP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RR  171 (1255)
T KOG0444|consen   95 IPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRR  171 (1255)
T ss_pred             CCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHH
Confidence            5666666666666666666665 55666666666666666666666 55544 345555666666666666 445443  


Q ss_pred             -cCcccccccCCCc
Q 017621           87 -KKVPLLYVSGNNF   99 (368)
Q Consensus        87 -~~~~~~~~~~N~~   99 (368)
                       ..+..+.+++|++
T Consensus       172 L~~LqtL~Ls~NPL  185 (1255)
T KOG0444|consen  172 LSMLQTLKLSNNPL  185 (1255)
T ss_pred             HhhhhhhhcCCChh
Confidence             3445566777764

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.81  E-value=4.6e-10  Score=105.98  Aligned_cols=104  Identities=21%  Similarity=0.212  Sum_probs=83.5

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |+.|+++..=.+++.+|++|++||||+|.+.-.=+++++.+++|+.||||+|+++.--|.+|..+++|+.|+|++|+++ 
T Consensus       276 L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-  354 (873)
T KOG4194|consen  276 LETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-  354 (873)
T ss_pred             cccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-
Confidence            5678888777788889999999999999998766788999999999999999999555567888888888999988887 


Q ss_pred             ccc----ccccCcccccccCCCccccccc
Q 017621           81 SIP----ESVKKVPLLYVSGNNFEVEIPS  105 (368)
Q Consensus        81 ~~p----~~~~~~~~~~~~~N~~~~~~P~  105 (368)
                      .+.    ..+.++..++++.|.+++.+-+
T Consensus       355 ~l~e~af~~lssL~~LdLr~N~ls~~IED  383 (873)
T KOG4194|consen  355 HLAEGAFVGLSSLHKLDLRSNELSWCIED  383 (873)
T ss_pred             HHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence            332    2345677788888888776654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.80  E-value=4e-09  Score=93.40  Aligned_cols=127  Identities=24%  Similarity=0.372  Sum_probs=92.1

Q ss_pred             HHHHhccCCCceeeEEEEEeeCC-----eEEEEEeecCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 017621          238 ARLLSQIWHRNIVKLYGFCLHRK-----CMFLIYEYMEMGSLFCVLRTDEE-AVGLDWAKRVNIVKGMAHALSYLHHHCT  311 (368)
Q Consensus       238 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~  311 (368)
                      ..-+-++.|.|||+++.|+.+..     ...++.|||..|++..+|++... ...+....-.+++.||..||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            34456677999999999987643     47889999999999999976432 23466777788999999999999984 8


Q ss_pred             CCeeecCCCCCCeeecCCCCeEEeeecccee---cCC-CCCCccccccccccccCCCC
Q 017621          312 PPIVHRDISSNNVLLNSELEAFVADFGVARL---LNF-DSSNRTLLAGTSGYIAPASE  365 (368)
Q Consensus       312 ~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~---~~~-~~~~~~~~~gt~~y~aPE~d  365 (368)
                      |+|+|+++..+-|++..++-+|+.----...   +.. ....+....|-++|.|||++
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg  254 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG  254 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC
Confidence            8999999999999999988888632110000   000 01112223467889999864

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.79  E-value=3.2e-09  Score=88.20  Aligned_cols=94  Identities=32%  Similarity=0.470  Sum_probs=35.4

Q ss_pred             CCCCCccccCCcccc-CCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCccc-CCCCCCceecccCCcc
Q 017621            1 MYNNKLDGPIPQELM-NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL-GEIPRIDTVNLSMNNL   78 (368)
Q Consensus         1 l~~n~l~g~~p~~~~-~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~-~~~~~l~~l~l~~n~l   78 (368)
                      |++|+++- |. .++ .+++|+.||||+|.++ .++ .+..+++|+.|+|++|+++ .+++.+ ..+++|+.|++++|+|
T Consensus        26 L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I  100 (175)
T PF14580_consen   26 LRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKI  100 (175)
T ss_dssp             ------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS--
T ss_pred             cccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcC
Confidence            45677763 43 465 5778999999999997 664 6888899999999999998 666554 3588999999999988


Q ss_pred             cccccc-----cccCcccccccCCCcc
Q 017621           79 SGSIPE-----SVKKVPLLYVSGNNFE  100 (368)
Q Consensus        79 ~g~~p~-----~~~~~~~~~~~~N~~~  100 (368)
                      +. +-.     .+..+..+++.+|+++
T Consensus       101 ~~-l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen  101 SD-LNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             -S-CCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CC-hHHhHHHHcCCCcceeeccCCccc
Confidence            73 221     2334556788888764

>PRK09902 hypothetical protein; Provisional

Probab=98.79  E-value=9.7e-08  Score=81.18  Aligned_cols=142  Identities=15%  Similarity=0.090  Sum_probs=101.3

Q ss_pred             eeecCCccEEEEEcCCCCEEEEEEccccchhh---HHhHHHHHHHHHHHhccCCCc--eeeEEEEEe-eC----CeEEEE
Q 017621          196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEE---LASLESFRNEARLLSQIWHRN--IVKLYGFCL-HR----KCMFLI  265 (368)
Q Consensus       196 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~~----~~~~lv  265 (368)
                      -|+||-+-|++.... |+.+-+|.-.......   ......|.+|...+.++..-+  +.++. ++. ..    -.-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            457888999998763 4468888764211111   123468899999999885433  44444 332 11    236899


Q ss_pred             EeecCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC--eEEeeecccee
Q 017621          266 YEYMEM-GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE--AFVADFGVARL  342 (368)
Q Consensus       266 ~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFg~a~~  342 (368)
                      +|-+++ -+|.+++..... ...+......+..++++.+.-||+.   ++.|+|+-+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 488888765322 2356777788999999999999999   9999999999999986666  89999987764


Q ss_pred             c
Q 017621          343 L  343 (368)
Q Consensus       343 ~  343 (368)
                      .
T Consensus       180 ~  180 (216)
T PRK09902        180 R  180 (216)
T ss_pred             h
Confidence            3

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.75  E-value=7.2e-08  Score=90.56  Aligned_cols=141  Identities=16%  Similarity=0.278  Sum_probs=108.5

Q ss_pred             CccEEEEE-cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee----CCeEEEEEeecCC-CCh
Q 017621          201 YGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH----RKCMFLIYEYMEM-GSL  274 (368)
Q Consensus       201 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L  274 (368)
                      -.+.|++. ..||..|++|+++.......   .....-++.++++.|+|+|++.+++..    +..+++||+|+++ ++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            35788986 45899999999954332211   112335678899999999999998763    4568999999986 466


Q ss_pred             hHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          275 FCVLRTD------------EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       275 ~~~l~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      .++.-..            ......++...+.++.|+..||.++|+.   |..-+-|.|.+|+++.+.+++|+..|....
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence            6544221            1223478889999999999999999999   999999999999999999999998888877


Q ss_pred             cCCCC
Q 017621          343 LNFDS  347 (368)
Q Consensus       343 ~~~~~  347 (368)
                      +..+.
T Consensus       443 l~~d~  447 (655)
T KOG3741|consen  443 LQEDP  447 (655)
T ss_pred             ecCCC
Confidence            66554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.72  E-value=3.4e-07  Score=80.04  Aligned_cols=139  Identities=16%  Similarity=0.173  Sum_probs=85.2

Q ss_pred             eeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCc--eeeEEEEEeeCCeEEEEEeecCC
Q 017621          194 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN--IVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      ..||+|..+.||+.   .+..+++|.......     .....+|.+++..+..-.  +.+.+++....+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~-----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD-----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCC-----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            56899999999984   245678888765332     245678999998885433  46778888777788899999998


Q ss_pred             CC-hhHHh---------------------hcCCCCCCCCHHHHH-HHHHH----------HHH-HHHHHhcC-CCCCeee
Q 017621          272 GS-LFCVL---------------------RTDEEAVGLDWAKRV-NIVKG----------MAH-ALSYLHHH-CTPPIVH  316 (368)
Q Consensus       272 g~-L~~~l---------------------~~~~~~~~l~~~~~~-~i~~~----------i~~-~L~~LH~~-~~~~ivH  316 (368)
                      .+ +...+                     +.-.. ......... .+..+          +.+ ...+|... ..+.++|
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            63 11111                     11000 001111100 01000          011 12222211 1235789


Q ss_pred             cCCCCCCeeecCCCCeEEeeecccee
Q 017621          317 RDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       317 ~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      +|+.|.||++++++ +.++||+.+..
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcCc
Confidence            99999999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.70  E-value=2.6e-07  Score=78.95  Aligned_cols=148  Identities=18%  Similarity=0.210  Sum_probs=95.2

Q ss_pred             cHHHHHH--HhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHH------HHHHHHHHhccCC---C
Q 017621          179 TFQDMIE--ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLES------FRNEARLLSQIWH---R  247 (368)
Q Consensus       179 ~~~~~~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h---~  247 (368)
                      .+.++.+  ...+|+..+.+.......|.+-.. +|+.+++|..+............      ..+++..+.+++.   .
T Consensus        20 ~y~~l~~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~   98 (229)
T PF06176_consen   20 KYLELGEKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFT   98 (229)
T ss_pred             HHHHHHHHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence            4444444  356788888888777777777665 67889999887654332222221      2233443444432   2


Q ss_pred             ceeeEEEEEe-----eCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 017621          248 NIVKLYGFCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSN  322 (368)
Q Consensus       248 niv~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  322 (368)
                      ....++.+.+     .....+++|||++|..|.+...       ++.    .+...+.+++.-+|..   |++|+|..|.
T Consensus        99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpg  164 (229)
T PF06176_consen   99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPG  164 (229)
T ss_pred             ccccceeeeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcC
Confidence            2222222222     2234678999999987765432       222    2456677889999999   9999999999


Q ss_pred             CeeecCCCCeEEeeecccee
Q 017621          323 NVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       323 NIll~~~~~~kl~DFg~a~~  342 (368)
                      |++++++ .++++||+..+.
T Consensus       165 NFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  165 NFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             cEEEECC-cEEEEECccccc
Confidence            9999865 489999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.70  E-value=1.4e-09  Score=107.78  Aligned_cols=95  Identities=28%  Similarity=0.478  Sum_probs=56.1

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|...-...+.++..|+.|+||+|+|+ .||.++.+|.+|++|..-+|++. .+| .+..+++|+.+|+|.|+|+-
T Consensus       390 LsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  390 LSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             ecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence            4555555322234455555666666666665 55666666666666666666666 566 55566777777777777763


Q ss_pred             -cccccc--cCcccccccCCC
Q 017621           81 -SIPESV--KKVPLLYVSGNN   98 (368)
Q Consensus        81 -~~p~~~--~~~~~~~~~~N~   98 (368)
                       .+|...  .++..++++||.
T Consensus       467 ~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  467 VTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             hhhhhhCCCcccceeeccCCc
Confidence             344432  356677777775

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.70  E-value=1.9e-09  Score=101.56  Aligned_cols=95  Identities=38%  Similarity=0.617  Sum_probs=69.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |+.|+++ .+|..++.|+ |++|-+++|+++ .+|.+++.+..|..||.|.|++. .+|++++.+.+|..|++..|++. 
T Consensus       128 ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-  202 (722)
T KOG0532|consen  128 LSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-  202 (722)
T ss_pred             hccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-
Confidence            4566666 4777777776 777777777775 77777777777777777777777 77777777777777777777776 


Q ss_pred             cccccccCccc--ccccCCCcc
Q 017621           81 SIPESVKKVPL--LYVSGNNFE  100 (368)
Q Consensus        81 ~~p~~~~~~~~--~~~~~N~~~  100 (368)
                      .+|+.++.++.  +|+|.|+++
T Consensus       203 ~lp~El~~LpLi~lDfScNkis  224 (722)
T KOG0532|consen  203 DLPEELCSLPLIRLDFSCNKIS  224 (722)
T ss_pred             hCCHHHhCCceeeeecccCcee
Confidence            67777776664  788888766

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.68  E-value=4.9e-07  Score=78.12  Aligned_cols=159  Identities=22%  Similarity=0.265  Sum_probs=106.3

Q ss_pred             cccHHHHHHHhhcccccee---eeecCCccEEEEEcCCCCEEEEEEccccchhhHH---------------------hHH
Q 017621          177 RITFQDMIEATEDFHIKYC---IGTGGYGSVYRARLPSGKVVALKKLHRSETEELA---------------------SLE  232 (368)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------------~~~  232 (368)
                      ..|.+.+....+...+...   |++|.-+.||+|...++..+|+|+++.....-..                     ...
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            3456666666666666555   4567777899999888999999998654322111                     011


Q ss_pred             HHHHHHHHHhccC--CCceeeEEEEEeeCCeEEEEEeecCCCCh-hHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 017621          233 SFRNEARLLSQIW--HRNIVKLYGFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH  309 (368)
Q Consensus       233 ~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~  309 (368)
                      ...+|.+-|.++.  +-.+.+.+++..    -.|||||+..... .-.|+.    .++...+...+..++++.+.-|-..
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHh
Confidence            2245777777773  444555555543    4699999965311 111111    1133335677888888888888763


Q ss_pred             CCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       310 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      +  ++||+||..=|||+. ++.+.|+|||-|.....+
T Consensus       186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             c--CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence            3  999999999999999 889999999999876543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.66  E-value=1.6e-08  Score=69.09  Aligned_cols=54  Identities=37%  Similarity=0.474  Sum_probs=47.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLI   54 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l   54 (368)
                      |++|+++..-+..+.++++|++|++++|+++..-|..|..|++|+.|+|++|+|
T Consensus         8 l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    8 LSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             ETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            578999975557889999999999999999966667899999999999999986

...

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.64  E-value=2.6e-09  Score=101.77  Aligned_cols=97  Identities=27%  Similarity=0.425  Sum_probs=85.8

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCcccc-ccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLS-GSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~-g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      ||.|+|+ .+|..++.|++|+.|++.+|+++ ..||+.||+|.+|+.+.+++|+|. -+|+.+..|..|+.|.|++|+|-
T Consensus       275 lSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi  352 (1255)
T KOG0444|consen  275 LSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI  352 (1255)
T ss_pred             cccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee
Confidence            6889999 59999999999999999999987 378999999999999999999999 99999999999999999999998


Q ss_pred             ccccccc---cCcccccccCCCcc
Q 017621           80 GSIPESV---KKVPLLYVSGNNFE  100 (368)
Q Consensus        80 g~~p~~~---~~~~~~~~~~N~~~  100 (368)
                       ++|+.+   ..+..+++..|.-.
T Consensus       353 -TLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  353 -TLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             -echhhhhhcCCcceeeccCCcCc
Confidence             889875   45667888888543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.62  E-value=3.1e-07  Score=88.68  Aligned_cols=143  Identities=20%  Similarity=0.241  Sum_probs=89.7

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHH----h--------------------HH----------HHHHHH
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELA----S--------------------LE----------SFRNEA  238 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~--------------------~~----------~~~~E~  238 (368)
                      .+.||.-+.|+||+|+.++|+.||||+-++.-.....    .                    .+          .|.+|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            3668999999999999999999999988765322100    0                    00          234444


Q ss_pred             HHHhc----cCCCc------eeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 017621          239 RLLSQ----IWHRN------IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH  308 (368)
Q Consensus       239 ~~l~~----l~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~  308 (368)
                      +-..+    +.|-+      |.+++-.+  .....|+||||+|..+.+.-.-...  +++...+...+.+...-+-+  .
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf--~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIF--K  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHH--h
Confidence            43333    23444      33333222  3457899999999877554332221  25555443333332222222  2


Q ss_pred             CCCCCeeecCCCCCCeeecC----CCCeEEeeeccceecC
Q 017621          309 HCTPPIVHRDISSNNVLLNS----ELEAFVADFGVARLLN  344 (368)
Q Consensus       309 ~~~~~ivH~Dlkp~NIll~~----~~~~kl~DFg~a~~~~  344 (368)
                      .   |++|+|-.|.||+++.    ++.+.+-|||+...+.
T Consensus       320 ~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 T---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             c---CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            2   8999999999999984    6789999999987654

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.60  E-value=3.6e-08  Score=62.08  Aligned_cols=40  Identities=35%  Similarity=0.516  Sum_probs=30.3

Q ss_pred             CCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCC
Q 017621           18 SKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP   59 (368)
Q Consensus        18 ~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p   59 (368)
                      ++|+.|+|++|+|+ .+|+.+++|++|+.|+|++|+++ .+|
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~   40 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS   40 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence            46888888888887 77877888888888888888887 443

...

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.58  E-value=5.8e-09  Score=103.46  Aligned_cols=97  Identities=32%  Similarity=0.470  Sum_probs=86.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCcc-ccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSE-IGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~-~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |.||.|+-.+-+-|-+..+|++|+||+|++. .+|.. +.++..|+.|+||+|.|+ .+|..+.+|.+|++|...+|+|.
T Consensus       366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~  443 (1081)
T KOG0618|consen  366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL  443 (1081)
T ss_pred             HhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee
Confidence            5689999988888999999999999999995 88875 689999999999999999 99999999999999999999998


Q ss_pred             cccccc--ccCcccccccCCCcc
Q 017621           80 GSIPES--VKKVPLLYVSGNNFE  100 (368)
Q Consensus        80 g~~p~~--~~~~~~~~~~~N~~~  100 (368)
                       ..|+.  +.++.++|+|.|+++
T Consensus       444 -~fPe~~~l~qL~~lDlS~N~L~  465 (1081)
T KOG0618|consen  444 -SFPELAQLPQLKVLDLSCNNLS  465 (1081)
T ss_pred             -echhhhhcCcceEEecccchhh
Confidence             77842  346778999999876

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.57  E-value=6.1e-09  Score=98.56  Aligned_cols=82  Identities=23%  Similarity=0.267  Sum_probs=59.7

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCC-ccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSIS-SEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p-~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      ||+|.+...=+..|.-+++|++|+||+|+++ .+| .+|.-|.+|+.|+|++|+++-.--..|..+++|..|||++|.|+
T Consensus       300 lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls  378 (873)
T KOG4194|consen  300 LSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELS  378 (873)
T ss_pred             cchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEE
Confidence            6788888888888888899999999999998 555 45666667777777777766444445566667777777777776


Q ss_pred             cccc
Q 017621           80 GSIP   83 (368)
Q Consensus        80 g~~p   83 (368)
                      +.|-
T Consensus       379 ~~IE  382 (873)
T KOG4194|consen  379 WCIE  382 (873)
T ss_pred             EEEe
Confidence            6554

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.56  E-value=7.5e-08  Score=97.27  Aligned_cols=12  Identities=33%  Similarity=0.465  Sum_probs=5.4

Q ss_pred             CcEEEecCcccc
Q 017621           20 LRILILGNNLLS   31 (368)
Q Consensus        20 l~~l~l~~N~~~   31 (368)
                      |+.|+|++|+|+
T Consensus       344 Lq~LdLS~N~Ls  355 (788)
T PRK15387        344 LQELSVSDNQLA  355 (788)
T ss_pred             cceEecCCCccC
Confidence            444444444444

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.53  E-value=9.7e-08  Score=96.77  Aligned_cols=90  Identities=27%  Similarity=0.502  Sum_probs=45.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|+ .+|..+.  ++|+.|+|++|+|+ .||..+.  ++|+.|+|++|+++ .+|..+.  ++|+.|++++|+|+ 
T Consensus       206 Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-  275 (754)
T PRK15370        206 LDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-  275 (754)
T ss_pred             ecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-
Confidence            3556666 3555443  35666666666665 4555432  24555555555555 4444432  34555555555555 


Q ss_pred             ccccccc-CcccccccCCCcc
Q 017621           81 SIPESVK-KVPLLYVSGNNFE  100 (368)
Q Consensus        81 ~~p~~~~-~~~~~~~~~N~~~  100 (368)
                      .+|..+. ++..+++++|+++
T Consensus       276 ~LP~~l~~sL~~L~Ls~N~Lt  296 (754)
T PRK15370        276 CLPENLPEELRYLSVYDNSIR  296 (754)
T ss_pred             ccccccCCCCcEEECCCCccc
Confidence            3444332 3444555555443

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.50  E-value=1.9e-06  Score=75.41  Aligned_cols=145  Identities=20%  Similarity=0.195  Sum_probs=83.5

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCC--ceeeEEEEEee---CCeEEEEEe
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR--NIVKLYGFCLH---RKCMFLIYE  267 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e  267 (368)
                      ++.++.|..+.||+....+ ..+++|.....     .....+.+|..++..+...  -+.+++.+...   ....+++|+
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            4678999999999999866 68999987654     1235667888888887433  35566664433   335789999


Q ss_pred             ecCCCChhH----------------Hhh---cC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHH
Q 017621          268 YMEMGSLFC----------------VLR---TD-EEAVGLDWAK---------RVNI------------VKGMAH-ALSY  305 (368)
Q Consensus       268 ~~~~g~L~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~i~~-~L~~  305 (368)
                      ++++..+..                .+.   .. ..........         ....            ...+.+ .++.
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE  155 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence            999887766                111   11 0000111100         0000            111222 2333


Q ss_pred             Hhc----CCCCCeeecCCCCCCeeec-CCCCeEEeeeccceec
Q 017621          306 LHH----HCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLL  343 (368)
Q Consensus       306 LH~----~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFg~a~~~  343 (368)
                      ++.    .....++|+|+.|.|||++ +++.+.|+||+.+...
T Consensus       156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence            332    1234799999999999999 5566679999887653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.49  E-value=1.4e-08  Score=102.14  Aligned_cols=148  Identities=20%  Similarity=0.224  Sum_probs=106.4

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .+++.+.+-+-+|.++.++.++-. .|...+.|.............+....+-.+.-..+||.++...--+......+++
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            456777778889999999988632 3444444444332222222234444454555555677777666555567779999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ++|..+++|...++....   .+..-+......+.++++|||..   .+.|+|++|.|++...++..++.|||..
T Consensus       883 ~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             hHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccc
Confidence            999999999998886542   44444555677788999999998   7999999999999999999999999844

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.49  E-value=2.2e-06  Score=75.98  Aligned_cols=141  Identities=13%  Similarity=0.093  Sum_probs=84.9

Q ss_pred             eeecCC-ccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEeecCCCC
Q 017621          196 IGTGGY-GSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEMGS  273 (368)
Q Consensus       196 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~  273 (368)
                      |..|.. ..||+.... +..+.+|......      ...+.+|++++..+ .+--+.+++++....+..++|||+++|.+
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            445555 789999864 4678888876543      13456788888877 34446677887777667899999999877


Q ss_pred             hhHHh-------------------hcCCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHhc---
Q 017621          274 LFCVL-------------------RTDEE-AVGLDW--AKRVNIVK--------------------GMAHALSYLHH---  308 (368)
Q Consensus       274 L~~~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~i~~~L~~LH~---  308 (368)
                      +....                   +.... ......  ........                    .+...+..|-.   
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            65331                   11000 000110  00000000                    01111222211   


Q ss_pred             -CCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          309 -HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       309 -~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                       ...+.++|+|+.|.|||++++....|+||+.+..-
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g  194 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA  194 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence             11346899999999999999877889999988643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.45  E-value=2.5e-07  Score=93.62  Aligned_cols=68  Identities=24%  Similarity=0.374  Sum_probs=47.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|+|+ .+|+.+.  ++|+.|+|++|+|+ .||.   .+++|++|+|++|+|+ .+|...   ++|+.|++++|.|+
T Consensus       208 Ls~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~lp---~sL~~L~Ls~N~L~  275 (788)
T PRK15387        208 VGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVLP---PGLLELSIFSNPLT  275 (788)
T ss_pred             cCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCcc---cccceeeccCCchh
Confidence            5778888 6888776  47888899999887 6775   3578888888888888 566432   34444444444444

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.44  E-value=1.3e-07  Score=95.82  Aligned_cols=89  Identities=34%  Similarity=0.558  Sum_probs=53.7

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      ++|+|++ +|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .
T Consensus       312 s~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~  381 (754)
T PRK15370        312 QSNSLTA-LPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-N  381 (754)
T ss_pred             cCCcccc-CCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-C
Confidence            3455543 443332  45666666666666 3565553  56777777777776 5665542  56777777777777 4


Q ss_pred             cccccc-CcccccccCCCcc
Q 017621           82 IPESVK-KVPLLYVSGNNFE  100 (368)
Q Consensus        82 ~p~~~~-~~~~~~~~~N~~~  100 (368)
                      +|..+. .+..+++++|+++
T Consensus       382 LP~~l~~sL~~LdLs~N~L~  401 (754)
T PRK15370        382 LPENLPAALQIMQASRNNLV  401 (754)
T ss_pred             CCHhHHHHHHHHhhccCCcc
Confidence            555442 4556677777665

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.40  E-value=2.7e-08  Score=94.07  Aligned_cols=95  Identities=26%  Similarity=0.435  Sum_probs=76.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      ++||+++ .+|.+++.+.+|..||.+.|++. .+|+.++.+.+|+.|++..|++. .+|+.++ .-.|..||+|+|+++ 
T Consensus       150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-  224 (722)
T KOG0532|consen  150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-  224 (722)
T ss_pred             EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-
Confidence            4788888 59999998889999999999997 88999998888888888888888 7888877 456778888888888 


Q ss_pred             cccccccCc---ccccccCCCcc
Q 017621           81 SIPESVKKV---PLLYVSGNNFE  100 (368)
Q Consensus        81 ~~p~~~~~~---~~~~~~~N~~~  100 (368)
                      .||-.+..|   ..+.+.+|++.
T Consensus       225 ~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  225 YLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             ecchhhhhhhhheeeeeccCCCC
Confidence            778766544   45667777653

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.40  E-value=1.8e-07  Score=77.74  Aligned_cols=76  Identities=30%  Similarity=0.440  Sum_probs=38.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccc-cCCCCCCeeeeecccccccCC--cccCCCCCCceecccCCc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP--SQLGEIPRIDTVNLSMNN   77 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~-~~~~~L~~l~l~~N~l~g~~p--~~~~~~~~l~~l~l~~n~   77 (368)
                      |++|.++. ++ .+..+++|+.|+|++|+++ .++..+ ..+++|+.|+|++|++. .+-  ..+..++.|+.|++.+|+
T Consensus        49 Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NP  124 (175)
T PF14580_consen   49 LSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVLSLEGNP  124 (175)
T ss_dssp             -TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EEE-TT-G
T ss_pred             CCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCcceeeccCCc
Confidence            68899995 66 4788999999999999998 676666 46999999999999998 443  356789999999999999


Q ss_pred             ccc
Q 017621           78 LSG   80 (368)
Q Consensus        78 l~g   80 (368)
                      ++.
T Consensus       125 v~~  127 (175)
T PF14580_consen  125 VCE  127 (175)
T ss_dssp             GGG
T ss_pred             ccc
Confidence            983

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.39  E-value=2.2e-07  Score=58.51  Aligned_cols=40  Identities=43%  Similarity=0.723  Sum_probs=34.6

Q ss_pred             CCCCeeeeecccccccCCcccCCCCCCceecccCCccccccc
Q 017621           42 QELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIP   83 (368)
Q Consensus        42 ~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p   83 (368)
                      ++|+.|+|++|+++ .+|+.++.|++|+.|++++|+|+ .+|
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~   40 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS   40 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence            57999999999999 89998999999999999999998 443

...

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.36  E-value=2.1e-06  Score=72.75  Aligned_cols=104  Identities=25%  Similarity=0.311  Sum_probs=81.4

Q ss_pred             HHHHHHhccCC-CceeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 017621          236 NEARLLSQIWH-RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI  314 (368)
Q Consensus       236 ~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  314 (368)
                      .|.-+++.+++ +++++++|+|-    .++|.||...+++......-..-...+|..+.+|+.++++.++++++.....+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47778888865 69999999994    36789999877664321110111236999999999999999999998644467


Q ss_pred             eecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          315 VHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       315 vH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      .-.|++++|+-+++++++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            78999999999999999999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.36  E-value=9.8e-08  Score=83.70  Aligned_cols=88  Identities=25%  Similarity=0.323  Sum_probs=58.5

Q ss_pred             cccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccccc---
Q 017621            7 DGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIP---   83 (368)
Q Consensus         7 ~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p---   83 (368)
                      +|..-.++..++-|+.||||+|.++ .|..+.--+|.++.|+||+|.+. .+- .+..+++|+.||||+|.|+ .+-   
T Consensus       273 ~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh  348 (490)
T KOG1259|consen  273 NGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWH  348 (490)
T ss_pred             CCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhH
Confidence            4444455556667788888888887 77777777788888888888777 443 3777778888888888776 222   


Q ss_pred             ccccCcccccccCCC
Q 017621           84 ESVKKVPLLYVSGNN   98 (368)
Q Consensus        84 ~~~~~~~~~~~~~N~   98 (368)
                      ..++++..+.+++|.
T Consensus       349 ~KLGNIKtL~La~N~  363 (490)
T KOG1259|consen  349 LKLGNIKTLKLAQNK  363 (490)
T ss_pred             hhhcCEeeeehhhhh
Confidence            224445555555553

>PLN02876 acyl-CoA dehydrogenase

Probab=98.35  E-value=7.6e-06  Score=85.10  Aligned_cols=79  Identities=23%  Similarity=0.353  Sum_probs=56.8

Q ss_pred             ceeeeecCCccEEEEEcCCC---CEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCce--eeEEEEEeeC---CeEE
Q 017621          193 KYCIGTGGYGSVYRARLPSG---KVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNI--VKLYGFCLHR---KCMF  263 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~  263 (368)
                      .+.++.|.+..+|+....++   ..+++|+........  ....+.+|.++++.+. |+++  .+++.+|.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            46688899999999876543   467788765432211  1246778999999995 6665  7778887764   4678


Q ss_pred             EEEeecCCCC
Q 017621          264 LIYEYMEMGS  273 (368)
Q Consensus       264 lv~e~~~~g~  273 (368)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999999764

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.34  E-value=5.1e-06  Score=70.23  Aligned_cols=128  Identities=23%  Similarity=0.379  Sum_probs=90.8

Q ss_pred             hccccceeeeecCC-ccEEEEEcCCCCEEEEEEccc---cch--------h-hH------HhHHHHHHHHHHHhccC---
Q 017621          188 EDFHIKYCIGTGGY-GSVYRARLPSGKVVALKKLHR---SET--------E-EL------ASLESFRNEARLLSQIW---  245 (368)
Q Consensus       188 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~--------~-~~------~~~~~~~~E~~~l~~l~---  245 (368)
                      .+++..+.||.|.. |.||+++. +|+.+|+|.+..   ...        . ..      ...+-|..|.+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 99999998 677999999322   100        0 00      22346788999887774   


Q ss_pred             CCce--eeEEEEEeeC------------------CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 017621          246 HRNI--VKLYGFCLHR------------------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY  305 (368)
Q Consensus       246 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~  305 (368)
                      +.++  |+++||..-.                  -...||.||.+...            .+...    -+.+|.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHH
Confidence            4456  8999987422                  12457778776432            12222    34567777888


Q ss_pred             HhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       306 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      +|..   +|+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            9998   9999999999986     5689999865

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.31  E-value=7.2e-06  Score=67.22  Aligned_cols=131  Identities=20%  Similarity=0.264  Sum_probs=87.1

Q ss_pred             ccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCcee-eEEEEEeeCCeEEEEEeec
Q 017621          191 HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIV-KLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       191 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~  269 (368)
                      ...+.|++|.+|.||++.+. +..+|+|+-+....     ...+..|++++..++-.++. +++.|..+    ++.|||+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i   94 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI   94 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence            34567999999999999984 55888887665432     36788999999998766664 45555333    4569999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC-CCCeeecCCCCeEEeeeccceecC
Q 017621          270 EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDIS-SNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       270 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      .|-.|.+.-..      .+......    +++.---|-..   ||-|+.|. |..+++..++.+.|+||..|+...
T Consensus        95 ~G~~L~~~~~~------~~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~  157 (201)
T COG2112          95 DGRPLGKLEIG------GDRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK  157 (201)
T ss_pred             cCcchhhhhhc------ccHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence            98787665432      12223332    33331223333   88888875 455555566699999999998543

>PRK10593 hypothetical protein; Provisional

Probab=98.29  E-value=1.8e-05  Score=72.27  Aligned_cols=78  Identities=19%  Similarity=0.161  Sum_probs=56.4

Q ss_pred             ccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC---CceeeEEEEEeeC---CeEEE
Q 017621          191 HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH---RNIVKLYGFCLHR---KCMFL  264 (368)
Q Consensus       191 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~l  264 (368)
                      .-.+.||.|..+.||+....+++ +.+|..+....     ...+..|.+.++.+.-   -.+.++++++...   +..++
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARSFST-----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEeccccc-----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            34567999999999999875664 66676432111     1477889999988842   3678888877643   66899


Q ss_pred             EEeecCCCCh
Q 017621          265 IYEYMEMGSL  274 (368)
Q Consensus       265 v~e~~~~g~L  274 (368)
                      |||+++++++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.27  E-value=2.1e-05  Score=66.95  Aligned_cols=137  Identities=23%  Similarity=0.340  Sum_probs=92.6

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchh-------------hHHhHHHHHHHHHHHhccC------CCceeeEE
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE-------------ELASLESFRNEARLLSQIW------HRNIVKLY  253 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~~~E~~~l~~l~------h~niv~l~  253 (368)
                      ...||+|+.-.||.  +++....+||+.......             .....++..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45699999998885  445566788988766500             0012345666666655555      88999999


Q ss_pred             EEEeeCCeEEEEEeecCC--C----ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec
Q 017621          254 GFCLHRKCMFLIYEYMEM--G----SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN  327 (368)
Q Consensus       254 ~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  327 (368)
                      |+.+++...-+|+|.+.+  |    +|.++++...    ++. ...   ..+-+-..||-..   .|+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~---~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELR---QALDEFKRYLLDH---HIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHH---HHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence            999999888899998643  2    5677775432    444 322   3333445677777   899999999999996


Q ss_pred             CC--C--CeEEee-ecccee
Q 017621          328 SE--L--EAFVAD-FGVARL  342 (368)
Q Consensus       328 ~~--~--~~kl~D-Fg~a~~  342 (368)
                      ..  +  .+.|+| ||....
T Consensus       153 ~~~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             ecCCCceEEEEEeCCCCccc
Confidence            33  2  577888 565443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.25  E-value=1.9e-07  Score=82.00  Aligned_cols=95  Identities=26%  Similarity=0.389  Sum_probs=77.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      ||+|.++ .+-.+..-+++++.|+||+|.++ .+. ++..|++|+.||||+|.|+ .+-.+=..+-+++.|+|+.|.+. 
T Consensus       291 LS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-  365 (490)
T KOG1259|consen  291 LSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-  365 (490)
T ss_pred             ccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-
Confidence            6788888 47777777899999999999998 554 5999999999999999999 77676677889999999999885 


Q ss_pred             ccc--ccccCcccccccCCCcc
Q 017621           81 SIP--ESVKKVPLLYVSGNNFE  100 (368)
Q Consensus        81 ~~p--~~~~~~~~~~~~~N~~~  100 (368)
                      .+.  ..+.++-.+++++|++.
T Consensus       366 ~LSGL~KLYSLvnLDl~~N~Ie  387 (490)
T KOG1259|consen  366 TLSGLRKLYSLVNLDLSSNQIE  387 (490)
T ss_pred             hhhhhHhhhhheeccccccchh
Confidence            332  23456677899999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.24  E-value=1.1e-05  Score=71.15  Aligned_cols=73  Identities=14%  Similarity=0.192  Sum_probs=44.9

Q ss_pred             eeeeecCCc-cEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCC---ceeeEEEEEeeC---CeEEEEE
Q 017621          194 YCIGTGGYG-SVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR---NIVKLYGFCLHR---KCMFLIY  266 (368)
Q Consensus       194 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~  266 (368)
                      +.++.|+.. .||+..    ..+++|......     ....+.+|.+++..+...   -+.++++.....   ...+++|
T Consensus         3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~   73 (235)
T cd05155           3 EPVDSGGTDNATFRLG----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY   73 (235)
T ss_pred             eeccCCCcccceEEcC----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence            457766665 599762    357778755422     124678899888777421   334444443332   2358899


Q ss_pred             eecCCCChh
Q 017621          267 EYMEMGSLF  275 (368)
Q Consensus       267 e~~~~g~L~  275 (368)
                      ++++|.++.
T Consensus        74 ~~i~G~~l~   82 (235)
T cd05155          74 RWLEGETAT   82 (235)
T ss_pred             EeecCCCCC
Confidence            999987663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.23  E-value=4.3e-07  Score=86.54  Aligned_cols=93  Identities=29%  Similarity=0.439  Sum_probs=55.9

Q ss_pred             CCCCccccCCccccCCC-CCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            2 YNNKLDGPIPQELMNCS-KLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~-~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      .+|.++ .+|+....++ +|+.|++++|+++ .+|..+..++.|+.|++++|+++ .+|...+.++.|..|++++|+++ 
T Consensus       124 ~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-  199 (394)
T COG4886         124 DNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-  199 (394)
T ss_pred             CCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-
Confidence            345555 3555555553 6666666666665 56666666666666666666666 66665555666666666666666 


Q ss_pred             ccccc--cc-CcccccccCCC
Q 017621           81 SIPES--VK-KVPLLYVSGNN   98 (368)
Q Consensus        81 ~~p~~--~~-~~~~~~~~~N~   98 (368)
                      .+|..  .. .+..+.+++|.
T Consensus       200 ~l~~~~~~~~~L~~l~~~~N~  220 (394)
T COG4886         200 DLPPEIELLSALEELDLSNNS  220 (394)
T ss_pred             cCchhhhhhhhhhhhhhcCCc
Confidence            55553  22 35556666663

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.22  E-value=1.9e-07  Score=89.88  Aligned_cols=161  Identities=19%  Similarity=0.154  Sum_probs=112.9

Q ss_pred             HhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCc-eeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN-IVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l  264 (368)
                      .+..+..-+-.++|+++++||.+....+....+.+...        ....-++++|.+++||| .+..++-++.++..++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            33444445567899999999998654454556666443        23345889999999999 6777777777788999


Q ss_pred             EEeecCCC-ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          265 IYEYMEMG-SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       265 v~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +++++.++ +-.....  .....+...+...+.+.-+++++++|+.   .-+|+|    ||+..+ +..|..||+....+
T Consensus       312 ~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L  381 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQL  381 (829)
T ss_pred             hhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCccc
Confidence            99999877 2211111  1111234444556667778899999987   568998    777665 68899999998877


Q ss_pred             CCCCCCccccccccccccCCCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPASE  365 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE~d  365 (368)
                      .... ......+|+.++|||++
T Consensus       382 ~~~~-~~~t~~~~~~~~~pev~  402 (829)
T KOG0576|consen  382 TRTM-KPRTAIGTPEPLAPEVI  402 (829)
T ss_pred             Cccc-ccccCCCCCCCCCchhh
Confidence            6544 34456799999999964

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.22  E-value=1.5e-07  Score=73.32  Aligned_cols=82  Identities=22%  Similarity=0.354  Sum_probs=66.3

Q ss_pred             cCCCCCcEEEecCccccccCCccccCC-CCCCeeeeecccccccCCcccCCCCCCceecccCCccccccccccc---Ccc
Q 017621           15 MNCSKLRILILGNNLLSGSISSEIGKL-QELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVK---KVP   90 (368)
Q Consensus        15 ~~l~~l~~l~l~~N~~~g~~p~~~~~~-~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~~~~---~~~   90 (368)
                      .....|+.++|++|.|. ..|..|... +.+++|+|++|.++ .+|..+..++.|+.+|++.|.|. ..|+.+.   ++.
T Consensus        50 ~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~  126 (177)
T KOG4579|consen   50 SKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLD  126 (177)
T ss_pred             hCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHH
Confidence            34456778899999997 889998765 48999999999999 99999999999999999999998 6677654   344


Q ss_pred             cccccCCCc
Q 017621           91 LLYVSGNNF   99 (368)
Q Consensus        91 ~~~~~~N~~   99 (368)
                      .++..+|..
T Consensus       127 ~Lds~~na~  135 (177)
T KOG4579|consen  127 MLDSPENAR  135 (177)
T ss_pred             HhcCCCCcc
Confidence            455555543

>PLN03210 Resistant to P

Probab=98.17  E-value=3.4e-06  Score=90.82  Aligned_cols=97  Identities=19%  Similarity=0.206  Sum_probs=61.1

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      ++|++. .+|..+..+++|+.|+|++|+..+.+| .++.+++|+.|+|++|.....+|..++.+++|+.|++++|..-+.
T Consensus       619 ~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~  696 (1153)
T PLN03210        619 QGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEI  696 (1153)
T ss_pred             cCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCc
Confidence            455555 366666677777777777665445666 467777777777777665567777777777777777776543335


Q ss_pred             cccc--ccCcccccccCCCcc
Q 017621           82 IPES--VKKVPLLYVSGNNFE  100 (368)
Q Consensus        82 ~p~~--~~~~~~~~~~~N~~~  100 (368)
                      +|..  +.++..+++++|...
T Consensus       697 Lp~~i~l~sL~~L~Lsgc~~L  717 (1153)
T PLN03210        697 LPTGINLKSLYRLNLSGCSRL  717 (1153)
T ss_pred             cCCcCCCCCCCEEeCCCCCCc
Confidence            5653  234445555555433

syringae 6; Provisional

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.15  E-value=5.3e-07  Score=81.91  Aligned_cols=96  Identities=21%  Similarity=0.247  Sum_probs=80.1

Q ss_pred             ccccCC-ccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccccc
Q 017621            6 LDGPIP-QELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPE   84 (368)
Q Consensus         6 l~g~~p-~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~   84 (368)
                      ..+..| ..+..|++|+.|+|++|++++.-+..|..+..|+.|.|..|++.-.--.+|.+++.|+.|+|.+|+||-.-|.
T Consensus       261 ~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~  340 (498)
T KOG4237|consen  261 PDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG  340 (498)
T ss_pred             cCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecc
Confidence            344455 3478899999999999999999899999999999999999999955556789999999999999999966676


Q ss_pred             cccC---cccccccCCCccc
Q 017621           85 SVKK---VPLLYVSGNNFEV  101 (368)
Q Consensus        85 ~~~~---~~~~~~~~N~~~~  101 (368)
                      .+..   +..+.+-+|+|.+
T Consensus       341 aF~~~~~l~~l~l~~Np~~C  360 (498)
T KOG4237|consen  341 AFQTLFSLSTLNLLSNPFNC  360 (498)
T ss_pred             cccccceeeeeehccCcccC
Confidence            6654   4557788888764

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.14  E-value=1.5e-07  Score=73.27  Aligned_cols=81  Identities=21%  Similarity=0.340  Sum_probs=71.2

Q ss_pred             CCCCCccccCCccccCC-CCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNC-SKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l-~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.|.. .|+.+... +.++.|+|++|+++ .+|.++..+++|+.|+++.|.|. ..|..+..+.+|..|+..+|.+.
T Consensus        60 ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen   60 LSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             cccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            68899985 67666654 47999999999998 99999999999999999999999 88888888999999999999987


Q ss_pred             cccccc
Q 017621           80 GSIPES   85 (368)
Q Consensus        80 g~~p~~   85 (368)
                       .||-.
T Consensus       137 -eid~d  141 (177)
T KOG4579|consen  137 -EIDVD  141 (177)
T ss_pred             -cCcHH
Confidence             66654

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.14  E-value=3.8e-05  Score=67.57  Aligned_cols=73  Identities=16%  Similarity=0.106  Sum_probs=47.0

Q ss_pred             eeeeecCCccEEEEEcCC--CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC-CceeeEEEEEeeCCeEEEEEeecC
Q 017621          194 YCIGTGGYGSVYRARLPS--GKVVALKKLHRSETEELASLESFRNEARLLSQIWH-RNIVKLYGFCLHRKCMFLIYEYME  270 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~  270 (368)
                      +.|..|-...+|+....+  ++.|++|........   . -...+|+.++..+.. .-.+++++... .   .++|||++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~-~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~   75 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---I-IDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP   75 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---e-ecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence            557778788999998764  678889977543211   1 122468888888743 33345554432 1   37999999


Q ss_pred             CCCh
Q 017621          271 MGSL  274 (368)
Q Consensus       271 ~g~L  274 (368)
                      |.++
T Consensus        76 G~~l   79 (235)
T cd05157          76 GRTL   79 (235)
T ss_pred             CCcC
Confidence            8665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	368
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-36
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-35
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-22
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-21
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-21
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-21
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-21
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-21
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-21
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-21
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-21
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-21
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-21
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-21
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-21
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-21
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-20
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-20
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-20
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-20
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-20
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-20
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-20
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-20
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-20
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-20
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-20
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-19
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-19
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-16
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-13
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-10
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
3soa_A	444	Full-Length Human Camkii Length = 444		1e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		6e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-06
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		7e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-06
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		8e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-05
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		8e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-04
2lav_A	361	Nmr Solution Structure Of Human Vaccinia-Related Ki		7e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-04
2kty_A	368	Solution Structure Of Human Vaccinia Related Kinase		8e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 76/188 (40%), Positives = 115/188 (61%), Gaps = 4/188 (2%)
Query: 177 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN 236
           R + +++  A+++F  K  +G GG+G VY+ RL  G +VA+K+L + E  +   L+ F+ 
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERXQGGELQ-FQT 84
Query: 237 EARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNI 295
           E  ++S   HRN+++L GFC+      L+Y YM  GS+   LR   E+   LDW KR  I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF-DSSNRTLLA 354
             G A  L+YLH HC P I+HRD+ + N+LL+ E EA V DFG+A+L+++ D      + 
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 204
Query: 355 GTSGYIAP 362
           GT G+IAP
Sbjct: 205 GTIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 74/188 (39%), Positives = 111/188 (59%), Gaps = 4/188 (2%)
Query: 177 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN 236
           R + +++  A+++F  K  +G GG+G VY+ RL  G +VA+K+L    T+       F+ 
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQ--GGELQFQT 76
Query: 237 EARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNI 295
           E  ++S   HRN+++L GFC+      L+Y YM  GS+   LR   E+   LDW KR  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF-DSSNRTLLA 354
             G A  L+YLH HC P I+HRD+ + N+LL+ E EA V DFG+A+L+++ D      + 
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVR 196
Query: 355 GTSGYIAP 362
           G  G+IAP
Sbjct: 197 GXIGHIAP 204

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/189 (38%), Positives = 100/189 (52%), Gaps = 9/189 (4%)
Query: 177 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN 236
           R+   D+ EAT +F  K+ IG G +G VY+  L  G  VALK   R   E    +E F  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK---RRTPESSQGIEEFET 84
Query: 237 EARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNI 295
           E   LS   H ++V L GFC  R  M LIY+YME G+L   L  +D   + + W +R+ I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSN-RTLL 353
             G A  L YLH   T  I+HRD+ S N+LL+      + DFG+++     D ++   ++
Sbjct: 145 CIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 354 AGTSGYIAP 362
            GT GYI P
Sbjct: 202 KGTLGYIDP 210

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/189 (37%), Positives = 98/189 (51%), Gaps = 9/189 (4%)
Query: 177 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN 236
           R+   D+ EAT +F  K+ IG G +G VY+  L  G  VALK   R   E    +E F  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK---RRTPESSQGIEEFET 84
Query: 237 EARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNI 295
           E   LS   H ++V L GFC  R  M LIY+YME G+L   L  +D   + + W +R+ I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN--FDSSNRTLL 353
             G A  L YLH   T  I+HRD+ S N+LL+      + DFG+++       +    ++
Sbjct: 145 CIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 354 AGTSGYIAP 362
            GT GYI P
Sbjct: 202 KGTLGYIDP 210

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 148
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 201

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 139
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 192

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 178

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 121
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 174

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 127
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 180

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 175

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPP 175

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 178

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 123
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +   +  SS RT L+GT  Y+ P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPP 176

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 127
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 180

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 126
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 179

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPP 175

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 175

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 123
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 176

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 119
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 120 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 172

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 127
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 180

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 175

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR  + K ++ALK L +++ E+       R E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS R  L GT  Y+ P
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPP 175

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 124
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +A+FG +  ++  SS RT L GT  Y+ P
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPP 177

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 97/178 (54%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +A+FG +  ++  SS RT L GT  Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPP 178

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 96/178 (53%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 124
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS R  L GT  Y+ P
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPP 177

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 96/178 (53%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 123
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS R  L GT  Y+ P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPP 176

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 96/178 (53%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS R  L GT  Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPP 178

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 96/178 (53%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS R  L GT  Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPP 178

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 96/178 (53%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS R  L GT  Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPP 175

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 95/178 (53%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY   G ++  L   ++    D  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 180

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 96/178 (53%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 122
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS R  L GT  Y+ P
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPP 175

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 96/178 (53%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 148
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS R  L GT  Y+ P
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPP 201

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/176 (34%), Positives = 96/176 (54%), Gaps = 9/176 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSRFDEQRTATYITELANALSYC 128
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS RT L GT  Y+ P
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 179

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 96/178 (53%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSKFDEQRTATYITELANALS 125
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS R  L GT  Y+ P
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPP 178

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 94/178 (52%), Gaps = 9/178 (5%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQI 244
           A EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NI++LYG+      ++LI EY   G ++  L   ++    D  +    +  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           Y H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS R  L GT  Y+ P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPP 180

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 95/176 (53%), Gaps = 9/176 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF I   +G G +G+VY AR    K ++ALK L +++ E+       R E  + S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NI++LYG+      ++LI EY  +G+++   R  ++    D  +    +  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVY---RELQKLSRFDEQRTATYITELANALSYC 128
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  ++HRDI   N+LL S  E  +ADFG +  ++  SS R  L GT  Y+ P
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPP 179

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 94/176 (53%), Gaps = 15/176 (8%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRS---ETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G GG+G VY+  + +   VA+KKL       TEEL   + F  E +++++  H N+V+L
Sbjct: 39  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK--QQFDQEIKVMAKCQHENLVEL 95
Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH--HHC 310
            GF      + L+Y YM  GSL   L   +    L W  R  I +G A+ +++LH  HH 
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLN--FDSSNRTLLAGTSGYIAPAS 364
               +HRDI S N+LL+    A ++DFG+AR       +   + + GT+ Y+AP +
Sbjct: 155 ----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEA 206

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 93/176 (52%), Gaps = 15/176 (8%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRS---ETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G GG+G VY+  + +   VA+KKL       TEEL   + F  E +++++  H N+V+L
Sbjct: 39  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK--QQFDQEIKVMAKCQHENLVEL 95
Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH--HHC 310
            GF      + L+Y YM  GSL   L   +    L W  R  I +G A+ +++LH  HH 
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLN--FDSSNRTLLAGTSGYIAPAS 364
               +HRDI S N+LL+    A ++DFG+AR       +     + GT+ Y+AP +
Sbjct: 155 ----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEA 206

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 95/189 (50%), Gaps = 3/189 (1%)
Query: 174 YDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLES 233
           + G +   DM     D +IK  IG G +G+V+RA    G  VA+K L   +      +  
Sbjct: 23  FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNE 80
Query: 234 FRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV 293
           F  E  ++ ++ H NIV   G       + ++ EY+  GSL+ +L        LD  +R+
Sbjct: 81  FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 353
           ++   +A  ++YLH+   PPIVHRD+ S N+L++ +    V DFG++RL           
Sbjct: 141 SMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA 199
Query: 354 AGTSGYIAP 362
           AGT  ++AP
Sbjct: 200 AGTPEWMAP 208

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 93/176 (52%), Gaps = 15/176 (8%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRS---ETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G GG+G VY+  + +   VA+KKL       TEEL   + F  E +++++  H N+V+L
Sbjct: 33  MGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK--QQFDQEIKVMAKCQHENLVEL 89
Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH--HHC 310
            GF      + L+Y YM  GSL   L   +    L W  R  I +G A+ +++LH  HH 
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 148
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPAS 364
               +HRDI S N+LL+    A ++DFG+AR     +       + GT+ Y+AP +
Sbjct: 149 ----IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEA 200

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 96/189 (50%), Gaps = 3/189 (1%)
Query: 174 YDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLES 233
           + G +   DM     D +IK  IG G +G+V+RA    G  VA+K L   +      +  
Sbjct: 23  FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNE 80
Query: 234 FRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV 293
           F  E  ++ ++ H NIV   G       + ++ EY+  GSL+ +L        LD  +R+
Sbjct: 81  FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 353
           ++   +A  ++YLH+   PPIVHR++ S N+L++ +    V DFG++RL      +    
Sbjct: 141 SMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 354 AGTSGYIAP 362
           AGT  ++AP
Sbjct: 200 AGTPEWMAP 208

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 97/185 (52%), Gaps = 20/185 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELA-SLESFRNEARLLSQIWHR 247
           +  ++  IG GG+G VYRA    G  VA+K       E+++ ++E+ R EA+L + + H 
Sbjct: 8   ELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL--RTDEEAVGLDWAKRVNIVKGMAHALSY 305
           NI+ L G CL    + L+ E+   G L  VL  +     + ++WA  V I +GM    +Y
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA--VQIARGM----NY 120
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELE--------AFVADFGVARLLNFDSSNRTLLAGTS 357
           LH     PI+HRD+ S+N+L+  ++E          + DFG+AR   +  + +   AG  
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAAGAY 178
Query: 358 GYIAP 362
            ++AP
Sbjct: 179 AWMAP 183

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/175 (33%), Positives = 89/175 (50%), Gaps = 15/175 (8%)
Query: 197 GTGGYGSVYRARLPSGKVVALKKLHRS---ETEELASLESFRNEARLLSQIWHRNIVKLY 253
           G GG+G VY+  + +   VA+KKL       TEEL   + F  E ++ ++  H N+V+L 
Sbjct: 31  GEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK--QQFDQEIKVXAKCQHENLVELL 87
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH--HHCT 311
           GF      + L+Y Y   GSL   L   +    L W  R  I +G A+ +++LH  HH  
Sbjct: 88  GFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH-- 145
Query: 312 PPIVHRDISSNNVLLNSELEAFVADFGVARLLN--FDSSNRTLLAGTSGYIAPAS 364
              +HRDI S N+LL+    A ++DFG+AR           + + GT+ Y AP +
Sbjct: 146 ---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEA 197

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 20/195 (10%)
Query: 179 TFQDMIEATEDF---------HIKYCIGTGGYGSVYRA--RLPSGK--VVALKKLHRSET 225
           TF+D  EA  +F          I+  IG G +G V     +LP  +   VA+K L    T
Sbjct: 15  TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 74
Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 285
           E+      F +EA ++ Q  H N++ L G       + +I E+ME GSL   LR ++   
Sbjct: 75  EK--QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 132
Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            +   + V +++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R L  
Sbjct: 133 TV--IQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 187
Query: 346 DSSNRTLLAGTSGYI 360
           D+S+ T  +   G I
Sbjct: 188 DTSDPTYTSALGGKI 202

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/181 (33%), Positives = 92/181 (50%), Gaps = 20/181 (11%)
Query: 179 TFQDMIEATEDF---------HIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSET 225
           TF+D  +   +F          I   +G G +G V   R +LPS K   VA+K L    T
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 285
           E+      F  EA ++ Q  H NI++L G     K + ++ EYME GSL   LR  +   
Sbjct: 87  EK--QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF 144
Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            +   + V +++G+A  + YL        VHRD+++ N+L+NS L   V+DFG+AR+L  
Sbjct: 145 TV--IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLED 199
Query: 346 D 346
           D
Sbjct: 200 D 200

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 99/189 (52%), Gaps = 12/189 (6%)
Query: 176 GRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPS-GK---VVALKKLHRSETEELASL 231
           G + F   I+ +    I+  IG G +G V R RL + GK    VA+K L    TE     
Sbjct: 3   GSMEFAKEIDVSY-VKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER--QR 59
Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK 291
             F +EA ++ Q  H NI++L G   +   + ++ E+ME G+L   LR ++    +   +
Sbjct: 60  REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQ 117
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
            V +++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R L  +SS+ T
Sbjct: 118 LVGMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 174
Query: 352 LLAGTSGYI 360
             +   G I
Sbjct: 175 YTSSLGGKI 183

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/173 (33%), Positives = 93/173 (53%), Gaps = 11/173 (6%)
Query: 192 IKYCIGTGGYGSVYRARLPS-GK---VVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           I+  IG G +G V R RL + GK    VA+K L    TE       F +EA ++ Q  H 
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER--QRREFLSEASIMGQFEHP 77
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NI++L G   +   + ++ E+ME G+L   LR ++    +   + V +++G+A  + YL 
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYLA 135
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
                  VHRD+++ N+L+NS L   V+DFG++R L  +SS+ T  +   G I
Sbjct: 136 EMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 20/181 (11%)
Query: 179 TFQDMIEATEDF---------HIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSET 225
           TF+D  +   +F          I   +G G +G V   R +LPS K   VA+K L    T
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 285
           E+      F  EA ++ Q  H NI++L G     K + ++ EYME GSL   LR  +   
Sbjct: 87  EK--QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF 144
Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            +   + V +++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  
Sbjct: 145 TV--IQLVGMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 346 D 346
           D
Sbjct: 200 D 200

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 7/186 (3%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLL 241
           M    ED+ + Y IGTG YG   + R  S GK++  K+L      E A  +   +E  LL
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLL 59
Query: 242 SQIWHRNIVKLYGFCLHRK--CMFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKG 298
            ++ H NIV+ Y   + R    ++++ EY E G L  V+ +  +E   LD    + ++  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 299 MAHALSYLHHHCTP--PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT 356
           +  AL   H        ++HRD+   NV L+ +    + DFG+AR+LN D+S      GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179
Query: 357 SGYIAP 362
             Y++P
Sbjct: 180 PYYMSP 185

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 7/186 (3%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLL 241
           M    ED+ + Y IGTG YG   + R  S GK++  K+L      E A  +   +E  LL
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLL 59
Query: 242 SQIWHRNIVKLYGFCLHRK--CMFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKG 298
            ++ H NIV+ Y   + R    ++++ EY E G L  V+ +  +E   LD    + ++  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 299 MAHALSYLHHHCTP--PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT 356
           +  AL   H        ++HRD+   NV L+ +    + DFG+AR+LN D+S      GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 179
Query: 357 SGYIAP 362
             Y++P
Sbjct: 180 PYYMSP 185

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 20/181 (11%)
Query: 179 TFQDMIEATEDF---------HIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSET 225
           TF+D  +   +F          I   +G G +G V   R +LPS K   VA+K L    T
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 285
           E+      F  EA ++ Q  H NI++L G     K + ++ EYME GSL   LR  +   
Sbjct: 87  EK--QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF 144
Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            +   + V +++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  
Sbjct: 145 TV--IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 346 D 346
           D
Sbjct: 200 D 200

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 20/181 (11%)
Query: 179 TFQDMIEATEDF---------HIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSET 225
           TF+D  +   +F          I   +G G +G V   R +LPS K   VA+K L    T
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 285
           E+      F  EA ++ Q  H NI++L G     K + ++ EYME GSL   LR  +   
Sbjct: 87  EK--QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF 144
Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            +   + V +++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  
Sbjct: 145 TV--IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 346 D 346
           D
Sbjct: 200 D 200

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 91/181 (50%), Gaps = 20/181 (11%)
Query: 179 TFQDMIEATEDF---------HIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSET 225
           TF+D  +   +F          I   +G G +G V   R +LPS K   VA+K L    T
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 285
           E+      F  EA ++ Q  H NI++L G     K + ++ EYME GSL   LR  +   
Sbjct: 87  EK--QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF 144
Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            +   + V +++G+A  + YL        VHRD+++ N+L+NS L   V+DFG+ R+L  
Sbjct: 145 TV--IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199
Query: 346 D 346
           D
Sbjct: 200 D 200

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 91/171 (53%), Gaps = 12/171 (7%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESFR 235
           F   ++AT +  I   +G G +G V   R +LPS K   VA+K L    TE+      F 
Sbjct: 26  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFL 82
Query: 236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI 295
            EA ++ Q  H NI++L G     K + ++ EYME GSL   LR  +    +   + V +
Sbjct: 83  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGM 140
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           ++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  D
Sbjct: 141 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 188

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 91/171 (53%), Gaps = 12/171 (7%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESFR 235
           F   ++AT +  I   +G G +G V   R +LPS K   VA+K L    TE+      F 
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFL 65
Query: 236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI 295
            EA ++ Q  H NI++L G     K + ++ EYME GSL   LR  +    +   + V +
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGM 123
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           ++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  D
Sbjct: 124 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 91/171 (53%), Gaps = 12/171 (7%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESFR 235
           F   ++AT +  I   +G G +G V   R +LPS K   VA+K L    TE+      F 
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFL 94
Query: 236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI 295
            EA ++ Q  H NI++L G     K + ++ EYME GSL   LR  +    +   + V +
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGM 152
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           ++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  D
Sbjct: 153 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 91/171 (53%), Gaps = 12/171 (7%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESFR 235
           F   ++AT +  I   +G G +G V   R +LPS K   VA+K L    TE+      F 
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFL 94
Query: 236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI 295
            EA ++ Q  H NI++L G     K + ++ EYME GSL   LR  +    +   + V +
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGM 152
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           ++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  D
Sbjct: 153 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/171 (34%), Positives = 91/171 (53%), Gaps = 12/171 (7%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESFR 235
           F   ++AT +  I   +G G +G V   R +LPS K   VA+K L    TE+      F 
Sbjct: 36  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFL 92
Query: 236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI 295
            EA ++ Q  H NI++L G     K + ++ EYME GSL   LR  +    +   + V +
Sbjct: 93  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGM 150
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           ++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  D
Sbjct: 151 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 198

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF I   +G G +G+VY AR    K ++ALK L +S+ E+       R E  + S + H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NI+++Y +   RK ++L+ E+   G L+  L   ++    D  +    ++ +A AL Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC 131
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H      ++HRDI   N+L+  + E  +ADFG +  ++  S  R  + GT  Y+ P
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPP 182

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 91/176 (51%), Gaps = 9/176 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF I   +G G +G+VY AR    K ++ALK L +S+ E+       R E  + S + H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NI+++Y +   RK ++L+ E+   G L+  L   ++    D  +    ++ +A AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYC 130
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H      ++HRDI   N+L+  + E  +ADFG +  ++  S  R  + GT  Y+ P
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPP 181

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 93/176 (52%), Gaps = 9/176 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF I   +G G +G+VY AR   S  +VALK L +S+ E+       R E  + + + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NI++LY +   R+ ++LI EY   G L+  L   +++   D  +   I++ +A AL Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYC 139
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H      ++HRDI   N+LL  + E  +ADFG +  ++  S  R  + GT  Y+ P
Sbjct: 140 H---GKKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPP 190

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/157 (36%), Positives = 85/157 (54%), Gaps = 12/157 (7%)
Query: 195 CIGTGGYGSVYRARL--PSGKV---VALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
            IG G +G VY+  L   SGK    VA+K L    TE+      F  EA ++ Q  H NI
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNI 108
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           ++L G     K M +I EYME G+L   LR  +    +   + V +++G+A  + YL + 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLRGIAAGMKYLANM 166
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                VHRD+++ N+L+NS L   V+DFG++R+L  D
Sbjct: 167 N---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 91/181 (50%), Gaps = 20/181 (11%)
Query: 179 TFQDMIEATEDF---------HIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSET 225
           TF+D  +   +F          I   +G G +G V   R +LPS K   VA+K L    T
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 285
           E+      F  EA ++ Q  H NI++L G     K + ++ E ME GSL   LR  +   
Sbjct: 87  EK--QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF 144
Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            +   + V +++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  
Sbjct: 145 TV--IQLVGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 346 D 346
           D
Sbjct: 200 D 200

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 90/186 (48%), Gaps = 7/186 (3%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLL 241
           M    ED+ + Y IGTG YG   + R  S GK++  K+L      E A  +   +E  LL
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLL 59
Query: 242 SQIWHRNIVKLYGFCLHRK--CMFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKG 298
            ++ H NIV+ Y   + R    ++++ EY E G L  V+ +  +E   LD    + ++  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 299 MAHALSYLHHHCTP--PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT 356
           +  AL   H        ++HRD+   NV L+ +    + DFG+AR+LN D        GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGT 179
Query: 357 SGYIAP 362
             Y++P
Sbjct: 180 PYYMSP 185

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 20/181 (11%)
Query: 179 TFQDMIEATEDF---------HIKYCIGTGGYGSVYRARLP-SGK---VVALKKLHRSET 225
           TF+D  +A  +F          I+  IG G +G V   RL   GK    VA+K L    T
Sbjct: 11  TFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT 70
Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 285
           ++      F +EA ++ Q  H NI+ L G     K + +I EYME GSL   LR ++   
Sbjct: 71  DK--QRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF 128
Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            +   + V +++G+   + YL        VHRD+++ N+L+NS L   V+DFG++R+L  
Sbjct: 129 TV--IQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMSRVLED 183
Query: 346 D 346
           D
Sbjct: 184 D 184

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/172 (34%), Positives = 91/172 (52%), Gaps = 12/172 (6%)
Query: 179 TFQDMIEATEDFHIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESF 234
           +F   IEA+   HI+  IG+G  G V   R R+P  +   VA+K L    TE       F
Sbjct: 41  SFTREIEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDF 97
Query: 235 RNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 294
            +EA ++ Q  H NI++L G     +   ++ EYME GSL   LRT +    +   + V 
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVG 155
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           +++G+   + YL        VHRD+++ NVL++S L   V+DFG++R+L  D
Sbjct: 156 MLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/172 (34%), Positives = 91/172 (52%), Gaps = 12/172 (6%)
Query: 179 TFQDMIEATEDFHIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESF 234
           +F   IEA+   HI+  IG+G  G V   R R+P  +   VA+K L    TE       F
Sbjct: 41  SFTREIEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDF 97
Query: 235 RNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 294
            +EA ++ Q  H NI++L G     +   ++ EYME GSL   LRT +    +   + V 
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVG 155
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           +++G+   + YL        VHRD+++ NVL++S L   V+DFG++R+L  D
Sbjct: 156 MLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 11/179 (6%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           +  E F +   +G G YGSVY+A    +G++VA+K++        + L+    E  ++ Q
Sbjct: 26  QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQ 80
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
               ++VK YG       ++++ EY   GS+  ++R   + +  D  +   I++     L
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED--EIATILQSTLKGL 138
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            YLH       +HRDI + N+LLN+E  A +ADFGVA  L    + R  + GT  ++AP
Sbjct: 139 EYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAP 194

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/171 (33%), Positives = 90/171 (52%), Gaps = 12/171 (7%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESFR 235
           F   ++AT +  I   +G G +G V   R +LPS K   VA+K L    TE+      F 
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFL 65
Query: 236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI 295
            EA ++ Q  H NI++L G     K + ++ E ME GSL   LR  +    +   + V +
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGM 123
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           ++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  D
Sbjct: 124 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 55/166 (33%), Positives = 91/166 (54%), Gaps = 15/166 (9%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKL----HRSETEELASLESFRNEARL 240
           A  +   +  IG GG+G V++ RL   K VVA+K L       ETE +   + F+ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 241 LSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
           +S + H NIVKLYG   +   M  + E++  G L+   R  ++A  + W+ ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYH--RLLDKAHPIKWSVKLRLMLDIA 132
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLL-----NSELEAFVADFGVAR 341
             + Y+ +   PPIVHRD+ S N+ L     N+ + A VADFG+++
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 93/185 (50%), Gaps = 10/185 (5%)
Query: 178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNE 237
           + FQ ++E  +       +G G YG VY+A+   G++VALK++     +E     + R E
Sbjct: 14  LYFQGLMEKYQKLE---KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-E 69
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK 297
             LL ++ H NIV L       +C+ L++E+ME   L  VL  DE   GL  ++    + 
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLY 126
Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTS 357
            +   +++ H H    I+HRD+   N+L+NS+    +ADFG+AR       + T    T 
Sbjct: 127 QLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 358 GYIAP 362
            Y AP
Sbjct: 184 WYRAP 188

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/171 (33%), Positives = 90/171 (52%), Gaps = 12/171 (7%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESFR 235
           F   ++AT +  I   +G G +G V   R +LPS K   VA+K L    TE+      F 
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFL 94
Query: 236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI 295
            EA ++ Q  H NI++L G     K + ++ E ME GSL   LR  +    +   + V +
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGM 152
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           ++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  D
Sbjct: 153 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/166 (33%), Positives = 90/166 (54%), Gaps = 15/166 (9%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGK-VVALKKL----HRSETEELASLESFRNEARL 240
           A  +   +  IG GG+G V++ RL   K VVA+K L       ETE +   + F+ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 241 LSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
           +S + H NIVKLYG   +   M  + E++  G L+   R  ++A  + W+ ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYH--RLLDKAHPIKWSVKLRLMLDIA 132
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLL-----NSELEAFVADFGVAR 341
             + Y+ +   PPIVHRD+ S N+ L     N+ + A VADFG ++
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/185 (31%), Positives = 93/185 (50%), Gaps = 10/185 (5%)
Query: 178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNE 237
           + FQ ++E  +       +G G YG VY+A+   G++VALK++     +E     + R E
Sbjct: 14  LYFQGLMEKYQKLE---KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-E 69
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK 297
             LL ++ H NIV L       +C+ L++E+ME   L  VL  DE   GL  ++    + 
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLY 126
Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTS 357
            +   +++ H H    I+HRD+   N+L+NS+    +ADFG+AR       + T    T 
Sbjct: 127 QLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 358 GYIAP 362
            Y AP
Sbjct: 184 WYRAP 188

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 89/173 (51%), Gaps = 11/173 (6%)
Query: 192 IKYCIGTGGYGSVYRA--RLPSGK--VVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           I+  IG G +G V     +LP  +   VA+K L    TE+      F +EA ++ Q  H 
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEASIMGQFDHP 68
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           N++ L G       + +I E+ME GSL   LR ++    +   + V +++G+A  + YL 
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYLA 126
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
                  VHR +++ N+L+NS L   V+DFG++R L  D+S+ T  +   G I
Sbjct: 127 DMN---YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 176

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 10/181 (5%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  EDF +   +G G +  VYRA  + +G  VA+K + +    +   ++  +NE ++  Q
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV--NIVKGMAH 301
           + H +I++LY +      ++L+ E    G +   L+   +    + A+     I+ GM  
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML- 126
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
              YLH H    I+HRD++ +N+LL   +   +ADFG+A  L         L GT  YI+
Sbjct: 127 ---YLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180
Query: 362 P 362
           P
Sbjct: 181 P 181

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 87/156 (55%), Gaps = 15/156 (9%)
Query: 196 IGTGGYGSVYRARLPSGK-VVALKKL----HRSETEELASLESFRNEARLLSQIWHRNIV 250
           IG GG+G V++ RL   K VVA+K L       ETE +   + F+ E  ++S + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
           KLYG   +   M  + E++  G L+   R  ++A  + W+ ++ ++  +A  + Y+ +  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYH--RLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 311 TPPIVHRDISSNNVLL-----NSELEAFVADFGVAR 341
            PPIVHRD+ S N+ L     N+ + A VADF +++
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 93/181 (51%), Gaps = 20/181 (11%)
Query: 179 TFQDMIEATEDFH---------IKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSET 225
           T++D  +A  +F          I+  IG G +G V   R +LP  +   VA+K L    T
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 285
           E+      F  EA ++ Q  H NI+ L G     K + ++ EYME GSL   L+ ++   
Sbjct: 64  EK--QRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQF 121
Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            +   + V +++G++  + YL        VHRD+++ N+L+NS L   V+DFG++R+L  
Sbjct: 122 TV--IQLVGMLRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLED 176
Query: 346 D 346
           D
Sbjct: 177 D 177

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 26/196 (13%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + +DF I   +GTG +G V+  R   +G+  A+K L +     L  +E   +E  +LS +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEE---AVGLDWAKRVNIVKGMAH 301
            H  I++++G     + +F+I +Y+E G LF +LR  +     V   +A  V +      
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL------ 117
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           AL YLH   +  I++RD+   N+LL+      + DFG A+ +         L GT  YIA
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYXLCGTPDYIA 171
Query: 362 P----------ASEWW 367
           P          + +WW
Sbjct: 172 PEVVSTKPYNKSIDWW 187

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 84/161 (52%), Gaps = 11/161 (6%)
Query: 190 FHIKYCIGTGGYGSVYRARLP-SGK---VVALKKLHRSETEELASLESFRNEARLLSQIW 245
             I+  IG G +G V   RL   GK    VA+K L    T++      F +EA ++ Q  
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK--QRRDFLSEASIMGQFD 73
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H NI+ L G     K + +I EYME GSL   LR ++    +   + V +++G+   + Y
Sbjct: 74  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKY 131
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           L        VHRD+++ N+L+NS L   V+DFG++R+L  D
Sbjct: 132 LSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 169

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 84/161 (52%), Gaps = 11/161 (6%)
Query: 190 FHIKYCIGTGGYGSVYRARLP-SGK---VVALKKLHRSETEELASLESFRNEARLLSQIW 245
             I+  IG G +G V   RL   GK    VA+K L    T++      F +EA ++ Q  
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK--QRRDFLSEASIMGQFD 67
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H NI+ L G     K + +I EYME GSL   LR ++    +   + V +++G+   + Y
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKY 125
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           L        VHRD+++ N+L+NS L   V+DFG++R+L  D
Sbjct: 126 LSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 163

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/183 (32%), Positives = 92/183 (50%), Gaps = 18/183 (9%)
Query: 176 GRITFQDMIEAT-EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEE 227
           G + F+D      E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE
Sbjct: 1   GAMAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE 59
Query: 228 LASLESFRNEARLLSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAV 285
              L  F  E  +L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +
Sbjct: 60  --HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 117
Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
             D  K +     +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  
Sbjct: 118 --DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 172
Query: 346 DSS 348
           D  
Sbjct: 173 DKE 175

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 64
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 11  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 67
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 125
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 64
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 39  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 95
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 153
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 154 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 7   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 63
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 64  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 121
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 122 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 168

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 6   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 62
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 63  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 120
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 121 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 167

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 12  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 68
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 69  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 126
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 127 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 173

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 26  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 82
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 140
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 141 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 187

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 13  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 69
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 70  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 127
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 128 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 174

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 15  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 71
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 72  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 129
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 130 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 176

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 26  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 82
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 140
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 141 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 187

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 64
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 86/170 (50%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 11  EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 67
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+   E +  D  K +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI--DHIKLLQYTSQ 125
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ED  +   IG G +G V+  RL     +VA+K    +   +L +   F  EAR+L Q  H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSH 171
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIV+L G C  ++ ++++ E ++ G     LRT  E   L     + +V   A  + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYL 229
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
              C    +HRD+++ N L+  +    ++DFG++R
Sbjct: 230 ESKCC---IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 8/155 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ED  +   IG G +G V+  RL     +VA+K    +   +L +   F  EAR+L Q  H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSH 171
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIV+L G C  ++ ++++ E ++ G     LRT  E   L     + +V   A  + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYL 229
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
              C    +HRD+++ N L+  +    ++DFG++R
Sbjct: 230 ESKCC---IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 91/184 (49%), Gaps = 27/184 (14%)
Query: 196 IGTGGYGSVYRARLPSG-KVVALKKLHRSE------TEELASLESFR----NEARLLSQI 244
           +G+G YG V   +  +G    A+K + +S+      +++  ++E F     NE  LL  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG---LDWAKRVNIVKGMAH 301
            H NI+KL+     +K  +L+ E+ E G LF      E+ +     D     NI+K +  
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELF------EQIINRHKFDECDAANIMKQILS 157
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLL---NSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
            + YLH H    IVHRDI   N+LL   NS L   + DFG++   + D   R  L GT+ 
Sbjct: 158 GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-GTAY 213
Query: 359 YIAP 362
           YIAP
Sbjct: 214 YIAP 217

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 18/182 (9%)
Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHR 247
           F +   +G G YG VY+ R + +G++ A+K +  +  EE    E  + E  +L +   HR
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 81
Query: 248 NIVKLYGFCLHR------KCMFLIYEYMEMGSLFCVLR-TDEEAVGLDWAKRVNIVKGMA 300
           NI   YG  + +        ++L+ E+   GS+  +++ T    +  +W     I + + 
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 139
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
             LS+LH H    ++HRDI   NVLL    E  + DFGV+  L+     R    GT  ++
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 361 AP 362
           AP
Sbjct: 197 AP 198

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 11  EERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 67
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI E++  GSL   L+  +E +  D  K +     
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI--DHIKLLQYTSQ 125
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++  ++  +G G +G V +A+    K VA+K++  SE+E     ++F  E R LS++ H 
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI-ESESER----KAFIVELRQLSRVNHP 62
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NIVKLYG CL+  C  L+ EY E GSL+ VL   E       A  ++     +  ++YLH
Sbjct: 63  NIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                 ++HRD+   N+LL +      + DFG A  +    +N     G++ ++AP
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAP 173

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 92/176 (52%), Gaps = 12/176 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++  ++  +G G +G V +A+    K VA+K++  SE+E     ++F  E R LS++ H 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI-ESESER----KAFIVELRQLSRVNHP 61
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NIVKLYG CL+  C  L+ EY E GSL+ VL   E       A  ++     +  ++YLH
Sbjct: 62  NIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                 ++HRD+   N+LL +      + DFG A  +    +N     G++ ++AP
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAP 172

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+K+   +G G +GSV   R       +G+VVA+KKL  S TEE   L  F  E  +
Sbjct: 9   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEE--HLRDFEREIEI 65
Query: 241 LSQIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +  D  K +     
Sbjct: 66  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 123
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +   + YL    T   +HR++++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 124 ICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE 170

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 88/175 (50%), Gaps = 7/175 (4%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E +H    IG G YG VY+A+   G+  ALKK+   + +E     + R E  +L ++ H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NIVKLY     +K + L++E+++   L  +L   E   GL+     + +  + + ++Y H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH 117
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                 ++HRD+   N+L+N E E  +ADFG+AR         T    T  Y AP
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 7/175 (4%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E +H    IG G YG VY+A+   G+  ALKK+ R E E+     +   E  +L ++ H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHS 60
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NIVKLY     +K + L++E+++   L  +L   E   GL+     + +  + + ++Y H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH 117
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                 ++HRD+   N+L+N E E  +ADFG+AR         T    T  Y AP
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 84/149 (56%), Gaps = 9/149 (6%)
Query: 196 IGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G +G   +     +G+V+ +K+L R + E   +  +F  E +++  + H N++K  G
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                K +  I EY++ G+L  ++++ +      W++RV+  K +A  ++YLH   +  I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLL 343
           +HRD++S+N L+       VADFG+ARL+
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLM 158

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 7/175 (4%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E +H    IG G YG VY+A+   G+  ALKK+ R E E+     +   E  +L ++ H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHS 60
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NIVKLY     +K + L++E+++   L  +L   E   GL+     + +  + + ++Y H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH 117
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                 ++HRD+   N+L+N E E  +ADFG+AR         T    T  Y AP
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 192 IKYCIGTGGYGSVY--RARLPSGK--VVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           I+  IG G +G V   R +LP  +   VA+K L    TE+      F  EA ++ Q  H 
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEK--QRRDFLCEASIMGQFDHP 104
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           N+V L G     K + ++ E+ME G+L   LR  +    +   + V +++G+A  + YL 
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV--IQLVGMLRGIAAGMRYLA 162
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                  VHRD+++ N+L+NS L   V+DFG++R++  D
Sbjct: 163 DMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 8/149 (5%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+     +   VA+K L         S+++F  EA L+  + H  +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
               + +++I EYM  GSL   L++DE    L   K ++    +A  ++Y+        +
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKN---YI 132
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLN 344
           HRD+ + NVL++  L   +ADFG+AR++ 
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIE 161

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEA--RLLS 242
           AT  +     IG G YG+VY+AR P SG  VALK +     EE   + + R  A  R L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 243 QIWHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVN 294
              H N+V+L   C   +      + L++E+++       LRT        GL      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-----LRTYLDKAPPPGLPAETIKD 116
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
           +++     L +LH +C   IVHRD+   N+L+ S     +ADFG+AR+ ++
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 164

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 81
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 137
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLI 165

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 83
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 84  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 139
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLI 167

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 84
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 85  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 140
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLI 168

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEA--RLLS 242
           AT  +     IG G YG+VY+AR P SG  VALK +     EE   + + R  A  R L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 243 QIWHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVN 294
              H N+V+L   C   +      + L++E+++       LRT        GL      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-----LRTYLDKAPPPGLPAETIKD 116
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
           +++     L +LH +C   IVHRD+   N+L+ S     +ADFG+AR+ ++
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 164

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEA--RLLS 242
           AT  +     IG G YG+VY+AR P SG  VALK +     EE   + + R  A  R L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 243 QIWHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVN 294
              H N+V+L   C   +      + L++E+++       LRT        GL      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-----LRTYLDKAPPPGLPAETIKD 116
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
           +++     L +LH +C   IVHRD+   N+L+ S     +ADFG+AR+ ++
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 164

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 85
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 86  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 141
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLI 169

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 85/175 (48%), Gaps = 9/175 (5%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ +   IG G +  V  AR + +GK VA+K + +++    +SL+    E R++  + H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVLNHP 66
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NIVKL+      K ++L+ EY   G +F  L      V   W K           +S + 
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL------VAHGWMKEKEARAKFRQIVSAVQ 120
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +     IVHRD+ + N+LL++++   +ADFG +    F +   T   G+  Y AP
Sbjct: 121 YCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAP 174

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 75
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 80
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 81  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 136
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLI 164

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 77
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 78  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 133
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLI 161

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 81
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 82  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 137
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLI 165

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 75
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+     +   VA+K L         S+++F  EA L+  + H  +V+LY  
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
               + +++I E+M  GSL   L++DE    L   K ++    +A  ++Y+        +
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKN---YI 131
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + NVL++  L   +ADFG+AR++
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVI 159

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 76
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 77  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 132
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLI 160

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 70
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 71  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 126
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLI 154

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 75
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 15/189 (7%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR--LPSGKVVALKKLHRSETEELASLESFRNEA-- 238
           +  A + +     IG G YG V++AR     G+ VALK++     EE   L + R  A  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 239 RLLSQIWHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV 293
           R L    H N+V+L+  C   +      + L++E+++      + +  E  V  +  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 353
           +++  +   L +LH H    +VHRD+   N+L+ S  +  +ADFG+AR+ +F  +  +++
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 354 AGTSGYIAP 362
             T  Y AP
Sbjct: 181 V-TLWYRAP 188

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 15/189 (7%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR--LPSGKVVALKKLHRSETEELASLESFRNEA-- 238
           +  A + +     IG G YG V++AR     G+ VALK++     EE   L + R  A  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 239 RLLSQIWHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV 293
           R L    H N+V+L+  C   +      + L++E+++      + +  E  V  +  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 353
           +++  +   L +LH H    +VHRD+   N+L+ S  +  +ADFG+AR+ +F  +  +++
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 354 AGTSGYIAP 362
             T  Y AP
Sbjct: 181 V-TLWYRAP 188

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 80/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G  G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 75
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+ + N+L++  L   +ADFG+ARL+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI 159

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ +   IG G +  V  AR + +GK VA+K + +++    +SL+    E R++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVLNHP 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           NIVKL+      K ++L+ EY   G +F  L    R  E+     + + V+       A+
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-------AV 126
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            Y H      IVHRD+ + N+LL++++   +ADFG +    F +   T   G+  Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAP 181

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ +   IG G +  V  AR + +GK VA+K + +++    +SL+    E R++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVLNHP 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           NIVKL+      K ++L+ EY   G +F  L    R  E+      AK   IV     A+
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA---RAKFRQIVS----AV 126
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            Y H      IVHRD+ + N+LL++++   +ADFG +    F +   T   G+  Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAP 181

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 93/189 (49%), Gaps = 15/189 (7%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR--LPSGKVVALKKLHRSETEELASLESFRNEA-- 238
           +  A + +     IG G YG V++AR     G+ VALK++     EE   L + R  A  
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 239 RLLSQIWHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV 293
           R L    H N+V+L+  C   +      + L++E+++      + +  E  V  +  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 353
           +++  +   L +LH H    +VHRD+   N+L+ S  +  +ADFG+AR+ +F  +  +++
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 354 AGTSGYIAP 362
             T  Y AP
Sbjct: 181 V-TLWYRAP 188

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 87/179 (48%), Gaps = 7/179 (3%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKE 65
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           + H NIVKL         ++L++E++       +  +    + L   K  + +  +   L
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGL 123
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           ++ H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 124 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 179

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 86/176 (48%), Gaps = 7/176 (3%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   LS+ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFC 119
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 87/179 (48%), Gaps = 7/179 (3%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKE 65
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           + H NIVKL         ++L++E++       +  +    + L   K  + +  +   L
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGL 123
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           ++ H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 124 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 179

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++ M     +  +    + L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++ M     +  +    + L   K  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 120 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 81/148 (54%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G +G V+         VA+K L +       S ++F  EA L+ Q+ H+ +V+LY  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA- 71
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
            + ++ +++I EYME GSL   L+T    + L   K +++   +A  ++++        +
Sbjct: 72  VVTQEPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YI 127
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HR++ + N+L++  L   +ADFG+ARL+
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLI 155

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++ M     +  +    + L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 121 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++ M     +  +    + L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 119 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G V+     +   VA+K +      E    E F  EA ++ ++ H  +V+LYG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-----VNIVKGMAHALSYLHHHC 310
           CL +  + L++E+ME G L   LRT     GL  A+      +++ +GMA    YL   C
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMA----YLEEAC 123
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
              ++HRD+++ N L+       V+DFG+ R +
Sbjct: 124 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 153

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G V+     +   VA+K +      E    E F  EA ++ ++ H  +V+LYG 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-----VNIVKGMAHALSYLHHHC 310
           CL +  + L++E+ME G L   LRT     GL  A+      +++ +GMA    YL   C
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMA----YLEEAC 121
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
              ++HRD+++ N L+       V+DFG+ R +
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 151

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 8/168 (4%)
Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G +G V   +   +G  VA+K L+R +   L  +   R E + L    H +I+KLY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                  +F++ EY+  G LF  +  +     LD  +   + + +   + Y H H    +
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM---V 137
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           VHRD+   NVLL++ + A +ADFG++ +++ D        G+  Y AP
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRXSCGSPNYAAP 184

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 9/156 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   +   +G G +G V+         VA+K L         S ESF  EA+++ ++ H 
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTM----SPESFLEEAQIMKKLKHD 64
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+ D E   L     V++   +A  ++Y+ 
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIE 122
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
                  +HRD+ S N+L+ + L   +ADFG+ARL+
Sbjct: 123 RMN---YIHRDLRSANILVGNGLICKIADFGLARLI 155

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 88/160 (55%), Gaps = 13/160 (8%)
Query: 196 IGTGGYGSVYRARLP-SGKVVALKKL---HRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G G + +VY+AR   + ++VA+KK+   HRSE ++  +  + R E +LL ++ H NI+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIG 76
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L     H+  + L++++ME   L  +++ +   +     K   ++      L YLH H  
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW- 132
Query: 312 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
             I+HRD+  NN+LL+      +ADFG+A+  +F S NR 
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRA 168

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 28/180 (15%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 70
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 71  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 125
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA 363
            YL        +HRD+++ N L+       VADFG++RL+  D+           Y APA
Sbjct: 126 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----------YTAPA 171

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G V+     +   VA+K +      E    E F  EA ++ ++ H  +V+LYG 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-----VNIVKGMAHALSYLHHHC 310
           CL +  + L++E+ME G L   LRT     GL  A+      +++ +GMA    YL   C
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMA----YLEEAC 126
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
              ++HRD+++ N L+       V+DFG+ R +
Sbjct: 127 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 156

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 17/179 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ +   IG G +  V  AR + +GK VA++ + +++    +SL+    E R++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNS-SSLQKLFREVRIMKVLNHP 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           NIVKL+      K ++L+ EY   G +F  L    R  E+      AK   IV     A+
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA---RAKFRQIVS----AV 126
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            Y H      IVHRD+ + N+LL++++   +ADFG +    F +   T   G+  Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAP 181

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG----MAHA 302
            NIVKL         ++L++E++        L+T  +A  L     + ++K     +   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQD-----LKTFMDASALT-GIPLPLIKSYLFQLLQG 114
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           L++ H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 115 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +GTG +G V   +      VA+K +      E    + F  EA+++  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C  ++ +F+I EYM  G L   LR  E        + + + K +  A+ YL    +   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
           HRD+++ N L+N +    V+DFG++R +  D    ++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV 179

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 7/176 (3%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 65
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   L++ 
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 123
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 124 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 176

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAM 129
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 130 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 84/173 (48%), Gaps = 32/173 (18%)
Query: 196 IGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           IG G +G V++AR P         +VA+K L    + ++ +   F+ EA L+++  + NI
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMAEFDNPNI 112
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSL-----------FCVL-------RTDEEAVG---LD 288
           VKL G C   K M L++EYM  G L            C L       R    + G   L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 289 WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            A+++ I + +A  ++YL        VHRD+++ N L+   +   +ADFG++R
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 28/180 (15%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 71
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 126
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA 363
            YL        +HRD+++ N L+       VADFG++RL+  D+           Y APA
Sbjct: 127 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----------YTAPA 172

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 67
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAM 122
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 123 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G YG V + R   +G++VA+KK   S+ +++    + R E +LL Q+ H N+V L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV--GLDWAKRVNIVKGMAHALSYLHHHCTP 312
            C  +K  +L++E+++   L      D E    GLD+      +  + + + + H H   
Sbjct: 92  VCKKKKRWYLVFEFVDHTIL-----DDLELFPNGLDYQVVQKYLFQIINGIGFCHSH--- 143
Query: 313 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            I+HRDI   N+L++      + DFG AR L            T  Y AP
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 10/177 (5%)
Query: 188 EDF-HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF  I   +G G +G VY+A+     V+A  K+  +++EE   LE +  E  +L+   H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDH 93
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIV-KGMAHALSY 305
            NIVKL     +   ++++ E+   G++  V+   E  +      ++ +V K    AL+Y
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNY 150
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH +    I+HRD+ + N+L   + +  +ADFGV+         R    GT  ++AP
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 7/176 (3%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 70
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 71  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 125
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 126 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 166

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAM 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 129
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 130 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 15/161 (9%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG----MA 300
            H NIVKL         ++L++E++        L+T  +A  L     + ++K     + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQD-----LKTFMDASALT-GIPLPLIKSYLFQLL 116
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             L++ H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 117 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 75  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 129
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 130 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 129
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 130 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 87/178 (48%), Gaps = 7/178 (3%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           + H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 119 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 173

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAM 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 74
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 129
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 130 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 7/176 (3%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAM 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 67
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 68  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAM 122
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 123 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 7/176 (3%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAM 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 7/176 (3%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 128
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 89/169 (52%), Gaps = 11/169 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +  + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 75  ST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSII 128
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           HRD+ SNN+ L+ +L   + DFG+A + +  S +     L+G+  ++AP
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 9/146 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +GTG +G V   +      VA+K +      E    + F  EA+++  + H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C  ++ +F+I EYM  G L   LR  E        + + + K +  A+ YL    +   +
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 316 HRDISSNNVLLNSELEAFVADFGVAR 341
           HRD+++ N L+N +    V+DFG++R
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSR 148

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +GTG +G V   +      VA+K +      E    + F  EA+++  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C  ++ +F+I EYM  G L   LR  E        + + + K +  A+ YL    +   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+++ N L+N +    V+DFG++R +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYV 170

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 71
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 126
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 127 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 89/169 (52%), Gaps = 11/169 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +  + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 73  ST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           HRD+ SNN+ L+ +L   + DFG+A + +  S +     L+G+  ++AP
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 7/176 (3%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 89/169 (52%), Gaps = 11/169 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +  + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 78  ST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSII 131
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           HRD+ SNN+ L+ +L   + DFG+A + +  S +     L+G+  ++AP
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 89/169 (52%), Gaps = 11/169 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +  + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 78  ST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSII 131
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           HRD+ SNN+ L+ +L   + DFG+A + +  S +     L+G+  ++AP
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 9/146 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +GTG +G V   +      VA+K +      E    + F  EA+++  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C  ++ +F+I EYM  G L   LR  E        + + + K +  A+ YL    +   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 127
Query: 316 HRDISSNNVLLNSELEAFVADFGVAR 341
           HRD+++ N L+N +    V+DFG++R
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 184 IEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           IEA+E   +   IG+G +G+VY+ +      V + K+     E+    ++FRNE  +L +
Sbjct: 33  IEASE-VMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQF---QAFRNEVAVLRK 88
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H NI+   G+ + +  + ++ ++ E  SL+  L   E    +   + ++I +  A  +
Sbjct: 89  TRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGM 145
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
            YLH      I+HRD+ SNN+ L+  L   + DFG+A
Sbjct: 146 DYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 82
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 83  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 137
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 138 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 178

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 9/146 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +GTG +G V   +      VA+K +      E    + F  EA+++  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C  ++ +F+I EYM  G L   LR  E        + + + K +  A+ YL    +   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 127
Query: 316 HRDISSNNVLLNSELEAFVADFGVAR 341
           HRD+++ N L+N +    V+DFG++R
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 71
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 126
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 127 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 9/146 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +GTG +G V   +      VA+K +      E    + F  EA+++  + H  +V+LYG 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C  ++ +F+I EYM  G L   LR  E        + + + K +  A+ YL    +   +
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 126
Query: 316 HRDISSNNVLLNSELEAFVADFGVAR 341
           HRD+++ N L+N +    V+DFG++R
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSR 152

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +GTG +G V   +      VA+K +      E    + F  EA+++  + H  +V+LYG 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C  ++ +F+I EYM  G L   LR  E        + + + K +  A+ YL    +   +
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 133
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+++ N L+N +    V+DFG++R +
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYV 161

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ +   IG G +  V  AR + +GK VA+K + +++    +SL+    E R++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIMKVLNHP 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           NIVKL+      K ++L+ EY   G +F  L    R  E+     + + V+       A+
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-------AV 126
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            Y H      IVHRD+ + N+LL++++   +ADFG +    F  +      G   Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDAFCGAPPYAAP 181

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 69
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 89/169 (52%), Gaps = 11/169 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +  + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 100 ST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSII 153
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           HRD+ SNN+ L+ +L   + DFG+A + +  S +     L+G+  ++AP
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 202

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 10/177 (5%)
Query: 188 EDF-HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF  I   +G G +G VY+A+     V+A  K+  +++EE   LE +  E  +L+   H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDH 93
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIV-KGMAHALSY 305
            NIVKL     +   ++++ E+   G++  V+   E  +      ++ +V K    AL+Y
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNY 150
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH +    I+HRD+ + N+L   + +  +ADFGV+         R    GT  ++AP
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 10/177 (5%)
Query: 188 EDF-HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF  I   +G G +G VY+A+     V+A  K+  +++EE   LE +  E  +L+   H
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDH 93
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIV-KGMAHALSY 305
            NIVKL     +   ++++ E+   G++  V+   E  +      ++ +V K    AL+Y
Sbjct: 94  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNY 150
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH +    I+HRD+ + N+L   + +  +ADFGV+         R    GT  ++AP
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 19/153 (12%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G V+     +   VA+K +      E    + F  EA ++ ++ H  +V+LYG 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE----DDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-----VNIVKGMAHALSYLHHHC 310
           CL +  + L++E+ME G L   LRT     GL  A+      +++ +GMA    YL   C
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMA----YLEEAC 143
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
              ++HRD+++ N L+       V+DFG+ R +
Sbjct: 144 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 173

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 85/185 (45%), Gaps = 22/185 (11%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V++ R   +G++VA+KK   SE + +    + R E R+L Q+ H N+V L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HHCTPP 313
               ++ + L++EY +   L      D    G+      +I      A+++ H H+C   
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLH---ELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC--- 123
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLN-----FDSSNRT-------LLAGTSGYIA 361
            +HRD+   N+L+       + DFG ARLL      +D    T       LL G + Y  
Sbjct: 124 -IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182
Query: 362 PASEW 366
           P   W
Sbjct: 183 PVDVW 187

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 89/169 (52%), Gaps = 11/169 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +  + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 101 ST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSII 154
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           HRD+ SNN+ L+ +L   + DFG+A + +  S +     L+G+  ++AP
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 203

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 16/176 (9%)
Query: 178 ITFQDM----IEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLES 233
           + FQ M    +E T D  +K+ +G G YG VY        +    K  + +T E+   E 
Sbjct: 19  LYFQSMDKWEMERT-DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEV---EE 74
Query: 234 FRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR--TDEEAVGLDWAK 291
           F  EA ++ +I H N+V+L G C      +++ EYM  G+L   LR    EE   +    
Sbjct: 75  FLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAV---V 131
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            + +   ++ A+ YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 132 LLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT 184

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 90/179 (50%), Gaps = 7/179 (3%)
Query: 184 IEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           ++  E + I   +G G +G VY+A+      +A  K+  +++EE   LE +  E  +L+ 
Sbjct: 7   LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILAT 64
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H  IVKL G   H   ++++ E+   G++  ++   E   GL   +   + + M  AL
Sbjct: 65  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVVCRQMLEAL 122
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           ++LH   +  I+HRD+ + NVL+  E +  +ADFGV+         R    GT  ++AP
Sbjct: 123 NFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 178

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 89/169 (52%), Gaps = 11/169 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
               + + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 73  STAPQ-LAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           HRD+ SNN+ L+ +L   + DFG+A + +  S +     L+G+  ++AP
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/184 (32%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEA 238
           FQ M +  E F     IG G +G V++     + KVVA+K +   E E+       + E 
Sbjct: 20  FQSM-DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE--DIQQEI 76
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
            +LSQ     + K YG  L    +++I EY+  GS   +L    E   LD  +   I++ 
Sbjct: 77  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILRE 132
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           +   L YLH       +HRDI + NVLL+   E  +ADFGVA  L      R    GT  
Sbjct: 133 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 189
Query: 359 YIAP 362
           ++AP
Sbjct: 190 WMAP 193

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 25/172 (14%)
Query: 189 DFHIKYCIGTGGYGSVYRARL----PSGK--VVALKKLHRSETEELASLESFRNEARLLS 242
           D  +K  +G G +G V+ A      P+    +VA+K L   +   LA+ + F+ EA LL+
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLT 72
Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD------------EEAVG-LDW 289
            + H +IVK YG C     + +++EYM+ G L   LR               +A G L  
Sbjct: 73  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           ++ ++I   +A  + YL    +   VHRD+++ N L+ + L   + DFG++R
Sbjct: 133 SQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 90/179 (50%), Gaps = 7/179 (3%)
Query: 184 IEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           ++  E + I   +G G +G VY+A+      +A  K+  +++EE   LE +  E  +L+ 
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILAT 72
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H  IVKL G   H   ++++ E+   G++  ++   E   GL   +   + + M  AL
Sbjct: 73  CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVVCRQMLEAL 130
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           ++LH   +  I+HRD+ + NVL+  E +  +ADFGV+         R    GT  ++AP
Sbjct: 131 NFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G +G VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHP 67
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAM 122
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HRD+++ N L+       VADFG++RL+  D+
Sbjct: 123 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 120 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 20/175 (11%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALK---KLHRSETEELASLESFRNEA 238
           +++ TE   +K  +G+G +G+VY+   +P G+ V +    K+    T   A++E F +EA
Sbjct: 34  ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEA 91
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVN 294
            +++ + H ++V+L G CL    + L+ + M  G L   +   ++ +G    L+W   V 
Sbjct: 92  LIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC--VQ 148
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 349
           I KGM     YL       +VHRD+++ NVL+ S     + DFG+ARLL  D   
Sbjct: 149 IAKGMM----YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 196

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 63
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 121
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 122 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 120 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++     + KVVA+K +   E      +E  + E  +LSQ     + K YG
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    +++I EY+  GS   +L    E   LD  +   I++ +   L YLH       
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 140
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI + NVLL+   E  +ADFGVA  L      R    GT  ++AP
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 188

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 78/153 (50%), Gaps = 19/153 (12%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G V+     +   VA+K +      E    E F  EA ++ ++ H  +V+LYG 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-----VNIVKGMAHALSYLHHHC 310
           CL +  + L+ E+ME G L   LRT     GL  A+      +++ +GMA    YL   C
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMA----YLEEAC 124
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
              ++HRD+++ N L+       V+DFG+ R +
Sbjct: 125 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFV 154

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 88/179 (49%), Gaps = 17/179 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ +   IG G +  V  AR + +GK VA++ + +++    +SL+    E R++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNS-SSLQKLFREVRIMKVLNHP 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           NIVKL+      K ++L+ EY   G +F  L    R  E+      AK   IV     A+
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEA---RAKFRQIVS----AV 126
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            Y H      IVHRD+ + N+LL++++   +ADFG +    F  +      G+  Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTF-GNKLDEFCGSPPYAAP 181

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++     + KVVA+K +   E      +E  + E  +LSQ     + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    +++I EY+  GS   +L    E   LD  +   I++ +   L YLH       
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 125
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI + NVLL+   E  +ADFGVA  L      R    GT  ++AP
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 173

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 119 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 120 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++     + KVVA+K +   E      +E  + E  +LSQ     + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    +++I EY+  GS   +L    E   LD  +   I++ +   L YLH       
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKK--- 125
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI + NVLL+   E  +ADFGVA  L      R    GT  ++AP
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 173

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E+++      +  +    + L   K  + +  +   L+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 121 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 276
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQISSAM 331
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HR++++ N L+       VADFG++RL+  D+
Sbjct: 332 EYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 119 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 88/169 (52%), Gaps = 11/169 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +  + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 73  ST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           HRD+ SNN+ L+ +L   + DFG+A   +  S +     L+G+  ++AP
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 118 FCHSHR---VLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 19/180 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ ++  IG G +  V  AR + +G+ VA+K + +++     SL+    E R++  + H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNP-TSLQKLFREVRIMKILNHP 74
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           NIVKL+      K ++L+ EY   G +F  L    R  E+     + + V+       A+
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-------AV 127
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-TLLAGTSGYIAP 362
            Y H      IVHRD+ + N+LL+ ++   +ADFG +    F   N+     G+  Y AP
Sbjct: 128 QYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSN--EFTVGNKLDTFCGSPPYAAP 182

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
           + E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H NIVKL         ++L++E++       +  +    + L   K  + +  +   L+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   L++ 
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 120
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           H H    ++HRD+   N+L+N+E    +ADFG+AR
Sbjct: 121 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +  + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 93  ST-KPQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLH---AKSII 146
Query: 316 HRDISSNNVLLNSELEAFVADFGVA 340
           HRD+ SNN+ L+ +L   + DFG+A
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 11/168 (6%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G+VY AR + + +VVA+KK+  S  +     +    E R L ++ H N ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L     +L+ EY  +GS   +L   ++   L   +   +  G    L+YLH H    +
Sbjct: 122 CYLREHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHN---M 175
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRD+ + N+LL+      + DFG A ++    +      GT  ++AP
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAP 219

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +  + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 101 ST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH---AKSII 154
Query: 316 HRDISSNNVLLNSELEAFVADFGVA 340
           HRD+ SNN+ L+ +L   + DFG+A
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 92/175 (52%), Gaps = 20/175 (11%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALK---KLHRSETEELASLESFRNEA 238
           +++ TE   +K  +G+G +G+VY+   +P G+ V +    K+    T   A++E F +EA
Sbjct: 11  ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEA 68
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVN 294
            +++ + H ++V+L G CL    + L+ + M  G L   +   ++ +G    L+W   V 
Sbjct: 69  LIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC--VQ 125
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 349
           I KGM     YL       +VHRD+++ NVL+ S     + DFG+ARLL  D   
Sbjct: 126 IAKGMM----YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 173

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+ A       VA+K +         S+E+F  EA ++  + H 
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHD 70
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +VKL+   + ++ +++I E+M  GSL   L++DE        K ++    +A  ++++ 
Sbjct: 71  KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  +HRD+ + N+L+++ L   +ADFG+AR++ 
Sbjct: 129 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 162

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 17/164 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           D  +K+ +G G YG VY        + VA+K L     E+   +E F  EA ++ +I H 
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 315
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           N+V+L G C      ++I E+M  G+L   L    R +  AV L     + +   ++ A+
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAM 370
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        +HR++++ N L+       VADFG++RL+  D+
Sbjct: 371 EYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 411

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ +I H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKIRHE 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 132 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 88/169 (52%), Gaps = 11/169 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +  + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 77  ST-KPQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLH---AKSII 130
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           HRD+ SNN+ L+ +    + DFG+A + +  S +     L+G+  ++AP
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 7/176 (3%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVAL K+ R +TE      +   E  LL ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   L++ 
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 119
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 7/176 (3%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVAL K+ R +TE      +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +    + L   K  + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFC 118
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 9/156 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHE 322
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 323 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
                  VHRD+ + N+L+   L   VADFG+ARL+
Sbjct: 381 RMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+++ N+L+   L   VADFG+ARL+ 
Sbjct: 132 RMN---YVHRDLAAANILVGENLVCKVADFGLARLIE 165

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 18/188 (9%)
Query: 186 ATEDFHIKY----CIGTGGYGSVYR-ARLPSGKVVALKKLH----RSETEELASL-ESFR 235
           A ++F+ KY     IG G    V R     +G   A+K +     R   E+L  + E+ R
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 236 NEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 294
            E  +L Q+  H +I+ L         MFL+++ M  G LF  L    E V L   +  +
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRS 204
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++ +  A+S+LH +    IVHRD+   N+LL+  ++  ++DFG +  L      R  L 
Sbjct: 205 IMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-LC 260
Query: 355 GTSGYIAP 362
           GT GY+AP
Sbjct: 261 GTPGYLAP 268

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 90/173 (52%), Gaps = 13/173 (7%)
Query: 195 CIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +G G +G V   +   +G+  A+K + + + ++    ES   E +LL Q+ H NI+KLY
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
            F   +   +L+ E    G LF  + + +    +D A+   I++ +   ++Y+H +    
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 146
Query: 314 IVHRDISSNNVLLNS---ELEAFVADFGVARLLNFDSSNRTL-LAGTSGYIAP 362
           IVHRD+   N+LL S   +    + DFG++   +F++S +     GT+ YIAP
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKIGTAYYIAP 197

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 66
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 67  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVE 124
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 125 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 158

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 11/168 (6%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G+VY AR + + +VVA+KK+  S  +     +    E R L ++ H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L     +L+ EY  +GS   +L   ++   L   +   +  G    L+YLH H    +
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHN---M 136
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRD+ + N+LL+      + DFG A ++    +      GT  ++AP
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAP 180

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 90/172 (52%), Gaps = 13/172 (7%)
Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G +G V   +   +G+  A+K + + + ++    ES   E +LL Q+ H NI+KLY 
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 99
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
           F   +   +L+ E    G LF  + + +    +D A+   I++ +   ++Y+H +    I
Sbjct: 100 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---KI 153
Query: 315 VHRDISSNNVLLNS---ELEAFVADFGVARLLNFDSSNRTL-LAGTSGYIAP 362
           VHRD+   N+LL S   +    + DFG++   +F++S +     GT+ YIAP
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKIGTAYYIAP 203

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 29/199 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR----LPSGKVVALKKLHRS----ETEELASLESFRNEAR 239
           E F +   +G GGYG V++ R      +GK+ A+K L ++      ++ A  ++ RN   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 240 LLSQIWHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           +L ++ H  IV L Y F    K ++LI EY+  G LF  ++ + E + ++      + + 
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELF--MQLEREGIFMEDTACFYLAE- 129
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           ++ AL +LH      I++RD+   N++LN +    + DFG+ +    D +      GT  
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 359 YIAP----------ASEWW 367
           Y+AP          A +WW
Sbjct: 187 YMAPEILMRSGHNRAVDWW 205

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 21/173 (12%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKK--LHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG G  G V  A +  SGK+VA+KK  L + +  EL       NE  ++    H N+V++
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-----LFNEVVIMRDYQHENVVEM 213
Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           Y   L    ++++ E++E G+L  ++   R +EE +         +   +  ALS LH  
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-------VCLAVLQALSVLHAQ 266
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRDI S+++LL  +    ++DFG    ++ +   R  L GT  ++AP
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 316

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 21/173 (12%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKK--LHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG G  G V  A +  SGK+VA+KK  L + +  EL       NE  ++    H N+V++
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-----LFNEVVIMRDYQHENVVEM 91
Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           Y   L    ++++ E++E G+L  ++   R +EE +         +   +  ALS LH  
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQ 144
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRDI S+++LL  +    ++DFG    ++ +   R  L GT  ++AP
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 194

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 29/199 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR----LPSGKVVALKKLHRS----ETEELASLESFRNEAR 239
           E F +   +G GGYG V++ R      +GK+ A+K L ++      ++ A  ++ RN   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 240 LLSQIWHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           +L ++ H  IV L Y F    K ++LI EY+  G LF  ++ + E + ++      + + 
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELF--MQLEREGIFMEDTACFYLAE- 129
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           ++ AL +LH      I++RD+   N++LN +    + DFG+ +    D +      GT  
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 359 YIAP----------ASEWW 367
           Y+AP          A +WW
Sbjct: 187 YMAPEILMRSGHNRAVDWW 205

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 78/153 (50%), Gaps = 19/153 (12%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G V+     +   VA+K +      E    E F  EA ++ ++ H  +V+LYG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-----VNIVKGMAHALSYLHHHC 310
           CL +  + L++E+ME G L   LRT     GL  A+      +++ +GMA    YL    
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMA----YLEE-- 121
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
              ++HRD+++ N L+       V+DFG+ R +
Sbjct: 122 -ASVIHRDLAARNCLVGENQVIKVSDFGMTRFV 153

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 21/173 (12%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKK--LHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG G  G V  A +  SGK+VA+KK  L + +  EL       NE  ++    H N+V++
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-----LFNEVVIMRDYQHENVVEM 93
Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           Y   L    ++++ E++E G+L  ++   R +EE +         +   +  ALS LH  
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQ 146
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRDI S+++LL  +    ++DFG    ++ +   R  L GT  ++AP
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 196

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 91/173 (52%), Gaps = 13/173 (7%)
Query: 195 CIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +G G +G V   +   +G+  A+K + + + ++    ES   E +LL Q+ H NI+KLY
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
            F   +   +L+ E    G LF  + + +    +D A+   I++ +   ++Y+H +    
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 169
Query: 314 IVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTL-LAGTSGYIAP 362
           IVHRD+   N+LL S+ +     + DFG++   +F++S +     GT+ YIAP
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKIGTAYYIAP 220

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+ A       VA+K +         S+E+F  EA ++  + H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHD 243
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +VKL+   + ++ +++I E+M  GSL   L++DE        K ++    +A  ++++ 
Sbjct: 244 KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  +HRD+ + N+L+++ L   +ADFG+AR++ 
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 335

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 92/180 (51%), Gaps = 23/180 (12%)
Query: 189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALK--KLHRSETEELASLESFRNEARLLSQIW 245
           D ++K  IG G  G V  AR   SG+ VA+K   L + +  EL       NE  ++    
Sbjct: 48  DSYVK--IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-----LFNEVVIMRDYQ 100
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHA 302
           H N+V++Y   L  + ++++ E+++ G+L  ++   R +EE +         + + +  A
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA-------TVCEAVLQA 153
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           L+YLH      ++HRDI S+++LL  +    ++DFG    ++ D   R  L GT  ++AP
Sbjct: 154 LAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAP 210

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 21/173 (12%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKK--LHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG G  G V  A +  SGK+VA+KK  L + +  EL       NE  ++    H N+V++
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-----LFNEVVIMRDYQHENVVEM 82
Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           Y   L    ++++ E++E G+L  ++   R +EE +         +   +  ALS LH  
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQ 135
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRDI S+++LL  +    ++DFG    ++ +   R  L GT  ++AP
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 185

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 9/156 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHE 239
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
                  VHRD+ + N+L+   L   VADFG+ARL+
Sbjct: 298 RM---NYVHRDLRAANILVGENLVCKVADFGLARLI 330

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++     + +VVA+K +   E E+       + E  +LSQ     + K YG
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI--QQEITVLSQCDSSYVTKYYG 88
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    +++I EY+  GS   +LR    A   D  +   ++K +   L YLH       
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEKK--- 141
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI + NVLL+ + +  +ADFGVA  L      R    GT  ++AP
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 189

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 90/173 (52%), Gaps = 13/173 (7%)
Query: 195 CIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +G G +G V   +   +G+  A+K + + + ++    ES   E +LL Q+ H NI+KLY
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
            F   +   +L+ E    G LF  + + +    +D A+   I++ +   ++Y+H +    
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 170
Query: 314 IVHRDISSNNVLLNS---ELEAFVADFGVARLLNFDSSNRTL-LAGTSGYIAP 362
           IVHRD+   N+LL S   +    + DFG++   +F++S +     GT+ YIAP
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDKIGTAYYIAP 221

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 9/156 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHE 239
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
                  VHRD+ + N+L+   L   VADFG+ARL+
Sbjct: 298 RM---NYVHRDLRAANILVGENLVCKVADFGLARLI 330

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ +   IG G +  V  AR + +GK VA+K + +++    +SL+    E R+   + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNS-SSLQKLFREVRIXKVLNHP 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           NIVKL+      K ++L+ EY   G +F  L    R  E+      AK   IV     A+
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEA---RAKFRQIVS----AV 126
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            Y H      IVHRD+ + N+LL+++    +ADFG +    F  +      G   Y AP
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTF-GNKLDAFCGAPPYAAP 181

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 132 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 62
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 63  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 120
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 121 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 154

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 21/173 (12%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKK--LHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG G  G V  A +  SGK+VA+KK  L + +  EL       NE  ++    H N+V++
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-----LFNEVVIMRDYQHENVVEM 136
Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           Y   L    ++++ E++E G+L  ++   R +EE +         +   +  ALS LH  
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQ 189
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRDI S+++LL  +    ++DFG    ++ +   R  L GT  ++AP
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 239

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 21/173 (12%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKK--LHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG G  G V  A +  SGK+VA+KK  L + +  EL       NE  ++    H N+V++
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-----LFNEVVIMRDYQHENVVEM 86
Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           Y   L    ++++ E++E G+L  ++   R +EE +         +   +  ALS LH  
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLQALSVLHAQ 139
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRDI S+++LL  +    ++DFG    ++ +   R  L GT  ++AP
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAP 189

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 132 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 64
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 122
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 123 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 156

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHE 70
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLK-GETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 129 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 162

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHE 70
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLK-GETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 129 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 162

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 132 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 17/179 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ +   IG G +  V  AR + +G+ VA+K + +++     SL+    E R++  + H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHP 71
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           NIVKL+      K ++LI EY   G +F  L    R  E+     + + V+       A+
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-------AV 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            Y H      IVHRD+ + N+LL++++   +ADFG +          T   G+  Y AP
Sbjct: 125 QYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-FCGSPPYAAP 179

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 9/156 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHE 239
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
                  VHRD+ + N+L+   L   VADFG+ARL+
Sbjct: 298 RM---NYVHRDLRAANILVGENLVCKVADFGLARLI 330

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 81/155 (52%), Gaps = 9/155 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+ A       VA+K +         S+E+F  EA ++  + H 
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHD 237
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +VKL+   + ++ +++I E+M  GSL   L++DE        K ++    +A  ++++ 
Sbjct: 238 KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
                  +HRD+ + N+L+++ L   +ADFG+AR+
Sbjct: 296 QRN---YIHRDLRAANILVSASLVCKIADFGLARV 327

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVCEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 189 DFHIKYCIGTGGYGSVYRAR----LPSGK--VVALKKLHRSETEELASLESFRNEARLLS 242
           D  +K+ +G G +G V+ A     LP     +VA+K L   E  E A  + F+ EA LL+
Sbjct: 42  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESAR-QDFQREAELLT 98
Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----------DEEAVG-LDWA 290
            + H++IV+ +G C   + + +++EYM  G L   LR+           ++ A G L   
Sbjct: 99  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 291 KRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + + +   +A  + YL        VHRD+++ N L+   L   + DFG++R
Sbjct: 159 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 76/145 (52%), Gaps = 9/145 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +  + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 89  ST-KPQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 316 HRDISSNNVLLNSELEAFVADFGVA 340
           HRD+ SNN+ L+ +    + DFG+A
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 21/173 (12%)
Query: 196 IGTGGYGSVYRARLP-SGKVVALKK--LHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG G  G V  A    +GK VA+KK  L + +  EL       NE  ++    H N+V +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL-----LFNEVVIMRDYHHDNVVDM 107
Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVL---RTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           Y   L    ++++ E++E G+L  ++   R +EE +         +   +  ALSYLH+ 
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYLHNQ 160
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRDI S+++LL S+    ++DFG    ++ +   R  L GT  ++AP
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAP 210

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 189 DFHIKYCIGTGGYGSVYRAR----LPSGK--VVALKKLHRSETEELASLESFRNEARLLS 242
           D  +K+ +G G +G V+ A     LP     +VA+K L   E  E A  + F+ EA LL+
Sbjct: 13  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESAR-QDFQREAELLT 69
Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----------DEEAVG-LDWA 290
            + H++IV+ +G C   + + +++EYM  G L   LR+           ++ A G L   
Sbjct: 70  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 129
Query: 291 KRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + + +   +A  + YL        VHRD+++ N L+   L   + DFG++R
Sbjct: 130 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 85/163 (52%), Gaps = 19/163 (11%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFR---NEARLLSQIWHRNIV 250
            +G+G +G+V++   +P G+ + +    +   E+ +  +SF+   +    +  + H +IV
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYL 306
           +L G C     + L+ +Y+ +GSL   +R    A+G    L+W   V I KGM     YL
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGM----YYL 149
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 349
             H    +VHR++++ NVLL S  +  VADFGVA LL  D   
Sbjct: 150 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHE 63
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + + ++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 64  KLVQLYAV-VSEEPIXIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVE 121
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 122 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 155

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 189 DFHIKYCIGTGGYGSVYRAR----LPSGK--VVALKKLHRSETEELASLESFRNEARLLS 242
           D  +K+ +G G +G V+ A     LP     +VA+K L   E  E A  + F+ EA LL+
Sbjct: 19  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESAR-QDFQREAELLT 75
Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----------DEEAVG-LDWA 290
            + H++IV+ +G C   + + +++EYM  G L   LR+           ++ A G L   
Sbjct: 76  MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 135
Query: 291 KRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           + + +   +A  + YL        VHRD+++ N L+   L   + DFG++R
Sbjct: 136 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 88/173 (50%), Gaps = 13/173 (7%)
Query: 195 CIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +G G +G V   +   +G+  A+K + + + ++    ES   E +LL Q+ H NI KLY
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
            F   +   +L+ E    G LF  + + +    +D A+   I++ +   ++Y H +    
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYXHKN---K 146
Query: 314 IVHRDISSNNVLLNS---ELEAFVADFGVARLLNFDSSNRTLLA-GTSGYIAP 362
           IVHRD+   N+LL S   +    + DFG++   +F++S +     GT+ YIAP
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKXKDKIGTAYYIAP 197

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEIXINKMLN 63
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 120
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEIXINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKL---HRSETEELASLESFRNEA--R 239
           AT  +     IG G YG+VY+AR P SG  VALK +   +         + + R  A  R
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 240 LLSQIWHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRT---DEEAVGLDWAK 291
            L    H N+V+L   C   +      + L++E+++       LRT        GL    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-----LRTYLDKAPPPGLPAET 121
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
             ++++     L +LH +C   IVHRD+   N+L+ S     +ADFG+AR+ ++
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEIXINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 85/163 (52%), Gaps = 19/163 (11%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFR---NEARLLSQIWHRNIV 250
            +G+G +G+V++   +P G+ + +    +   E+ +  +SF+   +    +  + H +IV
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKV-IEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYL 306
           +L G C     + L+ +Y+ +GSL   +R    A+G    L+W   V I KGM     YL
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGM----YYL 131
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 349
             H    +VHR++++ NVLL S  +  VADFGVA LL  D   
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 83/168 (49%), Gaps = 8/168 (4%)
Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G +G V       +G  VA+K L+R +   L  +   + E + L    H +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                   F++ EY+  G LF  +        ++ A+R  + + +  A+ Y H H    +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-ARR--LFQQILSAVDYCHRHM---V 132
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           VHRD+   NVLL++ + A +ADFG++ +++     RT   G+  Y AP
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAP 179

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 76/145 (52%), Gaps = 9/145 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H NI+   G+
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
               + + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH      I+
Sbjct: 89  STAPQ-LAIVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 316 HRDISSNNVLLNSELEAFVADFGVA 340
           HRD+ SNN+ L+ +    + DFG+A
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 90/186 (48%), Gaps = 16/186 (8%)
Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +D+ ++  IG+G    V  A   P  + VA+K+++  + +   S++    E + +SQ  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHH 72
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLF-----CVLRTDEEAVGLDWAKRVNIVKGMAH 301
            NIV  Y   + +  ++L+ + +  GS+       V + + ++  LD +    I++ +  
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD-----SSNRTLLAGT 356
            L YLH +     +HRD+ + N+LL  +    +ADFGV+  L        +  R    GT
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 357 SGYIAP 362
             ++AP
Sbjct: 190 PCWMAP 195

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 90/186 (48%), Gaps = 16/186 (8%)
Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +D+ ++  IG+G    V  A   P  + VA+K+++  + +   S++    E + +SQ  H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHH 67
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLF-----CVLRTDEEAVGLDWAKRVNIVKGMAH 301
            NIV  Y   + +  ++L+ + +  GS+       V + + ++  LD +    I++ +  
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD-----SSNRTLLAGT 356
            L YLH +     +HRD+ + N+LL  +    +ADFGV+  L        +  R    GT
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 357 SGYIAP 362
             ++AP
Sbjct: 185 PCWMAP 190

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 22/166 (13%)
Query: 192 IKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           +K  +G G +G V+ A            +VA+K L  +      + + F  EA LL+ + 
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQ 73
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-DEEAV---------GLDWAKRVNI 295
           H +IVK YG C+    + +++EYM+ G L   LR    +AV          L  ++ ++I
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +A  + YL    +   VHRD+++ N L+   L   + DFG++R
Sbjct: 134 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNM----SPEAFLQEAQVMKKLRHE 240
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 241 KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 298
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
                  VHRD+ + N+L+   L   VADFG+ RL+
Sbjct: 299 RMN---YVHRDLRAANILVGENLVCKVADFGLGRLI 331

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 8/177 (4%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E + I   +G GG  +VY A      + VA+K +     E+  +L+ F  E    SQ+ H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
           +NIV +        C +L+ EY+E  +L   + +    + +D A  +N    +   + + 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTA--INFTNQILDGIKHA 127
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP 362
           H      IVHRDI   N+L++S     + DFG+A+ L+  S  +T  + GT  Y +P
Sbjct: 128 HDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  G L   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVMEYMSKGCLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  + + + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINAMLN 63
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 120
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L         S E+F  EA+++ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHE 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY   +  + ++++ EYM  G L   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVTEYMSKGCLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                  VHRD+ + N+L+   L   VADFG+ARL+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ +   IG G +  V  AR + +G+ VA+K + +++     SL+    E R++  + H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHP 74
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           NIVKL+      K ++LI EY   G +F  L    R  E+     + + V+       A+
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-------AV 127
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            Y H      IVHRD+ + N+LL++++   +ADFG +              G   Y AP
Sbjct: 128 QYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYAAP 182

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 11/171 (6%)
Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YG V   +   +G   A+K + +S     ++  +  +E  +L Q+ H NI+KLY 
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
           F   ++  +L+ E    G LF  +   ++   +D A    I+K +    +YLH H    I
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQVLSGTTYLHKH---NI 142
Query: 315 VHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           VHRD+   N+LL S+       + DFG++         +  L GT+ YIAP
Sbjct: 143 VHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-GTAYYIAP 192

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 120
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 120
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGK----VVALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+     VA+K+L R  T   A+ E   +E
Sbjct: 15  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 71
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 128
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 129 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 172

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G+G +G V   +      VA+K +      E    + F  EA+ + ++ H  +VK YG 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
           C     ++++ EY+  G L   LR+     GL+ ++ + +   +   +++L  H     +
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 316 HRDISSNNVLLNSELEAFVADFGVARLL 343
           HRD+++ N L++ +L   V+DFG+ R +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYV 154

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 11/171 (6%)
Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YG V   +   +G   A+K + +S     ++  +  +E  +L Q+ H NI+KLY 
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
           F   ++  +L+ E    G LF  +   ++   +D A    I+K +    +YLH H    I
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQVLSGTTYLHKH---NI 125
Query: 315 VHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           VHRD+   N+LL S+       + DFG++         +  L GT+ YIAP
Sbjct: 126 VHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-GTAYYIAP 175

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 12  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 68
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWC--V 125
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 126 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 169

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 120
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 120
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 61
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 118
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 119 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 120
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 63
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 120
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G  G+VY A  + +G+ VA+++++    ++    E   NE  ++ +  + NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    ++++ EY+  GSL  V+        +D  +   + +    AL +LH +    +
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI S+N+LL  +    + DFG    +  + S R+ + GT  ++AP
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 70
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 128 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 171

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 36  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 92
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 93  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 149
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 150 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 193

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 67
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 125 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 69
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 127 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 170

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G  G+VY A  + +G+ VA+++++    ++    E   NE  ++ +  + NIV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    ++++ EY+  GSL  V+        +D  +   + +    AL +LH +    +
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QV 138
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI S+N+LL  +    + DFG    +  + S R+ + GT  ++AP
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 186

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 12  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 68
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 69  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 125
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 126 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 169

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 67
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWC--V 124
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 125 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 21  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 77
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 78  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 134
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 135 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 178

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G  G+VY A  + +G+ VA+++++    ++    E   NE  ++ +  + NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    ++++ EY+  GSL  V+        +D  +   + +    AL +LH +    +
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI S+N+LL  +    + DFG    +  + S R+ + GT  ++AP
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 185

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 11/149 (7%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G YG V+++    +G+VVA+KK+  +      +  +FR    L     H NIV L  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 255 FCL--HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTP 312
                + + ++L+++YME   L  V+R    A  L+   +  +V  +   + YLH   + 
Sbjct: 77  VLRADNDRDVYLVFDYMET-DLHAVIR----ANILEPVHKQYVVYQLIKVIKYLH---SG 128
Query: 313 PIVHRDISSNNVLLNSELEAFVADFGVAR 341
            ++HRD+  +N+LLN+E    VADFG++R
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 69
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 127 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 170

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 70
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 128 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 171

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 93/171 (54%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 17  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 73
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL    + LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 74  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 130
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 131 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 174

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 70
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 128 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 171

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 18  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 74
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 132 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 175

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 70
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 128 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 171

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 67
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 125 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 8/168 (4%)
Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G +G V       +G  VA+K L+R +   L  +   + E + L    H +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                   F++ EY+  G LF  +        ++ A+R  + + +  A+ Y H H    +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-ARR--LFQQILSAVDYCHRHM---V 132
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           VHRD+   NVLL++ + A +ADFG++ +++ D        G+  Y AP
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRDSCGSPNYAAP 179

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 19/183 (10%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 247 RNIVKLYGFCLHR-KCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAH 301
              VKLY FC    + ++    Y + G L   +R     DE       A+ V+       
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS------- 148
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGY 359
           AL YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y
Sbjct: 149 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 360 IAP 362
           ++P
Sbjct: 206 VSP 208

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 93/176 (52%), Gaps = 22/176 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 67
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 349
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL  +   
Sbjct: 125 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 37/201 (18%)
Query: 189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     +G G +G V +AR     +  A+KK+  +E E+L+++ S   E  LL+ + H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILS---EVMLLASLNHQ 62
Query: 248 NIVKLYGFCLHRK-------------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 294
            +V+ Y   L R+              +F+  EY E G+L+ ++ ++      D   R  
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR-- 120
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR-------LLNFDS 347
           + + +  ALSY+H   +  I+HRD+   N+ ++      + DFG+A+       +L  DS
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 348 S-------NRTLLAGTSGYIA 361
                   N T   GT+ Y+A
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVA 198

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSE-TEELASLESFRNEARLLS 242
           E+F +   +GTG YG V+  R  SG    K+ A+K L ++   ++  + E  R E ++L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 243 QIWHRN-IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG-M 299
            I     +V L Y F    K + LI +Y+  G LF  L   E          V I  G +
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFT----EHEVQIYVGEI 168
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSG 358
             AL +LH      I++RDI   N+LL+S     + DFG+++    D + R     GT  
Sbjct: 169 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 359 YIAP------------ASEWW 367
           Y+AP            A +WW
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWW 246

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 92/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 5   ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 61
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 118
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 119 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G  G+VY A  + +G+ VA+++++    ++    E   NE  ++ +  + NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    ++++ EY+  GSL  V+        +D  +   + +    AL +LH +    +
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI S+N+LL  +    + DFG    +  + S R+ + GT  ++AP
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAP 185

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 122
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 123 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 361 AP 362
           +P
Sbjct: 180 SP 181

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 121
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 122 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 361 AP 362
           +P
Sbjct: 179 SP 180

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G+G YG V   R     V    K+ R  +   +S      E  +L  + H NI+KLY F
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDE--EAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
              ++  +L+ E  + G LF     DE    +  +      I+K +   ++YLH H    
Sbjct: 105 FEDKRNYYLVMECYKGGELF-----DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---N 156
Query: 314 IVHRDISSNNVLLNS-ELEAF--VADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           IVHRD+   N+LL S E +A   + DFG++ +       +  L GT+ YIAP
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-GTAYYIAP 207

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 94/178 (52%), Gaps = 22/178 (12%)
Query: 176 GRITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELAS 230
           G +    +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+
Sbjct: 1   GAMALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKAN 58
Query: 231 LESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG---- 286
            E   +EA +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    
Sbjct: 59  KEIL-DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL 116
Query: 287 LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
           L+W   V I +GM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 117 LNWC--VQIAEGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 165

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 90/175 (51%), Gaps = 20/175 (11%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALK---KLHRSETEELASLESFRNEA 238
           +++ TE   +K  +G+G +G+VY+   +P G+ V +    K+ R  T   A+ E   +EA
Sbjct: 13  ILKETELRKVK-VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEIL-DEA 70
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVN 294
            +++ +    + +L G CL      L+ + M  G L   +R +   +G    L+W   + 
Sbjct: 71  YVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWC--MQ 127
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 349
           I KGM    SYL       +VHRD+++ NVL+ S     + DFG+ARLL+ D + 
Sbjct: 128 IAKGM----SYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 175

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 120
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 361 AP 362
           +P
Sbjct: 178 SP 179

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 119
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 120 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 361 AP 362
           +P
Sbjct: 177 SP 178

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 144
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 361 AP 362
           +P
Sbjct: 202 SP 203

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 91/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 69
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG A+LL 
Sbjct: 127 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG 170

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 88/185 (47%), Gaps = 21/185 (11%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSG-----KVVALKKLHRSETEELASLESFRNEARL 240
           T+++ +   +G G +  V R  ++P+G     K++  KKL   + ++L        EAR+
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKL------EREARI 56
Query: 241 LSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
              + H NIV+L+         +L+++ +  G LF      E+ V  ++    +    + 
Sbjct: 57  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQ 110
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTS 357
             L  ++H     IVHRD+   N+LL S+ +     +ADFG+A  +  D       AGT 
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTP 170
Query: 358 GYIAP 362
           GY++P
Sbjct: 171 GYLSP 175

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 91/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 69
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG A+LL 
Sbjct: 127 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG 170

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 145
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 361 AP 362
           +P
Sbjct: 203 SP 204

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 7/201 (3%)
Query: 164 KCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHR 222
           K   EF  W        ++M    EDF I   IG G +G V   ++  + ++ A+K L++
Sbjct: 50  KYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNK 109
Query: 223 SETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE 282
            E  + A    FR E  +L     + I  L+        ++L+ +Y   G L  +L   E
Sbjct: 110 WEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFE 169
Query: 283 EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
           + +  D A+    +  M  A+  +H       VHRDI  +NVLL+      +ADFG    
Sbjct: 170 DKLPEDMARFY--IGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLK 224
Query: 343 LNFDSSNRTLLA-GTSGYIAP 362
           +N D + ++ +A GT  YI+P
Sbjct: 225 MNDDGTVQSSVAVGTPDYISP 245

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 142
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 361 AP 362
           +P
Sbjct: 200 SP 201

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 7/201 (3%)
Query: 164 KCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHR 222
           K   EF  W        ++M    EDF I   IG G +G V   ++  + ++ A+K L++
Sbjct: 66  KYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNK 125
Query: 223 SETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE 282
            E  + A    FR E  +L     + I  L+        ++L+ +Y   G L  +L   E
Sbjct: 126 WEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFE 185
Query: 283 EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
           + +  D A+    +  M  A+  +H       VHRDI  +NVLL+      +ADFG    
Sbjct: 186 DKLPEDMARFY--IGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLK 240
Query: 343 LNFDSSNRTLLA-GTSGYIAP 362
           +N D + ++ +A GT  YI+P
Sbjct: 241 MNDDGTVQSSVAVGTPDYISP 261

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 84/192 (43%), Gaps = 18/192 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           EDF +   +G G +G V+ A    + +  A+K L +        +E    E R+LS  W 
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H  +  ++     ++ +F + EY+  G L   +++       D ++       +   L +
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQF 134
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP--- 362
           LH   +  IV+RD+  +N+LL+ +    +ADFG+ +      +      GT  YIAP   
Sbjct: 135 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 363 -------ASEWW 367
                  + +WW
Sbjct: 192 LGQKYNHSVDWW 203

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 91/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 69
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG A+LL 
Sbjct: 127 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG 170

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 91/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 15  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 71
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 72  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 128
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG A+LL 
Sbjct: 129 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG 172

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 144
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 361 AP 362
           +P
Sbjct: 202 SP 203

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 91/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 18  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 74
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG A+LL 
Sbjct: 132 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG 175

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 144
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 361 AP 362
           +P
Sbjct: 202 SP 203

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 147
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 148 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 361 AP 362
           +P
Sbjct: 205 SP 206

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 142
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 361 AP 362
           +P
Sbjct: 200 SP 201

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 91/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 67
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG A+LL 
Sbjct: 125 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLG 168

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 142
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 361 AP 362
           +P
Sbjct: 200 SP 201

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 9/178 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
              VKLY      + ++    Y + G   C+L+   +    D          +  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNG---CLLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYIAP 362
           H      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y++P
Sbjct: 149 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 144
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 361 AP 362
           +P
Sbjct: 202 SP 203

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 144
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 361 AP 362
           +P
Sbjct: 202 SP 203

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 88/185 (47%), Gaps = 21/185 (11%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSG-----KVVALKKLHRSETEELASLESFRNEARL 240
           T+++ +   +G G +  V R  ++P+G     K++  KKL   + ++L        EAR+
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKL------EREARI 56
Query: 241 LSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
              + H NIV+L+         +L+++ +  G LF      E+ V  ++    +    + 
Sbjct: 57  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQ 110
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTS 357
             L  ++H     IVHRD+   N+LL S+ +     +ADFG+A  +  D       AGT 
Sbjct: 111 QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTP 170
Query: 358 GYIAP 362
           GY++P
Sbjct: 171 GYLSP 175

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 17/173 (9%)
Query: 196 IGTGGYGSVYR------ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G GG+   +         + +GK+V    L +    E  S+E       +   + H+++
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME-----ISIHRSLAHQHV 101
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           V  +GF      +F++ E     SL   L   +    L   +    ++ +     YLH +
Sbjct: 102 VGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRD+   N+ LN +LE  + DFG+A  + +D   + +L GT  YIAP
Sbjct: 159 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 208

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 17/173 (9%)
Query: 196 IGTGGYGSVYR------ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G GG+   +         + +GK+V    L +    E  S+E       +   + H+++
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME-----ISIHRSLAHQHV 103
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           V  +GF      +F++ E     SL   L   +    L   +    ++ +     YLH +
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRD+   N+ LN +LE  + DFG+A  + +D   + +L GT  YIAP
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 164 KCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHR 222
           K   +F  W     +  +++    +DF I   IG G +  V   ++  +G+V A+K +++
Sbjct: 37  KYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNK 96
Query: 223 SETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE 282
            +  +   +  FR E  +L     R I +L+        ++L+ EY   G L  +L    
Sbjct: 97  WDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG 156
Query: 283 EAVGLDWAK----RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG 338
           E +  + A+     + +     H L Y         VHRDI  +N+LL+      +ADFG
Sbjct: 157 ERIPAEMARFYLAEIVMAIDSVHRLGY---------VHRDIKPDNILLDRCGHIRLADFG 207
Query: 339 VARLLNFDSSNRTLLA-GTSGYIAP 362
               L  D + R+L+A GT  Y++P
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSP 232

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 126
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 127 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 361 AP 362
           +P
Sbjct: 184 SP 185

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 84/192 (43%), Gaps = 18/192 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           EDF +   +G G +G V+ A    + +  A+K L +        +E    E R+LS  W 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H  +  ++     ++ +F + EY+  G L   +++       D ++       +   L +
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQF 133
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP--- 362
           LH   +  IV+RD+  +N+LL+ +    +ADFG+ +      +      GT  YIAP   
Sbjct: 134 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEIL 190
Query: 363 -------ASEWW 367
                  + +WW
Sbjct: 191 LGQKYNHSVDWW 202

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 141
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 361 AP 362
           +P
Sbjct: 199 SP 200

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 17/173 (9%)
Query: 196 IGTGGYGSVYR------ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G GG+   +         + +GK+V    L +    E  S+E       +   + H+++
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME-----ISIHRSLAHQHV 77
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           V  +GF      +F++ E     SL   L   +    L   +    ++ +     YLH +
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRD+   N+ LN +LE  + DFG+A  + +D   + +L GT  YIAP
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 84/168 (50%), Gaps = 11/168 (6%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G  G+VY A  + +G+ VA+++++    ++    E   NE  ++ +  + NIV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    ++++ EY+  GSL  V+        +D  +   + +    AL +LH +    +
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QV 138
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HR+I S+N+LL  +    + DFG    +  + S R+ + GT  ++AP
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 186

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 49/226 (21%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRARLPSGKVV-ALKKLHRSETEEL--ASLESFRNEAR 239
           ++E  + +H+K  IG G YG V  A     + + A+K +++++  ++    +E  + E R
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 240 LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF-------------CVL-------- 278
           L+ ++ H NI +LY      + + L+ E    G L              C +        
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 279 ---RTDEEAV---------GLDWAKR----VNIVKGMAHALSYLHHHCTPPIVHRDISSN 322
                +EEA+          LD+ +R     NI++ +  AL YLH+     I HRDI   
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPE 197
Query: 323 NVLL--NSELEAFVADFGVA----RLLNFDSSNRTLLAGTSGYIAP 362
           N L   N   E  + DFG++    +L N +    T  AGT  ++AP
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 145
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 361 AP 362
           +P
Sbjct: 203 SP 204

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 92/176 (52%), Gaps = 22/176 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGK----VVALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  +G+G +G+VY+   +P G+     VA+ +L R  T   A+ E   +E
Sbjct: 45  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIMEL-REATSPKANKEIL-DE 101
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 102 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 158
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 349
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL  +   
Sbjct: 159 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 207

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIW 245
           D   +  IG G +G V +AR+    +    A+K++    +++      F  E  +L ++ 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLG 73
Query: 246 HR-NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-------------TDEEAVGLDWAK 291
           H  NI+ L G C HR  ++L  EY   G+L   LR              +  A  L   +
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            ++    +A  + YL        +HRD+++ N+L+     A +ADFG++R
Sbjct: 134 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIW 245
           D   +  IG G +G V +AR+    +    A+K++    +++      F  E  +L ++ 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLG 83
Query: 246 HR-NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-------------TDEEAVGLDWAK 291
           H  NI+ L G C HR  ++L  EY   G+L   LR              +  A  L   +
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            ++    +A  + YL        +HRD+++ N+L+     A +ADFG++R
Sbjct: 144 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 17/173 (9%)
Query: 196 IGTGGYGSVYR------ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G GG+   +         + +GK+V    L +    E  S+E       +   + H+++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME-----ISIHRSLAHQHV 79
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           V  +GF      +F++ E     SL   L   +    L   +    ++ +     YLH +
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRD+   N+ LN +LE  + DFG+A  + +D   +  L GT  YIAP
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  + +G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 18  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 74
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 132 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 175

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 17/173 (9%)
Query: 196 IGTGGYGSVYR------ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G GG+   +         + +GK+V    L +    E  S+E       +   + H+++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME-----ISIHRSLAHQHV 79
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           V  +GF      +F++ E     SL   L   +    L   +    ++ +     YLH +
Sbjct: 80  VGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRD+   N+ LN +LE  + DFG+A  + +D   +  L GT  YIAP
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 28/190 (14%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--H 246
           D  +  C+G G YG V+R     G+ VA+K +  S  E+     S+  E  L + +   H
Sbjct: 9   DITLLECVGKGRYGEVWRGSW-QGENVAVK-IFSSRDEK-----SWFRETELYNTVMLRH 61
Query: 247 RNIVKLYGFCLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
            NI+      +  +     ++LI  Y EMGSL+  L    +   LD    + IV  +A  
Sbjct: 62  ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASG 117
Query: 303 LSYLH-----HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA--- 354
           L++LH         P I HRD+ S N+L+    +  +AD G+A +++  S+N+  +    
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNP 176
Query: 355 --GTSGYIAP 362
             GT  Y+AP
Sbjct: 177 RVGTKRYMAP 186

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  + +G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 11  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 67
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 125 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 22/171 (12%)
Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVV----ALKKLHRSETEELASLESFRNE 237
           +++ TE   IK  + +G +G+VY+   +P G+ V    A+K+L R  T   A+ E   +E
Sbjct: 18  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DE 74
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRV 293
           A +++ + + ++ +L G CL      LI + M  G L   +R  ++ +G    L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            I KGM    +YL       +VHRD+++ NVL+ +     + DFG+A+LL 
Sbjct: 132 QIAKGM----NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 175

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 20/167 (11%)
Query: 196 IGTGGYGSVYRARLP-----SGKVVALKKLH-RSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G V   R       +G+ VA+K L   S    +A L   + E  +L  ++H NI
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL---KKEIEILRNLYHENI 85
Query: 250 VKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR--VNIVKGMAHALSY 305
           VK  G C       + LI E++  GSL   L  ++  + L    +  V I KGM +  S 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
            +       VHRD+++ NVL+ SE +  + DFG+ + +  D    T+
Sbjct: 146 QY-------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 185

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 19/169 (11%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+KY   +G G +GSV   R       +G +VA+K+L  S  ++      F+ E ++
Sbjct: 8   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 64
Query: 241 LSQIWHRNIVKLYG--FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  +    IVK  G  +   R+ + L+ EY+  G L   L+       LD ++ +     
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQ 122
Query: 299 MAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           +   + YL    C    VHRD+++ N+L+ SE    +ADFG+A+LL  D
Sbjct: 123 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLD 167

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 141
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 361 AP 362
           +P
Sbjct: 199 SP 200

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 17/173 (9%)
Query: 196 IGTGGYGSVYR------ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G GG+   +         + +GK+V    L +    E  S+E       +   + H+++
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME-----ISIHRSLAHQHV 83
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
           V  +GF      +F++ E     SL   L   +    L   +    ++ +     YLH +
Sbjct: 84  VGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               ++HRD+   N+ LN +LE  + DFG+A  + +D   +  L GT  YIAP
Sbjct: 141 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 190

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G VY+     + +VVA+K +   E E+       + E  +LSQ     I + +G
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIE--DIQQEITVLSQCDSPYITRYFG 84
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
             L    +++I EY+  GS   +L+       L+      I++ +   L YLH       
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSERK--- 137
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRDI + NVLL+ + +  +ADFGVA  L      R    GT  ++AP
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 185

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 19/169 (11%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+KY   +G G +GSV   R       +G +VA+K+L  S  ++      F+ E ++
Sbjct: 9   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 65
Query: 241 LSQIWHRNIVKLYG--FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  +    IVK  G  +   R+ + L+ EY+  G L   L+       LD ++ +     
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQ 123
Query: 299 MAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           +   + YL    C    VHRD+++ N+L+ SE    +ADFG+A+LL  D
Sbjct: 124 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLD 168

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 19/169 (11%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+KY   +G G +GSV   R       +G +VA+K+L  S  ++      F+ E ++
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 77
Query: 241 LSQIWHRNIVKLYG--FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  +    IVK  G  +   R+ + L+ EY+  G L   L+       LD ++ +     
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQ 135
Query: 299 MAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           +   + YL    C    VHRD+++ N+L+ SE    +ADFG+A+LL  D
Sbjct: 136 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLD 180

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 17/182 (9%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +   AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+ V+       A
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 142
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S  +      GT+ Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 361 AP 362
           +P
Sbjct: 200 SP 201

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 20/167 (11%)
Query: 196 IGTGGYGSVYRARLP-----SGKVVALKKLH-RSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G V   R       +G+ VA+K L   S    +A L   + E  +L  ++H NI
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL---KKEIEILRNLYHENI 73
Query: 250 VKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR--VNIVKGMAHALSY 305
           VK  G C       + LI E++  GSL   L  ++  + L    +  V I KGM +  S 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
            +       VHRD+++ NVL+ SE +  + DFG+ + +  D    T+
Sbjct: 134 QY-------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 173

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 11/179 (6%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   +G G  G V  A    + + VA+K +      +    E+ + E  +   + 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 62
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+VK YG        +L  EY   G LF  +  D   +G+           +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 119
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           LH      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 195 CIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           C+G G YG V+R     G+ VA+K     + +         N   L     H NI+    
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLR----HENILGFIA 69
Query: 255 FCLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH--- 307
             +  +     ++LI  Y EMGSL+  L    +   LD    + IV  +A  L++LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 308 --HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-----GTSGYI 360
                 P I HRD+ S N+L+    +  +AD G+A +++  S+N+  +      GT  Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 361 AP 362
           AP
Sbjct: 185 AP 186

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 21/152 (13%)
Query: 196 IGTGGYGSV----YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           IG G +G V    YR     G  VA+K +        A+ ++F  EA +++Q+ H N+V+
Sbjct: 14  IGKGEFGDVMLGDYR-----GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQ 63
Query: 252 LYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAV-GLDWAKRVNIVKGMAHALSYLHHH 309
           L G  +  K  ++++ EYM  GSL   LR+   +V G D   + ++   +  A+ YL  +
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGN 121
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                VHRD+++ NVL++ +  A V+DFG+ +
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 80/148 (54%), Gaps = 13/148 (8%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG G +G V       G  VA+K +        A+ ++F  EA +++Q+ H N+V+L G 
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 256 CLHRKC-MFLIYEYMEMGSLFCVLRTDEEAV-GLDWAKRVNIVKGMAHALSYLHHHCTPP 313
            +  K  ++++ EYM  GSL   LR+   +V G D   + ++   +  A+ YL  +    
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGN---N 309
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVAR 341
            VHRD+++ NVL++ +  A V+DFG+ +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 21/152 (13%)
Query: 196 IGTGGYGSV----YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           IG G +G V    YR     G  VA+K +        A+ ++F  EA +++Q+ H N+V+
Sbjct: 29  IGKGEFGDVMLGDYR-----GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQ 78
Query: 252 LYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAV-GLDWAKRVNIVKGMAHALSYLHHH 309
           L G  +  K  ++++ EYM  GSL   LR+   +V G D   + ++   +  A+ YL  +
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGN 136
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                VHRD+++ NVL++ +  A V+DFG+ +
Sbjct: 137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 80/148 (54%), Gaps = 13/148 (8%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG G +G V       G  VA+K +        A+ ++F  EA +++Q+ H N+V+L G 
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 256 CLHRKC-MFLIYEYMEMGSLFCVLRTDEEAV-GLDWAKRVNIVKGMAHALSYLHHHCTPP 313
            +  K  ++++ EYM  GSL   LR+   +V G D   + ++   +  A+ YL  +    
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGN---N 128
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVAR 341
            VHRD+++ NVL++ +  A V+DFG+ +
Sbjct: 129 FVHRDLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 30/181 (16%)
Query: 199 GGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLS--QIWHRNIVKLYGFC 256
           G +G V++A+L + + VA+K         +   +S++NE  + S   + H NI++  G  
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIF------PIQDKQSWQNEYEVYSLPGMKHENILQFIGAE 87
Query: 257 LHRKC----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC-- 310
                    ++LI  + E GSL   L+ +     + W +  +I + MA  L+YLH     
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPG 143
Query: 311 -----TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT----LLAGTSGYIA 361
                 P I HRDI S NVLL + L A +ADFG+A  L F++           GT  Y+A
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA--LKFEAGKSAGDTHGQVGTRRYMA 201
Query: 362 P 362
           P
Sbjct: 202 P 202

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 96/191 (50%), Gaps = 21/191 (10%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           + DF +K  +G G YG V  A   P+G++VA+KK+   + + L +L + R E ++L    
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLR-EIKILKHFK 67
Query: 246 HRNIVKLYGFCLHRKCMF-------LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           H NI+ +  F + R   F       +I E M+   L  V+ T  + +  D  +    +  
Sbjct: 68  HENIITI--FNIQRPDSFENFNEVYIIQELMQT-DLHRVIST--QMLSDDHIQY--FIYQ 120
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG-TS 357
              A+  LH      ++HRD+  +N+L+NS  +  V DFG+AR+++  +++ +   G  S
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 358 GYIAPASEWWH 368
           G +   +  W+
Sbjct: 178 GMVEFVATRWY 188

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 28/184 (15%)
Query: 195 CIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--HRNIVKL 252
           C+G G YG V+R     G+ VA+K +  S  E+     S+  E  L + +   H NI+  
Sbjct: 44  CVGKGRYGEVWRGSW-QGENVAVK-IFSSRDEK-----SWFRETELYNTVMLRHENILGF 96
Query: 253 YGFCLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH- 307
               +  +     ++LI  Y EMGSL+  L    +   LD    + IV  +A  L++LH 
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHI 152
Query: 308 ----HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-----GTSG 358
                   P I HRD+ S N+L+    +  +AD G+A +++  S+N+  +      GT  
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKR 211
Query: 359 YIAP 362
           Y+AP
Sbjct: 212 YMAP 215

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 16/173 (9%)
Query: 196 IGTGGYG-SVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G ++       G+   +K+++ S        ES R E  +L+ + H NIV+   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-RREVAVLANMKHPNIVQYRE 90
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                  ++++ +Y E G LF  +        +E   LDW  ++ +      AL ++H  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL------ALKHVHDR 144
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               I+HRDI S N+ L  +    + DFG+AR+LN          GT  Y++P
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G   +G VY+  L         + VA+K L   +  E    E FR+EA L +++ H N+
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSL--FCVLRTDEEAVG-----------LDWAKRVNIV 296
           V L G     + + +I+ Y   G L  F V+R+    VG           L+    V++V
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +A  + YL  H    +VH+D+++ NVL+  +L   ++D G+ R
Sbjct: 152 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR 193

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 22/193 (11%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKVV-ALKKLHRS---ETEELASLESFRNEARLLSQI 244
           DFH    IG G +G V  AR  + +V  A+K L +    + +E   + S RN   LL  +
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN--VLLKNV 96
Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            H  +V L+        ++ + +Y+  G LF  L+   E   L+   R    + +A AL 
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ--RERCFLEPRARFYAAE-IASALG 153
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP-- 362
           YLH   +  IV+RD+   N+LL+S+    + DFG+ +     +S  +   GT  Y+AP  
Sbjct: 154 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 363 --------ASEWW 367
                     +WW
Sbjct: 211 LHKQPYDRTVDWW 223

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 33/196 (16%)
Query: 189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     +G G +G V +AR     +  A+KK+  +E E+L+++ S   E  LL+ + H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILS---EVMLLASLNHQ 62
Query: 248 NIVKLYGFCLHRK-------------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 294
            +V+ Y   L R+              +F+  EY E  +L+ ++ ++      D   R  
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR-- 120
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR-------LLNFDS 347
           + + +  ALSY+H   +  I+HRD+   N+ ++      + DFG+A+       +L  DS
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 348 SNRTLLAGTSGYIAPA 363
            N   L G+S  +  A
Sbjct: 178 QN---LPGSSDNLTSA 190

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 21/191 (10%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           + DF +K  +G G YG V  A   P+G++VA+KK+   + + L +L + R E ++L    
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLR-EIKILKHFK 67
Query: 246 HRNIVKLYGFCLHRKCMF-------LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           H NI+ +  F + R   F       +I E M+   L  V+ T  + +  D  +    +  
Sbjct: 68  HENIITI--FNIQRPDSFENFNEVYIIQELMQT-DLHRVIST--QMLSDDHIQY--FIYQ 120
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG-TS 357
              A+  LH      ++HRD+  +N+L+NS  +  V DFG+AR+++  +++ +   G  S
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 358 GYIAPASEWWH 368
           G     +  W+
Sbjct: 178 GMTEXVATRWY 188

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 82/181 (45%), Gaps = 15/181 (8%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF I   IG G +G V   +L +  KV A+K L++ E  + A    FR E  +L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK----RVNIVKGMAHA 302
           + I  L+        ++L+ +Y   G L  +L   E+ +  + A+     + I     H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA-RLLNFDSSNRTLLAGTSGYIA 361
           L Y         VHRDI  +N+L++      +ADFG   +L+   +   ++  GT  YI+
Sbjct: 194 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 362 P 362
           P
Sbjct: 245 P 245

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 16/179 (8%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    SG+ VA+KKL R    E+ +  ++R E  LL  + H N++ L  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 108
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWA--KRVNIVKGMAHALSYLHHHCT 311
                  +   Y++     +   ++TD ++ +G++++  K   +V  M   L Y+H   +
Sbjct: 109 VFTPASSLRNFYDFY---LVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---S 162
Query: 312 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS--EWWH 368
             +VHRD+   N+ +N + E  + DFG+AR  + + +   +   T  Y AP     W H
Sbjct: 163 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---TRWYRAPEVILSWMH 218

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 19/169 (11%)
Query: 188 EDFHIKYC--IGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARL 240
           E+ H+KY   +G G +GSV   R       +G +VA+K+L  S  ++      F+ E ++
Sbjct: 5   EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQI 61
Query: 241 LSQIWHRNIVKLYG--FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           L  +    IVK  G  +   R  + L+ EY+  G L   L+       LD ++ +     
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQ--RHRARLDASRLLLYSSQ 119
Query: 299 MAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           +   + YL    C    VHRD+++ N+L+ SE    +ADFG+A+LL  D
Sbjct: 120 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLD 164

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 7/168 (4%)
Query: 196 IGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G GG+   Y    + + +V A K + +S   +    E    E  +   + + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
           F      ++++ E     SL   L    +AV    A+    ++     + YLH++    +
Sbjct: 110 FFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN---RV 163
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRD+   N+ LN +++  + DFG+A  + FD   +  L GT  YIAP
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAP 211

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G   +G VY+  L         + VA+K L   +  E    E FR+EA L +++ H N+
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSL--FCVLRTDEEAVG-----------LDWAKRVNIV 296
           V L G     + + +I+ Y   G L  F V+R+    VG           L+    V++V
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +A  + YL  H    +VH+D+++ NVL+  +L   ++D G+ R
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 193 KYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +  +G G YG VY  R  S +V +A+K++   ++     L     E  L   + H+NIV+
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL---HEEIALHKHLKHKNIVQ 83
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAKRVNIVKGMAHALS 304
             G       + +  E +  GSL  +LR+       +E+ +G          K +   L 
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-------YTKQILEGLK 136
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           YLH +    IVHRDI  +NVL+N+      ++DFG ++ L   +       GT  Y+AP
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 98/193 (50%), Gaps = 26/193 (13%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           + DF +K  +G G YG V  A   P+G++VA+KK+   + + L +L + R E ++L    
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLR-EIKILKHFK 67
Query: 246 HRNIVKLYGFCLHRKCMF-------LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           H NI+ +  F + R   F       +I E M+   L  V+ T  + +  D  +    +  
Sbjct: 68  HENIITI--FNIQRPDSFENFNEVYIIQELMQT-DLHRVIST--QMLSDDHIQY--FIYQ 120
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT----LLA 354
              A+  LH      ++HRD+  +N+L+NS  +  V DFG+AR+++  +++ +      +
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 355 GTSGYIAPASEWW 367
           G + Y+  A+ W+
Sbjct: 178 GMTEYV--ATRWY 188

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            IGTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EYM  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    VADFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 7/168 (4%)
Query: 196 IGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G GG+   Y    + + +V A K + +S   +    E    E  +   + + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
           F      ++++ E     SL   L    +AV    A+    ++     + YLH++    +
Sbjct: 110 FFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN---RV 163
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRD+   N+ LN +++  + DFG+A  + FD   +  L GT  YIAP
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAP 211

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            IGTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EYM  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    VADFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 11/150 (7%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    SG+ VA+KKL R    E+ +  ++R E  LL  + H N++ L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 90
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWA--KRVNIVKGMAHALSYLHHHCT 311
                  +   Y++     +   ++TD ++ +GL ++  K   +V  M   L Y+H   +
Sbjct: 91  VFTPASSLRNFYDFY---LVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIH---S 144
Query: 312 PPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +VHRD+   N+ +N + E  + DFG+AR
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLAR 174

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 21/185 (11%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSG-----KVVALKKLHRSETEELASLESFRNEARL 240
           T+++ +   IG G +  V R  +L +G     K++  KKL   + ++L        EAR+
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKL------EREARI 56
Query: 241 LSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
              + H NIV+L+         +L+++ +  G LF      E+ V  ++    +    + 
Sbjct: 57  CRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQ 110
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTS 357
             L  + H     +VHRD+   N+LL S+ +     +ADFG+A  +  D       AGT 
Sbjct: 111 QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTP 170
Query: 358 GYIAP 362
           GY++P
Sbjct: 171 GYLSP 175

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 3/175 (1%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           +F I+  IG G +  VYRA  L  G  VALKK+   +  +  +      E  LL Q+ H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           N++K Y   +    + ++ E  + G L  +++  ++   L       + K      S L 
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--IPERTVWKYFVQLCSALE 150
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H  +  ++HRDI   NV + +     + D G+ R  +  ++    L GT  Y++P
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 193 KYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +  +G G YG VY  R  S +V +A+K++   ++     L     E  L   + H+NIV+
Sbjct: 13  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL---HEEIALHKHLKHKNIVQ 69
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAKRVNIVKGMAHALS 304
             G       + +  E +  GSL  +LR+       +E+ +G          K +   L 
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-------YTKQILEGLK 122
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           YLH +    IVHRDI  +NVL+N+      ++DFG ++ L   +       GT  Y+AP
Sbjct: 123 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 178

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIW 245
           D   +  IG G +G V +AR+    +    A+K++    +++      F  E  +L ++ 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLG 80
Query: 246 HR-NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-------------TDEEAVGLDWAK 291
           H  NI+ L G C HR  ++L  EY   G+L   LR              +  A  L   +
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            ++    +A  + YL        +HR++++ N+L+     A +ADFG++R
Sbjct: 141 LLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQ 243
           +D  +   +G G +G V R     PSGK V  A+K L      +  +++ F  E   +  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           + HRN+++LYG  L    M ++ E   +GSL   LR  +    L    R  +   +A  +
Sbjct: 72  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 128
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
            YL    +   +HRD+++ N+LL +     + DFG+ R L
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 89
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 145
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  S          VHRD+++ N +L+ +    VADFG+AR
Sbjct: 146 KYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 30/198 (15%)
Query: 180 FQDMIEAT---EDFHIKYCIGTGGYGSVYRA--RLPS----GKVVALKKLHRSETEELAS 230
           FQ M   T   +D+ +   +G G +  V R   + P+     K++  KKL   + ++L  
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKL-- 77
Query: 231 LESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDW- 289
                 EAR+   + H NIV+L+         +L+++ +  G LF      E+ V  ++ 
Sbjct: 78  ----EREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYY 127
Query: 290 --AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLN 344
             A   + +  +  +++++H H    IVHRD+   N+LL S+ +     +ADFG+A  + 
Sbjct: 128 SEADASHCIHQILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ 184
Query: 345 FDSSNRTLLAGTSGYIAP 362
            +       AGT GY++P
Sbjct: 185 GEQQAWFGFAGTPGYLSP 202

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQ 243
           +D  +   +G G +G V R     PSGK V  A+K L      +  +++ F  E   +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           + HRN+++LYG  L    M ++ E   +GSL   LR  +    L    R  +   +A  +
Sbjct: 78  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 134
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
            YL    +   +HRD+++ N+LL +     + DFG+ R L
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 109
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 165
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  S          VHRD+++ N +L+ +    VADFG+AR
Sbjct: 166 KYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 108
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 164
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  S          VHRD+++ N +L+ +    VADFG+AR
Sbjct: 165 KYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 37/201 (18%)
Query: 189 DFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     +G G +G V +AR     +  A+KK+  +E E+L+++ S   E  LL+ + H+
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILS---EVXLLASLNHQ 62
Query: 248 NIVKLYGFCLHRK-------------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 294
            +V+ Y   L R+              +F+  EY E  +L+ ++ ++      D   R  
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR-- 120
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR-------LLNFDS 347
           + + +  ALSY+H   +  I+HR++   N+ ++      + DFG+A+       +L  DS
Sbjct: 121 LFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 348 S-------NRTLLAGTSGYIA 361
                   N T   GT+ Y+A
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVA 198

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQ 243
           +D  +   +G G +G V R     PSGK V  A+K L      +  +++ F  E   +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           + HRN+++LYG  L    M ++ E   +GSL   LR  +    L    R  +   +A  +
Sbjct: 68  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
            YL    +   +HRD+++ N+LL +     + DFG+ R L
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQ 243
           +D  +   +G G +G V R     PSGK V  A+K L      +  +++ F  E   +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           + HRN+++LYG  L    M ++ E   +GSL   LR  +    L    R  +   +A  +
Sbjct: 68  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
            YL    +   +HRD+++ N+LL +     + DFG+ R L
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 90
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 146
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  S          VHRD+++ N +L+ +    VADFG+AR
Sbjct: 147 KYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQ 243
           +D  +   +G G +G V R     PSGK V  A+K L      +  +++ F  E   +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           + HRN+++LYG  L    M ++ E   +GSL   LR  +    L    R  +   +A  +
Sbjct: 78  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 134
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
            YL    +   +HRD+++ N+LL +     + DFG+ R L
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 90
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 146
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  S          VHRD+++ N +L+ +    VADFG+AR
Sbjct: 147 KYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 88
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 144
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  S          VHRD+++ N +L+ +    VADFG+AR
Sbjct: 145 KYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQ 243
           +D  +   +G G +G V R     PSGK V  A+K L      +  +++ F  E   +  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           + HRN+++LYG  L    M ++ E   +GSL   LR  +    L    R  +   +A  +
Sbjct: 72  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 128
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
            YL    +   +HRD+++ N+LL +     + DFG+ R L
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 87
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 143
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  S          VHRD+++ N +L+ +    VADFG+AR
Sbjct: 144 KYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S++ H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKLNHQ 108
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG+V++A+   + ++VALK++   + +E     + R E  LL ++ H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 255 FCLHRKCMFLIYEY--MEMGSLF--CVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                K + L++E+   ++   F  C    D E V        + +  +   L + H   
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-------SFLFQLLKGLGFCHSR- 120
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
              ++HRD+   N+L+N   E  +ADFG+AR
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 82
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 138
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  S          VHRD+++ N +L+ +    VADFG+AR
Sbjct: 139 KYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 89
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 145
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  S          VHRD+++ N +L+ +    VADFG+AR
Sbjct: 146 KYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 85
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 141
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  S          VHRD+++ N +L+ +    VADFG+AR
Sbjct: 142 KYLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 7/168 (4%)
Query: 196 IGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G GG+   Y    + + +V A K + +S   +    E    E  +   + + ++V  +G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
           F      ++++ E     SL   L    +AV    A+    ++     + YLH++    +
Sbjct: 110 FFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN---RV 163
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRD+   N+ LN +++  + DFG+A  + FD   +  L GT  YIAP
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 211

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 7/168 (4%)
Query: 196 IGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G GG+   Y    + + +V A K + +S   +    E    E  +   + + ++V  +G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
           F      ++++ E     SL   L    +AV    A+    ++     + YLH++    +
Sbjct: 94  FFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN---RV 147
Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRD+   N+ LN +++  + DFG+A  + FD   +  L GT  YIAP
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 195

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQ 243
           +D  +   +G G +G V R     PSGK V  A+K L      +  +++ F  E   +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           + HRN+++LYG  L    M ++ E   +GSL   LR  +    L    R  +   +A  +
Sbjct: 68  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
            YL    +   +HRD+++ N+LL +     + DFG+ R L
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ++++ +K  +G G +  V R    +  +    K+  ++       +    EAR+  ++ H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDW---AKRVNIVKGMAHAL 303
            NIV+L+         +L+++ +  G LF      E+ V  ++   A   + ++ +  ++
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESI 141
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTSGYI 360
           +Y H +    IVHR++   N+LL S+ +     +ADFG+A  +N DS      AGT GY+
Sbjct: 142 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYL 197
Query: 361 AP 362
           +P
Sbjct: 198 SP 199

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S++ H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKLNHQ 94
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 155 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 29/196 (14%)
Query: 190 FHIKYCIGTGGYGSV-YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           F I   IG G +G V    +  + K+ A+K +++ +  E   + +   E +++  + H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAHALS 304
           +V L+      + MF++ + +  G L   L+ +    EE V L        +  +  AL 
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-------FICELVMALD 129
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP-- 362
           YL +     I+HRD+  +N+LL+      + DF +A +L  ++   T +AGT  Y+AP  
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAPEM 185
Query: 363 -----------ASEWW 367
                      A +WW
Sbjct: 186 FSSRKGAGYSFAVDWW 201

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 149
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 205
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL---NFDS 347
               S          VHRD+++ N +L+ +    VADFG+AR +    FDS
Sbjct: 206 KFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 22/156 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YG+V  A    +G  VA+KKL+R    EL +  ++R E RLL  + H N++ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLD 91
Query: 255 FCLHRKCM------FLIYEYM--EMGSLFCVLRTDEEAVGLDWAKRVN-IVKGMAHALSY 305
                + +      +L+  +M  ++G L        E +G D   R+  +V  M   L Y
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGED---RIQFLVYQMLKGLRY 143
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +H      I+HRD+   N+ +N + E  + DFG+AR
Sbjct: 144 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ++++ +K  +G G +  V R    +  +    K+  ++       +    EAR+  ++ H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDW---AKRVNIVKGMAHAL 303
            NIV+L+         +L+++ +  G LF      E+ V  ++   A   + ++ +  ++
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESI 118
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTSGYI 360
           +Y H +    IVHR++   N+LL S+ +     +ADFG+A  +N DS      AGT GY+
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYL 174
Query: 361 AP 362
           +P
Sbjct: 175 SP 176

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ++++ +K  +G G +  V R    +  +    K+  ++       +    EAR+  ++ H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDW---AKRVNIVKGMAHAL 303
            NIV+L+         +L+++ +  G LF      E+ V  ++   A   + ++ +  ++
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESI 118
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTSGYI 360
           +Y H   +  IVHR++   N+LL S+ +     +ADFG+A  +N DS      AGT GY+
Sbjct: 119 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYL 174
Query: 361 AP 362
           +P
Sbjct: 175 SP 176

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ++++ +K  +G G +  V R    +  +    K+  ++       +    EAR+  ++ H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDW---AKRVNIVKGMAHAL 303
            NIV+L+         +L+++ +  G LF      E+ V  ++   A   + ++ +  ++
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELF------EDIVAREFYSEADASHCIQQILESI 117
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTSGYI 360
           +Y H   +  IVHR++   N+LL S+ +     +ADFG+A  +N DS      AGT GY+
Sbjct: 118 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYL 173
Query: 361 AP 362
           +P
Sbjct: 174 SP 175

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFNHQ 134
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 195 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 91
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 147
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL---NFDS 347
               S          VHRD+++ N +L+ +    VADFG+AR +    FDS
Sbjct: 148 KFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 191

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 95
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 151
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL---NFDS 347
               S          VHRD+++ N +L+ +    VADFG+AR +    FDS
Sbjct: 152 KFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 195

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFNHQ 108
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 88
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 144
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL---NFDS 347
               S          VHRD+++ N +L+ +    VADFG+AR +    FDS
Sbjct: 145 KFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 188

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFNHQ 100
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 101 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 160
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 161 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 91
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 147
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL---NFDS 347
               S          VHRD+++ N +L+ +    VADFG+AR +    FDS
Sbjct: 148 KFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDS 191

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 28/176 (15%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 90
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 146
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL---NFDS-SNRT 351
               S          VHRD+++ N +L+ +    VADFG+AR +    FDS  N+T
Sbjct: 147 KFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 191 HIKYCIGTGGYGSVYRARL--PSGKVV--ALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L    GK +  A+K L+R    ++  +  F  E  ++    H
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSH 90
Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLR------TDEEAVGLDWAKRVNIVKGM 299
            N++ L G CL  +    ++  YM+ G L   +R      T ++ +G      + + KGM
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG----LQVAKGM 146
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL---NFDS 347
               S          VHRD+++ N +L+ +    VADFG+AR +    FDS
Sbjct: 147 KFLAS-------KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 190

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFNHQ 111
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 112 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 171
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 172 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFNHQ 93
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 11/178 (6%)
Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           F  K  +G+G +G V+      SG    +K +++  ++    +E    E  +L  + H N
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPN 81
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           I+K++        M+++ E  E G L   ++        L       ++K M +AL+Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 308 HHCTPPIVHRDISSNNVLLNS---ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
              +  +VH+D+   N+L           + DFG+A L   D  + T  AGT+ Y+AP
Sbjct: 142 ---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAP 195

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDEL----DFLMEALIISKFNHQ 108
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 169 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFNHQ 110
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 111 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 170
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 171 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFNHQ 93
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 87/167 (52%), Gaps = 22/167 (13%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++AR   +G+ VALKK+     +E   + + R E ++L  + H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 84
Query: 255 FCL-----HRKC---MFLIYEYME---MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
            C      + +C   ++L++++ E    G L  VL      V    ++   +++ + + L
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGL 138
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
            Y+H +    I+HRD+ + NVL+  +    +ADFG+AR  +   +++
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFNHQ 94
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 155 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 89/177 (50%), Gaps = 23/177 (12%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ--IWHRNI--- 249
           +G G YG V + R +PSG+++A+K++        A++ S + + RLL    I  R +   
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIR-------ATVNS-QEQKRLLMDLDISMRTVDCP 110
Query: 250 --VKLYGFCLHRKCMFLIYEYME--MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
             V  YG       +++  E M+  +   +  +    + +  D   ++ +   +  AL +
Sbjct: 111 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEH 168
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH   +  ++HRD+  +NVL+N+  +  + DFG++  L  DS  +T+ AG   Y+AP
Sbjct: 169 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL-VDSVAKTIDAGCKPYMAP 222

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFNHQ 85
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 86  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 145
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 146 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 21/153 (13%)
Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G Y +VY+ +   +  +VALK++ R E EE A   + R E  LL  + H NIV L+ 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 67
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI--VK----GMAHALSYLHH 308
                K + L++EY++          D +    D    +N+  VK     +   L+Y H 
Sbjct: 68  IIHTEKSLTLVFEYLD---------KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                ++HRD+   N+L+N   E  +ADFG+AR
Sbjct: 119 Q---KVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 150 RDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARL 209
           R   V  +ET +  +  DE   +       ++   E  E   +  CIG G +G V++   
Sbjct: 355 RSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIE---LGRCIGEGQFGDVHQGIY 411
Query: 210 PS----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI 265
            S       VA+K      ++ +   E F  EA  + Q  H +IVKL G  +    +++I
Sbjct: 412 MSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKLIG-VITENPVWII 468
Query: 266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVL 325
            E   +G L   L+       LD A  +     ++ AL+YL    +   VHRDI++ NVL
Sbjct: 469 MELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 523
Query: 326 LNSELEAFVADFGVARLL 343
           ++S     + DFG++R +
Sbjct: 524 VSSNDCVKLGDFGLSRYM 541

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFNHQ 120
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 121 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+AR
Sbjct: 181 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 86/164 (52%), Gaps = 16/164 (9%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++AR   +G+ VALKK+     +E   + + R E ++L  + H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 84
Query: 255 FCL-----HRKC---MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            C      + +C   ++L++++ E   L  +L        L   KRV  ++ + + L Y+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 141
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
           H +    I+HRD+ + NVL+  +    +ADFG+AR  +   +++
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 9/152 (5%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   I   IG G +G VY  R      + L  + R   ++L   ++F+ E     Q  H 
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQL---KAFKREVMAYRQTRHE 89
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           N+V   G C+    + +I    +  +L+ V+R  +  + LD  K   I + +   + YLH
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGV 339
                 I+H+D+ S NV  ++  +  + DFG+
Sbjct: 148 ---AKGILHKDLKSKNVFYDNG-KVVITDFGL 175

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 86/164 (52%), Gaps = 16/164 (9%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++AR   +G+ VALKK+     +E   + + R E ++L  + H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 84
Query: 255 FCL-----HRKC---MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            C      + +C   ++L++++ E   L  +L        L   KRV  ++ + + L Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 141
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
           H +    I+HRD+ + NVL+  +    +ADFG+AR  +   +++
Sbjct: 142 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 182

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 86/164 (52%), Gaps = 16/164 (9%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G V++AR   +G+ VALKK+     +E   + + R E ++L  + H N+V L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 83
Query: 255 FCL-----HRKC---MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            C      + +C   ++L++++ E   L  +L        L   KRV  ++ + + L Y+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRV--MQMLLNGLYYI 140
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
           H +    I+HRD+ + NVL+  +    +ADFG+AR  +   +++
Sbjct: 141 HRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 87/178 (48%), Gaps = 6/178 (3%)
Query: 188 EDFHIKY-CIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           ED+ + +  +G GG+G V+  ++  +GK+ A KKL++   ++    +    E ++L+++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            R IV L      +  + L+   M  G + + +   DE+  G    + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +LH      I++RD+   NVLL+ +    ++D G+A  L    +     AGT G++AP
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 86/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            IGTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    VADFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TEE   L    +E  ++  I  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEE--DLSDLVSEMEMMKMIGKH 100
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I EY   G+L   LR      G++++  +N V          
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 298 -----GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    +   +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 87/178 (48%), Gaps = 6/178 (3%)
Query: 188 EDFHIKY-CIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           ED+ + +  +G GG+G V+  ++  +GK+ A KKL++   ++    +    E ++L+++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            R IV L      +  + L+   M  G + + +   DE+  G    + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +LH      I++RD+   NVLL+ +    ++D G+A  L    +     AGT G++AP
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 15/183 (8%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E   +  CIG G +G V++    S       VA+K      ++ +   E F  EA  + Q
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 67
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H +IVKL G  +    +++I E   +G L   L+  +    LD A  +     ++ AL
Sbjct: 68  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTAL 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGT--SGYIA 361
           +YL    +   VHRDI++ NVL++S     + DFG++R +  DS+      G     ++A
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMA 180
Query: 362 PAS 364
           P S
Sbjct: 181 PES 183

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 87/178 (48%), Gaps = 6/178 (3%)
Query: 188 EDFHIKY-CIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           ED+ + +  +G GG+G V+  ++  +GK+ A KKL++   ++    +    E ++L+++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            R IV L      +  + L+   M  G + + +   DE+  G    + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +LH      I++RD+   NVLL+ +    ++D G+A  L    +     AGT G++AP
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 19/172 (11%)
Query: 183 MIEATEDFHIKY-------CIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASL 231
           M  +T D+ I+        CIG G +G V++    S +     VA+K      ++ +   
Sbjct: 26  MGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-- 83
Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK 291
           E F  EA  + Q  H +IVKL G  +    +++I E   +G L   L+  + +  LD A 
Sbjct: 84  EKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS--LDLAS 140
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
            +     ++ AL+YL    +   VHRDI++ NVL++S     + DFG++R +
Sbjct: 141 LILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 189

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 19/172 (11%)
Query: 183 MIEATEDFHIKY-------CIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASL 231
           M  +T D+ I+        CIG G +G V++    S +     VA+K      ++ +   
Sbjct: 3   MGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-- 60
Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK 291
           E F  EA  + Q  H +IVKL G  +    +++I E   +G L   L+  + +  LD A 
Sbjct: 61  EKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS--LDLAS 117
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
            +     ++ AL+YL    +   VHRDI++ NVL++S     + DFG++R +
Sbjct: 118 LILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 87/178 (48%), Gaps = 6/178 (3%)
Query: 188 EDFHIKY-CIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           ED+ + +  +G GG+G V+  ++  +GK+ A KKL++   ++    +    E ++L+++ 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
            R IV L      +  + L+   M  G + + +   DE+  G    + +     +   L 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +LH      I++RD+   NVLL+ +    ++D G+A  L    +     AGT G++AP
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 18/194 (9%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
             ++F     +G G +G V  AR+  +G + A+K L +    +   +E    E R+LS  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 245 W-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H  + +L+        +F + E++  G L   ++        D A+       +  AL
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISAL 137
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA-- 361
            +LH      I++RD+  +NVLL+ E    +ADFG+ +    +        GT  YIA  
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 362 --------PASEWW 367
                   PA +WW
Sbjct: 195 ILQEMLYGPAVDWW 208

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 196 IGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G +G V+R     +G+V   K ++   T       + +NE  +++Q+ H  ++ L+ 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFIN---TPYPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
               +  M LI E++  G LF   R   E   +  A+ +N ++     L ++H H    I
Sbjct: 116 AFEDKYEMVLILEFLSGGELFD--RIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 315 VHRDISSNNVLLNSELEAFVA--DFGVARLLNFDSSNRTLLAGTSGYIAP 362
           VH DI   N++  ++  + V   DFG+A  LN D   +   A T+ + AP
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-TAEFAAP 219

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V++ +  PSG V+A K +H      L    + RN+     Q+ H
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 121
Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  E+ +G      + ++KG
Sbjct: 122 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG 178
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
               L+YL       I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT  
Sbjct: 179 ----LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRS 230
Query: 359 YIAP 362
           Y++P
Sbjct: 231 YMSP 234

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG+V++A+   + ++VALK++   + +E     + R E  LL ++ H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 255 FCLHRKCMFLIYEY--MEMGSLF--CVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                K + L++E+   ++   F  C    D E V        + +  +   L + H   
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-------SFLFQLLKGLGFCHSR- 120
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
              ++HRD+   N+L+N   E  +A+FG+AR
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E   +  CIG G +G V++    S       VA+K      ++ +   E F  EA  + Q
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 67
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H +IVKL G  +    +++I E   +G L   L+  + +  LD A  +     ++ AL
Sbjct: 68  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTAL 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           +YL    +   VHRDI++ NVL++S     + DFG++R +
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 161

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 15/174 (8%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVYRARLPS--GKVVALK-KLHRSETEELASLESFRN 236
            +D++   + F +   +G G +GSV  A+L    G  V +  K+ +++    + +E F  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 237 EARLLSQIWHRNIVKLYGFCLHRKCM------FLIYEYMEMGSLFCVL---RTDEEAVGL 287
           EA  + +  H ++ KL G  L  +         +I  +M+ G L   L   R  E    L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 288 DWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                V  +  +A  + YL        +HRD+++ N +L  ++   VADFG++R
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 150 RDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARL 209
           R   V  +ET +  +  DE   +       ++   E  E   +  CIG G +G V++   
Sbjct: 355 RSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIE---LGRCIGEGQFGDVHQGIY 411
Query: 210 PS----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI 265
            S       VA+K      ++ +   E F  EA  + Q  H +IVKL G  +    +++I
Sbjct: 412 MSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKLIG-VITENPVWII 468
Query: 266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVL 325
            E   +G L   L+       LD A  +     ++ AL+YL    +   VHRDI++ NVL
Sbjct: 469 MELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 523
Query: 326 LNSELEAFVADFGVARLL 343
           +++     + DFG++R +
Sbjct: 524 VSATDCVKLGDFGLSRYM 541

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFRNEARLLSQ 243
           E   +  CIG G +G V++    S +     VA+K      ++ +   E F  EA  + Q
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 69
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H +IVKL G  +    +++I E   +G L   L+  +    LD A  +     ++ AL
Sbjct: 70  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTAL 126
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           +YL    +   VHRDI++ NVL++S     + DFG++R +
Sbjct: 127 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 163

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFRNEARLLSQ 243
           E   +  CIG G +G V++    S +     VA+K      ++ +   E F  EA  + Q
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 70
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H +IVKL G  +    +++I E   +G L   L+  + +  LD A  +     ++ AL
Sbjct: 71  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTAL 127
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           +YL    +   VHRDI++ NVL++S     + DFG++R +
Sbjct: 128 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 164

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFRNEARLLSQ 243
           E   +  CIG G +G V++    S +     VA+K      ++ +   E F  EA  + Q
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 67
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H +IVKL G  +    +++I E   +G L   L+  + +  LD A  +     ++ AL
Sbjct: 68  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTAL 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           +YL    +   VHRDI++ NVL++S     + DFG++R +
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 161

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 22/161 (13%)
Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHR--SETEELASLESFRNEARLLSQIWHR 247
           +G G +G VY  ++      PS   VA+K L    SE +EL     F  EA ++S+  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLMEALIISKFNHQ 94
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHAL 303
           NIV+  G  L     F++ E M  G L   LR       +   L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVA---DFGVAR 341
            YL  +     +HRDI++ N LL       VA   DFG+A+
Sbjct: 155 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 88/174 (50%), Gaps = 21/174 (12%)
Query: 196 IGTGGYGSVY--RARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G+G +  V+  + RL +GK+ ALK + +S     +SLE   NE  +L +I H NIV L 
Sbjct: 17  LGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
                    +L+ + +  G LF   R  E  V  +    + +++ +  A+ YLH +    
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFD--RILERGVYTEKDASL-VIQQVLSAVKYLHEN---G 126
Query: 314 IVHRDISSNNVLL-----NSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           IVHRD+   N+L      NS++   + DFG++++    +   +   GT GY+AP
Sbjct: 127 IVHRDLKPENLLYLTPEENSKI--MITDFGLSKMEQ--NGIMSTACGTPGYVAP 176

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFRNEARLLSQ 243
           E   +  CIG G +G V++    S +     VA+K      ++ +   E F  EA  + Q
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 64
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H +IVKL G  +    +++I E   +G L   L+  +    LD A  +     ++ AL
Sbjct: 65  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTAL 121
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           +YL    +   VHRDI++ NVL++S     + DFG++R +
Sbjct: 122 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 87/194 (44%), Gaps = 27/194 (13%)
Query: 178 ITFQDMIEATEDFHIKYCIGTGGYGSVYR------ARLPSGKVVALKKLHRSETEELASL 231
           + FQ M +  E+      +G G +  V R       +  + K++  KKL   + ++L   
Sbjct: 18  LYFQSMYQLFEE------LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL--- 68
Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK 291
                EAR+   + H NIV+L+         +LI++ +  G LF      E+ V  ++  
Sbjct: 69  ---EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYS 119
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSS 348
             +    +   L  + H     +VHRD+   N+LL S+L+     +ADFG+A  +  +  
Sbjct: 120 EADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 179
Query: 349 NRTLLAGTSGYIAP 362
                AGT GY++P
Sbjct: 180 AWFGFAGTPGYLSP 193

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 88/179 (49%), Gaps = 12/179 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E ++I   +G G +G V + +   + +  A+K ++++  +   +    R E  LL ++ H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NI+KL+         +++ E    G LF  +   +     D A+   I+K +   ++Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 307 HHHCTPPIVHRDISSNNVLLNS---ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    IVHRD+   N+LL S   + +  + DFG++     ++  +  + GT+ YIAP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAP 192

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 26/184 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V++ +  PSG V+A K +H      L    + RN+     Q+ H
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 62
Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  E+ +G      + ++KG
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG 119
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
               L+YL       I+HRD+  +N+L+NS  E  + DFGV+  L  + +N     GT  
Sbjct: 120 ----LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE--FVGTRS 171
Query: 359 YIAP 362
           Y++P
Sbjct: 172 YMSP 175

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  LAGT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLAGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 32/181 (17%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I EY   G+L   LR      G++++  +N V          
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 298 -----GMAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL-NFDSSNR 350
                 +A  + YL    C    +HRD+++ NVL+       +ADFG+AR + N D   +
Sbjct: 160 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 351 T 351
           T
Sbjct: 216 T 216

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 31/182 (17%)
Query: 196 IGTGGYGSVYRARLPSGKVVAL-------KKLHRSETEELASLESFRNEARLLSQIWHRN 248
           IG G + +VY+  L +   V +       +KL +SE +       F+ EA  L  + H N
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQ------RFKEEAEXLKGLQHPN 86
Query: 249 IVKLY----GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAH 301
           IV+ Y         +KC+ L+ E    G+L   L+     +  V   W ++  I+KG   
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ--ILKG--- 141
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTSGYI 360
            L +LH   TPPI+HRD+  +N+ +     +  + D G+A L    +S    + GT  + 
Sbjct: 142 -LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFX 197
Query: 361 AP 362
           AP
Sbjct: 198 AP 199

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V++ +  PSG V+A K +H      L    + RN+     Q+ H
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 59
Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  E+ +G      + ++KG
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG 116
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
               L+YL       I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT  
Sbjct: 117 ----LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRS 168
Query: 359 YIAP 362
           Y++P
Sbjct: 169 YMSP 172

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V++ +  PSG V+A K +H      L    + RN+     Q+ H
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 86
Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  E+ +G      + ++KG
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG 143
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
               L+YL       I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT  
Sbjct: 144 ----LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRS 195
Query: 359 YIAP 362
           Y++P
Sbjct: 196 YMSP 199

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 9/175 (5%)
Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ I   +G G +G V  A    +G+ VALK +++    +         E   L  + H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           +I+KLY     +  + ++ EY        +++ D+  +    A+R    + +  A+ Y H
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK--MSEQEARR--FFQQIISAVEYCH 120
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            H    IVHRD+   N+LL+  L   +ADFG++ ++  D +      G+  Y AP
Sbjct: 121 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAP 171

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 19/167 (11%)
Query: 196 IGTGGYGSVYRAR-LPSGK-----VVALKKLHRSETEELASLESFRNEARLLSQI-WHRN 248
           +G G +G V  A     GK      VA+K L    T      E+  +E +++S +  H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEA-------VGLDWAKRVNIVKGMAH 301
           IV L G C H   + +I EY   G L   LR   EA         L+    ++    +A 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            +++L    +   +HRD+++ NVLL +   A + DFG+AR +  DS+
Sbjct: 172 GMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 215

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 19/167 (11%)
Query: 196 IGTGGYGSVYRAR-LPSGK-----VVALKKLHRSETEELASLESFRNEARLLSQI-WHRN 248
           +G G +G V  A     GK      VA+K L    T      E+  +E +++S +  H N
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEA-------VGLDWAKRVNIVKGMAH 301
           IV L G C H   + +I EY   G L   LR   EA         L+    ++    +A 
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            +++L    +   +HRD+++ NVLL +   A + DFG+AR +  DS+
Sbjct: 164 GMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 207

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V + +  PSG ++A K +H      L    + RN+     Q+ H
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIH------LEIKPAIRNQIIRELQVLH 69
Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  EE +G      + +++G
Sbjct: 70  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSIAVLRG 126
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           +A+ L   H      I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT  
Sbjct: 127 LAY-LREKHQ-----IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRS 178
Query: 359 YIAP 362
           Y+AP
Sbjct: 179 YMAP 182

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           F  K  +GTG +  V  A    +GK+ A+K + +   +   S  S  NE  +L +I H N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES--SIENEIAVLRKIKHEN 81
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVL-----RTDEEAVGLDWAKRVNIVKGMAHAL 303
           IV L         ++L+ + +  G LF  +      T+++A  L        ++ +  A+
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTL--------IRQVLDAV 133
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEA---FVADFGVARLLNFDSSNRTLLAGTSGYI 360
            YLH      IVHRD+   N+L  S+ E     ++DFG++++        T   GT GY+
Sbjct: 134 YYLHRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMST-ACGTPGYV 189
Query: 361 AP 362
           AP
Sbjct: 190 AP 191

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V++ +  PSG V+A K +H      L    + RN+     Q+ H
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 59
Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  E+ +G      + ++KG
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG 116
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
               L+YL       I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT  
Sbjct: 117 ----LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRS 168
Query: 359 YIAP 362
           Y++P
Sbjct: 169 YMSP 172

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 88/179 (49%), Gaps = 12/179 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E ++I   +G G +G V + +   + +  A+K ++++  +   +    R E  LL ++ H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NI+KL+         +++ E    G LF  +   +     D A+   I+K +   ++Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 307 HHHCTPPIVHRDISSNNVLLNS---ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    IVHRD+   N+LL S   + +  + DFG++     ++  +  + GT+ YIAP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAP 192

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 9/175 (5%)
Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ I   +G G +G V  A    +G+ VALK +++    +         E   L  + H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           +I+KLY     +  + ++ EY        +++ D+  +    A+R    + +  A+ Y H
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK--MSEQEARR--FFQQIISAVEYCH 130
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            H    IVHRD+   N+LL+  L   +ADFG++ ++  D +      G+  Y AP
Sbjct: 131 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAP 181

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 9/175 (5%)
Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ I   +G G +G V  A    +G+ VALK +++    +         E   L  + H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           +I+KLY     +  + ++ EY        +++ D+  +    A+R    + +  A+ Y H
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK--MSEQEARR--FFQQIISAVEYCH 129
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            H    IVHRD+   N+LL+  L   +ADFG++ ++  D +      G+  Y AP
Sbjct: 130 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAP 180

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I EY   G+L   LR      G++++  +N V          
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 298 -----GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    +   +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V++ +  PSG V+A K +H      L    + RN+     Q+ H
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 59
Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  E+ +G      + ++KG
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG 116
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
               L+YL       I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT  
Sbjct: 117 ----LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRS 168
Query: 359 YIAP 362
           Y++P
Sbjct: 169 YMSP 172

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 88/179 (49%), Gaps = 12/179 (6%)
Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E ++I   +G G +G V + +   + +  A+K ++++  +   +    R E  LL ++ H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NI+KL+         +++ E    G LF  +   +     D A+   I+K +   ++Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 307 HHHCTPPIVHRDISSNNVLLNS---ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    IVHRD+   N+LL S   + +  + DFG++     ++  +  + GT+ YIAP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAP 192

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I EY   G+L   LR      G++++  +N V          
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 298 -----GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    +   +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDIN 208

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 9/175 (5%)
Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++ I   +G G +G V  A    +G+ VALK +++    +         E   L  + H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           +I+KLY     +  + ++ EY        +++ D+  +    A+R    + +  A+ Y H
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK--MSEQEARR--FFQQIISAVEYCH 124
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            H    IVHRD+   N+LL+  L   +ADFG++ ++  D +      G+  Y AP
Sbjct: 125 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAP 175

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E   +  CIG G +G V++    S       VA+K      ++ +   E F  EA  + Q
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 67
Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H +IVKL G  +    +++I E   +G L   L+  +    LD A  +     ++ AL
Sbjct: 68  FDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTAL 124
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           +YL    +   VHRDI++ NVL+++     + DFG++R +
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM 161

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I EY   G+L   LR      G++++  +N V          
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 298 -----GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    +   +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V++ +  PSG V+A K +H      L    + RN+     Q+ H
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 59
Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  E+ +G      + ++KG
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG 116
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
               L+YL       I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT  
Sbjct: 117 ----LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRS 168
Query: 359 YIAP 362
           Y++P
Sbjct: 169 YMSP 172

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V++ +  PSG V+A K +H      L    + RN+     Q+ H
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 59
Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  E+ +G      + ++KG
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG 116
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
               L+YL       I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT  
Sbjct: 117 ----LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRS 168
Query: 359 YIAP 362
           Y++P
Sbjct: 169 YMSP 172

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 82/173 (47%), Gaps = 14/173 (8%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G Y +VY+     +G  VALK++ + ++EE     + R E  L+ ++ H NIV+LY 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIR-EISLMKELKHENIVRLYD 70
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVK----GMAHALSYLHHH 309
                  + L++E+M+          D   VG       +N+VK     +   L++ H +
Sbjct: 71  VIHTENKLTLVFEFMDND---LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               I+HRD+   N+L+N   +  + DFG+AR      +  +    T  Y AP
Sbjct: 128 ---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 77/180 (42%), Gaps = 20/180 (11%)
Query: 195 CIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           C+G G YG V+R  L  G+ VA+K     + +         N   L     H NI+    
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLR----HDNILGFIA 69
Query: 255 FCLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA-LSYLHHH 309
             +  +     ++LI  Y E GSL+  L+       L     V+   G+AH  +      
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARL-------LNFDSSNRTLLAGTSGYIAP 362
             P I HRD  S NVL+ S L+  +AD G+A +       L+  ++ R    GT  Y+AP
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV---GTKRYMAP 186

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 94/191 (49%), Gaps = 17/191 (8%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEAR 239
           FQ M      + I   IG+GG   V++      ++ A+K ++  E +   +L+S+RNE  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIA 78
Query: 240 LLSQIWHRN--IVKLYGFCLHRKCMFLIYEYMEMGS--LFCVLRTDEEAVGLDWAKRVNI 295
            L+++   +  I++LY + +  + ++++   ME G+  L   L+  +    +D  +R + 
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKK---SIDPWERKSY 132
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLL 353
            K M  A+  +H H    IVH D+   N L+   +   + DFG+A  +  D+++  +   
Sbjct: 133 WKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQ 188
Query: 354 AGTSGYIAPAS 364
            GT  Y+ P +
Sbjct: 189 VGTVNYMPPEA 199

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I EY   G+L   LR      G++++  +N V          
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 298 -----GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    +   +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 34  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 93
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +     H+L       
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD------ 147
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
              +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 148 ---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEYLAPEIILSKG 200
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 201 YNKAVDWW 208

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 31/173 (17%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 146
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I EY   G+L   LR      G++++  +N V          
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 298 -----GMAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    C    +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 206 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDIN 254

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 21/227 (9%)
Query: 138 ALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIG 197
           AL++ + F   R++K +            D F     D     +D+    ED+ +   IG
Sbjct: 31  ALVYDLDFPALRKNKNI------------DNFLSRYKDTINKIRDLRMKAEDYEVVKVIG 78
Query: 198 TGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFC 256
            G +G V   R  S  KV A+K L + E  + +    F  E  +++      +V+L+   
Sbjct: 79  RGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 138
Query: 257 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVH 316
              + ++++ EYM  G L  ++   +  V   WA+       +  AL  +H   +   +H
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFY--TAEVVLALDAIH---SMGFIH 191
Query: 317 RDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTSGYIAP 362
           RD+  +N+LL+      +ADFG    +N +   R   A GT  YI+P
Sbjct: 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 19/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     +G G +G V   R   +G+  A+K L +        +     E+R+L    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L    E V  +   R    + +  AL YL
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H   +  +V+RDI   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 179 DNDYGRAVDWW 189

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 19/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     +G G +G V   R   +G+  A+K L +        +     E+R+L    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L    E V  +   R    + +  AL YL
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H   +  +V+RDI   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 179 DNDYGRAVDWW 189

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 19/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     +G G +G V   R   +G+  A+K L +        +     E+R+L    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L    E V  +   R    + +  AL YL
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H   +  +V+RDI   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 179 DNDYGRAVDWW 189

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 19/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     +G G +G V   R   +G+  A+K L +        +     E+R+L    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L    E V  +   R    + +  AL YL
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H   +  +V+RDI   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 179 DNDYGRAVDWW 189

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 21/227 (9%)
Query: 138 ALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCIG 197
           AL++ + F   R++K +            D F     D     +D+    ED+ +   IG
Sbjct: 36  ALVYDLDFPALRKNKNI------------DNFLSRYKDTINKIRDLRMKAEDYEVVKVIG 83
Query: 198 TGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFC 256
            G +G V   R  S  KV A+K L + E  + +    F  E  +++      +V+L+   
Sbjct: 84  RGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 143
Query: 257 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVH 316
              + ++++ EYM  G L  ++   +  V   WA+       +  AL  +H   +   +H
Sbjct: 144 QDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFY--TAEVVLALDAIH---SMGFIH 196
Query: 317 RDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTSGYIAP 362
           RD+  +N+LL+      +ADFG    +N +   R   A GT  YI+P
Sbjct: 197 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 243

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 26/184 (14%)
Query: 188 EDFHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V++ +  PSG V+A K +H      L    + RN+     Q+ H
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLH 78
Query: 247 R----NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKG 298
                 IV  YG       + +  E+M+ GSL  VL    R  E+ +G      + ++KG
Sbjct: 79  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIAVIKG 135
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
               L+YL       I+HRD+  +N+L+NS  E  + DFGV+  L  DS   + + GT  
Sbjct: 136 ----LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV-GTRS 187
Query: 359 YIAP 362
           Y++P
Sbjct: 188 YMSP 191

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 9/172 (5%)
Query: 192 IKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIV 250
           I+  +G G +G V  A    + + VALK + R   ++         E   L  + H +I+
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 251 KLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
           KLY        + ++ EY   G LF  +  +++ +  D  +R    + +  A+ Y H H 
Sbjct: 73  KLYDVITTPTDIVMVIEYAG-GELFDYI-VEKKRMTEDEGRR--FFQQIICAIEYCHRH- 127
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
              IVHRD+   N+LL+  L   +ADFG++ ++  D +      G+  Y AP
Sbjct: 128 --KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAP 176

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 87
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I EY   G+L   LR      G++++  +N V          
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 298 -----GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    +   +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 147 VSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDIN 195

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 79/181 (43%), Gaps = 32/181 (17%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I EY   G+L   LR      G++ +  +N V          
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 298 -----GMAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL-NFDSSNR 350
                 +A  + YL    C    +HRD+++ NVL+       +ADFG+AR + N D   +
Sbjct: 160 VSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 351 T 351
           T
Sbjct: 216 T 216

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 19/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     +G G +G V   R   +G+  A+K L +        +     E+R+L    H 
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L    E V  +   R    + +  AL YL
Sbjct: 69  FLTALKYAFQTHDRLCFVM-EYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 124
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H   +  +V+RDI   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 125 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 181
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 182 DNDYGRAVDWW 192

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 85/184 (46%), Gaps = 9/184 (4%)
Query: 181 QDMIEATEDFHIKYCIGTGGYGSVYRARLPSG-KVVALKKLHRSETEELASLESFRNEAR 239
           +D+    ED+ +   IG G +G V   R  S  KV A+K L + E  + +    F  E  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 240 LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGM 299
           +++      +V+L+      + ++++ EYM  G L  ++   +  V   WA+       +
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFY--TAEV 182
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTSG 358
             AL  +H   +   +HRD+  +N+LL+      +ADFG    +N +   R   A GT  
Sbjct: 183 VLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 359 YIAP 362
           YI+P
Sbjct: 240 YISP 243

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 19/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     +G G +G V   R   +G+  A+K L +        +     E+R+L    H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L    E V  +   R    + +  AL YL
Sbjct: 66  FLTALKYAFQTHDRLCFVM-EYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H   +  +V+RDI   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 178
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 179 DNDYGRAVDWW 189

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 188 EDFHIKYCIGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           +++ +   +G+G  G V  A      +  + K+++ +K       E     +   E  +L
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI---VKG 298
            ++ H  I+K+  F    +  +++ E ME G LF      ++ VG    K          
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 121
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAG 355
           M  A+ YLH +    I+HRD+   NVLL+S+ E     + DFG +++L   S  RT L G
Sbjct: 122 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCG 177
Query: 356 TSGYIAP 362
           T  Y+AP
Sbjct: 178 TPTYLAP 184

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 19/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     +G G +G V   R   +G+  A+K L +        +     E+R+L    H 
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L    E V  +   R    + +  AL YL
Sbjct: 71  FLTALKYAFQTHDRLCFVM-EYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 126
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H   +  +V+RDI   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 127 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE 183
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 184 DNDYGRAVDWW 194

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 188 EDFHIKYCIGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           +++ +   +G+G  G V  A      +  + K+++ +K       E     +   E  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI---VKG 298
            ++ H  I+K+  F    +  +++ E ME G LF      ++ VG    K          
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 122
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAG 355
           M  A+ YLH +    I+HRD+   NVLL+S+ E     + DFG +++L   S  RT L G
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCG 178
Query: 356 TSGYIAP 362
           T  Y+AP
Sbjct: 179 TPTYLAP 185

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 188 EDFHIKYCIGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           +++ +   +G+G  G V  A      +  + K+++ +K       E     +   E  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI---VKG 298
            ++ H  I+K+  F    +  +++ E ME G LF      ++ VG    K          
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 122
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAG 355
           M  A+ YLH +    I+HRD+   NVLL+S+ E     + DFG +++L   S  RT L G
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCG 178
Query: 356 TSGYIAP 362
           T  Y+AP
Sbjct: 179 TPTYLAP 185

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 188 EDFHIKYCIGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           +++ +   +G+G  G V  A      +  + K+++ +K       E     +   E  +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI---VKG 298
            ++ H  I+K+  F    +  +++ E ME G LF      ++ VG    K          
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 122
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAG 355
           M  A+ YLH +    I+HRD+   NVLL+S+ E     + DFG +++L   S  RT L G
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCG 178
Query: 356 TSGYIAP 362
           T  Y+AP
Sbjct: 179 TPTYLAP 185

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 92
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I EY   G+L   LR      G++++  +N V          
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 298 -----GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    +   +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 152 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 200

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 89
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I EY   G+L   LR      G++++  +N V          
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 298 -----GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    +   +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 149 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 197

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 33/198 (16%)
Query: 190 FHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           F +   +G G +G V+  +  SG    ++ A+K L ++ T ++      + E  +L ++ 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA-TLKVRDRVRTKMERDILVEVN 84
Query: 246 HRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMA 300
           H  IVKL Y F    K ++LI +++  G LF  L  +    EE V    A+       +A
Sbjct: 85  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LA 136
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGY 359
            AL +LH   +  I++RD+   N+LL+ E    + DFG+++  + D   +     GT  Y
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEY 192
Query: 360 IAP----------ASEWW 367
           +AP          +++WW
Sbjct: 193 MAPEVVNRRGHTQSADWW 210

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLXGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 45/189 (23%)
Query: 176 GRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFR 235
           G   F  +++AT  FH+K   G  GY +V           A+K L   E    + L    
Sbjct: 32  GEGEFGKVVKATA-FHLK---GRAGYTTV-----------AVKML--KENASPSELRDLL 74
Query: 236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT--------------- 280
           +E  +L Q+ H +++KLYG C     + LI EY + GSL   LR                
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 281 --------DEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEA 332
                   DE A+ +     ++    ++  + YL       +VHRD+++ N+L+    + 
Sbjct: 135 NSSSLDHPDERALTM--GDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKM 189
Query: 333 FVADFGVAR 341
            ++DFG++R
Sbjct: 190 KISDFGLSR 198

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 188 EDFHIKYCIGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           +++ +   +G+G  G V  A      +  + K+++ +K       E     +   E  +L
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI---VKG 298
            ++ H  I+K+  F    +  +++ E ME G LF      ++ VG    K          
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 128
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAG 355
           M  A+ YLH +    I+HRD+   NVLL+S+ E     + DFG +++L   S  RT L G
Sbjct: 129 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCG 184
Query: 356 TSGYIAP 362
           T  Y+AP
Sbjct: 185 TPTYLAP 191

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           ++ + +   +G GG   V+ AR L   + VA+K L      + +    FR EA+  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 246 HRNIVKLYGFCLHRKCM----FLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-VNIVKGMA 300
           H  IV +Y             +++ EY++  +L  ++ T+    G    KR + ++    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADAC 126
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR----TLLAGT 356
            AL++ H +    I+HRD+   N+L+++     V DFG+AR +  DS N       + GT
Sbjct: 127 QALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAI-ADSGNSVXQTAAVIGT 182
Query: 357 SGYIAP 362
           + Y++P
Sbjct: 183 AQYLSP 188

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 33/198 (16%)
Query: 190 FHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           F +   +G G +G V+  +  SG    ++ A+K L ++ T ++      + E  +L ++ 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA-TLKVRDRVRTKMERDILVEVN 84
Query: 246 HRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMA 300
           H  IVKL Y F    K ++LI +++  G LF  L  +    EE V    A+       +A
Sbjct: 85  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LA 136
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGY 359
            AL +LH   +  I++RD+   N+LL+ E    + DFG+++  + D   +     GT  Y
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEY 192
Query: 360 IAP----------ASEWW 367
           +AP          +++WW
Sbjct: 193 MAPEVVNRRGHTQSADWW 210

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 43  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 102
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 103 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL------TFEYLH--- 153
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 209
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 210 YNKAVDWW 217

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 33/198 (16%)
Query: 190 FHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           F +   +G G +G V+  +  SG    ++ A+K L ++ T ++      + E  +L ++ 
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA-TLKVRDRVRTKMERDILVEVN 85
Query: 246 HRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMA 300
           H  IVKL Y F    K ++LI +++  G LF  L  +    EE V    A+       +A
Sbjct: 86  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LA 137
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGY 359
            AL +LH   +  I++RD+   N+LL+ E    + DFG+++  + D   +     GT  Y
Sbjct: 138 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEY 193
Query: 360 IAP----------ASEWW 367
           +AP          +++WW
Sbjct: 194 MAPEVVNRRGHTQSADWW 211

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPAIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 77/175 (44%), Gaps = 31/175 (17%)
Query: 196 IGTGGYGSVYRAR-LPSGK-----VVALKKLHRSETEELASLESFRNEARLLSQI-WHRN 248
           +G G +G V  A     GK      VA+K L    T      E+  +E +++S +  H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV--------------- 293
           IV L G C H   + +I EY   G L   LR     +  D A  +               
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            + +GMA   S    +C    +HRD+++ NVLL +   A + DFG+AR +  DS+
Sbjct: 172 QVAQGMAFLAS---KNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 77/175 (44%), Gaps = 31/175 (17%)
Query: 196 IGTGGYGSVYRAR-LPSGK-----VVALKKLHRSETEELASLESFRNEARLLSQI-WHRN 248
           +G G +G V  A     GK      VA+K L    T      E+  +E +++S +  H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV--------------- 293
           IV L G C H   + +I EY   G L   LR     +  D A  +               
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            + +GMA   S    +C    +HRD+++ NVLL +   A + DFG+AR +  DS+
Sbjct: 172 QVAQGMAFLAS---KNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 35  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 94
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 95  FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL------TFEYLH--- 145
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 201
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 202 YNKAVDWW 209

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 31/197 (15%)
Query: 190 FHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           F +   +G G +G V+  R      SG + A+K L ++ T ++      + E  +L+ + 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKA-TLKVRDRVRTKMERDILADVN 88
Query: 246 HRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMA 300
           H  +VKL Y F    K ++LI +++  G LF  L  +    EE V    A+       +A
Sbjct: 89  HPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LA 140
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
             L +LH   +  I++RD+   N+LL+ E    + DFG+++             GT  Y+
Sbjct: 141 LGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYM 197
Query: 361 AP----------ASEWW 367
           AP          +++WW
Sbjct: 198 APEVVNRQGHSHSADWW 214

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 87/185 (47%), Gaps = 21/185 (11%)
Query: 187 TEDFHIKYCIGTGGYGSVYRA-RLPSGK-----VVALKKLHRSETEELASLESFRNEARL 240
           TE++ +   +G G +  V R  ++ +G+     ++  KKL   + ++L        EAR+
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL------EREARI 63
Query: 241 LSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
              + H NIV+L+         +LI++ +  G LF      E+ V  ++    +    + 
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQ 117
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTS 357
             L  + H     +VHR++   N+LL S+L+     +ADFG+A  +  +       AGT 
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 358 GYIAP 362
           GY++P
Sbjct: 178 GYLSP 182

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 179
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 235
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 236 YNKAVDWW 243

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY   G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N++++ +    V DFG+A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 45/189 (23%)
Query: 176 GRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFR 235
           G   F  +++AT  FH+K   G  GY +V           A+K L   E    + L    
Sbjct: 32  GEGEFGKVVKATA-FHLK---GRAGYTTV-----------AVKML--KENASPSELRDLL 74
Query: 236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT--------------- 280
           +E  +L Q+ H +++KLYG C     + LI EY + GSL   LR                
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 281 --------DEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEA 332
                   DE A+ +     ++    ++  + YL       +VHRD+++ N+L+    + 
Sbjct: 135 NSSSLDHPDERALTM--GDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKM 189
Query: 333 FVADFGVAR 341
            ++DFG++R
Sbjct: 190 KISDFGLSR 198

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 26/196 (13%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           +DF +   IG G Y  V   RL  + ++ A+K + +    +   ++  + E  +  Q   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAH 301
           H  +V L+        +F + EY+  G L   ++      EE      A+       ++ 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-------ISL 121
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           AL+YLH      I++RD+  +NVLL+SE    + D+G+ +         +   GT  YIA
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 178
Query: 362 P----------ASEWW 367
           P          + +WW
Sbjct: 179 PEILRGEDYGFSVDWW 194

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 85/188 (45%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY   G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N++++ +    V DFG+A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 26/196 (13%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           +DF +   IG G Y  V   RL  + ++ A+K + +    +   ++  + E  +  Q   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAH 301
           H  +V L+        +F + EY+  G L   ++      EE      A+       ++ 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-------ISL 117
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           AL+YLH      I++RD+  +NVLL+SE    + D+G+ +         +   GT  YIA
Sbjct: 118 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 174
Query: 362 P----------ASEWW 367
           P          + +WW
Sbjct: 175 PEILRGEDYGFSVDWW 190

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 45/189 (23%)
Query: 176 GRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFR 235
           G   F  +++AT  FH+K   G  GY +V           A+K L   E    + L    
Sbjct: 32  GEGEFGKVVKATA-FHLK---GRAGYTTV-----------AVKML--KENASPSELRDLL 74
Query: 236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT--------------- 280
           +E  +L Q+ H +++KLYG C     + LI EY + GSL   LR                
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 281 --------DEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEA 332
                   DE A+ +     ++    ++  + YL       +VHRD+++ N+L+    + 
Sbjct: 135 NSSSLDHPDERALTM--GDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKM 189
Query: 333 FVADFGVAR 341
            ++DFG++R
Sbjct: 190 KISDFGLSR 198

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 87/177 (49%), Gaps = 23/177 (12%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ--IWHRNI--- 249
           +G G YG V + R +PSG+++A+K++        A++ S + + RLL    I  R +   
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIR-------ATVNS-QEQKRLLMDLDISMRTVDCP 66
Query: 250 --VKLYGFCLHRKCMFLIYEYME--MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
             V  YG       +++  E M+  +   +  +    + +  D   ++ +   +  AL +
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEH 124
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH   +  ++HRD+  +NVL+N+  +  + DFG++  L  D   + + AG   Y+AP
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPYMAP 178

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY   G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N++++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY   G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N++++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           ++ + +   +G GG   V+ AR L   + VA+K L      + +    FR EA+  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 246 HRNIVKLYGFCLHRKCM----FLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-VNIVKGMA 300
           H  IV +Y             +++ EY++  +L  ++ T+    G    KR + ++    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADAC 126
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTS 357
            AL++ H +    I+HRD+   N+++++     V DFG+AR +    ++ T  A   GT+
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 358 GYIAP 362
            Y++P
Sbjct: 184 QYLSP 188

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           ++ + +   +G GG   V+ AR L   + VA+K L      + +    FR EA+  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 246 HRNIVKLYGFCLHRKCM----FLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-VNIVKGMA 300
           H  IV +Y             +++ EY++  +L  ++ T+    G    KR + ++    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADAC 126
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTS 357
            AL++ H +    I+HRD+   N+++++     V DFG+AR +    ++ T  A   GT+
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 358 GYIAP 362
            Y++P
Sbjct: 184 QYLSP 188

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 83/190 (43%), Gaps = 36/190 (18%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARL--LSQIWHRNIVKLY 253
           IG G YG+VY+  L   + VA+K          A+ ++F NE  +  +  + H NI +  
Sbjct: 21  IGRGRYGAVYKGSLDE-RPVAVKVFS------FANRQNFINEKNIYRVPLMEHDNIARFI 73
Query: 254 G-----FCLHRKCMFLIYEYMEMGSL--FCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                     R    L+ EY   GSL  +  L T       DW     +   +   L+YL
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLAHSVTRGLAYL 127
Query: 307 H------HHCTPPIVHRDISSNNVLLNSELEAFVADFGVA------RLLNFDSSNRTLLA 354
           H       H  P I HRD++S NVL+ ++    ++DFG++      RL+     +   ++
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 355 --GTSGYIAP 362
             GT  Y+AP
Sbjct: 188 EVGTIRYMAP 197

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 20/174 (11%)
Query: 184 IEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLS 242
           ++  +++ IK+ IG G YG VY A    + K VA+KK++R   E+L   +    E  +L+
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRM-FEDLIDCKRILREITILN 82
Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI----VKG 298
           ++    I++L+   +         + ++   L+ VL   +  +   +   + +    VK 
Sbjct: 83  RLKSDYIIRLHDLIIPE-------DLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKT 135
Query: 299 MAHAL----SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           + + L     ++H      I+HRD+   N LLN +    + DFG+AR +N D  
Sbjct: 136 ILYNLLLGEKFIHE---SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 11/133 (8%)
Query: 211 SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMFLIYEY 268
           +G++VA+K L      +L S   ++ E  +L  ++H +IVK  G C  +  K + L+ EY
Sbjct: 37  TGEMVAVKALKEGCGPQLRS--GWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 94
Query: 269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS 328
           + +GSL   L      VGL  A+ +   + +   ++YLH       +HR +++ NVLL++
Sbjct: 95  VPLGSLRDYL--PRHCVGL--AQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDN 147
Query: 329 ELEAFVADFGVAR 341
           +    + DFG+A+
Sbjct: 148 DRLVKIGDFGLAK 160

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N++++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIISKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 11/133 (8%)
Query: 211 SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMFLIYEY 268
           +G++VA+K L      +L S   ++ E  +L  ++H +IVK  G C  +  K + L+ EY
Sbjct: 36  TGEMVAVKALKEGCGPQLRS--GWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 93
Query: 269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS 328
           + +GSL   L      VGL  A+ +   + +   ++YLH       +HR +++ NVLL++
Sbjct: 94  VPLGSLRDYL--PRHCVGL--AQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDN 146
Query: 329 ELEAFVADFGVAR 341
           +    + DFG+A+
Sbjct: 147 DRLVKIGDFGLAK 159

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 32/180 (17%)
Query: 196 IGTGGYGSVYRAR-LPSGK-----VVALKKLHRSETEELASLESFRNEARLLSQI-WHRN 248
           +G G +G V  A     GK      VA+K L    T      E+  +E +++S +  H N
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV------------GLD-------- 288
           IV L G C H   + +I EY   G L   LR   EA+            GLD        
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 289 WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
               ++    +A  +++L    +   +HRD+++ NVLL +   A + DFG+AR +  DS+
Sbjct: 157 LRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 88/183 (48%), Gaps = 33/183 (18%)
Query: 199 GGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ--IWHRNIVKLY--- 253
           G +G V++A+L +   VA+K         L   +S+++E  + S   + H N+++     
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIF------PLQDKQSWQSEREIFSTPGMKHENLLQFIAAE 78
Query: 254 --GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC- 310
             G  L  + ++LI  + + GSL   L+ +     + W +  ++ + M+  LSYLH    
Sbjct: 79  KRGSNLEVE-LWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVP 133
Query: 311 -------TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD----SSNRTLLAGTSGY 359
                   P I HRD  S NVLL S+L A +ADFG+A  + F+      +     GT  Y
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA--VRFEPGKPPGDTHGQVGTRRY 191
Query: 360 IAP 362
           +AP
Sbjct: 192 MAP 194

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 29/172 (16%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I  Y   G+L   LR      G++++  +N V          
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 298 -----GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    +   +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL------TFEYLH--- 151
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 207
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 208 YNKAVDWW 215

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 26/196 (13%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           +DF +   IG G Y  V   RL  + ++ A+K + +    +   ++  + E  +  Q   
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAH 301
           H  +V L+        +F + EY+  G L   ++      EE      A+       ++ 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-------ISL 132
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           AL+YLH      I++RD+  +NVLL+SE    + D+G+ +         +   GT  YIA
Sbjct: 133 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 189
Query: 362 P----------ASEWW 367
           P          + +WW
Sbjct: 190 PEILRGEDYGFSVDWW 205

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY   G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N++++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 91/191 (47%), Gaps = 17/191 (8%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEAR 239
           FQ M      + I   IG+GG   V++      ++ A+K ++  E +   +L+S+RNE  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIA 78
Query: 240 LLSQIWHRN--IVKLYGFCLHRKCMFLIYEYMEMGS--LFCVLRTDEEAVGLDWAKRVNI 295
            L+++   +  I++LY + +  + ++++   ME G+  L   L+  +    +D  +R + 
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKK---SIDPWERKSY 132
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLL 353
            K M  A+  +H H    IVH D+   N L+   +   + DFG+A  +  D     +   
Sbjct: 133 WKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQ 188
Query: 354 AGTSGYIAPAS 364
            GT  Y+ P +
Sbjct: 189 VGTVNYMPPEA 199

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 69  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 179
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 235
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 236 YNKAVDWW 243

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +     H+L       
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD------ 154
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
              +++RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 155 ---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 207
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 208 YNKAVDWW 215

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 26/187 (13%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 129 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 179
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP-------- 362
           +  +++RD+   N+L++ +    V DFG A+ +         L GT  Y+AP        
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGATWTLCGTPEYLAPEIILSKGY 236
Query: 363 --ASEWW 367
             A +WW
Sbjct: 237 NKAVDWW 243

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 188 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRS-----ETEELASL-ESFRNEARL 240
           E++  K  +G G    V R    P+ K  A+K +  +       EE+  L E+   E  +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 241 LSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGM 299
           L ++  H NI++L          FL+++ M+ G LF  L    E V L   +   I++ +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 133
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGY 359
              +  LH      IVHRD+   N+LL+ ++   + DFG +  L+     R+ + GT  Y
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS-VCGTPSY 189
Query: 360 IAP 362
           +AP
Sbjct: 190 LAP 192

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 29/172 (16%)
Query: 196 IGTGGYGSVYRARL-------PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A         P   V VA+K L    TE+   L    +E  ++  I  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK--------- 297
           +NI+ L G C     +++I  Y   G+L   LR      G++++  +N V          
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRA-RRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 298 -----GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                 +A  + YL    +   +HRD+++ NVL+       +ADFG+AR +N
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 20/170 (11%)
Query: 184 IEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLS 242
           +   +++ IK+ IG G YG VY A    + K VA+KK++R   E+L   +    E  +L+
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILN 80
Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI----VKG 298
           ++    I++LY   +         + ++   L+ VL   +  +   +   + +    +K 
Sbjct: 81  RLKSDYIIRLYDLIIPD-------DLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT 133
Query: 299 MAHAL----SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
           + + L    +++H      I+HRD+   N LLN +    V DFG+AR +N
Sbjct: 134 ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G G +GSV +   R+   ++    K+ +  TE+ A  E    EA+++ Q+ +  IV+L 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C   + + L+ E    G L   L    E + +  +    ++  ++  + YL       
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK---N 130
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
            VHRD+++ NVLL +   A ++DFG+++ L  D S  T
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 188 EDFHIKYCIGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           +++ +   +G+G  G V  A      +  + ++++ +K       E     +   E  +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI---VKG 298
            ++ H  I+K+  F    +  +++ E ME G LF      ++ VG    K          
Sbjct: 195 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 247
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAG 355
           M  A+ YLH +    I+HRD+   NVLL+S+ E     + DFG +++L   S  RT L G
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCG 303
Query: 356 TSGYIAP 362
           T  Y+AP
Sbjct: 304 TPTYLAP 310

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           ++ + +   +G GG   V+ AR L   + VA+K L      + +    FR EA+  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 246 HRNIVKLYGFCLHRKCM----FLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-VNIVKGMA 300
           H  IV +Y             +++ EY++  +L  ++ T+    G    KR + ++    
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADAC 126
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTS 357
            AL++ H +    I+HRD+   N+++++     V DFG+AR +    ++ T  A   GT+
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 358 GYIAP 362
            Y++P
Sbjct: 184 QYLSP 188

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 13/174 (7%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G   +V+R R   +G + A+K  +      L  ++    E  +L ++ H+NIVKL+ 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNN--ISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 255 F--CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTP 312
                  +   LI E+   GSL+ VL     A GL  ++ + +++ +   +++L  +   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 313 PIVHRDISSNNVLL----NSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            IVHR+I   N++     + +    + DFG AR L  D      L GT  Y+ P
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVXLYGTEEYLHP 184

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 188 EDFHIKYCIGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           +++ +   +G+G  G V  A      +  + ++++ +K       E     +   E  +L
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI---VKG 298
            ++ H  I+K+  F    +  +++ E ME G LF      ++ VG    K          
Sbjct: 209 KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQ 261
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAG 355
           M  A+ YLH +    I+HRD+   NVLL+S+ E     + DFG +++L   S  RT L G
Sbjct: 262 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCG 317
Query: 356 TSGYIAP 362
           T  Y+AP
Sbjct: 318 TPTYLAP 324

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/154 (23%), Positives = 65/154 (42%), Gaps = 8/154 (5%)
Query: 196 IGTGGYGSVYRARLPSGKVVALK---KLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G G +GSV    L      +LK   K  + +      +E F +EA  +    H N+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 253 YGFCLHRKCM-----FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            G C+           +I  +M+ G L   L       G        ++K M      + 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +      +HRD+++ N +L  ++   VADFG+++
Sbjct: 162 YLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 15/183 (8%)
Query: 188 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRS-----ETEELASL-ESFRNEARL 240
           E++  K  +G G    V R    P+ K  A+K +  +       EE+  L E+   E  +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 241 LSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGM 299
           L ++  H NI++L          FL+++ M+ G LF  L    E V L   +   I++ +
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 120
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGY 359
              +  LH      IVHRD+   N+LL+ ++   + DFG +  L+     R  + GT  Y
Sbjct: 121 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSY 176
Query: 360 IAP 362
           +AP
Sbjct: 177 LAP 179

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 22/156 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIY----QILRG----LKY 136
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 81/180 (45%), Gaps = 13/180 (7%)
Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            ED+ +   IG G +G V   R   S KV A+K L + E  + +    F  E  +++   
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
              +V+L+      K ++++ EYM  G L  ++   +  V   WAK       +  AL  
Sbjct: 134 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFY--TAEVVLALDA 189
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT---LLAGTSGYIAP 362
           +H   +  ++HRD+  +N+LL+      +ADFG    +  D +         GT  YI+P
Sbjct: 190 IH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAVGTPDYISP 244

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 84/196 (42%), Gaps = 26/196 (13%)
Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           +DF +   IG G Y  V   RL  + ++ A++ + +    +   ++  + E  +  Q   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD----EEAVGLDWAKRVNIVKGMAH 301
           H  +V L+        +F + EY+  G L   ++      EE      A+       ++ 
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-------ISL 164
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           AL+YLH      I++RD+  +NVLL+SE    + D+G+ +         +   GT  YIA
Sbjct: 165 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 362 P----------ASEWW 367
           P          + +WW
Sbjct: 222 PEILRGEDYGFSVDWW 237

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 84/194 (43%), Gaps = 24/194 (12%)
Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF+    +G G +G V  A R  + ++ A+K L +    +   +E    E R+L+ +   
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 248 NIVKLYGFCLHR-KCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHAL 303
             +     C      ++ + EY+  G L   ++     +E   + +A  ++I       L
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI------GL 133
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP- 362
            +LH      I++RD+  +NV+L+SE    +ADFG+ +    D        GT  YIAP 
Sbjct: 134 FFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPE 190
Query: 363 ---------ASEWW 367
                    + +WW
Sbjct: 191 IIAYQPYGKSVDWW 204

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 15/183 (8%)
Query: 188 EDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRS-----ETEELASL-ESFRNEARL 240
           E++  K  +G G    V R    P+ K  A+K +  +       EE+  L E+   E  +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 241 LSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGM 299
           L ++  H NI++L          FL+++ M+ G LF  L    E V L   +   I++ +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 133
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGY 359
              +  LH      IVHRD+   N+LL+ ++   + DFG +  L+     R  + GT  Y
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSY 189
Query: 360 IAP 362
           +AP
Sbjct: 190 LAP 192

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 13/174 (7%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G   +V+R R   +G + A+K    +    L  ++    E  +L ++ H+NIVKL+ 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 255 F--CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTP 312
                  +   LI E+   GSL+ VL     A GL  ++ + +++ +   +++L  +   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 313 PIVHRDISSNNVLL----NSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            IVHR+I   N++     + +    + DFG AR L  D      L GT  Y+ P
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHP 184

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 69/132 (52%), Gaps = 14/132 (10%)
Query: 198 TGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCL 257
            G YG ++   +    +  L K HR+ +E      SF   A ++S++ H+++V  YG C+
Sbjct: 32  VGDYGQLHETEV---LLKVLDKAHRNYSE------SFFEAASMMSKLSHKHLVLNYGVCV 82
Query: 258 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHR 317
                 L+ E+++ GSL   L+ ++  + + W  ++ + K +A A+ +L  +    ++H 
Sbjct: 83  CGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT---LIHG 137
Query: 318 DISSNNVLLNSE 329
           ++ + N+LL  E
Sbjct: 138 NVCAKNILLIRE 149

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 25/177 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 146
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T    T  Y AP
Sbjct: 147 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAP 197

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           ++ + +   +G GG   V+ AR L   + VA+K L      + +    FR EA+  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 246 HRNIVKLYGFCLHRKCM----FLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-VNIVKGMA 300
           H  IV +Y             +++ EY++  +L  ++ T+    G    KR + ++    
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADAC 126
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTS 357
            AL++ H +    I+HRD+   N+++++     V DFG+AR +    ++ T  A   GT+
Sbjct: 127 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 358 GYIAP 362
            Y++P
Sbjct: 184 QYLSP 188

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY   G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N++++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     IG+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 24  EVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 82
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 138
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T   
Sbjct: 139 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTD---DEMTGYV 188
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 189 ATRWYRAPEIMLNWMH 204

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY   G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N++++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 136
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 190
Query: 365 -EWWH 368
             W H
Sbjct: 191 LNWMH 195

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 97
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 153
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 154 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 73
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 129
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 130 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   + + +G   A+K L + +  +L  +E   NE R+L  +    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY   G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N++++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 150
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T    T  Y AP   
Sbjct: 151 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 204
Query: 365 -EWWH 368
             W H
Sbjct: 205 LNWMH 209

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 29/179 (16%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G+G YGSV   Y ARL   + VA+KKL R     + +  ++R E RLL  + H N++ L
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 253 YGFCLHRKCMFLIYEYMEMGSLF---------CVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
                    +    E   + +L          C   +DE    L        V  +   L
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL--------VYQLLRGL 136
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            Y+H   +  I+HRD+  +NV +N + E  + DFG+AR  +      T    T  Y AP
Sbjct: 137 KYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---EEMTGYVATRWYRAP 189

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 27/174 (15%)
Query: 196 IGTGGYGSVYRAR-LPSGK-----VVALKKLHRSETEELASLESFRNEARLLSQI-WHRN 248
           +G G +G V  A     GK      VA+K L    T      E+  +E +++S +  H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKML--KSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR--------------VN 294
           IV L G C H   + +I EY   G L   LR  +   GL+++                ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRR-KRPPGLEYSYNPSHNPEEQLSSRDLLH 170
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
               +A  +++L    +   +HRD+++ NVLL +   A + DFG+AR +  DS+
Sbjct: 171 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 97
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 153
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T   
Sbjct: 154 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYV 203
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 204 ATRWYRAPEIMLNWMH 219

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   +G   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY   G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N++++ +    V DFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 74/133 (55%), Gaps = 11/133 (8%)
Query: 211 SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMFLIYEY 268
           +G++VA+K L      +  S   ++ E  +L  ++H +I+K  G C  +  K + L+ EY
Sbjct: 42  TGEMVAVKALKADCGPQHRS--GWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS 328
           + +GSL   L     ++GL  A+ +   + +   ++YLH   +   +HR++++ NVLL++
Sbjct: 100 VPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDN 152
Query: 329 ELEAFVADFGVAR 341
           +    + DFG+A+
Sbjct: 153 DRLVKIGDFGLAK 165

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 147
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR     +   T    T  Y AP   
Sbjct: 148 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIM 201
Query: 365 -EWWH 368
             W H
Sbjct: 202 LNWMH 206

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 147
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR     +   T    T  Y AP   
Sbjct: 148 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIM 201
Query: 365 -EWWH 368
             W H
Sbjct: 202 LNWMH 206

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           +  +  +GTG +  V  A    + K+VA+K + +   E      S  NE  +L +I H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALE--GKEGSMENEIAVLHKIKHPN 77
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           IV L         ++LI + +  G LF  +         D ++   ++  +  A+ YLH 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH- 133
Query: 309 HCTPPIVHRDISSNNVL---LNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                IVHRD+   N+L   L+ + +  ++DFG++++ +  S   T   GT GY+AP
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAP 187

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 22/156 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 147
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR     +   T    T  Y AP   
Sbjct: 148 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIM 201
Query: 365 -EWWH 368
             W H
Sbjct: 202 LNWMH 206

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 96
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 152
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR         T   
Sbjct: 153 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV 202
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 203 ATRWYRAPEIMLNWMH 218

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 22/156 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           +  +  +GTG +  V  A    + K+VA+K + +   E      S  NE  +L +I H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPN 77
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           IV L         ++LI + +  G LF  +         D ++   ++  +  A+ YLH 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLHD 134
Query: 309 HCTPPIVHRDISSNNVL---LNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                IVHRD+   N+L   L+ + +  ++DFG++++ +  S   T   GT GY+AP
Sbjct: 135 LG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAP 187

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 20/176 (11%)
Query: 196 IGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YGSV +    PSG+++A+K++ RS  +E    +   +   ++       IV+ YG
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 255 FCLHRKCMFLIYEYMEMG------SLFCVLRT--DEEAVGLDWAKRVNIVKGMAHALSYL 306
                   ++  E M          ++ VL     EE +G        I      AL++L
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-------KITLATVKALNHL 141
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             +    I+HRDI  +N+LL+      + DFG++  L  DS  +T  AG   Y+AP
Sbjct: 142 KENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAP 194

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 68/132 (51%), Gaps = 14/132 (10%)
Query: 198 TGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCL 257
            G YG ++   +    +  L K HR+ +E      SF   A ++S++ H+++V  YG C 
Sbjct: 32  VGDYGQLHETEV---LLKVLDKAHRNYSE------SFFEAASMMSKLSHKHLVLNYGVCF 82
Query: 258 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHR 317
                 L+ E+++ GSL   L+ ++  + + W  ++ + K +A A+ +L  +    ++H 
Sbjct: 83  CGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT---LIHG 137
Query: 318 DISSNNVLLNSE 329
           ++ + N+LL  E
Sbjct: 138 NVCAKNILLIRE 149

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 71/133 (53%), Gaps = 11/133 (8%)
Query: 211 SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFC--LHRKCMFLIYEY 268
           +G++VA+K L      +  S   ++ E  +L  ++H +I+K  G C       + L+ EY
Sbjct: 59  TGEMVAVKALKADAGPQHRS--GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS 328
           + +GSL   L     ++GL  A+ +   + +   ++YLH       +HRD+++ NVLL++
Sbjct: 117 VPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDN 169
Query: 329 ELEAFVADFGVAR 341
           +    + DFG+A+
Sbjct: 170 DRLVKIGDFGLAK 182

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   +G   A+K L + +  +L  +E   NE R+   +    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLE 108
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY   G +F  LR      E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 159
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    VADFG A+ +      RT  L GT  Y+AP       
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIILSKG 215
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 216 YNKAVDWW 223

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           ++ + +   +G GG   V+ AR L   + VA+K L      + +    FR EA+  + + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 246 HRNIVKLYGFCLHRKCM----FLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-VNIVKGMA 300
           H  IV +Y             +++ EY++  +L  ++ T+    G    KR + ++    
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADAC 143
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTS 357
            AL++ H +    I+HRD+   N+++++     V DFG+AR +    ++ T  A   GT+
Sbjct: 144 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 358 GYIAP 362
            Y++P
Sbjct: 201 QYLSP 205

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G G +GSV +   R+   ++    K+ +  TE+ A  E    EA+++ Q+ +  IV+L 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C   + + L+ E    G L   L    E + +  +    ++  ++  + YL       
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEKN--- 456
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
            VHR++++ NVLL +   A ++DFG+++ L  D S  T
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           +  +  +GTG +  V  A    + K+VA+K + +   E      S  NE  +L +I H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALE--GKEGSMENEIAVLHKIKHPN 77
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           IV L         ++LI + +  G LF  +         D ++   ++  +  A+ YLH 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH- 133
Query: 309 HCTPPIVHRDISSNNVL---LNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                IVHRD+   N+L   L+ + +  ++DFG++++ +  S   T   GT GY+AP
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAP 187

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 24/229 (10%)
Query: 148 RRRDKKVEPTETGEITKCADEFAIWNYDGRI------TFQDMIEATED-----FHIKYCI 196
           R+R +  +  E G+I +     +  NYD  +       +   +E   D     + I   +
Sbjct: 1   RKRRRGYDVDEQGKIVRGKGTVSS-NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEEL 59
Query: 197 GTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           GTG +G V+R     +G   A K +    T   +  E+ R E + +S + H  +V L+  
Sbjct: 60  GTGAFGVVHRVTERATGNNFAAKFVM---TPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
                 M +IYE+M  G LF  +  +   +  D A  V  ++ +   L ++H +     V
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA--VEYMRQVCKGLCHMHENN---YV 171
Query: 316 HRDISSNNVLLNSEL--EAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H D+   N++  ++   E  + DFG+   L+   S + +  GT+ + AP
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-VTTGTAEFAAP 219

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 22/156 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 82
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 138
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T   
Sbjct: 139 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTD---DEMTGYV 188
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 189 ATRWYRAPEIMLNWMH 204

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 25/177 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 146
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T    T  Y AP
Sbjct: 147 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAP 197

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 133
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR         T   
Sbjct: 134 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGXV 183
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 184 ATRWYRAPEIMLNWMH 199

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 82/192 (42%), Gaps = 31/192 (16%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     IG+GG+G V++A+    GK   +K++  +        E    E + L+++ H 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHV 64
Query: 248 NIVKLYGFCL-----------------HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWA 290
           NIV  Y  C                    KC+F+  E+ + G+L   +        LD  
Sbjct: 65  NIVH-YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKV 122
Query: 291 KRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
             + + + +   + Y+H   +  +++RD+  +N+ L    +  + DFG+   L  D   R
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKR 178
Query: 351 TLLAGTSGYIAP 362
               GT  Y++P
Sbjct: 179 XRSKGTLRYMSP 190

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           +  +  +GTG +  V  A    + K+VA+K + +   E      S  NE  +L +I H N
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALE--GKEGSMENEIAVLHKIKHPN 77
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           IV L         ++LI + +  G LF  +         D ++   ++  +  A+ YLH 
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH- 133
Query: 309 HCTPPIVHRDISSNNVL---LNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                IVHRD+   N+L   L+ + +  ++DFG++++ +  S   T   GT GY+AP
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAP 187

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 88
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 144
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR         T   
Sbjct: 145 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYV 194
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 195 ATRWYRAPEIMLNWMH 210

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 137
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 138 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 191
Query: 365 -EWWH 368
             W H
Sbjct: 192 LNWMH 196

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 25/188 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  +  + SG  +A+KKL R     + +  ++R E RLL  
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKH 106
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L         +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 107 MKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 162
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T   
Sbjct: 163 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYV 212
Query: 355 GTSGYIAP 362
            T  Y AP
Sbjct: 213 ATRWYRAP 220

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 73/133 (54%), Gaps = 11/133 (8%)
Query: 211 SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMFLIYEY 268
           +G++VA+K L      +  S   ++ E  +L  ++H +I+K  G C  +  K + L+ EY
Sbjct: 42  TGEMVAVKALKADCGPQHRS--GWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS 328
           + +GSL   L     ++GL  A+ +   + +   ++YLH       +HR++++ NVLL++
Sbjct: 100 VPLGSLRDYL--PRHSIGL--AQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDN 152
Query: 329 ELEAFVADFGVAR 341
           +    + DFG+A+
Sbjct: 153 DRLVKIGDFGLAK 165

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 136
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 190
Query: 365 -EWWH 368
             W H
Sbjct: 191 LNWMH 195

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 79
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 135
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T   
Sbjct: 136 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYV 185
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 186 ATRWYRAPEIMLNWMH 201

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 16/187 (8%)
Query: 185 EATEDFH-IKYCIGTGGYGSVYRARLPSGKVVA----LKKLHRSETEELASLESFRNEAR 239
           +  EDF+ I   +G+G +  V + R  S  +      +KK     +    S E    E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 240 LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGM 299
           +L Q+ H N++ L+    +R  + LI E +  G LF  L   E    L   +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLLNFDSSNRTLLAG 355
              ++YLH   T  I H D+   N++L  +        + DFG+A  +  D      + G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFG 180
Query: 356 TSGYIAP 362
           T  ++AP
Sbjct: 181 TPEFVAP 187

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 137
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 138 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 191
Query: 365 -EWWH 368
             W H
Sbjct: 192 LNWMH 196

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 33/206 (16%)
Query: 168 EFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRS 223
           +F  + YD +  F       E+      +G+G +G V  A       +G  + +      
Sbjct: 30  DFREYEYDLKWEF-----PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 84
Query: 224 ETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE 282
           E  + +  E+  +E ++++Q+  H NIV L G C     ++LI+EY   G L   LR+  
Sbjct: 85  EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 283 EAVGLDWAKRVN--------------------IVKGMAHALSYLHHHCTPPIVHRDISSN 322
           E    D  +  N                        +A  + +L        VHRD+++ 
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201
Query: 323 NVLLNSELEAFVADFGVARLLNFDSS 348
           NVL+       + DFG+AR +  DS+
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDSN 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 88
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 144
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T   
Sbjct: 145 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYV 194
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 195 ATRWYRAPEIMLNWMH 210

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 147
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 148 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 201
Query: 365 -EWWH 368
             W H
Sbjct: 202 LNWMH 206

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 89
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 145
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T   
Sbjct: 146 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYV 195
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 196 ATRWYRAPEIMLNWMH 211

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 89
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 145
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T   
Sbjct: 146 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYV 195
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 196 ATRWYRAPEIMLNWMH 211

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 29/169 (17%)
Query: 196 IGTGGYGSVYRAR---LPSGKV-----VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A    L   K      VA+K L    TE+   L    +E  ++  I  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-------------- 292
           +NI+ L G C     +++I EY   G+L   L+   E  GL+++                
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-REPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           V+    +A  + YL    +   +HRD+++ NVL+  +    +ADFG+AR
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 145
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T    T  Y AP   
Sbjct: 146 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 199
Query: 365 -EWWH 368
             W H
Sbjct: 200 LNWMH 204

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 139
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T    T  Y AP   
Sbjct: 140 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 193
Query: 365 -EWWH 368
             W H
Sbjct: 194 LNWMH 198

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 145
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 146 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 199
Query: 365 -EWWH 368
             W H
Sbjct: 200 LNWMH 204

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 142
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T    T  Y AP   
Sbjct: 143 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 196
Query: 365 -EWWH 368
             W H
Sbjct: 197 LNWMH 201

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 96
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 152
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR         T   
Sbjct: 153 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV 202
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 203 ATRWYRAPEIMLNWMH 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 29/179 (16%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G+G YGSV   Y ARL   + VA+KKL R     + +  ++R E RLL  + H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 253 YGFCLHRKCMFLIYEYMEMGSLF---------CVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
                    +    E   + +L          C   +DE    L        V  +   L
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL--------VYQLLRGL 144
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            Y+H   +  I+HRD+  +NV +N + E  + DFG+AR  +      T    T  Y AP
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQAD---EEMTGYVATRWYRAP 197

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 146
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 147 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 200
Query: 365 -EWWH 368
             W H
Sbjct: 201 LNWMH 205

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 24/229 (10%)
Query: 148 RRRDKKVEPTETGEITKCADEFAIWNYDGRI------TFQDMIEATED-----FHIKYCI 196
           R+R +  +  E G+I +     +  NYD  +       +   +E   D     + I   +
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSS-NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEEL 165
Query: 197 GTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           GTG +G V+R     +G   A K +    T   +  E+ R E + +S + H  +V L+  
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVM---TPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
                 M +IYE+M  G LF  +  +   +  D A  V  ++ +   L ++H +     V
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA--VEYMRQVCKGLCHMHENN---YV 277
Query: 316 HRDISSNNVLLNSEL--EAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H D+   N++  ++   E  + DFG+   L+   S + +  GT+ + AP
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-VTTGTAEFAAP 325

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 22/156 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 163
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 164 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 97
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 153
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR         T   
Sbjct: 154 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV 203
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 204 ATRWYRAPEIMLNWMH 219

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 75
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 76  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 131
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 132 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 142
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR         T    T  Y AP   
Sbjct: 143 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 196
Query: 365 -EWWH 368
             W H
Sbjct: 197 LNWMH 201

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 100
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 156
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR         T   
Sbjct: 157 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV 206
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 207 ATRWYRAPEIMLNWMH 222

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 16/187 (8%)
Query: 185 EATEDFH-IKYCIGTGGYGSVYRARLPSGKVVA----LKKLHRSETEELASLESFRNEAR 239
           +  EDF+ I   +G+G +  V + R  S  +      +KK     +    S E    E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 240 LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGM 299
           +L Q+ H N++ L+    +R  + LI E +  G LF  L   E    L   +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLLNFDSSNRTLLAG 355
              ++YLH   T  I H D+   N++L  +        + DFG+A  +  D      + G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFG 180
Query: 356 TSGYIAP 362
           T  ++AP
Sbjct: 181 TPEFVAP 187

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 16/187 (8%)
Query: 185 EATEDFH-IKYCIGTGGYGSVYRARLPSGKVVA----LKKLHRSETEELASLESFRNEAR 239
           +  EDF+ I   +G+G +  V + R  S  +      +KK     +    S E    E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 240 LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGM 299
           +L Q+ H N++ L+    +R  + LI E +  G LF  L   E    L   +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLLNFDSSNRTLLAG 355
              ++YLH   T  I H D+   N++L  +        + DFG+A  +  D      + G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFG 180
Query: 356 TSGYIAP 362
           T  ++AP
Sbjct: 181 TPEFVAP 187

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 16/187 (8%)
Query: 185 EATEDFH-IKYCIGTGGYGSVYRARLPSGKVVA----LKKLHRSETEELASLESFRNEAR 239
           +  EDF+ I   +G+G +  V + R  S  +      +KK     +    S E    E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 240 LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGM 299
           +L Q+ H N++ L+    +R  + LI E +  G LF  L   E    L   +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 300 AHALSYLHHHCTPPIVHRDISSNNV-LLNSEL---EAFVADFGVARLLNFDSSNRTLLAG 355
              ++YLH   T  I H D+   N+ LL+  +      + DFG+A  +  D      + G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFG 180
Query: 356 TSGYIAP 362
           T  ++AP
Sbjct: 181 TPEFVAP 187

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 16/187 (8%)
Query: 185 EATEDFH-IKYCIGTGGYGSVYRARLPSGKVVA----LKKLHRSETEELASLESFRNEAR 239
           +  EDF+ I   +G+G +  V + R  S  +      +KK     +    S E    E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 240 LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGM 299
           +L Q+ H N++ L+    +R  + LI E +  G LF  L   E    L   +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLLNFDSSNRTLLAG 355
              ++YLH   T  I H D+   N++L  +        + DFG+A  +  D      + G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFG 180
Query: 356 TSGYIAP 362
           T  ++AP
Sbjct: 181 TPEFVAP 187

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G+G YGSV   Y ARL   + VA+KKL R     + +  ++R E RLL  + H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 253 YGFCLHRKCMFLIYE-YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
                    +    E Y+    +   L    ++  L       +V  +   L Y+H   +
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---S 149
Query: 312 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I+HRD+  +NV +N + E  + DFG+AR  +      T    T  Y AP
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQAD---EEMTGYVATRWYRAP 197

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 88/196 (44%), Gaps = 18/196 (9%)
Query: 175 DGRITFQDMIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALK--KLHRSETEELASL 231
           D  + F+D+ E  E       IG G +  V R     +G+  A+K   + +  +    S 
Sbjct: 17  DDDVLFEDVYELCE------VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK 291
           E  + EA +   + H +IV+L         +++++E+M+ G+  C         G  +++
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD-GADLCFEIVKRADAGFVYSE 129
Query: 292 RV--NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFD 346
            V  + ++ +  AL Y H +    I+HRD+   NVLL S+  +    + DFGVA  L   
Sbjct: 130 AVASHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES 186
Query: 347 SSNRTLLAGTSGYIAP 362
                   GT  ++AP
Sbjct: 187 GLVAGGRVGTPHFMAP 202

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   ++++ EY+  G +F  LR      E     +A ++ +         YLH   
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT------FEYLH--- 158
Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP------- 362
           +  +++RD+   N+L++ +    V DFG A+ +      RT  L GT   +AP       
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEALAPEIILSKG 214
Query: 363 ---ASEWW 367
              A +WW
Sbjct: 215 YNKAVDWW 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 79
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 135
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 136 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 83
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 139
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 140 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 21/193 (10%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVA---LKKLHRSETEELASLESFR 235
           FQ M+E  + + +   +G+G +  V + R   +GK  A   +KK     +    S E   
Sbjct: 20  FQSMVE--DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE 77
Query: 236 NEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI 295
            E  +L +I H NI+ L+    ++  + LI E +  G LF  L  ++E++  D A     
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEA--TQF 134
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLL------NSELEAFVADFGVARLLNFDSSN 349
           +K +   + YLH   +  I H D+   N++L      N  ++  + DFG+A  +   +  
Sbjct: 135 LKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIEAGNEF 189
Query: 350 RTLLAGTSGYIAP 362
           + +  GT  ++AP
Sbjct: 190 KNIF-GTPEFVAP 201

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 28/189 (14%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           DF    C+G GG+G V+ A+          K  R    ELA  E    E + L+++ H  
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR-EKVMREVKALAKLEHPG 64
Query: 249 IVKLYGFCLHRKCMFL-------IYEYMEMG-----------SLFCVLRTDEEAVGLDWA 290
           IV+ +   L +            +Y Y++M            +  C +   E +V L   
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL--- 121
Query: 291 KRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
              +I   +A A+ +LH   +  ++HRD+  +N+    +    V DFG+   ++ D   +
Sbjct: 122 ---HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 351 TLLAGTSGY 359
           T+L     Y
Sbjct: 176 TVLTPMPAY 184

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 76/149 (51%), Gaps = 11/149 (7%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G +G V++     +G  +A K +   +T  +   E  +NE  +++Q+ H N+++LY 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKII---KTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
               +  + L+ EY++ G LF   R  +E+  L     +  +K +   + ++H      I
Sbjct: 154 AFESKNDIVLVMEYVDGGELFD--RIIDESYNLTELDTILFMKQICEGIRHMHQMY---I 208
Query: 315 VHRDISSNNVL-LNSELEAF-VADFGVAR 341
           +H D+   N+L +N + +   + DFG+AR
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQME-----LDHERMSYLLYQMLXGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 20/166 (12%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLFCVLRTDEEAVGLDWAKRVNI 295
           + H N++ L       + +      +L+   M  ++ ++    +  ++ V         +
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-------L 130
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +  +   L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 44/205 (21%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF     IG+GG+G V++A+    GK   ++++  +        E    E + L+++ H 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN-------EKAEREVKALAKLDHV 65
Query: 248 NIVKLYGFCL------------------------------HRKCMFLIYEYMEMGSLFCV 277
           NIV  Y  C                                 KC+F+  E+ + G+L   
Sbjct: 66  NIVH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 278 LRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF 337
           +        LD    + + + +   + Y+H   +  ++HRD+  +N+ L    +  + DF
Sbjct: 125 IEK-RRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 338 GVARLLNFDSSNRTLLAGTSGYIAP 362
           G+   L  D   RT   GT  Y++P
Sbjct: 181 GLVTSLKND-GKRTRSKGTLRYMSP 204

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 89/194 (45%), Gaps = 30/194 (15%)
Query: 186 ATEDFHIKYC-------IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNE 237
           A E+F +K         +G G YG V + R +PSG++ A+K++        A++ S + +
Sbjct: 25  AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIR-------ATVNS-QEQ 76
Query: 238 ARLLSQ--IWHRNI-----VKLYGFCLHRKCMFLIYEYME--MGSLFCVLRTDEEAVGLD 288
            RLL    I  R +     V  YG       +++  E  +  +   +  +    + +  D
Sbjct: 77  KRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPED 136
Query: 289 WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
              ++ +   +  AL +LH   +  ++HRD+  +NVL+N+  +    DFG++  L  D  
Sbjct: 137 ILGKIAV--SIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYL-VDDV 191
Query: 349 NRTLLAGTSGYIAP 362
            + + AG   Y AP
Sbjct: 192 AKDIDAGCKPYXAP 205

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 82/170 (48%), Gaps = 14/170 (8%)
Query: 190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           + I++ IGTG YG V  A      +VVA+KK+ R   E+L   +    E  +L+++ H +
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDH 113
Query: 249 IVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           +VK+    + +       ++++ E  +      + RT    V L       ++  +   +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGV 169
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL 353
            Y+H   +  I+HRD+   N L+N +    V DFG+AR +++  +  + L
Sbjct: 170 KYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 25/195 (12%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLFCVLRTDEEAVGLDWAKRVNI 295
           + H N++ L       + +      +L+   M  ++ ++    +  ++ V         +
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-------L 130
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAG 355
           +  +   L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T    
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVA 184
Query: 356 TSGYIAPAS--EWWH 368
           T  Y AP     W H
Sbjct: 185 TRWYRAPEIMLNWMH 199

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + D+G+AR         T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 191 HIKYCIGTGGYGSVYRA----RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY      +  +    A+K L  S   E+  +E+F  E  L+  + H
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNH 81
Query: 247 RNIVKLYGFCLHRKCM-FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
            N++ L G  L  + +  ++  YM  G L   +R+ +    +     ++    +A  + Y
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEY 139
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           L        VHRD+++ N +L+      VADFG+AR
Sbjct: 140 L---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 79/191 (41%), Gaps = 18/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           +F     +G G +G V   +   +G+  A+K L +        +     E R+L    H 
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L + E     D A+       +  AL YL
Sbjct: 71  FLTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSALDYL 126
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H      +V+RD+   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 127 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 184
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 185 DNDYGRAVDWW 195

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 27/168 (16%)
Query: 196 IGTGGYGSVYRAR---LPSGKV-----VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A    L   K      VA+K L    TE+   L    +E  ++  I  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSL-------------FCVLRTDEEAVGLDWAKRV 293
           +NI+ L G C     +++I EY   G+L             +C   +      L     V
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +    +A  + YL    +   +HRD+++ NVL+  +    +ADFG+AR
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/177 (23%), Positives = 77/177 (43%), Gaps = 28/177 (15%)
Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL--------------ASLESF 234
           D+ I   +  G +  +        K  ALKK  +S  E+               +  + F
Sbjct: 32  DYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 235 RNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV- 293
           +NE ++++ I +   +   G   +   +++IYEYME  S   +L+ DE    LD      
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDS---ILKFDEYFFVLDKNYTCF 147
Query: 294 -------NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
                   I+K + ++ SY+H+     I HRD+  +N+L++      ++DFG +  +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 79/191 (41%), Gaps = 18/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           +F     +G G +G V   +   +G+  A+K L +        +     E R+L    H 
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L + E     D A+       +  AL YL
Sbjct: 70  FLTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSALDYL 125
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H      +V+RD+   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 126 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 183
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 184 DNDYGRAVDWW 194

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 27/196 (13%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL +     + +  ++R E RLL  
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKH 89
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVN 294
           + H N++ L       + +      +L+   M  ++ ++  C   TD+    L +     
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----Q 145
Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA 354
           I++G    L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR  +      T   
Sbjct: 146 ILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYV 195
Query: 355 GTSGYIAPAS--EWWH 368
            T  Y AP     W H
Sbjct: 196 ATRWYRAPEIMLNWMH 211

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 27/168 (16%)
Query: 196 IGTGGYGSVYRAR---LPSGKV-----VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A    L   K      VA+K L    TE+   L    +E  ++  I  H
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 78
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSL-------------FCVLRTDEEAVGLDWAKRV 293
           +NI+ L G C     +++I EY   G+L             +C   +      L     V
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +    +A  + YL    +   +HRD+++ NVL+  +    +ADFG+AR
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 141
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 143
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 79/191 (41%), Gaps = 18/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           +F     +G G +G V   +   +G+  A+K L +        +     E R+L    H 
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L + E     D A+       +  AL YL
Sbjct: 69  FLTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSALDYL 124
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H      +V+RD+   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 125 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 182
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 183 DNDYGRAVDWW 193

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 141
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 142 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 161
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 162 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 79/191 (41%), Gaps = 18/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           +F     +G G +G V   +   +G+  A+K L +        +     E R+L    H 
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L + E     D A+       +  AL YL
Sbjct: 209 FLTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSALDYL 264
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H      +V+RD+   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 323 DNDYGRAVDWW 333

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 79/191 (41%), Gaps = 18/191 (9%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           +F     +G G +G V   +   +G+  A+K L +        +     E R+L    H 
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 211
Query: 248 NIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +  L Y F  H +  F++ EY   G LF  L + E     D A+       +  AL YL
Sbjct: 212 FLTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSALDYL 267
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP---- 362
           H      +V+RD+   N++L+ +    + DFG+ +    D +      GT  Y+AP    
Sbjct: 268 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 325
Query: 363 ------ASEWW 367
                 A +WW
Sbjct: 326 DNDYGRAVDWW 336

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G YG VY+A    + + VA+K++     EE     + R E  LL ++ HRNI++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKS 100
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC-TPP 313
              H   + LI+EY E   L   +  + +         + ++K   + L    + C +  
Sbjct: 101 VIHHNHRLHLIFEYAE-NDLKKYMDKNPDV-------SMRVIKSFLYQLINGVNFCHSRR 152
Query: 314 IVHRDISSNNVLLN----SELEAF-VADFGVAR 341
            +HRD+   N+LL+    SE     + DFG+AR
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 149
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 150 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 204

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 141
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 142 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 141
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 22/198 (11%)
Query: 176 GRITFQDMIEATED-FHIKYCIGTGGYGSVYRARLP-SGKVVA---LKKLHRSETEELAS 230
           G  TF+   E  ED + +   +G+G +  V + R   +GK  A   +KK   S +    S
Sbjct: 1   GMSTFRQ--EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVS 58
Query: 231 LESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWA 290
            E    E  +L +I H NI+ L+    ++  + LI E +  G LF  L  ++E++  D A
Sbjct: 59  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEA 117
Query: 291 KRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL------NSELEAFVADFGVARLLN 344
                +K +   + YLH   +  I H D+   N++L      N  ++  + DFG+A  + 
Sbjct: 118 --TQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIE 170
Query: 345 FDSSNRTLLAGTSGYIAP 362
             +  + +  GT  ++AP
Sbjct: 171 AGNEFKNIF-GTPEFVAP 187

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 141
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAP 196

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 145
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 139
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 145
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL---AGTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 200

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 146
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL---AGTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 201

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 146
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 94
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 147
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 148 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 85
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 138
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 139 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 145
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 139
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 87/194 (44%), Gaps = 24/194 (12%)
Query: 180 FQDMIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEA 238
           F+DM + T +      +G G Y  V  A  L +GK  A+K + +      + +  FR   
Sbjct: 10  FEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV--FREVE 62
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
            L     ++NI++L  F       +L++E ++ GS+   ++  +     +  +   +V+ 
Sbjct: 63  TLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH---FNEREASRVVRD 119
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSS------- 348
           +A AL +LH   T  I HRD+   N+L  S  +     + DF +   +  ++S       
Sbjct: 120 VAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTP 176
Query: 349 NRTLLAGTSGYIAP 362
             T   G++ Y+AP
Sbjct: 177 ELTTPCGSAEYMAP 190

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 145
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQME-----LDHERMSYLLYQMLXGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 29/169 (17%)
Query: 196 IGTGGYGSVYRAR---LPSGKV-----VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A    L   K      VA+K L    TE+   L    +E  ++  I  H
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 134
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-------------- 292
           +NI+ L G C     +++I EY   G+L   L+      GL+++                
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           V+    +A  + YL    +   +HRD+++ NVL+  +    +ADFG+AR
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 29/169 (17%)
Query: 196 IGTGGYGSVYRAR---LPSGKV-----VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A    L   K      VA+K L    TE+   L    +E  ++  I  H
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 82
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-------------- 292
           +NI+ L G C     +++I EY   G+L   L+      GL+++                
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           V+    +A  + YL    +   +HRD+++ NVL+  +    +ADFG+AR
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 187

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQME-----LDHERMSYLLYQMLXGIKHL 135
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-----------TAGTSFMMTP 177

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 23/176 (13%)
Query: 179 TFQDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNE 237
           +F    +  +++ I   IG G YG V  AR   +G+ VA+KK+  +      +  + R E
Sbjct: 46  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-E 104
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----------EAVGL 287
            ++L    H NI+ +      +  +     Y E  S++ VL   E          + + L
Sbjct: 105 LKILKHFKHDNIIAI------KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTL 158
Query: 288 DWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           +  +    +  +   L Y+H   +  ++HRD+  +N+L+N   E  + DFG+AR L
Sbjct: 159 EHVR--YFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 209

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 23  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 79
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLD-------WAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+   A+  +        +K
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G+G +G+V +   ++         K+ ++E  + A  +    EA ++ Q+ +  IV++ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C     M L+ E  E+G L   L+ +      +    + +V  ++  + YL       
Sbjct: 438 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI---IELVHQVSMGMKYLEESN--- 490
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            VHRD+++ NVLL ++  A ++DFG+++ L  D +
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 525

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 29/169 (17%)
Query: 196 IGTGGYGSVYRAR---LPSGKV-----VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A    L   K      VA+K L    TE+   L    +E  ++  I  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-------------- 292
           +NI+ L G C     +++I EY   G+L   L+      GL+++                
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           V+    +A  + YL    +   +HRD+++ NVL+  +    +ADFG+AR
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 29/169 (17%)
Query: 196 IGTGGYGSVYRAR---LPSGKV-----VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A    L   K      VA+K L    TE+   L    +E  ++  I  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWA--------------KR 292
           +NI+ L G C     +++I EY   G+L   L+      GL+++                
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           V+    +A  + YL    +   +HRD+++ NVL+  +    +ADFG+AR
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G+G +G+V +   ++         K+ ++E  + A  +    EA ++ Q+ +  IV++ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C     M L+ E  E+G L   L+ +      +    + +V  ++  + YL       
Sbjct: 437 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI---IELVHQVSMGMKYLEESN--- 489
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            VHRD+++ NVLL ++  A ++DFG+++ L  D +
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 23/176 (13%)
Query: 179 TFQDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNE 237
           +F    +  +++ I   IG G YG V  AR   +G+ VA+KK+  +      +  + R E
Sbjct: 45  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-E 103
Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE----------EAVGL 287
            ++L    H NI+ +      +  +     Y E  S++ VL   E          + + L
Sbjct: 104 LKILKHFKHDNIIAI------KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTL 157
Query: 288 DWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           +  +    +  +   L Y+H   +  ++HRD+  +N+L+N   E  + DFG+AR L
Sbjct: 158 EHVR--YFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 13  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 69
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLD-------WAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+   A+  +        +K
Sbjct: 70  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 129
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 130 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 29/169 (17%)
Query: 196 IGTGGYGSVYRAR---LPSGKV-----VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A    L   K      VA+K L    TE+   L    +E  ++  I  H
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 86
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-------------- 292
           +NI+ L G C     +++I EY   G+L   L+      GL+++                
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           V+    +A  + YL    +   +HRD+++ NVL+  +    +ADFG+AR
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 191

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L    H NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 143
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 29/169 (17%)
Query: 196 IGTGGYGSVYRAR---LPSGKV-----VALKKLHRSETEELASLESFRNEARLLSQIW-H 246
           +G G +G V  A    L   K      VA+K L    TE+   L    +E  ++  I  H
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 85
Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR-------------- 292
           +NI+ L G C     +++I EY   G+L   L+      GL+++                
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           V+    +A  + YL    +   +HRD+++ NVL+  +    +ADFG+AR
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 190

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 196 IGTGGYGSVYRARLP-SGKVVA---LKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R   +GK  A   +KK   S +    S E    E  +L +I H NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L  ++E++  D A     +K +   + YLH   +
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEA--TQFLKQILDGVHYLH---S 126
Query: 312 PPIVHRDISSNNVLL------NSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      N  ++  + DFG+A  +   +  + +  GT  ++AP
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIEAGNEFKNIF-GTPEFVAP 180

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 16/183 (8%)
Query: 190 FHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           + +K  +GTGG+G V R     +G+ VA+K+  +  + +  + E +  E +++ ++ H N
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHPN 74
Query: 249 IVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           +V         + +       L  EY E G L   L   E   GL       ++  ++ A
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLN---SELEAFVADFGVARLLNFDSSNRTLLAGTSGY 359
           L YLH +    I+HRD+   N++L      L   + D G A+ L+      T   GT  Y
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQY 190
Query: 360 IAP 362
           +AP
Sbjct: 191 LAP 193

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 16/183 (8%)
Query: 190 FHIKYCIGTGGYGSVYR-ARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           + +K  +GTGG+G V R     +G+ VA+K+  +  + +  + E +  E +++ ++ H N
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHPN 73
Query: 249 IVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           +V         + +       L  EY E G L   L   E   GL       ++  ++ A
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLN---SELEAFVADFGVARLLNFDSSNRTLLAGTSGY 359
           L YLH +    I+HRD+   N++L      L   + D G A+ L+      T   GT  Y
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQY 189
Query: 360 IAP 362
           +AP
Sbjct: 190 LAP 192

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G+G +G+V +   ++         K+ ++E  + A  +    EA ++ Q+ +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C     M L+ E  E+G L   L+ +           + +V  ++  + YL       
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 147
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            VHRD+++ NVLL ++  A ++DFG+++ L  D +
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G+G +G+V +   ++         K+ ++E  + A  +    EA ++ Q+ +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C     M L+ E  E+G L   L+ +           + +V  ++  + YL       
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 147
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            VHRD+++ NVLL ++  A ++DFG+++ L  D +
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 18/196 (9%)
Query: 176 GRITFQDMIEATEDFH-IKYCIGTGGYGSVYRARLPSGKVVA----LKKLHRSETEELAS 230
           G  TF+   +  EDF+ I   +G+G +  V + R  S  +      +KK     +     
Sbjct: 1   GMETFKQ--QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVC 58
Query: 231 LESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWA 290
            E    E  +L Q+ H NI+ L+    +R  + LI E +  G LF  L   E    L   
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEE 115
Query: 291 KRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLLNFD 346
           +  + +K +   ++YLH   T  I H D+   N++L  +        + DFG+A  +  D
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-D 171
Query: 347 SSNRTLLAGTSGYIAP 362
                 + GT  ++AP
Sbjct: 172 GVEFKNIFGTPEFVAP 187

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 38/192 (19%)
Query: 192 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--HRNI 249
           ++  IG G +G V+R +   G+ VA+K    S  EE     S+  EA +   +   H NI
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREE----RSWFREAEIYQTVMLRHENI 98
Query: 250 VKLYGFCLHRK-------CMFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKGMAH 301
           +   GF             ++L+ +Y E GSLF  L R      G+     + +    A 
Sbjct: 99  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTAS 150
Query: 302 ALSYLHHHCT-----PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---- 352
            L++LH         P I HRD+ S N+L+       +AD G+A  +  DS+  T+    
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAP 208
Query: 353 --LAGTSGYIAP 362
               GT  Y+AP
Sbjct: 209 NHRVGTKRYMAP 220

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G+G +G+V +   ++         K+ ++E  + A  +    EA ++ Q+ +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C     M L+ E  E+G L   L+ +           + +V  ++  + YL       
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE---SN 131
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            VHRD+++ NVLL ++  A ++DFG+++ L  D +
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G+G +G+V +   ++         K+ ++E  + A  +    EA ++ Q+ +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C     M L+ E  E+G L   L+ +           + +V  ++  + YL       
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE---SN 131
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            VHRD+++ NVLL ++  A ++DFG+++ L  D +
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 38/192 (19%)
Query: 192 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--HRNI 249
           ++  IG G +G V+R +   G+ VA+K    S  EE     S+  EA +   +   H NI
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREE----RSWFREAEIYQTVMLRHENI 59
Query: 250 VKLYGFCLHRK-------CMFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKGMAH 301
           +   GF             ++L+ +Y E GSLF  L R      G+     + +    A 
Sbjct: 60  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTAS 111
Query: 302 ALSYLHHHCT-----PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---- 352
            L++LH         P I HRD+ S N+L+       +AD G+A  +  DS+  T+    
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAP 169
Query: 353 --LAGTSGYIAP 362
               GT  Y+AP
Sbjct: 170 NHRVGTKRYMAP 181

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + DF +AR  +      T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTD---DEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA++K+  S  E     +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 145
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L    H NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+T   +          I++G    L Y+H  
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 143
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 144 -SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 24/181 (13%)
Query: 190 FHIKYCIGTGGYGSVYRA--RLPSGKVVALKKL-HRSETEELASLESFRNEARLLSQIWH 246
           + +K CI  GG G +Y A  R  +G+ V LK L H  + E  A   + R   + L+++ H
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAER---QFLAEVVH 138
Query: 247 RNIVKLYGFCLHRK-----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
            +IV+++ F  H         +++ EY+   SL        +   L  A+ +  +  +  
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILP 193
Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           ALSYLH      +V+ D+   N++L  E    +    V+R+ +F       L GT G+ A
Sbjct: 194 ALSYLHSIG---LVYNDLKPENIMLTEEQLKLIDLGAVSRINSFG-----YLYGTPGFQA 245
Query: 362 P 362
           P
Sbjct: 246 P 246

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 38/192 (19%)
Query: 192 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--HRNI 249
           ++  IG G +G V+R +   G+ VA+K    S  EE     S+  EA +   +   H NI
Sbjct: 8   LQESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREE----RSWFREAEIYQTVMLRHENI 60
Query: 250 VKLYGFCLHRK-------CMFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKGMAH 301
           +   GF             ++L+ +Y E GSLF  L R      G+     + +    A 
Sbjct: 61  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTAS 112
Query: 302 ALSYLHHHCT-----PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---- 352
            L++LH         P I HRD+ S N+L+       +AD G+A  +  DS+  T+    
Sbjct: 113 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAP 170
Query: 353 --LAGTSGYIAP 362
               GT  Y+AP
Sbjct: 171 NHRVGTKRYMAP 182

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G+G +G+V +   ++         K+ ++E  + A  +    EA ++ Q+ +  IV++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C     M L+ E  E+G L   L+ +           + +V  ++  + YL       
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE---SN 137
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            VHRD+++ NVLL ++  A ++DFG+++ L  D +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 38/192 (19%)
Query: 192 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--HRNI 249
           ++  IG G +G V+R +   G+ VA+K    S  EE     S+  EA +   +   H NI
Sbjct: 33  LQESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREE----RSWFREAEIYQTVMLRHENI 85
Query: 250 VKLYGFCLHRK-------CMFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKGMAH 301
           +   GF             ++L+ +Y E GSLF  L R      G+     + +    A 
Sbjct: 86  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTAS 137
Query: 302 ALSYLHHHCT-----PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---- 352
            L++LH         P I HRD+ S N+L+       +AD G+A  +  DS+  T+    
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAP 195
Query: 353 --LAGTSGYIAP 362
               GT  Y+AP
Sbjct: 196 NHRVGTKRYMAP 207

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G+G +G+V +   ++         K+ ++E  + A  +    EA ++ Q+ +  IV++ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C     M L+ E  E+G L   L+ +           + +V  ++  + YL       
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE---SN 145
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            VHRD+++ NVLL ++  A ++DFG+++ L  D +
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPAFVAP 186

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 38/192 (19%)
Query: 192 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--HRNI 249
           ++  IG G +G V+R +   G+ VA+K    S  EE     S+  EA +   +   H NI
Sbjct: 10  LQESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREE----RSWFREAEIYQTVMLRHENI 62
Query: 250 VKLYGFCLHRK-------CMFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKGMAH 301
           +   GF             ++L+ +Y E GSLF  L R      G+     + +    A 
Sbjct: 63  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTAS 114
Query: 302 ALSYLHHHCT-----PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---- 352
            L++LH         P I HRD+ S N+L+       +AD G+A  +  DS+  T+    
Sbjct: 115 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAP 172
Query: 353 --LAGTSGYIAP 362
               GT  Y+AP
Sbjct: 173 NHRVGTKRYMAP 184

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 143
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 185

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 131
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 185

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G+G +G+V +   ++         K+ ++E  + A  +    EA ++ Q+ +  IV++ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C     M L+ E  E+G L   L+ +           + +V  ++  + YL       
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE---SN 125
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            VHRD+++ NVLL ++  A ++DFG+++ L  D +
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 38/192 (19%)
Query: 192 IKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--HRNI 249
           ++  IG G +G V+R +   G+ VA+K    S  EE     S+  EA +   +   H NI
Sbjct: 13  LQESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREE----RSWFREAEIYQTVMLRHENI 65
Query: 250 VKLYGFCLHRK-------CMFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKGMAH 301
           +   GF             ++L+ +Y E GSLF  L R      G+     + +    A 
Sbjct: 66  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTAS 117
Query: 302 ALSYLHHHCT-----PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---- 352
            L++LH         P I HRD+ S N+L+       +AD G+A  +  DS+  T+    
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAP 175
Query: 353 --LAGTSGYIAP 362
               GT  Y+AP
Sbjct: 176 NHRVGTKRYMAP 187

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 180
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 181 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 222

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 131
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 185

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 186

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 196 IGTGGYGSVYRA--RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
           +G+G +G+V +   ++         K+ ++E  + A  +    EA ++ Q+ +  IV++ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G C     M L+ E  E+G L   L+ +           + +V  ++  + YL       
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEE---SN 127
Query: 314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            VHRD+++ NVLL ++  A ++DFG+++ L  D +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 186

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 25/176 (14%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARL-LSQIWHRNIVKLY 253
           +G G +G V+R +   +G   A+KK+          LE FR E  +  + +    IV LY
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 132
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA-HALSYLHHHCTP 312
           G       + +  E +E GSL  +++     +G     R     G A   L YLH   T 
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLH---TR 185
Query: 313 PIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLA-----GTSGYIAP 362
            I+H D+ ++NVLL+S+   A + DFG A  L  D   ++LL      GT  ++AP
Sbjct: 186 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 241

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 186

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 55/128 (42%), Gaps = 11/128 (8%)
Query: 4   NKLDGPIPQELMNCSKLRXXXXXXXXXXXXXXXXXXKLQELNYLDLSHNLINGKIPSQLG 63
           N L+G IPQELM    L                       LN++ LS+N + G+IP  +G
Sbjct: 449 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 508
Query: 64  EIPRIDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIPSTSAKAPPPHHKGNDK 120
            +  +  + LS N+ SG+IP  +   + +  L ++ N F   IP+   K           
Sbjct: 509 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ--------SG 560
Query: 121 KIATRLVA 128
           KIA   +A
Sbjct: 561 KIAANFIA 568

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 87
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 141
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 142 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 183

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 143
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 185

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 186

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 186

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 25/176 (14%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARL-LSQIWHRNIVKLY 253
           +G G +G V+R +   +G   A+KK+          LE FR E  +  + +    IV LY
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA-HALSYLHHHCTP 312
           G       + +  E +E GSL  +++     +G     R     G A   L YLH   T 
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLH---TR 169
Query: 313 PIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLA-----GTSGYIAP 362
            I+H D+ ++NVLL+S+   A + DFG A  L  D   ++LL      GT  ++AP
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  +  FG+AR         T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 135
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 177

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 136
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 137 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 178

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 180
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 181 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 222

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L   + VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +L+ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 136
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 137 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 178

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 55/128 (42%), Gaps = 11/128 (8%)
Query: 4   NKLDGPIPQELMNCSKLRXXXXXXXXXXXXXXXXXXKLQELNYLDLSHNLINGKIPSQLG 63
           N L+G IPQELM    L                       LN++ LS+N + G+IP  +G
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 511
Query: 64  EIPRIDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIPSTSAKAPPPHHKGNDK 120
            +  +  + LS N+ SG+IP  +   + +  L ++ N F   IP+   K           
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ--------SG 563
Query: 121 KIATRLVA 128
           KIA   +A
Sbjct: 564 KIAANFIA 571

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + D G+AR         T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 186

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 186

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 186

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + D G+AR         T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDRGLAR---HTDDEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 20/166 (12%)
Query: 185 EATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 77
Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYM--EMGSLFCVLRTDEEAVGLDWAKRVNI 295
           + H N++ L       + +      +L+   M  ++ ++    +  ++ V         +
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF-------L 130
Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +  +   L Y+H   +  I+HRD+  +N+ +N + E  + DFG+ R
Sbjct: 131 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 186

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++++ + ME   L+ +L+    +          I++G    L Y+H  
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMET-DLYKLLKCQHLSNDHICYFLYQILRG----LKYIH-- 145
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 27/185 (14%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 255 FCLHRKCM------FLIYEYM--EMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
                + +      +L+   M  ++ ++  C   TD+    L +     I++G    L Y
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----QILRG----LKY 140
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS- 364
           +H   +  I+HRD+  +N+ +N + E  + D G+AR         T    T  Y AP   
Sbjct: 141 IH---SADIIHRDLKPSNLAVNEDCELKILDGGLAR---HTDDEMTGYVATRWYRAPEIM 194
Query: 365 -EWWH 368
             W H
Sbjct: 195 LNWMH 199

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 186

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R  S G   A K + +  T+      S E    E  +L +I H N++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           L+    ++  + LI E +  G LF  L   E    L   +    +K + + + YLH   +
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---S 132
Query: 312 PPIVHRDISSNNVLLNS----ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             I H D+   N++L      +    + DFG+A  ++F +  + +  GT  ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAP 186

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     KV VA+KK+  S  E     +    E ++L +  H NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 255 FCL-----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     K ++L+   M    L+ +L+T   +          I++G    L Y+H  
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQHLSNDHICYFLYQILRG----LKYIH-- 161
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L     T  Y AP
Sbjct: 162 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 216

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 25/176 (14%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARL-LSQIWHRNIVKLY 253
           +G G +G V+R +   +G   A+KK+          LE FR E  +  + +    IV LY
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 130
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA-HALSYLHHHCTP 312
           G       + +  E +E GSL  +++     +G     R     G A   L YLH   T 
Sbjct: 131 GAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLH---TR 183
Query: 313 PIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLA-----GTSGYIAP 362
            I+H D+ ++NVLL+S+   A + DFG A  L  D   ++LL      GT  ++AP
Sbjct: 184 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 239

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 99/232 (42%), Gaps = 25/232 (10%)
Query: 152 KKVEPTETGEITKCADEFA---IWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRA- 207
           +K E  + G+ TK  +E     I  +D     +D ++ T DF+    +G G +G V  + 
Sbjct: 304 QKFERAKIGQGTKAPEEKTANTISKFDNNGN-RDRMKLT-DFNFLMVLGKGSFGKVMLSE 361
Query: 208 RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-KCMFLIY 266
           R  + ++ A+K L +    +   +E    E R+L+       +     C      ++ + 
Sbjct: 362 RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421
Query: 267 EYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVL 325
           EY+  G L   +    + VG       V     +A  L +L    +  I++RD+  +NV+
Sbjct: 422 EYVNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVM 474
Query: 326 LNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP----------ASEWW 367
           L+SE    +ADFG+ +   +D        GT  YIAP          + +WW
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWW 526

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 81/192 (42%), Gaps = 20/192 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF+    +G G +G V  + R  + ++ A+K L +    +   +E    E R+L+     
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 248 NIVKLYGFCLHR-KCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSY 305
             +     C      ++ + EY+  G L   +    + VG       V     +A  L +
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI----QQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP--- 362
           L    +  I++RD+  +NV+L+SE    +ADFG+ +   +D        GT  YIAP   
Sbjct: 137 LQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII 193
Query: 363 -------ASEWW 367
                  + +WW
Sbjct: 194 AYQPYGKSVDWW 205

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 8   AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 64
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+       +        +K
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 124
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 125 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
             ++  +  GG+  VY A+ + SG+  ALK+L  +E E+  ++       + LS   H N
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS--GHPN 87
Query: 249 IVKLYGFCLHR----------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           IV+   FC             +  FL+   +  G L   L+  E    L     + I   
Sbjct: 88  IVQ---FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
              A+ ++H    PPI+HRD+   N+LL+++    + DFG A
Sbjct: 145 TCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G+G  G V++ R   +G V+A+K++ RS  +E         +  L S      IV+ +G
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP-YIVQCFG 91
Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV--NIVKGMAHALSYLHHHCTP 312
             +    +F+  E M      C  +  +   G    +R+   +   +  AL YL      
Sbjct: 92  TFITNTDVFIAMELMGT----CAEKLKKRMQG-PIPERILGKMTVAIVKALYYLKEKHG- 145
Query: 313 PIVHRDISSNNVLLNSELEAFVADFGVA-RLLNFDSSNRTLLAGTSGYIAP 362
            ++HRD+  +N+LL+   +  + DFG++ RL++  + +R+  AG + Y+AP
Sbjct: 146 -VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--AGCAAYMAP 193

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 17  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 73
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+       +        +K
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQME-----LDHERMSYLLYQMLVGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 23/175 (13%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARL-LSQIWHRNIVKLY 253
           +G G +G V+R     +G   A+KK+          LE FR E  +  + +    IV LY
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G       + +  E +E GSL  +++   E   L   + +  +      L YLH   +  
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVK---EQGCLPEDRALYYLGQALEGLEYLH---SRR 205
Query: 314 IVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLA-----GTSGYIAP 362
           I+H D+ ++NVLL+S+   A + DFG A  L  D   ++LL      GT  ++AP
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAP 260

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 23  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 79
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+       +        +K
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 139
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQME-----LDHERMSYLLYQMLVGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 10  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 66
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+       +        +K
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 16  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 72
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+       +        +K
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQME-----LDHERMSYLLYQMLVGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 16  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 72
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+       +        +K
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 14  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 70
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+       +        +K
Sbjct: 71  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 130
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 131 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 17  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 73
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+       +        +K
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV----VALKKLHRSETEELASLESFRNEARLL 241
           A ED  +   +G G +G VY     + K     VA+K   +  T  L + E F +EA ++
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIM 79
Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
             + H +IVKL G  +  +  ++I E    G L   L  ++ ++ +     V     +  
Sbjct: 80  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICK 136
Query: 302 ALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           A++YL   +C    VHRDI+  N+L+ S     + DFG++R +
Sbjct: 137 AMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI 175

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 35/179 (19%)
Query: 196 IGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRN 248
           +G G +G V  A      +  +   VA+K L  S    L   E+  +E ++LS +  H N
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMN 111
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV-------------------GLDW 289
           IV L G C       +I EY   G L   LR   ++                        
Sbjct: 112 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +    + KGMA   S    +C    +HRD+++ N+LL       + DFG+AR +  DS+
Sbjct: 172 SFSYQVAKGMAFLAS---KNC----IHRDLAARNILLTHGRITKICDFGLARHIKNDSN 223

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 37/203 (18%)
Query: 190 FHIKYCIGTGGYGSVYRA------RLPSGKVVALKKLHRSE------------------T 225
           + +K  IG G YG V  A         + KV++ KKL R                     
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFC--LHRKCMFLIYEYMEMGSLFCVLRTDEE 283
           +    +E    E  +L ++ H N+VKL       +   +++++E +  G +  V     +
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--K 132
Query: 284 AVGLDWAKRV--NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  D A+    +++KG    + YLH+     I+HRDI  +N+L+  +    +ADFGV+ 
Sbjct: 133 PLSEDQARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 342 LLNFDSSNRTLLAGTSGYIAPAS 364
                 +  +   GT  ++AP S
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPES 208

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV----VALKKLHRSETEELASLESFRNEARLL 241
           A ED  +   +G G +G VY     + K     VA+K   +  T  L + E F +EA ++
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIM 67
Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
             + H +IVKL G  +  +  ++I E    G L   L  ++ ++ +     V     +  
Sbjct: 68  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICK 124
Query: 302 ALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           A++YL   +C    VHRDI+  N+L+ S     + DFG++R +
Sbjct: 125 AMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI 163

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV----VALKKLHRSETEELASLESFRNEARLL 241
           A ED  +   +G G +G VY     + K     VA+K   +  T  L + E F +EA ++
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIM 63
Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
             + H +IVKL G  +  +  ++I E    G L   L  ++ ++ +     V     +  
Sbjct: 64  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICK 120
Query: 302 ALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           A++YL   +C    VHRDI+  N+L+ S     + DFG++R +
Sbjct: 121 AMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI 159

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 35/179 (19%)
Query: 196 IGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRN 248
           +G G +G V  A      +  +   VA+K L  S    L   E+  +E ++LS +  H N
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMN 111
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV-------------------GLDW 289
           IV L G C       +I EY   G L   LR   ++                        
Sbjct: 112 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +    + KGMA   S    +C    +HRD+++ N+LL       + DFG+AR +  DS+
Sbjct: 172 SFSYQVAKGMAFLAS---KNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 223

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 82
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 136
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 137 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 178

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 35/179 (19%)
Query: 196 IGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRN 248
           +G G +G V  A      +  +   VA+K L  S    L   E+  +E ++LS +  H N
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMN 88
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV-------------------GLDW 289
           IV L G C       +I EY   G L   LR   ++                        
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +    + KGMA   S    +C    +HRD+++ N+LL       + DFG+AR +  DS+
Sbjct: 149 SFSYQVAKGMAFLAS---KNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 35/179 (19%)
Query: 196 IGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRN 248
           +G G +G V  A      +  +   VA+K L  S    L   E+  +E ++LS +  H N
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMN 106
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV-------------------GLDW 289
           IV L G C       +I EY   G L   LR   ++                        
Sbjct: 107 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 166
Query: 290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +    + KGMA   S    +C    +HRD+++ N+LL       + DFG+AR +  DS+
Sbjct: 167 SFSYQVAKGMAFLAS---KNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 218

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 143
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 185

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG+G  G V  A     G  VA+KKL R    +  +  ++R E  LL  + H+NI+ L  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 90
Query: 255 FCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
               +K +      +L+ E M+  +L  V+  +     LD  +   ++  M   + +LH 
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIHME-----LDHERMSYLLYQMLCGIKHLH- 143
Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +  I+HRD+  +N+++ S+    + DFG+AR
Sbjct: 144 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG+G  G V  A     G  VA+KKL R    +  +  ++R E  LL  + H+NI+ L  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 88
Query: 255 FCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
               +K +      +L+ E M+  +L  V+  +     LD  +   ++  M   + +LH 
Sbjct: 89  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIHME-----LDHERMSYLLYQMLCGIKHLH- 141
Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +  I+HRD+  +N+++ S+    + DFG+AR
Sbjct: 142 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 172

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 35/179 (19%)
Query: 196 IGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRN 248
           +G G +G V  A      +  +   VA+K L  S    L   E+  +E ++LS +  H N
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMN 104
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV-------------------GLDW 289
           IV L G C       +I EY   G L   LR   ++                        
Sbjct: 105 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           +    + KGMA   S    +C    +HRD+++ N+LL       + DFG+AR +  DS+
Sbjct: 165 SFSYQVAKGMAFLAS---KNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSN 216

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 34  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 90
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 144
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 145 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMVP 186

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 37  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 93
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 147
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 148 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 189

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 74/170 (43%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 45  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 101
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+       +        +K
Sbjct: 102 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 161
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R
Sbjct: 162 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR-----------TAGTSFMMTP 184

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 23/175 (13%)
Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARL-LSQIWHRNIVKLY 253
           +G G +G V+R     +G   A+KK+          LE FR E  +  + +    IV LY
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G       + +  E +E GSL  +++   E   L   + +  +      L YLH   +  
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVK---EQGCLPEDRALYYLGQALEGLEYLH---SRR 186
Query: 314 IVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLA-----GTSGYIAP 362
           I+H D+ ++NVLL+S+   A + DFG A  L  D   + LL      GT  ++AP
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAP 241

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMEP 184

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 32/176 (18%)
Query: 196 IGTGGYGSV---YRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           IG+G  G V   Y A L     VA+KKL R    +  +  ++R E  L+  + H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 253 YGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
                 +K +      +++ E M+  +L  V++ +     LD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H   +  I+HRD+  +N+++ S+    + DFG+AR            AGTS  + P
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMMEP 184

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         ++F+N E +++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 20/182 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF +   IG GG+G VY  R   +GK+ A+K L +   +         NE  +LS +   
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 248 N----IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMA 300
           +    +   Y F    K  F++ + M  G L   L       EA    +A    I+ G+ 
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYA--AEIILGLE 306
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
           H    +H+     +V+RD+   N+LL+      ++D G+A   +F         GT GY+
Sbjct: 307 H----MHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYM 357
Query: 361 AP 362
           AP
Sbjct: 358 AP 359

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 73/170 (42%), Gaps = 20/170 (11%)
Query: 186 ATEDFHIKYCIGTGGYGSVYRARLPSGKV-------VALKKLHRSETEELASLESFRNEA 238
           A E   +   +G G +G VY   +  G V       VA+K ++  E   +     F NEA
Sbjct: 10  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEA 66
Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------DEEAVGLDWAK 291
            ++ +    ++V+L G     +   +I E M  G L   LR+       +        +K
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            + +   +A  ++YL+ +     VHRD+++ N  +  +    + DFG+ R
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 20/182 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF +   IG GG+G VY  R   +GK+ A+K L +   +         NE  +LS +   
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 248 N----IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMA 300
           +    +   Y F    K  F++ + M  G L   L       EA    +A    I+ G+ 
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYA--AEIILGLE 306
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
           H    +H+     +V+RD+   N+LL+      ++D G+A   +F         GT GY+
Sbjct: 307 H----MHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYM 357
Query: 361 AP 362
           AP
Sbjct: 358 AP 359

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 20/182 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF +   IG GG+G VY  R   +GK+ A+K L +   +         NE  +LS +   
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 248 N----IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMA 300
           +    +   Y F    K  F++ + M  G L   L       EA    +A    I+ G+ 
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYA--AEIILGLE 306
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
           H    +H+     +V+RD+   N+LL+      ++D G+A   +F         GT GY+
Sbjct: 307 H----MHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYM 357
Query: 361 AP 362
           AP
Sbjct: 358 AP 359

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 79/182 (43%), Gaps = 20/182 (10%)
Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           DF +   IG GG+G VY  R   +GK+ A+K L +   +         NE  +LS +   
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 248
Query: 248 N----IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR---VNIVKGMA 300
           +    +   Y F    K  F++ + M  G L   L   +  V  +   R     I+ G+ 
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLE 305
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
           H    +H+     +V+RD+   N+LL+      ++D G+A   +F         GT GY+
Sbjct: 306 H----MHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGTHGYM 356
Query: 361 AP 362
           AP
Sbjct: 357 AP 358

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 27/165 (16%)
Query: 196 IGTGGYGSVYRA-RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY- 253
           +G GG G V+ A      K VA+KK+  ++ +   S++    E +++ ++ H NIVK++ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVFE 75
Query: 254 -------------GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
                        G       ++++ EYME   L  VL   E+   L+   R+ + + + 
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARLFMYQ-LL 130
Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLN 344
             L Y+H   +  ++HRD+   N+ +N+E L   + DFG+AR+++
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 74/182 (40%), Gaps = 26/182 (14%)
Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--HRNIVKLY 253
           IG G YG V+  +   G+ VA+K    +E        S+  E  +   +   H NI+   
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA------SWFRETEIYQTVLMRHENILGFI 97
Query: 254 GFCLHRKC----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
              +        ++LI +Y E GSL+  L+    +  LD    + +       L +LH  
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 310 C-----TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL----LAGTSGYI 360
                  P I HRD+ S N+L+       +AD G+A     D++   +      GT  Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 361 AP 362
            P
Sbjct: 214 PP 215

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 89/185 (48%), Gaps = 27/185 (14%)
Query: 192 IKYC----IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN-EARLLSQI-W 245
           I +C    +G G  G++    +   + VA+K++       L    SF + E +LL +   
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-------LPECFSFADREVQLLRESDE 76
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N+++ +     R+  ++  E         V + D   +GL+    + +++     L++
Sbjct: 77  HPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAH 133
Query: 306 LHHHCTPPIVHRDISSNNVLLN-----SELEAFVADFGVARLLNFDS---SNRTLLAGTS 357
           LH   +  IVHRD+  +N+L++      +++A ++DFG+ + L       S R+ + GT 
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 358 GYIAP 362
           G+IAP
Sbjct: 191 GWIAP 195

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/110 (25%), Positives = 48/110 (43%), Gaps = 4/110 (3%)
Query: 4   NKLDGPIPQELMNCSKLRXXXXXXXXXXXXXXXXXXKLQELNYLDLSHNLINGKIPSQLG 63
           N L GPIP  +   ++L                   +++ L  LD S+N ++G +P  + 
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 64  EIPRIDTVNLSMNNLSGSIPESVKKVPLLY----VSGNNFEVEIPSTSAK 109
            +P +  +    N +SG+IP+S      L+    +S N    +IP T A 
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 18/196 (9%)
Query: 175 DGRITFQDMIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALK--KLHRSETEELASL 231
           D  + F+D+ E  E       IG G +  V R     +G+  A+K   + +  +    S 
Sbjct: 17  DDDVLFEDVYELCE------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK 291
           E  + EA +   + H +IV+L         +++++E+M+ G+  C         G  +++
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD-GADLCFEIVKRADAGFVYSE 129
Query: 292 RV--NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFD 346
            V  + ++ +  AL Y H +    I+HRD+  + VLL S+  +    +  FGVA  L   
Sbjct: 130 AVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 347 SSNRTLLAGTSGYIAP 362
                   GT  ++AP
Sbjct: 187 GLVAGGRVGTPHFMAP 202

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         ++F+N E +++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         ++F+N E +++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 85/190 (44%), Gaps = 28/190 (14%)
Query: 190 FHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRS----ETEELASLESFR-----NEARL 240
           + ++  I +G YG+V       G  VA+K++  +     T  + S +SF       E RL
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILS-DSFLCKRVLREIRL 82
Query: 241 LSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCV---LRTDEEAVGLDWAKRV---- 293
           L+   H NI+ L       + +F+ +E   M  L+ V   +RTD   V  D  +R+    
Sbjct: 83  LNHFHHPNILGL-------RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD--QRIVISP 133
Query: 294 -NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
            +I   M H L  LH      +VHRD+   N+LL    +  + DF +AR    D +N+T 
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTH 192
Query: 353 LAGTSGYIAP 362
                 Y AP
Sbjct: 193 YVTHRWYRAP 202

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 18/196 (9%)
Query: 175 DGRITFQDMIEATEDFHIKYCIGTGGYGSVYRA-RLPSGKVVALK--KLHRSETEELASL 231
           D  + F+D+ E  E       IG G +  V R     +G+  A+K   + +  +    S 
Sbjct: 19  DDDVLFEDVYELCE------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 72
Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK 291
           E  + EA +   + H +IV+L         +++++E+M+ G+  C         G  +++
Sbjct: 73  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD-GADLCFEIVKRADAGFVYSE 131
Query: 292 RV--NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFD 346
            V  + ++ +  AL Y H +    I+HRD+  + VLL S+  +    +  FGVA  L   
Sbjct: 132 AVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 188
Query: 347 SSNRTLLAGTSGYIAP 362
                   GT  ++AP
Sbjct: 189 GLVAGGRVGTPHFMAP 204

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 85/190 (44%), Gaps = 28/190 (14%)
Query: 190 FHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRS----ETEELASLESFR-----NEARL 240
           + ++  I +G YG+V       G  VA+K++  +     T  + S +SF       E RL
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILS-DSFLCKRVLREIRL 82
Query: 241 LSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCV---LRTDEEAVGLDWAKRV---- 293
           L+   H NI+ L       + +F+ +E   M  L+ V   +RTD   V  D  +R+    
Sbjct: 83  LNHFHHPNILGL-------RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD--QRIVISP 133
Query: 294 -NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
            +I   M H L  LH      +VHRD+   N+LL    +  + DF +AR    D +N+T 
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTH 192
Query: 353 LAGTSGYIAP 362
                 Y AP
Sbjct: 193 YVTHRWYRAP 202

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 34/184 (18%)
Query: 195 CIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
            IG G +G V++A+L     VA+KK+ +         + F+N E +++  + H N+V L 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQD--------KRFKNRELQIMRIVKHPNVVDLK 98
Query: 254 GFCL----HRKCMF--LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK----GMAHAL 303
            F       +  +F  L+ EY+       V R       L     + ++K     +  +L
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA 363
           +Y+H      I HRDI   N+LL+          GV +L++F S+ + L+AG        
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLLDPP-------SGVLKLIDFGSA-KILIAGEPNVSXIC 203
Query: 364 SEWW 367
           S ++
Sbjct: 204 SRYY 207

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/120 (30%), Positives = 55/120 (45%), Gaps = 9/120 (7%)
Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H NIVKL+     +   FL+ E +  G LF  ++  +        +   I++ +  A+S+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVSH 121
Query: 306 LHHHCTPPIVHRDISSNNVLL---NSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +H      +VHRD+   N+L    N  LE  + DFG ARL   D+        T  Y AP
Sbjct: 122 MH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 107
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 166
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 167 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 18/185 (9%)
Query: 173 NYDGRITFQDMIEATED-FHIKYC-IGTGGYGSVYRARLPSGKVVALKKLHRSETEELAS 230
           +YD ++      E  ED F  + C +G G YG VY+A+   GK      L + E   + S
Sbjct: 4   DYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-S 62
Query: 231 LESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLD 288
           + + R E  LL ++ H N++ L    L    + ++L+++Y E   L+ +++    +    
Sbjct: 63  MSACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKAN- 119
Query: 289 WAKRVNIVKGMAHALSY-----LHHHCTPPIVHRDISSNNVLLNSE----LEAFVADFGV 339
             K V + +GM  +L Y     +H+     ++HRD+   N+L+  E        +AD G 
Sbjct: 120 -KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
Query: 340 ARLLN 344
           ARL N
Sbjct: 179 ARLFN 183

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 84
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 143
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 144 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKL- 252
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 253 ---YGFCLHRKCMF--LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
              Y     +  ++  L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 80  YFFYSSGEKKDVVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 113
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 254 GFCL------HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 92
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 151
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 152 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 80
Query: 254 GFCL------HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 81  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 139
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 140 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 98
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 157
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 158 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 87
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 146
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 147 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 117
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 176
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 177 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 30/185 (16%)
Query: 190 FHIKYCIGTGGYGSVYRARLPSGKVV-ALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           + ++  IG G +G V  A     ++  A KK+ +   E++   + F+ E  ++  + H N
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---DRFKQEIEIMKSLDHPN 67
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLF------CVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           I++LY        ++L+ E    G LF       V R  + A          I+K +  A
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLSA 118
Query: 303 LSYLHHHCTPPIVHRDISSNNVLL-----NSELEAFVADFGVARLLNFDSSNRTLLAGTS 357
           ++Y H      + HRD+   N L      +S L+  + DFG+A         RT + GT 
Sbjct: 119 VAYCHKLN---VAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTKV-GTP 172
Query: 358 GYIAP 362
            Y++P
Sbjct: 173 YYVSP 177

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 254 GFCL------HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 254 GFCL------HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 115
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 174
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 175 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 158
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 217
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 218 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 91
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 113
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 91
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 150
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 151 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 22/158 (13%)
Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           IG G +G VY+A+L  SG++VA+KK+ +         + F+N E +++ ++ H NIV+L 
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 83
Query: 254 GFCLHRK------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNI-VKGMAHALSYL 306
            F            + L+ +Y+   +++ V R    A        V + +  +  +L+Y+
Sbjct: 84  YFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 142
Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLL 343
           H      I HRDI   N+LL+ +     + DFG A+ L
Sbjct: 143 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 30/185 (16%)
Query: 190 FHIKYCIGTGGYGSVYRARLPSGKVV-ALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           + ++  IG G +G V  A     ++  A KK+ +   E++   + F+ E  ++  + H N
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV---DRFKQEIEIMKSLDHPN 84
Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLF------CVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           I++LY        ++L+ E    G LF       V R  + A          I+K +  A
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLSA 135
Query: 303 LSYLHHHCTPPIVHRDISSNNVLL-----NSELEAFVADFGVARLLNFDSSNRTLLAGTS 357
           ++Y H      + HRD+   N L      +S L+  + DFG+A         RT + GT 
Sbjct: 136 VAYCHKLN---VAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTKV-GTP 189
Query: 358 GYIAP 362
            Y++P
Sbjct: 190 YYVSP 194

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 74/167 (44%), Gaps = 18/167 (10%)
Query: 196 IGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR-N 248
           +G G +G V  A      +  + + VA+K L    T   +   +  +E ++L  I H  N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLN 94
Query: 249 IVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDE--------EAVGLDWAKRVNIVKGM 299
           +V L G C      + +I E+ + G+L   LR+          E +  D+    +++   
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                 +    +   +HRD+++ N+LL+ +    + DFG+AR +  D
Sbjct: 155 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 18/159 (11%)
Query: 196 IGTGGYGSVYRAR---LPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY      +  G+    VA+K ++  E+  L     F NEA ++      ++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 81
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGL---DWAKRVNIVKGMAHA 302
           V+L G     +   ++ E M  G L   LR+     E   G       + + +   +A  
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           ++YL+       VHRD+++ N ++  +    + DFG+ R
Sbjct: 142 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 18/159 (11%)
Query: 196 IGTGGYGSVYRAR---LPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY      +  G+    VA+K ++  E+  L     F NEA ++      ++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 79
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGL---DWAKRVNIVKGMAHA 302
           V+L G     +   ++ E M  G L   LR+     E   G       + + +   +A  
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           ++YL+       VHRD+++ N ++  +    + DFG+ R
Sbjct: 140 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 18/161 (11%)
Query: 196 IGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR-N 248
           +G G +G V  A      +  + + VA+K L    T   +   +  +E ++L  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLN 92
Query: 249 IVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY-- 305
           +V L G C      + +I E+ + G+L   LR+      + +         + H + Y  
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLIXYSF 151
Query: 306 -----LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                +    +   +HRD+++ N+LL+ +    + DFG+AR
Sbjct: 152 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLAR 192

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 18/159 (11%)
Query: 196 IGTGGYGSVYRAR---LPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY      +  G+    VA+K ++  E+  L     F NEA ++      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGL---DWAKRVNIVKGMAHA 302
           V+L G     +   ++ E M  G L   LR+     E   G       + + +   +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           ++YL+       VHRD+++ N ++  +    + DFG+ R
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 18/161 (11%)
Query: 196 IGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR-N 248
           +G G +G V  A      +  + + VA+K L    T   +   +  +E ++L  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLN 92
Query: 249 IVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY-- 305
           +V L G C      + +I E+ + G+L   LR+      + +         + H + Y  
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLICYSF 151
Query: 306 -----LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                +    +   +HRD+++ N+LL+ +    + DFG+AR
Sbjct: 152 QVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR 192

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 18/159 (11%)
Query: 196 IGTGGYGSVYRAR---LPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY      +  G+    VA+K ++  E+  L     F NEA ++      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGL---DWAKRVNIVKGMAHA 302
           V+L G     +   ++ E M  G L   LR+     E   G       + + +   +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           ++YL+       VHRD+++ N ++  +    + DFG+ R
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 196 IGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V  A     K  VA+KK+  S  E     +    E ++L +  H N++ +  
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKI--SPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 255 FCLHR-----KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH 309
                     + ++++ + ME   L+ +L++ + +          I++G    L Y+H  
Sbjct: 109 ILRASTLEAMRDVYIVQDLMET-DLYKLLKSQQLSNDHICYFLYQILRG----LKYIH-- 161
Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGYIAP 362
            +  ++HRD+  +N+L+N+  +  + DFG+AR+ + +  +   L     T  Y AP
Sbjct: 162 -SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP 216

>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 29/193 (15%)
Query: 166 ADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVA-----LKKL 220
           A++FA+    G I   DM  A +++ +   IG GG+G +Y A + S + V      + K+
Sbjct: 20  AEQFAV----GEI-ITDM--AKKEWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV 72
Query: 221 HRSETEELASLESFRNEARLLSQI--WHRN-------IVKLYGFCLHRKCMFLIYEYMEM 271
             S+   L +   F   A    QI  W R        + K +G  LH K     Y +M M
Sbjct: 73  EPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNG-KSYRFMIM 131
Query: 272 GSLFCVLRTDEEAVGLDWAKR--VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN-- 327
                 L+   EA    ++++  + +   +   L Y+H H     VH DI ++N+LLN  
Sbjct: 132 DRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188
Query: 328 SELEAFVADFGVA 340
           +  + ++ D+G+A
Sbjct: 189 NPDQVYLVDYGLA 201

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 18/159 (11%)
Query: 196 IGTGGYGSVYRAR---LPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY      +  G+    VA+K ++  E+  L     F NEA ++      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGL---DWAKRVNIVKGMAHA 302
           V+L G     +   ++ E M  G L   LR+     E   G       + + +   +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           ++YL+       VHRD+++ N ++  +    + DFG+ R
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 18/159 (11%)
Query: 196 IGTGGYGSVYRAR---LPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY      +  G+    VA+K ++  E+  L     F NEA ++      ++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGL---DWAKRVNIVKGMAHA 302
           V+L G     +   ++ E M  G L   LR+     E   G       + + +   +A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           ++YL+       VHRD+++ N ++  +    + DFG+ R
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 29/193 (15%)
Query: 166 ADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVA-----LKKL 220
           A++FA+    G I   DM  A +++ +   IG GG+G +Y A + S + V      + K+
Sbjct: 20  AEQFAV----GEI-ITDM--AKKEWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV 72
Query: 221 HRSETEELASLESFRNEARLLSQI--WHR-------NIVKLYGFCLHRKCMFLIYEYMEM 271
             S+   L +   F   A    QI  W R        + K +G  LH K     Y +M M
Sbjct: 73  EPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNG-KSYRFMIM 131
Query: 272 GSLFCVLRTDEEAVGLDWAKR--VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE 329
                 L+   EA    ++++  + +   +   L Y+H H     VH DI ++N+LLN +
Sbjct: 132 DRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188
Query: 330 --LEAFVADFGVA 340
              + ++ D+G+A
Sbjct: 189 NPDQVYLVDYGLA 201

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 76/169 (44%), Gaps = 21/169 (12%)
Query: 196 IGTGGYGSVYRA------RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR-N 248
           +G G +G V  A      +  + + VA+K L    T   +   +  +E ++L  I H  N
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLN 93
Query: 249 IVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG---MAHALS 304
           +V L G C      + +I E+ + G+L   LR+      + +    ++ K    + H + 
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKTPEDLYKDFLTLEHLIC 152
Query: 305 Y-------LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           Y       +    +   +HRD+++ N+LL+ +    + DFG+AR +  D
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	368
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-67
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-58
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-51
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-50
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-48
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-47
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-47
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-46
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-43
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-42
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-40
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-39
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-39
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-38
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-38
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-37
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-34
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-33
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-32
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-30
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-27
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-26
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-22
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-31
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-27
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-27
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-25
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-25
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-24
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-07
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-29
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-29
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-28
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-27
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-27
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-26
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-24
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-24
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-23
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-23
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-23
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-23
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-21
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-21
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-05
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-04
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-09
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-13
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-11
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-06
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-11
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-09
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-08
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-07
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-06
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-06
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-09
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-09
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-09
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-06
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-07
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-04
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-05
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-05
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-05
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-06
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-05
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-04
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	6e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  213 bits (544), Expect = 8e-67
 Identities = 74/188 (39%), Positives = 112/188 (59%), Gaps = 4/188 (2%)

Query: 177 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN 236
           R + +++  A+++F  K  +G GG+G VY+ RL  G +VA+K+L   E         F+ 
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL--KEERTQGGELQFQT 76

Query: 237 EARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSL-FCVLRTDEEAVGLDWAKRVNI 295
           E  ++S   HRN+++L GFC+      L+Y YM  GS+  C+    E    LDW KR  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RTLLA 354
             G A  L+YLH HC P I+HRD+ + N+LL+ E EA V DFG+A+L+++  ++  T + 
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 355 GTSGYIAP 362
           GT G+IAP
Sbjct: 197 GTIGHIAP 204

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  191 bits (487), Expect = 2e-58
 Identities = 70/191 (36%), Positives = 101/191 (52%), Gaps = 13/191 (6%)

Query: 177 RITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN 236
           R+   D+ EAT +F  K+ IG G +G VY+  L  G  VALK+     ++    +E F  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---GIEEFET 84

Query: 237 EARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNI 295
           E   LS   H ++V L GFC  R  M LIY+YME G+L   L  +D   + + W +R+ I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144

Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR----T 351
             G A  L YLH   T  I+HRD+ S N+LL+      + DFG+++       ++    T
Sbjct: 145 CIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK--GTELDQTHLST 199

Query: 352 LLAGTSGYIAP 362
           ++ GT GYI P
Sbjct: 200 VVKGTLGYIDP 210

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  172 bits (439), Expect = 2e-51
 Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 13/195 (6%)

Query: 177 RITFQDMIEATEDFHIKYC------IGTGGYGSVYRARLPSGKVVALKKLHRSETEELAS 230
             +F ++   T +F  +        +G GG+G VY+  +     VA+KKL          
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 72

Query: 231 LES-FRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDW 289
           L+  F  E +++++  H N+V+L GF      + L+Y YM  GSL   L   +    L W
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL--NFDS 347
             R  I +G A+ +++LH +     +HRDI S N+LL+    A ++DFG+AR       +
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 348 SNRTLLAGTSGYIAP 362
              + + GT+ Y+AP
Sbjct: 190 VMTSRIVGTTAYMAP 204

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  168 bits (428), Expect = 6e-50
 Identities = 55/175 (31%), Positives = 91/175 (52%), Gaps = 3/175 (1%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
            D +IK  IG G +G+V+RA    G  VA+K L   +      +  F  E  ++ ++ H 
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHP 94

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NIV   G       + ++ EY+  GSL+ +L        LD  +R+++   +A  ++YL 
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL- 153

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H+  PPIVHR++ S N+L++ +    V DFG++RL      +    AGT  ++AP
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  163 bits (415), Expect = 8e-48
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 22/198 (11%)

Query: 178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNE 237
           +  +++   +    +      G +G V++A+L   + VA+K     + +          E
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ----NEYE 68

Query: 238 ARLLSQIWHRNIVKLYGFCLH----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV 293
              L  + H NI++  G           ++LI  + E GSL   L+ +     + W +  
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELC 124

Query: 294 NIVKGMAHALSYLHHH-------CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           +I + MA  L+YLH           P I HRDI S NVLL + L A +ADFG+A      
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 347 SS--NRTLLAGTSGYIAP 362
            S  +     GT  Y+AP
Sbjct: 185 KSAGDTHGQVGTRRYMAP 202

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  161 bits (410), Expect = 3e-47
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 12/176 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++  ++  +G G +G V +A+    K VA+K++      +     +F  E R LS++ H 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK-----AFIVELRQLSRVNHP 61

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NIVKLYG CL+  C+  + EY E GSL+ VL   E       A  ++     +  ++YLH
Sbjct: 62  NIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                 ++HRD+   N+LL +      + DFG A  +    +N     G++ ++AP
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAP 172

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  160 bits (407), Expect = 5e-47
 Identities = 56/185 (30%), Positives = 90/185 (48%), Gaps = 18/185 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPS-GKVVALKKLHR----SETEELASLESFRNEARLLS 242
            +   +  IG GG+G V++ RL     VVA+K L       ETE +   + F+ E  ++S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
            + H NIVKLYG   +   M  + E++  G L+  L        + W+ ++ ++  +A  
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAF-----VADFGVARLLNFDSSNRTLLAGTS 357
           + Y+  +  PPIVHRD+ S N+ L S  E       VADFG+++      S      G  
Sbjct: 135 IEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL---GNF 190

Query: 358 GYIAP 362
            ++AP
Sbjct: 191 QWMAP 195

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  157 bits (398), Expect = 8e-46
 Identities = 56/184 (30%), Positives = 91/184 (49%), Gaps = 16/184 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELA-SLESFRNEARLLSQIWH 246
            +  ++  IG GG+G VYRA    G  VA+K       E+++ ++E+ R EA+L + + H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NI+ L G CL    + L+ E+   G L  VL        +     VN    +A  ++YL
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYL 121

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF--------VADFGVARLLNFDSSNRTLLAGTSG 358
           H     PI+HRD+ S+N+L+  ++E          + DFG+AR      + +   AG   
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAAGAYA 179

Query: 359 YIAP 362
           ++AP
Sbjct: 180 WMAP 183

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  149 bits (378), Expect = 7e-43
 Identities = 36/177 (20%), Positives = 68/177 (38%), Gaps = 11/177 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           +  +    +     G +++ R   G  + +K L   +         F  E   L    H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHP 67

Query: 248 NIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           N++ + G C         LI  +M  GSL+ VL      V +D ++ V     MA  +++
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAF 126

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH    P I    ++S +V+++ ++ A ++   V       S           ++AP
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYAPAWVAP 177

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  148 bits (376), Expect = 3e-42
 Identities = 49/190 (25%), Positives = 93/190 (48%), Gaps = 23/190 (12%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
            D      +G G +G   +     +G+V+ +K+L R + E   +  +F  E +++  + H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEH 66

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            N++K  G     K +  I EY++ G+L  ++++ +      W++RV+  K +A  ++YL
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYL 124

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN--------------RTL 352
           H      I+HRD++S+N L+       VADFG+ARL+  + +               R  
Sbjct: 125 HSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 353 LAGTSGYIAP 362
           + G   ++AP
Sbjct: 182 VVGNPYWMAP 191

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  146 bits (370), Expect = 4e-41
 Identities = 49/206 (23%), Positives = 79/206 (38%), Gaps = 32/206 (15%)

Query: 178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNE 237
               +     ++  +   IG G YG+VY+  L   + VA+K    +        ++F NE
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN------RQNFINE 55

Query: 238 AR--LLSQIWHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWA 290
                +  + H NI +                 L+ EY   GSL   L         DW 
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWV 111

Query: 291 KRVNIVKGMAHALSYLH------HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL- 343
               +   +   L+YLH       H  P I HRD++S NVL+ ++    ++DFG++  L 
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 344 -------NFDSSNRTLLAGTSGYIAP 362
                    + +      GT  Y+AP
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAP 197

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  142 bits (360), Expect = 7e-40
 Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 14/180 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   I   IG G +G VY  R   G+V A++ +      E   L++F+ E     Q  H 
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNE-DQLKAFKREVMAYRQTRHE 89

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           N+V   G C+    + +I    +  +L+ V+R  +    LD  K   I + +   + YLH
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLH 147

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-----TLLAGTSGYIAP 362
                 I+H+D+ S NV  +   +  + DFG+  +     + R      +  G   ++AP
Sbjct: 148 ---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  140 bits (355), Expect = 3e-39
 Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 26/191 (13%)

Query: 187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARL--LSQI 244
             D  +  C+G G YG V+R     G+ VA+K     +       +S+  E  L     +
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVML 59

Query: 245 WHRNIVKLYGFCLHRKC----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
            H NI+      +  +     ++LI  Y EMGSL+  L+       LD    + IV  +A
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIA 115

Query: 301 HALSYLH-----HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS----NRT 351
             L++LH         P I HRD+ S N+L+    +  +AD G+A + +  ++       
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 352 LLAGTSGYIAP 362
              GT  Y+AP
Sbjct: 176 PRVGTKRYMAP 186

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  141 bits (356), Expect = 5e-39
 Identities = 46/190 (24%), Positives = 75/190 (39%), Gaps = 26/190 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEAR--LLSQIW 245
           +   +   IG G YG V+  +   G+ VA+K    +E        S+  E        + 
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE------EASWFRETEIYQTVLMR 89

Query: 246 HRNIVKLYGFCLHRKC----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
           H NI+      +        ++LI +Y E GSL+  L++      LD    + +      
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVS 145

Query: 302 ALSYLH-----HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL--- 353
            L +LH         P I HRD+ S N+L+       +AD G+A     D++   +    
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 354 -AGTSGYIAP 362
             GT  Y+ P
Sbjct: 206 RVGTKRYMPP 215

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  136 bits (344), Expect = 9e-38
 Identities = 48/177 (27%), Positives = 87/177 (49%), Gaps = 11/177 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
               +   IG+G +G+VY+ +   G V A+K L+ +       L++F+NE  +L +  H 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHV 80

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NI+   G+      + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH
Sbjct: 81  NILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLH 137

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN--FDSSNRTLLAGTSGYIAP 362
                 I+HRD+ SNN+ L+ +    + DFG+A   +    S     L+G+  ++AP
Sbjct: 138 AK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  136 bits (345), Expect = 2e-37
 Identities = 46/190 (24%), Positives = 74/190 (38%), Gaps = 26/190 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEAR--LLSQIW 245
               ++  IG G +G V+R +   G+ VA+K     E        S+  EA       + 
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLR 94

Query: 246 HRNIVKLYGFCLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
           H NI+               ++L+ +Y E GSLF  L        +     + +    A 
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTAS 150

Query: 302 ALSYLH-----HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLL--- 353
            L++LH         P I HRD+ S N+L+       +AD G+A   +  +    +    
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 354 -AGTSGYIAP 362
             GT  Y+AP
Sbjct: 211 RVGTKRYMAP 220

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  127 bits (322), Expect = 4e-34
 Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 22/184 (11%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKL---HRSETEELASLESFRNEARLLSQ 243
           E +     IG G +G     +    G+   +K++     S  E     E  R E  +L+ 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE----REESRREVAVLAN 79

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNIVKG 298
           + H NIV+          ++++ +Y E G LF  +        +E   LDW  +      
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ------ 133

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           +  AL ++H      I+HRDI S N+ L  +    + DFG+AR+LN          GT  
Sbjct: 134 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190

Query: 359 YIAP 362
           Y++P
Sbjct: 191 YLSP 194

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  124 bits (313), Expect = 5e-33
 Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 3/109 (2%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + +  + G IP  L     L  L    N LSG++   I  L  L  +    N I+G IP 
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

Query: 61  QLGEIPRIDTV-NLSMNNLSGSIPESVKKVPL--LYVSGNNFEVEIPST 106
             G   ++ T   +S N L+G IP +   + L  + +S N  E +    
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVL 216

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  121 bits (306), Expect = 5e-32
 Identities = 31/108 (28%), Positives = 56/108 (51%), Gaps = 4/108 (3%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
            N L GPIP  +   ++L  L + +  +SG+I   + +++ L  LD S+N ++G +P  +
Sbjct: 86  INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145

Query: 63  GEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPST 106
             +P +  +    N +SG+IP+S     K    + +S N    +IP T
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  118 bits (297), Expect = 1e-30
 Identities = 28/109 (25%), Positives = 50/109 (45%), Gaps = 5/109 (4%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N+L G IP    N + L  + L  N+L G  S   G  +    + L+ N +   +  
Sbjct: 181 ISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
            +G    ++ ++L  N + G++P+ + ++     L VS NN   EIP  
Sbjct: 240 -VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  109 bits (275), Expect = 1e-27
 Identities = 26/100 (26%), Positives = 49/100 (49%), Gaps = 3/100 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N L+G       +    + + L  N L+  +   +G  + LN LDL +N I G +P 
Sbjct: 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQ 262

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPES--VKKVPLLYVSGNN 98
            L ++  + ++N+S NNL G IP+   +++  +   + N 
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  105 bits (264), Expect = 5e-26
 Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 6/112 (5%)

Query: 1   MYNNKLDG--PIPQELMNCSKLRILILGN-NLLSGSISSEIGKLQELNYLDLSHNLINGK 57
           +    L    PIP  L N   L  L +G  N L G I   I KL +L+YL ++H  ++G 
Sbjct: 57  LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116

Query: 58  IPSQLGEIPRIDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIPST 106
           IP  L +I  + T++ S N LSG++P S+     +  +   GN     IP +
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 93.8 bits (234), Expect = 6e-22
 Identities = 25/110 (22%), Positives = 47/110 (42%), Gaps = 6/110 (5%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGS--ISSEIGKLQELNYLDLSH-NLINGKIP 59
           N    G +        ++  L L    L     I S +  L  LN+L +   N + G IP
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIPST 106
             + ++ ++  + ++  N+SG+IP+ +   K +  L  S N     +P +
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  123 bits (312), Expect = 5e-33
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 19/184 (10%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
            +F I+  IG G +  VYRA  L  G  VALKK+   +  +  +      E  LL Q+ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT--------DEEAVGLDWAKRVNIVKG 298
            N++K Y   +    + ++ E  + G L  +++          E  V             
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-------WKYFVQ 144

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           +  AL ++H      ++HRDI   NV + +     + D G+ R  +  ++    L GT  
Sbjct: 145 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201

Query: 359 YIAP 362
           Y++P
Sbjct: 202 YMSP 205

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  120 bits (304), Expect = 9e-32
 Identities = 43/180 (23%), Positives = 88/180 (48%), Gaps = 15/180 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
             + I   IG+GG   V++      ++ A+K ++  E +   +L+S+RNE   L+++   
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 86

Query: 248 N--IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           +  I++LY + +  + ++++ E      L   L+  ++++     K     K M  A+  
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK-KKKSIDPWERKS--YWKNMLEAVHT 142

Query: 306 LHHHCTPPIVHRDISSNNVLL-NSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAP 362
           +H H    IVH D+   N L+ +  L+  + DFG+A  +  D+++  +    GT  Y+ P
Sbjct: 143 IHQHG---IVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  120 bits (303), Expect = 9e-32
 Identities = 57/180 (31%), Positives = 83/180 (46%), Gaps = 16/180 (8%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            E F     IG G +G V++     + KVVA+K +   E E+   +E  + E  +LSQ  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCD 78

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHA 302
              + K YG  L    +++I EY+  GS   +L     DE  +         I++ +   
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKG 131

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           L YLH       +HRDI + NVLL+   E  +ADFGVA  L      R    GT  ++AP
Sbjct: 132 LDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 188

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  120 bits (303), Expect = 2e-31
 Identities = 44/180 (24%), Positives = 88/180 (48%), Gaps = 15/180 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH- 246
             + I   IG+GG   V++      ++ A+K ++  E +   +L+S+RNE   L+++   
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 67

Query: 247 -RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
              I++LY + +  + ++++ E      L   L+  +    +D  +R +  K M  A+  
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHT 123

Query: 306 LHHHCTPPIVHRDISSNNVLL-NSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAP 362
           +H H    IVH D+   N L+ +  L+  + DFG+A  +  D+++  +    GT  Y+ P
Sbjct: 124 IHQHG---IVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  120 bits (302), Expect = 6e-31
 Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 8/161 (4%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ED  +   IG G +G V+  RL +    VA+K    +   +      F  EAR+L Q  H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSH 171

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIV+L G C  ++ ++++ E ++ G     LRT+   + +     + +V   A  + YL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYL 229

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
                   +HRD+++ N L+  +    ++DFG++R      
Sbjct: 230 ESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  119 bits (300), Expect = 1e-30
 Identities = 43/180 (23%), Positives = 86/180 (47%), Gaps = 15/180 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH- 246
             + I   IG+GG   V++      ++ A+K ++  E +   +L+S+RNE   L+++   
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 114

Query: 247 -RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
              I++LY + +  + ++++ E      L   L+  +    +D  +R +  K M  A+  
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHT 170

Query: 306 LHHHCTPPIVHRDISSNNVLL-NSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           +H H    IVH D+   N L+ +  L+  + DFG+A  +  D+++       G   Y+ P
Sbjct: 171 IHQHG---IVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (295), Expect = 1e-30
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 10/171 (5%)

Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            +G G YG VY  R L +   +A+K++   ++     L     E  L   + H+NIV+  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH---EEIALHKHLKHKNIVQYL 85

Query: 254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP 313
           G       + +  E +  GSL  +LR+    +  +        K +   L YLH +    
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142

Query: 314 IVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           IVHRDI  +NVL+N+     +  +DFG ++ L   +       GT  Y+AP
Sbjct: 143 IVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (291), Expect = 3e-30
 Identities = 62/180 (34%), Positives = 93/180 (51%), Gaps = 17/180 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF I   +G G +G+VY AR   S  ++ALK L +++ E+       R E  + S + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
            NI++LYG+      ++LI EY  +G+++  L+     DE+            +  +A+A
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR-----TAT--YITELANA 121

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LSY H      ++HRDI   N+LL S  E  +ADFG +      SS RT L GT  Y+ P
Sbjct: 122 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLCGTLDYLPP 176

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  115 bits (291), Expect = 4e-30
 Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 21/178 (11%)

Query: 195 CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLY 253
            IG G + +VY+     +   VA  +L   +  + +  + F+ EA +L  + H NIV+ Y
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 254 GFCL----HRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSY 305
                    +KC+ L+ E M  G+L   L+       + +   W +   I+KG    L +
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS-WCR--QILKG----LQF 144

Query: 306 LHHHCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH   TPPI+HRD+  +N+ +        + D G+A L    +S    + GT  ++AP
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAP 199

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  115 bits (289), Expect = 7e-30
 Identities = 56/192 (29%), Positives = 82/192 (42%), Gaps = 19/192 (9%)

Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           M    ED+ + Y IGTG YG   + R    GK++  K+L      E A  +   +E  LL
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLL 59

Query: 242 SQIWHRNIVKLYG-FCLHRKCMFLIY-EYMEMGSLFCVLRTD-------EEAVGLDWAKR 292
            ++ H NIV+ Y            I  EY E G L  V+          +E   L    +
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 293 VNIVKGMAHALSYLH--HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
                 +  AL   H        ++HRD+   NV L+ +    + DFG+AR+LN D+S  
Sbjct: 120 ------LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173

Query: 351 TLLAGTSGYIAP 362
               GT  Y++P
Sbjct: 174 KTFVGTPYYMSP 185

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  120 bits (302), Expect = 8e-30
 Identities = 40/109 (36%), Positives = 58/109 (53%), Gaps = 3/109 (2%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + NN   G IP  L NCS+L  L L  N LSG+I S +G L +L  L L  N++ G+IP 
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
           +L  +  ++T+ L  N+L+G IP  +        + +S N    EIP  
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  118 bits (297), Expect = 3e-29
 Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 3/109 (2%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           ++ N L+G IPQELM    L  LIL  N L+G I S +     LN++ LS+N + G+IP 
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
            +G +  +  + LS N+ SG+IP  +        L ++ N F   IP+ 
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  117 bits (296), Expect = 4e-29
 Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 3/109 (2%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N L G IP  L + SKLR L L  N+L G I  E+  ++ L  L L  N + G+IPS
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
            L     ++ ++LS N L+G IP+ + ++    +L +S N+F   IP+ 
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  117 bits (296), Expect = 5e-29
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 3/107 (2%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           +    G       N   +  L +  N+LSG I  EIG +  L  L+L HN I+G IP ++
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVPLLY---VSGNNFEVEIPST 106
           G++  ++ ++LS N L G IP+++  + +L    +S NN    IP  
Sbjct: 677 GDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  116 bits (294), Expect = 9e-29
 Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 1/105 (0%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N L G IP  L NC+ L  + L NN L+G I   IG+L+ L  L LS+N  +G IP+
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPS 105
           +LG+   +  ++L+ N  +G+IP ++ K     ++ N    +   
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK-IAANFIAGKRYV 576

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  115 bits (290), Expect = 3e-28
 Identities = 38/111 (34%), Positives = 54/111 (48%), Gaps = 5/111 (4%)

Query: 1   MYNNKLDGPIPQELMNCSK--LRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKI 58
           + +N   GPI   L    K  L+ L L NN  +G I   +    EL  L LS N ++G I
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434

Query: 59  PSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
           PS LG + ++  + L +N L G IP+ +  V     L +  N+   EIPS 
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 485

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  113 bits (285), Expect = 1e-27
 Identities = 36/119 (30%), Positives = 51/119 (42%), Gaps = 6/119 (5%)

Query: 2   YNNKLDGPIPQELM-NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP- 59
             NK  G IP  L   C  L  L L  N   G++    G    L  L LS N  +G++P 
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVP----LLYVSGNNFEVEIPSTSAKAPPPH 114
             L ++  +  ++LS N  SG +PES+  +      L +S NNF   I     + P   
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  111 bits (281), Expect = 4e-27
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 7/113 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSE-IGKLQELNYLDLSHNLINGKIP 59
           +  N   G +P    +CS L  L L +N  SG +  + + K++ L  LDLS N  +G++P
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360

Query: 60  SQLGEI-PRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFEVEIPST 106
             L  +   + T++LS NN SG I  ++ + P      LY+  N F  +IP T
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  106 bits (267), Expect = 2e-25
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 3/107 (2%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
             +  G   ++L   S      + + +  G  S        + +LD+S+N+++G IP ++
Sbjct: 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652

Query: 63  GEIPRIDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIPST 106
           G +P +  +NL  N++SGSIP+ V   + + +L +S N  +  IP  
Sbjct: 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  106 bits (267), Expect = 3e-25
 Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 7/109 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + +N     IP  L +CS L+ L +  N LSG  S  I    EL  L++S N   G IP 
Sbjct: 207 VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPS 105
               +  +  ++L+ N  +G IP+ +      +  L +SGN+F   +P 
Sbjct: 266 LP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  102 bits (257), Expect = 5e-24
 Identities = 31/110 (28%), Positives = 53/110 (48%), Gaps = 9/110 (8%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + NN+L G IP+ +     L IL L NN  SG+I +E+G  + L +LDL+ NL NG IP+
Sbjct: 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYV-----SGNNFEVEIPS 105
            + +     +  ++ N ++G     +K   +        +   F+     
Sbjct: 557 AMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  101 bits (254), Expect = 1e-23
 Identities = 29/113 (25%), Positives = 50/113 (44%), Gaps = 9/113 (7%)

Query: 1   MYNNKLDGPIPQELM---NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGK 57
           +  N + G      +    C +L+ L +  N +SG +   + +   L +LD+S N  +  
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG 215

Query: 58  IPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPSTS 107
           IP  LG+   +  +++S N LSG    ++       LL +S N F   IP   
Sbjct: 216 IPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP 267

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 22/111 (19%), Positives = 43/111 (38%), Gaps = 5/111 (4%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNL--LSGSISSEIGKLQELNYLDLSHNLINGKI 58
           +  N + G     + N    +      NL    G  S ++ +L   N  +++  +  G  
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624

Query: 59  PSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYV---SGNNFEVEIPST 106
                    +  +++S N LSG IP+ +  +P L++     N+    IP  
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 93.8 bits (234), Expect = 4e-21
 Identities = 35/112 (31%), Positives = 48/112 (42%), Gaps = 7/112 (6%)

Query: 1   MYNNKLDGPIP--QELMNCSKLRILILGNNLLSGSISSEIG-KLQELNYLDLSHNLINGK 57
           +  N L GP+     L +CS L+ L + +N L        G KL  L  LDLS N I+G 
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 58  IPSQL---GEIPRIDTVNLSMNNLSGSIPES-VKKVPLLYVSGNNFEVEIPS 105
                        +  + +S N +SG +  S    +  L VS NNF   IP 
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF 218

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 93.4 bits (233), Expect = 7e-21
 Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 8/111 (7%)

Query: 2   YNNKLDGPIP-QELMNCSKLRILILGNNLLSGSISSEI---GKLQELNYLDLSHNLINGK 57
            +N LD P      +  + L +L L  N +SG+            EL +L +S N I+G 
Sbjct: 134 SSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGD 193

Query: 58  IPSQLGEIPRIDTVNLSMNNLSGSIPE--SVKKVPLLYVSGNNFEVEIPST 106
           +   +     ++ +++S NN S  IP       +  L +SGN    +    
Sbjct: 194 VD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRA 242

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 26/111 (23%), Positives = 45/111 (40%), Gaps = 7/111 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
              N     +   L++ + L  L L N+ ++GS+ S       L  LDLS N ++G + +
Sbjct: 60  KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTT 118

Query: 61  --QLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPS 105
              LG    +  +N+S N L      S       + +L +S N+       
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVV 169

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 21/95 (22%), Positives = 40/95 (42%), Gaps = 6/95 (6%)

Query: 18  SKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNN 77
           + + +     N+   ++SS +  L  L  L LS++ ING +         + +++LS N+
Sbjct: 53  TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNS 111

Query: 78  LSGSIPESV-----KKVPLLYVSGNNFEVEIPSTS 107
           LSG +           +  L VS N  +     + 
Sbjct: 112 LSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSG 146

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 51.1 bits (123), Expect = 3e-07
 Identities = 11/71 (15%), Positives = 32/71 (45%), Gaps = 2/71 (2%)

Query: 39  GKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPE--SVKKVPLLYVSG 96
            K+  ++      N+    + S L  +  ++++ LS ++++GS+        +  L +S 
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109

Query: 97  NNFEVEIPSTS 107
           N+    + + +
Sbjct: 110 NSLSGPVTTLT 120

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  115 bits (290), Expect = 1e-29
 Identities = 47/174 (27%), Positives = 85/174 (48%), Gaps = 23/174 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKV---VALKKLHRSETEELASLESFRNEARLLS 242
            +F     +G+G +G+VY+        KV   VA+K+L  + + +  + +   +EA +++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 72

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKG 298
            + + ++ +L G CL    + LI + M  G L   +R  ++ +G    L+W   V I KG
Sbjct: 73  SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKG 129

Query: 299 MAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
           M     YL         VHRD+++ NVL+ +     + DFG+A+LL  +     
Sbjct: 130 MN----YLEDRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  115 bits (290), Expect = 1e-29
 Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 17/181 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
             +     +G GG+   +      + +V A K + +S   +    E    E  +   + H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNIVKGMAH 301
           +++V  +GF      +F++ E     SL  + +     T+ EA       R   ++ +  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 152

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
              YLH +    ++HRD+   N+ LN +LE  + DFG+A  + +D   + +L GT  YIA
Sbjct: 153 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209

Query: 362 P 362
           P
Sbjct: 210 P 210

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  114 bits (288), Expect = 1e-29
 Identities = 48/173 (27%), Positives = 74/173 (42%), Gaps = 24/173 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARLLS 242
                   +G G +G V   R       +G+ VA+K L          +   + E  +L 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILR 78

Query: 243 QIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIV 296
            ++H NIVK  G C       + LI E++  GSL   L  ++  +     L +A  V I 
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA--VQIC 136

Query: 297 KGMAHALSYLH-HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           KGM     YL         VHRD+++ NVL+ SE +  + DFG+ + +  D  
Sbjct: 137 KGMD----YLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  114 bits (287), Expect = 2e-29
 Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 17/181 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
             +     +G GG+   +      + +V A K + +S   +    E    E  +   + H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRVNIVKGMAH 301
           +++V  +GF      +F++ E     SL  + +     T+ EA       R   ++ +  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-------R-YYLRQIVL 126

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
              YLH +    ++HRD+   N+ LN +LE  + DFG+A  + +D   + +L GT  YIA
Sbjct: 127 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183

Query: 362 P 362
           P
Sbjct: 184 P 184

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  114 bits (287), Expect = 2e-29
 Identities = 46/186 (24%), Positives = 91/186 (48%), Gaps = 16/186 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +D+ ++  IG+G    V  A   P  + VA+K+++  + +   S++    E + +SQ  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCHH 72

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNIVKGMAH 301
            NIV  Y   + +  ++L+ + +  GS+  +++      + ++  LD +    I++ +  
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN-----FDSSNRTLLAGT 356
            L YLH +     +HRD+ + N+LL  +    +ADFGV+  L        +  R    GT
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 357 SGYIAP 362
             ++AP
Sbjct: 190 PCWMAP 195

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  113 bits (286), Expect = 2e-29
 Identities = 42/198 (21%), Positives = 79/198 (39%), Gaps = 41/198 (20%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
            DF     IG+GG+G V++A+    GK   +K++  +        E    E + L+++ H
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDH 63

Query: 247 RNIVKLYGF----------------CLHRKCMFLIYEYMEMGSLFCVLRT------DEEA 284
            NIV   G                     KC+F+  E+ + G+L   +        D+  
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 285 VGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                   + + + +   + Y+H      +++RD+  +N+ L    +  + DFG+   L 
Sbjct: 124 A-------LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173

Query: 345 FDSSNRTLLAGTSGYIAP 362
            D        GT  Y++P
Sbjct: 174 NDGKRTR-SKGTLRYMSP 190

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  113 bits (285), Expect = 3e-29
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 18/169 (10%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFRNEARLLSQ 243
           +D  +   +G G +G V R     PSGK   VA+K L      +  +++ F  E   +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGM 299
           + HRN+++LYG  L    M ++ E   +GSL   LR  +          +A  V + +GM
Sbjct: 78  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGM 134

Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
                YL        +HRD+++ N+LL +     + DFG+ R L  +  
Sbjct: 135 G----YLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  113 bits (286), Expect = 3e-29
 Identities = 39/200 (19%), Positives = 78/200 (39%), Gaps = 30/200 (15%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
            DF    C+G GG+G V+ A+        A+K++     E   + E    E + L+++ H
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62

Query: 247 RNIVKLYGFCLHRKCM------------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 294
             IV+ +   L +               ++  +     +L   +         + +  ++
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS------- 347
           I   +A A+ +LH      ++HRD+  +N+    +    V DFG+   ++ D        
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 348 -----SNRTLLAGTSGYIAP 362
                +  T   GT  Y++P
Sbjct: 180 PMPAYARHTGQVGTKLYMSP 199

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  113 bits (285), Expect = 3e-29
 Identities = 48/176 (27%), Positives = 87/176 (49%), Gaps = 6/176 (3%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF +   +G G +  VYRA  + +G  VA+K + +    +   ++  +NE ++  Q+ H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            +I++LY +      ++L+ E    G +   L+   +    + A+    +  +   + YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYL 128

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    I+HRD++ +N+LL   +   +ADFG+A  L         L GT  YI+P
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  112 bits (283), Expect = 3e-29
 Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 11/160 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
            +      IG+G +G V+     +   VA+K +      E    E F  EA ++ ++ H 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 63

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL- 306
            +V+LYG CL +  + L+ E+ME G L   LRT       +    + +   +   ++YL 
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLE 121

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                   +HRD+++ N L+       V+DFG+ R +  D
Sbjct: 122 EACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  113 bits (285), Expect = 4e-29
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 19/182 (10%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            E + I   +G G +G VY+A+   +G + A K +     EEL   E +  E  +L+   
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCD 74

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNIVKGMA 300
           H  IVKL G   H   ++++ E+   G++  ++        E  + +       + + M 
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQML 127

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
            AL++LH      I+HRD+ + NVL+  E +  +ADFGV+         R    GT  ++
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 184

Query: 361 AP 362
           AP
Sbjct: 185 AP 186

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  113 bits (285), Expect = 6e-29
 Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 25/173 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARLLS 242
                   +G G +GSV   R       +G +VA+K+L  S  +       F+ E ++L 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---QQRDFQREIQILK 79

Query: 243 QIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIV 296
            +    IVK  G      R+ + L+ EY+  G L   L+     +     L ++    I 
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQIC 137

Query: 297 KGMAHALSYLH-HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           KGM     YL    C    VHRD+++ N+L+ SE    +ADFG+A+LL  D  
Sbjct: 138 KGME----YLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (283), Expect = 6e-29
 Identities = 46/180 (25%), Positives = 86/180 (47%), Gaps = 17/180 (9%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            + +     IG G  G+VY A  + +G+ VA+++++  +  +    E   NE  ++ +  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENK 75

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHA 302
           + NIV      L    ++++ EY+  GSL  V+     DE  +         + +    A
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQA 128

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           L +LH +    ++HRDI S+N+LL  +    + DFG    +  + S R+ + GT  ++AP
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  114 bits (287), Expect = 7e-29
 Identities = 37/189 (19%), Positives = 77/189 (40%), Gaps = 27/189 (14%)

Query: 177 RITFQDMIEA---TEDFHIKYCIGTG--GYGSVYRAR-LPSGKVVALKK--LHRSETEEL 228
            + FQ M         + +   IG G     +V  AR  P+G+ V +++  L     E +
Sbjct: 11  NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV 70

Query: 229 ASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT------DE 282
             L   + E  +     H NIV      +    ++++  +M  GS   ++ T      +E
Sbjct: 71  TFL---QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 127

Query: 283 EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
            A+         I++G+  AL Y+HH      VHR + ++++L++ + + +++       
Sbjct: 128 LAIAY-------ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177

Query: 343 LNFDSSNRT 351
           +      + 
Sbjct: 178 MISHGQRQR 186

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  112 bits (282), Expect = 7e-29
 Identities = 55/172 (31%), Positives = 81/172 (47%), Gaps = 25/172 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARLLS 242
                   +G G +GSV   R       +G+VVA+KKL +  TEE   L  F  E  +L 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEE--HLRDFEREIEILK 66

Query: 243 QIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIV 296
            + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +     L +     I 
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQIC 124

Query: 297 KGMAHALSYLH-HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
           KGM     YL         +HRD+++ N+L+ +E    + DFG+ ++L  D 
Sbjct: 125 KGME----YLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  113 bits (284), Expect = 8e-29
 Identities = 49/191 (25%), Positives = 78/191 (40%), Gaps = 33/191 (17%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKK--LHRSETEELASLESFRNEARLL 241
           E       +  +G G +G V+R +   +G   A+KK  L     EEL             
Sbjct: 55  EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV----------AC 104

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVK 297
           + +    IV LYG       + +  E +E GSL  +++      E+            + 
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-------YYLG 157

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTL---- 352
                L YLH      I+H D+ ++NVLL+S+   A + DFG A  L  D   ++L    
Sbjct: 158 QALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214

Query: 353 -LAGTSGYIAP 362
            + GT  ++AP
Sbjct: 215 YIPGTETHMAP 225

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  112 bits (282), Expect = 1e-28
 Identities = 55/173 (31%), Positives = 81/173 (46%), Gaps = 25/173 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP-----SGKVVALKKLHRSETEELASLESFRNEARLLS 242
                   +G G +GSV   R       +G+VVA+KKL +  TEE   L  F  E  +L 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEE--HLRDFEREIEILK 97

Query: 243 QIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIV 296
            + H NIVK  G C    R+ + LI EY+  GSL   L+  +E +     L +     I 
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQIC 155

Query: 297 KGMAHALSYLH-HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           KGM     YL         +HRD+++ N+L+ +E    + DFG+ ++L  D  
Sbjct: 156 KGME----YLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  111 bits (279), Expect = 2e-28
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 11/160 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           +D      +GTG +G V   +      VA+K +      E    + F  EA+++  + H 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHE 79

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL- 306
            +V+LYG C  ++ +F+I EYM  G L   LR           + + + K +  A+ YL 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE 137

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                   +HRD+++ N L+N +    V+DFG++R +  D
Sbjct: 138 SKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  114 bits (286), Expect = 4e-28
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 9/160 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWH 246
            D  +K+ +G G YG VY        + VA+K L     E     E F  EA ++ +I H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKH 275

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            N+V+L G C      ++I E+M  G+L   LR       +     + +   ++ A+ YL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL 334

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                   +HR++++ N L+       VADFG++RL+  D
Sbjct: 335 EKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  111 bits (279), Expect = 4e-28
 Identities = 47/180 (26%), Positives = 86/180 (47%), Gaps = 17/180 (9%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
                    IG G  G V  AR   SG+ VA+K +   + +     E   NE  ++    
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQ 100

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNIVKGMAHA 302
           H N+V++Y   L  + ++++ E+++ G+L  ++     +EE +         + + +  A
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT-------VCEAVLQA 153

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           L+YLH      ++HRDI S+++LL  +    ++DFG    ++ D   R  L GT  ++AP
Sbjct: 154 LAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  111 bits (279), Expect = 4e-28
 Identities = 47/173 (27%), Positives = 86/173 (49%), Gaps = 21/173 (12%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKV---VALKKLHRSETEELASLESFRNEARLLS 242
            +F     +G+G +G+VY+        KV   VA+K+L  + + +  + +   +EA +++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 72

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKG 298
            + + ++ +L G CL    + LI + M  G L   +R  ++ +G    L+W   V I KG
Sbjct: 73  SVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKG 129

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
           M     YL       +VHRD+++ NVL+ +     + DFG+A+LL  +     
Sbjct: 130 MN----YLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  110 bits (278), Expect = 4e-28
 Identities = 39/190 (20%), Positives = 72/190 (37%), Gaps = 21/190 (11%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           + +     +G GG+  V     L  G   ALK++   E ++    E  + EA +     H
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNH 85

Query: 247 RNIVKLYGFCLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAH 301
            NI++L  +CL  +      +L+  + + G+L+  +   ++    L   + + ++ G+  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA------- 354
            L  +H        HRD+   N+LL  E +  + D G                       
Sbjct: 146 GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 355 --GTSGYIAP 362
              T  Y AP
Sbjct: 203 QRCTISYRAP 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  110 bits (278), Expect = 5e-28
 Identities = 55/164 (33%), Positives = 82/164 (50%), Gaps = 11/164 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL---PSGKV-VALKKLHRSETEELASLESFRNEARLLSQ 243
              HI+  IG+G  G V   RL       V VA+K L    TE       F +EA ++ Q
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQ 106

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H NI++L G     +   ++ EYME GSL   LRT +        + V +++G+   +
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGM 164

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        VHRD+++ NVL++S L   V+DFG++R+L  D 
Sbjct: 165 RYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  110 bits (276), Expect = 5e-28
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 13/161 (8%)

Query: 192 IKYCIGTGGYGSVYRARL--PSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
               +G G +GSV +        ++ VA+K L +   +     E    EA+++ Q+ +  
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPY 71

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL-H 307
           IV+L G C   + + L+ E    G L   L    E   +  +    ++  ++  + YL  
Sbjct: 72  IVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEE 128

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
            +     VHRD+++ NVLL +   A ++DFG+++ L  D S
Sbjct: 129 KNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  111 bits (278), Expect = 9e-28
 Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 22/182 (12%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF     +G G  G V++    PSG V+A K +H      +        E ++L +   
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHECNS 90

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
             IV  YG       + +  E+M+ GSL  VL+      E+ +G        +   +   
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-------VSIAVIKG 143

Query: 303 LSYLH--HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
           L+YL   H     I+HRD+  +N+L+NS  E  + DFGV+  L  DS   +   GT  Y+
Sbjct: 144 LTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGTRSYM 197

Query: 361 AP 362
           +P
Sbjct: 198 SP 199

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  109 bits (274), Expect = 1e-27
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 13/157 (8%)

Query: 196 IGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G+G +G+V +      KV   VA+K L ++E  + A  +    EA ++ Q+ +  IV++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHHCT 311
            G C   +   L+ E  E+G L   L+ +     +     + +V  ++  + YL   +  
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNF- 138

Query: 312 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
              VHRD+++ NVLL ++  A ++DFG+++ L  D +
Sbjct: 139 ---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  109 bits (275), Expect = 1e-27
 Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 21/182 (11%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            E F +   +G G YGSVY+A    +G++VA+K++     E    L+    E  ++ Q  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVES--DLQEIIKEISIMQQCD 82

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNIVKGMA 300
             ++VK YG       ++++ EY   GS+  ++R       E+ +         I++   
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-------ILQSTL 135

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
             L YLH       +HRDI + N+LLN+E  A +ADFGVA  L    + R  + GT  ++
Sbjct: 136 KGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWM 192

Query: 361 AP 362
           AP
Sbjct: 193 AP 194

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  108 bits (272), Expect = 1e-27
 Identities = 38/157 (24%), Positives = 78/157 (49%), Gaps = 11/157 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E+  +   +G+G +G V   +      VA+K +      E    + F  EA+ + ++ H 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHP 63

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL- 306
            +VK YG C     ++++ EY+  G L   LR+  +   L+ ++ + +   +   +++L 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLE 121

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
            H      +HRD+++ N L++ +L   V+DFG+ R +
Sbjct: 122 SHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYV 154

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  109 bits (275), Expect = 1e-27
 Identities = 44/170 (25%), Positives = 76/170 (44%), Gaps = 22/170 (12%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLS 242
                   +G G +G V           +G++VA+K L      +      ++ E  +L 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILR 88

Query: 243 QIWHRNIVKLYGFCLHRKC--MFLIYEYMEMGSLFCVLRTDEEAVG--LDWAKRVNIVKG 298
            ++H +I+K  G C       + L+ EY+ +GSL   L      +   L +A    I +G
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEG 146

Query: 299 MAHALSYLH-HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
           MA    YLH  H     +HRD+++ NVLL+++    + DFG+A+ +    
Sbjct: 147 MA----YLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  113 bits (283), Expect = 1e-27
 Identities = 48/181 (26%), Positives = 80/181 (44%), Gaps = 24/181 (13%)

Query: 190 FHIKYCIGTGGYGSVYRA---RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           + +K CI  GG G +Y A    + +G+ V LK L  S   E         E + L+++ H
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEA--QAMAMAERQFLAEVVH 138

Query: 247 RNIVKLYGFCLH-----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
            +IV+++ F  H         +++ EY+   SL        +   L  A+ +  +  +  
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILP 193

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           ALSYLH      +V+ D+   N++L  E +  + D G    +N        L GT G+ A
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY----LYGTPGFQA 245

Query: 362 P 362
           P
Sbjct: 246 P 246

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  110 bits (277), Expect = 2e-27
 Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 11/164 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFRNEARLLSQ 243
            +  I   +G G +G V   RL         VA+K L    TE+      F  EA ++ Q
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQ 102

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H NI++L G     K + ++ EYME GSL   LR  +        + V +++G+A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGM 160

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            YL        VHRD+++ N+L+NS L   V+DFG+ R+L  D 
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 2e-27
 Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 28/190 (14%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
              F +   +G G YG VY+ R + +G++ A+K +  +  EE    E  + E  +L +  
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYS 78

Query: 246 -HRNIVKLYGFCLHRKC------MFLIYEYMEMGSLFCVLRT------DEEAVGLDWAKR 292
            HRNI   YG  + +        ++L+ E+   GS+  +++        EE +       
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY----- 133

Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
             I + +   LS+LH H    ++HRDI   NVLL    E  + DFGV+  L+     R  
Sbjct: 134 --ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188

Query: 353 LAGTSGYIAP 362
             GT  ++AP
Sbjct: 189 FIGTPYWMAP 198

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  108 bits (273), Expect = 3e-27
 Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 21/170 (12%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL----PSGKV-VALKKLHRSETEELASLESFRNEARLLS 242
            +      +G+G +G+V++        S K+ V +K +      +  S ++  +    + 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIG 70

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKG 298
            + H +IV+L G C     + L+ +Y+ +GSL   +R    A+G    L+W   V I KG
Sbjct: 71  SLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKG 127

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           M     YL  H    +VHR++++ NVLL S  +  VADFGVA LL  D  
Sbjct: 128 MY----YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  108 bits (271), Expect = 3e-27
 Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 9/160 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKV-VALKKLHRSETEELASLESFRNEARLLSQIWH 246
            D  +K+ +G G YG VY        + VA+K L     E     E F  EA ++ +I H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKH 68

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            N+V+L G C      ++I E+M  G+L   LR       +     + +   ++ A+ YL
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL 127

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                   +HRD+++ N L+       VADFG++RL+  D
Sbjct: 128 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  107 bits (270), Expect = 3e-27
 Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 17/180 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF I   +G G +G+VY AR   +  ++ALK L +S+ E+       R E  + S + H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHA 302
            NI+++Y +   RK ++L+ E+   G L+  L    R DE+      +     ++ +A A
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-----SAT--FMEELADA 126

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           L Y H      ++HRDI   N+L+  + E  +ADFG +      S  R  + GT  Y+ P
Sbjct: 127 LHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA--PSLRRRTMCGTLDYLPP 181

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  108 bits (271), Expect = 5e-27
 Identities = 57/167 (34%), Positives = 86/167 (51%), Gaps = 14/167 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKV---VALKKLHRSETEELASLESFRNEARLLS 242
                +  IG G +G VY+  L   SGK    VA+K L    TE+      F  EA ++ 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMG 101

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           Q  H NI++L G     K M +I EYME G+L   LR  +        + V +++G+A  
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAG 159

Query: 303 LSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
           + YL + +     VHRD+++ N+L+NS L   V+DFG++R+L  D  
Sbjct: 160 MKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  107 bits (269), Expect = 6e-27
 Identities = 47/209 (22%), Positives = 85/209 (40%), Gaps = 47/209 (22%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
             DF     +G G +G V +AR     +  A+KK+  +E +      +  +E  LL+ + 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL----STILSEVMLLASLN 60

Query: 246 HRNIVKLYGFCLHR-------------KCMFLIYEYMEMGSLFCVLR-----TDEEAVGL 287
           H+ +V+ Y   L R               +F+  EY E G+L+ ++         +    
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY-- 118

Query: 288 DWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD- 346
                  + + +  ALSY+H      I+HRD+   N+ ++      + DFG+A+ ++   
Sbjct: 119 -----WRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170

Query: 347 -------------SSNRTLLAGTSGYIAP 362
                        S N T   GT+ Y+A 
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVAT 199

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  109 bits (275), Expect = 6e-27
 Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 9/159 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L           E+F  EA+++ ++ H 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 239

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY      + ++++ EYM  GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 240 KLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 297

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                  VHRD+ + N+L+   L   VADFG+ARL+  +
Sbjct: 298 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  109 bits (275), Expect = 7e-27
 Identities = 40/159 (25%), Positives = 81/159 (50%), Gaps = 9/159 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+ A       VA+K +           E+F  EA ++  + H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV----EAFLAEANVMKTLQHD 243

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +VKL+     ++ +++I E+M  GSL   L++DE +      K ++    +A  ++++ 
Sbjct: 244 KLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIE 301

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                  +HRD+ + N+L+++ L   +ADFG+AR++  +
Sbjct: 302 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  108 bits (271), Expect = 7e-27
 Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 21/182 (11%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            + F     IG G +G+VY AR + + +VVA+KK+  S  +     +    E R L ++ 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-----DEEAVGLDWAKRVNIVKGMA 300
           H N ++  G  L     +L+ EY   GS   +L        E  +         +  G  
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA-------VTHGAL 164

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
             L+YLH H    ++HRD+ + N+LL+      + DFG A ++    +      GT  ++
Sbjct: 165 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPYWM 217

Query: 361 AP 362
           AP
Sbjct: 218 AP 219

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  110 bits (276), Expect = 7e-27
 Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 9/159 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L           E+F  EA+++ ++ H 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 322

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY        ++++ EYM  GSL   L+ +     L   + V++   +A  ++Y+ 
Sbjct: 323 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE 380

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                  VHRD+ + N+L+   L   VADFG+ARL+  +
Sbjct: 381 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (269), Expect = 8e-27
 Identities = 43/181 (23%), Positives = 78/181 (43%), Gaps = 18/181 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEAR-LLSQIW 245
            D      +G+G  G V++ R   +G V+A+K++ RS  +E    +    +   +L    
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE--ENKRILMDLDVVLKSHD 82

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAH 301
              IV+ +G  +    +F+  E M   +     R      E  +G        +   +  
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-------KMTVAIVK 135

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           AL YL       ++HRD+  +N+LL+   +  + DFG++  L  D   +   AG + Y+A
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMA 192

Query: 362 P 362
           P
Sbjct: 193 P 193

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  106 bits (267), Expect = 1e-26
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   +   +G G +G V+         VA+K L +         ++F  EA L+ Q+ H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY        +++I EYME GSL   L+T      L   K +++   +A  ++++ 
Sbjct: 69  RLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
                  +HRD+ + N+L++  L   +ADFG+ARL+  +
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  106 bits (268), Expect = 1e-26
 Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 8/169 (4%)

Query: 196 IGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G GG G VY A      ++VALK +  + + +       + EAR   ++   ++V ++ 
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
           F      +++    +    L  +LR       L   + V IV+ +  AL   H       
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GA 155

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP 362
            HRD+   N+L++++  A++ DFG+A     +   +     GT  Y+AP
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAP 204

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  107 bits (268), Expect = 1e-26
 Identities = 40/194 (20%), Positives = 69/194 (35%), Gaps = 25/194 (12%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKL---HRSETEELASLESFRNEARLLSQ 243
           + F     +G G YG V++ R    G++ A+K+     R   +    L     E     +
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL----AEVGSHEK 112

Query: 244 IW-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           +  H   V+L         ++L  E     SL            L  A+    ++    A
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--AWGASLPEAQVWGYLRDTLLA 169

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           L++LH      +VH D+   N+ L       + DFG+   L    +      G   Y+AP
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAP 225

Query: 363 ---------ASEWW 367
                    A++ +
Sbjct: 226 ELLQGSYGTAADVF 239

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  107 bits (268), Expect = 1e-26
 Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 13/182 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
             + +   +G G   +V+R R   +G + A+K  +         ++    E  +L ++ H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66

Query: 247 RNIVKLYGF--CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
           +NIVKL+        +   LI E+   GSL+ VL     A GL  ++ + +++ +   ++
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNRTLLAGTSGYI 360
           +L  +    IVHR+I   N++     +      + DFG AR L  D    +L  GT  Y+
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYL 182

Query: 361 AP 362
            P
Sbjct: 183 HP 184

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  108 bits (273), Expect = 1e-26
 Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 11/155 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++  +   IG G +G V       G  VA+K +    T +     +F  EA +++Q+ H 
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 246

Query: 248 NIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
           N+V+L G  +  K  ++++ EYM  GSL   LR+   +V L     +     +  A+ YL
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 305

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +     VHRD+++ NVL++ +  A V+DFG+ +
Sbjct: 306 EGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  110 bits (275), Expect = 1e-26
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 13/157 (8%)

Query: 196 IGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G G +GSV +      K    VA+K L +   +     E    EA+++ Q+ +  IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRL 401

Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL-HHHCT 311
            G C   + + L+ E    G L   L    E   +  +    ++  ++  + YL   +  
Sbjct: 402 IGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKNF- 457

Query: 312 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
              VHR++++ NVLL +   A ++DFG+++ L  D S
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  108 bits (271), Expect = 2e-26
 Identities = 41/184 (22%), Positives = 83/184 (45%), Gaps = 23/184 (12%)

Query: 189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHR 247
            F  K  +G G  G++    +   + VA+K++                E +LL +   H 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE------CFSFADREVQLLRESDEHP 78

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLF-CVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
           N+++ +     R+  ++  E     +L   V + D   +GL+    + +++     L++L
Sbjct: 79  NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHL 134

Query: 307 HHHCTPPIVHRDISSNNVLL-----NSELEAFVADFGVARLLNFDSSNRTLL---AGTSG 358
           H      IVHRD+  +N+L+     + +++A ++DFG+ + L     + +      GT G
Sbjct: 135 HSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 359 YIAP 362
           +IAP
Sbjct: 192 WIAP 195

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  106 bits (267), Expect = 3e-26
 Identities = 29/197 (14%), Positives = 59/197 (29%), Gaps = 27/197 (13%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR------LPSGKVVALKKLHRSETEELASLESFRNEARL 240
           ++  ++ + +G G +  VY A         + +   LK    +   E             
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---YIGTQLMER 120

Query: 241 LSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG--LDWAKRVNIVKG 298
           L        +K Y   L +    L+ E    G+L   +   +      +     ++    
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF-----------VADFGVARLLNFDS 347
           M + +  +H      I+H DI  +N +L +                + D G +  +    
Sbjct: 181 MLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 348 SNRTL--LAGTSGYIAP 362
                     TSG+   
Sbjct: 238 KGTIFTAKCETSGFQCV 254

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  105 bits (265), Expect = 3e-26
 Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 22/185 (11%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEAR-LLSQIW 245
           ED      IG G YGSV +    PSG+++A+K++  +  E+    +    +   ++    
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSD 79

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------IVKGM 299
              IV+ YG        ++  E M   S     +     +       +       I    
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLD----DVIPEEILGKITLAT 134

Query: 300 AHALSYLH--HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTS 357
             AL++L         I+HRDI  +N+LL+      + DFG++  L  DS  +T  AG  
Sbjct: 135 VKALNHLKENLK----IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCR 189

Query: 358 GYIAP 362
            Y+AP
Sbjct: 190 PYMAP 194

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  104 bits (262), Expect = 5e-26
 Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 22/165 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFRNEARLLSQ 243
           ED  +   +G G +G VY        G+   VA+K   +  T +  + E F +EA ++  
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKN 69

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGM 299
           + H +IVKL G     +  ++I E    G L   L  ++ ++     + ++  + I K M
Sbjct: 70  LDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKAM 126

Query: 300 AHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           A    YL   +C    VHRDI+  N+L+ S     + DFG++R +
Sbjct: 127 A----YLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI 163

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  106 bits (267), Expect = 5e-26
 Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 13/182 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
             + +   +G G   +V+R R   +G + A+K  +         ++    E  +L ++ H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66

Query: 247 RNIVKLYGF--CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
           +NIVKL+        +   LI E+   GSL+ VL     A GL  ++ + +++ +   ++
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNRTLLAGTSGYI 360
           +L  +    IVHR+I   N++     +      + DFG AR L  D    +L  GT  Y+
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYL 182

Query: 361 AP 362
            P
Sbjct: 183 HP 184

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  104 bits (261), Expect = 7e-26
 Identities = 35/198 (17%), Positives = 71/198 (35%), Gaps = 30/198 (15%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           T +FH    IG+G +GSV++      G + A+K+  +         ++   E    + + 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLG 68

Query: 246 -HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHAL 303
            H ++V+ +        M +  EY   GSL   +  +   +     A+  +++  +   L
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFV-------------------ADFGVARLLN 344
            Y+H      +VH DI  +N+ ++                           D G    ++
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 345 FDSSNRTLLAGTSGYIAP 362
                     G S ++A 
Sbjct: 186 SPQV----EEGDSRFLAN 199

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  108 bits (270), Expect = 8e-26
 Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 16/184 (8%)

Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
            + +K  +GTGG+G V R     +G+ VA+K+  +  + +  + E +  E +++ ++ H 
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHP 72

Query: 248 NIVKLY------GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
           N+V                   L  EY E G L   L   E   GL       ++  ++ 
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTSG 358
           AL YLH +    I+HRD+   N++L    +     + D G A+ L+        + GT  
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQ 188

Query: 359 YIAP 362
           Y+AP
Sbjct: 189 YLAP 192

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  103 bits (260), Expect = 8e-26
 Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 13/156 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++  +   IG G +G V       G  VA+K +    T +     +F  EA +++Q+ H 
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 74

Query: 248 NIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
           N+V+L G  +  K  ++++ EYM  GSL   LR+   +V L     +     +  A+ YL
Sbjct: 75  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 133

Query: 307 -HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             ++     VHRD+++ NVL++ +  A V+DFG+ +
Sbjct: 134 EGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK 165

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  105 bits (262), Expect = 2e-25
 Identities = 21/224 (9%), Positives = 53/224 (23%), Gaps = 37/224 (16%)

Query: 170 AIWNYDGRITFQDMI-EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEE 227
            +W  +   T   ++ +      +   +  G    V+  R +   +  ALK         
Sbjct: 43  TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102

Query: 228 LASLESFRNEARLLSQIWHRNIVKLYGFC--------------------------LHRKC 261
            + LE         +++   +  +                                    
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 262 MFLIYEYM--EMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRD 318
             L+      ++  LF  L       G         +   +    + L       +VH  
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGH 219

Query: 319 ISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            + +N+ +  +    + D      +    +     +    Y   
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALWKVG---TRGPASSVPVTYAPR 260

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  103 bits (259), Expect = 2e-25
 Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 12/171 (7%)

Query: 196 IGTGGYGSVYRA---RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G GG  +VY A    L     VA+K +     E+  +L+ F  E    SQ+ H+NIV +
Sbjct: 19  LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTP 312
                   C +L+ EY+E  +L   + +      L     +N    +   + + H     
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM--- 130

Query: 313 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT-LLAGTSGYIAP 362
            IVHRDI   N+L++S     + DFG+A+ L+  S  +T  + GT  Y +P
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  103 bits (260), Expect = 2e-25
 Identities = 44/150 (29%), Positives = 79/150 (52%), Gaps = 8/150 (5%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G YG V + R   +G++VA+KK   S+ +++    + R E +LL Q+ H N+V L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
            C  +K  +L++E+++  ++   L  +    GLD+      +  + + + + H H    I
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSHN---I 145

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLN 344
           +HRDI   N+L++      + DFG AR L 
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLA 175

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  102 bits (257), Expect = 2e-25
 Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 14/161 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFRNEARLLSQ 243
           E   +  CIG G +G V++     P      VA+K      ++     E F  EA  + Q
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 72

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H +IVKL G       +++I E   +G L   L+  + ++ L  A  +     ++ AL
Sbjct: 73  FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTAL 129

Query: 304 SYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           +YL         VHRDI++ NVL++S     + DFG++R +
Sbjct: 130 AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM 166

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  104 bits (262), Expect = 3e-25
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 32/231 (13%)

Query: 150 RDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCI----GTGGYGSVY 205
           + K+       EI        ++ +   +T  D     +    +Y +    G+G  G V 
Sbjct: 94  KGKRRPLNNNSEIALSLSRNKVFVFF-DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVK 152

Query: 206 RAR-LPSGKVVALK-----KLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR 259
            A    + K VA++     K       E     +   E  +L ++ H  I+K+  F    
Sbjct: 153 LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DA 211

Query: 260 KCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
           +  +++ E ME G LF   V      +                 M  A+ YLH +    I
Sbjct: 212 EDYYIVLELMEGGELFDKVVGNKRLKEATC--------KLYFYQMLLAVQYLHENG---I 260

Query: 315 VHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           +HRD+   NVLL+S+ E     + DFG +++L   S  RT L GT  Y+AP
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAP 310

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  102 bits (257), Expect = 5e-25
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 8/150 (5%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG V++ R   +G++VA+KK   SE + +    + R E R+L Q+ H N+V L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
               ++ + L++EY +  ++   L  D    G+      +I      A+++ H H     
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLN 344
           +HRD+   N+L+       + DFG ARLL 
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLT 153

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  104 bits (262), Expect = 5e-25
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 23/188 (12%)

Query: 187 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           T  F  +Y      G G +G V   +   +G+  A+K + + + ++    ES   E +LL
Sbjct: 21  TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVK 297
            Q+ H NI+KLY F   +   +L+ E    G LF  + +     E            I++
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIR 133

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLA 354
            +   ++Y+H +    IVHRD+   N+LL S+ +     + DFG++         +    
Sbjct: 134 QVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-KI 189

Query: 355 GTSGYIAP 362
           GT+ YIAP
Sbjct: 190 GTAYYIAP 197

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  100 bits (252), Expect = 1e-24
 Identities = 36/173 (20%), Positives = 78/173 (45%), Gaps = 26/173 (15%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFRNEAR 239
           ED      +G G +  +++                V LK L ++        ESF   A 
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAAS 64

Query: 240 LLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGM 299
           ++S++ H+++V  YG C+      L+ E+++ GSL   L+ ++  + + W  ++ + K +
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQL 122

Query: 300 AHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAF--------VADFGVARLL 343
           A A+ +L  +      +H ++ + N+LL  E +          ++D G++  +
Sbjct: 123 AAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  100 bits (252), Expect = 2e-24
 Identities = 42/177 (23%), Positives = 72/177 (40%), Gaps = 23/177 (12%)

Query: 182 DMIEATEDFHIKY---------CIGTGGYGSVYRARLPSGK----VVALKKLHRSETEEL 228
           ++++A +   I            IG G +G VY   L          A+K L+R      
Sbjct: 10  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG- 68

Query: 229 ASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAVGL 287
             +  F  E  ++    H N++ L G CL  +    ++  YM+ G L   +R +      
Sbjct: 69  -EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--P 125

Query: 288 DWAKRVNIVKGMAHALSYLH-HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
                +     +A  + YL         VHRD+++ N +L+ +    VADFG+AR +
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM 178

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  100 bits (251), Expect = 2e-24
 Identities = 39/179 (21%), Positives = 78/179 (43%), Gaps = 11/179 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEAR-LLSQIW 245
           +D      +G G YG V + R +PSG+++A+K++  +   +    +    +    +  + 
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVD 64

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
               V  YG       +++  E M+        +  ++   +       I   +  AL +
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 306 LH--HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH        ++HRD+  +NVL+N+  +  + DFG++  L  D   + + AG   Y+AP
Sbjct: 125 LHSKLS----VIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAP 178

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  100 bits (251), Expect = 2e-24
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 9/157 (5%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG G YG VY+A+   G+  ALKK+   + +E     + R E  +L ++ H NIVKLY  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
              +K + L++E+++   L  +L  D    GL+     + +  + + ++Y H      ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122

Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
           HRD+   N+L+N E E  +ADFG+AR   F    R  
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARA--FGIPVRKY 157

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  102 bits (255), Expect = 3e-24
 Identities = 38/208 (18%), Positives = 85/208 (40%), Gaps = 36/208 (17%)

Query: 181 QDMIEATEDFHIKYC----IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN 236
            ++    +           +G G  G+V       G+ VA+K++           +    
Sbjct: 4   ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALM 57

Query: 237 EARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAK 291
           E +LL++   H N+++ Y      + +++  E     +L  ++     +DE         
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116

Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF-------------VADFG 338
            +++++ +A  +++LH      I+HRD+   N+L+++                  ++DFG
Sbjct: 117 PISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173

Query: 339 VARLLNFDSSNRTL----LAGTSGYIAP 362
           + + L+   S+        +GTSG+ AP
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAP 201

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  100 bits (250), Expect = 3e-24
 Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 22/166 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFRNEARLLSQ 243
              H    IG G +G VY              A+K L R    +   +E+F  E  L+  
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLREGLLMRG 78

Query: 244 IWHRNIVKLYGFCLHRKCM-FLIYEYMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKG 298
           + H N++ L G  L  + +  ++  YM  G L   +R+ +        + +   + + +G
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG--LQVARG 136

Query: 299 MAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           M     YL         VHRD+++ N +L+      VADFG+AR +
Sbjct: 137 ME----YLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDI 174

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  100 bits (252), Expect = 3e-24
 Identities = 45/195 (23%), Positives = 82/195 (42%), Gaps = 14/195 (7%)

Query: 179 TFQDMIEATEDFHIKY----CIGTGGYGSVYRAR-LPSGKVVALKKLHRS--ETEELASL 231
              DM +    F   Y     IG G +  V R     +G+  A+K +  +   +    S 
Sbjct: 11  GILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70

Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF-CVLRTDEEAVGLDWA 290
           E  + EA +   + H +IV+L         +++++E+M+   L   +++  +       A
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130

Query: 291 KRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDS 347
              + ++ +  AL Y H +    I+HRD+  + VLL S+  +    +  FGVA  L    
Sbjct: 131 VASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187

Query: 348 SNRTLLAGTSGYIAP 362
                  GT  ++AP
Sbjct: 188 LVAGGRVGTPHFMAP 202

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  100 bits (251), Expect = 4e-24
 Identities = 39/194 (20%), Positives = 75/194 (38%), Gaps = 24/194 (12%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELAS--------------LES 233
            D+ I   +  G +  +        K  ALKK  +S  E+                  + 
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 234 FRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLD 288
           F+NE ++++ I +   +   G   +   +++IYEYME  S+                 + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 289 WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS 348
                 I+K + ++ SY+H+     I HRD+  +N+L++      ++DFG +        
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEY--MVDK 205

Query: 349 NRTLLAGTSGYIAP 362
                 GT  ++ P
Sbjct: 206 KIKGSRGTYEFMPP 219

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 10/172 (5%)

Query: 184 IEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLS 242
           + ++  F     +G G Y +VY+     +G  VALK++ + ++EE     + R E  L+ 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIR-EISLMK 58

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEM--GSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
           ++ H NIV+LY        + L++E+M+                 GL+          + 
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
             L++ H +    I+HRD+   N+L+N   +  + DFG+AR   F     T 
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA--FGIPVNTF 165

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  102 bits (256), Expect = 5e-24
 Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 14/161 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL--PSGKV--VALKKLHRSETEELASLESFRNEARLLSQ 243
           E   +  CIG G +G V++     P      VA+K      ++     E F  EA  + Q
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFLQEALTMRQ 447

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H +IVKL G       +++I E   +G L   L+  + ++ L  A  +     ++ AL
Sbjct: 448 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTAL 504

Query: 304 SYLH-HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           +YL         VHRDI++ NVL++S     + DFG++R +
Sbjct: 505 AYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM 541

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  100 bits (250), Expect = 7e-24
 Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 14/159 (8%)

Query: 191 HIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L          A+K L+R        +  F  E  ++    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 149

Query: 247 RNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
            N++ L G CL  +    ++  YM+ G L   +R +           +     +A  + +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKF 207

Query: 306 L-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
           L         VHRD+++ N +L+ +    VADFG+AR +
Sbjct: 208 LASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM 242

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  101 bits (253), Expect = 9e-24
 Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 24/188 (12%)

Query: 187 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLL 241
                  Y      G+G YG V   R   +    A+K + ++     +S      E  +L
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVL 90

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVK 297
             + H NI+KLY F   ++  +L+ E  + G LF  +      +E            I+K
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-------VIIK 143

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLA 354
            +   ++YLH H    IVHRD+   N+LL S+ +     + DFG++ +       +    
Sbjct: 144 QVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE-RL 199

Query: 355 GTSGYIAP 362
           GT+ YIAP
Sbjct: 200 GTAYYIAP 207

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 98.8 bits (247), Expect = 9e-24
 Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 9/157 (5%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           +G G YG VY+A+   G++VALK++     +E     + R E  LL ++ H NIV L   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87

Query: 256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIV 315
               +C+ L++E+ME   L  VL  DE   GL  ++    +  +   +++ H H    I+
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQHR---IL 141

Query: 316 HRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
           HRD+   N+L+NS+    +ADFG+AR   F    R+ 
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARA--FGIPVRSY 176

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 11/166 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E +     +G G Y +VY+ +   +  +VALK++ R E EE A   + R E  LL  + H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIR-EVSLLKDLKH 59

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIV L+      K + L++EY++   L   L  D+    ++       +  +   L+Y 
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
           H      ++HRD+   N+L+N   E  +ADFG+AR        +T 
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTY 157

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 98.4 bits (246), Expect = 1e-23
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 9/158 (5%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG VY+AR   +G+VVALKK+      E     + R E  LL ++ H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                  ++L++E++    L   +       G+      + +  +   L++ H H    +
Sbjct: 70  VIHTENKLYLVFEFLHQ-DLKKFMD-ASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 124

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
           +HRD+   N+L+N+E    +ADFG+AR   F    RT 
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTY 160

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 19/168 (11%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFRNEARLLSQ 243
           + F +   +G G +GSV  A+L         VA+K L        + +E F  EA  + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKE 81

Query: 244 IWHRNIVKLYGFCL------HRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVN 294
             H ++ KL G  L            +I  +M+ G L   L      E    L     V 
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 295 IVKGMAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +  +A  + YL   +     +HRD+++ N +L  ++   VADFG++R
Sbjct: 142 FMVDIACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR 185

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 20/160 (12%)

Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY  ++      PS   VA+K L    +E+      F  EA ++S+  H+NI
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALIISKFNHQNI 95

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNIVKGMAHALSY 305
           V+  G  L     F++ E M  G L   LR       +   L     +++ + +A    Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 306 L-HHHCTPPIVHRDISSNNVLLNSELEAFV---ADFGVAR 341
           L  +H     +HRDI++ N LL       V    DFG+AR
Sbjct: 156 LEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 42/177 (23%), Positives = 84/177 (47%), Gaps = 18/177 (10%)

Query: 196 IGTGGYGSVYRA---RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G GG   V+ A   R    + VA+K L      + +    FR EA+  + + H  IV +
Sbjct: 20  LGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 253 Y--GF--CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           Y  G          +++ EY++  +L  ++ T+     +   + + ++     AL++ H 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ 134

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT---LLAGTSGYIAP 362
           +    I+HRD+   N+++++     V DFG+AR +    ++ T    + GT+ Y++P
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 97.6 bits (244), Expect = 2e-23
 Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 10/158 (6%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G YG+V++A+   + ++VALK++   + +E     + R E  LL ++ H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                K + L++E+ +   L      D     LD     + +  +   L + H      +
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---V 122

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
           +HRD+   N+L+N   E  +A+FG+AR   F    R  
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARA--FGIPVRCY 158

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 98.4 bits (246), Expect = 2e-23
 Identities = 51/175 (29%), Positives = 91/175 (52%), Gaps = 13/175 (7%)

Query: 182 DMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKL---HRSETEELASLESFRNE 237
           D+    + +     +G G + +VY+AR   + ++VA+KK+   HRSE ++  +  + R E
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-E 62

Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK 297
            +LL ++ H NI+ L     H+  + L++++ME   L  ++   + ++ L  +     + 
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYML 119

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
                L YLH H    I+HRD+  NN+LL+      +ADFG+A+   F S NR  
Sbjct: 120 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAY 169

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 26/192 (13%)

Query: 184 IEATEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEA 238
           +     F  +Y I    G G +G V + +   + +  A+K ++++  +      +   E 
Sbjct: 14  LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREV 72

Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEAVGLDWAKRV 293
            LL ++ H NI+KL+         +++ E    G LF  +      ++ +A         
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------A 124

Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNR 350
            I+K +   ++Y+H H    IVHRD+   N+LL S+ +     + DFG++     ++  +
Sbjct: 125 RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181

Query: 351 TLLAGTSGYIAP 362
               GT+ YIAP
Sbjct: 182 D-RIGTAYYIAP 192

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 45/189 (23%), Positives = 84/189 (44%), Gaps = 25/189 (13%)

Query: 187 TEDFHIKYC----IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLL 241
              F  +Y     +G G +  V R   + +G+  A   ++  +       +    EAR+ 
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARIC 64

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIV 296
             + H NIV+L+         +LI++ +  G LF   V R   ++ +A         + +
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA--------SHCI 116

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLL 353
           + +  A+ + H      +VHR++   N+LL S+L+     +ADFG+A  +  +       
Sbjct: 117 QQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173

Query: 354 AGTSGYIAP 362
           AGT GY++P
Sbjct: 174 AGTPGYLSP 182

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 97.7 bits (244), Expect = 4e-23
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 30/175 (17%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKV---VALKKLHRSETEELASLESFRNEARLLSQI 244
            D   +  IG G +G V +AR+    +    A+K++    +++      F  E  +L ++
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 82

Query: 245 W-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN--------- 294
             H NI+ L G C HR  ++L  EY   G+L   LR              N         
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 295 --------IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                   + +GM + LS          +HRD+++ N+L+     A +ADFG++R
Sbjct: 143 QLLHFAADVARGMDY-LS--QKQF----IHRDLAARNILVGENYVAKIADFGLSR 190

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 97.9 bits (244), Expect = 5e-23
 Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 20/160 (12%)

Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G VY  ++      PS   VA+K L    +E+      F  EA ++S+  H+NI
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALIISKFNHQNI 136

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLR----TDEEAVGLDWAKRVNIVKGMAHALSY 305
           V+  G  L     F++ E M  G L   LR       +   L     +++ + +A    Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 306 L-HHHCTPPIVHRDISSNNVLLNSELEAFV---ADFGVAR 341
           L  +H     +HRDI++ N LL       V    DFG+AR
Sbjct: 197 LEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 97.0 bits (242), Expect = 6e-23
 Identities = 36/168 (21%), Positives = 69/168 (41%), Gaps = 20/168 (11%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLL 241
           E   +   +G G +G VY               VA+K ++ + +        F NEA ++
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVM 82

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-------TDEEAVGLDWAKRVN 294
            +    ++V+L G     +   +I E M  G L   LR        +        +K + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142

Query: 295 IVKGMAHALSYLH-HHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +   +A  ++YL+ +      VHRD+++ N ++  +    + DFG+ R
Sbjct: 143 MAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTR 186

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 96.6 bits (241), Expect = 7e-23
 Identities = 36/167 (21%), Positives = 71/167 (42%), Gaps = 18/167 (10%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFRNEARLLSQ 243
               +   +G G +GSV    L         VA+K + + +      +E F +EA  +  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKD 92

Query: 244 IWHRNIVKLYGFCL-----HRKCMFLIYEYMEMGSLFCVLRT---DEEAVGLDWAKRVNI 295
             H N+++L G C+           +I  +M+ G L   L     +     +     +  
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 296 VKGMAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +  +A  + YL + +     +HRD+++ N +L  ++   VADFG+++
Sbjct: 153 MVDIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSK 195

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 95.8 bits (239), Expect = 7e-23
 Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 26/189 (13%)

Query: 187 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLL 241
              F  +Y I    G G +G V + +   + +  A+K ++++  +      +   E  LL
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELL 75

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIV 296
            ++ H NI+KL+         +++ E    G LF   + R   ++ +A          I+
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARII 127

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLL 353
           K +   ++Y+H H    IVHRD+   N+LL S+ +     + DFG++     ++  +   
Sbjct: 128 KQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-R 183

Query: 354 AGTSGYIAP 362
            GT+ YIAP
Sbjct: 184 IGTAYYIAP 192

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 96.6 bits (241), Expect = 8e-23
 Identities = 52/190 (27%), Positives = 82/190 (43%), Gaps = 27/190 (14%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALK-----KLHRSETEELASLESFRNEARL 240
            +++ +   +G+G  G V  A    + K VA+K     K       E     +   E  +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 241 LSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNI 295
           L ++ H  I+K+  F    +  +++ E ME G LF   V      +              
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC--------KLY 119

Query: 296 VKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTL 352
              M  A+ YLH +    I+HRD+   NVLL+S+ E     + DFG +++L   S  RT 
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT- 175

Query: 353 LAGTSGYIAP 362
           L GT  Y+AP
Sbjct: 176 LCGTPTYLAP 185

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 95.4 bits (238), Expect = 8e-23
 Identities = 44/189 (23%), Positives = 77/189 (40%), Gaps = 28/189 (14%)

Query: 187 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLL 241
             D +  Y +    G G +G V  A    +    A KK+ +     +  ++ F+ E  ++
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIM 60

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIV 296
             + H NI++LY        ++L+ E    G LF   V +    + +A          I+
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIM 112

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLL 353
           K +  A++Y H      + HRD+   N L  ++       + DFG+A         RT  
Sbjct: 113 KDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-K 168

Query: 354 AGTSGYIAP 362
            GT  Y++P
Sbjct: 169 VGTPYYVSP 177

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 43/176 (24%), Positives = 71/176 (40%), Gaps = 26/176 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK------VVALKKLHRSETEELASLESFRNEARLL 241
                   +G   +G VY+  L           VA+K L       L   E FR+EA L 
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REEFRHEAMLR 66

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR--------- 292
           +++ H N+V L G     + + +I+ Y   G L   L        +              
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 293 ----VNIVKGMAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
               V++V  +A  + YL  HH     VH+D+++ NVL+  +L   ++D G+ R +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREV 178

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 16/163 (9%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G YG VY+A    + + VA+K++     EE     + R E  LL ++ HRNI++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKS 100

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
              H   + LI+EY E   L   +   ++   +      + +  + + +++ H       
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHSRR---C 153

Query: 315 VHRDISSNNVLLNSELEAF-----VADFGVARLLNFDSSNRTL 352
           +HRD+   N+LL+    +      + DFG+AR   F    R  
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQF 194

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 54/199 (27%), Positives = 80/199 (40%), Gaps = 35/199 (17%)

Query: 187 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRS----------ETEELASL 231
                  Y      G+G YG V   +        A+K + +S                  
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90

Query: 232 ESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-----TDEEAVG 286
           E   NE  LL  + H NI+KL+     +K  +L+ E+ E G LF  +       + +A  
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA-- 148

Query: 287 LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLL 343
                  NI+K +   + YLH H    IVHRDI   N+LL ++       + DFG++   
Sbjct: 149 ------ANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

Query: 344 NFDSSNRTLLAGTSGYIAP 362
           + D   R    GT+ YIAP
Sbjct: 200 SKDYKLRD-RLGTAYYIAP 217

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 22/150 (14%), Positives = 47/150 (31%), Gaps = 13/150 (8%)

Query: 195 CIGTGGYGSVYRA---RLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
             G       ++A    L   + VAL  +          L+   +    LS+I    + +
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
           +      R    ++ E++  GSL  V  T            +  ++ +A A    H    
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA-- 148

Query: 312 PPIVHRDISSNNVLLNSELEAFVADFGVAR 341
             +       + V ++ + +  +A      
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPATMP 177

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 94.9 bits (237), Expect = 2e-22
 Identities = 48/189 (25%), Positives = 85/189 (44%), Gaps = 29/189 (15%)

Query: 187 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           T +    +      G+G +  V+  +   +GK+ ALK + +S         S  NE  +L
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVL 60

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIV 296
            +I H NIV L          +L+ + +  G LF   + R   T+++A          ++
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA--------SLVI 112

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLL 353
           + +  A+ YLH +    IVHRD+   N+L  +  E     + DFG++++    +   +  
Sbjct: 113 QQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTA 167

Query: 354 AGTSGYIAP 362
            GT GY+AP
Sbjct: 168 CGTPGYVAP 176

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 94.2 bits (235), Expect = 2e-22
 Identities = 47/192 (24%), Positives = 83/192 (43%), Gaps = 11/192 (5%)

Query: 176 GRITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESF 234
           GR          + F  K  +G+G +G V+      SG    +K +++  ++    +E  
Sbjct: 10  GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQI 67

Query: 235 RNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRV 293
             E  +L  + H NI+K++        M+++ E  E G L   + + +     L      
Sbjct: 68  EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127

Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNR 350
            ++K M +AL+Y H      +VH+D+   N+L           + DFG+A L   D  + 
Sbjct: 128 ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184

Query: 351 TLLAGTSGYIAP 362
              AGT+ Y+AP
Sbjct: 185 N-AAGTALYMAP 195

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 38/183 (20%), Positives = 78/183 (42%), Gaps = 24/183 (13%)

Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
                  +G G +G V++     +G  +A K +     ++    E  +NE  +++Q+ H 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR----TDEEAVGLDWAKRVNIVKGMAH 301
           N+++LY     +  + L+ EY++ G LF   +      T+ +         +  +K +  
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT--------ILFMKQICE 198

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTSGY 359
            + ++H      I+H D+   N+L  +     +   DFG+AR        +    GT  +
Sbjct: 199 GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEF 254

Query: 360 IAP 362
           +AP
Sbjct: 255 LAP 257

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 94.2 bits (235), Expect = 3e-22
 Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 26/189 (13%)

Query: 187 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           +  F   Y +    G G +  V R     +G   A K ++  +       +    EAR+ 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARIC 59

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIV 296
            ++ H NIV+L+         +L+++ +  G LF   V R   ++ +A         + +
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA--------SHCI 111

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLL 353
           + +  +++Y H +    IVHR++   N+LL S+ +     +ADFG+A  +N   +     
Sbjct: 112 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-F 167

Query: 354 AGTSGYIAP 362
           AGT GY++P
Sbjct: 168 AGTPGYLSP 176

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 95.9 bits (239), Expect = 3e-22
 Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 29/226 (12%)

Query: 150 RDKKVEPTETGEITKCADEFAIWNYDGRITFQDMIEATEDFHIKYCI----GTGGYGSVY 205
              KV     G      D+F   +   +   Q +       +  Y I    G+G +G V+
Sbjct: 10  HGSKVRGKYDGPKINDYDKF-YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68

Query: 206 RAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL 264
           R     +G+V   K ++     +     + +NE  +++Q+ H  ++ L+     +  M L
Sbjct: 69  RCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125

Query: 265 IYEYMEMGSLF--CVLR----TDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRD 318
           I E++  G LF          ++ E         +N ++     L ++H H    IVH D
Sbjct: 126 ILEFLSGGELFDRIAAEDYKMSEAEV--------INYMRQACEGLKHMHEH---SIVHLD 174

Query: 319 ISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           I   N++  ++  + V   DFG+A  LN D   +     T+ + AP
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAP 219

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 45/193 (23%), Positives = 77/193 (39%), Gaps = 29/193 (15%)

Query: 187 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALK---KLHRSETEELASLESFRNEA 238
            +     Y I    G+G +  V + R   +G   A K   K     +      E    E 
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRV 293
            +L Q+ H NI+ L+    +R  + LI E +  G LF     +   ++EEA         
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA--------T 118

Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSN 349
           + +K +   ++YLH      I H D+   N++L  +        + DFG+A  +      
Sbjct: 119 SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175

Query: 350 RTLLAGTSGYIAP 362
           +  + GT  ++AP
Sbjct: 176 KN-IFGTPEFVAP 187

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 26/193 (13%)

Query: 183 MIEATEDFHIKY----CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNE 237
           M+ A+  F   Y     +G G +  V R     +G   A K ++  +       +    E
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLERE 78

Query: 238 ARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKR 292
           AR+  ++ H NIV+L+         +L+++ +  G LF   V R   ++ +A        
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA-------- 130

Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSN 349
            + ++ +  +++Y H +    IVHR++   N+LL S+ +     +ADFG+A  +N   + 
Sbjct: 131 SHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187

Query: 350 RTLLAGTSGYIAP 362
               AGT GY++P
Sbjct: 188 HG-FAGTPGYLSP 199

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 94.7 bits (236), Expect = 5e-22
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 30/189 (15%)

Query: 187 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLL 241
            +     + +    G G    VYR +   + K  ALK L ++  ++       R E  +L
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-----IVRTEIGVL 102

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIV 296
            ++ H NI+KL         + L+ E +  G LF   V +   ++ +A         + V
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA--------ADAV 154

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLL 353
           K +  A++YLH +    IVHRD+   N+L  +        +ADFG+++++      +T +
Sbjct: 155 KQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-V 210

Query: 354 AGTSGYIAP 362
            GT GY AP
Sbjct: 211 CGTPGYCAP 219

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 26/177 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRN----EARLLS 242
             +     IG G +G V++AR   +G+ VALKK+   E E+    E F      E ++L 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEK----EGFPITALREIKILQ 71

Query: 243 QIWHRNIVKLYG--------FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN 294
            + H N+V L          +   +  ++L++++ E   L  +L      V    ++   
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIKR 128

Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
           +++ + + L Y+H +    I+HRD+ + NVL+  +    +ADFG+AR   F  +  +
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA--FSLAKNS 180

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 95.7 bits (238), Expect = 8e-22
 Identities = 49/228 (21%), Positives = 93/228 (40%), Gaps = 22/228 (9%)

Query: 148 RRRDKKVEPTETGEITKCADEFAI----WNYDGRITFQDMI--EATEDFHIKYCI----G 197
           R+R +  +  E G+I +     +     + +D    +         +     Y I    G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166

Query: 198 TGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFC 256
           TG +G V+R     +G   A K +      +    E+ R E + +S + H  +V L+   
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRHPTLVNLHDAF 223

Query: 257 LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVH 316
                M +IYE+M  G LF   +  +E   +   + V  ++ +   L ++H +     VH
Sbjct: 224 EDDNEMVMIYEFMSGGELFE--KVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVH 278

Query: 317 RDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            D+   N++  ++    +   DFG+   L+   S +    GT+ + AP
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAP 325

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 93.5 bits (233), Expect = 8e-22
 Identities = 45/188 (23%), Positives = 76/188 (40%), Gaps = 29/188 (15%)

Query: 188 EDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLS 242
           ++ + KY I    G G +G V+R     S K    K +    T++       + E  +L+
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILN 56

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR----TDEEAVGLDWAKRVNIV 296
              HRNI+ L+      + + +I+E++    +F           + E         V+ V
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI--------VSYV 108

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLA 354
             +  AL +LH H    I H DI   N++  +   + +   +FG AR L    + R  L 
Sbjct: 109 HQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LF 164

Query: 355 GTSGYIAP 362
               Y AP
Sbjct: 165 TAPEYYAP 172

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 93.5 bits (233), Expect = 9e-22
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 26/165 (15%)

Query: 196 IGTGGYGSVYRARLPSGK------VVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G V+ A   +        +VA+K L +  +E   + + F+ EA LL+ + H++I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASES--ARQDFQREAELLTMLQHQHI 105

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLR------------TDEEAVGLDWAKRVNIVK 297
           V+ +G C   + + +++EYM  G L   LR             D     L   + + +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 298 GMAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +A  + YL   H     VHRD+++ N L+   L   + DFG++R
Sbjct: 166 QVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMSR 206

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.5 bits (235), Expect = 1e-21
 Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 26/176 (14%)

Query: 192 IKYCIGTGGYGSVYRAR---LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
               +G G YG VY+A+       K  ALK++         S+ + R E  LL ++ H N
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACR-EIALLRELKHPN 79

Query: 249 IVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN--IVKGMAH--- 301
           ++ L    L    + ++L+++Y E   L+ +++    +       ++   +VK + +   
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 302 -ALSYLHHHCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNRTL 352
             + YLH +    ++HRD+   N+L+  E        +AD G ARL  F+S  + L
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSPLKPL 189

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 92.6 bits (231), Expect = 1e-21
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 25/180 (13%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALK---KLHRSETEELASLESFRNEARLLSQIWHRNIVK 251
           +G+G +  V + R   +GK  A K   K   S +    S E    E  +L +I H NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMAHALSYL 306
           L+    ++  + LI E +  G LF     +   T++EA           +K +   + YL
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA--------TQFLKQILDGVHYL 124

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H      I H D+   N++L  +        + DFG+A  +   +  +  + GT  ++AP
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-IFGTPEFVAP 180

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 45/193 (23%), Positives = 78/193 (40%), Gaps = 29/193 (15%)

Query: 187 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALK---KLHRSETEELASLESFRNEA 238
            +     Y I    G+G +  V + R   +G   A K   K     +    S E    E 
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRV 293
            +L Q+ H N++ L+    +R  + LI E +  G LF     +   ++EEA         
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA--------T 118

Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSN 349
           + +K +   ++YLH      I H D+   N++L  +        + DFG+A  +      
Sbjct: 119 SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175

Query: 350 RTLLAGTSGYIAP 362
           +  + GT  ++AP
Sbjct: 176 KN-IFGTPEFVAP 187

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 28/201 (13%), Positives = 64/201 (31%), Gaps = 44/201 (21%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEA---RLLSQIW------ 245
           +G     +   A    +G+   +   + +E     +++  + E    RLL  I       
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 246 ----------------HRNIVKLYGFCLHRKCM--FLIYEYMEM------GSLFCVLRTD 281
                            + ++++         +  F +Y  M+         L     T 
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 282 EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           +    L    R+ +   +   L+ LHH+    +VH  +   +++L+     F+  F    
Sbjct: 201 KS---LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 342 LLNFDSSNRTLLAGTSGYIAP 362
                   R + + + G+  P
Sbjct: 255 RDG----ARVVSSVSRGFEPP 271

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 13/180 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF I   IG G +  V   ++  +G+V A+K +++ +  +   +  FR E  +L     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 247 RNIVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHAL 303
           R I +L+ F       ++L+ EY   G L  +L    E +  + A+     IV     A+
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM----AI 175

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTSGYIAP 362
             +H       VHRDI  +N+LL+      +ADFG    L  D + R+L+A GT  Y++P
Sbjct: 176 DSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 42/171 (24%), Positives = 74/171 (43%), Gaps = 13/171 (7%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHR 247
             ++  +  GG+  VY A+ + SG+  ALK+L  +E E+  ++     E   + ++  H 
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI---IQEVCFMKKLSGHP 86

Query: 248 NIVKLYGFCLHRK-------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
           NIV+        K         FL+   +  G L   L+  E    L     + I     
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
            A+ ++H    PPI+HRD+   N+LL+++    + DFG A  ++       
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 46/193 (23%), Positives = 79/193 (40%), Gaps = 29/193 (15%)

Query: 187 TEDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALK---KLHRSETEELASLESFRNEA 238
            E+    Y      G+G +  V + R   +G   A K   K     +    S E    E 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 239 RLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRV 293
            +L +I H N++ L+    ++  + LI E +  G LF     +   T+EEA         
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA--------T 117

Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSN 349
             +K + + + YLH      I H D+   N++L           + DFG+A  ++F +  
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174

Query: 350 RTLLAGTSGYIAP 362
           +  + GT  ++AP
Sbjct: 175 KN-IFGTPEFVAP 186

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 28/199 (14%), Positives = 64/199 (32%), Gaps = 38/199 (19%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEA---RLLSQIWHRNIVK 251
           +G     +   A    +G+   +   + +E     +++  + E    RLL  I ++   K
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 252 LYGFCLHRKCM------------------------FLIYEYME--MGSLFCVLRTDEEAV 285
           ++   +    +                        F +Y  M+  + +   VL +     
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 286 G-LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
             L    R+ +   +   L+ LHH+    +VH  +   +++L+     F+  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 345 FDSSNRTLLAGTSGYIAPA 363
                  +     G+  P 
Sbjct: 263 ----ASAVSPIGRGFAPPE 277

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 33/175 (18%)

Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRN 248
           +G G +G V  A         +   VA+K L  +   +    E+  +E +++S +  H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHEN 111

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-------------- 294
           IV L G C H   + +I EY   G L   LR     +  D A  +               
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 295 -IVKGMAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
            + +GMA    +L   +C    +HRD+++ NVLL +   A + DFG+AR +  DS
Sbjct: 172 QVAQGMA----FLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 13/180 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF I   IG G +G V   +L  + KV A+K L++ E  + A    FR E  +L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 247 RNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHAL 303
           + I  L Y F      ++L+ +Y   G L  +L   E+ +  + A+     +V     A+
Sbjct: 134 KWITTLHYAFQDDNN-LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI----AI 188

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA-GTSGYIAP 362
             +H       VHRDI  +N+L++      +ADFG    L  D + ++ +A GT  YI+P
Sbjct: 189 DSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 42/186 (22%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGK------VVALKKLHRSETEELASLESFRNEARLL 241
            +      IG G +G V++AR P         +VA+K L    + +      F+ EA L+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 104

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------- 294
           ++  + NIVKL G C   K M L++EYM  G L   LR+         +           
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164

Query: 295 ------------------IVKGMAHALSYLH-HHCTPPIVHRDISSNNVLLNSELEAFVA 335
                             +  GMA    YL         VHRD+++ N L+   +   +A
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMA----YLSERKF----VHRDLATRNCLVGENMVVKIA 216

Query: 336 DFGVAR 341
           DFG++R
Sbjct: 217 DFGLSR 222

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 92.8 bits (231), Expect = 4e-21
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 13/203 (6%)

Query: 164 KCADEFAIWNYDGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHR 222
           K  D F     D     +D+    ED+ +   IG G +G V   R   + KV A+K L +
Sbjct: 45  KNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK 104

Query: 223 SETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDE 282
            E  + +    F  E  +++      +V+L+      + ++++ EYM  G L  ++    
Sbjct: 105 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--N 162

Query: 283 EAVGLDWAK--RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
             V   WA+     +V     AL  +H       +HRD+  +N+LL+      +ADFG  
Sbjct: 163 YDVPEKWARFYTAEVVL----ALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215

Query: 341 RLLNFDSSNRT-LLAGTSGYIAP 362
             +N +   R     GT  YI+P
Sbjct: 216 MKMNKEGMVRCDTAVGTPDYISP 238

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 92.2 bits (229), Expect = 4e-21
 Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 49/231 (21%)

Query: 178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELAS--LESF 234
                ++E  + +H+K  IG G YG V  A    +  + A+K +++++  ++    +E  
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75

Query: 235 RNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF------------------- 275
           + E RL+ ++ H NI +LY      + + L+ E    G L                    
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135

Query: 276 ------CVLRTDEEAVGLDWAKRV------------NIVKGMAHALSYLHHHCTPPIVHR 317
                 C    +E   G     R             NI++ +  AL YLH+     I HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHR 192

Query: 318 DISSNNVLLNSELEAFV--ADFGVARLLNFDSSNR----TLLAGTSGYIAP 362
           DI   N L ++     +   DFG+++     ++      T  AGT  ++AP
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 28/193 (14%)

Query: 186 ATEDFHIKY----CIGTGGYGSVYRAR-LPSGKVVALK-----KLHRSETEELASLESFR 235
           A ++F+ KY     IG G    V R     +G   A+K         S  +     E+ R
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 236 NEARLLSQIW-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDW 289
            E  +L Q+  H +I+ L         MFL+++ M  G LF     +   +++E      
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET----- 202

Query: 290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN 349
               +I++ +  A+S+LH +    IVHRD+   N+LL+  ++  ++DFG +  L      
Sbjct: 203 ---RSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256

Query: 350 RTLLAGTSGYIAP 362
           R  L GT GY+AP
Sbjct: 257 RE-LCGTPGYLAP 268

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 92.8 bits (231), Expect = 4e-21
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 18/181 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           + F I   IG G +G V   +   + K+ A+K +++ +  E   + +   E +++  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 247 RNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAH 301
             +V L Y F      MF++ + +  G L   L+      EE V L   +       +  
Sbjct: 75  PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-------LVM 126

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           AL YL +     I+HRD+  +N+LL+      + DF +A +L  ++   T +AGT  Y+A
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMA 182

Query: 362 P 362
           P
Sbjct: 183 P 183

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 91.5 bits (228), Expect = 4e-21
 Identities = 46/186 (24%), Positives = 69/186 (37%), Gaps = 35/186 (18%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLL 241
                   +G G +G V  A         +   VA+K L  S        E+  +E ++L
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80

Query: 242 SQIW-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------ 294
           S +  H NIV L G C       +I EY   G L   LR   ++                
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 295 -------------IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                        + KGMA  L+  +       +HRD+++ N+LL       + DFG+AR
Sbjct: 141 ALDLEDLLSFSYQVAKGMAF-LASKN------CIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 342 LLNFDS 347
            +  DS
Sbjct: 194 DIKNDS 199

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 45/193 (23%), Positives = 74/193 (38%), Gaps = 34/193 (17%)

Query: 187 TEDFHIKY-------CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEA 238
              F+  Y        +G G +    +     S +  A+K + +          + + E 
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEI 56

Query: 239 RLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKR 292
             L     H NIVKL+     +   FL+ E +  G LF     +   ++ EA        
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEA-------- 108

Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSN 349
             I++ +  A+S++H      +VHRD+   N+L   E +     + DFG ARL   D+  
Sbjct: 109 SYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165

Query: 350 RTLLAGTSGYIAP 362
                 T  Y AP
Sbjct: 166 LKTPCFTLHYAAP 178

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 91.1 bits (227), Expect = 5e-21
 Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 35/172 (20%)

Query: 196 IGTGGYGSVYRARLPSGK------VVALKKLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G G +G V+ A   +        +VA+K L +  T      + F+ EA LL+ + H +I
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAA--RKDFQREAELLTNLQHEHI 79

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN--------------- 294
           VK YG C     + +++EYM+ G L   LR       +    +                 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 295 --IVKGMAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL 343
             I  GM     YL   H     VHRD+++ N L+ + L   + DFG++R +
Sbjct: 140 SQIASGMV----YLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDV 183

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 91.1 bits (227), Expect = 6e-21
 Identities = 49/159 (30%), Positives = 73/159 (45%), Gaps = 20/159 (12%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLE----SFRNEARLL---SQIWHR 247
           IG G YG+VY+AR   SG  VALK + R              + R E  LL       H 
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVR-EVALLRRLEAFEHP 74

Query: 248 NIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           N+V+L   C   +      + L++E+++   L   L       GL      ++++     
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLPAETIKDLMRQFLRG 132

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
           L +LH +C   IVHRD+   N+L+ S     +ADFG+AR
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 90.8 bits (226), Expect = 8e-21
 Identities = 41/185 (22%), Positives = 72/185 (38%), Gaps = 34/185 (18%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLL 241
           +   +   +G G +G V  A         + + VA+K L    T       +  +E ++L
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84

Query: 242 SQIW-HRNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN----- 294
             I  H N+V L G C      + +I E+ + G+L   LR+             +     
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 295 ------------IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL 342
                       + KGM   L+          +HRD+++ N+LL+ +    + DFG+AR 
Sbjct: 145 LTLEHLICYSFQVAKGMEF-LASRK------CIHRDLAARNILLSEKNVVKICDFGLARD 197

Query: 343 LNFDS 347
           +  D 
Sbjct: 198 IYKDP 202

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 90.4 bits (225), Expect = 9e-21
 Identities = 46/195 (23%), Positives = 83/195 (42%), Gaps = 29/195 (14%)

Query: 185 EATEDFHIKY----CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASL------ES 233
            +T  F+  Y     +G G    V R    P+ K  A+K +  +     ++       E+
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 234 FRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGL 287
              E  +L ++  H NI++L          FL+++ M+ G LF     +   +++E    
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127

Query: 288 DWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
                  I++ +   +  LH      IVHRD+   N+LL+ ++   + DFG +  L+   
Sbjct: 128 ------KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 178

Query: 348 SNRTLLAGTSGYIAP 362
             R  + GT  Y+AP
Sbjct: 179 KLRE-VCGTPSYLAP 192

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 41/186 (22%), Positives = 74/186 (39%), Gaps = 27/186 (14%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           T+ + +K  IG G Y    R     +    A+K + +S        +       LL    
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS------KRDPTEEIEILLRYGQ 74

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVNIVKGMA 300
           H NI+ L       K ++++ E M+ G L    + +   ++ EA          ++  + 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA--------SAVLFTIT 126

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAF----VADFGVARLLNFDSSNRTLLAGT 356
             + YLH      +VHRD+  +N+L   E        + DFG A+ L  ++        T
Sbjct: 127 KTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYT 183

Query: 357 SGYIAP 362
           + ++AP
Sbjct: 184 ANFVAP 189

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 42/180 (23%), Positives = 68/180 (37%), Gaps = 35/180 (19%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFRNEAR 239
           +   +   +G G +G V  A               VA+K L    TE+   L    +E  
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92

Query: 240 LLSQIW-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN---- 294
           ++  I  H+NI+ L G C     +++I EY   G+L   LR                   
Sbjct: 93  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 295 -------------IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
                        + +GM + L+          +HRD+++ NVL+       +ADFG+AR
Sbjct: 153 QMTFKDLVSCTYQLARGMEY-LASQK------CIHRDLAARNVLVTENNVMKIADFGLAR 205

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 24/160 (15%)

Query: 196 IGTGGYGSVYRAR--LPSGKVVALKKLHRSETEELASLESFRNEARLL---SQIWHRNIV 250
           IG G YG V++AR     G+ VALK++     EE   L + R E  +L       H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 77

Query: 251 KLY-----GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH---- 301
           +L+             + L++E+++   L   L       G+        +K M      
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVP----TETIKDMMFQLLR 131

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            L +LH H    +VHRD+   N+L+ S  +  +ADFG+AR
Sbjct: 132 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 42/185 (22%), Positives = 76/185 (41%), Gaps = 40/185 (21%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLL 241
           ++  +   +G G +G V +A             VA+K L  + +     L    +E  +L
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN------- 294
            Q+ H +++KLYG C     + LI EY + GSL   LR   +          +       
Sbjct: 81  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 295 ------------------IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD 336
                             I +GM + L+ +       +VHRD+++ N+L+    +  ++D
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQY-LAEMK------LVHRDLAARNILVAEGRKMKISD 193

Query: 337 FGVAR 341
           FG++R
Sbjct: 194 FGLSR 198

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 46/180 (25%), Positives = 71/180 (39%), Gaps = 40/180 (22%)

Query: 196 IGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRN 248
           +G+G +G V  A             VA+K L           E+  +E ++++Q+  H N
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQLGSHEN 110

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN-------------- 294
           IV L G C     ++LI+EY   G L   LR+  E    D  +  N              
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 295 ----------IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
                     + KGM   L +         VHRD+++ NVL+       + DFG+AR + 
Sbjct: 171 FEDLLCFAYQVAKGMEF-LEFKS------CVHRDLAARNVLVTHGKVVKICDFGLARDIM 223

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 44/181 (24%), Positives = 68/181 (37%), Gaps = 37/181 (20%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFRNEAR 239
           +   +   +G G +G V  A               VA+K L    TE+   L    +E  
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 138

Query: 240 LLSQIW-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN---- 294
           ++  I  H+NI+ L G C     +++I EY   G+L   LR                   
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 295 -------------IVKGMAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
                        + +GM     YL    C    +HRD+++ NVL+       +ADFG+A
Sbjct: 199 QMTFKDLVSCTYQLARGME----YLASQKC----IHRDLAARNVLVTENNVMKIADFGLA 250

Query: 341 R 341
           R
Sbjct: 251 R 251

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 44/196 (22%), Positives = 78/196 (39%), Gaps = 36/196 (18%)

Query: 187 TEDFHIKYCI-----GTGGYGSVYRAR-LPSGKVVALK---KLHRSETEELASLESFRNE 237
            E+F+  Y +     G G +  V +     +G+  A K   K  R +           +E
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR----AEILHE 78

Query: 238 ARLLSQIWHR-NIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLRTDE-----EAVGLDW 289
             +L        ++ L+    +   + LI EY   G +F  C+    E     +      
Sbjct: 79  IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV----- 133

Query: 290 AKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFD 346
              + ++K +   + YLH +    IVH D+   N+LL+S        + DFG++R +   
Sbjct: 134 ---IRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187

Query: 347 SSNRTLLAGTSGYIAP 362
              R ++ GT  Y+AP
Sbjct: 188 CELREIM-GTPEYLAP 202

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 88.4 bits (220), Expect = 4e-20
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 27/197 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR   + +  A+K L +    +   +     E  ++S++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHA 302
              VKLY      + ++    Y + G L   +R     DE       A+       +  A
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-------IVSA 142

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RTL-LAGTSGYI 360
           L YLH      I+HRD+   N+LLN ++   + DFG A++L+ +S   R     GT+ Y+
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 361 AP----------ASEWW 367
           +P          +S+ W
Sbjct: 200 SPELLTEKSACKSSDLW 216

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 43/181 (23%), Positives = 70/181 (38%), Gaps = 37/181 (20%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFRNEAR 239
           +   +   +G G +G V  A               VA+K L    TE+   L    +E  
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126

Query: 240 LLSQIW-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVN---- 294
           ++  I  H+NI+ L G C     +++I EY   G+L   L+              +    
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 295 -------------IVKGMAHALSYL-HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
                        + +GM     YL    C    +HRD+++ NVL+  +    +ADFG+A
Sbjct: 187 QLSSKDLVSCAYQVARGME----YLASKKC----IHRDLAARNVLVTEDNVMKIADFGLA 238

Query: 341 R 341
           R
Sbjct: 239 R 239

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 42/198 (21%), Positives = 75/198 (37%), Gaps = 36/198 (18%)

Query: 187 TEDFHIKY-----CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARL 240
           +  F   Y      +G G +  V     L + +  A+K + +              E  +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEM 63

Query: 241 LSQIW-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLF--CVLR---TDEEAVGLDWAKRVN 294
           L Q   HRN+++L  F       +L++E M  GS+      R    + EA          
Sbjct: 64  LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA--------SV 115

Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRT 351
           +V+ +A AL +LH+     I HRD+   N+L     +     + DF +   +  +     
Sbjct: 116 VVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172

Query: 352 L-------LAGTSGYIAP 362
           +         G++ Y+AP
Sbjct: 173 ISTPELLTPCGSAEYMAP 190

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 5/104 (4%)

Query: 1   MYNNKLDGPI-PQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP 59
           M  N       P        L  L L    L     +    L  L  L++SHN       
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVP----LLYVSGNNF 99
                +  +  ++ S+N++  S  + ++  P     L ++ N+F
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 18/110 (16%), Positives = 36/110 (32%), Gaps = 4/110 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +   ++         + S L  LIL  N +          L  L  L      +      
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118

Query: 61  QLGEIPRIDTVNLSMNNL-SGSIPESVKKVP---LLYVSGNNFEVEIPST 106
            +G +  +  +N++ N + S  +PE    +     L +S N  +    + 
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 20/108 (18%), Positives = 37/108 (34%), Gaps = 4/108 (3%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIPSQ 61
           +              S L +L +  N    +   +I  +L+ L +LDLS   +    P+ 
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
              +  +  +N+S NN         K +    +L  S N+        
Sbjct: 490 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 17/110 (15%), Positives = 35/110 (31%), Gaps = 4/110 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N L         +  +L++L L    +          L  L+ L L+ N I      
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFE-VEIPST 106
               +  +  +     NL+      +  +     L V+ N  +  ++P  
Sbjct: 95  AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 18/111 (16%), Positives = 36/111 (32%), Gaps = 5/111 (4%)

Query: 1   MYNNKLDGPIPQE-LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKI- 58
             ++ L         ++   L  L + +     + +     L  L  L ++ N       
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

Query: 59  PSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
           P    E+  +  ++LS   L    P +   +    +L +S NNF       
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 16/111 (14%), Positives = 39/111 (35%), Gaps = 6/111 (5%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
           +  N +   +    +   +L  L   ++ L       +   L+ L YLD+SH        
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPST 106
                +  ++ + ++ N+   +    +    + +  L +S    E   P+ 
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 21/120 (17%), Positives = 41/120 (34%), Gaps = 27/120 (22%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
             +L+   P    + S L++L + +N      +     L  L  LD S N I      +L
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538

Query: 63  GEIPR-IDTVNLSMNNLSGS--------------------------IPESVKKVPLLYVS 95
              P  +  +NL+ N+ + +                           P   + +P+L ++
Sbjct: 539 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLN 598

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 20/100 (20%), Positives = 28/100 (28%), Gaps = 5/100 (5%)

Query: 10  IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRID 69
           IP  L      + L L  N L    S       EL  LDLS   I          +  + 
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 70  TVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
           T+ L+ N +      +   +     L     N        
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 24/111 (21%), Positives = 39/111 (35%), Gaps = 7/111 (6%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLS--GSISSEIGKLQELNYLDLSHNLINGKIP 59
                 G      ++   L  L L  N LS  G  S        L YLDLS N +   + 
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MS 389

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPST 106
           S    + +++ ++   +NL      SV    + +  L +S  +  V     
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 21/90 (23%), Positives = 41/90 (45%), Gaps = 6/90 (6%)

Query: 1   MYNNKLDG-PIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNY----LDLSHNLIN 55
           + +N +    +P+   N + L  L L +N +     +++  L ++      LDLS N +N
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 56  GKIPSQLGEIPRIDTVNLSMNNLSGSIPES 85
              P    EI R+  + L  N  S ++ ++
Sbjct: 191 FIQPGAFKEI-RLHKLTLRNNFDSLNVMKT 219

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 18/110 (16%), Positives = 35/110 (31%), Gaps = 11/110 (10%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLIN--GKI 58
           + N K       +L +  +L           G  +     L  L +LDLS N ++  G  
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365

Query: 59  PSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPS 105
                    +  ++LS N +   +  +   +     L    +N +     
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 12/100 (12%), Positives = 20/100 (20%), Gaps = 5/100 (5%)

Query: 3   NNKLDGPIPQELMNCSKLRILIL---GNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP 59
              L+      L     L I        +     I      L  ++   L    I     
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNF 99
                      + L            +K +  L  + N  
Sbjct: 300 --FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG 337

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 14/115 (12%), Positives = 31/115 (26%), Gaps = 12/115 (10%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
           Y +     I       + +    L +  +               +L+L +         +
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLK 323

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGN--NFEVEIPSTSAKAP 111
           L  +       L+  +  G    S   +P    L +S N  +F+     +     
Sbjct: 324 LKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 14/77 (18%), Positives = 30/77 (38%), Gaps = 4/77 (5%)

Query: 1   MYNNKLDGPIPQELMNC-SKLRILILGNNLLSGSISSE--IGKLQELNYLDLSHNLINGK 57
              N +     QEL +  S L  L L  N  + +   +  +  +++   L +    +   
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 584

Query: 58  IPSQLGEIPRIDTVNLS 74
            PS    +P +  +N++
Sbjct: 585 TPSDKQGMPVLS-LNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 17/119 (14%), Positives = 31/119 (26%), Gaps = 14/119 (11%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSE-IGKLQELNYLDLSHNLINGK-- 57
           +  N ++   P        L  L L NN  S ++    I  L  L    L       +  
Sbjct: 184 LSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242

Query: 58  ----IPSQLGEIPRIDTVNLSMNNLSGSIPESV------KKVPLLYVSGNNFEVEIPST 106
                 S L  +  +      +  L   + + +        V    +     E     +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS 301

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 46/183 (25%), Positives = 70/183 (38%), Gaps = 36/183 (19%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLY 253
           +G G  G V +     + +  ALK L              R E  L  +     +IV++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIV 121

Query: 254 GFC----LHRKCMFLIYEYMEMGSLF-------CVLRTDEEAVGLDWAKRVNIVKGMAHA 302
                    RKC+ ++ E ++ G LF           T+ EA          I+K +  A
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEA 173

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNFDSSNRTLLAGTSGY 359
           + YLH      I HRD+   N+L  S+       + DFG A+     +S  T    T  Y
Sbjct: 174 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYY 229

Query: 360 IAP 362
           +AP
Sbjct: 230 VAP 232

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 26/194 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           + F     +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHALS 304
             +VKL         ++++ EY+  G +F  LR          A+     IV        
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVL----TFE 155

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGYIAP- 362
           YLH      +++RD+   N+L++ +    V DFG A+ +      RT  L GT   +AP 
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPE 208

Query: 363 ---------ASEWW 367
                    A +WW
Sbjct: 209 IILSKGYNKAVDWW 222

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 82.4 bits (204), Expect = 7e-18
 Identities = 47/197 (23%), Positives = 71/197 (36%), Gaps = 42/197 (21%)

Query: 187 TEDFHIKY-----CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARL 240
                  Y      +G G  G V       +G+  ALK L+ S           R E   
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDH 74

Query: 241 LSQIW-HRNIVKLYGFC----LHRKCMFLIYEYMEMGSLF-------CVLRTDEEAVGLD 288
             Q     +IV +          ++C+ +I E ME G LF           T+ EA    
Sbjct: 75  HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA--- 131

Query: 289 WAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVARLLNF 345
                 I++ +  A+ +LH H    I HRD+   N+L  S+ +     + DFG A+    
Sbjct: 132 -----EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--T 181

Query: 346 DSSNRTLLAGTSGYIAP 362
             +       T  Y+AP
Sbjct: 182 TQNALQTPCYTPYYVAP 198

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 23/111 (20%), Positives = 43/111 (38%), Gaps = 5/111 (4%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + +N+L     +    C+ L  L L +N +    ++   K + L  LDLSHN ++     
Sbjct: 80  LQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFEVEIPST 106
              ++  +  + LS N +     E +          L +S N  +   P  
Sbjct: 140 TQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGC 190

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 23/109 (21%), Positives = 37/109 (33%), Gaps = 4/109 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           ++ +   G     L   S L IL L +N            L EL  +DL  N +N    S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKV----PLLYVSGNNFEVEIPS 105
                  + ++NL  N ++    +           L +  N F+    S
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 22/107 (20%), Positives = 38/107 (35%), Gaps = 3/107 (2%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
            N +    P+       L++L L +N LS            L  L L  N I     +  
Sbjct: 58  FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
            +   + T++LS N LS +   +  ++     L +S N  +      
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 18/118 (15%), Positives = 40/118 (33%), Gaps = 6/118 (5%)

Query: 1   MYNNKLDGPIP-QELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLING--K 57
           +  N++   +  QE      +  + L  N       +    +  L  L L    +     
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471

Query: 58  IPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPSTSAKAPP 112
            PS    +  +  ++LS NN++    + ++ +    +L +  NN        +   P 
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 22/107 (20%), Positives = 36/107 (33%), Gaps = 3/107 (2%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           +N+L           S+L  L +G N +S        KL  L  L+L HN ++       
Sbjct: 34  HNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF 93

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
                +  ++L  N++         K      L +S N        T
Sbjct: 94  AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGT 140

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 21/110 (19%), Positives = 38/110 (34%), Gaps = 6/110 (5%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSIS-SEIGKLQELNYLDLSHNLINGKIPSQ 61
            NK+             L +L LG N +   ++  E   L+ +  + LS+N       + 
Sbjct: 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449

Query: 62  LGEIPRIDTVNLSMNNLSG--SIPESVKKVP---LLYVSGNNFEVEIPST 106
              +P +  + L    L    S P   + +    +L +S NN        
Sbjct: 450 FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 25/119 (21%), Positives = 39/119 (32%), Gaps = 13/119 (10%)

Query: 1   MYNNKLDG--PIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLIN--- 55
           +    L      P        L IL L NN ++      +  L++L  LDL HN +    
Sbjct: 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLW 520

Query: 56  -----GKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
                G     L  +  +  +NL  N       E  K +    ++ +  NN      S 
Sbjct: 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASV 579

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 24/116 (20%), Positives = 44/116 (37%), Gaps = 10/116 (8%)

Query: 1   MYNNKLDGPIPQEL--MNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKI 58
           + NNK+     +EL     S L+ L L +N +          +  L  L L++  +   +
Sbjct: 152 LSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSL 211

Query: 59  PSQLGEI---PRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFEVEIPST 106
             +L        I  ++LS + LS +   +   +       L +S NN  V    +
Sbjct: 212 TEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 15/120 (12%), Positives = 36/120 (30%), Gaps = 12/120 (10%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNL------- 53
           +  N L+           +L    L  N +    S  +  L  + YL+L  +        
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314

Query: 54  --INGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPSTSA 108
             +          +  ++ +N+  N++ G        +     L +S +   +   +   
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 22/107 (20%), Positives = 46/107 (42%), Gaps = 6/107 (5%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           + KL   +P +L   + + +L L +N L    ++   +  +L  LD+  N I+   P   
Sbjct: 13  HLKLTQ-VPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC 69

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
            ++P +  +NL  N LS    ++         L++  N+ +    + 
Sbjct: 70  QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 26/98 (26%), Positives = 34/98 (34%), Gaps = 4/98 (4%)

Query: 15  MNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ-LGEIPRIDTVNL 73
           +  S L IL L  N +S   S     L  L  LDL  N I  ++  Q    +  I  + L
Sbjct: 378 LAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYL 437

Query: 74  SMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPSTSA 108
           S N        S   VP    L +     +    S S 
Sbjct: 438 SYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 19/120 (15%), Positives = 39/120 (32%), Gaps = 14/120 (11%)

Query: 1   MYNNKLDGPIPQELMNC--SKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKI 58
           + N++L        +    + L +L L  N L+   +     L +L Y  L +N I    
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288

Query: 59  PSQLGEIPR---------IDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
              L  +               ++S+ +L      S + +     L +  N+      + 
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 19/100 (19%), Positives = 33/100 (33%), Gaps = 5/100 (5%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGK-LQELNYLDLSHNLINGKIP 59
           +  N L+        N   L+ L L  NL++       G   + L  LD+  N  +    
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626

Query: 60  SQLGEIPRIDTVNLSMNNLSGSI----PESVKKVPLLYVS 95
           S    +  I+  + ++  LS       P      P+    
Sbjct: 627 SIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFD 666

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 16/115 (13%), Positives = 43/115 (37%), Gaps = 12/115 (10%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLI-------- 54
             +       +  N   L  + + N      + + +  L E+  ++++ N          
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD 293

Query: 55  NGKIPSQLGEIPRIDTVNLSMNNL-SGSIPESVKKVP---LLYVSGNNFEVEIPS 105
           + +  +      +I  + +  NNL +  +  S++K+    +L    N  E ++P+
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA 348

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 22/124 (17%), Positives = 39/124 (31%), Gaps = 20/124 (16%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSG-------SISSEIGKLQELNYLDLSHNL 53
           + NN++     +     S L  + L  N+L+          +        L  +DL  N 
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499

Query: 54  INGKIPS--QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYV---------SGNNFEVE 102
           +   +    +   +P +  ++LS N+ S   P        L            GN    E
Sbjct: 500 LTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557

Query: 103 IPST 106
            P  
Sbjct: 558 WPEG 561

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 80.9 bits (200), Expect = 9e-17
 Identities = 17/125 (13%), Positives = 41/125 (32%), Gaps = 21/125 (16%)

Query: 1   MYNNKLDG-------PIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNL 53
              N++         P+         +  + L NN +S            L+ ++L  N+
Sbjct: 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM 468

Query: 54  ING-------KIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFEV 101
           +                    + +++L  N L+  + +  +   L     + +S N+F  
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFS- 526

Query: 102 EIPST 106
           + P+ 
Sbjct: 527 KFPTQ 531

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 77.8 bits (192), Expect = 8e-16
 Identities = 15/112 (13%), Positives = 34/112 (30%), Gaps = 12/112 (10%)

Query: 3   NNKLDGPIPQELM--NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNL------I 54
            NKL   +  +        L  + L  N  S    ++      L    + +         
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554

Query: 55  NGKIPSQLGEIPRIDTVNLSMNNLSGSIPESV-KKVPLLYVSGNNFEVEIPS 105
             + P  +   P +  + +  N++   + E +   + +L +  N       S
Sbjct: 555 LREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNISIDLS 605

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 77.8 bits (192), Expect = 9e-16
 Identities = 24/118 (20%), Positives = 41/118 (34%), Gaps = 8/118 (6%)

Query: 1   MYNNKL-DGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP 59
           +  N L   P+   L    KL +L    N L G +    G   +L  L+L++N I     
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPA 370

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFEVEIPSTSAKAPP 112
           +  G   +++ ++ + N L   IP       +     +  S N              P
Sbjct: 371 NFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 19/118 (16%), Positives = 43/118 (36%), Gaps = 14/118 (11%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
              N+L+G +P    +  KL  L L  N ++   ++  G  +++  L  +HN +   IP+
Sbjct: 337 CLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPN 394

Query: 61  --QLGEIPRIDTVNLSMNNLSGSIPESVKKVPL----------LYVSGNNFEVEIPST 106
                 +  +  ++ S N +     ++   +            + +S N         
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 16/102 (15%), Positives = 35/102 (34%), Gaps = 9/102 (8%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
             +N +   + + +M  +KLR   +GN+        E  + +   Y              
Sbjct: 190 QLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDL 243

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNF 99
           +   +  +  V +        +P  +K +P   L+ V+ N  
Sbjct: 244 KWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 74.7 bits (184), Expect = 8e-15
 Identities = 15/105 (14%), Positives = 29/105 (27%), Gaps = 13/105 (12%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNL------LSGSISSEIGKLQELNYLDLSHNLING 56
            N      P + +N S L+   + N                I     L  L +  N I  
Sbjct: 522 YNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK 580

Query: 57  KIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNN 98
            +  ++   P I  +++  N         V       +  +  + 
Sbjct: 581 -VNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 14/99 (14%), Positives = 29/99 (29%), Gaps = 9/99 (9%)

Query: 16  NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLING----KIPSQLGEIPRIDTV 71
           +  ++  L L     SG +   IG+L EL  L L  +          P  +      +  
Sbjct: 79  SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138

Query: 72  NLSMNNLSGSIP-----ESVKKVPLLYVSGNNFEVEIPS 105
                +   +       E    +    ++ +  +  I  
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 12/113 (10%), Positives = 28/113 (24%), Gaps = 10/113 (8%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSG----SISSEIGKLQELNYLDLSHNLINGKI 58
                G +P  +   ++L +L LG++             I                    
Sbjct: 90  GFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF 149

Query: 59  PSQLG--EIPRIDTVNLSMNNLSGSIPESVKKVPL---LYVSGNNFEVEIPST 106
                  +   +    ++ +    SI +S +       +    NN    +   
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKA 201

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 13/79 (16%), Positives = 27/79 (34%), Gaps = 3/79 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
              N+     P+ +  C  L  L +G+N +   ++ +I     ++ LD+  N       S
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLS 605

Query: 61  QLGEIPRIDTVNLSMNNLS 79
            +          L  +   
Sbjct: 606 YVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 12/120 (10%), Positives = 34/120 (28%), Gaps = 16/120 (13%)

Query: 2   YNNKLDGP----IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLIN-- 55
            ++          P+ +                  +    +      ++ DL  + IN  
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF---VDYDPREDFSDLIKDCINSD 169

Query: 56  ---GKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPSTSAK 109
                I        +   +    NN++  + ++V ++      Y+  + F  E    + +
Sbjct: 170 PQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 7/89 (7%), Positives = 27/89 (30%), Gaps = 7/89 (7%)

Query: 28  NLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG----SIP 83
           ++        +     +  L L     +G++P  +G++  ++ + L  +          P
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

Query: 84  ESVKKVP---LLYVSGNNFEVEIPSTSAK 109
           + +              +++        +
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPR 155

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 17/172 (9%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +  V  AR + +G+ VA+K + +++     SL+    E R++  + H NIVKL+ 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFE 81

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                K ++LI EY   G +F  L    R  E+      A+     + +  A+ Y H   
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE-----ARS--KFRQIVSAVQYCHQKR 134

Query: 311 TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
              IVHRD+ + N+LL++++   +ADFG +              G   Y AP
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAP 182

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 80.3 bits (198), Expect = 4e-17
 Identities = 39/243 (16%), Positives = 75/243 (30%), Gaps = 71/243 (29%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKL-----------HRSETEELASLE--- 232
            DF    C+G GG+G V+ A+        A+K++              E + LA LE   
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 233 -----------------------------------------SFRNEARLLSQIWHRNIVK 251
                                                    +   + R +     +N V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCT 311
                  +  +++  +     +L   +         +    ++I   +A A+ +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184

Query: 312 PPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS------------NRTLLAGTSGY 359
             ++HRD+  +N+    +    V DFG+   ++ D                T   GT  Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 360 IAP 362
           ++P
Sbjct: 243 MSP 245

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 78.4 bits (194), Expect = 9e-17
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 18/173 (10%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G +G V       +G  VA+K L+R +   L  +   + E + L    H +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVL----RTDE-EAVGLDWAKRVNIVKGMAHALSYLHHH 309
                   F++ EY+  G LF  +    R +E EA          + + +  A+ Y H H
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA--------RRLFQQILSAVDYCHRH 130

Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               +VHRD+   NVLL++ + A +ADFG++ +++     RT   G+  Y AP
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAP 179

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 79.4 bits (196), Expect = 9e-17
 Identities = 48/178 (26%), Positives = 72/178 (40%), Gaps = 22/178 (12%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALK-----KLHRSETEELASLESFRNEARLLSQIWHRNI 249
           +G+G +G V+ A      K V +K     K+      E   L     E  +LS++ H NI
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 250 VKLYGFCLHRKCMFLIYEYMEMGS-LFCVL----RTDEEAVGLDWAKRVNIVKGMAHALS 304
           +K+     ++    L+ E    G  LF  +    R DE       A    I + +  A+ 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL-----ASY--IFRQLVSAVG 144

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           YL       I+HRDI   N+++  +    + DFG A  L       T   GT  Y AP
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAP 198

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 43/185 (23%), Positives = 72/185 (38%), Gaps = 28/185 (15%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRN---EARLLSQI----WHR 247
           +G GG+G+V+    L     VA+K + R+     + L        E  LL ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGS-LF--CVLRT--DEEAVGLDWAKRVNIVKGMAHA 302
            +++L  +   ++   L+ E       LF     +    E       ++       +  A
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP-----SRC--FFGQVVAA 151

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           + + H      +VHRDI   N+L++     A + DFG   LL+ D        GT  Y  
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTD-FDGTRVYSP 206

Query: 362 PASEW 366
           P  EW
Sbjct: 207 P--EW 209

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 28/195 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF I   +GTG +G V+  R   +G+  A+K L +     L  +E   +E  +LS + H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHAL 303
             I++++G     + +F+I +Y+E G LF +LR        V   +A  V        AL
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 119

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGYIAP 362
            YLH      I++RD+   N+LL+      + DFG A+ +     + T  L GT  YIAP
Sbjct: 120 EYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAP 172

Query: 363 ----------ASEWW 367
                     + +WW
Sbjct: 173 EVVSTKPYNKSIDWW 187

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 28/167 (16%)

Query: 196 IGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G +G VY+A+L  SG++VA+KK+ + +  +       R E +++ ++ H NIV+L  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------R-ELQIMRKLDHCNIVRLRY 114

Query: 255 FCLHR------KCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKG----MAHAL 303
           F            + L+ +Y+   +++ V R        L     V  VK     +  +L
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP----VIYVKLYMYQLFRSL 169

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSN 349
           +Y+H      I HRDI   N+LL+ +     + DFG A+ L     N
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 18/173 (10%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G +G V   +   +G  VA+K L+R +   L  +   R E + L    H +I+KLY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVL----RTDE-EAVGLDWAKRVNIVKGMAHALSYLHHH 309
                  +F++ EY+  G LF  +    R DE E+          + + +   + Y H H
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES--------RRLFQQILSGVDYCHRH 135

Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               +VHRD+   NVLL++ + A +ADFG++ +++     RT   G+  Y AP
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAP 184

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.4 bits (191), Expect = 3e-16
 Identities = 47/183 (25%), Positives = 75/183 (40%), Gaps = 26/183 (14%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRS---ETEELASLESFRNEARLLSQIWHR--NI 249
           +G+GG+GSVY    +     VA+K + +    +  EL +      E  LL ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 250 VKLYGFCLHRKCMFLIYEYME-MGSLF--CVLRT--DEEAVGLDWAKRVNIVKGMAHALS 304
           ++L  +        LI E  E +  LF     R    EE      A+       +  A+ 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----ARS--FFWQVLEAVR 163

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA 363
           + H+     ++HRDI   N+L++    E  + DFG   LL  D+       GT  Y  P 
Sbjct: 164 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD-FDGTRVYSPP- 217

Query: 364 SEW 366
            EW
Sbjct: 218 -EW 219

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 18/192 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
             F     +G GG+G V   ++  +GK+ A KKL +   ++        NE ++L ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           R +V L  +    K  + L+   M  G L   +    +A G   A+ V     +   L  
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGLED 301

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP--- 362
           LH      IV+RD+   N+LL+      ++D G+A  +    + +    GT GY+AP   
Sbjct: 302 LHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVV 357

Query: 363 -------ASEWW 367
                  + +WW
Sbjct: 358 KNERYTFSPDWW 369

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.6 bits (191), Expect = 8e-16
 Identities = 41/188 (21%), Positives = 80/188 (42%), Gaps = 14/188 (7%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           +  + + I++ IGTG YG V  A      +VVA+KK+ R   + +      R E  +L++
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNR 108

Query: 244 IWHRNIVKLY-----GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           + H ++VK+              ++++ E  +      + RT      L       ++  
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVY---LTELHIKTLLYN 164

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           +   + Y+H      I+HRD+   N L+N +    V DFG+AR +++  +  + L  +  
Sbjct: 165 LLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

Query: 359 YIAPASEW 366
                   
Sbjct: 222 EDDMNLVT 229

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 19/117 (16%), Positives = 32/117 (27%), Gaps = 16/117 (13%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLING------ 56
             K          N   L  + L N      +   +  L EL  L+++ N          
Sbjct: 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535

Query: 57  ---KIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFEVEIPS 105
              ++       P+I    +  NNL    P S     +     L    N     + +
Sbjct: 536 DWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEA 590

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 21/137 (15%), Positives = 53/137 (38%), Gaps = 33/137 (24%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSG-------------------SISSEIGKLQE 43
            N++   I + +   +KL+I+   N+  +                    +       L++
Sbjct: 434 TNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKD 492

Query: 44  LNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG---------SIPESVKKVP---L 91
           L  ++L +     ++P  L ++P + ++N++ N              + +     P   +
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552

Query: 92  LYVSGNNFEVEIPSTSA 108
            Y+  NN E E P++++
Sbjct: 553 FYMGYNNLE-EFPASAS 568

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 18/113 (15%), Positives = 44/113 (38%), Gaps = 13/113 (11%)

Query: 3   NNKLDGPIPQELM--NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNL------I 54
            NKL   +  +        L  + +  N  S S  ++     +L    + H        I
Sbjct: 737 FNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRI 794

Query: 55  NGKIPSQLGEIPRIDTVNLSMNNLSGSIPESV-KKVPLLYVSGN-NFEVEIPS 105
             + P+ +   P +  + +  N++   + E +  ++ +L ++ N N  +++ S
Sbjct: 795 LRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADNPNISIDVTS 846

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 19/123 (15%), Positives = 38/123 (30%), Gaps = 19/123 (15%)

Query: 1   MYNNKLDG-----PIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLI- 54
              NK+           +         + L  N +    +        ++ + LS+NL+ 
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710

Query: 55  ------NGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFEVEI 103
                              + T++L  N L+ S+ +  +   L     + VS N F    
Sbjct: 711 SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SF 768

Query: 104 PST 106
           P+ 
Sbjct: 769 PTQ 771

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 15/138 (10%), Positives = 37/138 (26%), Gaps = 24/138 (17%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLING------ 56
           N ++        ++    +I  L N +    IS  I +L +L  +  +++          
Sbjct: 411 NPEMKPIKKDSRISLKDTQIGNLTNRI--TFISKAIQRLTKLQIIYFANSPFTYDNIAVD 468

Query: 57  -------------KIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFE 100
                                +  +  V L        +P+ +  +P    L ++ N   
Sbjct: 469 WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528

Query: 101 VEIPSTSAKAPPPHHKGN 118
                 +        +  
Sbjct: 529 SAAQLKADWTRLADDEDT 546

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 13/81 (16%), Positives = 23/81 (28%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG 63
           +        +L N  ++  L L      G +   IG+L EL  L    +           
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 64  EIPRIDTVNLSMNNLSGSIPE 84
           E    D      + +     +
Sbjct: 369 EELTPDMSEERKHRIRMHYKK 389

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 20/122 (16%), Positives = 38/122 (31%), Gaps = 15/122 (12%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGK-LQELNYLDLSHNLINGKIP 59
             +NK+     +      KL  L L  N +   I  +      ++  L  SHN +   IP
Sbjct: 580 CVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IP 635

Query: 60  S--QLGEIPRIDTVNLSMNNLSGSIPESVKKVPL--------LYVSGNNFEVEIPSTSAK 109
           +      +  + +V+ S N +          +          + +S N  +       A 
Sbjct: 636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT 695

Query: 110 AP 111
             
Sbjct: 696 GS 697

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 18/140 (12%), Positives = 46/140 (32%), Gaps = 36/140 (25%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISS------------------------- 36
                 G +P  +   ++L++L  G +  + S                            
Sbjct: 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390

Query: 37  EIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG------SIPESVKKVP 90
            +   Q LN  DL  + IN     ++  I +   ++L    +         I ++++++ 
Sbjct: 391 FLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLT 448

Query: 91  ---LLYVSGNNFEVEIPSTS 107
              ++Y + + F  +  +  
Sbjct: 449 KLQIIYFANSPFTYDNIAVD 468

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 15/80 (18%), Positives = 30/80 (37%), Gaps = 5/80 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHN-LINGKIP 59
              N++    P  +  C  L  L +G+N +   +  ++    +L  LD++ N  I+  + 
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVT 845

Query: 60  SQLGEIPRIDTVNLSMNNLS 79
           S    I       L  +   
Sbjct: 846 SVCPYI-EAGMYVLLYDKTQ 864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 44/193 (22%), Positives = 85/193 (44%), Gaps = 17/193 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           + F     +G GG+G V+  ++  +GK+ A KKL++   ++    +    E ++L+++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 247 RNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG-MAHALS 304
           R IV L  +    K  + L+   M  G +   +   +E        R       +   L 
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP-- 362
           +LH      I++RD+   NVLL+ +    ++D G+A  L    +     AGT G++AP  
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

Query: 363 --------ASEWW 367
                   + +++
Sbjct: 361 LLGEEYDFSVDYF 373

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 11/170 (6%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G YG V  A    + + VA+K +      +    E+ + E  +   + H N+VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG 72

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                   +L  EY   G LF  +   E  +G+           +   + YLH      I
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 126

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
            HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 27/161 (16%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF 255
           IG G +G V++A+L     VA+KK+ + +  +       R E +++  + H N+V L  F
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------R-ELQIMRIVKHPNVVDLKAF 100

Query: 256 CLHR------KCMFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKG----MAHALS 304
                       + L+ EY+   +++   R   +    +     + ++K     +  +L+
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLA 155

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLN 344
           Y+H      I HRDI   N+LL+       + DFG A++L 
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 41/188 (21%), Positives = 77/188 (40%), Gaps = 41/188 (21%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLES-FRNEARLLSQIWHRNIVKLY 253
           +G G YG V       +    A+K L + +   + + E+  + E +LL ++ H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 254 GFCLH--RKCMFLIYEYMEMGS--LFCVLRTDEEAVGLDWAKRVNIVKG-----MAH--- 301
               +  ++ M+++ EY   G   +             D      + +       AH   
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEML------------DS-----VPEKRFPVCQAHGYF 115

Query: 302 -----ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LA 354
                 L YLH      IVH+DI   N+LL +     ++  GVA  L+  +++ T     
Sbjct: 116 CQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172

Query: 355 GTSGYIAP 362
           G+  +  P
Sbjct: 173 GSPAFQPP 180

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 38/177 (21%), Positives = 68/177 (38%), Gaps = 21/177 (11%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRN-------- 236
                + ++  I +G YG+V       G  VA+K++  + ++         +        
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV-NILSDSFLCKRVL 77

Query: 237 -EARLLSQIWHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWA 290
            E RLL+   H NI+ L    +H +      ++L+ E M    L  V+        +   
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIV--ISPQ 134

Query: 291 KRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS 347
                +  +   L  LH      +VHRD+   N+LL    +  + DF +AR    D+
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 19/173 (10%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G +G V  A    + + VALK + R   ++         E   L  + H +I+KLY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVL----RTDE-EAVGLDWAKRVNIVKGMAHALSYLHHH 309
                  + ++ EY   G LF  +    R  E E             + +  A+ Y H H
Sbjct: 77  VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGR--------RFFQQIICAIEYCHRH 127

Query: 310 CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               IVHRD+   N+LL+  L   +ADFG++ ++   +  +T   G+  Y AP
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAP 176

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 40/161 (24%), Positives = 61/161 (37%), Gaps = 35/161 (21%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLY 253
           +G G  G V +     + +  ALK L              R E  L  +     +IV++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIV 77

Query: 254 GFC----LHRKCMFLIYEYMEMGSLF-------CVLRTDEEAVGLDWAKRVNIVKGMAHA 302
                    RKC+ ++ E ++ G LF           T+ EA          I+K +  A
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------EIMKSIGEA 129

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAF---VADFGVA 340
           + YLH      I HRD+   N+L  S+       + DFG A
Sbjct: 130 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 43/183 (23%), Positives = 81/183 (44%), Gaps = 19/183 (10%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           +    +     IG G YG V  A    +   VA+KK+   E +      + R E ++L +
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR-EIKILLR 81

Query: 244 IWHRNIVKLYGFCLHRKC-----MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
             H NI+ +              ++++ + ME   L+ +L+T      L        +  
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH----LSNDHICYFLYQ 136

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           +   L Y+H   +  ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +   L   + 
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL---TE 190

Query: 359 YIA 361
           Y+A
Sbjct: 191 YVA 193

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 11/170 (6%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           +G G YG V  A    + + VA+K +      +    E+ + E  +   + H N+VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLNHENVVKFYG 72

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                   +L  EY   G LF  +   E  +G+           +   + YLH      I
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 126

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
            HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 33/200 (16%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-- 244
            DF +   IG GG+G VY  R   +GK+ A+K L +   +         NE  +LS +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 245 -WHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKG 298
                IV + Y F    K +  I + M  G L   L       E  +    A+       
Sbjct: 249 GDCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE------- 300

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           +   L ++H+     +V+RD+   N+LL+      ++D G+A   +    +     GT G
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHG 355

Query: 359 YIAP-----------ASEWW 367
           Y+AP           +++W+
Sbjct: 356 YMAPEVLQKGVAYDSSADWF 375

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 16/167 (9%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E    +     +G+G YG+V  A    +G  VA+KKL+R    EL +  ++R E RLL  
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKH 80

Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK 297
           + H N++ L       + +      +L+  +M    L  +++ ++    L   +   +V 
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK----LGEDRIQFLVY 135

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            M   L Y+H      I+HRD+   N+ +N + E  + DFG+AR  +
Sbjct: 136 QMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 44/199 (22%), Positives = 78/199 (39%), Gaps = 45/199 (22%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRS-----------------------ETEELASL 231
           IG G YG V  A         A+K L +                          +    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 232 ESFRNEARLLSQIWHRNIVKLYG--FCLHRKCMFLIYEYMEMGSLFCVLR----TDEEAV 285
           E    E  +L ++ H N+VKL       +   +++++E +  G +  V      ++++A 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
                      + +   + YLH+     I+HRDI  +N+L+  +    +ADFGV+    F
Sbjct: 141 --------FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE--F 187

Query: 346 DSSNRTL--LAGTSGYIAP 362
             S+  L    GT  ++AP
Sbjct: 188 KGSDALLSNTVGTPAFMAP 206

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 48/194 (24%), Positives = 92/194 (47%), Gaps = 17/194 (8%)

Query: 176 GRITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESF 234
           GR+           + +   +G G YG V+++    +G+VVA+KK+  +      +  +F
Sbjct: 1   GRVDR----HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF 56

Query: 235 RNEARLLSQI-WHRNIVKLYGFCL--HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK 291
           R E  +L+++  H NIV L       + + ++L+++YME   L  V+R +     L+   
Sbjct: 57  R-EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI----LEPVH 110

Query: 292 RVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRT 351
           +  +V  +   + YLH   +  ++HRD+  +N+LLN+E    VADFG++R          
Sbjct: 111 KQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

Query: 352 LLAGTSGYIAPASE 365
            +  +        +
Sbjct: 168 NIPLSINENTENFD 181

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 17/167 (10%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  + +     +G+G YGSV  A    SG+ VA+KKL R    E+ +  ++R E  LL  
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKH 79

Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK 297
           + H N++ L         +      +L+  +M+   L  ++            K   +V 
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK-----FSEEKIQYLVY 133

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN 344
            M   L Y+H   +  +VHRD+   N+ +N + E  + DFG+AR  +
Sbjct: 134 QMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 43/187 (22%), Positives = 78/187 (41%), Gaps = 14/187 (7%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
              +++ IK+ IG G YG VY A    + K VA+KK++R   + +      R E  +L++
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNR 81

Query: 244 IWHRNIVKLYGFCL--HRKCM---FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
           +    I++LY   +          +++ E  +   L  + +T      L       I+  
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF---LTEEHIKTILYN 137

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           +    +++H      I+HRD+   N LLN +    V DFG+AR +N +     +      
Sbjct: 138 LLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 359 YIAPASE 365
                  
Sbjct: 195 EEPGPHN 201

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 40/186 (21%), Positives = 74/186 (39%), Gaps = 38/186 (20%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKK--LHRS----ETEELASLESFRNE 237
           +  + F ++   G G +G+V   +   +G  VA+KK          E + +         
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIM--------- 70

Query: 238 ARLLSQIWHRNIVKLYGFCLHRK-------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWA 290
            + L+ + H NIV+L  +             + ++ EY+   +L    R          A
Sbjct: 71  -QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR---QVA 125

Query: 291 KRVNIVKG----MAHALSYLHHHCTPPIVHRDISSNNVLLNS---ELEAFVADFGVARLL 343
               ++K     +  ++  LH   +  + HRDI  +NVL+N     L+  + DFG A+ L
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK--LCDFGSAKKL 182

Query: 344 NFDSSN 349
           +    N
Sbjct: 183 SPSEPN 188

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 19/101 (18%), Positives = 34/101 (33%), Gaps = 3/101 (2%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
            N+  D  +     N + L  L L    L          L  L  L++SHN +     S 
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNF 99
             ++  + T++ S N +  S               ++ N+ 
Sbjct: 517 YNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 14/108 (12%), Positives = 34/108 (31%), Gaps = 4/108 (3%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
             +++    +       L  LIL  N +          L  L  L      +       +
Sbjct: 65  RCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124

Query: 63  GEIPRIDTVNLSMNNLSG-SIPESVKKVP---LLYVSGNNFEVEIPST 106
           G++  +  +N++ N +    +P     +     + +S N  +    + 
Sbjct: 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 19/110 (17%), Positives = 37/110 (33%), Gaps = 4/110 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N L         N S+L+ L L    +          L  L+ L L+ N I    P 
Sbjct: 39  LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG 98

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNF-EVEIPST 106
               +  ++ +      L+      + ++     L V+ N     ++P+ 
Sbjct: 99  SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 17/79 (21%), Positives = 32/79 (40%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +   +L+           +L++L + +N L    SS   +L  L+ LD S N I      
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539

Query: 61  QLGEIPRIDTVNLSMNNLS 79
                  +   NL+ N+++
Sbjct: 540 LQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 18/111 (16%), Positives = 38/111 (34%), Gaps = 6/111 (5%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSIS-SEIGKLQELNYLDLSHNLINGKIP 59
           +  N     +    M   +L+ L   ++ L      S    L++L YLD+S+        
Sbjct: 383 LSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVP----LLYVSGNNFEVEIPST 106
                +  ++T+ ++ N+   +   +V         L +S    E      
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 19/111 (17%), Positives = 31/111 (27%), Gaps = 5/111 (4%)

Query: 1   MYNNKLDGPIPQE-LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP 59
             ++ L         ++  KL  L +               L  LN L ++ N       
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465

Query: 60  SQ-LGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
           S        +  ++LS   L          +    LL +S NN      S 
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 20/107 (18%), Positives = 33/107 (30%), Gaps = 6/107 (5%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           + KL   +P ++   S  + + L  N L    S       EL +LDLS   I        
Sbjct: 20  DQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAW 76

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
             +  +  + L+ N +    P S   +     L              
Sbjct: 77  HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFP 123

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 19/88 (21%), Positives = 38/88 (43%), Gaps = 6/88 (6%)

Query: 3   NNKLDG-PIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELN----YLDLSHNLINGK 57
           +N +    +P    N + L  + L  N +     +++  L+E       LD+S N I+  
Sbjct: 137 HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-F 195

Query: 58  IPSQLGEIPRIDTVNLSMNNLSGSIPES 85
           I  Q  +  ++  + L  N  S +I ++
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKT 223

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 21/98 (21%), Positives = 36/98 (36%), Gaps = 9/98 (9%)

Query: 16  NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS--QLGEIPRIDTVNL 73
           +   L+ L L  N  S  IS +   L  L+YLDLS N ++              +  ++L
Sbjct: 326 DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383

Query: 74  SMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPSTSA 108
           S N     +  +   +     L    +  +  +   SA
Sbjct: 384 SFNGAI-IMSANFMGLEELQHLDFQHSTLK-RVTEFSA 419

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 12/104 (11%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
              +     +++    K + L +    L          L  L  L L+ N  +  I  + 
Sbjct: 294 GVSIKYL--EDVPKHFKWQSLSIIRCQLK---QFPTLDLPFLKSLTLTMNKGS--ISFKK 346

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFEV 101
             +P +  ++LS N LS S   S   +       L +S N   +
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII 390

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 12/91 (13%), Positives = 27/91 (29%), Gaps = 6/91 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRI----LILGNNLLSGSISSEIGKLQELNYLDLSHNLING 56
           +  N +      +L    +       L +  N +   I  +  +  +L+ L L  N  + 
Sbjct: 160 LSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSS 218

Query: 57  KIPS-QLGEIPRIDTVNLSMNNLSGSIPESV 86
            I    L  +  +    L +          +
Sbjct: 219 NIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 9/107 (8%), Positives = 31/107 (28%), Gaps = 4/107 (3%)

Query: 3   NNKLDGPIPQELMNCSKLRILIL--GNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
              L+   P  +     + I                +   L  ++ + L+   I   +  
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLED 302

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTS 107
            + +  +  ++++    L       +  +  L ++ N   +     +
Sbjct: 303 -VPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVA 348

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.7 bits (174), Expect = 9e-14
 Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 28/194 (14%)

Query: 177 RITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFR 235
           RI +      + DF +K  +G G YG V  A   P+G++VA+KK+   +    A L + R
Sbjct: 4   RIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLR 58

Query: 236 NEARLLSQIWHRNIVKLY---------GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG 286
            E ++L    H NI+ ++          F      +++I E M+   L  V+ T      
Sbjct: 59  -EIKILKHFKHENIITIFNIQRPDSFENF----NEVYIIQELMQT-DLHRVISTQM---- 108

Query: 287 LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           L        +     A+  LH      ++HRD+  +N+L+NS  +  V DFG+AR+++  
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165

Query: 347 SSNRTLLAGTSGYI 360
           +++ +   G    +
Sbjct: 166 AADNSEPTGQQSGM 179

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 40/164 (24%), Positives = 77/164 (46%), Gaps = 17/164 (10%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
              + +     IG+G  G V  A      + VA+KKL R    +  +  ++R E  L+  
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKC 117

Query: 244 IWHRNIVKLY------GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK 297
           + H+NI+ L             + ++L+ E M+  +L  V++ +     LD  +   ++ 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----LDHERMSYLLY 171

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            M   + +LH   +  I+HRD+  +N+++ S+    + DFG+AR
Sbjct: 172 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 44/202 (21%), Positives = 80/202 (39%), Gaps = 48/202 (23%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRN------- 236
           +    +     +G GG G V+ A      K VA+KK+               +       
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI------------VLTDPQSVKHA 55

Query: 237 --EARLLSQIWHRNIVKLY--------------GFCLHRKCMFLIYEYMEMGSLFCVLRT 280
             E +++ ++ H NIVK++              G       ++++ EYME   L  VL  
Sbjct: 56  LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ 114

Query: 281 DEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGV 339
                 L        +  +   L Y+H   +  ++HRD+   N+ +N+E L   + DFG+
Sbjct: 115 GP----LLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGL 167

Query: 340 ARLLNFDSSNRTLLAGTSGYIA 361
           AR+++   S++  L   S  + 
Sbjct: 168 ARIMDPHYSHKGHL---SEGLV 186

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 44/196 (22%), Positives = 74/196 (37%), Gaps = 26/196 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
            +F     +G G +G V   +   +G+  A+K L +        +     E R+L    H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 247 RNIVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAH 301
             +  L  +       +  + EY   G LF  L       E+      A+       +  
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-------IVS 259

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           AL YLH      +V+RD+   N++L+ +    + DFG+ +    D +      GT  Y+A
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317

Query: 362 P----------ASEWW 367
           P          A +WW
Sbjct: 318 PEVLEDNDYGRAVDWW 333

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 46/185 (24%), Positives = 84/185 (45%), Gaps = 18/185 (9%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
              + +     IG+G  G V  A      + VA+KKL R    +  +  ++R E  L+  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKC 80

Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK 297
           + H+NI+ L      +K +      +++ E M+  +L  V++ +     LD  +   ++ 
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----LDHERMSYLLY 134

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTS 357
            M   + +LH   +  I+HRD+  +N+++ S+    + DFG+AR     S   T    T 
Sbjct: 135 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTR 190

Query: 358 GYIAP 362
            Y AP
Sbjct: 191 YYRAP 195

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 14/107 (13%), Positives = 31/107 (28%), Gaps = 3/107 (2%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
             ++         +  +L  L+L  N L     + +   + L +L      I+      L
Sbjct: 66  RCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
                ++++ L  N++S              +L    N         
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 24/104 (23%), Positives = 43/104 (41%), Gaps = 7/104 (6%)

Query: 3   NNKLDGPIPQE---LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP 59
            N       Q+   L    +L IL+L    LS         L+ +N++DLSHN +     
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFE 100
             L  +  I  +NL+ N++S  +P  +  +     + +  N  +
Sbjct: 518 EALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 17/116 (14%), Positives = 36/116 (31%), Gaps = 6/116 (5%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N L       L     L+ L      +S      +   + L  L L  N I+     
Sbjct: 88  LTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP 147

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP-----LLYVSGNNFEVEIPSTSAKAP 111
           +     ++  ++   N +     E +  +       L ++GN+    I   +  + 
Sbjct: 148 KGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSA 202

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 14/109 (12%), Positives = 25/109 (22%), Gaps = 3/109 (2%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
              N L             L  L L    +             L+ L L+ N +     +
Sbjct: 40  FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET 99

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
            L     +  +      +S      +        LY+  N+        
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 65.8 bits (161), Expect = 7e-12
 Identities = 23/113 (20%), Positives = 44/113 (38%), Gaps = 6/113 (5%)

Query: 1   MYNNKLD--GPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKI 58
           + ++ ++       +L N S L+ L L  N      +    +  +L  LDL+   +  K 
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416

Query: 59  P-SQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPSTS 107
             S    +  +  +NLS + L  S  +    +P    L + GN+F       +
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 18/103 (17%), Positives = 32/103 (31%), Gaps = 5/103 (4%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
             +             S L+ L L    LS  + S +  L  L  L LS N         
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQIS 320

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFE 100
               P +  +++  N     +        + +  L +S ++ E
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 21/113 (18%), Positives = 39/113 (34%), Gaps = 7/113 (6%)

Query: 1   MYNNKLDGPIPQE-LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP 59
           +   +L     Q    N   L++L L ++LL  S       L  L +L+L  N       
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466

Query: 60  SQLGEI---PRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
            +   +    R++ + LS  +LS     +   +     + +S N         
Sbjct: 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 19/110 (17%), Positives = 39/110 (35%), Gaps = 7/110 (6%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ- 61
              L   +P  L+  S L+ L+L  N               L +L +  N    ++ +  
Sbjct: 287 ATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFEVEIPST 106
           L  +  +  ++LS +++  S   +++   L     L +S N         
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 22/111 (19%), Positives = 43/111 (38%), Gaps = 6/111 (5%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLL--SGSISSEIGKLQELNYLDLSHNLINGKIP 59
            N K        L N   LR L L ++ +  S   + ++  L  L  L+LS+N       
Sbjct: 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVP----LLYVSGNNFEVEIPST 106
               E P+++ ++L+   L     +S  +      +L +S +  ++     
Sbjct: 394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 1/79 (1%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
              L         +   +  + L +N L+ S    +  L+ + YL+L+ N I+  +PS L
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLL 543

Query: 63  GEIPRIDTVNLSMNNLSGS 81
             + +  T+NL  N L  +
Sbjct: 544 PILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 19/108 (17%), Positives = 38/108 (35%), Gaps = 6/108 (5%)

Query: 3   NNKLDGPIPQELMNCSK--LRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +   +   P       +  +  + L  +      S+       L  LDL+   ++ ++PS
Sbjct: 237 DMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPS 295

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPS 105
            L  +  +  + LS N        S    P    L + GN   +E+ +
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 21/107 (19%), Positives = 35/107 (32%), Gaps = 6/107 (5%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           N  L+  IP  L   +    L    N+L    ++   +L  L +LDL+   I        
Sbjct: 21  NLGLNE-IPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF 77

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
               R+DT+ L+ N L      ++        L+             
Sbjct: 78  QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 13/115 (11%), Positives = 30/115 (26%), Gaps = 10/115 (8%)

Query: 1   MYNNKLDGPIPQELMNCSKLRI--LILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKI 58
             NN +     +++ +  +     L L  N ++  I            L+         I
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVI 218

Query: 59  PSQLG--EIPRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFEVEIPST 106
              L    I  +        +     P   + +       + +  + F     +T
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 26/176 (14%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG+G +G     R   + ++VA+K + R    +    E+ + E      + H NIV+   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKE 83

Query: 255 FCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRV--NIVKGMAHALSYLHH 308
             L    + +I EY   G L+  +    R  E+      A+     ++      +SY H 
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDE-----ARFFFQQLL----SGVSYCHS 134

Query: 309 HCTPPIVHRDISSNNVLL--NSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                I HRD+   N LL  +      + DFG ++     S  ++ + GT  YIAP
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAP 186

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 16/164 (9%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R     + +  ++R E RLL  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKH 84

Query: 244 IWHRNIVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVK 297
           + H N++ L       + +      +L+   M    L  +++  +    L       ++ 
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK----LTDDHVQFLIY 139

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR 341
            +   L Y+H   +  I+HRD+  +N+ +N + E  + DFG+AR
Sbjct: 140 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 35/204 (17%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSE-TEELASLESFRNEARLLS 242
           E+F +   +GTG YG V+  R      +GK+ A+K L ++   ++  + E  R E ++L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 243 QIWHRN-IVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIV 296
            I     +V L Y F    K + LI +Y+  G LF  L       E  V +   +     
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGE----- 167

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAG 355
             +  AL +LH      I++RDI   N+LL+S     + DFG+++    D + R     G
Sbjct: 168 --IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222

Query: 356 TSGYIAP------------ASEWW 367
           T  Y+AP            A +WW
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWW 246

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.3 bits (158), Expect = 5e-12
 Identities = 29/233 (12%), Positives = 60/233 (25%), Gaps = 59/233 (25%)

Query: 178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSETEELASLES 233
           + F   +  TE       IG G +G V++          K++A++           + E 
Sbjct: 11  VPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEE 69

Query: 234 FRNEARLLSQIW---------HRNIVKLYGFCLHRKC----------------------- 261
              E  +  ++              + L      +                         
Sbjct: 70  ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129

Query: 262 -------MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI 314
                  +F++ E+   G     +RT         A   +I+  +  +L+          
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKL----SSLATAKSILHQLTASLAVAEASL--RF 183

Query: 315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPASEWW 367
            HRD+   NVLL       +      +              + G      ++ 
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI---------PSCGLQVSIIDYT 227

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 22/99 (22%), Positives = 49/99 (49%), Gaps = 5/99 (5%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N++       + + +KL++L +G+N +S    S +  L +LN L L++N +  +   
Sbjct: 250 IGTNQISDINA--VKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME 305

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNN 98
            +G +  + T+ LS N+++   P  S+ K+     +   
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQV 344

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 57.2 bits (139), Expect = 3e-09
 Identities = 19/100 (19%), Positives = 40/100 (40%), Gaps = 7/100 (7%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
             +K+    P  + N + L  L L  N +     S +  L  L+Y     N I    P  
Sbjct: 163 TESKVKDVTP--IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITP-- 216

Query: 62  LGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNNFE 100
           +  + R++++ +  N ++   P  ++ ++  L +  N   
Sbjct: 217 VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQIS 256

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 55.2 bits (134), Expect = 1e-08
 Identities = 21/107 (19%), Positives = 51/107 (47%), Gaps = 7/107 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
            Y N++    P  + N ++L  L +GNN ++    S +  L +L +L++  N I+    +
Sbjct: 206 AYVNQITDITP--VANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD--IN 259

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNNFEVEIPST 106
            + ++ ++  +N+  N +S      ++ ++  L+++ N    E    
Sbjct: 260 AVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEV 306

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 54.5 bits (132), Expect = 2e-08
 Identities = 22/100 (22%), Positives = 44/100 (44%), Gaps = 8/100 (8%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N++    P  L N  KL  L +G N ++    S +  L  L  L L+ + I+   P 
Sbjct: 73  LNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP- 127

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPE--SVKKVPLLYVSGNN 98
            L  + ++ ++NL  N+    +    ++  +  L V+ + 
Sbjct: 128 -LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESK 166

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 52.9 bits (128), Expect = 6e-08
 Identities = 19/99 (19%), Positives = 41/99 (41%), Gaps = 6/99 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  + +    P  L N +K+  L LG N     +S  +  +  LNYL ++ + +    P 
Sbjct: 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP- 172

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNN 98
            +  +  + +++L+ N +    P  S+  +       N 
Sbjct: 173 -IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQ 210

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 22/126 (17%), Positives = 45/126 (35%), Gaps = 25/126 (19%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLING---- 56
           +    +   + QE      +  L++    ++ SI   I  L  L YL+L+ N I      
Sbjct: 29  LQKASVTDVVTQE--ELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISPL 84

Query: 57  ----------------KIPSQLGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNNF 99
                              S L  +  +  + L+ +N+S   P  ++ K+  L +  N+ 
Sbjct: 85  SNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHN 144

Query: 100 EVEIPS 105
             ++  
Sbjct: 145 LSDLSP 150

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 48.7 bits (117), Expect = 1e-06
 Identities = 10/54 (18%), Positives = 24/54 (44%), Gaps = 2/54 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLI 54
           + NN+L     + +   + L  L L  N ++      +  L +++  D ++ +I
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI--RPLASLSKMDSADFANQVI 345

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 63.7 bits (156), Expect = 2e-11
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 33/201 (16%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSE-TEELASLESFRNEARLLS 242
           E F +   +G GGYG V++ R      +GK+ A+K L ++            + E  +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 243 QIWHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVK 297
           ++ H  IV L Y F    K ++LI EY+  G LF  L       E+      A+      
Sbjct: 77  EVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAE------ 129

Query: 298 GMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGT 356
            ++ AL +LH      I++RD+   N++LN +    + DFG+ +  +      T    GT
Sbjct: 130 -ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGT 184

Query: 357 SGYIAP----------ASEWW 367
             Y+AP          A +WW
Sbjct: 185 IEYMAPEILMRSGHNRAVDWW 205

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 63.7 bits (156), Expect = 2e-11
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 45/206 (21%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLH------RSETEELASLESFRNE 237
             F +   +G G +G V+  +      + ++ A+K L       R              E
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-------E 76

Query: 238 ARLLSQIWHRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKR 292
             +L ++ H  IVKL Y F    K ++LI +++  G LF  L       EE V    A+ 
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE- 134

Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
                 +A AL +LH      I++RD+   N+LL+ E    + DFG+++  + D   +  
Sbjct: 135 ------LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAY 184

Query: 353 -LAGTSGYIAP----------ASEWW 367
              GT  Y+AP          +++WW
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWW 210

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 48/195 (24%), Positives = 74/195 (37%), Gaps = 25/195 (12%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
            DF     +G G +G V   R   +G+  A+K L +        +     E+R+L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 247 RNIVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHAL 303
             +  L  +       +  + EY   G LF  L   E     + A+     IV     AL
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIV----SAL 118

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGYIAP 362
            YLH      +V+RDI   N++L+ +    + DFG+ +              GT  Y+AP
Sbjct: 119 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAP 174

Query: 363 ----------ASEWW 367
                     A +WW
Sbjct: 175 EVLEDNDYGRAVDWW 189

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 36/182 (19%), Positives = 74/182 (40%), Gaps = 37/182 (20%)

Query: 172 WNYD-GRITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETE--- 226
           W+Y+   + +       +D+ +   +G G Y  V+ A  + + + V +K L   + +   
Sbjct: 23  WDYESHVVEW----GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK 78

Query: 227 -ELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF---LIYEYMEMGSLFCVLR--T 280
            E+  LE+ R            NI+ L    +         L++E++       + +  T
Sbjct: 79  REIKILENLRG---------GPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLT 128

Query: 281 DEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-EAFVADFGV 339
           D +            +  +  AL Y H      I+HRD+  +NV+++ E  +  + D+G+
Sbjct: 129 DYDI--------RFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 177

Query: 340 AR 341
           A 
Sbjct: 178 AE 179

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 46/198 (23%), Positives = 84/198 (42%), Gaps = 30/198 (15%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
            DF+    +G G +G V  +    + ++ A+K L +    +   +E    E R+L+    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 246 HRNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMA 300
              + +L+  C      ++ + EY+  G L   +    R  E       A+       +A
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-------IA 452

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAGTSGY 359
             L +L       I++RD+  +NV+L+SE    +ADFG+ +  +    + +T   GT  Y
Sbjct: 453 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDY 508

Query: 360 IAP----------ASEWW 367
           IAP          + +WW
Sbjct: 509 IAPEIIAYQPYGKSVDWW 526

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 24/104 (23%), Positives = 41/104 (39%), Gaps = 6/104 (5%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +Y N +    P  + + +KL+ L   NN +S    S +  L  +N+L   HN I+   P 
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP- 370

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIP 104
            L  + RI  + L+    + +       V +     N     I 
Sbjct: 371 -LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIA 413

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 26/101 (25%), Positives = 43/101 (42%), Gaps = 7/101 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
             NN++    P  L   + L  L L  N L   I + +  L  L  LDL++N I+   P 
Sbjct: 206 ATNNQISDITP--LGILTNLDELSLNGNQLK-DIGT-LASLTNLTDLDLANNQISNLAP- 260

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNNFE 100
            L  + ++  + L  N +S   P   +  +  L ++ N  E
Sbjct: 261 -LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE 300

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 23/105 (21%), Positives = 38/105 (36%), Gaps = 7/105 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N++    P  L   + L  L L  N L     S I  L+ L YL L  N I+   P 
Sbjct: 272 LGANQISNISP--LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP- 326

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNNFEVEIP 104
            +  + ++  +    N +S      ++  +  L    N      P
Sbjct: 327 -VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP 370

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 21/106 (19%), Positives = 46/106 (43%), Gaps = 9/106 (8%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + +N +       L   + L+ L  GN +        +  L  L  LD+S N ++    S
Sbjct: 141 LSSNTISDISA--LSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD--IS 193

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNNFEVEIPS 105
            L ++  ++++  + N +S   P   +  +  L ++GN  + +I +
Sbjct: 194 VLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLK-DIGT 238

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 14/100 (14%), Positives = 37/100 (37%), Gaps = 7/100 (7%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
               +   + Q   +  ++  L      +  SI   +  L  L  ++ S+N +    P  
Sbjct: 32  GKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-- 85

Query: 62  LGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNNFE 100
           L  + ++  + ++ N ++   P  ++  +  L +  N   
Sbjct: 86  LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 125

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 25/105 (23%), Positives = 42/105 (40%), Gaps = 8/105 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
             NN+L    P  L N +KL  +++ NN ++    + +  L  L  L L +N I    P 
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQIADI--TPLANLTNLTGLTLFNNQITDIDP- 129

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNNFEVEIP 104
            L  +  ++ + LS N +S       +  +  L    N      P
Sbjct: 130 -LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG-NQVTDLKP 172

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 11/87 (12%), Positives = 24/87 (27%), Gaps = 3/87 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + +            N S    +      L     + I         D++ NL +     
Sbjct: 382 LNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNE 438

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVK 87
                 +  T+       SG++ + +K
Sbjct: 439 VSYTFSQPVTIGKGTTTFSGTVTQPLK 465

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 30/199 (15%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           EDF +   +G G +G V+ A    + +  A+K L +        +E    E R+LS  W 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 246 HRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMA 300
           H  +  +   F      +F + EY+  G L   +    + D        A+       + 
Sbjct: 77  HPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE-------II 128

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAGTSGY 359
             L +LH      IV+RD+  +N+LL+ +    +ADFG+ +  +  D+   T   GT  Y
Sbjct: 129 LGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDY 184

Query: 360 IAP----------ASEWWH 368
           IAP          + +WW 
Sbjct: 185 IAPEILLGQKYNHSVDWWS 203

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 18/104 (17%), Positives = 42/104 (40%), Gaps = 6/104 (5%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
           + +              S L +L +  N    +   +I  +L+ L +LDLS   +    P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNF 99
           +    +  +  +N++ N L  S+P+ +      +  +++  N +
Sbjct: 488 TAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 23/115 (20%), Positives = 45/115 (39%), Gaps = 9/115 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLIN-GKIP 59
           +  N +           S L+ L+     L+   +  IG L+ L  L+++HNLI   K+P
Sbjct: 83  LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVP-------LLYVSGNNFEVEIPSTS 107
                +  ++ ++LS N +       ++ +         L +S N     I   +
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 18/110 (16%), Positives = 36/110 (32%), Gaps = 4/110 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +   ++         + S L  LIL  N +          L  L  L      +      
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118

Query: 61  QLGEIPRIDTVNLSMNNL-SGSIPESVKKVP---LLYVSGNNFEVEIPST 106
            +G +  +  +N++ N + S  +PE    +     L +S N  +    + 
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 16/106 (15%), Positives = 38/106 (35%), Gaps = 8/106 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI--GKLQELNYLDLSHNLINGKI 58
           +  N +   +    +   +L  L   ++ L   +S       L+ L YLD+SH       
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 59  PSQLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFE 100
                 +  ++ + ++ N+   +    +    + +  L +S    E
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 16/102 (15%), Positives = 31/102 (30%), Gaps = 3/102 (2%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N L         +  +L++L L    +          L  L+ L L+ N I      
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG 94

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNF 99
               +  +  +     NL+      +  +     L V+ N  
Sbjct: 95  AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 24/105 (22%), Positives = 40/105 (38%), Gaps = 11/105 (10%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLS--GSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +NK         ++   L  L L  N LS  G  S        L YLDLS N +   + S
Sbjct: 334 SNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSS 390

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFE 100
               + +++ ++   +NL   + E    + L     L +S  +  
Sbjct: 391 NFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR 434

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 19/91 (20%), Positives = 40/91 (43%), Gaps = 6/91 (6%)

Query: 1   MYNNKL-DGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNY----LDLSHNLIN 55
           + +N +    +P+   N + L  L L +N +     +++  L ++      LDLS N +N
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 56  GKIPSQLGEIPRIDTVNLSMNNLSGSIPESV 86
             I     +  R+  + L  N  S ++ ++ 
Sbjct: 191 -FIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 15/85 (17%), Positives = 24/85 (28%), Gaps = 3/85 (3%)

Query: 1   MYNNKLDGPIPQE-LMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKI 58
           M  N        +       L  L L    L   +S      L  L  L+++ N +    
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVP 510

Query: 59  PSQLGEIPRIDTVNLSMNNLSGSIP 83
                 +  +  + L  N    S P
Sbjct: 511 DGIFDRLTSLQKIWLHTNPWDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 21/109 (19%), Positives = 29/109 (26%), Gaps = 8/109 (7%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
                   IP  L      + L L  N L    S       EL  LDLS   I       
Sbjct: 15  MELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPST 106
              +  + T+ L+ N +  S+          +  L     N        
Sbjct: 72  YQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFP 119

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 37/195 (18%), Positives = 65/195 (33%), Gaps = 52/195 (26%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRN-EARLLSQIWHRNIVKLY 253
           +GTG +G V     + SGK  ALKK+ +           ++N E  ++  + H NI+KL 
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQD--------PRYKNRELDIMKVLDHVNIIKLV 66

Query: 254 GF---CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR----VNIV---------K 297
            +       +                    +     +         +N++         K
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 298 GMAH----------------------ALSYLHHHCTPPIVHRDISSNNVLLNSELEAF-V 334
            +                        A+ ++H      I HRDI   N+L+NS+     +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKL 183

Query: 335 ADFGVARLLNFDSSN 349
            DFG A+ L     +
Sbjct: 184 CDFGSAKKLIPSEPS 198

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 41/231 (17%), Positives = 79/231 (34%), Gaps = 70/231 (30%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLL 241
           +   +   +G G +G V  A         + + VA+K L    T       +  +E ++L
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 79

Query: 242 SQI-WHRNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRT------------------- 280
             I  H N+V L G C      + +I E+ + G+L   LR+                   
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGK 139

Query: 281 -DEEAVGLDWAKRVNIVKGMAHA----------LSYLHHHCTPPIVHR------------ 317
               A+ +D  +R++ +     +          LS +     P  +++            
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199

Query: 318 ------------------DISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
                             D+++ N+LL+ +    + DFG+AR +  D    
Sbjct: 200 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 26/196 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
            DFH    IG G +G V  AR        A+K L +    +    +   +E  +L +   
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 246 HRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHA 302
           H  +V L + F    K ++ + +Y+  G LF  L+  E       A+     I      A
Sbjct: 98  HPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIA----SA 151

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGYIA 361
           L YLH      IV+RD+   N+LL+S+    + DFG+ +  N + ++ T    GT  Y+A
Sbjct: 152 LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLA 207

Query: 362 P----------ASEWW 367
           P            +WW
Sbjct: 208 PEVLHKQPYDRTVDWW 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 59.9 bits (146), Expect = 3e-10
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 26/196 (13%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           +DF +   IG G Y  V   RL  + ++ A+K + +    +   ++  + E  +  Q   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 246 HRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAK--RVNIVKGMAHA 302
           H  +V L   F    + +F + EY+  G L   ++  +  +  + A+     I      A
Sbjct: 69  HPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEIS----LA 122

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAGTSGYIA 361
           L+YLH      I++RD+  +NVLL+SE    + D+G+ +  L    +  T   GT  YIA
Sbjct: 123 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIA 178

Query: 362 P----------ASEWW 367
           P          + +WW
Sbjct: 179 PEILRGEDYGFSVDWW 194

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 21/101 (20%), Positives = 47/101 (46%), Gaps = 4/101 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N+L+  +    +   +L  L + NN L  +++     +  L  LDLSHN +   +  
Sbjct: 255 LSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 312

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESV-KKVPLLYVSGNNFE 100
              +  R++ + L  N++  ++  S    +  L +S N+++
Sbjct: 313 NQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 25/103 (24%), Positives = 40/103 (38%), Gaps = 6/103 (5%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
           M  N +    P    N   L +L+L  N LS S+   I     +L  L +S+N +  +I 
Sbjct: 100 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIE 157

Query: 60  SQ-LGEIPRIDTVNLSMNNLSGSIPESV-KKVPLLYVSGNNFE 100
                    +  + LS N L+  +  S+   +    VS N   
Sbjct: 158 DDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS 199

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 14/108 (12%), Positives = 37/108 (34%), Gaps = 8/108 (7%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIPSQ 61
               D     E +  +  +I+   N+ +   + + +    +++  L+L+   I       
Sbjct: 30  MQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYA 88

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPS 105
                 I  + +  N +   +P  V      + +L +  N+    +P 
Sbjct: 89  FAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPR 134

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 43.1 bits (102), Expect = 8e-05
 Identities = 23/110 (20%), Positives = 42/110 (38%), Gaps = 8/110 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
             N+ +       L +  ++ +L L +  +   I +        +  L +  N I    P
Sbjct: 52  FKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPP 110

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPS 105
                +P +  + L  N+LS S+P  +     K+  L +S NN E  I  
Sbjct: 111 HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIED 158

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 20/109 (18%), Positives = 48/109 (44%), Gaps = 10/109 (9%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
             +N ++  +   +    +L IL L +N L+   +  +     L  +DLS+N +   +  
Sbjct: 212 ASHNSINV-VRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYH 266

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
              ++ R++ + +S N L  ++    + +P   +L +S N+    +   
Sbjct: 267 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN 313

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 57.7 bits (140), Expect = 4e-10
 Identities = 18/100 (18%), Positives = 44/100 (44%), Gaps = 4/100 (4%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + N       P  +   S L  L +    ++      +  L  L  LD+SH+  +  I +
Sbjct: 73  INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP--ESVKKVPLLYVSGNN 98
           ++  +P++++++LS N     I   +++ ++  L +  + 
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDG 170

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 59.5 bits (144), Expect = 6e-10
 Identities = 18/105 (17%), Positives = 44/105 (41%), Gaps = 5/105 (4%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           ++ L   +     +   ++ L L  N LS   ++++    +L  L+LS N++       L
Sbjct: 19  DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDL 76

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTS 107
             +  + T++L+ N +   +      +  L+ + NN    +  + 
Sbjct: 77  ESLSTLRTLDLNNNYVQ-ELLVG-PSIETLHAANNNIS-RVSCSR 118

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 24/107 (22%), Positives = 47/107 (43%), Gaps = 8/107 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N L      +L   +KL +L L +N+L    + ++  L  L  LDL++N +      
Sbjct: 41  LSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----Q 93

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTS 107
           +L   P I+T++ + NN+S       +    +Y++ N     +    
Sbjct: 94  ELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKIT-MLRDLD 139

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 21/97 (21%), Positives = 47/97 (48%), Gaps = 2/97 (2%)

Query: 10  IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRID 69
           I +   N ++ +I  + ++ L  +++S       +  LDLS N ++    + L    +++
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 70  TVNLSMNNLSGSIP-ESVKKVPLLYVSGNNFEVEIPS 105
            +NLS N L  ++  ES+  +  L ++ N  + E+  
Sbjct: 62  LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-ELLV 97

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 52.9 bits (127), Expect = 8e-08
 Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 4/85 (4%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N +   +  ++   +KL+ L L +N L+  +  E      + ++ L +N +   I  
Sbjct: 176 LQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPES 85
            L     ++  +L  N         
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRD 256

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 20/109 (18%), Positives = 36/109 (33%), Gaps = 8/109 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLING-KIP 59
             NN +   +          + + L NN ++     + G    + YLDL  N I+     
Sbjct: 106 AANNNISR-VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVPL--LYVSGNNFEVEIPST 106
                   ++ +NL  N +   +   V    L  L +S N     +   
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPE 209

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 12/76 (15%), Positives = 23/76 (30%), Gaps = 4/76 (5%)

Query: 33  SISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP-- 90
           +I              ++ + +   + S       +  ++LS N LS      +      
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 91  -LLYVSGNNFEVEIPS 105
            LL +S N    E   
Sbjct: 61  ELLNLSSNVLY-ETLD 75

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 30/198 (15%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           +DF +   IG G Y  V   RL  + ++ A++ + +    +   ++  + E  +  Q   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 246 HRNIVKLYGFCLHRKC-MFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMA 300
           H  +V L+  C   +  +F + EY+  G L   ++      EE      A+       ++
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-------IS 163

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAGTSGY 359
            AL+YLH      I++RD+  +NVLL+SE    + D+G+ +  L    +  T   GT  Y
Sbjct: 164 LALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNY 219

Query: 360 IAP----------ASEWW 367
           IAP          + +WW
Sbjct: 220 IAPEILRGEDYGFSVDWW 237

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 21/101 (20%), Positives = 47/101 (46%), Gaps = 4/101 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N+L+  +    +   +L  L + NN L  +++     +  L  LDLSHN +   +  
Sbjct: 261 LSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 318

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESV-KKVPLLYVSGNNFE 100
              +  R++ + L  N++  ++  S    +  L +S N+++
Sbjct: 319 NQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 25/103 (24%), Positives = 40/103 (38%), Gaps = 6/103 (5%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
           M  N +    P    N   L +L+L  N LS S+   I     +L  L +S+N +  +I 
Sbjct: 106 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIE 163

Query: 60  SQ-LGEIPRIDTVNLSMNNLSGSIPESV-KKVPLLYVSGNNFE 100
                    +  + LS N L+  +  S+   +    VS N   
Sbjct: 164 DDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 21/104 (20%), Positives = 41/104 (39%), Gaps = 9/104 (8%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
             N+ +       L +  ++ +L L +  +   I +        +  L +  N I   +P
Sbjct: 58  FKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLP 115

Query: 60  SQ-LGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNN 98
                 +P +  + L  N+LS S+P  +     K+  L +S NN
Sbjct: 116 PHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 158

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 30/198 (15%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           ++F     +G G +G V  AR+  +G + A+K L +    +   +E    E R+LS    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 246 HRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMA 300
           H  + +L   F    + +F + E++  G L   +    R DE       A+       + 
Sbjct: 83  HPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-------II 134

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL-LNFDSSNRTLLAGTSGY 359
            AL +LH      I++RD+  +NVLL+ E    +ADFG+ +  +    +  T   GT  Y
Sbjct: 135 SALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDY 190

Query: 360 IAP----------ASEWW 367
           IAP          A +WW
Sbjct: 191 IAPEILQEMLYGPAVDWW 208

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 57.6 bits (140), Expect = 1e-09
 Identities = 17/114 (14%), Positives = 41/114 (35%), Gaps = 8/114 (7%)

Query: 10  IPQELMNCS--KLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPR 67
               L + +      L L +  L      +  +L  L ++ +    +  ++P  + +   
Sbjct: 71  TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128

Query: 68  IDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIPSTSAKAPPPHHKGN 118
           ++T+ L+ N L  ++P S+    ++  L +       E+P   A          
Sbjct: 129 LETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 18/118 (15%), Positives = 36/118 (30%), Gaps = 16/118 (13%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +    L   +P  +   + L  L L  N L  ++ + I  L  L  L +       ++P 
Sbjct: 111 IDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168

Query: 61  QLGEIPRIDTV---------NLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIPST 106
            L                   L    +  S+P S+   + +  L +  +     +   
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPA 224

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 17/84 (20%), Positives = 36/84 (42%), Gaps = 4/84 (4%)

Query: 2   YNNKLDGPIPQELMNCSKLRILIL-GNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
               L    P      + L+ LIL   + L  ++  +I +L +L  LDL   +   ++PS
Sbjct: 238 GCTALRN-YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPS 295

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPE 84
            + ++P    + +   +L   + +
Sbjct: 296 LIAQLPANCIILVP-PHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 22/118 (18%), Positives = 44/118 (37%), Gaps = 15/118 (12%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILIL-GNNLL--------SGSISSEIGKLQELNYLDLSH 51
           +  N L   +P  + + ++LR L +     L        S   S E   L  L  L L  
Sbjct: 134 LARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192

Query: 52  NLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
             I   +P+ +  +  + ++ +  + LS ++  ++  +P    L + G       P  
Sbjct: 193 TGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPI 248

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 52.6 bits (127), Expect = 6e-08
 Identities = 15/100 (15%), Positives = 36/100 (36%), Gaps = 4/100 (4%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + N+ L   +   + +  KL  L L       +     G    L  L L        +P 
Sbjct: 213 IRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVP---LLYVSGN 97
            +  + +++ ++L        +P  + ++P   ++ V  +
Sbjct: 272 DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 12/101 (11%), Positives = 36/101 (35%), Gaps = 9/101 (8%)

Query: 11  PQELMNCSKLRILILGNNLLSGSISSEIGKLQELN--YLDLSHNLINGKIPSQLGEIPRI 68
                N +  +I       L  + +  +    +     L+L    +  + P Q   +  +
Sbjct: 49  AWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106

Query: 69  DTVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPST 106
             + +    L   +P+++++      L ++ N     +P++
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPAS 145

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 46.5 bits (111), Expect = 6e-06
 Identities = 9/57 (15%), Positives = 21/57 (36%)

Query: 10  IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIP 66
           +P ++   ++L  L L   +    + S I +L     + +  +L       +    P
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 18/105 (17%), Positives = 45/105 (42%), Gaps = 5/105 (4%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           ++ L   +     +   ++ L L  N LS   ++++    +L  L+LS N++  +    L
Sbjct: 19  DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD-L 76

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTS 107
             +  + T++L+ N +   +      +  L+ + NN    +  + 
Sbjct: 77  ESLSTLRTLDLNNNYVQ-ELLVG-PSIETLHAANNNIS-RVSCSR 118

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 56.5 bits (137), Expect = 3e-09
 Identities = 24/107 (22%), Positives = 47/107 (43%), Gaps = 8/107 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N L      +L   +KL +L L +N+L    + ++  L  L  LDL++N +      
Sbjct: 41  LSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----Q 93

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTS 107
           +L   P I+T++ + NN+S       +    +Y++ N     +    
Sbjct: 94  ELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKIT-MLRDLD 139

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 18/122 (14%), Positives = 38/122 (31%), Gaps = 8/122 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N +   +    +  +KL+ L L +N L+  +  E      + ++ L +N +   I  
Sbjct: 176 LQYNFIYD-VK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPSTSAKAPPPHHK 116
            L     ++  +L  N              ++V  +                  P   H 
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291

Query: 117 GN 118
           G 
Sbjct: 292 GA 293

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 20/98 (20%), Positives = 45/98 (45%), Gaps = 4/98 (4%)

Query: 10  IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRID 69
           I +   N ++ +I  + ++ L  +++S       +  LDLS N ++    + L    +++
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 70  TVNLSMNNLSGSIPE--SVKKVPLLYVSGNNFEVEIPS 105
            +NLS N L     +  S+  +  L ++ N  + E+  
Sbjct: 62  LLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLV 97

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 20/109 (18%), Positives = 36/109 (33%), Gaps = 8/109 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLING-KIP 59
             NN +   +          + + L NN ++     + G    + YLDL  N I+     
Sbjct: 106 AANNNISR-VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVPL--LYVSGNNFEVEIPST 106
                   ++ +NL  N +   +   V    L  L +S N     +   
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPE 209

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 12/76 (15%), Positives = 23/76 (30%), Gaps = 4/76 (5%)

Query: 33  SISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVP-- 90
           +I              ++ + +   + S       +  ++LS N LS      +      
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 91  -LLYVSGNNFEVEIPS 105
            LL +S N    E   
Sbjct: 61  ELLNLSSNVLY-ETLD 75

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 47/198 (23%), Positives = 82/198 (41%), Gaps = 30/198 (15%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
            DF+    +G G +G V  +    + ++ A+K L +    +   +E    E R+L+    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 246 HRNIVKL-YGFCLHRKCMFLIYEYMEMGSLFCVL----RTDEEAVGLDWAKRVNIVKGMA 300
              + +L   F    + ++ + EY+  G L   +    R  E       A+       +A
Sbjct: 80  PPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-------IA 131

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGY 359
             L +L       I++RD+  +NV+L+SE    +ADFG+ +  N      T    GT  Y
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDY 187

Query: 360 IAP----------ASEWW 367
           IAP          + +WW
Sbjct: 188 IAPEIIAYQPYGKSVDWW 205

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 20/119 (16%), Positives = 42/119 (35%), Gaps = 22/119 (18%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS- 60
            N  L   +P+       L  L+   N L+  +      L+ L   + +   ++   P  
Sbjct: 79  NNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLL 133

Query: 61  --------QLGEIPRID------TVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPS 105
                   QL ++P +        +++  N+L   +P+    +  +    N  E E+P 
Sbjct: 134 EYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQLE-ELPE 190

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 24/103 (23%), Positives = 41/103 (39%), Gaps = 15/103 (14%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           NNKL   +P       +L  LI   N L+  +      L++L    + +N +  + P   
Sbjct: 326 NNKLIE-LPALP---PRLERLIASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDIP 376

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPS 105
             +      +L MN+    +PE  + +  L+V  N    E P 
Sbjct: 377 ESVE-----DLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD 413

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 19/104 (18%), Positives = 35/104 (33%), Gaps = 14/104 (13%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
           +++ L   +P E  N           +    +     G+ +E+    L   L        
Sbjct: 19  HSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR------ 71

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPS 105
                +   + L+   LS S+PE    +  L  S N+   E+P 
Sbjct: 72  -----QAHELELNNLGLS-SLPELPPHLESLVASCNSLT-ELPE 108

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 52.7 bits (127), Expect = 9e-08
 Identities = 26/105 (24%), Positives = 46/105 (43%), Gaps = 12/105 (11%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
             NN L   +P   ++   L  ++ GNN+L      E+  L  L  +   +NL+   +P 
Sbjct: 202 ADNNSLKK-LPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPD 254

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPS 105
                P ++ +N+  N L+  +PE  + +  L VS N F   +  
Sbjct: 255 ---LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFS-GLSE 294

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 26/122 (21%), Positives = 43/122 (35%), Gaps = 28/122 (22%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELN--------------- 45
             NN L   +P        L  L + +N L+  +      L  L+               
Sbjct: 244 ADNNLLKT-LPDLP---PSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN 298

Query: 46  --YLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEI 103
             YL+ S N I   +       P ++ +N+S N L   +P    ++  L  S N+   E+
Sbjct: 299 LYYLNASSNEIR-SLCDLP---PSLEELNVSNNKLI-ELPALPPRLERLIASFNHLA-EV 352

Query: 104 PS 105
           P 
Sbjct: 353 PE 354

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 25/142 (17%), Positives = 49/142 (34%), Gaps = 42/142 (29%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELN--------------- 45
           + NN+L+  +P EL N S L+I+ + NN L   +      L+ +                
Sbjct: 138 VSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQLEELPELQNL 194

Query: 46  ----YLDLSHNLING------------------KIPSQLGEIPRIDTVNLSMNNLSGSIP 83
                +   +N +                    +   +L  +P + T+    N L  ++P
Sbjct: 195 PFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLP 253

Query: 84  ESVKKVPLLYVSGNNFEVEIPS 105
           +    +  L V  N    ++P 
Sbjct: 254 DLPPSLEALNVRDNYLT-DLPE 274

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 26/103 (25%), Positives = 47/103 (45%), Gaps = 14/103 (13%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
            N   G + +   N   L  L   +N +  S+      L+ELN   +S+N +  ++P+  
Sbjct: 286 ENIFSG-LSELPPN---LYYLNASSNEIR-SLCDLPPSLEELN---VSNNKLI-ELPA-- 334

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPS 105
              PR++ +  S N+L+  +PE  + +  L+V  N    E P 
Sbjct: 335 -LPPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPLR-EFPD 374

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 13/112 (11%), Positives = 32/112 (28%), Gaps = 22/112 (19%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELN----------------Y 46
            N L   +P+       L+ L +  N L          +++L                  
Sbjct: 346 FNHLAE-VPELP---QNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQ 400

Query: 47  LDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNN 98
           L +  N +  + P     +  +   +  + +      E+  K+       ++
Sbjct: 401 LHVETNPLR-EFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 22/99 (22%), Positives = 39/99 (39%), Gaps = 7/99 (7%)

Query: 4   NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIPSQL 62
               G          +L+ L L +N L  +  +       +LN L+LS   +  ++P  L
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVPL--LYVSGNNF 99
               ++  ++LS N L    P   +   +  L + GN F
Sbjct: 273 P--AKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 50.3 bits (120), Expect = 4e-07
 Identities = 22/126 (17%), Positives = 36/126 (28%), Gaps = 14/126 (11%)

Query: 1   MYNNKLDG--PIPQELMNCSK--LRILILGNNLLSGSISSEIGKLQELNYLDLSHNLING 56
           + N           EL    K  L++L +           ++     L+ LDLS N   G
Sbjct: 128 LRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187

Query: 57  KIP----SQLGEIPRIDTVNLSMNN---LSGSIPESVKKVPLL---YVSGNNFEVEIPST 106
           +          + P +  + L        SG           L    +S N+      + 
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247

Query: 107 SAKAPP 112
           S   P 
Sbjct: 248 SCDWPS 253

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 43.7 bits (103), Expect = 5e-05
 Identities = 20/80 (25%), Positives = 34/80 (42%), Gaps = 6/80 (7%)

Query: 3   NNKLDG-PIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
           +N L            S+L  L L    L   +   +    +L+ LDLS+N ++   PS 
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPS- 291

Query: 62  LGEIPRIDTVNLSMNNLSGS 81
             E+P++  ++L  N    S
Sbjct: 292 PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 40.3 bits (94), Expect = 5e-04
 Identities = 20/109 (18%), Positives = 42/109 (38%), Gaps = 11/109 (10%)

Query: 13  ELMNCSKLRILILGNNLLSGSISSEIGKLQ--ELNYLDLSHNLINGKIPSQLGEIPRIDT 70
            ++  S L+ L L N  ++G+    + +    +LN L+L +        + L E+ +   
Sbjct: 90  RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLK 148

Query: 71  VNLSMNNLSGSIPESV--------KKVPLLYVSGNNFEVEIPSTSAKAP 111
             L + +++ +   +           +  L +S N    E    SA  P
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 21/99 (21%), Positives = 41/99 (41%), Gaps = 9/99 (9%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N+L   +P      S+L+ L++  N L+ S+      L  L    +  N +  ++P 
Sbjct: 228 VSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPE 278

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNF 99
            L  +    TVNL  N LS    ++++++          
Sbjct: 279 SLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 24/105 (22%), Positives = 42/105 (40%), Gaps = 14/105 (13%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + +N L   +P       +LR L +  N L+ S+      L EL+        +   +PS
Sbjct: 68  IPDNNLTS-LPALP---PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPS 121

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPS 105
            L ++       +  N L+ S+P     +  L VS N     +P+
Sbjct: 122 GLCKL------WIFGNQLT-SLPVLPPGLQELSVSDNQLA-SLPA 158

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 26/105 (24%), Positives = 48/105 (45%), Gaps = 14/105 (13%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
            YNN+L   +P      S L+ L + +N L+ S+ +   +L +   L   +N +   +P+
Sbjct: 168 AYNNQLTS-LPMLP---SGLQELSVSDNQLA-SLPTLPSELYK---LWAYNNRLT-SLPA 218

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPS 105
               +  +    +S N L+ S+P    ++  L VSGN     +P 
Sbjct: 219 LPSGLKELI---VSGNRLT-SLPVLPSELKELMVSGNRLT-SLPM 258

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 46.8 bits (111), Expect = 7e-06
 Identities = 15/101 (14%), Positives = 40/101 (39%), Gaps = 13/101 (12%)

Query: 10  IPQELMNC--SKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPR 67
           + Q++  C  +   +L +G + L+ ++   +     +  L +  N +   +P+     P 
Sbjct: 30  VVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPA---LPPE 82

Query: 68  IDTVNLSMNNLSGSIPESV---KKVPLLYVSGNNFEVEIPS 105
           + T+ +S N L+ S+P       ++ +      +       
Sbjct: 83  LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG 122

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 15/96 (15%), Positives = 36/96 (37%), Gaps = 5/96 (5%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
            N+L   +P      S L  L +  N L+  +   +  L     ++L  N ++ +    L
Sbjct: 250 GNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 304

Query: 63  GEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNN 98
            EI      +  +     +   + ++   L+++  +
Sbjct: 305 REITSAPGYSGPIIRFDMAGASAPRETRALHLAAAD 340

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 54.4 bits (130), Expect = 3e-08
 Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 5/91 (5%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLING-KIPSQ 61
           +N+L   +P  L     L +L   +N L  ++   +  L  L  L L +N +        
Sbjct: 472 HNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQP 528

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESVKKVPLL 92
           L   PR+  +NL  N+L        +++  +
Sbjct: 529 LVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 46.7 bits (110), Expect = 7e-06
 Identities = 19/92 (20%), Positives = 43/92 (46%), Gaps = 6/92 (6%)

Query: 11  PQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDT 70
               M  + +R+L L +  L+  +   + +L  + +LDLSHN +   +P  L  +  ++ 
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEV 490

Query: 71  VNLSMNNLSGSIP--ESVKKVPLLYVSGNNFE 100
           +  S N L  ++    ++ ++  L +  N  +
Sbjct: 491 LQASDNALE-NVDGVANLPRLQELLLCNNRLQ 521

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 25/113 (22%), Positives = 47/113 (41%), Gaps = 8/113 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
           +  NK+      +L  C+ L++LIL ++ ++ +I  +    L  L +LDLS N ++    
Sbjct: 33  LSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSS 91

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVPL-----LYVSGNNFEVEIPSTS 107
           S  G +  +  +NL  N    ++  +     L     L +       EI    
Sbjct: 92  SWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 22/113 (19%), Positives = 40/113 (35%), Gaps = 8/113 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSE-IGKLQELNYLDLSHNLING-KI 58
           + +++++        +   L  L L +N LS S+SS   G L  L YL+L  N      +
Sbjct: 57  LKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGV 115

Query: 59  PSQLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPSTS 107
            S    +  + T+ +        I          +  L +   +      S S
Sbjct: 116 TSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQS 167

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 49.7 bits (119), Expect = 9e-07
 Identities = 19/105 (18%), Positives = 32/105 (30%), Gaps = 7/105 (6%)

Query: 2   YNNKLDG-PIPQELMNCSKLRILILGNNLLSGSISSE-IGKLQELNYLDLSHNLINGKIP 59
             N      +     N + L+ L +GN      I       L  LN L++    +     
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFE 100
             L  I  I  + L ++  +  + E        V  L +   N  
Sbjct: 166 QSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLA 209

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 24/108 (22%), Positives = 42/108 (38%), Gaps = 8/108 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +    L   +        K++ + + N+ +     S    L+ L +LDLS NL+  +   
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352

Query: 61  Q---LGEIPRIDTVNLSMNNLS--GSIPESVKKVP---LLYVSGNNFE 100
                G  P + T+ LS N+L       E +  +     L +S N F 
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 21/109 (19%), Positives = 45/109 (41%), Gaps = 8/109 (7%)

Query: 1   MYNNKLD--GPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKI 58
           +  N L       + L+    L  L +  N     +       +++ +L+LS   I   +
Sbjct: 368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VV 425

Query: 59  PSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTS 107
            + +     ++ +++S NNL  S    + ++  LY+S N  +  +P  S
Sbjct: 426 KTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELYISRNKLK-TLPDAS 470

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 9/78 (11%), Positives = 25/78 (32%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
                     +    + L  L +    L    S  +  ++++++L L  +     +    
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192

Query: 63  GEIPRIDTVNLSMNNLSG 80
             +  +  + L   NL+ 
Sbjct: 193 DILSSVRYLELRDTNLAR 210

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 23/103 (22%), Positives = 43/103 (41%), Gaps = 8/103 (7%)

Query: 10  IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRID 69
           IP  L   + ++ L L  N ++     ++     L  L L  + IN         +  ++
Sbjct: 20  IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77

Query: 70  TVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPSTSA 108
            ++LS N+LS S+  S       +  L + GN ++  +  TS 
Sbjct: 78  HLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSL 118

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 14/76 (18%), Positives = 25/76 (32%), Gaps = 6/76 (7%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQL 62
           NN LD      L    +L+ L +  N L  ++         L  + +S N +        
Sbjct: 440 NNNLDS-FSLFL---PRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIF 493

Query: 63  GEIPRIDTVNLSMNNL 78
             +  +  + L  N  
Sbjct: 494 DRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 9/72 (12%), Positives = 32/72 (44%), Gaps = 2/72 (2%)

Query: 15  MNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGE-IPRIDTVNL 73
           +    +R L +    L   +S+    L+++  + + ++ +   +P    + +  ++ ++L
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDL 341

Query: 74  SMNNLSGSIPES 85
           S N +     ++
Sbjct: 342 SENLMVEEYLKN 353

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 34/164 (20%), Positives = 69/164 (42%), Gaps = 24/164 (14%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALK------KLHRSETEELASLESFRNEARLLSQ-IWHR 247
           +G G + +V+ A+ + +   VA+K          +  +E+  L+   +        +   
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86

Query: 248 NIVKLYGFCLHRKC----MFLIYEYMEMGSLFCVL-RTDEEAVGLDWAKRVNIVKGMAHA 302
           +I+KL     H+      + +++E +   +L  ++ + +   + L + K+  I K +   
Sbjct: 87  HILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQ--ISKQLLLG 143

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAF------VADFGVA 340
           L Y+H  C   I+H DI   NVL+             +AD G A
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 31/162 (19%)

Query: 188 EDFHIKYCI----GTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLS 242
           + F+ +Y +    G G + +V+ +  +   K VA+K +  +E       E+  +E RLL 
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY----TETALDEIRLLK 88

Query: 243 QIW--------HRNIVKLYG-FCLHRK-----CMFLIYEYMEMGSLFCVL-RTDEEAVGL 287
            +            +V+L   F +        CM  ++E +    L   + +++ + + L
Sbjct: 89  SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM--VFEVLGH-HLLKWIIKSNYQGLPL 145

Query: 288 DWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE 329
              K+  I++ +   L YLH  C   I+H DI   N+LL+  
Sbjct: 146 PCVKK--IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVN 183

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 36/160 (22%), Positives = 68/160 (42%), Gaps = 18/160 (11%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALK------KLHRSETEELASLESFRNEARLLS 242
           + +   IG G +G V +A      + VALK      + HR   EE+  LE  R + +  +
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
                N++ +      R  + + +E + M +L+ +++ ++   G            +   
Sbjct: 159 ----MNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKF-QGFSLPLVRKFAHSILQC 212

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAF--VADFGVA 340
           L  LH +    I+H D+   N+LL  +  +   V DFG +
Sbjct: 213 LDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 21/105 (20%), Positives = 41/105 (39%), Gaps = 14/105 (13%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N L   +P+     + L  L   +N LS ++      L+ L+   + +N +   +P 
Sbjct: 87  ITQNALI-SLPELP---ASLEYLDACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPE 137

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPS 105
               +  I+      N L+  +PE    + +L V  N     +P 
Sbjct: 138 LPALLEYIN---ADNNQLT-MLPELPTSLEVLSVRNNQLT-FLPE 177

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 22/102 (21%), Positives = 37/102 (36%), Gaps = 10/102 (9%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQEL----NYLDLSHNLING 56
           + NN+L   +P+   +   L  L +  NLL  S+ +   +         +     N I  
Sbjct: 167 VRNNQL-TFLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT- 220

Query: 57  KIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNN 98
            IP  +  +    T+ L  N LS  I ES+ +          
Sbjct: 221 HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 19/107 (17%), Positives = 39/107 (36%), Gaps = 8/107 (7%)

Query: 2   YNNKLDGPIPQELMNC-SKLRIL-ILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP 59
           + N + G    +  +   K     + G N        +   + + + L L+   ++  +P
Sbjct: 18  FYNTISG-TYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLP 75

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPST 106
             L   P+I  + ++ N L  S+PE    +  L    N     +P  
Sbjct: 76  DNLP--PQITVLEITQNALI-SLPELPASLEYLDACDNRLS-TLPEL 118

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 21/111 (18%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + NN+L   +P+     + L  +   NN L+  +      L+ L    + +N +   +P 
Sbjct: 127 VDNNQLTM-LPELP---ALLEYINADNNQLT-MLPELPTSLEVL---SVRNNQLT-FLPE 177

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESV-------KKVPLLYVSGNNFEVEIP 104
               +  +D   +S N L  S+P          +         N     IP
Sbjct: 178 LPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIP 223

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 36/160 (22%), Positives = 61/160 (38%), Gaps = 16/160 (10%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALK------KLHRSETEELASLESFRNEARLLS 242
           + I   IG G +G V +A      + VA+K              E+  LE        + 
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
                 IV L    + R  + L++E +   +L+ +LR      G+         + M  A
Sbjct: 116 ----YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNF-RGVSLNLTRKFAQQMCTA 169

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAF--VADFGVA 340
           L +L       I+H D+   N+LL +   +   + DFG +
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 16/112 (14%), Positives = 41/112 (36%), Gaps = 11/112 (9%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSE--IGKLQELNYLDLSHNLINGKI 58
           +  N +   +    +   +L  L   ++ L   +S       L+ L YLD+SH       
Sbjct: 85  LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VA 141

Query: 59  PSQ-LGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPS 105
            +     +  ++ + ++ N+   +    +    + +  L +S    E ++  
Sbjct: 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP 192

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 19/107 (17%), Positives = 39/107 (36%), Gaps = 10/107 (9%)

Query: 1   MYNNKLDGPIPQE-LMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKI 58
           + +               S L +L +  N    +   +I  +L+ L +LDLS   +  ++
Sbjct: 133 ISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QL 190

Query: 59  PSQ-LGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFE 100
                  +  +  +N+S NN   S+          + +L  S N+  
Sbjct: 191 SPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM 236

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 21/86 (24%), Positives = 37/86 (43%), Gaps = 4/86 (4%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLS-GSISSEI-GKLQELNYLDLSHNLINGKI 58
           + +NKL           ++L  L L +N LS     S+       L YLDLS N +   +
Sbjct: 35  LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM 93

Query: 59  PSQLGEIPRIDTVNLSMNNLSGSIPE 84
            S    + +++ ++   +NL   + E
Sbjct: 94  SSNFLGLEQLEHLDFQHSNLK-QMSE 118

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 23/104 (22%), Positives = 41/104 (39%), Gaps = 7/104 (6%)

Query: 1   MYNNKLDGPIPQEL-----MNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLIN 55
           +  N L      EL        S L++L L +N L+         L  L  L L+ N + 
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517

Query: 56  GKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNF 99
               + L     ++ +++S N L    P+    + +L ++ N F
Sbjct: 518 VLSHNDL--PANLEILDISRNQLLAPNPDVFVSLSVLDITHNKF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 28/124 (22%), Positives = 46/124 (37%), Gaps = 14/124 (11%)

Query: 1   MYNNKLDGPIPQE--LMNCSKLRILILGNNLLSG-SISSEIGKLQELNYLDLSHNLINGK 57
           +Y   L   + ++    N   L  L L  N +    +    GKL  L  +D S N I   
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163

Query: 58  IPSQLG--EIPRIDTVNLSMNNLSGSIPESVKKVP---------LLYVSGNNFEVEIPST 106
              +L   +   +   +L+ N+L   +     K           +L VSGN + V+I   
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGN 223

Query: 107 SAKA 110
            + A
Sbjct: 224 FSNA 227

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 16/113 (14%), Positives = 35/113 (30%), Gaps = 10/113 (8%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
                L   +PQ L   +    L+L  N +    +S    L++L  L+L        I  
Sbjct: 11  YRFCNLTQ-VPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66

Query: 61  Q-LGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPSTSA 108
           +    +P +  ++L  + +   +          +  L +        +     
Sbjct: 67  EAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGY 118

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 19/104 (18%), Positives = 42/104 (40%), Gaps = 5/104 (4%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + +  +     +       L++L L  N ++         L  L  L+LS+NL+     S
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFE 100
               +P++  ++L  N+++  I +      +K+  L +  N   
Sbjct: 333 NFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 5/89 (5%)

Query: 15  MNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLS 74
           +  S +R L L +  +    S     L++L  L+L++N IN         +  +  +NLS
Sbjct: 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS 322

Query: 75  MNNLSGSIPESV----KKVPLLYVSGNNF 99
            N L   +  S      KV  + +  N+ 
Sbjct: 323 YNLLG-ELYSSNFYGLPKVAYIDLQKNHI 350

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 21/96 (21%), Positives = 34/96 (35%), Gaps = 4/96 (4%)

Query: 12  QELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTV 71
             L N SKL  L   +N +S  IS  +  L  L  + L +N I+   P  L     +  V
Sbjct: 167 TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222

Query: 72  NLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTS 107
            L+   ++         + +  V        I   +
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPAT 258

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 45.8 bits (109), Expect = 9e-06
 Identities = 20/98 (20%), Positives = 44/98 (44%), Gaps = 7/98 (7%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
            + ++    P  L   S L++L L  N ++ +IS  +  L  L YL + +  ++  +   
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DLTP- 168

Query: 62  LGEIPRIDTVNLSMNNLSG-SIPESVKKVPLLYVSGNN 98
           L  + ++ T+    N +S  S   S+  +  +++  N 
Sbjct: 169 LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQ 206

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 43.1 bits (102), Expect = 7e-05
 Identities = 18/88 (20%), Positives = 42/88 (47%), Gaps = 5/88 (5%)

Query: 12  QELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTV 71
           + +   + L  L L +N ++  ++  +  L ++  L+LS N +  K  S +  +  I T+
Sbjct: 57  EGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTL 112

Query: 72  NLSMNNLSGSIP-ESVKKVPLLYVSGNN 98
           +L+   ++   P   +  + +LY+  N 
Sbjct: 113 DLTSTQITDVTPLAGLSNLQVLYLDLNQ 140

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 26/87 (29%), Positives = 45/87 (51%), Gaps = 7/87 (8%)

Query: 14  LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNL 73
           L +  KL+ L L +N +S  I+  +  L +L  L L +N I     + L  + ++DT++L
Sbjct: 105 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSL 160

Query: 74  SMNNLSGSIP--ESVKKVPLLYVSGNN 98
             N +S  I     + K+  LY+S N+
Sbjct: 161 EDNQIS-DIVPLAGLTKLQNLYLSKNH 186

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 23/86 (26%), Positives = 40/86 (46%), Gaps = 5/86 (5%)

Query: 14  LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNL 73
           L N   L  L L  N +   +SS +  L++L  L L HN I+  I   L  +P+++++ L
Sbjct: 83  LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYL 138

Query: 74  SMNNLSGSIP-ESVKKVPLLYVSGNN 98
             N ++       + K+  L +  N 
Sbjct: 139 GNNKITDITVLSRLTKLDTLSLEDNQ 164

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 17/100 (17%), Positives = 38/100 (38%), Gaps = 9/100 (9%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +    +   + Q     + +  +I  N+ +  S+   I  L  +  L L+ N +   I  
Sbjct: 28  LKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DI-K 81

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP--ESVKKVPLLYVSGNN 98
            L  +  +  + L  N +   +   + +KK+  L +  N 
Sbjct: 82  PLTNLKNLGWLFLDENKIK-DLSSLKDLKKLKSLSLEHNG 120

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 19/107 (17%), Positives = 44/107 (41%), Gaps = 12/107 (11%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
            N K+      ++   ++L  L    N ++     ++ + + LN L+   N I  K+   
Sbjct: 157 LNKKITKL---DVTPQTQLTTLDCSFNKIT---ELDVSQNKLLNRLNCDTNNIT-KLD-- 207

Query: 62  LGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNNFEVEIPSTS 107
           L +  ++  ++ S N L+  I    + ++     S N    E+  ++
Sbjct: 208 LNQNIQLTFLDCSSNKLT-EIDVTPLTQLTYFDCSVNPLT-ELDVST 252

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 15/89 (16%), Positives = 38/89 (42%), Gaps = 8/89 (8%)

Query: 13  ELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVN 72
           ++     L  L    N ++  +  ++ +  +L +LD S N +  +I   +  + ++   +
Sbjct: 186 DVSQNKLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239

Query: 73  LSMNNLSGSIPESV-KKVPLLYVSGNNFE 100
            S+N L+  +  S   K+  L+    +  
Sbjct: 240 CSVNPLT-ELDVSTLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 18/98 (18%), Positives = 35/98 (35%), Gaps = 11/98 (11%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
             N +      +L    +L  L   +N L+     ++  L +L Y D S N +     S 
Sbjct: 199 DTNNITKL---DLNQNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCSVNPLTELDVST 252

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESV-KKVPLLYVSGNN 98
           L    ++ T++    +L   I  +   ++      G  
Sbjct: 253 L---SKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCR 286

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 19/98 (19%), Positives = 37/98 (37%), Gaps = 9/98 (9%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
             +N +      +L   + L  L   +N L+   + ++  L +L YL+   N +     S
Sbjct: 71  CTSNNITTL---DLSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKLTKLDVS 124

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNN 98
           Q    P +  +N + N L+        ++  L    N 
Sbjct: 125 QN---PLLTYLNCARNTLTEIDVSHNTQLTELDCHLNK 159

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 13/86 (15%), Positives = 32/86 (37%), Gaps = 6/86 (6%)

Query: 13  ELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVN 72
            +   + L  LI  +N ++   + ++ +   L YL    N +   +   +  + ++  +N
Sbjct: 59  GIEKLTGLTKLICTSNNIT---TLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLN 112

Query: 73  LSMNNLSGSIPESVKKVPLLYVSGNN 98
              N L+         +  L  + N 
Sbjct: 113 CDTNKLTKLDVSQNPLLTYLNCARNT 138

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 17/101 (16%), Positives = 38/101 (37%), Gaps = 10/101 (9%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
             +NKL   +   +   +KL  L    N L+     ++ +   L YL+ + N +  +I  
Sbjct: 92  CDSNKLTN-LD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID- 143

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLLYVSGNNFE 100
            +    ++  ++  +N     +      ++  L  S N   
Sbjct: 144 -VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT 183

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 28/104 (26%), Positives = 49/104 (47%), Gaps = 9/104 (8%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  N +      ++++ SKLRILI+ +N +     S     QEL YLDLSHN +  KI  
Sbjct: 28  ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISC 86

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPE-----SVKKVPLLYVSGNNF 99
                  +  ++LS N    ++P      ++ ++  L +S  + 
Sbjct: 87  H--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 26/104 (25%), Positives = 43/104 (41%), Gaps = 9/104 (8%)

Query: 1   MYNNKLD--GPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGK 57
           +  N+L     I +       L+ L +  N +S           + L  L++S N++   
Sbjct: 355 LQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414

Query: 58  IPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLL---YVSGNN 98
           I   L   PRI  ++L  N +  SIP+ V K+  L    V+ N 
Sbjct: 415 IFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQ 455

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 40.2 bits (94), Expect = 8e-04
 Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 8/91 (8%)

Query: 16  NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLG---EIPRIDTVN 72
             S    L   NNLL+ ++    G L EL  L L  N +  ++        ++  +  ++
Sbjct: 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLD 380

Query: 73  LSMNNLSGSIPESV----KKVPLLYVSGNNF 99
           +S N++S    +      K +  L +S N  
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 7e-06
 Identities = 16/92 (17%), Positives = 38/92 (41%), Gaps = 6/92 (6%)

Query: 12  QELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTV 71
            +  N  + R L L    +   I +    L + + +D S N I  K+      + R+ T+
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69

Query: 72  NLSMNNLS---GSIPESVKKVPLLYVSGNNFE 100
            ++ N +      + +++  +  L ++ N+  
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 46.2 bits (110), Expect = 9e-06
 Identities = 32/174 (18%), Positives = 60/174 (34%), Gaps = 48/174 (27%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH-R 247
           F +   IG G +G +   + L + + VA+K          +       E R   Q+    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQLGSGD 65

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEM-G--------------SLFCVLRTDEEAVGLDWAKR 292
            I ++Y F    K   ++   +E+ G              SL  VL              
Sbjct: 66  GIPQVYYFGPCGKYNAMV---LELLGPSLEDLFDLCDRTFSLKTVLM------------- 109

Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL-----NSELEAFVADFGVAR 341
             I   +   + Y+H      +++RD+   N L+      ++    + DF +A+
Sbjct: 110 --IAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 30/164 (18%), Positives = 61/164 (37%), Gaps = 30/164 (18%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH-R 247
           + +   IG+G +G +Y    + +G+ VA+K                  E+++   +    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQGGV 65

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEM--GSL-----FCVLRTDEEAVGLDWAKRVNIVKGMA 300
            I  +           ++   ME+   SL     FC  +   + V       + +   M 
Sbjct: 66  GIPTIRWCGAEGDYNVMV---MELLGPSLEDLFNFCSRKFSLKTV-------LLLADQMI 115

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLL---NSELEAFVADFGVAR 341
             + Y+H       +HRD+  +N L+         ++ DFG+A+
Sbjct: 116 SRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 23/91 (25%), Positives = 41/91 (45%), Gaps = 6/91 (6%)

Query: 10  IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRID 69
           +   L      + L L  N +   ISS +  ++ L  L L  NLI  KI +       ++
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 70  TVNLSMNNLSGSIP--ESVKKVPLLYVSGNN 98
            + +S N ++ S+   E +  + +LY+S N 
Sbjct: 97  ELWISYNQIA-SLSGIEKLVNLRVLYMSNNK 126

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 40/179 (22%), Positives = 66/179 (36%), Gaps = 52/179 (29%)

Query: 196 IGTGGYGSVYRARLPSGKVVALK-----KLHRSETEEL---------ASLESFRNEARLL 241
           IG GG+G +Y A + S + V        K+  S+   L         A+      +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEM---G--------------SLFCVLRTDEEA 284
            ++ +  + K +G  LH K     Y +M M   G              S   VL+     
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ----- 156

Query: 285 VGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE--AFVADFGVAR 341
                     +   +   L Y+H H     VH DI ++N+LLN +     ++ D+G+A 
Sbjct: 157 ----------LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 30/111 (27%), Positives = 48/111 (43%), Gaps = 10/111 (9%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
           +   KL G IP++L     L  L L +N +  +I  E   +  +L  L L HN I     
Sbjct: 179 ISEAKLTG-IPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIEN 234

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLL---YVSGNNFEVEIPSTS 107
             L  +P +  ++L  N LS  +P  +  + LL   Y+  NN   ++    
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVND 283

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 23/112 (20%), Positives = 41/112 (36%), Gaps = 12/112 (10%)

Query: 1   MYNNKL-DGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP 59
           M  N L +        +  KL  L +    L+  I  ++   + LN L L HN I   I 
Sbjct: 154 MGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIE 209

Query: 60  SQ-LGEIPRIDTVNLSMNNLSGSIPE----SVKKVPLLYVSGNNFEVEIPST 106
            + L    ++  + L  N +   I       +  +  L++  N     +P+ 
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAG 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 26/87 (29%), Positives = 45/87 (51%), Gaps = 7/87 (8%)

Query: 14  LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNL 73
           L +  KL+ L L +N +S  I+  +  L +L  L L +N I     + L  + ++DT++L
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSL 163

Query: 74  SMNNLSGSIP--ESVKKVPLLYVSGNN 98
             N +S  I     + K+  LY+S N+
Sbjct: 164 EDNQIS-DIVPLAGLTKLQNLYLSKNH 189

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 21/92 (22%), Positives = 35/92 (38%), Gaps = 6/92 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + NNK+       L   +KL  L L +N +S  I   +  L +L  L LS N I+  +  
Sbjct: 141 LGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL-R 194

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLL 92
            L  +  +D + L               + + 
Sbjct: 195 ALAGLKNLDVLELFSQECLNKPINHQSNLVVP 226

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 23/86 (26%), Positives = 42/86 (48%), Gaps = 5/86 (5%)

Query: 14  LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNL 73
           L N   L  L L  N +   +SS +  L++L  L L HN I+  I   L  +P+++++ L
Sbjct: 86  LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYL 141

Query: 74  SMNNLSG-SIPESVKKVPLLYVSGNN 98
             N ++  ++   + K+  L +  N 
Sbjct: 142 GNNKITDITVLSRLTKLDTLSLEDNQ 167

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 40.0 bits (94), Expect = 7e-04
 Identities = 17/100 (17%), Positives = 38/100 (38%), Gaps = 9/100 (9%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +    +   + Q     + +  +I  N+ +  S+   I  L  +  L L+ N +   I  
Sbjct: 31  LKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DI-K 84

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP--ESVKKVPLLYVSGNN 98
            L  +  +  + L  N +   +   + +KK+  L +  N 
Sbjct: 85  PLANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSLEHNG 123

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 22/102 (21%), Positives = 45/102 (44%), Gaps = 9/102 (8%)

Query: 1   MYNNKLDGPIPQE-LMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKI 58
           + +N L   + +    +   L +L+L NN +   +       + +L  L LS N I+ + 
Sbjct: 95  LSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RF 151

Query: 59  P----SQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSG 96
           P        ++P++  ++LS N L       ++K+P    +G
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 26/111 (23%), Positives = 42/111 (37%), Gaps = 10/111 (9%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
           + +  +   IPQ L     L  L L  N ++  + +     L  L  L LS N I+    
Sbjct: 178 IADTNITT-IPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDN 233

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLL---YVSGNNFEVEIPSTS 107
             L   P +  ++L+ N L   +P  +     +   Y+  NN    I S  
Sbjct: 234 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSND 282

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.7 bits (101), Expect = 3e-05
 Identities = 20/73 (27%), Positives = 36/73 (49%), Gaps = 2/73 (2%)

Query: 7   DGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIP 66
           +G +        +L  L   N  L+ SI++ + KL +L  L+LS N ++G +     + P
Sbjct: 31  EGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKCP 88

Query: 67  RIDTVNLSMNNLS 79
            +  +NLS N + 
Sbjct: 89  NLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.7 bits (101), Expect = 3e-05
 Identities = 20/89 (22%), Positives = 41/89 (46%), Gaps = 6/89 (6%)

Query: 16  NCSKLRILIL-GNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLS 74
             S ++ L+L  +    G +     + +EL +L   +  +   I + L ++ ++  + LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 75  MNNLSGSIPESVKKVP---LLYVSGNNFE 100
            N +SG +    +K P    L +SGN  +
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 38.9 bits (91), Expect = 6e-04
 Identities = 17/64 (26%), Positives = 30/64 (46%), Gaps = 1/64 (1%)

Query: 14  LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLING-KIPSQLGEIPRIDTVN 72
           L   +KL+ L L +N +SG +     K   L +L+LS N I        L ++  + +++
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119

Query: 73  LSMN 76
           L   
Sbjct: 120 LFNC 123

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 31/164 (18%), Positives = 65/164 (39%), Gaps = 30/164 (18%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HR 247
           F +   IG+G +G +Y    + + + VA+K  +               E+++   +    
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKIYRILQGGT 63

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEM--GSL-----FCVLRTDEEAVGLDWAKRVNIVKGMA 300
            I  +  F +      L+   M++   SL     FC  +   + V       + +   M 
Sbjct: 64  GIPNVRWFGVEGDYNVLV---MDLLGPSLEDLFNFCSRKLSLKTV-------LMLADQMI 113

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLL---NSELEAFVADFGVAR 341
           + + ++H       +HRDI  +N L+       + ++ DFG+A+
Sbjct: 114 NRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 20/105 (19%), Positives = 40/105 (38%), Gaps = 11/105 (10%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSE-IGKLQELNYLDLSHNLINGKIP 59
           +    +   +P  L     L  L +  N     I       L  L  L + ++ ++  I 
Sbjct: 203 LGMCNIKD-MP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIE 258

Query: 60  SQ-LGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNF 99
                 +  +  +NL+ NNLS S+P  +    + +  L++  N +
Sbjct: 259 RNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 9/104 (8%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
           +    L   IP  L    KL  L L  N LS +I       L  L  L +  + I     
Sbjct: 192 LAMCNLRE-IP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIER 248

Query: 60  SQLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNF 99
           +    +  +  +NL+ NNL+  +P  +      +  +++  N +
Sbjct: 249 NAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 26/111 (23%), Positives = 42/111 (37%), Gaps = 9/111 (8%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
           +  N +           + L  L L +N L+ +I +     L +L  L L +N I   IP
Sbjct: 95  LSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIP 152

Query: 60  SQL-GEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPS 105
           S     IP +  ++L        I E        +  L ++  N   EIP+
Sbjct: 153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN 202

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 27/104 (25%), Positives = 46/104 (44%), Gaps = 10/104 (9%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILG-NNLLSGSISSEI-GKLQELNYLDLSHNLINGKI 58
           + NN ++            LR L LG    LS  IS      L  L YL+L+   +  +I
Sbjct: 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EI 200

Query: 59  PSQLGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNN 98
           P+ L  + ++D ++LS N+LS +I          +  L++  + 
Sbjct: 201 PN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQ 242

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 14/103 (13%), Positives = 41/103 (39%), Gaps = 7/103 (6%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + +  ++           +L++L + +     +++        L  L ++H  +   +P 
Sbjct: 183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY 241

Query: 61  Q-LGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNN 98
             +  +  +  +NLS N +S +I  S+     ++  + + G  
Sbjct: 242 LAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQ 283

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 24/110 (21%), Positives = 40/110 (36%), Gaps = 8/110 (7%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIPSQ 61
            N +    P    N   LR L L +N L   I   +   L  L  LD+S N I   +   
Sbjct: 65  ENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYM 123

Query: 62  LGEIPRIDTVNLSMNNLSGSIPESV----KKVPLLYVSGNNFEVEIPSTS 107
             ++  + ++ +  N+L   I          +  L +   N    IP+ +
Sbjct: 124 FQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEA 171

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 22/91 (24%), Positives = 38/91 (41%), Gaps = 16/91 (17%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
           +  N +      ++   S+LR+L L +N +  S+   +    Q+L YLD+SHN       
Sbjct: 59  LSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN------- 110

Query: 60  SQLGEIPRIDTVNL-----SMNNLSGSIPES 85
            +L  I      +L     S N+    +P  
Sbjct: 111 -RLQNISCCPMASLRHLDLSFNDFD-VLPVC 139

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.7 bits (101), Expect = 9e-05
 Identities = 33/166 (19%), Positives = 61/166 (36%), Gaps = 32/166 (19%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH-R 247
           + +   IG G +G ++    L + + VA+K   R      +     R+E R    +    
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCT 66

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEM--GSL-----FCVLRTDEEAVGLDWAKRVNIVKGMA 300
            I  +Y F        L+   +++   SL      C  +   + V           K M 
Sbjct: 67  GIPNVYYFGQEGLHNVLV---IDLLGPSLEDLLDLCGRKFSVKTV-------AMAAKQML 116

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLL-----NSELEAFVADFGVAR 341
             +  +H      +V+RDI  +N L+      +    +V DFG+ +
Sbjct: 117 ARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.2 bits (101), Expect = 9e-05
 Identities = 22/93 (23%), Positives = 35/93 (37%), Gaps = 3/93 (3%)

Query: 10  IPQELMNCSKLRILILGNNLLSGSISSE-IGKLQELNYLDLSHNLINGKIPSQLGEIPRI 68
               L     L  L + N      +    +  L EL  L +  + +    P      PR+
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 69  DTVNLSMNNLSGSIPESVKKVPL--LYVSGNNF 99
             +NLS N L     ++V+ + L  L +SGN  
Sbjct: 83  SRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 23/70 (32%), Positives = 33/70 (47%), Gaps = 2/70 (2%)

Query: 10  IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRID 69
           I         L  L L N  L  S+S+ + KL +L  L+LS N I G +     ++P + 
Sbjct: 41  IEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98

Query: 70  TVNLSMNNLS 79
            +NLS N L 
Sbjct: 99  HLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 21/89 (23%), Positives = 40/89 (44%), Gaps = 6/89 (6%)

Query: 16  NCSKLRILIL-GNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLS 74
             + +R L+L       G I     +   L +L L +  +   + S L ++P++  + LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 75  MNNLSGSIPESVKKVP---LLYVSGNNFE 100
            N + G +    +K+P    L +SGN  +
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 6/78 (7%)

Query: 2   YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ 61
            NN+L       L++   L IL + NN L  SI   +G L +L  LDL  N I       
Sbjct: 114 DNNELRDTDS--LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NT-GG 167

Query: 62  LGEIPRIDTVNLSMNNLS 79
           L  + +++ ++L+     
Sbjct: 168 LTRLKKVNWIDLTGQKCV 185

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 12/77 (15%)

Query: 16  NCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP-----SQLGEIPRID 69
             S L+ L+     L+ S+ +   G L+ L  L+++HNLI          S L     ++
Sbjct: 98  GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNL---TNLE 152

Query: 70  TVNLSMNNLSGSIPESV 86
            ++LS N +  SI  + 
Sbjct: 153 HLDLSSNKIQ-SIYCTD 168

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 40.7 bits (96), Expect = 4e-04
 Identities = 20/88 (22%), Positives = 35/88 (39%), Gaps = 4/88 (4%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIP 59
           ++ N++          C  L IL L +N+L+  I +     L  L  LDLS N     + 
Sbjct: 39  LHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVD 97

Query: 60  SQ-LGEIPRIDTVNLSMNNLSGSIPESV 86
                 + R+ T++L    L   +   +
Sbjct: 98  PATFHGLGRLHTLHLDRCGLQ-ELGPGL 124

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.0 bits (95), Expect = 6e-04
 Identities = 59/405 (14%), Positives = 114/405 (28%), Gaps = 143/405 (35%)

Query: 16  NCSKLRILILGNN-----LLSGSISSEI-----------GKLQEL--NYLDLSHNLINGK 57
           +C   +IL+          LS + ++ I            +++ L   YLD         
Sbjct: 265 SC---KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR----PQD 317

Query: 58  IPSQLGEI-PRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTSAKAPPPHHK 116
           +P ++    PR     LS+      I ES++     +   +N++              H 
Sbjct: 318 LPREVLTTNPRR----LSI------IAESIRDGLATW---DNWK--------------HV 350

Query: 117 GNDKKIATRLVAIILPMSAFLALIFGILFVRRRRDKKVEPTETGEITKCADEFAIWNYDG 176
             DK     L  II                    +  +   E  E  K  D  +++    
Sbjct: 351 NCDK-----LTTII--------------------ESSLNVLEPAEYRKMFDRLSVFPPSA 385

Query: 177 RIT------------FQDMIEATEDFHIKYCIGTGGYGSVYRARLPS------GKVVALK 218
            I               D++      H    +      S     +PS       K+    
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--SIPSIYLELKVKLENEY 443

Query: 219 KLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY-----EYMEMGS 273
            LHRS  +     ++F ++   L   +       Y +        + +     E+ E  +
Sbjct: 444 ALHRSIVDHYNIPKTFDSDD--LIPPYLDQ----YFYS------HIGHHLKNIEHPERMT 491

Query: 274 LFCVLRTDEEAVGLDWAKR--------VNIVKGMAHALS----YLHHHCTPPIVHRDISS 321
           LF ++  D       + ++         N    + + L     Y  + C       D   
Sbjct: 492 LFRMVFLD-----FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC-------DNDP 539

Query: 322 NNVLLNSELEAFVADFGVARLLNFDSSN---RTLLAGTSGYIAPA 363
               L + +  F+       L+    ++     L+A        A
Sbjct: 540 KYERLVNAILDFLPKIE-ENLICSKYTDLLRIALMAEDEAIFEEA 583

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 39.9 bits (93), Expect = 6e-04
 Identities = 35/210 (16%), Positives = 67/210 (31%), Gaps = 47/210 (22%)

Query: 147 RRRRDKKVEPTETGEITKCADEFAIWNYDGR--ITFQDMIEATEDFHIKYCIGTGGYGSV 204
            R    + +  E    T          + G    +   ++ + +   I   +G G   +V
Sbjct: 57  LRVVQNRQKDYEGSTFT----------FIGLSLYSLHRLVRSGKVDAIGKLMGEGKESAV 106

Query: 205 YRARLPSGKVVALKKLHRSETEELASLESFR----------------NEARLLSQIWHRN 248
           +           + K H+        ++  R                NE R L ++    
Sbjct: 107 FNCYSEKFGECVV-KFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 165

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           + K+Y +  +   M    E ++   L+ V   + + V       +  V    H       
Sbjct: 166 VPKVYAWEGNAVLM----ELIDAKELYRVRVENPDEV---LDMILEEVAKFYHRG----- 213

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFG 338
                IVH D+S  NVL++ E   ++ DF 
Sbjct: 214 -----IVHGDLSQYNVLVSEE-GIWIIDFP 237

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 14/88 (15%), Positives = 31/88 (35%), Gaps = 8/88 (9%)

Query: 18  SKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIPSQ-LGEIPRIDTVNLSM 75
             L+ L +        I +     L  L  L L +N    ++ +     +  ++ + L+ 
Sbjct: 54  QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQ 112

Query: 76  NNL-SGSIPESV----KKVPLLYVSGNN 98
            NL    +  +       + +L +  NN
Sbjct: 113 CNLDGAVLSGNFFKPLTSLEMLVLRDNN 140

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	368
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.98
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.98
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.98
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.98
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.98
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.98
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.98
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.98
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.98
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.98
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.98
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.98
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.98
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.98
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.98
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.96
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.96
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.96
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.96
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.96
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.96
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.96
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.96
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.96
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.96
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.96
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.96
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.96
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.96
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.96
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.95
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.68
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.68
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.62
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.58
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.57
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.55
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.54
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.53
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.53
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.52
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.52
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.51
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.51
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.51
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.51
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.5
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.5
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.49
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.48
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.47
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.47
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.47
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.47
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.47
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.46
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.45
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.45
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.45
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.44
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.44
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.43
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.43
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.43
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.42
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.41
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.4
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.4
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.4
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.4
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.39
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.38
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.37
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.37
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.36
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.35
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.34
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.34
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.34
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.34
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.34
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.34
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.34
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.33
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.33
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.33
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.33
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.33
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.31
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.31
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.31
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.31
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.3
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.3
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.3
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.3
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.29
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.29
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.28
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.28
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.27
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.27
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.25
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.25
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.24
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.23
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.23
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.22
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.22
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.21
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.21
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.21
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.21
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.19
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.18
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.15
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.15
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.12
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.07
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.02
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.01
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.0
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.99
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.99
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.99
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.98
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.98
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.98
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.98
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.97
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.97
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.94
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.92
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.92
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.92
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.91
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.87
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.87
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.86
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.83
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.81
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.79
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.78
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.77
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.73
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.73
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.72
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.71
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.62
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.51
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.51
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.51
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.5
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.37
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.32
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.31
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.27
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.06
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.05
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.02
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.95
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.94
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.93
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.93
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.83
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.75
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.7
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.67
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.66
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.6
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.51
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.5
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.47
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.36
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.36
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.32
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.31
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.23
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.15
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.07
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.95
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.54
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	96.44
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.11
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	95.44
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.09
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	94.79
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	94.08
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.57
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	93.44
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	92.35
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	92.3
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	91.93
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	90.86
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	90.84
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	90.63
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	90.22
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.27
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	85.01
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	84.61
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	82.7

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-44  Score=328.86  Aligned_cols=170  Identities=27%  Similarity=0.437  Sum_probs=152.9

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|++ .+++.||||++.+....+....+.+.+|++++++++|||||++++++++++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999985 579999999998765544455678999999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||++|+|.++++...   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999998643   389999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CC--CccccccccccccCC
Q 017621          347 SS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~--~~~~~~gt~~y~aPE  363 (368)
                      ..  .....+||+.|||||
T Consensus       186 ~~~~~~~~~~GTp~YmAPE  204 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPE  204 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHH
T ss_pred             CCcccccCcccCcccCCHH
Confidence            32  344578999999998

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.7e-44  Score=331.32  Aligned_cols=171  Identities=26%  Similarity=0.407  Sum_probs=145.1

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++....... ...+.+.+|++++++++|||||++++++++++.+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            6899999999999999999985 469999999997654332 34578999999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||++|+|.+++..... ..+++.++..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus       103 Ey~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             eCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999976432 3378999999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      .......+||+.|||||
T Consensus       179 ~~~~~~~~GT~~YmAPE  195 (350)
T 4b9d_A          179 VELARACIGTPYYLSPE  195 (350)
T ss_dssp             HHHHHHHHSCCTTCCHH
T ss_pred             cccccccCCCccccCHH
Confidence            33344568999999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.6e-44  Score=327.17  Aligned_cols=166  Identities=28%  Similarity=0.437  Sum_probs=150.2

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      +.|++.+.||+|+||+||+|++ .+|+.||||++......   ..+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5699999999999999999986 47999999999654332   2356789999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||++|+|.+++...    .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       151 Ey~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          151 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             CCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             eCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            999999999999753    389999999999999999999999   9999999999999999999999999999988766


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      .......+||+.|||||
T Consensus       224 ~~~~~~~~GTp~YmAPE  240 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPE  240 (346)
T ss_dssp             SCCBCCCCSCGGGCCHH
T ss_pred             CCcccccccCcCcCCHH
Confidence            66666789999999998

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.8e-43  Score=329.23  Aligned_cols=167  Identities=28%  Similarity=0.434  Sum_probs=151.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .+.|++.+.||+|+||+||+|++ .+|+.||||++......   ..+.+.+|+++|++++|||||++++++.+++.+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            35799999999999999999986 46999999999754332   235688999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||||++|+|.++++..    .+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.+..
T Consensus       227 mEy~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          227 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EeCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            9999999999999753    289999999999999999999999   999999999999999999999999999998876


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      ........+||+.|||||
T Consensus       300 ~~~~~~~~~GTp~YmAPE  317 (423)
T 4fie_A          300 EVPRRKSLVGTPYWMAPE  317 (423)
T ss_dssp             SCCCBCCCEECTTTCCHH
T ss_pred             CCccccccccCcCcCCHH
Confidence            666666789999999998

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.7e-43  Score=312.60  Aligned_cols=169  Identities=25%  Similarity=0.448  Sum_probs=134.3

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||||++.+....+....+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            36899999999999999999986 46999999999876555444567899999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+ +|+|.+++.....   +++.++..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        92 mEy~-~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHHHSCS---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 5799999876543   99999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      .. .....+||+.|||||
T Consensus       165 ~~-~~~~~~GT~~Y~APE  181 (275)
T 3hyh_A          165 GN-FLKTSCGSPNYAAPE  181 (275)
T ss_dssp             -----------CTTSCHH
T ss_pred             CC-ccCCeeECcccCChh
Confidence            33 234568999999998

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-43  Score=321.26  Aligned_cols=169  Identities=24%  Similarity=0.354  Sum_probs=141.3

Q ss_pred             hccccceeeeecCCccEEEEEc----CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|++.+.||+|+||+||+|+.    .+++.||||++++...... ...++.+|++++++++|||||++++++++++..|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            5899999999999999999975    2478999999976543221 2246788999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +|||||++|+|.+++.+..   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       103 ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999998644   389999999999999999999999   9999999999999999999999999999977


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ..........+||+.|||||
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE  196 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPE  196 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHH
T ss_pred             cCCCccccccccCcccCCHH
Confidence            65555555678999999998

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.5e-42  Score=312.13  Aligned_cols=172  Identities=23%  Similarity=0.403  Sum_probs=138.1

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-----
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-----  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  260 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||||+++.....  ...+.+.+|++++++++|||||++++++.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            45799999999999999999985 47899999998754432  24467899999999999999999999987644     


Q ss_pred             -------eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeE
Q 017621          261 -------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF  333 (368)
Q Consensus       261 -------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  333 (368)
                             .+|+|||||++|+|.+++.........++..++.++.||++||+|||++   +|+||||||+|||++.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence                   3799999999999999998765544466777889999999999999999   999999999999999999999


Q ss_pred             EeeeccceecCCCCCC------------ccccccccccccCC
Q 017621          334 VADFGVARLLNFDSSN------------RTLLAGTSGYIAPA  363 (368)
Q Consensus       334 l~DFg~a~~~~~~~~~------------~~~~~gt~~y~aPE  363 (368)
                      |+|||+|+........            .+..+||+.|||||
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE  200 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE  200 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence            9999999887543221            23457999999998

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.7e-42  Score=313.27  Aligned_cols=170  Identities=27%  Similarity=0.486  Sum_probs=145.6

Q ss_pred             hccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++....   ...++|.+|+++|++++|||||+++|+|.+++.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh---HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            57889999999999999999853      477899999976543   245789999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC
Q 017621          262 MFLIYEYMEMGSLFCVLRTDE----------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE  331 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  331 (368)
                      .|||||||++|+|.++++...          ....++|.+++.++.||++||+|||++   +|+||||||+|||+++++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence            999999999999999997642          234599999999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          332 AFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       332 ~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      +||+|||+|+........  ....+||+.|||||
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE  200 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE  200 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHH
Confidence            999999999876543322  22346999999998

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-41  Score=307.02  Aligned_cols=168  Identities=27%  Similarity=0.465  Sum_probs=142.2

Q ss_pred             cccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee----CCeEEE
Q 017621          190 FHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH----RKCMFL  264 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  264 (368)
                      |++.+.||+|+||+||+|.+ .+++.||+|++....... ...++|.+|++++++++|||||++++++.+    ++.+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            36678899999999999985 468899999997654332 345789999999999999999999999875    356899


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCCeEEeeeccceec
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLL  343 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFg~a~~~  343 (368)
                      |||||++|+|.+++++..   .+++..+..++.||+.||+|||++ .++|+||||||+|||++ .++.+||+|||+|+..
T Consensus       107 vmEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            999999999999998643   389999999999999999999998 11399999999999998 4799999999999864


Q ss_pred             CCCCCCccccccccccccCCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..  ......+||+.|||||+
T Consensus       183 ~~--~~~~~~~GTp~YmAPE~  201 (290)
T 3fpq_A          183 RA--SFAKAVIGTPEFMAPEM  201 (290)
T ss_dssp             CT--TSBEESCSSCCCCCGGG
T ss_pred             CC--CccCCcccCccccCHHH
Confidence            32  33445689999999994

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.7e-42  Score=314.02  Aligned_cols=170  Identities=26%  Similarity=0.482  Sum_probs=140.2

Q ss_pred             hccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++....   ...++|.+|+++|++++|||||+++|+|.+.+.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            57888899999999999999853      478899999976543   245789999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEE------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                      .|||||||++|+|.++++....            ...++|.+++.|+.|||+||+|||++   +||||||||+|||++++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence            9999999999999999976432            23489999999999999999999999   99999999999999999


Q ss_pred             CCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          330 LEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       330 ~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      +.+||+|||+|+.......  .....+||+.|||||
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE  230 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE  230 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChh
Confidence            9999999999987654332  223457999999999

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=308.47  Aligned_cols=169  Identities=27%  Similarity=0.481  Sum_probs=140.9

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .+++++.+.||+|+||+||+|++.  ..||||+++..... ....++|.+|++++++++|||||++++++.+ +..||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            357888999999999999999974  35999998754432 2345789999999999999999999999865 5689999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||++|+|.++++....  .+++.+++.|+.|||+||+|||++   +||||||||+|||+++++.+||+|||+|+.....
T Consensus       111 Ey~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             ECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            99999999999976432  389999999999999999999999   9999999999999999999999999999876543


Q ss_pred             C--CCccccccccccccCCC
Q 017621          347 S--SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~--~~~~~~~gt~~y~aPE~  364 (368)
                      .  ......+||+.|||||+
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~  205 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEV  205 (307)
T ss_dssp             --------CCCCTTSCCHHH
T ss_pred             CcceeecccccCCCccCHHH
Confidence            2  22345689999999994

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.8e-42  Score=313.93  Aligned_cols=163  Identities=27%  Similarity=0.330  Sum_probs=141.1

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++....        ..+|+.++++++|||||++++++.+++.+|||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            35788899999999999999986 4689999999975432        24699999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-CeEEeeeccceecC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARLLN  344 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFg~a~~~~  344 (368)
                      ||||++|+|.++++...   .+++.++..++.||+.||+|||++   +||||||||+|||++.++ .+||+|||+|+.+.
T Consensus       129 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             EeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            99999999999998643   389999999999999999999999   999999999999999987 69999999999876


Q ss_pred             CCCCC-----ccccccccccccCC
Q 017621          345 FDSSN-----RTLLAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~~-----~~~~~gt~~y~aPE  363 (368)
                      .+...     ....+||+.|||||
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE  226 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPE  226 (336)
T ss_dssp             -----------CCCCCCGGGCCHH
T ss_pred             CCCcccceecCCccccCccccCHH
Confidence            54321     22358999999998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8e-42  Score=311.43  Aligned_cols=171  Identities=26%  Similarity=0.396  Sum_probs=145.7

Q ss_pred             hccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      .++++.+.||+|+||+||+|++      .+++.||||+++.....  ...++|.+|+.++++++|||||+++|+|.+++.
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            4677889999999999999985      24678999999754332  244789999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS  328 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  328 (368)
                      .+||||||++|+|.+++.....             ...++|.+++.++.|||+||+|||++   +||||||||+|||+++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence            9999999999999999965321             23589999999999999999999999   9999999999999999


Q ss_pred             CCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          329 ELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      ++.+||+|||+|+.......  ..+..+||+.|||||
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE  217 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE  217 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHH
Confidence            99999999999987644322  234457999999998

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8e-41  Score=305.08  Aligned_cols=168  Identities=26%  Similarity=0.390  Sum_probs=139.2

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC----eEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK----CMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  263 (368)
                      ++|.+.+.||+|+||+||+|++ +|+.||||++.......    ..+..|+..+.+++|||||++++++.+++    .+|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~----~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh----HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            5788899999999999999998 68999999997543221    23345666778899999999999998754    589


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH-----CTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                      ||||||++|+|.++++...    ++|..+.+++.|++.||+|||++     +.++|+||||||+|||++.++.+||+|||
T Consensus        78 lV~Ey~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEecCCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            9999999999999998643    89999999999999999999976     24589999999999999999999999999


Q ss_pred             cceecCCCCCC----ccccccccccccCCC
Q 017621          339 VARLLNFDSSN----RTLLAGTSGYIAPAS  364 (368)
Q Consensus       339 ~a~~~~~~~~~----~~~~~gt~~y~aPE~  364 (368)
                      +|+........    ....+||+.|||||+
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~  183 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEV  183 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHH
T ss_pred             CCccccCCCCceeeecccccccccccCHHH
Confidence            99987654332    234579999999993

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.6e-40  Score=304.42  Aligned_cols=179  Identities=23%  Similarity=0.361  Sum_probs=150.3

Q ss_pred             HHHHHHHhhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC-CceeeE
Q 017621          180 FQDMIEATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH-RNIVKL  252 (368)
Q Consensus       180 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l  252 (368)
                      ..+++...++|++.+.||+|+||+||+|++.      .++.||||.+.......  ..++|.+|+++|++++| ||||++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~--~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH--HHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3445556789999999999999999999743      24689999997654432  34689999999999965 899999


Q ss_pred             EEEEeeC-CeEEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecC
Q 017621          253 YGFCLHR-KCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRD  318 (368)
Q Consensus       253 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  318 (368)
                      +|+|.+. +.+|+|||||++|+|.++++....             ...+++.+++.++.|||+||+|||++   +|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9999764 568999999999999999975422             23489999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          319 ISSNNVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       319 lkp~NIll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      |||+|||+++++.+||+|||+|+.+..+..  .....+||+.|||||
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE  257 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  257 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHH
Confidence            999999999999999999999998754433  234467999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.1e-39  Score=319.08  Aligned_cols=169  Identities=25%  Similarity=0.306  Sum_probs=145.8

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHH---HHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESF---RNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.+............   +.++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            46899999999999999999985 4699999999976543332222333   3446777888999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+|||||+||+|.+++....   .+++..+..++.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999998643   389999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCCccccccccccccCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +....  ....+||+.|||||
T Consensus       342 ~~~~~--~~t~~GTp~YmAPE  360 (689)
T 3v5w_A          342 FSKKK--PHASVGTHGYMAPE  360 (689)
T ss_dssp             CSSCC--CCSCCSCGGGCCHH
T ss_pred             cCCCC--CCCccCCcCccCHH
Confidence            75433  34568999999998

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-39  Score=302.35  Aligned_cols=168  Identities=27%  Similarity=0.423  Sum_probs=143.4

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee------CC
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH------RK  260 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  260 (368)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++....... ...+.+.+|+++|+.++|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            5799999999999999999985 579999999997644322 234678899999999999999999998764      35


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      .+|||||||+ |+|.+++....   .+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 68999997644   399999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCC----CCccccccccccccCC
Q 017621          341 RLLNFDS----SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~----~~~~~~~gt~~y~aPE  363 (368)
                      +.+....    ......+||+.|||||
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APE  232 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPE  232 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHH
T ss_pred             eecccCccccccccccceeChHhcCHH
Confidence            8764322    2234568999999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-38  Score=297.02  Aligned_cols=164  Identities=26%  Similarity=0.350  Sum_probs=141.0

Q ss_pred             HhhccccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCC
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRK  260 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  260 (368)
                      ..++|++.+.||+|+||+||+|+.+    +++.||+|++.....     ..++.+|+++++.+ +||||+++++++.+.+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            4578999999999999999999742    467899999876443     24678899999998 7999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CCeEEeeecc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGV  339 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFg~  339 (368)
                      .+|+||||+++|+|.++++.      +++.++..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+
T Consensus        94 ~~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            99999999999999999852      88999999999999999999999   99999999999999877 7999999999


Q ss_pred             ceecCCCCC----------------------------CccccccccccccCC
Q 017621          340 ARLLNFDSS----------------------------NRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~----------------------------~~~~~~gt~~y~aPE  363 (368)
                      |+.......                            ..+..+||+.|||||
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE  216 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE  216 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            986643211                            122357999999998

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.8e-37  Score=303.50  Aligned_cols=168  Identities=24%  Similarity=0.419  Sum_probs=148.2

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++ .+|+.||+|++......   ..+.+.+|+++|+.++|||||++++++.+.+.+|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh---hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            36899999999999999999985 47999999998765433   346788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC--CCeEEeeeccceec
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE--LEAFVADFGVARLL  343 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFg~a~~~  343 (368)
                      ||||++|+|.+++.....  .+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+
T Consensus       233 ~E~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EECCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EeecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999999999999865432  389999999999999999999999   99999999999999854  89999999999988


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .... .....+||+.|||||
T Consensus       308 ~~~~-~~~~~~GT~~y~APE  326 (573)
T 3uto_A          308 DPKQ-SVKVTTGTAEFAAPE  326 (573)
T ss_dssp             CTTS-EEEEECSSGGGCCHH
T ss_pred             cCCC-ceeeeEECccccCHH
Confidence            6443 334568999999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.4e-35  Score=274.76  Aligned_cols=172  Identities=24%  Similarity=0.354  Sum_probs=151.9

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++++.........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            368999999999999999999864 6899999999765443334557788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999987643   389999999999999999999999   999999999999999999999999999987554


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      ........+||+.|+|||+
T Consensus       158 ~~~~~~~~~gt~~y~aPE~  176 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEV  176 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGG
T ss_pred             CCCcccccccChhhCChhh
Confidence            4444556789999999983

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.6e-36  Score=288.54  Aligned_cols=180  Identities=29%  Similarity=0.375  Sum_probs=154.3

Q ss_pred             HHHHHHHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee
Q 017621          180 FQDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH  258 (368)
Q Consensus       180 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  258 (368)
                      +.++....++|++.+.||+|+||+||+|++. +++.||+|++.+.........+.+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            4445556789999999999999999999865 578999999976444333333458899999999999999999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                      .+..|+||||+++|+|.+++.....  .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence            9999999999999999999986432  389999999999999999999999   99999999999999999999999999


Q ss_pred             cceecCCCCCC-ccccccccccccCCC
Q 017621          339 VARLLNFDSSN-RTLLAGTSGYIAPAS  364 (368)
Q Consensus       339 ~a~~~~~~~~~-~~~~~gt~~y~aPE~  364 (368)
                      +|+........ ....+||+.|+|||+
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~  247 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEI  247 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHH
T ss_pred             hhhhcccCCCcccccccCCcCeeChHH
Confidence            99877554332 234689999999984

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=9.7e-36  Score=277.49  Aligned_cols=172  Identities=27%  Similarity=0.436  Sum_probs=146.2

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  263 (368)
                      ..++|++.+.||+|+||+||+|+. .+++.||+|++.+.........+.+.+|.++++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            357899999999999999999985 46899999999865444444567788999999988 7999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +||||+++|+|.+++.....   +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       101 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999976433   89999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ..........+||+.|+|||
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE  194 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPE  194 (353)
T ss_dssp             CC---------CCGGGCCHH
T ss_pred             ccCCccccccCCCcCeEChh
Confidence            54444455678999999998

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.5e-35  Score=279.75  Aligned_cols=171  Identities=25%  Similarity=0.410  Sum_probs=148.9

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  264 (368)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++++.........+.+.+|..++.++ +||||+++++++.+.+..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999864 5789999999865444333445678899999887 89999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus       131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999997643   389999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCCccccccccccccCC
Q 017621          345 FDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE  363 (368)
                      .........+||+.|+|||
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE  223 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPE  223 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHH
T ss_pred             cCCCccccccCCcccCCch
Confidence            4444556678999999998

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=281.95  Aligned_cols=180  Identities=24%  Similarity=0.359  Sum_probs=155.1

Q ss_pred             cHHHHHHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEe
Q 017621          179 TFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCL  257 (368)
Q Consensus       179 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  257 (368)
                      .+++.....++|++.+.||+|+||+||+|+. .+++.||+|++.+.........+.+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            3444555578999999999999999999986 478999999997654433334456889999999999999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                      +.+..|+||||+++|+|.+++....  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence            9999999999999999999997643  2389999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCC-ccccccccccccCC
Q 017621          338 GVARLLNFDSSN-RTLLAGTSGYIAPA  363 (368)
Q Consensus       338 g~a~~~~~~~~~-~~~~~gt~~y~aPE  363 (368)
                      |+++........ ....+||+.|+|||
T Consensus       207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE  233 (412)
T 2vd5_A          207 GSCLKLRADGTVRSLVAVGTPDYLSPE  233 (412)
T ss_dssp             TTCEECCTTSCEECSSCCSCGGGCCHH
T ss_pred             hhheeccCCCccccceeccccCcCCHH
Confidence            999887654432 23458999999999

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4e-35  Score=272.41  Aligned_cols=173  Identities=25%  Similarity=0.431  Sum_probs=150.6

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  262 (368)
                      ...++|++.+.||+|+||+||+|+.. +++.||+|+++..........+.+..|.+++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            45678999999999999999999864 6889999999765433333456788899999887 999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+||||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999997643   389999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ...........+||+.|+|||
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE  188 (345)
T 1xjd_A          168 NMLGDAKTNTFCGTPDYIAPE  188 (345)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHH
T ss_pred             cccCCCcccCCCCCcccCChh
Confidence            654444455678999999998

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.3e-35  Score=271.78  Aligned_cols=171  Identities=26%  Similarity=0.411  Sum_probs=150.9

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  264 (368)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++...........+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            368999999999999999999864 6889999999865544444557788999999988 89999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            999999999999997643   389999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCCccccccccccccCC
Q 017621          345 FDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE  363 (368)
                      .........+||+.|+|||
T Consensus       162 ~~~~~~~~~~gt~~y~aPE  180 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPE  180 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHH
T ss_pred             CCCCcccccCCCccccCcc
Confidence            4444455678999999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.3e-35  Score=281.64  Aligned_cols=176  Identities=24%  Similarity=0.363  Sum_probs=151.9

Q ss_pred             HHHHHHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC
Q 017621          181 QDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR  259 (368)
Q Consensus       181 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  259 (368)
                      .++....++|++.+.||+|+||+||+|+.. +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344445689999999999999999999864 5889999999764433333335678899999999999999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      +..|+||||+++|+|.++++..    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence            9999999999999999999754    289999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCC-CccccccccccccCC
Q 017621          340 ARLLNFDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~-~~~~~~gt~~y~aPE  363 (368)
                      |+....... .....+||+.|+|||
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE  239 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPE  239 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHH
T ss_pred             eEeeccCCcccccCCcCCccccCHH
Confidence            988764432 223568999999998

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=272.61  Aligned_cols=171  Identities=25%  Similarity=0.411  Sum_probs=151.8

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+. .+++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            36899999999999999999985 46889999999765544445567889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++....   .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999998643   389999999999999999999999   999999999999999999999999999998754


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      . ......+||+.|+|||+
T Consensus       168 ~-~~~~~~~gt~~Y~aPE~  185 (384)
T 4fr4_A          168 E-TQITTMAGTKPYMAPEM  185 (384)
T ss_dssp             T-CCBCCCCSCGGGCCGGG
T ss_pred             C-CceeccCCCccccCCee
Confidence            3 33345689999999994

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.9e-35  Score=272.13  Aligned_cols=172  Identities=24%  Similarity=0.358  Sum_probs=151.2

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  263 (368)
                      ..++|++.+.||+|+||+||+|+.. +++.||+|++...........+.+.+|.+++..+ +||||+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999865 4789999999765443444557788999999988 8999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +||||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999997643   289999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ..........+||+.|+|||
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE  191 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPE  191 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHH
T ss_pred             ccCCcccccccCCccccChh
Confidence            54444455678999999998

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-34  Score=266.02  Aligned_cols=168  Identities=31%  Similarity=0.503  Sum_probs=149.5

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++.+.........+.+.+|..+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            468999999999999999999864 6899999999765444434567788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++.....   +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999986543   89999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      .   ....+||+.|+|||
T Consensus       159 ~---~~~~~gt~~y~aPE  173 (318)
T 1fot_A          159 V---TYTLCGTPDYIAPE  173 (318)
T ss_dssp             C---BCCCCSCTTTCCHH
T ss_pred             c---cccccCCccccCHh
Confidence            2   23458999999998

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.7e-34  Score=260.73  Aligned_cols=168  Identities=27%  Similarity=0.427  Sum_probs=150.5

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|++......   ..+.+.+|+.++++++||||+++++++...+..|+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            46899999999999999999985 57899999998654332   236788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++...    .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999999999764    289999999999999999999999   999999999999999999999999999998876


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........||+.|+|||+
T Consensus       169 ~~~~~~~~~gt~~y~aPE~  187 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEV  187 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHH
T ss_pred             cccccCCccCCcCccChhh
Confidence            6555566789999999984

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.4e-35  Score=272.64  Aligned_cols=171  Identities=27%  Similarity=0.399  Sum_probs=140.4

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHH-HhccCCCceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARL-LSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            468999999999999999999864 588999999976554333344566777776 577899999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999997643   388999999999999999999999   99999999999999999999999999998755


Q ss_pred             CCCCCccccccccccccCC
Q 017621          345 FDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE  363 (368)
                      .........+||+.|+|||
T Consensus       191 ~~~~~~~~~~gt~~y~aPE  209 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPE  209 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHH
T ss_pred             cCCCccccccCCccccCHH
Confidence            4444455678999999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.7e-34  Score=267.53  Aligned_cols=168  Identities=26%  Similarity=0.375  Sum_probs=149.9

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            368999999999999999999864 6899999999765544444567889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999999998643   389999999999999999999999   999999999999999999999999999997653


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      .   ....+||+.|+|||
T Consensus       194 ~---~~~~~gt~~y~aPE  208 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPE  208 (350)
T ss_dssp             C---BCCCEECGGGCCHH
T ss_pred             C---cccccCCccccCHH
Confidence            3   23458999999998

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.2e-34  Score=263.89  Aligned_cols=169  Identities=28%  Similarity=0.496  Sum_probs=149.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++...... ....+.+.+|+++++.++||||+++++++...+..|+|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            46899999999999999999986 57999999998764332 23456788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++.....   +++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            999999999999976433   89999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      .. .....+||+.|+|||
T Consensus       167 ~~-~~~~~~gt~~y~aPE  183 (328)
T 3fe3_A          167 GG-KLDAFCGAPPYAAPE  183 (328)
T ss_dssp             SC-GGGTTSSSGGGCCHH
T ss_pred             CC-ccccccCCcceeCcc
Confidence            33 344568999999998

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6e-34  Score=278.19  Aligned_cols=174  Identities=25%  Similarity=0.393  Sum_probs=153.6

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++.+.........+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999864 6999999999765544444567889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          266 YEYMEMGSLFCVLRTDEE-AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |||+++|+|.+++..... ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999876432 33589999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccCC
Q 017621          345 FDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE  363 (368)
                      .........+||+.|+|||
T Consensus       341 ~~~~~~~~~~GT~~Y~APE  359 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPE  359 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHH
T ss_pred             CCCcccccccCCccccChh
Confidence            5554445568999999998

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.9e-33  Score=258.90  Aligned_cols=179  Identities=27%  Similarity=0.428  Sum_probs=156.2

Q ss_pred             CCcccHHHHHHHhhc----------cccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhc
Q 017621          175 DGRITFQDMIEATED----------FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQ  243 (368)
Q Consensus       175 ~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~  243 (368)
                      .+.++++++..+++.          |+..+.||+|+||+||+|+.. +|+.||||++......   ..+.+.+|+.++++
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~   98 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRD   98 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTT
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHh
Confidence            346788888887764          777889999999999999865 7999999998654322   34678899999999


Q ss_pred             cCCCceeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 017621          244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNN  323 (368)
Q Consensus       244 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  323 (368)
                      ++||||+++++++...+..++||||+++++|.+++...    .+++..+..++.|++.||+|||++   +|+||||||+|
T Consensus        99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N  171 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS  171 (321)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence            99999999999999999999999999999999998753    389999999999999999999999   99999999999


Q ss_pred             eeecCCCCeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          324 VLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       324 Ill~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      |+++.++.+||+|||+++.............||+.|+|||
T Consensus       172 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE  211 (321)
T 2c30_A          172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE  211 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHH
T ss_pred             EEECCCCcEEEeeeeeeeecccCccccccccCCccccCHh
Confidence            9999999999999999988765554455668999999998

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.5e-34  Score=259.74  Aligned_cols=171  Identities=29%  Similarity=0.429  Sum_probs=144.7

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|++ .+++.||+|.+...........+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            35799999999999999999985 46899999998655444444567899999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999997643   389999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-CccccccccccccCC
Q 017621          346 DSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~-~~~~~~gt~~y~aPE  363 (368)
                      ... ......||+.|+|||
T Consensus       164 ~~~~~~~~~~gt~~y~aPE  182 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPE  182 (294)
T ss_dssp             -----------CCSSCCHH
T ss_pred             ccccccCccccCccccCHh
Confidence            332 233457999999998

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.9e-34  Score=262.55  Aligned_cols=188  Identities=40%  Similarity=0.757  Sum_probs=161.8

Q ss_pred             CCcccHHHHHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEE
Q 017621          175 DGRITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG  254 (368)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  254 (368)
                      ...+++.++....++|++.+.||+|+||+||+|+..+++.||+|++.......  ....+.+|+++++.++||||+++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEE
Confidence            34678899999999999999999999999999998889999999997654322  2236889999999999999999999


Q ss_pred             EEeeCCeEEEEEeecCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeE
Q 017621          255 FCLHRKCMFLIYEYMEMGSLFCVLRTDEE-AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF  333 (368)
Q Consensus       255 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  333 (368)
                      ++...+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+++.++|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999986542 33489999999999999999999998777899999999999999999999


Q ss_pred             EeeeccceecCCCCCC-ccccccccccccCCC
Q 017621          334 VADFGVARLLNFDSSN-RTLLAGTSGYIAPAS  364 (368)
Q Consensus       334 l~DFg~a~~~~~~~~~-~~~~~gt~~y~aPE~  364 (368)
                      |+|||+++........ .....||+.|+|||+
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~  206 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY  206 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHH
T ss_pred             eccCccccccCcccccccccccCCcCccCHHH
Confidence            9999999987544332 334569999999983

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2e-33  Score=259.21  Aligned_cols=174  Identities=22%  Similarity=0.390  Sum_probs=146.6

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC----
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK----  260 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  260 (368)
                      ..++|++.+.||+|+||+||+|++. +++.||||++......  ...+.+.+|++++++++||||+++++++.+.+    
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            4578999999999999999999865 7899999998754422  23478899999999999999999999986543    


Q ss_pred             -----------------------------------------------------eEEEEEeecCCCChhHHhhcCCCCCCC
Q 017621          261 -----------------------------------------------------CMFLIYEYMEMGSLFCVLRTDEEAVGL  287 (368)
Q Consensus       261 -----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~l  287 (368)
                                                                           ..++||||+++++|.+++.........
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 389999999999999999877655557


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC------------Ccccccc
Q 017621          288 DWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS------------NRTLLAG  355 (368)
Q Consensus       288 ~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~------------~~~~~~g  355 (368)
                      ++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.......            .....+|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            7778899999999999999999   999999999999999999999999999998765421            2233579


Q ss_pred             ccccccCCC
Q 017621          356 TSGYIAPAS  364 (368)
Q Consensus       356 t~~y~aPE~  364 (368)
                      |+.|+|||+
T Consensus       239 t~~y~aPE~  247 (332)
T 3qd2_B          239 TKLYMSPEQ  247 (332)
T ss_dssp             CGGGSCHHH
T ss_pred             CcCccChHH
Confidence            999999983

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.9e-34  Score=277.85  Aligned_cols=172  Identities=26%  Similarity=0.365  Sum_probs=151.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+. .+++.||+|++.............+.+|+++++.++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999986 47999999999765444444556788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++..... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999976432 3489999999999999999999999   999999999999999999999999999988764


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      ... ....+||+.|+|||
T Consensus       339 ~~~-~~~~~GT~~Y~APE  355 (576)
T 2acx_A          339 GQT-IKGRVGTVGYMAPE  355 (576)
T ss_dssp             TCC-EECCCSCGGGCCHH
T ss_pred             Ccc-ccccCCCccccCHH
Confidence            332 33458999999998

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.5e-34  Score=263.70  Aligned_cols=172  Identities=27%  Similarity=0.428  Sum_probs=138.0

Q ss_pred             hhccccceeeeecCCccEEEEEc----CCCCEEEEEEccccchh-hHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      .++|++.+.||+|+||+||+|+.    .+++.||+|++...... .......+.+|+++++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999986    47899999999765322 12234567889999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .|+||||+++++|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999997643   388999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCCCccccccccccccCCC
Q 017621          342 LLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ............+||+.|+|||+
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~  192 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEI  192 (327)
T ss_dssp             ---------CTTSSCCTTSCHHH
T ss_pred             ccccCCccccccCCCcCccCHhh
Confidence            76544444445689999999983

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.1e-33  Score=255.17  Aligned_cols=170  Identities=28%  Similarity=0.532  Sum_probs=146.7

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|++.....   ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            46899999999999999999986 4689999998865433   2447889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.++++....  .+++.++..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        86 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            999999999999986432  389999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCc--------------cccccccccccCCC
Q 017621          346 DSSNR--------------TLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~--------------~~~~gt~~y~aPE~  364 (368)
                      .....              ...+||+.|+|||+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  193 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM  193 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHH
Confidence            32211              14579999999983

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-33  Score=263.38  Aligned_cols=170  Identities=25%  Similarity=0.397  Sum_probs=148.1

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhH---HhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|++........   ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999864 689999999876543211   1346789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC----CeEEeeec
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL----EAFVADFG  338 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFg  338 (368)
                      |+||||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999997643   389999999999999999999999   999999999999998877    79999999


Q ss_pred             cceecCCCCCCccccccccccccCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +++....... ....+||+.|+|||
T Consensus       165 ~a~~~~~~~~-~~~~~gt~~y~aPE  188 (361)
T 2yab_A          165 LAHEIEDGVE-FKNIFGTPEFVAPE  188 (361)
T ss_dssp             SCEECCTTCC-CCCCCSCGGGCCHH
T ss_pred             CceEcCCCCc-cccCCCCccEECch
Confidence            9998764332 34457999999998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.5e-34  Score=260.14  Aligned_cols=175  Identities=30%  Similarity=0.485  Sum_probs=141.9

Q ss_pred             HHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ...++|++.+.||+|+||+||+|+. +++.||+|++....... ...+++.+|++++++++||||+++++++.+.+..++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            3467899999999999999999987 68889999987654332 345688999999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP--IVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ||||+++|+|.+++........+++..++.++.|++.||+|||++   +  |+||||||+||+++.++.+||+|||+++.
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999999999998755434489999999999999999999998   7  99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccCCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ............||+.|+|||+
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~  210 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEV  210 (309)
T ss_dssp             -------------CCTTSCHHH
T ss_pred             ccccccccccCCCCccccChhh
Confidence            6544444445679999999983

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.3e-33  Score=257.17  Aligned_cols=172  Identities=30%  Similarity=0.459  Sum_probs=146.5

Q ss_pred             HhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ..++|++.+.||+|+||+||+|++.+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            34689999999999999999999888999999998754332 22346788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++ +|.+.+....  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        98 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            999985 8888877543  2389999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........||+.|+|||+
T Consensus       172 ~~~~~~~~~~t~~y~aPE~  190 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDV  190 (311)
T ss_dssp             CCC---CCCCCCTTCCHHH
T ss_pred             CcccccCCcccCCcCCHHH
Confidence            5555555689999999983

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.5e-34  Score=275.54  Aligned_cols=172  Identities=23%  Similarity=0.340  Sum_probs=139.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++.............+.+|+++++.++||||+++++++.+.+..|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46899999999999999999985 46899999999764333333446778899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||+ +   +|+||||||+|||++.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999999987643   38999999999999999999998 7   99999999999999999999999999998755


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........+||+.|+|||+
T Consensus       301 ~~~~~~~~~~gt~~y~aPE~  320 (446)
T 4ejn_A          301 KDGATMKTFCGTPEYLAPEV  320 (446)
T ss_dssp             C-----CCSSSCGGGCCHHH
T ss_pred             CCCcccccccCCccccCHhh
Confidence            44444556789999999983

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.5e-33  Score=263.11  Aligned_cols=172  Identities=27%  Similarity=0.419  Sum_probs=147.2

Q ss_pred             hhccccceeeeecCCccEEEEEc--------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCL  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  257 (368)
                      .++|++.+.||+|+||+||+|++        .++..||+|+++.....  ...+++.+|+++++++ +||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH--HHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            46899999999999999999974        23567999999765432  3457899999999999 8999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV  324 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  324 (368)
                      +.+..|+||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||++   +|+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence            99999999999999999999976432             13478999999999999999999999   999999999999


Q ss_pred             eecCCCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          325 LLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       325 ll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      |++.++.+||+|||+++.......  ......||+.|+|||
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE  275 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE  275 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHh
Confidence            999999999999999997754332  223346788999999

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2e-33  Score=260.02  Aligned_cols=170  Identities=26%  Similarity=0.419  Sum_probs=147.7

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|++...........+.+.+|+++++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35799999999999999999985 57899999998765443333346788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+ +|+|.+++....   .+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 678988886543   389999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      ... ....+||+.|+|||+
T Consensus       161 ~~~-~~~~~gt~~y~aPE~  178 (336)
T 3h4j_B          161 GNF-LKTSCGSPNYAAPEV  178 (336)
T ss_dssp             SBT-TCCCTTSTTTSCGGG
T ss_pred             Ccc-cccccCCcCcCCHHH
Confidence            332 334579999999994

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.5e-33  Score=266.28  Aligned_cols=173  Identities=24%  Similarity=0.354  Sum_probs=150.2

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ...++|++.+.||+|+||+||+|.. .+++.+|+|++....... ...+.+.+|+++++.++||||+++++++.+.+..|
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            3567899999999999999999975 578999999987655432 23467899999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec---CCCCeEEeeeccc
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN---SELEAFVADFGVA  340 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFg~a  340 (368)
                      +||||+++|+|.+.+.....   +++..+..++.||+.||+|||++   +|+||||||+|||++   .++.+||+|||++
T Consensus        87 lv~E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            99999999999999886543   89999999999999999999999   999999999999998   4678999999999


Q ss_pred             eecCCCCCCccccccccccccCCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +............+||+.|+|||+
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~  184 (444)
T 3soa_A          161 IEVEGEQQAWFGFAGTPGYLSPEV  184 (444)
T ss_dssp             BCCCTTCCBCCCSCSCGGGCCHHH
T ss_pred             EEecCCCceeecccCCcccCCHHH
Confidence            887665555556789999999983

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-33  Score=253.62  Aligned_cols=171  Identities=25%  Similarity=0.388  Sum_probs=142.6

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhh-----------------------HHhHHHHHHHHHHHh
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEE-----------------------LASLESFRNEARLLS  242 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~  242 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++.......                       ....+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46899999999999999999985 468899999987643221                       112356889999999


Q ss_pred             ccCCCceeeEEEEEee--CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCC
Q 017621          243 QIWHRNIVKLYGFCLH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDIS  320 (368)
Q Consensus       243 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  320 (368)
                      +++||||+++++++.+  .+..|+||||+++++|.+++..    ..+++.++..++.|+++||+|||++   +|+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            9999999999999987  5689999999999999876543    2489999999999999999999999   99999999


Q ss_pred             CCCeeecCCCCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          321 SNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       321 p~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+|||++.++.+||+|||+++.............||+.|+|||+
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~  208 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPES  208 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGG
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhh
Confidence            99999999999999999999987655444445679999999994

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.8e-33  Score=282.79  Aligned_cols=172  Identities=24%  Similarity=0.361  Sum_probs=151.6

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  263 (368)
                      ..++|++.+.||+|+||+||+|+.. +++.||||++.+.........+.+..|.+++..+ +||+|+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999854 6889999999765443334456788899999988 7999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +||||+++|+|.++++....   +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999999986433   89999999999999999999999   9999999999999999999999999999976


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ..........+||+.|+|||
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE  512 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPE  512 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHH
T ss_pred             ccCCcccccccCCCcccCHh
Confidence            55555556678999999998

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.8e-33  Score=251.53  Aligned_cols=170  Identities=26%  Similarity=0.380  Sum_probs=146.7

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|++. +++.||+|++....... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            57999999999999999999864 68999999987554322 23467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++ ++.+.+....  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            99986 6665555432  2389999999999999999999999   9999999999999999999999999999987655


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........||+.|+|||+
T Consensus       155 ~~~~~~~~~t~~y~aPE~  172 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDV  172 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHH
T ss_pred             cccccCCccccCCcChHH
Confidence            555556689999999984

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.3e-33  Score=260.43  Aligned_cols=175  Identities=23%  Similarity=0.339  Sum_probs=147.9

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhH--HhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL--ASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      .++|++.+.||+|+||+||+|.. .+++.||+|++........  ...+.+.+|+++++.++||||+++++++.+.+..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46799999999999999999985 4689999999864322111  13467899999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC---eEEeeecc
Q 017621          264 LIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE---AFVADFGV  339 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFg~  339 (368)
                      +||||+++++|.+.+.... ....+++..+..++.||++||+|||++   +|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988775432 223489999999999999999999999   9999999999999986654   99999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++............+||+.|+|||+
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~  204 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEV  204 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHH
T ss_pred             eeEecCCCeeecCCcCCcCccCHHH
Confidence            9987655444445689999999983

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-33  Score=263.31  Aligned_cols=169  Identities=18%  Similarity=0.246  Sum_probs=142.3

Q ss_pred             hhccccceeeeecCCccEEEEE------cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC---CCceeeEEEEEe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRAR------LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW---HRNIVKLYGFCL  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  257 (368)
                      .++|.+.+.||+|+||+||+|.      ..+++.||+|++.....      .++.+|+++++.++   |+||+++++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP------WEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH------HHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh------hHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            4679999999999999999994      44688999999976543      45667777777775   999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-------
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDE--EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-------  328 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------  328 (368)
                      ..+..|+||||+++|+|.+++....  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence            9999999999999999999997421  223489999999999999999999999   9999999999999998       


Q ss_pred             ----CCCeEEeeeccceecCCC--CCCccccccccccccCCC
Q 017621          329 ----ELEAFVADFGVARLLNFD--SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       329 ----~~~~kl~DFg~a~~~~~~--~~~~~~~~gt~~y~aPE~  364 (368)
                          ++.+||+|||+|+.+...  .......+||+.|+|||+
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~  256 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEM  256 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHH
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHH
Confidence                899999999999876422  223345679999999983

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.6e-33  Score=259.16  Aligned_cols=181  Identities=37%  Similarity=0.635  Sum_probs=154.6

Q ss_pred             ccHHHHHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEe
Q 017621          178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCL  257 (368)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  257 (368)
                      +++.++...+++|++.+.||+|+||+||+|++.+++.||+|++......   ..+.+.+|+++++.++||||+++++++.
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            3344455567899999999999999999999888999999998765432   3467899999999999999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEE-AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                      +.+..++||||+++|+|.+++..... ...+++.++..++.|+++||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEee
Confidence            99999999999999999999875432 23589999999999999999999999   999999999999999999999999


Q ss_pred             eccceecCCCCC--CccccccccccccCCC
Q 017621          337 FGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       337 Fg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ||+++.......  ......||+.|+|||+
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  212 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEY  212 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHH
T ss_pred             cccccccccccccccccccCCCccccCHHH
Confidence            999987643222  2334569999999993

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-32  Score=253.76  Aligned_cols=168  Identities=27%  Similarity=0.357  Sum_probs=147.4

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|.+. +++.||+|.+.....    ..+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc----cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            468999999999999999999864 688999999875433    235688999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC--CCCeEEeeeccceec
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS--ELEAFVADFGVARLL  343 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFg~a~~~  343 (368)
                      |||+++|+|.+++....  ..+++.++..++.|++.||+|||++   +|+||||||+|||++.  ++.+||+|||+++..
T Consensus        80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            99999999999997543  2489999999999999999999999   9999999999999987  789999999999987


Q ss_pred             CCCCCCccccccccccccCCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      .... ......||+.|+|||+
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~  174 (321)
T 1tki_A          155 KPGD-NFRLLFTAPEYYAPEV  174 (321)
T ss_dssp             CTTC-EEEEEESCGGGSCHHH
T ss_pred             CCCC-ccccccCChhhcCcHH
Confidence            6433 3344679999999983

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.8e-33  Score=253.61  Aligned_cols=170  Identities=32%  Similarity=0.463  Sum_probs=143.6

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      ++|++.+.||+|+||+||+|+..+++.||+|++....... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5799999999999999999998889999999987654322 233678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++ +|.+++....  ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            9985 8998887643  2389999999999999999999999   99999999999999999999999999998776444


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                      .......||+.|+|||+
T Consensus       155 ~~~~~~~~t~~y~aPE~  171 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDV  171 (288)
T ss_dssp             -------CCCTTCCHHH
T ss_pred             cccccccccccccCchh
Confidence            44445579999999983

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.2e-33  Score=267.80  Aligned_cols=171  Identities=27%  Similarity=0.483  Sum_probs=150.7

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|.+.+.||+|+||+||+|++. +|+.||||++...........+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            357999999999999999999864 7999999999765443333456889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999997643   389999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .. .....+||+.|+|||+
T Consensus       169 ~~-~~~~~~gt~~y~aPE~  186 (476)
T 2y94_A          169 GE-FLRTSCGSPNYAAPEV  186 (476)
T ss_dssp             TC-CBCCCCSCSTTCCHHH
T ss_pred             cc-cccccCCCcCeEChhh
Confidence            33 2344589999999983

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.7e-33  Score=256.43  Aligned_cols=170  Identities=27%  Similarity=0.446  Sum_probs=145.5

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999864 78999999986544322  235688999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++.....   +++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             EECCTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            999999999999875433   89999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCC--CccccccccccccCCC
Q 017621          346 DSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ...  .....+||+.|+|||+
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~  178 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPEL  178 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHH
T ss_pred             CCcccccCCCccCcCccCcHH
Confidence            322  2334579999999983

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.2e-33  Score=255.85  Aligned_cols=170  Identities=34%  Similarity=0.488  Sum_probs=143.4

Q ss_pred             hhccccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||+||+|++.    .+..||||++......  ...+.+.+|++++++++||||+++++++.+.+..
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE--RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            467999999999999999999863    3456999999765432  2346889999999999999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+||||+++|+|.++++....  .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999975432  389999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCC---ccccccccccccCC
Q 017621          343 LNFDSSN---RTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~---~~~~~gt~~y~aPE  363 (368)
                      .......   .....+|+.|+|||
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE  224 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPE  224 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHH
T ss_pred             cccCccceeeccCCCCcccccCHh
Confidence            7654322   12234678899998

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-32  Score=247.56  Aligned_cols=173  Identities=27%  Similarity=0.501  Sum_probs=137.9

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|+. .+++.||+|.+...........+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46899999999999999999986 57899999999765443333457889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....  ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999999998643  2489999999999999999999999   999999999999999999999999999988765


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........||+.|+|||+
T Consensus       165 ~~~~~~~~~~~~~y~aPE~  183 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEI  183 (278)
T ss_dssp             -------------------
T ss_pred             CCCcceeccCCCCcCCcch
Confidence            4444445679999999994

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.5e-33  Score=256.41  Aligned_cols=169  Identities=31%  Similarity=0.475  Sum_probs=143.7

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC----eE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK----CM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  262 (368)
                      .++|++.+.||+|+||+||+|++. ++.||||++......    ...+.+|+.++++++||||+++++++....    ..
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ----SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH----HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            468999999999999999999874 789999999754332    245566999999999999999999998744    47


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCeeecCCCCCCeeecCCCCeEEe
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH-------CTPPIVHRDISSNNVLLNSELEAFVA  335 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------~~~~ivH~Dlkp~NIll~~~~~~kl~  335 (368)
                      ++||||+++|+|.++++...    +++..+..++.|++.||+|||+.       +.++|+||||||+|||++.++.+||+
T Consensus        98 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            99999999999999997643    89999999999999999999976       13389999999999999999999999


Q ss_pred             eeccceecCCCCC--CccccccccccccCCC
Q 017621          336 DFGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       336 DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      |||+++.......  ......||+.|+|||+
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  204 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEV  204 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhh
Confidence            9999987754333  2333579999999994

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-32  Score=256.45  Aligned_cols=172  Identities=26%  Similarity=0.430  Sum_probs=148.4

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..|
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3457899999999999999999986 468999999997654322 24467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CCeEEeeeccc
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE---LEAFVADFGVA  340 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFg~a  340 (368)
                      +||||+++|+|.+.+....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.+   +.+||+|||++
T Consensus       105 lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            9999999999999887643   389999999999999999999999   99999999999999865   45999999999


Q ss_pred             eecCCCCCCccccccccccccCCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +...... .....+||+.|+|||+
T Consensus       179 ~~~~~~~-~~~~~~gt~~y~aPE~  201 (362)
T 2bdw_A          179 IEVNDSE-AWHGFAGTPGYLSPEV  201 (362)
T ss_dssp             BCCTTCC-SCCCSCSCTTTCCHHH
T ss_pred             eEecCCc-ccccCCCCccccCHHH
Confidence            8776432 2344679999999983

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-32  Score=252.66  Aligned_cols=170  Identities=22%  Similarity=0.255  Sum_probs=140.1

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  264 (368)
                      .++|++.+.||+|+||+||+|++. +++.||||++........ ...++..|+..+.++ +||||+++++++.+++..|+
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            368999999999999999999865 799999999865433322 223445566666555 99999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+ +++|.+++....  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       135 v~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 569988887643  2489999999999999999999999   99999999999999999999999999998875


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      .... .....||+.|+|||+
T Consensus       209 ~~~~-~~~~~gt~~y~aPE~  227 (311)
T 3p1a_A          209 TAGA-GEVQEGDPRYMAPEL  227 (311)
T ss_dssp             -------CCCCCGGGCCGGG
T ss_pred             cCCC-CcccCCCccccCHhH
Confidence            4332 334579999999995

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.6e-32  Score=248.42  Aligned_cols=185  Identities=31%  Similarity=0.559  Sum_probs=159.4

Q ss_pred             CcccHHHHHHHhhccccc------eeeeecCCccEEEEEcCCCCEEEEEEccccch-hhHHhHHHHHHHHHHHhccCCCc
Q 017621          176 GRITFQDMIEATEDFHIK------YCIGTGGYGSVYRARLPSGKVVALKKLHRSET-EELASLESFRNEARLLSQIWHRN  248 (368)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~n  248 (368)
                      ..+++.++...+++|...      +.||+|+||+||+|.. +++.||+|++..... ......+.+.+|++++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            457899999999998877      8999999999999997 688999999865432 12223568899999999999999


Q ss_pred             eeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 017621          249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS  328 (368)
Q Consensus       249 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  328 (368)
                      |+++++++.+.+..++||||+++++|.+++........+++..+..++.|++.||+|||++   +|+||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence            9999999999999999999999999999997654445589999999999999999999999   9999999999999999


Q ss_pred             CCCeEEeeeccceecCCCCCC--ccccccccccccCCC
Q 017621          329 ELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      ++.+||+|||+++........  .....||+.|+|||+
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~  206 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA  206 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHH
Confidence            999999999999876543322  233579999999983

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-32  Score=251.94  Aligned_cols=171  Identities=27%  Similarity=0.419  Sum_probs=148.3

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC--eEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK--CMFL  264 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  264 (368)
                      ++|++.+.||+|+||+||+|++. +++.||||++......  ...+.+.+|++++++++||||+++++++...+  ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            57999999999999999999864 5899999998754432  23467889999999999999999999998765  7899


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----cCCCCeEEeeeccc
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL----NSELEAFVADFGVA  340 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFg~a  340 (368)
                      ||||+++++|.+++........+++..+..++.|++.||+|||++   +|+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999998765555589999999999999999999999   99999999999999    77888999999999


Q ss_pred             eecCCCCCCccccccccccccCCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +....... .....||+.|+|||+
T Consensus       164 ~~~~~~~~-~~~~~gt~~y~aPE~  186 (319)
T 4euu_A          164 RELEDDEQ-FVSLYGTEEYLHPDM  186 (319)
T ss_dssp             EECCTTCC-BCCCCSCGGGCCHHH
T ss_pred             eecCCCCc-eeecccCCCccCHHH
Confidence            98765433 334579999999984

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-32  Score=252.07  Aligned_cols=170  Identities=25%  Similarity=0.410  Sum_probs=147.7

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhH---HhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||.||+|... +++.||+|++........   ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467999999999999999999864 689999999876433211   1346789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC----CeEEeeec
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL----EAFVADFG  338 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFg  338 (368)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||++   +|+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999997543   389999999999999999999999   999999999999999887    89999999


Q ss_pred             cceecCCCCCCccccccccccccCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +++....... .....||+.|+|||
T Consensus       164 ~a~~~~~~~~-~~~~~gt~~y~aPE  187 (326)
T 2y0a_A          164 LAHKIDFGNE-FKNIFGTPEFVAPE  187 (326)
T ss_dssp             TCEECCTTSC-CCCCCSCTTTCCHH
T ss_pred             CCeECCCCCc-cccccCCcCcCCce
Confidence            9998754332 23457999999998

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.6e-32  Score=253.09  Aligned_cols=165  Identities=25%  Similarity=0.351  Sum_probs=128.0

Q ss_pred             hccccc---eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeE
Q 017621          188 EDFHIK---YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       188 ~~~~~~---~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  262 (368)
                      ++|++.   +.||+|+||+||+|.+. +++.||||++....      ...+.+|+.+++.+. ||||+++++++.+.+..
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            445553   78999999999999864 68999999986532      256778999999996 99999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---CeEEeeecc
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL---EAFVADFGV  339 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFg~  339 (368)
                      |+||||+++|+|.+++....   .+++.++..++.|++.||+|||++   +|+||||||+|||++.++   .+||+|||+
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~  155 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGF  155 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred             EEEEEccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccc
Confidence            99999999999999998754   389999999999999999999999   999999999999998765   899999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++............+||+.|+|||+
T Consensus       156 a~~~~~~~~~~~~~~~t~~y~aPE~  180 (325)
T 3kn6_A          156 ARLKPPDNQPLKTPCFTLHYAAPEL  180 (325)
T ss_dssp             CEECCC-------------------
T ss_pred             ceecCCCCCcccccCCCcCccCHHH
Confidence            9987655554555689999999995

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=6.7e-34  Score=263.46  Aligned_cols=165  Identities=19%  Similarity=0.224  Sum_probs=136.6

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchh-----hHHhHHHHHHHHHHHhccC---------CCceeeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE-----ELASLESFRNEARLLSQIW---------HRNIVKL  252 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~niv~l  252 (368)
                      .++|++.+.||+|+||+||+|++ +++.||||++......     .....+.+.+|+++++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46899999999999999999998 7899999999765321     1223467888999988886         7777776


Q ss_pred             EEEEe-----------------e-------------CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 017621          253 YGFCL-----------------H-------------RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA  302 (368)
Q Consensus       253 ~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~  302 (368)
                      .+.+.                 +             .+..|+||||+++|++.+.+..    ..+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            66542                 2             6789999999999977666643    237999999999999999


Q ss_pred             HHHHh-cCCCCCeeecCCCCCCeeecCCC--------------------CeEEeeeccceecCCCCCCcccccccccccc
Q 017621          303 LSYLH-HHCTPPIVHRDISSNNVLLNSEL--------------------EAFVADFGVARLLNFDSSNRTLLAGTSGYIA  361 (368)
Q Consensus       303 L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~a  361 (368)
                      |+||| ++   +|+||||||+|||++.++                    .+||+|||+|+.....     ..+||+.|||
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a  245 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence            99999 88   999999999999999887                    8999999999977532     3479999999


Q ss_pred             CCC
Q 017621          362 PAS  364 (368)
Q Consensus       362 PE~  364 (368)
                      ||+
T Consensus       246 PE~  248 (336)
T 2vuw_A          246 EDL  248 (336)
T ss_dssp             SGG
T ss_pred             hhh
Confidence            995

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.98  E-value=5e-33  Score=254.84  Aligned_cols=172  Identities=23%  Similarity=0.407  Sum_probs=140.7

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC----e
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK----C  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  261 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++.............+.+|++++++++||||+++++++...+    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36799999999999999999985 578999999998765444455678899999999999999999999987654    3


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .|+||||+++++|.++++...   .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            499999999999999997643   389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCC---CccccccccccccCCC
Q 017621          342 LLNFDSS---NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~---~~~~~~gt~~y~aPE~  364 (368)
                      .......   ......||+.|+|||+
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~  190 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQ  190 (311)
T ss_dssp             -----------------CCTTCCHHH
T ss_pred             cccccccccccccccCcCcccCCHHH
Confidence            7654322   2233569999999983

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.98  E-value=1.5e-32  Score=246.21  Aligned_cols=169  Identities=25%  Similarity=0.423  Sum_probs=147.1

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||+||+|.+.+++.||+|++......    .+++.+|++++++++||||+++++++.+.+..++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            3689999999999999999999888889999999765433    257889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++.....  .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             ECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EeCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999999976433  389999999999999999999999   9999999999999999999999999999866432


Q ss_pred             CC-CccccccccccccCCC
Q 017621          347 SS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE~  364 (368)
                      .. ......||+.|+|||+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~  178 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEV  178 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHH
T ss_pred             ccccccCcccccccCCHHH
Confidence            11 1223457888999983

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.98  E-value=1.2e-32  Score=255.73  Aligned_cols=165  Identities=24%  Similarity=0.361  Sum_probs=143.0

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  263 (368)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++.....       ...+|++++.++ +||||+++++++.+.+..|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            4678999999999999999999864 688999999875432       234688888888 8999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC----CCeEEeeecc
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE----LEAFVADFGV  339 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFg~  339 (368)
                      +||||+++|+|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+|||+.++    +.+||+|||+
T Consensus        93 lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            9999999999999997653   389999999999999999999999   99999999999998543    3599999999


Q ss_pred             ceecCCCCCCccccccccccccCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ++............+||+.|+|||
T Consensus       167 a~~~~~~~~~~~~~~gt~~y~aPE  190 (342)
T 2qr7_A          167 AKQLRAENGLLMTPCYTANFVAPE  190 (342)
T ss_dssp             CEECBCTTCCBCCSSCCSSCCCHH
T ss_pred             cccCcCCCCceeccCCCccccCHH
Confidence            998765554455568999999998

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.98  E-value=1.7e-32  Score=252.06  Aligned_cols=173  Identities=25%  Similarity=0.403  Sum_probs=134.2

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||+||+|... +++.||+|++......  ...+.+.+|++++++++||||+++++++.+++..|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            3468999999999999999999864 6899999998754322  223578899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          265 IYEYMEMGSLFCVLRTDE---EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      ||||++ |+|.+++....   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccce
Confidence            999998 59998886432   123488999999999999999999999   99999999999999999999999999999


Q ss_pred             ecCCCCCCccccccccccccCCC
Q 017621          342 LLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      .............||+.|+|||+
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~  179 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDV  179 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHH
T ss_pred             ecCCCcccCCCCcccccccCchH
Confidence            87655444445679999999983

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.98  E-value=3.7e-32  Score=251.71  Aligned_cols=172  Identities=24%  Similarity=0.425  Sum_probs=151.7

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999864 5789999998765433334557889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....   .+++.++..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999887643   389999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........||+.|+|||+
T Consensus       194 ~~~~~~~~~gt~~y~aPE~  212 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEV  212 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHH
T ss_pred             CcccccccCCCccccCHHH
Confidence            5555555689999999983

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.98  E-value=6e-32  Score=245.47  Aligned_cols=172  Identities=24%  Similarity=0.425  Sum_probs=151.6

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999865 5889999998765433334557889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....   .+++.++..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999887543   389999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........||+.|+|||+
T Consensus       168 ~~~~~~~~~~~~~y~aPE~  186 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEV  186 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHH
T ss_pred             CccccccccCCCCcCCcch
Confidence            5555555679999999983

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.98  E-value=8.6e-33  Score=266.71  Aligned_cols=170  Identities=26%  Similarity=0.419  Sum_probs=132.8

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-----C
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-----K  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  260 (368)
                      .++|++.+.||+|+||+||+|++. +++.||||++..... .....+++.+|+++++.++||||+++++++...     +
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            368999999999999999999854 689999999865432 223457889999999999999999999998543     5


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+||||+. ++|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            6999999985 69999987643   389999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCC---------------------------CccccccccccccCCC
Q 017621          341 RLLNFDSS---------------------------NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~---------------------------~~~~~~gt~~y~aPE~  364 (368)
                      +.......                           ..+..+||++|+|||+
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  254 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL  254 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHH
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHH
Confidence            87653221                           1234578999999993

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.98  E-value=1.8e-32  Score=256.32  Aligned_cols=166  Identities=25%  Similarity=0.364  Sum_probs=136.9

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++......    .+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            457999999999999999999865 7899999999764432    25678999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC--eEEeeeccceec
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE--AFVADFGVARLL  343 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFg~a~~~  343 (368)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.  +||+|||+++..
T Consensus        95 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           95 MEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            99999999999987543   389999999999999999999999   9999999999999987765  999999999854


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .... .....+||+.|+|||
T Consensus       169 ~~~~-~~~~~~gt~~y~aPE  187 (361)
T 3uc3_A          169 VLHS-QPKSTVGTPAYIAPE  187 (361)
T ss_dssp             -------------CTTSCHH
T ss_pred             cccC-CCCCCcCCCCcCChh
Confidence            3322 223457999999998

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.98  E-value=3.3e-32  Score=243.81  Aligned_cols=169  Identities=24%  Similarity=0.447  Sum_probs=147.4

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||.||+|+..++..||+|++......    .+++.+|++++.+++||||+++++++.+.+..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            4689999999999999999999888889999999765433    257889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++.....  .+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             ECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999976432  389999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCC-ccccccccccccCCC
Q 017621          347 SSN-RTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~-~~~~~gt~~y~aPE~  364 (368)
                      ... .....||+.|+|||+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~  176 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEV  176 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHH
T ss_pred             hhhcccCCCcCcccCCHHH
Confidence            321 223356778999984

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.98  E-value=1.2e-32  Score=254.40  Aligned_cols=167  Identities=19%  Similarity=0.271  Sum_probs=144.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  264 (368)
                      .++|++.+.||+|+||+||+|+. .+++.||||++......     +.+.+|+++++++ +||||+++++++...+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            35799999999999999999985 57899999998654322     4578899999999 99999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC-----eEEeeecc
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE-----AFVADFGV  339 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFg~  339 (368)
                      ||||+ +++|.+++....  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.     +||+|||+
T Consensus        83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            99999 899999998642  2489999999999999999999999   9999999999999998887     99999999


Q ss_pred             ceecCCCCCC-------ccccccccccccCCC
Q 017621          340 ARLLNFDSSN-------RTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~-------~~~~~gt~~y~aPE~  364 (368)
                      ++.+......       ....+||+.|+|||+
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  188 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINT  188 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHH
Confidence            9987543321       235679999999983

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.98  E-value=2.7e-32  Score=256.28  Aligned_cols=171  Identities=32%  Similarity=0.493  Sum_probs=135.6

Q ss_pred             hhccccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||+||+|++.    ++..||||.++.....  ...+++.+|++++++++||||+++++++.+.+..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            357999999999999999999864    5678999999765332  2446899999999999999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++|+|.++++...  ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999999998643  2389999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC---ccccccccccccCCC
Q 017621          343 LNFDSSN---RTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~---~~~~~gt~~y~aPE~  364 (368)
                      .......   .....+|+.|+|||+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~  221 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEA  221 (373)
T ss_dssp             -----------------CTTSCHHH
T ss_pred             cccCCccceeccCCCcCCCccChhh
Confidence            7543321   112245778999983

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.98  E-value=6.3e-32  Score=247.22  Aligned_cols=171  Identities=29%  Similarity=0.412  Sum_probs=142.0

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            367999999999999999999864 5899999998665433 23346788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             EECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            99999999998887543   389999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........||+.|+|||+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~  173 (311)
T 4agu_A          155 PSDYYDDEVATRWYRSPEL  173 (311)
T ss_dssp             -----------GGGCCHHH
T ss_pred             cccccCCCcCCccccChHH
Confidence            5444455679999999983

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.98  E-value=1.1e-31  Score=253.00  Aligned_cols=169  Identities=25%  Similarity=0.404  Sum_probs=146.8

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|... +++.||+|++......   ....+.+|+++++.++||||+++++++.+.+..++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh---hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            467999999999999999999864 6889999998765432   235788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC--CCCeEEeeeccceec
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS--ELEAFVADFGVARLL  343 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFg~a~~~  343 (368)
                      |||+++|+|.+++....  ..+++.++..++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||+++..
T Consensus       127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence            99999999999987543  2389999999999999999999999   9999999999999974  478999999999987


Q ss_pred             CCCCCCccccccccccccCCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..... ....+||+.|+|||+
T Consensus       202 ~~~~~-~~~~~gt~~y~aPE~  221 (387)
T 1kob_A          202 NPDEI-VKVTTATAEFAAPEI  221 (387)
T ss_dssp             CTTSC-EEEECSSGGGCCHHH
T ss_pred             CCCcc-eeeeccCCCccCchh
Confidence            64432 334579999999983

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.98  E-value=2.6e-32  Score=261.32  Aligned_cols=170  Identities=28%  Similarity=0.417  Sum_probs=142.9

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-----C
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-----K  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  260 (368)
                      .++|++.+.||+|+||+||+|.+ .+++.||||++..... .....+++.+|++++++++||||+++++++...     +
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            46899999999999999999985 4688999999976432 223457889999999999999999999999776     5


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+||||++ ++|.++++...   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            6999999997 59999997643   389999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCC----------------------CccccccccccccCCC
Q 017621          341 RLLNFDSS----------------------NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~----------------------~~~~~~gt~~y~aPE~  364 (368)
                      +.......                      ..+..+||++|+|||+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  222 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL  222 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHH
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHH
Confidence            98754321                      1245689999999994

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.98  E-value=8.2e-32  Score=252.30  Aligned_cols=177  Identities=29%  Similarity=0.434  Sum_probs=151.8

Q ss_pred             HHHHHHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccc-----hhhHHhHHHHHHHHHHHhcc-CCCceeeEE
Q 017621          181 QDMIEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSE-----TEELASLESFRNEARLLSQI-WHRNIVKLY  253 (368)
Q Consensus       181 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  253 (368)
                      .......++|++.+.||+|+||+||+|++. +|+.||||++....     .......+.+.+|+.+++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344556678999999999999999999874 79999999986543     11122346788999999999 899999999


Q ss_pred             EEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeE
Q 017621          254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF  333 (368)
Q Consensus       254 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  333 (368)
                      +++...+..|+||||+++++|.+++....   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999997543   389999999999999999999999   999999999999999999999


Q ss_pred             EeeeccceecCCCCCCccccccccccccCCC
Q 017621          334 VADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       334 l~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+|||++..+..... ....+||+.|+|||+
T Consensus       241 l~DfG~~~~~~~~~~-~~~~~gt~~y~aPE~  270 (365)
T 2y7j_A          241 LSDFGFSCHLEPGEK-LRELCGTPGYLAPEI  270 (365)
T ss_dssp             ECCCTTCEECCTTCC-BCCCCSCGGGCCHHH
T ss_pred             EEecCcccccCCCcc-cccCCCCCCccChhh
Confidence            999999988764332 344679999999983

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=5.3e-32  Score=246.39  Aligned_cols=164  Identities=31%  Similarity=0.528  Sum_probs=138.1

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhc--cCCCceeeEEEEEee----CC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ--IWHRNIVKLYGFCLH----RK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~  260 (368)
                      .++|++.+.||+|+||+||+|+. +++.||||++.....      +.+.+|.+++..  ++||||+++++++..    .+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            46899999999999999999987 688999999865432      345556666655  799999999998654    34


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCCeeecCCCCe
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH--------HHCTPPIVHRDISSNNVLLNSELEA  332 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~  332 (368)
                      ..++||||+++|+|.++++..    .+++..+..++.|++.||+|||        +.   +|+||||||+|||++.++.+
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred             eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence            689999999999999999643    3899999999999999999999        77   99999999999999999999


Q ss_pred             EEeeeccceecCCCCCC----ccccccccccccCCC
Q 017621          333 FVADFGVARLLNFDSSN----RTLLAGTSGYIAPAS  364 (368)
Q Consensus       333 kl~DFg~a~~~~~~~~~----~~~~~gt~~y~aPE~  364 (368)
                      ||+|||+++........    .....||+.|+|||+
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  188 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV  188 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHH
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhh
Confidence            99999999876544332    223479999999994

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=6.3e-32  Score=247.32  Aligned_cols=173  Identities=24%  Similarity=0.356  Sum_probs=143.0

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++......+....+.+.+|+.++++++||||+++++++...+..|+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999864 688999999986655444456789999999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++++|.+++....   .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999997643   389999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC-CccccccccccccCCC
Q 017621          345 FDSS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~-~~~~~~gt~~y~aPE~  364 (368)
                      .... ......||+.|+|||+
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~  206 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPER  206 (309)
T ss_dssp             -----------CCGGGCCGGG
T ss_pred             ccccccccccCCCcCccCHHH
Confidence            4322 2234579999999983

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=5.3e-32  Score=251.92  Aligned_cols=168  Identities=29%  Similarity=0.460  Sum_probs=146.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .+.|+..+.||+|+||+||+|+. .+++.||||++...........+++.+|++++++++||||+++++++...+..|+|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            45699999999999999999985 57899999998765444444557889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+. |+|.+++....  ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99998 58888775432  2389999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .    ....||+.|+|||+
T Consensus       207 ~----~~~~gt~~y~aPE~  221 (348)
T 1u5q_A          207 A----NSFVGTPYWMAPEV  221 (348)
T ss_dssp             B----CCCCSCGGGCCHHH
T ss_pred             C----CcccCCcceeCHhh
Confidence            2    23579999999994

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=1e-31  Score=253.71  Aligned_cols=173  Identities=17%  Similarity=0.289  Sum_probs=148.5

Q ss_pred             hhccccceeeeec--CCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          187 TEDFHIKYCIGTG--GYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       187 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      .++|++.+.||+|  +||+||+|++. +++.||||++....... ...+.+.+|+++++.++||||+++++++.+.+..|
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            4689999999999  99999999865 68999999997654322 34577889999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +||||+++|+|.+++..... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||.+...
T Consensus       103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            99999999999999976532 2389999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCC-------CCccccccccccccCCC
Q 017621          344 NFDS-------SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~~~-------~~~~~~~gt~~y~aPE~  364 (368)
                      ....       ......+||+.|+|||+
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~  206 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEV  206 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHH
T ss_pred             ccccccccccccccccccccccccCHHH
Confidence            3221       11223479999999984

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=6e-32  Score=253.84  Aligned_cols=164  Identities=23%  Similarity=0.394  Sum_probs=137.2

Q ss_pred             ccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeec
Q 017621          191 HIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       191 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  269 (368)
                      ...+.||+|+||+||+|.. .+++.||+|++......   ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            3367899999999999985 56899999999765432   3467899999999999999999999999999999999999


Q ss_pred             CCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee--cCCCCeEEeeeccceecCCCC
Q 017621          270 EMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL--NSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       270 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      ++++|.+++....  ..+++..+..++.||+.||+|||++   +|+||||||+|||+  +.++.+||+|||+++......
T Consensus       169 ~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          169 DGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             TTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            9999999887543  2389999999999999999999999   99999999999999  567899999999999876433


Q ss_pred             CCccccccccccccCC
Q 017621          348 SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE  363 (368)
                      . ....+||+.|+|||
T Consensus       244 ~-~~~~~gt~~y~aPE  258 (373)
T 2x4f_A          244 K-LKVNFGTPEFLAPE  258 (373)
T ss_dssp             B-CCCCCSSCTTCCHH
T ss_pred             c-cccccCCCcEeChh
Confidence            2 23457999999998

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=2e-32  Score=255.58  Aligned_cols=181  Identities=23%  Similarity=0.375  Sum_probs=149.9

Q ss_pred             cHHHHHHHhhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceee
Q 017621          179 TFQDMIEATEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVK  251 (368)
Q Consensus       179 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  251 (368)
                      ...+.....++|++.+.||+|+||.||+|++      .+++.||||++......  ...+.+.+|+++++++ +||||++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH--HHHHHHHHHHHHHHhhcCCcceee
Confidence            3445555678999999999999999999972      35688999999765433  2346789999999999 8999999


Q ss_pred             EEEEEeeCC-eEEEEEeecCCCChhHHhhcCCC-----------------------------------------------
Q 017621          252 LYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEE-----------------------------------------------  283 (368)
Q Consensus       252 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------  283 (368)
                      +++++.+.+ ..++||||+++|+|.++++....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998765 48999999999999999976432                                               


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          284 ----------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       284 ----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                                      ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            11288999999999999999999999   99999999999999999999999999998765433


Q ss_pred             C--CccccccccccccCCC
Q 017621          348 S--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~--~~~~~~gt~~y~aPE~  364 (368)
                      .  ......||+.|+|||+
T Consensus       248 ~~~~~~~~~~t~~y~aPE~  266 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPET  266 (359)
T ss_dssp             TCEEC--CEECGGGCCHHH
T ss_pred             cchhccccCCCceeEChhh
Confidence            2  2334578999999993

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=2.8e-32  Score=256.64  Aligned_cols=170  Identities=28%  Similarity=0.450  Sum_probs=145.2

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++. +++.||||.++.....  ...+++.+|++++++++||||+++++++...+..|+|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH--HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            468999999999999999999875 7899999998754322  2345788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.++++....  .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       191 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999999975432  389999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCC--ccccccccccccCC
Q 017621          346 DSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~--~~~~~gt~~y~aPE  363 (368)
                      ....  .....+++.|+|||
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE  285 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPE  285 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHH
T ss_pred             CceeecCCCCCCCcCcCCHh
Confidence            2111  11223577899998

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=2.4e-32  Score=256.16  Aligned_cols=172  Identities=27%  Similarity=0.408  Sum_probs=144.1

Q ss_pred             hhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      .++|++.+.||+|+||+||+|+..      +++.||||++.......  ...++.+|+.++++++||||+++++++.+.+
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            467999999999999999999842      46789999997543332  3357889999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---CeE
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDE----EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL---EAF  333 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k  333 (368)
                      ..|+||||+++|+|.+++....    ....+++.+++.++.||+.||+|||++   +|+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999997542    223489999999999999999999999   999999999999999555   599


Q ss_pred             EeeeccceecCCCC--CCccccccccccccCC
Q 017621          334 VADFGVARLLNFDS--SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       334 l~DFg~a~~~~~~~--~~~~~~~gt~~y~aPE  363 (368)
                      |+|||+++......  .......||+.|+|||
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE  256 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE  256 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHH
Confidence            99999998653221  2233456899999999

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=3.1e-32  Score=252.24  Aligned_cols=173  Identities=26%  Similarity=0.391  Sum_probs=148.4

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhH-----HhHHHHHHHHHHHhccCCCceeeEEEEEee
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL-----ASLESFRNEARLLSQIWHRNIVKLYGFCLH  258 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  258 (368)
                      +..++|++.+.||+|+||+||+|++ .+++.||||++........     ...+.+.+|++++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            3467899999999999999999985 5688999999876532211     122456789999999999999999999999


Q ss_pred             CCeEEEEEeecCCC-ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          259 RKCMFLIYEYMEMG-SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       259 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                      .+..++||||+.+| +|.+++.....   +++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999777 99999986543   89999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccCCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+++....... ....+||+.|+|||+
T Consensus       175 g~a~~~~~~~~-~~~~~gt~~y~aPE~  200 (335)
T 3dls_A          175 GSAAYLERGKL-FYTFCGTIEYCAPEV  200 (335)
T ss_dssp             TTCEECCTTCC-BCEECSCGGGCCHHH
T ss_pred             ccceECCCCCc-eeccCCCccccChhh
Confidence            99998764433 334579999999983

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=5.7e-32  Score=250.87  Aligned_cols=174  Identities=30%  Similarity=0.482  Sum_probs=147.3

Q ss_pred             HhhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR  259 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  259 (368)
                      ..++|++.+.||+|+||.||+|++.      +++.||+|.+......  ...+.+.+|++++++++||||+++++++.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            4578999999999999999999863      3478999999765432  2346889999999999999999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecC
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEE---------------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRD  318 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  318 (368)
                      +..|+||||+++|+|.+++.....                     ...+++.+++.++.||++||+|||++   +|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            999999999999999999976421                     13589999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCCeEEeeeccceecCCCC--CCccccccccccccCCC
Q 017621          319 ISSNNVLLNSELEAFVADFGVARLLNFDS--SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       319 lkp~NIll~~~~~~kl~DFg~a~~~~~~~--~~~~~~~gt~~y~aPE~  364 (368)
                      |||+|||++.++.+||+|||+++......  .......||+.|+|||+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  247 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  247 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhh
Confidence            99999999999999999999998764322  12233468999999993

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=4.7e-32  Score=244.75  Aligned_cols=169  Identities=26%  Similarity=0.442  Sum_probs=144.1

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||.||+|++.++..||+|++......    .+++.+|++++++++||||+++++++.+.+..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            5689999999999999999999888889999999865433    257889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++....  ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           99 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999999997633  2389999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CC-CccccccccccccCCC
Q 017621          347 SS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE~  364 (368)
                      .. ......||+.|+|||+
T Consensus       174 ~~~~~~~~~~~~~y~aPE~  192 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEV  192 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHH
T ss_pred             ccccccCCccCcccCCHHH
Confidence            11 1223357888999983

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=1e-31  Score=242.17  Aligned_cols=170  Identities=35%  Similarity=0.559  Sum_probs=145.5

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            468999999999999999999854 5789999998765544444457789999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++.....   +++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999999876433   89999999999999999999999   999999999999999999999999999866543


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .  ......||+.|+|||+
T Consensus       162 ~--~~~~~~~~~~y~aPE~  178 (279)
T 3fdn_A          162 S--RRTDLCGTLDYLPPEM  178 (279)
T ss_dssp             --------CCCCTTCCHHH
T ss_pred             c--cccccCCCCCccCHhH
Confidence            2  2234579999999983

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=4e-32  Score=252.31  Aligned_cols=169  Identities=25%  Similarity=0.432  Sum_probs=141.8

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC--CceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH--RNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l  264 (368)
                      .++|++.+.||+|+||.||+|...+++.||+|++...... ....+.+.+|++++.+++|  |||+++++++...+..|+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            3579999999999999999999888999999998754332 2345788999999999976  999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||| +.+++|.+++....   .+++.++..++.|++.||+|||++   +|+||||||+|||++ ++.+||+|||+++...
T Consensus        87 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 55789999998653   389999999999999999999999   999999999999997 5789999999998775


Q ss_pred             CCCC--CccccccccccccCCC
Q 017621          345 FDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ....  .....+||+.|+|||+
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~  180 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEA  180 (343)
T ss_dssp             -----------CCCCSSCCHHH
T ss_pred             cccccccCCCCcCCcCcCCHHH
Confidence            4332  2234579999999995

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=6.2e-32  Score=255.90  Aligned_cols=171  Identities=27%  Similarity=0.419  Sum_probs=147.6

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC--eEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK--CMFL  264 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  264 (368)
                      ++|++.+.||+|+||+||+|++. +++.||||++......  ...+.+.+|++++++++||||+++++++...+  ..++
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            57999999999999999999864 5899999999754332  23467789999999999999999999998765  7899


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----cCCCCeEEeeeccc
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL----NSELEAFVADFGVA  340 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFg~a  340 (368)
                      ||||+++|+|.+++........+++..+..++.|++.||+|||++   +|+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999998765555589999999999999999999999   99999999999999    77788999999999


Q ss_pred             eecCCCCCCccccccccccccCCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +....... .....||+.|+|||+
T Consensus       164 ~~~~~~~~-~~~~~gt~~y~aPE~  186 (396)
T 4eut_A          164 RELEDDEQ-FVSLYGTEEYLHPDM  186 (396)
T ss_dssp             EECCCGGG-SSCSSSCCTTCCHHH
T ss_pred             eEccCCCc-cccccCCccccCHHH
Confidence            88754332 234579999999994

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=6.5e-32  Score=255.08  Aligned_cols=170  Identities=29%  Similarity=0.457  Sum_probs=134.2

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCC--
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRK--  260 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--  260 (368)
                      ...++|++.+.||+|+||.||+|.+ .+++.||||++...... ....+++.+|+.++..+. ||||+++++++...+  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            3467899999999999999999985 57899999998654322 234467788999999996 999999999997544  


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+||||++ ++|.++++..    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+|
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            6899999998 5899988763    388999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCC---------------------CCCccccccccccccCC
Q 017621          341 RLLNFD---------------------SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~---------------------~~~~~~~~gt~~y~aPE  363 (368)
                      +.+...                     ....+..+||+.|+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  200 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPE  200 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHH
Confidence            876431                     11123457999999998

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.2e-31  Score=252.83  Aligned_cols=173  Identities=27%  Similarity=0.394  Sum_probs=147.5

Q ss_pred             hhccccceeeeecCCccEEEEEc--------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCL  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  257 (368)
                      .++|.+.+.||+|+||+||+|++        .++..||+|++......  ...+++.+|+++++++ +||||+++++++.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH--HHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            46899999999999999999984        23457999999765433  3446789999999999 9999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV  324 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  324 (368)
                      ..+..++||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||++   +|+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence            99999999999999999999976432             23489999999999999999999999   999999999999


Q ss_pred             eecCCCCeEEeeeccceecCCCCC--CccccccccccccCCC
Q 017621          325 LLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       325 ll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      |++.++.+||+|||+++.......  ......||+.|+|||+
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  264 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA  264 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHH
Confidence            999999999999999987654322  2233467899999993

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.5e-31  Score=247.30  Aligned_cols=174  Identities=26%  Similarity=0.440  Sum_probs=141.5

Q ss_pred             cHHHHHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc--CCCceeeEEEEE
Q 017621          179 TFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI--WHRNIVKLYGFC  256 (368)
Q Consensus       179 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~  256 (368)
                      +........++|++.+.||+|+||.||+|+.. ++.||||++.....      ..+.+|.+++...  +||||+++++++
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            33444455689999999999999999999974 88999999864332      3344455555554  999999999999


Q ss_pred             eeC----CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeeecCCCCCCeeec
Q 017621          257 LHR----KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC-----TPPIVHRDISSNNVLLN  327 (368)
Q Consensus       257 ~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~  327 (368)
                      ...    ...|+||||+++|+|.++++..    .+++..++.++.|++.||+|||+++     .++|+||||||+|||++
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~  176 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK  176 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence            887    7899999999999999999764    3899999999999999999999752     34899999999999999


Q ss_pred             CCCCeEEeeeccceecCCCCCC----ccccccccccccCC
Q 017621          328 SELEAFVADFGVARLLNFDSSN----RTLLAGTSGYIAPA  363 (368)
Q Consensus       328 ~~~~~kl~DFg~a~~~~~~~~~----~~~~~gt~~y~aPE  363 (368)
                      .++.+||+|||+++........    .....||+.|+|||
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  216 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE  216 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHH
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChh
Confidence            9999999999999876543322    12457999999999

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=6.9e-32  Score=254.96  Aligned_cols=168  Identities=25%  Similarity=0.430  Sum_probs=142.3

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC--CCceeeEEEEEeeCCeEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--HRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv  265 (368)
                      ++|++.+.||+|+||+||+|...+++.||||++...... ....+.+.+|++++++++  ||||+++++++...+..|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            469999999999999999999888999999998764332 234578899999999996  59999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      || +.+++|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+|||++ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 56789999998654   388999999999999999999999   999999999999995 58999999999987754


Q ss_pred             CCC--CccccccccccccCCC
Q 017621          346 DSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ...  .....+||+.|+|||+
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~  227 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEA  227 (390)
T ss_dssp             -------CCSCCCGGGCCHHH
T ss_pred             CCccccCCCCCcCCCccChHH
Confidence            332  2234579999999994

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.97  E-value=6.9e-32  Score=245.21  Aligned_cols=170  Identities=31%  Similarity=0.515  Sum_probs=140.8

Q ss_pred             hhccccceeeeecCCccEEEEEc-----CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  259 (368)
                      .++|++.+.||+|+||+||+|++     .+++.||+|++......   ..+.+.+|++++++++||||+++++++...  
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            46899999999999999999973     36889999998765432   346789999999999999999999998654  


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      ...++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             CceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            458999999999999999986543  389999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCC---CccccccccccccCCC
Q 017621          340 ARLLNFDSS---NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~---~~~~~~gt~~y~aPE~  364 (368)
                      ++.......   ......||..|+|||+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~  188 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPES  188 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHH
Confidence            987754332   1223457888999983

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=6e-32  Score=262.63  Aligned_cols=172  Identities=26%  Similarity=0.465  Sum_probs=149.7

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||+||+|+.. +++.||||++...........+.+.+|++++++++||||+++++++.+.+..|+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3468999999999999999999864 789999999865543333345788999999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCCeEEeeeccce
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL---NSELEAFVADFGVAR  341 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFg~a~  341 (368)
                      ||||+.+|+|.+.+.....   +++..+..++.||+.||.|||++   +|+||||||+|||+   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHTCSC---CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999999876543   89999999999999999999999   99999999999999   567899999999998


Q ss_pred             ecCCCCCCccccccccccccCCC
Q 017621          342 LLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ...... .....+||+.|+|||+
T Consensus       178 ~~~~~~-~~~~~~gt~~y~aPE~  199 (484)
T 3nyv_A          178 HFEASK-KMKDKIGTAYYIAPEV  199 (484)
T ss_dssp             HBCCCC-SHHHHTTGGGTCCHHH
T ss_pred             Eccccc-ccccCCCCccccCcee
Confidence            776443 3344579999999984

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=8.4e-32  Score=250.72  Aligned_cols=166  Identities=28%  Similarity=0.435  Sum_probs=130.1

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++. +++.||+|++.....     .+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            467999999999999999999865 578999999875432     25678899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCCeEEeeecccee
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS---ELEAFVADFGVARL  342 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFg~a~~  342 (368)
                      |||+++|+|.+++....   .+++.++..++.|++.||+|||++   +|+||||||+|||++.   ++.+||+|||+++.
T Consensus       127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999999997643   389999999999999999999999   9999999999999975   88999999999987


Q ss_pred             cCCCCCCccccccccccccCCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..... .....+||+.|+|||+
T Consensus       201 ~~~~~-~~~~~~gt~~y~aPE~  221 (349)
T 2w4o_A          201 VEHQV-LMKTVCGTPGYCAPEI  221 (349)
T ss_dssp             -------------CGGGSCHHH
T ss_pred             cCccc-ccccccCCCCccCHHH
Confidence            65432 2234579999999983

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=1.4e-31  Score=240.57  Aligned_cols=171  Identities=26%  Similarity=0.464  Sum_probs=141.9

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+...........+.+.+|+++++.++||||+++++++...+..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            357999999999999999999865 7899999998765443334557889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999997643   289999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      ... .....||+.|+|||+
T Consensus       164 ~~~-~~~~~~~~~y~aPE~  181 (276)
T 2h6d_A          164 GEF-LRTSCGSPNYAAPEV  181 (276)
T ss_dssp             --------------CCTGG
T ss_pred             Ccc-eecccCCccccCHHH
Confidence            322 234478999999995

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=1.8e-31  Score=244.32  Aligned_cols=172  Identities=26%  Similarity=0.433  Sum_probs=147.2

Q ss_pred             hhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      .++|++.+.||+|+||.||+|.+      .+++.||+|++......  ...+.+.+|++++++++||||+++++++.+.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP--SELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            56899999999999999999975      24578999999765432  34578899999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEE---------------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDI  319 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  319 (368)
                      ..++||||+++++|.+++.....                     ...+++.+++.++.|+++||+|||++   +|+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence            99999999999999999976432                     12378999999999999999999999   9999999


Q ss_pred             CCCCeeecCCCCeEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          320 SSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       320 kp~NIll~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      ||+||+++.++.+||+|||+++........  .....||+.|+|||
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  222 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE  222 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHH
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChh
Confidence            999999999999999999999877543321  23345788999999

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=1.4e-31  Score=247.56  Aligned_cols=172  Identities=27%  Similarity=0.424  Sum_probs=145.7

Q ss_pred             hhccccceeeeecCCccEEEEEc--------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL--------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCL  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  257 (368)
                      .++|++.+.||+|+||+||+|++        .+++.||+|++......  ...+.+.+|+++++++ +||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH--HHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            46899999999999999999985        24678999999765432  2456789999999999 9999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV  324 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  324 (368)
                      +.+..|+||||+++|+|.+++.....             ...+++.+++.++.||++||+|||++   +|+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence            99999999999999999999986532             12488999999999999999999999   999999999999


Q ss_pred             eecCCCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          325 LLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       325 ll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      +++.++.+||+|||+++.......  ......||+.|+|||
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  229 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPE  229 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChH
Confidence            999999999999999987754332  122345788999999

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=7.8e-32  Score=248.89  Aligned_cols=172  Identities=25%  Similarity=0.378  Sum_probs=137.5

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ...++|++.+.||+|+||+||+|.+ .+++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            3457899999999999999999985 478899999997654322 23456788999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-----CCCCeEEeeec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN-----SELEAFVADFG  338 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~DFg  338 (368)
                      +||||+++ +|.+++.....   +++..+..++.||+.||+|||++   +|+||||||+|||++     .++.+||+|||
T Consensus       110 lv~e~~~~-~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCSE-EHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCCC-CHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999984 99999986543   89999999999999999999999   999999999999994     45569999999


Q ss_pred             cceecCCCCCCccccccccccccCCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +++.............||+.|+|||+
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~  208 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEI  208 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHH
T ss_pred             CccccCCcccccCCCcCCccccCHHH
Confidence            99887655444555678999999983

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=1.8e-31  Score=254.49  Aligned_cols=172  Identities=28%  Similarity=0.404  Sum_probs=136.9

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchh-----hHHhHHHHHHHHHHHhccCCCceeeEEEEEee
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE-----ELASLESFRNEARLLSQIWHRNIVKLYGFCLH  258 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  258 (368)
                      ...++|.+.+.||+|+||+||+|.+ .+++.||+|++......     .......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4567899999999999999999985 46899999998754321     11122357899999999999999999999754


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CCeEEe
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE---LEAFVA  335 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~  335 (368)
                       +..|+||||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.+   ..+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence             55899999999999999887543   389999999999999999999999   99999999999999754   459999


Q ss_pred             eeccceecCCCCCCccccccccccccCCC
Q 017621          336 DFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       336 DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |||+++...... .....+||+.|+|||+
T Consensus       285 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~  312 (419)
T 3i6u_A          285 DFGHSKILGETS-LMRTLCGTPTYLAPEV  312 (419)
T ss_dssp             CSSTTTSCC------------CTTCCTTT
T ss_pred             ecccceecCCCc-cccccCCCCCccCcee
Confidence            999998775432 2334679999999996

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=7.9e-32  Score=246.62  Aligned_cols=172  Identities=27%  Similarity=0.423  Sum_probs=147.8

Q ss_pred             hhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  259 (368)
                      .++|++.+.||+|+||.||+|++      .+++.||+|++......  ...+.+.+|+++++++ +||||+++++++...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH--HHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            46899999999999999999973      35678999999765432  2347889999999999 999999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEE---------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV  324 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  324 (368)
                      +..++||||+++|+|.+++.....               ...+++..++.++.|++.||.|||++   +|+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence            999999999999999999976532               12489999999999999999999999   999999999999


Q ss_pred             eecCCCCeEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          325 LLNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       325 ll~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      +++.++.+||+|||+++........  .....||+.|+|||
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  217 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE  217 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChH
Confidence            9999999999999999887654332  22345788999999

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.1e-31  Score=249.62  Aligned_cols=175  Identities=27%  Similarity=0.396  Sum_probs=141.5

Q ss_pred             HHHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhH--HhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          184 IEATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEEL--ASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       184 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      ....++|++.+.||+|+||.||+|++. +++.||+|++........  ...+.+.+|++++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344678999999999999999999975 589999999975432211  11246788999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..++||||+++ +|.+++....  ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999986 8888887543  2378889999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccCCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +............+||+.|+|||+
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~  183 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPEL  183 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHH
T ss_pred             eeccCCcccCCcccccccccCchH
Confidence            887655544555689999999984

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=1.2e-31  Score=254.03  Aligned_cols=165  Identities=26%  Similarity=0.404  Sum_probs=132.0

Q ss_pred             hhccccc-eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhc-cCCCceeeEEEEEee----C
Q 017621          187 TEDFHIK-YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQ-IWHRNIVKLYGFCLH----R  259 (368)
Q Consensus       187 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~  259 (368)
                      .++|.+. +.||+|+||+||+|.+. +++.||||++...        ..+.+|++++.+ .+||||+++++++..    .
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~  131 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR  131 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence            3567776 78999999999999864 6889999998632        345678888754 489999999999876    5


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCCeEEee
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS---ELEAFVAD  336 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D  336 (368)
                      +..|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.   ++.+||+|
T Consensus       132 ~~~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          132 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             cEEEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence            678999999999999999986432 3489999999999999999999999   9999999999999997   78999999


Q ss_pred             eccceecCCCCCCccccccccccccCCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ||+++...... .....+||+.|+|||+
T Consensus       208 FG~a~~~~~~~-~~~~~~gt~~y~aPE~  234 (400)
T 1nxk_A          208 FGFAKETTSHN-SLTTPCYTPYYVAPEV  234 (400)
T ss_dssp             CTTCEECC------------CTTCCGGG
T ss_pred             cccccccCCCC-ccccCCCCCCccCHhh
Confidence            99998765332 2345689999999994

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=2.3e-32  Score=252.61  Aligned_cols=173  Identities=27%  Similarity=0.415  Sum_probs=146.1

Q ss_pred             HhhccccceeeeecCCccEEEEEcCC------CCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEee
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLH  258 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  258 (368)
                      ..++|++.+.||+|+||.||+|....      ...||+|.+......  ...+.+.+|+++++++ +||||+++++++..
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA--DEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            45789999999999999999998532      347999999765432  2346789999999999 89999999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEE-----------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN  327 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~  327 (368)
                      .+..++||||+++|+|.+++.....           ...+++..+..++.|++.||+|||++   +|+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence            9999999999999999999875321           23479999999999999999999999   999999999999999


Q ss_pred             CCCCeEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          328 SELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       328 ~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      .++.+||+|||+++........  .....||+.|+|||
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  236 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE  236 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHH
Confidence            9999999999999876543322  22345788999999

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=2.2e-31  Score=242.50  Aligned_cols=170  Identities=25%  Similarity=0.437  Sum_probs=143.3

Q ss_pred             hhccccceeeeecCCccEEEEE-----cCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--
Q 017621          187 TEDFHIKYCIGTGGYGSVYRAR-----LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  259 (368)
                      .++|++.+.||+|+||.||+|+     ..+++.||+|++......  ...+.+.+|++++++++||||+++++++...  
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            3468999999999999999998     346889999999765422  2446789999999999999999999999876  


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      +..++||||+++++|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence            668999999999999999965432  389999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCC---CccccccccccccCC
Q 017621          340 ARLLNFDSS---NRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~---~~~~~~gt~~y~aPE  363 (368)
                      ++.......   ......||..|+|||
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE  199 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPE  199 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCe
Confidence            998765442   223346888999998

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=4.4e-31  Score=237.29  Aligned_cols=171  Identities=27%  Similarity=0.447  Sum_probs=148.3

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||.||+|... +++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            4578999999999999999999864 6899999998654332  234678899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++++|.+++....   .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||.+....
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            999999999999987543   389999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCC--CCccccccccccccCCC
Q 017621          345 FDS--SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~--~~~~~~~gt~~y~aPE~  364 (368)
                      ...  .......||+.|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~  178 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPEL  178 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGG
T ss_pred             CCcchhcccCCccccCccChHH
Confidence            332  12334579999999994

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=2.2e-31  Score=240.54  Aligned_cols=170  Identities=31%  Similarity=0.520  Sum_probs=148.3

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            468999999999999999999864 5788999998765443333456789999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999997643   389999999999999999999999   999999999999999999999999999977653


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..  .....||+.|+|||+
T Consensus       167 ~~--~~~~~~~~~y~aPE~  183 (284)
T 2vgo_A          167 LR--RRTMCGTLDYLPPEM  183 (284)
T ss_dssp             SC--BCCCCSCGGGCCHHH
T ss_pred             cc--cccccCCCCcCCHHH
Confidence            22  234579999999983

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=4.3e-31  Score=237.65  Aligned_cols=169  Identities=24%  Similarity=0.383  Sum_probs=147.4

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||+||+|.+. ++..+|+|++......   ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            4568999999999999999999864 5779999998654332   34678999999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCCeEEeeeccce
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL---NSELEAFVADFGVAR  341 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFg~a~  341 (368)
                      ||||+++++|.+++.....   +++..+..++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||++.
T Consensus        84 v~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEeccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            9999999999998876432   89999999999999999999999   99999999999999   788999999999998


Q ss_pred             ecCCCCCCccccccccccccCCC
Q 017621          342 LLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ....... .....||+.|+|||+
T Consensus       158 ~~~~~~~-~~~~~~t~~y~aPE~  179 (277)
T 3f3z_A          158 RFKPGKM-MRTKVGTPYYVSPQV  179 (277)
T ss_dssp             ECCTTSC-BCCCCSCTTTCCHHH
T ss_pred             eccCccc-hhccCCCCCccChHH
Confidence            8764433 334579999999983

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=9.8e-32  Score=259.34  Aligned_cols=167  Identities=26%  Similarity=0.340  Sum_probs=135.9

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC------
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR------  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  259 (368)
                      .++|++.+.||+|+||+||+|.+ .+++.||||++...... ....+++.+|+.+++.++||||+++++++...      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccC-hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            46899999999999999999985 46889999999764322 23456788999999999999999999999654      


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      ...|+||||+++ ++.+.+..     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            457999999986 56666643     288999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++...... ..+..+||+.|+|||+
T Consensus       211 a~~~~~~~-~~~~~~gt~~y~aPE~  234 (464)
T 3ttj_A          211 ARTAGTSF-MMTPYVVTRYYRAPEV  234 (464)
T ss_dssp             C-----CC-CC----CCCTTCCHHH
T ss_pred             eeecCCCc-ccCCCcccccccCHHH
Confidence            98775432 2344689999999983

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=4.3e-32  Score=250.11  Aligned_cols=169  Identities=26%  Similarity=0.370  Sum_probs=136.6

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.......  ....+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc--cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            57999999999999999999864 78999999987543221  1124557999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||++ |+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        80 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             ECCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             cccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            9998 589888876533  388999999999999999999999   9999999999999999999999999999876654


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........||+.|+|||+
T Consensus       154 ~~~~~~~~~t~~y~aPE~  171 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDI  171 (324)
T ss_dssp             ---------CGGGCCHHH
T ss_pred             ccccccccCcccccChhh
Confidence            444455678999999983

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=2.2e-31  Score=246.07  Aligned_cols=171  Identities=28%  Similarity=0.439  Sum_probs=141.9

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|++. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            468999999999999999999864 5899999998654432 22346678999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.++.....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....
T Consensus       103 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999998888776543   389999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........||+.|+|||+
T Consensus       177 ~~~~~~~~~~t~~y~aPE~  195 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPEL  195 (331)
T ss_dssp             -------CCCCCTTCCHHH
T ss_pred             CccccCCCcCCccccCccc
Confidence            5444455679999999983

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=1.3e-31  Score=248.76  Aligned_cols=179  Identities=28%  Similarity=0.432  Sum_probs=145.3

Q ss_pred             HHHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchh--hHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC
Q 017621          183 MIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE--ELASLESFRNEARLLSQIWHRNIVKLYGFCLHR  259 (368)
Q Consensus       183 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  259 (368)
                      +.+..++|++.+.||+|+||+||+|.. .+++.||+|++......  .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            456778999999999999999999985 46889999998654321  123456889999999999999999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCC-------------------------------------CCCCCHHHHHHHHHHHHHH
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEE-------------------------------------AVGLDWAKRVNIVKGMAHA  302 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~~  302 (368)
                      +..++||||+++|+|.+++.....                                     ...+++..+..++.|+++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999998852100                                     1113567788899999999


Q ss_pred             HHHHhcCCCCCeeecCCCCCCeeecCCC--CeEEeeeccceecCCCCC----CccccccccccccCCC
Q 017621          303 LSYLHHHCTPPIVHRDISSNNVLLNSEL--EAFVADFGVARLLNFDSS----NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       303 L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFg~a~~~~~~~~----~~~~~~gt~~y~aPE~  364 (368)
                      |+|||++   +|+||||||+||+++.++  .+||+|||+++.+.....    ......||+.|+|||+
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  245 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV  245 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHH
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchh
Confidence            9999999   999999999999998776  899999999987643222    2234579999999983

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=3.2e-31  Score=239.33  Aligned_cols=171  Identities=20%  Similarity=0.330  Sum_probs=145.1

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  263 (368)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++....... ....++.+|+..+..+ +||||+++++++.+.+..+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            4578999999999999999999865 78999999987643322 2346778899999999 9999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-------------
Q 017621          264 LIYEYMEMGSLFCVLRTDEE-AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-------------  329 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------  329 (368)
                      +||||+++++|.+++..... ...+++..+..++.||+.||+|||++   +|+||||||+||+++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999999975421 13489999999999999999999999   99999999999999844             


Q ss_pred             ------CCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          330 ------LEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       330 ------~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                            ..+||+|||.+.......    ...||+.|+|||+
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~  201 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEV  201 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHH
T ss_pred             cccCCceEEEEcccccccccCCcc----ccCCCccccChhH
Confidence                  479999999998875432    2359999999983

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=3.1e-31  Score=258.82  Aligned_cols=171  Identities=31%  Similarity=0.480  Sum_probs=144.2

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhH----------HhHHHHHHHHHHHhccCCCceeeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEEL----------ASLESFRNEARLLSQIWHRNIVKLYGF  255 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~  255 (368)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++........          ...+.+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            578999999999999999999864 688999999876543211          234678899999999999999999999


Q ss_pred             EeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---Ce
Q 017621          256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL---EA  332 (368)
Q Consensus       256 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~  332 (368)
                      +.+.+..|+||||+++|+|.+.+....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999999887543   389999999999999999999999   999999999999998776   69


Q ss_pred             EEeeeccceecCCCCCCccccccccccccCCC
Q 017621          333 FVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       333 kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ||+|||+++....... ....+||+.|+|||+
T Consensus       189 kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~  219 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK-LRDRLGTAYYIAPEV  219 (504)
T ss_dssp             EECCCTTCEECCTTSC-BCCCCSCTTTCCHHH
T ss_pred             EEEECCCCEEcCCCCc-cccccCCcCCCCHHH
Confidence            9999999998764432 334579999999984

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=1.1e-31  Score=261.12  Aligned_cols=171  Identities=28%  Similarity=0.461  Sum_probs=147.5

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||.||+|.+. ++..||||.+.....    ..++|.+|++++++++||||+++++++...+..|+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            3567999999999999999999875 488999999976543    24689999999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++|+|.++++.... ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       294 v~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            9999999999999986432 3489999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC-CccccccccccccCCC
Q 017621          345 FDSS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~-~~~~~~gt~~y~aPE~  364 (368)
                      .... ......+|+.|+|||+
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~  390 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPES  390 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHH
T ss_pred             CCceeecCCCcCCcceeCHhH
Confidence            3321 1223356789999993

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=3.4e-31  Score=243.71  Aligned_cols=172  Identities=25%  Similarity=0.394  Sum_probs=148.5

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhH---HhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++........   ...+++.+|+.++++++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3467999999999999999999864 689999999876433211   134678999999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC----CeEEeee
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL----EAFVADF  337 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DF  337 (368)
                      .++||||+++++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            999999999999999997643   389999999999999999999999   999999999999999887    7999999


Q ss_pred             ccceecCCCCCCccccccccccccCCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+++....... .....||+.|+|||+
T Consensus       164 g~~~~~~~~~~-~~~~~gt~~y~aPE~  189 (321)
T 2a2a_A          164 GLAHEIEDGVE-FKNIFGTPEFVAPEI  189 (321)
T ss_dssp             TTCEECCTTCC-CCCCCSCGGGCCHHH
T ss_pred             ccceecCcccc-ccccCCCCCccCccc
Confidence            99988764332 234579999999983

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.6e-32  Score=253.80  Aligned_cols=172  Identities=30%  Similarity=0.425  Sum_probs=146.3

Q ss_pred             hhccccceeeeecCCccEEEEEc----CCCCEEEEEEccccchh-hHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  260 (368)
                      .++|++.+.||+|+||+||+|+.    .+++.||||+++..... .....+.+.+|+++++.+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36899999999999999999986    47899999998754321 111234567799999999 6999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+||||+++|+|.+++....   .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999997643   389999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCC-CccccccccccccCCC
Q 017621          341 RLLNFDSS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~-~~~~~~gt~~y~aPE~  364 (368)
                      +....... .....+||+.|+|||+
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~  231 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDI  231 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHH
T ss_pred             eecccCCCCcccCcccCcCccChhh
Confidence            87643322 2334579999999984

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=6.6e-32  Score=260.15  Aligned_cols=171  Identities=26%  Similarity=0.460  Sum_probs=145.9

Q ss_pred             HHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ...++|++.+.||+|+||+||+|.+.++..||||+++....    ..++|.+|++++++++||||+++++++. .+..|+
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            34578999999999999999999988888999999976442    3478999999999999999999999987 567899


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++|+|.++++.... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       260 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            9999999999999975421 2378899999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCC-CccccccccccccCCC
Q 017621          345 FDSS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~-~~~~~~gt~~y~aPE~  364 (368)
                      .... ......+|+.|+|||+
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~  356 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEA  356 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHH
T ss_pred             CCceeccCCCcccccccCHHH
Confidence            3211 1122346789999983

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=5.3e-31  Score=237.87  Aligned_cols=170  Identities=26%  Similarity=0.440  Sum_probs=146.8

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            46899999999999999999985 46899999998764432 23446788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC---eEEeeecccee
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE---AFVADFGVARL  342 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFg~a~~  342 (368)
                      |||+++++|.+.+....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            99999999988887643   389999999999999999999999   9999999999999986655   99999999987


Q ss_pred             cCCCCCCccccccccccccCCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ...... .....||+.|+|||+
T Consensus       158 ~~~~~~-~~~~~~~~~y~aPE~  178 (284)
T 3kk8_A          158 VNDSEA-WHGFAGTPGYLSPEV  178 (284)
T ss_dssp             CCSSCB-CCCSCSCGGGCCHHH
T ss_pred             cccCcc-ccCCCCCcCCcCchh
Confidence            764332 334579999999984

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=2.4e-31  Score=258.50  Aligned_cols=171  Identities=25%  Similarity=0.447  Sum_probs=145.6

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||+||+|+.. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            4568999999999999999999864 7899999998653221 1234678899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec---CCCCeEEeeeccce
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN---SELEAFVADFGVAR  341 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFg~a~  341 (368)
                      ||||+++|+|.+.+....   .+++..+..++.||+.||.|||++   +|+||||||+|||++   .++.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999999887543   389999999999999999999999   999999999999995   45679999999998


Q ss_pred             ecCCCCCCccccccccccccCCC
Q 017621          342 LLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ....... ....+||+.|+|||+
T Consensus       173 ~~~~~~~-~~~~~gt~~y~aPE~  194 (486)
T 3mwu_A          173 CFQQNTK-MKDRIGTAYYIAPEV  194 (486)
T ss_dssp             TBCCC-----CCTTGGGGCCGGG
T ss_pred             ECCCCCc-cCCCcCCCCCCCHHH
Confidence            7654332 334579999999995

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=1.5e-31  Score=249.91  Aligned_cols=175  Identities=24%  Similarity=0.328  Sum_probs=148.0

Q ss_pred             ccHHHHHHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-----CCceee
Q 017621          178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-----HRNIVK  251 (368)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~  251 (368)
                      +++++.....++|++.+.||+|+||+||+|++ .+++.||||++.....    ..+.+..|+++++.+.     ||||++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK----YTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH----HHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh----hhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            33444444568999999999999999999986 5688999999875332    2356778999999886     999999


Q ss_pred             EEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---
Q 017621          252 LYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS---  328 (368)
Q Consensus       252 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---  328 (368)
                      +++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence            999999999999999999 8899999986543 2489999999999999999999999   9999999999999975   


Q ss_pred             ----------------------CCCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          329 ----------------------ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       329 ----------------------~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                                            ++.+||+|||+++......   ....||+.|+|||+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~---~~~~gt~~y~aPE~  230 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH---GSIINTRQYRAPEV  230 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC---CSCCSCGGGCCHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCCC---cCccCcccccCcHH
Confidence                                  7899999999998754322   34579999999984

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=2.5e-31  Score=258.88  Aligned_cols=171  Identities=28%  Similarity=0.437  Sum_probs=142.2

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||+||+|+.. ++..||+|++....... ...+.+.+|+++++.++||||+++++++.+.+..|+
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3467999999999999999999864 68899999987654322 224678899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CCeEEeeeccce
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE---LEAFVADFGVAR  341 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFg~a~  341 (368)
                      ||||+++|+|.+.+....   .+++..+..++.||+.||.|||++   +|+||||||+|||++..   +.+||+|||+++
T Consensus       114 v~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            999999999998887543   389999999999999999999999   99999999999999764   559999999998


Q ss_pred             ecCCCCCCccccccccccccCCC
Q 017621          342 LLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ....... ....+||+.|+|||+
T Consensus       188 ~~~~~~~-~~~~~gt~~y~aPE~  209 (494)
T 3lij_A          188 VFENQKK-MKERLGTAYYIAPEV  209 (494)
T ss_dssp             ECBTTBC-BCCCCSCTTTCCHHH
T ss_pred             ECCCCcc-ccccCCCcCeeCHHH
Confidence            8764332 334579999999983

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.6e-31  Score=246.67  Aligned_cols=173  Identities=28%  Similarity=0.458  Sum_probs=145.2

Q ss_pred             HhhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEee
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLH  258 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  258 (368)
                      ..++|++.+.||+|+||.||+|.+      .++..||+|.+......  ...+.+.+|+.+++++ +||||+++++++..
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            457899999999999999999985      24568999999754322  2346789999999999 99999999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecC
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEEA--------------------VGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRD  318 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  318 (368)
                      .+..++||||+++|+|.+++......                    ..+++..++.++.||+.||+|||++   +|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence            99999999999999999999765321                    2378999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCCeEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          319 ISSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       319 lkp~NIll~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      |||+|||++.++.+||+|||++.........  .....||+.|+|||
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  244 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE  244 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence            9999999999999999999999877544332  23346788999999

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=6.4e-31  Score=239.71  Aligned_cols=169  Identities=34%  Similarity=0.485  Sum_probs=149.2

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .+.|++.+.||+|+||.||+|.. .+++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            35699999999999999999985 46899999998754432  2347889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++...    .+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        99 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           99 MEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            9999999999998753    389999999999999999999999   999999999999999999999999999988765


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .........||+.|+|||+
T Consensus       172 ~~~~~~~~~~~~~y~aPE~  190 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEV  190 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHH
T ss_pred             cccccCccCCCcCccCHHH
Confidence            5444455679999999984

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=3.6e-31  Score=254.65  Aligned_cols=165  Identities=27%  Similarity=0.446  Sum_probs=141.5

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-eEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-CMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|... ++.||||+++...     ..+.|.+|++++++++||||+++++++...+ ..|+|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            568999999999999999999874 7799999997654     2367899999999999999999999987665 79999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.++++.... ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       266 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999999986432 2378999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..   ....+|+.|+|||+
T Consensus       342 ~~---~~~~~~~~y~aPE~  357 (450)
T 1k9a_A          342 TQ---DTGKLPVKWTAPEA  357 (450)
T ss_dssp             --------CCCTTTSCHHH
T ss_pred             cc---cCCCCCcceeCHHH
Confidence            22   22357889999983

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=1.5e-31  Score=239.10  Aligned_cols=169  Identities=25%  Similarity=0.409  Sum_probs=146.8

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||.||+|...+++.||+|++......    .+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            3679999999999999999999888889999999765432    267889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++.....  .+++..+..++.|+++||+|||++   +++||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CCCTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eCCCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            99999999999976532  388999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CC-CccccccccccccCCC
Q 017621          347 SS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE~  364 (368)
                      .. ......||+.|+|||+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~  176 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEV  176 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHH
T ss_pred             cccccccccccccccChhh
Confidence            11 1223457889999983

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=3.3e-31  Score=239.69  Aligned_cols=172  Identities=27%  Similarity=0.459  Sum_probs=142.1

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|.+.+.||+|+||+||+|+. .+++.+|+|++......  ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            36799999999999999999985 46889999998764322  2347889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCCeEEeeeccce
Q 017621          266 YEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL---NSELEAFVADFGVAR  341 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFg~a~  341 (368)
                      |||+++|+|.+.+.... ....+++..+..++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||+++
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            99999999998885431 123489999999999999999999999   99999999999999   456789999999998


Q ss_pred             ecCCCCCCccccccccccccCCC
Q 017621          342 LLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ....... .....||+.|+|||+
T Consensus       176 ~~~~~~~-~~~~~~t~~y~aPE~  197 (285)
T 3is5_A          176 LFKSDEH-STNAAGTALYMAPEV  197 (285)
T ss_dssp             C-----------CTTGGGCCHHH
T ss_pred             ecCCccc-CcCcccccCcCChHH
Confidence            7654332 334579999999983

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=1.4e-31  Score=247.02  Aligned_cols=170  Identities=25%  Similarity=0.454  Sum_probs=137.2

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCC----EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      .++|++.+.||+|+||+||+|++. +++    .||+|.+......  ...+++.+|+.++++++||||+++++++.+.+ 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            357999999999999999999853 444    3688887653322  24478999999999999999999999998765 


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .++|+||+++|+|.+++.....  .+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence            7899999999999999986443  389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCCC--ccccccccccccCCC
Q 017621          342 LLNFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      ........  .....||+.|+|||+
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~  190 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALES  190 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHH
T ss_pred             EccCCcccccccCCCccccccChHH
Confidence            87544332  223457889999993

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.97  E-value=2.9e-31  Score=239.45  Aligned_cols=169  Identities=29%  Similarity=0.425  Sum_probs=132.7

Q ss_pred             hhccccceeeeecCCccEEEEEcCC----CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||+||+|.+..    +..||+|.+......  ...+.+.+|+.++++++||||+++++++. ++..
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            4689999999999999999998642    457999998764332  24467899999999999999999999985 4568


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+||||+++++|.+++....  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence            99999999999999997643  2389999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccCC
Q 017621          343 LNFDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~-~~~~~~gt~~y~aPE  363 (368)
                      ...... ......+|+.|+|||
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE  187 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPE  187 (281)
T ss_dssp             -------------CCGGGCCHH
T ss_pred             cCcccccccccCCCcccccChh
Confidence            754332 122345788999998

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=6.8e-31  Score=240.31  Aligned_cols=175  Identities=25%  Similarity=0.379  Sum_probs=137.5

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|++++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45799999999999999999985 57899999998764433334557889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          266 YEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |||+++++|.+++.... ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999886421 123489999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..........||+.|+|||+
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~  207 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPER  207 (310)
T ss_dssp             -----------CCSSCCHHH
T ss_pred             CCCccccccCCCeeEeChHH
Confidence            54444445579999999983

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=1.2e-30  Score=236.07  Aligned_cols=168  Identities=31%  Similarity=0.541  Sum_probs=142.3

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHH----hHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELA----SLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++.........    ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            36799999999999999999986 57899999998654432211    1267899999999999999999999997765 


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeecCCCC-----eEE
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP--IVHRDISSNNVLLNSELE-----AFV  334 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl  334 (368)
                       ++||||+++|+|.+.+....  ..+++..+..++.|++.||+|||++   +  |+||||||+||+++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence             69999999999998887543  2489999999999999999999998   7  999999999999988776     999


Q ss_pred             eeeccceecCCCCCCccccccccccccCCC
Q 017621          335 ADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       335 ~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +|||+++....   ......||+.|+|||+
T Consensus       171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~  197 (287)
T 4f0f_A          171 ADFGLSQQSVH---SVSGLLGNFQWMAPET  197 (287)
T ss_dssp             CCCTTCBCCSS---CEECCCCCCTTSCGGG
T ss_pred             CCCCccccccc---cccccCCCccccCchh
Confidence            99999985432   2344579999999995

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=3.2e-31  Score=237.68  Aligned_cols=170  Identities=32%  Similarity=0.530  Sum_probs=132.3

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhh-HHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEE-LASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|.+ .++.||+|++....... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            35799999999999999999997 48899999987643332 23356789999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC--------CCCeEEeee
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS--------ELEAFVADF  337 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~DF  337 (368)
                      |||+++++|.+++...    .+++..+..++.|+++||+|||++...+|+||||||+||+++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999999998643    3899999999999999999999982112999999999999986        678999999


Q ss_pred             ccceecCCCCCCccccccccccccCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      |+++.......  ....||+.|+|||
T Consensus       161 g~~~~~~~~~~--~~~~~~~~y~aPE  184 (271)
T 3dtc_A          161 GLAREWHRTTK--MSAAGAYAWMAPE  184 (271)
T ss_dssp             CC---------------CCGGGSCHH
T ss_pred             Ccccccccccc--cCCCCccceeCHH
Confidence            99987654332  2357999999998

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=1.9e-31  Score=249.74  Aligned_cols=172  Identities=19%  Similarity=0.308  Sum_probs=139.2

Q ss_pred             hhccccceeeeecCCccEEEEEcCC------CCEEEEEEccccchhhHHh--------HHHHHHHHHHHhccCCCceeeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRSETEELAS--------LESFRNEARLLSQIWHRNIVKL  252 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l  252 (368)
                      .++|++.+.||+|+||+||+|.+..      ++.||+|++..........        ...+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4589999999999999999998654      4789999987654321111        1234456777888999999999


Q ss_pred             EEEEeeC----CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-
Q 017621          253 YGFCLHR----KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN-  327 (368)
Q Consensus       253 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-  327 (368)
                      ++++...    ...|+||||+ +++|.+++....  ..+++..++.++.||+.||+|||++   +|+||||||+|||++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence            9998764    4589999999 999999998643  2389999999999999999999999   999999999999999 


Q ss_pred             -CCCCeEEeeeccceecCCCCCC-------ccccccccccccCCC
Q 017621          328 -SELEAFVADFGVARLLNFDSSN-------RTLLAGTSGYIAPAS  364 (368)
Q Consensus       328 -~~~~~kl~DFg~a~~~~~~~~~-------~~~~~gt~~y~aPE~  364 (368)
                       .++.+||+|||+++.+......       ....+||+.|+|||+
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  232 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDA  232 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHH
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHH
Confidence             8899999999999876543211       133469999999984

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.97  E-value=5.3e-31  Score=240.89  Aligned_cols=172  Identities=31%  Similarity=0.448  Sum_probs=139.7

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchh--hHHhHHHHHHHHHHHhccC---CCceeeEEEEEeeC
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE--ELASLESFRNEARLLSQIW---HRNIVKLYGFCLHR  259 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  259 (368)
                      ..++|++.+.||+|+||+||+|++ .+++.||+|++......  .......+.+|+++++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999996 56899999998643211  0111235566777776664   99999999999875


Q ss_pred             C-----eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEE
Q 017621          260 K-----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFV  334 (368)
Q Consensus       260 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  334 (368)
                      .     ..++||||++ ++|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence            5     5899999997 599999986543 3389999999999999999999999   9999999999999999999999


Q ss_pred             eeeccceecCCCCCCccccccccccccCC
Q 017621          335 ADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       335 ~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +|||+++....... ....+||+.|+|||
T Consensus       162 ~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE  189 (308)
T 3g33_A          162 ADFGLARIYSYQMA-LTPVVVTLWYRAPE  189 (308)
T ss_dssp             CSCSCTTTSTTCCC-SGGGGCCCSSCCHH
T ss_pred             eeCccccccCCCcc-cCCccccccccCch
Confidence            99999987654333 34567999999998

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=6.9e-31  Score=237.00  Aligned_cols=170  Identities=25%  Similarity=0.414  Sum_probs=144.1

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhH---HhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEEL---ASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.+........   ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357999999999999999999865 689999999876433211   1357889999999999999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC----CeEEeeec
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL----EAFVADFG  338 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFg  338 (368)
                      ++||||+++++|.+++....   .+++.++..++.|++.||+|||++   +|+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999997543   389999999999999999999999   999999999999998877    89999999


Q ss_pred             cceecCCCCCCccccccccccccCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ++........ .....||+.|+|||
T Consensus       158 ~~~~~~~~~~-~~~~~~~~~y~aPE  181 (283)
T 3bhy_A          158 IAHKIEAGNE-FKNIFGTPEFVAPE  181 (283)
T ss_dssp             TCEECC---------CCCGGGCCHH
T ss_pred             cceeccCCCc-ccccCCCcCccCcc
Confidence            9987754332 23456999999998

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=6.1e-32  Score=248.54  Aligned_cols=178  Identities=22%  Similarity=0.355  Sum_probs=148.8

Q ss_pred             HHHHHhhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEE
Q 017621          182 DMIEATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGF  255 (368)
Q Consensus       182 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  255 (368)
                      ++....++|++.+.||+|+||.||+|.+.      +++.||+|.+......  .....+.+|++++++++||||++++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            33445678999999999999999999753      3678999999765432  234678899999999999999999999


Q ss_pred             EeeCCeEEEEEeecCCCChhHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 017621          256 CLHRKCMFLIYEYMEMGSLFCVLRTDEE-------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS  328 (368)
Q Consensus       256 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  328 (368)
                      +.+.+..++||||+++|+|.+++.....       ...+++..+..++.|++.||+|||++   +|+||||||+||+++.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence            9999999999999999999999875321       13478999999999999999999999   9999999999999999


Q ss_pred             CCCeEEeeeccceecCCCCC--CccccccccccccCCC
Q 017621          329 ELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ++.+||+|||+++.......  ......||+.|+|||+
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  211 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhh
Confidence            99999999999987643322  1223457899999983

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=9.8e-31  Score=237.32  Aligned_cols=170  Identities=27%  Similarity=0.380  Sum_probs=143.3

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      +|.....||+|+||.||+|.+ .+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            345556899999999999985 5688999999876532   234678899999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCCeEEeeeccceecCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-ELEAFVADFGVARLLNFD  346 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFg~a~~~~~~  346 (368)
                      |+++++|.+++........+++..+..++.|++.||+|||++   +|+||||||+||+++. ++.+||+|||+++.....
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            999999999998765444577889999999999999999999   9999999999999987 899999999999887644


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........||+.|+|||+
T Consensus       177 ~~~~~~~~~~~~y~aPE~  194 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEI  194 (295)
T ss_dssp             ----CCCCCCGGGCCHHH
T ss_pred             CCcccccCCCccccChhh
Confidence            333445579999999984

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=1.7e-31  Score=257.02  Aligned_cols=169  Identities=28%  Similarity=0.478  Sum_probs=140.1

Q ss_pred             HhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ..++|++.+.||+|+||+||+|.+.++..||||+++....    ..++|.+|++++++++||||+++++++.+ +..|+|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            4568999999999999999999988788899999986543    23678999999999999999999999876 668999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.++++... ...+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus       257 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             ehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            99999999999997532 12389999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-CccccccccccccCC
Q 017621          346 DSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~-~~~~~~gt~~y~aPE  363 (368)
                      ... ......+|+.|+|||
T Consensus       333 ~~~~~~~~~~~~~~y~aPE  351 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPE  351 (452)
T ss_dssp             ----------CCGGGSCHH
T ss_pred             CceecccCCcccccccCHh
Confidence            322 222345788999999

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=1.1e-30  Score=240.92  Aligned_cols=169  Identities=29%  Similarity=0.461  Sum_probs=145.3

Q ss_pred             hhccccceeeeecCCccEEEEEc-----CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEe--eC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCL--HR  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~  259 (368)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++......   ..+.+.+|++++++++||||+++++++.  +.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---QQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHH---HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHH---HHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            36899999999999999999983     46889999999765432   3467899999999999999999999887  45


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      +..++||||+++++|.+++.....  .+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             ceEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence            679999999999999999976432  389999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCC---CccccccccccccCC
Q 017621          340 ARLLNFDSS---NRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~---~~~~~~gt~~y~aPE  363 (368)
                      ++.......   ......||+.|+|||
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE  200 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPE  200 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHH
T ss_pred             ceecccCCccceeeccCCccccccCHH
Confidence            998754432   122346888999998

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=5.9e-31  Score=239.33  Aligned_cols=170  Identities=27%  Similarity=0.501  Sum_probs=139.9

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee------
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH------  258 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  258 (368)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|++....    ...+.+.+|+.++++++||||+++++++.+      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            457899999999999999999985 478999999986432    234678899999999999999999998865      


Q ss_pred             -------CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC
Q 017621          259 -------RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE  331 (368)
Q Consensus       259 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~  331 (368)
                             .+..|+||||+++++|.+++....  ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence                   356899999999999999998643  2378889999999999999999999   9999999999999999999


Q ss_pred             eEEeeeccceecCCCC--------------CCccccccccccccCCC
Q 017621          332 AFVADFGVARLLNFDS--------------SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       332 ~kl~DFg~a~~~~~~~--------------~~~~~~~gt~~y~aPE~  364 (368)
                      +||+|||+++......              .......||+.|+|||+
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  201 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV  201 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccc
Confidence            9999999998764321              12234579999999984

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=4.1e-31  Score=238.03  Aligned_cols=169  Identities=28%  Similarity=0.501  Sum_probs=144.8

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||.||+|...+++.||+|.+.....    ..+.+.+|++++++++||||+++++++.+ +..++||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   86 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence            468999999999999999999988888999999876443    23678899999999999999999999874 4589999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++.... ...+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++.....
T Consensus        87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             ecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            9999999999997532 12489999999999999999999999   9999999999999999999999999999887543


Q ss_pred             CC-CccccccccccccCCC
Q 017621          347 SS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE~  364 (368)
                      .. ......||+.|+|||+
T Consensus       163 ~~~~~~~~~~~~~y~aPE~  181 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEA  181 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHH
T ss_pred             ccccccCCCCccCccChhh
Confidence            22 1223457889999984

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=8.7e-32  Score=265.27  Aligned_cols=159  Identities=20%  Similarity=0.143  Sum_probs=126.3

Q ss_pred             eeecCCccEEEEE-cCCCCEEEEEEccccc-------hhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEE
Q 017621          196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSE-------TEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       196 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .+.|+.|.+..++ .-.|+.+|+|.+....       .......++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556666555543 2358889999986542       12233457899999999999 7999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||++|++|.+++.....   ++..   +|+.||+.||+|+|++   |||||||||+|||+++++.+||+|||+|+....+
T Consensus       322 Eyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999987543   5543   4899999999999999   9999999999999999999999999999988766


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      .......+||+.|||||
T Consensus       393 ~~~~~t~vGTp~YmAPE  409 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNE  409 (569)
T ss_dssp             -CCSHHHHHHHHHHHHH
T ss_pred             CccccCceechhhccHH
Confidence            66666778999999998

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=4.2e-31  Score=243.13  Aligned_cols=175  Identities=25%  Similarity=0.422  Sum_probs=130.2

Q ss_pred             HhhccccceeeeecCCccEEEEEcCCC----CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLPSG----KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      ..++|++.+.||+|+||+||+|++...    ..||+|++....... ...+++.+|++++++++||||+++++++...+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            356899999999999999999986543    279999997643322 235789999999999999999999999987765


Q ss_pred             E------EEEEeecCCCChhHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCe
Q 017621          262 M------FLIYEYMEMGSLFCVLRTDE---EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEA  332 (368)
Q Consensus       262 ~------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  332 (368)
                      .      ++||||+++|+|.+++....   ....+++..+..++.|+++||+|||++   +|+||||||+|||+++++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            5      99999999999999986432   122489999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccceecCCCCC--CccccccccccccCCC
Q 017621          333 FVADFGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       333 kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ||+|||+++.......  ......+|+.|+|||+
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  210 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALES  210 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHH
T ss_pred             EEeeccccccccccccccccccccCcccccCchh
Confidence            9999999987654332  1223457889999983

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=1e-31  Score=247.64  Aligned_cols=169  Identities=27%  Similarity=0.423  Sum_probs=137.7

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCE----EEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKV----VALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      ++|++.+.||+|+||+||+|.+. +++.    ||+|.+......  ...+.+.+|+.++++++||||+++++++.+ +..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence            57999999999999999999853 4443    788877543221  123466789999999999999999999864 568


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++|+|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence            999999999999999976432  388899999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCC--CccccccccccccCCC
Q 017621          343 LNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ......  ......||+.|+|||+
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~  188 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALES  188 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHH
T ss_pred             cCcccccccccCCCCcccccChHH
Confidence            754332  2334568889999983

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=3e-31  Score=246.55  Aligned_cols=171  Identities=23%  Similarity=0.394  Sum_probs=147.7

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHH--------------hHHHHHHHHHHHhccCCCceeeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELA--------------SLESFRNEARLLSQIWHRNIVKL  252 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~l  252 (368)
                      .++|++.+.||+|+||.||+|.. +++.||+|.+.........              ..+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999998 8999999998654322111              12678999999999999999999


Q ss_pred             EEEEeeCCeEEEEEeecCCCChhHH------hhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCee
Q 017621          253 YGFCLHRKCMFLIYEYMEMGSLFCV------LRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVL  325 (368)
Q Consensus       253 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIl  325 (368)
                      ++++.+.+..|+||||+++++|.++      +.... ...+++..+..++.|++.||.|||+ +   +|+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            9999999999999999999999998      54421 3458999999999999999999998 8   9999999999999


Q ss_pred             ecCCCCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          326 LNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       326 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++.++.+||+|||++......  ......||+.|+|||+
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~  221 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEF  221 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGG
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchh
Confidence            999999999999999886543  3344579999999995

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=1.7e-30  Score=238.83  Aligned_cols=166  Identities=25%  Similarity=0.424  Sum_probs=142.1

Q ss_pred             cccceeeeecCCccEEEEEc-----CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeE
Q 017621          190 FHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCM  262 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  262 (368)
                      |++.+.||+|+||+||++..     .+++.||+|++......  ...+.+.+|++++++++||||+++++++.+.  ...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP--QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh--HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            48999999999999998863     26789999999865432  2456789999999999999999999999874  678


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++|+|.+++....    +++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence            99999999999999997643    89999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCC---CccccccccccccCCC
Q 017621          343 LNFDSS---NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~---~~~~~~gt~~y~aPE~  364 (368)
                      ......   ......||+.|+|||+
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~  208 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPEC  208 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHH
T ss_pred             ccccccccccccCCCCCceeeChHH
Confidence            765432   1233468889999983

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.97  E-value=8.2e-31  Score=234.66  Aligned_cols=167  Identities=20%  Similarity=0.320  Sum_probs=144.4

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC--CeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR--KCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  264 (368)
                      .++|++.+.||+|+||.||+|++ +++.||+|++....... ...+.+.+|++++++++||||+++++++.+.  +..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            35799999999999999999998 48899999997654322 2346799999999999999999999999887  77899


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP--IVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ||||+++|+|.+++..... ..+++..+..++.|++.||+|||++   +  |+||||||+||+++.++.++|+|||++..
T Consensus        87 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             eecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence            9999999999999986542 3489999999999999999999998   7  99999999999999999999999998765


Q ss_pred             cCCCCCCccccccccccccCCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ...     ....||+.|+|||+
T Consensus       163 ~~~-----~~~~~t~~y~aPE~  179 (271)
T 3kmu_A          163 FQS-----PGRMYAPAWVAPEA  179 (271)
T ss_dssp             TSC-----TTCBSCGGGSCHHH
T ss_pred             ecc-----cCccCCccccChhh
Confidence            332     22468999999983

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=1.1e-30  Score=243.36  Aligned_cols=170  Identities=26%  Similarity=0.436  Sum_probs=142.8

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee-------
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH-------  258 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  258 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++....... .....+.+|+++++.++||||+++++++..       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            46899999999999999999986 578999999986554322 223567889999999999999999999887       


Q ss_pred             -CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          259 -RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       259 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                       .+..|+||||+++ +|.+.+.....  .+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence             4468999999985 77777765432  389999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCC----CCccccccccccccCC
Q 017621          338 GVARLLNFDS----SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       338 g~a~~~~~~~----~~~~~~~gt~~y~aPE  363 (368)
                      |+++.+....    .......||+.|+|||
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  198 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPE  198 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHH
T ss_pred             hhcccccccccccccccCCcccccCccCch
Confidence            9998765322    2233457899999998

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=7.5e-32  Score=253.69  Aligned_cols=170  Identities=16%  Similarity=0.173  Sum_probs=137.8

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHH---HHHhccCCCceeeEE-------EE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEA---RLLSQIWHRNIVKLY-------GF  255 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  255 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||||++...........+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999996 46899999999754333333457888999   556666899999998       77


Q ss_pred             EeeCCe-----------------EEEEEeecCCCChhHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 017621          256 CLHRKC-----------------MFLIYEYMEMGSLFCVLRTDEE----AVGLDWAKRVNIVKGMAHALSYLHHHCTPPI  314 (368)
Q Consensus       256 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  314 (368)
                      +.+.+.                 .|+||||+ +|+|.+++.....    ...+++..++.++.||+.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            665532                 88999999 5799999975322    11133578888999999999999999   99


Q ss_pred             eecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       315 vH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +||||||+|||++.++.+||+|||+++....   .....+| +.|+|||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~  273 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPEL  273 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhh
Confidence            9999999999999999999999999986432   3344578 99999995

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.97  E-value=7.3e-31  Score=236.76  Aligned_cols=166  Identities=27%  Similarity=0.499  Sum_probs=143.9

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee------
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH------  258 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  258 (368)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....       +.+.+|++++++++||||+++++++..      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            4578999999999999999999865 78999999987543       345689999999999999999998864      


Q ss_pred             ----------CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC
Q 017621          259 ----------RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS  328 (368)
Q Consensus       259 ----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~  328 (368)
                                ....++||||+++++|.+++.... ...+++..+..++.|++.||.|||++   +|+||||||+||++++
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                      445899999999999999997543 23489999999999999999999999   9999999999999999


Q ss_pred             CCCeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          329 ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ++.+||+|||+++....... .....||+.|+|||
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE  191 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPE  191 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC-CCCCCSCCTTSCHH
T ss_pred             CCCEEECcchhheecccccc-ccccCCcccccChh
Confidence            99999999999988765432 23457999999998

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.97  E-value=7.9e-31  Score=238.49  Aligned_cols=171  Identities=31%  Similarity=0.458  Sum_probs=144.4

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|++++++++||||+++++++...+..|+||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccch-hhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence            57999999999999999999864 68999999987543221 23367889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||++ ++|.+++..... ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||++......
T Consensus        82 e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  156 (299)
T 2r3i_A           82 EFLH-QDLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  156 (299)
T ss_dssp             ECCS-EEHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             Eccc-CCHHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHeEEcCCCCEEECcchhhhhccCC
Confidence            9998 599999876532 3388999999999999999999999   9999999999999999999999999999877644


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........||+.|+|||+
T Consensus       157 ~~~~~~~~~~~~y~aPE~  174 (299)
T 2r3i_A          157 VRTYTHEVVTLWYRAPEI  174 (299)
T ss_dssp             SBCTTSCBCCCTTCCHHH
T ss_pred             ccccCcccccccccCcHH
Confidence            444444578999999983

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=5.3e-31  Score=246.93  Aligned_cols=166  Identities=28%  Similarity=0.367  Sum_probs=137.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-----
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-----  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  260 (368)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++...... ....+++.+|+++++.++||||+++++++...+     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            45799999999999999999986 57899999999654322 234567889999999999999999999998653     


Q ss_pred             -eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          261 -CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       261 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                       ..|+||||+ +++|.++++..    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence             469999999 78999998763    389999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++.....   ....+||+.|+|||+
T Consensus       175 a~~~~~~---~~~~~~t~~y~aPE~  196 (367)
T 1cm8_A          175 ARQADSE---MTGYVVTRWYRAPEV  196 (367)
T ss_dssp             CEECCSS---CCSSCSCGGGCCTHH
T ss_pred             ccccccc---cCcCcCCCCcCCHHH
Confidence            9986532   234578999999983

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=4.2e-31  Score=241.62  Aligned_cols=167  Identities=31%  Similarity=0.485  Sum_probs=135.7

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||+||+|+. .++.||+|++....     ..+.+.+|++++++++||||+++++++.+  ..++||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~   78 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM   78 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence            35799999999999999999987 47889999997543     23678899999999999999999998874  478999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC-eEEeeeccceecCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE-AFVADFGVARLLNF  345 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DFg~a~~~~~  345 (368)
                      ||+++|+|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            99999999999987654445789999999999999999999932239999999999999998886 79999999986543


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..   ....||+.|+|||+
T Consensus       159 ~~---~~~~gt~~y~aPE~  174 (307)
T 2eva_A          159 HM---TNNKGSAAWMAPEV  174 (307)
T ss_dssp             ---------CCTTSSCHHH
T ss_pred             cc---ccCCCCCceEChhh
Confidence            22   23469999999983

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=4.8e-31  Score=238.74  Aligned_cols=165  Identities=23%  Similarity=0.453  Sum_probs=142.8

Q ss_pred             hhccccceeeeecCCccEEEEEcCC-C-------CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS-G-------KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH  258 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  258 (368)
                      .++|++.+.||+|+||+||+|.+.. +       ..||+|.+.....   ...+.+.+|++++++++||||+++++++.+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            4689999999999999999997542 3       4799999865432   244788999999999999999999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC-------
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE-------  331 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------  331 (368)
                      .+..++||||+++|+|.+++.....  .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.       
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence            9999999999999999999986543  388999999999999999999999   9999999999999998887       


Q ss_pred             -eEEeeeccceecCCCCCCccccccccccccCC
Q 017621          332 -AFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       332 -~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                       +||+|||++.....    .....||+.|+|||
T Consensus       159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE  187 (289)
T 4fvq_A          159 FIKLSDPGISITVLP----KDILQERIPWVPPE  187 (289)
T ss_dssp             EEEECCCCSCTTTSC----HHHHHHTTTTSCHH
T ss_pred             eeeeccCcccccccC----ccccCCcCcccCHH
Confidence             99999999875432    23346899999998

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=1.1e-30  Score=237.29  Aligned_cols=167  Identities=21%  Similarity=0.309  Sum_probs=144.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  264 (368)
                      .++|++.+.||+|+||+||+|.. .+++.||+|++......     +.+.+|+++++.+ +|+|++++++++.+....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            35799999999999999999985 57899999998654322     4577899999999 89999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC-----eEEeeecc
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE-----AFVADFGV  339 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFg~  339 (368)
                      ||||+ +++|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.     +||+|||+
T Consensus        84 v~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            99999 8999999986532  389999999999999999999999   9999999999999987776     99999999


Q ss_pred             ceecCCCCC-------CccccccccccccCCC
Q 017621          340 ARLLNFDSS-------NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~-------~~~~~~gt~~y~aPE~  364 (368)
                      ++.......       ......||+.|+|||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  189 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINT  189 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchh
Confidence            998765432       1234579999999984

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=2.4e-30  Score=235.16  Aligned_cols=172  Identities=26%  Similarity=0.387  Sum_probs=148.6

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccc------hhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEe
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSE------TEELASLESFRNEARLLSQIW-HRNIVKLYGFCL  257 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  257 (368)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....      .......+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999864 68899999986543      111233467889999999995 999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                      ..+..++||||+++++|.+++....   .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            9999999999999999999997643   389999999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccCCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |++........ .....||+.|+|||+
T Consensus       169 g~~~~~~~~~~-~~~~~~~~~y~aPE~  194 (298)
T 1phk_A          169 GFSCQLDPGEK-LREVCGTPSYLAPEI  194 (298)
T ss_dssp             TTCEECCTTCC-BCCCCSCGGGCCHHH
T ss_pred             cchhhcCCCcc-cccccCCccccCHHH
Confidence            99988764332 334579999999984

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=4.4e-31  Score=238.91  Aligned_cols=171  Identities=29%  Similarity=0.466  Sum_probs=148.5

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|.+.....    ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            4568999999999999999999865 488999999876543    24678899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++++|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999999976433 3489999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCC-CccccccccccccCCC
Q 017621          345 FDSS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~-~~~~~~gt~~y~aPE~  364 (368)
                      .... ......||+.|+|||+
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~  183 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPES  183 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHH
T ss_pred             CCccccccCCccccCcCChhh
Confidence            4432 2233457889999983

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=6.8e-31  Score=242.37  Aligned_cols=182  Identities=23%  Similarity=0.345  Sum_probs=149.7

Q ss_pred             cccHHHHHHHhhccccc-eeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEE
Q 017621          177 RITFQDMIEATEDFHIK-YCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLY  253 (368)
Q Consensus       177 ~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  253 (368)
                      .+.++......++|.+. +.||+|+||+||+|... +++.||+|++....... .....+.+|+.++..+ +||||++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            44555666777888887 89999999999999864 68999999987644322 2346788999999999 569999999


Q ss_pred             EEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CC
Q 017621          254 GFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS---EL  330 (368)
Q Consensus       254 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~  330 (368)
                      +++.+.+..|+||||+++|+|.+++.... ...+++.++..++.|++.||+|||++   +|+||||||+|||++.   ++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence            99999999999999999999999986542 23489999999999999999999999   9999999999999987   78


Q ss_pred             CeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          331 EAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       331 ~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      .+||+|||+++....... .....||+.|+|||+
T Consensus       172 ~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~  204 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEI  204 (327)
T ss_dssp             CEEECCGGGCEEC----------CCCGGGCCHHH
T ss_pred             cEEEeeCccccccCCccc-cccccCCcCccCCee
Confidence            999999999998754332 234579999999983

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=1.2e-30  Score=239.14  Aligned_cols=169  Identities=32%  Similarity=0.502  Sum_probs=143.3

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+.....     .+.+.+|++++++++||||+++++++...+..|+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            4568999999999999999999864 589999999875432     2578899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++++|.+++....  ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus       102 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             EeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            999999999999987422  2389999999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..........||+.|+|||+
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~  196 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEV  196 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHH
T ss_pred             hhccccCccCCCCCccChhh
Confidence            55444455679999999983

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=9.7e-31  Score=244.59  Aligned_cols=178  Identities=24%  Similarity=0.370  Sum_probs=142.2

Q ss_pred             cHHHHHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchh--------hHHhHHHHHHHHHHHhccCCCcee
Q 017621          179 TFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE--------ELASLESFRNEARLLSQIWHRNIV  250 (368)
Q Consensus       179 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv  250 (368)
                      ...++....++|++.+.||+|+||.||+|.+.+++.||||++......        .....+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            456777788999999999999999999999888999999998653221        122347889999999999999999


Q ss_pred             eEEEEEee-----CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 017621          251 KLYGFCLH-----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVL  325 (368)
Q Consensus       251 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  325 (368)
                      ++++++..     ....|+||||++ |+|.+.+....  ..+++..+..++.||+.||.|||++   +|+||||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence            99999854     346899999998 58888887543  3489999999999999999999999   9999999999999


Q ss_pred             ecCCCCeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          326 LNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       326 l~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ++.++.+||+|||+++...... ......||+.|+|||
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE  203 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPE  203 (362)
T ss_dssp             ECTTCCEEECCTTC----------------CGGGCCHH
T ss_pred             EcCCCCEEEEecCccccccccc-ccceecccceecCcH
Confidence            9999999999999998654332 233457999999998

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=2.7e-30  Score=239.49  Aligned_cols=173  Identities=26%  Similarity=0.406  Sum_probs=147.0

Q ss_pred             ccHHHHHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhc--cCCCceeeEEEE
Q 017621          178 ITFQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQ--IWHRNIVKLYGF  255 (368)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~  255 (368)
                      .++.-.....++|++.+.||+|+||.||+|+. +++.||+|++....      .+.+.+|.+++..  ++||||++++++
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~  104 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAA  104 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence            34444445678999999999999999999997 58999999986532      2466778888877  799999999999


Q ss_pred             EeeCC----eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeeecCCCCCC
Q 017621          256 CLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH--------HHCTPPIVHRDISSNN  323 (368)
Q Consensus       256 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~N  323 (368)
                      +...+    ..++||||+++|+|.+++...    .+++.+++.++.|++.||+|||        +.   +|+||||||+|
T Consensus       105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~N  177 (342)
T 1b6c_B          105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKN  177 (342)
T ss_dssp             EECCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGG
T ss_pred             ecccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHH
Confidence            98876    799999999999999999764    3899999999999999999999        66   99999999999


Q ss_pred             eeecCCCCeEEeeeccceecCCCCCC----ccccccccccccCCC
Q 017621          324 VLLNSELEAFVADFGVARLLNFDSSN----RTLLAGTSGYIAPAS  364 (368)
Q Consensus       324 Ill~~~~~~kl~DFg~a~~~~~~~~~----~~~~~gt~~y~aPE~  364 (368)
                      ||++.++.+||+|||+++........    .....||+.|+|||+
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  222 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  222 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHH
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhh
Confidence            99999999999999999877654321    234579999999983

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.9e-31  Score=249.09  Aligned_cols=169  Identities=25%  Similarity=0.413  Sum_probs=131.8

Q ss_pred             hccccceeeeecCCccEEEEEcC--C--CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee-CCeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP--S--GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH-RKCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  262 (368)
                      ..|++.+.||+|+||+||+|...  +  +..||+|.+......  ...+++.+|+.++++++||||+++++++.. ++..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            35778899999999999999853  2  246899998754322  345789999999999999999999998754 5678


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++|+|.++++....  .+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~  241 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  241 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence            999999999999999976432  378999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC----CccccccccccccCC
Q 017621          343 LNFDSS----NRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~----~~~~~~gt~~y~aPE  363 (368)
                      ......    ......||+.|+|||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~y~aPE  266 (373)
T 3c1x_A          242 MYDKEFDSVHNKTGAKLPVKWMALE  266 (373)
T ss_dssp             ----------------CCGGGSCHH
T ss_pred             ccccccccccccCCCCCcccccChH
Confidence            643321    123346788999998

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=3.1e-30  Score=233.72  Aligned_cols=168  Identities=24%  Similarity=0.419  Sum_probs=142.8

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee----CCeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH----RKCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  262 (368)
                      +.|++.+.||+|+||.||+|.+ .++..||+|.+....... ...+.+.+|+.++++++||||+++++++..    ....
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            3478889999999999999985 468899999987544322 345788999999999999999999999875    3568


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeec-CCCCeEEeeecc
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP--IVHRDISSNNVLLN-SELEAFVADFGV  339 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DFg~  339 (368)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||++   +  |+||||||+||+++ .++.+||+|||+
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            99999999999999997643   389999999999999999999998   7  99999999999998 789999999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +......  ......||+.|+|||+
T Consensus       179 ~~~~~~~--~~~~~~~t~~y~aPE~  201 (290)
T 1t4h_A          179 ATLKRAS--FAKAVIGTPEFMAPEM  201 (290)
T ss_dssp             GGGCCTT--SBEESCSSCCCCCGGG
T ss_pred             ccccccc--ccccccCCcCcCCHHH
Confidence            9765432  2334579999999994

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=1.6e-30  Score=237.28  Aligned_cols=168  Identities=26%  Similarity=0.441  Sum_probs=143.9

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|.+.+.||+|+||+||+|+.. +++.||+|++......   ..+.+.+|++++++++||||+++++++.+.+..|+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            3568999999999999999999864 7899999999754332   23568899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCCeEEeeeccce
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL---NSELEAFVADFGVAR  341 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFg~a~  341 (368)
                      ||||+++++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||++   +.++.+||+|||+++
T Consensus        84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           84 VMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            999999999999887543   389999999999999999999999   99999999999999   788999999999997


Q ss_pred             ecCCCCCCccccccccccccCCC
Q 017621          342 LLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      .....  ......||+.|+|||+
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~  178 (304)
T 2jam_A          158 MEQNG--IMSTACGTPGYVAPEV  178 (304)
T ss_dssp             CCCCB--TTHHHHSCCCBCCTTT
T ss_pred             ecCCC--ccccccCCCCccChHH
Confidence            65432  2234579999999994

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=5.8e-31  Score=245.97  Aligned_cols=169  Identities=28%  Similarity=0.363  Sum_probs=145.1

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++. +++.||+|++......  ...+.+.+|++++++++||||+++++++.+++..|+|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH--HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            467999999999999999999864 6899999998765332  2446789999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||+.+  +|+||||||+|||++.++.+||+|||++.....
T Consensus       110 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             ECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999997643   3899999999999999999999832  799999999999999999999999999976533


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..  .....||+.|+|||+
T Consensus       185 ~~--~~~~~gt~~y~aPE~  201 (360)
T 3eqc_A          185 SM--ANSFVGTRSYMSPER  201 (360)
T ss_dssp             HC------CCCCTTCCHHH
T ss_pred             cc--ccCCCCCCCeECHHH
Confidence            22  233579999999983

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=1.1e-30  Score=239.45  Aligned_cols=168  Identities=21%  Similarity=0.379  Sum_probs=138.4

Q ss_pred             hccccc-eeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEE
Q 017621          188 EDFHIK-YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       188 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  264 (368)
                      +.|++. +.||+|+||+||+|.. .+++.||||++......   ..+.+.+|++++.++ +||||+++++++.+.+..|+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            568774 7899999999999985 46899999998754322   346788999999885 79999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC---eEEeeeccce
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE---AFVADFGVAR  341 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFg~a~  341 (368)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.   +||+|||+++
T Consensus        89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999999999997643   389999999999999999999999   9999999999999998776   9999999998


Q ss_pred             ecCCCCC-------CccccccccccccCCC
Q 017621          342 LLNFDSS-------NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~-------~~~~~~gt~~y~aPE~  364 (368)
                      .......       .....+||+.|+|||+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  192 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEV  192 (316)
T ss_dssp             -------------------CCSGGGCCHHH
T ss_pred             ccccCCccccccccccccccCCcCccChHH
Confidence            6643211       1223469999999994

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=9.8e-31  Score=240.69  Aligned_cols=171  Identities=29%  Similarity=0.423  Sum_probs=140.6

Q ss_pred             HhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchh-----hHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE-----ELASLESFRNEARLLSQIWHRNIVKLYGFCLHR  259 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  259 (368)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++......     .......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            457899999999999999999986 46889999998754321     112234678999999999999999999998776


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC---eEEee
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE---AFVAD  336 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D  336 (368)
                      + .|+||||+++++|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 899999999999999887543   389999999999999999999999   9999999999999987654   99999


Q ss_pred             eccceecCCCCCCccccccccccccCCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ||+++...... ......||+.|+|||+
T Consensus       161 fg~~~~~~~~~-~~~~~~gt~~y~aPE~  187 (322)
T 2ycf_A          161 FGHSKILGETS-LMRTLCGTPTYLAPEV  187 (322)
T ss_dssp             CTTCEECCCCH-HHHHHHSCCTTCCHHH
T ss_pred             Cccceeccccc-ccccccCCcCccCchh
Confidence            99998875322 2234579999999995

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=4.4e-31  Score=237.77  Aligned_cols=174  Identities=32%  Similarity=0.545  Sum_probs=145.3

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee--CCeEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH--RKCMF  263 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  263 (368)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.+....... ...+.+.+|++++++++||||+++++++.+  .+..|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            468999999999999999999864 68999999987644322 345688999999999999999999998754  56899


Q ss_pred             EEEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eeecCCCCCCeeecCCCCeEEeee
Q 017621          264 LIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPP-----IVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                      +||||+++++|.+++.... ....+++..+..++.|++.||+|||+.   +     |+||||||+||+++.++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            9999999999999987532 223489999999999999999999998   7     999999999999999999999999


Q ss_pred             ccceecCCCCCCccccccccccccCCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+++.............||+.|+|||+
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~  187 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQ  187 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHH
T ss_pred             chheeeccccccccccCCCccccChHH
Confidence            999877544333344579999999983

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=2.4e-31  Score=251.65  Aligned_cols=166  Identities=23%  Similarity=0.315  Sum_probs=135.1

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC------e
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK------C  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  261 (368)
                      .+|++.+.||+|+||+||+|++..+..+|+|++.....       ...+|+++++.++||||+++++++...+      .
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            47999999999999999999987777799998865332       1236999999999999999999986543      3


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCCeEEeeeccc
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN-SELEAFVADFGVA  340 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFg~a  340 (368)
                      .++||||++++.+............+++..+..++.||+.||+|||++   +|+||||||+|||++ .++.+||+|||++
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            889999998754433332222223489999999999999999999999   999999999999999 7999999999999


Q ss_pred             eecCCCCCCccccccccccccCCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +....... .....||+.|+|||+
T Consensus       190 ~~~~~~~~-~~~~~~t~~y~aPE~  212 (394)
T 4e7w_A          190 KILIAGEP-NVSYICSRYYRAPEL  212 (394)
T ss_dssp             EECCTTCC-CCSSCSCGGGCCHHH
T ss_pred             ccccCCCC-CcccccCcCccCHHH
Confidence            98754433 234578999999983

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=1.4e-31  Score=262.87  Aligned_cols=169  Identities=28%  Similarity=0.478  Sum_probs=144.3

Q ss_pred             HhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ..++|++.+.||+|+||+||+|.+.++..||||+++....    ..++|.+|++++++++||||+++++++.+ +..|+|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            4567999999999999999999988888899999976543    23678999999999999999999999876 668999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.++++... ...+++.+++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus       340 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             ECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            99999999999997532 12388999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCC-CccccccccccccCC
Q 017621          346 DSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~-~~~~~~gt~~y~aPE  363 (368)
                      ... ......++..|+|||
T Consensus       416 ~~~~~~~~~~~~~~y~aPE  434 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPE  434 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHH
T ss_pred             CceecccCCcCcccccCHH
Confidence            211 112235678999999

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.7e-30  Score=239.35  Aligned_cols=174  Identities=29%  Similarity=0.514  Sum_probs=142.6

Q ss_pred             HHHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEee--
Q 017621          183 MIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLH--  258 (368)
Q Consensus       183 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--  258 (368)
                      +....++|++.+.||+|+||.||+|++ .+++.||+|++......    .+.+.+|+.+++++ +||||+++++++..  
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            344567899999999999999999986 57899999998654332    26788999999999 89999999999987  


Q ss_pred             ----CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEE
Q 017621          259 ----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFV  334 (368)
Q Consensus       259 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  334 (368)
                          .+..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++   +|+||||||+||+++.++.+||
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence                467999999999999999998643 23489999999999999999999999   9999999999999999999999


Q ss_pred             eeeccceecCCCCCCccccccccccccCCC
Q 017621          335 ADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       335 ~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +|||++..............||+.|+|||+
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~  200 (326)
T 2x7f_A          171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEV  200 (326)
T ss_dssp             CCCTTTC-------------CCGGGCCHHH
T ss_pred             eeCcCceecCcCccccccccCCccccChhh
Confidence            999999877544333445579999999984

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.6e-30  Score=233.91  Aligned_cols=169  Identities=27%  Similarity=0.416  Sum_probs=142.7

Q ss_pred             hhccccce-eeeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKY-CIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||+|++......  ...+++.+|++++++++||||+++++++ ..+..
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~   84 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL   84 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence            35677776 9999999999999753   5778999999865332  3457889999999999999999999999 45568


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++++|.+++....  ..+++..+..++.|+++||.|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence            99999999999999997543  3389999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCCC---ccccccccccccCC
Q 017621          343 LNFDSSN---RTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~---~~~~~gt~~y~aPE  363 (368)
                      .......   .....||+.|+|||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE  183 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPE  183 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHH
T ss_pred             eccCcceeeccccccccccccCHH
Confidence            7543321   22335789999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=1.9e-30  Score=235.97  Aligned_cols=169  Identities=26%  Similarity=0.417  Sum_probs=140.0

Q ss_pred             hccccceeeeecCCccEEEEEcCC----CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEe-eCCeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCL-HRKCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~  262 (368)
                      .+|++.+.||+|+||+||+|.+.+    ...+|+|.+......  ...+.+.+|+.++++++||||+++++++. .++..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH--HHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            468889999999999999998532    236899998764432  34578899999999999999999999865 45678


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++|+|.++++...  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence            99999999999999997643  3378999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCC----CCccccccccccccCC
Q 017621          343 LNFDS----SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~----~~~~~~~gt~~y~aPE  363 (368)
                      .....    .......||+.|+|||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE  202 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALE  202 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHH
T ss_pred             ccccchhccccccCCCCCccccChH
Confidence            64322    1223346788999998

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=1.3e-30  Score=236.27  Aligned_cols=169  Identities=28%  Similarity=0.484  Sum_probs=133.5

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||+||+|+..  ..||+|+++..... ....+.+.+|++++++++||||+++++++ ..+..++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            467999999999999999999864  35999998765432 23457899999999999999999999965 455689999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++++|.+++....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence            9999999999997543  3389999999999999999999999   9999999999999999999999999999866432


Q ss_pred             C--CCccccccccccccCCC
Q 017621          347 S--SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~--~~~~~~~gt~~y~aPE~  364 (368)
                      .  .......||+.|+|||+
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~  193 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEV  193 (289)
T ss_dssp             ----------CCCTTCCHHH
T ss_pred             cccccccccCCCccccCchh
Confidence            2  22334579999999983

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=1e-30  Score=239.45  Aligned_cols=175  Identities=22%  Similarity=0.411  Sum_probs=134.7

Q ss_pred             HhhccccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-  260 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  260 (368)
                      ..++|.+.+.||+|+||.||+|...    +++.||+|.+....... ...+.+.+|++++++++||||+++++++.+.+ 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            4578999999999999999999753    34589999997653322 23467899999999999999999999998755 


Q ss_pred             ----eEEEEEeecCCCChhHHhhcC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeE
Q 017621          261 ----CMFLIYEYMEMGSLFCVLRTD---EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF  333 (368)
Q Consensus       261 ----~~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  333 (368)
                          ..++||||+++++|.+++...   .....+++..++.++.|+++||.|||++   +|+||||||+||+++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence                359999999999999998532   1234589999999999999999999999   999999999999999999999


Q ss_pred             EeeeccceecCCCCC--CccccccccccccCCC
Q 017621          334 VADFGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       334 l~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      |+|||+++.......  ......+++.|+|||+
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  220 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES  220 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHH
T ss_pred             EeecCcceecccccccCcccccCCCccccCchh
Confidence            999999987654322  2233467889999984

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=1.1e-30  Score=235.48  Aligned_cols=169  Identities=26%  Similarity=0.362  Sum_probs=139.8

Q ss_pred             hhccccceeeeecCCccEEEEEcCC----CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||+||+|.+..    +..||+|.+......  ...+.+.+|++++++++||||+++++++.++ ..
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL--DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH--HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc--hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence            4689999999999999999997432    346999999765432  2347889999999999999999999998754 46


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+||||+++++|.+++....  ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            89999999999999997643  2389999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccCC
Q 017621          343 LNFDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~-~~~~~~gt~~y~aPE  363 (368)
                      ...... ......||+.|+|||
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE  184 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPE  184 (281)
T ss_dssp             C---------CCCCCGGGCCHH
T ss_pred             cccccccccccCCCCcceeCch
Confidence            654322 223345788999998

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=5e-30  Score=236.56  Aligned_cols=162  Identities=20%  Similarity=0.337  Sum_probs=142.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEee--CCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLH--RKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~  262 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++.....      +.+.+|++++++++ ||||+++++++.+  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch------HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            36899999999999999999975 5789999999875432      56889999999996 9999999999988  5678


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-CeEEeeeccce
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-EAFVADFGVAR  341 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFg~a~  341 (368)
                      ++||||+++++|.++++.      +++.++..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+++
T Consensus       109 ~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            999999999999998853      78899999999999999999999   999999999999999776 89999999998


Q ss_pred             ecCCCCCCccccccccccccCCC
Q 017621          342 LLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ....... .....||+.|+|||+
T Consensus       180 ~~~~~~~-~~~~~~~~~y~aPE~  201 (330)
T 3nsz_A          180 FYHPGQE-YNVRVASRYFKGPEL  201 (330)
T ss_dssp             ECCTTCC-CCSCCSCGGGCCHHH
T ss_pred             EcCCCCc-cccccccccccChhh
Confidence            7764433 334579999999984

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=4.6e-31  Score=240.37  Aligned_cols=171  Identities=29%  Similarity=0.442  Sum_probs=141.5

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.....   ...+.+.+|+++++.++||||+++++++...+..++
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            4568999999999999999999865 588999999865432   234688899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      ||||+++++|.+++....  ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        94 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999887532  2389999999999999999999999   99999999999999999999999999976433


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..........||+.|+|||+
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~  188 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEV  188 (302)
T ss_dssp             HHHHC-----CCGGGCCHHH
T ss_pred             ccccccccccCChhhcCCee
Confidence            22222233579999999984

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=1.1e-30  Score=239.37  Aligned_cols=179  Identities=23%  Similarity=0.373  Sum_probs=149.2

Q ss_pred             HHHHHHHhhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeE
Q 017621          180 FQDMIEATEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKL  252 (368)
Q Consensus       180 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  252 (368)
                      ..+.....++|++.+.||+|+||+||+|++      .+++.||+|++......  ...+.+.+|++++.++ +||||+++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc--HHHHHHHHHHHHHHhcccCCCeeeE
Confidence            344444568999999999999999999973      35688999999765433  2346788999999999 79999999


Q ss_pred             EEEEeeCC-eEEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecC
Q 017621          253 YGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRD  318 (368)
Q Consensus       253 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  318 (368)
                      ++++...+ ..++||||+++++|.+++.....             ...+++..+..++.|+++||.|||++   +|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            99988754 58999999999999999986543             12278899999999999999999999   999999


Q ss_pred             CCCCCeeecCCCCeEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          319 ISSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       319 lkp~NIll~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      |||+||+++.++.+||+|||+++........  .....||+.|+|||
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE  220 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  220 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCch
Confidence            9999999999999999999999876544332  23456899999998

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.8e-30  Score=240.19  Aligned_cols=171  Identities=33%  Similarity=0.478  Sum_probs=137.8

Q ss_pred             hhccccceeeeecCCccEEEEEcCC-----CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS-----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      .++|++.+.||+|+||+||+|....     +..||+|.+......  .....+.+|++++++++||||+++++++.+.+.
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            3568888999999999999997532     246999998764432  234678899999999999999999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence            999999999999999997643  2389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCCC---ccccccccccccCCC
Q 017621          342 LLNFDSSN---RTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~---~~~~~gt~~y~aPE~  364 (368)
                      ........   .....+|+.|+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~  221 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEA  221 (333)
T ss_dssp             ---------------CCCGGGSCHHH
T ss_pred             hhccccccccccCCCCccccccCchh
Confidence            77543221   122346889999983

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=1.3e-30  Score=241.13  Aligned_cols=167  Identities=29%  Similarity=0.477  Sum_probs=135.2

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHH--HHhccCCCceeeEEEEEee-----C
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEAR--LLSQIWHRNIVKLYGFCLH-----R  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~~-----~  259 (368)
                      .++|++.+.||+|+||.||+|+. +++.||||++.....      +.+..|.+  .+..++||||+++++++..     .
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            46899999999999999999987 688999999865432      23333444  4556899999999986543     2


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeeecCCCCCCeeecCCCCeE
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC------TPPIVHRDISSNNVLLNSELEAF  333 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~k  333 (368)
                      ...++||||+++|+|.+++....    .++..+..++.||++||+|||+.+      .++|+||||||+|||++.++.+|
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             ceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            35789999999999999997643    588999999999999999999863      23899999999999999999999


Q ss_pred             EeeeccceecCCCCC--------CccccccccccccCCC
Q 017621          334 VADFGVARLLNFDSS--------NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       334 l~DFg~a~~~~~~~~--------~~~~~~gt~~y~aPE~  364 (368)
                      |+|||+++.+.....        .....+||+.|+|||+
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  199 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV  199 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHH
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchh
Confidence            999999987753221        1224479999999994

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=3.8e-30  Score=234.63  Aligned_cols=173  Identities=22%  Similarity=0.343  Sum_probs=142.3

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhh-HHhHHHHHHHHHHHhccCCCceeeEEEEEe--eCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEE-LASLESFRNEARLLSQIWHRNIVKLYGFCL--HRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  262 (368)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++....... ....+.+.+|++++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999986 468899999997643322 123467899999999999999999999984  45578


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+||||++++ +.+++..... ..+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999876 7777765432 3489999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC--CccccccccccccCCC
Q 017621          343 LNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ......  ......||+.|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~  182 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEI  182 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHH
T ss_pred             cCccccccccccCCCCCCCcChhh
Confidence            753222  2234569999999984

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=240.90  Aligned_cols=170  Identities=25%  Similarity=0.454  Sum_probs=134.8

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCC----EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      .++|++.+.||+|+||+||+|++. +++    .||+|.+......  ...+++.+|+.++++++||||+++++++...+ 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            357999999999999999999853 444    3577777543322  23468899999999999999999999998765 


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .++|+||+.+|+|.+++.....  .+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             ceEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            7899999999999999976533  389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCCC--ccccccccccccCCC
Q 017621          342 LLNFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      ........  .....||+.|+|||+
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~  190 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALES  190 (327)
T ss_dssp             --------------CCCGGGSCHHH
T ss_pred             EccCccccccccCCCccccccCHHH
Confidence            77543322  223457889999983

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=260.19  Aligned_cols=168  Identities=26%  Similarity=0.408  Sum_probs=136.2

Q ss_pred             hccccce-eeeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKY-CIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      +++.+.+ .||+|+||+||+|.+.   ++..||||+++.....  ...+++.+|++++++++||||+++++++.. +..|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            3444444 7999999999999753   4567999999765322  245789999999999999999999999976 5589


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +||||+++|+|.+++....  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       412 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             EEEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999999999997543  3489999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCC---ccccccccccccCC
Q 017621          344 NFDSSN---RTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~---~~~~~gt~~y~aPE  363 (368)
                      ......   .....+|+.|+|||
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE  509 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPE  509 (613)
T ss_dssp             C--------------CCTTSCHH
T ss_pred             cCCCceeeeccCCCCccceeCHh
Confidence            543221   12234578999998

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=1.7e-30  Score=235.35  Aligned_cols=172  Identities=27%  Similarity=0.445  Sum_probs=134.5

Q ss_pred             hhccccceeeeecCCccEEEEEc--CCCC--EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL--PSGK--VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||+||+|++  .+++  .||+|++...........+.+.+|++++++++||||+++++++...+ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            35899999999999999999974  2333  68999987654444445678999999999999999999999998765 8


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++++|.+++....  ..+++..+..++.|+++||.|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence            89999999999999997643  2388999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCCC---ccccccccccccCCC
Q 017621          343 LNFDSSN---RTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~---~~~~~gt~~y~aPE~  364 (368)
                      .......   .....||+.|+|||+
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~  195 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPES  195 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHH
T ss_pred             ccccccchhhhccCCCCceeeCchh
Confidence            7544332   223467889999983

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=1.3e-30  Score=237.28  Aligned_cols=174  Identities=26%  Similarity=0.454  Sum_probs=129.3

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+......  ...+++.+|++++++++||||+++++++...+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            3568999999999999999999864 6889999998754332  234678899999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          265 IYEYMEMGSLFCVLRTD-----EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      ||||+++++|.+++...     .....+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999988641     1123489999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCC-----CccccccccccccCCC
Q 017621          340 ARLLNFDSS-----NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~-----~~~~~~gt~~y~aPE~  364 (368)
                      +........     ......||+.|+|||+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEV  197 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHH
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHH
Confidence            977643221     1234579999999983

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=5.3e-30  Score=236.21  Aligned_cols=170  Identities=31%  Similarity=0.503  Sum_probs=144.2

Q ss_pred             hhccccceeeeecCCccEEEEEc-----CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-----PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  260 (368)
                      .++|++.+.||+|+||.||+|+.     .+++.||+|++.....   ...+.+.+|++++++++||||+++++++...+ 
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---HHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            45799999999999999999983     4688999999876433   23467899999999999999999999987654 


Q ss_pred             -eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          261 -CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       261 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                       ..++||||+++++|.+++.....  .+++.+++.++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CceEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence             68999999999999999986532  389999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCC---ccccccccccccCCC
Q 017621          340 ARLLNFDSSN---RTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~---~~~~~gt~~y~aPE~  364 (368)
                      ++........   .....+|..|+|||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~  219 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPES  219 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHH
T ss_pred             hhhccccccccccccCCCCceeEECchh
Confidence            9987654321   223457888999983

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=3e-30  Score=236.70  Aligned_cols=172  Identities=22%  Similarity=0.350  Sum_probs=142.3

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee----CCe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH----RKC  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  261 (368)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++.....   ...+.+.+|+++++.++||||+++++++..    ...
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH---HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            46899999999999999999986 5789999998865433   244678899999999999999999999873    347


Q ss_pred             EEEEEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          262 MFLIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      .|+||||+++|+|.+++.... ....+++.++..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            899999999999999887521 123489999999999999999999999   9999999999999999999999999998


Q ss_pred             eecCCCCCC---------ccccccccccccCCC
Q 017621          341 RLLNFDSSN---------RTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~---------~~~~~gt~~y~aPE~  364 (368)
                      .........         .....||+.|+|||+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  214 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPEL  214 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGG
T ss_pred             hhcccccccccccccccccccccCCcccCCHhH
Confidence            875422111         123457999999995

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=1.2e-30  Score=242.43  Aligned_cols=171  Identities=20%  Similarity=0.252  Sum_probs=136.8

Q ss_pred             hhccccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhH--------HhHHHHHHHHHHHhccCCCceeeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEEL--------ASLESFRNEARLLSQIWHRNIVKLYG  254 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~  254 (368)
                      .++|++.+.||+|+||+||+|.+.    ++..+|+|++........        .....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357999999999999999999864    577899999876532211        11234677889999999999999999


Q ss_pred             EEee----CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 017621          255 FCLH----RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL  330 (368)
Q Consensus       255 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  330 (368)
                      ++..    .+..|+||||+ +++|.+++....   .+++.+++.++.||+.||+|||++   +|+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            9988    67899999999 899999997654   389999999999999999999999   999999999999999887


Q ss_pred             --CeEEeeeccceecCCCCC-------CccccccccccccCCC
Q 017621          331 --EAFVADFGVARLLNFDSS-------NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       331 --~~kl~DFg~a~~~~~~~~-------~~~~~~gt~~y~aPE~  364 (368)
                        .+||+|||+++.+.....       ......||+.|+|||+
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  231 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDA  231 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHH
Confidence              999999999987743221       1244579999999983

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.9e-30  Score=233.69  Aligned_cols=169  Identities=25%  Similarity=0.375  Sum_probs=141.0

Q ss_pred             ccccceeeeecCCccEEEEEcC-C---CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE-E
Q 017621          189 DFHIKYCIGTGGYGSVYRARLP-S---GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM-F  263 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~  263 (368)
                      .|+..+.||+|+||+||+|.+. +   +..+|+|.+......  ...+.+.+|++++++++||||+++++++.+.+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM--QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            4666789999999999999742 2   337999998764432  3457889999999999999999999999876654 9


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +||||+.+|+|.+++....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus       100 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            9999999999999997643  3488999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCC----CCccccccccccccCCC
Q 017621          344 NFDS----SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~~~----~~~~~~~gt~~y~aPE~  364 (368)
                      ....    .......||+.|+|||+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~  199 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALES  199 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHH
T ss_pred             cCCcccccccCcCCCCCccccChhh
Confidence            4321    22234568999999983

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=7.1e-31  Score=250.45  Aligned_cols=165  Identities=27%  Similarity=0.398  Sum_probs=133.8

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC------C
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR------K  260 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  260 (368)
                      .+|++.+.||+|+||+||+|++. +++.||||++.....       ...+|+++++.++||||+++++++...      .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            36899999999999999999864 689999999865321       234699999999999999999988542      2


Q ss_pred             eEEEEEeecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-CCeEEeeec
Q 017621          261 CMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFG  338 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFg  338 (368)
                      ..++||||+++ ++.+.+... .....+++..+..++.||++||+|||++   +|+||||||+|||++.+ +.+||+|||
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence            46799999986 666555421 1223489999999999999999999999   99999999999999965 578999999


Q ss_pred             cceecCCCCCCccccccccccccCCC
Q 017621          339 VARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       339 ~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +++....... ....+||+.|+|||+
T Consensus       203 ~a~~~~~~~~-~~~~~~t~~y~aPE~  227 (420)
T 1j1b_A          203 SAKQLVRGEP-NVSYICSRYYRAPEL  227 (420)
T ss_dssp             TCEECCTTCC-CCSCCSCTTSCCHHH
T ss_pred             hhhhcccCCC-ceeeeeCCCcCCHHH
Confidence            9998754333 234578999999983

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=5.2e-30  Score=239.93  Aligned_cols=168  Identities=27%  Similarity=0.400  Sum_probs=143.8

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-----C
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-----K  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  260 (368)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++......  ...+.+.+|++++++++||||+++++++...     .
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc--HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            458999999999999999999854 6889999999754332  2346788999999999999999999999765     3


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+||||++ |+|.++++..    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence            6899999998 5999988754    289999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCC---ccccccccccccCCC
Q 017621          341 RLLNFDSSN---RTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~---~~~~~gt~~y~aPE~  364 (368)
                      +........   ....+||+.|+|||+
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~  202 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEI  202 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHH
Confidence            877543221   234579999999994

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=4e-30  Score=241.37  Aligned_cols=167  Identities=26%  Similarity=0.335  Sum_probs=132.8

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-----
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-----  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  260 (368)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++...... ....+.+.+|+.+++.++||||+++++++...+     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            36899999999999999999985 46889999998754322 234467889999999999999999999998664     


Q ss_pred             -eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          261 -CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       261 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                       ..|+||||+++ +|.+.+..     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence             78999999985 78888753     288999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++...... .....+||+.|+|||+
T Consensus       174 a~~~~~~~-~~~~~~gt~~y~aPE~  197 (371)
T 2xrw_A          174 ARTAGTSF-MMTPYVVTRYYRAPEV  197 (371)
T ss_dssp             -----------------CTTCCHHH
T ss_pred             cccccccc-ccCCceecCCccCHHH
Confidence            98765332 2334579999999983

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=1.7e-30  Score=235.08  Aligned_cols=173  Identities=24%  Similarity=0.375  Sum_probs=131.9

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+. .+++.||+|++....... ...+.+.++...++.++||||+++++++.+.+..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            46899999999999999999986 578999999997653332 2234455556668888999999999999999999999


Q ss_pred             EeecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          266 YEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |||+++ +|.+++... .....+++..+..++.|++.||+|||+++  +|+||||||+||+++.++.+||+|||+++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            999984 887776531 12234899999999999999999999842  89999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      .... .....||+.|+|||+
T Consensus       162 ~~~~-~~~~~~t~~y~aPE~  180 (290)
T 3fme_A          162 DDVA-KDIDAGCKPYMAPER  180 (290)
T ss_dssp             ---------CCCCCCSCHHH
T ss_pred             cccc-ccccCCCccccChhh
Confidence            4332 233479999999996

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=5.1e-30  Score=245.12  Aligned_cols=166  Identities=20%  Similarity=0.316  Sum_probs=140.8

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc------CCCceeeEEEEEeeC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI------WHRNIVKLYGFCLHR  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~  259 (368)
                      ..+|++.+.||+|+||+||+|.+ .+++.||||++.....    ..+.+.+|+++++.+      +|+||+++++++...
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR----FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc----hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            45799999999999999999975 4588999999976432    235667788877776      577999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC--eEEeee
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE--AFVADF  337 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DF  337 (368)
                      +..++||||+. ++|.+++..... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.  +||+||
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             CeEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence            99999999996 699998876542 3489999999999999999999999   9999999999999999887  999999


Q ss_pred             ccceecCCCCCCccccccccccccCCC
Q 017621          338 GVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+++.....   ....+||+.|+|||+
T Consensus       247 G~a~~~~~~---~~~~~gt~~y~aPE~  270 (429)
T 3kvw_A          247 GSSCYEHQR---VYTYIQSRFYRAPEV  270 (429)
T ss_dssp             TTCEETTCC---CCSSCSCGGGCCHHH
T ss_pred             ccceecCCc---ccccCCCCCccChHH
Confidence            999875432   234579999999984

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=4e-30  Score=237.14  Aligned_cols=173  Identities=28%  Similarity=0.417  Sum_probs=141.3

Q ss_pred             hhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      .++|++.+.||+|+||.||+|++      .+++.||+|.+......  ....++.+|+.++++++||||+++++++.+.+
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch--hhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            46899999999999999999984      35778999999754332  23467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCCeE
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEE----AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS---ELEAF  333 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k  333 (368)
                      ..|+||||+++++|.+++.....    ...+++.+++.++.|++.||.|||++   +|+||||||+|||++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999999986532    13488999999999999999999999   9999999999999984   44699


Q ss_pred             EeeeccceecCCCCC--CccccccccccccCCC
Q 017621          334 VADFGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       334 l~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      |+|||+++.......  ......||+.|+|||+
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  216 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA  216 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhH
Confidence            999999986543322  2233468999999983

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=3.9e-30  Score=259.73  Aligned_cols=162  Identities=29%  Similarity=0.435  Sum_probs=139.1

Q ss_pred             hccccceeeeecCCccEEEEEcC--CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe----
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP--SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC----  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  261 (368)
                      ++|++.+.||+|+||+||+|.+.  +++.||||++......  ...+.+.+|++++++++||||+++++++...+.    
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA--EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH--HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            68999999999999999999864  5889999998754332  234678899999999999999999999987655    


Q ss_pred             -EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          262 -MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       262 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                       .|+||||+++++|.+++..     .+++.+++.++.||+.||+|||++   +|+||||||+|||++.+ .+||+|||++
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence             7999999999999887754     389999999999999999999999   99999999999999986 8999999999


Q ss_pred             eecCCCCCCccccccccccccCCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +.....    ....||+.|+|||+
T Consensus       229 ~~~~~~----~~~~gt~~y~aPE~  248 (681)
T 2pzi_A          229 SRINSF----GYLYGTPGFQAPEI  248 (681)
T ss_dssp             EETTCC----SCCCCCTTTSCTTH
T ss_pred             hhcccC----CccCCCccccCHHH
Confidence            887543    34579999999993

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=1.4e-30  Score=244.55  Aligned_cols=169  Identities=10%  Similarity=0.065  Sum_probs=127.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc--CCCceeeEE-------EEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI--WHRNIVKLY-------GFC  256 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  256 (368)
                      ..+|++.+.||+|+||+||+|++ .+++.||+|++...........+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34699999999999999999985 47899999999886654445567788885544444  699988755       444


Q ss_pred             eeC-----------------CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCC
Q 017621          257 LHR-----------------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKR------VNIVKGMAHALSYLHHHCTPP  313 (368)
Q Consensus       257 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~  313 (368)
                      ...                 ...|+||||++ |+|.+++......  +++..+      ..++.||+.||+|||++   +
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--YVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--cchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            433                 34899999999 8999999864322  444555      67789999999999999   9


Q ss_pred             eeecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       314 ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |+||||||+|||++.++.+||+|||+++.....   .....||+.|+|||+
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~  262 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREF  262 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHH
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhh
Confidence            999999999999999999999999999876422   223467799999984

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=3.2e-30  Score=243.09  Aligned_cols=169  Identities=25%  Similarity=0.352  Sum_probs=136.8

Q ss_pred             HHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee----
Q 017621          184 IEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH----  258 (368)
Q Consensus       184 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----  258 (368)
                      ....++|++.+.||+|+||+||+|.+ .+++.||+|++.....       ...+|+++++.++||||+++++++..    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            34567899999999999999999985 5789999999865432       22469999999999999999999844    


Q ss_pred             ----------------------------------CCeEEEEEeecCCCChhHHhhcC-CCCCCCCHHHHHHHHHHHHHHH
Q 017621          259 ----------------------------------RKCMFLIYEYMEMGSLFCVLRTD-EEAVGLDWAKRVNIVKGMAHAL  303 (368)
Q Consensus       259 ----------------------------------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L  303 (368)
                                                        ....++||||++ |+|.+.+... .....+++..+..++.||+.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              334899999998 4877766531 1223489999999999999999


Q ss_pred             HHHhcCCCCCeeecCCCCCCeeec-CCCCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          304 SYLHHHCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       304 ~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +|||++   +|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||+
T Consensus       155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~  212 (383)
T 3eb0_A          155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPEL  212 (383)
T ss_dssp             HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHH
T ss_pred             HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHH
Confidence            999999   999999999999998 688999999999997754433 234578999999983

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=3.5e-30  Score=233.68  Aligned_cols=169  Identities=18%  Similarity=0.325  Sum_probs=137.3

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEE-eeCCeE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFC-LHRKCM  262 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~  262 (368)
                      ...++|++.+.||+|+||+||+|++ .+++.||+|++......     +.+.+|+++++.++|++++..+.++ ...+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            3457899999999999999999985 57889999986554322     3577899999999888777666654 667889


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCCeEEeeecc
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL---NSELEAFVADFGV  339 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFg~  339 (368)
                      ++||||+ +++|.+++.....  .+++..+..++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||+
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             EEEEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            9999999 8999999975432  389999999999999999999999   99999999999999   7889999999999


Q ss_pred             ceecCCCCC-------CccccccccccccCCC
Q 017621          340 ARLLNFDSS-------NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~-------~~~~~~gt~~y~aPE~  364 (368)
                      ++.......       ......||+.|+|||+
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  186 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINT  186 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHH
Confidence            998765432       1234579999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=5.2e-30  Score=236.36  Aligned_cols=170  Identities=28%  Similarity=0.510  Sum_probs=140.1

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCE--EEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKV--VALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|++.+.||+|+||.||+|++. ++..  +|+|.+......  ...+.+.+|+++++++ +||||+++++++.+.+..|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            68999999999999999999864 4554  499988653322  2346788999999999 9999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 017621          264 LIYEYMEMGSLFCVLRTDE-------------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL  330 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  330 (368)
                      +||||+++++|.+++....             ....+++.+++.++.|+++||+|||++   +|+||||||+||+++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence            9999999999999997643             123589999999999999999999999   999999999999999999


Q ss_pred             CeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          331 EAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       331 ~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .+||+|||+++...... ......+|+.|+|||
T Consensus       180 ~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE  211 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIE  211 (327)
T ss_dssp             CEEECCTTCEESSCEEC-CC----CCTTTCCHH
T ss_pred             eEEEcccCcCccccccc-cccCCCCCccccChh
Confidence            99999999997543222 223345788999998

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=8.6e-30  Score=230.97  Aligned_cols=169  Identities=25%  Similarity=0.414  Sum_probs=140.2

Q ss_pred             hhccccce-eeeecCCccEEEEEc---CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKY-CIGTGGYGSVYRARL---PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+ .||+|+||+||+|.+   .+++.||+|++...... ....+++.+|+++++.++||||+++++++ ..+..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            46788888 999999999999953   34688999999765332 23357899999999999999999999999 55678


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+++++|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            99999999999999998653   389999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCCC---ccccccccccccCC
Q 017621          343 LNFDSSN---RTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~---~~~~~gt~~y~aPE  363 (368)
                      .......   .....||+.|+|||
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE  190 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPE  190 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHH
T ss_pred             eccCCCcccccccCCCCceeeChH
Confidence            7544332   12234678999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=4.6e-30  Score=237.11  Aligned_cols=171  Identities=25%  Similarity=0.356  Sum_probs=131.2

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEe-------
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCL-------  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------  257 (368)
                      ..+|++.+.||+|+||.||+|++ .+++.||+|++......   ..+.+.+|+.+++++. ||||+++++++.       
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHH---HHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchH---HHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            35799999999999999999985 47899999998654332   3467889999999995 999999999984       


Q ss_pred             -eCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eeecCCCCCCeeecCCCCeEE
Q 017621          258 -HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPP--IVHRDISSNNVLLNSELEAFV  334 (368)
Q Consensus       258 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl  334 (368)
                       .....++||||++ |+|.+++........+++..++.++.||+.||+|||++   +  |+||||||+|||++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence             3445899999996 69988887533334489999999999999999999998   7  999999999999999999999


Q ss_pred             eeeccceecCCCCCC------------ccccccccccccCCC
Q 017621          335 ADFGVARLLNFDSSN------------RTLLAGTSGYIAPAS  364 (368)
Q Consensus       335 ~DFg~a~~~~~~~~~------------~~~~~gt~~y~aPE~  364 (368)
                      +|||+++........            .....||+.|+|||+
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~  221 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEI  221 (337)
T ss_dssp             CCCTTCBCCSSCC-----------------------------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhh
Confidence            999999877543221            113469999999995

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.96  E-value=1.7e-30  Score=259.58  Aligned_cols=162  Identities=27%  Similarity=0.423  Sum_probs=133.8

Q ss_pred             eeeeecCCccEEEEEc---CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecC
Q 017621          194 YCIGTGGYGSVYRARL---PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYME  270 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  270 (368)
                      +.||+|+||+||+|.+   ..++.||||+++..... ....+++.+|++++++++||||+++++++.. +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            4799999999999954   34678999999764332 2345789999999999999999999999975 45889999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC--
Q 017621          271 MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS--  348 (368)
Q Consensus       271 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~--  348 (368)
                      +|+|.+++....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+.....  
T Consensus       453 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          453 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999997643   389999999999999999999999   999999999999999999999999999987754332  


Q ss_pred             -CccccccccccccCC
Q 017621          349 -NRTLLAGTSGYIAPA  363 (368)
Q Consensus       349 -~~~~~~gt~~y~aPE  363 (368)
                       ......||+.|+|||
T Consensus       527 ~~~~~~~~t~~y~APE  542 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPE  542 (635)
T ss_dssp             --------CGGGSCHH
T ss_pred             ccccCCCCceeeeChh
Confidence             122345788999998

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.96  E-value=3.3e-30  Score=241.51  Aligned_cols=166  Identities=28%  Similarity=0.379  Sum_probs=125.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC------
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR------  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  259 (368)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++...... ....+++.+|+++++.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            46899999999999999999985 56899999999754322 23446788999999999999999999998754      


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      ...|+|+||+ +++|.++++..    .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             CeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            5689999999 57998888652    389999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++.....   ....+||+.|+|||+
T Consensus       179 a~~~~~~---~~~~~~t~~y~aPE~  200 (367)
T 2fst_X          179 ARHTADE---MTGYVATRWYRAPEI  200 (367)
T ss_dssp             ---------------CCCTTCCHHH
T ss_pred             ccccccc---CCCcCcCcCccChHH
Confidence            9876432   234579999999983

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.96  E-value=9.8e-30  Score=236.79  Aligned_cols=168  Identities=27%  Similarity=0.441  Sum_probs=141.5

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-----C
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-----K  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  260 (368)
                      .++|++.+.||+|+||.||+|.+. +++.||||++......  ....++.+|++++++++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP--LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc--hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            468999999999999999999864 6889999999754332  2346788999999999999999999988764     6


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+||||++ ++|.+++...    .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            7899999998 5899988763    389999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCC----------ccccccccccccCCC
Q 017621          341 RLLNFDSSN----------RTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~----------~~~~~gt~~y~aPE~  364 (368)
                      +........          ....+||+.|+|||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  193 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV  193 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCee
Confidence            877533211          123478999999993

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=3.2e-30  Score=232.20  Aligned_cols=165  Identities=27%  Similarity=0.439  Sum_probs=135.0

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-CeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-KCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+. +++.||+|.+....     ..+.+.+|++++++++||||+++++++.+. +..++|
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            46899999999999999999987 48899999997643     236788999999999999999999987654 478999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++..... ..+++..+..++.|+++||+|||++   +++||||||+||+++.++.+||+|||+++....
T Consensus        94 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            999999999999975432 2278899999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..   ....+|+.|+|||+
T Consensus       170 ~~---~~~~~~~~y~aPE~  185 (278)
T 1byg_A          170 TQ---DTGKLPVKWTAPEA  185 (278)
T ss_dssp             ---------CCTTTSCHHH
T ss_pred             cc---cCCCccccccCHHH
Confidence            22   23357899999983

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.96  E-value=6.9e-30  Score=231.82  Aligned_cols=167  Identities=18%  Similarity=0.328  Sum_probs=140.5

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEE-eeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFC-LHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l  264 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++......     +++.+|+++++.++|++++..+.++ ...+..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            46899999999999999999985 57899999998654432     4678899999999888866655554 66778899


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCCeEEeeeccce
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL---NSELEAFVADFGVAR  341 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFg~a~  341 (368)
                      ||||+ +++|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+|||+   ++++.+||+|||+++
T Consensus        83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            99999 8999999975432  389999999999999999999999   99999999999999   488899999999998


Q ss_pred             ecCCCCCC-------ccccccccccccCCC
Q 017621          342 LLNFDSSN-------RTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~-------~~~~~gt~~y~aPE~  364 (368)
                      ........       .....||+.|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  186 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINT  186 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHH
T ss_pred             cccccccccccccccccccccccccCChhh
Confidence            87654321       234579999999984

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.96  E-value=5.6e-30  Score=239.10  Aligned_cols=175  Identities=22%  Similarity=0.283  Sum_probs=130.7

Q ss_pred             HHHHHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC
Q 017621          181 QDMIEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR  259 (368)
Q Consensus       181 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  259 (368)
                      .+.....++|++.+.||+|+||+||+|++ .+++.||||++......    ...+.+|++.++.++||||+++++++...
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            34566778999999999999999999986 46899999988654322    23556788888999999999999998764


Q ss_pred             Ce-------EEEEEeecCCCChhHHhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCeeecCCCCCCeeecC-
Q 017621          260 KC-------MFLIYEYMEMGSLFCVLRT-DEEAVGLDWAKRVNIVKGMAHALSYLH--HHCTPPIVHRDISSNNVLLNS-  328 (368)
Q Consensus       260 ~~-------~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-  328 (368)
                      +.       .++||||+++ +|.+.+.. ......+++..+..++.|++.||.|||  ++   +|+||||||+|||++. 
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~  167 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA  167 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred             ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence            33       8899999986 55443332 122334889999999999999999999  77   9999999999999996 


Q ss_pred             CCCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          329 ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       329 ~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++.+||+|||+++....... .....||+.|+|||+
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~  202 (360)
T 3e3p_A          168 DGTLKLCDFGSAKKLSPSEP-NVAYICSRYYRAPEL  202 (360)
T ss_dssp             TTEEEECCCTTCBCCCTTSC-CCSTTSCGGGCCHHH
T ss_pred             CCcEEEeeCCCceecCCCCC-cccccCCcceeCHHH
Confidence            89999999999987764433 234578999999984

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=1.1e-29  Score=229.70  Aligned_cols=172  Identities=25%  Similarity=0.445  Sum_probs=146.6

Q ss_pred             HHhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            45678999999999999999999864 6899999998654322 123467889999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC---CCeEEeeeccc
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE---LEAFVADFGVA  340 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFg~a  340 (368)
                      +||||+++++|.+.+....   .+++.++..++.|++.||+|||++   +++||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999998886543   389999999999999999999999   99999999999999754   47999999999


Q ss_pred             eecCCCCCCccccccccccccCCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ........ .....||+.|+|||+
T Consensus       172 ~~~~~~~~-~~~~~~~~~y~aPE~  194 (287)
T 2wei_A          172 TCFQQNTK-MKDRIGTAYYIAPEV  194 (287)
T ss_dssp             GTBCCCSS-CSCHHHHHTTCCHHH
T ss_pred             eeecCCCc-cccccCcccccChHH
Confidence            87654332 233468999999984

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.96  E-value=2.4e-30  Score=245.77  Aligned_cols=169  Identities=27%  Similarity=0.425  Sum_probs=126.5

Q ss_pred             hhcccc-ceeeeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee--CC
Q 017621          187 TEDFHI-KYCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH--RK  260 (368)
Q Consensus       187 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  260 (368)
                      .+.|++ .+.||+|+||+||+|+..   +++.||+|++......     +.+.+|++++++++||||+++++++..  ..
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            345666 457999999999999854   5789999999765432     467889999999999999999999954  67


Q ss_pred             eEEEEEeecCCCChhHHhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee----cCCC
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDE------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL----NSEL  330 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~  330 (368)
                      ..|+||||+++ +|.+++....      ....+++..+..++.||+.||+|||++   +|+||||||+|||+    +.++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence            89999999974 8877775321      122489999999999999999999999   99999999999999    6778


Q ss_pred             CeEEeeeccceecCCCC---CCccccccccccccCCC
Q 017621          331 EAFVADFGVARLLNFDS---SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       331 ~~kl~DFg~a~~~~~~~---~~~~~~~gt~~y~aPE~  364 (368)
                      .+||+|||+++......   ......+||+.|+|||+
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  206 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL  206 (405)
T ss_dssp             CEEECCTTCCC----------------CCCTTCCHHH
T ss_pred             cEEEEECCCceecCCCCcccccCCCceecCcccCchh
Confidence            99999999998775432   22334679999999983

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.96  E-value=9.2e-30  Score=246.05  Aligned_cols=167  Identities=20%  Similarity=0.341  Sum_probs=141.2

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC-CceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH-RNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l  264 (368)
                      .++|++.+.||+|+||.||+|++ .+++.||||++......     +++.+|+++++.++| +++..+..++...+..++
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            36899999999999999999985 57899999987654332     357789999999976 666667777788889999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee---cCCCCeEEeeeccce
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL---NSELEAFVADFGVAR  341 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFg~a~  341 (368)
                      ||||+ +++|.+++.....  .+++..++.++.||+.||+|||++   +|+||||||+|||+   +.++.+||+|||+++
T Consensus        81 vme~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            99999 8999999975432  389999999999999999999999   99999999999999   688999999999999


Q ss_pred             ecCCCCCC-------ccccccccccccCCC
Q 017621          342 LLNFDSSN-------RTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~~-------~~~~~gt~~y~aPE~  364 (368)
                      .+......       .....||+.|+|||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  184 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNT  184 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHH
Confidence            87654322       224679999999984

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.96  E-value=7.9e-30  Score=255.62  Aligned_cols=170  Identities=28%  Similarity=0.423  Sum_probs=140.6

Q ss_pred             HhhccccceeeeecCCccEEEEEcC----CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP----SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  261 (368)
                      ..++|++.+.||+|+||+||+|.+.    .+..||+|.+......  ...+.+.+|+.++++++||||+++++++.+ +.
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~  464 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVITE-NP  464 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence            3567999999999999999999853    2457999998754332  244688999999999999999999999854 56


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .|+||||+++|+|.++++...  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence            899999999999999998643  2389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCC-CccccccccccccCC
Q 017621          342 LLNFDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       342 ~~~~~~~-~~~~~~gt~~y~aPE  363 (368)
                      ....... ......||+.|+|||
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE  562 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPE  562 (656)
T ss_dssp             SCCC----------CCGGGCCHH
T ss_pred             ecCCCcceeccCCCCCcceeCHH
Confidence            7654322 122345788999999

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=2e-29  Score=231.11  Aligned_cols=166  Identities=27%  Similarity=0.388  Sum_probs=133.9

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEe--------
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCL--------  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------  257 (368)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.....   ...+++.+|++++++++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh---HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            367999999999999999999865 589999999875543   24567889999999999999999999874        


Q ss_pred             ------eCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCC
Q 017621          258 ------HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN-SEL  330 (368)
Q Consensus       258 ------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~  330 (368)
                            +.+..|+||||++ |+|.++++..    .+++..+..++.|++.||+|||++   +|+||||||+||+++ +++
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence                  3467899999998 5999998643    388999999999999999999999   999999999999997 567


Q ss_pred             CeEEeeeccceecCCCCC---CccccccccccccCC
Q 017621          331 EAFVADFGVARLLNFDSS---NRTLLAGTSGYIAPA  363 (368)
Q Consensus       331 ~~kl~DFg~a~~~~~~~~---~~~~~~gt~~y~aPE  363 (368)
                      .+||+|||+++.......   ......||+.|+|||
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  194 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR  194 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcH
Confidence            999999999987653221   223346799999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=2.4e-29  Score=232.30  Aligned_cols=166  Identities=20%  Similarity=0.362  Sum_probs=142.1

Q ss_pred             hhccccceeeeecCCccEEEEEc--CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCc------eeeEEEEEee
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL--PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN------IVKLYGFCLH  258 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~  258 (368)
                      .++|++.+.||+|+||+||+|.+  .+++.||+|++.....    ..+.+.+|+++++.++|++      ++++++++..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR----YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc----hhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            35899999999999999999985  3688999999875432    3467888999999987765      9999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC----------
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS----------  328 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----------  328 (368)
                      .+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+|||++.          
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            99999999999 7899999976542 3488999999999999999999999   9999999999999987          


Q ss_pred             ---------CCCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          329 ---------ELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       329 ---------~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                               ++.+||+|||+++.....   .....||+.|+|||+
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~  205 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEV  205 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHH
T ss_pred             cccccccccCCCceEeeCcccccCccc---cccccCCccccChHH
Confidence                     668999999999875432   234579999999983

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=3.3e-30  Score=240.17  Aligned_cols=164  Identities=21%  Similarity=0.274  Sum_probs=138.7

Q ss_pred             hccccceeeeecCCccEEEEEcCC---------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceee-------
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPS---------GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVK-------  251 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------  251 (368)
                      ++|++.+.||+|+||.||+|++..         ++.||+|.+...        +.+.+|++++++++||||++       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            589999999999999999998653         789999998653        35678999999999999988       


Q ss_pred             --------EEEEEee-CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCC
Q 017621          252 --------LYGFCLH-RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSN  322 (368)
Q Consensus       252 --------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  322 (368)
                              +++++.. ++..|+||||+ +++|.+++.... ...+++..+..++.||+.||+|||++   +|+||||||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~  188 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE  188 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence                    6777776 67899999999 899999998652 23489999999999999999999999   9999999999


Q ss_pred             CeeecCCC--CeEEeeeccceecCCCCC-------CccccccccccccCCC
Q 017621          323 NVLLNSEL--EAFVADFGVARLLNFDSS-------NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       323 NIll~~~~--~~kl~DFg~a~~~~~~~~-------~~~~~~gt~~y~aPE~  364 (368)
                      |||++.++  .+||+|||+++.+.....       ......||+.|+|||+
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  239 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDL  239 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHH
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHH
Confidence            99999998  999999999987654321       1233479999999983

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.96  E-value=5e-30  Score=245.61  Aligned_cols=165  Identities=22%  Similarity=0.343  Sum_probs=128.3

Q ss_pred             ccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEEEe
Q 017621          189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      .|...+.||+|+||+||.+...+|+.||||++....      .+.+.+|++++.++ +||||+++++++.+.+..|+|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            455678899999999987766689999999986532      24567899999887 89999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCC----CCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC-------------C
Q 017621          268 YMEMGSLFCVLRTDEEAVG----LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-------------L  330 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~----l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~  330 (368)
                      |++ |+|.+++........    .++..++.++.||+.||+|||++   +|+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCce
Confidence            996 699999986532110    12334578999999999999999   99999999999999754             4


Q ss_pred             CeEEeeeccceecCCCCCC----ccccccccccccCC
Q 017621          331 EAFVADFGVARLLNFDSSN----RTLLAGTSGYIAPA  363 (368)
Q Consensus       331 ~~kl~DFg~a~~~~~~~~~----~~~~~gt~~y~aPE  363 (368)
                      .+||+|||+++........    ....+||+.|+|||
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  202 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE  202 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHH
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHH
Confidence            8999999999987654321    23457999999999

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.96  E-value=2.1e-29  Score=230.86  Aligned_cols=171  Identities=25%  Similarity=0.415  Sum_probs=141.2

Q ss_pred             HHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC--CCceeeEEEEEeeCCeE
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--HRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~  262 (368)
                      ...++|++.+.||+|+||.||+|.+.+++.||+|++...... ....+.+.+|++++.+++  ||||+++++++...+..
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            345689999999999999999999888999999998754332 234578899999999997  59999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+||| +.+++|.+++....   .+++.++..++.|+++||.|||++   +|+||||||+||++++ +.+||+|||+++.
T Consensus       104 ~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             EEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccc
Confidence            99999 56789999998654   389999999999999999999999   9999999999999965 8999999999987


Q ss_pred             cCCCCC--CccccccccccccCCC
Q 017621          343 LNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ......  ......||+.|+|||+
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~  199 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEA  199 (313)
T ss_dssp             --------------CCGGGCCHHH
T ss_pred             ccCccccccccCCCCCCCcCCHHH
Confidence            654332  1234579999999995

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.96  E-value=1.4e-29  Score=237.69  Aligned_cols=165  Identities=28%  Similarity=0.393  Sum_probs=137.8

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE---
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM---  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  262 (368)
                      .++|.+.+.||+|+||+||+|.+ .+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..   
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            46899999999999999999985 46899999999764332 23456788999999999999999999999877654   


Q ss_pred             ---EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          263 ---FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       263 ---~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                         |+||||++ ++|.+.+..     .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999998 588877743     289999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++.....   .....||+.|+|||+
T Consensus       191 a~~~~~~---~~~~~~t~~y~aPE~  212 (371)
T 4exu_A          191 ARHADAE---MTGYVVTRWYRAPEV  212 (371)
T ss_dssp             C-----------CTTCCCTTSCHHH
T ss_pred             ccccccC---cCCcccCccccCHHH
Confidence            9876433   234578999999983

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.96  E-value=1.1e-29  Score=233.74  Aligned_cols=172  Identities=31%  Similarity=0.485  Sum_probs=140.7

Q ss_pred             HhhccccceeeeecCCccEEEEEc--CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc---CCCceeeEEEEEe---
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARL--PSGKVVALKKLHRSETEELASLESFRNEARLLSQI---WHRNIVKLYGFCL---  257 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---  257 (368)
                      ..++|++.+.||+|+||.||+|++  .+++.||+|++....... .....+.+|+.+++.+   +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            457899999999999999999986  467899999986543221 1113455677776666   8999999999987   


Q ss_pred             --eCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEe
Q 017621          258 --HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVA  335 (368)
Q Consensus       258 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  335 (368)
                        .....++||||++ |+|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence              4567899999998 699999876532 2389999999999999999999999   99999999999999999999999


Q ss_pred             eeccceecCCCCCCccccccccccccCCC
Q 017621          336 DFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       336 DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      |||+++...... ......||+.|+|||+
T Consensus       163 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  190 (326)
T 1blx_A          163 DFGLARIYSFQM-ALTSVVVTLWYRAPEV  190 (326)
T ss_dssp             SCCSCCCCCGGG-GGCCCCCCCTTCCHHH
T ss_pred             cCcccccccCCC-CccccccccceeCHHH
Confidence            999998765322 2334578999999983

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=2.5e-29  Score=237.53  Aligned_cols=166  Identities=24%  Similarity=0.341  Sum_probs=138.1

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC--------CCceeeEEEEEe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW--------HRNIVKLYGFCL  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~  257 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++.....    ..+.+.+|+++++.++        ||||+++++++.
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH----YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc----chHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            46899999999999999999985 4688999999975432    3467889999999985        888999999987


Q ss_pred             ----eCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC---
Q 017621          258 ----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL---  330 (368)
Q Consensus       258 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---  330 (368)
                          .....|+||||+ ++++.+.+.... ...+++..+..++.||+.||+|||+++  +|+||||||+|||++.++   
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence                456799999999 456666665432 234899999999999999999999864  799999999999999775   


Q ss_pred             ----------------------------------------------CeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          331 ----------------------------------------------EAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       331 ----------------------------------------------~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                                                                    .+||+|||+++.....   ....+||+.|+|||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE  263 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence                                                          7999999999887543   23347999999998

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.96  E-value=6.2e-29  Score=230.11  Aligned_cols=166  Identities=25%  Similarity=0.405  Sum_probs=121.5

Q ss_pred             Hhhccccce-eeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee----C
Q 017621          186 ATEDFHIKY-CIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH----R  259 (368)
Q Consensus       186 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~  259 (368)
                      ..++|.+.+ .||+|+||+||+|.+. +++.||+|++.....       ........++.++||||+++++++..    .
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            356888854 6999999999999865 689999999865321       11222234566799999999999876    4


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCCeEEee
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS---ELEAFVAD  336 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D  336 (368)
                      ...++||||+++|+|.+++..... ..+++.++..++.|++.||.|||++   +|+||||||+||+++.   ++.+||+|
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence            568999999999999999986542 3489999999999999999999999   9999999999999976   45599999


Q ss_pred             eccceecCCCCCCccccccccccccCCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ||+++......  .....||+.|+|||+
T Consensus       175 fg~~~~~~~~~--~~~~~~t~~y~aPE~  200 (336)
T 3fhr_A          175 FGFAKETTQNA--LQTPCYTPYYVAPEV  200 (336)
T ss_dssp             CTTCEEC---------------------
T ss_pred             cccceeccccc--cccCCCCcCccChhh
Confidence            99998765332  234578999999995

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.96  E-value=1.8e-29  Score=241.35  Aligned_cols=166  Identities=24%  Similarity=0.383  Sum_probs=132.4

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ..+|.+.+.||+|+||+||.....+++.||||++.....      +.+.+|+++++.+ +||||+++++++.+.+..|+|
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            346889999999999996655555889999999875432      2345799999999 899999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-----CCCeEEeeeccc
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-----ELEAFVADFGVA  340 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFg~a  340 (368)
                      |||++ |+|.+++......  ..+..+..++.||+.||+|||++   +|+||||||+|||++.     ...+||+|||++
T Consensus        97 ~E~~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EECCC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            99997 5999999865422  44556678999999999999999   9999999999999953     235789999999


Q ss_pred             eecCCCC---CCccccccccccccCCC
Q 017621          341 RLLNFDS---SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~---~~~~~~~gt~~y~aPE~  364 (368)
                      +......   ......+||+.|+|||+
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~  197 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEM  197 (432)
T ss_dssp             ECC------------CCSCTTSCCGGG
T ss_pred             eeccCCCcceeeccccCCCcCccChhh
Confidence            8875432   22344679999999994

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=9.2e-30  Score=233.01  Aligned_cols=172  Identities=23%  Similarity=0.342  Sum_probs=136.9

Q ss_pred             HHHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhH---HhHHHHHHHHHHHhcc----CCCceeeEEEE
Q 017621          184 IEATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL---ASLESFRNEARLLSQI----WHRNIVKLYGF  255 (368)
Q Consensus       184 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~niv~l~~~  255 (368)
                      ....++|++.+.||+|+||.||+|++ .+++.||+|++........   .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34567899999999999999999986 4688999999976543211   1223456788988888    89999999999


Q ss_pred             EeeCCeEEEEEee-cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCCeE
Q 017621          256 CLHRKCMFLIYEY-MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN-SELEAF  333 (368)
Q Consensus       256 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k  333 (368)
                      +...+..++|||| +.+++|.+++....   .+++..+..++.|+++||+|||++   +|+||||||+||+++ .++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 78999999997643   389999999999999999999999   999999999999999 889999


Q ss_pred             EeeeccceecCCCCCCccccccccccccCC
Q 017621          334 VADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       334 l~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      |+|||+++......  .....||+.|+|||
T Consensus       181 l~dfg~~~~~~~~~--~~~~~~~~~y~aPE  208 (312)
T 2iwi_A          181 LIDFGSGALLHDEP--YTDFDGTRVYSPPE  208 (312)
T ss_dssp             ECCCSSCEECCSSC--BCCCCSCTTTSCHH
T ss_pred             EEEcchhhhcccCc--ccccCCcccccCce
Confidence            99999998875432  33457999999998

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.96  E-value=3.8e-29  Score=233.08  Aligned_cols=165  Identities=28%  Similarity=0.388  Sum_probs=137.6

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCe----
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKC----  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  261 (368)
                      .++|.+.+.||+|+||.||+|.+ .+|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+.    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            35799999999999999999986 46899999998764322 2344678899999999999999999999987654    


Q ss_pred             --EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          262 --MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       262 --~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                        .|+||||++ ++|.+++..     .+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence              499999998 588877743     289999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccCCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ++.....   .....||+.|+|||+
T Consensus       173 ~~~~~~~---~~~~~~t~~y~aPE~  194 (353)
T 3coi_A          173 ARHADAE---MTGYVVTRWYRAPEV  194 (353)
T ss_dssp             TTC-----------CCSBCCSCHHH
T ss_pred             ccCCCCC---ccccccCcCcCCHHH
Confidence            9875432   234578999999983

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=8.2e-29  Score=224.11  Aligned_cols=145  Identities=14%  Similarity=0.069  Sum_probs=129.5

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||.||+|++. +++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999864 58999999998765544445678999999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ||+++++|.++++..     ....++..++.|++.||+|||++   +|+||||||+|||++.++.+||+++|..
T Consensus       111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~  176 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM  176 (286)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred             EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecccc
Confidence            999999999999642     35567889999999999999999   9999999999999999999999977655

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.96  E-value=2.4e-29  Score=249.13  Aligned_cols=172  Identities=28%  Similarity=0.401  Sum_probs=145.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee------C
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH------R  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~  259 (368)
                      .++|++.+.||+|+||.||+|.+ .+++.||||++......  ...+.+.+|++++++++||||+++++++..      .
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH--HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            46899999999999999999986 46889999998765332  345778999999999999999999998765      6


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCC---eEEee
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELE---AFVAD  336 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D  336 (368)
                      +..|+||||+++|+|.+++........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence            67899999999999999998765555689999999999999999999999   9999999999999997765   89999


Q ss_pred             eccceecCCCCCCccccccccccccCCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ||++........ .....||+.|+|||+
T Consensus       168 FG~a~~~~~~~~-~~~~~gt~~Y~APE~  194 (676)
T 3qa8_A          168 LGYAKELDQGEL-CTEFVGTLQYLAPEL  194 (676)
T ss_dssp             CCCCCBTTSCCC-CCCCCSCCTTCSSCS
T ss_pred             cccccccccccc-cccccCCcccCChHH
Confidence            999988764432 334579999999995

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.96  E-value=1.7e-29  Score=232.31  Aligned_cols=171  Identities=23%  Similarity=0.349  Sum_probs=144.3

Q ss_pred             HHhhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhH---HhHHHHHHHHHHHhccC--CCceeeEEEEEee
Q 017621          185 EATEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL---ASLESFRNEARLLSQIW--HRNIVKLYGFCLH  258 (368)
Q Consensus       185 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~  258 (368)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++........   ...+.+.+|+.++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3457899999999999999999985 5788999999865432210   11235667999999995  5999999999999


Q ss_pred             CCeEEEEEeecCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCCeEEee
Q 017621          259 RKCMFLIYEYMEM-GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN-SELEAFVAD  336 (368)
Q Consensus       259 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~D  336 (368)
                      .+..++||||+.+ ++|.+++....   .+++..+..++.|+++||+|||++   +|+||||||+|||++ +++.+||+|
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence            9999999999986 89999987643   389999999999999999999999   999999999999999 789999999


Q ss_pred             eccceecCCCCCCccccccccccccCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ||+++......  .....||+.|+|||
T Consensus       194 fg~~~~~~~~~--~~~~~gt~~y~aPE  218 (320)
T 3a99_A          194 FGSGALLKDTV--YTDFDGTRVYSPPE  218 (320)
T ss_dssp             CTTCEECCSSC--BCCCCSCGGGSCHH
T ss_pred             Ccccccccccc--ccCCCCCccCCChH
Confidence            99998875432  23457999999998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.96  E-value=1.1e-28  Score=227.45  Aligned_cols=172  Identities=26%  Similarity=0.324  Sum_probs=125.7

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHH-HHhccCCCceeeEEEEEeeCCeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEAR-LLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.......  ...++..|+. +++.++||||+++++++...+..++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH--HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch--HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            36799999999999999999986 468999999997654322  2245555665 7778899999999999999999999


Q ss_pred             EEeecCCCChhHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          265 IYEYMEMGSLFCVLRTD--EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ||||+++ +|.+++...  .....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||+++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            9999985 777776531  11234899999999999999999999852  799999999999999999999999999987


Q ss_pred             cCCCCCCccccccccccccCCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ...... .....||+.|+|||+
T Consensus       176 ~~~~~~-~~~~~gt~~y~aPE~  196 (327)
T 3aln_A          176 LVDSIA-KTRDAGCRPYMAPER  196 (327)
T ss_dssp             ----------------------
T ss_pred             cccccc-cccCCCCccccCcee
Confidence            654322 233479999999996

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=2.4e-28  Score=230.13  Aligned_cols=169  Identities=25%  Similarity=0.351  Sum_probs=140.1

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CC-----ceeeEEEEEee
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HR-----NIVKLYGFCLH  258 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~  258 (368)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++.....    ..+++.+|+++++.++ |+     +|+++++++..
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA----FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH----HHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3578999999999999999999854 688999999975432    3356777888888874 44     49999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec--CCCCeEEee
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN--SELEAFVAD  336 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~D  336 (368)
                      .+..|+||||++ ++|.+++..... ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             CCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            999999999996 599999986532 3389999999999999999999953 22899999999999995  477899999


Q ss_pred             eccceecCCCCCCccccccccccccCCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ||+++.....   .....||+.|+|||+
T Consensus       205 FG~a~~~~~~---~~~~~~t~~y~aPE~  229 (382)
T 2vx3_A          205 FGSSCQLGQR---IYQYIQSRFYRSPEV  229 (382)
T ss_dssp             CTTCEETTCC---CCSSCSCGGGCCHHH
T ss_pred             ccCceecccc---cccccCCccccChHH
Confidence            9999887533   234579999999983

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=1.6e-29  Score=231.98  Aligned_cols=170  Identities=26%  Similarity=0.449  Sum_probs=138.8

Q ss_pred             HhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ..++|++.+.||+|+||.||+|+...  .+|+|++....... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            35689999999999999999998743  49999987543221 1234677899999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.+++....  ..+++..+..++.|++.||+|||++   +|+||||||+||+++ ++.+||+|||+++....
T Consensus       108 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             eecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            99999999999997643  3488999999999999999999999   999999999999998 67999999999876532


Q ss_pred             C-----CCCccccccccccccCCC
Q 017621          346 D-----SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~-----~~~~~~~~gt~~y~aPE~  364 (368)
                      .     ........||+.|+|||+
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~  205 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEI  205 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHH
T ss_pred             ccccccccccccCCCcccccChHH
Confidence            1     122233469999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.96  E-value=2.5e-28  Score=227.03  Aligned_cols=166  Identities=24%  Similarity=0.344  Sum_probs=139.5

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CC-CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCc------eeeEEEEEee
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SG-KVVALKKLHRSETEELASLESFRNEARLLSQIWHRN------IVKLYGFCLH  258 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~  258 (368)
                      .++|++.+.||+|+||+||+|.+. ++ +.||+|++.....    ..+.+.+|+++++.++|++      ++.+++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK----YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc----chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            468999999999999999999863 34 6899999975432    2367788999999998776      9999999999


Q ss_pred             CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeee------------
Q 017621          259 RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLL------------  326 (368)
Q Consensus       259 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll------------  326 (368)
                      .+..++||||+ ++++.+.+..... ..+++.++..++.||+.||+|||++   +|+||||||+|||+            
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CCeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence            99999999999 5677777765432 3489999999999999999999999   99999999999999            


Q ss_pred             -------cCCCCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          327 -------NSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       327 -------~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                             +.++.+||+|||+++......   ....||+.|+|||+
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~  210 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEHH---TTIVATRHYRPPEV  210 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSCC---CSSCSCGGGCCHHH
T ss_pred             ccccccccCCCcEEEeecCccccccccc---cCCcCCCcccCCee
Confidence                   667899999999998754332   34579999999983

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.96  E-value=1.3e-28  Score=225.72  Aligned_cols=170  Identities=24%  Similarity=0.367  Sum_probs=125.9

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....... ...+.+..+..+++.++||||+++++++.+.+..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            468999999999999999999864 68999999997654332 2234455555678888999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |||+ ++.+..+.....  ..+++..+..++.|+++||.|||+ .   +|+||||||+||+++.++.+||+|||++....
T Consensus       103 ~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 445555554322  238999999999999999999998 5   89999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      .... .....||+.|+|||+
T Consensus       177 ~~~~-~~~~~~~~~y~aPE~  195 (318)
T 2dyl_A          177 DDKA-KDRSAGCAAYMAPER  195 (318)
T ss_dssp             -----------CCTTCCHHH
T ss_pred             CCcc-ccccCCCccccChhh
Confidence            4322 234579999999985

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=2.6e-29  Score=246.30  Aligned_cols=156  Identities=18%  Similarity=0.268  Sum_probs=121.6

Q ss_pred             ccceeeeecCCccEEEEEcCCCCEEEEEEccccch-----hhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          191 HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSET-----EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       191 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ...+.||+|+||+||+|.. .++.+++|+......     ......+++.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999965 577888887644321     1222346789999999999999999666666677778999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++++|.++++.           +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999875           457999999999999999   9999999999999999  999999999998764


Q ss_pred             CCCC-------ccccccccccccCC
Q 017621          346 DSSN-------RTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~-------~~~~~gt~~y~aPE  363 (368)
                      ....       ....+||+.|||||
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APE  506 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDE  506 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHH
T ss_pred             ccccccchhhhhhhhcCCCCcCCHH
Confidence            3221       13568999999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.95  E-value=1.4e-28  Score=230.59  Aligned_cols=166  Identities=24%  Similarity=0.392  Sum_probs=139.2

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-----------CCceeeEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-----------HRNIVKLYG  254 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~  254 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||||++.....    ..+.+.+|++++++++           ||||+++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            35799999999999999999985 5788999999975432    2366788999998886           899999999


Q ss_pred             EEeeCC----eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec---
Q 017621          255 FCLHRK----CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN---  327 (368)
Q Consensus       255 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---  327 (368)
                      ++...+    ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++  +|+||||||+|||++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence            988654    789999999 7899999976433 23899999999999999999999853  899999999999994   


Q ss_pred             ---CCCCeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          328 ---SELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       328 ---~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                         ..+.+||+|||+++......   ....||+.|+|||
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~t~~y~aPE  205 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEHY---TNSIQTREYRSPE  205 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBCC---CSCCSCGGGCCHH
T ss_pred             CCcCcceEEEcccccccccCCCC---CCCCCCccccCcH
Confidence               34489999999998875432   3347999999998

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.95  E-value=4.1e-27  Score=214.21  Aligned_cols=147  Identities=26%  Similarity=0.419  Sum_probs=127.4

Q ss_pred             hhccccc-eeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHH-hccCCCceeeEEEEEee----C
Q 017621          187 TEDFHIK-YCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLL-SQIWHRNIVKLYGFCLH----R  259 (368)
Q Consensus       187 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~  259 (368)
                      .++|.+. +.||+|+||.||+|.. .+++.||+|++...        ..+.+|++++ +..+||||+++++++..    .
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            3567777 7899999999999986 56899999998642        3456788887 55599999999999887    6


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCCeEEee
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS---ELEAFVAD  336 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D  336 (368)
                      +..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||++   +|+||||||+||+++.   ++.+||+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence            779999999999999999987542 3489999999999999999999999   9999999999999998   78999999


Q ss_pred             eccceecCC
Q 017621          337 FGVARLLNF  345 (368)
Q Consensus       337 Fg~a~~~~~  345 (368)
                      ||++.....
T Consensus       164 fg~a~~~~~  172 (299)
T 3m2w_A          164 FGFAKETTG  172 (299)
T ss_dssp             CTTCEECTT
T ss_pred             ccccccccc
Confidence            999987653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.94  E-value=5.4e-27  Score=223.12  Aligned_cols=170  Identities=15%  Similarity=0.185  Sum_probs=126.8

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC-Cce---------ee----
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH-RNI---------VK----  251 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni---------v~----  251 (368)
                      ..+|+..+.||+|+||+||+|.+ .+++.||||++...........+.+.+|+.+++.++| +|.         +.    
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34688889999999999999984 5799999999885544444446789999999999977 211         11    


Q ss_pred             --------EEEEEee-----CCeEEEEEeecCCCChhHHhhc----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 017621          252 --------LYGFCLH-----RKCMFLIYEYMEMGSLFCVLRT----DEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPI  314 (368)
Q Consensus       252 --------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  314 (368)
                              +..++..     ....+++|+++ +++|.++++.    ......+++..++.++.||++||+|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                    1111111     12356777766 5799988841    11223377889999999999999999999   99


Q ss_pred             eecCCCCCCeeecCCCCeEEeeeccceecCCCCCCccccccccccccCCC
Q 017621          315 VHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       315 vH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +||||||+|||++.++.+||+|||+++.....   ....+| +.|+|||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~  278 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPET  278 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchh
Confidence            99999999999999999999999999876533   344578 99999995

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=4.8e-26  Score=205.26  Aligned_cols=147  Identities=18%  Similarity=0.230  Sum_probs=115.8

Q ss_pred             HHHHHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhH---------------HhHHHHHHHHHHHhcc
Q 017621          180 FQDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEEL---------------ASLESFRNEARLLSQI  244 (368)
Q Consensus       180 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l  244 (368)
                      +..+......|.+.+.||+|+||.||+|.+.+|+.||+|.++.......               .....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3344445556778899999999999999987799999999865332110               1346788999999999


Q ss_pred             CCCceeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 017621          245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV  324 (368)
Q Consensus       245 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  324 (368)
                      +  | +++.+++.. +..|+||||+++++|.+ +..         .....++.|++.||.|||++   +|+||||||+||
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI  224 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV  224 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence            8  4 556565443 45699999999999988 422         12346999999999999999   999999999999


Q ss_pred             eecCCCCeEEeeeccceecC
Q 017621          325 LLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       325 ll~~~~~~kl~DFg~a~~~~  344 (368)
                      |++ ++.+||+|||+|+...
T Consensus       225 Ll~-~~~vkl~DFG~a~~~~  243 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSVEVG  243 (282)
T ss_dssp             EEE-TTEEEECCCTTCEETT
T ss_pred             EEE-CCcEEEEECCCCeECC
Confidence            999 9999999999998654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=1.5e-22  Score=180.08  Aligned_cols=143  Identities=21%  Similarity=0.220  Sum_probs=109.2

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCE--EEEEEccccchh---------------------hHHhHHHHHHHHHHHhcc
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKV--VALKKLHRSETE---------------------ELASLESFRNEARLLSQI  244 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~---------------------~~~~~~~~~~E~~~l~~l  244 (368)
                      -|++.+.||+|+||.||+|.. .+|+.  ||||+++.....                     .......+.+|++++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            467889999999999999987 67888  999987543211                     001124678899999999


Q ss_pred             CCCce--eeEEEEEeeCCeEEEEEeecCC-C----ChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeee
Q 017621          245 WHRNI--VKLYGFCLHRKCMFLIYEYMEM-G----SLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH-HHCTPPIVH  316 (368)
Q Consensus       245 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH  316 (368)
                      .|+++  +.++++    +..++||||+.+ |    +|.+....      .++..+..++.|++.||.||| +.   +|+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            88864  344432    346899999942 4    56555432      224456789999999999999 88   9999


Q ss_pred             cCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          317 RDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       317 ~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||||+|||+++  .++|+|||+|.....+
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence            999999999998  9999999999876543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=3.7e-19  Score=165.00  Aligned_cols=142  Identities=13%  Similarity=0.158  Sum_probs=103.0

Q ss_pred             ccccceeeeecCCccEEEEEcCCCCEEEEEEccccchh---------------hHH----hHHHHHHHHHHHhccCCCce
Q 017621          189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE---------------ELA----SLESFRNEARLLSQIWHRNI  249 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~----~~~~~~~E~~~l~~l~h~ni  249 (368)
                      =|++...||+|++|.||+|...+|+.||||+++.....               ...    ..-...+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            38999999999999999999989999999987542110               000    00112356777777755554


Q ss_pred             eeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC
Q 017621          250 VKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE  329 (368)
Q Consensus       250 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~  329 (368)
                      ....-+....  .+|||||+++++|.++...         .....++.|++.+|.|||+.   +||||||||.|||++++
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE  241 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence            3222222222  3799999999888654321         12346889999999999998   99999999999999877


Q ss_pred             C----------CeEEeeeccceecC
Q 017621          330 L----------EAFVADFGVARLLN  344 (368)
Q Consensus       330 ~----------~~kl~DFg~a~~~~  344 (368)
                      +          .+.|+||+-+....
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCcccccccccceEEEEeCCcccCC
Confidence            6          38899999887654

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.68  E-value=3.1e-17  Score=167.72  Aligned_cols=105  Identities=31%  Similarity=0.520  Sum_probs=92.7

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      +.|.++|.+|..++++++|+.|||++|+++|.+|.+|+.|++|+.|||++|+++|.+|+.++.+++|+.|+||+|+|+|.
T Consensus       616 ~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~  695 (768)
T 3rgz_A          616 TSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGR  695 (768)
T ss_dssp             TSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEC
T ss_pred             ccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCc
Confidence            45888899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC---cccccccCCCcccccccC
Q 017621           82 IPESVKK---VPLLYVSGNNFEVEIPST  106 (368)
Q Consensus        82 ~p~~~~~---~~~~~~~~N~~~~~~P~~  106 (368)
                      +|..+..   +..+++++|+++|.+|..
T Consensus       696 ip~~l~~l~~L~~L~ls~N~l~g~iP~~  723 (768)
T 3rgz_A          696 IPQAMSALTMLTEIDLSNNNLSGPIPEM  723 (768)
T ss_dssp             CCGGGGGCCCCSEEECCSSEEEEECCSS
T ss_pred             CChHHhCCCCCCEEECcCCcccccCCCc
Confidence            9987765   445789999999988864

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.68  E-value=3.4e-17  Score=167.43  Aligned_cols=104  Identities=41%  Similarity=0.590  Sum_probs=96.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|+|.+|.++++|++|+.|+|++|+++|.||.+|+.+++|+.||||+|+++|.+|..++.+++|+.|++|+|+|+|
T Consensus       639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g  718 (768)
T 3rgz_A          639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG  718 (768)
T ss_dssp             CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred             CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence            68999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccc--ccCcccccccCCCcccccc
Q 017621           81 SIPES--VKKVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~--~~~~~~~~~~~N~~~~~~P  104 (368)
                      .||..  +..++...+.+|+..|..|
T Consensus       719 ~iP~~~~~~~~~~~~~~gN~~Lcg~~  744 (768)
T 3rgz_A          719 PIPEMGQFETFPPAKFLNNPGLCGYP  744 (768)
T ss_dssp             ECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred             cCCCchhhccCCHHHhcCCchhcCCC
Confidence            99974  5577778888997655443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.62  E-value=9.7e-16  Score=129.78  Aligned_cols=99  Identities=22%  Similarity=0.245  Sum_probs=49.5

Q ss_pred             CCCCccccCCc-cccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            2 YNNKLDGPIPQ-ELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         2 ~~n~l~g~~p~-~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      ++|++++..|. .++++++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        37 ~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  116 (192)
T 1w8a_A           37 NDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC  116 (192)
T ss_dssp             CSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCE
T ss_pred             CCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCe
Confidence            44555443332 24455555555555555554445555555555555555555555544445555555555555555555


Q ss_pred             ccccccc---CcccccccCCCcc
Q 017621           81 SIPESVK---KVPLLYVSGNNFE  100 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~  100 (368)
                      .+|..+.   ++..+++++|.+.
T Consensus       117 ~~~~~~~~l~~L~~L~L~~N~l~  139 (192)
T 1w8a_A          117 VMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             ECTTSSTTCTTCCEEECTTCCBC
T ss_pred             eCHHHhhcCCCCCEEEeCCCCcc
Confidence            4444433   2233455555544

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.58  E-value=1.3e-15  Score=139.02  Aligned_cols=110  Identities=34%  Similarity=0.556  Sum_probs=99.2

Q ss_pred             CCCCCccc--cCCccccCCCCCcEEEecC-ccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCc
Q 017621            1 MYNNKLDG--PIPQELMNCSKLRILILGN-NLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNN   77 (368)
Q Consensus         1 l~~n~l~g--~~p~~~~~l~~l~~l~l~~-N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~   77 (368)
                      |++|.++|  .+|+.++++++|+.|+|++ |+++|.+|..|+.+++|++|+|++|+++|.+|..++.+++|+.|++++|+
T Consensus        57 L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~  136 (313)
T 1ogq_A           57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA  136 (313)
T ss_dssp             EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             CCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCc
Confidence            46899999  9999999999999999995 99999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccc---CcccccccCCCcccccccCCCCC
Q 017621           78 LSGSIPESVK---KVPLLYVSGNNFEVEIPSTSAKA  110 (368)
Q Consensus        78 l~g~~p~~~~---~~~~~~~~~N~~~~~~P~~~~~~  110 (368)
                      ++|.+|..+.   ++..+++++|.+++.+|......
T Consensus       137 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  172 (313)
T 1ogq_A          137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF  172 (313)
T ss_dssp             EESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCC
T ss_pred             cCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhh
Confidence            9999998776   45568999999998888665544

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.57  E-value=4.5e-15  Score=128.47  Aligned_cols=110  Identities=16%  Similarity=0.158  Sum_probs=92.2

Q ss_pred             CCCCCccccCCc-cccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQ-ELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~-~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|+|++..|. .+.++++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..+..+++|+.|+|++|+|+
T Consensus        39 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  118 (220)
T 2v70_A           39 LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT  118 (220)
T ss_dssp             CCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCC
T ss_pred             cCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCC
Confidence            678999987664 4788999999999999999776778999999999999999999888888999999999999999999


Q ss_pred             cccccccc---CcccccccCCCcccccccCCCCC
Q 017621           80 GSIPESVK---KVPLLYVSGNNFEVEIPSTSAKA  110 (368)
Q Consensus        80 g~~p~~~~---~~~~~~~~~N~~~~~~P~~~~~~  110 (368)
                      +..|..+.   ++..+++++|.+++..|......
T Consensus       119 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  152 (220)
T 2v70_A          119 CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL  152 (220)
T ss_dssp             CBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTC
T ss_pred             eECHhHcCCCccCCEEECCCCcCCEECHHHhcCC
Confidence            87777665   45568899999987666555443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.55  E-value=2.3e-15  Score=137.43  Aligned_cols=107  Identities=29%  Similarity=0.516  Sum_probs=96.0

Q ss_pred             CCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccc
Q 017621            3 NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSI   82 (368)
Q Consensus         3 ~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~   82 (368)
                      +|.+.+.+|..++++++|+.|+|++|+++|.+|..|+.+++|++|+|++|+++|.+|..++.+++|+.|++++|+++|.+
T Consensus        86 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  165 (313)
T 1ogq_A           86 INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI  165 (313)
T ss_dssp             ETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEEC
T ss_pred             CCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcC
Confidence            48999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccC----cccccccCCCcccccccCCCC
Q 017621           83 PESVKK----VPLLYVSGNNFEVEIPSTSAK  109 (368)
Q Consensus        83 p~~~~~----~~~~~~~~N~~~~~~P~~~~~  109 (368)
                      |..+..    +..+++++|.+++.+|.....
T Consensus       166 p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~  196 (313)
T 1ogq_A          166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFAN  196 (313)
T ss_dssp             CGGGGCCCTTCCEEECCSSEEEEECCGGGGG
T ss_pred             CHHHhhhhhcCcEEECcCCeeeccCChHHhC
Confidence            987764    455889999998877765443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.54  E-value=1.7e-14  Score=122.18  Aligned_cols=96  Identities=25%  Similarity=0.387  Sum_probs=57.7

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      ++|+++ .+|..+.  ++|+.|+|++|+++ .+|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++.
T Consensus        18 ~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i   93 (193)
T 2wfh_A           18 SNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI   93 (193)
T ss_dssp             TTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC
T ss_pred             CCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEe
Confidence            455555 4555443  45666666666665 5666666666666666666666655555666666666666666666655


Q ss_pred             cccccc---CcccccccCCCccc
Q 017621           82 IPESVK---KVPLLYVSGNNFEV  101 (368)
Q Consensus        82 ~p~~~~---~~~~~~~~~N~~~~  101 (368)
                      .|..+.   ++..+++++|.++.
T Consensus        94 ~~~~f~~l~~L~~L~L~~N~l~~  116 (193)
T 2wfh_A           94 PPRTFDGLKSLRLLSLHGNDISV  116 (193)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCB
T ss_pred             CHHHhCCCCCCCEEECCCCCCCe
Confidence            444443   33445666666653

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.53  E-value=2.3e-14  Score=123.95  Aligned_cols=102  Identities=21%  Similarity=0.226  Sum_probs=56.1

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCc-cccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISS-EIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~-~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      ++|.++. +|..+.  ..++.|+|++|++++..|. .|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        19 s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~   95 (220)
T 2v70_A           19 SNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN   95 (220)
T ss_dssp             CSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCc
Confidence            4555553 555443  2345666666666544332 35566666666666666665555556666666666666666665


Q ss_pred             ccccccc---CcccccccCCCcccccccC
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIPST  106 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P~~  106 (368)
                      ..|..+.   ++..+++++|.+++..|..
T Consensus        96 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  124 (220)
T 2v70_A           96 VQHKMFKGLESLKTLMLRSNRITCVGNDS  124 (220)
T ss_dssp             CCGGGGTTCSSCCEEECTTSCCCCBCTTS
T ss_pred             cCHhHhcCCcCCCEEECCCCcCCeECHhH
Confidence            4444333   3444566666665544433

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.53  E-value=2.5e-16  Score=152.65  Aligned_cols=103  Identities=21%  Similarity=0.188  Sum_probs=76.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCcccc-CCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIG-KLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~-~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.+++..|..++++++|+.|+|++|+++|.+|..+. .+++|+.|+|++|.+++. |. +..+++|+.|+|++|+|+
T Consensus       127 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~  204 (487)
T 3oja_A          127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLA  204 (487)
T ss_dssp             CCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCC
T ss_pred             CCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCC
Confidence            567888887777788888888888888888887777775 688888888888888865 32 335788888888888888


Q ss_pred             cccccccc---CcccccccCCCcccccccCC
Q 017621           80 GSIPESVK---KVPLLYVSGNNFEVEIPSTS  107 (368)
Q Consensus        80 g~~p~~~~---~~~~~~~~~N~~~~~~P~~~  107 (368)
                      +..| .+.   .+..+++++|.+++ +|...
T Consensus       205 ~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l  233 (487)
T 3oja_A          205 FMGP-EFQSAAGVTWISLRNNKLVL-IEKAL  233 (487)
T ss_dssp             EECG-GGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred             CCCH-hHcCCCCccEEEecCCcCcc-cchhh
Confidence            6433 343   45567888888875 45443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.52  E-value=3.1e-14  Score=118.01  Aligned_cols=99  Identities=15%  Similarity=0.278  Sum_probs=85.8

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      +++|+|+. +|..+.  ++|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++
T Consensus        16 ~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~   92 (170)
T 3g39_A           16 CSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKS   92 (170)
T ss_dssp             CTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             eCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCE
Confidence            57899985 888774  789999999999998888899999999999999999997777778999999999999999997


Q ss_pred             ccccccc---CcccccccCCCcccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVE  102 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~  102 (368)
                      ..|..+.   ++..+++++|++.+.
T Consensus        93 ~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           93 IPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             eCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            6665554   566789999998754

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.52  E-value=3.8e-14  Score=122.59  Aligned_cols=108  Identities=21%  Similarity=0.195  Sum_probs=87.2

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..|..+.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+|++
T Consensus        39 l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~  118 (220)
T 2v9t_B           39 LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINC  118 (220)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCE
Confidence            57888888767788889999999999999988778889999999999999999995544557889999999999999998


Q ss_pred             ccccccc---CcccccccCCCcccccccCCC
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIPSTSA  108 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P~~~~  108 (368)
                      ..|..+.   ++..+++++|.++...+....
T Consensus       119 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  149 (220)
T 2v9t_B          119 LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS  149 (220)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred             eCHHHcCCCCCCCEEECCCCcCCEECHHHHh
Confidence            7777665   455688999988765444333

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.51  E-value=1.3e-14  Score=133.44  Aligned_cols=106  Identities=21%  Similarity=0.249  Sum_probs=66.7

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      ++|+++ .+|..++++++|+.|+|++|+++ .+|..++.+++|+.|+|++|++.+.+|..++.+++|+.|++++|++.+.
T Consensus       191 ~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~  268 (328)
T 4fcg_A          191 EWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT  268 (328)
T ss_dssp             EEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCB
T ss_pred             cCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhh
Confidence            445555 56666666666666666666666 3555666666666666666666666666666666666666666666666


Q ss_pred             ccccccC---cccccccCCCcccccccCCCC
Q 017621           82 IPESVKK---VPLLYVSGNNFEVEIPSTSAK  109 (368)
Q Consensus        82 ~p~~~~~---~~~~~~~~N~~~~~~P~~~~~  109 (368)
                      +|..+..   +..+++++|++.+.+|.....
T Consensus       269 ~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~  299 (328)
T 4fcg_A          269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ  299 (328)
T ss_dssp             CCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred             cchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence            6655443   334666666666666655443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.51  E-value=4.5e-14  Score=117.53  Aligned_cols=98  Identities=16%  Similarity=0.266  Sum_probs=83.8

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      +++|+|+ .+|..+.  ++|+.|+|++|+|++..|..|+.+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++
T Consensus        19 ~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~   95 (174)
T 2r9u_A           19 CQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKS   95 (174)
T ss_dssp             CCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             eCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccce
Confidence            4788886 6898775  899999999999998888899999999999999999997656667999999999999999996


Q ss_pred             ccccccc---CcccccccCCCccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~  101 (368)
                      ..|..+.   ++..+++++|.+.+
T Consensus        96 l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           96 IPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             CCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             eCHHHhccccCCCEEEeCCCCccc
Confidence            5544454   56678999998864

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.51  E-value=4.2e-14  Score=117.92  Aligned_cols=83  Identities=22%  Similarity=0.222  Sum_probs=41.6

Q ss_pred             CCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccccccc---cCcccccc
Q 017621           18 SKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESV---KKVPLLYV   94 (368)
Q Consensus        18 ~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~~~---~~~~~~~~   94 (368)
                      ++|+.|+|++|++++..+..++.+++|+.|+|++|++++..|..++.+++|+.|++++|+|++..|..+   .++..+++
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            455555555555553333334555555555555555554434444555555555555555554333322   23344555


Q ss_pred             cCCCcc
Q 017621           95 SGNNFE  100 (368)
Q Consensus        95 ~~N~~~  100 (368)
                      ++|.++
T Consensus       108 ~~N~l~  113 (177)
T 2o6r_A          108 DTNQLK  113 (177)
T ss_dssp             CSSCCS
T ss_pred             cCCcce
Confidence            555554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.51  E-value=9.4e-14  Score=123.28  Aligned_cols=148  Identities=12%  Similarity=0.047  Sum_probs=114.5

Q ss_pred             HHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCe
Q 017621          183 MIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKC  261 (368)
Q Consensus       183 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  261 (368)
                      +......|++...++.|+.+.||++... ++.+++|........   ....+.+|+++++.+ .+..+.++++++...+.
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            3445567888888898999999999864 688999998653211   113578899999988 46778899999999899


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC-------------------------------  310 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------  310 (368)
                      .|+||||++|.++.+.+..        ......++.+++++|..||+..                               
T Consensus        85 ~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             eEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            9999999999998765321        1123467889999999999810                               


Q ss_pred             -------------------------CCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          311 -------------------------TPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       311 -------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                                               ...++|+|++|.|||++++..+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                     13589999999999998765667999998764

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.50  E-value=4.2e-14  Score=122.31  Aligned_cols=100  Identities=19%  Similarity=0.245  Sum_probs=89.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCc-cccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISS-EIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~-~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|++++..|..+.++++|+.|+|++|+|+ .+|. .|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|+
T Consensus        63 Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  141 (220)
T 2v9t_B           63 LSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ  141 (220)
T ss_dssp             CCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence            6899999988999999999999999999999 5555 4789999999999999999999999999999999999999999


Q ss_pred             cccccccc---CcccccccCCCccc
Q 017621           80 GSIPESVK---KVPLLYVSGNNFEV  101 (368)
Q Consensus        80 g~~p~~~~---~~~~~~~~~N~~~~  101 (368)
                      +..|..+.   ++..+++++|++.+
T Consensus       142 ~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          142 TIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             EECHHHHhCCCCCCEEEeCCCCcCC
Confidence            77666555   45678999999875

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.50  E-value=1.4e-14  Score=144.94  Aligned_cols=101  Identities=22%  Similarity=0.473  Sum_probs=66.7

Q ss_pred             CCCccccCCccccCCCCCcEEEecCcccccc-----------------CCcccc--CCCCCCeeeeecccccccCCcccC
Q 017621            3 NNKLDGPIPQELMNCSKLRILILGNNLLSGS-----------------ISSEIG--KLQELNYLDLSHNLINGKIPSQLG   63 (368)
Q Consensus         3 ~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~-----------------~p~~~~--~~~~L~~l~l~~N~l~g~~p~~~~   63 (368)
                      +|+|+| ||++++++++|+.|+|++|+|+|.                 +|.+++  ++++|++|+|++|+++|.+|..++
T Consensus       192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~  270 (636)
T 4eco_A          192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK  270 (636)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred             cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence            456666 666666666677777777776664                 666666  666777777777776666776666


Q ss_pred             CCCCCceecccCCc-ccc-cccccc---------cCcccccccCCCccccccc
Q 017621           64 EIPRIDTVNLSMNN-LSG-SIPESV---------KKVPLLYVSGNNFEVEIPS  105 (368)
Q Consensus        64 ~~~~l~~l~l~~n~-l~g-~~p~~~---------~~~~~~~~~~N~~~~~~P~  105 (368)
                      ++++|+.|++++|+ |+| .+|..+         .++..+++++|.++ .+|.
T Consensus       271 ~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~  322 (636)
T 4eco_A          271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV  322 (636)
T ss_dssp             TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred             cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence            66677777777666 666 666544         34445666666666 5555

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.49  E-value=1.1e-13  Score=120.36  Aligned_cols=103  Identities=18%  Similarity=0.273  Sum_probs=84.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..|..+.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|+ 
T Consensus        47 Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-  125 (229)
T 3e6j_A           47 LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-  125 (229)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-
T ss_pred             cCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-
Confidence            6789999888888999999999999999997443345788999999999999999766677888999999999999998 


Q ss_pred             ccccccc---CcccccccCCCcccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P  104 (368)
                      .+|..+.   ++..+++++|.++.-.+
T Consensus       126 ~lp~~~~~l~~L~~L~L~~N~l~~~~~  152 (229)
T 3e6j_A          126 ELPRGIERLTHLTHLALDQNQLKSIPH  152 (229)
T ss_dssp             SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred             ccCcccccCCCCCEEECCCCcCCccCH
Confidence            7787654   45568899998875433

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.48  E-value=5.3e-14  Score=138.41  Aligned_cols=99  Identities=22%  Similarity=0.299  Sum_probs=89.5

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|++ +|. +++|++|+.|+|++|+|+ .+|..|+.|++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++
T Consensus       448 Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~  522 (567)
T 1dce_A          448 LAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQ  522 (567)
T ss_dssp             CTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCS
T ss_pred             ecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCC
Confidence            68999997 786 999999999999999998 999999999999999999999996 78 89999999999999999998


Q ss_pred             cc-cccccC---cccccccCCCcccccc
Q 017621           81 SI-PESVKK---VPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~-p~~~~~---~~~~~~~~N~~~~~~P  104 (368)
                      .. |..+..   +..+++++|.+++..|
T Consensus       523 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          523 SAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             SSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            76 887664   5568999999987544

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.47  E-value=2.1e-14  Score=147.26  Aligned_cols=80  Identities=20%  Similarity=0.384  Sum_probs=38.9

Q ss_pred             CCccccCCccccCCCCCcEEEecCccccc-----------------cCCcccc--CCCCCCeeeeecccccccCCcccCC
Q 017621            4 NKLDGPIPQELMNCSKLRILILGNNLLSG-----------------SISSEIG--KLQELNYLDLSHNLINGKIPSQLGE   64 (368)
Q Consensus         4 n~l~g~~p~~~~~l~~l~~l~l~~N~~~g-----------------~~p~~~~--~~~~L~~l~l~~N~l~g~~p~~~~~   64 (368)
                      |+|+| ||.++++|++|+.|+|++|+|+|                 .||.+++  +|++|+.|+|++|+++|.+|..++.
T Consensus       435 N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~  513 (876)
T 4ecn_A          435 NRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD  513 (876)
T ss_dssp             CEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGG
T ss_pred             Ccccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhC
Confidence            44444 44444444455555555555544                 2444444  4455555555555544455544444


Q ss_pred             CCCCceecccCCc-ccc-cccc
Q 017621           65 IPRIDTVNLSMNN-LSG-SIPE   84 (368)
Q Consensus        65 ~~~l~~l~l~~n~-l~g-~~p~   84 (368)
                      +++|+.|+|++|+ |+| .+|.
T Consensus       514 L~~L~~L~Ls~N~~lsg~~iP~  535 (876)
T 4ecn_A          514 LPELQSLNIACNRGISAAQLKA  535 (876)
T ss_dssp             CSSCCEEECTTCTTSCHHHHHH
T ss_pred             CCCCCEEECcCCCCcccccchH
Confidence            4555555555544 444 4444

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.47  E-value=5e-14  Score=113.94  Aligned_cols=100  Identities=22%  Similarity=0.249  Sum_probs=86.7

Q ss_pred             CCCCCcc-ccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLD-GPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~-g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.++ |.+|..+..+++|+.|+|++|++++.  ..++.+++|+.|+|++|++++.+|..+..+++|+.|++++|+++
T Consensus        24 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~  101 (149)
T 2je0_A           24 LDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK  101 (149)
T ss_dssp             CTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCC
T ss_pred             ccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCC
Confidence            5789998 88999899999999999999999865  78999999999999999999889998888999999999999999


Q ss_pred             cc-cccccc---CcccccccCCCcccc
Q 017621           80 GS-IPESVK---KVPLLYVSGNNFEVE  102 (368)
Q Consensus        80 g~-~p~~~~---~~~~~~~~~N~~~~~  102 (368)
                      +. .|..+.   ++..+++++|.+++.
T Consensus       102 ~~~~~~~~~~l~~L~~L~l~~N~l~~~  128 (149)
T 2je0_A          102 DLSTIEPLKKLENLKSLDLFNCEVTNL  128 (149)
T ss_dssp             SHHHHGGGGGCTTCCEEECTTCGGGGS
T ss_pred             ChHHHHHHhhCCCCCEEeCcCCcccch
Confidence            73 345554   556789999988754

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.47  E-value=8e-14  Score=128.95  Aligned_cols=99  Identities=24%  Similarity=0.297  Sum_probs=86.2

Q ss_pred             CCC-CccccCCccccCCCCCcEEEecC-ccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            2 YNN-KLDGPIPQELMNCSKLRILILGN-NLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         2 ~~n-~l~g~~p~~~~~l~~l~~l~l~~-N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      ++| +|++ +|. |..+++|+.|+|++ |+|++..|..|+.|++|+.|+|++|+|+|..|..|+.+++|+.|+|++|+|+
T Consensus        16 ~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~   93 (347)
T 2ifg_A           16 TRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE   93 (347)
T ss_dssp             CSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred             CCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccc
Confidence            455 8886 898 99999999999996 9999777788999999999999999999999999999999999999999999


Q ss_pred             ccccccccC--cccccccCCCcccc
Q 017621           80 GSIPESVKK--VPLLYVSGNNFEVE  102 (368)
Q Consensus        80 g~~p~~~~~--~~~~~~~~N~~~~~  102 (368)
                      +..|..+..  +..+++.+|.+.+.
T Consensus        94 ~~~~~~~~~~~L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           94 SLSWKTVQGLSLQELVLSGNPLHCS  118 (347)
T ss_dssp             CCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred             eeCHHHcccCCceEEEeeCCCccCC
Confidence            655554443  66789999998753

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.47  E-value=5.9e-14  Score=118.72  Aligned_cols=84  Identities=23%  Similarity=0.330  Sum_probs=79.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|++..|..+.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++++.+|..+..+++|+.|+|++|+|++
T Consensus        61 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            68999999999999999999999999999998888889999999999999999999999999999999999999999998


Q ss_pred             cccc
Q 017621           81 SIPE   84 (368)
Q Consensus        81 ~~p~   84 (368)
                      ..+-
T Consensus       141 ~c~l  144 (192)
T 1w8a_A          141 NCHL  144 (192)
T ss_dssp             SGGG
T ss_pred             cCcc
Confidence            7663

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.47  E-value=3e-14  Score=142.56  Aligned_cols=103  Identities=21%  Similarity=0.316  Sum_probs=95.4

Q ss_pred             CCCCCcccc-----------------CCcccc--CCCCCcEEEecCccccccCCccccCCCCCCeeeeeccc-ccc-cCC
Q 017621            1 MYNNKLDGP-----------------IPQELM--NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNL-ING-KIP   59 (368)
Q Consensus         1 l~~n~l~g~-----------------~p~~~~--~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~-l~g-~~p   59 (368)
                      |++|.|+|.                 +|.+++  ++++|+.|+|++|+++|.+|..|+++++|+.|+|++|+ ++| .+|
T Consensus       213 Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp  292 (636)
T 4eco_A          213 MGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLK  292 (636)
T ss_dssp             EESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHH
T ss_pred             CcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccch
Confidence            568999996                 999999  99999999999999999999999999999999999998 999 999


Q ss_pred             cccCCC------CCCceecccCCcccccccc--ccc---CcccccccCCCcccccc
Q 017621           60 SQLGEI------PRIDTVNLSMNNLSGSIPE--SVK---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        60 ~~~~~~------~~l~~l~l~~n~l~g~~p~--~~~---~~~~~~~~~N~~~~~~P  104 (368)
                      ..++.+      ++|+.|++++|+++ .+|.  .+.   ++..+++++|.++|.+|
T Consensus       293 ~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip  347 (636)
T 4eco_A          293 DDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP  347 (636)
T ss_dssp             HHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC
T ss_pred             HHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh
Confidence            998887      99999999999999 8998  665   45678999999999888

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.46  E-value=1.6e-13  Score=119.39  Aligned_cols=101  Identities=21%  Similarity=0.295  Sum_probs=86.7

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|++..+..+.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++
T Consensus        71 L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~  149 (229)
T 3e6j_A           71 LGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS  149 (229)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCC
T ss_pred             CCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCc
Confidence            6899997655556789999999999999999665666899999999999999999 999999999999999999999996


Q ss_pred             ccccccc---CcccccccCCCcccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVE  102 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~  102 (368)
                      ..+..+.   ++..+++++|++.+.
T Consensus       150 ~~~~~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A          150 IPHGAFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             CCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred             cCHHHHhCCCCCCEEEeeCCCccCC
Confidence            5555454   566789999998754

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.45  E-value=2.7e-13  Score=119.64  Aligned_cols=104  Identities=19%  Similarity=0.179  Sum_probs=77.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..|..+.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        42 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  121 (251)
T 3m19_A           42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS  121 (251)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             ccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCC
Confidence            56788887777778888888888888888887666677888888888888888886666677778888888888888875


Q ss_pred             cccccc---cCcccccccCCCcccccc
Q 017621           81 SIPESV---KKVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~---~~~~~~~~~~N~~~~~~P  104 (368)
                      ..|..+   .++..+++++|.++...|
T Consensus       122 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~  148 (251)
T 3m19_A          122 LPSGVFDRLTKLKELRLNTNQLQSIPA  148 (251)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             cChhHhccCCcccEEECcCCcCCccCH
Confidence            544433   345567777777764433

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.45  E-value=2.5e-13  Score=119.80  Aligned_cols=99  Identities=19%  Similarity=0.219  Sum_probs=44.4

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      ++|++++..|..+.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++.
T Consensus        67 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  146 (251)
T 3m19_A           67 DYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI  146 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence            44444444444444444555555555555433333344444555555555555433333344444555555555554433


Q ss_pred             cccccc---CcccccccCCCcc
Q 017621           82 IPESVK---KVPLLYVSGNNFE  100 (368)
Q Consensus        82 ~p~~~~---~~~~~~~~~N~~~  100 (368)
                      .|..+.   ++..+++++|.++
T Consensus       147 ~~~~~~~l~~L~~L~L~~N~l~  168 (251)
T 3m19_A          147 PAGAFDKLTNLQTLSLSTNQLQ  168 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCS
T ss_pred             CHHHcCcCcCCCEEECCCCcCC
Confidence            332222   2333444444444

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.45  E-value=2e-13  Score=121.95  Aligned_cols=108  Identities=19%  Similarity=0.238  Sum_probs=89.1

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.+++..|..++++++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..++.+++|+.|++++|+|++
T Consensus        92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  171 (272)
T 3rfs_A           92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS  171 (272)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence            57899998777778899999999999999997666668999999999999999997777778899999999999999997


Q ss_pred             ccccccc---CcccccccCCCcccccccCCC
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIPSTSA  108 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P~~~~  108 (368)
                      ..|..+.   ++..+++++|.+++..|....
T Consensus       172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  202 (272)
T 3rfs_A          172 LPEGVFDKLTQLKDLRLYQNQLKSVPDGVFD  202 (272)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred             cCHHHhcCCccCCEEECCCCcCCccCHHHHh
Confidence            6665444   566788999998875554333

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.44  E-value=1.1e-13  Score=114.24  Aligned_cols=100  Identities=28%  Similarity=0.248  Sum_probs=85.3

Q ss_pred             CCCCCcc-ccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLD-GPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~-g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|+++ |.+|..+..+++|+.|+|++|++++.  ..++.+++|+.|+|++|++++.+|..+..+++|+.|++++|+|+
T Consensus        31 l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  108 (168)
T 2ell_A           31 LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK  108 (168)
T ss_dssp             CCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCC
T ss_pred             CCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccC
Confidence            5789998 88999889999999999999999855  78999999999999999999888888888999999999999999


Q ss_pred             ccc-ccccc---CcccccccCCCcccc
Q 017621           80 GSI-PESVK---KVPLLYVSGNNFEVE  102 (368)
Q Consensus        80 g~~-p~~~~---~~~~~~~~~N~~~~~  102 (368)
                      +.. +..+.   ++..+++++|.++..
T Consensus       109 ~~~~~~~l~~l~~L~~L~l~~N~l~~~  135 (168)
T 2ell_A          109 DISTLEPLKKLECLKSLDLFNCEVTNL  135 (168)
T ss_dssp             SSGGGGGGSSCSCCCEEECCSSGGGTS
T ss_pred             cchhHHHHhcCCCCCEEEeeCCcCcch
Confidence            632 24444   556788999988754

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.44  E-value=3.2e-13  Score=115.55  Aligned_cols=104  Identities=20%  Similarity=0.229  Sum_probs=84.5

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..+..+.++++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..+..+++|+.|++++|+|++
T Consensus        35 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  114 (208)
T 2o6s_A           35 LETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS  114 (208)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             cCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcc
Confidence            57899997666667899999999999999985545557899999999999999996666678899999999999999996


Q ss_pred             ccccccc---CcccccccCCCcccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P  104 (368)
                      ..|..+.   ++..+++++|.+++..+
T Consensus       115 ~~~~~~~~l~~L~~L~l~~N~l~~~~~  141 (208)
T 2o6s_A          115 LPDGVFDKLTQLKDLRLYQNQLKSVPD  141 (208)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             cCHhHhccCCcCCEEECCCCccceeCH
Confidence            6555443   56678899998875443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.43  E-value=5.7e-14  Score=144.09  Aligned_cols=102  Identities=23%  Similarity=0.264  Sum_probs=91.8

Q ss_pred             CCCCCccc-----------------cCCcccc--CCCCCcEEEecCccccccCCccccCCCCCCeeeeeccc-ccc-cCC
Q 017621            1 MYNNKLDG-----------------PIPQELM--NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNL-ING-KIP   59 (368)
Q Consensus         1 l~~n~l~g-----------------~~p~~~~--~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~-l~g-~~p   59 (368)
                      |++|+|+|                 .+|++++  +|++|+.|+|++|+++|.+|..|++|++|+.|+|++|+ ++| .+|
T Consensus       455 Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP  534 (876)
T 4ecn_A          455 FANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLK  534 (876)
T ss_dssp             EESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHH
T ss_pred             CcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccch
Confidence            46788888                 5999998  99999999999999999999999999999999999998 999 999


Q ss_pred             cccCCCC-------CCceecccCCcccccccc--ccc---CcccccccCCCcccccc
Q 017621           60 SQLGEIP-------RIDTVNLSMNNLSGSIPE--SVK---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        60 ~~~~~~~-------~l~~l~l~~n~l~g~~p~--~~~---~~~~~~~~~N~~~~~~P  104 (368)
                      ..++.++       +|+.|+|++|+|+ .+|.  .+.   ++..+++++|.++ .+|
T Consensus       535 ~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp  589 (876)
T 4ecn_A          535 ADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE  589 (876)
T ss_dssp             HHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC
T ss_pred             HHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch
Confidence            8777665       9999999999999 8998  665   4566899999998 777

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.43  E-value=3.9e-14  Score=143.48  Aligned_cols=99  Identities=27%  Similarity=0.415  Sum_probs=52.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++. .+|..+.+|++|+.|+|++|+|+ .||..|+.|++|+.|||++|+|+ .+|..++.|++|+.|+|++|.|+ 
T Consensus       231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-  306 (727)
T 4b8c_D          231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-  306 (727)
T ss_dssp             CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-
T ss_pred             CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-
Confidence            3455555 45555555555555555555555 55555555555555555555555 55555555555555555555554 


Q ss_pred             cccccccC---cccccccCCCccccc
Q 017621           81 SIPESVKK---VPLLYVSGNNFEVEI  103 (368)
Q Consensus        81 ~~p~~~~~---~~~~~~~~N~~~~~~  103 (368)
                      .+|..+..   +..+++++|.+++.+
T Consensus       307 ~lp~~~~~l~~L~~L~L~~N~l~~~~  332 (727)
T 4b8c_D          307 TLPWEFGNLCNLQFLGVEGNPLEKQF  332 (727)
T ss_dssp             CCCSSTTSCTTCCCEECTTSCCCSHH
T ss_pred             ccChhhhcCCCccEEeCCCCccCCCC
Confidence            44544432   333455555554433

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.43  E-value=5.3e-13  Score=119.18  Aligned_cols=103  Identities=23%  Similarity=0.236  Sum_probs=86.2

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++ + +.+.++++|+.|+|++|++++..|..++.+++|+.|+|++|++++..|..++.+++|+.|++++|+|++
T Consensus        70 l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  147 (272)
T 3rfs_A           70 LGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS  147 (272)
T ss_dssp             CTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCc
Confidence            57899987 4 478999999999999999997666678999999999999999997777788999999999999999997


Q ss_pred             cccccc---cCcccccccCCCccccccc
Q 017621           81 SIPESV---KKVPLLYVSGNNFEVEIPS  105 (368)
Q Consensus        81 ~~p~~~---~~~~~~~~~~N~~~~~~P~  105 (368)
                      ..|..+   .++..+++++|.+++..|.
T Consensus       148 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~  175 (272)
T 3rfs_A          148 LPKGVFDKLTNLTELDLSYNQLQSLPEG  175 (272)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             cCHHHhccCccCCEEECCCCCcCccCHH
Confidence            666544   3566789999998865443

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.42  E-value=6.8e-13  Score=113.48  Aligned_cols=97  Identities=18%  Similarity=0.187  Sum_probs=59.7

Q ss_pred             CCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccc
Q 017621            3 NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSI   82 (368)
Q Consensus         3 ~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~   82 (368)
                      +|.++ .+|..+  .++|+.|+|++|++++..+..|+.+++|+.|+|++|++++..+..+..+++|+.|++++|+|++..
T Consensus        16 ~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~   92 (208)
T 2o6s_A           16 SQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLP   92 (208)
T ss_dssp             SSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccC
Confidence            44454 355444  246777777777776444444667777777777777777554455667777777777777777444


Q ss_pred             cccc---cCcccccccCCCcccc
Q 017621           83 PESV---KKVPLLYVSGNNFEVE  102 (368)
Q Consensus        83 p~~~---~~~~~~~~~~N~~~~~  102 (368)
                      +..+   .++..+++++|.++..
T Consensus        93 ~~~~~~l~~L~~L~L~~N~l~~~  115 (208)
T 2o6s_A           93 NGVFDKLTQLKELALNTNQLQSL  115 (208)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCC
T ss_pred             HhHhcCccCCCEEEcCCCcCccc
Confidence            4333   3455566777766643

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.41  E-value=3.4e-13  Score=129.21  Aligned_cols=104  Identities=16%  Similarity=0.196  Sum_probs=88.2

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++.+|..++++++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..++.+++|+.|++++|++++
T Consensus       282 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  361 (455)
T 3v47_A          282 LSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA  361 (455)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCE
T ss_pred             ecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccc
Confidence            57889998888889999999999999999988878889999999999999999988888888899999999999999988


Q ss_pred             ccccccc---CcccccccCCCcccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P  104 (368)
                      ..|..+.   ++..+++++|.++...+
T Consensus       362 ~~~~~~~~l~~L~~L~L~~N~l~~~~~  388 (455)
T 3v47_A          362 LGDQSFLGLPNLKELALDTNQLKSVPD  388 (455)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             cChhhccccccccEEECCCCccccCCH
Confidence            7777665   45568899998875433

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.41  E-value=2.3e-13  Score=125.00  Aligned_cols=97  Identities=15%  Similarity=0.172  Sum_probs=88.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++ +|+.++++++|+.|+|++|++.|.+|..++.+++|+.|+|++|++.+.+|..++.+++|+.|++++|++.|
T Consensus       213 L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~  291 (328)
T 4fcg_A          213 IRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS  291 (328)
T ss_dssp             EESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred             ccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence            46899996 78889999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccc---ccccCCC
Q 017621           81 SIPESVKKVPL---LYVSGNN   98 (368)
Q Consensus        81 ~~p~~~~~~~~---~~~~~N~   98 (368)
                      .+|..+..++.   +++..|.
T Consensus       292 ~iP~~l~~L~~L~~l~l~~~~  312 (328)
T 4fcg_A          292 RLPSLIAQLPANCIILVPPHL  312 (328)
T ss_dssp             CCCGGGGGSCTTCEEECCGGG
T ss_pred             hccHHHhhccCceEEeCCHHH
Confidence            99999887664   4455443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.40  E-value=1.6e-13  Score=139.05  Aligned_cols=105  Identities=25%  Similarity=0.477  Sum_probs=91.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|+ .+|.+|++|++|+.|+|++|+|+ .||..|+.|++|+.|+|++|.|+ .+|..++.+++|+.|+|++|+|+|
T Consensus       254 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~  330 (727)
T 4b8c_D          254 LNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK  330 (727)
T ss_dssp             CTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS
T ss_pred             eeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC
Confidence            6889999 89999999999999999999998 88999999999999999999998 889999999999999999999999


Q ss_pred             cccccccCcc----cccccCCCcccccccCCC
Q 017621           81 SIPESVKKVP----LLYVSGNNFEVEIPSTSA  108 (368)
Q Consensus        81 ~~p~~~~~~~----~~~~~~N~~~~~~P~~~~  108 (368)
                      .+|..+..+.    .+++++|.+++.+|....
T Consensus       331 ~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~  362 (727)
T 4b8c_D          331 QFLKILTEKSVTGLIFYLRDNRPEIPLPHERR  362 (727)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred             CChHHHhhcchhhhHHhhccCcccCcCccccc
Confidence            9888775432    367889999988876543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.40  E-value=1.1e-12  Score=110.91  Aligned_cols=101  Identities=21%  Similarity=0.275  Sum_probs=89.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|+ .+|..+.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        38 L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~  116 (193)
T 2wfh_A           38 LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISV  116 (193)
T ss_dssp             CCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred             CCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCe
Confidence            6789998 689999999999999999999997777789999999999999999998888899999999999999999996


Q ss_pred             ccccccc---CcccccccCCCcccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVE  102 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~  102 (368)
                      ..+..+.   ++..+++++|++.+.
T Consensus       117 ~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A          117 VPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             eChhhhhcCccccEEEeCCCCeecC
Confidence            5444454   566789999998753

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.40  E-value=3.2e-13  Score=134.49  Aligned_cols=109  Identities=17%  Similarity=0.212  Sum_probs=73.7

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCcccc-ccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLS-GSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~-g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      +++|.+.+..|..+..+++|+.|+|++|++. +.+|..|..+++|+.|||++|+|++..|..++.+++|+.|+|++|+|+
T Consensus       452 ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~  531 (635)
T 4g8a_A          452 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF  531 (635)
T ss_dssp             CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred             ccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCC
Confidence            3567777777776777777777777777643 345666777777777777777777777777777777777777777777


Q ss_pred             cccccccc---CcccccccCCCcccccccCCCC
Q 017621           80 GSIPESVK---KVPLLYVSGNNFEVEIPSTSAK  109 (368)
Q Consensus        80 g~~p~~~~---~~~~~~~~~N~~~~~~P~~~~~  109 (368)
                      +..|..+.   ++..+++++|.+++..|.....
T Consensus       532 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~  564 (635)
T 4g8a_A          532 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH  564 (635)
T ss_dssp             BCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTC
T ss_pred             CCChhHHhCCCCCCEEECCCCcCCCCCHHHHHh
Confidence            65555544   3445677777777666555443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.40  E-value=5.8e-13  Score=110.32  Aligned_cols=83  Identities=20%  Similarity=0.244  Sum_probs=74.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|++..|..+.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+++.
T Consensus        37 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           37 LYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             cCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            68999999889899999999999999999996655567999999999999999997777789999999999999999986


Q ss_pred             ccc
Q 017621           81 SIP   83 (368)
Q Consensus        81 ~~p   83 (368)
                      ..+
T Consensus       117 ~c~  119 (170)
T 3g39_A          117 ACS  119 (170)
T ss_dssp             TBG
T ss_pred             Cch
Confidence            644

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.39  E-value=1.4e-12  Score=115.21  Aligned_cols=139  Identities=17%  Similarity=0.107  Sum_probs=101.8

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCc--eeeEEEEEeeCCeEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN--IVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv  265 (368)
                      .++.+....+.|..+.||++...+|+.+++|......      ...+.+|+++++.+.+.+  +.+++++....+..++|
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            3455444334566699999988778889999876531      135678999998885444  56688888888889999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC-----------------------------------  310 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------  310 (368)
                      |||++|.++.  ...      ..   ...++.++++.|..||+..                                   
T Consensus        94 ~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           94 LGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            9999998873  211      11   1256778888888888742                                   


Q ss_pred             --------------------CCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          311 --------------------TPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       311 --------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                                          ...++|+|++|.||++++++.+.|+||+.+...
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                112999999999999988766779999998654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.38  E-value=1.1e-12  Score=118.97  Aligned_cols=109  Identities=17%  Similarity=0.208  Sum_probs=69.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccc-cCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSG-SISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g-~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.+++..|..+.++++|+.|+|++|++++ .+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|+++
T Consensus       133 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  212 (306)
T 2z66_A          133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF  212 (306)
T ss_dssp             CTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred             CCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccC
Confidence            45666666666666666667777777776665 45666666677777777777776666666666677777777777766


Q ss_pred             cccccccc---CcccccccCCCcccccccCCCC
Q 017621           80 GSIPESVK---KVPLLYVSGNNFEVEIPSTSAK  109 (368)
Q Consensus        80 g~~p~~~~---~~~~~~~~~N~~~~~~P~~~~~  109 (368)
                      +..+..+.   ++..+++++|.+++..|.....
T Consensus       213 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  245 (306)
T 2z66_A          213 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH  245 (306)
T ss_dssp             BCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCC
T ss_pred             ccChhhccCcccCCEeECCCCCCcccCHHHHHh
Confidence            54443333   4455667777666655544443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.37  E-value=7.4e-13  Score=120.19  Aligned_cols=102  Identities=19%  Similarity=0.271  Sum_probs=91.8

Q ss_pred             CCCCCccc-cCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDG-PIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g-~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.+++ .+|..+.++++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+.|++++|+++
T Consensus       157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  236 (306)
T 2z66_A          157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM  236 (306)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred             CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence            57899987 68889999999999999999999888899999999999999999999877778999999999999999999


Q ss_pred             ccccccccC----cccccccCCCcccc
Q 017621           80 GSIPESVKK----VPLLYVSGNNFEVE  102 (368)
Q Consensus        80 g~~p~~~~~----~~~~~~~~N~~~~~  102 (368)
                      +..|..+..    +..+++++|.+++.
T Consensus       237 ~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          237 TSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             BCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             ccCHHHHHhhhccCCEEEccCCCeecc
Confidence            988887654    45689999998764

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.37  E-value=1.1e-12  Score=125.61  Aligned_cols=104  Identities=20%  Similarity=0.264  Sum_probs=72.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..|..+.++++|+.|+|++|++++..|..++.+++|+.|+|++|++++..|..++.+++|+.|++++|+|++
T Consensus       306 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  385 (455)
T 3v47_A          306 LAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS  385 (455)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCcccc
Confidence            46777777667777777777777777777776666677777777777777777777777777777777777777777775


Q ss_pred             ccccccc---CcccccccCCCcccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P  104 (368)
                      ..+..+.   ++..+++++|++++..|
T Consensus       386 ~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          386 VPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCHhHhccCCcccEEEccCCCcccCCC
Confidence            4443333   45556777777766544

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.36  E-value=1.2e-12  Score=108.77  Aligned_cols=81  Identities=20%  Similarity=0.254  Sum_probs=72.2

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|++..|..+.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|+.
T Consensus        40 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           40 LNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             eCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCccc
Confidence            68999999889999999999999999999996444457999999999999999996655669999999999999999985


Q ss_pred             c
Q 017621           81 S   81 (368)
Q Consensus        81 ~   81 (368)
                      .
T Consensus       120 ~  120 (174)
T 2r9u_A          120 E  120 (174)
T ss_dssp             T
T ss_pred             c
Confidence            4

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.35  E-value=1.6e-12  Score=120.91  Aligned_cols=101  Identities=21%  Similarity=0.228  Sum_probs=82.9

Q ss_pred             CCCCCccccCCcccc-CCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELM-NCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~-~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|+|++..+..+. ++++|+.|+|++|+|++..|..|..+++|+.|||++|+|++..|..+..+++|+.|+|++|+|+
T Consensus        46 Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~  125 (361)
T 2xot_A           46 LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV  125 (361)
T ss_dssp             CCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCccc
Confidence            678899887666676 8889999999999998766677889999999999999999777778888999999999999998


Q ss_pred             cccccccc---CcccccccCCCccc
Q 017621           80 GSIPESVK---KVPLLYVSGNNFEV  101 (368)
Q Consensus        80 g~~p~~~~---~~~~~~~~~N~~~~  101 (368)
                      +..|..+.   ++..+++++|.++.
T Consensus       126 ~~~~~~~~~l~~L~~L~L~~N~l~~  150 (361)
T 2xot_A          126 VVDRNAFEDMAQLQKLYLSQNQISR  150 (361)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCS
T ss_pred             EECHHHhCCcccCCEEECCCCcCCe
Confidence            76666654   45568888888775

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.34  E-value=1.5e-12  Score=116.97  Aligned_cols=105  Identities=20%  Similarity=0.215  Sum_probs=89.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.+++..|..+.++++|+.|+|++|++++..+..|+.+++|+.|+|++|++++..+..+..+++|+.|++++|++++
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence            57899998888889999999999999999986655668999999999999999996666679999999999999999998


Q ss_pred             ccccccc---CcccccccCCCccccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIPS  105 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P~  105 (368)
                      ..|..+.   ++..+++++|.+++..+.
T Consensus       192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~  219 (285)
T 1ozn_A          192 VHPHAFRDLGRLMTLYLFANNLSALPTE  219 (285)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHH
T ss_pred             cCHhHccCcccccEeeCCCCcCCcCCHH
Confidence            8787765   455689999998864443

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.34  E-value=2.3e-12  Score=116.12  Aligned_cols=105  Identities=23%  Similarity=0.277  Sum_probs=88.8

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|+ .+|..+.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        84 Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  162 (290)
T 1p9a_G           84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (290)
T ss_dssp             CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             CCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence            6789998 689899999999999999999996666789999999999999999997777778999999999999999995


Q ss_pred             cccccc---cCcccccccCCCcccccccCC
Q 017621           81 SIPESV---KKVPLLYVSGNNFEVEIPSTS  107 (368)
Q Consensus        81 ~~p~~~---~~~~~~~~~~N~~~~~~P~~~  107 (368)
                      ..+..+   .++..+++++|.++ .+|...
T Consensus       163 l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~  191 (290)
T 1p9a_G          163 LPAGLLNGLENLDTLLLQENSLY-TIPKGF  191 (290)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCC-CCCTTT
T ss_pred             cCHHHhcCcCCCCEEECCCCcCC-ccChhh
Confidence            444333   46677899999987 455443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.34  E-value=1.6e-12  Score=128.12  Aligned_cols=107  Identities=14%  Similarity=0.194  Sum_probs=77.4

Q ss_pred             CCCCCccccCC-ccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeeccccc-ccCCcccCCCCCCceecccCCcc
Q 017621            1 MYNNKLDGPIP-QELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLIN-GKIPSQLGEIPRIDTVNLSMNNL   78 (368)
Q Consensus         1 l~~n~l~g~~p-~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~-g~~p~~~~~~~~l~~l~l~~n~l   78 (368)
                      |++|.+++..| ..+.++++|+.|+|++|++++.+|..+..+++|+.|+|++|.++ +.+|..++.+++|+.|++++|++
T Consensus       403 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l  482 (570)
T 2z63_A          403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL  482 (570)
T ss_dssp             CTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred             ccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCcc
Confidence            46677777655 35677778888888888887777777777888888888888776 57777777778888888888888


Q ss_pred             ccccccccc---CcccccccCCCcccccccCC
Q 017621           79 SGSIPESVK---KVPLLYVSGNNFEVEIPSTS  107 (368)
Q Consensus        79 ~g~~p~~~~---~~~~~~~~~N~~~~~~P~~~  107 (368)
                      ++..|..+.   ++..+++++|.+++..|...
T Consensus       483 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  514 (570)
T 2z63_A          483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF  514 (570)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred             ccCChhhhhcccCCCEEeCCCCcCCCCCHHHh
Confidence            776676654   34457777777776544433

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.34  E-value=1.8e-12  Score=120.67  Aligned_cols=82  Identities=26%  Similarity=0.223  Sum_probs=37.5

Q ss_pred             CcEEEecCccccccCCcccc-CCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccccccccc---Cccccccc
Q 017621           20 LRILILGNNLLSGSISSEIG-KLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVK---KVPLLYVS   95 (368)
Q Consensus        20 l~~l~l~~N~~~g~~p~~~~-~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~~~~---~~~~~~~~   95 (368)
                      ++.|+|++|+|++..+..+. .+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++..+..+.   ++..++++
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  120 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY  120 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence            44555555555433333333 455555555555555544444445555555555555555433222222   23334455


Q ss_pred             CCCccc
Q 017621           96 GNNFEV  101 (368)
Q Consensus        96 ~N~~~~  101 (368)
                      +|.++.
T Consensus       121 ~N~i~~  126 (361)
T 2xot_A          121 NNHIVV  126 (361)
T ss_dssp             SSCCCE
T ss_pred             CCcccE
Confidence            554443

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.34  E-value=3.9e-12  Score=114.69  Aligned_cols=99  Identities=22%  Similarity=0.206  Sum_probs=85.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.+++ +|.. +.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        62 L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~  138 (290)
T 1p9a_G           62 LDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT  138 (290)
T ss_dssp             CTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred             CCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc
Confidence            57899997 4543 78999999999999998 889999999999999999999997777889999999999999999996


Q ss_pred             ccccccc---CcccccccCCCcccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVE  102 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~  102 (368)
                      ..|..+.   ++..+++++|.++.-
T Consensus       139 ~~~~~~~~l~~L~~L~L~~N~l~~l  163 (290)
T 1p9a_G          139 LPPGLLTPTPKLEKLSLANNNLTEL  163 (290)
T ss_dssp             CCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred             cChhhcccccCCCEEECCCCcCCcc
Confidence            6555444   566789999998743

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.34  E-value=5e-13  Score=121.82  Aligned_cols=101  Identities=21%  Similarity=0.254  Sum_probs=71.5

Q ss_pred             CCCCCc-cccCCcccc-------CCCCCcEEEecCccccccCCccc--cCCCCCCeeeeecccccccCCcccCCC-----
Q 017621            1 MYNNKL-DGPIPQELM-------NCSKLRILILGNNLLSGSISSEI--GKLQELNYLDLSHNLINGKIPSQLGEI-----   65 (368)
Q Consensus         1 l~~n~l-~g~~p~~~~-------~l~~l~~l~l~~N~~~g~~p~~~--~~~~~L~~l~l~~N~l~g~~p~~~~~~-----   65 (368)
                      |++|.+ .+.+|..+.       ++++|+.|+|++|+++|.+|..+  +.+++|+.|+|++|++++. |+.++.+     
T Consensus        70 L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~  148 (312)
T 1wwl_A           70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLK  148 (312)
T ss_dssp             CCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCC
T ss_pred             cccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhc
Confidence            456666 556676665       67778888888888877777776  7777788888888877766 7666666     


Q ss_pred             CCCceecccCCccccccccccc---CcccccccCCCcccc
Q 017621           66 PRIDTVNLSMNNLSGSIPESVK---KVPLLYVSGNNFEVE  102 (368)
Q Consensus        66 ~~l~~l~l~~n~l~g~~p~~~~---~~~~~~~~~N~~~~~  102 (368)
                      ++|+.|++++|++++..|..+.   ++..+++++|.+.+.
T Consensus       149 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  188 (312)
T 1wwl_A          149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE  188 (312)
T ss_dssp             TTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHH
T ss_pred             CCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcc
Confidence            7777778877777766656554   344577777776654

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.34  E-value=1.5e-12  Score=129.67  Aligned_cols=101  Identities=16%  Similarity=0.111  Sum_probs=77.1

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|++..|.+|.++++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|..+++|+.|+|++|+|++
T Consensus        59 Ls~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~  138 (635)
T 4g8a_A           59 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS  138 (635)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCC
T ss_pred             eeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCC
Confidence            67888887666778888888888888888886556678888888888888888886666678888888888888888886


Q ss_pred             ccccccc---CcccccccCCCccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~  101 (368)
                      ..|..+.   ++..+++++|.++.
T Consensus       139 l~~~~~~~L~~L~~L~Ls~N~l~~  162 (635)
T 4g8a_A          139 LENFPIGHLKTLKELNVAHNLIQS  162 (635)
T ss_dssp             STTCCCTTCTTCCEEECCSSCCCC
T ss_pred             CChhhhhcCcccCeeccccCcccc
Confidence            5444444   45567777777653

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.33  E-value=1.9e-12  Score=116.20  Aligned_cols=110  Identities=17%  Similarity=0.179  Sum_probs=93.3

Q ss_pred             CCCCC-ccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNK-LDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~-l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|. ++...|..+.++++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..++.+++|+.|++++|+++
T Consensus        87 l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  166 (285)
T 1ozn_A           87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS  166 (285)
T ss_dssp             CCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccc
Confidence            57887 77666888999999999999999999887888999999999999999999777777999999999999999999


Q ss_pred             cccccccc---CcccccccCCCcccccccCCCCC
Q 017621           80 GSIPESVK---KVPLLYVSGNNFEVEIPSTSAKA  110 (368)
Q Consensus        80 g~~p~~~~---~~~~~~~~~N~~~~~~P~~~~~~  110 (368)
                      +..+..+.   ++..+++++|.++...|......
T Consensus       167 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  200 (285)
T 1ozn_A          167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL  200 (285)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred             ccCHHHhcCccccCEEECCCCcccccCHhHccCc
Confidence            65554454   56678999999987767655443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.33  E-value=1e-12  Score=111.45  Aligned_cols=98  Identities=17%  Similarity=0.251  Sum_probs=78.4

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      ++|.++  .++.+.++++|+.|+|++|++++..|..++.|++|+.|+|++|++++..|..++.+++|+.|++++|++.+.
T Consensus        74 ~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~  151 (197)
T 4ezg_A           74 NNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD  151 (197)
T ss_dssp             ESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC
T ss_pred             cCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc
Confidence            466554  345788899999999999999887888899999999999999999988888899999999999999983335


Q ss_pred             ccc--cccCcccccccCCCccc
Q 017621           82 IPE--SVKKVPLLYVSGNNFEV  101 (368)
Q Consensus        82 ~p~--~~~~~~~~~~~~N~~~~  101 (368)
                      +|.  .+.++..+++++|.++.
T Consensus       152 ~~~l~~l~~L~~L~l~~n~i~~  173 (197)
T 4ezg_A          152 IMPLKTLPELKSLNIQFDGVHD  173 (197)
T ss_dssp             CGGGGGCSSCCEEECTTBCCCC
T ss_pred             cHhhcCCCCCCEEECCCCCCcC
Confidence            662  23356678888888764

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.33  E-value=3.5e-13  Score=139.16  Aligned_cols=99  Identities=22%  Similarity=0.267  Sum_probs=82.5

Q ss_pred             CCCCcc-----ccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCC
Q 017621            2 YNNKLD-----GPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMN   76 (368)
Q Consensus         2 ~~n~l~-----g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n   76 (368)
                      ++|.++     +..|..+.++++|+.|+|++|++++..|..|+.+++|+.|+|++|+|++..|..+.  ++|+.|+|++|
T Consensus       459 s~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N  536 (844)
T 3j0a_A          459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRN  536 (844)
T ss_dssp             ESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEE
T ss_pred             CCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCC
Confidence            456655     44455677888999999999999988787889999999999999999976666654  88999999999


Q ss_pred             cccccccccccCcccccccCCCcccc
Q 017621           77 NLSGSIPESVKKVPLLYVSGNNFEVE  102 (368)
Q Consensus        77 ~l~g~~p~~~~~~~~~~~~~N~~~~~  102 (368)
                      +|+|..|..+.++..+++++|++.|.
T Consensus       537 ~l~~~~~~~~~~L~~l~l~~Np~~C~  562 (844)
T 3j0a_A          537 QLLAPNPDVFVSLSVLDITHNKFICE  562 (844)
T ss_dssp             CCCCCCSCCCSSCCEEEEEEECCCCS
T ss_pred             cCCCCChhHhCCcCEEEecCCCcccc
Confidence            99999998888889999999998774

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.33  E-value=1.6e-12  Score=129.23  Aligned_cols=99  Identities=19%  Similarity=0.193  Sum_probs=54.7

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccc-cCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSG-SISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g-~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      ++|.+++.+|..++++++|+.|+|++|++++ .+|..++.+++|+.|+|++|++++..|..++.+++|+.|++++|++++
T Consensus       432 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  511 (606)
T 3vq2_A          432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF  511 (606)
T ss_dssp             TTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             cCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCC
Confidence            4555555555555555555555555555554 245555555555555555555555555555555555555555555555


Q ss_pred             cccccccC---cccccccCCCcc
Q 017621           81 SIPESVKK---VPLLYVSGNNFE  100 (368)
Q Consensus        81 ~~p~~~~~---~~~~~~~~N~~~  100 (368)
                      .+|..+..   +..+++++|.++
T Consensus       512 ~~~~~~~~l~~L~~L~l~~N~l~  534 (606)
T 3vq2_A          512 LDSSHYNQLYSLSTLDCSFNRIE  534 (606)
T ss_dssp             EEGGGTTTCTTCCEEECTTSCCC
T ss_pred             cCHHHccCCCcCCEEECCCCcCc
Confidence            55554433   334555555554

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.33  E-value=1.5e-12  Score=126.97  Aligned_cols=104  Identities=23%  Similarity=0.296  Sum_probs=79.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccc--cCCccccCCCCCCeeeeecccccccCCcc-cCCCCCCceecccCCc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSG--SISSEIGKLQELNYLDLSHNLINGKIPSQ-LGEIPRIDTVNLSMNN   77 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g--~~p~~~~~~~~L~~l~l~~N~l~g~~p~~-~~~~~~l~~l~l~~n~   77 (368)
                      |++|++++.+|..++++++|+.|+|++|++++  .+|..++.+++|+.|||++|++++.+|.. +..+++|+.|++++|+
T Consensus       331 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~  410 (520)
T 2z7x_B          331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI  410 (520)
T ss_dssp             CCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSC
T ss_pred             eECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCC
Confidence            56788888788888888888888888888876  56677888888888888888888767764 6777888888888888


Q ss_pred             cccccccccc-CcccccccCCCccccccc
Q 017621           78 LSGSIPESVK-KVPLLYVSGNNFEVEIPS  105 (368)
Q Consensus        78 l~g~~p~~~~-~~~~~~~~~N~~~~~~P~  105 (368)
                      +++.+|..+. ++..+++++|.++ .+|.
T Consensus       411 l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~  438 (520)
T 2z7x_B          411 LTDTIFRCLPPRIKVLDLHSNKIK-SIPK  438 (520)
T ss_dssp             CCGGGGGSCCTTCCEEECCSSCCC-CCCG
T ss_pred             CCcchhhhhcccCCEEECCCCccc-ccch
Confidence            8877777663 6777778877776 4554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.32  E-value=5.1e-12  Score=112.59  Aligned_cols=104  Identities=18%  Similarity=0.178  Sum_probs=87.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..+..+.++++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..+..++.+++|+.|++++|++++
T Consensus        92 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  171 (270)
T 2o6q_A           92 VTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR  171 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence            57899998666677899999999999999997777778999999999999999996666678999999999999999997


Q ss_pred             ccccccc---CcccccccCCCcccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P  104 (368)
                      ..|..+.   ++..+++++|.++...+
T Consensus       172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~  198 (270)
T 2o6q_A          172 VPEGAFDKLTELKTLKLDNNQLKRVPE  198 (270)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             eChhHhccCCCcCEEECCCCcCCcCCH
Confidence            6555454   56678999998875433

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.31  E-value=9.6e-12  Score=115.52  Aligned_cols=143  Identities=19%  Similarity=0.289  Sum_probs=106.0

Q ss_pred             cceeeeecCCccEEEEEcCCCCEEEEEEcc--ccchhhHHhHHHHHHHHHHHhccC--CCceeeEEEEEeeC---CeEEE
Q 017621          192 IKYCIGTGGYGSVYRARLPSGKVVALKKLH--RSETEELASLESFRNEARLLSQIW--HRNIVKLYGFCLHR---KCMFL  264 (368)
Q Consensus       192 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~l  264 (368)
                      ..+.++.|.++.||+....+ ..+++|+..  .....  .....+.+|.++++.+.  +..+++++.++.+.   +..|+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            35678999999999998754 678888876  33211  12246778999999886  45678899988776   45899


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC----------------------------------  310 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  310 (368)
                      ||||++|..+.+..     ...++..++..++.++++.|..||+..                                  
T Consensus       119 vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            99999987774311     112677888889999999999999731                                  


Q ss_pred             ---------------------CCCeeecCCCCCCeeecCCCC--eEEeeecccee
Q 017621          311 ---------------------TPPIVHRDISSNNVLLNSELE--AFVADFGVARL  342 (368)
Q Consensus       311 ---------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DFg~a~~  342 (368)
                                           ...++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 246999999999999997753  58999998875

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.31  E-value=7.7e-12  Score=111.45  Aligned_cols=105  Identities=17%  Similarity=0.186  Sum_probs=86.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+++...+..+.++++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..++.+++|+.|++++|+|++
T Consensus        68 l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  147 (270)
T 2o6q_A           68 LNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS  147 (270)
T ss_dssp             CCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCc
Confidence            57899996444456889999999999999986555677999999999999999998888889999999999999999996


Q ss_pred             ccccccc---CcccccccCCCccccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIPS  105 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P~  105 (368)
                      ..+..+.   ++..+++++|.++...+.
T Consensus       148 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~  175 (270)
T 2o6q_A          148 LPKGVFDKLTSLKELRLYNNQLKRVPEG  175 (270)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             cCHhHccCCcccceeEecCCcCcEeChh
Confidence            5554444   566789999988765443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.31  E-value=2.5e-12  Score=126.52  Aligned_cols=80  Identities=25%  Similarity=0.333  Sum_probs=75.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccC-CcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKI-PSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~-p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|+|+ .+|..+++|++|+.|+|++|+|++ +| .++.|++|+.|+|++|+|++.. |..++.+++|+.|+|++|+|+
T Consensus       470 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~  546 (567)
T 1dce_A          470 LSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC  546 (567)
T ss_dssp             CCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence            6899999 899999999999999999999996 78 9999999999999999999887 999999999999999999999


Q ss_pred             cccc
Q 017621           80 GSIP   83 (368)
Q Consensus        80 g~~p   83 (368)
                      +.+|
T Consensus       547 ~~~~  550 (567)
T 1dce_A          547 QEEG  550 (567)
T ss_dssp             GSSS
T ss_pred             CCcc
Confidence            7655

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.31  E-value=1.2e-12  Score=105.76  Aligned_cols=81  Identities=23%  Similarity=0.241  Sum_probs=73.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeeccccccc-CCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGK-IPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~-~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.+++.  ..++++++|+.|+|++|++++.+|..+..+++|+.|+|++|++++. .|..++.+++|+.|++++|+++
T Consensus        49 l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~  126 (149)
T 2je0_A           49 TINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT  126 (149)
T ss_dssp             CTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred             CcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence            578999986  6899999999999999999988998888999999999999999973 5588999999999999999999


Q ss_pred             cccc
Q 017621           80 GSIP   83 (368)
Q Consensus        80 g~~p   83 (368)
                      +..+
T Consensus       127 ~~~~  130 (149)
T 2je0_A          127 NLND  130 (149)
T ss_dssp             GSTT
T ss_pred             chHH
Confidence            7654

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.30  E-value=1e-11  Score=103.25  Aligned_cols=103  Identities=17%  Similarity=0.217  Sum_probs=87.1

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..+..+.++++|+.|+|++|++++..+..++.+++|+.|+|++|++++..|..+..+++|+.|++++|+|++
T Consensus        35 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  114 (177)
T 2o6r_A           35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKS  114 (177)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             eCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceE
Confidence            67899997666678999999999999999996555567999999999999999997777778999999999999999996


Q ss_pred             ccccccc---CcccccccCCCccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEI  103 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~  103 (368)
                      ..+..+.   ++..+++++|++++..
T Consensus       115 ~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A          115 VPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             eCHHHhcCCcccCEEEecCCCeeccC
Confidence            5544433   5667899999987644

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.30  E-value=4.3e-12  Score=125.04  Aligned_cols=106  Identities=26%  Similarity=0.298  Sum_probs=85.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccc--cCCccccCCCCCCeeeeecccccccCCcc-cCCCCCCceecccCCc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSG--SISSEIGKLQELNYLDLSHNLINGKIPSQ-LGEIPRIDTVNLSMNN   77 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g--~~p~~~~~~~~L~~l~l~~N~l~g~~p~~-~~~~~~l~~l~l~~n~   77 (368)
                      |++|++++.+|..++++++|+.|+|++|++++  .+|..++.+++|+.|+|++|++++.+|.. +..+++|+.|++++|+
T Consensus       360 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~  439 (562)
T 3a79_B          360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM  439 (562)
T ss_dssp             CCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSC
T ss_pred             CCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCC
Confidence            57888888888888888899999999998885  44567888889999999999988867764 6778888888888888


Q ss_pred             ccccccccc-cCcccccccCCCcccccccCC
Q 017621           78 LSGSIPESV-KKVPLLYVSGNNFEVEIPSTS  107 (368)
Q Consensus        78 l~g~~p~~~-~~~~~~~~~~N~~~~~~P~~~  107 (368)
                      ++|.+|..+ .++..+++++|.++ .+|...
T Consensus       440 l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~  469 (562)
T 3a79_B          440 LTGSVFRCLPPKVKVLDLHNNRIM-SIPKDV  469 (562)
T ss_dssp             CCGGGGSSCCTTCSEEECCSSCCC-CCCTTT
T ss_pred             CCcchhhhhcCcCCEEECCCCcCc-ccChhh
Confidence            888888877 47778888888776 455443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.30  E-value=2.5e-12  Score=106.09  Aligned_cols=98  Identities=19%  Similarity=0.178  Sum_probs=82.8

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeeccccccc-CCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGK-IPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~-~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.+++.  ..++++++|+.|+|++|++++.+|..+..+++|+.|+|++|++++. .+..+..+++|+.|++++|+++
T Consensus        56 l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~  133 (168)
T 2ell_A           56 LINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT  133 (168)
T ss_dssp             EESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred             CcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence            468899875  7899999999999999999988898888899999999999999953 2378999999999999999999


Q ss_pred             cccc---ccc---cCcccccccCCCcc
Q 017621           80 GSIP---ESV---KKVPLLYVSGNNFE  100 (368)
Q Consensus        80 g~~p---~~~---~~~~~~~~~~N~~~  100 (368)
                      +..+   ..+   .++..+++++|...
T Consensus       134 ~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          134 NLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             TSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             chHHHHHHHHHhCccCcEecCCCCChh
Confidence            6544   244   45667888888764

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.30  E-value=4.4e-12  Score=125.96  Aligned_cols=105  Identities=18%  Similarity=0.156  Sum_probs=66.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..|..+.++++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..++.+++|++|++++|++++
T Consensus        39 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~  118 (606)
T 3vq2_A           39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS  118 (606)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCC
T ss_pred             CCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccc
Confidence            45666766666666677777777777777766556666777777777777777776666666667777777777776665


Q ss_pred             ccccccc---CcccccccCCCccc-cccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEV-EIPS  105 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~-~~P~  105 (368)
                      ..|..+.   ++..+++++|.++. .+|.
T Consensus       119 ~~~~~~~~l~~L~~L~L~~n~l~~~~lp~  147 (606)
T 3vq2_A          119 LESFPIGQLITLKKLNVAHNFIHSCKLPA  147 (606)
T ss_dssp             SSSSCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred             ccccccCCCCCCCEEeCCCCcccceechH
Confidence            4444443   33445666666553 3344

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.29  E-value=6.3e-12  Score=112.29  Aligned_cols=108  Identities=16%  Similarity=0.129  Sum_probs=89.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..+..+.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..+..+++|+.|++++|++++
T Consensus        35 ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  114 (276)
T 2z62_A           35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS  114 (276)
T ss_dssp             CTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCC
T ss_pred             CCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccc
Confidence            57899998777789999999999999999987666689999999999999999998888889999999999999999987


Q ss_pred             ccccccc---CcccccccCCCccc-ccccCCC
Q 017621           81 SIPESVK---KVPLLYVSGNNFEV-EIPSTSA  108 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~-~~P~~~~  108 (368)
                      ..+..+.   ++..+++++|.++. .+|....
T Consensus       115 ~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~  146 (276)
T 2z62_A          115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS  146 (276)
T ss_dssp             STTCCCTTCTTCCEEECCSSCCCCCCCCGGGG
T ss_pred             cCchhcccCCCCCEEECcCCccceecCchhhc
Confidence            6554554   55678899998875 3454443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.29  E-value=6.4e-12  Score=112.23  Aligned_cols=94  Identities=21%  Similarity=0.125  Sum_probs=68.7

Q ss_pred             cCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccccccccc-
Q 017621            9 PIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVK-   87 (368)
Q Consensus         9 ~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~~~~-   87 (368)
                      .+|..+.  ++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..|..+. 
T Consensus        21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (276)
T 2z62_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (276)
T ss_dssp             SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence            3666554  4688888888888765555788888888888888888866666788888888888888888866655554 


Q ss_pred             --CcccccccCCCcccccc
Q 017621           88 --KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        88 --~~~~~~~~~N~~~~~~P  104 (368)
                        ++..+++++|.+....+
T Consensus        99 l~~L~~L~l~~n~l~~~~~  117 (276)
T 2z62_A           99 LSSLQKLVAVETNLASLEN  117 (276)
T ss_dssp             CTTCCEEECTTSCCCCSTT
T ss_pred             CccccEEECCCCCccccCc
Confidence              45567788887765433

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.28  E-value=7.6e-12  Score=120.63  Aligned_cols=108  Identities=16%  Similarity=0.156  Sum_probs=85.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..|..+.++++|+.|+|++|++++..|..|+++++|+.|+|++|++++..+..+..+++|+.|+|++|++++
T Consensus        39 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~  118 (477)
T 2id5_A           39 LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI  118 (477)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCE
T ss_pred             CCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCcccc
Confidence            57888888778888888899999999999887778888889999999999998885555567888889999999888887


Q ss_pred             ccccccc---CcccccccCCCcccccccCCC
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIPSTSA  108 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P~~~~  108 (368)
                      ..|..+.   ++..+++++|.++...|....
T Consensus       119 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  149 (477)
T 2id5_A          119 LLDYMFQDLYNLKSLEVGDNDLVYISHRAFS  149 (477)
T ss_dssp             ECTTTTTTCTTCCEEEECCTTCCEECTTSST
T ss_pred             CChhHccccccCCEEECCCCccceeChhhcc
Confidence            7676554   455678888887765554433

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.28  E-value=6.5e-12  Score=124.72  Aligned_cols=101  Identities=14%  Similarity=0.048  Sum_probs=87.5

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.+++..|..++++++|++|+|++|++++..|..|+++++|+.|+|++|++++..|..++.+++|+.|++++|++++
T Consensus        40 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~  119 (606)
T 3t6q_A           40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS  119 (606)
T ss_dssp             CTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSC
T ss_pred             ccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCccc
Confidence            67899998888899999999999999999998888899999999999999999998889999999999999999999987


Q ss_pred             ccccccc---CcccccccCCCccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~  101 (368)
                      ..|..+.   ++..+++++|.+++
T Consensus       120 l~~~~~~~l~~L~~L~L~~n~l~~  143 (606)
T 3t6q_A          120 IDFIPLHNQKTLESLYLGSNHISS  143 (606)
T ss_dssp             GGGSCCTTCTTCCEEECCSSCCCC
T ss_pred             CCcchhccCCcccEEECCCCcccc
Confidence            5455554   45667888888775

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.27  E-value=9.4e-12  Score=123.52  Aligned_cols=101  Identities=16%  Similarity=0.181  Sum_probs=71.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.+++..|..++++++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++..|..++.+++|+.|+|++|.|++
T Consensus        82 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~  161 (597)
T 3oja_B           82 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER  161 (597)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred             CCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCC
Confidence            46777777666677777777777777777776666667777777777777777774444445777777777777777777


Q ss_pred             ccccccc---CcccccccCCCccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~  101 (368)
                      ..|..+.   ++..+++++|.+++
T Consensus       162 ~~~~~~~~l~~L~~L~L~~N~l~~  185 (597)
T 3oja_B          162 IEDDTFQATTSLQNLQLSSNRLTH  185 (597)
T ss_dssp             CCTTTTTTCTTCCEEECTTSCCSB
T ss_pred             CChhhhhcCCcCcEEECcCCCCCC
Confidence            6665554   34456777776654

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.27  E-value=1.1e-12  Score=119.49  Aligned_cols=99  Identities=21%  Similarity=0.223  Sum_probs=74.5

Q ss_pred             CCCCCccccCCccc--cCCCCCcEEEecCccccccCCccccCC-----CCCCeeeeecccccccCCcccCCCCCCceecc
Q 017621            1 MYNNKLDGPIPQEL--MNCSKLRILILGNNLLSGSISSEIGKL-----QELNYLDLSHNLINGKIPSQLGEIPRIDTVNL   73 (368)
Q Consensus         1 l~~n~l~g~~p~~~--~~l~~l~~l~l~~N~~~g~~p~~~~~~-----~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l   73 (368)
                      |++|+++|.+|..+  .++++|+.|+|++|++++. |..++.+     ++|+.|+|++|++++..|..++.+++|+.|++
T Consensus       102 L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  180 (312)
T 1wwl_A          102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL  180 (312)
T ss_dssp             EEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEEC
T ss_pred             ccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEEC
Confidence            45778888888776  7788888888888888765 7777766     78888888888888777778888888888888


Q ss_pred             cCCcccccc--c-----ccccCcccccccCCCcc
Q 017621           74 SMNNLSGSI--P-----ESVKKVPLLYVSGNNFE  100 (368)
Q Consensus        74 ~~n~l~g~~--p-----~~~~~~~~~~~~~N~~~  100 (368)
                      ++|+++|.+  |     ..+.++..+++++|.++
T Consensus       181 s~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  214 (312)
T 1wwl_A          181 SDNPELGERGLISALCPLKFPTLQVLALRNAGME  214 (312)
T ss_dssp             CSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred             CCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence            888877652  2     23345666778888765

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.27  E-value=3.6e-12  Score=124.98  Aligned_cols=104  Identities=22%  Similarity=0.248  Sum_probs=78.7

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..|..+.++++|+.|+|++|++++..|..|+.+++|++|||++|++++..|..++.+++|+.|++++|++++
T Consensus        33 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  112 (549)
T 2z81_A           33 LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT  112 (549)
T ss_dssp             CCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSS
T ss_pred             CcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccc
Confidence            57788888777788888888888888888887777778888888888888888887766678888888888888888875


Q ss_pred             -ccccccc---CcccccccCCCcccccc
Q 017621           81 -SIPESVK---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 -~~p~~~~---~~~~~~~~~N~~~~~~P  104 (368)
                       .+|..+.   ++..+++++|.+.+.+|
T Consensus       113 ~~~~~~~~~l~~L~~L~L~~n~~~~~~~  140 (549)
T 2z81_A          113 LGVTSLFPNLTNLQTLRIGNVETFSEIR  140 (549)
T ss_dssp             SCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred             cchhhhhhccCCccEEECCCCccccccC
Confidence             3454443   45557777777555544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.25  E-value=1.1e-11  Score=122.99  Aligned_cols=108  Identities=20%  Similarity=0.184  Sum_probs=66.9

Q ss_pred             CCCCCccccCCcc-ccCCCCCcEEEecCccccccCCccccCCCCCCeeeeeccccccc---CCcccCCCCCCceecccCC
Q 017621            1 MYNNKLDGPIPQE-LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGK---IPSQLGEIPRIDTVNLSMN   76 (368)
Q Consensus         1 l~~n~l~g~~p~~-~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~---~p~~~~~~~~l~~l~l~~n   76 (368)
                      |++|++++..|+. +.++++|+.|+|++|++++..|..++.+++|+.|+|++|++++.   .+..+..+++|+.|++++|
T Consensus       407 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n  486 (606)
T 3t6q_A          407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC  486 (606)
T ss_dssp             CTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTS
T ss_pred             CCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCC
Confidence            4566666665544 66666777777777777666666666677777777777766652   2244666666666666666


Q ss_pred             ccccccccccc---CcccccccCCCcccccccCCC
Q 017621           77 NLSGSIPESVK---KVPLLYVSGNNFEVEIPSTSA  108 (368)
Q Consensus        77 ~l~g~~p~~~~---~~~~~~~~~N~~~~~~P~~~~  108 (368)
                      ++++..|..+.   .+..+++++|.+++..|....
T Consensus       487 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~  521 (606)
T 3t6q_A          487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS  521 (606)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGT
T ss_pred             ccCccChhhhccccCCCEEECCCCccCcCChhHhC
Confidence            66665555544   334466666666655554433

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.25  E-value=3e-12  Score=116.49  Aligned_cols=99  Identities=20%  Similarity=0.263  Sum_probs=78.0

Q ss_pred             CCCCCcccc--CC--ccccCCCCCcEEEecCccccccCCcc----ccCCCCCCeeeeecccccccCCcccCCC---CCCc
Q 017621            1 MYNNKLDGP--IP--QELMNCSKLRILILGNNLLSGSISSE----IGKLQELNYLDLSHNLINGKIPSQLGEI---PRID   69 (368)
Q Consensus         1 l~~n~l~g~--~p--~~~~~l~~l~~l~l~~N~~~g~~p~~----~~~~~~L~~l~l~~N~l~g~~p~~~~~~---~~l~   69 (368)
                      |++|++.+.  +|  ..++++++|+.|+|++|+++ .+|..    ++.+++|+.|||++|++++.+|+.++.+   ++|+
T Consensus       176 Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~  254 (310)
T 4glp_A          176 LSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALN  254 (310)
T ss_dssp             CCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCC
T ss_pred             CCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCC
Confidence            578887763  32  23468889999999999997 44442    5788999999999999998888888777   6999


Q ss_pred             eecccCCccccccccccc-CcccccccCCCccc
Q 017621           70 TVNLSMNNLSGSIPESVK-KVPLLYVSGNNFEV  101 (368)
Q Consensus        70 ~l~l~~n~l~g~~p~~~~-~~~~~~~~~N~~~~  101 (368)
                      .|+|++|+|+ .+|..+. ++..+++++|.+++
T Consensus       255 ~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~  286 (310)
T 4glp_A          255 SLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNR  286 (310)
T ss_dssp             CEECCSSCCC-SCCSCCCSCCSCEECCSCCCCS
T ss_pred             EEECCCCCCC-chhhhhcCCCCEEECCCCcCCC
Confidence            9999999998 6777654 67788999998875

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.24  E-value=1.6e-11  Score=121.94  Aligned_cols=100  Identities=22%  Similarity=0.188  Sum_probs=85.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCcc-ccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSE-IGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~-~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.+++..|..++++++|+.|+|++|+++ .+|.. |+.+++|+.|+|++|.+++..|..++.+++|+.|++++|.|+
T Consensus       106 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  184 (597)
T 3oja_B          106 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT  184 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             CCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence            6899999988888899999999999999998 55655 699999999999999999999999999999999999999999


Q ss_pred             ccccccccCcccccccCCCccc
Q 017621           80 GSIPESVKKVPLLYVSGNNFEV  101 (368)
Q Consensus        80 g~~p~~~~~~~~~~~~~N~~~~  101 (368)
                      +..+..+..+..+++++|.+++
T Consensus       185 ~~~~~~l~~L~~L~l~~n~l~~  206 (597)
T 3oja_B          185 HVDLSLIPSLFHANVSYNLLST  206 (597)
T ss_dssp             BCCGGGCTTCSEEECCSSCCSE
T ss_pred             CcChhhhhhhhhhhcccCcccc
Confidence            7655556666666666665543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.24  E-value=1.4e-11  Score=118.02  Aligned_cols=103  Identities=16%  Similarity=0.134  Sum_probs=76.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..|..+.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++
T Consensus        82 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  161 (452)
T 3zyi_A           82 LMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES  161 (452)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCE
T ss_pred             CcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcce
Confidence            57788888778888888888888888888887777788888888888888888886666668888888888888888874


Q ss_pred             ccccccc---CcccccccCCCccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEI  103 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~  103 (368)
                      ..+..+.   ++..+++++|+....+
T Consensus       162 ~~~~~~~~l~~L~~L~l~~~~~l~~i  187 (452)
T 3zyi_A          162 IPSYAFNRVPSLMRLDLGELKKLEYI  187 (452)
T ss_dssp             ECTTTTTTCTTCCEEECCCCTTCCEE
T ss_pred             eCHhHHhcCCcccEEeCCCCCCcccc
Confidence            4333333   3444666664443333

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.23  E-value=8.4e-12  Score=128.82  Aligned_cols=102  Identities=20%  Similarity=0.201  Sum_probs=66.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccC-CccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSI-SSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~-p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.+++..|.++.++++|+.|+|++|.+.+.| |..|++|++|++|+|++|++++..|..++.+++|+.|+|++|.++
T Consensus        31 Ls~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~  110 (844)
T 3j0a_A           31 LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS  110 (844)
T ss_dssp             EESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCS
T ss_pred             CCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCC
Confidence            4567777766667777777777777777665666 556677777777777777777666777777777777777777776


Q ss_pred             cccccc--c---cCcccccccCCCcccc
Q 017621           80 GSIPES--V---KKVPLLYVSGNNFEVE  102 (368)
Q Consensus        80 g~~p~~--~---~~~~~~~~~~N~~~~~  102 (368)
                      +.+|..  +   .++..+++++|.+++.
T Consensus       111 ~~~~~~~~~~~L~~L~~L~Ls~N~l~~~  138 (844)
T 3j0a_A          111 DAVLKDGYFRNLKALTRLDLSKNQIRSL  138 (844)
T ss_dssp             SCCSTTCCCSSCSSCCEEEEESCCCCCC
T ss_pred             cccccCccccccCCCCEEECCCCccccc
Confidence            655443  2   2344566666665543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.23  E-value=8.9e-12  Score=105.62  Aligned_cols=100  Identities=16%  Similarity=0.188  Sum_probs=85.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.++ .+| .+..+++|+.|+|++|.++ . +..++.+++|+.|+|++|++++..|..++.+++|+.|++++|++++
T Consensus        51 l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~  126 (197)
T 4ezg_A           51 LANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD  126 (197)
T ss_dssp             EESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBG
T ss_pred             ccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCc
Confidence            4678888 677 6999999999999999775 3 4589999999999999999999999999999999999999999998


Q ss_pred             ccccccc---CcccccccCCCcccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P  104 (368)
                      ..|..+.   ++..+++++|.+...+|
T Consensus       127 ~~~~~l~~l~~L~~L~L~~n~~i~~~~  153 (197)
T 4ezg_A          127 SILTKINTLPKVNSIDLSYNGAITDIM  153 (197)
T ss_dssp             GGHHHHTTCSSCCEEECCSCTBCCCCG
T ss_pred             HhHHHHhhCCCCCEEEccCCCCccccH
Confidence            7787665   45568999998444444

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.23  E-value=8.4e-12  Score=103.77  Aligned_cols=95  Identities=16%  Similarity=0.165  Sum_probs=68.1

Q ss_pred             CCCCCccccCCccccCCC-CCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCS-KLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~-~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|+++. +|. +..+. +|+.|+|++|++++.  ..++.+++|+.|+|++|++++..|..++.+++|+.|++++|+|+
T Consensus        26 l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~  101 (176)
T 1a9n_A           26 LRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV  101 (176)
T ss_dssp             CTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC
T ss_pred             eeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC
Confidence            56788874 553 55554 888888888888753  57888888888888888888543344477888888888888885


Q ss_pred             ccccc--ccc---CcccccccCCCcc
Q 017621           80 GSIPE--SVK---KVPLLYVSGNNFE  100 (368)
Q Consensus        80 g~~p~--~~~---~~~~~~~~~N~~~  100 (368)
                       .+|.  .+.   ++..+++++|.++
T Consensus       102 -~~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A          102 -ELGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             -CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             -cchhhHhhhcCCCCCEEEecCCCCC
Confidence             5565  443   4556778888775

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.23  E-value=1.2e-11  Score=112.51  Aligned_cols=100  Identities=18%  Similarity=0.146  Sum_probs=72.3

Q ss_pred             CCCCCccccCCccc--cCCCCCcEEEecCccccccCC----ccccCCCCCCeeeeecccccccCCcccCCCCCCceeccc
Q 017621            1 MYNNKLDGPIPQEL--MNCSKLRILILGNNLLSGSIS----SEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLS   74 (368)
Q Consensus         1 l~~n~l~g~~p~~~--~~l~~l~~l~l~~N~~~g~~p----~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~   74 (368)
                      |++|.+++.+|..+  .++++|+.|+|++|++++..|    ..+..+++|+.|+|++|++++..|..++.+++|+.|+|+
T Consensus        98 l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls  177 (310)
T 4glp_A           98 LEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLS  177 (310)
T ss_dssp             EESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECC
T ss_pred             eeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECC
Confidence            45788888888777  778888888888888887655    344567888888888888887777778888888888888


Q ss_pred             CCccccc--cc-----ccccCcccccccCCCcc
Q 017621           75 MNNLSGS--IP-----ESVKKVPLLYVSGNNFE  100 (368)
Q Consensus        75 ~n~l~g~--~p-----~~~~~~~~~~~~~N~~~  100 (368)
                      +|+++|.  +|     ..+.++..+++++|.++
T Consensus       178 ~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~  210 (310)
T 4glp_A          178 DNPGLGERGLMAALCPHKFPAIQNLALRNTGME  210 (310)
T ss_dssp             SCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC
T ss_pred             CCCCccchhhhHHHhhhcCCCCCEEECCCCCCC
Confidence            8887652  21     22345556777777664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.22  E-value=1.9e-11  Score=112.04  Aligned_cols=100  Identities=24%  Similarity=0.367  Sum_probs=76.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.++. +|..+.  ++|+.|+|++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|+++ 
T Consensus       178 l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-  253 (330)
T 1xku_A          178 IADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-  253 (330)
T ss_dssp             CCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-
T ss_pred             CCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-
Confidence            46777774 676554  68888888888888777778888888888888888888777778888888888888888888 


Q ss_pred             cccccccC---cccccccCCCcccccc
Q 017621           81 SIPESVKK---VPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~~---~~~~~~~~N~~~~~~P  104 (368)
                      .+|..+..   +..+++++|.++...+
T Consensus       254 ~lp~~l~~l~~L~~L~l~~N~i~~~~~  280 (330)
T 1xku_A          254 KVPGGLADHKYIQVVYLHNNNISAIGS  280 (330)
T ss_dssp             SCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred             cCChhhccCCCcCEEECCCCcCCccCh
Confidence            77776553   4557888888775433

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.22  E-value=1.7e-11  Score=117.52  Aligned_cols=87  Identities=16%  Similarity=0.179  Sum_probs=51.1

Q ss_pred             cccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccccccccc---Cc
Q 017621           13 ELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVK---KV   89 (368)
Q Consensus        13 ~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~~~~---~~   89 (368)
                      .+.++++|+.|+|++|+++ .+| .+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..|..+.   ++
T Consensus       191 ~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  268 (452)
T 3zyi_A          191 AFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL  268 (452)
T ss_dssp             TTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             hccCCCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCC
Confidence            4556666666666666665 333 455666666666666666665566666666666666666666655454443   33


Q ss_pred             ccccccCCCccc
Q 017621           90 PLLYVSGNNFEV  101 (368)
Q Consensus        90 ~~~~~~~N~~~~  101 (368)
                      ..+++++|.++.
T Consensus       269 ~~L~L~~N~l~~  280 (452)
T 3zyi_A          269 VELNLAHNNLSS  280 (452)
T ss_dssp             CEEECCSSCCSC
T ss_pred             CEEECCCCcCCc
Confidence            445566665553

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.22  E-value=1.2e-11  Score=121.41  Aligned_cols=109  Identities=17%  Similarity=0.192  Sum_probs=93.2

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccc-cCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLING-KIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g-~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|++++..|..++++++|+.|+|++|++++..|..|+.+++|++|+|++|++++ .+|..++.+++|+.|++++|++.
T Consensus        57 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~  136 (549)
T 2z81_A           57 LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF  136 (549)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC
T ss_pred             CCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccc
Confidence            68999999888899999999999999999997766679999999999999999997 57889999999999999999966


Q ss_pred             ccccc-ccc---CcccccccCCCcccccccCCCC
Q 017621           80 GSIPE-SVK---KVPLLYVSGNNFEVEIPSTSAK  109 (368)
Q Consensus        80 g~~p~-~~~---~~~~~~~~~N~~~~~~P~~~~~  109 (368)
                      +.+|. .+.   ++..+++++|.+++..|.....
T Consensus       137 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~  170 (549)
T 2z81_A          137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS  170 (549)
T ss_dssp             CEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred             cccCHhhhhcccccCeeeccCCcccccChhhhhc
Confidence            67764 454   4556889999998877755443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.22  E-value=1.9e-11  Score=120.27  Aligned_cols=105  Identities=17%  Similarity=0.258  Sum_probs=60.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCC-ccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSIS-SEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p-~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.+++ +|+.+.++++|+.|+|++|++++..| ..+..+++|+.|+|++|.+++.+|..+..+++|+.|++++|+++
T Consensus       380 l~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  458 (570)
T 2z63_A          380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ  458 (570)
T ss_dssp             CCSCSEEE-EEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEG
T ss_pred             CCCCcccc-ccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCc
Confidence            34556654 33336666666666666666665444 34566666666666666666666666666666666666666665


Q ss_pred             -cccccccc---CcccccccCCCcccccccC
Q 017621           80 -GSIPESVK---KVPLLYVSGNNFEVEIPST  106 (368)
Q Consensus        80 -g~~p~~~~---~~~~~~~~~N~~~~~~P~~  106 (368)
                       +.+|..+.   ++..+++++|.+++..|..
T Consensus       459 ~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~  489 (570)
T 2z63_A          459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTA  489 (570)
T ss_dssp             GGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred             cccchhhhhcccCCCEEECCCCccccCChhh
Confidence             45555443   3334566666665544443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.22  E-value=2.1e-11  Score=111.85  Aligned_cols=99  Identities=26%  Similarity=0.377  Sum_probs=67.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++ +|..+.  ++|+.|+|++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|+|+ 
T Consensus       179 l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-  254 (332)
T 2ft3_A          179 ISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-  254 (332)
T ss_dssp             CCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-
T ss_pred             CcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-
Confidence            45677765 665554  56777777777777665667777777777777777777666666777777777777777777 


Q ss_pred             ccccccc---CcccccccCCCccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEI  103 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~  103 (368)
                      .+|..+.   .+..+++++|.++...
T Consensus       255 ~lp~~l~~l~~L~~L~l~~N~l~~~~  280 (332)
T 2ft3_A          255 RVPAGLPDLKLLQVVYLHTNNITKVG  280 (332)
T ss_dssp             BCCTTGGGCTTCCEEECCSSCCCBCC
T ss_pred             ecChhhhcCccCCEEECCCCCCCccC
Confidence            6666554   3445677777766443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.21  E-value=2.1e-11  Score=116.48  Aligned_cols=94  Identities=19%  Similarity=0.201  Sum_probs=65.6

Q ss_pred             cCC-ccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccccccccc
Q 017621            9 PIP-QELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVK   87 (368)
Q Consensus         9 ~~p-~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~~~~   87 (368)
                      .+| ..+.++++|+.|+|++|+++ .+| .+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..|..+.
T Consensus       175 ~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  252 (440)
T 3zyj_A          175 YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFD  252 (440)
T ss_dssp             EECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSST
T ss_pred             eeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhc
Confidence            344 35777777777777777776 556 477777777777777777777777777777777777777777766565544


Q ss_pred             ---CcccccccCCCcccccc
Q 017621           88 ---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        88 ---~~~~~~~~~N~~~~~~P  104 (368)
                         ++..+++++|.++...+
T Consensus       253 ~l~~L~~L~L~~N~l~~~~~  272 (440)
T 3zyj_A          253 NLQSLVEINLAHNNLTLLPH  272 (440)
T ss_dssp             TCTTCCEEECTTSCCCCCCT
T ss_pred             CCCCCCEEECCCCCCCccCh
Confidence               44556777777764333

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.21  E-value=1.2e-11  Score=120.45  Aligned_cols=97  Identities=29%  Similarity=0.276  Sum_probs=61.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|+ .+|..+.  ++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..++.+++|+.|+|++|+|+ 
T Consensus         7 ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-   82 (520)
T 2z7x_B            7 RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-   82 (520)
T ss_dssp             CTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-
T ss_pred             cCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-
Confidence            4566666 3666555  56666777777666555556666666777777766666666666666666666666666666 


Q ss_pred             ccccc-ccCcccccccCCCccc
Q 017621           81 SIPES-VKKVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p~~-~~~~~~~~~~~N~~~~  101 (368)
                      .+|.. +.++..+++++|.+++
T Consensus        83 ~lp~~~l~~L~~L~L~~N~l~~  104 (520)
T 2z7x_B           83 KISCHPTVNLKHLDLSFNAFDA  104 (520)
T ss_dssp             EEECCCCCCCSEEECCSSCCSS
T ss_pred             ecCccccCCccEEeccCCcccc
Confidence            34442 3345556666666654

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.21  E-value=1.3e-11  Score=107.88  Aligned_cols=101  Identities=14%  Similarity=0.210  Sum_probs=76.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCcc-ccccCCccccCCCCCCeeeeec-ccccccCCcccCCCCCCceecccCCcc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNL-LSGSISSEIGKLQELNYLDLSH-NLINGKIPSQLGEIPRIDTVNLSMNNL   78 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~-~~g~~p~~~~~~~~L~~l~l~~-N~l~g~~p~~~~~~~~l~~l~l~~n~l   78 (368)
                      |++|++++..+..+.++++|+.|+|++|+ +++.-+..|..+++|+.|+|++ |++++..|..+..+++|+.|++++|++
T Consensus        38 l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l  117 (239)
T 2xwt_C           38 LIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL  117 (239)
T ss_dssp             EESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECC
T ss_pred             EeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCC
Confidence            46788887666678888889999999886 7644445788888899999988 888866667788888889999988888


Q ss_pred             cccccc--cccCcc---cccccCC-Ccccc
Q 017621           79 SGSIPE--SVKKVP---LLYVSGN-NFEVE  102 (368)
Q Consensus        79 ~g~~p~--~~~~~~---~~~~~~N-~~~~~  102 (368)
                      ++ +|.  .+..+.   .+++++| .++.-
T Consensus       118 ~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i  146 (239)
T 2xwt_C          118 KM-FPDLTKVYSTDIFFILEITDNPYMTSI  146 (239)
T ss_dssp             CS-CCCCTTCCBCCSEEEEEEESCTTCCEE
T ss_pred             cc-ccccccccccccccEEECCCCcchhhc
Confidence            85 665  223444   6778888 66543

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.21  E-value=1.5e-11  Score=113.50  Aligned_cols=80  Identities=21%  Similarity=0.154  Sum_probs=70.8

Q ss_pred             CCC-CCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYN-NKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~-n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++ |+|++..|..|++|++|+.|+|++|+|+|..|..|++|++|+.|||++|+|++..|..+..++ |+.|+|++|.|+
T Consensus        38 l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           38 IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             CCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             ccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            575 999998888999999999999999999998888999999999999999999965555565555 999999999998


Q ss_pred             cc
Q 017621           80 GS   81 (368)
Q Consensus        80 g~   81 (368)
                      ..
T Consensus       117 c~  118 (347)
T 2ifg_A          117 CS  118 (347)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.21  E-value=1.8e-11  Score=120.59  Aligned_cols=76  Identities=25%  Similarity=0.308  Sum_probs=38.0

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      ++|.+++..|..+.++++|+.|+|++|++++..|..|+.+++|++|||++|+++ .+|..  .+++|+.|++++|++++
T Consensus        60 s~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~  135 (562)
T 3a79_B           60 SQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDV  135 (562)
T ss_dssp             CSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSB
T ss_pred             CCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccc
Confidence            445555444444555555555555555555444444555555555555555555 44444  44555555555555543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.21  E-value=2.4e-11  Score=122.37  Aligned_cols=105  Identities=19%  Similarity=0.162  Sum_probs=71.2

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.+++..|..++++++|+.|+|++|++++..|..|+++++|+.|+|++|++++..+..++.+++|++|++++|++++
T Consensus        32 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~  111 (680)
T 1ziw_A           32 LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK  111 (680)
T ss_dssp             CCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC
T ss_pred             CCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCc
Confidence            46777777555567777777777777777777667777777777777777777774333457777777777777777775


Q ss_pred             ccccccc---CcccccccCCCccccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIPS  105 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P~  105 (368)
                      ..|..+.   ++..+++++|.+++..|.
T Consensus       112 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~  139 (680)
T 1ziw_A          112 IKNNPFVKQKNLITLDLSHNGLSSTKLG  139 (680)
T ss_dssp             CCSCTTTTCTTCCEEECCSSCCSCCCCC
T ss_pred             cChhHccccCCCCEEECCCCcccccCch
Confidence            5545443   344566777766655444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.21  E-value=9e-12  Score=120.54  Aligned_cols=104  Identities=19%  Similarity=0.211  Sum_probs=75.7

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCc----------------ccCC
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS----------------QLGE   64 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~----------------~~~~   64 (368)
                      |++|.+++..|..++++++|+.|+|++|.+++..|  ++.+++|+.|||++|.+++..|.                ....
T Consensus        41 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~  118 (487)
T 3oja_A           41 LSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR  118 (487)
T ss_dssp             CCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECC
T ss_pred             eeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccc
Confidence            68899999888899999999999999999987665  88999999999999888854321                0112


Q ss_pred             CCCCceecccCCccccccccccc---CcccccccCCCcccccccC
Q 017621           65 IPRIDTVNLSMNNLSGSIPESVK---KVPLLYVSGNNFEVEIPST  106 (368)
Q Consensus        65 ~~~l~~l~l~~n~l~g~~p~~~~---~~~~~~~~~N~~~~~~P~~  106 (368)
                      +++|+.|+|++|+|++..|..+.   .+..+++++|.+++..|..
T Consensus       119 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  163 (487)
T 3oja_A          119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE  163 (487)
T ss_dssp             CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGG
T ss_pred             cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHH
Confidence            45666677777777766565443   3445677777777655543

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.19  E-value=1.6e-11  Score=102.14  Aligned_cols=95  Identities=16%  Similarity=0.253  Sum_probs=80.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccc-cCCCCCCeeeeecccccccCCc--ccCCCCCCceecccCCc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEI-GKLQELNYLDLSHNLINGKIPS--QLGEIPRIDTVNLSMNN   77 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~-~~~~~L~~l~l~~N~l~g~~p~--~~~~~~~l~~l~l~~n~   77 (368)
                      |++|.+++.  +.+.++++|+.|+|++|++++ +|+.+ +.+++|+.|+|++|+++ .+|.  .+..+++|+.|++++|+
T Consensus        49 Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~  124 (176)
T 1a9n_A           49 FSDNEIRKL--DGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNP  124 (176)
T ss_dssp             CCSSCCCEE--CCCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSG
T ss_pred             CCCCCCCcc--cccccCCCCCEEECCCCcccc-cCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCC
Confidence            689999985  679999999999999999984 56554 99999999999999996 7887  88999999999999999


Q ss_pred             cccccccc----c---cCcccccccCCCcc
Q 017621           78 LSGSIPES----V---KKVPLLYVSGNNFE  100 (368)
Q Consensus        78 l~g~~p~~----~---~~~~~~~~~~N~~~  100 (368)
                      ++ .+|..    +   ..+..++++.|...
T Consensus       125 i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          125 VT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             GG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            98 56653    3   35667888888654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.19  E-value=2.5e-11  Score=112.38  Aligned_cols=78  Identities=24%  Similarity=0.294  Sum_probs=35.0

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      ++|++++..+..+.++++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..+..++.+++|+.|++++|+++
T Consensus        60 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  137 (353)
T 2z80_A           60 SNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK  137 (353)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS
T ss_pred             CCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc
Confidence            344444433334444444444444444444433444444444444444444444222222444444444444444444

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.19  E-value=2.3e-11  Score=117.29  Aligned_cols=102  Identities=20%  Similarity=0.151  Sum_probs=83.2

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.+++..|..+.++++|+.|+|++|++++..+..|+.+++|+.|+|++|++++..|..+..+++|+.|++++|++++
T Consensus        63 L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~  142 (477)
T 2id5_A           63 LNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY  142 (477)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCE
T ss_pred             CCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccce
Confidence            57889998888889999999999999999984444457889999999999999998888888889999999999999887


Q ss_pred             ccccccc---CcccccccCCCcccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVE  102 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~  102 (368)
                      ..|..+.   ++..+++++|.++..
T Consensus       143 ~~~~~~~~l~~L~~L~l~~n~l~~~  167 (477)
T 2id5_A          143 ISHRAFSGLNSLEQLTLEKCNLTSI  167 (477)
T ss_dssp             ECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred             eChhhccCCCCCCEEECCCCcCccc
Confidence            7666554   455677888877643

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.18  E-value=5e-11  Score=111.87  Aligned_cols=98  Identities=17%  Similarity=0.238  Sum_probs=47.8

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcc-cCCCCCCceecccCCcccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQ-LGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~-~~~~~~l~~l~l~~n~l~g   80 (368)
                      ++|.+++..|..+.++++|+.|+|++|++++..|..|+.+++|+.|+|++|+++ .+|.. ++.+++|+.|++++|++++
T Consensus        77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~  155 (390)
T 3o6n_A           77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER  155 (390)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred             CCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCc
Confidence            445555444445555555555555555555444444555555555555555555 33332 3455555555555555554


Q ss_pred             ccccccc---CcccccccCCCcc
Q 017621           81 SIPESVK---KVPLLYVSGNNFE  100 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~  100 (368)
                      ..|..+.   ++..+++++|.++
T Consensus       156 ~~~~~~~~l~~L~~L~l~~n~l~  178 (390)
T 3o6n_A          156 IEDDTFQATTSLQNLQLSSNRLT  178 (390)
T ss_dssp             CCTTTTSSCTTCCEEECCSSCCS
T ss_pred             cChhhccCCCCCCEEECCCCcCC
Confidence            4343332   2333455555444

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.18  E-value=4.1e-11  Score=114.39  Aligned_cols=104  Identities=15%  Similarity=0.104  Sum_probs=78.3

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..+..+.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+|++
T Consensus        71 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~  150 (440)
T 3zyj_A           71 LHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES  150 (440)
T ss_dssp             CCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCE
T ss_pred             ccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccc
Confidence            57888888777888888888888888888887666788888888888888888886555678888888888888888885


Q ss_pred             ccccccc---CcccccccCCCcccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P  104 (368)
                      ..+..+.   ++..+++++|+....+|
T Consensus       151 ~~~~~~~~l~~L~~L~l~~~~~l~~i~  177 (440)
T 3zyj_A          151 IPSYAFNRIPSLRRLDLGELKRLSYIS  177 (440)
T ss_dssp             ECTTTTTTCTTCCEEECCCCTTCCEEC
T ss_pred             cCHHHhhhCcccCEeCCCCCCCcceeC
Confidence            4443433   44456676654443333

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.16  E-value=7.4e-11  Score=110.70  Aligned_cols=100  Identities=22%  Similarity=0.188  Sum_probs=88.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCcc-ccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSE-IGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~-~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.+++..|..++++++|+.|+|++|+++ .+|.. |+.+++|+.|+|++|++++..|..++.+++|+.|++++|+++
T Consensus       100 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  178 (390)
T 3o6n_A          100 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT  178 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred             CCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence            6789999988888999999999999999998 67766 599999999999999999888889999999999999999999


Q ss_pred             ccccccccCcccccccCCCccc
Q 017621           80 GSIPESVKKVPLLYVSGNNFEV  101 (368)
Q Consensus        80 g~~p~~~~~~~~~~~~~N~~~~  101 (368)
                      +.-+..+..+..+++++|.++.
T Consensus       179 ~~~~~~l~~L~~L~l~~n~l~~  200 (390)
T 3o6n_A          179 HVDLSLIPSLFHANVSYNLLST  200 (390)
T ss_dssp             BCCGGGCTTCSEEECCSSCCSE
T ss_pred             ccccccccccceeecccccccc
Confidence            7655666777788888887764

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.16  E-value=4e-11  Score=120.69  Aligned_cols=102  Identities=23%  Similarity=0.188  Sum_probs=71.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCc-cccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISS-EIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~-~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.+++..|..+++|++|+.|+|++|+++ .+|. .|+.+++|++|+|++|++++..|..++.+++|+.|++++|.++
T Consensus        56 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  134 (680)
T 1ziw_A           56 VGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS  134 (680)
T ss_dssp             CCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCS
T ss_pred             CCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCccc
Confidence            4677777777777777777777777777777 4444 5777777777777777777666667777777777777777777


Q ss_pred             cccccccc---CcccccccCCCccccc
Q 017621           80 GSIPESVK---KVPLLYVSGNNFEVEI  103 (368)
Q Consensus        80 g~~p~~~~---~~~~~~~~~N~~~~~~  103 (368)
                      +..|..+.   ++..+++++|.+++..
T Consensus       135 ~~~~~~~~~l~~L~~L~L~~n~l~~~~  161 (680)
T 1ziw_A          135 STKLGTQVQLENLQELLLSNNKIQALK  161 (680)
T ss_dssp             CCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred             ccCchhhcccccCCEEEccCCcccccC
Confidence            66665443   4445667777665443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.15  E-value=4.2e-11  Score=110.88  Aligned_cols=107  Identities=15%  Similarity=0.227  Sum_probs=88.8

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCcc-ccCCCCCCeeeeecccccccCCc--ccCCCCCCceecccCCc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSE-IGKLQELNYLDLSHNLINGKIPS--QLGEIPRIDTVNLSMNN   77 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~-~~~~~~L~~l~l~~N~l~g~~p~--~~~~~~~l~~l~l~~n~   77 (368)
                      |++|++++..|..+.++++|+.|+|++|+++ .+|.. ++.+++|+.|+|++|+++ .+|.  .+..+++|+.|++++|+
T Consensus        83 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~  160 (353)
T 2z80_A           83 LTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD  160 (353)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESS
T ss_pred             CCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCc
Confidence            6789999988888999999999999999998 45655 899999999999999999 5665  78999999999999994


Q ss_pred             -ccccccccccC---cccccccCCCcccccccCCCC
Q 017621           78 -LSGSIPESVKK---VPLLYVSGNNFEVEIPSTSAK  109 (368)
Q Consensus        78 -l~g~~p~~~~~---~~~~~~~~N~~~~~~P~~~~~  109 (368)
                       +++..|..+..   +..+++++|.+++..|.....
T Consensus       161 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~  196 (353)
T 2z80_A          161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKS  196 (353)
T ss_dssp             SCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT
T ss_pred             cccccCHHHccCCCCCCEEECCCCCcCccCHHHHhc
Confidence             66555555554   556899999988766654433

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.15  E-value=3.1e-11  Score=105.40  Aligned_cols=102  Identities=16%  Similarity=0.203  Sum_probs=82.7

Q ss_pred             CCCCC-ccccCCccccCCCCCcEEEecC-ccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCc---eecccC
Q 017621            1 MYNNK-LDGPIPQELMNCSKLRILILGN-NLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRID---TVNLSM   75 (368)
Q Consensus         1 l~~n~-l~g~~p~~~~~l~~l~~l~l~~-N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~---~l~l~~   75 (368)
                      |++|+ +++..+..+.++++|+.|+|++ |++++.-+..|..+++|+.|+|++|++++ +|+ ++.+++|+   .|++++
T Consensus        62 l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~  139 (239)
T 2xwt_C           62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITD  139 (239)
T ss_dssp             EECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEES
T ss_pred             CCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCC
Confidence            45786 7765556889999999999998 99986555688999999999999999996 887 88888888   999999


Q ss_pred             C-ccccccccccc---Ccc-cccccCCCccccccc
Q 017621           76 N-NLSGSIPESVK---KVP-LLYVSGNNFEVEIPS  105 (368)
Q Consensus        76 n-~l~g~~p~~~~---~~~-~~~~~~N~~~~~~P~  105 (368)
                      | ++++..+..+.   .+. .+++++|.++ .+|.
T Consensus       140 N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~  173 (239)
T 2xwt_C          140 NPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQG  173 (239)
T ss_dssp             CTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECT
T ss_pred             CcchhhcCcccccchhcceeEEEcCCCCCc-ccCH
Confidence            9 99865554454   556 7889999887 5553

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.15  E-value=8.3e-11  Score=107.92  Aligned_cols=94  Identities=23%  Similarity=0.316  Sum_probs=47.4

Q ss_pred             CCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccc
Q 017621            3 NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSI   82 (368)
Q Consensus         3 ~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~   82 (368)
                      +|.++ .+|.++.  ++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..|..++.+++|+.|++++|+++ .+
T Consensus        42 ~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l  117 (332)
T 2ft3_A           42 DLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EI  117 (332)
T ss_dssp             SSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SC
T ss_pred             CCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-cc
Confidence            44444 3444442  35555555555555443445555555555555555555555555555555555555555555 33


Q ss_pred             cccc-cCcccccccCCCcc
Q 017621           83 PESV-KKVPLLYVSGNNFE  100 (368)
Q Consensus        83 p~~~-~~~~~~~~~~N~~~  100 (368)
                      |..+ .++..+++++|.++
T Consensus       118 ~~~~~~~L~~L~l~~n~i~  136 (332)
T 2ft3_A          118 PPNLPSSLVELRIHDNRIR  136 (332)
T ss_dssp             CSSCCTTCCEEECCSSCCC
T ss_pred             CccccccCCEEECCCCccC
Confidence            3322 24444555555444

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.14  E-value=9.3e-13  Score=111.82  Aligned_cols=97  Identities=25%  Similarity=0.374  Sum_probs=84.1

Q ss_pred             CCCCCccccCCc------cccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceeccc
Q 017621            1 MYNNKLDGPIPQ------ELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLS   74 (368)
Q Consensus         1 l~~n~l~g~~p~------~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~   74 (368)
                      |++|.|+|.+|.      .++++++|+.|+|++|++++ +| .+..+++|+.|+|++|+++ .+|..+..+++|+.|+++
T Consensus        25 l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~  101 (198)
T 1ds9_A           25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWIS  101 (198)
T ss_dssp             CSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEE
T ss_pred             hheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECc
Confidence            467889999887      89999999999999999985 88 9999999999999999999 899888888999999999


Q ss_pred             CCcccccccc--cccCcccccccCCCccc
Q 017621           75 MNNLSGSIPE--SVKKVPLLYVSGNNFEV  101 (368)
Q Consensus        75 ~n~l~g~~p~--~~~~~~~~~~~~N~~~~  101 (368)
                      +|++++ +|.  .+.++..+++++|.++.
T Consensus       102 ~N~l~~-l~~~~~l~~L~~L~l~~N~i~~  129 (198)
T 1ds9_A          102 YNQIAS-LSGIEKLVNLRVLYMSNNKITN  129 (198)
T ss_dssp             EEECCC-HHHHHHHHHSSEEEESEEECCC
T ss_pred             CCcCCc-CCccccCCCCCEEECCCCcCCc
Confidence            999996 563  12356678999998764

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.14  E-value=7.8e-11  Score=115.56  Aligned_cols=68  Identities=24%  Similarity=0.439  Sum_probs=31.5

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|+|++ +|..+.  ++|+.|+|++|+|+ .||   +.+++|+.|+|++|+|++ +|. +..  +|+.|+|++|+|+
T Consensus        66 Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~  133 (571)
T 3cvr_A           66 LNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLT  133 (571)
T ss_dssp             CCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCS
T ss_pred             eCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCC
Confidence            34555554 554442  44555555555554 444   234445555555554443 444 322  4444444444444

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.12  E-value=1e-10  Score=107.10  Aligned_cols=97  Identities=25%  Similarity=0.363  Sum_probs=58.9

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      +++.++ .+|..+.  ++|+.|+|++|++++..+..|+.+++|+.|+|++|++++..|..++.+++|+.|++++|+++ .
T Consensus        39 ~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~  114 (330)
T 1xku_A           39 SDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-E  114 (330)
T ss_dssp             TTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-B
T ss_pred             cCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-c
Confidence            344555 3555443  46666677777666544446666666777777766666666666666666667777666666 4


Q ss_pred             ccccc-cCcccccccCCCcccc
Q 017621           82 IPESV-KKVPLLYVSGNNFEVE  102 (368)
Q Consensus        82 ~p~~~-~~~~~~~~~~N~~~~~  102 (368)
                      +|..+ .++..+++++|.++..
T Consensus       115 l~~~~~~~L~~L~l~~n~l~~~  136 (330)
T 1xku_A          115 LPEKMPKTLQELRVHENEITKV  136 (330)
T ss_dssp             CCSSCCTTCCEEECCSSCCCBB
T ss_pred             cChhhcccccEEECCCCccccc
Confidence            44433 3455566666665543

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.12  E-value=3e-11  Score=110.24  Aligned_cols=96  Identities=24%  Similarity=0.324  Sum_probs=60.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++..|..+.++++|+.|+|++|++++..|  +..+++|+.|+|++|++++ +|    .+++|+.|++++|++++
T Consensus        41 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L~l~~n~l~~  113 (317)
T 3o53_A           41 LSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----VGPSIETLHAANNNISR  113 (317)
T ss_dssp             CTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EE----ECTTCCEEECCSSCCSE
T ss_pred             CcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-cc----CCCCcCEEECCCCccCC
Confidence            45666666555666666777777777777765433  6666777777777776663 22    22566666666666665


Q ss_pred             cccccccCcccccccCCCccccc
Q 017621           81 SIPESVKKVPLLYVSGNNFEVEI  103 (368)
Q Consensus        81 ~~p~~~~~~~~~~~~~N~~~~~~  103 (368)
                      ..+..+.++..+++++|.++...
T Consensus       114 ~~~~~~~~L~~L~l~~N~l~~~~  136 (317)
T 3o53_A          114 VSCSRGQGKKNIYLANNKITMLR  136 (317)
T ss_dssp             EEECCCSSCEEEECCSSCCCSGG
T ss_pred             cCccccCCCCEEECCCCCCCCcc
Confidence            55555556666666666665433

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.11  E-value=1.3e-10  Score=113.99  Aligned_cols=91  Identities=24%  Similarity=0.343  Sum_probs=78.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|+ .+|   ..+++|+.|+|++|+|++ ||. +..  +|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++
T Consensus        87 Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~  154 (571)
T 3cvr_A           87 ITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM  154 (571)
T ss_dssp             CCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred             CcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc
Confidence            6899999 688   457899999999999996 898 766  99999999999997 887   67899999999999996


Q ss_pred             cccccccCcccccccCCCccccccc
Q 017621           81 SIPESVKKVPLLYVSGNNFEVEIPS  105 (368)
Q Consensus        81 ~~p~~~~~~~~~~~~~N~~~~~~P~  105 (368)
                       +|..+.++..+++++|.+++ +|.
T Consensus       155 -lp~~l~~L~~L~Ls~N~L~~-lp~  177 (571)
T 3cvr_A          155 -LPELPTSLEVLSVRNNQLTF-LPE  177 (571)
T ss_dssp             -CCCCCTTCCEEECCSSCCSC-CCC
T ss_pred             -CCCcCCCcCEEECCCCCCCC-cch
Confidence             78766678889999998876 554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.08  E-value=1.3e-10  Score=105.99  Aligned_cols=102  Identities=22%  Similarity=0.207  Sum_probs=67.7

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCcccc-CCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIG-KLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~-~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|++++..|..++++++|+.|+|++|++++..|..+. .+++|+.|+|++|++++. |.. ..+++|+.|++++|+|+
T Consensus       127 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~-~~l~~L~~L~Ls~N~l~  204 (317)
T 3o53_A          127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQ-VVFAKLKTLDLSSNKLA  204 (317)
T ss_dssp             CCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECC-CCCTTCCEEECCSSCCC
T ss_pred             CCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccc-cccccCCEEECCCCcCC
Confidence            466777766666777777777777777777766666653 677777777777777744 332 34777777888888777


Q ss_pred             cccccccc---CcccccccCCCcccccccC
Q 017621           80 GSIPESVK---KVPLLYVSGNNFEVEIPST  106 (368)
Q Consensus        80 g~~p~~~~---~~~~~~~~~N~~~~~~P~~  106 (368)
                      + +|..+.   ++..+++++|.++. +|..
T Consensus       205 ~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~  232 (317)
T 3o53_A          205 F-MGPEFQSAAGVTWISLRNNKLVL-IEKA  232 (317)
T ss_dssp             E-ECGGGGGGTTCSEEECTTSCCCE-ECTT
T ss_pred             c-chhhhcccCcccEEECcCCcccc-hhhH
Confidence            4 444343   45567788887763 4443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.08  E-value=1e-12  Score=111.54  Aligned_cols=99  Identities=23%  Similarity=0.323  Sum_probs=84.7

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.+++ +| .+.++++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++ +| .++.+++|+.|++++|++++
T Consensus        55 ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~  129 (198)
T 1ds9_A           55 LSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN  129 (198)
T ss_dssp             CSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC
T ss_pred             CCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc
Confidence            57899997 78 8999999999999999998 889988889999999999999996 66 68889999999999999995


Q ss_pred             ccc-cc---ccCcccccccCCCcccccc
Q 017621           81 SIP-ES---VKKVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p-~~---~~~~~~~~~~~N~~~~~~P  104 (368)
                      ..+ ..   +.++..+++++|.+++.+|
T Consensus       130 ~~~~~~l~~l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A          130 WGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             HHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred             hhHHHHHhcCCCCCEEEecCCccccccc
Confidence            322 23   3456778999999887655

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.07  E-value=2.5e-10  Score=109.33  Aligned_cols=94  Identities=27%  Similarity=0.474  Sum_probs=60.5

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++ +| +++++++|+.|+|++|++++ +|..+   ++|+.|+|++|++++ +| .++.+++|+.|++++|++++
T Consensus       138 L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~  209 (454)
T 1jl5_A          138 VSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK  209 (454)
T ss_dssp             CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS
T ss_pred             CcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc
Confidence            45666665 66 46667777777777777763 55433   366777777777764 55 46677777777777777774


Q ss_pred             cccccccCcccccccCCCcccccc
Q 017621           81 SIPESVKKVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~~~~~~~~~~N~~~~~~P  104 (368)
                       +|....++..+++++|.++ .+|
T Consensus       210 -l~~~~~~L~~L~l~~n~l~-~lp  231 (454)
T 1jl5_A          210 -LPDLPLSLESIVAGNNILE-ELP  231 (454)
T ss_dssp             -CCCCCTTCCEEECCSSCCS-SCC
T ss_pred             -CCCCcCcccEEECcCCcCC-ccc
Confidence             5555556666777777665 444

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.06  E-value=1.6e-10  Score=106.49  Aligned_cols=98  Identities=29%  Similarity=0.433  Sum_probs=77.5

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++ +|+ +..+++|+.|+|++|++++ + +.+..+++|+.|+|++|++++ + +.+..+++|+.|++++|++++
T Consensus       228 l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~  301 (347)
T 4fmz_A          228 IGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGN  301 (347)
T ss_dssp             CCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCG
T ss_pred             ccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCC
Confidence            57888886 444 8888999999999999974 4 468889999999999999885 4 457788899999999999988


Q ss_pred             ccccccc---CcccccccCCCcccccc
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P  104 (368)
                      ..|..+.   ++..+++++|.+++..|
T Consensus       302 ~~~~~l~~l~~L~~L~L~~n~l~~~~~  328 (347)
T 4fmz_A          302 EDMEVIGGLTNLTTLFLSQNHITDIRP  328 (347)
T ss_dssp             GGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred             cChhHhhccccCCEEEccCCccccccC
Confidence            7776554   45568899998876554

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.02  E-value=2.5e-11  Score=116.34  Aligned_cols=94  Identities=20%  Similarity=0.281  Sum_probs=53.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCC-------------CeeeeecccccccCCcccCCCCC
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQEL-------------NYLDLSHNLINGKIPSQLGEIPR   67 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L-------------~~l~l~~N~l~g~~p~~~~~~~~   67 (368)
                      |++|+| |.+|+++++|++|+.|+|++|+++|.+|.+++.+.+|             +.|++++|.+++ +|..   .++
T Consensus        18 l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~   92 (454)
T 1jl5_A           18 RHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPH   92 (454)
T ss_dssp             -----------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTT
T ss_pred             cccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCC
Confidence            568889 8999999999999999999999999999998887754             777777777774 4442   246


Q ss_pred             CceecccCCcccccccccccCcccccccCCCcc
Q 017621           68 IDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFE  100 (368)
Q Consensus        68 l~~l~l~~n~l~g~~p~~~~~~~~~~~~~N~~~  100 (368)
                      |+.|++++|++++ +|..+.++..+++++|.++
T Consensus        93 L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~  124 (454)
T 1jl5_A           93 LESLVASCNSLTE-LPELPQSLKSLLVDNNNLK  124 (454)
T ss_dssp             CSEEECCSSCCSS-CCCCCTTCCEEECCSSCCS
T ss_pred             CCEEEccCCcCCc-cccccCCCcEEECCCCccC
Confidence            6666666666665 5554444555555555444

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.01  E-value=5.5e-10  Score=100.55  Aligned_cols=96  Identities=27%  Similarity=0.410  Sum_probs=68.7

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++ +++ +.++++|+.|+|++|++++ +| .+..+++|+.|+|++|++++ + +.+..+++|+.|++++|++++
T Consensus        75 L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~  148 (291)
T 1h6t_A           75 LNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD  148 (291)
T ss_dssp             CCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC
T ss_pred             ccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCc
Confidence            56788886 444 7888888888888888874 44 48888888888888888885 3 456777888888888888875


Q ss_pred             cccc--cccCcccccccCCCccccc
Q 017621           81 SIPE--SVKKVPLLYVSGNNFEVEI  103 (368)
Q Consensus        81 ~~p~--~~~~~~~~~~~~N~~~~~~  103 (368)
                      . +.  .+.++..+++++|.++...
T Consensus       149 ~-~~l~~l~~L~~L~L~~N~l~~~~  172 (291)
T 1h6t_A          149 I-TVLSRLTKLDTLSLEDNQISDIV  172 (291)
T ss_dssp             C-GGGGGCTTCSEEECCSSCCCCCG
T ss_pred             c-hhhccCCCCCEEEccCCccccch
Confidence            4 21  2335556777777776543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.00  E-value=4.7e-11  Score=111.93  Aligned_cols=101  Identities=21%  Similarity=0.280  Sum_probs=79.9

Q ss_pred             CCCCCcc-ccCC---ccccCCCCCcEEEecCcccc--c---cCCccccCCCCCCeeeeeccccc----ccCCcccCCCCC
Q 017621            1 MYNNKLD-GPIP---QELMNCSKLRILILGNNLLS--G---SISSEIGKLQELNYLDLSHNLIN----GKIPSQLGEIPR   67 (368)
Q Consensus         1 l~~n~l~-g~~p---~~~~~l~~l~~l~l~~N~~~--g---~~p~~~~~~~~L~~l~l~~N~l~----g~~p~~~~~~~~   67 (368)
                      |++|+++ +.+|   ..+.++++|+.|+|++|+++  |   .+|..+..+++|+.|+|++|.++    +.+|..+..+++
T Consensus       166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~  245 (386)
T 2ca6_A          166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN  245 (386)
T ss_dssp             CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred             CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence            5788887 5566   46778888999999999887  3   34447888899999999999986    788888888899


Q ss_pred             CceecccCCccccc----cccc-----ccCcccccccCCCccc
Q 017621           68 IDTVNLSMNNLSGS----IPES-----VKKVPLLYVSGNNFEV  101 (368)
Q Consensus        68 l~~l~l~~n~l~g~----~p~~-----~~~~~~~~~~~N~~~~  101 (368)
                      |+.|+|++|+|++.    +|..     +.++..+++++|.++.
T Consensus       246 L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~  288 (386)
T 2ca6_A          246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL  288 (386)
T ss_dssp             CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             cCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence            99999999998865    4554     3456778899998876

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.99  E-value=8.7e-10  Score=97.73  Aligned_cols=92  Identities=18%  Similarity=0.306  Sum_probs=51.7

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.++. +| .+..+++|+.|+|++|++++ +|. ++.+++|+.|+|++|++++ +|....  ++|+.|++++|++++
T Consensus        48 l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~  120 (263)
T 1xeu_A           48 GDNSNIQS-LA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDNNELRD  120 (263)
T ss_dssp             CTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCSSCCSB
T ss_pred             CcCCCccc-ch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccCCccCC
Confidence            45666663 55 56667777777777777763 343 6677777777777777763 443222  555555555555553


Q ss_pred             cccc--cccCcccccccCCCcc
Q 017621           81 SIPE--SVKKVPLLYVSGNNFE  100 (368)
Q Consensus        81 ~~p~--~~~~~~~~~~~~N~~~  100 (368)
                       +|.  .+.++..+++++|.++
T Consensus       121 -~~~l~~l~~L~~L~Ls~N~i~  141 (263)
T 1xeu_A          121 -TDSLIHLKNLEILSIRNNKLK  141 (263)
T ss_dssp             -SGGGTTCTTCCEEECTTSCCC
T ss_pred             -ChhhcCcccccEEECCCCcCC
Confidence             221  1123334555555544

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.99  E-value=8.6e-10  Score=105.73  Aligned_cols=93  Identities=18%  Similarity=0.161  Sum_probs=54.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.+.+.+  .++.+++|+.|+|++|++++ +|  ++.+++|+.|+|++|++++.   .++.+++|+.|++++|+|++
T Consensus       155 l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~  226 (457)
T 3bz5_A          155 CHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE  226 (457)
T ss_dssp             CTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC
T ss_pred             CCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc
Confidence            3455555555  35666667777777777664 44  66666666666666666643   25566666666666666665


Q ss_pred             ccc-ccccCcccccccCCCcccc
Q 017621           81 SIP-ESVKKVPLLYVSGNNFEVE  102 (368)
Q Consensus        81 ~~p-~~~~~~~~~~~~~N~~~~~  102 (368)
                       +| ..+..+..+++++|.+++.
T Consensus       227 -ip~~~l~~L~~L~l~~N~l~~~  248 (457)
T 3bz5_A          227 -IDVTPLTQLTYFDCSVNPLTEL  248 (457)
T ss_dssp             -CCCTTCTTCSEEECCSSCCSCC
T ss_pred             -cCccccCCCCEEEeeCCcCCCc
Confidence             34 1223444566666666543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.98  E-value=7.6e-10  Score=99.64  Aligned_cols=95  Identities=21%  Similarity=0.398  Sum_probs=75.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      +++|.+.. +| .+..+++|+.|+|++|++++ ++. ++.+++|+.|+|++|++++ +|. +..+++|+.|++++|++++
T Consensus        53 l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~  126 (291)
T 1h6t_A           53 ANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGISD  126 (291)
T ss_dssp             CTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCC
T ss_pred             ccCCCccc-Ch-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCCC
Confidence            46788875 55 48889999999999999985 454 9999999999999999985 444 8889999999999999986


Q ss_pred             cccc--cccCcccccccCCCcccc
Q 017621           81 SIPE--SVKKVPLLYVSGNNFEVE  102 (368)
Q Consensus        81 ~~p~--~~~~~~~~~~~~N~~~~~  102 (368)
                       ++.  .+.++..+++++|.++..
T Consensus       127 -~~~l~~l~~L~~L~l~~n~l~~~  149 (291)
T 1h6t_A          127 -INGLVHLPQLESLYLGNNKITDI  149 (291)
T ss_dssp             -CGGGGGCTTCCEEECCSSCCCCC
T ss_pred             -ChhhcCCCCCCEEEccCCcCCcc
Confidence             332  234566788999987653

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.98  E-value=8.3e-10  Score=100.21  Aligned_cols=95  Identities=18%  Similarity=0.320  Sum_probs=56.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++ +| .+.++++|+.|+|++|++++ +|. +..+++|+.|+|++|++++..|  ++.+++|+.|++++|++++
T Consensus        92 L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~  165 (308)
T 1h6u_A           92 LSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD  165 (308)
T ss_dssp             CCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             ccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence            45666665 33 46667777777777777763 443 6667777777777776664332  5666666666666666664


Q ss_pred             ccc-ccccCcccccccCCCccc
Q 017621           81 SIP-ESVKKVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p-~~~~~~~~~~~~~N~~~~  101 (368)
                      ..+ ..+.++..+++++|.++.
T Consensus       166 ~~~l~~l~~L~~L~l~~n~l~~  187 (308)
T 1h6u_A          166 LTPLANLSKLTTLKADDNKISD  187 (308)
T ss_dssp             CGGGTTCTTCCEEECCSSCCCC
T ss_pred             ChhhcCCCCCCEEECCCCccCc
Confidence            322 112234445666665543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.98  E-value=8.4e-10  Score=109.23  Aligned_cols=73  Identities=30%  Similarity=0.474  Sum_probs=34.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|+|++. |+ +.+|++|+.|+|++|++++ +| .+..|++|+.|+|++|++++ + +.+..|++|+.|+|++|+|+
T Consensus        72 Ls~N~l~~~-~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~  144 (605)
T 1m9s_A           72 LNGNKLTDI-KP-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT  144 (605)
T ss_dssp             CTTSCCCCC-GG-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCC
T ss_pred             eeCCCCCCC-hh-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccC
Confidence            345555542 22 4555555555555555542 22 44555555555555555543 2 22444444444444444444

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.98  E-value=1e-09  Score=99.67  Aligned_cols=93  Identities=17%  Similarity=0.356  Sum_probs=52.5

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      ++|.++. +| .+..+++|+.|+|++|+++ .+|. +..+++|+.|+|++|++++ +| .+..+++|+.|++++|++++ 
T Consensus        49 ~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-  121 (308)
T 1h6u_A           49 FGTGVTT-IE-GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-  121 (308)
T ss_dssp             TTSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-
T ss_pred             eCCCccC-ch-hhhccCCCCEEEccCCcCC-CChh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-
Confidence            4555553 44 4566666666666666665 3343 6666666666666666663 33 45566666666666666664 


Q ss_pred             ccc--cccCcccccccCCCccc
Q 017621           82 IPE--SVKKVPLLYVSGNNFEV  101 (368)
Q Consensus        82 ~p~--~~~~~~~~~~~~N~~~~  101 (368)
                      +|.  .+.++..+++++|.+++
T Consensus       122 ~~~l~~l~~L~~L~l~~n~l~~  143 (308)
T 1h6u_A          122 VTPLAGLSNLQVLYLDLNQITN  143 (308)
T ss_dssp             CGGGTTCTTCCEEECCSSCCCC
T ss_pred             chhhcCCCCCCEEECCCCccCc
Confidence            232  12234445566665543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.97  E-value=8.1e-10  Score=109.35  Aligned_cols=95  Identities=29%  Similarity=0.433  Sum_probs=70.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.|++ +| .+.+|++|+.|+|++|++++ + +.+..|++|+.|+|++|++++.  +.+..+++|+.|+|++|+|++
T Consensus        94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~  167 (605)
T 1m9s_A           94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD  167 (605)
T ss_dssp             CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred             CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence            57788876 44 68888888888888888874 4 4688888888888888888854  567788888888888888886


Q ss_pred             cccc-cccCcccccccCCCccc
Q 017621           81 SIPE-SVKKVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p~-~~~~~~~~~~~~N~~~~  101 (368)
                      ..|- .+..+..|++++|.++.
T Consensus       168 ~~~l~~l~~L~~L~Ls~N~i~~  189 (605)
T 1m9s_A          168 IVPLAGLTKLQNLYLSKNHISD  189 (605)
T ss_dssp             CGGGTTCTTCCEEECCSSCCCB
T ss_pred             chhhccCCCCCEEECcCCCCCC
Confidence            6551 12345567788887764

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.97  E-value=9.4e-10  Score=105.46  Aligned_cols=95  Identities=17%  Similarity=0.186  Sum_probs=75.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++ +|  ++.+++|+.|+|++|++++.   .++.+++|+.|+|++|++++ +|  ++.+++|+.|++++|+|+|
T Consensus       177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~  247 (457)
T 3bz5_A          177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE  247 (457)
T ss_dssp             CCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred             CCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence            57888987 66  78889999999999999864   48889999999999999997 66  7888999999999999998


Q ss_pred             cccccccCc----------ccccccCCCcccccc
Q 017621           81 SIPESVKKV----------PLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~~~~~~----------~~~~~~~N~~~~~~P  104 (368)
                      ..+..+..+          ..+++++|.+.+.+|
T Consensus       248 ~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~  281 (457)
T 3bz5_A          248 LDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ  281 (457)
T ss_dssp             CCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred             cCHHHCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence            665555444          345666666666665

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.94  E-value=1.7e-10  Score=107.16  Aligned_cols=103  Identities=20%  Similarity=0.164  Sum_probs=83.8

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCC----ccccCCC-CCCeeeeecccccccCCcccCCC-----CCCce
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSIS----SEIGKLQ-ELNYLDLSHNLINGKIPSQLGEI-----PRIDT   70 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p----~~~~~~~-~L~~l~l~~N~l~g~~p~~~~~~-----~~l~~   70 (368)
                      |++|+++|.+|..+...++|+.|+|++|++++.-+    ..+..++ +|+.|+|++|++++..+..+..+     ++|+.
T Consensus         5 ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~   84 (362)
T 3goz_A            5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTS   84 (362)
T ss_dssp             CCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCE
T ss_pred             cccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccE
Confidence            67899999998877777779999999999986554    6778888 89999999999998888777665     89999


Q ss_pred             ecccCCcccccccccc--------cCcccccccCCCccccc
Q 017621           71 VNLSMNNLSGSIPESV--------KKVPLLYVSGNNFEVEI  103 (368)
Q Consensus        71 l~l~~n~l~g~~p~~~--------~~~~~~~~~~N~~~~~~  103 (368)
                      |+|++|++++..+..+        .++..+++++|.++...
T Consensus        85 L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  125 (362)
T 3goz_A           85 LNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKS  125 (362)
T ss_dssp             EECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSC
T ss_pred             EECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHH
Confidence            9999999987665532        35667889999886543

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.92  E-value=8e-10  Score=97.97  Aligned_cols=94  Identities=16%  Similarity=0.265  Sum_probs=79.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+++. ++ .+..+++|+.|+|++|+++ .+| .++.+++|+.|+|++|++++. |+ +..+++|+.|++++|++++
T Consensus        26 l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~   99 (263)
T 1xeu_A           26 LGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN   99 (263)
T ss_dssp             HTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC
T ss_pred             hcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC
Confidence            35677775 44 5788999999999999998 777 799999999999999999954 44 9999999999999999996


Q ss_pred             cccc-cccCcccccccCCCccc
Q 017621           81 SIPE-SVKKVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p~-~~~~~~~~~~~~N~~~~  101 (368)
                       +|. ...++..+++++|.++.
T Consensus       100 -l~~~~~~~L~~L~L~~N~l~~  120 (263)
T 1xeu_A          100 -LNGIPSACLSRLFLDNNELRD  120 (263)
T ss_dssp             -CTTCCCSSCCEEECCSSCCSB
T ss_pred             -cCccccCcccEEEccCCccCC
Confidence             443 22567789999999875

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.92  E-value=1.1e-09  Score=105.29  Aligned_cols=97  Identities=24%  Similarity=0.342  Sum_probs=71.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.+++ +|+ +..+++|+.|+|++|++++. +. ++.+++|+.|+|++|++++..|  +..+++|+.|++++|++++
T Consensus       272 l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~  345 (466)
T 1o6v_A          272 LGANQISN-ISP-LAGLTALTNLELNENQLEDI-SP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD  345 (466)
T ss_dssp             CCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCC-GG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             CCCCccCc-ccc-ccCCCccCeEEcCCCcccCc-hh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC
Confidence            56788886 443 77888888888888888754 33 7788888888888888887665  6678888888888888876


Q ss_pred             cccc--cccCcccccccCCCcccccc
Q 017621           81 SIPE--SVKKVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        81 ~~p~--~~~~~~~~~~~~N~~~~~~P  104 (368)
                      . |.  .+.++..+++++|.+++..|
T Consensus       346 ~-~~l~~l~~L~~L~l~~n~l~~~~~  370 (466)
T 1o6v_A          346 V-SSLANLTNINWLSAGHNQISDLTP  370 (466)
T ss_dssp             C-GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred             c-hhhccCCCCCEEeCCCCccCccch
Confidence            4 32  22345567788888776655

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.92  E-value=1.4e-09  Score=100.10  Aligned_cols=99  Identities=22%  Similarity=0.458  Sum_probs=76.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      +++|.+++..+  +..+++|+.|+|++|++++ +|. +..+++|+.|+|++|.+++ + +.+..+++|+.|++++|++++
T Consensus       206 l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~  279 (347)
T 4fmz_A          206 AYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD  279 (347)
T ss_dssp             CCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC
T ss_pred             cccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC
Confidence            46788876433  7888999999999999984 454 8889999999999999985 4 467888999999999999985


Q ss_pred             cccc--cccCcccccccCCCcccccccC
Q 017621           81 SIPE--SVKKVPLLYVSGNNFEVEIPST  106 (368)
Q Consensus        81 ~~p~--~~~~~~~~~~~~N~~~~~~P~~  106 (368)
                      . |.  .+.++..+++++|.++...|..
T Consensus       280 ~-~~~~~l~~L~~L~L~~n~l~~~~~~~  306 (347)
T 4fmz_A          280 I-SVLNNLSQLNSLFLNNNQLGNEDMEV  306 (347)
T ss_dssp             C-GGGGGCTTCSEEECCSSCCCGGGHHH
T ss_pred             C-hhhcCCCCCCEEECcCCcCCCcChhH
Confidence            3 42  3346677889999887665543

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.91  E-value=1.8e-09  Score=103.74  Aligned_cols=96  Identities=28%  Similarity=0.424  Sum_probs=79.1

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|.+++..|  +.++++|+.|+|++|++++. |. +..+++|+.|+|++|++++..|  ++.+++|+.|++++|++++
T Consensus       250 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~  323 (466)
T 1o6v_A          250 LANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD  323 (466)
T ss_dssp             CCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSC
T ss_pred             CCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCC
Confidence            57889987544  88999999999999999854 44 8899999999999999996544  7889999999999999998


Q ss_pred             ccc-ccccCcccccccCCCcccc
Q 017621           81 SIP-ESVKKVPLLYVSGNNFEVE  102 (368)
Q Consensus        81 ~~p-~~~~~~~~~~~~~N~~~~~  102 (368)
                      ..| ..+.++..+++++|.+++.
T Consensus       324 ~~~~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          324 ISPVSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             CGGGGGCTTCCEEECCSSCCCCC
T ss_pred             chhhccCccCCEeECCCCccCCc
Confidence            766 2344667789999988764

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.88  E-value=2.2e-10  Score=107.32  Aligned_cols=102  Identities=22%  Similarity=0.301  Sum_probs=68.8

Q ss_pred             CCCCCccc----cCCccccCC---------CCCcEEEecCcccc-ccCC---ccccCCCCCCeeeeeccccc--c---cC
Q 017621            1 MYNNKLDG----PIPQELMNC---------SKLRILILGNNLLS-GSIS---SEIGKLQELNYLDLSHNLIN--G---KI   58 (368)
Q Consensus         1 l~~n~l~g----~~p~~~~~l---------~~l~~l~l~~N~~~-g~~p---~~~~~~~~L~~l~l~~N~l~--g---~~   58 (368)
                      |++|.+++    .++..+..+         ++|+.|+|++|+++ +.+|   ..+..+++|+.|+|++|+++  |   .+
T Consensus       129 L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~  208 (386)
T 2ca6_A          129 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLL  208 (386)
T ss_dssp             CCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHH
T ss_pred             CcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHH
Confidence            45666642    344555555         77888888888886 4555   46667778888888888777  3   45


Q ss_pred             CcccCCCCCCceecccCCccc----cccccccc---CcccccccCCCcccc
Q 017621           59 PSQLGEIPRIDTVNLSMNNLS----GSIPESVK---KVPLLYVSGNNFEVE  102 (368)
Q Consensus        59 p~~~~~~~~l~~l~l~~n~l~----g~~p~~~~---~~~~~~~~~N~~~~~  102 (368)
                      |..+..+++|+.|+|++|.|+    +.+|..+.   ++..+++++|.++..
T Consensus       209 ~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~  259 (386)
T 2ca6_A          209 LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR  259 (386)
T ss_dssp             HTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred             HHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence            557777788888888888875    56665543   455677888877643

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.87  E-value=4.6e-10  Score=102.88  Aligned_cols=100  Identities=17%  Similarity=0.202  Sum_probs=76.7

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCcccccc-CCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCC-cc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGS-ISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMN-NL   78 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~-~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n-~l   78 (368)
                      |++|.+++..|. +.++++|+.|+|++|++++. +|..+..+++|+.|+|++|++++..|..++.+++|+.|++++| .+
T Consensus        77 l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l  155 (336)
T 2ast_B           77 CPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF  155 (336)
T ss_dssp             CTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSC
T ss_pred             cCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCC
Confidence            467778876554 66788888888888888765 7778888888888888888888888888888888888888888 67


Q ss_pred             ccc-cccc---ccCcccccccCC-Cccc
Q 017621           79 SGS-IPES---VKKVPLLYVSGN-NFEV  101 (368)
Q Consensus        79 ~g~-~p~~---~~~~~~~~~~~N-~~~~  101 (368)
                      ++. +|..   +.++..+++++| .++.
T Consensus       156 ~~~~l~~~~~~~~~L~~L~l~~~~~l~~  183 (336)
T 2ast_B          156 SEFALQTLLSSCSRLDELNLSWCFDFTE  183 (336)
T ss_dssp             CHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred             CHHHHHHHHhcCCCCCEEcCCCCCCcCh
Confidence            753 5543   345667788888 6653

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.87  E-value=2.6e-09  Score=105.93  Aligned_cols=78  Identities=24%  Similarity=0.302  Sum_probs=45.1

Q ss_pred             CCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccccccccC---cccccc
Q 017621           18 SKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKK---VPLLYV   94 (368)
Q Consensus        18 ~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~~~~~---~~~~~~   94 (368)
                      ++|+.|+|++|++++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..+..   +..+++
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  291 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence            445555555555552 44   34455666666666666 4555   4456666666666666 56655543   334666


Q ss_pred             cCCCcccccc
Q 017621           95 SGNNFEVEIP  104 (368)
Q Consensus        95 ~~N~~~~~~P  104 (368)
                      ++|++++..|
T Consensus       292 ~~N~l~~~~~  301 (622)
T 3g06_A          292 EGNPLSERTL  301 (622)
T ss_dssp             CSCCCCHHHH
T ss_pred             cCCCCCCcCH
Confidence            7776665444

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.86  E-value=6.5e-09  Score=94.04  Aligned_cols=137  Identities=22%  Similarity=0.221  Sum_probs=98.3

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCc--eeeEEEEEeeCC---eEEEEE
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRN--IVKLYGFCLHRK---CMFLIY  266 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~  266 (368)
                      .+.++.|....||+..    ..+++|+....     .....+.+|.++++.+ .+..  +.+++......+   ..|+||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            4568999999999864    45888886533     1236788899999887 3433  345555443333   358999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH-------------------------------------  309 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------  309 (368)
                      |+++|.++.+....     .++..++..++.++++.+..||+.                                     
T Consensus        96 ~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             ECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             cccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            99999887653321     266777778888888888888861                                     


Q ss_pred             ------------------CCCCeeecCCCCCCeeecC--CCCeEEeeeccceec
Q 017621          310 ------------------CTPPIVHRDISSNNVLLNS--ELEAFVADFGVARLL  343 (368)
Q Consensus       310 ------------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DFg~a~~~  343 (368)
                                        ..+.++|+|++|.||++++  ...+.|+||+.+..-
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                              1135799999999999998  456789999998764

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.83  E-value=5.1e-10  Score=103.97  Aligned_cols=101  Identities=24%  Similarity=0.293  Sum_probs=80.1

Q ss_pred             CCCCCccccCC----ccccCCC-CCcEEEecCccccccCCccccCC-----CCCCeeeeecccccccCCcccCC----C-
Q 017621            1 MYNNKLDGPIP----QELMNCS-KLRILILGNNLLSGSISSEIGKL-----QELNYLDLSHNLINGKIPSQLGE----I-   65 (368)
Q Consensus         1 l~~n~l~g~~p----~~~~~l~-~l~~l~l~~N~~~g~~p~~~~~~-----~~L~~l~l~~N~l~g~~p~~~~~----~-   65 (368)
                      |++|.+++..+    ..+.+++ +|+.|+|++|++++..+..++.+     ++|+.|+|++|++++..+..++.    + 
T Consensus        29 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~  108 (362)
T 3goz_A           29 LSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP  108 (362)
T ss_dssp             CTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSC
T ss_pred             ccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCC
Confidence            67888887666    6677888 89999999999987777777765     89999999999999877775444    3 


Q ss_pred             CCCceecccCCcccccccccc--------cCcccccccCCCccc
Q 017621           66 PRIDTVNLSMNNLSGSIPESV--------KKVPLLYVSGNNFEV  101 (368)
Q Consensus        66 ~~l~~l~l~~n~l~g~~p~~~--------~~~~~~~~~~N~~~~  101 (368)
                      ++|+.|+|++|+|++..+..+        .++..+++++|.++.
T Consensus       109 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~  152 (362)
T 3goz_A          109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI  152 (362)
T ss_dssp             TTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred             CCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCH
Confidence            799999999999986655433        356778899998774

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.81  E-value=8.4e-09  Score=102.31  Aligned_cols=88  Identities=23%  Similarity=0.368  Sum_probs=50.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|+ .+|..+.  ++|+.|+|++|+|+ .||.   .+++|+.|||++|+++ .+|.   .+++|+.|++++|+|++
T Consensus        47 ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~  115 (622)
T 3g06_A           47 VGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH  115 (622)
T ss_dssp             CCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC
T ss_pred             ecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC
Confidence            4566666 5666554  56666777766666 5555   4566666666666666 4555   34555555555555553


Q ss_pred             cccccccCcccccccCCCcc
Q 017621           81 SIPESVKKVPLLYVSGNNFE  100 (368)
Q Consensus        81 ~~p~~~~~~~~~~~~~N~~~  100 (368)
                       +|..+.++..+++++|.++
T Consensus       116 -l~~~l~~L~~L~L~~N~l~  134 (622)
T 3g06_A          116 -LPALPSGLCKLWIFGNQLT  134 (622)
T ss_dssp             -CCCCCTTCCEEECCSSCCS
T ss_pred             -CCCCCCCcCEEECCCCCCC
Confidence             3433334444444444433

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.79  E-value=9.9e-10  Score=96.93  Aligned_cols=68  Identities=29%  Similarity=0.373  Sum_probs=52.7

Q ss_pred             cCCCCCcEEEecCccccc--cCCccccCCCCCCeeeeecccccccCCcccCCCC--CCceecccCCcccccccc
Q 017621           15 MNCSKLRILILGNNLLSG--SISSEIGKLQELNYLDLSHNLINGKIPSQLGEIP--RIDTVNLSMNNLSGSIPE   84 (368)
Q Consensus        15 ~~l~~l~~l~l~~N~~~g--~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~--~l~~l~l~~n~l~g~~p~   84 (368)
                      .++++|+.|+|++|+|++  .+|..+..+++|+.|||++|+|++.  ..+..+.  .|+.|+|++|.+++.+|.
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~  238 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD  238 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence            457788888888888887  6667777888888888888888865  3344444  888888888888887763

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.78  E-value=6.5e-09  Score=96.02  Aligned_cols=97  Identities=20%  Similarity=0.254  Sum_probs=69.0

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCc-cccCCCCCCeeeeecccccccCCc-ccCCCCCCce-ecccCCcc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISS-EIGKLQELNYLDLSHNLINGKIPS-QLGEIPRIDT-VNLSMNNL   78 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~-~~~~~~~L~~l~l~~N~l~g~~p~-~~~~~~~l~~-l~l~~n~l   78 (368)
                      ++|+|+ .+|..+.  ++++.|+|++|+|+ .||. .|.++++|+.|+|++|++.+.+|. .+.+++++.. +.+++|+|
T Consensus        17 ~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l   92 (350)
T 4ay9_X           17 QESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL   92 (350)
T ss_dssp             ESTTCC-SCCTTCC--TTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTC
T ss_pred             cCCCCC-ccCcCcC--CCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcc
Confidence            356777 5777663  57888888888887 5664 578888888888888888777765 5677777654 56667888


Q ss_pred             ccccccccc---CcccccccCCCcccc
Q 017621           79 SGSIPESVK---KVPLLYVSGNNFEVE  102 (368)
Q Consensus        79 ~g~~p~~~~---~~~~~~~~~N~~~~~  102 (368)
                      ++..|..+.   ++..+++++|.+...
T Consensus        93 ~~l~~~~f~~l~~L~~L~l~~n~l~~~  119 (350)
T 4ay9_X           93 LYINPEAFQNLPNLQYLLISNTGIKHL  119 (350)
T ss_dssp             CEECTTSBCCCTTCCEEEEEEECCSSC
T ss_pred             cccCchhhhhccccccccccccccccC
Confidence            865565554   455677888877643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.77  E-value=6.8e-08  Score=87.45  Aligned_cols=137  Identities=18%  Similarity=0.118  Sum_probs=93.2

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCC---ceeeEEEEEe-eCCeEEEEEee
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR---NIVKLYGFCL-HRKCMFLIYEY  268 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~  268 (368)
                      .+.++.|....||+.    +..+++|+....     .....+.+|.+++..+.+.   .+.+++.+.. ..+..|+||||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            456788888899988    466888875321     1236788999999999642   3566777764 44567899999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH---------------------------------------  309 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------  309 (368)
                      ++|..+.+..-.     .++..+...++.++++.|..||+.                                       
T Consensus        95 i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           95 VQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             CCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             cCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            999877653211     133444444555555555555532                                       


Q ss_pred             ------------------CCCCeeecCCCCCCeeecC---CCCe-EEeeeccceec
Q 017621          310 ------------------CTPPIVHRDISSNNVLLNS---ELEA-FVADFGVARLL  343 (368)
Q Consensus       310 ------------------~~~~ivH~Dlkp~NIll~~---~~~~-kl~DFg~a~~~  343 (368)
                                        ..+.++|+|++|.||+++.   ++.+ .|+||+.+..-
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                              2235699999999999987   4554 79999988754

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.73  E-value=1.4e-08  Score=93.74  Aligned_cols=98  Identities=14%  Similarity=0.064  Sum_probs=74.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCc-cccCCCCCCe-eeeecccccccCCcccCCCCCCceecccCCcc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISS-EIGKLQELNY-LDLSHNLINGKIPSQLGEIPRIDTVNLSMNNL   78 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~-~~~~~~~L~~-l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l   78 (368)
                      |++|+|+..-+..+.+|++|+.|+|++|++.+.+|. .|.++++|+. ++++.|++++..|..+..+++|+.|++++|+|
T Consensus        37 Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l  116 (350)
T 4ay9_X           37 FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI  116 (350)
T ss_dssp             EESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECC
T ss_pred             ccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccccccc
Confidence            578999864445689999999999999999878875 5788888775 66778999977788899999999999999999


Q ss_pred             ccccccccc---CcccccccCCC
Q 017621           79 SGSIPESVK---KVPLLYVSGNN   98 (368)
Q Consensus        79 ~g~~p~~~~---~~~~~~~~~N~   98 (368)
                      ++..+..+.   ++..+++.+++
T Consensus       117 ~~~~~~~~~~~~~l~~l~l~~~~  139 (350)
T 4ay9_X          117 KHLPDVHKIHSLQKVLLDIQDNI  139 (350)
T ss_dssp             SSCCCCTTCCBSSCEEEEEESCT
T ss_pred             ccCCchhhcccchhhhhhhcccc
Confidence            865444332   23345665543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.73  E-value=1.4e-07  Score=83.52  Aligned_cols=136  Identities=20%  Similarity=0.174  Sum_probs=95.9

Q ss_pred             eeeecCCc-cEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeEEEEEeecCC
Q 017621          195 CIGTGGYG-SVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       195 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      .+..|..+ .||+.... ++..+++|+-...      ....+.+|.+.++.+. +--+.++++++.+.+..|+|||+++|
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            35556555 69998764 4567888976432      2246778999888773 33467889999999999999999999


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC-----------------------------------------  310 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------------  310 (368)
                      .++.+......       .....+..+++..|.-||+..                                         
T Consensus       105 ~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          105 KTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             EEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             ccccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            88766544321       122345566666666666421                                         


Q ss_pred             --------------CCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          311 --------------TPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       311 --------------~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                                    .+.++|+|+.+.|||+++++.+-|+||+.+..-
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                          113789999999999998777779999988753

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.72  E-value=5e-09  Score=95.91  Aligned_cols=77  Identities=16%  Similarity=0.187  Sum_probs=49.7

Q ss_pred             CCCC-Ccccc-CCccccCCC-CCcEEEecCc--ccc-ccCCccccCCCCCCeeeeeccc-ccccCCcccCCCCCCceecc
Q 017621            1 MYNN-KLDGP-IPQELMNCS-KLRILILGNN--LLS-GSISSEIGKLQELNYLDLSHNL-INGKIPSQLGEIPRIDTVNL   73 (368)
Q Consensus         1 l~~n-~l~g~-~p~~~~~l~-~l~~l~l~~N--~~~-g~~p~~~~~~~~L~~l~l~~N~-l~g~~p~~~~~~~~l~~l~l   73 (368)
                      |++| .+++. +|..+.+++ +|+.|+|++|  .++ +.+|..+..+++|+.|+|++|. +++..+..++.+++|+.|++
T Consensus       175 l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l  254 (336)
T 2ast_B          175 LSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSL  254 (336)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEEC
T ss_pred             CCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeC
Confidence            3455 66553 455566666 7777777777  444 4556666667777777777776 66666666666677777777


Q ss_pred             cCCc
Q 017621           74 SMNN   77 (368)
Q Consensus        74 ~~n~   77 (368)
                      ++|.
T Consensus       255 ~~~~  258 (336)
T 2ast_B          255 SRCY  258 (336)
T ss_dssp             TTCT
T ss_pred             CCCC
Confidence            7663

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.51  E-value=6e-09  Score=91.89  Aligned_cols=91  Identities=23%  Similarity=0.267  Sum_probs=66.9

Q ss_pred             ccCCCCCcE--EEecCccc---cccCCccccCCCCCCeeeeecccccc--cCCcccCCCCCCceecccCCcccccc-ccc
Q 017621           14 LMNCSKLRI--LILGNNLL---SGSISSEIGKLQELNYLDLSHNLING--KIPSQLGEIPRIDTVNLSMNNLSGSI-PES   85 (368)
Q Consensus        14 ~~~l~~l~~--l~l~~N~~---~g~~p~~~~~~~~L~~l~l~~N~l~g--~~p~~~~~~~~l~~l~l~~n~l~g~~-p~~   85 (368)
                      +...+.|..  ++++.|+.   .+.++....++++|+.|+||+|+|++  .+|..+..+++|+.|+|++|+|++.- -..
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~  216 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK  216 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhh
Confidence            333444554  67788843   33333333579999999999999998  77788889999999999999999641 122


Q ss_pred             cc--CcccccccCCCcccccc
Q 017621           86 VK--KVPLLYVSGNNFEVEIP  104 (368)
Q Consensus        86 ~~--~~~~~~~~~N~~~~~~P  104 (368)
                      +.  .+..+++++|++++..|
T Consensus       217 l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          217 IKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             GTTSCCSEEECTTSTTGGGCS
T ss_pred             cccCCcceEEccCCcCccccC
Confidence            33  66778999999987654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.51  E-value=1.5e-07  Score=86.86  Aligned_cols=83  Identities=7%  Similarity=-0.010  Sum_probs=54.9

Q ss_pred             ceee-eecCCccEEEEEcC-------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-C--CceeeEEEEEeeC--
Q 017621          193 KYCI-GTGGYGSVYRARLP-------SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-H--RNIVKLYGFCLHR--  259 (368)
Q Consensus       193 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  259 (368)
                      .+.| +.|....+|+....       +++.+++|...............+.+|.++++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 77888999998754       26678899865432000000134667888888873 3  3567788887665  


Q ss_pred             -CeEEEEEeecCCCChh
Q 017621          260 -KCMFLIYEYMEMGSLF  275 (368)
Q Consensus       260 -~~~~lv~e~~~~g~L~  275 (368)
                       +..|+||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999986654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.51  E-value=8.7e-09  Score=98.52  Aligned_cols=102  Identities=18%  Similarity=0.153  Sum_probs=80.0

Q ss_pred             CCCCCccccCCccccC-----CCCCcEEEecCcccccc----CCccccCCCCCCeeeeecccccccCCcccCC-----CC
Q 017621            1 MYNNKLDGPIPQELMN-----CSKLRILILGNNLLSGS----ISSEIGKLQELNYLDLSHNLINGKIPSQLGE-----IP   66 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~-----l~~l~~l~l~~N~~~g~----~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~-----~~   66 (368)
                      |++|.+++..+..+..     .++|+.|+|++|++++.    +|..+..+++|+.|||++|++++..+..+..     .+
T Consensus       291 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~  370 (461)
T 1z7x_W          291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS  370 (461)
T ss_dssp             CTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred             CCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCC
Confidence            5778887654444443     36899999999999865    6677888999999999999999776665543     67


Q ss_pred             CCceecccCCcccc----cccccc---cCcccccccCCCcccc
Q 017621           67 RIDTVNLSMNNLSG----SIPESV---KKVPLLYVSGNNFEVE  102 (368)
Q Consensus        67 ~l~~l~l~~n~l~g----~~p~~~---~~~~~~~~~~N~~~~~  102 (368)
                      +|+.|++++|++++    .+|..+   .++..+++++|.++..
T Consensus       371 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          371 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             CCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             ceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            99999999999986    777664   4667789999988753

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.50  E-value=4e-09  Score=100.86  Aligned_cols=102  Identities=19%  Similarity=0.193  Sum_probs=74.3

Q ss_pred             CCCCCccccC-----CccccCCCCCcEEEecCcccccc----CCccccCCCCCCeeeeecccccccCCcccCC-----CC
Q 017621            1 MYNNKLDGPI-----PQELMNCSKLRILILGNNLLSGS----ISSEIGKLQELNYLDLSHNLINGKIPSQLGE-----IP   66 (368)
Q Consensus         1 l~~n~l~g~~-----p~~~~~l~~l~~l~l~~N~~~g~----~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~-----~~   66 (368)
                      |++|.++..-     +.....+++|+.|+|++|++++.    +|..+..+++|+.|||++|.+++.-+..+..     .+
T Consensus       234 Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~  313 (461)
T 1z7x_W          234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGC  313 (461)
T ss_dssp             CCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTC
T ss_pred             ccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCc
Confidence            4677776542     22223578999999999999854    7778888999999999999988665554433     26


Q ss_pred             CCceecccCCccccc----ccccc---cCcccccccCCCcccc
Q 017621           67 RIDTVNLSMNNLSGS----IPESV---KKVPLLYVSGNNFEVE  102 (368)
Q Consensus        67 ~l~~l~l~~n~l~g~----~p~~~---~~~~~~~~~~N~~~~~  102 (368)
                      +|+.|++++|.+++.    +|..+   .++..+++++|.++..
T Consensus       314 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~  356 (461)
T 1z7x_W          314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA  356 (461)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH
T ss_pred             cceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccc
Confidence            899999999998865    34433   4566788999887654

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.37  E-value=4e-08  Score=91.48  Aligned_cols=84  Identities=18%  Similarity=0.279  Sum_probs=41.0

Q ss_pred             CCCCcEEEecCccccc----cCCccccCCCCCCeeeeeccccccc----CCcccCCCCCCceecccCCccccc----ccc
Q 017621           17 CSKLRILILGNNLLSG----SISSEIGKLQELNYLDLSHNLINGK----IPSQLGEIPRIDTVNLSMNNLSGS----IPE   84 (368)
Q Consensus        17 l~~l~~l~l~~N~~~g----~~p~~~~~~~~L~~l~l~~N~l~g~----~p~~~~~~~~l~~l~l~~n~l~g~----~p~   84 (368)
                      .++|+.|+|++|.++.    .++..+..+++|+.|||++|.++..    ++..+..+++|+.|+|++|.|+..    ++.
T Consensus       154 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~  233 (372)
T 3un9_A          154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR  233 (372)
T ss_dssp             TCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHH
Confidence            3455555555555542    1333344555566666666655532    233444455566666666655531    122


Q ss_pred             cc---cCcccccccCCCcc
Q 017621           85 SV---KKVPLLYVSGNNFE  100 (368)
Q Consensus        85 ~~---~~~~~~~~~~N~~~  100 (368)
                      .+   ..+..+++++|.++
T Consensus       234 ~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          234 AAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             HHHHCSSCCEEECTTSSCC
T ss_pred             HHHhCCCCCEEeccCCCCC
Confidence            11   23445556666544

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.32  E-value=1.3e-06  Score=79.97  Aligned_cols=141  Identities=19%  Similarity=0.298  Sum_probs=78.5

Q ss_pred             eeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-----CCceeeEE-E--EEeeCCeEEEE
Q 017621          194 YCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-----HRNIVKLY-G--FCLHRKCMFLI  265 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv  265 (368)
                      +.|+.|..+.||+....++ .+++|+.....       +++..|.+++..+.     .|.++... +  +....+..+++
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l  109 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV  109 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence            4466677889999987554 58899887521       22233444444442     34444311 1  12346678999


Q ss_pred             EeecCCCChh--------------HHhhc----CC-C-C-----CCCCHHHH----------------------------
Q 017621          266 YEYMEMGSLF--------------CVLRT----DE-E-A-----VGLDWAKR----------------------------  292 (368)
Q Consensus       266 ~e~~~~g~L~--------------~~l~~----~~-~-~-----~~l~~~~~----------------------------  292 (368)
                      |||++|..+.              ..++.    .. . .     ....|...                            
T Consensus       110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  189 (346)
T 2q83_A          110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL  189 (346)
T ss_dssp             EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred             EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence            9999986542              01111    00 0 0     00122211                            


Q ss_pred             ---HHHHHHHHHHHHHHhc----------CCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          293 ---VNIVKGMAHALSYLHH----------HCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       293 ---~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                         ..+..++..++++|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence               0111223445666653          0234899999999999998888999999998864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.31  E-value=2e-06  Score=80.57  Aligned_cols=78  Identities=13%  Similarity=0.101  Sum_probs=49.4

Q ss_pred             ceeeeecCCccEEEEEcC-CCCEEEEEEccccch--hh--HHhHHHHHHHHHHHhccCC--C-ceeeEEEEEeeCCeEEE
Q 017621          193 KYCIGTGGYGSVYRARLP-SGKVVALKKLHRSET--EE--LASLESFRNEARLLSQIWH--R-NIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~--~~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  264 (368)
                      .+.+|.|..+.||++... +++.+++|.......  ..  ....+++..|.++++.+..  | .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999764 467899997653221  00  0122456778888887732  3 34566654  3444689


Q ss_pred             EEeecCCC
Q 017621          265 IYEYMEMG  272 (368)
Q Consensus       265 v~e~~~~g  272 (368)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.27  E-value=7.2e-06  Score=74.09  Aligned_cols=138  Identities=21%  Similarity=0.225  Sum_probs=91.5

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC---CCceeeEEEEEeeCCeEEEEEeec
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW---HRNIVKLYGFCLHRKCMFLIYEYM  269 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~  269 (368)
                      .+.|+.|....+|+... ++..+++|.....      ....+..|.+.|+.+.   ...+++++++....+..|+||||+
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            46788999999999986 4678888976542      1356788999888883   356888999888888899999999


Q ss_pred             CCCChh--------H---HhhcCCC--CC-----------------CCCHHHHH---HHH----------------HHHH
Q 017621          270 EMGSLF--------C---VLRTDEE--AV-----------------GLDWAKRV---NIV----------------KGMA  300 (368)
Q Consensus       270 ~~g~L~--------~---~l~~~~~--~~-----------------~l~~~~~~---~i~----------------~~i~  300 (368)
                      ++..+.        .   .++....  ..                 .-+|....   ++.                .++.
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            987642        1   1121111  00                 12454321   111                1111


Q ss_pred             HHH-HHHhc-CCCCCeeecCCCCCCeeecCCCCeEEeeec
Q 017621          301 HAL-SYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFG  338 (368)
Q Consensus       301 ~~L-~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg  338 (368)
                      +.+ ..|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            112 23421 2246899999999999999887 8899984

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.09  E-value=2.9e-07  Score=85.61  Aligned_cols=86  Identities=19%  Similarity=0.256  Sum_probs=66.2

Q ss_pred             CCCCCccc----cCCccccCCCCCcEEEecCccccc----cCCccccCCCCCCeeeeeccccccc----CCcccCCCCCC
Q 017621            1 MYNNKLDG----PIPQELMNCSKLRILILGNNLLSG----SISSEIGKLQELNYLDLSHNLINGK----IPSQLGEIPRI   68 (368)
Q Consensus         1 l~~n~l~g----~~p~~~~~l~~l~~l~l~~N~~~g----~~p~~~~~~~~L~~l~l~~N~l~g~----~p~~~~~~~~l   68 (368)
                      |++|.|+.    .++..+..+++|+.|+|++|+++.    .++..+..+++|+.|||++|.++..    ++..+..+++|
T Consensus       162 Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L  241 (372)
T 3un9_A          162 LSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSL  241 (372)
T ss_dssp             CCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSC
T ss_pred             CCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCC
Confidence            56777765    344455778899999999999974    3356677889999999999999853    44556667999


Q ss_pred             ceecccCCcccccccccc
Q 017621           69 DTVNLSMNNLSGSIPESV   86 (368)
Q Consensus        69 ~~l~l~~n~l~g~~p~~~   86 (368)
                      +.|+|++|.|+..-...+
T Consensus       242 ~~L~Ls~N~i~~~g~~~L  259 (372)
T 3un9_A          242 ELLHLYFNELSSEGRQVL  259 (372)
T ss_dssp             CEEECTTSSCCHHHHHHH
T ss_pred             CEEeccCCCCCHHHHHHH
Confidence            999999999985433333

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.06  E-value=3e-07  Score=90.68  Aligned_cols=88  Identities=17%  Similarity=0.166  Sum_probs=52.8

Q ss_pred             ccCCCCCcEEEecC--ccccccCCcccc-CCCCCCeeeeecccccc-cCCcccCCCCCCceecccCCcccccccc----c
Q 017621           14 LMNCSKLRILILGN--NLLSGSISSEIG-KLQELNYLDLSHNLING-KIPSQLGEIPRIDTVNLSMNNLSGSIPE----S   85 (368)
Q Consensus        14 ~~~l~~l~~l~l~~--N~~~g~~p~~~~-~~~~L~~l~l~~N~l~g-~~p~~~~~~~~l~~l~l~~n~l~g~~p~----~   85 (368)
                      +.++++|+.|+|++  |.+++..+..++ .+++|+.|+|++|++++ .+|..+..+++|+.|++++|+|++....    .
T Consensus       432 ~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~  511 (592)
T 3ogk_B          432 LIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTK  511 (592)
T ss_dssp             HHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHH
T ss_pred             HHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHh
Confidence            45566666666653  235554444443 36777777777777765 3445556677777777777777644222    2


Q ss_pred             ccCcccccccCCCccc
Q 017621           86 VKKVPLLYVSGNNFEV  101 (368)
Q Consensus        86 ~~~~~~~~~~~N~~~~  101 (368)
                      +.++..+++++|+++.
T Consensus       512 l~~L~~L~ls~n~it~  527 (592)
T 3ogk_B          512 LPSLRYLWVQGYRASM  527 (592)
T ss_dssp             CSSCCEEEEESCBCCT
T ss_pred             cCccCeeECcCCcCCH
Confidence            3455667777776553

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.05  E-value=3.8e-05  Score=72.47  Aligned_cols=31  Identities=16%  Similarity=0.267  Sum_probs=27.4

Q ss_pred             CCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          312 PPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       312 ~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +.++|+|++|.|||++.++ ++++||+.+..-
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            3899999999999998876 999999988754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.02  E-value=3.2e-05  Score=68.94  Aligned_cols=79  Identities=19%  Similarity=0.168  Sum_probs=55.8

Q ss_pred             ccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-C--CceeeEEEEEeeCCeEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-H--RNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  265 (368)
                      +..-.+.+|.|..+.||+.+..+|+.|.+|+.......   ....|..|++.|+.+. .  --+.+++++.  .  -++|
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv   88 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA   88 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence            45556789999999999999999999999986543321   1245778999888873 2  2344555542  2  3789


Q ss_pred             EeecCCCCh
Q 017621          266 YEYMEMGSL  274 (368)
Q Consensus       266 ~e~~~~g~L  274 (368)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987643

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.95  E-value=8.1e-07  Score=87.56  Aligned_cols=76  Identities=13%  Similarity=0.094  Sum_probs=61.0

Q ss_pred             ccccCCcccc-CCCCCcEEEecCccccc-cCCccccCCCCCCeeeeeccccccc-CCcccCCCCCCceecccCCccccc
Q 017621            6 LDGPIPQELM-NCSKLRILILGNNLLSG-SISSEIGKLQELNYLDLSHNLINGK-IPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         6 l~g~~p~~~~-~l~~l~~l~l~~N~~~g-~~p~~~~~~~~L~~l~l~~N~l~g~-~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      +++..+..++ .+++|+.|+|++|++++ .++..+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|++++.
T Consensus       450 l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          450 LTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             CCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             ccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence            3444444444 37899999999999987 5566678899999999999999866 445556799999999999999865

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.94  E-value=8.8e-07  Score=73.86  Aligned_cols=89  Identities=15%  Similarity=0.128  Sum_probs=59.7

Q ss_pred             cccCCCCCcEEEecCc-cccc----cCCccccCCCCCCeeeeeccccccc----CCcccCCCCCCceecccCCccccc--
Q 017621           13 ELMNCSKLRILILGNN-LLSG----SISSEIGKLQELNYLDLSHNLINGK----IPSQLGEIPRIDTVNLSMNNLSGS--   81 (368)
Q Consensus        13 ~~~~l~~l~~l~l~~N-~~~g----~~p~~~~~~~~L~~l~l~~N~l~g~----~p~~~~~~~~l~~l~l~~n~l~g~--   81 (368)
                      .+...++|+.|+|++| .++.    .+...+...++|+.|||++|+++..    +...+...++|+.|+|++|.|+..  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            3556778888888888 7752    2344566678888888888888642    334445557888888888888742  


Q ss_pred             --cccccc---Ccccccc--cCCCccc
Q 017621           82 --IPESVK---KVPLLYV--SGNNFEV  101 (368)
Q Consensus        82 --~p~~~~---~~~~~~~--~~N~~~~  101 (368)
                        +...+.   .+..+++  ++|.+..
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCH
Confidence              233332   4666788  7777653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.93  E-value=0.00019  Score=65.02  Aligned_cols=158  Identities=12%  Similarity=0.128  Sum_probs=88.2

Q ss_pred             ccHHHHHHHhhcccc-----ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCc--ee
Q 017621          178 ITFQDMIEATEDFHI-----KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN--IV  250 (368)
Q Consensus       178 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv  250 (368)
                      ++.+++....+.|.+     ...++ |....||+....+|+.+++|.......    ..+.+..|..++..+....  ++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeec
Confidence            455666666555543     23466 778899999877777899999864321    1245566777777663222  33


Q ss_pred             eEEEE-----EeeCCeEEEEEeecCCCChh----H-------H---hhc----CC--CCCCCCHHHH-------------
Q 017621          251 KLYGF-----CLHRKCMFLIYEYMEMGSLF----C-------V---LRT----DE--EAVGLDWAKR-------------  292 (368)
Q Consensus       251 ~l~~~-----~~~~~~~~lv~e~~~~g~L~----~-------~---l~~----~~--~~~~l~~~~~-------------  292 (368)
                      +++..     ....+..+++|+|++|..+.    +       .   ++.    ..  .....++...             
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  165 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL  165 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence            44432     22345678999999875431    0       0   110    00  0001121110             


Q ss_pred             ---------HHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          293 ---------VNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       293 ---------~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                               ...+.+++..++-+-. .....++|+|+++.|||++ + .+.++||+.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                     1111222222222211 1233689999999999999 4 889999987764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.93  E-value=3e-05  Score=70.18  Aligned_cols=159  Identities=13%  Similarity=0.089  Sum_probs=87.4

Q ss_pred             ccHHHHHHHhhcccc-----ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCc--ee
Q 017621          178 ITFQDMIEATEDFHI-----KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN--IV  250 (368)
Q Consensus       178 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv  250 (368)
                      ++.+++....++|.+     .+.|+.|....+|+....++ .+++|.......     .+.+..|.+++..+....  +.
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCC
Confidence            556677777777765     24466677889999986555 578898765311     134455777766663212  23


Q ss_pred             eEEEE------EeeCCeEEEEEeecCCCChhH--------------HhhcC----CCCC----C-CCHHHHHH-------
Q 017621          251 KLYGF------CLHRKCMFLIYEYMEMGSLFC--------------VLRTD----EEAV----G-LDWAKRVN-------  294 (368)
Q Consensus       251 ~l~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~~~----~-l~~~~~~~-------  294 (368)
                      +++..      ....+..+++|+|++|..+..              .++..    ....    . ..|.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            33321      123456789999999754311              01110    0000    0 01221100       


Q ss_pred             -----HHHHHHHHHHHHhcC----CCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          295 -----IVKGMAHALSYLHHH----CTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       295 -----i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                           +...+...++++...    ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                 011234445555421    234789999999999999876667999988754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.83  E-value=8.6e-05  Score=67.57  Aligned_cols=142  Identities=20%  Similarity=0.174  Sum_probs=72.5

Q ss_pred             eeeeecCCcc-EEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC--CceeeEEEEEeeCCeEEEEEeecC
Q 017621          194 YCIGTGGYGS-VYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH--RNIVKLYGFCLHRKCMFLIYEYME  270 (368)
Q Consensus       194 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~  270 (368)
                      +.|+.|.... +|+....+++.+++|.......      +.+..|++++..+..  -.+.+++.+....+  +++||++.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~   95 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG   95 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence            3455554444 7787764467777876544321      123345666665532  23556666644443  78999997


Q ss_pred             CCChhHHhhcCC---------------------C--CCCCCHHHHH-------H-H------------HHHHHHHHHHHh
Q 017621          271 MGSLFCVLRTDE---------------------E--AVGLDWAKRV-------N-I------------VKGMAHALSYLH  307 (368)
Q Consensus       271 ~g~L~~~l~~~~---------------------~--~~~l~~~~~~-------~-i------------~~~i~~~L~~LH  307 (368)
                      +..+.+.+....                     .  ...++.....       . +            ...+...++.+.
T Consensus        96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~  175 (333)
T 3csv_A           96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL  175 (333)
T ss_dssp             SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred             CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            766644332110                     0  0001111000       0 0            001112222221


Q ss_pred             ---cCCCCCeeecCCCCCCeeecCC----CCeEEeeeccceec
Q 017621          308 ---HHCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLL  343 (368)
Q Consensus       308 ---~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFg~a~~~  343 (368)
                         ......++|+|+.+.|||++.+    +.+.|+||+.+..-
T Consensus       176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence               1123479999999999999875    67899999988653

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.75  E-value=4.2e-05  Score=69.57  Aligned_cols=81  Identities=15%  Similarity=0.245  Sum_probs=61.5

Q ss_pred             CCCCcEEEecCccccccCCc-cccCCCCCCeeeeecccccccCCcccCCCCCCc-eecccCCccccccc-cccc---Ccc
Q 017621           17 CSKLRILILGNNLLSGSISS-EIGKLQELNYLDLSHNLINGKIPSQLGEIPRID-TVNLSMNNLSGSIP-ESVK---KVP   90 (368)
Q Consensus        17 l~~l~~l~l~~N~~~g~~p~-~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~-~l~l~~n~l~g~~p-~~~~---~~~   90 (368)
                      |++|+.|+|++|+++ .||. .|..|++|+.|+|++| ++..-+.+|..|++|+ .+++++ +++ .|+ ..+.   ++.
T Consensus       225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~  300 (329)
T 3sb4_A          225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLR  300 (329)
T ss_dssp             CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEE
T ss_pred             cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCC
Confidence            788999999999998 5654 6889999999999988 7744456788899998 999987 666 343 4454   455


Q ss_pred             cccccCCCccc
Q 017621           91 LLYVSGNNFEV  101 (368)
Q Consensus        91 ~~~~~~N~~~~  101 (368)
                      .+++++|+++.
T Consensus       301 ~l~l~~n~i~~  311 (329)
T 3sb4_A          301 YVLATGDKITT  311 (329)
T ss_dssp             EEEECSSCCCE
T ss_pred             EEEeCCCccCc
Confidence            67787787654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.70  E-value=0.00014  Score=67.42  Aligned_cols=141  Identities=19%  Similarity=0.221  Sum_probs=81.5

Q ss_pred             eeeeecCCccEEEEEcC--------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeEEE
Q 017621          194 YCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  264 (368)
                      +.+..|-...+|++...        +++.+++|+.....    .....+.+|.++++.+. +.-..++++++.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            45666778899999864        24789999864321    12345668999888873 3333567766653    28


Q ss_pred             EEeecCCCChhHH-----------------hhcCCC--CCCC--CHHHHHHHHHHHHH-------------------HHH
Q 017621          265 IYEYMEMGSLFCV-----------------LRTDEE--AVGL--DWAKRVNIVKGMAH-------------------ALS  304 (368)
Q Consensus       265 v~e~~~~g~L~~~-----------------l~~~~~--~~~l--~~~~~~~i~~~i~~-------------------~L~  304 (368)
                      ||||++|..+..-                 ++....  ....  -+.+..++..++..                   .++
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999998654310                 011110  1111  23444444443321                   223


Q ss_pred             HH----hcC-CCCCeeecCCCCCCeeecCC----CCeEEeeecccee
Q 017621          305 YL----HHH-CTPPIVHRDISSNNVLLNSE----LEAFVADFGVARL  342 (368)
Q Consensus       305 ~L----H~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DFg~a~~  342 (368)
                      +|    ... ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33    221 12368999999999999876    7899999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.67  E-value=0.00013  Score=65.35  Aligned_cols=71  Identities=14%  Similarity=0.081  Sum_probs=43.1

Q ss_pred             ceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCce-eeEEEEEeeCCeEEEEEeec-C
Q 017621          193 KYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI-VKLYGFCLHRKCMFLIYEYM-E  270 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~  270 (368)
                      .+.|+.|....+|+.     +.+++|+....... .   ....+|..+++.+....+ .+++++.  .+.-++++||+ +
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~---~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-Y---INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----C---CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-e---eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            677888999999999     45888877643211 0   112457777766632222 4555543  33347899999 6


Q ss_pred             CCCh
Q 017621          271 MGSL  274 (368)
Q Consensus       271 ~g~L  274 (368)
                      +.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            5444

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.66  E-value=0.00013  Score=69.00  Aligned_cols=73  Identities=23%  Similarity=0.272  Sum_probs=48.2

Q ss_pred             ceeeeecCCccEEEEEcCC--------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCce-eeEEEEEeeCCeEE
Q 017621          193 KYCIGTGGYGSVYRARLPS--------GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI-VKLYGFCLHRKCMF  263 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~  263 (368)
                      .+.|+.|-...+|++...+        ++.+++|+......     .+.+.+|..+++.+...++ .++++.+.+    .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence            3567778888999998643        57899998743211     1344568888888743333 567766542    2


Q ss_pred             EEEeecCCCCh
Q 017621          264 LIYEYMEMGSL  274 (368)
Q Consensus       264 lv~e~~~~g~L  274 (368)
                      +|+||++|.++
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            89999986443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.60  E-value=3.8e-06  Score=82.71  Aligned_cols=97  Identities=13%  Similarity=0.189  Sum_probs=51.8

Q ss_pred             CCCccccCCcccc-CCCCCcEEEec--C----ccccc-----cCCccccCCCCCCeeeeecccccccCCcccCC-CCCCc
Q 017621            3 NNKLDGPIPQELM-NCSKLRILILG--N----NLLSG-----SISSEIGKLQELNYLDLSHNLINGKIPSQLGE-IPRID   69 (368)
Q Consensus         3 ~n~l~g~~p~~~~-~l~~l~~l~l~--~----N~~~g-----~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~-~~~l~   69 (368)
                      +|.+++..+..+. ++++|+.|+|+  +    |++++     .++.-+..+++|+.|+|++ ++++..+..++. +++|+
T Consensus       381 ~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~  459 (594)
T 2p1m_B          381 CRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKME  459 (594)
T ss_dssp             ESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCC
T ss_pred             cCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhcc
Confidence            3455554444444 46667777776  3    45541     1112245566666666655 555554444444 56666


Q ss_pred             eecccCCccccccccc----ccCcccccccCCCcc
Q 017621           70 TVNLSMNNLSGSIPES----VKKVPLLYVSGNNFE  100 (368)
Q Consensus        70 ~l~l~~n~l~g~~p~~----~~~~~~~~~~~N~~~  100 (368)
                      .|+|++|.+++..+..    +.++..+++++|.++
T Consensus       460 ~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~  494 (594)
T 2p1m_B          460 MLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG  494 (594)
T ss_dssp             EEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred             EeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence            6666666665443322    234555666666653

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.51  E-value=0.00011  Score=57.12  Aligned_cols=57  Identities=21%  Similarity=0.290  Sum_probs=44.3

Q ss_pred             cEEEecCcccc-ccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621           21 RILILGNNLLS-GSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus        21 ~~l~l~~N~~~-g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      ..++.+++.|+ ..+|..+.  ++|+.|||++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            58899999986 46776543  36899999999999544456788889999999988874

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.50  E-value=7.7e-06  Score=68.04  Aligned_cols=100  Identities=10%  Similarity=0.139  Sum_probs=73.9

Q ss_pred             CCCC-Ccccc----CCccccCCCCCcEEEecCccccc----cCCccccCCCCCCeeeeeccccccc----CCcccCCCCC
Q 017621            1 MYNN-KLDGP----IPQELMNCSKLRILILGNNLLSG----SISSEIGKLQELNYLDLSHNLINGK----IPSQLGEIPR   67 (368)
Q Consensus         1 l~~n-~l~g~----~p~~~~~l~~l~~l~l~~N~~~g----~~p~~~~~~~~L~~l~l~~N~l~g~----~p~~~~~~~~   67 (368)
                      |++| .++..    +...+...++|+.|+|++|+++.    .+...+...++|+.|+|++|.++..    +...+...++
T Consensus        43 L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~  122 (185)
T 1io0_A           43 LNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTS  122 (185)
T ss_dssp             CTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSS
T ss_pred             ecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCC
Confidence            4556 55532    33456677899999999999963    2344566778999999999999864    5667788899


Q ss_pred             Cceecc--cCCcccccc----cccc---cCcccccccCCCcc
Q 017621           68 IDTVNL--SMNNLSGSI----PESV---KKVPLLYVSGNNFE  100 (368)
Q Consensus        68 l~~l~l--~~n~l~g~~----p~~~---~~~~~~~~~~N~~~  100 (368)
                      |+.|+|  ++|.|+..-    .+.+   ..+..+++++|.+.
T Consensus       123 L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          123 LIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             CCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             ceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            999999  889997432    2222   35777899999864

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.47  E-value=1.2e-05  Score=79.16  Aligned_cols=65  Identities=11%  Similarity=0.149  Sum_probs=36.3

Q ss_pred             CCCCCcEEEecCccccccCCcccc-CCCCCCeeeeecc-ccccc-CCcccCCCCCCceecccCCcccc
Q 017621           16 NCSKLRILILGNNLLSGSISSEIG-KLQELNYLDLSHN-LINGK-IPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus        16 ~l~~l~~l~l~~N~~~g~~p~~~~-~~~~L~~l~l~~N-~l~g~-~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      .+++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+..+++|+.|++++|.+++
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~  170 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDD  170 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEEC
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCC
Confidence            455666666666666655555554 4666666666666 34322 33333455666666666666554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.36  E-value=0.00033  Score=63.57  Aligned_cols=86  Identities=10%  Similarity=-0.030  Sum_probs=60.7

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCC-eeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELN-YLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~-~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|+++..-+..+.+|++|+.|+|++| ++..=+..|.+|++|+ .++|++ +++-.-+.+|..|++|+.+++++|+++
T Consensus       233 L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~  310 (329)
T 3sb4_A          233 ISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT  310 (329)
T ss_dssp             CTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC
T ss_pred             CCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC
Confidence            4566777544456788888888888887 6633334678888888 888888 676444577888888888888888887


Q ss_pred             ccccccccC
Q 017621           80 GSIPESVKK   88 (368)
Q Consensus        80 g~~p~~~~~   88 (368)
                      ..-+..+..
T Consensus       311 ~I~~~aF~~  319 (329)
T 3sb4_A          311 TLGDELFGN  319 (329)
T ss_dssp             EECTTTTCT
T ss_pred             ccchhhhcC
Confidence            332334443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.36  E-value=0.00021  Score=55.63  Aligned_cols=51  Identities=20%  Similarity=0.236  Sum_probs=41.3

Q ss_pred             CCCCcc-ccCCccccCCCCCcEEEecCccccccCCc-cccCCCCCCeeeeeccccc
Q 017621            2 YNNKLD-GPIPQELMNCSKLRILILGNNLLSGSISS-EIGKLQELNYLDLSHNLIN   55 (368)
Q Consensus         2 ~~n~l~-g~~p~~~~~l~~l~~l~l~~N~~~g~~p~-~~~~~~~L~~l~l~~N~l~   55 (368)
                      ++++|+ ..+|..+.  ++|+.|+|++|+|+ .||. .|..+++|+.|+|++|.+.
T Consensus        16 s~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           16 GRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             CSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            567776 45886654  47999999999998 5665 5789999999999999775

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.32  E-value=0.00054  Score=65.15  Aligned_cols=74  Identities=19%  Similarity=0.192  Sum_probs=46.1

Q ss_pred             ceeeeecCCccEEEEEcCC-CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCce-eeEEEEEeeCCeEEEEEeecC
Q 017621          193 KYCIGTGGYGSVYRARLPS-GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI-VKLYGFCLHRKCMFLIYEYME  270 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~  270 (368)
                      .+.|+.|-...+|++...+ +..+++|+.......   .. ...+|..++..+...++ .++++++.  +  .+||||++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~  184 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD  184 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence            4567778888999998754 477888887442211   00 12468888888854444 56777663  2  25999998


Q ss_pred             CCCh
Q 017621          271 MGSL  274 (368)
Q Consensus       271 ~g~L  274 (368)
                      |.++
T Consensus       185 G~~l  188 (458)
T 2qg7_A          185 GYAL  188 (458)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            7544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.31  E-value=0.00043  Score=63.92  Aligned_cols=74  Identities=15%  Similarity=0.053  Sum_probs=43.4

Q ss_pred             ceeeeecCCccEEEEEcCC---------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCc-eeeEEEEEeeCCeE
Q 017621          193 KYCIGTGGYGSVYRARLPS---------GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN-IVKLYGFCLHRKCM  262 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~  262 (368)
                      .+.++.|....+|+....+         ++.+++|+.......    ......|.++++.+...+ ..++++..  .  -
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--N--G  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence            3457778888999998643         268888987543211    112356777777774333 44666544  2  2


Q ss_pred             EEEEeecCCCCh
Q 017621          263 FLIYEYMEMGSL  274 (368)
Q Consensus       263 ~lv~e~~~~g~L  274 (368)
                      ++||||++|..+
T Consensus       110 ~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 GRIEEWLYGDPL  121 (369)
T ss_dssp             EEEEECCCSEEC
T ss_pred             cEEEEEecCCcC
Confidence            689999987543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.23  E-value=4.2e-05  Score=70.57  Aligned_cols=85  Identities=13%  Similarity=0.237  Sum_probs=61.0

Q ss_pred             CCCCCcEEEecC--cccccc-----CCccc--cCCCCCCeeeeecccccccCCcccC---CCCCCceecccCCccccc--
Q 017621           16 NCSKLRILILGN--NLLSGS-----ISSEI--GKLQELNYLDLSHNLINGKIPSQLG---EIPRIDTVNLSMNNLSGS--   81 (368)
Q Consensus        16 ~l~~l~~l~l~~--N~~~g~-----~p~~~--~~~~~L~~l~l~~N~l~g~~p~~~~---~~~~l~~l~l~~n~l~g~--   81 (368)
                      .+++|+.|+|+.  |...|.     +...+  ..+++|+.|+|++|.++...+..+.   .+++|+.|+|+.|.|++.  
T Consensus       217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~  296 (362)
T 2ra8_A          217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA  296 (362)
T ss_dssp             BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred             cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence            689999999964  332222     11122  3589999999999999866554443   578999999999999863  


Q ss_pred             --ccc---cccCcccccccCCCcc
Q 017621           82 --IPE---SVKKVPLLYVSGNNFE  100 (368)
Q Consensus        82 --~p~---~~~~~~~~~~~~N~~~  100 (368)
                        ++.   .+..+..++++.|.++
T Consensus       297 ~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          297 RLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             HHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             HHHHhhcccCCcceEEECCCCcCC
Confidence              333   3456778999988765

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.15  E-value=0.001  Score=60.75  Aligned_cols=32  Identities=28%  Similarity=0.454  Sum_probs=28.1

Q ss_pred             CCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          312 PPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       312 ~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      ..++|+|+.+.||++++++.+.++||+.+..-
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            47899999999999998888999999887653

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.07  E-value=9.9e-05  Score=68.08  Aligned_cols=86  Identities=15%  Similarity=0.111  Sum_probs=60.8

Q ss_pred             CCCCcEEEecCccccccCCcccc--CCCCCCeeeeec--ccccccC-----Cccc--CCCCCCceecccCCcccccccc-
Q 017621           17 CSKLRILILGNNLLSGSISSEIG--KLQELNYLDLSH--NLINGKI-----PSQL--GEIPRIDTVNLSMNNLSGSIPE-   84 (368)
Q Consensus        17 l~~l~~l~l~~N~~~g~~p~~~~--~~~~L~~l~l~~--N~l~g~~-----p~~~--~~~~~l~~l~l~~n~l~g~~p~-   84 (368)
                      +++|+.|+|..+.++......++  .+|+|+.|+|+.  |+..|..     ...+  ..+++|+.|+|++|.++...+. 
T Consensus       192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~  271 (362)
T 2ra8_A          192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM  271 (362)
T ss_dssp             CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred             CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence            78999999999888654334454  799999999974  3332221     1122  3579999999999999854433 


Q ss_pred             -----cccCcccccccCCCcccc
Q 017621           85 -----SVKKVPLLYVSGNNFEVE  102 (368)
Q Consensus        85 -----~~~~~~~~~~~~N~~~~~  102 (368)
                           .+.++..++++.|.+...
T Consensus       272 la~a~~~~~L~~LdLs~n~L~d~  294 (362)
T 2ra8_A          272 FLESDILPQLETMDISAGVLTDE  294 (362)
T ss_dssp             HHHCSSGGGCSEEECCSSCCBHH
T ss_pred             HHhCccCCCCCEEECCCCCCChH
Confidence                 234677899999988753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.54  E-value=0.0048  Score=57.93  Aligned_cols=74  Identities=8%  Similarity=-0.027  Sum_probs=46.6

Q ss_pred             ceeeeecCCccEEEEEcCC--------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeEE
Q 017621          193 KYCIGTGGYGSVYRARLPS--------GKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  263 (368)
                      .+.+..|-...+|+....+        ++.+++|+.......   . -...+|.++++.+. +.-..++++.+  .  -+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~  146 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---F-YDSKVELDVFRYLSNINIAPNIIADF--P--EG  146 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---C-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---h-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CC
Confidence            3556667788999998653        578999987543211   1 12246788877773 33345566543  2  26


Q ss_pred             EEEeecCCCCh
Q 017621          264 LIYEYMEMGSL  274 (368)
Q Consensus       264 lv~e~~~~g~L  274 (368)
                      +||||++|..+
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998654

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=96.44  E-value=0.0094  Score=55.59  Aligned_cols=85  Identities=12%  Similarity=0.152  Sum_probs=47.1

Q ss_pred             ccccCCCCCcEEEecCcccc-----ccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccccc-cc
Q 017621           12 QELMNCSKLRILILGNNLLS-----GSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIP-ES   85 (368)
Q Consensus        12 ~~~~~l~~l~~l~l~~N~~~-----g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p-~~   85 (368)
                      ..+.+|++|+.++|.+|.++     -.-+..|..|++|+.++|. |+++-.-..+|..|++|+.+.+.+| ++ .|+ ..
T Consensus       265 ~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~a  341 (401)
T 4fdw_A          265 RAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSA  341 (401)
T ss_dssp             TTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTTS
T ss_pred             hHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHh
Confidence            34566667777777666654     1222456667777777776 3355233345666677777777443 43 222 22


Q ss_pred             cc--CcccccccCCCc
Q 017621           86 VK--KVPLLYVSGNNF   99 (368)
Q Consensus        86 ~~--~~~~~~~~~N~~   99 (368)
                      +.  ++..+.+++|..
T Consensus       342 F~~~~L~~l~l~~n~~  357 (401)
T 4fdw_A          342 FNNTGIKEVKVEGTTP  357 (401)
T ss_dssp             SSSSCCCEEEECCSSC
T ss_pred             CCCCCCCEEEEcCCCC
Confidence            22  455566666654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.11  E-value=0.00091  Score=54.63  Aligned_cols=88  Identities=11%  Similarity=0.158  Sum_probs=57.7

Q ss_pred             CCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecc-cccccCCcccCCC----CCCceecccCC-ccccccc
Q 017621           10 IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHN-LINGKIPSQLGEI----PRIDTVNLSMN-NLSGSIP   83 (368)
Q Consensus        10 ~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N-~l~g~~p~~~~~~----~~l~~l~l~~n-~l~g~~p   83 (368)
                      +|.....--+|+.|||+++.++..=-..+..|++|+.|+|+++ ++|-.==..++.+    ++|+.|+|+++ ++|-.==
T Consensus        53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl  132 (176)
T 3e4g_A           53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI  132 (176)
T ss_dssp             SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred             CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence            4543222236999999999987433346789999999999998 4664333344443    47999999987 5763111


Q ss_pred             ---ccccCcccccccCC
Q 017621           84 ---ESVKKVPLLYVSGN   97 (368)
Q Consensus        84 ---~~~~~~~~~~~~~N   97 (368)
                         ..+.++..+++++-
T Consensus       133 ~~L~~~~~L~~L~L~~c  149 (176)
T 3e4g_A          133 IALHHFRNLKYLFLSDL  149 (176)
T ss_dssp             HHGGGCTTCCEEEEESC
T ss_pred             HHHhcCCCCCEEECCCC
Confidence               12345666777654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=95.44  E-value=0.0049  Score=50.26  Aligned_cols=45  Identities=7%  Similarity=0.063  Sum_probs=24.9

Q ss_pred             CccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCC-ccc
Q 017621           35 SSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMN-NLS   79 (368)
Q Consensus        35 p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n-~l~   79 (368)
                      |.....-.+|+.||||++.++-.=-..+..|++|+.|+|+++ ++|
T Consensus        54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~It   99 (176)
T 3e4g_A           54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIE   99 (176)
T ss_dssp             CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCC
T ss_pred             CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccC
Confidence            443322345667777666655332334556666677777666 354

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.09  E-value=0.069  Score=49.65  Aligned_cols=29  Identities=24%  Similarity=0.468  Sum_probs=24.7

Q ss_pred             eeecCCCCCCeee------cCCCCeEEeeecccee
Q 017621          314 IVHRDISSNNVLL------NSELEAFVADFGVARL  342 (368)
Q Consensus       314 ivH~Dlkp~NIll------~~~~~~kl~DFg~a~~  342 (368)
                      ++|+|+.+.|||+      +++..++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      3456799999998864

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=94.79  E-value=0.058  Score=50.17  Aligned_cols=65  Identities=17%  Similarity=0.232  Sum_probs=53.2

Q ss_pred             CccccCCCCCcEEEecCccccccCC-ccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621           11 PQELMNCSKLRILILGNNLLSGSIS-SEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus        11 p~~~~~l~~l~~l~l~~N~~~g~~p-~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      +..+.+|++|+.++|.+ +++ .|+ ..|.+|++|+.++|..| ++-.-+.+|..| +|+.+.+++|.+.
T Consensus       293 ~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~  358 (401)
T 4fdw_A          293 PYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP  358 (401)
T ss_dssp             TTTTTTCTTCCEECCCT-TCC-EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC
T ss_pred             HHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc
Confidence            35688999999999994 576 444 57899999999999666 664456788899 9999999999876

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=94.08  E-value=0.012  Score=48.78  Aligned_cols=83  Identities=13%  Similarity=0.183  Sum_probs=55.6

Q ss_pred             cCCCCCcEEEecCc-cccc----cCCccccCCCCCCeeeeecccccccCCc----ccCCCCCCceecccCCccccccc--
Q 017621           15 MNCSKLRILILGNN-LLSG----SISSEIGKLQELNYLDLSHNLINGKIPS----QLGEIPRIDTVNLSMNNLSGSIP--   83 (368)
Q Consensus        15 ~~l~~l~~l~l~~N-~~~g----~~p~~~~~~~~L~~l~l~~N~l~g~~p~----~~~~~~~l~~l~l~~n~l~g~~p--   83 (368)
                      .+-+.|+.|+|++| ++..    .|-..+..-+.|+.|+|++|+++-.--.    .|..-+.|+.|+|+.|.|+..--  
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a  117 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR  117 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence            45578999999986 7741    1334566677899999999999833222    33344789999999999974211  


Q ss_pred             --ccc---cCcccccccCC
Q 017621           84 --ESV---KKVPLLYVSGN   97 (368)
Q Consensus        84 --~~~---~~~~~~~~~~N   97 (368)
                        +.+   ..+..+++++|
T Consensus       118 la~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          118 LLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHhhCCceeEEECCCC
Confidence              122   13566777654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.57  E-value=0.19  Score=42.02  Aligned_cols=90  Identities=4%  Similarity=0.089  Sum_probs=65.4

Q ss_pred             cCCCceeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCC
Q 017621          244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNN  323 (368)
Q Consensus       244 l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  323 (368)
                      -.||+++.. .+-.+.+.+.+.++.-+.+.=+..++.      ++...+++++.+|+...++++++     +|--+.|+|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~------~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N  109 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS------FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE  109 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG------SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh------cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence            358888866 466666766666665443222222332      77889999999999888777655     788999999


Q ss_pred             eeecCCCCeEEeeeccceecCC
Q 017621          324 VLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       324 Ill~~~~~~kl~DFg~a~~~~~  345 (368)
                      |+++.++.+++.-.|+-..+.+
T Consensus       110 L~f~~~~~p~i~~RGik~~l~P  131 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVDP  131 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBSC
T ss_pred             EEEcCCCCEEEEEccCccCCCC
Confidence            9999999999999998655443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=93.44  E-value=0.38  Score=40.39  Aligned_cols=88  Identities=14%  Similarity=0.130  Sum_probs=64.1

Q ss_pred             CCCceeeEEEEEeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeeecCCCCCC
Q 017621          245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS-YLHHHCTPPIVHRDISSNN  323 (368)
Q Consensus       245 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlkp~N  323 (368)
                      .||++  -...-.+++.+.+.++.-+++.-+..++.      ++..++++++.+|+.... +++.+     +|--+.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCce
Confidence            57887  34444667777777776544433344432      778889999999888776 56544     788899999


Q ss_pred             eeecCCCCeEEeeeccceecCC
Q 017621          324 VLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       324 Ill~~~~~~kl~DFg~a~~~~~  345 (368)
                      |++|.++.+++.-.|+-..+.+
T Consensus       115 L~f~~~~~p~i~hRGi~~~lpP  136 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESLPP  136 (219)
T ss_dssp             EEECTTCCEEESCCEETTTBSS
T ss_pred             EEEeCCCcEEEEEcCCcccCCC
Confidence            9999999999999998655543

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=92.35  E-value=0.066  Score=32.26  Aligned_cols=13  Identities=15%  Similarity=0.197  Sum_probs=5.2

Q ss_pred             HHHHHhhhhhhcc
Q 017621          139 LIFGILFVRRRRD  151 (368)
Q Consensus       139 ~i~~~~~~~rrr~  151 (368)
                      ++.+++++.|||+
T Consensus        26 i~~~~~~~~RRRr   38 (44)
T 2l2t_A           26 VGLTFAVYVRRKS   38 (44)
T ss_dssp             HHHHHHHHHHTTC
T ss_pred             HHHHHHHHhhhhh
Confidence            3334344444433

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=92.30  E-value=0.19  Score=46.33  Aligned_cols=81  Identities=16%  Similarity=0.358  Sum_probs=51.6

Q ss_pred             cccCCCCCcEEEecCccccccCC-ccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccccc-ccc---
Q 017621           13 ELMNCSKLRILILGNNLLSGSIS-SEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPE-SVK---   87 (368)
Q Consensus        13 ~~~~l~~l~~l~l~~N~~~g~~p-~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~-~~~---   87 (368)
                      .+.+|++|+.+.+. +.++ .|+ ..|.+|.+|+.++|..| ++-.-..+|..|.+|+.+.+..+ ++ .|.. .+.   
T Consensus       283 aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~  357 (394)
T 4gt6_A          283 AFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCT  357 (394)
T ss_dssp             TTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCT
T ss_pred             ccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCC
Confidence            45677888888886 4454 344 46788888888888765 55233456778888888888644 54 3432 333   


Q ss_pred             CcccccccCCC
Q 017621           88 KVPLLYVSGNN   98 (368)
Q Consensus        88 ~~~~~~~~~N~   98 (368)
                      +|..+.+.+|.
T Consensus       358 ~L~~i~~~~~~  368 (394)
T 4gt6_A          358 ALNNIEYSGSR  368 (394)
T ss_dssp             TCCEEEESSCH
T ss_pred             CCCEEEECCce
Confidence            45556666654

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=91.93  E-value=0.079  Score=31.98  Aligned_cols=13  Identities=38%  Similarity=0.618  Sum_probs=5.2

Q ss_pred             HHHHHhhhhhhcc
Q 017621          139 LIFGILFVRRRRD  151 (368)
Q Consensus       139 ~i~~~~~~~rrr~  151 (368)
                      ++++++++.|||+
T Consensus        27 i~~~~~~~~RRr~   39 (44)
T 2ks1_B           27 VALGIGLFMRRRH   39 (44)
T ss_dssp             HHHHHHHHHHTTT
T ss_pred             HHHHHHHHhhhhH
Confidence            3334344444433

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=90.86  E-value=0.079  Score=43.90  Aligned_cols=63  Identities=14%  Similarity=0.150  Sum_probs=45.9

Q ss_pred             ccCCCCCcEEEecCccccc----cCCccccCCCCCCeeeeecccccccCC----cccCCCCCCceecccCC
Q 017621           14 LMNCSKLRILILGNNLLSG----SISSEIGKLQELNYLDLSHNLINGKIP----SQLGEIPRIDTVNLSMN   76 (368)
Q Consensus        14 ~~~l~~l~~l~l~~N~~~g----~~p~~~~~~~~L~~l~l~~N~l~g~~p----~~~~~~~~l~~l~l~~n   76 (368)
                      |..-+.|+.|+|++|++..    .|...+..=+.|+.|+|+.|+++..=-    +.+..-+.|+.|+|++|
T Consensus        66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A           66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence            4455689999999999972    222334456789999999999984322    23444568999999976

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=90.84  E-value=0.4  Score=43.79  Aligned_cols=64  Identities=17%  Similarity=0.262  Sum_probs=46.8

Q ss_pred             cccCCCCCcEEEecCccccccCC-ccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621           13 ELMNCSKLRILILGNNLLSGSIS-SEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus        13 ~~~~l~~l~~l~l~~N~~~g~~p-~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      .+.++.+|+.+.+..+ ++ .|+ ..|..|++|+.+++.+|.++-.-..+|.+|.+|+.+.+..+ ++
T Consensus       258 aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~  322 (379)
T 4h09_A          258 LLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK  322 (379)
T ss_dssp             TTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC
T ss_pred             ccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc
Confidence            4567788898888755 44 344 46788999999999888888333457888889998888644 44

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=90.63  E-value=0.27  Score=45.34  Aligned_cols=62  Identities=18%  Similarity=0.307  Sum_probs=46.6

Q ss_pred             cccCCCCCcEEEecCccccccCC-ccccCCCCCCeeeeecccccccC-CcccCCCCCCceecccCCccc
Q 017621           13 ELMNCSKLRILILGNNLLSGSIS-SEIGKLQELNYLDLSHNLINGKI-PSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus        13 ~~~~l~~l~~l~l~~N~~~g~~p-~~~~~~~~L~~l~l~~N~l~g~~-p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      .+.++++|+.+.+.+| ++ .|+ ..|.+|++|+.++|.++ ++ .| ..+|.+|++|+.+.+..| ++
T Consensus       292 ~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~  355 (394)
T 4fs7_A          292 TFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR  355 (394)
T ss_dssp             TTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC
T ss_pred             cccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc
Confidence            4567889999999765 55 443 46888999999999755 66 44 457888999999988766 55

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=90.22  E-value=0.12  Score=31.05  Aligned_cols=9  Identities=22%  Similarity=0.663  Sum_probs=3.6

Q ss_pred             Hhhhhhhcc
Q 017621          143 ILFVRRRRD  151 (368)
Q Consensus       143 ~~~~~rrr~  151 (368)
                      ++++||||.
T Consensus        32 ~~~~RRR~~   40 (44)
T 2jwa_A           32 GILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHCS
T ss_pred             Hhheehhhh
Confidence            334444433

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.27  E-value=0.064  Score=50.93  Aligned_cols=62  Identities=18%  Similarity=0.115  Sum_probs=17.4

Q ss_pred             ceeeeecCCccEEEEEcCC-CCEEEE------EEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee
Q 017621          193 KYCIGTGGYGSVYRARLPS-GKVVAL------KKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH  258 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  258 (368)
                      .+.+|   ||.||+|.+.. ...||+      |..+..... ......+.+|..++...+|||+++.+++...
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~-~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS-EKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCcccccccccc-ccccccccccccccccccccccCCCcceEEe
Confidence            45565   99999998753 357888      665543322 2234568889999999999999999887653

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=85.01  E-value=1.7  Score=39.48  Aligned_cols=69  Identities=9%  Similarity=0.075  Sum_probs=50.7

Q ss_pred             ccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccccc
Q 017621           12 QELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIP   83 (368)
Q Consensus        12 ~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p   83 (368)
                      ..+.++++|+.+.+..+ ++..=...|..+.+|+.+.+..+ ++-.-...+..|++|+.+.+.+|.++ .|+
T Consensus       234 ~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~  302 (379)
T 4h09_A          234 GAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLE  302 (379)
T ss_dssp             TTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EEC
T ss_pred             ccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccc-eeh
Confidence            34667889999999876 54232456788999999998755 55233356788999999999888887 444

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=84.61  E-value=1  Score=41.38  Aligned_cols=64  Identities=14%  Similarity=0.351  Sum_probs=51.2

Q ss_pred             ccccCCCCCcEEEecCccccccC-CccccCCCCCCeeeeecccccccCC-cccCCCCCCceecccCCccc
Q 017621           12 QELMNCSKLRILILGNNLLSGSI-SSEIGKLQELNYLDLSHNLINGKIP-SQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus        12 ~~~~~l~~l~~l~l~~N~~~g~~-p~~~~~~~~L~~l~l~~N~l~g~~p-~~~~~~~~l~~l~l~~n~l~   79 (368)
                      ..+.+|++|+.++|..| ++ .| ...|.+|.+|+.+.|..| ++ .|+ .+|.+|++|+.+++++|...
T Consensus       305 ~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~  370 (394)
T 4gt6_A          305 SVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQ  370 (394)
T ss_dssp             TTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHHH
T ss_pred             eeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCceee
Confidence            45778999999999875 55 44 457899999999999765 66 554 57899999999999987653

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=82.70  E-value=2.3  Score=38.87  Aligned_cols=63  Identities=14%  Similarity=0.215  Sum_probs=46.0

Q ss_pred             ccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621           12 QELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus        12 ~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      ..+.++..|+.+.+..+.+.   ...|..+.+|+.+.+.+| ++-.=..++..|++|+.+++.++ ++
T Consensus       270 ~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~  332 (394)
T 4fs7_A          270 SLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE  332 (394)
T ss_dssp             CTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC
T ss_pred             cccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc
Confidence            34667888888888877643   346788999999999766 55233456888999999998744 54

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	368
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-46
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-46
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-43
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-42
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-41
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-41
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-40
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-40
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-40
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-39
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-38
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-38
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-37
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-36
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-36
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-36
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-34
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-33
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-33
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-30
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-27
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-21
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-04
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.002
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.001
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.001

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 3e-46
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 10/178 (5%)

Query: 186 ATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQI 244
             +DF     +G G  G V++    PSG V+A K +H      +        E ++L + 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHEC 61

Query: 245 WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALS 304
               IV  YG       + +  E+M+ GSL  VL+   +A  +       +   +   L+
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLT 118

Query: 305 YLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           YL       I+HRD+  +N+L+NS  E  + DFGV+  L    S      GT  Y++P
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSP 172

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 3e-46
 Identities = 61/176 (34%), Positives = 92/176 (52%), Gaps = 9/176 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF I   +G G +G+VY AR   S  ++ALK L +++ E+       R E  + S + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NI++LYG+      ++LI EY  +G+++  L+        D  +    +  +A+ALSY 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H      ++HRDI   N+LL S  E  +ADFG +      SS RT L GT  Y+ P
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPP 173

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 4e-46
 Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 7/181 (3%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ED+ + Y IGTG YG   + R    GK++  K+L      E A  +   +E  LL ++ H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 62

Query: 247 RNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVG-LDWAKRVNIVKGMAHAL 303
            NIV+ Y   + R    ++++ EY E G L  V+    +    LD    + ++  +  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 304 SYLHHH--CTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
              H        ++HRD+   NV L+ +    + DFG+AR+LN D+S      GT  Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 362 P 362
           P
Sbjct: 183 P 183

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 5e-46
 Identities = 48/177 (27%), Positives = 89/177 (50%), Gaps = 11/177 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
               +   IG+G +G+VY+ +      VA+K L+ +       L++F+NE  +L +  H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHV 64

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NI+   G+      + ++ ++ E  SL+  L   E     +  K ++I +  A  + YLH
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLH 121

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
                 I+HRD+ SNN+ L+ +L   + DFG+A + +  S +     L+G+  ++AP
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 7e-46
 Identities = 46/176 (26%), Positives = 83/176 (47%), Gaps = 10/176 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   +   +G G +G V+         VA+K L +         ++F  EA L+ Q+ H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY        +++I EYME GSL   L+     + L   K +++   +A  ++++ 
Sbjct: 69  RLVRLYAVVTQEP-IYIITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-RTLLAGTSGYIAP 362
                  +HRD+ + N+L++  L   +ADFG+ARL+  +    R        + AP
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (384), Expect = 6e-44
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 11/177 (6%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            + F     IG G +G+VY AR + + +VVA+KK+  S  +     +    E R L ++ 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H N ++  G  L     +L+ EY    +   +    +    L   +   +  G    L+Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAY 130

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH H    ++HRD+ + N+LL+      + DFG A ++   +S      GT  ++AP
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAP 180

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-43
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 11/178 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           ED+ +   +G G YG V  A    + + VA+K +      +    E+ + E  +   + H
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 62

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            N+VK YG        +L  EY   G LF  +  D    G+           +   + YL
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYL 119

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           H      I HRDI   N+LL+      ++DFG+A +  +++  R L  + GT  Y+AP
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 3e-43
 Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 10/176 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           +D      +GTG +G V   +      VA+K +      E    + F  EA+++  + H 
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHE 59

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LYG C  ++ +F+I EYM  G L   LR           + + + K +  A+ YL 
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 117

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGYIAP 362
                  +HRD+++ N L+N +    V+DFG++R +  D    ++       +  P
Sbjct: 118 SKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-42
 Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 9/177 (5%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            + + I   +G G +G VY+A+   +  + A K +     EEL   E +  E  +L+   
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCD 67

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H NIVKL     +   ++++ E+   G++  V+   E    L  ++   + K    AL+Y
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNY 125

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH +    I+HRD+ + N+L   + +  +ADFGV+         R    GT  ++AP
Sbjct: 126 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 179

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 9e-42
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 10/176 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E   ++  +G G +G V+         VA+K L           E+F  EA+++ ++ H 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LY      + ++++ EYM  GSL   L+  E    L   + V++   +A  ++Y+ 
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD-SSNRTLLAGTSGYIAP 362
                  VHRD+ + N+L+   L   VADFG+ARL+  +  + R        + AP
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  146 bits (368), Expect = 1e-41
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 25/202 (12%)

Query: 179 TFQDMIEATEDFH---------IKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSET 225
           TF+D  EA  +F          I+  IG G +G V    L         VA+K L    T
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 226 EELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAV 285
           E+      F +EA ++ Q  H N++ L G       + +I E+ME GSL   LR ++   
Sbjct: 68  EK--QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125

Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
                + V +++G+A  + YL        VHRD+++ N+L+NS L   V+DFG++R L  
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 346 DSSNRTLLA-----GTSGYIAP 362
           D+S+ T  +         + AP
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAP 202

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 7e-41
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 14/176 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           ++  +   IG G +G V       G  VA+K +    T +     +F  EA +++Q+ H 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHS 60

Query: 248 NIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
           N+V+L G  +  K  ++++ EYM  GSL   LR+   +V L     +     +  A+ YL
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 119

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
             +     VHRD+++ NVL++ +  A V+DFG+ +     SS +        + AP
Sbjct: 120 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAP 169

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 1e-40
 Identities = 41/176 (23%), Positives = 76/176 (43%), Gaps = 10/176 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
            +      IG+G +G V+     +   VA+K +      E    E F  EA ++ ++ H 
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +V+LYG CL +  + L++E+ME G L   LRT            + +   +      + 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEG---MA 115

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL-LAGTSGYIAP 362
           +     ++HRD+++ N L+       V+DFG+ R +  D    +        + +P
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-40
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 9/178 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           EDF     +G G + +V  AR L + +  A+K L +    +   +     E  ++S++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
              VKLY      + ++    Y + G L   +R        D          +  AL YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYL 124

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYIAP 362
           H      I+HRD+   N+LLN ++   + DFG A++L+ +S         GT+ Y++P
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 3e-40
 Identities = 45/177 (25%), Positives = 86/177 (48%), Gaps = 11/177 (6%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            + +     IG G  G+VY A  + +G+ VA+++++  +  +    E   NE  ++ +  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENK 75

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           + NIV      L    ++++ EY+  GSL  V+        +D  +   + +    AL +
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEF 131

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH +    ++HRDI S+N+LL  +    + DFG    +  + S R+ + GT  ++AP
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 4e-40
 Identities = 48/204 (23%), Positives = 81/204 (39%), Gaps = 34/204 (16%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASLESFRNEARLL 241
           E+      +G+G +G V  A             VA+K L           E+  +E +++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 94

Query: 242 SQIW-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRT-------------------- 280
           +Q+  H NIV L G C     ++LI+EY   G L   LR+                    
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 281 DEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
           +E+   L +   +     +A  + +L        VHRD+++ NVL+       + DFG+A
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 341 RLLNFDSSNRTL--LAGTSGYIAP 362
           R +  DS+            ++AP
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAP 235

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 5e-40
 Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 29/199 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLL 241
                   +G G +G V  A         +   VA+K L  S        E+  +E ++L
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80

Query: 242 SQIW-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR---------------TDEEAV 285
           S +  H NIV L G C       +I EY   G L   LR                +++ +
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            LD    ++    +A  +++L        +HRD+++ N+LL       + DFG+AR +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 346 DSSN--RTLLAGTSGYIAP 362
           DS+   +        ++AP
Sbjct: 198 DSNYVVKGNARLPVKWMAP 216

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 6e-40
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 13/173 (7%)

Query: 196 IGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG 254
           IG G + +VY+     +   VA  +L   +  + +  + F+ EA +L  + H NIV+ Y 
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 255 FCL----HRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC 310
                   +KC+ L+ E M  G+L   L+  +    +      +  + +   L +LH   
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRT 132

Query: 311 TPPIVHRDISSNNVLLNSEL-EAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            PPI+HRD+  +N+ +        + D G+A L    +S    + GT  ++AP
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAP 182

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (353), Expect = 1e-39
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 10/177 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
            D  +K+ +G G YG VY          VA+K L     E    +E F  EA ++ +I H
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKH 72

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            N+V+L G C      ++I E+M  G+L   LR +     +     + +   ++ A+ YL
Sbjct: 73  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-TLLAGTSGYIAP 362
                   +HRD+++ N L+       VADFG++RL+  D+            + AP
Sbjct: 132 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-39
 Identities = 45/189 (23%), Positives = 82/189 (43%), Gaps = 15/189 (7%)

Query: 181 QDMIEATEDFHI-KYCIGTGGYGSVYRARL---PSGKVVALKKLHRSETEELASLESFRN 236
           + +    ++  I    +G G +GSV +           VA+K L +   +     E    
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 58

Query: 237 EARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIV 296
           EA+++ Q+ +  IV+L G C   + + L+ E    G L   L    E   +  +    ++
Sbjct: 59  EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELL 115

Query: 297 KGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN---RTLL 353
             ++  + YL        VHRD+++ NVLL +   A ++DFG+++ L  D S    R+  
Sbjct: 116 HQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 354 AGTSGYIAP 362
                + AP
Sbjct: 173 KWPLKWYAP 181

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  140 bits (354), Expect = 4e-39
 Identities = 43/178 (24%), Positives = 83/178 (46%), Gaps = 12/178 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           + + I   +G+G +G V+R     +G+V   K ++     +     + +NE  +++Q+ H
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 85

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
             ++ L+     +  M LI E++  G LF  +    E   +  A+ +N ++     L ++
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHM 143

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    IVH DI   N++  ++  + V   DFG+A  LN       +   T+ + AP
Sbjct: 144 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAP 197

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  138 bits (349), Expect = 2e-38
 Identities = 42/178 (23%), Positives = 79/178 (44%), Gaps = 12/178 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           + + I   +GTG +G V+R     +G   A K +      +    E+ R E + +S + H
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRH 82

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
             +V L+        M +IYE+M  G LF  +   +E   +   + V  ++ +   L ++
Sbjct: 83  PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H +     VH D+   N++  ++    +   DFG+   L+   S +    GT+ + AP
Sbjct: 141 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAP 194

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-38
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 13/182 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           +D  +   +G G +G V R    +       VA+K L      +  +++ F  E   +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           + HRN+++LYG  L    M ++ E   +GSL   LR  +    L    R      +A  +
Sbjct: 68  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN---RTLLAGTSGYI 360
            YL        +HRD+++ N+LL +     + DFG+ R L  +  +   +        + 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 361 AP 362
           AP
Sbjct: 182 AP 183

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 7e-38
 Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 14/173 (8%)

Query: 196 IGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKL 252
           +G+G +G+V +         K VA+K L     +  A  +    EA ++ Q+ +  IV++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRM 73

Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTP 312
            G C   +   L+ E  E+G L   L+ +     +     + +V  ++  + YL      
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN-- 127

Query: 313 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN---RTLLAGTSGYIAP 362
             VHRD+++ NVLL ++  A ++DFG+++ L  D +    +T       + AP
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (339), Expect = 1e-37
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 34/204 (16%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLL 241
            +      IG G +G V++AR P         +VA+K L    + ++     F+ EA L+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 70

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR---------------------T 280
           ++  + NIVKL G C   K M L++EYM  G L   LR                     +
Sbjct: 71  AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 281 DEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA 340
                 L  A+++ I + +A  ++YL        VHRD+++ N L+   +   +ADFG++
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 341 RLLNFDSSNR--TLLAGTSGYIAP 362
           R +      +     A    ++ P
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPP 211

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 1e-37
 Identities = 44/188 (23%), Positives = 70/188 (37%), Gaps = 22/188 (11%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
               ++  IG G +G V+R +   G+ VA+K     E            E      + H 
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHE 57

Query: 248 NIVKLYGFCLHR----KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           NI+               ++L+ +Y E GSLF  L        +     + +    A  L
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGL 113

Query: 304 SYLHHHC-----TPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN----RTLLA 354
           ++LH         P I HRD+ S N+L+       +AD G+A   +  +           
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 355 GTSGYIAP 362
           GT  Y+AP
Sbjct: 174 GTKRYMAP 181

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 3e-37
 Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 8/177 (4%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW- 245
           EDF +   +G G +G V+ A    + +  A+K L +        +E    E R+LS  W 
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H  +  ++     ++ +F + EY+  G L   ++        D ++       +   L +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH      IV+RD+  +N+LL+ +    +ADFG+ +      +      GT  YIAP
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 5e-37
 Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 13/181 (7%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E + I   +G G +G V+R     S K    K +    T++       + E  +L+ 
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNI 57

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             HRNI+ L+      + + +I+E++    +F  +     A  L+  + V+ V  +  AL
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEAL 115

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFV--ADFGVARLLNFDSSNRTLLAGTSGYIA 361
            +LH H    I H DI   N++  +   + +   +FG AR L    + R  L     Y A
Sbjct: 116 QFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYA 171

Query: 362 P 362
           P
Sbjct: 172 P 172

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (335), Expect = 7e-37
 Identities = 42/177 (23%), Positives = 76/177 (42%), Gaps = 7/177 (3%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
            + +  +  +GTG +  V  A    + K+VA+K + +   E      S  NE  +L +I 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIK 65

Query: 246 HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
           H NIV L         ++LI + +  G LF  +    E           ++  +  A+ Y
Sbjct: 66  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKY 122

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           LH         +  +     L+ + +  ++DFG++++ +  S   T   GT GY+AP
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAP 178

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-36
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 23/192 (11%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSG---KVVALKKLHRSETEELASLESFRNEARLLSQI 244
            D   +  IG G +G V +AR+         A+K++    +++      F  E  +L ++
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 67

Query: 245 W-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-------------TDEEAVGLDWA 290
             H NI+ L G C HR  ++L  EY   G+L   LR              +  A  L   
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 291 KRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR 350
           + ++    +A  + YL        +HRD+++ N+L+     A +ADFG++R        +
Sbjct: 128 QLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKK 183

Query: 351 TLLAGTSGYIAP 362
           T+      ++A 
Sbjct: 184 TMGRLPVRWMAI 195

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  132 bits (332), Expect = 2e-36
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 10/176 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           +DF I   +GTG +G V+  R   +G+  A+K L +     L  +E   +E  +LS + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
             I++++G     + +F+I +Y+E G LF +LR  +                 A     L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AAEVCLAL 117

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            +  +  I++RD+   N+LL+      + DFG A+ +         L GT  YIAP
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAP 170

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-36
 Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 13/179 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E   +  CIG G +G V++    S       VA+K      ++ +   E F  EA  + Q
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQEALTMRQ 64

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
             H +IVKL G       +++I E   +G L            LD A  +     ++ AL
Sbjct: 65  FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTAL 121

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR-TLLAGTSGYIA 361
           +YL        VHRDI++ NVL++S     + DFG++R +   +  + +       ++A
Sbjct: 122 AYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  130 bits (327), Expect = 6e-36
 Identities = 42/184 (22%), Positives = 88/184 (47%), Gaps = 14/184 (7%)

Query: 187 TEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           ++ + +   +G GG   V+ AR L   + VA+K L      + +    FR EA+  + + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 246 HRNIVKLYGFCLHR----KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
           H  IV +Y             +++ EY++  +L  ++ T+     +   + + ++     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---LAGTSG 358
           AL++ H +    I+HRD+   N+++++     V DFG+AR +    ++ T    + GT+ 
Sbjct: 123 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 359 YIAP 362
           Y++P
Sbjct: 180 YLSP 183

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  128 bits (323), Expect = 2e-35
 Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 17/189 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELAS------LESFRNEARL 240
           E++  K  +G G    V R    P+ K  A+K +  +     ++       E+   E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 241 LSQI-WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGM 299
           L ++  H NI++L          FL+++ M+ G LF  L    E V L   +   I++ +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119

Query: 300 AHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGY 359
              +  LH      IVHRD+   N+LL+ ++   + DFG +  L+        + GT  Y
Sbjct: 120 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSY 175

Query: 360 IAPASEWWH 368
           +AP  E   
Sbjct: 176 LAP--EIIE 182

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  130 bits (327), Expect = 3e-35
 Identities = 44/178 (24%), Positives = 69/178 (38%), Gaps = 12/178 (6%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNE---ARLLSQ 243
            DF +   IG GG+G VY  R   +GK+ A+K L +   +         NE     L+S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
                IV +         +  I + M  G L   L           A        +   L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
            ++H+     +V+RD+   N+LL+      ++D G+A   +F         GT GY+A
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMA 173

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-34
 Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 15/183 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSG-----KVVALKKLHRSETEELASLESFRNEARLLS 242
                +  IG G +G VY+  L +        VA+K L    TE+      F  EA ++ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMG 64

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           Q  H NI++L G     K M +I EYME G+        E+       + V +++G+A  
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLA---GTSGY 359
           +    +      VHRD+++ N+L+NS L   V+DFG++R+L  D       +       +
Sbjct: 123 M---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 360 IAP 362
            AP
Sbjct: 180 TAP 182

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  124 bits (312), Expect = 9e-34
 Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 7/175 (4%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
           E +H    IG G YG VY+A+   G+  ALKK+   + +E     +   E  +L ++ H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60

Query: 248 NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
           NIVKLY     +K + L++E+++      +   +    GL+     + +  + + ++Y H
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCH 117

Query: 308 HHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
                 ++HRD+   N+L+N E E  +ADFG+AR         T    T  Y AP
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 1e-33
 Identities = 40/176 (22%), Positives = 68/176 (38%), Gaps = 7/176 (3%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
            DF     +G G +G V   R   +G+  A+K L +        +     E+R+L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
             +  L         +  + EY   G LF  L  +         +        A  +S L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFY---GAEIVSAL 118

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            +  +  +V+RDI   N++L+ +    + DFG+ +    D +      GT  Y+AP
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-33
 Identities = 39/190 (20%), Positives = 77/190 (40%), Gaps = 20/190 (10%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLL 241
           E   +   +G G +G VY               VA+K ++ + +        F NEA ++
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVG-------LDWAKRVN 294
            +    ++V+L G     +   +I E M  G L   LR+   A+           +K + 
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 295 IVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNR--TL 352
           +   +A  ++YL+ +     VHRD+++ N ++  +    + DFG+ R +      R    
Sbjct: 138 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 353 LAGTSGYIAP 362
                 +++P
Sbjct: 195 GLLPVRWMSP 204

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-33
 Identities = 38/183 (20%), Positives = 79/183 (43%), Gaps = 15/183 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRS---ETEELASLESFRNEARLLSQ 243
           + +     +G+G +  V + R   +G   A K + +     +    S E    E  +L +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 244 IWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHAL 303
           I H N++ L+    ++  + LI E +  G LF     ++E++  + A        +   L
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEF-----LKQIL 123

Query: 304 SYLHHHCTPPIVHRDISSNNVLLNSE----LEAFVADFGVARLLNFDSSNRTLLAGTSGY 359
           + +++  +  I H D+   N++L           + DFG+A  ++F +     + GT  +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEF 182

Query: 360 IAP 362
           +AP
Sbjct: 183 VAP 185

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 6e-33
 Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 7/176 (3%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           E+F     IG G YG VY+AR   +G+VVALKK+ R +TE      +   E  LL ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
            NIVKL         ++L++E++       +  +     G+      + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFC 118

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H H    ++HRD+   N+L+N+E    +ADFG+AR         T    T  Y AP
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 6e-33
 Identities = 41/181 (22%), Positives = 70/181 (38%), Gaps = 16/181 (8%)

Query: 191 HIKYCIGTGGYGSVYRARLPSGK----VVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           H    IG G +G VY   L          A+K L+R        +  F  E  ++    H
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 87

Query: 247 RNIVKLYGFCLHRK-CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSY 305
            N++ L G CL  +    ++  YM+ G L   +R +     +       +          
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142

Query: 306 LHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS----SNRTLLAGTSGYIA 361
           +    +   VHRD+++ N +L+ +    VADFG+AR +         N+T       ++A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 362 P 362
            
Sbjct: 203 L 203

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-32
 Identities = 42/182 (23%), Positives = 85/182 (46%), Gaps = 15/182 (8%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKV----VALKKLHRSETEELASLESFRNEARLLS 242
            +F     +G+G +G+VY+   +P G+     VA+K+L  + + +  + +   +EA +++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMA 66

Query: 243 QIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
            + + ++ +L G CL    + LI + M  G L       E    +     +N    +A  
Sbjct: 67  SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKG 123

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL--LAGTSGYI 360
           ++YL       +VHRD+++ NVL+ +     + DFG+A+LL  +              ++
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 361 AP 362
           A 
Sbjct: 181 AL 182

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-32
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 9/170 (5%)

Query: 196 IGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELAS--LESFRNEARLLSQIWHRNIVKL 252
           +G G + +VY+AR   + ++VA+KK+      E       +   E +LL ++ H NI+ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 253 YGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTP 312
                H+  + L++++ME      +    + ++ L  +     +      L YLH H   
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 313 PIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
            I+HRD+  NN+LL+      +ADFG+A+     +   T    T  Y AP
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 9e-32
 Identities = 40/190 (21%), Positives = 72/190 (37%), Gaps = 9/190 (4%)

Query: 183 MIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           + +    +     IG G YG V  A    +   VA+KK+   E +     +    E ++L
Sbjct: 3   VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY--CQRTLREIKIL 60

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
            +  H NI+ +           +   Y+    +   L    +   L        +  +  
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL---LAGTSG 358
            L Y+H      ++HRD+  +N+LLN+  +  + DFG+AR+ + D  +         T  
Sbjct: 121 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 359 YIAPASEWWH 368
           Y AP      
Sbjct: 178 YRAPEIMLNS 187

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-31
 Identities = 42/181 (23%), Positives = 73/181 (40%), Gaps = 14/181 (7%)

Query: 189 DFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHR---SETEELASLESFRNEARLLSQI 244
            + +   +G+GG+GSVY    +     VA+K + +   S+  EL +      E  LL ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 245 --WHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
                 +++L  +        LI E  E         T+     L      +    +  A
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEA 122

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLLNFDSSNRTLLAGTSGYIA 361
           + + H+     ++HRDI   N+L++ +  E  + DFG   LL    +  T   GT  Y  
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSP 177

Query: 362 P 362
           P
Sbjct: 178 P 178

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-31
 Identities = 45/199 (22%), Positives = 78/199 (39%), Gaps = 29/199 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRARLPS--------GKVVALKKLHRSETEELASLESFRNEAR 239
           +   +   +G G +G V  A               VA+K L    TE+   L    +E  
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70

Query: 240 LLSQIW-HRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLR-------------TDEEAV 285
           ++  I  H+NI+ L G C     +++I EY   G+L   L+             +     
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 286 GLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF 345
            L     V+    +A  + YL        +HRD+++ NVL+  +    +ADFG+AR ++ 
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 346 DSSNRTLLA--GTSGYIAP 362
               +          ++AP
Sbjct: 188 IDYYKKTTNGRLPVKWMAP 206

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (298), Expect = 3e-31
 Identities = 43/176 (24%), Positives = 72/176 (40%), Gaps = 10/176 (5%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           + F     +GTG +G V   +   SG   A+K L + +  +L  +E   NE R+L  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
             +VKL         ++++ EY+  G +F  LR                   +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           H      +++RD+   N+L++ +    V DFG A+           L GT   +AP
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAP 207

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 2e-30
 Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 19/182 (10%)

Query: 189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHR 247
            +     IG G +G VY+A+L  SG++VA+KK+ + +            E +++ ++ H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHC 73

Query: 248 NIVKLYGFCLH------RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
           NIV+L  F            + L+ +Y+                 L        +  +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAF-VADFGVARLLNFDSSNRTLLAGTSGYI 360
           +L+Y+H      I HRDI   N+LL+ +     + DFG A+ L     N + +     Y 
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYR 189

Query: 361 AP 362
           AP
Sbjct: 190 AP 191

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 5e-30
 Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 8/176 (4%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           + +     IG G YG+V++A+   + ++VALK++   + +E     S   E  LL ++ H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60

Query: 247 RNIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYL 306
           +NIV+L+      K + L++E+ +          +             +   +   L  L
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGL 114

Query: 307 HHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
               +  ++HRD+   N+L+N   E  +A+FG+AR         +    T  Y  P
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 8e-30
 Identities = 43/198 (21%), Positives = 78/198 (39%), Gaps = 28/198 (14%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR------LPSGKVVALKKLHRSETEELASLESFRNEARLL 241
           +   +   +G G +G V  A         + + VA+K L    T       +  +E ++L
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 70

Query: 242 SQIWHR-NIVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRT-------------DEEAVG 286
             I H  N+V L G C      + +I E+ + G+L   LR+             D     
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 287 LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD 346
           L     +     +A  + +L        +HRD+++ N+LL+ +    + DFG+AR +  D
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 347 SSN--RTLLAGTSGYIAP 362
                +        ++AP
Sbjct: 188 PDYVRKGDARLPLKWMAP 205

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-29
 Identities = 47/188 (25%), Positives = 81/188 (43%), Gaps = 20/188 (10%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
             +     IG G +G V++AR   +G+ VALKK+     +E     +   E ++L  + H
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKH 68

Query: 247 RNIVKLYGFCLHRK--------CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKG 298
            N+V L   C  +          ++L++++ E      +     +   L   KRV     
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV----- 122

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS----NRTLLA 354
           M   L+ L++     I+HRD+ + NVL+  +    +ADFG+AR  +   +      T   
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 355 GTSGYIAP 362
            T  Y  P
Sbjct: 183 VTLWYRPP 190

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-29
 Identities = 45/185 (24%), Positives = 74/185 (40%), Gaps = 23/185 (12%)

Query: 188 EDFHI-KYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW 245
           +D+ +    +G G  G V +     + +  ALK L              R E  L  +  
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRAS 62

Query: 246 -HRNIVKLYGFC----LHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
              +IV++          RKC+ ++ E ++ G LF  ++ D         +   I+K + 
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIG 121

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELE---AFVADFGVARLLNFDSSNRTLLAGTS 357
            A+ YLH      I HRD+   N+L  S+       + DFG A+     +S  T    T 
Sbjct: 122 EAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTP 177

Query: 358 GYIAP 362
            Y+AP
Sbjct: 178 YYVAP 182

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 3e-29
 Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 11/184 (5%)

Query: 186 ATEDFHIKYCIGTGGYGSVYRAR--LPSGKVVALKKLHRSETEELASLESFR--NEARLL 241
           A + +     IG G YG V++AR     G+ VALK++     EE   L + R     R L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 242 SQIWHRNIVKLYGFCLHRKCMFLIYEYMEMGSLFCV---LRTDEEAVGLDWAKRVNIVKG 298
               H N+V+L+  C   +        +    +              G+      +++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 299 MAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSG 358
           +   L +LH H    +VHRD+   N+L+ S  +  +ADFG+AR+ +F  +  + +  T  
Sbjct: 125 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVTLW 180

Query: 359 YIAP 362
           Y AP
Sbjct: 181 YRAP 184

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  112 bits (281), Expect = 4e-29
 Identities = 35/203 (17%), Positives = 81/203 (39%), Gaps = 26/203 (12%)

Query: 172 WNYDG-RITFQDMIEATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELA 229
           W+Y+   + + +     +D+ +   +G G Y  V+ A  + + + V +K L   + ++  
Sbjct: 22  WDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-- 75

Query: 230 SLESFRNEARLLSQI-WHRNIVKLYGFCLHR--KCMFLIYEYMEMGSLFCVLRTDEEAVG 286
                + E ++L  +    NI+ L         +   L++E++       + +T      
Sbjct: 76  ----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------ 125

Query: 287 LDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNF 345
           L        +  +  AL Y H      I+HRD+  +NV+++ E  +  + D+G+A   + 
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH- 181

Query: 346 DSSNRTLLAGTSGYIAPASEWWH 368
                 +   +  +  P     +
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDY 204

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 1e-28
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 13/181 (7%)

Query: 188 EDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSE-TEELASLESFRNEARLLS 242
           E+F +   +GTG YG V+  R      +GK+ A+K L ++   ++  + E  R E ++L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 243 QIWHR-NIVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAH 301
            I     +V L+        + LI +Y+  G LF  L         +      +   +  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGE 137

Query: 302 ALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA-RLLNFDSSNRTLLAGTSGYI 360
            +  L H     I++RDI   N+LL+S     + DFG++   +  ++       GT  Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 361 A 361
           A
Sbjct: 198 A 198

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (268), Expect = 2e-27
 Identities = 28/185 (15%), Positives = 63/185 (34%), Gaps = 23/185 (12%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           + +   IG+G +G +Y    + +G+ VA+K                  E+++   +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGV 63

Query: 249 IVKLYGFCLH-RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            +    +C        ++ E +             +         + +   M   + Y+H
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIH 120

Query: 308 HHCTPPIVHRDISSNNVLLNSE---LEAFVADFGVARLLNFDSSN-------RTLLAGTS 357
                  +HRD+  +N L+         ++ DFG+A+      ++          L GT+
Sbjct: 121 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 358 GYIAP 362
            Y + 
Sbjct: 178 RYASI 182

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  105 bits (263), Expect = 9e-27
 Identities = 33/187 (17%), Positives = 64/187 (34%), Gaps = 25/187 (13%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           + +   IG G +G ++    L + + VA+K   R            R+E R    +    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCT 61

Query: 249 -IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLH 307
            I  +Y F        L+ + +       +     +             K M   +  +H
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIH 118

Query: 308 HHCTPPIVHRDISSNNVLLNSEL-----EAFVADFGVARLLNFDSSN-------RTLLAG 355
                 +V+RDI  +N L+           +V DFG+ +      +        +  L+G
Sbjct: 119 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 356 TSGYIAP 362
           T+ Y++ 
Sbjct: 176 TARYMSI 182

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 1e-26
 Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 13/190 (6%)

Query: 179 TFQDMIEATEDFHIKY----CIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLES 233
             Q++ +   +    Y     +G+G YG+V  A    +G  VA+KKL+R    EL   + 
Sbjct: 5   YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF-AKR 63

Query: 234 FRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE-YMEMGSLFCVLRTDEEAVGLDWAKR 292
              E RLL  + H N++ L       + +    + Y+ M  +   L    +   L   + 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 293 VNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
             +V  M   L Y+H        HRD+   N+ +N + E  + DFG+AR  +   S  T 
Sbjct: 124 QFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTG 177

Query: 353 LAGTSGYIAP 362
              T  Y AP
Sbjct: 178 YVVTRWYRAP 187

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 4e-25
 Identities = 43/182 (23%), Positives = 74/182 (40%), Gaps = 18/182 (9%)

Query: 188 EDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH 246
           + +     IG+G  G V  A      + VA+KKL R    +    +    E  L+  + H
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 75

Query: 247 RNIVKLYGFCLHRKCM------FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMA 300
           +NI+ L      +K +      +L+ E M+      +          D  +   ++  M 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQML 129

Query: 301 HALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYI 360
             + +LH      I+HRD+  +N+++ S+    + DFG+AR     S   T    T  Y 
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 185

Query: 361 AP 362
           AP
Sbjct: 186 AP 187

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 9e-24
 Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 9/180 (5%)

Query: 185 EATEDFHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQ 243
           E  E +     +G+G YGSV  A    +G  VA+KKL R   + +   +    E RLL  
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKH 73

Query: 244 IWHRNIVKLYGFCLHRKCMFLI-YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHA 302
           + H N++ L       + +      Y+    +   L    +   L       ++  +   
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133

Query: 303 LSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTLLAGTSGYIAP 362
           L Y+H        HRD+  +N+ +N + E  + DFG+AR  + + +       T  Y AP
Sbjct: 134 LKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAP 187

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.1 bits (220), Expect = 1e-21
 Identities = 28/164 (17%), Positives = 56/164 (34%), Gaps = 17/164 (10%)

Query: 196 IGTGGYGSVYRARLPSGKVVALKKLHRSETE-------ELASLESFRNEARLLSQIWHRN 248
           +G G   +V+           +K      T               F   A   ++   R 
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 249 IVKLYGFCLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH 308
           + KL G  + +     +Y +    ++   L   +E   +       ++  +   ++  +H
Sbjct: 68  LQKLQGLAVPK-----VYAWEG-NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 309 HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSNRTL 352
                IVH D+S  NVL+ SE   ++ DF  +  +  +     L
Sbjct: 122 RG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREIL 161

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 82.4 bits (202), Expect = 4e-18
 Identities = 35/192 (18%), Positives = 73/192 (38%), Gaps = 27/192 (14%)

Query: 190 FHIKYCIGTGGYGSVYRAR-LPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRN 248
           + +   +G G + +V+ A+ + +   VA+K +   +       E+  +E +LL ++   +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDAD 70

Query: 249 IVKLYGFCLHR---------------KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRV 293
             K      +                  + +++E +    L  + + +   + L + K+ 
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ- 129

Query: 294 NIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE-LEAFVADFGVARLLNFDSSNRT- 351
            I K +   L Y+H  C   I+H DI   NVL+        +    +A L N    +   
Sbjct: 130 -ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186

Query: 352 -LLAGTSGYIAP 362
                T  Y +P
Sbjct: 187 TNSIQTREYRSP 198

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 59.2 bits (142), Expect = 2e-10
 Identities = 21/76 (27%), Positives = 35/76 (46%), Gaps = 6/76 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +Y N +    P  + + +KL+ L   NN +S    S +  L  +N+L   HN I+   P 
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP- 368

Query: 61  QLGEIPRIDTVNLSMN 76
            L  + RI  + L+  
Sbjct: 369 -LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.2 bits (134), Expect = 2e-09
 Identities = 17/84 (20%), Positives = 35/84 (41%), Gaps = 5/84 (5%)

Query: 15  MNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLS 74
            N   L  L L  N +S      +  L +L  L  ++N ++    S L  +  I+ ++  
Sbjct: 304 SNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359

Query: 75  MNNLSGSIP-ESVKKVPLLYVSGN 97
            N +S   P  ++ ++  L ++  
Sbjct: 360 HNQISDLTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.8 bits (102), Expect = 2e-05
 Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 6/83 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
             NN++    P      + L  L L  N L       +  L  L  LDL++N I+   P 
Sbjct: 204 ATNNQISDITPL--GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP- 258

Query: 61  QLGEIPRIDTVNLSMNNLSGSIP 83
            L  + ++  + L  N +S   P
Sbjct: 259 -LSGLTKLTELKLGANQISNISP 280

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 3e-04
 Identities = 9/59 (15%), Positives = 21/59 (35%), Gaps = 4/59 (6%)

Query: 1  MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP 59
          +    +   + Q   +  ++  L      +  SI   +  L  L  ++ S+N +    P
Sbjct: 29 LGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP 83

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 57.1 bits (136), Expect = 9e-10
 Identities = 16/52 (30%), Positives = 25/52 (48%), Gaps = 1/52 (1%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHN 52
           + NN++ G +PQ L     L  L +  N L G I  + G LQ  +    ++N
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANN 301

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 56.3 bits (134), Expect = 1e-09
 Identities = 19/69 (27%), Positives = 32/69 (46%), Gaps = 1/69 (1%)

Query: 15  MNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLS 74
                L  L L NN + G++   + +L+ L+ L++S N + G+IP   G + R D    +
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYA 299

Query: 75  MNNLSGSIP 83
            N      P
Sbjct: 300 NNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 54.0 bits (128), Expect = 8e-09
 Identities = 18/57 (31%), Positives = 32/57 (56%), Gaps = 2/57 (3%)

Query: 45  NYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPES--VKKVPLLYVSGNNF 99
           N LDL +N I G +P  L ++  + ++N+S NNL G IP+   +++  +   + N  
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 37.4 bits (85), Expect = 0.002
 Identities = 12/39 (30%), Positives = 21/39 (53%), Gaps = 3/39 (7%)

Query: 70  TVNLSMNNLSGSIPESVKKVP---LLYVSGNNFEVEIPS 105
            ++L  N + G++P+ + ++     L VS NN   EIP 
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 49.7 bits (117), Expect = 2e-07
 Identities = 21/90 (23%), Positives = 39/90 (43%), Gaps = 2/90 (2%)

Query: 10  IPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRID 69
           +P++L       +L L NN ++     +   L+ L+ L L +N I+   P     + +++
Sbjct: 25  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 70  TVNLSMNNLSGSIPESVKKVPLLYVSGNNF 99
            + LS N L     +  K +  L V  N  
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRVHENEI 112

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 38.1 bits (87), Expect = 0.001
 Identities = 19/99 (19%), Positives = 32/99 (32%), Gaps = 3/99 (3%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
               K  G          KL  + + +  ++   +   G    L  L L  N I     +
Sbjct: 133 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAA 189

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNF 99
            L  +  +  + LS N++S     S+   P L     N 
Sbjct: 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 38.1 bits (87), Expect = 0.001
 Identities = 19/129 (14%), Positives = 36/129 (27%), Gaps = 23/129 (17%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLIN----- 55
           + NNK+    P       KL  L L  N L          LQEL   +     +      
Sbjct: 62  LINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN 121

Query: 56  ------------------GKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGN 97
                             G        + ++  + ++  N++         +  L++ GN
Sbjct: 122 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGN 181

Query: 98  NFEVEIPST 106
                  ++
Sbjct: 182 KITKVDAAS 190

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 2e-06
 Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 9/85 (10%)

Query: 14  LMNCSKLRILILGNNLLSG----SISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPR-- 67
               S LR+L L +  +S     S+++ +     L  LDLS+N +      QL E  R  
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 68  ---IDTVNLSMNNLSGSIPESVKKV 89
              ++ + L     S  + + ++ +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 1e-05
 Identities = 13/85 (15%), Positives = 31/85 (36%), Gaps = 5/85 (5%)

Query: 1  MYNNKL-DGPIPQELMNCSKLRILILGNNLLSG----SISSEIGKLQELNYLDLSHNLIN 55
          +   +L D    + L    + +++ L +  L+      ISS +     L  L+L  N + 
Sbjct: 9  IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68

Query: 56 GKIPSQLGEIPRIDTVNLSMNNLSG 80
                + +  +  +  +   +L  
Sbjct: 69 DVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.1 bits (97), Expect = 6e-05
 Identities = 21/79 (26%), Positives = 37/79 (46%), Gaps = 6/79 (7%)

Query: 27  NNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESV 86
            N  S  I S       L  L++S+N +  ++P+     PR++ +  S N+L+  +PE  
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPELP 323

Query: 87  KKVPLLYVSGNNFEVEIPS 105
           + +  L+V  N    E P 
Sbjct: 324 QNLKQLHVEYNPLR-EFPD 341

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 5e-04
 Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 14/77 (18%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           + NNKL   +P       +L  LI   N L+  +      L++   L + +N +  + P 
Sbjct: 291 VSNNKLIE-LPALP---PRLERLIASFNHLA-EVPELPQNLKQ---LHVEYNPLR-EFPD 341

Query: 61  QLGEIPRIDTVNLSMNN 77
               +      +L MN+
Sbjct: 342 IPESVE-----DLRMNS 353

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (96), Expect = 7e-05
 Identities = 13/91 (14%), Positives = 36/91 (39%), Gaps = 3/91 (3%)

Query: 3  NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGK-IPSQ 61
             L   +   L++   +       + +   ++      + + ++DLS+++I    +   
Sbjct: 9  GKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGI 66

Query: 62 LGEIPRIDTVNLSMNNLSGSIPESVKKVPLL 92
          L +  ++  ++L    LS  I  ++ K   L
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL 97

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.2 bits (92), Expect = 1e-04
 Identities = 18/107 (16%), Positives = 39/107 (36%), Gaps = 1/107 (0%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           +  NK+     +  +   +L+ L L +N +S  +      L  L  L+L+ N  N     
Sbjct: 85  LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC-NCH 143

Query: 61  QLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFEVEIPSTS 107
                  +   +L+        P  V+ V +  +  + F+    ++ 
Sbjct: 144 LAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSENSE 190

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (89), Expect = 3e-04
 Identities = 13/71 (18%), Positives = 26/71 (36%), Gaps = 3/71 (4%)

Query: 13 ELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVN 72
          +  N  + R L L    +   I +    L + + +D S N I          + R+ T+ 
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69

Query: 73 LSMNNLSGSIP 83
          ++ N +     
Sbjct: 70 VNNNRICRIGE 80

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 3e-04
 Identities = 11/51 (21%), Positives = 20/51 (39%), Gaps = 4/51 (7%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSH 51
             +NK+    P  L +   L  + L NN +S      +     L  + L++
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 5e-04
 Identities = 17/61 (27%), Positives = 25/61 (40%), Gaps = 4/61 (6%)

Query: 14  LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNL 73
           L N SKL  L   +N +S      +  L  L  + L +N I+   P  L     +  V L
Sbjct: 169 LANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 74  S 74
           +
Sbjct: 225 T 225

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 5e-04
 Identities = 17/123 (13%), Positives = 39/123 (31%), Gaps = 23/123 (18%)

Query: 1   MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS 60
           ++ N++     +       L  L+L  N ++         L  L  L L  N ++     
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219

Query: 61  QLGEIPRIDTVNLSMN-----------------------NLSGSIPESVKKVPLLYVSGN 97
            L  +  +  + L+ N                        +  S+P+ +    L  ++ N
Sbjct: 220 ALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAAN 279

Query: 98  NFE 100
           + +
Sbjct: 280 DLQ 282

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.4 bits (86), Expect = 5e-04
 Identities = 17/82 (20%), Positives = 36/82 (43%), Gaps = 6/82 (7%)

Query: 21  RILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPS--QLGEIPRIDTVNLSMNNL 78
           R+L L +  L+  +   + +L  + +LDLSHN +    P+   L  +  +   + ++ N+
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58

Query: 79  SGSIPESVKKVPLLYVSGNNFE 100
            G       +   L +  N  +
Sbjct: 59  DGVANLPRLQE--LLLCNNRLQ 78

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.6 bits (84), Expect = 0.001
 Identities = 18/101 (17%), Positives = 30/101 (29%), Gaps = 26/101 (25%)

Query: 3   NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELN----------------- 45
           +  L   +   L     +  L L +N L     + +  L+ L                  
Sbjct: 7   HKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVAN 63

Query: 46  -----YLDLSHNLING-KIPSQLGEIPRIDTVNLSMNNLSG 80
                 L L +N +        L   PR+  +NL  N+L  
Sbjct: 64  LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	368
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.98
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.98
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.58
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.53
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.51
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.48
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.37
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.29
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.27
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.26
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.23
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.16
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.1
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.09
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.06
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.05
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.05
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.85
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.84
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.81
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.79
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.76
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.72
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.71
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.67
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.66
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.65
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.63
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.54
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.42
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.36
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.34
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.3
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.23
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.2
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.12
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.05
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.9
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.9
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.75
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.64
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.52
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.46
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.41
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.31
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.27
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.45
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.06
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	92.63
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	92.0

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-42  Score=306.45  Aligned_cols=169  Identities=28%  Similarity=0.465  Sum_probs=146.6

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||||++......+  ..+++.+|++++++++||||+++++++.+++..|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            36899999999999999999986 468999999987654322  336789999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||||++|+|.+++....   .+++.++..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        82 mEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            99999999999997543   389999999999999999999999   999999999999999999999999999998754


Q ss_pred             CC--CCccccccccccccCC
Q 017621          346 DS--SNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~--~~~~~~~gt~~y~aPE  363 (368)
                      ..  ......+||+.|||||
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE  175 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPE  175 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTH
T ss_pred             CCccccccceeeCcCccCHh
Confidence            32  2234568999999998

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-42  Score=302.46  Aligned_cols=168  Identities=35%  Similarity=0.576  Sum_probs=150.6

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++.+....+....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999864 68999999997655554455678899999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||++|+|.+++.....   +++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999976443   89999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                        .....+||+.|||||
T Consensus       160 --~~~~~~Gt~~Y~APE  174 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPE  174 (263)
T ss_dssp             --CCEETTEEGGGCCHH
T ss_pred             --cccccCCCCcccCHH
Confidence              234568999999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-41  Score=304.64  Aligned_cols=166  Identities=27%  Similarity=0.434  Sum_probs=149.9

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++......   ..+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            4799999999999999999986 56999999998754332   3467899999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||++|+|.+++...    .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            999999999988753    389999999999999999999999   9999999999999999999999999999988766


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      .......+||+.|||||
T Consensus       170 ~~~~~~~~gt~~Y~aPE  186 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPE  186 (293)
T ss_dssp             TCCBCCCCSCGGGCCHH
T ss_pred             cccccccccCCCccChh
Confidence            55566678999999998

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=309.80  Aligned_cols=171  Identities=25%  Similarity=0.362  Sum_probs=154.3

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|+. .+++.||||++++.........+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36899999999999999999985 57999999999876544444567889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||||++|+|.+++.....   +++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999999986543   89999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      ........+||+.|||||
T Consensus       158 ~~~~~~~~~GT~~Y~aPE  175 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPE  175 (337)
T ss_dssp             TTCCBCCCEECGGGCCGG
T ss_pred             CCcccccceeCHHHhhhh
Confidence            555556678999999998

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-41  Score=304.74  Aligned_cols=170  Identities=27%  Similarity=0.437  Sum_probs=148.6

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|++ .+++.||||++.+....+....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            6799999999999999999986 578999999997655444445678999999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||++|+|.+++.....   +++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999998876543   89999999999999999999999   9999999999999999999999999999987543


Q ss_pred             CC--CccccccccccccCC
Q 017621          347 SS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~--~~~~~~gt~~y~aPE  363 (368)
                      ..  .....+||+.|||||
T Consensus       162 ~~~~~~~~~~GT~~Y~APE  180 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPE  180 (288)
T ss_dssp             --------CCCCGGGCCHH
T ss_pred             CcccccccccCCccccCce
Confidence            32  234468999999998

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-41  Score=300.11  Aligned_cols=176  Identities=31%  Similarity=0.536  Sum_probs=136.6

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee--CCeEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH--RKCMF  263 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  263 (368)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|.+......+ ...+.+.+|++++++++|||||++++++.+  .+.+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            36899999999999999999985 578999999987654432 345778999999999999999999999865  45689


Q ss_pred             EEEeecCCCChhHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          264 LIYEYMEMGSLFCVLRTDE-EAVGLDWAKRVNIVKGMAHALSYLHHHC--TPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      +|||||++|+|.+++.... ....+++..++.++.||+.||+|||++.  ..+|+||||||+|||++.++.+||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            9999999999999986432 2234899999999999999999999861  114999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +.+..........+||+.|||||
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE  184 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPE  184 (269)
T ss_dssp             HHC-----------CCCSCCCHH
T ss_pred             eecccCCCccccCCCCcccCCHH
Confidence            98866555555678999999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-41  Score=302.26  Aligned_cols=169  Identities=28%  Similarity=0.410  Sum_probs=148.0

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      +.|++.+.||+|+||+||+|++ .+++.||||++......   ..+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            4689999999999999999986 46899999998764332   3467889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||++|+|.+++....  ..+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            9999999999876533  2389999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      .......+||+.|||||+
T Consensus       164 ~~~~~~~~Gt~~y~APE~  181 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEV  181 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHH
T ss_pred             cccccccccccccCCHHH
Confidence            333345689999999994

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-40  Score=300.75  Aligned_cols=167  Identities=31%  Similarity=0.508  Sum_probs=150.5

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++++....+....+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            6899999999999999999986 569999999997655544455678999999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||++|+|..++.....   +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999998886544   78889999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                         ....+||+.|||||
T Consensus       158 ---~~~~~Gt~~Y~APE  171 (316)
T d1fota_         158 ---TYTLCGTPDYIAPE  171 (316)
T ss_dssp             ---BCCCCSCTTTCCHH
T ss_pred             ---cccccCcccccCHH
Confidence               23468999999998

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-41  Score=306.42  Aligned_cols=167  Identities=29%  Similarity=0.400  Sum_probs=146.2

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++ .+|+.||+|+++.....  ...+++.+|+.++++++|||||++++++.+.+..|+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            56899999999999999999985 57899999998764322  2346889999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |||+++|+|.+++.+...   +++..+..++.|++.||.|||+ +   +|+||||||+|||+++++.+||+|||+|+...
T Consensus        83 mEy~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            999999999999976433   8999999999999999999997 5   89999999999999999999999999998764


Q ss_pred             CCCCCccccccccccccCC
Q 017621          345 FDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE  363 (368)
                      ...  ....+||+.|||||
T Consensus       157 ~~~--~~~~~GT~~Y~APE  173 (322)
T d1s9ja_         157 DSM--ANSFVGTRSYMSPE  173 (322)
T ss_dssp             HHT--C---CCSSCCCCHH
T ss_pred             CCc--cccccCCccccCch
Confidence            322  23468999999998

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-40  Score=297.80  Aligned_cols=168  Identities=27%  Similarity=0.422  Sum_probs=148.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .+.|+..+.||+|+||+||+|++ .+++.||||++...........+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            34699999999999999999985 57889999999776554445567899999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      ||||++|++..++....   .+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        94 ~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            99999999877665543   389999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .    ...+||+.|||||+
T Consensus       168 ~----~~~~GT~~Y~APE~  182 (309)
T d1u5ra_         168 A----NSFVGTPYWMAPEV  182 (309)
T ss_dssp             B----CCCCSCGGGCCHHH
T ss_pred             C----CccccCccccCHHH
Confidence            2    33579999999994

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-40  Score=291.76  Aligned_cols=168  Identities=26%  Similarity=0.425  Sum_probs=139.0

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      ++|++.+.||+|+||+||+|++.+++.||||+++.....    .++|.+|++++++++|||||+++|++.+++..|+|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            578999999999999999999888889999999765433    3679999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++|+|.+++.....  .+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             ecCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            9999999999876433  388999999999999999999999   99999999999999999999999999998775443


Q ss_pred             C-CccccccccccccCCC
Q 017621          348 S-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~-~~~~~~gt~~y~aPE~  364 (368)
                      . ......||+.|||||+
T Consensus       156 ~~~~~~~~gt~~y~aPE~  173 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEV  173 (263)
T ss_dssp             ---------CTTSCCHHH
T ss_pred             ceeecceecCcccCChHH
Confidence            2 2234579999999983

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-40  Score=298.07  Aligned_cols=171  Identities=29%  Similarity=0.468  Sum_probs=149.2

Q ss_pred             HhhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEE
Q 017621          186 ATEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       186 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  264 (368)
                      ..++|++.+.||+|+||+||+|++. +++.||||+++....    ..++|.+|++++++++|||||++++++.+++..|+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3568999999999999999999864 588999999976443    24679999999999999999999999999999999


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecC
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLN  344 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~  344 (368)
                      |||||++|+|.+++..... ..+++..+..++.||++||+|||++   +|+||||||+|||+++++.+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence            9999999999999976432 3489999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCC-ccccccccccccCCC
Q 017621          345 FDSSN-RTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~-~~~~~gt~~y~aPE~  364 (368)
                      ..... .....||+.|||||+
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~  187 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPES  187 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHH
T ss_pred             CCCceeeccccccccccChHH
Confidence            54332 233468999999983

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.3e-40  Score=295.63  Aligned_cols=169  Identities=33%  Similarity=0.499  Sum_probs=133.7

Q ss_pred             hccccceeeeecCCccEEEEEcC-CC---CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SG---KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|++.+.||+|+||+||+|++. ++   ..||||.+......  ...++|.+|++++++++|||||++++++.+.+..|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            45677889999999999999864 23   36899998765443  23468999999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +|||||++|+|.+++.....  .+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999998876433  389999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCC-----ccccccccccccCC
Q 017621          344 NFDSSN-----RTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~-----~~~~~gt~~y~aPE  363 (368)
                      ......     .....||+.|||||
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE  203 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPE  203 (299)
T ss_dssp             -----------------CGGGSCHH
T ss_pred             cCCCCcceeeecccccCCccccCHH
Confidence            543322     12245799999998

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=290.87  Aligned_cols=169  Identities=28%  Similarity=0.501  Sum_probs=146.6

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||+||+|++++++.||||+++....    ..++|.+|++++++++|||||++++++.+ +..|+||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            468999999999999999999988888999999976443    23679999999999999999999998865 4579999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|.+++.... ...+++.+++.++.||++||+|||++   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        87 Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence            9999999999876543 23489999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CC-CccccccccccccCCC
Q 017621          347 SS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE~  364 (368)
                      .. ......||+.|||||+
T Consensus       163 ~~~~~~~~~gt~~y~APE~  181 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEA  181 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHH
T ss_pred             ccccccccCCcccccChHH
Confidence            32 2334578999999983

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-40  Score=296.00  Aligned_cols=168  Identities=27%  Similarity=0.426  Sum_probs=130.7

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .+.|++.+.||+|+||+||+|++. +++.||||++.......  ..+.+.+|++++++++|||||++++++.+++..|+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            456999999999999999999864 68999999997654432  235688999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec---CCCCeEEeeecccee
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN---SELEAFVADFGVARL  342 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFg~a~~  342 (368)
                      ||||++|+|.+++....   .+++.++..++.||+.||+|||++   +|+||||||+|||+.   +++.+||+|||+|+.
T Consensus        86 mE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             ECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             EeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            99999999999997643   389999999999999999999999   999999999999994   578999999999987


Q ss_pred             cCCCCCCccccccccccccCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ...... ....+||+.|||||
T Consensus       160 ~~~~~~-~~~~~GT~~y~APE  179 (307)
T d1a06a_         160 EDPGSV-LSTACGTPGYVAPE  179 (307)
T ss_dssp             --------------CTTSCHH
T ss_pred             ccCCCe-eeeeeeCccccCcH
Confidence            654332 33468999999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-39  Score=290.44  Aligned_cols=169  Identities=28%  Similarity=0.499  Sum_probs=140.8

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||+||+|+..  ..||||+++...... ...++|.+|++++++++|||||++++++.+ +..++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            467899999999999999999864  369999997653322 345789999999999999999999998765 4589999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |||++|+|.+++.....  .+++..+..++.||++||+|||++   +||||||||+|||++.++.+||+|||+|+.....
T Consensus        83 Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             ECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             ecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            99999999999975433  389999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC--CccccccccccccCCC
Q 017621          347 SS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~--~~~~~~gt~~y~aPE~  364 (368)
                      ..  ......||+.|||||+
T Consensus       158 ~~~~~~~~~~gt~~y~APE~  177 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEV  177 (276)
T ss_dssp             --------CCCCGGGCCHHH
T ss_pred             CCcccccccccCcccCCHHH
Confidence            22  2345679999999994

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.9e-39  Score=296.33  Aligned_cols=168  Identities=24%  Similarity=0.414  Sum_probs=147.9

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++......   ..+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh---hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            35899999999999999999985 57899999999765443   346788999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec--CCCCeEEeeeccceec
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN--SELEAFVADFGVARLL  343 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFg~a~~~  343 (368)
                      ||||++|+|.+++.....  .+++.++..++.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+|+.+
T Consensus       102 mE~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEcCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            999999999999865432  389999999999999999999999   999999999999996  4578999999999987


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .... .....+||+.|||||
T Consensus       177 ~~~~-~~~~~~gT~~Y~aPE  195 (350)
T d1koaa2         177 DPKQ-SVKVTTGTAEFAAPE  195 (350)
T ss_dssp             CTTS-CEEEECSCTTTCCHH
T ss_pred             cccc-ccceecCcccccCHH
Confidence            6443 334568999999998

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-39  Score=284.55  Aligned_cols=168  Identities=27%  Similarity=0.466  Sum_probs=141.4

Q ss_pred             cccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee----CCeEEE
Q 017621          190 FHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH----RKCMFL  264 (368)
Q Consensus       190 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  264 (368)
                      |++.+.||+|+||+||+|++. +++.||+|++....... ...+.+.+|++++++++|||||++++++.+    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            466778999999999999864 68899999987654322 345689999999999999999999999875    356899


Q ss_pred             EEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec-CCCCeEEeeeccceec
Q 017621          265 IYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN-SELEAFVADFGVARLL  343 (368)
Q Consensus       265 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFg~a~~~  343 (368)
                      ||||+++|+|.+++.+..   .+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+|+..
T Consensus        90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            999999999999997643   389999999999999999999998 11399999999999996 5789999999999865


Q ss_pred             CCCCCCccccccccccccCCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ..  ......+||+.|||||+
T Consensus       166 ~~--~~~~~~~GT~~Y~aPE~  184 (270)
T d1t4ha_         166 RA--SFAKAVIGTPEFMAPEM  184 (270)
T ss_dssp             CT--TSBEESCSSCCCCCGGG
T ss_pred             cC--CccCCcccCccccCHHH
Confidence            43  23345689999999994

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-39  Score=297.53  Aligned_cols=167  Identities=26%  Similarity=0.380  Sum_probs=150.4

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++++.||+|+||+||+|++ .+|+.||||++.+....+....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5899999999999999999986 479999999997655444455678999999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+.+|+|.+++....   .+++..+..++.||+.||.|||++   +||||||||+|||++.++.+||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999987654   389999999999999999999999   9999999999999999999999999999987533


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                         ....+||+.|||||
T Consensus       195 ---~~~~~Gt~~Y~APE  208 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPE  208 (350)
T ss_dssp             ---BCCCEECGGGCCHH
T ss_pred             ---cccccCccccCCHH
Confidence               23468999999998

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-38  Score=294.01  Aligned_cols=168  Identities=25%  Similarity=0.409  Sum_probs=147.9

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++......   ..+.+.+|++++++++|||||++++++.+++.+|+||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5799999999999999999985 57999999998765543   2357889999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec--CCCCeEEeeeccceecC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN--SELEAFVADFGVARLLN  344 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFg~a~~~~  344 (368)
                      |||++|+|.+.+....  ..+++.++..++.||+.||+|||++   +|+||||||+|||++  .++.+||+|||+|+.+.
T Consensus       106 E~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         106 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence            9999999998876543  2389999999999999999999999   999999999999998  67899999999999886


Q ss_pred             CCCCCccccccccccccCCC
Q 017621          345 FDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       345 ~~~~~~~~~~gt~~y~aPE~  364 (368)
                      .... .....||+.|||||+
T Consensus       181 ~~~~-~~~~~gt~~y~aPE~  199 (352)
T d1koba_         181 PDEI-VKVTTATAEFAAPEI  199 (352)
T ss_dssp             TTSC-EEEECSSGGGCCHHH
T ss_pred             CCCc-eeeccCcccccCHHH
Confidence            5433 344679999999983

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-39  Score=289.29  Aligned_cols=169  Identities=25%  Similarity=0.410  Sum_probs=147.6

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhh---HHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEE---LASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++.+.....   ....+.+.+|++++++++|||||++++++.+.+..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5799999999999999999986 578999999986543321   123578999999999999999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC----CeEEeeecc
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL----EAFVADFGV  339 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFg~  339 (368)
                      +|||||++|+|.+++....   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++    .+|++|||+
T Consensus        90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999997643   389999999999999999999999   999999999999998776    499999999


Q ss_pred             ceecCCCCCCccccccccccccCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      |+....... .....||+.|||||
T Consensus       164 a~~~~~~~~-~~~~~~t~~y~APE  186 (293)
T d1jksa_         164 AHKIDFGNE-FKNIFGTPEFVAPE  186 (293)
T ss_dssp             CEECTTSCB-CSCCCCCGGGCCHH
T ss_pred             hhhcCCCcc-ccccCCCCcccCHH
Confidence            998764432 33457999999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-39  Score=284.92  Aligned_cols=168  Identities=26%  Similarity=0.450  Sum_probs=148.8

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      ++|++.+.||+|+||+||+|+.++++.||||+++.....    .++|.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            589999999999999999999988889999999765443    2679999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+++|+|.+++.....  .+++..+.+++.|+++||+|||++   +|+||||||+|||+++++.+||+|||+++......
T Consensus        80 y~~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          80 YMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CCTTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             ccCCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            9999999998765433  388999999999999999999999   99999999999999999999999999998765443


Q ss_pred             C-CccccccccccccCCC
Q 017621          348 S-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~-~~~~~~gt~~y~aPE~  364 (368)
                      . ......||+.|+|||+
T Consensus       155 ~~~~~~~~~t~~y~aPE~  172 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEV  172 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHH
T ss_pred             ceeecccCCCCCcCCcHH
Confidence            3 2334579999999983

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-39  Score=291.98  Aligned_cols=170  Identities=25%  Similarity=0.451  Sum_probs=150.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHh-ccCCCceeeEEEEEeeCCeEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLS-QIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      ++|++.+.||+|+||+||+|++. +++.||||++++.........+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            58999999999999999999864 68999999997654433344567777887765 68999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++.....   +++.++..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999986543   89999999999999999999999   999999999999999999999999999997766


Q ss_pred             CCCCccccccccccccCC
Q 017621          346 DSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE  363 (368)
                      ........+||+.|+|||
T Consensus       156 ~~~~~~~~~gt~~y~aPE  173 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPE  173 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHH
T ss_pred             ccccccccCCCCCcCCHH
Confidence            555566678999999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.4e-39  Score=296.13  Aligned_cols=168  Identities=25%  Similarity=0.299  Sum_probs=144.6

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHH---HHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFR---NEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++.+...........+.   +|+++++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            6899999999999999999986 46999999998754433322223333   4577788889999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +|||||++|+|.+++.....   +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999976433   78999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ....  ....+||+.|||||
T Consensus       158 ~~~~--~~~~~GT~~y~APE  175 (364)
T d1omwa3         158 SKKK--PHASVGTHGYMAPE  175 (364)
T ss_dssp             SSSC--CCSCCSCGGGCCHH
T ss_pred             CCCc--ccccccccccchhH
Confidence            6433  33457999999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.3e-38  Score=282.71  Aligned_cols=169  Identities=27%  Similarity=0.411  Sum_probs=148.9

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchh------hHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeC
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETE------ELASLESFRNEARLLSQIW-HRNIVKLYGFCLHR  259 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  259 (368)
                      ++|++.+.||+|+||+||+|+. .+++.||||++......      .....+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999986 57899999998664322      1223457889999999996 99999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                      +..|+|||||++|+|.++++...   .+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999997644   389999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ++....... ....+||+.|+|||
T Consensus       157 a~~~~~~~~-~~~~~gt~~y~~PE  179 (277)
T d1phka_         157 SCQLDPGEK-LREVCGTPSYLAPE  179 (277)
T ss_dssp             CEECCTTCC-BCCCCSCGGGCCHH
T ss_pred             eeEccCCCc-eeeeeccCCCCCHH
Confidence            998765433 34468999999998

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-39  Score=286.47  Aligned_cols=168  Identities=27%  Similarity=0.474  Sum_probs=139.9

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      .++|++.+.||+|+||+||+|++++++.||||++......    .+.|.+|+.++++++|||||++++++.+ +..|+||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence            3689999999999999999999888889999999765432    3679999999999999999999999865 5579999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+++|+|..++..... ..++|.+++.++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.....
T Consensus        91 Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            99999999988875332 2389999999999999999999999   9999999999999999999999999999877543


Q ss_pred             CC-CccccccccccccCC
Q 017621          347 SS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~-~~~~~~gt~~y~aPE  363 (368)
                      .. ......||+.|+|||
T Consensus       167 ~~~~~~~~~gt~~y~aPE  184 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPE  184 (285)
T ss_dssp             ---------CCGGGSCHH
T ss_pred             CceeeccccccccccChH
Confidence            32 233457999999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=290.33  Aligned_cols=172  Identities=28%  Similarity=0.458  Sum_probs=143.7

Q ss_pred             hhccccceeeeecCCccEEEEEcCC------CCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS------GKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  259 (368)
                      .++|++.+.||+|+||+||+|++..      ...||+|.+......  .....+.+|+.++.++ +|||||++++++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            4689999999999999999998532      236999998654332  2346788999999998 899999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCC
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEE--------------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDI  319 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  319 (368)
                      +..|+|||||++|+|.++++....                    ...+++..++.++.||++||+|||++   +|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence            999999999999999999976432                    12489999999999999999999999   9999999


Q ss_pred             CCCCeeecCCCCeEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          320 SSNNVLLNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       320 kp~NIll~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      ||+|||++.++.+||+|||+|+........  .....||+.|||||
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  236 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE  236 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence            999999999999999999999877654432  23456899999998

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-38  Score=280.69  Aligned_cols=169  Identities=27%  Similarity=0.413  Sum_probs=142.9

Q ss_pred             hcccccee-eeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYC-IGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|.+.+. ||+|+||+||+|.+.   ++..||||+++.....  ...++|.+|++++++++|||||++++++.++ ..|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH--HHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence            46777774 999999999999753   3557999999765432  3457899999999999999999999998754 589


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +|||||++|+|.+++....  ..+++.++..++.||++||+|||++   +|+||||||+|||++.++.+||+|||+|+.+
T Consensus        85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence            9999999999999886543  2389999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCC---ccccccccccccCCC
Q 017621          344 NFDSSN---RTLLAGTSGYIAPAS  364 (368)
Q Consensus       344 ~~~~~~---~~~~~gt~~y~aPE~  364 (368)
                      ......   .....||+.|||||+
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~  183 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPEC  183 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHH
T ss_pred             cccccccccccccccCccccChHH
Confidence            654322   234568999999984

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-38  Score=281.89  Aligned_cols=169  Identities=33%  Similarity=0.492  Sum_probs=138.1

Q ss_pred             hccccceeeeecCCccEEEEEcCCC-----CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSG-----KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      +.|++.+.||+|+||+||+|.++..     ..||||++.......  ...+|.+|++++++++|||||+++|++.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH--HHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            5688899999999999999986432     369999987654432  346789999999999999999999999999999


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++||||+.++++.+++.....  .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999988876433  389999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCCC---ccccccccccccCC
Q 017621          343 LNFDSSN---RTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~---~~~~~gt~~y~aPE  363 (368)
                      .......   .....||+.|||||
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE  183 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPE  183 (283)
T ss_dssp             --------------CCCGGGSCHH
T ss_pred             ccCCCccceEeccCCCCccccCHH
Confidence            7543322   23346899999999

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=284.55  Aligned_cols=167  Identities=28%  Similarity=0.366  Sum_probs=146.4

Q ss_pred             hhccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  265 (368)
                      .++|++.+.||+|+||+||+|.+. +++.||||.++.....    ...+.+|+++++.++|||||++++++++++.+|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            467999999999999999999864 6889999999875443    25678999999999999999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCC--CCeEEeeeccceec
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSE--LEAFVADFGVARLL  343 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFg~a~~~  343 (368)
                      ||||++|+|.+++....  ..+++.++..++.||++||+|||++   +|+||||||+|||++.+  ..+||+|||+++..
T Consensus        80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            99999999999997643  2389999999999999999999999   99999999999999854  58999999999887


Q ss_pred             CCCCCCccccccccccccCC
Q 017621          344 NFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .... .....+||+.|+|||
T Consensus       155 ~~~~-~~~~~~~t~~y~ape  173 (321)
T d1tkia_         155 KPGD-NFRLLFTAPEYYAPE  173 (321)
T ss_dssp             CTTC-EEEEEESCGGGSCHH
T ss_pred             ccCC-cccccccccccccch
Confidence            5432 334467999999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-38  Score=280.41  Aligned_cols=162  Identities=27%  Similarity=0.424  Sum_probs=135.3

Q ss_pred             eeeeecCCccEEEEEcC---CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEeecC
Q 017621          194 YCIGTGGYGSVYRARLP---SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEYME  270 (368)
Q Consensus       194 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  270 (368)
                      +.||+|+||+||+|.+.   .++.||||+++..... ....++|.+|++++++++|||||++++++..+ ..|+||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            46999999999999753   3568999998754332 23457899999999999999999999999654 5789999999


Q ss_pred             CCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCCC-
Q 017621          271 MGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSSN-  349 (368)
Q Consensus       271 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~~-  349 (368)
                      +|+|.++++....   +++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        91 ~g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          91 LGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             TEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            9999999986543   89999999999999999999999   9999999999999999999999999999987644332 


Q ss_pred             --ccccccccccccCC
Q 017621          350 --RTLLAGTSGYIAPA  363 (368)
Q Consensus       350 --~~~~~gt~~y~aPE  363 (368)
                        .....||+.|||||
T Consensus       165 ~~~~~~~gt~~y~APE  180 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPE  180 (277)
T ss_dssp             EC----CCCGGGCCHH
T ss_pred             ccccccCCCceecCch
Confidence              22357899999998

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.5e-38  Score=280.51  Aligned_cols=172  Identities=23%  Similarity=0.404  Sum_probs=142.0

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC----e
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK----C  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  261 (368)
                      .++|++.+.||+|+||+||+|++ .+++.||||+++.....+....+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            35799999999999999999985 579999999998765554455678999999999999999999999987653    4


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .|+||||+++++|.+++.....   +++.++..++.||++||+|||++   +|+||||||+|||++.++..+++|||.++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            8999999999999998876543   89999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCC---CccccccccccccCCC
Q 017621          342 LLNFDSS---NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~---~~~~~~gt~~y~aPE~  364 (368)
                      .......   .....+||+.|||||+
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~  185 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQ  185 (277)
T ss_dssp             ECC----------------TTCCHHH
T ss_pred             hhccccccccccccccCcccccCHHH
Confidence            7643322   2344679999999983

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-38  Score=285.19  Aligned_cols=167  Identities=28%  Similarity=0.365  Sum_probs=139.6

Q ss_pred             cceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhH--HhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEee
Q 017621          192 IKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEEL--ASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYEY  268 (368)
Q Consensus       192 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  268 (368)
                      .++.||+|+||+||+|++. +|+.||||+++.......  ...+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3678999999999999964 689999999976443221  1234688999999999999999999999999999999999


Q ss_pred             cCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCCC
Q 017621          269 MEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS  348 (368)
Q Consensus       269 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~  348 (368)
                      +.++++..+.....   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        82 ~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            99887776655332   388889999999999999999999   999999999999999999999999999988766555


Q ss_pred             CccccccccccccCCC
Q 017621          349 NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       349 ~~~~~~gt~~y~aPE~  364 (368)
                      .....+||+.|||||+
T Consensus       156 ~~~~~~gt~~y~aPE~  171 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPEL  171 (299)
T ss_dssp             CCCCSCCCCTTCCHHH
T ss_pred             cccceecChhhccHHH
Confidence            5556689999999984

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-38  Score=282.31  Aligned_cols=171  Identities=30%  Similarity=0.445  Sum_probs=144.4

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++.+.||+|+||+||+|++ .+++.||||+++..... ....+++.+|++++++++|||||++++++.+++..|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            5899999999999999999985 57999999999654332 223468899999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      ||+.++ +.+++.... ...+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.....
T Consensus        81 e~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          81 EFLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             ECCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             eecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            999764 444443322 23489999999999999999999999   9999999999999999999999999999887665


Q ss_pred             CCCccccccccccccCCC
Q 017621          347 SSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE~  364 (368)
                      ........||+.|+|||+
T Consensus       156 ~~~~~~~~gt~~y~apE~  173 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEI  173 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHH
T ss_pred             cccceeecccceeeehhh
Confidence            555556689999999984

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-37  Score=281.19  Aligned_cols=165  Identities=27%  Similarity=0.408  Sum_probs=140.2

Q ss_pred             hhccccce-eeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEee----C
Q 017621          187 TEDFHIKY-CIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLH----R  259 (368)
Q Consensus       187 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~  259 (368)
                      .++|++.. .||+|+||+||+|++ .+++.||||+++..        +.+.+|++++.++ +|||||++++++++    +
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            46898875 699999999999985 57899999998642        3567799887665 89999999999875    4


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC---CCCeEEee
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS---ELEAFVAD  336 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D  336 (368)
                      ..+|+|||||++|+|.+++..... ..+++.++..++.||+.||+|||++   +|+||||||+|||+++   ++.+||+|
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence            568999999999999999986432 3489999999999999999999999   9999999999999985   46799999


Q ss_pred             eccceecCCCCCCccccccccccccCCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ||+|+....... ....+||+.|||||+
T Consensus       158 FG~a~~~~~~~~-~~~~~gt~~y~aPE~  184 (335)
T d2ozaa1         158 FGFAKETTSHNS-LTTPCYTPYYVAPEV  184 (335)
T ss_dssp             CTTCEECCCCCC-CCCCSCCCSSCCCCC
T ss_pred             cceeeeccCCCc-cccccCCcccCCcHH
Confidence            999998765433 344689999999994

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-37  Score=281.37  Aligned_cols=179  Identities=30%  Similarity=0.457  Sum_probs=149.5

Q ss_pred             HHHHHHhhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEE
Q 017621          181 QDMIEATEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYG  254 (368)
Q Consensus       181 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  254 (368)
                      .+++...++|++.+.||+|+||+||+|+..      +++.||||+++.....  ...++|.+|++++++++||||+++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--HHHHHHHHHHHHHHhcCCCCccccee
Confidence            344445678999999999999999999853      4578999999765433  23468999999999999999999999


Q ss_pred             EEeeCCeEEEEEeecCCCChhHHhhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 017621          255 FCLHRKCMFLIYEYMEMGSLFCVLRTDE---------------------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPP  313 (368)
Q Consensus       255 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  313 (368)
                      ++.+.+..+++|||+++|+|.+++....                     ....+++..++.++.|++.||+|||++   +
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~  160 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K  160 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---C
Confidence            9999999999999999999999986432                     123488999999999999999999999   9


Q ss_pred             eeecCCCCCCeeecCCCCeEEeeeccceecCCCCC--CccccccccccccCCC
Q 017621          314 IVHRDISSNNVLLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       314 ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~  364 (368)
                      ||||||||+|||++.++.+||+|||+|+.......  ..+..+||+.|+|||+
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~  213 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  213 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHH
Confidence            99999999999999999999999999987644322  2334578999999983

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3e-37  Score=277.50  Aligned_cols=170  Identities=29%  Similarity=0.426  Sum_probs=144.7

Q ss_pred             hccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEEe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIYE  267 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  267 (368)
                      ++|++.+.||+|+||+||+|++++++.||||++...... ....+++.+|+.++++++||||+++++++...+..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            589999999999999999999989999999999765433 2334788999999999999999999999999999999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      |+.++.+..+.....   .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||.|.......
T Consensus        81 ~~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CCSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            999877766665443   389999999999999999999999   99999999999999999999999999998876555


Q ss_pred             CCccccccccccccCCC
Q 017621          348 SNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~~~~~~gt~~y~aPE~  364 (368)
                      .......||+.|+|||.
T Consensus       155 ~~~~~~~~~~~y~~pE~  171 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDV  171 (286)
T ss_dssp             -------CCCTTCCHHH
T ss_pred             cccceecccchhhhHHH
Confidence            55555679999999983

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-37  Score=275.02  Aligned_cols=170  Identities=26%  Similarity=0.420  Sum_probs=134.1

Q ss_pred             hccccceeeeecCCccEEEEEcC--CC--CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP--SG--KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|++.+.||+|+||+||+|+..  ++  ..||||++.+....+....++|.+|++++++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            67999999999999999999742  23  36899999876555555567899999999999999999999999764 678


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                      +||||+++|++.+.+.....  .+++..++.++.||++||.|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999988775432  389999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCC---ccccccccccccCC
Q 017621          344 NFDSSN---RTLLAGTSGYIAPA  363 (368)
Q Consensus       344 ~~~~~~---~~~~~gt~~y~aPE  363 (368)
                      ......   .....||..|+|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE  184 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPE  184 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHH
T ss_pred             ccCCCcceecCccccCcccCCHH
Confidence            654432   23346888999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-37  Score=272.81  Aligned_cols=170  Identities=29%  Similarity=0.424  Sum_probs=133.3

Q ss_pred             hhccccceeeeecCCccEEEEEcCC----CCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPS----GKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .++|++.+.||+|+||+||+|++..    +..||||.++.....  ...+.|.+|++++++++||||+++++++.+ +..
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence            4689999999999999999998532    356899998654433  345789999999999999999999999864 568


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      |+||||+++|+|.+++.....  .+++..++.++.||++||+|||++   +|+||||||+||++++++.+||+|||+|+.
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence            999999999999998765432  389999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-CccccccccccccCCC
Q 017621          343 LNFDSS-NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~-~~~~~~gt~~y~aPE~  364 (368)
                      ...... ......||+.|+|||+
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~  180 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPES  180 (273)
T ss_dssp             -------------CCGGGCCHHH
T ss_pred             ccCCcceeccceecCcccchhhH
Confidence            654332 2334578999999984

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-36  Score=273.68  Aligned_cols=169  Identities=26%  Similarity=0.381  Sum_probs=138.9

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC----eE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK----CM  262 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  262 (368)
                      .++|.+.+.||+|+||+||+|++ +|+.||||+++.....    ......|+..+.+++||||+++++++.+.+    .+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            35788999999999999999997 6889999998654321    122334556667889999999999998654    58


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHH-----CTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                      |+|||||++|+|.+++++.    .++|.+++.++.|++.||+|+|+.     ..++|+||||||+|||++.++.+||+||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            9999999999999999864    289999999999999999999973     1249999999999999999999999999


Q ss_pred             ccceecCCCCC----CccccccccccccCCC
Q 017621          338 GVARLLNFDSS----NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~----~~~~~~gt~~y~aPE~  364 (368)
                      |+++.......    ......||+.|||||+
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  183 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  183 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHH
T ss_pred             CccccccCCCcceeccccceecccCcCChhh
Confidence            99998755432    2234579999999996

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-36  Score=275.57  Aligned_cols=172  Identities=24%  Similarity=0.399  Sum_probs=135.5

Q ss_pred             hhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  259 (368)
                      .++|++.+.||+|+||+||+|++.      +++.||||+++......  ..+.+.+|...+.++ +|+||+.+++++...
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH--HHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            468999999999999999999742      35689999997544332  346778888888887 789999999988764


Q ss_pred             -CeEEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCee
Q 017621          260 -KCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVL  325 (368)
Q Consensus       260 -~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl  325 (368)
                       +..++|||||++|+|.++++....             ...+++.+++.++.||++||+|||++   +|+||||||+|||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL  166 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL  166 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence             468999999999999999975432             23488999999999999999999999   9999999999999


Q ss_pred             ecCCCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          326 LNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       326 l~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      +++++.+||+|||+|+.......  .....+||+.|||||
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE  206 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  206 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHH
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchh
Confidence            99999999999999987654333  234467999999998

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=277.16  Aligned_cols=168  Identities=24%  Similarity=0.456  Sum_probs=137.6

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCC----EEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGK----VVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCM  262 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  262 (368)
                      .+|++.+.||+|+||+||+|.+. +|+    .||+|+++.....  ...++|.+|++++++++|||||+++++|.+++ .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST-V   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-e
Confidence            47999999999999999999853 444    5899988654332  24578999999999999999999999998754 6


Q ss_pred             EEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          263 FLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       263 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      ++++||+.+|+|.+.+.....  .+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             eEEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence            788999999999988876533  389999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCC--ccccccccccccCC
Q 017621          343 LNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      .......  .....||+.|||||
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE  183 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALE  183 (317)
T ss_dssp             TTTTCC--------CCTTTSCHH
T ss_pred             cccccccccccccccCccccChH
Confidence            7654332  23346899999998

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-37  Score=273.62  Aligned_cols=168  Identities=24%  Similarity=0.351  Sum_probs=141.5

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhH---HhHHHHHHHHHHHhccC--CCceeeEEEEEeeCCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEEL---ASLESFRNEARLLSQIW--HRNIVKLYGFCLHRKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  261 (368)
                      ++|++.+.||+|+||+||+|++ .+++.||||++......+.   ....++.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999985 5789999999875432211   11234668999999986  8999999999999999


Q ss_pred             EEEEEeecCC-CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-CCCeEEeeecc
Q 017621          262 MFLIYEYMEM-GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-ELEAFVADFGV  339 (368)
Q Consensus       262 ~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFg~  339 (368)
                      .|+||||+.+ +++.+++....   .+++.++..++.||++||+|||++   +|+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 57778776543   389999999999999999999999   9999999999999985 47999999999


Q ss_pred             ceecCCCCCCccccccccccccCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      |+.....  ..+..+||+.|||||
T Consensus       158 a~~~~~~--~~~~~~GT~~y~aPE  179 (273)
T d1xwsa_         158 GALLKDT--VYTDFDGTRVYSPPE  179 (273)
T ss_dssp             CEECCSS--CBCCCCSCGGGSCHH
T ss_pred             ceecccc--cccccccCCCcCCHH
Confidence            9876433  234568999999998

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-36  Score=268.55  Aligned_cols=165  Identities=27%  Similarity=0.448  Sum_probs=135.4

Q ss_pred             hhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee-CCeEEEE
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH-RKCMFLI  265 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  265 (368)
                      .++|++.+.||+|+||.||+|++ .|+.||||+++....     .++|.+|++++++++||||++++|++.+ .+.+|+|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            35789999999999999999998 578899999976442     3678999999999999999999999865 4568999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCC
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNF  345 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~  345 (368)
                      |||+++|+|.+++..... ..+++..+++++.||+.||.|||+.   +|+||||||+|||++.++.+|++|||+++....
T Consensus        80 ~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence            999999999999975432 2389999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccCCC
Q 017621          346 DSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       346 ~~~~~~~~~gt~~y~aPE~  364 (368)
                      .   .....+|+.|+|||+
T Consensus       156 ~---~~~~~~~~~y~aPE~  171 (262)
T d1byga_         156 T---QDTGKLPVKWTAPEA  171 (262)
T ss_dssp             ---------CCTTTSCHHH
T ss_pred             C---CccccccccCCChHH
Confidence            2   233468999999983

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-36  Score=271.78  Aligned_cols=170  Identities=28%  Similarity=0.503  Sum_probs=141.2

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCC--EEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeCCeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGK--VVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  263 (368)
                      ++|++.+.||+|+||+||+|++. ++.  .||||++......  ...++|.+|+++++++ +|||||++++++.+.+..|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            68999999999999999999864 343  4788887544332  2346799999999999 7999999999999999999


Q ss_pred             EEEeecCCCChhHHhhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC
Q 017621          264 LIYEYMEMGSLFCVLRTD-------------EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL  330 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~  330 (368)
                      +||||+++|+|.++++..             .....+++.++..++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence            999999999999999754             2234589999999999999999999999   999999999999999999


Q ss_pred             CeEEeeeccceecCCCCCCccccccccccccCC
Q 017621          331 EAFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       331 ~~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      .+||+|||+|+........ ....||..|+|||
T Consensus       165 ~~kl~DfG~a~~~~~~~~~-~~~~gt~~y~aPE  196 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKK-TMGRLPVRWMAIE  196 (309)
T ss_dssp             CEEECCTTCEESSCEECCC-----CCTTTCCHH
T ss_pred             ceEEccccccccccccccc-cceecCCcccchH
Confidence            9999999999876543322 3446899999998

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-36  Score=271.25  Aligned_cols=172  Identities=27%  Similarity=0.423  Sum_probs=148.1

Q ss_pred             hhccccceeeeecCCccEEEEEc------CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEeeC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL------PSGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCLHR  259 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  259 (368)
                      .++|++.+.||+|+||.||+|++      .+++.||||+++.....  ....+|.+|+.+++++ +|||||++++++.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            46899999999999999999974      34678999999765433  2446789999999999 799999999999999


Q ss_pred             CeEEEEEeecCCCChhHHhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDE---------------EAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV  324 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  324 (368)
                      +..|+|||||++|+|.++++...               ....+++..+..++.||++||+|||++   +++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence            99999999999999999997543               123489999999999999999999999   999999999999


Q ss_pred             eecCCCCeEEeeeccceecCCCCCC--ccccccccccccCC
Q 017621          325 LLNSELEAFVADFGVARLLNFDSSN--RTLLAGTSGYIAPA  363 (368)
Q Consensus       325 ll~~~~~~kl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE  363 (368)
                      +++.++.+|++|||.++........  ....+||+.|+|||
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE  217 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE  217 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHH
Confidence            9999999999999999987654332  23457999999998

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-35  Score=267.21  Aligned_cols=172  Identities=27%  Similarity=0.391  Sum_probs=142.3

Q ss_pred             hhccccceeeeecCCccEEEEEcC--------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhcc-CCCceeeEEEEEe
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP--------SGKVVALKKLHRSETEELASLESFRNEARLLSQI-WHRNIVKLYGFCL  257 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  257 (368)
                      .++|++.+.||+|+||.||+|+..        ++..||||+++.....  ....++.+|...+.++ +|||||+++++|.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh--HHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            468999999999999999999742        2347999999765543  2346788899999888 8999999999999


Q ss_pred             eCCeEEEEEeecCCCChhHHhhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCe
Q 017621          258 HRKCMFLIYEYMEMGSLFCVLRTDEE-------------AVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNV  324 (368)
Q Consensus       258 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI  324 (368)
                      +++..++||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||++   +||||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence            99999999999999999999975431             23489999999999999999999999   999999999999


Q ss_pred             eecCCCCeEEeeeccceecCCCCC--CccccccccccccCC
Q 017621          325 LLNSELEAFVADFGVARLLNFDSS--NRTLLAGTSGYIAPA  363 (368)
Q Consensus       325 ll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE  363 (368)
                      |++.++.+||+|||+++.......  ......||+.|+|||
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  207 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE  207 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhh
Confidence            999999999999999998765433  233457999999998

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-35  Score=264.22  Aligned_cols=165  Identities=25%  Similarity=0.426  Sum_probs=139.0

Q ss_pred             ceeeeecCCccEEEEEcCCC----CEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee-CCeEEEEEe
Q 017621          193 KYCIGTGGYGSVYRARLPSG----KVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH-RKCMFLIYE  267 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  267 (368)
                      .++||+|+||+||+|++.++    ..||||+++.....  ...++|.+|++++++++||||++++|++.+ ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            57899999999999986432    25899998754332  345789999999999999999999999876 468999999


Q ss_pred             ecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCCC
Q 017621          268 YMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFDS  347 (368)
Q Consensus       268 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~~  347 (368)
                      ||++|+|.+++.....  ..++..++.++.|++.||.|+|+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       110 ~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999999886543  378888999999999999999999   99999999999999999999999999999875432


Q ss_pred             CC----ccccccccccccCCC
Q 017621          348 SN----RTLLAGTSGYIAPAS  364 (368)
Q Consensus       348 ~~----~~~~~gt~~y~aPE~  364 (368)
                      ..    .....||+.|+|||+
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~  205 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALES  205 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHH
T ss_pred             cccceecccccccccccChHH
Confidence            21    223468999999984

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-35  Score=267.21  Aligned_cols=173  Identities=22%  Similarity=0.357  Sum_probs=147.4

Q ss_pred             hhccccceeeeecCCccEEEEEcC------CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARLP------SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  260 (368)
                      .++|++.+.||+|+||+||+|.+.      +++.||||+++.....  .....|.+|++++++++||||+++++++...+
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh--HHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            468999999999999999999752      3578999999764433  24467899999999999999999999999999


Q ss_pred             eEEEEEeecCCCChhHHhhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeE
Q 017621          261 CMFLIYEYMEMGSLFCVLRTD-------EEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAF  333 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  333 (368)
                      ..++||||+++|+|.+++...       .....+++..+..++.|+++||.|||++   +|+||||||+|||+++++++|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEE
Confidence            999999999999999988642       2223478999999999999999999999   999999999999999999999


Q ss_pred             EeeeccceecCCCCCC--ccccccccccccCCC
Q 017621          334 VADFGVARLLNFDSSN--RTLLAGTSGYIAPAS  364 (368)
Q Consensus       334 l~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~  364 (368)
                      |+|||+|+........  .....||+.|+|||+
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~  206 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  206 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHH
Confidence            9999999877544332  233468999999984

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-35  Score=273.62  Aligned_cols=164  Identities=26%  Similarity=0.376  Sum_probs=135.2

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC------Ce
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR------KC  261 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  261 (368)
                      +|+..++||+|+||+||+|++ .+++.||||++.....       ...+|++++++++||||+++++++...      .+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            688899999999999999986 4699999999976432       234699999999999999999998543      35


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-CeEEeeeccc
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-EAFVADFGVA  340 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFg~a  340 (368)
                      +|+|||||+++.+..+.........+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||++
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            799999998765444433222334589999999999999999999999   999999999999999775 8999999999


Q ss_pred             eecCCCCCCccccccccccccCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      +....... ....+||+.|+|||
T Consensus       171 ~~~~~~~~-~~~~~gt~~y~aPE  192 (350)
T d1q5ka_         171 KQLVRGEP-NVSYICSRYYRAPE  192 (350)
T ss_dssp             EECCTTSC-CCSCCSCTTSCCHH
T ss_pred             hhccCCcc-cccccccccccChH
Confidence            88764433 33457999999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.8e-34  Score=264.31  Aligned_cols=161  Identities=20%  Similarity=0.330  Sum_probs=139.2

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeC--CeEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHR--KCMF  263 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~  263 (368)
                      ++|++.+.||+|+||+||+|++ .+++.||||+++....      +++.+|+++|++++ ||||+++++++...  ...+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH------HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            5899999999999999999986 5789999999875432      56789999999995 99999999998754  5699


Q ss_pred             EEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCC-CeEEeeecccee
Q 017621          264 LIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSEL-EAFVADFGVARL  342 (368)
Q Consensus       264 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFg~a~~  342 (368)
                      +||||+++++|..+.+      .+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|+.
T Consensus       109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence            9999999999977643      289999999999999999999999   999999999999998655 689999999998


Q ss_pred             cCCCCCCccccccccccccCCC
Q 017621          343 LNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       343 ~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      ...... ....+||+.|+|||.
T Consensus       180 ~~~~~~-~~~~~~t~~y~aPE~  200 (328)
T d3bqca1         180 YHPGQE-YNVRVASRYFKGPEL  200 (328)
T ss_dssp             CCTTCC-CCSCCSCGGGCCHHH
T ss_pred             ccCCCc-ccccccCccccCccc
Confidence            764433 344579999999983

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-35  Score=267.18  Aligned_cols=170  Identities=29%  Similarity=0.460  Sum_probs=136.3

Q ss_pred             hhccccceeeeecCCccEEEEEc-CC-CCEEEEEEccccchhhHHhHHHHHHHHHHHhcc---CCCceeeEEEEEee---
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PS-GKVVALKKLHRSETEELASLESFRNEARLLSQI---WHRNIVKLYGFCLH---  258 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---  258 (368)
                      .++|++.+.||+|+||+||+|++ .+ ++.||||+++.....+. ....+.+|+.+++.+   +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            46899999999999999999986 34 56799999865433221 123455677776655   79999999999853   


Q ss_pred             --CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEee
Q 017621          259 --RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVAD  336 (368)
Q Consensus       259 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  336 (368)
                        ....+++|||++++++........  ..+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ccCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence              346899999999877655544332  3489999999999999999999999   999999999999999999999999


Q ss_pred             eccceecCCCCCCccccccccccccCC
Q 017621          337 FGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       337 Fg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ||+++...... .....+||+.|||||
T Consensus       160 fg~~~~~~~~~-~~~~~~gT~~Y~APE  185 (305)
T d1blxa_         160 FGLARIYSFQM-ALTSVVVTLWYRAPE  185 (305)
T ss_dssp             CCSCCCCCGGG-GGCCCCCCCTTCCHH
T ss_pred             hhhhhhhcccc-cCCCcccChhhcCcc
Confidence            99998654332 334568999999998

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-34  Score=267.88  Aligned_cols=165  Identities=28%  Similarity=0.372  Sum_probs=136.8

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC-----
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK-----  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  260 (368)
                      .++|++++.||+|+||+||+|.+ .+|+.||||+++..... ....+.+.+|+++|++++|||||+++++|...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            45799999999999999999985 56999999999764432 234578889999999999999999999998654     


Q ss_pred             -eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeecc
Q 017621          261 -CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGV  339 (368)
Q Consensus       261 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~  339 (368)
                       .+|+||||+ +.+|..+.+..    .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence             479999999 45777777643    389999999999999999999999   999999999999999999999999999


Q ss_pred             ceecCCCCCCccccccccccccCC
Q 017621          340 ARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       340 a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      |+.....   .+...||+.|+|||
T Consensus       168 a~~~~~~---~~~~~~t~~y~aPE  188 (346)
T d1cm8a_         168 ARQADSE---MTGYVVTRWYRAPE  188 (346)
T ss_dssp             CEECCSS---CCSSCSCGGGCCTH
T ss_pred             eeccCCc---cccccccccccCHH
Confidence            9887543   23457999999998

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-34  Score=264.95  Aligned_cols=169  Identities=25%  Similarity=0.331  Sum_probs=139.2

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCC----e
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRK----C  261 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  261 (368)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++......  ...+++.+|+++|++++||||+++++++....    .
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh--HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            35799999999999999999975 57999999999764432  34467889999999999999999999987653    2


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .+++++|+.+|+|.+++...    .+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+||+|||+|+
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            34455667789999999754    389999999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCC---CccccccccccccCCC
Q 017621          342 LLNFDSS---NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       342 ~~~~~~~---~~~~~~gt~~y~aPE~  364 (368)
                      .......   .....+||+.|+|||+
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~  183 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEI  183 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGG
T ss_pred             eccCCCccceeeccccccceechHHH
Confidence            7654322   2234579999999994

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-34  Score=256.99  Aligned_cols=169  Identities=25%  Similarity=0.361  Sum_probs=149.4

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeCCeEEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHRKCMFLIY  266 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  266 (368)
                      ++|++++.||+|+||+||+|++ .+++.||||+++..... ....+++.+|+.+++.++||||+++++++.+.+..++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            5799999999999999999986 57899999998654432 234578899999999999999999999999999999999


Q ss_pred             eecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccceecCCC
Q 017621          267 EYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVARLLNFD  346 (368)
Q Consensus       267 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~~~~  346 (368)
                      |++.++++..++....   .+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||.|+.....
T Consensus        81 ~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          81 EFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999999888877543   388999999999999999999999   9999999999999999999999999999988766


Q ss_pred             CCCccccccccccccCC
Q 017621          347 SSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       347 ~~~~~~~~gt~~y~aPE  363 (368)
                      ........+++.|+|||
T Consensus       155 ~~~~~~~~~~~~~~~pe  171 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPD  171 (292)
T ss_dssp             CSCCCSCCSCGGGCCHH
T ss_pred             Cccceeeccccchhhhh
Confidence            55555567888999997

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-34  Score=262.96  Aligned_cols=171  Identities=26%  Similarity=0.412  Sum_probs=138.4

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee-------
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH-------  258 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  258 (368)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++......+ ...+++.+|++++++++||||+++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            47899999999999999999986 579999999986654322 234678899999999999999999998865       


Q ss_pred             -CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeee
Q 017621          259 -RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADF  337 (368)
Q Consensus       259 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  337 (368)
                       .+..|+||||++++.+.......   ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             cCceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence             34589999999877665444332   2388899999999999999999999   9999999999999999999999999


Q ss_pred             ccceecCCCCC----CccccccccccccCCC
Q 017621          338 GVARLLNFDSS----NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       338 g~a~~~~~~~~----~~~~~~gt~~y~aPE~  364 (368)
                      |+++.......    .....+||+.|+|||+
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~  192 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPEL  192 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHH
Confidence            99987653222    2233579999999983

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6e-34  Score=256.45  Aligned_cols=166  Identities=21%  Similarity=0.310  Sum_probs=140.7

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC-CceeeEEEEEeeCCeEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH-RNIVKLYGFCLHRKCMFLI  265 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv  265 (368)
                      ++|++.+.||+|+||+||+|++ .+++.||||++......     +.+.+|++.++.++| +|++.+++++.++...++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            5799999999999999999985 46889999988654322     356778899999965 8999999999999999999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecC-----CCCeEEeeeccc
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNS-----ELEAFVADFGVA  340 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFg~a  340 (368)
                      |||+ +++|.+++.....  .+++..+..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+|
T Consensus        80 me~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence            9999 5799998876443  389999999999999999999999   9999999999999974     578999999999


Q ss_pred             eecCCCCC-------CccccccccccccCCC
Q 017621          341 RLLNFDSS-------NRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~-------~~~~~~gt~~y~aPE~  364 (368)
                      +.+.....       .....+||+.|||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~  184 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINT  184 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHH
Confidence            98754322       2334579999999983

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-34  Score=264.58  Aligned_cols=170  Identities=30%  Similarity=0.442  Sum_probs=145.8

Q ss_pred             hccccceeeeecCCccEEEEEc----CCCCEEEEEEccccchh-hHHhHHHHHHHHHHHhccCC-CceeeEEEEEeeCCe
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL----PSGKVVALKKLHRSETE-ELASLESFRNEARLLSQIWH-RNIVKLYGFCLHRKC  261 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  261 (368)
                      ++|++.+.||+|+||+||+|+.    .+|+.||||.+++.... +....+.+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999974    25889999998754321 11223567889999999976 899999999999999


Q ss_pred             EEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccce
Q 017621          262 MFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVAR  341 (368)
Q Consensus       262 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~  341 (368)
                      .+++|||+.+|+|.+++.....   +++..+..++.||+.||+|+|++   +|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999976543   78889999999999999999999   99999999999999999999999999998


Q ss_pred             ecCCCCC-CccccccccccccCC
Q 017621          342 LLNFDSS-NRTLLAGTSGYIAPA  363 (368)
Q Consensus       342 ~~~~~~~-~~~~~~gt~~y~aPE  363 (368)
                      .+..... ......||+.|+|||
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe  200 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPD  200 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHH
T ss_pred             hhcccccccccccccccccchhH
Confidence            7754332 234467999999997

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.5e-33  Score=260.32  Aligned_cols=166  Identities=27%  Similarity=0.344  Sum_probs=138.1

Q ss_pred             hhccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEeeC-----C
Q 017621          187 TEDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLHR-----K  260 (368)
Q Consensus       187 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  260 (368)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++...... ....+++.+|++++++++|||||++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            46799999999999999999985 57999999999765432 23446788999999999999999999998643     3


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..+++|+|+.+|+|.+++...    .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            356777888899999998653    389999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                      ......   .....||+.|+|||
T Consensus       169 ~~~~~~---~~~~~g~~~y~apE  188 (348)
T d2gfsa1         169 RHTDDE---MTGYVATRWYRAPE  188 (348)
T ss_dssp             -CCTGG---GSSSCHHHHTSCHH
T ss_pred             cccCcc---cccccccccccCch
Confidence            765432   33457999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.98  E-value=1e-32  Score=249.29  Aligned_cols=165  Identities=18%  Similarity=0.291  Sum_probs=134.4

Q ss_pred             hccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCce-eeEEEEEeeCCeEEEE
Q 017621          188 EDFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI-VKLYGFCLHRKCMFLI  265 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv  265 (368)
                      ++|++.+.||+|+||+||+|++ .+++.||||++......     +++.+|+++++.++|+|+ +.+.+++.+.+..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            4699999999999999999985 56899999987654332     357789999999977665 5556666788889999


Q ss_pred             EeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeec---CCCCeEEeeecccee
Q 017621          266 YEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLN---SELEAFVADFGVARL  342 (368)
Q Consensus       266 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFg~a~~  342 (368)
                      |||+. +++.+.+.....  .+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+|+.
T Consensus        82 me~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          82 MELLG-PSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EECCC-CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEcC-CchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            99995 566666654332  389999999999999999999999   999999999999975   455799999999998


Q ss_pred             cCCCCC-------CccccccccccccCC
Q 017621          343 LNFDSS-------NRTLLAGTSGYIAPA  363 (368)
Q Consensus       343 ~~~~~~-------~~~~~~gt~~y~aPE  363 (368)
                      +.....       ......||+.|||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE  183 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASIN  183 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHH
T ss_pred             ccccccccceeccccCCcCCCccccCHH
Confidence            764332       223457999999998

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9e-33  Score=255.48  Aligned_cols=166  Identities=26%  Similarity=0.325  Sum_probs=129.8

Q ss_pred             hccccceeeeecCCccEEEEEcC-CCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCceeeEEEEEee------CC
Q 017621          188 EDFHIKYCIGTGGYGSVYRARLP-SGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIVKLYGFCLH------RK  260 (368)
Q Consensus       188 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  260 (368)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...... ....+++.+|+.++++++||||+++++++..      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            57999999999999999999864 6999999999765432 2344678899999999999999999999964      36


Q ss_pred             eEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEeeeccc
Q 017621          261 CMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVADFGVA  340 (368)
Q Consensus       261 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a  340 (368)
                      ..|+|||||.++.+ +.+..     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence            78999999976544 44432     289999999999999999999999   9999999999999999999999999999


Q ss_pred             eecCCCCCCccccccccccccCCC
Q 017621          341 RLLNFDSSNRTLLAGTSGYIAPAS  364 (368)
Q Consensus       341 ~~~~~~~~~~~~~~gt~~y~aPE~  364 (368)
                      +...... .....+||+.|+|||+
T Consensus       167 ~~~~~~~-~~~~~~~t~~y~aPE~  189 (355)
T d2b1pa1         167 RTAGTSF-MMTPYVVTRYYRAPEV  189 (355)
T ss_dssp             ---------------CCTTCCHHH
T ss_pred             hcccccc-ccccccccccccChhh
Confidence            8765433 3344579999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=2e-28  Score=226.80  Aligned_cols=165  Identities=24%  Similarity=0.311  Sum_probs=130.6

Q ss_pred             ccccceeeeecCCccEEEEEc-CCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-----------CCceeeEEEEE
Q 017621          189 DFHIKYCIGTGGYGSVYRARL-PSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-----------HRNIVKLYGFC  256 (368)
Q Consensus       189 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~  256 (368)
                      +|++.+.||+|+||+||+|++ .+|+.||||+++.....    .+.+.+|+.+++.++           |+||+++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            599999999999999999986 57999999999765432    356778888887775           57899999987


Q ss_pred             ee--CCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCC--
Q 017621          257 LH--RKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSELE--  331 (368)
Q Consensus       257 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~--  331 (368)
                      ..  ....+++|+++..+..............+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++.  
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence            64  35677777777655443333322333448899999999999999999998 5   8999999999999986653  


Q ss_pred             ----eEEeeeccceecCCCCCCccccccccccccCC
Q 017621          332 ----AFVADFGVARLLNFDSSNRTLLAGTSGYIAPA  363 (368)
Q Consensus       332 ----~kl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  363 (368)
                          ++++|||.+.......   ...+||+.|+|||
T Consensus       167 ~~~~~kl~dfg~s~~~~~~~---~~~~gt~~y~aPE  199 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEHY---TNSIQTREYRSPE  199 (362)
T ss_dssp             TEEEEEECCCTTCEETTBCC---CSCCSCGGGCCHH
T ss_pred             ccceeeEeeccccccccccc---ccccccccccChh
Confidence                8999999998765432   3457999999999

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=3.5e-25  Score=186.12  Aligned_cols=138  Identities=20%  Similarity=0.268  Sum_probs=107.8

Q ss_pred             ccceeeeecCCccEEEEEcCCCCEEEEEEccccchh---------------hHHhHHHHHHHHHHHhccCCCceeeEEEE
Q 017621          191 HIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETE---------------ELASLESFRNEARLLSQIWHRNIVKLYGF  255 (368)
Q Consensus       191 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~niv~l~~~  255 (368)
                      .+.+.||+|+||+||+|++.+|+.||||+++.....               .........+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            467899999999999999888999999987532111               01122345678899999999999998866


Q ss_pred             EeeCCeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeeecCCCCCCeeecCCCCeEEe
Q 017621          256 CLHRKCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHCTPPIVHRDISSNNVLLNSELEAFVA  335 (368)
Q Consensus       256 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  335 (368)
                      ..    .+++|||+++..+.+          ++......++.|++++++|||++   +|+||||||+|||++++ .++|+
T Consensus        83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence            32    379999998765432          33344567899999999999999   99999999999999965 58999


Q ss_pred             eeccceecCCC
Q 017621          336 DFGVARLLNFD  346 (368)
Q Consensus       336 DFg~a~~~~~~  346 (368)
                      |||+|+....+
T Consensus       145 DFG~a~~~~~~  155 (191)
T d1zara2         145 DFPQSVEVGEE  155 (191)
T ss_dssp             CCTTCEETTST
T ss_pred             ECCCcccCCCC
Confidence            99999876543

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.58  E-value=7.8e-16  Score=138.32  Aligned_cols=110  Identities=35%  Similarity=0.582  Sum_probs=99.4

Q ss_pred             CCCCCccc--cCCccccCCCCCcEEEecC-ccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCc
Q 017621            1 MYNNKLDG--PIPQELMNCSKLRILILGN-NLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNN   77 (368)
Q Consensus         1 l~~n~l~g--~~p~~~~~l~~l~~l~l~~-N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~   77 (368)
                      |++|.++|  .+|++|++|++|+.|+|++ |+++|.||.+|++|++|++|||++|+++|..|..+..+..|+.+++++|+
T Consensus        57 L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~  136 (313)
T d1ogqa_          57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA  136 (313)
T ss_dssp             EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             CCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccc
Confidence            46788888  6899999999999999997 89999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccCcc---cccccCCCcccccccCCCCC
Q 017621           78 LSGSIPESVKKVP---LLYVSGNNFEVEIPSTSAKA  110 (368)
Q Consensus        78 l~g~~p~~~~~~~---~~~~~~N~~~~~~P~~~~~~  110 (368)
                      +.+.+|..+..++   .+++++|.+++.+|......
T Consensus       137 ~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l  172 (313)
T d1ogqa_         137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF  172 (313)
T ss_dssp             EESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCC
T ss_pred             ccccCchhhccCcccceeeccccccccccccccccc
Confidence            9999999887654   57899999999888765543

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.53  E-value=4.4e-15  Score=133.29  Aligned_cols=101  Identities=26%  Similarity=0.398  Sum_probs=88.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      +++|.+.|.+|..+.++++|+.|++++|.++|.+| .++.+++|+.|||++|+|+|.+|+.++.+++|+.|+|++|+|+|
T Consensus       204 l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g  282 (313)
T d1ogqa_         204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG  282 (313)
T ss_dssp             CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred             ccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccc
Confidence            45788888899889999999999999999998765 79999999999999999999999999999999999999999999


Q ss_pred             ccccc--ccCcccccccCCCcccc
Q 017621           81 SIPES--VKKVPLLYVSGNNFEVE  102 (368)
Q Consensus        81 ~~p~~--~~~~~~~~~~~N~~~~~  102 (368)
                      .+|+.  +.++..+++++|++.+.
T Consensus       283 ~iP~~~~L~~L~~l~l~~N~~l~g  306 (313)
T d1ogqa_         283 EIPQGGNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             ECCCSTTGGGSCGGGTCSSSEEES
T ss_pred             cCCCcccCCCCCHHHhCCCccccC
Confidence            99963  45677788999985543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.51  E-value=1.9e-14  Score=119.74  Aligned_cols=104  Identities=20%  Similarity=0.300  Sum_probs=65.4

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccC-CccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSI-SSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~-p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      ++|+|+ .+|+.+.  ++++.|+|++|+|++.+ +..|+.+++|+.|+|++|++++..+..+..+++|+.|+|++|+|++
T Consensus        16 s~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~   92 (192)
T d1w8aa_          16 TGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE   92 (192)
T ss_dssp             TTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCE
T ss_pred             eCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccc
Confidence            466666 4666554  46777777777776544 3445667777777777777776666667777777777777777775


Q ss_pred             ccccccc---CcccccccCCCcccccccCCC
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIPSTSA  108 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P~~~~  108 (368)
                      ..|..+.   .+..+++++|.++.-.|..+.
T Consensus        93 l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~  123 (192)
T d1w8aa_          93 ISNKMFLGLHQLKTLNLYDNQISCVMPGSFE  123 (192)
T ss_dssp             ECSSSSTTCTTCCEEECCSSCCCEECTTSST
T ss_pred             cCHHHHhCCCcccccccCCccccccCHHHhc
Confidence            4444444   344566777776654444333

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.48  E-value=4.1e-14  Score=108.86  Aligned_cols=95  Identities=21%  Similarity=0.326  Sum_probs=81.8

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+++ .+| .+.++++|++|+|++|+++ .+|+.++.+++|+.|+|++|+++ .+| .++.+++|+.|++++|+|+.
T Consensus         5 Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~   79 (124)
T d1dcea3           5 LAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQ   79 (124)
T ss_dssp             CTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCS
T ss_pred             cCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCC
Confidence            6899998 566 4899999999999999998 78999999999999999999999 566 48899999999999999984


Q ss_pred             ccc--cccc---CcccccccCCCccc
Q 017621           81 SIP--ESVK---KVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p--~~~~---~~~~~~~~~N~~~~  101 (368)
                       +|  ..+.   ++..+++++|+++.
T Consensus        80 -~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          80 -SAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             -SSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             -CCCchhhcCCCCCCEEECCCCcCCc
Confidence             33  3343   56678999998864

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.37  E-value=7.9e-13  Score=109.71  Aligned_cols=102  Identities=22%  Similarity=0.244  Sum_probs=89.7

Q ss_pred             CCCCCccccCC-ccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIP-QELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p-~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|.|++.++ ..+.++++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|+
T Consensus        36 Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~  115 (192)
T d1w8aa_          36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS  115 (192)
T ss_dssp             CCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCC
T ss_pred             eCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCcccc
Confidence            68999998665 56688999999999999999998999999999999999999999877888999999999999999999


Q ss_pred             cccccccc---CcccccccCCCcccc
Q 017621           80 GSIPESVK---KVPLLYVSGNNFEVE  102 (368)
Q Consensus        80 g~~p~~~~---~~~~~~~~~N~~~~~  102 (368)
                      +..|..+.   ++..+++++|++.+.
T Consensus       116 ~i~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_         116 CVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             EECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             ccCHHHhcCCcccccccccccccccc
Confidence            76666555   456789999988654

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=1.9e-12  Score=114.20  Aligned_cols=100  Identities=21%  Similarity=0.234  Sum_probs=46.6

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      ++|.+....+..+..+++|+.+++++|++++..+..|..+++|+.|+|++|++++..|..+..+++|+.+++++|++++.
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i  192 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV  192 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence            34444443333444444555555555555433333444455555555555555544444444455555555555555544


Q ss_pred             cccccc---CcccccccCCCccc
Q 017621           82 IPESVK---KVPLLYVSGNNFEV  101 (368)
Q Consensus        82 ~p~~~~---~~~~~~~~~N~~~~  101 (368)
                      .|..+.   ++..+++++|.+..
T Consensus       193 ~~~~f~~l~~L~~L~l~~N~i~~  215 (284)
T d1ozna_         193 HPHAFRDLGRLMTLYLFANNLSA  215 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSC
T ss_pred             ChhHhhhhhhccccccccccccc
Confidence            444433   22334455554443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.27  E-value=2.1e-12  Score=103.92  Aligned_cols=62  Identities=23%  Similarity=0.274  Sum_probs=29.0

Q ss_pred             cCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621           15 MNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus        15 ~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      .++.+|+.|+|++|+++ .||.-+..+++|+.||||+|+++ .++ .+..+++|+.|++++|+++
T Consensus        15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~   76 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC   76 (162)
T ss_dssp             ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC
T ss_pred             cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc
Confidence            34444455555555554 34433344444555555555444 332 2444445555555555544

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.26  E-value=7.5e-12  Score=99.97  Aligned_cols=98  Identities=23%  Similarity=0.257  Sum_probs=80.3

Q ss_pred             CCCCccccCCccccCCCCCcEEEecCcc-ccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            2 YNNKLDGPIPQELMNCSKLRILILGNNL-LSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~l~~N~-~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      +++++. .+|..+..+++|+.|+|++|+ ++..-+..|.++++|+.|+|++|+|+...|.+|..+++|+.|+|++|+|+ 
T Consensus        16 ~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-   93 (156)
T d2ifga3          16 TRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-   93 (156)
T ss_dssp             CSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-
T ss_pred             cCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-
Confidence            455565 478889999999999998764 87433457999999999999999999777888999999999999999999 


Q ss_pred             ccccc-cc--CcccccccCCCccc
Q 017621           81 SIPES-VK--KVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p~~-~~--~~~~~~~~~N~~~~  101 (368)
                      .+|.. +.  .+..+++++|++.+
T Consensus        94 ~l~~~~~~~~~l~~L~L~~Np~~C  117 (156)
T d2ifga3          94 SLSWKTVQGLSLQELVLSGNPLHC  117 (156)
T ss_dssp             CCCSTTTCSCCCCEEECCSSCCCC
T ss_pred             ccChhhhccccccccccCCCcccC
Confidence            56654 33  45578999998853

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.23  E-value=7.4e-12  Score=95.94  Aligned_cols=76  Identities=26%  Similarity=0.390  Sum_probs=68.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCC--cccCCCCCCceecccCCcc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIP--SQLGEIPRIDTVNLSMNNL   78 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p--~~~~~~~~l~~l~l~~n~l   78 (368)
                      |++|+|+ .+|+.++.+++|+.|+|++|+++ .+| +++.+++|+.|++++|+++ .+|  ..++.+++|+.|++++|++
T Consensus        27 ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L~l~~N~i  102 (124)
T d1dcea3          27 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL  102 (124)
T ss_dssp             CCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEEECTTSGG
T ss_pred             CCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccC-CCCCchhhcCCCCCCEEECCCCcC
Confidence            6899998 58989999999999999999998 566 6999999999999999999 444  4688999999999999999


Q ss_pred             cc
Q 017621           79 SG   80 (368)
Q Consensus        79 ~g   80 (368)
                      +.
T Consensus       103 ~~  104 (124)
T d1dcea3         103 CQ  104 (124)
T ss_dssp             GG
T ss_pred             Cc
Confidence            84

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=4.1e-11  Score=104.39  Aligned_cols=106  Identities=23%  Similarity=0.266  Sum_probs=80.1

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++ +|..+.++++|+.|+|++|++.+.-+..+..+.+|+.|++++|.+++..|..+..++.|+.+++++|+|++
T Consensus        84 Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~  162 (266)
T d1p9ag_          84 LSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (266)
T ss_dssp             CCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             cccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence            57888886 56678888899999999988886666677788888888888888886656666778888888888888886


Q ss_pred             ccccccc---CcccccccCCCcccccccCCC
Q 017621           81 SIPESVK---KVPLLYVSGNNFEVEIPSTSA  108 (368)
Q Consensus        81 ~~p~~~~---~~~~~~~~~N~~~~~~P~~~~  108 (368)
                      ..|..+.   ++..+++++|.++ .+|....
T Consensus       163 ~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~  192 (266)
T d1p9ag_         163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFF  192 (266)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCC-CCCTTTT
T ss_pred             cCccccccccccceeecccCCCc-ccChhHC
Confidence            6555444   4556788888877 5665433

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.10  E-value=7.6e-11  Score=104.62  Aligned_cols=78  Identities=27%  Similarity=0.290  Sum_probs=54.0

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++|..++..|..+.++++++.|++++|++++..|..+..+++|+.|+|++|.|+ .+|+.+..+++|+.|+|++|+|+
T Consensus       178 l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         178 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             CTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred             CCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence            3566666666666667777777777777776555666667777777777777776 66666777777777777777776

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.09  E-value=9.1e-11  Score=103.09  Aligned_cols=106  Identities=18%  Similarity=0.183  Sum_probs=60.8

Q ss_pred             CCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccc
Q 017621            3 NNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSI   82 (368)
Q Consensus         3 ~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~   82 (368)
                      .|.++...|..+.++++|+.|+|++|.+.+..+..+..+++|+.+++++|++++..|..+..++.|+.|++++|+|++..
T Consensus        90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~  169 (284)
T d1ozna_          90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (284)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence            44455444555666666666666666665444555566666666666666666444555666666666666666666444


Q ss_pred             ccccc---CcccccccCCCcccccccCCC
Q 017621           83 PESVK---KVPLLYVSGNNFEVEIPSTSA  108 (368)
Q Consensus        83 p~~~~---~~~~~~~~~N~~~~~~P~~~~  108 (368)
                      |..+.   .+..+++++|.+++..|....
T Consensus       170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~  198 (284)
T d1ozna_         170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFR  198 (284)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred             hhhhccccccchhhhhhccccccChhHhh
Confidence            44433   233455666666554444433

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.06  E-value=8.2e-11  Score=94.41  Aligned_cols=96  Identities=16%  Similarity=0.176  Sum_probs=79.2

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+++. +|....++++|++|+|++|+++ .++ .|..+++|+.|+|++|+++...|..+..+++|+.|++++|+++ 
T Consensus        25 L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-  100 (162)
T d1a9na_          25 LRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-  100 (162)
T ss_dssp             CTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-
T ss_pred             CCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-
Confidence            68999985 7876678999999999999998 775 6999999999999999999544445677999999999999998 


Q ss_pred             cccc--cc---cCcccccccCCCcc
Q 017621           81 SIPE--SV---KKVPLLYVSGNNFE  100 (368)
Q Consensus        81 ~~p~--~~---~~~~~~~~~~N~~~  100 (368)
                      .++.  .+   .++..+++++|+++
T Consensus       101 ~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_         101 ELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ccccccccccccccchhhcCCCccc
Confidence            4443  33   45667889999775

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.05  E-value=3.4e-10  Score=98.35  Aligned_cols=105  Identities=21%  Similarity=0.153  Sum_probs=82.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|+. +|. ++.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+.+..+..+..+.++..|++++|.+++
T Consensus        62 L~~N~l~~-l~~-~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~  138 (266)
T d1p9ag_          62 LDRAELTK-LQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT  138 (266)
T ss_dssp             CTTSCCCE-EEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred             cccccccc-ccc-cccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccce
Confidence            57888884 664 578899999999999998 557788899999999999999997777788888999999999999985


Q ss_pred             cccccc---cCcccccccCCCcccccccCCC
Q 017621           81 SIPESV---KKVPLLYVSGNNFEVEIPSTSA  108 (368)
Q Consensus        81 ~~p~~~---~~~~~~~~~~N~~~~~~P~~~~  108 (368)
                      ..|..+   ..+..+++++|.++...+....
T Consensus       139 l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~  169 (266)
T d1p9ag_         139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLN  169 (266)
T ss_dssp             CCTTTTTTCTTCCEEECTTSCCSCCCTTTTT
T ss_pred             eccccccccccchhcccccccccccCccccc
Confidence            444433   3456688999988865554433

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.05  E-value=1.6e-10  Score=92.07  Aligned_cols=78  Identities=21%  Similarity=0.143  Sum_probs=66.1

Q ss_pred             CCCC-CccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621            1 MYNN-KLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus         1 l~~n-~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      |++| .++..-+..|.++++|+.|+|++|+|+..-|..|..+++|+.|||++|+|+ .+|..+....+|+.|+|++|+|.
T Consensus        38 l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          38 IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             cCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence            3444 588655677999999999999999999666778999999999999999999 77766555568999999999995

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.85  E-value=3.7e-09  Score=93.43  Aligned_cols=94  Identities=27%  Similarity=0.418  Sum_probs=78.7

Q ss_pred             CCCccccCCccccCCCCCcEEEecCccccccCCc-cccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccc
Q 017621            3 NNKLDGPIPQELMNCSKLRILILGNNLLSGSISS-EIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGS   81 (368)
Q Consensus         3 ~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~-~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~   81 (368)
                      +++|+ .+|+.+.  ++++.|+|++|+++ .+|+ .|.++++|+.|++++|.++...|..+..++.|+.|++++|+++ .
T Consensus        19 ~~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~   93 (305)
T d1xkua_          19 DLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-E   93 (305)
T ss_dssp             TSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-B
T ss_pred             CCCCC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-c
Confidence            55677 6888775  68999999999998 6665 7999999999999999999777889999999999999999999 5


Q ss_pred             ccccc-cCcccccccCCCccc
Q 017621           82 IPESV-KKVPLLYVSGNNFEV  101 (368)
Q Consensus        82 ~p~~~-~~~~~~~~~~N~~~~  101 (368)
                      +|..+ ..+..+..+.|.+..
T Consensus        94 l~~~~~~~l~~L~~~~n~l~~  114 (305)
T d1xkua_          94 LPEKMPKTLQELRVHENEITK  114 (305)
T ss_dssp             CCSSCCTTCCEEECCSSCCCB
T ss_pred             Cccchhhhhhhhhccccchhh
Confidence            66554 356677788887654

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.84  E-value=1.8e-09  Score=98.32  Aligned_cols=63  Identities=24%  Similarity=0.323  Sum_probs=30.6

Q ss_pred             ccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621           14 LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus        14 ~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      +..+++++.|+|++|++++. + .+..+++|+.|+|++|+++ .+| .++.+++|+.|++++|+|++
T Consensus       303 ~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~  365 (384)
T d2omza2         303 ISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISD  365 (384)
T ss_dssp             GGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCB
T ss_pred             cchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCC
Confidence            44444555555555555432 2 2444555555555555554 233 34455555555555555554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.81  E-value=2.7e-08  Score=85.66  Aligned_cols=151  Identities=12%  Similarity=0.060  Sum_probs=101.4

Q ss_pred             HHHHHHhhccccceeeeecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeC
Q 017621          181 QDMIEATEDFHIKYCIGTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHR  259 (368)
Q Consensus       181 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  259 (368)
                      .++....+.|+..+..+.++.+.||+... +++.+++|+........   ...+.+|...+..+. +--+.+++.+...+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            35666677887766655455678999875 55667788775433221   234567777777662 43467788888888


Q ss_pred             CeEEEEEeecCCCChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------
Q 017621          260 KCMFLIYEYMEMGSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHHHC-----------------------------  310 (368)
Q Consensus       260 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------  310 (368)
                      +..++||++++|.++.+.....     ..   ...++.++++.+..||+..                             
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             CceEEEEEeccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence            8999999999988776543221     11   2234555666666666321                             


Q ss_pred             ---------------------------CCCeeecCCCCCCeeecCCCCeEEeeeccceec
Q 017621          311 ---------------------------TPPIVHRDISSNNVLLNSELEAFVADFGVARLL  343 (368)
Q Consensus       311 ---------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~~  343 (368)
                                                 ...++|+|+.|.|||+++++..-|+||+.+..-
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence                                       113789999999999998766779999988653

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.79  E-value=2.9e-11  Score=100.48  Aligned_cols=85  Identities=24%  Similarity=0.375  Sum_probs=69.4

Q ss_pred             ccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccccc--cccCc
Q 017621           12 QELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPE--SVKKV   89 (368)
Q Consensus        12 ~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~--~~~~~   89 (368)
                      .++.+|++|+.|+|++|+++ .++ .+..|++|+.|+|++|+++ .+|.....+++|+.|++++|+++. ++.  .+.++
T Consensus        42 ~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~~~~l~~L  117 (198)
T d1m9la_          42 ATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLVNL  117 (198)
T ss_dssp             HHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHHHHHHHHS
T ss_pred             hHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cccccccccc
Confidence            46888999999999999998 676 6889999999999999998 788766667789999999999984 443  23456


Q ss_pred             ccccccCCCcc
Q 017621           90 PLLYVSGNNFE  100 (368)
Q Consensus        90 ~~~~~~~N~~~  100 (368)
                      ..+++++|.++
T Consensus       118 ~~L~L~~N~i~  128 (198)
T d1m9la_         118 RVLYMSNNKIT  128 (198)
T ss_dssp             SEEEESEEECC
T ss_pred             cccccccchhc
Confidence            77888888775

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.76  E-value=1.2e-10  Score=96.65  Aligned_cols=96  Identities=24%  Similarity=0.359  Sum_probs=75.9

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+++ .++ .+.+|++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .++ .+..+++|+.|++++|+++.
T Consensus        55 Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~  129 (198)
T d1m9la_          55 LSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITN  129 (198)
T ss_dssp             CSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECCC
T ss_pred             CcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccccchhcc
Confidence            5778888 466 5889999999999999997 78876677788999999999998 454 47788999999999999984


Q ss_pred             ccc--c---cccCcccccccCCCcccc
Q 017621           81 SIP--E---SVKKVPLLYVSGNNFEVE  102 (368)
Q Consensus        81 ~~p--~---~~~~~~~~~~~~N~~~~~  102 (368)
                       ++  .   .+..+..+++++|++...
T Consensus       130 -~~~~~~l~~l~~L~~L~L~~N~l~~~  155 (198)
T d1m9la_         130 -WGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             -HHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred             -ccccccccCCCccceeecCCCccccC
Confidence             33  2   334566788999987643

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.72  E-value=4.5e-09  Score=95.56  Aligned_cols=71  Identities=30%  Similarity=0.531  Sum_probs=62.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNN   77 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~   77 (368)
                      |++|++++ ++ .+.++++|+.|+|++|+++ .+| .++.|++|+.|+|++|++++..|  +..+++|+.|+|++|.
T Consensus       314 ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         314 LYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             CCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             CCCCCCCC-Cc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            57899997 44 3889999999999999998 455 79999999999999999996554  8899999999999984

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.71  E-value=1.6e-08  Score=83.51  Aligned_cols=83  Identities=20%  Similarity=0.318  Sum_probs=44.2

Q ss_pred             ccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccccccc-ccccCcccc
Q 017621           14 LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIP-ESVKKVPLL   92 (368)
Q Consensus        14 ~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p-~~~~~~~~~   92 (368)
                      +..+++|+.|+|++|++++ +++ ++++++|+.|++++|.+. .+|+ +..++.|+.|++++|.+....+ ..+..+..+
T Consensus        58 l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L  133 (199)
T d2omxa2          58 VEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITDIDPLKNLTNLNRL  133 (199)
T ss_dssp             GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEE
T ss_pred             cccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-cccc-cccccccccccccccccccccccchhhhhHHh
Confidence            5555666666666666653 232 556666666666666555 3332 5555666666666665553221 122344455


Q ss_pred             cccCCCcc
Q 017621           93 YVSGNNFE  100 (368)
Q Consensus        93 ~~~~N~~~  100 (368)
                      ++++|.+.
T Consensus       134 ~l~~n~l~  141 (199)
T d2omxa2         134 ELSSNTIS  141 (199)
T ss_dssp             ECCSSCCC
T ss_pred             hhhhhhhc
Confidence            56665543

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.67  E-value=2.4e-08  Score=82.40  Aligned_cols=94  Identities=28%  Similarity=0.399  Sum_probs=73.1

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|++++ +++ ++++++|+.|++++|.+. .+| .++++++|+.|++++|.+...  ..+..+++|+.|++++|+++.
T Consensus        69 Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~  142 (199)
T d2omxa2          69 FSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD  142 (199)
T ss_dssp             CCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred             cccccccC-ccc-ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc
Confidence            67899987 444 899999999999999997 555 588899999999999888843  346778899999999998873


Q ss_pred             cccc--cccCcccccccCCCccc
Q 017621           81 SIPE--SVKKVPLLYVSGNNFEV  101 (368)
Q Consensus        81 ~~p~--~~~~~~~~~~~~N~~~~  101 (368)
                       +|.  .+..+..+++++|.++.
T Consensus       143 -~~~l~~~~~L~~L~l~~n~l~~  164 (199)
T d2omxa2         143 -ISALSGLTSLQQLNFSSNQVTD  164 (199)
T ss_dssp             -CGGGTTCTTCSEEECCSSCCCC
T ss_pred             -cccccccccccccccccccccC
Confidence             442  23355667888887764

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.66  E-value=1.4e-08  Score=85.65  Aligned_cols=63  Identities=29%  Similarity=0.445  Sum_probs=42.0

Q ss_pred             ccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621           14 LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus        14 ~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      +.++++|+.|++++|++++. + .++++++|+.|||++|++++ +|+ +..+++|+.|++++|++++
T Consensus       147 ~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~  209 (227)
T d1h6ua2         147 LAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD  209 (227)
T ss_dssp             GGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB
T ss_pred             hccccccccccccccccccc-h-hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC
Confidence            55666777777777777532 2 36677777777777777763 433 5667777777777777773

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.65  E-value=2.9e-08  Score=82.63  Aligned_cols=58  Identities=21%  Similarity=0.277  Sum_probs=26.4

Q ss_pred             CCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCccc
Q 017621           18 SKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus        18 ~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~   79 (368)
                      .+|+.|++++|+++ .++ .+..+++|+.|+|++|++++ +| .++.+++|+.|++++|+++
T Consensus        46 ~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~  103 (210)
T d1h6ta2          46 NSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK  103 (210)
T ss_dssp             HTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred             cCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc
Confidence            34444555555544 222 24444555555555555442 22 1344445555555555544

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.63  E-value=3.2e-08  Score=82.38  Aligned_cols=93  Identities=20%  Similarity=0.419  Sum_probs=69.8

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      +++|.+.. ++ .+..+++|+.|+|++|++++ ++ .++.|++|+.|+|++|+++ .+| .+..+++|+.|++++|.++ 
T Consensus        53 l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-  125 (210)
T d1h6ta2          53 ANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-  125 (210)
T ss_dssp             CTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-
T ss_pred             CcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-
Confidence            46777775 44 37889999999999999985 55 4788999999999999998 566 4788899999999999886 


Q ss_pred             cccc--cccCcccccccCCCcc
Q 017621           81 SIPE--SVKKVPLLYVSGNNFE  100 (368)
Q Consensus        81 ~~p~--~~~~~~~~~~~~N~~~  100 (368)
                      .++.  .+..+..+++++|.++
T Consensus       126 ~~~~l~~l~~l~~l~~~~n~l~  147 (210)
T d1h6ta2         126 DINGLVHLPQLESLYLGNNKIT  147 (210)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCC
T ss_pred             cccccccccccccccccccccc
Confidence            3332  2224445667777655

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.54  E-value=2.9e-08  Score=83.61  Aligned_cols=69  Identities=28%  Similarity=0.336  Sum_probs=58.1

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccC
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSM   75 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~   75 (368)
                      +++|.+++. + .++++++|+.|+|++|+++ .+| .++.+++|+.|+|++|+++ .+|+ +..+++|+.|++++
T Consensus       158 l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~-~l~-~l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         158 IGNAQVSDL-T-PLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTN  226 (227)
T ss_dssp             CCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEEEEEE
T ss_pred             ccccccccc-h-hhcccccceecccCCCccC-CCh-hhcCCCCCCEEECcCCcCC-CCcc-cccCCCCCEEEeeC
Confidence            457777653 3 4889999999999999998 455 4899999999999999999 5653 88999999999984

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.42  E-value=4.6e-07  Score=77.24  Aligned_cols=131  Identities=18%  Similarity=0.133  Sum_probs=85.4

Q ss_pred             eeeecCC-ccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCC--CceeeEEEEEeeCCeEEEEEeecCC
Q 017621          195 CIGTGGY-GSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWH--RNIVKLYGFCLHRKCMFLIYEYMEM  271 (368)
Q Consensus       195 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~  271 (368)
                      .+..|.. +.||+....++..+++|.......      ..+..|.+.++.+..  --+.+++.+..+++..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            3445543 679999987888889998765432      235667777776632  3356778888888889999999988


Q ss_pred             CChhHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 017621          272 GSLFCVLRTDEEAVGLDWAKRVNIVKGMAHALSYLHH-------------------------------------------  308 (368)
Q Consensus       272 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-------------------------------------------  308 (368)
                      .++.+..        ....   ..+.++++.|.-||+                                           
T Consensus        91 ~~~~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (255)
T d1nd4a_          91 QDLLSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  159 (255)
T ss_dssp             EETTTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             ccccccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence            6653210        1101   112223333333331                                           


Q ss_pred             --------CC----CCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          309 --------HC----TPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       309 --------~~----~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                              ..    .+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus       160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                    11    12379999999999999876677999998865

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.36  E-value=3.1e-07  Score=81.78  Aligned_cols=55  Identities=27%  Similarity=0.425  Sum_probs=36.1

Q ss_pred             CCCCCeeeeecccccccCCcccCCCCCCceecccCCcccccccccccCcccccccCCCcc
Q 017621           41 LQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLYVSGNNFE  100 (368)
Q Consensus        41 ~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~~~~~~~~~~~~~N~~~  100 (368)
                      +++|+.|+|++|+++ .+|+.   +++|+.|+|++|+|+ .+|+.+.++..+++++|+++
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPLR  337 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCS
T ss_pred             CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccccCCCCEEECcCCcCC
Confidence            556777777777776 56643   356666777777776 56666666666777777654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.34  E-value=3.2e-07  Score=77.61  Aligned_cols=94  Identities=20%  Similarity=0.334  Sum_probs=72.6

Q ss_pred             CCCccccCCccccCCCCCcEEEecCccccccCCc-cccCCCCCCeeeeecccccccCCc-ccCCCCCCceeccc-CCccc
Q 017621            3 NNKLDGPIPQELMNCSKLRILILGNNLLSGSISS-EIGKLQELNYLDLSHNLINGKIPS-QLGEIPRIDTVNLS-MNNLS   79 (368)
Q Consensus         3 ~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~-~~~~~~~L~~l~l~~N~l~g~~p~-~~~~~~~l~~l~l~-~n~l~   79 (368)
                      +++++ .+|+++.  ++++.|+|++|+++ .+|. .|.++++|+.|+|++|.+...+|. .+..++.+..+.+. .|+++
T Consensus        17 ~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~   92 (242)
T d1xwdc1          17 ESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL   92 (242)
T ss_dssp             SCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCC
T ss_pred             CCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccc
Confidence            45566 6887764  57999999999998 5554 689999999999999998876654 57888999998875 47787


Q ss_pred             cccccccc---CcccccccCCCcc
Q 017621           80 GSIPESVK---KVPLLYVSGNNFE  100 (368)
Q Consensus        80 g~~p~~~~---~~~~~~~~~N~~~  100 (368)
                      ...|..+.   .+..+++++|.+.
T Consensus        93 ~~~~~~~~~l~~L~~l~l~~~~l~  116 (242)
T d1xwdc1          93 YINPEAFQNLPNLQYLLISNTGIK  116 (242)
T ss_dssp             EECTTSEECCTTCCEEEEESCCCC
T ss_pred             ccccccccccccccccccchhhhc
Confidence            66665554   5566888888765

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.30  E-value=5.4e-07  Score=76.18  Aligned_cols=81  Identities=14%  Similarity=0.148  Sum_probs=69.4

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCc-cccCCCCCCeeeeec-ccccccCCcccCCCCCCceecccCCcc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISS-EIGKLQELNYLDLSH-NLINGKIPSQLGEIPRIDTVNLSMNNL   78 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~-~~~~~~~L~~l~l~~-N~l~g~~p~~~~~~~~l~~l~l~~n~l   78 (368)
                      |++|+++...+..+.++++|+.|+|++|.+...+|. .|..++.++.|+++. |+++...|..+..+++|+.+++++|++
T Consensus        36 Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l  115 (242)
T d1xwdc1          36 FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI  115 (242)
T ss_dssp             EESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCC
T ss_pred             CcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhh
Confidence            468999864455689999999999999999876654 688999999999864 788888888899999999999999999


Q ss_pred             ccc
Q 017621           79 SGS   81 (368)
Q Consensus        79 ~g~   81 (368)
                      +..
T Consensus       116 ~~~  118 (242)
T d1xwdc1         116 KHL  118 (242)
T ss_dssp             CSC
T ss_pred             ccc
Confidence            743

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.23  E-value=8.1e-07  Score=78.97  Aligned_cols=87  Identities=22%  Similarity=0.324  Sum_probs=43.6

Q ss_pred             CCCCCccccCCccccCCCCCcEEEecCccccccCCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccCCcccc
Q 017621            1 MYNNKLDGPIPQELMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      |++|+|+ .+|+.   +++|+.|+|++|+|+ .+|..+   .+|+.|++++|+++ .++..   .+.|+.|++++|.++ 
T Consensus        45 Ls~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-  111 (353)
T d1jl5a_          45 LNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-  111 (353)
T ss_dssp             CTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-
T ss_pred             eCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc-
Confidence            4555555 35532   245566666666665 555432   34555666666555 44431   134566666666665 


Q ss_pred             ccccc--ccCcccccccCCCcc
Q 017621           81 SIPES--VKKVPLLYVSGNNFE  100 (368)
Q Consensus        81 ~~p~~--~~~~~~~~~~~N~~~  100 (368)
                      .+|..  +..+..+++++|.+.
T Consensus       112 ~lp~~~~l~~L~~L~l~~~~~~  133 (353)
T d1jl5a_         112 KLPELQNSSFLKIIDVDNNSLK  133 (353)
T ss_dssp             SCCCCTTCTTCCEEECCSSCCS
T ss_pred             cccchhhhccceeecccccccc
Confidence            34431  223444555555443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.20  E-value=1.5e-07  Score=74.82  Aligned_cols=86  Identities=24%  Similarity=0.268  Sum_probs=46.3

Q ss_pred             ccCCCCCcEEEecCccccccCCccccCCCCCCeeeeeccccccc--CCcccCCCCCCceecccCCcccccccc----ccc
Q 017621           14 LMNCSKLRILILGNNLLSGSISSEIGKLQELNYLDLSHNLINGK--IPSQLGEIPRIDTVNLSMNNLSGSIPE----SVK   87 (368)
Q Consensus        14 ~~~l~~l~~l~l~~N~~~g~~p~~~~~~~~L~~l~l~~N~l~g~--~p~~~~~~~~l~~l~l~~n~l~g~~p~----~~~   87 (368)
                      +..+..+..+++.+|... .++..+..+++|+.||||+|+++..  ++..+..+++|+.|+|++|.++ .+++    ...
T Consensus        38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~  115 (162)
T d1koha1          38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGL  115 (162)
T ss_dssp             TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTC
T ss_pred             hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhcc
Confidence            344444444555444443 4444445566777777777776632  2233455667777777777766 3333    112


Q ss_pred             CcccccccCCCccc
Q 017621           88 KVPLLYVSGNNFEV  101 (368)
Q Consensus        88 ~~~~~~~~~N~~~~  101 (368)
                      .+..+++++|+++.
T Consensus       116 ~L~~L~L~~Npl~~  129 (162)
T d1koha1         116 KLEELWLDGNSLSD  129 (162)
T ss_dssp             CCSSCCCTTSTTSS
T ss_pred             ccceeecCCCCcCc
Confidence            34456666666543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.12  E-value=1.3e-07  Score=75.23  Aligned_cols=68  Identities=28%  Similarity=0.229  Sum_probs=54.3

Q ss_pred             cCCCCCcEEEecCcccccc--CCccccCCCCCCeeeeecccccccCCc-ccCCCCCCceecccCCccccccc
Q 017621           15 MNCSKLRILILGNNLLSGS--ISSEIGKLQELNYLDLSHNLINGKIPS-QLGEIPRIDTVNLSMNNLSGSIP   83 (368)
Q Consensus        15 ~~l~~l~~l~l~~N~~~g~--~p~~~~~~~~L~~l~l~~N~l~g~~p~-~~~~~~~l~~l~l~~n~l~g~~p   83 (368)
                      .++++|+.|+|++|+++..  ++..+..|++|+.|||++|+++ .+++ .......|+.|++++|+++....
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~  132 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR  132 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence            4688999999999999842  3455778999999999999999 5654 33344579999999999986554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.05  E-value=7.1e-06  Score=74.50  Aligned_cols=79  Identities=14%  Similarity=0.116  Sum_probs=48.1

Q ss_pred             ceeeeecCCccEEEEEcCC-CCEEEEEEccccch--hh--HHhHHHHHHHHHHHhcc-CC--CceeeEEEEEeeCCeEEE
Q 017621          193 KYCIGTGGYGSVYRARLPS-GKVVALKKLHRSET--EE--LASLESFRNEARLLSQI-WH--RNIVKLYGFCLHRKCMFL  264 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~--~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~l  264 (368)
                      .+.||.|....||+....+ ++.+++|.-.+...  .+  ....++...|.+.+..+ .+  ..+++++.+.  .+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            4568999999999998754 67889996433110  00  01223455677777666 22  3466666553  444678


Q ss_pred             EEeecCCCC
Q 017621          265 IYEYMEMGS  273 (368)
Q Consensus       265 v~e~~~~g~  273 (368)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999998654

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.90  E-value=5.1e-06  Score=71.97  Aligned_cols=85  Identities=26%  Similarity=0.322  Sum_probs=43.2

Q ss_pred             CCCCCcEEEecCc-cccccCCccccCCCCCCeeeeec-ccccccCCcccCCCCCCceecccCCcccccccccccCccccc
Q 017621           16 NCSKLRILILGNN-LLSGSISSEIGKLQELNYLDLSH-NLINGKIPSQLGEIPRIDTVNLSMNNLSGSIPESVKKVPLLY   93 (368)
Q Consensus        16 ~l~~l~~l~l~~N-~~~g~~p~~~~~~~~L~~l~l~~-N~l~g~~p~~~~~~~~l~~l~l~~n~l~g~~p~~~~~~~~~~   93 (368)
                      +|++|+.|+|++| .+++..+..++.+++|+.|+|++ ++++..-...++++++|+.|+++++--.+.++.-...++.+.
T Consensus       173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l~~l~~~lp~L~  252 (284)
T d2astb2         173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ  252 (284)
T ss_dssp             HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCHHHHHHHSTTSE
T ss_pred             ccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHHHHHHHHhCcccc
Confidence            4555666666553 35544455555566666666655 355554445555556666666655422222222223344455


Q ss_pred             ccCCCcc
Q 017621           94 VSGNNFE  100 (368)
Q Consensus        94 ~~~N~~~  100 (368)
                      +..++++
T Consensus       253 i~~~~ls  259 (284)
T d2astb2         253 INCSHFT  259 (284)
T ss_dssp             ESCCCSC
T ss_pred             ccCccCC
Confidence            5555544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.90  E-value=2e-05  Score=69.46  Aligned_cols=135  Identities=13%  Similarity=0.136  Sum_probs=77.3

Q ss_pred             ccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCcee-----eEE--EEEeeCCeEEEEEeecCCCCh
Q 017621          202 GSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNIV-----KLY--GFCLHRKCMFLIYEYMEMGSL  274 (368)
Q Consensus       202 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-----~l~--~~~~~~~~~~lv~e~~~~g~L  274 (368)
                      -.||+++.++|+.|++|+.++....    .+++..|.+.+..|....+.     ..-  ......+..+.++++++|..+
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            5899999999999999998765322    25667788877776432221     111  123445678899999986433


Q ss_pred             h----HHh--------------hcC--CCCCCCC-------------------H---HHHHHHHHHHHHHHHHH-hcCCC
Q 017621          275 F----CVL--------------RTD--EEAVGLD-------------------W---AKRVNIVKGMAHALSYL-HHHCT  311 (368)
Q Consensus       275 ~----~~l--------------~~~--~~~~~l~-------------------~---~~~~~i~~~i~~~L~~L-H~~~~  311 (368)
                      .    +.+              ...  ......+                   .   ......+.++...+.-. .+...
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            1    000              000  0000111                   1   11122333333333322 12223


Q ss_pred             CCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          312 PPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       312 ~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                      .+++|+|+.+.|||++++  ..++||+-|..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            478999999999999743  45899998764

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.75  E-value=2.4e-06  Score=76.20  Aligned_cols=67  Identities=21%  Similarity=0.226  Sum_probs=36.7

Q ss_pred             ccCCCCCcEEEecCcccccc-----CCccccCCCCCCeeeeeccccccc----CCcccCCCCCCceecccCCcccc
Q 017621           14 LMNCSKLRILILGNNLLSGS-----ISSEIGKLQELNYLDLSHNLINGK----IPSQLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus        14 ~~~l~~l~~l~l~~N~~~g~-----~p~~~~~~~~L~~l~l~~N~l~g~----~p~~~~~~~~l~~l~l~~n~l~g   80 (368)
                      +..+++|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..++.|+.|++++|.|++
T Consensus       182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  257 (344)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence            34455666666666665421     222345566666666666665422    33344555666666666666653

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.64  E-value=2e-06  Score=78.99  Aligned_cols=83  Identities=18%  Similarity=0.197  Sum_probs=46.6

Q ss_pred             CCCcEEEecCccccccCCc----cccCCCCCCeeeeeccccccc----CCcccC-CCCCCceecccCCccccc----ccc
Q 017621           18 SKLRILILGNNLLSGSISS----EIGKLQELNYLDLSHNLINGK----IPSQLG-EIPRIDTVNLSMNNLSGS----IPE   84 (368)
Q Consensus        18 ~~l~~l~l~~N~~~g~~p~----~~~~~~~L~~l~l~~N~l~g~----~p~~~~-~~~~l~~l~l~~n~l~g~----~p~   84 (368)
                      .+|+.+++++|.++..-..    .+..+++|+.|||++|+++..    ++..+. ..+.|+.|+|++|+|+..    ++.
T Consensus       312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~  391 (460)
T d1z7xw1         312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  391 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence            4577777777776533222    223455677777777776542    333332 245677777777777531    222


Q ss_pred             cc---cCcccccccCCCcc
Q 017621           85 SV---KKVPLLYVSGNNFE  100 (368)
Q Consensus        85 ~~---~~~~~~~~~~N~~~  100 (368)
                      .+   .++..+++++|+++
T Consensus       392 ~l~~~~~L~~L~Ls~N~i~  410 (460)
T d1z7xw1         392 TLLANHSLRELDLSNNCLG  410 (460)
T ss_dssp             HHHHCCCCCEEECCSSSCC
T ss_pred             HHhcCCCCCEEECCCCcCC
Confidence            22   34556677777665

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.52  E-value=5.2e-06  Score=73.88  Aligned_cols=86  Identities=16%  Similarity=0.207  Sum_probs=56.9

Q ss_pred             CCCCCcEEEecCccccc----cCCccccCCCCCCeeeeeccccccc-----CCcccCCCCCCceecccCCccccc----c
Q 017621           16 NCSKLRILILGNNLLSG----SISSEIGKLQELNYLDLSHNLINGK-----IPSQLGEIPRIDTVNLSMNNLSGS----I   82 (368)
Q Consensus        16 ~l~~l~~l~l~~N~~~g----~~p~~~~~~~~L~~l~l~~N~l~g~-----~p~~~~~~~~l~~l~l~~n~l~g~----~   82 (368)
                      ....|+.|++++|+++-    .+...+..++.|+.|+|++|+++..     +...+..+++|+.|+|++|.|+..    +
T Consensus       156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L  235 (344)
T d2ca6a1         156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL  235 (344)
T ss_dssp             TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred             cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence            45678888888888752    2233455677888888888887632     344566778888888888887632    2


Q ss_pred             cccc---cCcccccccCCCccc
Q 017621           83 PESV---KKVPLLYVSGNNFEV  101 (368)
Q Consensus        83 p~~~---~~~~~~~~~~N~~~~  101 (368)
                      ...+   ..+..+++++|.++.
T Consensus       236 ~~~l~~~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         236 AIALKSWPNLRELGLNDCLLSA  257 (344)
T ss_dssp             HHHGGGCTTCCEEECTTCCCCH
T ss_pred             cccccccccchhhhhhcCccCc
Confidence            2222   245567888887653

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.46  E-value=5.3e-06  Score=76.12  Aligned_cols=99  Identities=19%  Similarity=0.198  Sum_probs=63.5

Q ss_pred             CCCCccccC-CccccCCCCCcEEEecCcccc----ccCCccccCCCCCCeeeeeccccccc----CCcccCC-CCCCcee
Q 017621            2 YNNKLDGPI-PQELMNCSKLRILILGNNLLS----GSISSEIGKLQELNYLDLSHNLINGK----IPSQLGE-IPRIDTV   71 (368)
Q Consensus         2 ~~n~l~g~~-p~~~~~l~~l~~l~l~~N~~~----g~~p~~~~~~~~L~~l~l~~N~l~g~----~p~~~~~-~~~l~~l   71 (368)
                      ++|++++.- ..-+..+++|+.|+|++|.++    ..|+..+..+++|+.|||++|+++-.    +...+.. ..+|+.|
T Consensus        10 ~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L   89 (460)
T d1z7xw1          10 QCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKL   89 (460)
T ss_dssp             ESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEE
T ss_pred             eCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEE
Confidence            456665532 122455678888888888887    24445567888888888888888621    2233322 3478888


Q ss_pred             cccCCccccc----ccccc---cCcccccccCCCcc
Q 017621           72 NLSMNNLSGS----IPESV---KKVPLLYVSGNNFE  100 (368)
Q Consensus        72 ~l~~n~l~g~----~p~~~---~~~~~~~~~~N~~~  100 (368)
                      +|++|+++..    ++..+   ..+..+++++|.+.
T Consensus        90 ~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          90 SLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             ECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             ECCCCCccccccccccchhhccccccccccccccch
Confidence            8888888742    33333   34566788888765

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.41  E-value=2.2e-05  Score=67.85  Aligned_cols=84  Identities=18%  Similarity=0.181  Sum_probs=65.2

Q ss_pred             ccCCCCCcEEEecCcccccc-CCccccCCCCCCeeeeecccccccCCcccCCCCCCceecccC-Cccccc----cccccc
Q 017621           14 LMNCSKLRILILGNNLLSGS-ISSEIGKLQELNYLDLSHNLINGKIPSQLGEIPRIDTVNLSM-NNLSGS----IPESVK   87 (368)
Q Consensus        14 ~~~l~~l~~l~l~~N~~~g~-~p~~~~~~~~L~~l~l~~N~l~g~~p~~~~~~~~l~~l~l~~-n~l~g~----~p~~~~   87 (368)
                      .....+|++|||+++.+++. ++.-+..|++|++|+|+++.++...+..++.+++|+.|++++ +.++..    +.....
T Consensus        42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~  121 (284)
T d2astb2          42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS  121 (284)
T ss_dssp             CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCT
T ss_pred             hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHH
Confidence            34566899999999998754 445578899999999999999999999999999999999998 467631    122345


Q ss_pred             CcccccccCC
Q 017621           88 KVPLLYVSGN   97 (368)
Q Consensus        88 ~~~~~~~~~N   97 (368)
                      ++..+++++.
T Consensus       122 ~L~~L~ls~c  131 (284)
T d2astb2         122 RLDELNLSWC  131 (284)
T ss_dssp             TCCEEECCCC
T ss_pred             hccccccccc
Confidence            6777888763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.31  E-value=0.00047  Score=62.11  Aligned_cols=73  Identities=23%  Similarity=0.231  Sum_probs=47.4

Q ss_pred             ceeeeecCCccEEEEEcCC--------CCEEEEEEccccchhhHHhHHHHHHHHHHHhccC-CCceeeEEEEEeeCCeEE
Q 017621          193 KYCIGTGGYGSVYRARLPS--------GKVVALKKLHRSETEELASLESFRNEARLLSQIW-HRNIVKLYGFCLHRKCMF  263 (368)
Q Consensus       193 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  263 (368)
                      ++.|+.|-.-.+|++..++        .+.|.+++.......     ....+|..+++.+. +.-..++++++.+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-----idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-----SHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-----HHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-----hHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            3557777778999998543        356777776532211     23456888888884 4334577887753    5


Q ss_pred             EEEeecCCCCh
Q 017621          264 LIYEYMEMGSL  274 (368)
Q Consensus       264 lv~e~~~~g~L  274 (368)
                      +|+||+++..+
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            89999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.27  E-value=0.0006  Score=59.22  Aligned_cols=160  Identities=10%  Similarity=0.011  Sum_probs=83.8

Q ss_pred             cccHHHHHHHhhccccceee-----eecCCccEEEEEcCCCCEEEEEEccccchhhHHhHHHHHHHHHHHhccCCCce--
Q 017621          177 RITFQDMIEATEDFHIKYCI-----GTGGYGSVYRARLPSGKVVALKKLHRSETEELASLESFRNEARLLSQIWHRNI--  249 (368)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--  249 (368)
                      .++.+|+.....+|.+.+..     ..|---+.|+.+..+|+ +++|+.......     +++..|++++..+...++  
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pv   75 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSC   75 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C-----CHHHHHHHHHHHHHHTTCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH-----HHHHHHHHHHHhhhhccccc
Confidence            35678888888899775443     34555678999876654 889988653221     234446666666643222  


Q ss_pred             ---eeEE---EEEeeCCeEEEEEeecCCCChhH--------------Hhh----cC--CCCCC-----------------
Q 017621          250 ---VKLY---GFCLHRKCMFLIYEYMEMGSLFC--------------VLR----TD--EEAVG-----------------  286 (368)
Q Consensus       250 ---v~l~---~~~~~~~~~~lv~e~~~~g~L~~--------------~l~----~~--~~~~~-----------------  286 (368)
                         +...   .+....+....++.+..+.....              .++    ..  .....                 
T Consensus        76 p~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (316)
T d2ppqa1          76 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA  155 (316)
T ss_dssp             CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred             cccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhh
Confidence               2110   01222345566666666533210              000    00  00000                 


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHhc-CCCCCeeecCCCCCCeeecCCCCeEEeeecccee
Q 017621          287 -LDWAKRVNIVKGMAHALSYLHH-HCTPPIVHRDISSNNVLLNSELEAFVADFGVARL  342 (368)
Q Consensus       287 -l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg~a~~  342 (368)
                       .........+......+.-.+. ....++||+|+.+.||+++.+...-|+||+.|..
T Consensus       156 ~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         156 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence             0000111222222222332222 2244899999999999999887778999998753

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.45  E-value=0.0003  Score=55.30  Aligned_cols=85  Identities=12%  Similarity=0.160  Sum_probs=58.1

Q ss_pred             cCCCCCcEEEecCc-ccccc----CCccccCCCCCCeeeeecccccccCCc----ccCCCCCCceecccCCcccccccc-
Q 017621           15 MNCSKLRILILGNN-LLSGS----ISSEIGKLQELNYLDLSHNLINGKIPS----QLGEIPRIDTVNLSMNNLSGSIPE-   84 (368)
Q Consensus        15 ~~l~~l~~l~l~~N-~~~g~----~p~~~~~~~~L~~l~l~~N~l~g~~p~----~~~~~~~l~~l~l~~n~l~g~~p~-   84 (368)
                      .+.++|+.|+|+++ .++..    +-..+...+.|+.|+|++|.++-.-..    .+...+.|+.|+|++|.++..--. 
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            35688999999974 46421    223567788999999999998743333    334568999999999999743211 


Q ss_pred             ---cc---cCcccccccCCCc
Q 017621           85 ---SV---KKVPLLYVSGNNF   99 (368)
Q Consensus        85 ---~~---~~~~~~~~~~N~~   99 (368)
                         .+   .++..+++++|..
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~  112 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQ  112 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSS
T ss_pred             HHHHHHhCCcCCEEECCCCcC
Confidence               22   2356677877753

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.06  E-value=0.00097  Score=52.18  Aligned_cols=67  Identities=15%  Similarity=0.146  Sum_probs=51.8

Q ss_pred             cccCCCCCcEEEecCccccc----cCCccccCCCCCCeeeeecccccccCC----cccCCCCCCceecccCCccc
Q 017621           13 ELMNCSKLRILILGNNLLSG----SISSEIGKLQELNYLDLSHNLINGKIP----SQLGEIPRIDTVNLSMNNLS   79 (368)
Q Consensus        13 ~~~~l~~l~~l~l~~N~~~g----~~p~~~~~~~~L~~l~l~~N~l~g~~p----~~~~~~~~l~~l~l~~n~l~   79 (368)
                      .+...++|+.|+|++|.++.    .+...+...+.|+.|+|++|.++..--    ..+...++|+.|++++|.++
T Consensus        39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence            46677889999999999973    222345567899999999999985422    34666789999999999775

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=92.63  E-value=0.013  Score=45.21  Aligned_cols=67  Identities=15%  Similarity=0.108  Sum_probs=48.9

Q ss_pred             ccCCCCCcEEEecC-cccccc----CCccccCCCCCCeeeeecccccccCCc----ccCCCCCCceecccCCcccc
Q 017621           14 LMNCSKLRILILGN-NLLSGS----ISSEIGKLQELNYLDLSHNLINGKIPS----QLGEIPRIDTVNLSMNNLSG   80 (368)
Q Consensus        14 ~~~l~~l~~l~l~~-N~~~g~----~p~~~~~~~~L~~l~l~~N~l~g~~p~----~~~~~~~l~~l~l~~n~l~g   80 (368)
                      ..+.++|+.|+|++ |.++..    +-..+...++|+.|+|++|.++..--.    .+...++++.+++++|.++.
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~   88 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG   88 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence            34678999999998 556522    222455789999999999998754333    33456899999999998864

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=92.00  E-value=0.021  Score=43.91  Aligned_cols=67  Identities=12%  Similarity=0.132  Sum_probs=49.1

Q ss_pred             cccCCCCCcEEEecCcccccc----CCccccCCCCCCeeeeecccccccCC----cccCCCCCCce--ecccCCccc
Q 017621           13 ELMNCSKLRILILGNNLLSGS----ISSEIGKLQELNYLDLSHNLINGKIP----SQLGEIPRIDT--VNLSMNNLS   79 (368)
Q Consensus        13 ~~~~l~~l~~l~l~~N~~~g~----~p~~~~~~~~L~~l~l~~N~l~g~~p----~~~~~~~~l~~--l~l~~n~l~   79 (368)
                      .+...++|+.|+|++|.++..    +-..+...++|+.+++++|.++..--    ..+...++|+.  |++++|.+.
T Consensus        41 al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          41 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence            355778999999999998743    22245678999999999999874422    45667788886  455677775